PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Yang, MX; Xuan, ZQ; Wang, QY; Yan, SC; Zhou, DS; Naman, CB; Zhang, JR; He, S; Yan, XJ; Cui, W				Yang, Mengxiang; Xuan, Zhenquan; Wang, Qiyao; Yan, Sicheng; Zhou, Dongsheng; Naman, C. Benjamin; Zhang, Jinrong; He, Shan; Yan, Xiaojun; Cui, Wei			Fucoxanthin has potential for therapeutic efficacy in neurodegenerative disorders by acting on multiple targets	NUTRITIONAL NEUROSCIENCE			English	Article; Early Access						Fucoxanthin; functional food; edible brown algae; amyloid aggregation; oxidative stress; neuroinflammation; neurotransmission dysregulation; gut microbiota; neurodegenerative disorders	PROTECTS DOPAMINERGIC-NEURONS; TRAUMATIC BRAIN-INJURY; MICROSPHERE F-LM; OXIDATIVE-STRESS; PARKINSONS-DISEASE; METABOLITE FUCOXANTHINOL; COGNITIVE IMPAIRMENTS; UNDARIA-PINNATIFIDA; INHIBITORY-ACTIVITY; MOLECULAR DOCKING	Fucoxanthin, one of the most abundant carotenoids from edible brown seaweeds, for years has been used as a bioactive dietary supplement and functional food ingredient. Recently, fucoxanthin was reported to penetrate the blood-brain barrier, and was superior to other carotenoids to exert anti-neurodegenerative disorder effects via acting on multiple targets, including amyloid protein aggregation, oxidative stress, neuroinflammation, neuronal loss, neurotransmission dysregulation and gut microbiota disorder. However, the concentration of fucoxanthin required for in vivo neuroprotective effects is somewhat high, and the poor bioavailability of this molecule might prevent its clinical use. As such, new strategies have been introduced to overcome these obstacles, and may help to develop fucoxanthin as a novel lead for neurodegenerative disorders. Moreover, it has been shown that some metabolites of fucoxanthin may produce potent in vivo neuroprotective effects. Altogether, these studies suggest the possibility for future development of fucoxanthin as a one-compound-multiple-target or pro-drug type pharmaceutical or nutraceutical treatment for neurodegenerative disorders.	[Yang, Mengxiang; Zhou, Dongsheng; Cui, Wei] Ningbo Kangning Hosp, Ningbo, Peoples R China; [Yang, Mengxiang; Xuan, Zhenquan; Wang, Qiyao; Yan, Sicheng; Cui, Wei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Translat Med Ctr Pain Emot & Cognit,Ningbo Key La, Ningbo 315211, Peoples R China; [Naman, C. Benjamin; Zhang, Jinrong; He, Shan; Yan, Xiaojun] Ningbo Univ, Li Dak Sum Yip Yio Chin Kenneth Li Marine Biophar, Ningbo 315211, Peoples R China; [Yan, Xiaojun] Zhejiang Ocean Univ, Innovat & Applicat Inst, Lab Seafood Proc, Zhoushan 316022, Peoples R China		Cui, W (corresponding author), Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Translat Med Ctr Pain Emot & Cognit,Ningbo Key La, Ningbo 315211, Peoples R China.; Yan, XJ (corresponding author), Ningbo Univ, Li Dak Sum Yip Yio Chin Kenneth Li Marine Biophar, Ningbo 315211, Peoples R China.; Yan, XJ (corresponding author), Zhejiang Ocean Univ, Innovat & Applicat Inst, Lab Seafood Proc, Zhoushan 316022, Peoples R China.; Cui, W (corresponding author), Sch Med, Dept Physiol, Ningbo, Peoples R China.	yanxj@zjou.edu.cn; cuiwei@nbu.edu.cn	Naman, C. Benjamin/AAH-5884-2021	Naman, C. Benjamin/0000-0002-4361-506X; Yang, Mengxiang/0000-0003-2137-6309	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870853]; Major program of Ningbo Science and Technology Innovation 2025 [2019B1006]; National Natural Science Foundation of Ningbo [2018A610313]; Ningbo municipal innovation team of life science and health [2015C110026]; LiDakSum Marine Biopharmaceutical Development Fund; K. C. Wong Magna Fund in Ningbo University	This work was supported by the National Natural Science Foundation of China (81870853), Major program of Ningbo Science and Technology Innovation 2025 (2019B1006), National Natural Science Foundation of Ningbo (2018A610313), Ningbo municipal innovation team of life science and health (2015C110026), LiDakSum Marine Biopharmaceutical Development Fund, and the K. C. Wong Magna Fund in Ningbo University.	Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x; Afzal S, 2019, MAR DRUGS, V17, DOI 10.3390/md17030189; Alghazwi M, 2019, NEUROCHEM INT, V124, P215, DOI 10.1016/j.neuint.2019.01.010; Aman R, 2005, J AGR FOOD CHEM, V53, P9512, DOI 10.1021/jf050926w; Asai A, 2004, DRUG METAB DISPOS, V32, P205, DOI 10.1124/dmd.32.2.205; Aungst BJ, 2017, J PHARM SCI-US, V106, P921, DOI 10.1016/j.xphs.2016.12.002; Ayyalasomayajula N, 2018, NUTR NEUROSCI, V21, P682, DOI 10.1080/1028415X.2017.1345425; Bae M, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158618; Bedarf JR, 2019, NERVENARZT, V90, P160, DOI 10.1007/s00115-018-0601-6; Ben Youssef S, 2021, NUTR NEUROSCI, V24, P197, DOI 10.1080/1028415X.2019.1616435; Beppu F, 2009, J TOXICOL SCI, V34, P693, DOI 10.2131/jts.34.693; Beppu F, 2009, J TOXICOL SCI, V34, P501, DOI 10.2131/jts.34.501; Bianchi VE, 2021, NUTR NEUROSCI, V24, P810, DOI 10.1080/1028415X.2019.1681088; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bostanciklioglu M, 2019, J APPL MICROBIOL, V127, P954, DOI 10.1111/jam.14264; Botchway BOA, 2018, J ALZHEIMERS DIS, V61, P867, DOI 10.3233/JAD-170874; Bullock R, 2007, CURR ALZHEIMER RES, V4, P277; Chan KC, 2009, J FOOD SCI, V74, pH225, DOI 10.1111/j.1750-3841.2009.01274.x; Chu YF, 2012, FOOD CHEM, V135, P2095, DOI 10.1016/j.foodchem.2012.04.148; Chukwuma CI, 2019, J ETHNOPHARMACOL, V235, P329, DOI 10.1016/j.jep.2019.02.024; Daverey A, 2016, NEUROSCIENCE, V333, P92, DOI 10.1016/j.neuroscience.2016.07.012; Dembitsky VM, 2007, PROG LIPID RES, V46, P328, DOI 10.1016/j.plipres.2007.07.001; Dimitrova-Shumkovska J, 2020, MAR DRUGS, V18, DOI 10.3390/md18050242; Doggui S, 2013, MOL NUTR FOOD RES, V57, P1660, DOI 10.1002/mnfr.201300130; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466; Filippov MA, 2021, NEURAL REGEN RES, V16, P223, DOI 10.4103/1673-5374.290878; Fung A, 2013, FOOD CHEM, V136, P1055, DOI 10.1016/j.foodchem.2012.09.024; Galasso C, 2018, MAR DRUGS, V16, DOI 10.3390/md16080247; Garcia F, 2020, MAR DRUGS, V18, DOI 10.3390/md18060335; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gibb AJ., 2001, NEUROTRANSMITTER REC; Gontijo VS, 2020, CURR NEUROPHARMACOL, V18, P348, DOI 10.2174/1385272823666191021124443; Gray R, 2014, LANCET, V384, P1196, DOI 10.1016/S0140-6736(14)60683-8; Gu MY, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700633; Guo BB, 2019, FOOD FUNCT, V10, P5644, DOI 10.1039/c9fo01018a; Haoujar I, 2019, MOLECULES, V24, DOI 10.3390/molecules24224037; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hashimoto T, 2009, BRIT J NUTR, V102, P242, DOI 10.1017/S0007114508199007; Hitoe S, 2017, FUNCT FOODS HEALTH D, V7, P246; Ho SC, 2013, FOOD CHEM, V138, P2275, DOI 10.1016/j.foodchem.2012.12.020; Hoffman JD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00298; Hu LX, 2018, BIOMED PHARMACOTHER, V106, P1484, DOI 10.1016/j.biopha.2018.07.088; Hung SY, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0355-7; Iio K, 2011, FOOD HYG SAFE SCI, V52, P183, DOI 10.3358/shokueishi.52.183; Ishihara Y, 2015, J BIOL CHEM, V290, P22805, DOI 10.1074/jbc.M115.659151; Sutachan JJ, 2012, NUTR NEUROSCI, V15, P120, DOI 10.1179/1476830511Y.0000000033; Jaswir I, 2019, MOLECULES, V24, DOI 10.3390/molecules24050947; Jiang X, 2019, METAB BRAIN DIS, V34, P431, DOI 10.1007/s11011-018-0368-2; Jin WH, 2020, MAR DRUGS, V18, DOI 10.3390/md18040222; Jung HA, 2017, FISHERIES SCI, V83, P123, DOI 10.1007/s12562-016-1036-2; Jung HA, 2016, FOOD CHEM TOXICOL, V89, P104, DOI 10.1016/j.fct.2016.01.014; Kandiah N, 2017, CLIN INTERV AGING, V12, P697, DOI 10.2147/CIA.S129145; Kang SS, 2018, EMBO J, V37, DOI 10.15252/embj.201798878; Kawee-ai A, 2013, NAT PROD COMMUN, V8, P1381; Kim KN, 2010, EUR J PHARMACOL, V649, P369, DOI 10.1016/j.ejphar.2010.09.032; Kim SK, 2011, ADV FOOD NUTR RES, V64, P111, DOI 10.1016/B978-0-12-387669-0.00009-0; Kuragano M, 2020, FOODS, V9, DOI 10.3390/foods9060825; Lee S, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800240; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Li JJ, 2015, MAR DRUGS, V13, P3368, DOI 10.3390/md13063368; Li XN, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105240; Li YL, 2020, MAR DRUGS, V18, DOI 10.3390/md18020116; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Lin JJ, 2016, MAR DRUGS, V14, DOI 10.3390/md14040067; Liu YX, 2019, FOOD FUNCT, V10, P4381, DOI 10.1039/c9fo00814d; Lourenco-Lopes C, 2020, FOODS, V9, DOI 10.3390/foods9081113; Maoka T, 2011, MAR DRUGS, V9, P278, DOI 10.3390/md9020278; Meng X, 2020, FOODS, V9, DOI 10.3390/foods9030340; Miranda CG, 2020, FOOD CHEM, V307, DOI 10.1016/j.foodchem.2019.125523; Miyashita K, 2009, FORUM NUTR, V61, P136, DOI 10.1159/000212746; Mok IK, 2018, FOOD CHEM, V258, P79, DOI 10.1016/j.foodchem.2018.03.047; Muradian K, 2015, NUTR METAB CARDIOVAS, V25, P891, DOI 10.1016/j.numecd.2015.05.010; Nataraj J, 2016, NUTR NEUROSCI, V19, P237, DOI 10.1179/1476830515Y.0000000010; Ni YH, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900603; Noviendri D, 2016, J OLEO SCI, V65, P641, DOI 10.5650/jos.ess16018; Pangestuti R, 2013, J AGR FOOD CHEM, V61, P3876, DOI 10.1021/jf400015k; Park HY, 2011, FOOD CHEM TOXICOL, V49, P1745, DOI 10.1016/j.fct.2011.04.020; Paudel P, 2019, CHEM-BIOL INTERACT, V310, DOI 10.1016/j.cbi.2019.108757; Peng J, 2011, MAR DRUGS, V9, P1806, DOI 10.3390/md9101806; Pugazhenthi S, 2017, BBA-MOL BASIS DIS, V1863, P1037, DOI 10.1016/j.bbadis.2016.04.017; Qu MY, 2011, NEUROSCI LETT, V505, P286, DOI 10.1016/j.neulet.2011.10.048; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Rao AV, 2002, NUTR NEUROSCI, V5, P291, DOI 10.1080/1028415021000033767; Rawson NSB, 2018, DRUG SAFETY, V41, P829, DOI 10.1007/s40264-018-0673-z; Rekatsina M, 2020, ADV THER, V37, P113, DOI 10.1007/s12325-019-01148-5; Rodrigues E, 2012, MAR DRUGS, V10, P1784, DOI 10.3390/md10081784; Roeckel LA, 2016, NEUROSCIENCE, V338, P160, DOI 10.1016/j.neuroscience.2016.06.029; Rose KN., 2019, NUTR NEUROSCI, V10, P1; Ruan QW, 2018, PHARMACOL RES, V128, P345, DOI 10.1016/j.phrs.2017.08.010; Sachindra NM, 2007, J AGR FOOD CHEM, V55, P8516, DOI 10.1021/jf071848a; Seo EJ, 2018, PHARMACOL RES, V129, P262, DOI 10.1016/j.phrs.2017.11.030; Singh A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081583; Stahl W, 2003, MOL ASPECTS MED, V24, P345, DOI 10.1016/S0098-2997(03)00030-X; Stringham JM, 2015, FOODS, V4, P678, DOI 10.3390/foods4040678; Subhramanyam CS, 2019, SEMIN CELL DEV BIOL, V94, P112, DOI 10.1016/j.semcdb.2019.05.004; Sun GQ, 2020, PHARMACOGN MAG, V16, P51, DOI 10.4103/pm.pm_318_19; Sun QM, 2019, MAR DRUGS, V17, DOI 10.3390/md17020121; Suri BK, 2019, EXP DERMATOL, V28, P976, DOI 10.1111/exd.13976; Syed YY, 2020, DRUGS, V80, P441, DOI 10.1007/s40265-020-01268-1; Toublet FX, 2019, MOLECULES, V24, DOI 10.3390/molecules24152786; Wang J, 2018, J NUTR BIOCHEM, V56, P16, DOI 10.1016/j.jnutbio.2018.01.009; Wang X, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1085073; Wang XY, 2019, CELL RES, V29, P787, DOI 10.1038/s41422-019-0216-x; Wang YY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801407; Weon JB, 2016, NUTR NEUROSCI, V19, P125, DOI 10.1179/1476830514Y.0000000152; Woo MN, 2009, MOL NUTR FOOD RES, V53, P1603, DOI 10.1002/mnfr.200900079; Wu HJ, 2015, MAR DRUGS, V13, P5750, DOI 10.3390/md13095750; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Xiang SY, 2017, J AGR FOOD CHEM, V65, P4092, DOI 10.1021/acs.jafc.7b00805; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Xu L, 2016, MOL NEUROBIOL, V53, P6709, DOI 10.1007/s12035-015-9593-4; Yim SK, 2020, MAR DRUGS, V18, DOI 10.3390/md18120603; Yu J, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1304678; Zhang L, 2018, AGING DIS, V9, P590, DOI 10.14336/AD.2017.0831; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang PF, 2019, EUR J MED CHEM, V176, P228, DOI 10.1016/j.ejmech.2019.05.020; Zhang YP, 2015, MAR DRUGS, V13, P6521, DOI 10.3390/md13106521; Zhao C, 2018, TRENDS FOOD SCI TECH, V72, P1, DOI 10.1016/j.tifs.2017.12.001; Zhao D, 2019, FOOD CHEM, V291, P87, DOI 10.1016/j.foodchem.2019.04.002; Zhao D, 2017, NEUROCHEM RES, V42, P667, DOI 10.1007/s11064-016-2123-6; Zhao D, 2014, FOOD CHEM, V145, P505, DOI 10.1016/j.foodchem.2013.08.045; Zhao JY, 2017, MOLECULES, V22, DOI 10.3390/molecules22101651; Zhao X., 2015, CHINESE PHARM J, V24, P60; Zheng J, 2014, MAR DRUGS, V12, P4214, DOI 10.3390/md12074214; Zhu JX, 2016, FOOD CHEM, V211, P365, DOI 10.1016/j.foodchem.2016.05.064	126	1	1	11	20	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.												10.1080/1028415X.2021.1926140		MAY 2021	14	Neurosciences; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Nutrition & Dietetics	SC9MU	WOS:000650988600001	33993853				2022-02-06	
J	Iacono, D; Raiciulescu, S; Olsen, C; Perl, DP				Iacono, Diego; Raiciulescu, Sorana; Olsen, Cara; Perl, Daniel P.			Traumatic Brain Injury Exposure Lowers Age of Cognitive Decline in AD and Non-AD Conditions	FRONTIERS IN NEUROLOGY			English	Article						TBI; earlier-onset; neurodegenerative disorders; APOE genotype; cognitive decline	DEMENTIA; ENCEPHALOPATHY; POPULATION; APOE; NEUROPATHOLOGY; CONSEQUENCES; DISEASE; TRIGGER	We aimed to detect the possible accelerating role of previous traumatic brain injury (TBI) exposures on the onset of later cognitive decline assessed across different brain diseases. We analyzed data from the National Alzheimer's Coordinating Center (NACC), which provide information on history of TBI and longitudinal data on cognitive and non-cognitive domains for each available subject. At the time of this investigation, a total of 609 NACC subjects resulted to have a documented history of TBI. We compared subjects with and without a history of previous TBI (of any type) at the time of their first cognitive decline assessment, and termed them, respectively, TBI+ and TBI- subjects. Three hundred and sixty-one TBI+ subjects (229 male/132 female) and 248 TBI- subjects (156 male/92 female) were available. The analyses included TBI+ and TBI- subjects with a clinical diagnosis of Mild Cognitive Impairment, Alzheimer's disease, Dementia with Lewy bodies, Progressive supranuclear palsy, Corticobasal degeneration, Frontotemporal dementia, Vascular dementia, non-AD Impairment, and Parkinson's disease. The data showed that the mean age of TBI+ subjects was lower than TBI- subjects at the time of their first cognitive decline assessment (71.6 +/- 11.2 vs. 74.8 +/- 9.5 year; p < 0.001). Moreover, the earlier onset of cognitive decline in TBI+ vs. TBI- subjects was independent of sex, race, attained education, APOE genotype, and importantly, clinical diagnoses. As for specific cognitive aspects, MMSE, Trail Making Test part B and WAIS-R scores did not differ between TBI+ and TBI- subjects, whereas Trail Making Test part A (p = 0.013) and Boston Naming test (p = 0.008) did. In addition, data showed that neuropsychiatric symptoms [based on Neuropsychiatry Inventory (NPI)] were much more frequent in TBI+ vs. TBI- subjects, including AD and non-AD neurodegenerative conditions such as PD. These cross-sectional analyses outcomes from longitudinally-assessed cohorts of TBI+ subjects that is, subjects with TBI exposure before the onset of cognitive decline in the contest of different neurodegenerative disorders and associated pathogenetic mechanisms, are novel, and indicate that a previous TBI exposure may act as a significant "age-lowering" factor on the onset of cognitive decline in either AD and non-AD conditions independently of demographic factors, education, APOE genotype, and current or upcoming clinical conditions.	[Iacono, Diego; Perl, Daniel P.] Uniformed Serv Univ Hlth Sci USU, Dept Def, Uniformed Serv Univ DoD USU Brain Tissue Reposito, Bethesda, MD 20814 USA; [Iacono, Diego] Uniformed Serv Univ Hlth Sci USU, F Edward Hebert Sch Med, Dept Neurol, Bethesda, MD 20814 USA; [Iacono, Diego; Perl, Daniel P.] Uniformed Serv Univ Hlth Sci USU, F Edward Hebert Sch Med, Dept Pathol, Bethesda, MD 20814 USA; [Iacono, Diego] Uniformed Serv Univ Hlth Sci USU, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Neurosci Grad Program, Bethesda, MD 20814 USA; [Iacono, Diego] Henry M Jackson Fdn Adv Mil Med HJF, Bethesda, MD 20817 USA; [Iacono, Diego] NINDS, Complex Neurodegenerat Disorders, Neurodegenerat Disorders Clin, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Raiciulescu, Sorana; Olsen, Cara] Uniformed Serv Univ Hlth Sci USU, F Edward Hebert Sch Med, Dept Prevent Med & Biostat, Bethesda, MD USA		Iacono, D (corresponding author), Uniformed Serv Univ Hlth Sci USU, Dept Def, Uniformed Serv Univ DoD USU Brain Tissue Reposito, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), Uniformed Serv Univ Hlth Sci USU, F Edward Hebert Sch Med, Dept Neurol, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), Uniformed Serv Univ Hlth Sci USU, F Edward Hebert Sch Med, Dept Pathol, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), Uniformed Serv Univ Hlth Sci USU, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Neurosci Grad Program, Bethesda, MD 20814 USA.; Iacono, D (corresponding author), Henry M Jackson Fdn Adv Mil Med HJF, Bethesda, MD 20817 USA.; Iacono, D (corresponding author), NINDS, Complex Neurodegenerat Disorders, Neurodegenerat Disorders Clin, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	diego.iacono.ctr@usuhs.edu			DoD/USU Brain Tissue Repository and Neuropathology Program, USU [31166104.0066323]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [30 AG019610, P30 AG013846, P30 AG062428-01, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P30 AG062421-01, P30 AG062422-01, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161]; The NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG047366, P30 AG010129, P50 AG016573, P30 AG062429-01, P50 AG023501, P30 AG035982, P30 AG028383, P30 AG053760, P30 AG010124, P50 AG005133, P50 AG005142, P30 AG012300, P30 AG049638, P50 AG005136, P30 AG062715-01, P50 AG005681, P50 AG047270]; NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976]	This study was supported by the DoD/USU Brain Tissue Repository and Neuropathology Program, USU award#31166104.0066323. We also acknowledge the NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P30 AG062428-01 (PI James Leverenz, MD) P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P30 AG062421-01 (PI Bradley Hyman, MD, PhD), P30 AG062422-01 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI Robert Vassar, PhD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P30 AG062429-01(PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P30 AG062715-01 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Belloy ME, 2019, NEURON, V101, P820, DOI 10.1016/j.neuron.2019.01.056; Benjamini D, 2021, BRAIN, V144, P800, DOI 10.1093/brain/awaa447; Berkowitz CL, 2018, JPAD-J PREV ALZHEIM, V5, P245, DOI 10.14283/jpad.2018.35; Bhidayasiri R, 2012, PARKINSONISM RELAT D, V18, P694, DOI 10.1016/j.parkreldis.2012.01.010; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; DePalma RG., 2015, BRAIN NEUROTRAUMA MO, DOI [10.1201/b18126-3, DOI 10.1201/B18126-3]; Deutsch MB, 2015, DEMENT GERIATR COGN, V39, P143, DOI 10.1159/000369787; Dickson DW, 2018, NEUROLOGY, V91, pE1182, DOI 10.1212/WNL.0000000000006212; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuller GW, 2016, NEUROEPIDEMIOLOGY, V47, P1, DOI 10.1159/000445997; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Iacono D, 2019, AGING-US, V11, P787, DOI 10.18632/aging.101757; Iacono D, 2018, MOV DISORD CLIN PRAC, V5, P492, DOI 10.1002/mdc3.12626; Iacono D, 2017, PHYS MED REH CLIN N, V28, P301, DOI 10.1016/j.pmr.2016.12.007; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kaplan E, 1983, BOSTON NAMING TEST; Kaufman Alan S., 2006, ASSESSING ADOLESCENT, V3rd ed, P3; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nguyen TP, 2018, J ALZHEIMERS DIS, V66, P717, DOI 10.3233/JAD-180586; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; R Core Team, 2016, R LANG ENV STAT COMP; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Riley E, 2019, NEUROPSYCHOLOGY, V33, P534, DOI 10.1037/neu0000529; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Robinson JL, 2018, BRAIN, V141, P2181, DOI 10.1093/brain/awy146; Rongve A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43458-2; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Shah SA, 2017, NEUROIMAGE-CLIN, V14, P233, DOI 10.1016/j.nicl.2017.01.010; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	52	1	1	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 12	2021	12								573401	10.3389/fneur.2021.573401			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	SH5WT	WOS:000654207200001	34054681	Green Published, gold			2022-02-06	
J	Wallace, J; Beidler, E; Covassin, T; Hibbler, T; Schatz, P				Wallace, Jessica; Beidler, Erica; Covassin, Tracey; Hibbler, Tamaria; Schatz, Philip			Understanding racial differences in computerized neurocognitive test performance and symptom-reporting to deliver culturally competent patient-centered care for sport-related concussion	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Collegiate athletes; ImPACT; neurocognitive performance; race; sport-related concussion	TEST-RETEST RELIABILITY; UNITED-STATES; HIGH-SCHOOL; POSITION STATEMENT; AFRICAN-AMERICAN; HIGHER-EDUCATION; TEST-SCORES; COLLEGIATE; HEALTH; RACE	Objective This study examined neurocognitive performance and symptoms between concussed Black and White collegiate athletes at baseline, post-injury, and change from baseline to post-injury. Method The Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) was used to measure neurocognitive performance and four concussion symptom clusters for 235 concussed collegiate athletes. Between-groups differences were documented at baseline and post-injury, along with change in scores for sex/race, and sport/race groups, using ANOVAs. Baseline scores, and days-to-post-test were covariates in post-injury comparisons. Symptom endorsement by race was evaluated using chi-square analyses. Results At baseline, group comparisons by race and sex showed that Black male/female athletes scored lower on reaction time (RT; p = .008), White females scored higher on verbal memory (VerbMem; p = .001), Black females scored lower on visual motor processing speed (VMS; p = .001), and Black football athletes scored slower/poorer on RT (p = .001) and VMS (p = .006). Post-injury, Black males scored lower on visual memory (VisMem; p = .005) and VMS (p = .002), and Black football athletes scored slower on VMS (p = .005), whereas White non-football athletes scored higher on VerbMem (p = .002) and reported fewer symptoms. Significant time-by-sport/race interactions were found for VerbMem (p < .001), VisMem (p < .001) and reported symptoms. With respect to post-injury symptom scores/endorsement, Black athletes scored significantly higher for physical (p = .01) and sleep (p = .01) symptoms. Conclusion These findings drive the conversation of how subjective measures of symptoms, and objective clinical concussion measures, may relate to the concussion recovery process and providing a culturally competent clinical management approach for diverse patients.	[Wallace, Jessica] Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Hibbler, Tamaria] Michigan State Univ, Dept Athlet, E Lansing, MI 48824 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane,2106 Capital Hall, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu					Abrishami D, 2018, RADIOL TECHNOL, V89, P441; Asken BM, 2020, SPORTS MED, V50, P1533, DOI 10.1007/s40279-020-01263-2; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Byrd, 2015, HUMANITY SOC, V39, P419, DOI DOI 10.1177/0160597615603750; Cohen J., 2013, STAT POWER ANAL BEHA; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Czerniak LL, 2021, SPORTS MED, V51, P351, DOI 10.1007/s40279-020-01393-7; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Elbulok-Charcape MM, 2014, CULT DIVERS ETHN MIN, V20, P353, DOI 10.1037/a0035023; Fyffe DC, 2011, J INT NEUROPSYCH SOC, V17, P625, DOI 10.1017/S1355617711000476; Geisler PR, 2003, J ATHL TRAINING, V38, P141; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goldman D, 2011, SOC SCI MED, V72, P1728, DOI 10.1016/j.socscimed.2011.02.047; Grodsky E, 2008, ANNU REV SOCIOL, V34, P385, DOI 10.1146/annurev.soc.34.040507.134711; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Harper SR, 2009, J HIGH EDUC-UK, V80, P389, DOI 10.1353/jhe.0.0052; Holmes L, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0058-8; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; Kent M, 2020, INT J SPORTS MED, V41, P682, DOI 10.1055/a-1107-3025; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kugelmass H, 2011, RES HIGH EDUC, V52, P323, DOI 10.1007/s11162-010-9200-5; Lovell M.R., 2006, IMPACT 2006 5 0 CLIN; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; Manly JJ, 2006, MED CARE, V44, pS10, DOI 10.1097/01.mlr.0000245427.22788.be; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Marra J, 2010, J ATHL TRAINING, V45, P380, DOI 10.4085/1062-6050-45.4.380; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mehta KM, 2004, J AM GERIATR SOC, V52, P2120, DOI 10.1111/j.1532-5415.2004.52575.x; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Mustaffa JB, 2017, INT J QUAL STUD EDUC, V30, P711, DOI 10.1080/09518398.2017.1350299; NCAA, 2020, SPORT SPONS PART DEM; Nettles MT, 2019, ANN AM ACAD POLIT SS, V683, P38, DOI 10.1177/0002716219847139; Pardini D., 2004, BR J SPORTS MED, V38, P661; Peek ME, 2010, SOC SCI MED, V71, P13, DOI 10.1016/j.socscimed.2010.03.018; Possin KL, 2021, JAMA NEUROL, V78, P377, DOI 10.1001/jamaneurol.2020.4763; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Smedley A, 2005, AM PSYCHOL, V60, P16, DOI 10.1037/0003-066X.60.1.16; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Teng EL, 2005, ALZ DIS ASSOC DIS, V19, P267, DOI 10.1097/01.wad.0000190805.13126.8e; Wallace J, 2020, AM J SPORT MED, V48, P2774, DOI 10.1177/0363546520946753; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; White GW, 2016, AM J ORTHOPSYCHIAT, V86, P10, DOI 10.1037/ort0000122; Yosso T., 2005, RACE ETHNIC EDUC-UK, V8, P69, DOI [10.1080/1361332052000341006, DOI 10.1080/1361332052000341006]	61	1	1	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2021.1912047		MAY 2021	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SA8QA	WOS:000649566700001	33980084				2022-02-06	
J	Shapiro, JS; Hearps, S; Rausa, VC; Anderson, V; Anderson, N; Pugh, R; Chau, T; Clarke, C; Davis, GA; Fabiano, F; Fan, F; Parkin, GM; Takagi, M; Babl, FE				Shapiro, Jesse S.; Hearps, Stephen; Rausa, Vanessa C.; Anderson, Vicki; Anderson, Nicholas; Pugh, Remy; Chau, Tracey; Clarke, Cathriona; Davis, Gavin A.; Fabiano, Fabian; Fan, Feiven; Parkin, Georgia M.; Takagi, Michael; Babl, Franz E.			Validation of the SCAT5 and Child SCAT5 Word-List Memory Task	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						assessment; concussion; pediatric; RAVLT; SCAT5	CONCUSSION	The Sports Concussion Assessment Tool-5th Edition (SCAT5) and the child version (Child SCAT5) are the current editions of the SCAT and have updated the memory testing component from previous editions. This study aimed to validate this new memory component against the Rey Auditory Verbal Learning Test (RAVLT) as the validated standard. This prospective, observational study, carried out within The Royal Children's Hospital Emergency Department, Melbourne, Australia, recruited 198 participants: 91 with concussion and 107 upper limb injury or healthy sibling controls. Partial Pearson correlations showed that memory acquisition and recall on delay aspects of the SCAT5 were significantly correlated with the RAVLT equivalents when controlling for age (p < 0.001, r = 0.565 and p < 0.001, r = 0.341, respectively). Factor analysis showed that all RAVLT and SCAT5 memory components load on to the same factor, accounting for 59.13% of variance. Logistic regression models for both the RAVLT and SCAT5, however, did not predict group membership (p > 0.05). Receiver operating curve analysis found that the area under the curve for all variables and models was below the recommended 0.7 threshold. This study demonstrated that the SCAT5 and Child SCAT5 memory paradigm is a valid measure of memory in concussed children.	[Shapiro, Jesse S.; Hearps, Stephen; Rausa, Vanessa C.; Anderson, Vicki; Anderson, Nicholas; Pugh, Remy; Chau, Tracey; Clarke, Cathriona; Davis, Gavin A.; Fabiano, Fabian; Fan, Feiven; Parkin, Georgia M.; Takagi, Michael; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Shapiro, Jesse S.; Anderson, Vicki; Takagi, Michael] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Davis, Gavin A.] Austin Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Davis, Gavin A.] Cabrini Hosp, Dept Neurosurg, Melbourne, Vic, Australia		Anderson, V (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Brain & Mind, Level 4 West,50 Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au		Parkin, Georgia/0000-0002-0588-2239	National Health and Medical Research Council Practitioner Fellowship, Canberra, AustraliaNational Health and Medical Research Council of Australia; Royal Children's Hospital Foundation, Melbourne, Australia	Franz Babl has been, in part, funded by a National Health and Medical Research Council Practitioner Fellowship, Canberra, Australia and the Royal Children's Hospital Foundation, Melbourne, Australia.	Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; BISHOP J, 1990, CLIN NEUROPSYCHOL, V4, P133, DOI DOI 10.1080/13854049008401506; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Dancey C.P., 2007, STAT MATHS PSYCHOL; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Delis D.C., 1994, CVLT C CALIFORNIA VE; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI [10.1080/13854049108404102, DOI 10.1080/13854049108404102]; Hosmer D W, 2013, APPL LOGISTIC REGRES, V398; IBM Corp, 2019, IBM SPSS STAT WIND V; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Rey A, 1958, [The clinical examination in psychology]. Presses Universitaries De France: Paris; Sheslow DA, 2003, WIDE RANGE ASSESSMEN; Strauss E., 2006, AM CHEM SOC; Talley J L, 1986, Arch Clin Neuropsychol, V1, P315, DOI 10.1016/0887-6177(86)90135-6; Vakil E, 2012, CHILD NEUROPSYCHOL, V18, P449, DOI 10.1080/09297049.2011.613816	19	1	1	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7414		MAY 2021	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RZ6OJ	WOS:000648720000001	33765839				2022-02-06	
J	Hiskens, MI; Schneiders, AG; Vella, RK; Fenning, AS				Hiskens, Matthew I.; Schneiders, Anthony G.; Vella, Rebecca K.; Fenning, Andrew S.			Repetitive mild traumatic brain injury affects inflammation and excitotoxic mRNA expression at acute and chronic time-points	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; LONG-TERM CONSEQUENCES; ANIMAL-MODELS; HEAD-INJURY; CLINICAL MANAGEMENT; TDP-43 EXPRESSION; FLUID BIOMARKERS; NEURONAL DEATH; TNF-ALPHA; ENCEPHALOPATHY	The cumulative effect of mild traumatic brain injuries (mTBI) can result in chronic neurological damage, however the molecular mechanisms underpinning this detriment require further investigation. A closed head weight drop model that replicates the biomechanics and head acceleration forces of human mTBI was used to provide an exploration of the acute and chronic outcomes following single and repeated impacts. Adult male C57BL/6J mice were randomly assigned into one of four impact groups (control; one, five and 15 impacts) which were delivered over 23 days. Outcomes were assessed 48 hours and 3 months following the final mTBI. Hippocampal spatial learning and memory assessment revealed impaired performance in the 15-impact group compared with control in the acute phase that persisted at chronic measurement. mRNA analyses were performed on brain tissue samples of the cortex and hippocampus using quantitative RT-PCR. Eight genes were assessed, namely MAPT, GFAP, AIF1, GRIA1, CCL11, TARDBP, TNF, and NEFL, with expression changes observed based on location and follow-up duration. The cortex and hippocampus showed vulnerability to insult, displaying upregulation of key excitotoxicity and inflammation genes. Serum samples showed no difference between groups for proteins phosphorylated tau and GFAP. These data suggest that the cumulative effect of the impacts was sufficient to induce mTBI pathophysiology and clinical features. The genes investigated in this study provide opportunity for further investigation of mTBI-related neuropathology and may provide targets in the development of therapies that help mitigate the effects of mTBI.	[Hiskens, Matthew I.; Schneiders, Anthony G.; Vella, Rebecca K.; Fenning, Andrew S.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia; [Hiskens, Matthew I.] Mackay Hosp & Hlth Serv, Mackay Inst Res & Innovat, Mackay, Qld, Australia		Hiskens, MI (corresponding author), Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld, Australia.; Hiskens, MI (corresponding author), Mackay Hosp & Hlth Serv, Mackay Inst Res & Innovat, Mackay, Qld, Australia.	m.hiskens@cqu.edu.au		Hiskens, Matthew/0000-0001-7054-1492	Australian Government Research Training SchemeAustralian Government; Mackay Hospital and Health Service; Mackay Institute of Research and Innovation	This project was supported by the Australian Government Research Training Scheme. Funding to publish this study was provided by the Mackay Hospital and Health Service and the Mackay Institute of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Ashton NJ, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0649-3; Bai RJ, 2017, MED SCI MONITOR, V23, P1707, DOI 10.12659/MSM.901124; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Candy S, 2017, BRAIN INJURY, V31, P1521, DOI 10.1080/02699052.2017.1363407; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fehily B., 2019, J NEUROCHEM; Freire MAM, 2012, W INDIAN MED J, V61, P751; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gozt A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10010023; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hiskens M., 2021, TRAUMA CARE, V1, P23, DOI DOI 10.3390/TRAUMACARE1010003; Hiskens MI, 2021, BRAIN INJURY, V35, P831, DOI 10.1080/02699052.2021.1909139; Hiskens MI, 2020, BIOMARKERS, V25, P213, DOI 10.1080/1354750X.2020.1735521; Hiskens MI, 2019, J NEUROSCI RES, V97, P1194, DOI 10.1002/jnr.24472; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; IQBAL K, 1986, LANCET, V2, P421; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Klintworth H, 2009, NEUROSCI LETT, V462, P1, DOI 10.1016/j.neulet.2009.06.065; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lodge D, 2009, NEUROPHARMACOLOGY, V56, P6, DOI 10.1016/j.neuropharm.2008.08.006; Cabezas IL, 2014, NEUROLOGIA, V29, P305, DOI 10.1016/j.nrl.2012.10.006; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Marmiroli P, 2012, CURR MED CHEM, V19, P1269, DOI 10.2174/092986712799462711; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Moisse K, 2009, BRAIN RES, V1296, P176, DOI 10.1016/j.brainres.2009.07.023; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Morimoto E, 2002, EXP NEUROL, V177, P95, DOI 10.1006/exnr.2002.7991; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Parajuli B, 2015, GLIA, V63, P2274, DOI 10.1002/glia.22892; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot4085, 10.1101/pdb.prot4044, 10.1101/pdb.prot3723, 10.1101/pdb.prot4453, 10.1101/pdb.prot3966, 10.1101/pdb.prot3871, 10.1101/pdb.prot4022, 10.1101/pdb.prot4027, 10.1101/pdb.prot4056, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050]; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00223; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhou Y., 2014, ASTROCYTIC NEURONAL, P140	96	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2021	16	5							e0251315	10.1371/journal.pone.0251315			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8UE	WOS:000665471900052	33961674	gold, Green Published			2022-02-06	
J	Eriksson, J; Nelson, D; Holst, A; Hellgren, E; Friman, O; Oldner, A				Eriksson, Jesper; Nelson, David; Holst, Anders; Hellgren, Elisabeth; Friman, Ola; Oldner, Anders			Temporal patterns of organ dysfunction after severe trauma	CRITICAL CARE			English	Article						Trauma; Critical care; Multiple organ dysfunction; Clustering; Data modelling	FAILURE ASSESSMENT; SEPTIC SHOCK; SEPSIS; POPULATION; MORTALITY; EPIDEMIOLOGY; DEFINITIONS; PREDICTION; DENVER; DAMPS	Background Understanding temporal patterns of organ dysfunction (OD) may aid early recognition of complications after trauma and assist timing and modality of treatment strategies. Our aim was to analyse and characterise temporal patterns of OD in intensive care unit-admitted trauma patients. Methods We used group-based trajectory modelling to identify temporal trajectories of OD after trauma. Modelling was based on the joint development of all six subdomains comprising the sequential organ failure assessment score measured daily during the first two weeks post trauma. Further, the time for trajectories to stabilise and transition to final group assignments were evaluated. Results Six-hundred and sixty patients were included in the final model. Median age was 40 years, and median ISS was 26 (IQR 17-38). We identified five distinct trajectories of OD. Group 1, mild OD (n = 300), median ISS of 20 (IQR 14-27), had an early resolution of OD and a low mortality. Group 2, moderate OD (n = 135), and group 3, severe OD (n = 87), were fairly similar in admission characteristics and initial OD but differed in subsequent OD trajectories, the latter experiencing an extended course and higher mortality. In group 3, 56% of the patients developed sepsis as compared with 19% in group 2. Group 4, extreme OD (n = 40), received most blood transfusions, had the highest proportion of shock at admission and a median ISS of 41 (IQR 29-50). They experienced significant and sustained OD affecting all organ systems and a 28-day mortality of 30%. Group 5, traumatic brain injury with OD (n = 98), had the highest mortality of 35% and the shortest time to death for non-survivors, median 3.5 (IQR 2.4-4.8) days. Groups 1 and 5 reached their final group assignment early, > 80% of the patients within 48 h. In contrast, groups 2 and 3 had a prolonged time to final group assignment. Conclusions We identified five distinct trajectories of OD after severe trauma during the first two weeks post-trauma. Our findings underline the heterogeneous course after trauma and describe some potentially important clinical insights that are suggested by the groupings and temporal trajectories.	[Eriksson, Jesper; Nelson, David; Hellgren, Elisabeth; Friman, Ola; Oldner, Anders] Karolinska Univ Hosp, Perioperat Med & Intens Care, S-17176 Stockholm, Sweden; [Eriksson, Jesper; Nelson, David; Oldner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anaesthesiol & Intens Care Med, Stockholm, Sweden; [Holst, Anders] Royal Inst Technol, KTH, Stockholm, Sweden; [Holst, Anders] Res Inst Sweden, RISE, Gothenburg, Sweden		Eriksson, J (corresponding author), Karolinska Univ Hosp, Perioperat Med & Intens Care, S-17176 Stockholm, Sweden.	jesper.b.eriksson@sll.se		Nelson, David/0000-0003-2530-8207	Swedish Carnegie Hero Funds; Karolinska InstituteKarolinska Institutet; Stockholm County CouncilStockholm County Council	The Swedish Carnegie Hero Funds and funds from Karolinska Institute supported the study. Financial support was also provided through the regional agreement on medical and clinical research (ALF) between Stockholm County Council and Karolinska Institute. None of the funding agents were involved in the study design, data collection, data analysis, manuscript preparation, or publication decisions.	Asehnoune K, 2017, INTENS CARE MED, V43, P1340, DOI 10.1007/s00134-017-4895-9; Brattstrom O, 2010, ACTA ANAESTH SCAND, V54, P1007, DOI 10.1111/j.1399-6576.2010.02266.x; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Cole E, 2020, BRIT J SURG, V107, P402, DOI 10.1002/bjs.11361; Deutschman CS, 2012, CHEST, V141, P201, DOI 10.1378/chest.11-2629; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eguia E, 2019, AM J SURG, V218, P851, DOI 10.1016/j.amjsurg.2019.03.005; Elmer J, 2020, RESUSCITATION, V148, P152, DOI 10.1016/j.resuscitation.2020.01.020; Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0321-5; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Hutchings L, 2017, J TRAUMA ACUTE CARE, V82, P534, DOI 10.1097/TA.0000000000001328; Hyllienmark P, 2013, ACTA ANAESTH SCAND, V57, P848, DOI 10.1111/aas.12111; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; Liu DM, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00046; Liu R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42637-5; Meyer A, 2018, LANCET RESP MED, V6, P905, DOI 10.1016/S2213-2600(18)30300-X; Nagin DS, 2018, STAT METHODS MED RES, V27, P2015, DOI 10.1177/0962280216673085; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Patel SV, 2014, INJURY, V45, P1522, DOI 10.1016/j.injury.2014.05.015; Rod NH, 2020, LANCET, V396, P489, DOI 10.1016/S0140-6736(20)30621-8; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; Sharma SK, 2016, J THORAC DIS, V8, P1406, DOI 10.21037/jtd.2016.05.22; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tchalla AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106363; van de Schoot R, 2017, STRUCT EQU MODELING, V24, P451, DOI 10.1080/10705511.2016.1247646; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vogel Jody A, 2014, J Trauma Acute Care Surg, V76, P140, DOI 10.1097/TA.0b013e3182a99da4; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Vourc'h M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01330	37	1	1	4	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	MAY 5	2021	25	1							165	10.1186/s13054-021-03586-6			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY0WV	WOS:000647638100001	33952314	gold, Green Published			2022-02-06	
J	Cui, WX; Wu, X; Feng, DY; Luo, JN; Shi, YW; Guo, W; Liu, HX; Wang, Q; Wang, L; Ge, SN; Qu, Y				Cui, Wenxing; Wu, Xun; Feng, Dayun; Luo, Jianing; Shi, Yingwu; Guo, Wei; Liu, Haixiao; Wang, Qiang; Wang, Liang; Ge, Shunnan; Qu, Yan			Acrolein Induces Systemic Coagulopathy via Autophagy-dependent Secretion of von Willebrand Factor in Mice after Traumatic Brain Injury	NEUROSCIENCE BULLETIN			English	Article						Traumatic brain injury; Coagulopathy; Autophagy; Acrolein; Von Willebrand factor	PROGRESSIVE HEMORRHAGIC INJURY; COAGULATION; ADAMTS13; BIOCHEMISTRY; MECHANISMS; CLEARANCE; HEALTH; DAMAGE; CELLS; MODEL	Traumatic brain injury (TBI)-induced coagulopathy has increasingly been recognized as a significant risk factor for poor outcomes, but the pathogenesis remains poorly understood. In this study, we aimed to investigate the causal role of acrolein, a typical lipid peroxidation product, in TBI-induced coagulopathy, and further explore the underlying molecular mechanisms. We found that the level of plasma acrolein in TBI patients suffering from coagulopathy was higher than that in those without coagulopathy. Using a controlled cortical impact mouse model, we demonstrated that the acrolein scavenger phenelzine prevented TBI-induced coagulopathy and recombinant ADAMTS-13 prevented acrolein-induced coagulopathy by cleaving von Willebrand factor (VWF). Our results showed that acrolein may contribute to an early hypercoagulable state after TBI by regulating VWF secretion. mRNA sequencing (mRNA-seq) and transcriptome analysis indicated that acrolein over-activated autophagy, and subsequent experiments revealed that acrolein activated autophagy partly by regulating the Akt/mTOR pathway. In addition, we demonstrated that acrolein was produced in the perilesional cortex, affected endothelial cell integrity, and disrupted the blood-brain barrier. In conclusion, in this study we uncovered a novel pro-coagulant effect of acrolein that may contribute to TBI-induced coagulopathy and vascular leakage, providing an alternative therapeutic target.	[Cui, Wenxing; Wu, Xun; Feng, Dayun; Luo, Jianing; Shi, Yingwu; Guo, Wei; Liu, Haixiao; Wang, Qiang; Wang, Liang; Ge, Shunnan; Qu, Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China		Ge, SN; Qu, Y (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710038, Peoples R China.	gesn8561@fmmu.edu.cn; yanqu0123@fmmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81630027]	This work was supported by the National Natural Science Foundation of China (81630027).	Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Brake Marisa A, 1800, Curr Protoc Mouse Biol, V9, pe61, DOI 10.1002/cpmo.61; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chen JM, 2018, BLOOD, V132, P141, DOI 10.1182/blood-2018-02-769000; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Dmitrieva NI, 2014, P NATL ACAD SCI USA, V111, P6485, DOI 10.1073/pnas.1404809111; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hsu MC, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01337-0; Hu HM, 2018, NEUROSCI BULL, V34, P951, DOI 10.1007/s12264-018-0232-8; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jing Y, 2020, NEUROSCI BULL, V36, P625, DOI 10.1007/s12264-020-00471-0; Johansson PI, 2011, CRIT CARE, V15, DOI 10.1186/cc10553; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kim JH, 2018, CELL DEATH DIFFER, V25, P1921, DOI 10.1038/s41418-018-0165-9; Kumar MA, 2019, J NEUROTRAUM, V36, P222, DOI 10.1089/neu.2018.5696; Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019; Liu, 2020, TRANSL STROKE RES; Liu AH, 2019, NEUROSCI BULL, V35, P471, DOI 10.1007/s12264-018-0324-5; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Plautz WE, 2018, TRANSFUSION, V58, P2453, DOI 10.1111/trf.14804; Pocernich CB, 2003, NEUROTOX RES, V5, P515, DOI 10.1007/BF03033161; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Russell RT, 2018, THROMB HAEMOSTASIS, V118, P676, DOI 10.1055/s-0038-1636528; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Shen YF, 2016, CLIN CHIM ACTA, V456, P75, DOI 10.1016/j.cca.2016.02.029; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Singh A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081583; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Torisu T, 2013, NAT MED, V19, P1281, DOI 10.1038/nm.3288; Wang HC, 2015, NEUROSCI BULL, V31, P491, DOI 10.1007/s12264-015-1546-4; Wang JM, 2019, FREE RADICAL BIO MED, V131, P345, DOI 10.1016/j.freeradbiomed.2018.12.014; Wu X, 2020, NEUROSCI BULL, V36, P1158, DOI 10.1007/s12264-020-00505-7; Wu YG, 2018, BLOOD, V132, P1075, DOI 10.1182/blood-2018-03-841932; Xiang YZ, 2016, CURR OPIN HEMATOL, V23, P288, DOI 10.1097/MOH.0000000000000230; Yang DB, 2014, PEPTIDES, V58, P26, DOI 10.1016/j.peptides.2014.05.015; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhao ZL, 2020, SEMIN THROMB HEMOST, V46, P167, DOI 10.1055/s-0039-3402427; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738; Zhou ZX, 2018, J ENVIRON SCI, V66, P182, DOI 10.1016/j.jes.2017.05.019; Zirak MR, 2019, FOOD CHEM TOXICOL, V129, P38, DOI 10.1016/j.fct.2019.04.034	57	1	1	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	AUG	2021	37	8					1160	1175		10.1007/s12264-021-00681-0		MAY 2021	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TX8RC	WOS:000646519400001	33939120	hybrid, Green Published			2022-02-06	
J	Liao, YT; Ku, YH; Chen, HM; Lu, ML; Chen, KJ; Yang, YH; Weng, JC; Chen, VCH				Liao, Yin-To; Ku, Yu-Hui; Chen, Hong-Ming; Lu, Mong-Liang; Chen, Ko-Jung; Yang, Yao-Hsu; Weng, Jun-Cheng; Chen, Vincent Chin-Hung			Effect of medication on risk of traumatic brain injury in patients with bipolar disorder: A nationwide population-based cohort study	JOURNAL OF PSYCHOPHARMACOLOGY			English	Article						Bipolar disorder; traumatic brain injury; antipsychotics; psychotropics	METHYLPHENIDATE; COMORBIDITY; ASSOCIATION; BURDEN; DRUGS	Background: Increased traumatic brain injury (TBI) risk was found in patients with bipolar disorder (BPD). Whether the medications for BPD and dosage moderate the risk of TBI is not clear. Aim: This study aimed to determine whether an association exists between BPD and TBI and whether the prescription of psychotropics moderates TBI risk. Methods: A total of 5606 individuals who had received diagnoses of BPD between January 1, 1997 and December 31, 2013 and 56,060 matched controls without BPD were identified from Taiwan's National Health Insurance Research Database. Cases and controls were followed until the date of TBI diagnosis. Results: BPD was associated with a high risk of TBI (adjusted hazard ratio (aHR): 1.85; 95% CI: 1.62-2.11). Patients with BPD, with or without a history of psychiatric hospitalization, had increased risks of TBI (aHR: 1.94, 95% CI: 1.57-2.4 and aHR: 1.82, 95% CI: 1.55-2.1, respectively). The prescription of typical antipsychotics (0 < defined daily dose (DDD) < 28: hazard ratio (HR) = 1.52, 95% CI: 1.19-1.94; > 28 DDD: HR = 1.54, 95% CI: 1.15-2.06) and tricyclic antidepressants (TCAs) (0 < DDD < 28: HR = 1.73, 95% CI: 1.26-2.39; > 28 DDD: HR = 1.52, 95% CI: 1.02-2.25) was associated with higher TBI risk. Patients receiving higher doses of benzodiazepines (BZDs) (cumulative dose > 28 DDD) had a higher TBI risk (HR = 1.53, 95% CI: 1.13-2.06). Conclusion: Patients with BPD have a higher risk of TBI. The use of typical antipsychotics, TCAs, or high-dose BZDs increases the risk of TBI in BPD.	[Liao, Yin-To] Chung Shan Med Univ, Dept Psychiat, Taichung, Taiwan; [Liao, Yin-To] Chung Shan Med Univ Hosp, Taichung, Taiwan; [Ku, Yu-Hui; Chen, Hong-Ming; Weng, Jun-Cheng; Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Wanfang Hosp, Dept Psychiat, Taipei, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Chen, Ko-Jung; Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Sch Tradit Chinese Med, Coll Med, Taoyuan, Taiwan; [Weng, Jun-Cheng] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Taoyuan, Taiwan		Chen, VCH (corresponding author), Chang Gung Mem Hosp & Univ, Dept Psychiat, 6 W Sec,Jiapu Rd, Puzi 613, Chiayi, Taiwan.	cch1966@gmail.com	Yang, Yao-Hsu/A-3450-2019	Yang, Yao-Hsu/0000-0002-8080-0504	Chiayi Chang Gung Memorial HospitalChang Gung Memorial Hospital [CLRPG6G0042]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Chiayi Chang Gung Memorial Hospital (CLRPG6G0042).	Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Carney CP, 2006, PSYCHOSOM MED, V68, P684, DOI 10.1097/01.psy.0000237316.09601.88; Catala-Lopez F, 2013, EUR NEUROPSYCHOPHARM, V23, P1337, DOI 10.1016/j.euroneuro.2013.04.001; Chang CM, 2016, J CLIN PSYCHOPHARM, V36, P32, DOI 10.1097/JCP.0000000000000440; Chang Z, 2017, JAMA PSYCHIAT, V74, P597, DOI 10.1001/jamapsychiatry.2017.0659; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; de Vries M, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.013; Deb S, 1999, AM J PSYCHIAT, V156, P374; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Ferrari AJ, 2016, BIPOLAR DISORD, V18, P440, DOI 10.1111/bdi.12423; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hammett S, 2017, ANN CLIN PSYCHIATRY, V29, P266; Hien LT, 2005, J AM GERIATR SOC, V53, P1290, DOI 10.1111/j.1532-5415.2005.53403.x; Huang MF, 2018, PSYCHIAT RES, V261, P517, DOI 10.1016/j.psychres.2017.12.061; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; John A, 2018, SCHIZOPHR RES, V199, P154, DOI 10.1016/j.schres.2018.04.009; Lai ECC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089795; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Leucht S, 2016, SCHIZOPHRENIA BULL, V42, pS90, DOI 10.1093/schbul/sbv167; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Liao YT, 2018, EUR CHILD ADOLES PSY, V27, P279, DOI 10.1007/s00787-017-1042-7; Liou YJ, 2018, J ADOLESCENT HEALTH, V63, P233, DOI 10.1016/j.jadohealth.2018.02.012; Lopez AY, 2017, MOL PSYCHIATR, V22, P1464, DOI 10.1038/mp.2016.233; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plans L, 2019, J AFFECT DISORDERS, V242, P111, DOI 10.1016/j.jad.2018.08.054; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Reilly-Harrington NA, 2018, CURR OBES REP, V7, P294, DOI 10.1007/s13679-018-0322-y; Sanchez-Moreno J, 2018, ACTA PSYCHIAT SCAND, V138, P145, DOI 10.1111/acps.12894; Sinha A, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0897-8; Su JA, 2017, J AFFECT DISORDERS, V218, P246, DOI 10.1016/j.jad.2017.04.037; Taipale H, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0285-3; Treves N, 2018, AGE AGEING, V47, P201, DOI 10.1093/ageing/afx167; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Wingard L, 2018, BIPOLAR DISORD, V20, P634, DOI 10.1111/bdi.12626; Wu CS, 2020, J AFFECT DISORDERS, V260, P617, DOI 10.1016/j.jad.2019.09.044	42	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-8811	1461-7285		J PSYCHOPHARMACOL	J. Psychopharmacol.	AUG	2021	35	8					962	970	02698811211013582	10.1177/02698811211013582		MAY 2021	9	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	TZ1XH	WOS:000651186900001	33938294				2022-02-06	
J	Ashall, A; Dobbin, N; Thorpe, C				Ashall, Adam; Dobbin, Nick; Thorpe, Cari			The concurrent validity and intrarater reliability of a hand-held dynamometer for the assessment of neck strength in semi-professional rugby union players	PHYSICAL THERAPY IN SPORT			English	Article						Rugby; Concussion playing position; Physiotherapy; Injury; Rehabilitation	CONCUSSION; PROGRAM; INJURY; RISK	Objectives: The main objective of this study was to determine the concurrent validity between a handheld (HHD) and mounted hand-held dynamometer (MHHD) for assessing isometric neck strength. Design: Observational design. Setting: Semiprofessional rugby club. Participants: Nineteen semi-professional rugby players (age = 26 +/- 5 years, stature = 186.5 +/- 6.5 cm, body mass = 98.7 +/- 12.8 kg). Main outcome measures: Concurrent validity (limits of agreement, correlation) between HHD and MHHD, the intrarater reliability (intra-class correlation, ICC) and comparison between playing positions. Results: Absolute peak and mean peak force were systematically lower when using the HHD compared to MHHD, with the mean bias ranging from-1.8 to-3.8 kgf (P < 0.05). Differences were not evident for flexion when applying the correction equations (-0.5 to 2.1 kgf, P > 0.05) but remained for extension. Correlations between methods were large-to-very large; the ICCs for both methods were good (ICC = 0.72-0.89), with no difference between positions (P < 0.05). Conclusion: The concurrent validity of HHD was considered acceptable when compared to the MHHD and the correction equation applied. Both methods are reliable and useful for assessing neck strength in rugby players, though, caution is needed when determining strength during neck extension. (c) 2021 Elsevier Ltd. All rights reserved.	[Ashall, Adam; Dobbin, Nick; Thorpe, Cari] Ealing Trailfinders Rugby Club, London, England; [Ashall, Adam] Manchester Metropolitan Univ, Dept Hlth Profess, Manchester, Lancs, England		Thorpe, C (corresponding author), Manchester Metropolitan Univ, Dept Hlth Profess, Manchester, Lancs, England.	M.Thorpe@mmu.ac.uk					Bitchell CL, 2020, PHYS THER SPORT, V42, P26, DOI 10.1016/j.ptsp.2019.12.001; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Coppieters Michel, 2002, Physiother Res Int, V7, P146; de Vet HC, 2011, MEASUREMENT MED PRAC, DOI DOI 10.1017/CBO9780511996214; Dobbin N, 2018, INT J SPORT PHYSIOL, V13, P235, DOI 10.1123/ijspp.2017-0166; Du Toit D. E., 2004, SA J SPORTS MED, V15, P3; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gagnon D, 2005, ARCH PHYS MED REHAB, V86, P1998, DOI 10.1016/j.apmr.2005.04.013; Gaines A., 2017, J SPORTS MED ALLIED, V3, P1; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Geary K, 2014, CLIN J SPORT MED, V24, P502, DOI 10.1097/JSM.0000000000000071; Geary K, 2013, J MANIP PHYSIOL THER, V36, P444, DOI 10.1016/j.jmpt.2013.05.026; Hamilton DF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004975; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hopkins W. G, 2002, SPORTS SCI; Jackson SM, 2017, MUSCULOSKEL SCI PRAC, V27, P137, DOI 10.1016/j.math.2016.07.010; Jones PA, 2010, J STRENGTH COND RES, V24, P1553, DOI 10.1519/JSC.0b013e3181dc4392; Katoh M, 2011, J PHYS THER SCI, V23, P553, DOI 10.1589/jpts.23.553; Kim WK, 2014, ANN REHABIL MED-ARM, V38, P84, DOI 10.5535/arm.2014.38.1.84; Kolber MJ, 2005, PHYS THER REV, V10, P99, DOI 10.1179/108331905X55730; Krause DA, 2019, SPORTS HEALTH, V11, P59, DOI 10.1177/1941738118812767; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; Naish R, 2013, J SPORT SCI MED, V12, P542; Oliver P. E., 2011, J SCI MED SPORT, V11, P96; Roberts S., 2017, RFU COMMUNITY RUGBY; Scott DA, 2004, ARCH PHYS MED REHAB, V85, P598, DOI 10.1016/j.apmr.2003.07.013; Seminati E, 2017, SPORT BIOMECH, V16, P58, DOI 10.1080/14763141.2016.1194453; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Sung KS, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2703-0; Toninato J, 2018, CONT CLIN TRIAL COMM, V11, P102, DOI 10.1016/j.conctc.2018.06.007; Tudini F, 2019, J MAN MANIP THER, V27, P222, DOI 10.1080/10669817.2019.1586167; Versteegh T, 2015, PHYSIOTHER CAN, V67, P58, DOI 10.3138/ptc.2013-66	36	1	1	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAY	2021	49						229	235		10.1016/j.ptsp.2021.03.007			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	RO1GA	WOS:000640795700033	33794446				2022-02-06	
J	Bloodworth-Race, S; Critchley, R; Hazael, R; Peare, A; Temple, T				Bloodworth-Race, S.; Critchley, R.; Hazael, R.; Peare, A.; Temple, T.			Testing the blast response of foam inserts for helmets	HELIYON			English	Article						Traumatic brain injury; Energy absorption; Open cell polyurethane foam; Sylgard; Synbone; Shocktube	TRAUMATIC BRAIN-INJURY; STRAIN-RATE; AMPLIFICATION; MITIGATION; BEHAVIOR; DESIGN	Modern era combat helmets have different iterations and configurations to offer greater protection from blunt impact or ballistic penetration to suit the theatre of operation, although there are currently no standards for blast protection. Moreover, incorporation of blast protection into the same constrained mass-volume envelope is extremely challenging as there is very little space for a material to absorb or dissipate the shockwave. Foam padding is fitted in contemporary combat helmet designs for comfort and standoff purposes. Examples were subjected to blastwaves generated from an air-driven shocktube, along with open cell polyurethane foam specimens of varying pores per inch and thicknesses to. Whilst the range of samples tested did not afford any superior blast mitigation behaviour over the foam already present in helmets, they exhibited comparable performance with a lower mass. There also appears to be positive correlation between increased mass and increased impulse transmitted through the foam. The literature suggests that multiple mechanisms of damage for blast induced mild Traumatic Brain Injury (bTBI) can be caused by the helmet itself, therefore additional protection from a blunt or ballistic impact may increase the risk of damage from a blast insult.	[Bloodworth-Race, S.; Critchley, R.; Hazael, R.] Cranfield Univ, Cranfield Forens Inst, Def Acad United Kingdom, Shrivenham SN6 8LA, England; [Peare, A.] Cranfield Univ, Ctr Def Engn, Def Acad United Kingdom, Shrivenham SN6 8LA, England; [Temple, T.] Cranfield Univ, Ctr Def Chem, Def Acad United Kingdom, Shrivenham SN6 8LA, England		Critchley, R (corresponding author), Cranfield Univ, Cranfield Forens Inst, Def Acad United Kingdom, Shrivenham SN6 8LA, England.	r.critchley@cranfield.ac.uk		Hazael, Rachael/0000-0001-6038-7700; Critchley, Richard/0000-0001-5423-9859			Allen T, 2015, PROCEDIA ENGINEER, V112, P104, DOI 10.1016/j.proeng.2015.07.183; Barnard E, 2013, NEW ENGL J MED, V368, P1045, DOI 10.1056/NEJMicm1203842; Bass Cameron R Dale, 2005, Int J Occup Saf Ergon, V11, P347; Bell S.J, 1996, PERS ARM SYST 1996 H; Bianchi M, 2008, J MATER SCI, V43, P5851, DOI 10.1007/s10853-008-2841-5; Bornstein H., 2013, WIT T ENG SCI, V77; Breeze J, 2016, INJURY, V47, P1932, DOI 10.1016/j.injury.2016.06.010; Britan A, 2011, COLLOID SURFACE A, V382, P145, DOI 10.1016/j.colsurfa.2011.01.019; Campos-Pires R., 2016, MODELLING BLAST BRAI, P173; Coxworth B., 2018, NEW ATLAS; Decker MJ, 2007, COMPOS SCI TECHNOL, V67, P565, DOI 10.1016/j.compscitech.2006.08.007; Engel Y, 2010, ANGEW CHEM INT EDIT, V49, P6830, DOI 10.1002/anie.201000847; Gama NV, 2018, MATERIALS, V11, DOI 10.3390/ma11101841; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gibson L.J., 1997, CELLULAR SOLIDS, P93; Gibson L.j., 1988, CELLULAR SOLIDS, P8; Gibson L.J., 1997, STRUCTURE CELLULAR S, P15; Gibson L.J., 1997, CELLULAR SOLIDS STRU, P309; Gould T., 2015, INNER LINER MAT PROT, P220; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hamouda AMS, 2012, WOODHEAD PUBL SER TE, P103; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Karlos V, 2016, INT J PROT STRUCT, V7, P409, DOI 10.1177/2041419616659572; Kitagawa K, 2006, SHOCK WAVES, V15, P437, DOI 10.1007/s00193-006-0042-1; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Mcarthur J., 2003, SHOCK VIB; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Moore DF, 2012, TRAUMATIC BRAIN INJU, P1; Moss W.C., SKULL FLEXURE BLAST; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nian WM, 2012, INT J IMPACT ENG, V50, P29, DOI 10.1016/j.ijimpeng.2012.06.005; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Ouellet S, 2006, POLYM TEST, V25, P731, DOI 10.1016/j.polymertesting.2006.05.005; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Petel OE, 2013, SHOCK WAVES, V23, P55, DOI 10.1007/s00193-012-0414-7; Queheillalt D.T., 2001, MATERR RES SOC; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Rutter B, SCHOLARS MINE SCHOLA; Saha MC, 2005, MAT SCI ENG A-STRUCT, V406, P328, DOI 10.1016/j.msea.2005.07.006; Sanami M, 2014, PROCEDIA ENGINEER, V72, P453, DOI 10.1016/j.proeng.2014.06.079; Sandhu I.S., 2017, PROCEDIA ENG; Seitz MW, 2006, SHOCK WAVES, V15, P177, DOI 10.1007/s00193-006-0033-2; Shim C, 2012, METALS-BASEL, V2, P170, DOI 10.3390/met2020170; Teland J., 2010, J ACOUST SOC AM, V127, P50002; Thom CG, 2009, SHOCK WAVES, V19, P39, DOI 10.1007/s00193-009-0186-x; Thom C.G., 2009, SOFT MAT AIR BLAST L; ThomasNet R.P.M, 2019, OPEN CELL VS CLOSED; Tsao J.W, 2012, TBI CLINICIANS GUIDE, P8; Turner Saro, 2014, MIPS HELMET PROTECTS; Uddin M., PULMONARY PRIMARY BL; Varas J.M., 2011, FRONT NEUROL; Wilgeroth J.M, 2008, EFFECT BLAST COMBAT; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhu W.K, 2011, NUMERICAL ANAL SHEAR	54	1	1	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	MAY	2021	7	5							e06990	10.1016/j.heliyon.2021.e06990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SV1PR	WOS:000663597600007	34036190	Green Published, gold			2022-02-06	
J	Cotae, AM; Tiglis, M; Cobilinschi, C; Baetu, AE; Iacob, DM; Grintescu, IM				Cotae, Ana-Maria; Tiglis, Mirela; Cobilinschi, Cristian; Baetu, Alexandru Emil; Iacob, Diana Maria; Grintescu, Ioana Marina			The Impact of Monitoring Depth of Anesthesia and Nociception on Postoperative Cognitive Function in Adult Multiple Trauma Patients	MEDICINA-LITHUANIA			English	Article						entropy; POCD; general emergency surgery; anesthesia depth	NEECHAM CONFUSION SCALE; CLINICAL-PRACTICE; DYSFUNCTION; DELIRIUM; PROPOFOL	Background and Objectives: Patients with traumatic injuries have often been excluded from studies that have attempted to pinpoint modifiable factors to predict the transient disturbance of the cognitive function in the postoperative settings. Anesthetists must be aware of the high risk of developing postoperative delirium and cognitive dysfunction (POCD) in patients undergoing emergency surgery. Monitoring the depth of anesthesia in order to tailor anesthetic delivery may reduce this risk. The primary aim of this study was to improve the prevention strategies for the immediate POCD by assessing anesthetic depth and nociception during emergency surgery. Material and Methods: Of 107 trauma ASA physical status II-IV patients aged over 18 years undergoing emergency noncardiac surgery, 95 patients were included in a prospective randomized study. Exclusion criteria were neurotrauma, chronic use of psychoactive substances or alcohol, impaired preoperative cognitive function, pre-existing psychopathological symptoms, or expected surgery time less than 2 h. Entropy and Surgical Pleth Index (SPI) values were constantly recorded for one group during anesthesia. POCD was assessed 24 h, 48 h, and 72 h after surgery using the Neelon and Champagne (NEECHAM) Confusion Scale. Results: Although in the intervention group, fewer patients experienced POCD episodes in comparison to the control group, the results were not statistically significant (p < 0.08). The study showed a statistically significant inverse correlation between fentanyl and the NEECHAM Confusion Scale at 24 h (r = -0.32, p = 0.0005) and 48 h (r = -0.46, p = 0.0002), sevoflurane and the NEECHAM Confusion Scale at 24 h (r = -0.38, p = 0.0014) and 48 h (r = -0.52, p = 0.0002), and noradrenaline and POCD events in the first 48 h (r = -0.46, p = 0.0013 for the first 24 h, respectively, and r = -0.46, p = 0.0002 for the next 24 h). Conclusions: Entropy and SPI monitoring during anesthesia may play an important role in diminishing the risk of developing immediate POCD after emergency surgery.	[Cotae, Ana-Maria; Tiglis, Mirela; Cobilinschi, Cristian; Baetu, Alexandru Emil; Iacob, Diana Maria; Grintescu, Ioana Marina] Clin Emergency Hosp Bucharest, Anaesthesia & Intens Care Clin, Bucharest 014461, Romania; [Cotae, Ana-Maria; Tiglis, Mirela; Cobilinschi, Cristian; Baetu, Alexandru Emil; Iacob, Diana Maria; Grintescu, Ioana Marina] Univ Med & Pharm Carol Davila, Dept Anesthesia & Intens Care, Fac Med, Bucharest 050474, Romania		Cotae, AM (corresponding author), Clin Emergency Hosp Bucharest, Anaesthesia & Intens Care Clin, Bucharest 014461, Romania.; Cotae, AM (corresponding author), Univ Med & Pharm Carol Davila, Dept Anesthesia & Intens Care, Fac Med, Bucharest 050474, Romania.	cotae_ana_maria@yahoo.com; Mirelatiglis@gmail.com; cob_rodion@yahoo.com; alexandru.baetu@gmail.com; diana.iacob10@gmail.com; ioana.grintescu@rospen.ro	Cotae, Ana Maria/AAD-2883-2022; Cobilinschi, Cristian/AAT-6555-2020	Cobilinschi, Cristian/0000-0002-1142-7427			Ancelin ML, 2001, BRIT J PSYCHIAT, V178, P360, DOI 10.1192/bjp.178.4.360; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; BEDFORD PD, 1955, LANCET, V2, P259; Bonhomme V, 2011, BRIT J ANAESTH, V106, P101, DOI 10.1093/bja/aeq291; Brassard P, 2009, BRIT J ANAESTH, V102, P800, DOI 10.1093/bja/aep065; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; Chen XZ, 2010, ANESTHESIOLOGY, V112, P1175, DOI 10.1097/ALN.0b013e3181d3d641; Culley D.J., 2018, POSTOPERATIVE CENTRA, V9, P123; El Hor T, 2013, ANESTHESIOLOGY, V118, P868, DOI 10.1097/ALN.0b013e3182850c36; Fedorow C, 2010, CURR OPIN ANESTHESIO, V23, P89, DOI 10.1097/ACO.0b013e3283346d10; Feinkohl I, 2017, Clin Pract Epidemiol Ment Health, V13, P27, DOI 10.2174/1745017901713010027; Feinkohl I, 2016, DIABETES-METAB RES, V32, P643, DOI 10.1002/dmrr.2786; Green D, 2015, BRIT J ANAESTH, V114, P343, DOI 10.1093/bja/aeu471; Gruenewald M, 2007, ANAESTHESIA, V62, P1224, DOI 10.1111/j.1365-2044.2007.05252.x; Hirsch J, 2015, BRIT J ANAESTH, V115, P418, DOI 10.1093/bja/aeu458; Kotekar N, 2018, CLIN INTERV AGING, V13, P2267, DOI 10.2147/CIA.S133896; Ma JH, 2012, J CARDIOTHOR VASC AN, V26, P818, DOI 10.1053/j.jvca.2012.01.028; MacKenzie KK, 2018, ANESTHESIOLOGY, V129, P417, DOI 10.1097/ALN.0000000000002323; Micha G, 2016, ACTA ANAESTH BELG, V67, P129; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Muller S, 2008, CRIT CARE, V12, DOI 10.1186/cc6794; Neelon VJ, 1996, NURS RES, V45, P324, DOI 10.1097/00006199-199611000-00002; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; Polderman KH, 2007, INTENS CARE MED, V33, P3, DOI 10.1007/s00134-006-0400-6; Ramaiah Ramesh, 2011, J Emerg Trauma Shock, V4, P1, DOI 10.4103/0974-2700.76816; Rundshagen I, 2007, BRIT J ANAESTH, V99, P686, DOI 10.1093/bja/aem231; Rundshagen I, 2014, DTSCH ARZTEBL INT, V111, DOI 10.3238/arztebl.2014.0119; Selnes OA, 2005, ANN NEUROL, V57, P615, DOI 10.1002/ana.20481; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Van Rompaey B, 2008, CRIT CARE, V12, DOI 10.1186/cc6790; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x; Won YJ, 2018, J INT MED RES, V46, P4386, DOI 10.1177/0300060518796749; Wu Shao-Chun, 2008, Acta Anaesthesiol Taiwan, V46, P106, DOI 10.1016/S1875-4597(08)60003-X	33	1	1	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.	MAY	2021	57	5							408	10.3390/medicina57050408			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SH7TS	WOS:000654337000001	33922552	Green Published, gold			2022-02-06	
J	Coxe, KA; Lee, G; Kagotho, N; Eads, R				Coxe, Kathryn A.; Lee, Guijin; Kagotho, Njeri; Eads, Ray			Mental Health Service Utilization among Adults with Head Injury with Loss of Consciousness: Implications for Social Work	HEALTH & SOCIAL WORK			English	Article						Andersen model of health; head injury; mental health service utilization; National Health and Nutrition Examination Survey; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CARE UTILIZATION; UNITED-STATES; PREVALENCE; DEPRESSION; BARRIERS; TBI; RACE/ETHNICITY; DEATHS; IMPACT	The purpose of this study was to identify factors associated with mental health service utilization among adults with head injury with loss of consciousness (LOC) using Andersen's model of health. This secondary data analysis used the 2011-2014 National Health and Nutrition Examination Survey with data collected from 7,399 adults. Binary logistic regression was conducted to determine odds associated with predisposing, enabling, and needs factors on head injury with LOC and mental health service utilization. A total of 948 (12.8 percent) adults 40 years and older self-reported head injury with LOC. Head injury with LOC was higher among men and people with lower income, illicit drug use history, and moderate to severe depression. Mental health service utilization for people with head injury with LOC was lower among older-age adults and those with no health insurance. However, utilization was higher among adults with military service, history of drug use, and moderate to severe depression. Social workers in health care settings play critical roles serving adults with traumatic brain injury (TBI) through mental health and substance use disorder treatment and bridging gaps in service access. Social workers should recognize the complex needs of clients with TBI and factors affecting mental health service use.	[Coxe, Kathryn A.; Kagotho, Njeri; Eads, Ray] Ohio State Univ, Coll Social Work, Columbus, OH 43210 USA; [Lee, Guijin] Wayne State Univ, Sch Social Work, Detroit, MI USA		Coxe, KA (corresponding author), Ohio State Univ, Coll Social Work, Columbus, OH 43210 USA.	coxe.6@osu.edu	Kagotho, Njeri/AAX-3122-2021	Eads, Ray/0000-0003-4244-7321; Coxe, Kathryn/0000-0002-7813-1081			Albrecht JS, 2017, ARCH PHYS MED REHAB, V98, P2548, DOI 10.1016/j.apmr.2017.06.007; American Psychiatric Association, 2017, ADD SUBST US DIS; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Arroll Bruce, 2017, BJGP Open, V1, DOI 10.3399/bjgpopen17X101025; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Centers for Disease Control and Prevention, 2019, TRAUMATIC BRAIN INJU; Conner KO, 2010, AM J GERIAT PSYCHIAT, V18, P531, DOI 10.1097/JGP.0b013e3181cc0366; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Fasoli DR, 2010, MED CARE, V48, P288, DOI 10.1097/MLR.0b013e3181cafbe3; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Graves JM, 2019, HEALTH SERV RES, V54, P337, DOI 10.1111/1475-6773.13096; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Johnson Clifford L, 2014, Vital Health Stat 2, P1; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kazdin AE, 2017, BEHAV RES THER, V88, P7, DOI 10.1016/j.brat.2016.06.004; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Kysar-Moon A, 2019, ARMED FORCES SOC, V45, P155, DOI 10.1177/0095327X18761852; Lee S. Y., 2019, BRAIN INJURY, V33, P1; Leo P., 2016, TRANSLATIONAL RES TR, P1; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lynch S, 2016, SOC WORK HEALTH CARE, V55, P651, DOI 10.1080/00981389.2016.1221871; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McHugo GJ, 2017, J HEAD TRAUMA REHAB, V32, pE65, DOI 10.1097/HTR.0000000000000249; Moore M, 2013, SOC WORK HEALTH CARE, V52, P498, DOI 10.1080/00981389.2012.714447; National Institute on Alcohol Abuse and Alcoholism, 2018, DRINK LEV DEF; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; Pepin R, 2009, AGING MENT HEALTH, V13, P769, DOI 10.1080/13607860902918231; Schneider ALC, 2018, NEW ENGL J MED, V379, P1176, DOI 10.1056/NEJMc1808550; Schneider-Cline W, 2019, BRAIN INJURY, V33, P899, DOI 10.1080/02699052.2019.1606450; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schunk D, 2008, ASTA-ADV STAT ANAL, V92, P101, DOI 10.1007/s10182-008-0053-6; StataCorp, 2017, STATA STAT SOFTWARE; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tamas V, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00366; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005	42	1	1	2	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0360-7283	1545-6854		HEALTH SOC WORK	Health Soc. Work	MAY	2021	46	2					125	135		10.1093/hsw/hlab005			11	Social Work	Social Science Citation Index (SSCI)	Social Work	TF7UV	WOS:000670923400006	33954747				2022-02-06	
J	Deeb, AP; Phelos, HM; Peitzman, AB; Billiar, TR; Sperry, JL; Brown, JB				Deeb, Andrew - Paul; Phelos, Heather M.; Peitzman, Andrew B.; Billiar, Timothy R.; Sperry, Jason L.; Brown, Joshua B.			The Whole is Greater Than the Sum of its Parts: GCS Versus GCS-Motor for Triage in Geriatric Trauma	JOURNAL OF SURGICAL RESEARCH			English	Article						Geriatric; Triage; Glasgow Coma Scale; Traumatic brain injury; Pre-hospital		Background: Trauma field triage matches injured patients to the appropriate level of care. Prior work suggests the Glasgow Coma Scale motor (GCSm) is as accurate as the total GCS (GCSt) and easier to use. However, older patients present with higher GCS for a given injury, and as such, it is unclear if this substitution is advisable. Our objective was to compare the GCS deficit patterns between geriatric and adult patients presenting with severe traumatic brain injury (TBI), as well as the diagnostic performance of the GCSm versus GCSt within the field triage criteria in these populations. Materials and Methods: We conducted a retrospective, observational cohort study of patients >16 y in the National Trauma Data Bank 2007-2015. GCS deficit patterns were compared between adults (16-65) and geriatric patients (>65). Measures of diagnostic performance of GCSt<13 versus GCSm<5 criteria to predict trauma center need (TCN) were compared. Results: In total, 4,480,185 patients were analyzed (28% geriatric). Geriatric patients more frequently presented with non-motor-only deficits than adults (16.4% versus 12.4%, P < 0.001), and these patients demonstrated higher severe TBI (40.3% versus 36.7%, P < 0.001) and craniotomy (5.8% versus 5.1%, P < 0.001) rates. GCSt was more sensitive and accurate in predicting TCN for geriatric patients and had lower rates of undertriage as compared to GCSm. Conclusions: Geriatric patients more frequently present with non-motor-only deficits after injury, and this is associated with severe head injury. Substitution of GCSm for GCSt would exacerbate undertriage in geriatric patients and, thus, the total GCS should be maintained for field triage in geriatric patients. (c) 2020 Elsevier Inc. All rights reserved.	[Deeb, Andrew - Paul; Phelos, Heather M.; Peitzman, Andrew B.; Billiar, Timothy R.; Sperry, Jason L.; Brown, Joshua B.] Univ Pittsburgh, Med Ctr, Dept Surg, Div Trauma & Gen Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA		Deeb, AP (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, Div Trauma & Gen Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	deeba@upmc.edu		Deeb, Andrew-Paul/0000-0003-0511-2127	National Institutes of Health, United StatesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2T32GM008516-26]	This work was supported by the National Institutes of Health, United States (Grant: 2T32GM008516-26, 2020).	Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Benjamin ER, 2018, J EMERG MED, V55, P278, DOI 10.1016/j.jemermed.2018.02.001; Beskind DL, 2014, PREHOSP EMERG CARE, V18, P68, DOI 10.3109/10903127.2013.844870; Brown JB, 2015, J TRAUMA ACUTE CARE, V78, P352, DOI 10.1097/TA.0000000000000523; Brown JB, 2014, J TRAUMA ACUTE CARE, V77, P95, DOI 10.1097/TA.0000000000000280; Brown JB, 2011, J TRAUMA, V70, P38, DOI 10.1097/TA.0b013e3182077ea8; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Chou R, 2017, ANN EMERG MED, V70, P143, DOI 10.1016/j.annemergmed.2016.11.032; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heffernan DS, 2010, J TRAUMA, V69, P813, DOI 10.1097/TA.0b013e3181f41af8; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kodadek LM, 2015, J SURG RES, V199, P220, DOI 10.1016/j.jss.2015.05.017; Kupas DF, 2016, ANN EMERG MED, V68, P744, DOI 10.1016/j.annemergmed.2016.06.017; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; Lerner EB, 2014, J TRAUMA ACUTE CARE, V76, P1157, DOI 10.1097/TA.0000000000000189; Martin JT, 2010, AM SURGEON, V76, P65; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Newgard CD, 2008, PREHOSP EMERG CARE, V12, P451, DOI 10.1080/10903120802290737; Pennsylvania Department of Health Bureau of Emgergency Medical Services, PENNSYLVANIA STATEWI; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Totten AM, COMP EFFECTIVENESS R; Velmahos GC, 2001, J AM COLL SURGEONS, V192, P147, DOI 10.1016/S1072-7515(00)00790-0; Wasserman EB, 2015, PREHOSP EMERG CARE, V19, P202, DOI 10.3109/10903127.2014.959225; Werman HA, 2011, PREHOSP DISASTER MED, V26, P170, DOI 10.1017/S1049023X11006315	30	1	1	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAY	2021	261						385	393		10.1016/j.jss.2020.12.051			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RF8UO	WOS:000635114100005	33493891				2022-02-06	
J	Evans, E; Gutman, R; Resnik, L; Zonfrillo, MR; Lueckel, SN; Kumar, RG; DeVone, F; Dams-O'Connor, K; Thomas, KS				Evans, Emily; Gutman, Roee; Resnik, Linda; Zonfrillo, Mark R.; Lueckel, Stephanie N.; Kumar, Raj G.; DeVone, Frank; Dams-O'Connor, Kristen; Thomas, Kali S.			Successful Community Discharge Among Older Adults With Traumatic Brain Injury in Skilled Nursing Facilities	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						accidental falls; aged; aged 80 years and older; brain injuries; rehabilitation; skilled nursing facilities	FOLLOW-UP; FILE LINKING; REHABILITATION; EPIDEMIOLOGY; COMPONENTS; PLACEMENT; OUTCOMES; LENGTH; SCALE; END	Objective: To identify patient, injury, and functional status characteristics associated with successful discharge to the community following a skilled nursing facility (SNF) stay among older adults hospitalized following traumatic brain injury (TBI). Setting: Skilled nursing facilities. Participants: Medicare fee-for-service beneficiaries admitted to an SNF after hospitalization for TBI. Design: Retrospective cohort study using Medicare administrative data merged with the National Trauma Data Bank using a multilayered Bayesian record linkage approach. Main Outcome Measure: Successful community discharge: discharged alive within 100 days of SNF admission and remaining in the community for 30 days or more without dying or admission to a healthcare facility. Results: Medicaid enrollment, incontinence, decreased independence with activities of daily living, and cognitive impairment were associated with lower odds of successful discharge, whereas race "other" was associated with higher odds of successful discharge. Injury factors including worse injury severity (Glasgow Coma Scale and Abbreviated Injury Scale scores) and fall-related injury mechanism were not associated with successful discharge. Conclusion: Among older adults with TBI who discharge to an SNF, sociodemographic and functional status characteristics are associated with successful discharge and may be useful to clinicians for discharge planning. Acute injury severity indices may have limited utility in predicting discharge disposition once a patient is admitted to an SNF for post-acute care.	[Evans, Emily; Resnik, Linda; Thomas, Kali S.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Ctr Gerontol & Healthcare Res,Brown Sch Publ Hlth, Providence, RI 02912 USA; [Gutman, Roee; DeVone, Frank] Brown Univ, Sch Publ Hlth, Dept Biostat, Providence, RI 02912 USA; [Resnik, Linda; Thomas, Kali S.] VA Med Ctr, Providence, RI USA; [Zonfrillo, Mark R.] Brown Univ, Warren Alpert Sch Med, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Warren Alpert Sch Med, Dept Pediat, Providence, RI 02912 USA; [Lueckel, Stephanie N.] Brown Univ, Warren Alpert Sch Med, Div Acute Care Surg & Surg Crit Care, Rhode Isl Hosp, Providence, RI 02912 USA; [Kumar, Raj G.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Evans, E (corresponding author), Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Box G-S121 6,121 S Main St, Providence, RI 02912 USA.	emily_evans@brown.edu; roee_gutman@brown.edu; linda_resnik@brown.edu; mark_zonfrillo@brown.edu; stephanie_lueckel@brown.edu; Raj.kumar@mountsinai.org; frank_devone@brown.edu; kristen.dams-o'connor@mountsinai.org; kali_thomas@brown.edu	Gutman, Roee/J-2355-2014	Gutman, Roee/0000-0001-7095-3016	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R21AG059120-01]; Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [PCORI/ME-2017C3-9241]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [5T32HS000011-33]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0009-01]; Department of Veterans AffairsUS Department of Veterans Affairs [CDA 14-422]; Foundation for Physical Therapy Research	This work was supported by the National Institute on Aging (1R21AG059120-01; K.S.T., R.G., L.R., E.E.), the Patient-Centered Outcomes Research Institute (PCORI/ME-2017C3-9241; R.G., F.D.), the Agency for Healthcare Research and Quality (5T32HS000011-33; E.E.), the National Institute on Disability, Independent Living, and Rehabilitation Research (90DPTB0009-01; K.O., R.K.), the Department of Veterans Affairs (CDA 14-422: K.S.T.), and the Foundation for Physical Therapy Research funded Center on Health Services Training and Research (E.E.).	[Anonymous], 2018, NATL TRAUMA DATA BAN; Bierman AS, 2001, J GEN INTERN MED, V16, P785, DOI 10.1111/j.1525-1497.2001.10918.x; Buntin MB, 2007, ARCH PHYS MED REHAB, V88, P1488, DOI 10.1016/j.apmr.2007.07.023; Butteroff C., 2017, MULTIPLE CHRONIC CON; Centers for Medicare & Medicaid Services (CMS) HHS, 2016, Fed Regist, V81, P51969; Cepoiu-Martin M, 2016, INT J GERIATR PSYCH, V31, P1151, DOI 10.1002/gps.4449; Chambers R., 2009, INFERENCE BASED ESTI; Conroy BE, 2009, TOP STROKE REHABIL, V16, P34, DOI 10.1310/tsr1601-34; Corrigan JD, 2014, J NEUROTRAUM, V31, P1000, DOI 10.1089/neu.2013.3145; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dams-O'Connor K, 2020, J HEAD TRAUMA REHAB, V35, P127, DOI 10.1097/HTR.0000000000000484; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Falvey JR, 2016, PHYS THER, V96, P1124, DOI 10.2522/ptj.20150526; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Greysen SR, 2014, J AM GERIATR SOC, V62, P1556, DOI 10.1111/jgs.12928; Gutman R, 2016, STAT MED, V35, P115, DOI 10.1002/sim.6586; Gutman R, 2013, J AM STAT ASSOC, V108, P34, DOI 10.1080/01621459.2012.726889; Hashmi ZG, 2018, JAMA SURG, V153, P852, DOI 10.1001/jamasurg.2018.0483; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2019, J HEAD TRAUMA REHAB, V34, P224, DOI 10.1097/HTR.0000000000000470; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Leland NE, 2015, MED CARE, V53, P879, DOI 10.1097/MLR.0000000000000419; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Lueckel SN., 2018, SURGERY; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rahman M, 2014, MED CARE RES REV, V71, P384, DOI 10.1177/1077558714533824; Rahman M, 2014, HEALTH SERV RES, V49, P798, DOI 10.1111/1475-6773.12142; Rubin DB, 2004, MULTIPLE IMPUTATION, V81; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheuren F, 1993, SURV METHODOL, V19, P39; Shan M., 2020, ARXIV200508549V12020; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas KS, 2017, MED CARE, V55, pE68, DOI 10.1097/MLR.0000000000000334; Yam CHK, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-396; Zarshenas S, 2019, J HEAD TRAUMA REHAB, V34, P52, DOI 10.1097/HTR.0000000000000403	49	1	1	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		E186	E198		10.1097/HTR.0000000000000638			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900013	33528173	Green Accepted			2022-02-06	
J	Frank, D; Gruenbaum, BF; Melamed, I; Grinshpun, J; Benjamin, Y; Vzhetson, I; Kravchenko, N; Dubilet, M; Boyko, M; Zlotnik, A				Frank, Dmitry; Gruenbaum, Benjamin F.; Melamed, Israel; Grinshpun, Julia; Benjamin, Yair; Vzhetson, Ievgeni; Kravchenko, Nadia; Dubilet, Michael; Boyko, Matthew; Zlotnik, Alexander			A Metric Test for Assessing Spatial Working Memory in Adult Rats following Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article							MINOR HEAD-INJURY; DORSAL HIPPOCAMPUS; SEX-DIFFERENCES; HORMONES; PERFORMANCE; CORTEX; EDEMA; TASK; MICE	Impairments to sensory, short-term, and long-term memory are common side effects after traumatic brain injury (TBI). Due to the ethical limitations of human studies, animal models provide suitable alternatives to test treatment methods, and to study the mechanisms and related complications of the condition. Experimental rodent models have historically been the most widely used due to their accessibility, low cost, reproducibility, and validated approaches. A metric test, which tests the ability to recall the placement of two objects at various distances and angles from one another, is a technique to study impairment in spatial working memory (SWM) after TBI. The significant advantages of metric tasks include the possibility of dynamic observation, low cost, reproducibility, relative ease of implementation, and low stress environment. Here, we present a metric test protocol to measure impairment of SWM in adult rats after TBI. This test provides a feasible way to evaluate physiology and pathophysiology of brain function more effectively.	[Frank, Dmitry; Grinshpun, Julia; Benjamin, Yair; Vzhetson, Ievgeni; Dubilet, Michael; Boyko, Matthew; Zlotnik, Alexander] Ben Gurion Univ Negev, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel; [Gruenbaum, Benjamin F.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Melamed, Israel] Soroka Univ, Med Ctr, Dept Neurosurg, Beer Sheva, Israel; [Melamed, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Kravchenko, Nadia] Dnepropetrovsk Natl Univ, Fac Biol Ecol & Med, Dept Physiol, Dnepropetrovsk, Ukraine		Boyko, M (corresponding author), Ben Gurion Univ Negev, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel.	matthewboykoresearch@gmail.com	Binyamin, Yair/AAW-3005-2020	Binyamin, Yair/0000-0003-2147-7353			Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P231, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT231; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Frank D, 2020, JOVE-J VIS EXP, DOI 10.3791/61198; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Goodrich-Hunsaker NJ, 2008, NEUROBIOL LEARN MEM, V90, P389, DOI 10.1016/j.nlm.2008.05.002; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Goodrich-Hunsaker NJ, 2005, BEHAV NEUROSCI, V119, P1307, DOI 10.1037/0735-7044.119.5.1307; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Halari R, 2005, BEHAV NEUROSCI, V119, P104, DOI 10.1037/0735-7044.119.1.104; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Janowsky JS, 1998, DEV NEUROPSYCHOL, V14, P421, DOI 10.1080/87565649809540719; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kuts R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01105; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Losurdo M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040229; Ma Cheng, 2019, Chin Neurosurg J, V5, P24, DOI 10.1186/s41016-019-0173-8; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; O'Leary TP, 2012, J NEUROSCI METH, V203, P315, DOI 10.1016/j.jneumeth.2011.09.027; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Penley SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50940; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Rosenfeld CS, 2014, JOVE-J VIS EXP, DOI 10.3791/51194; Rowe RK, 2018, NEUROMETHODS, V139, P97, DOI 10.1007/978-1-4939-8564-7_6; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Yarnell Angela M, 1800, Curr Protoc Neurosci, V75, DOI 10.1002/cpns.10	37	1	1	1	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2021		171							e62291	10.3791/62291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SN5PC	WOS:000658340400048	34028433				2022-02-06	
J	Gallaher, JR; Yohann, A; Purcell, LN; Kumwenda, KK; Charles, A				Gallaher, Jared R.; Yohann, Avital; Purcell, Laura N.; Kumwenda, Ken-Kellar; Charles, Anthony			Trends in head injury associated mortality in Malawi	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Sub-saharan Africa; TBI; Head trauma	TRAUMATIC BRAIN-INJURY; SUB-SAHARAN AFRICA; CRITICAL-CARE; EPIDEMIOLOGY; MANAGEMENT; OUTCOMES; DISEASE; SURGERY; IMPACT	Background: To address the problem of surgical workforce deficiencies in Malawi, we partnered with local institutions to establish a surgical residency-training and educational program for local surgeons in 2009. While this program has improved trauma-associated outcomes, it is unclear whether, without additional system improvements, the management of traumatic brain injury (TBI) has similarly advanced. This study sought to describe trends of TBI-associated in-hospital trauma mortality at a tertiary trauma center in sub-Saharan Africa. Methods: We conducted a retrospective analysis of all patients recorded in the Kamuzu Central Hospital trauma surveillance registry in Lilongwe, Malawi, from 2012 through 2017. Modified Poisson regression modeling was used to compare the risk ratio of TBI associated in-hospital death each year compared to the year 2012, after adjusting for relevant covariates. Results: 87,295 patients were recorded into the KCH Trauma Registry. 3,393 patients with TBI were identified, and most TBI patients were young males. In 2013 (RR 0.66, 95% CI 0.48, 0.92) and 2014 (RR 0.57, 95% CI 0.41, 0.79), the adjusted risk ratio of in-hospital death decreased compared to 2012 when adjusted for age, sex, initial AVPU score, transfer status, and multisystem trauma. However, the adjusted risk ratio of mortality in 2015 (0.73, 95% CI 0.53, 1.02) plateaued, with relatively minor improvements in 2016 (0.72, 95% CI 0.54, 0.97) and 2017 (0.71, 95% CI 0.53, 0.96). Conclusions: A decrease in TBI associated mortality was associated with the establishment of a residency and educational training program for general surgery. This program increased available surgeons, improved critical care and trauma training, and integrated some neurosurgical training. However, improvements in outcomes plateaued in the last few years of the study, despite these enhancements to surgical care. The general surgery workforce must be supplemented with improved neurosurgical services and neurocritical care to decrease TBI-related mortality. (c) 2020 Elsevier Ltd. All rights reserved. Methods: We conducted a retrospective analysis of all patients recorded in the Kamuzu Central Hospital trauma surveillance registry in Lilongwe, Malawi, from 2012 through 2017. Modified Poisson regression modeling was used to compare the risk ratio of TBI associated in-hospital death each year compared to the year 2012, after adjusting for relevant covariates. Results: 87,295 patients were recorded into the KCH Trauma Registry. 3,393 patients with TBI were identified, and most TBI patients were young males. In 2013 (RR 0.66, 95% CI 0.48, 0.92) and 2014 (RR 0.57, 95% CI 0.41, 0.79), the adjusted risk ratio of in-hospital death decreased compared to 2012 when adjusted for age, sex, initial AVPU score, transfer status, and multisystem trauma. However, the adjusted risk ratio of mortality in 2015 (0.73, 95% CI 0.53, 1.02) plateaued, with relatively minor improvements in 2016 (0.72, 95% CI 0.54, 0.97) and 2017 (0.71, 95% CI 0.53, 0.96). Conclusions: A decrease in TBI associated mortality was associated with the establishment of a residency and educational training program for general surgery. This program increased available surgeons, improved critical care and trauma training, and integrated some neurosurgical training. However, improvements in outcomes plateaued in the last few years of the study, despite these enhancements to surgical care. The general surgery workforce must be supplemented with improved neurosurgical services and neurocritical care to decrease TBI-related mortality.	[Gallaher, Jared R.; Yohann, Avital; Purcell, Laura N.; Charles, Anthony] Univ N Carolina, Sch Med, Dept Surg, Chapel Hill, NC 27515 USA; [Kumwenda, Ken-Kellar; Charles, Anthony] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi		Gallaher, JR (corresponding author), Univ N Carolina, Sch Med, 4006 Burnett Womack Bldg CB 7228, Chapel Hill, NC 27515 USA.	jared_gallaher@med.unc.edu			Department of Surgery at the University of North Carolina; National Institutes of Health, Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW009340]	This work was funded by the Department of Surgery at the University of North Carolina and The National Institutes of Health, Fogarty International Center (Laura N. Purcell: Grant D43TW009340) .	Abdelgadir J, 2018, J CLIN NEUROSCI, V47, P79, DOI 10.1016/j.jocn.2017.10.004; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Chen WS, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0519-5; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Eaton J, 2017, WORLD NEUROSURG, V105, P257, DOI 10.1016/j.wneu.2017.05.153; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Funk LM, 2013, WORLD J SURG, V37, P2520, DOI 10.1007/s00268-013-2172-9; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Grimes CE, 2012, WORLD J SURG, V36, P8, DOI 10.1007/s00268-011-1330-1; Grudziak J, 2017, WORLD J SURG, V41, P3031, DOI 10.1007/s00268-017-4272-4; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hode L, 2017, WORLD NEUROSURG, V99, P210, DOI 10.1016/j.wneu.2016.11.083; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Karekezi C, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19853; Kelly CA, 2004, ANN EMERG MED, V44, P108, DOI 10.1016/j.annemergmed.2004.03.028; Lalani HS, 2019, ANN AM THORAC SOC, V16, P157, DOI 10.1513/AnnalsATS.201809-630LE; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ngwira GM, 2019, J AUSTRALAS COLL ROA, V30, P48, DOI 10.33492/JACRS-D-18-00297; Okafor UV, 2009, INDIAN J CRIT CARE M, V13, P25, DOI 10.4103/0972-5229.53112; Organization W.H, 2017, ATL COUNTR RES NEUR, V2nd; Prin M, 2016, WORLD J SURG, V40, P2635, DOI 10.1007/s00268-016-3578-y; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Smart LR, 2017, WORLD NEUROSURG, V105, P238, DOI 10.1016/j.wneu.2017.05.101; Touray S, 2018, J CRIT CARE, V47, P245, DOI 10.1016/j.jcrc.2018.07.022; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	36	1	1	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2021	52	5					1170	1175		10.1016/j.injury.2020.12.031			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	RX4BJ	WOS:000647170200012	33419564				2022-02-06	
J	Garcia-Vinuales, S; Sciacca, MFM; Lanza, V; Santoro, AM; Grasso, G; Tundo, GR; Sbardella, D; Coletta, M; Grasso, G; La Rosa, C; Milardi, D				Garcia-Vinuales, Sara; Sciacca, Michele F. M.; Lanza, Valeria; Santoro, Anna Maria; Grasso, Giulia; Tundo, Grazia R.; Sbardella, Diego; Coletta, Massimiliano; Grasso, Giuseppe; La Rosa, Carmelo; Milardi, Danilo			The interplay between lipid and A beta amyloid homeostasis in Alzheimer's Disease: risk factors and therapeutic opportunities	CHEMISTRY AND PHYSICS OF LIPIDS			English	Article						amyloid aggregation; lipid bilayer; membrane damage; small molecules; proteasome	INSULIN-DEGRADING ENZYME; UBIQUITIN-PROTEASOME SYSTEM; HIPPOCAMPAL SYNAPTIC PLASTICITY; TYPE-2 DIABETES-MELLITUS; PAIRED HELICAL FILAMENTS; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; APOLIPOPROTEIN-E; PRECURSOR PROTEIN; GM1 GANGLIOSIDE	Alzheimer's Diseases (AD) is characterized by the accumulation of amyloid deposits of A beta peptide in the brain. Besides genetic background, the presence of other diseases and an unhealthy lifestyle are known risk factors for AD development. Albeit accumulating clinical evidence suggests that an impaired lipid metabolism is related to A beta deposition, mechanistic insights on the link between amyloid fibril formation/clearance and aberrant lipid interactions are still unavailable. Recently, many studies have described the key role played by membrane bound A beta assemblies in neurotoxicity. Moreover, it has been suggested that a derangement of the ubiquitin proteasome pathway and autophagy is significantly correlated with toxic A beta aggregation and dysregulation of lipid levels. Thus, studies focusing on the role played by lipids in A beta aggregation and proteostasis could represent a promising area of investigation for the design of valuable treatments. In this review we examine current knowledge concerning the effects of lipids in A beta aggregation and degradation processes, focusing on the therapeutic opportunities that a comprehensive understanding of all biophysical, biochemical, and biological processes involved may disclose.	[Garcia-Vinuales, Sara; Sciacca, Michele F. M.; Lanza, Valeria; Santoro, Anna Maria; Grasso, Giulia; Milardi, Danilo] CNR, Ist Cristallog, Catania, Italy; [Tundo, Grazia R.; Coletta, Massimiliano] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Sbardella, Diego] IRCSS Fdn GB Bietti, Rome, Italy; [Grasso, Giuseppe; La Rosa, Carmelo] Univ Catania, Dept Chem, Catania, Italy		Milardi, D (corresponding author), CNR, Ist Cristallog, Catania, Italy.	danilo.milardi@cnr.it	La Rosa, Carmelo/A-2631-2012; Sciacca, Michele/AAF-3352-2021; Grasso, Giuseppe/E-3893-2010; SBARDELLA, Diego/K-7519-2016	La Rosa, Carmelo/0000-0002-7123-5347; Sciacca, Michele/0000-0002-9981-3321; Grasso, Giuseppe/0000-0002-7179-4835; SBARDELLA, Diego/0000-0002-9924-7761; Lanza, Valeria/0000-0002-4529-807X; COLETTA, Massimiliano/0000-0002-5489-9467; TUNDO, Grazia Raffaella/0000-0002-3866-3171; Santoro, Anna Maria/0000-0002-1014-197X	European UnionEuropean Commission [665403]	S.G.V. acknowledges the European Union Horizon 2020 research and innovation program for funding her Ph.D. fellowship under the Marie Sklodowska-Curie grant agreement INCIPIT n. 665403.	ALZHEIMER A, 1995, CLIN ANAT, V8, P429, DOI DOI 10.1002/CA.980080612; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Andrich K, 2015, ADV EXP MED BIOL, V863, P139, DOI 10.1007/978-3-319-18365-7_7; Angelisova P, 1999, BLOOD, V93, P1437, DOI 10.1182/blood.V93.4.1437a; Arai C, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-00443-1; Ariosa AR, 2016, J MOL MED, V94, P1217, DOI 10.1007/s00109-016-1461-9; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashok BS, 2017, CLIN EXP PHARMACOL P, V44, P327, DOI 10.1111/1440-1681.12717; Atwood CS, 2003, BRAIN RES REV, V43, P164, DOI 10.1016/S0165-0173(03)00206-6; Ayasolla KR, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-21; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Barbero-Camps E, 2018, AUTOPHAGY, V14, P1129, DOI 10.1080/15548627.2018.1438807; Barker R, 2010, BRAIN RES, V1355, P7, DOI 10.1016/j.brainres.2010.08.025; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bellia F, 2019, METALLOMICS, V11, P278, DOI 10.1039/c8mt00288f; Bellia F, 2014, J MASS SPECTROM, V49, P274, DOI 10.1002/jms.3338; Bellia F, 2013, J MASS SPECTROM, V48, P135, DOI 10.1002/jms.3060; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Bera S, 2020, ACS CHEM NEUROSCI, V11, P1965, DOI 10.1021/acschemneuro.0c00166; Bera S, 2016, PHYS CHEM CHEM PHYS, V18, P16890, DOI 10.1039/c6cp02023b; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bharadwaj P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66602-9; Bhattacharyya D, 2019, ACS CHEM NEUROSCI, V10, P2229, DOI 10.1021/acschemneuro.8b00733; Biessels GJ, 2018, NAT REV ENDOCRINOL, V14, P591, DOI 10.1038/s41574-018-0048-7; Bishop GM, 2002, NEUROBIOL AGING, V23, P1101, DOI 10.1016/S0197-4580(02)00050-7; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bonfili L, 2011, BIOCHIMIE, V93, P931, DOI 10.1016/j.biochi.2011.02.003; Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Brender JR, 2013, PHYS CHEM CHEM PHYS, V15, P8908, DOI 10.1039/c3cp44696d; Breydo L, 2015, FEBS LETT, V589, P2640, DOI 10.1016/j.febslet.2015.07.013; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P1309, DOI 10.1097/NEN.0b013e3181c22569; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Cabrol C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005274; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cai ZY, 2016, CELL MOL NEUROBIOL, V36, P483, DOI 10.1007/s10571-015-0233-3; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Cakir B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031787; Campos-Pena V, 2009, J ALZHEIMERS DIS, V18, P919, DOI 10.3233/JAD-2009-1198; Canolle B, 2004, J NEUROCHEM, V88, P1521, DOI 10.1046/j.1471-4159.2003.02301.x; Cao B, 2018, DIABETES OBES METAB, V20, P2467, DOI 10.1111/dom.13373; Cao JQ, 2019, NEUROSCI LETT, V703, P68, DOI 10.1016/j.neulet.2019.03.016; Casanova E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030532; Casarejos MJ, 2011, NEUROCHEM INT, V58, P512, DOI 10.1016/j.neuint.2011.01.008; Cazzaniga E, 2011, NEUROCHEM RES, V36, P863, DOI 10.1007/s11064-011-0415-4; Cecarini V, 2016, MOL NEUROBIOL, V53, P3168, DOI 10.1007/s12035-015-9227-x; Champagne D, 2003, NEUROSCIENCE, V121, P99, DOI 10.1016/S0306-4522(03)00361-0; Chatani Eri, 2018, Biophys Rev, V10, P527, DOI 10.1007/s12551-017-0353-8; Chatterjee S, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-014-0559-3; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Chen B, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1421430; Chen CH, 2016, RSC ADV, V6, P15240, DOI 10.1039/c5ra27689f; Chen YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168765; Cheng HP, 2007, NAT CLIN PRACT NEURO, V3, P374, DOI 10.1038/ncpneuro0549; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Christie G, 1999, J NEUROCHEM, V73, P195, DOI 10.1046/j.1471-4159.1999.0730195.x; Churm R, 2017, OBES REV, V18, P140, DOI 10.1111/obr.12474; Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cole GM, 2010, J NUTR, V140, P869, DOI 10.3945/jn.109.113910; Colombo L, 2017, BIOPHYS CHEM, V229, P11, DOI 10.1016/j.bpc.2017.05.001; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; COSTANZO LL, 1995, J INORG BIOCHEM, V57, P115, DOI 10.1016/0162-0134(94)00017-5; Cox SJ, 2020, BIOCHEMISTRY-US, V59, P2249, DOI 10.1021/acs.biochem.0c00328; Crutcher KA, 2010, BRAIN RES, V1306, P106, DOI 10.1016/j.brainres.2009.10.021; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Cummings J, 2019, ALZH DEMENT-TRCI, V5, P272, DOI 10.1016/j.trci.2019.05.008; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; DAHLMANN B, 1985, BIOCHEM J, V228, P171, DOI 10.1042/bj2280171; Dal Vechio FH, 2014, FREE RADICAL BIO MED, V67, P304, DOI 10.1016/j.freeradbiomed.2013.11.017; Dang Z, 2012, ACS MED CHEM LETT, V3, P925, DOI 10.1021/ml3001962; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101818; Dato A.D., 2017, SCI REP, V7, P17098, DOI [10.1038/s41598-017-17008-7, DOI 10.1038/S41598-017-17008-7.]; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Derosa G, 2008, CURR CLIN PHARMACOL, V3, P77, DOI 10.2174/157488408784293688; Di Natale G, 2010, J PHYS CHEM B, V114, P13830, DOI 10.1021/jp1033036; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Drolle E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182194; Du J, 2013, J PHARM PHARMACOL, V65, P1753, DOI 10.1111/jphp.12108; Dubnovitsky A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066101; Duraes F, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020044; Ebrahimpour-koujan S, 2018, PHYTOMEDICINE, V44, P39, DOI 10.1016/j.phymed.2018.03.050; Economou NJ, 2016, J AM CHEM SOC, V138, P1772, DOI 10.1021/jacs.5b11913; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; El Gaamouch F, 2016, J ALZHEIMERS DIS, V53, P15, DOI 10.3233/JAD-160169; Elbaum-Garfinkle S, 2010, BIOPHYS J, V98, P2722, DOI 10.1016/j.bpj.2010.03.013; Eskici G, 2012, BIOCHEMISTRY-US, V51, P6289, DOI 10.1021/bi3006169; Fabelo N, 2014, NEUROBIOL AGING, V35, P1801, DOI 10.1016/j.neurobiolaging.2014.02.005; Fabiani C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00309; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Ferreira-Marques M, 2016, AGING-US, V8, P1470, DOI 10.18632/aging.100996; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; Florenzano F, 2017, ONCOTARGET, V8, P64745, DOI 10.18632/oncotarget.17371; Fortin JS, 2015, CAN J DIABETES, V39, P373, DOI 10.1016/j.jcjd.2015.01.291; Foster EM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00164; Fotuhi M, 2020, J ALZHEIMERS DIS, V76, P3, DOI 10.3233/JAD-200581; Fragkouli A, 2014, NEUROBIOL DIS, V70, P179, DOI 10.1016/j.nbd.2014.06.021; Fraschini F, 2002, CLIN DRUG INVEST, V22, P51, DOI 10.2165/00044011-200222010-00007; Furman R, 2016, ACS CHEM NEUROSCI, V7, P367, DOI 10.1021/acschemneuro.5b00316; Garcia-Vinuales S, 2020, ACS CHEM NEUROSCI, V11, P2566, DOI 10.1021/acschemneuro.0c00232; Getz GS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113479; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Gioia M, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114225; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gizynska M, 2019, J MED CHEM, V62, P359, DOI 10.1021/acs.jmedchem.8b01025; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Glenner G G, 1989, Prog Clin Biol Res, V317, P857; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glynn SJ, 2015, ORG BIOMOL CHEM, V13, P3887, DOI 10.1039/c4ob02512a; Goh KP, 2014, INT J SPORT NUTR EXE, V24, P2, DOI 10.1123/ijsnem.2013-0045; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gosztyla ML, 2018, J ALZHEIMERS DIS, V62, P1495, DOI 10.3233/JAD-171133; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Grasso G, 2017, J INORG BIOCHEM, V174, P130, DOI 10.1016/j.jinorgbio.2017.06.007; Grasso G, 2015, CHEM COMMUN, V51, P15724, DOI 10.1039/c5cc06786c; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Grasso G, 2017, COORDIN CHEM REV, V347, P1, DOI 10.1016/j.ccr.2017.06.004; Grasso G, 2015, BIOPHYS CHEM, V203, P33, DOI 10.1016/j.bpc.2015.05.010; Grasso G, 2014, INT J MOL SCI, V15, P16787, DOI 10.3390/ijms150916787; Grasso G, 2014, METALLOMICS, V6, P1346, DOI 10.1039/c4mt00076e; Grasso G, 2012, J INORG BIOCHEM, V117, P351, DOI 10.1016/j.jinorgbio.2012.06.010; Grasso G, 2011, CHEM-EUR J, V17, P2752, DOI 10.1002/chem.201002809; Grasso G, 2009, J MASS SPECTROM, V44, P735, DOI 10.1002/jms.1550; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; GREGORI L, 1995, J BIOL CHEM, V270, P19702, DOI 10.1074/jbc.270.34.19702; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Grimm MOW, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00063; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; HAASS C, 1993, J BIOL CHEM, V268, P3021; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Habchi J, 2018, NAT CHEM, V10, P673, DOI 10.1038/s41557-018-0031-x; Haghighatdoost F, 2018, PHARMACOL RES, V129, P141, DOI [10.1016/j.phrs.2017.12.033, 10.1016/j.phrs.2017.11033]; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hegde AN, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00324; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hernandez-Diaz S, 2020, CELL STRESS, V4, P167, DOI 10.15698/cst2020.07.225; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Hillen H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01154; Hohn A, 2016, ANTIOXID REDOX SIGN, V25, P902, DOI 10.1089/ars.2016.6815; Hong S, 2014, NEURON, V82, P308, DOI 10.1016/j.neuron.2014.02.027; Honma Y, 2018, HEPATOL RES, V48, P94, DOI 10.1111/hepr.12892; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Hu ZP, 2015, MOL NEUROBIOL, V52, P1190, DOI 10.1007/s12035-014-8921-4; Huang L, 2007, FEBS LETT, V581, P4955, DOI 10.1016/j.febslet.2007.09.031; Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630; Hull RL, 2005, DIABETES, V54, P2235, DOI 10.2337/diabetes.54.7.2235; Hung CC, 2006, BIOCHEM SOC T, V34, P743, DOI 10.1042/BST0340743; Hureau C, 2012, COORDIN CHEM REV, V256, P2164, DOI 10.1016/j.ccr.2012.03.037; Hwang JS, 2016, PHARMACOL RES, V114, P47, DOI 10.1016/j.phrs.2016.10.014; Igbavboa U, 1996, J NEUROCHEM, V66, P1717; Itzhaki RF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00324; Izmitli A, 2011, BBA-BIOMEMBRANES, V1808, P26, DOI 10.1016/j.bbamem.2010.09.024; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jia YM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101122; Jiang T, 2014, PHARMACOL RES, V81, P54, DOI 10.1016/j.phrs.2014.02.008; Jiang YL, 2014, INT J BIOL SCI, V10, P268, DOI 10.7150/ijbs.7929; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jones CL, 2017, ACS CHEM BIOL, V12, P2240, DOI 10.1021/acschembio.7b00489; Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaether C, 2004, J CELL BIOL, V167, P809, DOI 10.1083/jcb.200410090; Kakinen A, 2018, NANO RES, V11, P3636, DOI 10.1007/s12274-017-1930-7; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kaleli HN, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030553; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Katsiki M, 2007, REJUV RES, V10, P157, DOI 10.1089/rej.2006.0513; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Khalifeh M, 2020, BIOESSAYS, V42, DOI 10.1002/bies.201900195; Khan AR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-16; Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Kitada M., 2016, ROLE SIRT1 REGULATOR, P89, DOI [10.1016/B978-0-12-802937-4.00003-X, DOI 10.1016/B978-0-12-802937-4.00003-X]; Klinkradt S, 1997, INT J BIOCHEM CELL B, V29, P611, DOI 10.1016/S1357-2725(96)00143-4; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kokubo Hideko, 2009, Int J Alzheimers Dis, V2009, DOI 10.4061/2009/689285; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; KOO EH, 1994, J BIOL CHEM, V269, P17386; Korshavn KJ, 2017, J BIOL CHEM, V292, P4638, DOI 10.1074/jbc.M116.764092; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Kou XJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090927; Krezel A, 2016, ARCH BIOCHEM BIOPHYS, V611, P3, DOI 10.1016/j.abb.2016.04.010; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kurtishi A, 2019, MOL NEUROBIOL, V56, P3676, DOI 10.1007/s12035-018-1334-z; Kushwah N, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010132; La Rosa C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4948323; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lahdo R, 2004, BIOCHEM J, V382, P987, DOI 10.1042/BJ20040777; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lane RM, 2005, J LIPID RES, V46, P949, DOI 10.1194/jlr.M400486-JLR200; Lanza V, 2018, CURR MED CHEM, V25, P525, DOI 10.2174/0929867324666170518094404; Lazar AN, 2013, ACTA NEUROPATHOL, V125, P133, DOI 10.1007/s00401-012-1041-1; Lazzaro S, 2019, ANAL BIOANAL CHEM, V411, P6353, DOI 10.1007/s00216-019-02030-7; Ledesma MD, 2003, EMBO REP, V4, P1190, DOI 10.1038/sj.embor.7400021; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee JH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092597; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee YH, 2019, MOL METAB, V27, pS92, DOI 10.1016/j.molmet.2019.06.014; Leestemaker Y, 2017, CELL CHEM BIOL, V24, P725, DOI 10.1016/j.chembiol.2017.05.010; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li HH, 2018, NEURAL REGEN RES, V13, P198, DOI 10.4103/1673-5374.226379; Li L, 2010, NEURODEGENER DIS, V7, P265, DOI 10.1159/000276710; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Li ZQ, 2020, FRONT MED-PRC, V14, P533, DOI 10.1007/s11684-020-0786-5; Limanaqi F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21083028; Liu D, 2013, NEUROBIOL AGING, V34, P1564, DOI 10.1016/j.neurobiolaging.2012.11.020; Liu FF, 2009, J PHYS CHEM B, V113, P11320, DOI 10.1021/jp905580j; Liu JL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00632; Liu YH, 2020, MOL NEUROBIOL, V57, P3150, DOI 10.1007/s12035-020-01942-1; Loera-Valencia R, 2019, J STEROID BIOCHEM, V190, P104, DOI 10.1016/j.jsbmb.2019.03.003; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lv W, 2019, CAN J PHYSIOL PHARM, V97, P82, DOI 10.1139/cjpp-2016-0686; Lv Y, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181061; Maianti JP, 2014, NATURE, V511, P94, DOI 10.1038/nature13297; Marlow L, 2003, J MOL NEUROSCI, V20, P233, DOI 10.1385/JMN:20:3:233; Martinez-Valbuena I, 2019, ANN NEUROL, V86, P539, DOI 10.1002/ana.25570; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P1935, DOI 10.1016/j.bbamem.2007.02.009; Matsuzaki K, 2014, ACCOUNTS CHEM RES, V47, P2397, DOI 10.1021/ar500127z; Matsuzaki K, 2010, BBA-MOL CELL BIOL L, V1801, P868, DOI 10.1016/j.bbalip.2010.01.008; McGurran H, 2020, CURR ALZHEIMER RES, V17, P407, DOI 10.2174/1567205017666200624200651; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Meraz-Rios MA, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00059; Milardi D, 2021, CHEM REV, V121, P1845, DOI 10.1021/acs.chemrev.0c00981; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Montine TJ, 2005, AM J PATHOL, V166, P1283, DOI 10.1016/S0002-9440(10)62347-4; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JE, 2012, J ALZHEIMERS DIS, V29, P487, DOI 10.3233/JAD-2011-111928; Morley JE, 2010, J ALZHEIMERS DIS, V19, P441, DOI [10.3233/JAD-2010-1230, 10.3233/JAD-2009-1230]; Morozov AV, 2016, J ALZHEIMERS DIS, V54, P763, DOI 10.3233/JAD-160491; Mputhia Z, 2019, MOLECULES, V24, DOI 10.3390/molecules24183372; Muller-Schiffmann A, 2016, BRAIN, V139, P509, DOI 10.1093/brain/awv355; Mura E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029661; Naletova I, 2016, METALLOMICS, V8, P750, DOI 10.1039/c6mt00067c; Naliyaeya NN, 2019, BRIT J PHARMACOL, V176, P3447, DOI 10.1111/bph.14593; Nam E, 2020, BIOCHEMISTRY-US, V59, P15, DOI 10.1021/acs.biochem.9b00775; Nam E, 2018, ACS CHEM NEUROSCI, V9, P2655, DOI 10.1021/acschemneuro.8b00122; Nam G, 2019, CHEM LETT, V48, P951, DOI 10.1246/cl.190281; Nath A, 2020, NEUROLOGY, V94, P809, DOI 10.1212/WNL.0000000000009455; Ng TP, 2014, J ALZHEIMERS DIS, V41, P61, DOI 10.3233/JAD-131901; Niu Z, 2018, BBA-BIOMEMBRANES, V1860, P1663, DOI 10.1016/j.bbamem.2018.04.004; Niu Z, 2014, ANGEW CHEM INT EDIT, V53, P9294, DOI 10.1002/anie.201311106; Njomen E, 2019, J MED CHEM, V62, P6469, DOI 10.1021/acs.jmedchem.9b00101; Njomen E, 2018, BIOCHEMISTRY-US, V57, P4214, DOI 10.1021/acs.biochem.8b00579; Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a; Nunan J, 2003, J NEUROSCI RES, V74, P378, DOI 10.1002/jnr.10646; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Obara A, 2015, BIOCHEM BIOPH RES CO, V460, P1047, DOI 10.1016/j.bbrc.2015.03.148; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; Olszewski W., 2010, PRZEGLAD KARDIODIABE, V5, P98; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Orkaby AR, 2017, NEUROLOGY, V89, P1877, DOI [10.1212/WNL.0000000000004586, 10.1212/wnl.0000000000004586]; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Pannuzzo M, 2013, PHYS CHEM CHEM PHYS, V15, P8940, DOI 10.1039/c3cp44539a; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Park CW, 2020, MOL BRAIN, V13, DOI 10.1186/s13041-020-00632-2; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Pena-Bautista C, 2019, CLIN CHIM ACTA, V491, P85, DOI 10.1016/j.cca.2019.01.021; Pervin M, 2018, MOLECULES, V23, DOI 10.3390/molecules23061297; Peters I, 2009, BBA-BIOMEMBRANES, V1788, P964, DOI 10.1016/j.bbamem.2009.01.012; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Poirier J, 2014, NEUROBIOL AGING, V35, pS3, DOI 10.1016/j.neurobiolaging.2014.03.037; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Qu XF, 2019, EXP THER MED, V18, P2719, DOI 10.3892/etm.2019.7846; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rahman MA, 2017, BMB REP, V50, P345, DOI 10.5483/BMBRep.2017.50.7.069; Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001; Reddy G, 2020, CURR OPIN STRUC BIOL, V60, P101, DOI 10.1016/j.sbi.2019.12.011; Reddy PH, 2018, J ALZHEIMERS DIS, V61, P843, DOI 10.3233/JAD-170512; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Reid PC, 2007, J CELL MOL MED, V11, P383, DOI 10.1111/j.1582-4934.2007.00054.x; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; Riemann D, 2001, BIOCHEM J, V354, P47, DOI 10.1042/0264-6021:3540047; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rohn TT, 2013, INT J MOL SCI, V14, P14908, DOI 10.3390/ijms140714908; Romanucci V, 2020, BIOPHYS CHEM, V265, DOI 10.1016/j.bpc.2020.106434; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sahoo BR, 2018, CHEM COMMUN, V54, P12883, DOI 10.1039/c8cc07921h; Sahoo BR, 2018, J MOL BIOL, V430, P4230, DOI 10.1016/j.jmb.2018.08.018; Salahuddin P, 2016, EUR J MED CHEM, V114, P41, DOI 10.1016/j.ejmech.2016.02.065; Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Sanchez-Mejia RO, 2010, BBA-MOL CELL BIOL L, V1801, P784, DOI 10.1016/j.bbalip.2010.05.013; Sani MA, 2011, FEBS LETT, V585, P749, DOI 10.1016/j.febslet.2011.02.011; Santoro AM, 2016, CHEM SCI, V7, P1286, DOI 10.1039/c5sc03312h; Santoro AM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197190; Santoro AM, 2020, CHEMMEDCHEM, V15, P302, DOI 10.1002/cmdc.201900612; Santoro AM, 2012, J AM CHEM SOC, V134, P10451, DOI 10.1021/ja300781u; Sarkar D, 2020, CHEMMEDCHEM, V15, P293, DOI 10.1002/cmdc.201900620; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sato K, 2012, J NEUROSCI RES, V90, P870, DOI 10.1002/jnr.22796; Sbardella D, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165793; Sbardella D, 2018, CELL MOL LIFE SCI, V75, P3441, DOI 10.1007/s00018-018-2807-y; Sbardella D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132455; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Schultz BG, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0110-3; Sciacca M.F.M., 2020, LIPID CHAPERON HYPOT, DOI [10.26434/chemrxiv.12770504.v1, DOI 10.26434/CHEMRXIV.12770504.V1]; Sciacca MFM, 2018, CHEM COMMUN, V54, P3629, DOI 10.1039/c8cc01132j; Sciacca MFM, 2018, BBA-BIOMEMBRANES, V1860, P1793, DOI 10.1016/j.bbamem.2018.03.012; Sciacca MFM, 2017, ACS CHEM NEUROSCI, V8, P1767, DOI 10.1021/acschemneuro.7b00110; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Sciacca MFM, 2012, ARCH BIOCHEM BIOPHYS, V521, P111, DOI 10.1016/j.abb.2012.03.022; Scollo F, 2018, J PHYS CHEM LETT, V9, P5125, DOI 10.1021/acs.jpclett.8b02241; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sgourakis NG, 2015, STRUCTURE, V23, P216, DOI 10.1016/j.str.2014.10.022; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shibuya Y, 2015, FUTURE MED CHEM, V7, P2451, DOI 10.4155/fmc.15.161; Shieh JCC, 2020, MOL NEUROBIOL, V57, P1966, DOI 10.1007/s12035-019-01858-5; Shinall H, 2005, BIOCHEMISTRY-US, V44, P15345, DOI 10.1021/bi050650l; Shpilka T, 2015, EMBO J, V34, P2117, DOI 10.15252/embj.201490315; Silswal N, 2018, SHOCK, V50, P579, DOI 10.1097/SHK.0000000000001080; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smith DM, 2018, J EXP NEUROSCI, V12, DOI 10.1177/1179069518794675; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Straub JE, 2014, J PHYS CHEM LETT, V5, P633, DOI 10.1021/jz500054d; Suh JM, 2019, INORG CHEM, V58, P8, DOI 10.1021/acs.inorgchem.8b02813; Sun JC, 2018, DEV NEUROBIOL, V78, P340, DOI 10.1002/dneu.22556; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Swomley AM, 2014, BBA-MOL BASIS DIS, V1842, P1248, DOI 10.1016/j.bbadis.2013.09.015; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Thibaudeau TA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03509-0; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tian J, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00165; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Trader DJ, 2017, BBA-GEN SUBJECTS, V1861, P892, DOI 10.1016/j.bbagen.2017.01.003; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Tun H, 2002, J MOL NEUROSCI, V19, P31, DOI 10.1007/s12031-002-0007-5; Tundo GR, 2020, PHARMACOL THERAPEUT, V213, DOI 10.1016/j.pharmthera.2020.107579; Tundo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034376; Tundo GR, 2018, TRENDS BIOCHEM SCI, V43, P852, DOI 10.1016/j.tibs.2018.08.002; Tundo GR, 2017, CRIT REV BIOCHEM MOL, V52, P554, DOI 10.1080/10409238.2017.1337707; Uddin MS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00004; Ugbaja SC, 2021, BIOPHYS CHEM, V270, DOI 10.1016/j.bpc.2020.106536; Ukkola O, 2011, MOL CELL ENDOCRINOL, V340, P26, DOI 10.1016/j.mce.2011.02.009; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Villari V, 2017, CHEMISTRYSELECT, V2, P9122, DOI 10.1002/slct.201701148; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang CQ, 2019, NUTR NEUROSCI, V22, P453, DOI 10.1080/1028415X.2017.1416942; Wang JH, 2018, J ALZHEIMERS DIS, V63, P773, DOI 10.3233/JAD-170786; Wang J, 2017, NAT REV NEUROL, V13, P612, DOI 10.1038/nrneurol.2017.111; Wang Q, 2012, J ASIAN NAT PROD RES, V14, P413, DOI 10.1080/10286020.2012.657180; Wang YQ, 2016, EUR REV MED PHARMACO, V20, P2389; Wang YW, 2018, CELL RES, V28, P1186, DOI 10.1038/s41422-018-0091-x; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Watanabe N, 1996, PLANT CELL PHYSIOL, V37, P147, DOI 10.1093/oxfordjournals.pcp.a028925; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; Wilk S, 1997, MOL BIOL REP, V24, P119, DOI 10.1023/A:1006851428691; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293; Wimo A, 2010, WORLD ALZHEIMER REPO; Witkowska J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05997-4; Wood WG, 2002, NEUROBIOL AGING, V23, P685, DOI 10.1016/S0197-4580(02)00018-0; Xolalpa W, 2013, CURR PHARM DESIGN, V19, P4053, DOI 10.2174/1381612811319220014; Yang DS, 2017, HUM MOL GENET, V26, P843, DOI 10.1093/hmg/ddx001; Yang H, 2011, CURR CANCER DRUG TAR, V11, P296, DOI 10.2174/156800911794519743; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yao JQ, 2012, J EXP MED, V209, P2501, DOI 10.1084/jem.20121239; Ye GZ, 2019, J CELL MOL MED, V23, P4313, DOI 10.1111/jcmm.14323; Yiannopoulou KG, 2020, J CENT NERV SYST DIS, V12, DOI 10.1177/1179573520907397; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yokoyama H, 2015, DIABETOL INT, V6, P268, DOI 10.1007/s13340-014-0194-7; Young LM, 2014, J AM CHEM SOC, V136, P660, DOI 10.1021/ja406831n; Zeng YC, 2008, J NEUROCHEM, V106, P1275, DOI 10.1111/j.1471-4159.2008.05481.x; Zhan XH, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00042; Zhang SM, 2019, J TISSUE ENG REGEN M, V13, P1759, DOI 10.1002/term.2906; Zhang ZX, 2017, NEUROCHEM RES, V42, P468, DOI 10.1007/s11064-016-2093-8; Zhao XB, 2010, ACS CHEM NEUROSCI, V1, P655, DOI 10.1021/cn100067e; Zhao XS, 2016, CLIN CHIM ACTA, V456, P107, DOI 10.1016/j.cca.2016.02.024; Zhou X, 2014, NEURAL REGEN RES, V9, P92, DOI 10.4103/1673-5374.125335; Zhu L, 2015, P NATL ACAD SCI USA, V112, P11965, DOI 10.1073/pnas.1510011112; Zipfel P, 2020, J MED CHEM, V63, P10705, DOI 10.1021/acs.jmedchem.0c00352	428	1	1	7	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-3084	1873-2941		CHEM PHYS LIPIDS	Chem. Phys. Lipids	MAY	2021	236								105072	10.1016/j.chemphyslip.2021.105072			26	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	RF4OK	WOS:000634819400010	33675779				2022-02-06	
J	Haas, E; Ziegler, W; Scholderle, T				Haas, Elisabet; Ziegler, Wolfram; Schoelderle, Theresa			Developmental Courses in Childhood Dysarthria: Longitudinal Analyses of Auditory-Perceptual Parameters	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; CEREBRAL-PALSY; 4-YEAR-OLD CHILDREN; SPEAKING RATE; SPEECH; INTELLIGIBILITY; CLASSIFICATION; COMMUNICATION; RELIABILITY; LANGUAGE	Purpose: The aim of this longitudinal study was to describe developmental courses of childhood dysarthria against the background of typical speech motor development by collecting auditory-perceptual data. Method: Fourteen children (four girls, 10 boys; 5;1-8;4 [years; months] at Time 1) with neurological conditions (CNC) and 14 typically developing children (CTD) matched for age and gender were assessed at three points in time over an 18-month period. Speech samples were collected using the Bogenhausener Dysarthrie Skalen-Kindliche Dysarthrien (BoDyS-KiD; in English: Bogenhausen Dysarthria Scales-Childhood Dysarthria), a German tool for the assessment of childhood dysarthria, and analyzed by means of nine perceptual scales covering all clinically relevant speech components. Age normalization was performed according to a method published recently. Data from the matched controls were used to estimate whether the gradients of the CNC group's developmental trajectories exceeded those of typical development. Results: The children with neurological conditions presented heterogeneous speech profiles with a wide range of severity. At the group level, relatively stable trajectories of the age-normalized dysarthria total score were found over the observation period. The nine perceptual scales showed more or less parallel developments. All patients except two followed the growth curve describing the developmental course of the typically developing children. Conclusions: Most children took advantage of the developmental dynamics as they developed parallel to the age norm. With its comprehensive description of the developmental courses of 14 children with neurological conditions, this study may contribute to a more valid, statistically verified clinical assessment of the course of childhood dysarthria.	[Haas, Elisabet; Ziegler, Wolfram; Schoelderle, Theresa] Ludwig Maximilians Univ Munchen, Inst Phonet & Speech Proc, Clin Neuropsychol Res Grp, Munich, Germany		Haas, E (corresponding author), Ludwig Maximilians Univ Munchen, Inst Phonet & Speech Proc, Clin Neuropsychol Res Grp, Munich, Germany.	elisabet.haas@ekn-muenchen.de		Haas, Elisabet/0000-0002-8667-772X	German National Academic Foundation; German Research FoundationGerman Research Foundation (DFG) [SCHO 17421/1-1, ZI 469/17-1]; Reha Hilfe e.V.; Stefanie Baumeister	This research was supported by a PhD fellowship from the German National Academic Foundation awarded to the first author, as well as a grant from the German Research Foundation awarded to the second and the last authors (SCHO 17421/1-1, ZI 469/17-1). The authors thank the children and their families who participated in the study. Further thanks are due to Stefanie Baumeister and the Reha Hilfe e.V. for their support.	Allison KM, 2018, J SPEECH LANG HEAR R, V61, P2837, DOI 10.1044/2018_JSLHR-S-17-0356; Allison KM, 2018, J SPEECH LANG HEAR R, V61, P462, DOI 10.1044/2017_JSLHR-S-16-0414; Allison KM, 2014, INT J SPEECH-LANG PA, V16, P396, DOI 10.3109/17549507.2013.876667; Baty F, 2015, J STAT SOFTW, V66, P1; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; BLUMBERG ML, 1955, AMA AM J DIS CHILD, V89, P48, DOI 10.1001/archpedi.1955.02050110064009; Braza MD, 2019, AM J SPEECH-LANG PAT, V28, P1139, DOI 10.1044/2019_AJSLP-18-0233; Bunton K, 2007, J SPEECH LANG HEAR R, V50, P1481, DOI 10.1044/1092-4388(2007/102); Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Cahill LM, 2003, J HEAD TRAUMA REHAB, V18, P268, DOI 10.1097/00001199-200305000-00005; Chen LM, 2018, J SPEECH LANG HEAR R, V61, P525, DOI 10.1044/2017_JSLHR-S-17-0065; Darling-White M, 2018, J SPEECH LANG HEAR R, V61, P2502, DOI 10.1044/2018_JSLHR-S-17-0003; Dickinson HO, 2007, LANCET, V369, P2171, DOI 10.1016/S0140-6736(07)61013-7; Duffy JR., 2013, MOTOR SPEECH DISORDE; Fauconnier J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1458; Fox-Boyer A. V., 2013, TROG D TEST UBERPRUF, V6; Gamer M., 2019, IRR VARIOUS COEFFICI; Haas E, 2020, SPRACHE-STIMME-GEHOR, V44, P189, DOI 10.1055/a-1207-3491; Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x; Hodge MM, 2014, J COMMUN DISORD, V51, P51, DOI 10.1016/j.jcomdis.2014.06.007; Hustad KC, 2020, J SPEECH LANG HEAR R, V63, P32, DOI 10.1044/2019_JSLHR-19-00033; Hustad KC, 2019, J SPEECH LANG HEAR R, V62, P1599, DOI 10.1044/2018_JSLHR-S-18-0319; Hustad KC, 2018, DEV MED CHILD NEUROL, V60, P1156, DOI 10.1111/dmcn.13904; Hustad KC, 2017, DEV NEUROREHABIL, V20, P323, DOI 10.1080/17518423.2016.1239135; Hustad KC, 2012, J SPEECH LANG HEAR R, V55, P1177, DOI 10.1044/1092-4388(2011/11-0083); Hustad KC, 2010, J SPEECH LANG HEAR R, V53, P1496, DOI 10.1044/1092-4388(2010/09-0176); Kent R. D., 1995, J MED SPEECH-LANG PA, V3, P145; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lee JM, 2014, J SPEECH LANG HEAR R, V57, P1666, DOI 10.1044/2014_JSLHR-S-13-0292; Lee J, 2013, FOLIA PHONIATR LOGO, V65, P32, DOI 10.1159/000334531; Levy ES, 2016, COMMUN DISORD Q, V37, P171, DOI 10.1177/1525740115618917; Mahr TJ, 2020, J SPEECH LANG HEAR R, V63, P2880, DOI 10.1044/2020_JSLHR-20-00181; Martins IP, 2007, CHILD NEUROPSYCHOL, V13, P319, DOI 10.1080/09297040600837370; Mazzoni D., 2015, AUDACITY VERSION 2 0; Mei C, 2014, INT J SPEECH-LANG PA, V16, P427, DOI 10.3109/17549507.2014.917439; Morgan AT, 2010, FOLIA PHONIATR LOGO, V62, P120, DOI 10.1159/000287210; MURDOCH BE, 1994, EUR J DISORDER COMM, V29, P379; Natzke P, 2020, LANG SPEECH HEAR SER, V51, P882, DOI 10.1044/2020_LSHSS-19-00102; Netelenbos N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00172; Nip ISB, 2017, DEV NEUROREHABIL, V20, P1, DOI 10.3109/17518423.2015.1022809; Nip ISB, 2012, J MED SPEECH-LANG PA, V20, P88; Nordberg A, 2013, ACTA PAEDIATR, V102, P161, DOI 10.1111/apa.12076; Nordberg A, 2014, INT J SPEECH-LANG PA, V16, P386, DOI 10.3109/17549507.2014.917440; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Patel RR, 2014, J VOICE, V28, P476, DOI 10.1016/j.jvoice.2013.12.010; Patel R, 2012, J MED SPEECH-LANG PA, V20, P95; Pennington L, 2001, INT J LANG COMM DIS, V36, P371; Pennington L, 2013, RES DEV DISABIL, V34, P3202, DOI 10.1016/j.ridd.2013.06.035; Richter S, 2005, BRAIN LANG, V92, P153, DOI 10.1016/j.bandl.2004.06.015; Romski MA, 2005, INFANT YOUNG CHILD, V18, P174, DOI 10.1097/00001163-200507000-00002; Scholderle T, 2020, J SPEECH LANG HEAR R, V63, P1071, DOI 10.1044/2020_JSLHR-19-00114; Sigurdardottir S, 2011, DEV MED CHILD NEUROL, V53, P74, DOI 10.1111/j.1469-8749.2010.03790.x; Solomon NP, 1998, AM J SPEECH-LANG PAT, V7, P61, DOI 10.1044/1058-0360.0702.61; Tuszynski J., 2018, **DATA OBJECT**; van Mourik M, 1998, PEDIATR NEUROL, V18, P411, DOI 10.1016/S0887-8994(97)00232-4; WORKINGER MS, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P109; Ziegler W, 2017, J SPEECH LANG HEAR R, V60, P1516, DOI 10.1044/2017_JSLHR-S-16-0336; ZYSKI BJ, 1987, J COMMUN DISORD, V20, P367, DOI 10.1016/0021-9924(87)90025-6	59	1	1	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	MAY	2021	64	5					1421	1435		10.1044/2020_JSLHR-20-00492			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	UO8OU	WOS:000694951500001	33831306				2022-02-06	
J	Hentig, J; Cloghessy, K; Dunseath, C; Hyde, DR				Hentig, James; Cloghessy, Kaylee; Dunseath, Chloe; Hyde, David R.			A Scalable Model to Study the Effects of Blunt-Force Injury in Adult Zebrafish	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article							TRAUMATIC BRAIN-INJURY; GLIA; NEUROGENESIS; REGENERATION; CELLS	Blunt-force traumatic brain injuries (TBI) are the most common form of head trauma, which spans a range of severities and results in complex and heterogenous secondary effects. While there is no mechanism to replace or regenerate the lost neurons following a TBI in humans, zebrafish possess the ability to regenerate neurons throughout their body, including the brain. To examine the breadth of pathologies exhibited in zebrafish following a blunt-force TBI and to study the mechanisms underlying the subsequent neuronal regenerative response, we modified the commonly used rodent Marmarou weight drop for the use in adult zebrafish. Our simple blunt-force TBI model is scalable, inducing a mild, moderate, or severe TBI, and recapitulates many of the phenotypes observed following human TBI, such as contactand post-traumatic seizures, edema, subdural and intracerebral hematomas, and cognitive impairments, each displayed in an injury severity-dependent manner. TBI sequelae, which begin to appear within minutes of the injury, subside and return to near undamaged control levels within 7 days post-injury. The regenerative process begins as early as 48 hours post-injury (hpi), with the peak cell proliferation observed by 60 hpi. Thus, our zebrafish blunt-force TBI model produces characteristic primary and secondary injury TBI pathologies similar to human TBI, which allows for investigating disease onset and progression, along with the mechanisms of neuronal regeneration that is unique to zebrafish.	[Hentig, James; Cloghessy, Kaylee; Hyde, David R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Hentig, James; Cloghessy, Kaylee; Dunseath, Chloe; Hyde, David R.] Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA; [Hentig, James; Cloghessy, Kaylee; Dunseath, Chloe; Hyde, David R.] Univ Notre Dame, Ctr Stem Cells & Regenerat Med, Notre Dame, IN 46556 USA		Hyde, DR (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Hyde, DR (corresponding author), Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA.; Hyde, DR (corresponding author), Univ Notre Dame, Ctr Stem Cells & Regenerat Med, Notre Dame, IN 46556 USA.	dhyde@nd.edu			Center for Zebrafish Research at the University of Notre Dame; Center for Stem Cells and Regenerative Medicine at the University of Notre Dame; National Eye Institute of NIH [R01-EY018417]; National Science Foundation Graduate Research Fellowship ProgramNational Science Foundation (NSF); LTC Neil Hyland Fellowship of Notre Dame; Sentinels of Freedom Fellowship; Pat Tillman Scholarship	The authors would like to thank the Hyde lab members for their thoughtful discussions, the Freimann Life Sciences Center technicians for zebrafish care and husbandry, and the University of Notre Dame Optical Microscopy Core/NDIIF for the use of instruments and their services. This work was supported by the Center for Zebrafish Research at the University of Notre Dame, the Center for Stem Cells and Regenerative Medicine at the University of Notre Dame, and grants from National Eye Institute of NIH R01-EY018417 (DRH), the National Science Foundation Graduate Research Fellowship Program (JTH), LTC Neil Hyland Fellowship of Notre Dame (JTH), Sentinels of Freedom Fellowship (JTH), and the Pat Tillman Scholarship (JTH).	Alyenbaawi H, 2021, ELIFE, V10, DOI 10.7554/eLife.58744; Amamoto R, 2016, ELIFE, V5, DOI 10.7554/eLife.13998; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Campbell LJ, 2021, GLIA, V69, P546, DOI 10.1002/glia.23912; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Faul M, 2010, TRAUMATIC BRAIN INJU; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Ganz J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019018; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Green LA, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000159; Hentig JT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091445; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kaslin J, 2017, DEVELOPMENT, V144, P1462, DOI 10.1242/dev.144907; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lahne M, 2020, ANNU REV VIS SCI, V6, P171, DOI 10.1146/annurev-vision-121219-081808; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; Mussulini BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054515; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Skaggs K, 2014, GLIA, V62, P2061, DOI 10.1002/glia.22726; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	28	1	1	1	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2021		171							e62709	10.3791/62709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SN5PC	WOS:000658340400101	34125106				2022-02-06	
J	Herrold, AA; Kletzel, SL; Foecking, EM; Saban, KL; Przybycien-Szymanska, MM; Zilliox, M; Bhaumik, D; Lange, D; Radke, JR; Salinas, I; Pape, TBL				Herrold, Amy A.; Kletzel, Sandra L.; Foecking, Eileen M.; Saban, Karen L.; Przybycien-Szymanska, Magdalena M.; Zilliox, Michael; Bhaumik, Dulal; Lange, Dustin; Radke, Jay R.; Salinas, Ilse; Bender Pape, Theresa L.			miRNAs as Potential Biomarkers for Traumatic Brain Injury: Pathway From Diagnosis to Neurorehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						biomarker; genetics; microRNA; miRNA; TBI; traumatic brain injury	MICRORNA EXPRESSION; CEREBROSPINAL-FLUID; DOWN-REGULATION; CELL-DEATH; IN-VITRO; HIPPOCAMPUS; MIR-21; MILD; MANAGEMENT; APOPTOSIS	Background: Biomarkers that can advance precision neurorehabilitation of the traumatic brain injury (TBI) are needed. MicroRNAs (miRNAs) have biological properties that could make them well suited for playing key roles in differential diagnoses and prognoses and informing likelihood of responsiveness to specific treatments. Objective: To review the evidence of miRNA alterations after TBI and evaluate the state of science relative to potential neurorehabilitation applications of TBI-specific miRNAs. Methods: This scoping review includes 57 animal and human studies evaluating miRNAs after TBI. PubMed, Scopus, and Google Scholar search engines were used. Results: Gold standard analytic steps for miRNA biomarker assessment are presented. Published studies evaluating the evidence for miRNAs as potential biomarkers for TBI diagnosis, severity, natural recovery, and treatment-induced outcomes were reviewed including statistical evaluation. Growing evidence for specific miRNAs, including miR21, as TBI biomarkers is presented. Conclusions: There is evidence of differential miRNA expression in TBI in both human and animal models; however, gaps need to be filled in terms of replication using rigorous, standardized methods to isolate a consistent set of miRNA changes. Longitudinal studies in TBI are needed to understand how miRNAs could be implemented as biomarkers in clinical practice.	[Herrold, Amy A.; Kletzel, Sandra L.; Foecking, Eileen M.; Saban, Karen L.; Bhaumik, Dulal; Radke, Jay R.; Bender Pape, Theresa L.] Edward Hines Jr VA Hosp, Res Serv, 5000 S 5th Ave,MC 151H, Hines, IL 60141 USA; [Herrold, Amy A.; Kletzel, Sandra L.; Saban, Karen L.; Bhaumik, Dulal; Radke, Jay R.; Bender Pape, Theresa L.] Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, 5000 S 5th Ave,MC 151H, Hines, IL 60141 USA; [Herrold, Amy A.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Bender Pape, Theresa L.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Foecking, Eileen M.] Loyola Univ Chicago, Dept Otolaryngol Head & Neck Surg, Maywood, IL USA; [Foecking, Eileen M.; Salinas, Ilse] Chicago Assoc Res & Educ Sci CARES, Hines, IL USA; [Saban, Karen L.] Loyola Univ Chicago, Marcella Niehoff Sch Nursing, Maywood, IL USA; [Przybycien-Szymanska, Magdalena M.] Loyola Univ, Dept Neurol Surg, Stritch Sch Med, Maywood, IL 60153 USA; [Zilliox, Michael] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL USA; [Bhaumik, Dulal] Edward Hines Jr VA Hosp, Coordinating Ctr, Cooperat Studies Program, Hines, IL USA; [Bhaumik, Dulal] Univ Illinois Chicago UIC, Dept Psychiat, Chicago, IL USA; [Lange, Dustin] Univ Illinois, Chez Vet Ctr, Urbana, IL 61801 USA; [Radke, Jay R.] Loyola Univ Chicago, Stritch Sch Med, Infect Dis & Immunol Res Inst, Maywood, IL USA; [Radke, Jay R.] Loyola Univ Chicago, Stritch Sch Med, Div Infect Dis, Maywood, IL USA		Pape, TBL (corresponding author), Edward Hines Jr VA Hosp, Res Serv, 5000 S 5th Ave,MC 151H, Hines, IL 60141 USA.; Pape, TBL (corresponding author), Edward Hines Jr VA Hosp, Ctr Innovat Complex Chron Healthcare, 5000 S 5th Ave,MC 151H, Hines, IL 60141 USA.	amy.herrold@va.gov; sandra.kletzel@va.gov; efoecking@luc.edu; KSABAN@luc.edu; magdalena.szymanska@abbott.com; mizilliox@luc.edu; dbhaumik@uic.edu; dlange2@gmail.com; Jay.Radke@va.gov; igsalin2@gmail.com; Therresa.BenderPape@va.gov					Amur S, 2015, CLIN PHARMACOL THER, V98, P34, DOI 10.1002/cpt.136; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Boone DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06341-6; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2019, J NEUROTRAUM, V36, P1291, DOI 10.1089/neu.2018.5728; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Honeybul S, 2016, J CLIN NEUROSCI, V28, P12, DOI 10.1016/j.jocn.2016.01.002; Hu T, 2015, J MOL NEUROSCI, V57, P114, DOI 10.1007/s12031-015-0584-8; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Johnson D, 2017, J TRAUMA ACUTE CARE, V83, pS145, DOI 10.1097/TA.0000000000001475; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Lv JF, 2018, BRAIN RES, V1685, P91, DOI 10.1016/j.brainres.2018.01.032; Ma J, 2016, AM J TRANSL RES, V8, P1895; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Osei J, 2018, EXPERT OPIN BIOL TH, V18, P159, DOI 10.1080/14712598.2018.1484102; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Qin XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204051; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Stoicea N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00011; Sun LQ, 2018, BEHAV BRAIN RES, V340, P126, DOI 10.1016/j.bbr.2016.09.020; Sun LQ, 2017, ONCOTARGET, V8, P59181, DOI 10.18632/oncotarget.19469; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Wang L, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00053; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; You WD, 2016, CHIN J TRAUMATOL, V19, P11, DOI 10.1016/j.cjtee.2016.01.004; Yu YH, 2017, BIOCHEM BIOPH RES CO, V491, P478, DOI 10.1016/j.bbrc.2017.07.021; Zhang J, 2019, BIOMARKERS, V24, P166, DOI 10.1080/1354750X.2018.1531929	72	1	1	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		E155	E169		10.1097/HTR.0000000000000632			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900006	33201038				2022-02-06	
J	Hromas, GA; Houck, ZM; Asken, BM; Svingos, AM; Greif, SM; Heaton, SC; Jaffee, MS; Bauer, RM				Hromas, Gabrielle A.; Houck, Zachary M.; Asken, Breton M.; Svingos, Adrian M.; Greif, Sarah M.; Heaton, Shelley C.; Jaffee, Michael S.; Bauer, Russell M.			Making a Difference: Affective Distress Explains Discrepancy Between Objective and Subjective Cognitive Functioning After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affective distress; cognitive symptoms; concussion; mild traumatic brain injury; performance-based; self-report	CONCUSSION; DEPRESSION; PERFORMANCE; SYMPTOMS; ADULTS; RELIABILITY; COMPLAINTS; DISORDER; VALIDITY; MODERATE	Objective: To assess the relationship between subjective cognitive symptoms and objective cognitive test scores in patients after concussion. We additionally examined factors associated with subjective and objective cognitive dysfunction, as well as their discrepancy. Participants: Eighty-six individuals (65.1% female; 74.4% adult) from an interdisciplinary concussion clinic. Methods: Subjective and objective cognitive functioning was measured via the SCAT-Symptom Evaluation and the CNS Vital Signs Neurocognition Index (NCI), respectively. Cognitive discrepancy scores were derived by calculating standardized residuals (via linear regression) using subjective symptoms as the outcome and NCI score as the predictor. Hierarchical regression assessed predictors (age, education, time postinjury, attention-deficit/hyperactivity disorder, affective distress, and sleep disturbance) of cognitive discrepancy scores. Nonparametric analyses evaluated relationships between predictor variables, subjective symptoms, and NCI. Results: More severe affective and sleep symptoms (large and medium effects), less time postinjury (small effect), and older age (small effect) were associated with higher subjective cognitive symptoms. Higher levels of affective distress and less time since injury were associated with higher cognitive discrepancy scores (beta = .723, P < .001; beta = -.204, P < .05, respectively). Conclusion: Clinical interpretation of subjective cognitive dysfunction should consider these additional variables. Evaluation of affective distress is warranted in the context of higher subjective cognitive complaints than objective test performance.	[Hromas, Gabrielle A.; Houck, Zachary M.; Svingos, Adrian M.; Greif, Sarah M.; Heaton, Shelley C.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [Jaffee, Michael S.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Asken, Breton M.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Bauer, Russell M.] North Florida South Georgia Brain Rehabil Res Ctr, Gainesville, FL USA		Hromas, GA (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	galtomare@ufl.edu; zhouck@phhp.ufl.edu; basken8@phhp.ufl.edu; adriammchambers@phhp.ufl.edu; sgreif1021@ufl.edu; sheaton@phhp.ufl.edu; michaeljaffee@neurology.ufl.edu; rbauer@phhp.ufl.edu		Svingos, Adrian/0000-0001-7271-2136	North Florida/South Georgia Brain Rehabilitation Research Center [B9256C]; University of Florida Clinical and Translational Science Institute [NCATS 2UL1TR001427-05]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [NIMH 1R01 MH118514-01A1]; Florida Alzheimer's Disease Research Center [NIA/NIH P50 AG047266]	Dr Russell Bauer is supported by the North Florida/South Georgia Brain Rehabilitation Research Center (B9256C), The University of Florida Clinical and Translational Science Institute (NCATS 2UL1TR001427-05), National Institute of Mental Health (NIMH 1R01 MH118514-01A1), and the Florida Alzheimer's Disease Research Center (NIA/NIH P50 AG047266). The authors acknowledge the help from the UFH-ICC's research assistants, for their organization and management of data collection and entry.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, pXIII; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Cohen J, 1998, STAT POWER ANAL BEHA; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Houck Z, 2019, BRAIN INJURY, V33, P480, DOI 10.1080/02699052.2019.1565897; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mendes T, 2008, AGING MENT HEALTH, V12, P177, DOI 10.1080/13607860701797281; Miskowiak KW, 2016, ACTA PSYCHIAT SCAND, V134, P511, DOI 10.1111/acps.12649; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Srisurapanont M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04353-w; Stenberg J, 2020, NEUROPSYCHOLOGY, V34, P560, DOI 10.1037/neu0000632; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Svendsen AM, 2012, NORD J PSYCHIAT, V66, P248, DOI 10.3109/08039488.2011.626870; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	40	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		186	195		10.1097/HTR.0000000000000618			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900012	32898033				2022-02-06	
J	Hunt, JC; Herrera-Hernandez, E; Brandolino, A; Jazinski-Chambers, K; Maher, K; Jackson, B; Smith, RN; Lape, D; Cook, M; Bergner, C; Schramm, AT; Brasel, KJ; de Moya, MA; deRoon-Cassini, TA				Hunt, Joshua C.; Herrera-Hernandez, Erick; Brandolino, Amber; Jazinski-Chambers, Kelley; Maher, Kathryn; Jackson, Brianna; Smith, Randi N.; Lape, Diane; Cook, Mackenzie; Bergner, Carisa; Schramm, Andrew T.; Brasel, Karen J.; de Moya, Marc A.; deRoon-Cassini, Terri A.			Validation of the Injured Trauma Survivor Screen: An American Association for the Surgery of Trauma multi-institutional trial	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						PTSD; depression; screen; traumatic injury; trauma centers	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; FOLLOW-UP; DEPRESSION; PTSD	BACKGROUND Psychological distress is common following a traumatic injury event. The Injured Trauma Survivor Screen (ITSS) was developed at a level 1 trauma center to assess for posttraumatic stress disorder (PTSD) and major depressive episode (MDE) following admission for a traumatic injury. The ITSS sensitivity and specificity were analyzed 1 to 3 and 6 to 9 months postinjury to test the validity across trauma centers. METHOD Four level 1 trauma centers from the East, Midwest, South, and West in the United States recruited 375 eligible adult inpatients (excluded participants included those with moderate or severe traumatic brain injury, whose injury was self-inflicted, were noncommunicative, or were non-English speaking). Baseline sample (White/Caucasian, 63.2%; male, 62.4%; mean (SD) age, 45 (17.11) years; injured by motor vehicle collision, 42.4%) measurements were conducted during index hospitalization. At first follow-up, 69.6% (n = 261) were retained; at second follow-up, 61.3% (n = 230) were retained. Measurements included the ITSS, PTSD Checklist for DSM-5, Center for Epidemiologic Studies Depression Scale-Revised, and Clinician-Administered PTSD Scaled for DSM 5. RESULTS At follow-up 1, the ITSS PTSD subscale had a sensitivity of 75% and specificity of 78.8%, and the MDE subscale had a sensitivity of 80.4% and specificity of 65.6%. At follow-up 2, the PTSD subscale had a sensitivity of 72.7% and specificity of 83.1%, and the MDE subscale had a sensitivity of 76.1% and specificity of 68.3%. A combined risk group using two symptom based measures administered at baseline produced increased specificity. CONCLUSION The nine-item ITSS continues to be an efficient and effective risk screen for PTSD and MDE following traumatic injury requiring hospitalization. This multi-institutional validation study creates a solid foundation for further exploration of the generalizability of this screen's psychometric properties in distinct populations.	[Hunt, Joshua C.] Milwaukee VA Med Ctr, Mental Hlth Div, Milwaukee, WI USA; [Herrera-Hernandez, Erick; Brandolino, Amber; Jazinski-Chambers, Kelley; Schramm, Andrew T.; de Moya, Marc A.; deRoon-Cassini, Terri A.] Med Coll Wisconsin, Dept Surg, Div Trauma & Acute Care Surg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Maher, Kathryn; Jackson, Brianna] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Smith, Randi N.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Lape, Diane; Cook, Mackenzie; Brasel, Karen J.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Bergner, Carisa] Med Coll Wisconsin, Comprehens Injury Ctr, Milwaukee, WI 53226 USA		deRoon-Cassini, TA (corresponding author), Med Coll Wisconsin, Dept Surg, Div Trauma & Acute Care Surg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	tcassini@mcw.edu		Jackson, Brianna/0000-0002-9803-676X			American College of Surgeons, 2014, RESOURCES OPTIMAL CA, V6; Blanchard EB, 1996, BEHAV RES THER, V34, P775, DOI 10.1016/0005-7967(96)00038-1; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Brasel KJ, 2010, J TRAUMA, V68, P263, DOI 10.1097/TA.0b013e3181caa58f; Eaton W. W., 2004, USE PSYCHOL TESTING, P363; Geier TJ, 2019, DEPRESS ANXIETY, V36, P170, DOI 10.1002/da.22873; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Hunt JC., 2015, THESIS U WISCONSIN M; Hunt JC, 2018, PSYCHOL TRAUMA-US, V10, P551, DOI 10.1037/tra0000310; Hunt JC, 2018, J TRAUMA ACUTE CARE, V85, P263, DOI 10.1097/TA.0000000000001944; Hunt JC, 2017, J TRAUMA ACUTE CARE, V82, P93, DOI 10.1097/TA.0000000000001306; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kiely JM, 2006, J TRAUMA, V61, P791, DOI 10.1097/01.ta.0000239360.29852.1d; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; O'Donnell ML, 2008, J CONSULT CLIN PSYCH, V76, P923, DOI 10.1037/a0012918; Osenbach JE, 2014, PSYCHIATRY, V77, P386, DOI 10.1521/psyc.2014.77.4.386; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589; van Dam NT, 2011, PSYCHIAT RES, V186, P128, DOI 10.1016/j.psychres.2010.08.018; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	24	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2021	90	5					797	806		10.1097/TA.0000000000003079			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	RZ1DQ	WOS:000648339300018	33797497				2022-02-06	
J	Jacob, L; Azouvi, P; Kostev, K				Jacob, Louis; Azouvi, Philippe; Kostev, Karel			Age-Related Changes in the Association Between Traumatic Brain Injury and Dementia in Older Men and Women	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						age-related changes; association; dementia; men; traumatic brain injury; women	MILD COGNITIVE IMPAIRMENT; SEX-DIFFERENCES; EARLIER AGE; RISK; HISTORY; DECLINE; CONSCIOUSNESS; METAANALYSIS; OUTCOMES; ADULTS	Objective: To investigate age-related changes in the association between traumatic brain injury (TBI) and dementia in older men and women separately. Setting: A total of 243 general practices in the UK. Participants: This study included 4760 patients who received a first TBI diagnosis between 1995 and 2010 (index date), and 4760 patients without TBI who were matched to those with TBI by age, sex, index year, Charlson Comorbidity Index, alcohol dependence, and physician (index date: a randomly selected visit date). Design: Retrospective cohort study. Main measures: Incidence of dementia in the decade following index date. Results: Within 10 years of index date, 8.8% of men with TBI and 4.8% of those without TBI were diagnosed with dementia, while the respective figures were 9.0% and 6.7% in women (P values < .01). There was a significant association between TBI and dementia in men (hazard ratio [HR] = 2.29, 95% confidence interval [CI]: 1.64-3.19) and in women (HR = 1.33, 95% CI: 1.07-1.64). Furthermore, the association between TBI and dementia was significant in men aged 60 to 70 (HR = 2.51, 95% CI: 1.27-4.96) and 71 to 80 years (HR = 3.00, 95% CI: 1.82-4.93), whereas the relationship was only significant and potentially unreliable in women aged 81 to 90 years (HR = 1.49, 95% CI: 1.03-2.14). Conclusions: The age-related relationship between TBI and dementia differed between men and women. More research of a prospective nature and including behavioral data is needed to better understand these differences.	[Jacob, Louis] Univ Versailles St Quentin Yvelines, Fac Med, Montigny Le Bretonneux, France; [Jacob, Louis] CIBERSAM, Res & Dev Unit, Parc Sanitari St Joan Deu, Barcelona, Spain; [Azouvi, Philippe] Hop Raymond Poincare, Dept Phys Med & Rehabil, Garches, France; [Azouvi, Philippe] Univ Versailles St Quentin Yvelines, EA4047, UFR Sci Sante, Handi Resp, Simone Veil, France; [Kostev, Karel] IQVIA, Epidemiol, Frankfurt, Germany		Kostev, K (corresponding author), IQVIA, Epidemiol, Main Airport Ctr, Unterschweinstiege 2-14, D-60549 Frankfurt, Germany.	louis.jacob.contacts@gmail.com; philippe.azouvi@aphp.fr; karel.kostev@iqvia.com	Jacob, Louis/AAL-3956-2020; Kostev, Karel/S-4755-2019	Jacob, Louis/0000-0003-1071-1239; Kostev, Karel/0000-0002-2124-7227			Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Eum RS, 2017, J HEAD TRAUMA REHAB, V32, P158, DOI 10.1097/HTR.0000000000000246; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Feng ZX, 2017, SSM-POPUL HLTH, V3, P9, DOI 10.1016/j.ssmph.2016.11.009; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gelfand J.M, 2012, PHARMACOEPIDEM DR S, P224, DOI DOI 10.1002/9781119959946.CH15; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hai S, 2017, INT J GERONTOL, V11, P215, DOI 10.1016/j.ijge.2016.12.002; Harmand MGC, 2014, J AM MED DIR ASSOC, V15, P504, DOI 10.1016/j.jamda.2014.02.006; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Hu YY, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7296-x; Johansson L, 2019, J ALZHEIMERS DIS, V69, P433, DOI 10.3233/JAD-190148; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Lawrence T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012197; Lee J, 2018, J GERONTOL NURS, V44, P22, DOI 10.3928/00989134-20180814-01; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Monson KL, 2019, CLIN BIOMECH, V64, P98, DOI 10.1016/j.clinbiomech.2018.02.011; Moreira NCF, 2016, ADV NUTR, V7, P507, DOI 10.3945/an.115.011254; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Riedel BC, 2016, J STEROID BIOCHEM, V160, P134, DOI 10.1016/j.jsbmb.2016.03.012; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Sanders CL, 2018, ALZ DIS ASSOC DIS, V32, P298, DOI [10.1097/WAD.0000000000000274, 10.1097/wad.0000000000000274]; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Song J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/261672; Spira AP, 2014, CURR OPIN PSYCHIATR, V27, P478, DOI 10.1097/YCO.0000000000000106; Sundstrom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008565; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Zhou Z, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017497	43	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		E139	E146		10.1097/HTR.0000000000000624			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900002	33201033				2022-02-06	
J	Jakob, DA; Lewis, M; Benjamin, ER; Demetriades, D				Jakob, Dominik A.; Lewis, Meghan; Benjamin, Elizabeth R.; Demetriades, Demetrios			Isolated traumatic brain injury: Routine intubation for Glasgow Coma Scale 7 or 8 may be harmful!	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Intubation; traumatic brain injury; GCS 7; 8	MORTALITY; ETHANOL; ALCOHOL; ASSOCIATION; MANAGEMENT; OUTCOMES	INTRODUCTION Despite strong recommendations, there is no direct evidence supporting routine intubation of trauma patients with Glasgow Coma Scale (GCS) score of 7 or 8. We hypothesized that routine intubation may not be beneficial in isolated blunt head injury. METHODS A retrospective Trauma Quality Improvement Program study, including adult blunt trauma patients with GCS score of 7 or 8 and isolated head injury, was performed. Epidemiological and clinical characteristics, neurosurgical procedures, timing of intubation, and outcome variables were collected. The study population was stratified by the intubation procedure: immediate intubation (<= 1 hour of admission), delayed intubation (>1 hour of admission), and no intubation. Multivariable regression analysis was used to determine risk factors for mortality and complications, as well as factors predictive of the decision to intubate. RESULTS Of 2,727 patients with GCS score of 7 or 8 and isolated blunt head trauma, 1,866 patients (68.4%) were intubated within 1 hour of admission (immediate intubation), 223 (8.2%) had an intubation >1 hour of admission (delayed intubation), and 638 patients (23.4%) were not intubated at all. After correcting for age, sex, overall comorbidities, tachycardia, GCS, alcohol, illegal drug use, and head injury severity, immediate intubation was independently associated with higher mortality (odds ratio, 1.79; 95% confidence interval, 1.31-2.44; p < 0.001) and more overall complications (odds ratio, 2.46; 95% confidence interval, 1.62-3.73; p < 0.001). Increasing head Abbreviated Injury Scale (AIS) score, GCS score of 7, and tachycardia were identified as independent clinical factors associated with the decision to intubate. A policy of intubating all isolated blunt head injury patients 45 years or younger with head AIS score of 5 and GCS score of 7 would have improved intubation management, with seven immediate instead of delayed intubations and only three potentially unnecessary intubations. CONCLUSION In patients with GCS score of 7 or 8 and isolated head injury, immediate intubation was associated with higher mortality and more overall complications. Intubation management could have been improved by intubating all patients younger than 45 years with head AIS score of 5 and a GCS score of 7 on admission.	[Jakob, Dominik A.; Lewis, Meghan; Benjamin, Elizabeth R.; Demetriades, Demetrios] Univ Southern Calif, Los Angeles Cty Univ Southern Calif Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, Los Angeles, CA USA		Demetriades, D (corresponding author), Los Angeles Cty Univ Southern Calif Med Ctr, Dept Surg, Div Trauma & Surg Crit Care, 2051 Marengo St,Inpatient Tower C,5th Floor, Los Angeles, CA 90033 USA.	Demetrios.Demetriades@med.usc.edu		Jakob, Dominik/0000-0001-5977-6135			American College of Surgeons Committee on Trauma, 2018, STUD COURS MAN ATLS, V10th ed; Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; Berry C, 2011, AM SURGEON, V77, P1416; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; De Jong A, 2018, CRIT CARE MED, V46, P532, DOI 10.1097/CCM.0000000000002925; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Hatchimonji JS, 2021, EUR J TRAUMA EMERG S, V47, P2073, DOI 10.1007/s00068-020-01383-4; Heffner AC, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.011; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Leskovan JJ, 2020, ANN MED SURG, V57, P201, DOI 10.1016/j.amsu.2020.07.031; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Mort Thomas C, 2007, J Intensive Care Med, V22, P208, DOI 10.1177/0885066607301359; Muakkassa FF, 2010, J TRAUMA, V68, P1305, DOI 10.1097/TA.0b013e3181dcd137; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Rotheray KR, 2012, RESUSCITATION, V83, P86, DOI 10.1016/j.resuscitation.2011.07.017; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Sise MJ, 2009, J TRAUMA, V66, P32, DOI 10.1097/TA.0b013e318191bb0c; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185	23	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2021	90	5					874	879		10.1097/TA.0000000000003123			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	RZ1DQ	WOS:000648339300027	33605710				2022-02-06	
J	Khan, M; Qiao, F; Islam, SMT; Dhammu, TS; Kumar, P; Won, J; Singh, AK; Singh, I				Khan, Mushfiquddin; Qiao, Fei; Islam, S. M. Touhidul; Dhammu, Tajinder S.; Kumar, Pavan; Won, Jeseong; Singh, Avtar K.; Singh, Inderjit			GSNOR and ALDH2 alleviate traumatic spinal cord injury	BRAIN RESEARCH			English	Article						Alda-1; ALDH2; BMS score; GSNOR; N6022; Pain; Reactive aldehydes; Reactive oxygen species; SCI; S-nitrosylation	ALDEHYDE DEHYDROGENASE 2; S-NITROSOGLUTATHIONE; PHARMACOLOGICAL INHIBITION; FUNCTIONAL RECOVERY; OXIDATIVE DAMAGE; RAT MODEL; PEROXYNITRITE; BRAIN; PROTECTS; ALDA-1	Traumatic spinal cord injury (SCI) enhances the activity of S-nitrosoglutathione reductase (GSNOR) and inhibits the mitochondrial aldehyde dehydrogenase 2 (ALDH2) activity, resulting in prolonged and sustained pain and functional deficits. This study's objective was to test the hypotheses that GSNOR's specific inhibitor N6022 mitigates pain and improves functional recovery in a mouse model of SCI. Furthermore, the degree of recovery is enhanced and the rate of recovery is accelerated by an ALDH2 activator Alda-1. Using both wild-type and GSNOR(-/-) mice, the SCI model deployed for groups was contusion at the T9-T10 vertebral level. The enzymatic activity of GSNOR and ALDH2 was measured, and the expression of GSNOR and ALDH2 was determined by western blot analysis. Functional improvements in experimental animals were assessed with locomotor, sensorimotor, and pain-like behavior tests. Wild-type SCI animals had enhanced GSNOR activity and decreased ALDH2 activity, leading to neurovascular dysfunction, edema, and worsened functional outcomes, including locomotor deficits and pain. Compared to wild-type SCI mice, GSNOR(-/-) mice had better functional outcomes. Monotherapy with either GSNOR inhibition by N6022 or enhanced ALDH2 activity by Alda-1 correlated well with functional recovery and lessened pain. However, combination therapy provided synergistic pain-relieving effects and more significant functional recovery compared with monotherapy. Conclusively, dysregulations in GSNOR and ALDH2 are among the causative mechanisms of SCI injury. Either inhibiting GSNOR or activating ALDH2 ameliorates SCI. Combining the specific inhibitor of GSNOR (N6022) with the selective activator of ALDH2 (Alda-1) provides greater protection to the neurovascular unit and confers greater functional recovery. The study is novel, and the combination therapy (N6022 + Alda-1) possesses translational potential.	[Khan, Mushfiquddin; Islam, S. M. Touhidul; Dhammu, Tajinder S.; Kumar, Pavan; Singh, Inderjit] Med Univ South Carolina, Dept Pediat, 513 Darby Childrens Res Inst DCRI,173 Ashley Ave, Charleston, SC 29425 USA; [Qiao, Fei; Won, Jeseong; Singh, Avtar K.] Med Univ South Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson VA Med Ctr, Charleston, SC USA		Khan, M (corresponding author), Med Univ South Carolina, Dept Pediat, 513 Darby Childrens Res Inst DCRI,173 Ashley Ave, Charleston, SC 29425 USA.	khanm@musc.edu; qiaof@musc.edu; islamt@musc.edu; dhammu@musc.edu; mathur@gmail.com; wonj@musc.edu; singha@musc.edu; singhi@musc.edu			South Carolina Spinal Cord Injury Research Fund Board (SCIRF) [2017]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS114433]; US Department of Veterans AffairsUS Department of Veterans Affairs [RX002090, BX003401]; NIH from Extramural Research Facilities Program of the National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [C06 RR018823, C06 RR015455]	This study was supported by grants from the South Carolina Spinal Cord Injury Research Fund Board (SCIRF #2017 to MK) and the NIH grant R21 NS114433 (JW and MK). This work was also supported, in part, by grants from the US Department of Veterans Affairs (RX002090 and BX003401). Animal work was also supported by the NIH, Grants C06 RR018823, and No C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Ai L, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0694-x; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Blonder JP, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-3; Bodas M, 2017, ANTIOXID REDOX SIGN, V27, P433, DOI 10.1089/ars.2016.6895; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3638; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI 10.1089/neu.2008-0870; Casin KM, 2018, CIRC RES, V123, P1232, DOI 10.1161/CIRCRESAHA.118.313956; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Chen QM, 2013, J APPL PHYSIOL, V114, P752, DOI 10.1152/japplphysiol.01302.2012; Chou PCT, 2011, J MAGN RESON IMAGING, V33, P1301, DOI 10.1002/jmri.22574; Colagiovanni DB, 2012, REGUL TOXICOL PHARM, V62, P115, DOI 10.1016/j.yrtph.2011.12.012; Cabrera-Aldana EE, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4792932; Green LS, 2012, BIOCHEMISTRY-US, V51, P2157, DOI 10.1021/bi201785u; Hayashida K, 2019, CIRCULATION, V139, P815, DOI 10.1161/CIRCULATIONAHA.117.032488; He MS, 2018, LIFE SCI, V215, P227, DOI 10.1016/j.lfs.2018.10.019; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hua Y, 2018, MOL MED REP, V18, P3159, DOI 10.3892/mmr.2018.9309; Khan M, 2020, BRAIN RES, V1741, DOI 10.1016/j.brainres.2020.146879; Khan M, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104470; Khan M, 2019, NEURAL REGEN RES, V14, P973, DOI 10.4103/1673-5374.250572; Khan M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0450-z; Khan M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0311-y; Khan M, 2015, DRUG DES DEV THER, V9, P2233, DOI 10.2147/DDDT.S77115; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lee JY, 2018, J NEUROTRAUM, V35, P508, DOI 10.1089/neu.2017.5235; Li Y, 2018, NEUROCHEM RES, V43, P1339, DOI 10.1007/s11064-018-2549-0; Lin YZ, 2018, NEUROSCIENCE, V384, P120, DOI 10.1016/j.neuroscience.2018.05.029; Liu XZ, 2017, NEURAL REGEN RES, V12, P1166, DOI 10.4103/1673-5374.211198; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P209, DOI 10.1002/jnr.20863; Lu Q, 2017, AM J RESP CELL MOL, V57, P662, DOI 10.1165/rcmb.2016-0342OC; Luo XJ, 2014, CURR DRUG TARGETS, V15, P948, DOI 10.2174/1389450115666140828142401; Molloy J, 1998, CIRCULATION, V98, P1372, DOI 10.1161/01.CIR.98.14.1372; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Oghbaei H, 2020, J DIABETES METAB DIS, V19, P105, DOI 10.1007/s40200-019-00481-4; Pajoohesh-Ganji A, 2010, NEUROSCI RES, V67, P117, DOI 10.1016/j.neures.2010.02.009; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Que LG, 2018, IMMUN INFLAMM DIS, V6, P322, DOI 10.1002/iid3.220; Rivera-Meza M, 2019, NEUROPHARMACOLOGY, V146, P175, DOI 10.1016/j.neuropharm.2018.12.001; Saxena N, 2018, FREE RADICAL BIO MED, V121, P57, DOI 10.1016/j.freeradbiomed.2018.04.558; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Staab CA, 2009, CHEM-BIOL INTERACT, V178, P29, DOI 10.1016/j.cbi.2008.10.050; Sun XC, 2011, ACS MED CHEM LETT, V2, P402, DOI 10.1021/ml200045s; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Zhang R, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00373; Zhang T, 2018, FREE RADICAL RES, V52, P629, DOI 10.1080/10715762.2018.1459042; Zhang YY, 2017, J NEUROSCI, V37, P9741, DOI 10.1523/JNEUROSCI.0681-17.2017	49	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 1	2021	1758								147335	10.1016/j.brainres.2021.147335			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QT3XL	WOS:000626522900008	33545099				2022-02-06	
J	Kirschen, MP; Myers, SR; Neuman, MI; Grubenhoff, JA; Mannix, R; Stence, N; Yang, E; Woodford, AL; Rogers, T; Nordell, A; Vossough, A; Zonfrillo, MR				Kirschen, Matthew P.; Myers, Sage R.; Neuman, Mark, I; Grubenhoff, Joseph A.; Mannix, Rebekah; Stence, Nicholas; Yang, Edward; Woodford, Ashley L.; Rogers, Tyson; Nordell, Anna; Vossough, Arastoo; Zonfrillo, Mark R.			Intracranial Traumatic Hematoma Detection in Children Using a Portable Near-infrared Spectroscopy Device	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							INTRACEREBRAL HEMORRHAGE; INFRASCANNER; ACCURACY; SCORE	Introduction: We sought to validate a handheld, near-infrared spectroscopy (NIRS) device for detecting intracranial hematomas in children with head injury. Methods: Eligible patients were those <18 years old who were admitted to the emergency department at three academic children's hospitals with head trauma and who received a clinically indicated head computed tomography (HCT). Measurements were obtained by a blinded operator in bilateral frontal, temporal, parietal, and occipital regions. Qualifying hematomas were a priori determined to be within the brain scanner's detection limits of >3.5 milliliters in volume and <2.5 centimeters from the surface of the brain. The device's measurements were positive if the difference in optical density between hemispheres was >0.2 on three successive scans. We calculated diagnostic performance measures with corresponding exact two-sided 95% Clopper-Pearson confidence intervals (CI). Hypothesis test evaluated whether predictive performance exceeded chance agreement (predictive Youden's index > 0). Results: A total of 464 patients were enrolled and 344 met inclusion for primary data analysis: 10.5% (36/344) had evidence of a hematoma on HCT, and 4.7% (16/344) had qualifying hematomas. The handheld brain scanner demonstrated a sensitivity of 58.3% (21/36) and specificity of 67.9% (209/308) for hematomas of any size. For qualifying hematomas the scanner was designed to detect, sensitivity was 81% (13/16) and specificity was 67.4% (221/328). Predictive performance exceeded chance agreement with a predictive Youden's index of 0.11 (95% CI, 0.10 - 0.15; P < 0.001) for all hematomas, and 0.09 (95% CI, 0.08 - 0.12; P < 0.001) for qualifying hematomas. Conclusion: The handheld brain scanner can non-invasively detect a subset of intracranial hematomas in children and may serve an adjunctive role to head-injury neuroimaging decision rules that predict the risk of clinically significant intracranial pathology after head trauma.	[Kirschen, Matthew P.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Kirschen, Matthew P.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Kirschen, Matthew P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Myers, Sage R.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Neuman, Mark, I; Mannix, Rebekah] Boston Childrens Hosp, Dept Pediat, Div Emergency Med, Boston, MA USA; [Grubenhoff, Joseph A.] Univ Colorado, Dept Pediat, Aurora, CO USA; [Stence, Nicholas] Childrens Hosp Colorado, Dept Radiol, Aurora, CO USA; [Yang, Edward] Boston Childrens Hosp, Dept Radiol, Boston, MA USA; [Woodford, Ashley L.] Rowan Univ, Cooper Med Sch, Camden, NJ USA; [Rogers, Tyson; Nordell, Anna] North Amer Sci Associates Inc, Minneapolis, MN USA; [Vossough, Arastoo] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Pediat, Alpert Med Sch, Providence, RI 02912 USA		Kirschen, MP (corresponding author), Childrens Hosp Philadelphia, Dept Crit Care Med, 3401 Civ Ctr Blvd,Wood 6108, Philadelphia, PA 19104 USA.	kirschenm@chop.edu	Grubenhoff, Joseph A/H-9994-2019	Grubenhoff, Joseph A/0000-0001-5072-4064	Infrascan Inc.	By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. Financial support for the study was provided by Infrascan Inc. Infrascan Inc. did not play any role in study design, data collection, data analysis, data interpretation, or writing of the report.	Ayaz H, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.5.051411; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Beslow LA, 2014, STROKE, V45, P66, DOI 10.1161/STROKEAHA.113.003448; Bressan S, 2014, CHILD NERV SYST, V30, P477, DOI [10.1007/s00381-014-2368-9, 10.1007/s00381-013-2314-2]; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Coskun F, 2010, SCI RES ESSAYS, V5, P1911; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Hu TT, 2016, BIOL RES NURS, V18, P5, DOI 10.1177/1099800415577634; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lewartowska-Nyga Dorota, 2017, Dev Period Med, V21, P51; Lindley AA, 1999, EARLY HUM DEV, V56, P17, DOI 10.1016/S0378-3782(99)00033-X; Marion DW, 2006, NEUROSURGERY, V58, P655; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P591, DOI 10.1089/neu.1995.12.591; Salonia R, 2012, J NEUROTRAUM, V29, P1047, DOI 10.1089/neu.2011.1890; Semenova ZB, 2016, BRAIN INJURY, V30, P18, DOI 10.3109/02699052.2014.989401; Shan GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127272; Ukwuoma OI, 2018, PEDIATR EMERG CARE; Wang JT, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.4.045001; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Won SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199809; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988	25	1	1	1	1	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	MAY	2021	22	3					782	791		10.5811/westjem.2020.11.47251			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SN5XX	WOS:000658363300049	34125061	Green Published, gold			2022-02-06	
J	Kuperman, P; Granovsky, Y; Fadel, S; Bosak, N; Buxbaum, C; Hadad, R; Sprecher, E; Bahouth, H; Ben Lulu, H; Yarnitsky, D; Granot, M				Kuperman, Pora; Granovsky, Yelena; Fadel, Shiri; Bosak, Noam; Buxbaum, Chen; Hadad, Rafi; Sprecher, Elliot; Bahouth, Hany; Ben Lulu, Hen; Yarnitsky, David; Granot, Michal			Head- and neck-related symptoms post-motor vehicle collision (MVC): Separate entities or two-sides of the same coin?	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Post-traumatic pain; Mild traumatic brain injury; Whiplash-associated disorder; Post-concussion syndrome; Motor vehicle collision	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; WHIPLASH-ASSOCIATED DISORDERS; CHRONIC PAIN; CONCUSSION SYMPTOMS; DISABILITY INDEX; RELIABILITY; VALIDATION; PREDICTORS	Background and Aim: Although post-motor vehicle collision (MVC) pain and symptoms are largely convergent among those with mild traumatic brain injury (mTBI) and whiplash associated disorder (WAD), and patients oftentimes report initial neck and head complaints, the clinical picture of mTBI and WAD has been primarily studied as separate conditions which may result in an incomplete clinical picture. As such, this study was conducted to explore the role of pain and post-traumatic psychological features in explaining both head and neck-related symptom variability in a cohort of post-collision patients. This is with the goal of disentangling if contributory factors are uniquely related to each diagnosis, or are shared between the two. Methods: Patients recruited in the very early acute phase (<72 h) returned for clinical and psychological assessment at 6 months post-accident. In order to determine which factors were unique and which ones were overlapping the same potential contributors: mean head pain, mean neck pain, female gender, number of post-collision painful body areas, PTSD, and depression were included in the regression models for both neck disability index (NDI) and Rivermead post-concussion symptoms questionnaire (RPQ). Results: Of 223 recruited participants, 70 returned for a follow-up visit (age range 18-64, mean(SD) 37.6 (11.9), 29F). This cohort primarily met the criteria for mTBI, but also fulfilled the criteria for whiplash, reinforcing the duality of injury presentation. Correlations existed between the NDI and RPQ scores (Spearman's rho=0.66, p<0.001), however overlap was only partial. Regression analysis showed that after the removal of area-of-injury pain neck related disability (r = 0.80, p <0.001) was explained solely by number of painful body areas (beta=0.52, p <0.001). In contrast, post-concussion syndrome symptoms (r = 0.86, p<0.001) are influenced by clinical pain, painful body areas (beta=0.31, p = 0.0026), female gender (beta=0.19, p = 0.0053), and psychological factors of depression (beta=0.31, p = 0.0028) and PTSD symptoms (beta=0.36, p = 0.0013). Conclusions: It seems that while mechanisms of neck- and head-related symptoms in post-collision patients do share a common explanatory feature, of residual body pain, they are not entirely overlapping. In that psychological factors influence post-concussion syndrome symptoms, but not post-whiplash neck disability. (C) 2021 Published by Elsevier Ltd.	[Kuperman, Pora; Granot, Michal] Univ Haifa, Fac Welf & Hlth Sci, Abba Khoushy Ave 199, IL-31905 Haifa, Israel; [Granovsky, Yelena; Fadel, Shiri; Yarnitsky, David] Technion Israel Inst Technol, Fac Med, Efron St 1, Haifa, Israel; [Bosak, Noam; Buxbaum, Chen; Hadad, Rafi; Sprecher, Elliot; Yarnitsky, David] Rambam Hlth Care Campus, Dept Neurol, Haifa, Israel; [Bahouth, Hany; Ben Lulu, Hen] Rambam Hlth Care Campus, Trauma & Emergency Surg, Haifa, Israel		Granot, M (corresponding author), Univ Haifa, Fac Welf & Hlth Sci, Abba Khoushy Ave 199, IL-31905 Haifa, Israel.	y_granovsky@rambam.health.gov.il; s_fadel@rambam.health.gov.il; elliots@luxsci.net; h_bahouth@rambam.health.gov.il; h_berkovich@rambam.health.gov.il; dy@rmc.gov.il; granot@research.haifa.ac.il		Buxbaum, Chen/0000-0003-0400-7405	Office of the Assistant Secretary of Defense for Health Affairs [W81XWH1510603]; Role of Funder was only monetary in nature	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under award W81XWH1510603. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. Role of Funder was only monetary in nature.	Beeckmans K, 2017, ACTA NEUROL BELG, V117, P493, DOI 10.1007/s13760-017-0745-3; Campbell L, 2018, CLIN J PAIN, V34, P755, DOI 10.1097/AJP.0000000000000597; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS97, DOI 10.1016/j.jmpt.2008.11.014; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Croft AC, 2016, J CHIROPR MED, V15, P95, DOI 10.1016/j.jcm.2016.04.011; Davis CG, 2013, J FORENSIC LEG MED, V20, P74, DOI 10.1016/j.jflm.2012.05.004; Duckworth MP, 2018, PSYCHOL INJ LAW, V11, P288, DOI 10.1007/s12207-018-9334-x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Holm LW, 2007, J RHEUMATOL, V34, P193; Iezzi T, 2018, PSYCHOL INJ LAW, V11, P202, DOI 10.1007/s12207-018-9331-0; Jagnoor J, 2015, INJURY, V46, P1871, DOI 10.1016/j.injury.2014.08.044; Kenardy J, 2015, ARCH PHYS MED REHAB, V96, P410, DOI 10.1016/j.apmr.2014.10.007; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuperman P, 2020, PAIN REP, V5, DOI 10.1097/PR9.0000000000000821; Kuperman P, 2018, NEUROLOGY, V91, pE931, DOI 10.1212/WNL.0000000000006120; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morin M, 2016, J SPORTS MED; Peixoto C, 2018, J PAIN RES, V11, P1927, DOI 10.2147/JPR.S165077; Sang CN, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-016-0601-9; Shahidi B, 2020, GREATER SEVERITY FUN; Shashua A, 2016, SPINE, V41, P1036, DOI 10.1097/BRS.0000000000001445; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sterling M, 2004, MANUAL THER, V9, P60, DOI 10.1016/j.math.2004.01.006; Stern AF, 2014, OCCUP MED-OXFORD, V64, P393, DOI 10.1093/occmed/kqu024; Tesarz J, 2015, PAIN, V156, P577, DOI 10.1097/01.j.pain.0000460350.30707.8d; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, 2015, GLOB STAT REP ROAD S	39	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2021	52	5					1227	1233		10.1016/j.injury.2021.03.003			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	RX4BJ	WOS:000647170200021	33731289				2022-02-06	
J	Lackner, I; Weber, B; Haffner-Luntzer, M; Hristova, S; Gebhard, F; Lam, C; Morioka, K; Marcucio, RS; Miclau, T; Kalbitz, M				Lackner, Ina; Weber, Birte; Haffner-Luntzer, Melanie; Hristova, Simona; Gebhard, Florian; Lam, Charles; Morioka, Kazuhito; Marcucio, Ralph S.; Miclau, Theodore; Kalbitz, Miriam			Systemic and local cardiac inflammation after experimental long bone fracture, traumatic brain injury and combined trauma in mice	JOURNAL OF ORTHOPAEDIC TRANSLATION			English	Article						Cytokines; Damage-associated molecular patterns; Heart-fatty acid binding protein; Secondary cardiac injury; Toll-like receptor; Troponin I	SYSTOLIC DYSFUNCTION; TROPONIN; BIOMARKER; DISEASES	Background: Trauma is the leading cause of death and disability worldwide, especially in the young population. Cardiac injuries are an independent predictor for a poor overall outcome after trauma. The aim of the present study was to analyze systemic inflammation as well as local cardiac inflammation after experimental limb-, neuroand combined trauma in mice. Methods: Male C57BL/6 mice received either a closed tibia fracture (Fx), isolated traumatic brain injury (TBI) or a combination of both (Fx+TBI). Control animals underwent sham procedure. After 6 and 24 h, systemic levels of inflammatory mediators were analyzed, respectively. Locally, cardiac inflammation and cardiac structural alterations were investigated in left ventricular tissue of mice 6 and 24 h after trauma. Results: Mice showed enhanced systemic inflammation after combined trauma, which was manifested by increased levels of KC, MCP-1 and G-CSF. Locally, mice exhibited increased expression of inflammatory cytokines (IL-1 beta, TNF) in heart tissue, which was probably mediated via toll-like receptor (TLR) signaling. Furthermore, mice demonstrated a redistribution of connexin 43 in cardiac tissue, which appeared predominantly after combined trauma. Besides inflammation and structural cardiac alterations, expression of glucose transporter 4 (GLUT4) mRNA was increased in the heart early after TBI and after combination of TBI and limb fracture, indicating a modification of energy metabolism. Early after combination of TBI and tibia fracture, nitrosative stress was increased, manifested by elevation of nitrotyrosine in cardiac tissue. Finally, mice showed a trend of increased systemic levels of cardiac troponin I and heart-fatty acid binding protein (HFABP) after combined trauma, which was associated with a significant decrease of troponin I and HFABP mRNA expression in cardiac tissue after TBI and combination of TBI and limb fracture. Conclusion: Mice exhibited early cardiac alterations as well as alterations in cardiac glucose transporter expression, indicating a modification of energy metabolism, which might be linked to increased systemic- and local cardiac inflammation after limb-, neuro- and combined trauma. These cardiac alterations might predispose individuals for secondary cardiac damage after trauma that might compromise cardiac function after TBI and long bone fracture. Translational potential statement: Injuries to the head and extremities frequently occur after severe trauma. In our study, we analyzed the effects of closed tibia fracture, isolated TBI, and the combination of both injuries with regard to the development of post-traumatic secondary cardiac injuries.	[Lackner, Ina; Weber, Birte; Hristova, Simona; Gebhard, Florian; Kalbitz, Miriam] Univ Med Ctr Ulm, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany; [Haffner-Luntzer, Melanie] Univ Med Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany; [Weber, Birte; Haffner-Luntzer, Melanie; Lam, Charles; Morioka, Kazuhito; Marcucio, Ralph S.; Miclau, Theodore; Kalbitz, Miriam] Univ Calif San Francisco, Orthopaed Trauma Inst, Dept Orthopaed Surg, San Francisco, CA 94143 USA		Kalbitz, M (corresponding author), Univ Ulm, Med Sch, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Albert Einstein Allee 23, D-89081 Ulm, Germany.	miriam.kalbitz@uniklinik-ulm.de	Haffner-Luntzer, Melanie/L-3562-2019	Haffner-Luntzer, Melanie/0000-0002-3333-2613; Morioka, Kazuhito/0000-0001-5407-8178; Lam, Charles/0000-0002-6897-2549; Lackner, Ina/0000-0001-6410-9222	Hertha-Nathorff program; DAADDeutscher Akademischer Austausch Dienst (DAAD)European Commission; Orthopaedic Trauma Institute at UCSF; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)German Research Foundation (DFG) [251293561, CN07]	This study was supported by the Hertha-Nathorff program (travel grant to MHL and MK), the DAAD (travel grant to BW) and the Orthopaedic Trauma Institute at UCSF. This work was also conducted in the framework of the CRC 1149 funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project number 251293561 (Project CN07). We thank Patricia Scheible for the excellent technical assistance.	Agullo-Pascual E, 2014, FEBS LETT, V588, P1322, DOI 10.1016/j.febslet.2014.02.008; Al-Thani H, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/430832; Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15; Banks WA, 2016, BRAIN BEHAV IMMUN, V52, P81, DOI 10.1016/j.bbi.2015.10.002; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Braun CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187327; Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916; De'Ath HD, 2012, BRIT J SURG, V99, P789, DOI 10.1002/bjs.8728; De'Ath HD, 2013, SHOCK, V39, P415, DOI 10.1097/SHK.0b013e31828ded41; Dyhrfort P, 2019, J NEUROTRAUM, V36, P2872, DOI 10.1089/neu.2018.6320; Fattahi F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4302726; Foertsch S, 2019, BRAIN BEHAV IMMUN; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; HACKENBERRY LE, 1982, CRIT CARE MED, V10, P641; Haffner-Luntzer M, 2016, BRIT J PHARMACOL, V173, P2237, DOI 10.1111/bph.13503; HERSCH C, 1961, CIRCULATION, V23, P853, DOI 10.1161/01.CIR.23.6.853; Kalbitz M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18088-1; Kalbitz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187270; Kalbitz M, 2017, WORLD J SURG, V41, P162, DOI 10.1007/s00268-016-3650-7; Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R; Kalbitz M, 2016, J IMMUNOL, V197, P2353, DOI 10.4049/jimmunol.1600091; Kirchhoff C, 2008, CRIT CARE, V12, DOI 10.1186/cc7013; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Kovtun A, 2016, EUR CELLS MATER, V32, P152, DOI 10.22203/eCM.v032a10; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Lackner I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00064; Lackner I, 2020, SHOCK, V53, P620, DOI 10.1097/SHK.0000000000001400; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Levy RJ, 2005, CRIT CARE MED, V33, P2752, DOI 10.1097/01.CCM.0000189943.60945.77; Liu M, 2020, CELL MOL NEUROBIOL, V40; MacGregor AJ, 2012, INJURY, V43, P1551, DOI 10.1016/j.injury.2011.04.017; Mair J, 2018, EUR HEART J-ACUTE CA, V7, P553, DOI 10.1177/2048872617748553; Mangmool S, 2016, MOL ENDOCRINOL, V30, P118, DOI 10.1210/me.2015-1201; Martin M, 2005, J TRAUMA, V59, P1086, DOI 10.1097/01.ta.0000190249.19668.37; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Morioka K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48126-z; Morshed S, 2009, J BONE JOINT SURG AM, V91A, P3, DOI 10.2106/JBJS.H.00338; Papp A, 2003, ACTA ANAESTH SCAND, V47, P1257, DOI 10.1046/j.1399-6576.2003.00235.x; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Prystaz K, 2018, AM J PATHOL, V188, P474, DOI 10.1016/j.ajpath.2017.10.011; Rugg-Gunn FJ, 2004, LANCET, V364, P2212, DOI 10.1016/S0140-6736(04)17594-6; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Suto Y, 2018, J TRAUMA ACUTE CARE, V85, P275, DOI 10.1097/TA.0000000000001957; Wang TD, 1997, INT J CARDIOL, V58, P308, DOI 10.1016/S0167-5273(96)02879-3; Weber B, 2020, SHOCK, V54, P761, DOI 10.1097/SHK.0000000000001536; Weber B, 2019, PEDIATR RES, V86, P709, DOI 10.1038/s41390-019-0505-6; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Ye XD, 2018, ACTA PHARMACOL SIN, V39, P1155, DOI 10.1038/aps.2018.37; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	55	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2214-031X			J ORTHOP TRANSL	J. Orthop. Transl.	MAY	2021	28						39	46		10.1016/j.jot.2020.12.003			8	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	SO1CG	WOS:000658716900006	33717980	Green Published, gold			2022-02-06	
J	Lang, J; Wu, QH				Lang, Ji; Wu, Qianhong			Modeling of the transient cerebrospinal fluid flow under external impacts	EUROPEAN JOURNAL OF MECHANICS B-FLUIDS			English	Article						Brain concussion; Translational impact; Squeezing flow; Cerebrospinal fluid	TRAUMATIC BRAIN-INJURY; DYNAMICS; CONCUSSION; MECHANISMS; SEVERITY; ATROPHY; TISSUE; SIZE	In this paper, a theoretical model is developed to describe the cerebrospinal fluid (CSF) flow in the subarachnoid space as the head is exposed to sudden external impacts. Although extensive study has been performed, there is a lack of understanding of the transient CSF flow and its critical role in the concussion process. The problem involves a solid object, i.e. brain matter, bathed in a liquid environment, i.e. CSF, and enclosed in a rigid container, i.e. the skull. The relative motion of the inner object to the container causes a squeezing flow on one side of the object, and an expanding flow on the other side. The fluid pressure response underlies the damping effect on the object. To capture these features, both the inner object and the outer container are modeled as cylinders of different sizes. Constant acceleration is imposed on the container. The pressurization of the fluid and the resultant motion of the inner cylinder are analytically predicted. It shows that the relative motion of the inner object is very sensitive to the gap thickness and the density difference between the object and the surrounding liquid. The squeeze-damping effect of the CSF can effectively prevent direct contact between the inner object and the container. The paper presented herein, solving a fundamental fluid mechanics problem, reveals the critical physics involved in the response of the brain matter to external impacts on the head. It also provides interesting insights on the development of a new type of vibration isolation system for biomimetic applications. (C) 2021 Elsevier Masson SAS. All rights reserved.	[Lang, Ji; Wu, Qianhong] Villanova Univ, Cellular Biomech & Sports Sci Lab, 800 E Lancaster Ave, Villanova, PA 19085 USA; [Lang, Ji; Wu, Qianhong] Villanova Univ, Dept Mech Engn, 800 E Lancaster Ave, Villanova, PA 19085 USA		Wu, QH (corresponding author), Villanova Univ, Cellular Biomech & Sports Sci Lab, 800 E Lancaster Ave, Villanova, PA 19085 USA.	qianhong.wu@villanova.edu		Lang, Ji/0000-0002-8886-1766	National Science Foundation CBET Fluid Dynamics ProgramNational Science Foundation (NSF) [1511096]	This research was performed in partial fulfillment of the requirements for the Ph.D. degree from Villanova University by Ji Lang. Mr. Ji is supported by the National Science Foundation CBET Fluid Dynamics Program under Award #1511096. The authors would like to thank Mr. Bchara Sidnawi for his critical review of the paper.	Alexandrou A., 1999, VISCOUS FLUID FLOW, DOI [10.1201/9781420050288., DOI 10.1201/9781420050288]; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Bateman J, 2014, RES EXP UNDERGRAD; Bieszk E., 2014, BRAIN; Capek T.J., 2013, 2013 NCUR; CHAFI MS, 2007, BIOMED BIOTECHNOL EN, V2, P211; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; COOPER RM, 1960, ARSJ-AM ROCKET SOC J, V30, P725, DOI 10.2514/8.5212; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gevertz JL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000152; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hossain S.G.M, 2010, MAT MODELING ANAL DE; Kertzscher U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041677; Lang J, 2019, TRIBOL INT, V135, P259, DOI 10.1016/j.triboint.2019.02.046; Lang J, 2019, J FLUID ENG-T ASME, V141, DOI 10.1115/1.4042758; Lang J, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.4999071; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lantzsch R, 2007, J CRYST GROWTH, V305, P249, DOI 10.1016/j.jcrysgro.2007.03.047; LEVINE DN, 1986, NEUROLOGY, V36, P362, DOI 10.1212/WNL.36.3.362; Lim TT, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1872072; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Mehrabian A, 2015, J THEOR BIOL, V384, P19, DOI 10.1016/j.jtbi.2015.08.001; Mori E, 1997, AM J PSYCHIAT, V154, P18, DOI 10.1176/ajp.154.1.18; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nicholson C, 2001, REP PROG PHYS, V64, P815, DOI 10.1088/0034-4885/64/7/202; Poch O, 2020, SCIENCE, V367, P1212, DOI 10.1126/science.aaw7462; Saboori P, 2011, SCI IRAN, V18, P1492, DOI 10.1016/j.scient.2011.11.032; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; SHAFIEIAN M, 2012, P 2012 INT IRCOBI C, P00467; Sogbesan E.A., 2011, DESIGN ANAL BLAST IN; Tawse K, 2008, J YOUNG INVESTIG; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	38	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0997-7546	1873-7390		EUR J MECH B-FLUID	Eur. J. Mech. B-Fluids	MAY-JUN	2021	87						171	179		10.1016/j.euromechflu.2021.01.010			9	Mechanics; Physics, Fluids & Plasmas	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics; Physics	QT9QI	WOS:000626921100007					2022-02-06	
J	Li, SS; Xie, LL; Li, ZZ; Fan, YJ; Qi, MM; Xi, YG				Li, Shan-Shan; Xie, Ling-Ling; Li, Zhuang-Zhuang; Fan, Yong-Jian; Qi, Man-Man; Xi, Yan-Guo			Androgen is responsible for enhanced susceptibility of melatonin against traumatic brain injury in females	NEUROSCIENCE LETTERS			English	Article						Melatonin; Traumatic brain injury; Apoptosis; MAPK; Gender		Background: Numerous publications have demonstrated that melatonin administration is associated with mortality reduction and improvement in neurological outcomes after traumatic brain injury (TBI). However, there are significant sex differences in several diseases associated with melatonin. We aimed to determine whether androgen was responsible for enhanced susceptibility of melatonin against TBI in females, as well as potential molecular mechanisms. Methods: Weight-drop was used to establish a rodent model of TBI. Melatonin (10 mg/kg) and testosterone (1 mg/kg) were administered three times every day for three days after TBI using subcutaneous injection, respectively. Seven days after TBI, an open field assay was used to evaluate locomotor and exploratory activities. Neuronal amount, neuronal apoptosis, and expression of phosphorylated extracellularly regulated protein kinases 1/2 (ERK1/2), c-jun N-terminal kinase 1/2 (JNK1/2), and p38 mitogen-activated protein kinase (p38MAPK) in neurons were assessed using immunofluorescence assay seven days after TBI. The expression of caspase-3, Bax, and Bcl-2 in the frontal cortex was detected using western blot. Results: Compared with female rats, melatonin administration exhibited more neuroprotective effects (including improved locomotor and exploratory activities, elevated neuronal amount, and reduced neuronal apoptosis) in male rats exposed to TBI. Moreover, testosterone significantly improved locomotor and exploratory activities, elevated neuronal amount, decreased neuronal apoptosis, downregulated phosphorylation of JNK1/2- and p38MAPK-positive neurons, but upregulated phosphorylation of ERK1/2-positive neurons in the frontal cortex, and reduced the expressions of cleaved caspase-3, Bax, but increased Bcl-2 expressions in female rats exposed to TBI. Conclusions: Androgen was responsible for the enhanced susceptibility to TBI under melatonin supplementation in females through a mechanism that may be associated with MAPK pathway regulation.	[Li, Shan-Shan] Cangzhou Cent Hosp, Clin Lab, Cangzhou, Peoples R China; [Xie, Ling-Ling; Li, Zhuang-Zhuang] Cangzhou Cent Hosp, Dept Pharm, Cangzhou, Peoples R China; [Fan, Yong-Jian] Cangzhou Cent Hosp, Dept Ultrasonog, Cangzhou, Peoples R China; [Qi, Man-Man] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Xi, Yan-Guo] Cangzhou Cent Hosp, Dept Neurosurg, Cangzhou, Peoples R China		Xi, YG (corresponding author), Cangzhou Cent Hosp, Dept Neurosurg, Cangzhou, Peoples R China.	sanyecaoss@126.com; hddemon@126.com; lzz8700v@163.com; 2264480798@qq.com; vince914816@163.com; cz_xyg@163.com					Ahmadiasl N, 2013, IRAN J BASIC MED SCI, V16, P1209; Alagiakrishnan K, 2016, DISCOV MED, V21, P363; Arulsamy A, 2018, BEHAV BRAIN RES, V348, P127, DOI 10.1016/j.bbr.2018.04.009; Aste N, 2001, MICROSC RES TECHNIQ, V55, P37, DOI 10.1002/jemt.1154; Babaee A, 2015, IRAN J BASIC MED SCI, V18, P867; Carteri RB, 2019, J NEUROTRAUM, V36, P2246, DOI 10.1089/neu.2018.6266; Chalermpalanupap T, 2018, J NEUROSCI, V38, P74, DOI 10.1523/JNEUROSCI.1483-17.2017; Chen BH, 2018, BIOMED PHARMACOTHER, V108, P687, DOI 10.1016/j.biopha.2018.09.077; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Figueiro PW, 2019, INT J DEV NEUROSCI, V78, P198, DOI 10.1016/j.ijdevneu.2019.08.004; Fitts JM, 2004, J ANDROL, V25, P523; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Gong JY, 2007, ENDOCRINOLOGY, V148, P4489, DOI 10.1210/en.2006-1748; Guo GX, 2020, MOL CELL ENDOCRINOL, V503, DOI 10.1016/j.mce.2019.110671; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hill Steven M, 2013, Curr Aging Sci, V6, P125; Islas-Preciado D, 2020, HORM BEHAV, V125, DOI 10.1016/j.yhbeh.2020.104815; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Li Y, 2020, NEUROCHEM INT, V140, DOI 10.1016/j.neuint.2020.104842; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; Ma Y, 2019, EUR REV MED PHARMACO, V23, P1, DOI 10.26355/eurrev_201908_18620; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; Merrilees J, 2010, AMYOTROPH LATERAL SC, V11, P298, DOI 10.3109/17482961003605788; Mishra JS, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316674875; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Muniyan S, 2015, CELL SIGNAL, V27, P2261, DOI 10.1016/j.cellsig.2015.08.002; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Pahlavani MA, 1998, AGE, V21, P153, DOI 10.1007/s11357-998-0025-5; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; Reddy PH, 1999, PHILOS T ROY SOC B, V354, P1035, DOI 10.1098/rstb.1999.0456; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; Shi LG, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00093; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Vemuganti R, 2017, NEUROCHEM INT, V111, P1, DOI 10.1016/j.neuint.2017.09.014; Wongchitrat P, 2016, NEUROCHEM INT, V100, P97, DOI 10.1016/j.neuint.2016.09.006; Yu K, 2018, MOLECULES, V23, DOI 10.3390/molecules23020447; Zibandeh N, 2020, CORNEA, V39, P886, DOI 10.1097/ICO.0000000000002291	44	1	1	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 1	2021	752								135842	10.1016/j.neulet.2021.135842			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RC5UY	WOS:000632867200001	33766734				2022-02-06	
J	Macki, M; Pawloski, J; Fadel, H; Hamilton, T; Haider, S; Elmenini, J; Fakih, M; Johnson, JL; Rock, J				Macki, Mohamed; Pawloski, Jacob; Fadel, Hassan; Hamilton, Travis; Haider, Sameah; Elmenini, Jaafar; Fakih, Mohamed; Johnson, Jeffrey L.; Rock, Jack			The Effect of Antithrombotics on Hematoma Expansion in Small- to Moderate-Sized Traumatic Intraparenchymal Hemorrhages	WORLD NEUROSURGERY			English	Article						Anticoagulant; Antithrombotic agents; Hematoma; Intraparenchymal hemorrhage; Traumatic brain injury	BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; PLATELET TRANSFUSION; ANTIPLATELET AGENTS; HEAD TRAUMA; INTRACEREBRAL HEMORRHAGE; PREINJURY ANTIPLATELET; ELDERLY-PATIENTS; RISK-FACTORS; PROGRESSION	BACKGROUND: Although pre-injury antithrombotic agents, including antiplatelets and anticoagulants, are historically associated with expansion of traumatic intraparenchymal hemorrhage (tIPH), the literature has poorly elucidated the actual risk of hematoma expansion on repeat computed tomography (CT). The objective was to determine the effect of antithrombotic agents on hematoma expansion in tIPH by comparing patients with and without pre-injury antithrombotic medication. METHODS: The volume of all tIPHs over a 5-year period at an academic Level 1 trauma center was measured retrospectively. The initial tIPH was divided into 3 equally sized quantiles. The third tercile, representing the largest subset of tIPH, was then removed from the study population because these patients reflect a different pathophysiologic mechanism that may require a more acute and aggressive level of care with reversal agents and/or operative management. Per institutional policy, all patients with small-to moderate-sized hemorrhages received a 24-hour stability CT scan. Patients who received reversal agents were excluded. RESULTS: Of the 105 patients with a tIPH on the initial head CT scan, small- to moderate-sized hemorrhages were <5 cm(3). The size of tIPH on initial imaging did not statistically significantly differ between the antithrombotic cohort (0.7 +/- 0.1 cm(3)) and the non-antithrombotic cohort (0.5 +/- 0.1 cm(3)) (P = 0.091). Similarly, the volume of tIPH failed to differ on 24-hour repeat imaging (1.0 +/- 0.2 cm(3) vs. 0.6 +/- 0.1 cm(3), respectively, P = 0.172). Following a multiple linear regression, only history of stroke, not antithrombotic medications, predicted increased tIPH on 24-hour repeat imaging. CONCLUSIONS: In small- to moderate-sized tIPH, with-holding antithrombotic agents without reversal may be sufficient.	[Macki, Mohamed; Pawloski, Jacob; Fadel, Hassan; Hamilton, Travis; Haider, Sameah; Elmenini, Jaafar; Fakih, Mohamed; Rock, Jack] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Johnson, Jeffrey L.] Henry Ford Hosp, Dept Acute Care Surg, Detroit, MI 48202 USA		Rock, J (corresponding author), Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA.	Jrock1@hfhs.org		Haider, Sameah/0000-0002-6045-0965			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Barletta JF, 2020, NEUROCRIT CARE, V33, P405, DOI 10.1007/s12028-019-00899-x; Bydon M, 2014, SPINE J, V14, P2861, DOI 10.1016/j.spinee.2014.03.040; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Fan YH, 2004, J NEUROL, V251, P537, DOI 10.1007/s00415-004-0359-6; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Macki M, 2017, J CLIN NEUROSCI, V40, P44, DOI 10.1016/j.jocn.2016.12.008; Moustafa F, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0515-0; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pelaez CA, 2019, INJURY, V50, P73, DOI 10.1016/j.injury.2018.08.020; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Raimondi P, 2017, CURR PHARM DESIGN, V23, P1406, DOI 10.2174/1381612822666161205110843; Risch O, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/s13019-014-0166-9; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Shin SS, 2020, NEUROCRIT CARE, V32, P407, DOI 10.1007/s12028-019-00898-y; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	31	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						E101	E107		10.1016/j.wneu.2021.02.072			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RU9LH	WOS:000645460900013	33640526				2022-02-06	
J	Mahoney, EJ; Silva, MA; Reljic, T; Dams-O'Connor, K; Hammond, FM; Monden, KR; Chung, JYS; Dillahunt-Aspillaga, C; Nakase-Richardson, R				Mahoney, Elaine J.; Silva, Marc A.; Reljic, Tea; Dams-O'Connor, Kristen; Hammond, Flora M.; Monden, Kimberly R.; Chung, Joyce S.; Dillahunt-Aspillaga, Christina; Nakase-Richardson, Risa			Rehabilitation Needs at 5 Years Post-Traumatic Brain Injury: A VA TBI Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; military personnel; rehabilitation; traumatic; Veterans	NATIONAL INSTITUTE; ENVIRONMENTAL-FACTORS; SERVICE MEMBERS; VETERANS; DISABILITY; OUTCOMES; CONSCIOUSNESS; HEALTH; DISORDERS; BARRIERS	Objective: Describe rehabilitation needs and factors associated with unmet needs at 5 years post-traumatic brain injury (TBI). Setting: Five Veterans Affairs (VA) polytrauma rehabilitation centers (PRCs). Participants: VA TBI Model Systems participants (N = 283; 96% male, 75%, 57% severe TBI). Design: Prospective observational cohort. Main Measures: Rehabilitation Needs Survey (21-item survey that assesses cognitive, emotional, social, and functional needs); Craig Hospital Inventory of Environmental Factors (25-item survey of potential environmental barriers). Results: Participants endorsed a mean of 8 (SD: 6.2) ongoing and 3 (SD: 4.7) unmet rehabilitation needs at 5 years post-TBI. Approximately 65% of participants reported at least 1 rehabilitation need that remained unmet. The number and nature of needs differed across TBI severity groups. In unadjusted and adjusted linear regression models, Black race and environmental barriers (Craig Hospital Inventory of Environmental Factors total score) were predictive of unmet needs (P < .001). Those with greater unmet needs reported the physical environment (54%-63%), informational sources (54%), social attitudes (55%), healthcare access (40%), public policy (32%-37%), transportation availability (33%), and in-home assistance (32%) as the most frequent environmental barriers at 5 years post-TBI. Conclusion: Veterans and Service Members continue to have rehabilitation needs at 5 years post-TBI. Veterans Affairs programs to address ongoing needs and policy to support them are needed.	[Mahoney, Elaine J.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci MHBS, Tampa, FL USA; [Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr DVBIC, Tampa, FL USA; [Silva, Marc A.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Reljic, Tea] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Monden, Kimberly R.] Craig Hosp, Res Dept, Englewood, CO USA; [Monden, Kimberly R.] Univ Minnesota, Dept Rehabil Med, Minneapolis, MN USA; [Chung, Joyce S.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Dillahunt-Aspillaga, Christina] James A Haley Vet Hosp, Res Serv, Tampa, FL USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma TBI Rehabil, Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	elaine.mahoney@va.gov; marc.silva1@va.gov; treljic@health.usf.edu; kristen.dams-o'connor@mountsinai.org; flora.hammond@rhin.com; KMonden@craighospital.org; joyce.chung@va.gov; Christina.Dillahunt-Aspillaga@va.gov; Risa.Richardson@va.gov	Monden, Kimberley/AAE-9831-2020	Monden, Kimberley/0000-0002-5207-0452	VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015, HT0014-19-C-0004]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB00070, 90DRTB0002, 90DPTB0009]	This research was sponsored by VHA Central Office VA TBI Model Systems Program of Research; Subcontract from General Dynamics Information Technology (W91YTZ-13-C-0015; HT0014-19-C-0004) from the Defense and Veterans Brain Injury Center as official government work (contactdha.DVBICinfo@mail.mil with questions) and National Institute on Disability, Independent Living, and Rehabilitation Research (grant #90DPTB00070 (PI: Harrison-Felix), 90DRTB0002 (PI: Hammond), and #9t0DPTB0009 (Dams O'Connor).	Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; [Anonymous], 2016, HLTH US 2015 SPEC FE; [Anonymous], IBM SPSS STAT WINDOW; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Ephraim PL, 2006, ARCH PHYS MED REHAB, V87, P328, DOI 10.1016/j.apmr.2005.11.010; Gause LR, 2017, J HEAD TRAUMA REHAB, V32, P255, DOI 10.1097/HTR.0000000000000309; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lien WC, 2015, J NUTR HEALTH AGING, V19, P575, DOI 10.1007/s12603-015-0473-4; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Miles SR, 2020, ARCH PHYS MED REHAB, V101, P81, DOI 10.1016/j.apmr.2019.07.018; Miller KJ, 2017, MIL MED, V182, P137, DOI 10.7205/MILMED-D-16-00175; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P421, DOI 10.1097/HTR.0b013e3181c13439; Sashika H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005968; Sienko S, 2019, DISABIL HEALTH J, V12, P467, DOI 10.1016/j.dhjo.2019.02.008; Silva MA, 2018, BRAIN INJURY, V32, P994, DOI 10.1080/02699052.2018.1468576; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Tsai IH, 2017, REHABIL PSYCHOL, V62, P36, DOI 10.1037/rep0000117; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025	42	1	1	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		175	185		10.1097/HTR.0000000000000629			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900010	33201036				2022-02-06	
J	Mckenzie, N; Finn, J; Dobb, G; Bailey, P; Arendts, G; Celenza, A; Fatovich, D; Jenkins, I; Ball, S; Bray, J; Ho, KM				Mckenzie, Nicole; Finn, Judith; Dobb, Geoffrey; Bailey, Paul; Arendts, Glenn; Celenza, Antonio; Fatovich, Daniel; Jenkins, Ian; Ball, Stephen; Bray, Janet; Ho, Kwok M.			Arterial carbon dioxide tension has a non-linear association with survival after out-of-hospital cardiac arrest: A multicentre observational study	RESUSCITATION			English	Article						Arterial carbon dioxide tension; Out-of-hospital cardiac arrest; Post-resuscitation care; Survival; Neurological outcome	INTENSIVE-CARE-UNIT; BLOOD GAS TENSIONS; BRAIN-INJURY; RESUSCITATION; GUIDELINES; MORTALITY; OXYGEN; TRIAL	Purpose: International guidelines recommend targeting normocapnia in mechanically ventilated out-of-hospital cardiac arrest (OHCA) survivors, but the optimal arterial carbon dioxide (PaCO2) target remains controversial. We hypothesised that the relationship between PaCO2 and survival is non-linear, and targeting an intermediate level of PaCO2 compared to a low or high PaCO2 in the first 24-h of ICU admission is associated with an improved survival to hospital discharge (STHD) and at 12-months. Methods: We conducted a retrospective multi-centre cohort study of adults with non-traumatic OHCA requiring admission to one of four tertiary hospital intensive care units for mechanical ventilation. A four-knot restricted cubic spline function was used to allow non-linearity between the mean PaCO2 within the first 24 h of ICU admission after OHCA and survival, and optimal PaCO2 cut-points were identified from the spline curve to generate corresponding odds ratios. Results: We analysed 3769 PaCO2 results within the first 24-h of ICU admission, from 493 patients. PaCO2 and survival had an inverted U-shape association; normocapnia was associated with significantly improved STHD compared to either hypocapnia (<35 mmHg) (adjusted odds ratio [aOR] 0.45, 95% confidence interval [CI] 0.24-0.83) or hypercapnia (>45 mmHg) (aOR 0.45, 95% CI 0.24-0.84). Of the twelve predictors assessed, PaCO2 was the third most important predictor, and explained >11% of the variability in survival. The survival benefits of normocapnia extended to 12-months. Conclusions: Normocapnia within the first 24-h of intensive care admission after OHCA was associated with an improved survival compared to patients with hypocapnia or hypercapnia.	[Mckenzie, Nicole; Finn, Judith; Bailey, Paul; Fatovich, Daniel; Ball, Stephen; Ho, Kwok M.] Curtin Univ, Prehosp Resuscitat & Emergency Care Res Unit PREC, Bentley, WA, Australia; [Mckenzie, Nicole; Dobb, Geoffrey; Ho, Kwok M.] Royal Perth Hosp, Intens Care Unit, Perth, WA, Australia; [Finn, Judith; Bailey, Paul; Ball, Stephen] St John Western Australia, Belmont, WA, Australia; [Finn, Judith; Dobb, Geoffrey; Arendts, Glenn; Celenza, Antonio; Ho, Kwok M.] Univ Western Australia, Med Sch, Crawley, WA, Australia; [Finn, Judith; Bray, Janet] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Arendts, Glenn] Fiona Stanley Hosp, Murdoch, WA, Australia; [Celenza, Antonio; Fatovich, Daniel] Sir Charles Gairdner Hosp, Nedlands, WA, Australia; [Fatovich, Daniel] Royal Perth Hosp, Emergency Med, Perth, WA, Australia; [Jenkins, Ian] Fremantle Hosp, Fremantle, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia		Mckenzie, N (corresponding author), Curtin Univ, Sch Nursing Midwifery & Paramed, Prehosp Resuscitat & Emergency Care Res Unit PREC, GPO Box U1987, Perth, WA 6845, Australia.	nicole.mckenzie@curtin.edu.au	Fatovich, Daniel/J-5510-2013	Fatovich, Daniel/0000-0001-9414-6905; Arendts, Glenn/0000-0001-7830-7756; Mckenzie, Nicole/0000-0002-9953-3127	Australian Resuscitation Outcomes Consortium - NHMRC Centre of Research Excellence [1029983]; Australian Government Research Training ScholarshipAustralian Government; NHMRC Investigator grantNational Health and Medical Research Council of Australia [1174838]; St John WA; Heart Foundation Fellowship	Nicole Mckenzie received PhD funding from the Australian Resuscitation Outcomes Consortium - NHMRC Centre of Research Excellence (#1029983) and an Australian Government Research Training Scholarship.; The WA OHCA Registry is funded by St John WA. Judith Finn is a NHMRC Leadership Fellow, receiving salary and research funding from a NHMRC Investigator grant (#1174838).; Janet Bray received a Heart Foundation Fellowship.	Australian and New Zealand Comittee on Resuscitation, 2018, ANZCOR GUID 11 2 PRO; Australian and New Zealand Commitee on Resuscitation, 2018, ANZCOR GUID 11 7 POS; Australian Bureau of Statistics, 2017, REG POP AG SEX AUSTR; Beck B, 2016, EMERG MED AUSTRALAS, V28, P673, DOI 10.1111/1742-6723.12690; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Claesson A, 2017, RESUSCITATION, V110, P48, DOI 10.1016/j.resuscitation.2016.10.019; Department of Health, 2020, OUR HOSP; Eastwood GM, 2016, RESUSCITATION, V104, P83, DOI 10.1016/j.resuscitation.2016.03.023; Eastwood GM, 2015, J CRIT CARE, V30, P138, DOI 10.1016/j.jcrc.2014.09.022; Ebner F, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2119-5; Elmer J, 2017, SEMIN NEUROL, V37, P19, DOI 10.1055/s-0036-1597833; Harrell FE, CASE STUDY BINARY LO, V2nd; Harrell FE, 2015, SPRINGER SER STAT, P13, DOI 10.1007/978-3-319-19425-7_2; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Jakkula P, 2018, INTENS CARE MED, V44, P2112, DOI 10.1007/s00134-018-5453-9; Jamme M, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0409-3; JENNETT B, 1975, LANCET, V1, P480; KELSEY SF, 1986, AM J EMERG MED, V4, P72; Kilgannon JH, 2019, RESUSCITATION, V135, P212, DOI 10.1016/j.resuscitation.2018.11.015; Lee BK, 2014, AM J EMERG MED, V32, P55, DOI 10.1016/j.ajem.2013.09.044; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; McGuigan PJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03039-6; McKenzie N, 2018, RESUSCITATION, V128, P76, DOI 10.1016/j.resuscitation.2018.04.039; McKenzie N, 2017, RESUSCITATION, V111, P116, DOI 10.1016/j.resuscitation.2016.09.019; Monash University, TAME CARD ARR RAND C; Moon SW, 2007, RESUSCITATION, V72, P219, DOI 10.1016/j.resuscitation.2006.06.034; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Peluso L, 2020, RESUSCITATION, V150, P1, DOI 10.1016/j.resuscitation.2020.02.030; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1832-9; StJohn WesternAustralia, 2019, CLIN GUID AMB CAR W; Vaahersalo J, 2014, CRIT CARE MED, V42, P1463, DOI 10.1097/CCM.0000000000000228; Wang CH, 2015, RESUSCITATION, V89, P1, DOI 10.1016/j.resuscitation.2015.01.003	34	1	1	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	MAY	2021	162						82	90		10.1016/j.resuscitation.2021.01.035			9	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	RV5YT	WOS:000645908700018	33571603				2022-02-06	
J	Miller, GF; DePadilla, L; Xu, LK				Miller, Gabrielle F.; DePadilla, Lara; Xu, Likang			Costs of Nonfatal Traumatic Brain Injury in the United States, 2016	MEDICAL CARE			English	Article						TBI; economic burden; cost	EPIDEMIOLOGY; OUTCOMES; CHILDREN	Background: Traumatic brain injury (TBI) is a serious public health problem in the United States. Each year, TBIs substantially contribute to health care costs, which vary by severity. This is important to consider given the variability in recovery time by severity. Research Design: This study quantifies the annual incremental health care costs of nonfatal TBI in 2016 for the US population covered by a private health insurance, Medicaid, or Medicare health plan. This study uses MarketScan and defines severity with the abbreviated injury scale for the head and neck region. Nonfatal health care costs were compared by severity. Results: The estimated 2016 overall health care cost attributable to nonfatal TBI among MarketScan enrollees was $40.6 billion. Total estimated annual health care cost attributable to TBI for low severity TBIs during the first year postinjury were substantially higher than costs for middle and high severity TBIs among those with private health insurance and Medicaid. Conclusions: This study presents economic burden estimates for TBI that underscore the importance of developing strategies to prevent TBIs, regardless of severity. Although middle and high severity TBIs were more costly at the individual level, low severity TBIs, and head injuries diagnosed as "head injury unspecified" resulted in higher total estimated annual health care costs attributable to TBI.	[Miller, Gabrielle F.; Xu, Likang] CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway MS 5106-08, Atlanta, GA 30341 USA; [DePadilla, Lara] CDC, Div Overdose Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA		Miller, GF (corresponding author), CDC, Div Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway MS 5106-08, Atlanta, GA 30341 USA.	ygm3@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Association for the Advancement of Automotive Medicine, 2018, ABBREVIATED INJURY S, V6th; Beck L. F., 2010, Morbidity and Mortality Weekly Report, V59, P1681; Beyrer J., 2020, ISPOR; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Hedegaard Holly, 2016, Natl Health Stat Report, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; National Center for Injury Prevention and Control, 2015, PREV FALLS GUID IMPL; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Orman JAL., 2012, INJURY RES, P61; Pavlov V, 2019, BRAIN INJURY, V33, P1151, DOI 10.1080/02699052.2019.1629022; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; US Bureau of Economic Analysis, TABL 2 5 4 PRIC IND; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Zogg CK, 2018, EPIDEMIOLOGY, V29, P269, DOI 10.1097/EDE.0000000000000791	22	1	1	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7079	1537-1948		MED CARE	Med. Care	MAY	2021	59	5					451	455		10.1097/MLR.0000000000001511			5	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	RY2PA	WOS:000647758100012	33528230				2022-02-06	
J	Molero, Y; Sharp, DJ; Onofrio, BMD; Larsson, H; Fazel, S				Molero, Yasmina; Sharp, David James; Onofrio, Brian Matthew D.; Larsson, Henrik; Fazel, Seena			Psychotropic and pain medication use in individuals with traumatic brain injury-a Swedish total population cohort study of 240 000 persons	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							RISK-FACTORS; DISORDERS; REHABILITATION; OPIOIDS	Objective To examine psychotropic and pain medication use in a population-based cohort of individuals with traumatic brain injury (TBI), and compare them with controls from similar backgrounds. Methods We assessed Swedish nationwide registers to include all individuals diagnosed with incident TBI between 2006 and 2012 in hospitals or specialist outpatient care. Full siblings never diagnosed with TBI acted as controls. We examined dispensed prescriptions for psychotropic and pain medications for the 12 months before and after the TBI. Results We identified 239 425 individuals with incident TBI, and 199 658 unaffected sibling controls. In the TBI cohort, 36.6% had collected at least one prescription for a psychotropic or pain medication in the 12 months before the TBI. In the 12 months after, medication use increased to 45.0%, an absolute rate increase of 8.4% (p<0.001). The largest post-TBI increases were found for opioids (from 16.3% to 21.6%, p<0.001), and non-opioid pain medications (from 20.3% to 26.6%, p<0.001). The majority of prescriptions were short-term; 20.6% of those prescribed opioids and 37.3% of those with benzodiazepines collected prescriptions for more than 6 months. Increased odds of any psychotropic or pain medication were associated with individuals before (OR: 1.62, 95% CI: 1.59 to 1.65), and after the TBI (OR: 2.30, 95% CI: 2.26 to 2.34) as compared with sibling controls, and ORs were consistently increased for all medication classes. Conclusion High rates of psychotropic and pain medications after a TBI suggest that medical follow-up should be routine and review medication use.	[Molero, Yasmina] Karolinska Inst, Ctr Psychiat Res, Clin Neurosci, Stockholm, Sweden; [Molero, Yasmina; Fazel, Seena] Univ Oxford, Psychiat, Oxford OX1 2JD, England; [Molero, Yasmina; Onofrio, Brian Matthew D.; Larsson, Henrik] Karolinska Inst, Med Epidemiol & Biostat, Stockholm, Sweden; [Sharp, David James] Imperial Coll London, Brain Sci, London, England; [Onofrio, Brian Matthew D.] Indiana Univ, Psychol & Brain Sci, Bloomington, IN USA; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden		Molero, Y (corresponding author), Univ Oxford, Psychiat, Oxford OX1 2JD, England.	mikrodata@scb.se	Fazel, Seena/B-5307-2008	Fazel, Seena/0000-0002-5383-5365; Sharp, David/0000-0003-4995-2240; Molero, Yasmina/0000-0002-5663-2010	Wellcome TrustWellcome TrustEuropean Commission [202836/Z/16/Z]; Swedish Research Council for Health Working Life and WelfareSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte) [2015-0028]; Karolinska Institute FundsKarolinska Institutet [2016fobi50581]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This study was supported by the Wellcome Trust (No 202836/Z/16/Z), the Swedish Research Council for Health Working Life and Welfare (2015-0028) and Karolinska Institute Funds (2016fobi50581). The funders had no further role in the study design; in the collection, analysis and interpretation of data; or in the writing of the paper.	Albrecht JS, 2017, AM J GERIAT PSYCHIAT, V25, P415, DOI 10.1016/j.jagp.2016.11.018; Allison PD., 2009, FIXED EFFECTS REGRES; Bertenthal D, 2018, BRAIN INJURY, V32, P1188, DOI 10.1080/02699052.2018.1493535; Berterame S, 2016, LANCET, V387, P1644, DOI 10.1016/S0140-6736(16)00161-6; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Chihuri S, 2017, ACCIDENT ANAL PREV, V109, P123, DOI 10.1016/j.aap.2017.10.004; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2019, ADDICT BEHAV, V90, P143, DOI 10.1016/j.addbeh.2018.10.030; Cosano G, 2016, BRAIN INJURY, V30, P353, DOI 10.3109/02699052.2015.1118767; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Han M H Esther, 2008, Optometry, V79, P252, DOI 10.1016/j.optm.2008.01.001; Hudson TJ, 2018, PAIN MED, V19, P774, DOI 10.1093/pm/pnx208; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kessler RC, 2012, PSYCHOL MED, V42, P1997, DOI 10.1017/S0033291712000025; Kim S, 2019, BRAIN INJURY, V33, P442, DOI 10.1080/02699052.2019.1565896; Lader M, 2011, ADDICTION, V106, P2086, DOI 10.1111/j.1360-0443.2011.03563.x; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manchikanti L, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0564-x; Merino R, 2019, EUR J CLIN PHARMACOL, V75, P985, DOI 10.1007/s00228-019-02651-y; Milne RL, 2011, INT J EPIDEMIOL, V40, P1342, DOI 10.1093/ije/dyr110; Mosti C, 2018, J NEUROPSYCH CLIN N, V30, P220, DOI 10.1176/appi.neuropsych.17070141; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rosenblum A, 2008, EXP CLIN PSYCHOPHARM, V16, P405, DOI 10.1037/a0013628; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sciarra T, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00994; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Wiener J, 2019, BRAIN INJURY, V33, P559, DOI 10.1080/02699052.2019.1574328; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	40	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAY	2021	92	5					519	527		10.1136/jnnp-2020-324353			9	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	RP1HG	WOS:000641485800013	33563808	hybrid, Green Published			2022-02-06	
J	Moroni, C; Belin, C				Moroni, C.; Belin, C.			Contribution of the neuropsychological assessment in concussion	NEUROCHIRURGIE			English	Article						Concussion; Neuropsychology; Cognitive assessment; Behavioral assessment	TRAUMATIC BRAIN-INJURY; SHORT-TERM-MEMORY; WHIPLASH INJURY; NORMATIVE DATA; TEST BATTERY; SENSITIVITY; PERFORMANCE; MANAGEMENT	Introduction. - The neuropsychological assessment is a cornerstone in the care management of concussion or mild traumatic injury. Objective. - To present the different stages of an exhaustive neuropsychological assessment exploring cognitive and behavioral domains. Method. - Description of the value of the main tests available for behavioral and cognitive assessment. The choice of tests is based on the clinical experience and expertise of the authors. Results. - Questionnaires are mainly used to explore the behavioral sequelae (depression, anxiety or fatigue) and the impact of these potential difficulties in daily life. Four cognitive abilities could be impaired by concussion: attention, memory, visuospatial functions and executive functions. These abilities could be explored with "paper and pencil" tests or with computerized test batteries. While cognitive sequelae in the context of a moderate or a severe traumatic brain injury are consolidated, in the context of concussion, neuropsychological sequelae tend to resolve in a short time. As a consequence, several neuropsychological assessments could be conducting in a short period involving some methodological considerations. Moreover, as concussion could be reported in a Whiplash injury from a car crash with forensic consequences, it is crucial to propose tests to be sure that the weak performance obtained into the neuropsychological assessment is not explained by poor effort and/or malingering. Discussion/conclusion. - This article revises these aspects of a neuropsychological assessment in the specific context of concussion. (C) 2020 Elsevier Masson SAS. All rights reserved.	[Moroni, C.] Univ Lille SHS, Equipe Neuropsychol Audit Cognit Act, PSITEC EA 4072, Campus Pont Bois,BP 60149, F-59653 Villeneuve Dascq, France; [Belin, C.] Hop St Louis, AP HP, Serv Neurol, 1 Ave Claude Vellefaux, F-75475 Paris 10, France		Moroni, C (corresponding author), Univ Lille SHS, Equipe Neuropsychol Audit Cognit Act, PSITEC EA 4072, Campus Pont Bois,BP 60149, F-59653 Villeneuve Dascq, France.	christine.moroni@univ-lille.fr; catherine.belin@aphp.fr		MORONI, Christine/0000-0001-7816-9998			ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P362, DOI 10.1080/14640746608400055; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beeckmans K, 2017, ACTA NEUROL BELG, V117, P493, DOI 10.1007/s13760-017-0745-3; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Calamia M, 2011, CLIN NEUROPSYCHOL, V25, P670, DOI 10.1080/13854046.2011.564209; Delis D.C., 1987, CVLT CALIFORNIA VERB; Erlanger DM, 1999, CONCUSSION RESOLUTIO; Gentile S, 2003, EUR J CANCER CARE, V12, P58, DOI 10.1046/j.1365-2354.2003.00295.x; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kessels RPC, 2000, J INT NEUROPSYCH SOC, V6, P271, DOI 10.1017/S1355617700633027; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Manoli R, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2020.100913; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McNair DM, 1971, MANUAL PROFILE 14 MO; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Mittenberg W, 2008, TXB CLIN NEUROPSYCHO, P430; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rosenbaum AM, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P137, DOI 10.1007/0-387-32565-4_7; Ross MR, 2005, ARCH CLIN NEUROPSYCH, V20; Roussel M., 2008, FONCTIONS EXECUTIVES, P231; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schoenberg MR, 2006, ARCH CLIN NEUROPSYCH, V21, P693, DOI 10.1016/j.acn.2006.06.010; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith A., 1982, SYMBOL DIGIT MODALIT, DOI [10.1080/14640746608400055, DOI 10.1080/14640746608400055]; SPITZER WO, 1995, SPINE, V20, P2372; Sydeman, 1994, USE PSYCHOL TESTING, P292, DOI DOI 10.1002/9780470479216.CORPSY0943; TAMKIN AS, 1984, J CLIN PSYCHOL, V40, P1459, DOI 10.1002/1097-4679(198411)40:6<1459::AID-JCLP2270400633>3.0.CO;2-3; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Ziminermann P., 1994, TESTS EVALUATION ATT	38	1	1	1	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	MAY	2021	67	3					244	248		10.1016/j.neuchi.2020.06.134			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	RU4GM	WOS:000645106900006	33049285				2022-02-06	
J	Nagele, M; Vo, WP; Kolessar, M; Neaves, S; Juengst, SB				Nagele, Marielle; Vo, Willa P.; Kolessar, Michael; Neaves, Stephanie; Juengst, Shannon B.			Assessment of Impaired Self-Awareness by Cognitive Domain After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; self-awareness; executive function; cognition	EXECUTIVE FUNCTION; INPATIENT REHABILITATION; METACOGNITIVE SKILLS; DEFICITS; QUESTIONNAIRE; INTERVIEW; ADULTS; RELIABILITY; VALIDATION; BEHAVIOR	Purpose: To examine self-awareness in chronic traumatic brain injury (TBI) by cognitive domain, compare domain-specific self-awareness to global impaired self-awareness, and evaluate change in self-appraisal of cognitive ability from before to after neuropsychological testing. Method: Secondary analysis of a cross-sectional cohort of 59 participants with chronic TBI. We grouped participants as underestimators, fair estimators, and overestimators of their memory and executive functioning. We then compared these groups by global self-awareness measures, other clinical measures, and pre- to-posttest change in self-appraisal of cognitive performance. Results: Analyses revealed no significant differences in global self-awareness measures or depression between fair or underestimators and overestimators in Memory or Executive Function Domains. Only 12.50% of participants in the Memory Composite Domain and 6.89% of participants in the Executive Function Composite Domain changed their pre- to postneuropsychological test self-appraisal of cognitive ability. Conclusion: This study revealed most participants did not change their self-appraisal in response to completing neuropsychological testing alone. In conjunction with our findings that suggest global self-awareness measures may not adequately capture domain-specific self-awareness deficits in chronic TBI, this study provides support for development of targeted self-awareness assessment tools and the need for structured feedback, rather than naturalistic feedback alone, to improve self-awareness in chronic TBI.	[Nagele, Marielle; Vo, Willa P.; Kolessar, Michael; Neaves, Stephanie; Juengst, Shannon B.] Univ Texas Southwestern, Med Ctr, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Nagele, Marielle] Univ Texas Southwestern, Med Ctr, Clin Res Unit, Dallas, TX 75390 USA; [Kolessar, Michael] Ability KC, Bridgeton, MO USA		Juengst, SB (corresponding author), Univ Texas Southwestern, Med Ctr, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	shannon.juengst@tasouthwestern.edu		Vo, Willa/0000-0003-0550-0680; Juengst, Shannon/0000-0003-4709-545X; Nagele, Marielle/0000-0002-7719-1664	School of Health and Rehabilitation Science Research Development Fund, School and Health of Rehabilitation Science, University of Pittsburgh	This study was supported in part through funding received from the School of Health and Rehabilitation Science Research Development Fund, School and Health of Rehabilitation Science, University of Pittsburgh.	Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hurst FG, 2020, DISABIL REHABIL, V42, P651, DOI 10.1080/09638288.2018.1504993; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Leung DPK, 2011, INT J REHABIL RES, V34, P187, DOI 10.1097/MRR.0b013e3283487f31; Mahoney D., 2019, OP J OCCUPAT THERAPY, V7, DOI [https://doi.org/10.15453/2168-6408.1529, DOI 10.15453/2168-6408.1529, 10.15453/2168-6408.1529]; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malouf T, 2014, BRAIN INJURY, V28, P1523, DOI 10.3109/02699052.2014.922700; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth T, 2019, J REHABIL MED, V51, P376, DOI 10.2340/16501977-2537; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Robertson K, 2015, BRAIN INJURY, V29, P848, DOI 10.3109/02699052.2015.1005135; Ropacki S, 2014, ARCH CLIN NEUROPSYCH, V29; Ryals AJ, 2019, AGING NEUROPSYCHOL C, V26, P577, DOI 10.1080/13825585.2018.1503994; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Shaw S, 2015, PSYCHOL ASSESSMENT, V27, P138, DOI 10.1037/a0038195; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; Villalobos D, 2021, NEUROPSYCHOL REHABIL, V31, P983, DOI 10.1080/09602011.2020.1751663	36	1	1	1	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2021	66	2					139	147		10.1037/rep0000376			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	TF3LK	WOS:000670616800004	33382336				2022-02-06	
J	Nguyen, B; Ashraf, O; Richards, R; Tra, H; Huynh, T				Nguyen, Bach; Ashraf, Omar; Richards, Robin; Tra, Hoanh; Huynh, Trong			Cranioplasty Using Customized 3-Dimensional-Printed Titanium Implants: An International Collaboration Effort to Improve Neurosurgical Care	WORLD NEUROSURGERY			English	Article						-3D printing; Cranioplasty; Global neurosurgery; International collaboration	COMPUTER-AIDED-DESIGN; DECOMPRESSIVE CRANIECTOMY; MANUFACTURE; RECONSTRUCTION; EDUCATION	BACKGROUND: Evolutions in cranioplasty have allowed for the creation of customized implants via advances in 3 dimensional (3D) printing technology, although the high cost associated with this technique presents a barrier for low-income countries. Through an international collaboration, our team in Da Nang, Vietnam is able to create lowcost, customized titanium implants for patients with skull defects. We discuss the details of our collaboration and present our experience with this procedure. METHODS: We conducted a retrospective review of 35 patients who underwent cranioplasty using custom-made titanium implants. The molding and implant making processes were performed by our neurosurgeons using a 3D printer donated by the United Kingdom -based nongovernmental organization Facing the World. We obtained demographic and preoperative data (reason for skull defect, location, surface area measurement of defect) and postoperative data (complications, cosmetic outcome, and patient satisfaction). RESULTS: The median patient age was 27 years (range, 16-60 years). Primary indications for craniectomy included traumatic brain injury from motor vehicle accident (77.1%), cerebrovascular disease (11.4%), implant failure following previous cranioplasty (5.7%), and fall (5.7%). Postoperatively, all implants were found to have an excellent fit; at 6-month follow-up, none of the implants required removal. Complications included 4 postoperative hematomas and 1 surgical site infection. All the patients had improved aesthetic appearance and high satisfaction. CONCLUSIONS: Cranioplasty using customized titanium implants yields excellent results for patients with skull defects, demonstrating the practicality of this technique for cranioplasty in low-income countries. Our experience highlights the importance of ongoing international collaboration to improve neurosurgical care in these countries.	[Nguyen, Bach; Tra, Hoanh; Huynh, Trong] Danang Hosp, Neurosurg Dept, Danang, Vietnam; [Ashraf, Omar; Huynh, Trong] Rutgers Robert Wood Johnson Med Sch, Dept Neurosurg, New Brunswick, NJ 08901 USA; [Richards, Robin] Facing World, London, England		Huynh, T (corresponding author), Danang Hosp, Neurosurg Dept, Danang, Vietnam.; Huynh, T (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosurg, New Brunswick, NJ 08901 USA.	huynhdtrong@outlook.com		Nguyen, Ngoc Bach/0000-0002-1234-7541			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Almeida JP, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18291; CIA, WORLD FACTBOOK; Day RE, 2012, BRIT J ORAL MAX SURG, V50, P376, DOI 10.1016/j.bjoms.2011.05.001; Dean D, 2003, J CRANIOFAC SURG, V14, P819, DOI 10.1097/00001665-200311000-00002; El-Ghandour NMF, 2020, NEUROSURG FOCUS, V48, DOI 10.3171/2019.12.FOCUS19804; Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002; Gordon CR, 2014, OPER NEUROSURG, V10, P179, DOI 10.1227/NEU.0000000000000296; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Haglund MM, 2017, NEUROSURGERY, V80, P656, DOI 10.1093/neuros/nyw159; Hanasono MM, 2009, ANN PLAS SURG, V62, P653, DOI 10.1097/SAP.0b013e318184abc7; Harris DA, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13560; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Joffe J, 1999, BRIT J NEUROSURG, V13, P576, DOI 10.1080/02688699943088; Joffe JM, 1999, INT J ORAL MAX SURG, V28, P309; Kinsman Michael, 2020, Surg Neurol Int, V11, P288, DOI 10.25259/SNI_482_2020; Lethaus B, 2014, J CRANIO MAXILL SURG, V42, P1948, DOI 10.1016/j.jcms.2014.08.006; Li QF, 2020, ACCIDENT ANAL PREV, V144, DOI 10.1016/j.aap.2020.105642; Lieger O, 2010, ARCH FACIAL PLAST S, V12, P186, DOI 10.1001/archfacial.2010.26; Morales-Gomez JA, 2019, J NEUROSURG, V130, P1721, DOI 10.3171/2017.12.JNS172574; O'Reilly EB, 2015, J PLAST RECONSTR AES, V68, P329, DOI 10.1016/j.bjps.2014.11.001; Park EK, 2016, J CRANIOFAC SURG, V27, P943, DOI 10.1097/SCS.0000000000002656; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Rocque BG, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18254; Rosinski CL, 2020, NEUROSURGERY, V86, pE15, DOI 10.1093/neuros/nyz358; Tan ETW, 2016, J NEUROSURG, V124, P1531, DOI 10.3171/2015.5.JNS15119; Tehli O, 2015, OPER NEUROSURG, V11, P213, DOI 10.1227/NEU.0000000000000721; The World Bank, GDP CAPIT VIETN; Venturini S, 2018, WORLD NEUROSURG, V109, P98, DOI 10.1016/j.wneu.2017.09.117; World Federation of Neurosurgical Societies, GLOB NEUR WORKF MAP GLOB NEUR WORKF MAP; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470	31	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2021	149						174	180		10.1016/j.wneu.2021.02.104			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RX0FX	WOS:000646895900028	33647494				2022-02-06	
J	Nikam, RM; Yue, XY; Kandula, VV; Paudyal, B; Langhans, SA; Averill, LW; Choudhary, AK				Nikam, Rahul M.; Yue, Xuyi; Kandula, Vinay V.; Paudyal, Bishnuhari; Langhans, Sigrid A.; Averill, Lauren W.; Choudhary, Arabinda K.			Unravelling neuroinflammation in abusive head trauma with radiotracer imaging	PEDIATRIC RADIOLOGY			English	Article						Abusive head trauma; Brain; Child abuse; Children; Infants; Microglia; Neuroinflammation; [F-18]GE180	BRAIN-INJURY; TRANSLOCATOR PROTEIN; RAT MODEL; BENZODIAZEPINE-RECEPTOR; MICROGLIAL ACTIVATION; MOUSE MODEL; CEREBROSPINAL-FLUID; GLIAL ACTIVATION; ANIMAL-MODEL; PET	Abusive head trauma (AHT) is a leading cause of mortality and morbidity in child abuse, with a mortality rate of approximately 25%. In survivors, the prognosis remains dismal, with high prevalence of cerebral palsy, epilepsy and neuropsychiatric disorders. Early and accurate diagnosis of AHT is challenging, both clinically and radiologically, with up to one-third of cases missed on initial examination. Moreover, most of the management in AHT is supportive, reflective of the lack of clear understanding of specific pathogenic mechanisms underlying secondary insult, with approaches targeted toward decreasing intracranial hypertension and reducing cerebral metabolism, cell death and excitotoxicity. Multiple studies have elucidated the role of pro- and anti-inflammatory cytokines and chemokines with upregulation/recruitment of microglia/macrophages, oligodendrocytes and astrocytes in severe traumatic brain injury (TBI). In addition, recent studies in animal models of AHT have demonstrated significant upregulation of microglia, with a potential role of inflammatory cascade contributing to secondary insult. Despite the histological and biochemical evidence, there is a significant dearth of specific imaging approaches to identify this neuroinflammation in AHT. The primary motivation for development of such imaging approaches stems from the need to therapeutically target neuroinflammation and establish its utility in monitoring and prognostication. In the present paper, we discuss the available data suggesting the potential role of neuroinflammation in AHT and role of radiotracer imaging in aiding diagnosis and patient management.	[Nikam, Rahul M.; Kandula, Vinay V.; Averill, Lauren W.] Nemours Alfred I duPont Hosp Children, Dept Med Imaging, 1600 Rockland Rd, Wilmington, DE 19803 USA; [Nikam, Rahul M.; Yue, Xuyi; Paudyal, Bishnuhari; Langhans, Sigrid A.] Nemours Alfred I duPont Hosp Children, Katzin Diagnost & Res PET MR Ctr, Wilmington, DE 19803 USA; [Choudhary, Arabinda K.] Univ Arkansas Med Sci UAMS, Dept Radiol, Little Rock, AR USA		Nikam, RM (corresponding author), Nemours Alfred I duPont Hosp Children, Dept Med Imaging, 1600 Rockland Rd, Wilmington, DE 19803 USA.; Nikam, RM (corresponding author), Nemours Alfred I duPont Hosp Children, Katzin Diagnost & Res PET MR Ctr, Wilmington, DE 19803 USA.	Rahul.Nikam@nemours.org	Nikam, Rahul/AAN-4152-2020				Abcouwer SF, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-149; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Airas L, 2015, J NUCL MED, V56, P305, DOI 10.2967/jnumed.114.149955; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Brendel M, 2016, J NUCL MED, V57, P954, DOI 10.2967/jnumed.115.167858; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Duhaime AC, 2019, J NEUROSURG-PEDIATR, V24, P481, DOI 10.3171/2019.7.PEDS18394; Elia J, 2018, J AM ACAD CHILD PSY, V57, pS142, DOI 10.1016/j.jaac.2018.09.038; Fan Z, 2016, J NUCL MED, V57, P1753, DOI 10.2967/jnumed.115.169078; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Greeley CS, 2015, AM J ROENTGENOL, V204, P967, DOI 10.2214/AJR.14.14191; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Grossman R, 2012, FUTUR NEUROL, V7, P329, DOI 10.2217/FNL.12.25; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Hedlund GL, 2009, FORENSIC SCI MED PAT, V5, P280, DOI 10.1007/s12024-009-9132-6; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Hsieh KLC, 2015, AM J ROENTGENOL, V204, P944, DOI 10.2214/AJR.14.13228; O'Meara AMI, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00118; Jain BG, 2018, 15 INT CHILD NEUR C; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kleinman PK., 2015, DIAGNOSTIC IMAGING C; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Lee Bruce, 2005, NeuroRx, V2, P372; Lee JK, 2016, ANESTH ANALG, V122, P1971, DOI 10.1213/ANE.0000000000001298; Leventhal JM, 2014, PEDIATR RADIOL, V44, P537, DOI 10.1007/s00247-014-3074-1; Lind K, 2013, ARCH PEDIATRIE, V20, P446, DOI 10.1016/j.arcped.2012.04.019; Liu B, 2015, J NEUROSCI, V35, P15716, DOI 10.1523/JNEUROSCI.0996-15.2015; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Matschke J, 2009, DTSCH ARZTEBL INT, V106, P211, DOI 10.3238/arztebl.2009.0211; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Miller TR, 2018, PREV SCI, V19, P695, DOI 10.1007/s11121-017-0815-z; Miyazawa N, 1995, ACTA NEUROCHIR, V137, P207, DOI 10.1007/BF02187195; Nack A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020094; Nuno M, 2018, CHILD ABUSE NEGLECT, V85, P39, DOI 10.1016/j.chiabu.2018.08.011; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Orman G, 2020, J NEUROIMAGING, V30, P15, DOI 10.1111/jon.12670; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Pollanen MS, 2002, FORENSIC SCI INT, V126, P101, DOI 10.1016/S0379-0738(02)00008-7; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Ryan ME, 2020, PEDIATR RADIOL, V50, P13, DOI 10.1007/s00247-019-04481-7; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Shekdar K, 2016, INDIAN J PEDIATR, V83, P578, DOI 10.1007/s12098-016-2043-0; Soustiel JF, 2008, NEUROPATH APPL NEURO, V34, P412, DOI 10.1111/j.1365-2990.2007.00906.x; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Turkheimer FE, 2015, BIOCHEM SOC T, V43, P586, DOI 10.1042/BST20150058; Vazquez E, 2014, PEDIATR RADIOL, V44, P589, DOI 10.1007/s00247-014-3216-5; Venneti S, 2007, EXP NEUROL, V207, P118, DOI 10.1016/j.expneurol.2007.06.003; Venneti S, 2007, J NEUROCHEM, V102, P2118, DOI 10.1111/j.1471-4159.2007.04690.x; Wadsworth H, 2012, BIOORG MED CHEM LETT, V22, P1308, DOI 10.1016/j.bmcl.2011.12.084; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GX, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.030387; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zanotti-Fregonara P, 2020, MOL IMAGING BIOL, V22, P10, DOI 10.1007/s11307-019-01433-3; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771	72	1	1	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	MAY	2021	51	6			SI		966	970		10.1007/s00247-021-04995-z			5	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	SD6SY	WOS:000651506100015	33999238				2022-02-06	
J	Noyes, ET; Tang, XY; Sander, AM; Silva, MA; Walker, WC; Finn, JA; Cooper, DB; Nakase-Richardson, R				Noyes, Emily T.; Tang, Xinyu; Sander, Angelle M.; Silva, Marc A.; Walker, William C.; Finn, Jacob A.; Cooper, Douglas B.; Nakase-Richardson, Risa			Relationship of Medical Comorbidities to Psychological Health at 2 and 5 Years Following Traumatic Brain Injury (TBI)	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injuries; comorbidities; mental health; veterans; follow-up studies	FUNCTIONAL INDEPENDENCE MEASURE; MAJOR DEPRESSION; MODEL SYSTEM; SATISFACTION; LIFE; VETERANS; SLEEP; PREDICTORS; DISORDERS; VALIDITY	Objective: To examine the relationship between medical comorbidities and psychological health outcomes at 2 and 5 years following traumatic brain injury (TBI). Method: Veterans Affairs (VA) TBI Model System participants who completed a 2-year (n = 225) and/or 5-year (n = 283) follow-up with a comorbidities interview were included in the current study. Psychological health outcomes were assessed using the Patient Global Impression of Change (PGIC), Patient Health Questionnaire-9 (PHQ-9), and Satisfaction with Life Scale (SWLS). While controlling for known predictors of outcome, the relationship of overall comorbidity burden to psychological outcomes was examined cross-sectionally using generalized linear regression at 2 and 5 years post-TBI. Lasso regularization was used to examine relationships of specific comorbid conditions to outcome. Results: Greater comorbidity burden was significantly associated with lower satisfaction with life at 2 and 5 years post-TBI and was associated with greater depressive symptomatology at 5 years post-TBI. Chronic pain was associated with lower satisfaction with life and greater depressive symptoms at both 2- and 5-year follow-up. Sleep apnea was associated with lower satisfaction with life and greater depressive symptoms at 5-year follow-up. Rheumatoid arthritis was associated with lower satisfaction with life and lower levels of perceived improvement in health and well-being at the 5-year follow-up. Implications: Results suggest that medical comorbidities may have a cumulative impact on adverse psychological health outcomes in chronic stages of TBI. This study further highlights the complexity of patients with TBI and the importance of identifying medical comorbidities as they provide potential targets for intervention.	[Noyes, Emily T.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Noyes, Emily T.; Silva, Marc A.] James A Haley Vet Hosp, Mental Hlth & Behav Sci Sect, Tampa, FL 33612 USA; [Tang, Xinyu] James A Haley Vet Hosp, Tampa Vet Res & Educ Fdn, Tampa, FL 33612 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Silva, Marc A.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil PM&R, Richmond, VA USA; [Walker, William C.] Hunter Holmes McGuire Vet Affairs Med Ctr, Def & Vet Brain Injury Ctr DVBIC, Richmond, VA USA; [Finn, Jacob A.] Minneapolis VA Hlth Care Syst, Extended Care & Rehabil Serv, Minneapolis, MN USA; [Finn, Jacob A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Cooper, Douglas B.] Audie Murphy VA Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Cooper, Douglas B.] UT Hlth, Dept Psychiat, San Antonio, TX USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Polytrauma TBI Rehabil Mail Code 117, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Morsani Coll Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Mental Hlth & Behav Sci, Polytrauma TBI Rehabil Mail Code 117, Tampa, FL 33612 USA.	risa.richardson@va.gov		Noyes, Emily/0000-0002-6783-1701	VHA Central Office VA TBI Model Systems Program of Research; General Dynamics Information Technology from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015, HT0014-19-C-0004]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DPTB0016, 90DP0033]	This research was sponsored by VHA Central Office VA TBI Model Systems Program of Research; Subcontract from General Dynamics Information Technology (W91YTZ-13-C-0015; HT0014-19-C-0004) from the Defense and Veterans Brain Injury Center and National Institute on Disability, Independent Living, and Rehabilitation Research (Grant 90DPTB0016, PIs: Sherer and Angelle M. Sander; and 90DP0033, to William C. Walker). The authors report no conflicts of interest.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; [Anonymous], 2014, NAT HLTH NUTR EX SUR; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown RM, 2018, BRAIN INJURY, V32, P986, DOI 10.1080/02699052.2018.1468575; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gause LR, 2017, J HEAD TRAUMA REHAB, V32, P255, DOI 10.1097/HTR.0000000000000309; Graves DE, 2008, J SPINAL CORD MED, V31, P177, DOI 10.1080/10790268.2008.11760709; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; JENNETT B, 1977, LANCET, V1, P878; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kerner NA, 2016, AM J GERIAT PSYCHIAT, V24, P496, DOI 10.1016/j.jagp.2016.01.134; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; NETO F, 1993, J YOUTH ADOLESCENCE, V22, P125, DOI 10.1007/BF01536648; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Project Sanctuary, 2020, THER RETR THER RETR; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Silva MA, 2018, BRAIN INJURY, V32, P994, DOI 10.1080/02699052.2018.1468576; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Sullivan-Singh SJ, 2014, ARCH PHYS MED REHAB, V95, P1100, DOI 10.1016/j.apmr.2014.02.001; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2012, J R STAT SOC B, V74, P245, DOI 10.1111/j.1467-9868.2011.01004.x; Townsend J, 2018, COGENT PSYCHOL, V5, DOI 10.1080/23311908.2018.1444330; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005	46	1	1	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2021	66	2					107	117		10.1037/rep0000366			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	TF3LK	WOS:000670616800001	33119380	Bronze			2022-02-06	
J	Rosen, KB; Delpy, KB; Pape, MM; Kodosky, PN; Kruger, SE				Rosen, Kerry B.; Delpy, Kathleen B.; Pape, Marcy M.; Kodosky, Paula N.; Kruger, Sarah E.			Examining the Relationship Between Conventional Outcomes and Immersive Balance Task Performance in Service Members With Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SENSORY ORGANIZATION TEST; VESTIBULAR REHABILITATION; POSTUROGRAPHY; IMPAIRMENTS; CONCUSSION; PATTERNS; HISTORY	Introduction: Mild traumatic brain injury (mTBI) is associated with significant financial cost and reduced military readiness and impacts quality of life for active duty service members (SMs). Post-concussive symptoms can include vestibular impairments, such as chronic dizziness and postural instability, which can be compounded by psychological comorbidities like PTSD. Comprehensive vestibular evaluations are required to assess symptoms and guide clinical decision-making. At the National Intrepid Center of Excellence (NICoE), in addition to traditional vestibular assessments, clinicians can also leverage virtual environments (VEs) in the Computer-Assisted Rehabilitation Environment (CAREN) to further evaluate balance. The objective of this study was to examine the relationship between conventional outcomes and VE performance on immersive balance tasks in the CAREN, determine whether VE performance could predict conventional outcomes, and explore the impact of PTSD. Materials and Methods: This retrospective analysis included 112 SMs from the NICoE Intensive Outpatient Program who provided informed consent for their clinical data to be used for research purposes. All had a history of mTBI, underwent vestibular evaluations, and completed immersive balance tasks on the CAREN. Conventional outcomes included the Sensory Organization Test (SOT), Functional Gait Assessment (FGA), Activities Balance Confidence (ABC) Scale, and Dizziness Handicap Inventory (DHI). The PTSD Checklist-Military Version was added to account for behavioral symptoms. Computer-Assisted Rehabilitation Environment outcomes included total time to complete the Balance Cubes VE, with the platform static (BC-Static) and with random platform motion (BC-PM) as well as composite scores for the Shark Hunt VE, with (SH-Recall) and without a recall task (SH-Standard). Statistical analyses included independent t-tests to determine group differences, Pearson's correlations to examine relationships between conventional outcomes and VE performance, and binary logistic regressions to determine if VE performance predicted conventional outcomes based on clinically relevant cutoffs. Results: SMs who took less time to complete BC-Static had better overall balance, indicated by higher ABC, SOT, and FGA scores (P<.001). Those with greater self-reported dizziness, higher DHI scores, took longer to complete BC-Static (P<.05). FGA and SOT, objective gait and balance, were similarly correlated to BC-PM performance (P<.001). SMs with higher SOT scores, better balance, also tended to have higher SH-Standard scores (P<.1). SMs, who were above normative SOT, FGA, and ABC cutoffs, completed BC-Static significantly faster than those below (P<.05). This remained true for BC-PM but was only significant for SOT (P=.004). Performance on BC-Static, BC-PM, and SH-Standard was significant predictors of SOT score. For SMs with comorbid mTBI and PTSD, increased functional disability was observed in conventional outcomes and diminished VE performance was noted. Conclusion: Objective balance and gait, SOT and FGA, demonstrated the strongest relationships to immersive VE performance in the CAREN. Our findings suggest that these immersive balance tasks may be effective as an adjunct assessment to examine balance. Future work will focus on moving these VEs from the CAREN to a portable system, which could be more readily utilized in a variety of clinical settings, increasing accessibility.	[Rosen, Kerry B.; Delpy, Kathleen B.; Kruger, Sarah E.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Dept Res, Bethesda, MD 20889 USA; [Pape, Marcy M.; Kodosky, Paula N.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Dept Clin Operat, Bethesda, MD 20889 USA		Rosen, KB (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Dept Res, Bethesda, MD 20889 USA.				Congressionally Directed Medical Research ProgramUnited States Department of Defense [CDMRPL-17-0-PT160118]	This work is supported in part by the Congressionally Directed Medical Research Program under project number CDMRPL-17-0-PT160118.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Brungart D, 2019, J NEUROTRAUM, V36, P2443, DOI 10.1089/neu.2018.5630; Chiarovano E, 2018, GAIT POSTURE, V59, P217, DOI 10.1016/j.gaitpost.2017.10.019; Cohen HS, 2008, J VESTIBUL RES-EQUIL, V18, P295; Defense and Veterans Brain Injury Center (DVBIC), 2019, DOD NUMB TRAUM BRAIN; DIFABIO RP, 1995, PHYS THER, V75, P290, DOI 10.1093/ptj/75.4.290; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2012, IEEE ENG MED BIO, P6141, DOI 10.1109/EMBC.2012.6347395; Hebert JR, 2018, J HEAD TRAUMA REHAB, V33, P403, DOI 10.1097/HTR.0000000000000385; Highland KB, 2015, STUD HEALTH TECHNOL, V219, P23, DOI 10.3233/978-1-61499-595-1-23; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Karch SJ, 2019, MIL MED, V184, pE296, DOI 10.1093/milmed/usz064; King JE, 2018, MIL MED, V183, P237, DOI 10.1093/milmed/usx170; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Lu LH, 2019, ARCH CLIN NEUROPSYCH, V34, P236, DOI 10.1093/arclin/acy031; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Naber CM, 2011, OTOLARYNG HEAD NECK, V145, P117, DOI 10.1177/0194599811399371; Oh C, 2019, CYBERPSYCH BEH SOC N, V22, P365, DOI 10.1089/cyber.2018.0404; Onakomaiya MM, 2017, MIL MED, V182, P128, DOI 10.7205/MILMED-D-16-00054; ONeil ME, 2013, COMPLICATIONS MILD T, P8; Pape MM, 2016, J HEAD TRAUMA REHAB, V31, P339, DOI 10.1097/HTR.0000000000000179; Pletcher ER, 2017, J ATHL TRAINING, V52, P129, DOI 10.4085/1062-6050-52.1.05; Rawlins MLW, 2020, MIL MED, V185, pE269, DOI 10.1093/milmed/usz162; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Trueblood PR, 2018, ACTA OTO-LARYNGOL, V138, P597, DOI 10.1080/00016489.2018.1429653; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Viziano A, 2019, CLIN REHABIL, V33, P24, DOI 10.1177/0269215518788598; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Weathers F., 1993, 9 ANN C ISTSS SAN AN; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whitney SL, 2006, ARCH PHYS MED REHAB, V87, P402, DOI 10.1016/j.apmr.2005.11.002; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	40	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2021	186	5-6					577	586		10.1093/milmed/usaa578			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TF9TQ	WOS:000671057600031	33476371	hybrid			2022-02-06	
J	Schober, ME; Requena, DF; Ohde, JW; Maves, S; Pauly, JR				Schober, Michelle Elena; Requena, Daniela F.; Ohde, Joshua W.; Maves, Sydney; Pauly, James R.			Docosahexaenoic acid decreased inflammatory gene expression, but not 18-kDa translocator protein binding, in rat pup brain after controlled cortical impact	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Developing brain; traumatic brain injury; nutrition; polyunsaturated fatty acids; rat	FATTY-ACIDS; IN-VIVO; INJURY; ASTROCYTES; MICROGLIA; MODELS; TSPO; NEUROINFLAMMATION; ACTIVATION; RECEPTOR	BACKGROUND Traumatic brain injury is the leading cause of acquired neurologic disability in children. In our model of pediatric traumatic brain injury, controlled cortical impact (CCI) in rat pups, docosahexaenoic acid (DHA) improved lesion volume and cognitive testing as late as postinjury day (PID) 50. Docosahexaenoic acid decreased proinflammatory messenger RNA (mRNA) in microglia and macrophages at PIDs 3 and 7, but not 30. We hypothesized that DHA affected inflammatory markers differentially relative to impact proximity, early and persistently after CCI. METHODS To provide a temporal snapshot of regional neuroinflammation, we measured 18-kDa translocator protein (TSPO) binding using whole brain autoradiography at PIDs 3, 7, 30, and 50. Guided by TSPO results, we measured mRNA levels in contused cortex and underlying hippocampus for genes associated with proinflammatory and inflammation-resolving states at PIDs 2 and 3. RESULTS Controlled cortical impact increased TSPO binding at all time points, most markedly at PID 3 and in regions closest to impact, not blunted by DHA. Controlled cortical impact increased cortical and hippocampal mRNA proinflammatory markers, blunted by DHA at PID 2 in hippocampus. CONCLUSION Controlled cortical impact increased TSPO binding in the immature brain in a persistent manner more intensely with more severe injury, not altered by DHA. Controlled cortical impact increased PIDs 2 and 3 mRNA levels of proinflammatory and inflammation-resolving genes. Docosahexaenoic acid decreased proinflammatory markers associated with inflammasome activation at PID 2. We speculate that DHA's salutary effects on long-term outcomes result from early effects on the inflammasome. Future studies will examine functional effects of DHA on microglia both early and late after CCI.	[Schober, Michelle Elena] Univ Utah, Primary Childrens Hosp, Williams Bldg,POB 581289, Salt Lake City, UT 84158 USA; [Schober, Michelle Elena; Requena, Daniela F.; Maves, Sydney] Univ Utah, Div Crit Care, Dept Pediat, Salt Lake City, UT 84158 USA; [Ohde, Joshua W.; Pauly, James R.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA		Schober, ME (corresponding author), Univ Utah, Primary Childrens Hosp, Williams Bldg,POB 581289, Salt Lake City, UT 84158 USA.; Schober, ME (corresponding author), Univ Utah, Div Crit Care, Dept Pediat, Salt Lake City, UT 84158 USA.	michelle.schober@hsc.utah.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R21 NS090098-02]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Pediatric Critical Care Medicine at the University of Utah	The authors declare no conflicts of interest. This work was supported by the NINDS grant number 5R21 NS090098-02, National Institutes of Health, and by Pediatric Critical Care Medicine at the University of Utah. Neither funding agency had any role in the study design; data collection, analysis, and interpretation; writing of the report; or decision to submit the article for publication.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Anthony D, 1998, CURR BIOL, V8, P923, DOI 10.1016/S0960-9822(07)00373-9; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bastian L, 2002, BRIT J NUTR, V87, pS133, DOI 10.1079/BJN2001466; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Berman DR, 2013, NEONATOLOGY, V104, P71, DOI 10.1159/000351011; Butt CM., 2017, CURR RES CONCUSSION, V4, pE38; Cai W, 2018, TRANSL STROKE RES, V9, P669, DOI 10.1007/s12975-018-0662-7; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chechneva OV, 2016, NEURAL REGEN RES, V11, P1056, DOI 10.4103/1673-5374.187027; Cheung H, 2005, J IMMUNOL, V174, P5351, DOI 10.4049/jimmunol.174.9.5351; Chuntrasakul Chomchark, 2003, Journal of the Medical Association of Thailand, V86, P552; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dumont A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1723-x; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Fourrier C, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0939-x; Giacobbe J, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00122; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Ikonomidou C, 2011, ANTIOXID REDOX SIGN, V14, P1535, DOI 10.1089/ars.2010.3581; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; ITZHAK Y, 1995, DEV BRAIN RES, V84, P62, DOI 10.1016/0165-3806(94)00163-T; Jha MK, 2016, BIOCHEM PHARMACOL, V103, P1, DOI 10.1016/j.bcp.2015.11.003; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kim SW, 2018, NEUROPSYCHOPHARMACOL, V43, P1832, DOI 10.1038/s41386-018-0085-x; Lauritzen L, 2002, LIPIDS, V37, P237, DOI 10.1007/s11745-002-0886-2; Lauritzen L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010006; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Lien EL, 2009, PROSTAG LEUKOTR ESS, V81, P125, DOI 10.1016/j.plefa.2009.05.004; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Popernack ML, 2015, J PEDIATR HEALTH CAR, V29, pE1, DOI 10.1016/j.pedhc.2014.09.003; Potts Mathew B, 2006, NeuroRx, V3, P143; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Schain M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0733-2; Schober ME, 2020, BEHAV BRAIN RES, V378, DOI 10.1016/j.bbr.2019.112295; Schober ME, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112971; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Siriwardhana N, 2012, ADV FOOD NUTR RES, V65, P211, DOI 10.1016/B978-0-12-416003-3.00013-5; Stapleton RD, 2011, CRIT CARE MED, V39, P1655, DOI 10.1097/CCM.0b013e318218669d; Tremoleda JL, 2016, EUR J NUCL MED MOL I, V43, P1710, DOI 10.1007/s00259-016-3391-8; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Voet S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810248; Wawrocki S, 2016, ACTA BIOCHIM POL, V63, P59, DOI 10.18388/abp.2015_1153; Wierenga KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02130; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008	63	1	1	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2021	90	5					866	873		10.1097/TA.0000000000003084			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	RZ1DQ	WOS:000648339300026	33728886				2022-02-06	
J	Spiteri, C; Ponsford, J; Jones, H; McKay, A				Spiteri, Courtney; Ponsford, Jennie; Jones, Harvey; McKay, Adam			Comparing the Westmead Posttraumatic Amnesia Scale, Galveston Orientation and Amnesia Test, and Confusion Assessment Protocol as Measures of Acute Recovery Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						posttraumatic amnesia; posttraumatic confusional state; rehabilitation; traumatic brain injury	COGNITIVE TEST; SEVERITY; REHABILITATION; VALIDATION; MULTICENTER; AGITATION; DURATION; DELIRIUM; OUTCOMES	Background: The duration of the acute period of recovery following traumatic brain injury (TBI) remains a widely used criterion for injury severity and clinical management. Consensus regarding its most appropriate definition and assessment method has yet to be established. Objective: The present study compared the trajectory of recovery using 3 measures: the Westmead Post-Traumatic Amnesia Scale (WPTAS), the Galveston Orientation and Amnesia Test (GOAT), and the Confusion Assessment Protocol (CAP). Patterns of symptom recovery using the CAP were explored. Participants: Eighty-two participants with moderate to severe TBI in posttraumatic amnesia (PTA) on admission to an inpatient rehabilitation hospital. Design: Prospective longitudinal study. Outcome Measures: Length of PTA (days), agreement between measures (%, kappa coefficient), and pattern of symptom recovery. Results: Participants emerged from PTA earliest on the CAP followed the GOAT, and last on the WPTAS. There was good agreement between the CAP and the GOAT as to PTA status, but both tests had poor agreement with the WPTAS. Of patients considered out of PTA on the CAP, the majority exhibited signs of amnesia on the WPTAS and one-third had clinical levels of agitation. Conclusion: The WPTAS identifies a later stage of PTA recovery that requires specialized management due to ongoing amnesia and agitation. The CAP and the GOAT are less sensitive to this extended period of PTA.	[Spiteri, Courtney; Ponsford, Jennie; McKay, Adam] Monash Univ, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Spiteri, Courtney; Ponsford, Jennie; McKay, Adam] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Spiteri, Courtney; Ponsford, Jennie; Jones, Harvey; McKay, Adam] Epworth Healthcare, Richmond, Vic, Australia		McKay, A (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	Courtney.baxter@monash.edu; Jennie.Ponsford@monash.edu; harvey.jones@epworth.org.au; adam.mckay@monash.edu					Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Draganich C, 2019, BRAIN INJURY, V33, P1194, DOI 10.1080/02699052.2019.1631484; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Langhorn L, 2010, J CLIN NURS, V19, P2959, DOI 10.1111/j.1365-2702.2010.03330.x; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2008, ARCH PHYS MED REHAB, V89, P42, DOI 10.1016/j.apmr.2007.08.128; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds CP, 1943, LANCET, V1, P7; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wolffbrandt MM, 2013, REHABIL NURS, V38, P133, DOI 10.1002/rnj.82; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	43	1	1	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		156	163		10.1097/HTR.0000000000000607			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900007	32898032				2022-02-06	
J	Subbarao, BS; Stokke, J; Martin, SJ				Subbarao, Bruno S.; Stokke, Jesse; Martin, Samuel J.			Telerehabilitation in Acquired Brain Injury	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Telemedicine; Telerehabilitation; Telehealth; Acquired brain injury; Stroke; Traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; LONG-TERM DISABILITY; COGNITIVE IMPAIRMENT; UNITED-STATES; MILD; AMANTADINE; MANAGEMENT; AGITATION; VETERANS; STROKE		[Subbarao, Bruno S.] Phoenix Vet Healthcare Syst, Phys Med & Rehabil Dept, Bldg 34,650 E Indian Sch Rd, Phoenix, AZ 85012 USA; [Stokke, Jesse; Martin, Samuel J.] HonorHlth Rehabil Hosp, 8850 E Pima Ctr Pkwy, Scottsdale, AZ 85258 USA		Subbarao, BS (corresponding author), Phoenix Vet Healthcare Syst, Phys Med & Rehabil Dept, Bldg 34,650 E Indian Sch Rd, Phoenix, AZ 85012 USA.	brunopmrdoc@gmail.com					American Stroke Association, 2018, QUEST SHOULD PAIN; [Anonymous], Concussion danger signs; Assistant Secretary of Defense, 2015, TRAUMATIC BRAIN INJU; Bhalerao, 2010, BCMEDJ, V53, P26, DOI [10.1089/scd.2015.0160, DOI 10.1089/SCD.2015.0160]; Boes CJ, 2021, NEUROL-CLIN PRACT, V11, pE157, DOI 10.1212/CPJ.0000000000000876; Bronstein AM, 2010, RESTOR NEUROL NEUROS, V28, P83, DOI 10.3233/RNN-2010-0530; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Choi-Kwon S, 2011, INT J STROKE, V6, P328, DOI 10.1111/j.1747-4949.2011.00624.x; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Ciemins EL, 2009, TELEMED J E-HEALTH, V15, P476, DOI 10.1089/tmj.2008.0144; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Cotelli M, 2019, J TELEMED TELECARE, V25, P67, DOI 10.1177/1357633X17740390; Das J, 2018, NEUROSCI BIOBEHAV R, V90, P104, DOI 10.1016/j.neubiorev.2018.04.005; Delpont B, 2018, REV NEUROL-FRANCE, V174, P671, DOI 10.1016/j.neurol.2017.11.011; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; DeYoung N, 2019, J TELEMED TELECARE, V25, P197, DOI 10.1177/1357633X17752030; Dorsey ER, 2013, JAMA NEUROL, V70, P565, DOI 10.1001/jamaneurol.2013.123; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Ferro JM, 2016, NAT REV NEUROL, V12, P269, DOI 10.1038/nrneurol.2016.46; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; Fu C, 2017, GERIATR GERONTOL INT, V17, P2329, DOI 10.1111/ggi.13069; Galiano-Castillo N, 2016, CANCER-AM CANCER SOC, V122, P3166, DOI 10.1002/cncr.30172; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Harper KA, 2021, CLIN REHABIL, V35, P589, DOI 10.1177/0269215520963845; Hicks AJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01169; Kawaguchi A, 2018, TELEMED E-HEALTH, V24, P301, DOI 10.1089/tmj.2017.0100; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Krishnamurthi RV, 2013, LANCET GLOB HLTH, V1, pE2; Kruse RC, 2018, PM&R, V10, P898, DOI 10.1016/j.pmrj.2018.03.003; Laskowski ER, 2020, MAYO CLIN PROC, V95, P1715, DOI 10.1016/j.mayocp.2020.05.026; Laver KE, 2013, COCHRANE DATABASE SY, V2013; Lei C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224819; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Levy M, 2005, NEUROREHABILITATION, V20, P279; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Martinez RN, 2017, PM&R, V9, P231, DOI 10.1016/j.pmrj.2016.07.002; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; McEachern W, 2008, CAN J NEUROL SCI, V35, P643, DOI 10.1017/S0317167100009458; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Morland LA, 2010, J CLIN PSYCHIAT, V71, P855, DOI 10.4088/JCP.09m05604blu; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Norden JG, 2020, DIGIT HEALTH, V6, DOI 10.1177/2055207620958528; Nowak DA, 2011, CAN J NEUROL SCI, V38, P129, DOI 10.1017/S0317167100011173; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2018, J NEUROTRAUM, V35, P1620, DOI 10.1089/neu.2017.5379; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Pundik S, 2019, ANN PHYS REHABIL MED, V62, P397, DOI 10.1016/j.rehab.2018.07.006; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ratanjee-Vanmali H, 2020, J MED INTERNET RES, V22, DOI 10.2196/15875; Robblee J., Conducting a telemedicine neurologic exam. American Headache Society video; Sarfo FS, 2018, J STROKE CEREBROVASC, V27, P2306, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Seyffert M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149139; Shi D, 2018, NEUROL SCI, V39, P705, DOI 10.1007/s10072-018-3254-0; Stroke signs and symptoms, STROK SIGNS SYMPT; Thoomes EJ, 2018, SPINE J, V18, P179, DOI 10.1016/j.spinee.2017.08.241; Tong HC, 2002, SPINE, V27, P156; Verduzco-Gutierrez M, 2020, PM&R, V12, P714, DOI 10.1002/pmrj.12380; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Vos PE, 2002, Eur J Neurol, V9, P207; Whyte E, 2011, PM&R, V3, pS45, DOI 10.1016/j.pmrj.2011.05.007; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	73	1	1	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2021	32	2					223	238		10.1016/j.pmr.2021.01.001			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	RY1SP	WOS:000647697900004	33814054				2022-02-06	
J	Takahashi, CE; Virmani, D; Chung, DY; Ong, C; Cervantes-Arslanian, AM				Takahashi, Courtney E.; Virmani, Deepti; Chung, David Y.; Ong, Charlene; Cervantes-Arslanian, Anna M.			Blunt and Penetrating Severe Traumatic Brain Injury	NEUROLOGIC CLINICS			English	Article						Severe traumatic brain injury; Penetrating brain injury; Intensive care management Review article; Summary	EARLY-ONSET PNEUMONIA; ENDOVASCULAR MECHANICAL THROMBECTOMY; VENTILATOR-ASSOCIATED PNEUMONIA; CEREBRAL PERFUSION-PRESSURE; EXTERNAL VENTRICULAR DRAIN; PENTOSE-PHOSPHATE PATHWAY; BLOOD-CELL TRANSFUSION; INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; SUBARACHNOID HEMORRHAGE		[Takahashi, Courtney E.] Boston Med Ctr, Dept Neurol, 72 East Concord St,C-3, Boston, MA 02118 USA; [Virmani, Deepti; Chung, David Y.; Ong, Charlene] Boston Univ, Dept Neurol, Sch Med, 72 East Concord St,C-3, Boston, MA 02118 USA; [Virmani, Deepti; Chung, David Y.; Ong, Charlene; Cervantes-Arslanian, Anna M.] Boston Med Ctr, 72 East Concord St,C-3, Boston, MA 02118 USA; [Chung, David Y.] Harvard Med Sch, Dept Neurol, Div Neurocrit Care, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Chung, David Y.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Neurovasc Res Unit, Boston, MA 02115 USA; [Cervantes-Arslanian, Anna M.] Boston Univ, Sch Med, 72 East Concord St,C-3, Boston, MA 02118 USA		Takahashi, CE (corresponding author), Boston Med Ctr, Dept Neurol, 72 East Concord St,C-3, Boston, MA 02118 USA.	Courtney.takahashi@bmc.org					Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Al-Mufti F, 2018, WORLD NEUROSURG, V120, pE68, DOI 10.1016/j.wneu.2018.07.143; Al-Mufti F, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17431; Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; American College of Surgeons, 2015, MAN TRAUM BRAIN INJ; American Trauma Society, TRAUM CTR LEV EXPL; Andrade G, 2013, INTERV NEURORADIOL, V19, P445, DOI 10.1177/159101991301900407; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; [Anonymous], 2000, J Neurotrauma, V17, P563; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; BARROW DL, 1985, J NEUROSURG, V62, P248, DOI 10.3171/jns.1985.62.2.0248; Barsan W G, BRAIN OXYGEN OPTIMIZ; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; BITO L, 1966, J NEUROCHEM, V13, P1057, DOI 10.1111/j.1471-4159.1966.tb04265.x; Boas DA, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031412; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; Bonow RH, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.9.FOCUS19611; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; CDC Traumatic Brain Injury & Concussion, 2020, CTR DIS CONTR TRAUM; CHAUDHRI KA, 1994, ACTA NEUROCHIR, V126, P120, DOI 10.1007/BF01476420; Chen HS, 2020, AM J EMERG MED, V38, P364, DOI 10.1016/j.ajem.2019.158499; Chen KC, 2002, J NEUROCHEM, V81, P108, DOI 10.1046/j.1471-4159.2002.00793.x; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chornenki NLJ, 2019, THROMB RES, V179, P81, DOI 10.1016/j.thromres.2019.05.003; Chung DY, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-1009-9; Chung DY, 2016, J INTENSIVE CARE MED, V31, P415, DOI 10.1177/0885066615623465; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cryer H., 2015, AM COLL SURG TRAUMA; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; DEBRUN GM, 1988, NEUROSURGERY, V22, P285, DOI 10.1227/00006123-198802000-00001; DELGADO JMR, 1972, ARCH INT PHARMACOD T, V198, P9; Dereeper E, 2002, J CRIT CARE, V17, P58, DOI 10.1053/jcrc.2002.33032; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Donnelly J, 2018, ACTA NEUROCHIR SUPPL, V126, P209, DOI 10.1007/978-3-319-65798-1_43; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; El Ahmadieh TY, 2021, WORLD NEUROSURG, V145, pE163, DOI 10.1016/j.wneu.2020.09.152; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Esnault P, 2019, NEUROCRIT CARE, V30, P405, DOI 10.1007/s12028-018-0639-0; Fomchenko EI, 2018, CURR TREAT OPTION NE, V20, DOI 10.1007/s11940-018-0518-1; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gollwitzer S, 2015, CLIN NEUROPHYSIOL, V126, P1514, DOI 10.1016/j.clinph.2014.10.215; Gu JJ, 2019, NEUROSURG REV, V42, P499, DOI 10.1007/s10143-018-0991-8; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; HADDAD FS, 1991, NEUROSURGERY, V28, P1; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Henninger N, 2018, J TRAUMA ACUTE CARE, V84, P473, DOI 10.1097/TA.0000000000001733; Hepburn-Smith M, 2016, J NEUROSCI NURS, V48, P54, DOI 10.1097/JNN.0000000000000174; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; HOMBURG AM, 1993, ACTA NEUROL SCAND, V87, P488; HOUSER OW, 1979, MAYO CLIN PROC, V54, P651; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Hua F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008367.pub3; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Ilyas A, 2017, J NEUROINTERV SURG, V9, P1086, DOI 10.1136/neurintsurg-2016-012938; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kett-White R, 2002, NEUROSURGERY, V50, P1213, DOI 10.1097/00006123-200206000-00008; Khairat A, 2018, EPIDURAL HEMATOMA; Khalili Hosseinali, 2015, Bull Emerg Trauma, V3, P53; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Kitchen WJ, 2011, BRIT J NEUROSURG, V25, P632, DOI 10.3109/02688697.2011.578770; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; La Russa R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114148; Lazaridis C, 2014, NEUROCRIT CARE, V21, P345, DOI 10.1007/s12028-014-0007-7; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; Lewis TD, 2018, NEUROCRIT CARE, V28, P362, DOI 10.1007/s12028-017-0490-8; Liao CH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61884-5; Lin TK, 2012, J TRAUMA ACUTE CARE, V73, P131, DOI 10.1097/TA.0b013e31824aff74; Loggini A, 2020, J CRIT CARE, V56, P159, DOI 10.1016/j.jcrc.2019.12.026; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Lundberg N, 1962, J NEUROPATH EXP NEUR, V21, P489; Ma CY, 2010, CHIN J TRAUMATOL, V13, P293, DOI 10.3760/cma.j.issn.1008-1275.2010.05.008; Malak W, 2020, BIOMED J SCI TECH RE, V26; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Manoach S, 2007, ANN EMERG MED, V50, P236, DOI 10.1016/j.annemergmed.2007.01.009; Mansour A, 2021, NEUROCRIT CARE, V34, P918, DOI 10.1007/s12028-020-01106-y; Jimenez CM, 2013, WORLD NEUROSURG, V79, P749, DOI 10.1016/j.wneu.2012.06.025; McCredie VA, 2017, NEUROCRIT CARE, V26, P247, DOI 10.1007/s12028-016-0310-6; McFarlane TD, 2020, J HEAD TRAUMA REHAB, V35, pE310, DOI 10.1097/HTR.0000000000000539; McMillian WD, 2010, J TRAUMA, V69, P861, DOI 10.1097/TA.0b013e3181e83f8b; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Merino MA, 2010, NEUROCIRUGIA, V21, P289; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Muehlschlegel S, 2009, NEUROCRIT CARE, V11, P288, DOI 10.1007/s12028-009-9254-4; Munro CL, 2009, AM J CRIT CARE, V18, P428, DOI 10.4037/ajcc2009792; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; NAKAJIMA S, 1983, ARCH NEUROL-CHICAGO, V40, P271, DOI 10.1001/archneur.1983.04050050039004; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Nomura Motohiro, 2016, J Clin Med Res, V8, P342, DOI 10.14740/jocmr2489w; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pashapour A, 2014, NEURORADIOL J, V27, P461, DOI 10.15274/NRJ-2014-10079; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Poole D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113676; Prosser JD, 2011, OTOLARYNG CLIN N AM, V44, P857, DOI 10.1016/j.otc.2011.06.007; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Qureshi Adnan I, 2020, J Vasc Interv Neurol, V11, P27; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rasulo FA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1632-2; Reed MR, 2015, BJA EDUC, V15, P32, DOI 10.1093/bjaceaccp/mku009; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; Robba C, 2020, CHEST; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Robert T, 2017, ACTA NEUROCHIR, V159, P835, DOI 10.1007/s00701-017-3079-2; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rodriguez-Luna D, 2016, NEUROLOGY, V87, P357, DOI 10.1212/WNL.0000000000002897; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Sartelli M, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0033-6; Selb J, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.4.045005; SELHORST JB, 1985, NEUROSURGERY, V16, P357, DOI 10.1227/00006123-198503000-00013; Servadei F, 2014, WORLD NEUROSURG, V82, pE597, DOI 10.1016/j.wneu.2014.08.034; Sieg EP, 2018, WORLD NEUROSURG, V115, pE53, DOI 10.1016/j.wneu.2018.03.160; Sims CA, 2019, JAMA SURG, V154, P994, DOI 10.1001/jamasurg.2019.2884; Sloane C, 2000, J EMERG MED, V19, P259, DOI 10.1016/S0736-4679(00)00235-3; Sonig A, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.5.FOCUS1269; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Spaite DW, 2019, JAMA SURG, V154, DOI 10.1001/jamasurg.2019.1152; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; Stewart C, 2008, NEUROSURGERY, V63, P1159, DOI 10.1227/01.NEU.0000333265.19131.7C; Stocchetti N, 1998, ACT NEUR S, V71, P162; Stocchetti N, 2017, CURR OPIN CRIT CARE, V23, P110, DOI 10.1097/MCC.0000000000000393; Stuehmer C, 2009, J ORAL MAXIL SURG, V67, P775, DOI 10.1016/j.joms.2008.08.036; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Takano K, 2019, J MAGN RESON IMAGING, V49, P800, DOI 10.1002/jmri.26231; TAKI W, 1994, ACTA NEUROCHIR, V127, P6, DOI 10.1007/BF01808538; Talibi SS, 2020, BRIT J NEUROSURG, V34, P181, DOI 10.1080/02688697.2020.1725436; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tso MK, 2017, J NEUROSURG, V126, P1033, DOI 10.3171/2016.1.JNS151545; Valles J, 2013, CHEST, V143, P1219, DOI 10.1378/chest.12-1361; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vulcu S, 2019, WORLD NEUROSURG, V121, pE739, DOI 10.1016/j.wneu.2018.09.208; Wang AC, 2012, J TRAUMA ACUTE CARE, V72, P1599, DOI 10.1097/TA.0b013e318246ead4; Weng ST, 2019, WORLD NEUROSURG, V123, P128, DOI 10.1016/j.wneu.2018.11.214; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wilson CD, 2018, WORLD NEUROSURG, V110, pE901, DOI 10.1016/j.wneu.2017.11.116; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Yang Y, 2016, CNS DRUGS, V30, P677, DOI 10.1007/s40263-016-0365-0; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zubkov ZY, 2000, SURG NEUROL, V53, P126; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	203	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	MAY	2021	39	2					443	469		10.1016/j.ncl.2021.02.009			27	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RY2ZU	WOS:000647786200012	33896528				2022-02-06	
J	Tang, JS; Kang, YY; Huang, LJ; Feng, XH; Wu, L; Peng, Y				Tang, Jingshu; Kang, Yuying; Huang, Longjian; Feng, Xinhong; Wu, Lei; Peng, Ying			Neuroprotective effects of Hemocoagulase Agkistrodon on experimental traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Hemocoagulase Agkistrodon; Brain-blood barrier; Inflammatory cytokines; Brain edema; Neuroprotection		Traumatic brain injury (TBI) is the major cause of disability and mortality among young people and is associated with neurodegenerative diseases. However, the available clinical options have limited effectiveness. Here, we investigated the neuroprotective effect of Hemocoagulase Agkistrodon (HCA), a thrombin-like enzyme (TLE) isolated and purified from snake venom. Rats subjected to experimental TBI were administered a single dose of HCA or vehicle 10 min after injury. Neurological function was assessed with modified neurological severity score (mNSS). Brain edema were evaluated by measuring brain water content. Levels of hemoglobin and inflammatory cytokines were detected by Enzyme-linked immunosorbent assay (ELISA). In addition, assays including Evans blue extravasation, Western blot analysis and immunofluorescence staining were utilized to determined blood-brain barrier (BBB) integrity. Our results showed that HCA treatment ameliorated neurological deficits (p < 0.01), alleviated brain edema (p < 0.01) and hemorrhage (p < 0.01), decreased the production of the proinflammatory cytokines IL-1 beta (p < 0.01), TNF-alpha (p < 0.01) and IL-6 (p < 0.05), and increased the anti- inflammatory cytokine IL-10 at the contusion site (p < 0.01). Moreover, HCA administration reduced BBB disruption by regulating expression of tight junction proteins, including ZO-1, occludin and claudin-5 (ps < 0.01). Together, our results demonstrate that HCA might have therapeutic efficacy in acute TBI, suggesting a potential clinical application for mitigating the neuropathological damage associated with TBI.	[Tang, Jingshu; Kang, Yuying; Huang, Longjian; Wu, Lei; Peng, Ying] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Feng, Xinhong] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Neurol, Beijing 102218, Peoples R China		Peng, Y (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Dept Pharmacol, Beijing, Peoples R China.	ypeng@imm.ac.cn			National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81872855, 81673420]; CAMS Innovation Fund for Medical Sciences [2017-I2M-2-004]; National Science and Technology Major Special Project on Major New Drug Innovation of China [2018ZX09711001-003-005, 2018ZX09711001-003-009]; National Key R&D Program of China [2019YFC1708901]; Fundamental Research Funds for the Central Universities of ChinaFundamental Research Funds for the Central Universities [3332019070]; Disciplines construction project of China [20190200802]	This project was supported by grants from the National Natural Sciences Foundation of China (No. 81872855 and 81673420), CAMS Innovation Fund for Medical Sciences (No. 2017-I2M-2-004), National Science and Technology Major Special Project on Major New Drug Innovation of China (2018ZX09711001-003-005 and 2018ZX09711001-003-009), National Key R&D Program of China (No. 2019YFC1708901), Fundamental Research Funds for the Central Universities of China (3332019070) and Disciplines construction project of China (20190200802).	Abd El-Aziz TM, 2019, TOXINS, V11, DOI 10.3390/toxins11100564; Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; Bulters D, 2018, NAT REV NEUROL, V14, P416, DOI 10.1038/s41582-018-0020-0; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cong X, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109485; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Fair K., 2019, J NEUROTRAUM; Fan H, 2013, NEUROSCI BULL, V29, P501, DOI 10.1007/s12264-013-1354-7; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Festoff BW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00059; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Gardiner EE, 2008, J THROMB HAEMOST, V6, P1360, DOI 10.1111/j.1538-7836.2008.03057.x; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gusev EI, 2006, ZH NEVROL PSIKHIATR, V106, P31; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Huang L, 2015, J NEUROSCI, V35, P10390, DOI 10.1523/JNEUROSCI.0546-15.2015; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Komarova YA, 2017, CIRC RES, V120, P179, DOI 10.1161/CIRCRESAHA.116.306534; Kunalan S, 2018, TOXINS, V10, DOI 10.3390/toxins10110434; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li D, 2016, BRAIN RES BULL, V127, P195, DOI 10.1016/j.brainresbull.2016.09.014; Li HX, 2018, DRUG DES DEV THER, V12, P1385, DOI 10.2147/DDDT.S159210; Ma JL, 2019, CELL TRANSPLANT, V28, P585, DOI 10.1177/0963689719840353; Maas C, 2018, BLOOD, V131, P1903, DOI 10.1182/blood-2017-04-569111; Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X; Price L., 2016, TRANSLATIONAL RES TR; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Seon GM, 2017, ACTA BIOMATER, V48, P175, DOI 10.1016/j.actbio.2016.10.024; Tang JS, 2020, ACTA PHARMACOL SIN B, V10, P987, DOI 10.1016/j.apsb.2020.02.015; Thome JG, 2020, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00287; Ullah A, 2018, INT J BIOL MACROMOL, V114, P788, DOI 10.1016/j.ijbiomac.2018.03.164; Waheed H, 2017, CURR MED CHEM, V24, P1874, DOI 10.2174/0929867324666170605091546; Wei JM, 2010, CHINESE MED J-PEKING, V123, P589, DOI 10.3760/cma.j.issn.0366-6999.2010.05.016; Wong R, 2019, BRAIN BEHAV IMMUN, V76, P126, DOI 10.1016/j.bbi.2018.11.012; Zhu YJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02091-7	37	1	1	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAY	2021	170						1	10		10.1016/j.brainresbull.2021.01.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RA1MA	WOS:000631180800001	33548333				2022-02-06	
J	Tommy, T; Islam, AA; Hatta, M; Bukhari, A; Nasrullah; Adhimarta, W; Aminuddin; Zainuddin, AA				Tommy, Thomas; Islam, Andi A.; Hatta, Mochammad; Bukhari, Agussalim; Nasrullah; Adhimarta, Willy; Aminuddin; Zainuddin, Andi Alfian			Effect of folinic acid on serum homocysteine, TNF alpha, IL-10, and HMGB1 gene expression in head injury model	ANNALS OF MEDICINE AND SURGERY			English	Article						HMGB1; Homocysteine; IL-10; Neuroinflammation; Neuroprotection; TNF alpha	TRAUMATIC BRAIN-INJURY; INTERLEUKIN-10; THERAPY; CAPE	Background: Head injury or traumatic brain injury is the leading cause of mortality and morbidity. Many modalities of neuroprotection had been developed in brain injury but there was no much information regarding folinic acid's effect on neuroinflammation associated with homocysteine, TNF alpha, IL-10, and HMGB1. Objective: This study aimed to investigate whether folinic acid has improving effect on head injury model. Method: This study was done in the rat's head injury model using modified Marmarou weight drop model. Fifteen rats were randomized and grouped into 3 groups: Group A: Folinic acid (+), head injury (-); Group B: Folinic acid (-), head injury (+); Group C: Folinic acid (+), head injury (+). Folinic acid was administered intraperitoneally with a dose of 60 mg/m(2). Blood samples were taken immediately after head injury (H0), 12 h (H12), and 24 h (H24) after head injury from the lateral vein of tail. Serum level of homocysteine, TNF alpha, and IL-10 were measured using ELISA, and HMGB1 gene expression was measured with Real-Time RT-PCR. Results: This study found serum level of homocysteine, TNF alpha, IL-10 and HMGB1 gene expression were markedly increased at all time points after head injury. Significantly lower level of serum homocysteine, TNF alpha, IL-10 and HMGB1 gene expression were found after 24 h treatment with folinic acid in group C compared to those in group B. Conclusion: Folinic acid may have anti-inflammatory properties in traumatic brain injury by inhibition of serum level of homocysteine, TNF alpha, IL-10 and HMGB1 gene expression.	[Tommy, Thomas] Univ Pelita Harapan, Fac Med, Dept Neurosurg, Tangerang, Indonesia; [Islam, Andi A.; Nasrullah; Adhimarta, Willy] Hasanuddin Univ, Fac Med, Dept Neurosurg, Makassar, Indonesia; [Hatta, Mochammad] Hasanuddin Univ, Fac Med, Mol Biol & Immunol Lab, Makassar, Indonesia; [Bukhari, Agussalim] Hasanuddin Univ, Fac Med, Dept Nutr Sci, Jl Perintis Kemerdekaan KM 10, Makassar 90245, Indonesia; [Aminuddin] Hasanuddin Univ, Fac Med, Dept Nutr, Makassar, Indonesia; [Zainuddin, Andi Alfian] Hasanuddin Univ, Fac Med, Dept Publ Hlth & Community Med, Makassar, Indonesia		Bukhari, A (corresponding author), Hasanuddin Univ, Fac Med, Dept Nutr Sci, Jl Perintis Kemerdekaan KM 10, Makassar 90245, Indonesia.	thomastommy.neurosurg@gmail.com; andiasadul@yahoo.com; hattaram@yahoo.com; agussalim.bukhari@med.unhas.ac.id; nasrullah.makassar@gmail.com; willy.adhimarta@gmail.com; aminuddin@med.unhas.ac.id; a.alfian@med.unhas.ac.id		Aminuddin, Aminuddin/0000-0001-8564-7847; Hatta, Mochammad/0000-0002-8456-4203; Tommy, Thomas/0000-0002-3235-7309; Adhimarta, Willy/0000-0001-7992-4553			Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani S, 2018, NEUROSURG REV, V41, P513, DOI 10.1007/s10143-017-0880-6; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Geisler J, 1998, CLIN CANCER RES, V4, P2125; Gouma E, 2012, LAB ANIM-UK, V46, P40, DOI 10.1258/la.2011.011021; Hatta Mochammad, 2017, BMC Res Notes, V10, P202, DOI 10.1186/s13104-017-2517-9; Idrus H.H., 2019, IND J PUBL HLTH RES, V10, P1109, DOI [10.5958/0976-5506.2019.02045.X., DOI 10.5958/0976-5506.2019.02045.X]; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Nasution RA, 2020, ANN MED SURG, V57, P328, DOI 10.1016/j.amsu.2020.08.016; Nasution RA, 2020, ANN MED SURG, V57, P118, DOI 10.1016/j.amsu.2020.07.036; Nasution RA, 2020, ANN MED SURG, V57, P109, DOI 10.1016/j.amsu.2020.07.029; Nasution RA, 2020, ANN MED SURG, V54, P89, DOI 10.1016/j.amsu.2020.04.015; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Richard SA., 2017, J BEHAV BRAIN SCI, V7, P50, DOI [10.4236/jbbs.2017.72006, DOI 10.4236/JBBS.2017.72006]; Rosyidi RM, 2020, ANN MED SURG, V60, P36, DOI 10.1016/j.amsu.2020.10.013; Sapan HB, 2017, CHIN J TRAUMATOL, V20, P318, DOI 10.1016/j.cjtee.2017.05.003; Saxena A, 2015, CYTOKINE, V74, P27, DOI 10.1016/j.cyto.2014.10.031; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sirait RH, 2017, OPEN J ANESTHESIOL, V7, P35, DOI DOI 10.4236/0JANES.2017.72004; Soleimani A, 2011, IRAN J KIDNEY DIS, V5, P45; Sun L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1008-1; Tommy T, 2020, ANN MED SURG, V59, P106, DOI 10.1016/j.amsu.2020.09.025; Ummul Khairi Amsyah, 2019, Biomedical & Pharmacology Journal, V12, P2099, DOI 10.13005/bpj/1845; VanPatten S, 2018, J MED CHEM, V61, P5093, DOI 10.1021/acs.jmedchem.7b01136; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams RH, 1999, LAB MED, V30, P468, DOI 10.1093/labmed/30.7.468; Wu J.T, 2007, DISEASES-BASEL, V19, P6; Yang LJ, 2018, CELL PHYSIOL BIOCHEM, V46, P2532, DOI 10.1159/000489659	34	1	1	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	MAY	2021	65								102273	10.1016/j.amsu.2021.102273			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	SD4WS	WOS:000651374700012	33996045	gold, Green Published			2022-02-06	
J	Wallace, J; Beidler, E; Kerr, ZY; Hibbler, T; Anderson, M; Register-Mihalik, JK				Wallace, Jessica; Beidler, Erica; Kerr, Zachary Y.; Hibbler, Tamaria; Anderson, Morgan; Register-Mihalik, Johna K.			Assessing Differences in Concussion Symptom Knowledge and Sources of Information Among Black and White Collegiate-Athletes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						collegiate-athletes; concussion knowledge; equity; race; signs and symptoms	HEALTH-CARE-SYSTEM; REPORTING BEHAVIORS; SPORTS CONCUSSION; BASE-LINE; DISPARITIES; RACISM; PERCEPTIONS; CHALLENGES; EDUCATION; TRUST	Objective: Basic concussion symptom knowledge is fundamental to concussion identification; however, racial disparities in concussion knowledge exist in high school and youth sports. It is unknown whether similar differences exist in collegiate-athletes. Identifying racial disparities in concussion knowledge and sources of concussion information is essential to inform equitable approaches to knowledge translation and educational interventions. This study examined how Black and White collegiate-athletes differed in their knowledge of concussion symptoms and use of concussion information sources. Setting: National Collegiate Athletic Association (NCAA) institutions. Participants: Collegiate-athletes. Design: Cross-sectional. Main Measures: Collegiate-athletes completed a questionnaire that assessed personal and sports demographics, concussion symptom knowledge, and use of concussion information sources. Fisher's exact tests and Wilcoxon rank-sum tests examined differences in outcome measures between Black and White collegiate-athletes. A multivariable Poisson regression model examined the association between race and concussion symptom knowledge scores while accounting for sex, sports contact level, NCAA division, concussion history, and specific concussion information sources. Incidence rate ratios (IRRs) with 95% CIs excluding 1.00 were deemed significant. Results: A total of 768 (82.6% White, 17.4% Black) collegiate-athletes completed the questionnaire. Black athletes were more likely to have lower concussion symptom knowledge scores than White athletes (P < .001). In the multivariable Poisson regression model controlling for covariates, this finding was retained (IRR = 0.97; 95% CI, 0.94-0.997). White athletes were more likely to report school-based professional (P < .001), online medical sources (P = .02), and the NCAA (P = .008) as sources of concussion information. Black athletes were more likely to report referees (P = .03) as a source of concussion knowledge. Conclusion: Despite NCAA concussion education requirements for athletes, Black collegiate-athletes were found to have lower concussion knowledge than White collegiate-athletes. The findings highlight the need for equitable strategies to disseminate concussion information to diverse populations by improving the physician-patient relationship and investing in culturally appropriate educational materials.	[Wallace, Jessica; Beidler, Erica] Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane, Tuscaloosa, AL 35487 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Hibbler, Tamaria; Anderson, Morgan] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Wallace, J (corresponding author), Univ Alabama, Dept Hlth Sci, 270 Kilgore Lane, Tuscaloosa, AL 35487 USA.	jswallace1@ua.edu; johnsone1@duq.edu; zkerr@email.unc.edu; hollis22@ath.msu.edu; ande1997@msu.edu; johnakay@email.unc.edu					Armstrong K, 2008, J GEN INTERN MED, V23, P827, DOI 10.1007/s11606-008-0561-9; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Benkert R, 2006, J NATL MED ASSOC, V98, P1532; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; DePadilla L, 2020, J SCHOOL HEALTH, V90, P520, DOI 10.1111/josh.12900; Dickman SL, 2017, LANCET, V389, P1431, DOI 10.1016/S0140-6736(17)30398-7; Doyle JM, 2007, SOC PSYCHOL QUART, V70, P405; Feagin J, 2014, SOC SCI MED, V103, P7, DOI 10.1016/j.socscimed.2013.09.006; Hitlin S, 2006, CHILD DEV, V77, P1298, DOI 10.1111/j.1467-8624.2006.00935.x; Holmes L, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0058-8; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2020, J SPORT HEALTH SCI, VS2095-2546, P30055; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2017, CHILD CARE HLTH DEV, V43, P758, DOI 10.1111/cch.12433; Kroshus E, 2019, HEALTH PROMOT PRACT, V20, P372, DOI 10.1177/1524839918790231; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2017, AM J PREV MED, V52, P476, DOI 10.1016/j.amepre.2016.12.021; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Shepherd SM, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0744-x; Smedley BD, 2003, UNEQUAL TREATMENT CO; Spiegel JM, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0091-2; Strekalova YA, 2018, HEALTH EDUC BEHAV, V45, P1036, DOI 10.1177/1090198118757822; Thurman WA, 2019, ADV NURS SCI, V42, P89, DOI 10.1097/ANS.0000000000000265; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Williams DR, 2015, JAMA-J AM MED ASSOC, V314, P555, DOI 10.1001/jama.2015.9260	36	1	1	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2021	36	3			SI		139	148		10.1097/HTR.0000000000000672			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SM4ZF	WOS:000657614900003	33938514	Bronze			2022-02-06	
J	Wang, XP; Zhong, J; Lei, T; Wang, HJ; Zhu, LN; Chu, SS; Chen, D; Liu, L				Wang, Xue-Ping; Zhong, Jie; Lei, Ting; Wang, Hai-Jiao; Zhu, Li-Na; Chu, Shanshan; Chen, Deng; Liu, Ling			Development and external validation of a predictive nomogram model of posttraumatic epilepsy: A retrospective analysis	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Traumatic brain injury; Posttraumatic epilepsy; Risk factors; Nomogram model	TRAUMATIC BRAIN-INJURY; SEIZURE-FREE PATIENTS; ANTIEPILEPTIC DRUGS; HEAD-INJURY; RISK-FACTORS; EPIDEMIOLOGY; CHILDREN; OUTCOMES; HOSPITALIZATION; MULTICENTER	Objective: We aimed to develop and validate a predictive model of posttraumatic epilepsy (PTE). Methods: The training cohort was patients registered at West China Hospital and diagnosed as traumatic brain injury (TBI) between January 1, 2011, and December 31, 2017. On the basis of multivariable cox proportional hazards model using a forward stepwise method, the nomogram was generated. We externally validated this instrument in 834 participants from two independent cohorts to assess its performance. Results: The nomogram was built based on the results of multivariable cox proportional hazards regression analysis of 1301patients from West China Hospital. The prevalence of PTE was 12.8% (95% confidence interval [CI], 10.9-14.6%) in training cohort, 10.5% (95% CI, 7.5-13.4%) in the testing 1 cohort, and 6.1% (95% CI, 3.7-8.4%) in the testing 2 cohort. 7 independent predictors of PTE composed the nomogram (sex, time of loss of consciousness, subdural hemorrhage, contusion sites, early posttraumatic seizures, TBI severity, and treatment). The C-index was 0.846 (95% CI, 0.817-0.876), and the corresponding sensitivity and specificity were 0.867 and 0.738. External validations showed good discrimination in overall testing cohorts with a C-index of 0.895 (95% CI, 0.859-0.930), in the testing 1 cohort (C-index 0.897, 95% CI, 0.855-0.938) and testing 2 cohort (C-index, 0.883, 95% CI, 0.814-0.952). Calibration of this model was also good since the calibration plots were close to the ideal line. Conclusions: This nomogram was developed and validated in a large cohort for individualized prediction of PTE, which can identify individuals at high risk of epilepsy and help us find preventive drugs based on these targeted population.	[Wang, Xue-Ping; Wang, Hai-Jiao; Zhu, Li-Na; Chu, Shanshan; Chen, Deng; Liu, Ling] Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China; [Zhong, Jie] Sichuan Prov Peoples Hosp, Dept Ophthalmol, 32 West Second Sect First Ring Rd, Chengdu, Sichuan, Peoples R China; [Lei, Ting] Sichuan Univ, Shang Jin Nan Fu Hosp, Dept Neurosurg, West China Hosp, 253 Shang Jin Rd, Chengdu 610041, Sichuan, Peoples R China		Liu, L (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China.	zjllxx1968@163.com			1.3.5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University [2019HXFH048]; Science & Technology Department of Sichuan Province [2021YFS0174]	This study was funded by 1 center dot 3 center dot 5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University (grant number 2019HXFH048) and the Science & Technology Department of Sichuan Province (grant number 2021YFS0174) .	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Beghi E, 2013, EPILEPSIA, V54, P2, DOI 10.1111/epi.12305; Callegaro D, 2016, LANCET ONCOL, V17, P671, DOI 10.1016/S1470-2045(16)00010-3; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; DALESSANDRO R, 1988, ARCH NEUROL-CHICAGO, V45, P42, DOI 10.1001/archneur.1988.00520250048019; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Englander J, 2009, J NEUROTRAUM, V26, P1471, DOI 10.1089/neu.2008.0729; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Greenberg MK, 1996, NEUROLOGY, V47, P600; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hijazi Z, 2016, LANCET, V387, P2302, DOI 10.1016/S0140-6736(16)00741-8; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Jehi L, 2015, LANCET NEUROL, V14, P283, DOI 10.1016/S1474-4422(14)70325-4; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kuluz J, 2017, PEDIATR CRIT CARE ME, V18, P87, DOI 10.1097/PCC.0000000000000968; Lamberink HJ, 2017, LANCET NEUROL, V16, P523, DOI 10.1016/S1474-4422(17)30114-X; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; Shariat SF, 2006, CLIN CANCER RES, V12, P6663, DOI 10.1158/1078-0432.CCR-06-0372; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	46	1	1	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	MAY	2021	88						36	44		10.1016/j.seizure.2021.03.023			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ9GF	WOS:000648905900007	33812306				2022-02-06	
J	Whitehouse, DP; Kelleher-Unger, IR; Newcombe, VFJ				Whitehouse, Daniel P.; Kelleher-Unger, Isaac R.; Newcombe, Virginia F. J.			Head injury and concussion in cricket: Incidence, current guidance, and implications of sports concussion literature	TRANSLATIONAL SPORTS MEDICINE			English	Article						biomarkers; cricket; neuroimaging; sports concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; COGNITIVE IMPAIRMENT; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; FLUID BIOMARKERS; ELITE PLAYERS; ICE HOCKEY	Concussion following head injury remains a significant cause of injury in cricket, with recent high profile events highlighting the ongoing risk of head injury in the sport and the emerging use of concussion assessments for elite players following injury. Sport-related concussion has long been recognized to present significant concerns for athletes in both the short and long term, with an increasing evidence base surrounding diagnostic and prognostic approaches to the issue. Though cricket represents one of the most participated sports worldwide, there is a lack of evidence relating to the acute management and prognosis of head injury in cricket players. In this review, we searched the literature for terms related to head injury, concussion, and cricket, summarizing the main findings regarding the incidence, mortality, acute management, diagnostic approach, and outcome of cricket-related head injury. Further, this review places these findings in the wider context of sports-related concussion literature to ascertain both the current evidence base surrounding current cricket-related concussion guidelines, and the direction of research for future approaches to sports concussion management.	[Whitehouse, Daniel P.; Kelleher-Unger, Isaac R.; Newcombe, Virginia F. J.] Univ Cambridge, Univ Div Anaesthesia, Cambridge, England		Whitehouse, DP (corresponding author), Univ Cambridge, Univ Div Anaesthesia, Cambridge, England.	dw555@cam.ac.uk		Whitehouse, Daniel/0000-0002-0216-1866; Newcombe, Virginia/0000-0001-6044-9035			[Anonymous], 2018, ENGLAND WALES CRICKE; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BBC News, 2016, BBC NEWS; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Brukner P, 2017, J SCI MED SPORT, V20, P40; Chow BH, 2019, OPEN ACCESS J SPORTS, V10, P41, DOI 10.2147/OAJSM.S192338; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW., 2017, SCI REP-UK, V7, P1; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Cricket Australia, 2019, CONCUSSION HEAD TRAU; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goh S., 2019, J SCI MED SPORT, V22, P45; Hill T, 2019, SPORTS HEALTH, V11, P180, DOI 10.1177/1941738118811315; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Howson N., 2019, CRICKETER; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones ME, 2018, J SCI MED SPORT, V21, P558, DOI 10.1016/j.jsams.2017.10.013; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kaushal M, 2019, HUM BRAIN MAPP, V40, P1211, DOI 10.1002/hbm.24440; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kountouris A., 2017, BR J SPORTS MED, V51, P23; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Madhavan R, 2019, J NEUROTRAUM, V36, P650, DOI 10.1089/neu.2018.5739; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meier TB, 2020, ANN NEUROL, V87, P907, DOI 10.1002/ana.25725; Meier TB, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6471; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mohotti D, 2018, COMPUT METH PROG BIO, V158, P193, DOI 10.1016/j.cmpb.2018.02.017; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Orchard JW, 2016, OPEN ACCESS J SPORTS, V7, P187, DOI 10.2147/OAJSM.S117497; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Perera NKP, 2019, J SCI MED SPORT, V22, P1213, DOI 10.1016/j.jsams.2019.07.010; Peterson JG, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120913020; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Ranson C, 2013, BRIT J SPORT MED, V47, P644, DOI 10.1136/bjsports-2012-091898; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rutherford A, 2019, BRIT J SPORT MED, V53, P321, DOI 10.1136/bjsports-2017-097627; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shaw L, 2008, BRIT J SPORT MED, V42, P437, DOI 10.1136/bjsm.2007.041947; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Theadom A, 2020, NEUROEPIDEMIOLOGY, V54, P192, DOI 10.1159/000505424; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; Walker HL, 2010, ACCIDENT ANAL PREV, V42, P2094, DOI 10.1016/j.aap.2010.06.022; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	80	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	MAY	2021	4	3					319	326		10.1002/tsm2.222			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	SJ0LO	WOS:000655219300002		hybrid			2022-02-06	
J	Williams, JR; Meyer, MR; Ricard, JA; Sen, R; Young, CC; Feroze, AH; Greil, ME; Barros, G; Durfy, S; Hanak, B; Morton, RP; Temkin, NR; Barber, JK; Mac Donald, CL; Chesnut, RM				Williams, John R.; Meyer, Michael R.; Ricard, Jocelyn A.; Sen, Rajeev; Young, Christopher C.; Feroze, Abdullah H.; Greil, Madeline E.; Barros, Guilherme; Durfy, Sharon; Hanak, Brian; Morton, Ryan P.; Temkin, Nancy R.; Barber, Jason K.; Mac Donald, Christine L.; Chesnut, Randall M.			Re-examining decompressive craniectomy medial margin distance from midline as a metric for calculating the risk of post-traumatic hydrocephalus	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Severe traumatic brain injury; Decompressive craniectomy; Post-traumatic hydrocephalus	INTERHEMISPHERIC HYGROMA; COMPLICATIONS; EVACUATION	Decompressive craniectomy (DC) is a life-saving procedure in severe traumatic brain injury, but is associated with higher rates of post-traumatic hydrocephalus (PTH). The relationship between the medial craniectomy margin's proximity to midline and frequency of developing PTH is controversial. The primary study objective was to determine whether average medial craniectomy margin distance from midline was closer to midline in patients who developed PTH after DC for severe TBI compared to patients that did not. The secondary objective was to determine if a threshold distance from midline could be identified, at which the risk of developing PTH increased if the DC was performed closer to midline than this threshold. A retrospective review was performed of 380 patients undergoing DC at a single institution between March 2004 and November 2014. Clinical, operative and demographic variables were collected, including age, sex, DC parameters and occurrence of PTH. Statistical analysis compared mean axial craniectomy margin distance from midline in patients with versus without PTH. Distances from midline were tested as potential thresholds. No significant difference was identified in mean axial craniectomy margin distance from midline in patients developing PTH compared with patients with no PTH (n = 24, 12.8 mm versus n = 356, 16.6 mm respectively, p = 0.086). No significant cutoff distance from midline was identified (n = 212, p = 0.201). This study, the largest to date, was unable to identify a threshold with sufficient discrimination to support clinical recommendations in terms of DC margins with regard to midline, including thresholds reportedly significant in previously published research. (C) 2021 Elsevier Ltd. All rights reserved.	[Williams, John R.; Meyer, Michael R.; Sen, Rajeev; Young, Christopher C.; Greil, Madeline E.; Barros, Guilherme; Durfy, Sharon; Hanak, Brian; Temkin, Nancy R.; Barber, Jason K.; Mac Donald, Christine L.; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, 325 Ninth Ave,Box 359924, Seattle, WA 98104 USA; [Ricard, Jocelyn A.] Univ Minnesota, 3 Morrill Hall,100 Church St SE, Minneapolis, MN 55455 USA; [Feroze, Abdullah H.] Loma Linda Univ Hlth, Dept Neurosurg, 11234 Anderson St,Suite 2562B, Loma Linda, CA 92354 USA; [Morton, Ryan P.] Univ Texas Hlth San Antonio, Dept Neurosurg, 7703 Floyd Curl Dr,MC 7843, San Antonio, TX 78229 USA		Williams, JR (corresponding author), Univ Washington, Dept Neurol Surg, 325 Ninth Ave,Box 359924, Seattle, WA 98104 USA.	respub7@uw.edu					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, CURR OPIN CRIT CARE, V15, P548, DOI 10.1097/MCC.0b013e32833190da; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2019, J CLIN NEUROSCI, V63, P62, DOI 10.1016/j.jocn.2019.02.006; Takeuchi S, 2013, CLIN NEUROL NEUROSUR, V115, P317, DOI 10.1016/j.clineuro.2012.05.026; Walsh S, 2017, NEUROTOXICOLOGY, V61, P33, DOI 10.1016/j.neuro.2016.03.012; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Williams JR, 2018, NEUROSURGERY, V65, P111, DOI 10.1093/neuros/nyy303.189; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	22	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2021	87						125	131		10.1016/j.jocn.2021.02.025			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RN8BZ	WOS:000640577800024	33863519				2022-02-06	
J	Wray, A; Goubert, R; Gadepally, R; Boysen-Osborn, M; Wiechmann, W; Toohey, S				Wray, Alisa; Goubert, Ronald; Gadepally, Rishi; Boysen-Osborn, Megan; Wiechmann, Warren; Toohey, Shannon			Utilization of Educational Videos to Improve Communication and Discharge Instructions	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							EMERGENCY; COMPREHENSION	Introduction: When discharging a patient from the emergency department (ED), it is crucial to make sure that they understand their disposition and aftercare instructions. However, numerous factors make it difficult to ensure that patients understand their next steps. Our objective was to determine whether patient understanding of ED discharge and aftercare instructions could be improved through instructional videos in addition to standard written discharge instructions. Methods: This was a prospective pre- and post-intervention study conducted at a single-center, academic tertiary care ED. Patients presenting with the five selective chief complaints (closed head injury, vaginal bleeding, laceration care, splint care, and upper respiratory infection) were given questionnaires after their discharge instructions to test comprehension. Once video discharge instructions were implemented, patients received standard discharge instructions in addition to video discharge instructions and were given the same questionnaire. A total of 120 patients were enrolled in each group. Results: There were significantly better survey scores after video discharge instructions (VDI) vs standard discharge instructions (SDI) for the closed head injury (27% SDI vs 46% VDI, P = 0.003); upper respiratory infection (28% SDI vs 64% VDI; P < 0.0001); and vaginal bleeding in early pregnancy groups (20% SDI vs 60% VDI, P < 0.0001). There were no significant differences in survey scores between the splint care (53% SDI vs 66% VDI; P = 0.08) and suture care groups (29% SDI vs 31% VDI; P = 0.40). Conclusion: Video discharge instructions supplementing standard written instructions can help improve patient comprehension and information retention. This better understanding of aftercare instructions is essential to patient follow-up and has been shown to improve patient outcomes.	[Wray, Alisa; Goubert, Ronald; Gadepally, Rishi; Boysen-Osborn, Megan; Wiechmann, Warren; Toohey, Shannon] Univ Calif Irvine, Dept Emergency Med, Irvine, CA USA		Wray, A (corresponding author), Univ Calif Irvine, Dept Emergency Med, 333 City Blvd W,Suite 640, Orange, CA 92868 USA.	awray@hs.uci.edu					Bloch SA, 2013, PEDIATR EMERG CARE, V29, P699, DOI 10.1097/PEC.0b013e3182955480; Delp C, 1996, ACAD EMERG MED, V3, P264, DOI 10.1111/j.1553-2712.1996.tb03431.x; Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Griffey RT, 2014, ACAD EMERG MED, V21, P1109, DOI 10.1111/acem.12476; Houts PS, 2001, PATIENT EDUC COUNS, V43, P231, DOI 10.1016/S0738-3991(00)00171-3; Ismail S, 2016, J EMERG MED, V50, P177; Logan PD, 1996, SOUTHERN MED J, V89, P770, DOI 10.1097/00007611-199608000-00003; National Center for Education Statistics, NAT ASS AD LIT NAAL; Saidinejad M, 2014, PEDIATR EMERG CARE, V30, P211, DOI 10.1097/PEC.0000000000000097; Wood EB, 2017, J EMERG NURS, V43, P316, DOI 10.1016/j.jen.2016.11.003	10	1	1	0	0	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	MAY	2021	22	3					644	647		10.5811/westjem.2021.1.48968			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SN5XX	WOS:000658363300028	34125040	Green Published, gold			2022-02-06	
J	Yeo, V; Phillips, NL; Bogdanov, S; Brookes, N; Epps, A; Teng, A; Naismith, SL; Lah, S				Yeo, Vera; Phillips, Natalie L.; Bogdanov, Stefan; Brookes, Naomi; Epps, Adrienne; Teng, Arthur; Naismith, Sharon L.; Lah, Suncica			The persistence of sleep disturbance and its correlates in children with moderate to severe traumatic brain injury: A longitudinal study	SLEEP MEDICINE			English	Article						Sleep; Disturbance; Paediatric; Brain injury; Fatigue; Memory	EVERYDAY MEMORY; YOUNG-CHILDREN; INSOMNIA; FATIGUE; IMPACT; ADOLESCENTS; INTERVENTIONS; DIFFICULTIES; PREDICTORS; OUTCOMES	Objectives: The primary aim was to examine whether sleep disturbances persist in children in the chronic stage of recovery from moderate or severe traumatic brain injury (TBI). The secondary aim was to examine whether memory difficulties and/or other previously identified factors relate to sleep disturbances in children with moderate to severe TBI. Methods: This longitudinal study included 21 children with moderate to severe TBI, 8-18 years old, recruited from an urban tertiary paediatric specialised brain injury rehabilitation unit. Participants were seen 5 years and again 7 years post-injury, on average. Sleep disturbances were assessed with Sleep Disturbance Scale for Children (SDSC). Correlates that were considered included indicators of TBI severity, and questionnaires assessing everyday memory, fatigue, internalizing and externalizing behaviors and pain intensity. Results: The SDSC scores of children with moderate to severe TBI indicated greater disturbances in initiating and maintaining sleep, arousal, sleep-wake transition, and excessive somnolence relative to the norms, at follow-up. The mean SDSC scores and the number of participants with subclinical to clinical sleep disturbances on the SDSC remained unchanged from baseline to follow-up. At follow-up, the SDSC initiating and maintaining sleep, and excessive somnolence scales were associated with poorer everyday memory and greater fatigue. Conclusions: Children with moderate to severe TBI experience ongoing sleep disturbances for years post injury. Greater sleep disturbances are associated with worse functional outcomes. Further research into sleep disturbances and development of treatments is important, as it could improve the outcomes of children with TBI. (C) 2021 Elsevier B.V. All rights reserved.	[Yeo, Vera; Phillips, Natalie L.; Bogdanov, Stefan; Naismith, Sharon L.; Lah, Suncica] Univ Sydney, Sch Psychol, Camperdown, NSW, Australia; [Brookes, Naomi; Epps, Adrienne] Sydney Childrens Hosp, Rehabil Unit, Rehab2Kids, Randwick, NSW, Australia; [Teng, Arthur] Sydney Childrens Hosp, Dept Sleep Med, Randwick, NSW, Australia; [Teng, Arthur] Univ New South Wales, Sch Paediat & Womens Hlth, Kensington, NSW, Australia; [Naismith, Sharon L.] Univ Sydney, Brain & Mind Ctr, 94 Mallet St, Camperdown, NSW 2050, Australia; [Naismith, Sharon L.] Univ Sydney, Charles Perkins Ctr, Camperdown, NSW, Australia		Lah, S (corresponding author), Univ Sydney, Brain & Mind Ctr, 94 Mallet St, Camperdown, NSW 2050, Australia.	suncica.lah@sydney.edu.au					Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Ahuja S, 2018, NAT SCI SLEEP, V10, P255, DOI 10.2147/NSS.S125299; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Beebe DW, 2012, CHILD NEUROPSYCHOL, V18, P313, DOI 10.1080/09297049.2011.602014; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bogdanov S, 2021, J HEAD TRAUMA REHAB, V36, pE108, DOI 10.1097/HTR.0000000000000585; Bogdanov S, 2019, J HEAD TRAUMA REHAB, V34, P122, DOI 10.1097/HTR.0000000000000426; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Botchway EN, 2020, DISABIL REHABIL, V42, P2393, DOI 10.1080/09638288.2019.1578422; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Cellini N, 2017, SLEEP MED REV, V35, P101, DOI 10.1016/j.smrv.2016.09.003; Christiansz JA, 2018, SLEEP BREATH, V22, P517, DOI 10.1007/s11325-017-1570-x; Corkum P, 2016, J PEDIATR PSYCHOL, V41, P701, DOI 10.1093/jpepsy/jsw031; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Crichton A, 2018, J INT NEUROPSYCH SOC, V24, P224, DOI 10.1017/S1355617717000893; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Fischer JT, 2018, NEUROPSYCHOLOGY, V32, P161, DOI 10.1037/neu0000420; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; Hiscock H, 2015, BMJ BR MED J CLIN RE, V3 1).; Ho J, 2011, NEUROPSYCHOL REHABIL, V21, P183, DOI 10.1080/09602011.2010.547345; Hogan AM, 2008, PEDIATRICS, V122, P75, DOI 10.1542/peds.2007-2540; Kadis DS, 2004, EPILEPSY BEHAV, V5, P37, DOI 10.1016/j.yebeh.2003.10.008; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Ko AVY., 2018, CHILDHOOD TRAUMATIC, P333; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Lah S, 2021, NEUROPSYCHOL REHABIL, V31, P345, DOI 10.1080/09602011.2019.1693404; Lah S, 2011, BRAIN INJURY, V25, P44, DOI 10.3109/02699052.2010.531693; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lewandowski AS, 2011, PEDIATR CLIN N AM, V58, P699, DOI 10.1016/j.pcl.2011.03.012; Maski K, 2016, LANCET NEUROL, V15, P1170, DOI 10.1016/S1474-4422(16)30204-6; Medicine AAoS, 2014, INT CLASS SLEEP DIS, V3rd; Meltzer LJ, 2014, J PEDIATR PSYCHOL, V39, P932, DOI 10.1093/jpepsy/jsu041; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mindel JA, 2015, CLIN GUIDE PEDIAT SL, V3rd; Morgenthaler TI, 2006, SLEEP, V29, P1277; Morin CM, 2000, PSYCHOSOM MED, V62, P483, DOI 10.1097/00006842-200007000-00005; Morriss RK, 1997, J PSYCHOSOM RES, V42, P597, DOI 10.1016/S0022-3999(97)89895-9; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; Oitment C, 2013, EPILEPSY BEHAV, V28, P141, DOI 10.1016/j.yebeh.2013.04.013; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Phillips NL, 2020, SLEEP, V43, DOI 10.1093/sleep/zsaa040; Phillips NL, 2016, J NEUROTRAUM, V33, P2097, DOI 10.1089/neu.2015.4358; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Cordts KMP, 2020, NEUROCRIT CARE, V33, P196, DOI 10.1007/s12028-019-00883-5; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Slater G, 2012, J THORAC DIS, V4, P608, DOI 10.3978/j.issn.2072-1439.2012.10.07; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Stickgold R, 2013, TRENDS COGN SCI, V17, P261, DOI 10.1016/j.tics.2013.04.006; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Wei YN, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006322; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083; Zammit GK, 1999, SLEEP, V22, pS379; Zhang Yujie, 2019, Yale J Biol Med, V92, P63	71	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAY	2021	81						387	393		10.1016/j.sleep.2021.03.013			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RV7KG	WOS:000646006300055	33819841				2022-02-06	
J	Zeidan, S; Rohaut, B; Outin, H; Bolgert, F; Houot, M; Demoule, A; Chemouni, F; Combes, A; Navarro, V; Demeret, S				Zeidan, Sinead; Rohaut, Benjamin; Outin, Herve; Bolgert, Francis; Houot, Marion; Demoule, Alexandre; Chemouni, Frank; Combes, Alain; Navarro, Vincent; Demeret, Sophie			Not all patients with convulsive status epilepticus intubated in pre-hospital settings meet the criteria for refractory status epilepticus	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Refractory status epilepticus; Status epilepticus; Anticonvulsants; Critical care; Mechanical ventilation	RANDOMIZED-TRIAL; ADULTS; MORTALITY; GUIDELINES; PREDICTORS; MANAGEMENT; PROGNOSIS; PLACEBO; SYSTEMS; RISK	Introduction: : Mechanically ventilated patients admitted to the intensive care unit (ICU) for generalized convulsive status epilepticus (GCSE) are a heterogeneous population. Our objective was to evaluate the number of patients who fulfilled the diagnostic criteria for refractory GCSE and describe their initial management and prognosis. Methods: : This multicenter retrospective study was conducted in four French ICUs in Pitie-Salpetriere University Hospital in Paris and in the Hospital of Jossigny. Mechanically ventilated patients admitted to the ICU for GCSE between, January 1, 2014, and, December 31, 2016, were included. Patients with anoxia and traumatic brain injury were excluded. Their pre-hospital and ICU medical records were reviewed. The collected data included pre-hospital clinical status, pre-hospital antiepileptic treatment, reason for mechanical ventilation, duration of general anesthesia, and prognosis in the ICU. A retrospective initial diagnosis based on the findings of the analysis of the clinical records was attributed to each patient. Results: : Among the 98 patients included, 88.8% (n = 87/98) fulfilled the diagnostic criteria for GCSE; of these cases, 16.1% (n =14/87) were refractory. Eleven percent of the patients did not fulfill the criteria for GCSE at the time of initial management (retrospective diagnosis of single convulsive seizure, repetitive convulsive seizures, or psychogenic non-epileptic seizures). Most patients were intubated for coma (58.9%, n = 56/95, missing data: n = 3). In the ICU, the median [Q1-Q3] duration of general anesthesia before weaning was 12.3 h (5.0-18.0 h); 7% of the patients had a relapse of status epilepticus, and 2% died in the ICU. Conclusion: : Among the cases of confirmed GCSE in the mechanically ventilated patients admitted to the ICU, 16.1% were refractory, with an overall good prognosis. A significant proportion of patients did not fulfill the diagnostic criteria for refractory GCSE.	[Zeidan, Sinead; Rohaut, Benjamin; Bolgert, Francis; Demeret, Sophie] Hop La Pitie Salpetriere, APHP Sorbonne, Dept Neurol, Neuro Intens Care Unit, Paris, France; [Rohaut, Benjamin] Columbia Univ, Dept Neurol Crit Care Neurol, New York, NY USA; [Outin, Herve] CHI Poissy St Germain En Laye, Med Intens Care Unit, Poissy, France; [Houot, Marion] Hop La Pitie Salpetriere, AP HP, Dept Neurol,Inst Memory & Alzheimers Dis IM2A,APH, Ctr Excellence Neurodegenerat Dis CoEN,ICM,CIC Ne, Paris, France; [Demoule, Alexandre] Hop La Pitie Salpetriere, APHP Sorbonne, Med Intens Care Unit, Paris, France; [Chemouni, Frank] Grand Hop Est Francilien, Med & Surg Intens Care Unit, Marne La Vallee, France; [Combes, Alain] Hop La Pitie Salpetriere, APHP Sorbonne, Inst Cardiol, Med Intens Care Unit, Paris, France; [Navarro, Vincent] Hop La Pitie Salpetriere, APHP Sorbonne, Dept Clin Neurophysiol & Epileptol, Paris, France		Demeret, S (corresponding author), Hop La Pitie Salpetriere, APHP Sorbonne, Dept Neurol, Neuro Intens Care Unit, Paris, France.	sophie.demeret@aphp.fr	Demoule, Alexandre/ABG-4915-2021; Rohaut, Benjamin/O-9250-2017	Demoule, Alexandre/0000-0002-0432-7217; Rohaut, Benjamin/0000-0001-6752-8756			Adnet F, 2004, RESUSCITATION, V63, P7, DOI 10.1016/j.resuscitation.2004.04.001; Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Delaj L, 2017, ACTA NEUROL SCAND, V135, P92, DOI 10.1111/ane.12605; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Dham BS, 2014, NEUROCRIT CARE, V20, P476, DOI 10.1007/s12028-013-9935-x; Giovannini G, 2017, SEIZURE-EUR J EPILEP, V46, P31, DOI 10.1016/j.seizure.2017.01.004; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Holtkamp M, 2005, J NEUROL NEUROSUR PS, V76, P534, DOI 10.1136/jnnp.2004.041947; Kantanen AM, 2017, EPILEPSY RES, V133, P13, DOI 10.1016/j.eplepsyres.2017.03.009; Kapur J, 2019, NEW ENGL J MED, V381, P2103, DOI 10.1056/NEJMoa1905795; Kellinghaus C, 2019, ANN NEUROL, V85, P421, DOI 10.1002/ana.25416; Lai A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0914-9; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Legriel S, 2016, NEW ENGL J MED, V375, P2457, DOI 10.1056/NEJMoa1608193; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Marchi NA, 2015, CRIT CARE MED, V43, P1003, DOI 10.1097/CCM.0000000000000881; Mckay JH, 2019, J CLIN NEUROPHYSIOL, V36, P460, DOI 10.1097/WNP.0000000000000603; Navarro V, 2016, LANCET NEUROL, V15, P47, DOI 10.1016/S1474-4422(15)00296-3; Novy J, 2010, EPILEPSIA, V51, P251, DOI 10.1111/j.1528-1167.2009.02323.x; Outin H., RFE ETATS MAL EPILEP; Patel M, 2015, SEIZURE-EUR J EPILEP, V24, P33, DOI 10.1016/j.seizure.2014.11.005; Pichler M, 2017, HDB CLIN NEUROLOGY, V140; Reznik ME, 2016, J CLIN MED, V5, P54, DOI 10.3390/jcm5050054; Rossetti AO, 2013, J NEUROL, V260, P421, DOI 10.1007/s00415-012-6644-x; Rossetti AO, 2011, NEUROCRIT CARE, V14, P4, DOI 10.1007/s12028-010-9445-z; Rossetti AO, 2008, J NEUROL, V255, P1561, DOI 10.1007/s00415-008-0989-1; Seblova J, 2018, EUR J EMERG MED, V25, P446, DOI 10.1097/MEJ.0000000000000553; Sutter R, 2014, NEUROLOGY, V82, P656, DOI 10.1212/WNL.0000000000000009; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vooturi S, 2014, CLIN NEUROL NEUROSUR, V126, P7, DOI 10.1016/j.clineuro.2014.07.038; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070	34	1	1	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	MAY	2021	88						29	35		10.1016/j.seizure.2021.03.015			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ9GF	WOS:000648905900006	33799137				2022-02-06	
J	Merritt, VC; Sakamoto, MS; Sorg, SF; Clark, AL; Bondi, MW; Schiehser, DM; Delano-Wood, L				Merritt, Victoria C.; Sakamoto, McKenna S.; Sorg, Scott F.; Clark, Alexandra L.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa			Elevated Neuropsychological Intraindividual Variability Predicts Poorer Health-Related Quality of Life in Veterans with a History of Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						concussion; cognitive dispersion; head injury; health outcomes; IIV; military	SYMPTOMS; ASSOCIATIONS; PERFORMANCE	We examined the association between cognitive functioning and health-related quality of life (HR-QOL) in military veterans with a history of mild traumatic brain injury (mTBI) using two methods to assess cognition: mean performance on cognitive composite scores and across-test intraindividual variability (IIV). The sample included 73 veterans (84.9% male; age, mean = 32.47 years) who completed neuropsychological testing and self-report questionnaires similar to 7 years post-injury. Three cognitive composite scores representing mean performance were computed, including memory, attention/processing speed (A/PS), and executive functioning (EF). Three IIV indices were also calculated reflecting degree of dispersion across the same cognitive domains: memory-IIV, A/PS-IIV, and EF-IIV. The Posttraumatic Stress Disorder (PTSD) Checklist-Military Version (PCL-M) was used to assess current PTSD symptoms, and the World Health Organization Quality of Life Short Version Physical Health domain was used to assess HR-QOL. Hierarchical linear regressions adjusting for PTSD symptoms demonstrated that IIV indices, but not mean cognitive composite scores, significantly predicted HR-QOL. Specifically, memory-IIV, A/PS-IIV, and EF-IIV, when taken together, made an independent and significant contribution to the prediction of HR-QOL. Examination of the standardized coefficients showed that the A/PS-IIV index was uniquely associated with HR-QOL, such that higher A/PS-IIV scores significantly predicted poorer HR-QOL. Our results are the first to show that, in veterans with remote mTBI histories, greater fluctuations in cognitive performance significantly contribute to poorer HR-QOL, even after accounting for PTSD symptom severity. Moreover, findings suggest that, compared to traditional mean cognitive performance scores, measures of IIV may represent more sensitive indicators of clinical outcome and better align with subjective experiences of distress.	[Merritt, Victoria C.; Sakamoto, McKenna S.; Sorg, Scott F.; Clark, Alexandra L.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, San Diego, CA USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VA San Diego Healthcare Syst VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Merritt, Victoria C.; Sorg, Scott F.; Clark, Alexandra L.; Bondi, Mark W.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, San Diego, CA 92161 USA.	ldelano@health.ucsd.edu			Veterans Affairs research grants [CDA-2-034-07F, I01 CX000842-01, CDA-2-065-10S]; Department of Defense Investigator-Initiated Research GrantUnited States Department of Defense [W81XWH-10-2-0169]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS09870]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31NS0987]; Career Development Awards from the VA Clinical Science Research & Development Service [IK2 CX001952, CX001508-02]	This work was supported by Veterans Affairs research grants awarded to Drs. Delano-Wood (CDA-2-034-07F; I01 CX000842-01) and Schiehser (CDA-2-065-10S), as well as a Department of Defense Investigator-Initiated Research Grant awarded to Dr. Delano-Wood (W81XWH-10-2-0169). This work was further supported by a grant awarded by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (F31NS09870) to Dr. Clark and a grant awarded by the National Institutes of Health (F31NS0987) to Dr. Bondi. Drs. Merritt and Sorg both received salary support during this work from Career Development Awards from the VA Clinical Science Research & Development Service (Merritt: IK2 CX001952; Sorg: CX001508-02).	Bomyea J, 2019, PSYCHIAT RES, V272, P531, DOI 10.1016/j.psychres.2018.12.021; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Keane T.M., 1991, PCL M DSM 4; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; Martindale SL, 2016, REHABIL PSYCHOL, V61, P231, DOI 10.1037/rep0000076; Merritt VC, 2020, CLIN NEUROPSYCHOL, V34, P1226, DOI 10.1080/13854046.2020.1740324; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Sorg SF, 2021, J INT NEUROPSYCH SOC, V27, P305, DOI 10.1017/S1355617720000879; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tsai J, 2012, J CLIN PSYCHIAT, V73, P1110, DOI 10.4088/JCP.11m07587; Vandermorris S., 2015, HDB INTRAINDIVIDUAL, P145; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; World Health Organization, 1996, WHOQOL BREF INTRO AD	19	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7516		APR 2021	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RW8QJ	WOS:000646784200001	33599168				2022-02-06	
J	Chong, CD; Berisha, V; Ross, K; Kahn, M; Dumkrieger, G; Schwedt, TJ				Chong, Catherine D.; Berisha, Visar; Ross, Katherine; Kahn, Mazher; Dumkrieger, Gina; Schwedt, Todd J.			Distinguishing persistent post-traumatic headache from migraine: Classification based on clinical symptoms and brain structural MRI data	CEPHALALGIA			English	Article						Migraine; persistent post-traumatic headache; concussion; magnetic resonance imaging; principal component analysis; classification; mild traumatic brain injury	VALIDITY; SEGMENTATION; RELIABILITY; VALIDATION; INSOMNIA	Background Persistent post-traumatic headache most commonly has symptoms that overlap those of migraine. In some cases, it can be clinically difficult to differentiate persistent post-traumatic headache with a migraine phenotype from migraine. The objective of this study was to develop a classification model based on questionnaire data and structural neuroimaging data that distinguishes individuals with migraine from those with persistent post-traumatic headache. Methods Questionnaires assessing headache characteristics, sensory hypersensitivities, cognitive functioning, and mood, as well as T1-weighted magnetic resonance imaging and diffusion tensor data from 34 patients with migraine and 48 patients with persistent post-traumatic headache attributed to mild traumatic brain injury were included for analysis. The majority of patients with persistent post-traumatic headache had a migraine/probable migraine phenotype (77%). A machine-learning leave-one-out cross-validation algorithm determined the average accuracy for distinguishing individual migraine patients from individual patients with persistent post-traumatic headache. Results Based on questionnaire data alone, the average classification accuracy for determining whether an individual person had migraine or persistent post-traumatic headache was 71.9%. Adding imaging data features to the model improved the classification accuracy to 78%, including an average accuracy of 97.1% for identifying individual migraine patients and an average accuracy of 64.6% for identifying individual patients with persistent post-traumatic headache. The most important clinical features that contributed to the classification accuracy included questions related to anxiety and decision making. Cortical brain features and fibertract data from the following regions or tracts most contributed to the classification accuracy: Bilateral superior temporal, inferior parietal and posterior cingulate; right lateral occipital, uncinate, and superior longitudinal fasciculus. A post-hoc analysis showed that compared to incorrectly classified persistent post-traumatic headache patients, those who were correctly classified as having persistent post-traumatic headache had more severe physical, autonomic, anxiety and depression symptoms, were more likely to have post-traumatic stress disorder, and were more likely to have had mild traumatic brain injury attributed to blasts. Discussion A classification model that included a combination of questionnaire data and structural imaging parameters classified individual patients as having migraine versus persistent post-traumatic headache with good accuracy. The most important clinical measures that contributed to the classification accuracy included questions on mood. Regional brain structures and fibertracts that play roles in pain processing and pain integration were important brain features that contributed to the classification accuracy. The lower classification accuracy for patients with persistent post-traumatic headache compared to migraine may be related to greater heterogeneity of patients in the persistent post-traumatic headache cohort regarding their traumatic brain injury mechanisms, and physical, emotional, and cognitive symptoms.	[Chong, Catherine D.; Dumkrieger, Gina; Schwedt, Todd J.] Mayo Clin Arizona, Phoenix, AZ USA; [Chong, Catherine D.; Berisha, Visar; Kahn, Mazher] Arizona State Univ, Phoenix, AZ USA; [Ross, Katherine] Phoenix Vet Adm, Phoenix, AZ USA		Chong, CD (corresponding author), Mayo Clin, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Chong.Catherine@mayo.edu		Dumkrieger, Gina/0000-0001-9519-5370	Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program [W81XWH-15-1-0286, W81XWH-19-1-0534]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0286 and Award No. W81XWH-19-1-0534. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office.	Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Azhagusundari B., 2013, INT J INNOVATIVE TEC, V2, P18; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Berisha V, 2018, BRAIN LANG, V180, P42, DOI 10.1016/j.bandl.2018.04.005; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Capi M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072585; Chong CD, 2017, NEUROIMAGE-CLIN, V13, P223, DOI 10.1016/j.nicl.2016.10.023; Chong CD, 2015, CEPHALALGIA, V35, P1162, DOI 10.1177/0333102415573513; Chong CD., 2018, CEPHALALGIA, V39, P1366; Cohen J, 1998, STAT POWER ANAL BEHA; Coppola G, 2014, EUR J NEUROL, V21, P287, DOI 10.1111/ene.12296; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Echemendia RJ., BR J SPORTS MED, V51, P848; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Filippi M, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01356; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Kim SK, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01103-8; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Moulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095508; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Padula L., 2006, MED PSICOSOMATICA, V51, P167; Rao A, 2011, IEEE ENG MED BIO, P4499, DOI 10.1109/IEMBS.2011.6091115; Sarica A, 2014, J NEUROSCI METH, V224, P79, DOI 10.1016/j.jneumeth.2013.12.014; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Schwedt TJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116687; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Treister R, 2015, EUR J NEUROL, V22, P1124, DOI 10.1111/ene.12717; Wei HL, 2020, BRAIN IMAGING BEHAV, V14, P1805, DOI 10.1007/s11682-019-00116-5; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang SS, 2014, NEURAL REGEN RES, V9, P135, DOI 10.4103/1673-5374.125341	49	1	1	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JUL	2021	41	8					943	955	0333102421991819	10.1177/0333102421991819		APR 2021	13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SW0LU	WOS:000657894500001	33926241				2022-02-06	
J	Hammond, FM; Malec, JF; Corrigan, JD; Whiteneck, GG; Hart, T; Dams-O'Connor, K; Novack, TA; Bogner, J; Dahdah, MN; Eagye, CB; Sevigny, M; Ketchum, JM				Hammond, Flora M.; Malec, James F.; Corrigan, John D.; Whiteneck, Gale G.; Hart, Tessa; Dams-O'Connor, Kristen; Novack, Thomas A.; Bogner, Jennifer; Dahdah, Marie N.; Eagye, C. B.; Sevigny, Mitch; Ketchum, Jessica M.			Patterns of Functional Change Five to Ten Years after Moderate-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						chronic; function; outcome; rehabilitation; traumatic brain injuries	LONG-TERM RECOVERY; LONGITUDINAL DESCRIPTION; NATIONAL INSTITUTE; REHABILITATION; INDIVIDUALS; DISABILITY; OUTCOMES; SCALE; ORIENTATION; DEPRESSION	This study aims to characterize the patterns of functional change experienced between 5 and 10 years after moderate-severe traumatic brain injury (TBI). The study included TBI Model Systems national database participants (N = 372) at six sites who experienced TBI, received inpatient rehabilitation, and were followed at 5 and 10 years post-TBI. Outcome measures included self- or proxy-reported Functional Independence Measure (FIMTM) structured interview at 5 and 10 years post-TBI and domain change indices (DCIs) at 10 years to assess subjective change over the previous 5 years. When all seven FIM and subjective DCI subscales were considered together, 69% reported improvement in at least one subscale and 41% reported decline in at least one subscale; 51% reported more domains improved than declined, and 20% reported more domains declined than improved. Age at injury, post-traumatic amnesia duration, FIM, and depression and anxiety at year 5 were associated with FIM change and DCI measures. Although most persons with moderate-severe TBI do not experience widespread change from year 5 to 10 on individual FIM subscales or perceived domain-specific subscales, the vast majority do report change in one or more domains, with more improvement than decline and more change in subjective DCI than in FIM. Clinicians and researchers should be alert to the possibility of both positive and deleterious changes many years after TBI.	[Hammond, Flora M.; Malec, James F.] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Malec, James F.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH USA; [Whiteneck, Gale G.; Eagye, C. B.; Sevigny, Mitch; Ketchum, Jessica M.] Craig Hosp, Res Dept, Englewood, CO USA; [Whiteneck, Gale G.; Eagye, C. B.; Sevigny, Mitch; Ketchum, Jessica M.] Craig Hosp, Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Dams-O'Connor, Kristen] Mt Sinai Sch Med, Dept Rehabil & Human Performance, New York, NY USA; [Dams-O'Connor, Kristen] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dahdah, Marie N.] Baylor Scott & White Inst Rehabil, North Texas TBI Model Syst, Dallas, TX USA; [Dahdah, Marie N.] Baylor Scott & White Med Ctr Plano, Plano, TX USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	Flora.hammond@rhin.com			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01 HD074651] Funding Source: Medline		Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Centers for Disease Control and Prevention, BRFSS DAT US GUID; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2020, J HEAD TRAUMA REHAB, V35, P127, DOI 10.1097/HTR.0000000000000484; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Department of Health and Human Services and U.S. Department of Agriculture., 2020 DIET GUID AM; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond FM, 2021, J NEUROTRAUM, V38, P858, DOI 10.1089/neu.2020.7287; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Institute of Medicine, 2009, GULF WAR HLTH; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2478, DOI 10.1016/j.apmr.2013.06.019; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; *SUBST AB MENT HLT, 1998, NAT HOUS SURV DRUG A; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Wright A, 2012, J MAN MANIP THER, V20, P160, DOI 10.1179/2042618612Y.0000000001	39	1	1	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1526	1534		10.1089/neu.2020.7499		APR 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000645465000001	33779295				2022-02-06	
J	Hiles-Murison, B; Lavender, AP; Hackett, MJ; Armstrong, JJ; Nesbit, M; Rawlings, S; McGonigle, T; Warnock, A; Lam, V; Mamo, JCL; Fitzgerald, M; Takechi, R				Hiles-Murison, Bailey; Lavender, Andrew P.; Hackett, Mark J.; Armstrong, Joshua J.; Nesbit, Michael; Rawlings, Samuel; McGonigle, Terrence; Warnock, Andrew; Lam, Virginie; Mamo, John C. L.; Fitzgerald, Melinda; Takechi, Ryu			Blood-brain barrier disruption and ventricular enlargement are the earliest neuropathological changes in rats with repeated sub-concussive impacts over 2 weeks	SCIENTIFIC REPORTS			English	Article							COGNITIVE DECLINE; SATURATED-FAT; MOUSE MODEL; DYSFUNCTION; INJURY; MILD; HOMEOSTASIS; AGENTS	Repeated sub-concussive impact (e.g. soccer ball heading), a significantly lighter form of mild traumatic brain injury, is increasingly suggested to cumulatively alter brain structure and compromise neurobehavioural function in the long-term. However, the underlying mechanisms whereby repeated long-term sub-concussion induces cerebral structural and neurobehavioural changes are currently unknown. Here, we utilised an established rat model to investigate the effects of repeated sub-concussion on size of lateral ventricles, cerebrovascular blood-brain barrier (BBB) integrity, neuroinflammation, oxidative stress, and biochemical distribution. Following repeated sub-concussion 3 days per week for 2 weeks, the rats showed significantly enlarged lateral ventricles compared with the rats receiving sham-only procedure. The sub-concussive rats also presented significant BBB dysfunction in the cerebral cortex and hippocampal formation, whilst neuromotor function assessed by beamwalk and rotarod tests were comparable to the sham rats. Immunofluorescent and spectroscopic microscopy analyses revealed no significant changes in neuroinflammation, oxidative stress, lipid distribution or protein aggregation, within the hippocampus and cortex. These data collectively indicate that repeated sub-concussion for 2 weeks induce significant ventriculomegaly and BBB disruption, preceding neuromotor deficits.	[Hiles-Murison, Bailey; Hackett, Mark J.; Armstrong, Joshua J.; Nesbit, Michael; McGonigle, Terrence; Warnock, Andrew; Lam, Virginie; Mamo, John C. L.; Fitzgerald, Melinda; Takechi, Ryu] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Hiles-Murison, Bailey] Curtin Univ, Fac Hlth Sci, Curtin Med Sch, Bentley, WA, Australia; [Lavender, Andrew P.] Federat Univ Australia, Sch Sci Psychol & Sport, Mt Helen, Vic, Australia; [Lavender, Andrew P.; Rawlings, Samuel] Curtin Univ, Fac Hlth Sci, Sch Allied Hlth, Bentley, WA, Australia; [Hackett, Mark J.; Armstrong, Joshua J.] Curtin Univ, Fac Sci & Engn, Sch Mol & Life Sci, Bentley, WA, Australia; [Nesbit, Michael; Lam, Virginie; Mamo, John C. L.; Takechi, Ryu] Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Bentley, WA, Australia; [McGonigle, Terrence; Warnock, Andrew; Fitzgerald, Melinda] Ralph & Patricia Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia		Takechi, R (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia.; Takechi, R (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Bentley, WA, Australia.	R.Takechi@curtin.edu.au	Takechi, Ryusuke/D-3692-2012; Takechi, Ryu/T-9970-2019	Takechi, Ryusuke/0000-0001-6359-3382; Takechi, Ryu/0000-0001-6359-3382; Mamo, John/0000-0002-5741-7849; Lam, Virginie/0000-0001-8463-645X	Western Australian Department of Health; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	The project was supported by Western Australian Department of Health. RT and VL are financially supported by National Health and Medical Research Council.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; Fimognari N, 2018, ACS CHEM NEUROSCI, V9, P2774, DOI 10.1021/acschemneuro.8b00193; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hackett MJ, 2019, ACS CHEM NEUROSCI, V10, P2533, DOI 10.1021/acschemneuro.9b00039; Hackett MJ, 2015, FREE RADICAL BIO MED, V89, P806, DOI 10.1016/j.freeradbiomed.2015.08.029; Haider MN, 2018, BRAIN INJURY, V32, P809, DOI 10.1080/02699052.2018.1469045; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Hartnell D, 2020, ACS CHEM NEUROSCI, V11, P248, DOI 10.1021/acschemneuro.9b00257; Hasan-Olive MM, 2019, J NEUROPATH EXP NEUR, V78, P808, DOI 10.1093/jnen/nlz063; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Johansson B B, 1980, Adv Exp Med Biol, V131, P211; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Krishnamurthy S, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-16; Lavender AP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00491; Leskovjan AC, 2010, ANAL CHEM, V82, P2711, DOI 10.1021/ac1002728; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Mamo JCL, 2017, INT J OBESITY, V41, P926, DOI 10.1038/ijo.2017.57; Mamo JCL, 2019, DIABETES VASC DIS RE, V16, P87, DOI 10.1177/1479164118795274; Mao YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113408; Mathys Zoe K, 2017, Adv Neurobiol, V18, P199, DOI 10.1007/978-3-319-60189-2_10; Nesbit M, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.617221; Ott BR, 2010, J ALZHEIMERS DIS, V20, P647, DOI 10.3233/JAD-2010-1406; Paxinos G., 2014, PAXINOS WATSONS RAT, VSeventh; Pearce AJ, 2016, EBIOMEDICINE, V13, P3, DOI 10.1016/j.ebiom.2016.10.043; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; Rawlings S, 2020, BRAIN RES BULL, V165, P56, DOI 10.1016/j.brainresbull.2020.09.021; Sadoun A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16046; Sahyouni Ronald, 2017, J Concussion, V1, DOI 10.1177/2059700216684518; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Strahle J, 2012, TRANSL STROKE RES, V3, pS25, DOI 10.1007/s12975-012-0182-9; Takechi R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00399; Takechi R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-73; Takechi R, 2013, CLIN EXP PHARMACOL P, V40, P45, DOI 10.1111/1440-1681.12032; Tidy RJ, 2017, VIB SPECTROSC, V91, P68, DOI 10.1016/j.vibspec.2016.09.016; Tonni G, 2016, REV BRAS GINECOL OBS, V38, P436, DOI 10.1055/s-0036-1592315; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8; Zetterberg H, 2019, J INTERN MED, V285, P624, DOI 10.1111/joim.12863; Zheng W, 2012, PHARMACOL THERAPEUT, V133, P177, DOI 10.1016/j.pharmthera.2011.10.006	48	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 29	2021	11	1							9261	10.1038/s41598-021-88854-9			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK4RL	WOS:000656204600004	33927338	gold, Green Published, Green Submitted			2022-02-06	
J	Benavides, A; Bell, EF; Georgieff, MK; Josephson, CD; Stowell, SR; Feldman, HA; Nalbant, D; Tereshchenko, A; Sola-Visner, M; Nopoulos, P				Benavides, Amanda; Bell, Edward F.; Georgieff, Michael K.; Josephson, Cassandra D.; Stowell, Sean R.; Feldman, Henry A.; Nalbant, Demet; Tereshchenko, Alexander; Sola-Visner, Martha; Nopoulos, Peggy			Sex-specific cytokine responses and neurocognitive outcome after blood transfusions in preterm infants	PEDIATRIC RESEARCH			English	Article; Early Access							LOW-BIRTH-WEIGHT; TRAUMATIC BRAIN-INJURY; NEURODEVELOPMENTAL OUTCOMES; NEUROBEHAVIORAL OUTCOMES; SYSTEMIC INFLAMMATION; CELL TRANSFUSIONS; ELEVATED PLASMA; BORN; CHILDREN; ASSOCIATION	Background The objective of this study was to determine sex-specific differences in inflammatory cytokine responses to red blood cell (RBC) transfusion in preterm infants in the neonatal period and their relationship to later neurocognitive status. Methods Infants with a birth weight <1000 g and gestational age 22-29 weeks were enrolled in the Transfusion of Prematures (TOP) trial. The total number of transfusions was used as a marker of transfusion status. Nineteen cytokines and biomarkers were analyzed from 71 infants longitudinally during the neonatal period. Twenty-six infants completed the Bayley Scales of Infant & Toddler Development, 3rd Edition (Bayley-III) at 12 months' corrected age. Results Nine cytokine levels were significantly elevated in proportion to the number of transfusions received. Of those, one cytokine showed a sex-specific finding (p = 0.004): monocyte chemoattractant protein-1, MCP-1, rose substantially in females (8.9% change per additional transfusion), but not in males (-0.8% change). Higher concentrations of MCP-1 exclusively were associated with worse Bayley-III scores: decreased cognitive raw scores (p = 0.0005) and motor scaled scores (p < 0.0001). Conclusions This study provides evidence of a sex-specific difference in the inflammatory response to RBC transfusions during neonatal life, with MCP-1 levels rising only in females and inversely correlating with neurocognitive status at 12 months old. Impact It is important to understand the risk factors for abnormal neurodevelopment in preterm infants, including anemia and RBC transfusion, in order to improve outcomes and provide potential targets for therapy. Our study investigates and provides the first evidence of sex-specific differences in inflammatory cytokine responses to RBC transfusions in preterm infants in the neonatal period, and their relationship to later cognitive outcomes. This study critically suggests that different transfusion thresholds may have a sex-specific effect on neurodevelopment: females have worse cognitive outcomes with increased number of transfusions, while males have worse outcomes with lower number of transfusions.	[Benavides, Amanda; Nopoulos, Peggy] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Bell, Edward F.; Nopoulos, Peggy] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Georgieff, Michael K.] Univ Minnesota, Sch Med, Dept Pediat, Div Neonatol, Minneapolis, MN 55455 USA; [Josephson, Cassandra D.] Emory Univ, Sch Med, Dept Pediat, Aflac Canc Ctr, Atlanta, GA USA; [Josephson, Cassandra D.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Blood Disorders Serv, Atlanta, GA USA; [Josephson, Cassandra D.] Emory Univ, Sch Med, Ctr Transfus & Cellular Therapies, Dept Pathol & Lab Med, Atlanta, GA USA; [Stowell, Sean R.] Harvard Med Sch, Brigham & Womens Hosp, Joint Program Transfus Med, Dept Pathol, Boston, MA 02115 USA; [Feldman, Henry A.; Sola-Visner, Martha] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Nalbant, Demet] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Div Pharmaceut & Translat Therapeut, Iowa City, IA 52242 USA; [Tereshchenko, Alexander] Univ Pittsburgh, Dept Psychiat, Western Psychiat Hosp, Pittsburgh, PA USA; [Nopoulos, Peggy] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA		Benavides, A (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	amanda-benavides@uiowa.edu		Nopoulos, Peggy/0000-0001-8810-1903	National Institute for Heart, Lung, and Blood (NHLBI) Parent Project Grant [5P01HL046925-22, 5779]; National Institute for Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [5T32MH019113-26]	The design and conduct of this research study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript were made possible by National Institute for Heart, Lung, and Blood (NHLBI) Parent Project Grant #5P01HL046925-22, Sub-Project ID 5779, "Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and Their Treatments-Project 4," and National Institute for Mental Health (NIMH) Program Grant #5T32MH019113-26 "Iowa Neuroscience Specialty Program in Research Education (INSPIRE) Program Grant." We confirm that this manuscript has not been previously published and has not been submitted simultaneously for publication elsewhere. I, A.B., had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Aden U, 2010, BRAIN BEHAV IMMUN, V24, P747, DOI 10.1016/j.bbi.2009.10.010; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Arpino C, 2010, CHILD NERV SYST, V26, P1139, DOI 10.1007/s00381-010-1125-y; Arthur CM, 2019, TRANSFUSION, V59, P1233, DOI 10.1111/trf.15254; Aylward GP, 2014, J DEV BEHAV PEDIATR, V35, P392, DOI 10.1097/DBP.0000000000000075; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Bartha AI, 2004, PEDIATR RES, V56, P960, DOI 10.1203/01.PDR.0000144819.45689.BB; Basu S, 2015, J PERINATOL, V35, P855, DOI 10.1038/jp.2015.86; Benavides A, 2019, PEDIATR RES, V85, P55, DOI 10.1038/s41390-018-0187-5; Benjamini Y, 2001, ANN STAT, V29, P1165; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Carlo WA, 2011, J PEDIATR-US, V159, P919, DOI 10.1016/j.jpeds.2011.05.042; Cerri C, 2017, EPILEPSY RES, V136, P77, DOI 10.1016/j.eplepsyres.2017.07.016; Dammann O, 2014, PEDIATR RES, V75, P376, DOI 10.1038/pr.2013.238; Dani C, 2017, TRANSFUSION, V57, P1304, DOI 10.1111/trf.14080; Dani C, 2010, TRANSFUSION, V50, P1220, DOI 10.1111/j.1537-2995.2009.02575.x; Etemadi N, 2013, FEBS J, V280, P5283, DOI 10.1111/febs.12419; Franz AR, 2020, JAMA-J AM MED ASSOC, V324, P560, DOI 10.1001/jama.2020.10690; Georgieff MK, 2011, NUTR REV, V69, pS43, DOI 10.1111/j.1753-4887.2011.00432.x; Graham AM, 2018, BIOL PSYCHIAT, V83, P109, DOI 10.1016/j.biopsych.2017.05.027; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; HOLM S, 1979, SCAND J STAT, V6, P65; Howarth C, 2018, NEONATOLOGY, V114, P7, DOI 10.1159/000486584; Hutchinson EA, 2013, PEDIATRICS, V131, pE1053, DOI 10.1542/peds.2012-2311; Keir AK, 2015, TRANSFUSION, V55, P1340, DOI 10.1111/trf.12998; Keir AK, 2013, PEDIATR RES, V73, P75, DOI 10.1038/pr.2012.144; Kinjo T, 2011, EARLY HUM DEV, V87, P439, DOI 10.1016/j.earlhumdev.2011.03.006; Kirpalani H, 2020, NEW ENGL J MED, V383, P2639, DOI 10.1056/NEJMoa2020248; Leviton A, 2011, J PEDIATR-US, V158, P897, DOI 10.1016/j.jpeds.2010.11.059; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lu H., 2017, J MATERN FETAL NEONA, P1, DOI [10.1080/14767058.2017.1359532, DOI 10.1080/14767058.2017.1359532]; Maier RF, 2000, J PEDIATR-US, V136, P220, DOI 10.1016/S0022-3476(00)70105-3; McAdams RM, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/561494; McCoy TE, 2014, DEV NEUROPSYCHOL, V39, P226, DOI 10.1080/87565641.2013.874428; Mccoy TE, 2011, CHILD NEUROPSYCHOL, V17, P347, DOI 10.1080/09297049.2010.544647; Nopoulos PC, 2011, ARCH PEDIAT ADOL MED, V165, P443, DOI 10.1001/archpediatrics.2010.269; Orchinik LJ, 2011, J INT NEUROPSYCH SOC, V17, P1067, DOI 10.1017/S135561771100107X; Patel JR, 2012, ACTA NEUROPATHOL, V124, P847, DOI 10.1007/s00401-012-1034-0; Romero R, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12685; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; STRAUSS RG, 1991, AM J DIS CHILD, V145, P904, DOI 10.1001/archpedi.1991.02160080082025; Transfusion of Prematures Trial (TOP), 2012, NAT LIB MED US; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Van Steenwinckel J, 2014, BIOCHEM SOC T, V42, P557, DOI 10.1042/BST20130284; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; Wu D, 2011, DEV MED CHILD NEUROL, V53, P217, DOI 10.1111/j.1469-8749.2010.03884.x; Yu HH, 2014, APMIS, V122, P818, DOI 10.1111/apm.12223	53	1	1	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.												10.1038/s41390-021-01536-0		APR 2021	8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	RU5EV	WOS:000645172100001	33911194				2022-02-06	
J	Boase, K; Machamer, J; Temkin, NR; Dikmen, S; Wilson, L; Nelson, LD; Barber, J; Bodien, YG; Giacino, JT; Markowitz, AJ; McCrea, MA; Satris, G; Stein, MB; Taylor, SR; Manley, GT				Boase, Kim; Machamer, Joan; Temkin, Nancy R.; Dikmen, Sureyya; Wilson, Lindsay; Nelson, Lindsay D.; Barber, Jason; Bodien, Yelena G.; Giacino, Joseph T.; Markowitz, Amy J.; McCrea, Michael A.; Satris, Gabriela; Stein, Murray B.; Taylor, Sabrina R.; Manley, Geoffrey T.		TRACK-TBI Investigators	Central Curation of Glasgow Outcome Scale-Extended Data: Lessons Learned from TRACK-TBI	JOURNAL OF NEUROTRAUMA			English	Article						central review; clinical outcome assessments; data curation; GOSE; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CLINICAL-TRIALS; MISCLASSIFICATION; RECOMMENDATIONS; AGREEMENT	The Glasgow Outcome Scale (GOS) in its original or extended (GOSE) form is the most widely used assessment of global disability in traumatic brain injury (TBI) research. Several publications have reported concerns about assessor scoring inconsistencies, but without documentation of contributing factors. We reviewed 6801 GOSE assessments collected longitudinally, across 18 sites in the 5-year, observational Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. We recorded error rates (i.e., corrections to a section or an overall rating) based on site assessor documentation and categorized scoring issues, which then informed further training. In cohort 1 (n = 1261; February 2014 to May 2016), 24% of GOSEs had errors identified by central review. In cohort 2 (n = 1130; June 2016 to July 2018), acquired after curation of cohort 1 data, feedback, and further training of site assessors, the error rate was reduced to 10%. GOSE sections associated with the most frequent interpretation and scoring difficulties included whether current functioning represented a change from pre-injury (466 corrected ratings in cohort 1; 62 in cohort 2), defining dependency in the home and community (163 corrections in cohort 1; three in cohort 2) and return to work/school (72 corrections in cohort 1; 35 in cohort 2). These results highlight the importance of central review in improving consistency across sites and over time. Establishing clear scoring criteria, coupled with ongoing guidance and feedback to data collectors, is essential to avoid scoring errors and resultant misclassification, which carry potential to result in "failure" of clinical trials that rely on the GOSE as their primary outcome measure.	[Boase, Kim; Machamer, Joan; Temkin, Nancy R.; Dikmen, Sureyya; Barber, Jason] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9Th Ave, Seattle, WA 98104 USA; [Wilson, Lindsay] Univ Stirling, Sch Nat Sci, Div Psychol, Stirling, Scotland; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol Surg, Milwaukee, WI 53226 USA; [Bodien, Yelena G.; Giacino, Joseph T.] Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Charlestown, MA USA; [Markowitz, Amy J.; Satris, Gabriela; Taylor, Sabrina R.; Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Boase, K (corresponding author), Harborview Med Ctr, Dept Neurol Surg, Box 359924,325 9Th Ave, Seattle, WA 98104 USA.	kboase@uw.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Hemphill, Claude/0000-0003-4019-7525	NIH-NINDS - TRACKTBI [U01NS086090]; United States Department of Defense - TBI Endpoints Development Initiative [W81XWH-14-2-0176]; TRACK-TBI Precision Medicine [W81XWH-18-2-0042]; TRACKTBI NETWORK [W81XWH-15-9-0001]; NIH-NINDS - TRACK-TBI [U01NS086090]; National Football League (NFL) Scientific Advisory Board - TRACK-TBI LONGITUDINAL; United States Department of EnergyUnited States Department of Energy (DOE); One Mind; NeuroTruama SciencesLLC; Abbott LaboratoriesAbbott Laboratories; Department of Defense TBI Endpoints Development Initiative [W81XWH-14-2-0176]; TRACK-TBI NETWORK [W81XWH-15-9-0001]; CENTER-TBI (EU FP7 programme) [602150]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110856]	This work was supported by NIH-NINDS - TRACKTBI (Grant #U01NS086090) and United States Department of Defense - TBI Endpoints Development Initiative (Grant #W81XWH-14-2-0176). Dr. Manley discloses grants from the United States Department of Defense - TBI Endpoints Development Initiative (Grant #W81XWH-14-2-0176), TRACK-TBI Precision Medicine (Grant #W81XWH-18-2-0042), and TRACKTBI NETWORK (Grant #W81XWH-15-9-0001); NIH-NINDS - TRACK-TBI (Grant #U01NS086090); and the National Football League (NFL) Scientific Advisory Board - TRACK-TBI LONGITUDINAL. United States Department of Energy supports Dr. Manley for a precision medicine collaboration. One Mind has provided funding for TRACK-TBI patients stipends and support to clinical sites. He has received an unrestricted gift from the NFL to the UCSF Foundation to support research efforts of the TRACK-TBI NETWORK. Dr. Manley has also received funding fromNeuroTruama SciencesLLCto support TRACK-TBI data curation efforts. Additionally, Abbott Laboratories has provided funding for add-in TRACK-TBI clinical studies.; Amy Markowitz receives funding from the Department of Defense TBI Endpoints Development Initiative (Grant #W81XWH-14-2-0176) and TRACK-TBI NETWORK (Grant #W81XWH-15-9-0001). Ms Markowitz also receives salary support from the United States Department of Energy precision medicine collaboration and the philanthropic organization, One Mind.; Lindsay Wilson is supported by CENTER-TBI (EU FP7 programme 602150). Lindsay Nelson is supported by NINDS grant R01 NS110856.	Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; Ercole A, 2020, J CLIN TRANSL SCI, V4, P354, DOI 10.1017/cts.2020.24; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Horton L, 2018, J NEUROTRAUM, V35, P2005, DOI 10.1089/neu.2018.5648; JENNETT B, 1975, LANCET, V1, P480; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marmarou A., 2001, HEAD TRAUMA BASIC PR; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; National Institutes of Neurologic Disease and Stroke Common Data Elements, 2010, TRAUMATIC BRAIN INJU; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Temkin N.R., 2018, J NEUROTRAUM, V35; TRACK-TBI; International Traumatic Brain Injury Initiative, 2018, STANDARD OPERATING P; University of California, TRACK TBI TRANSF RES; University of Michigan; SIREN Network, 2018, BOOST 3 BRAIN OXYG O; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2021, J NEUROTRAUM, V38, P2435, DOI 10.1089/neu.2020.7527	27	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2419	2434		10.1089/neu.2020.7528		APR 2021	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000645447400001	33832330	Green Published, Green Accepted, Green Submitted, hybrid			2022-02-06	
J	Cortez, MM; Millsap, L; Rea, NA; Sciarretta, C; Brennan, KC				Cortez, Melissa M.; Millsap, Leah; Rea, Natalie A.; Sciarretta, Christopher; Brennan, K. C.			Photophobia and allodynia in persistent post-traumatic headache are associated with higher disease burden	CEPHALALGIA			English	Article						Central sensitization; traumatic brain injury; post-traumatic headache; photophobia; allodynia	MILD TRAUMATIC BRAIN; CUTANEOUS ALLODYNIA; CENTRAL SENSITIZATION; MIGRAINE; VALIDATION; MODEL; PAIN; CLASSIFICATION; IMPAIRMENT; PREVALENCE	Objective To assess photophobia and allodynia in subjects with post-traumatic headache and examine how these sensory hypersensitivities associate with clinical measures of disease burden. Background Post-traumatic headache is the most frequent and disabling long-term consequence of mild traumatic brain injury. There is evidence of sensory dysfunction in acute post-traumatic headache, and it is known from other headache conditions that sensory amplifications correlate with more severe disease. However, systematic studies in post-traumatic headache are surprisingly scarce. Methods We tested light and tactile sensitivity, along with measures of disease burden, in 30 persistent post-traumatic headache subjects and 35 controls. Results In all, 79% of post-traumatic headache subjects exhibited sensory hypersensitivity based on psychophysical assessment. Of those exhibiting hypersensitivity, 54% exhibited both light and tactile sensitivity. Finally, sensory thresholds were correlated across modalities, as well as with headache attack frequency. Conclusions In this study, post-traumatic headache subjects with both light and tactile sensitivity had significantly higher headache frequencies and lower sensitivity thresholds to both modalities, compared to those with single or no sensory hypersensitivity. This pattern suggests that hypersensitivity across multiple modalities may be functionally synergistic, reflect a higher disease burden, and may serve as candidate markers of disease.	[Cortez, Melissa M.; Millsap, Leah; Brennan, K. C.] Univ Utah, Dept Neurol, 729 Arapeen Dr, Salt Lake City, UT 84108 USA; [Rea, Natalie A.; Sciarretta, Christopher] Univ Utah, Sch Med, Salt Lake City, UT USA; [Rea, Natalie A.] Mayo Clin, Rochester, MN USA		Cortez, MM (corresponding author), Univ Utah, Dept Neurol, 729 Arapeen Dr, Salt Lake City, UT 84108 USA.	Melissa.cortez@hsc.utah.edu		Brennan, K.C./0000-0003-4193-5841	NIH NIMHD LRP; American Academy of Neurology Clinical Research Scholarship; American Academy of Neurology Medical Student Summer Research Program; NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 102978, 104742]; Fairclough Endowment for Headache Research	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: NIH NIMHD LRP and the American Academy of Neurology Clinical Research Scholarship (MMC); American Academy of Neurology Medical Student Summer Research Program (NAR); Fairclough Endowment for Headache Research (LM); NIH NINDS R01 NS 102978, 104742 (KCB).	Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Benromano T, 2015, EUR J PAIN, V19, P621, DOI 10.1002/ejp.583; BOHNEN N, 1991, BRIT J PSYCHIAT, V159, P860, DOI 10.1192/bjp.159.6.860; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Choi JY, 2009, CEPHALALGIA, V29, P953, DOI 10.1111/j.1468-2982.2008.01822.x; Cooke L, 2007, HEADACHE, V47, P531, DOI 10.1111/j.1526-4610.2006.00717.x; Cortez MM, 2017, CEPHALALGIA, V37, P801, DOI 10.1177/0333102416673205; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Levy D, 2020, CEPHALALGIA, V40, P675, DOI 10.1177/0333102419896368; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Lovati C, 2013, NEUROL SCI, V34, pS133, DOI 10.1007/s10072-013-1369-x; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Marcus DA, 2003, HEADACHE, V43, P117, DOI 10.1046/j.1526-4610.2003.03028.x; Martins Hugo André de Lima, 2012, Dement. neuropsychol., V6, P53, DOI 10.1590/S1980-57642012DN06010009; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Rendas-Baum R., 2014, HEALTH QUAL LIFE OUT, V12, P117, DOI [10.1186/s12955-014-0117-0, DOI 10.1186/s12955-014-0117-0, DOI 10.1186/S12955-014-0117-0]; Samaan Z, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-7; Seo JG, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0583-8; Seo JG, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0552-2; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Woehrle E, 2020, CLIN J SPORT MED, V30, pE130, DOI 10.1097/JSM.0000000000000635; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Young WB, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-018-0952-1	39	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	SEP	2021	41	10					1089	1099	03331024211010304	10.1177/03331024211010304		APR 2021	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UL3UU	WOS:000655992200001	33910382				2022-02-06	
J	Ballinger, K; McGuinty, D; Girardin, R; Zerkee, L; Ellis, MJ; Russell, K				Ballinger, Karen; McGuinty, Duncan; Girardin, Richard; Zerkee, Leanne; Ellis, Michael J.; Russell, Kelly			Clinical Outcomes of Pediatric Acute Sport- and Non-Sport-Related Concussions	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article; Early Access						Concussion; Sport; Non-sport; Pediatrics	SYMPTOMS; PREDICTORS	Objectives: The objectives were to examine clinical characteristics, length of recovery, and the prevalence of delayed physician-documented recovery, compare clinical outcomes among those with sport-related concussion (SRC) and non-sport-related concussion (nSRC), and identify risk factors for delayed recovery. Methods: Included patients (8-18 years) were assessed <= 14 days post-injury at a multidisciplinary concussion program and diagnosed with an acute SRC or nSRC. Physician-documented clinical recovery was defined as returning to pre-injury symptom status, attending full-time school without symptoms, completing Return-to-Sport strategy as needed, and normal physical examination. Delayed physician-documented recovery was defined as >28 days post-injury. Results: Four hundred and fifteen patients were included (77.8% SRC). There was no difference in loss of consciousness (SRC: 9.9% vs nSRC: 13.0%, p = 0.39) or post-traumatic amnesia (SRC: 24.1% vs SRC: 31.5%, p = 0.15) at the time of injury or any differences in median Post-Concussion Symptom Scale scores (SRC: 20 vs nSRC: 23, p = 0.15) at initial assessment. Among those with complete clinical follow-up, the median physician-documented clinical recovery was 20 days (SRC: 19 vs nSRC: 23; p = 0.37). There was no difference in the proportion of patients who developed delayed physician-documented recovery (SRC: 27.7% vs nSRC: 36.1%; p = 0.19). Higher initial symptom score increased the risk of delayed physician-documented recovery (IRR: 1.39; 95% CI: 1.29, 1.49). Greater material deprivation and social deprivation were associated with an increased risk of delayed physician-documented recovery. Conclusions: Most pediatric concussion patients who undergo early medical assessment and complete follow-up appear to make a complete clinical recovery within 4 weeks, regardless of mechanism.	[Ballinger, Karen; McGuinty, Duncan; Girardin, Richard; Zerkee, Leanne; Ellis, Michael J.; Russell, Kelly] Univ Manitoba, Dept Pediat & Child Hlth, 656-A JRBC,715 McDermot Ave, Winnipeg, MB, Canada; [Girardin, Richard; Ellis, Michael J.; Russell, Kelly] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Ellis, Michael J.] Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Excellence Neurodev & Rehabil Res Child Hlth ENRR, Winnipeg, MB, Canada		Russell, K (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, 656-A JRBC,715 McDermot Ave, Winnipeg, MB, Canada.	krussell@chrim.ca			Research Manitoba	This work was supported by Dr Russell's Establishment Grant from Manitoba Health Research Council (now Research Manitoba).	Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Chatterjee D, 2012, COMPUT THERM SCI, V4, P23, DOI 10.1615/ComputThermalScien.2012003930; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ewing-Cobbs L, 2018, J NEUROTRAUM, V35, pA98; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Ontario Neurotrauma Foundation, ONT NEUR FDN LIV GUI; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zuckerman SL, 2017, J NEUROSURG-PEDIATR, V19, P652, DOI 10.3171/2017.1.PEDS16611	20	1	1	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.											PII S0317167121000822	10.1017/cjn.2021.82		APR 2021	7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP8ND	WOS:000748875600001	33902784				2022-02-06	
J	Pinggera, D; Bauer, M; Unterhofer, M; Thome, C; Unterhofer, C				Pinggera, Daniel; Bauer, Marlies; Unterhofer, Michael; Thome, Claudius; Unterhofer, Claudia			Craniotomy size for traumatic acute subdural hematomas in elderly patients-same procedure for every age?	NEUROSURGICAL REVIEW			English	Article; Early Access						Acute subdural hematoma; Elderly; Outcome; Surgical technique	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; MORTALITY; MORBIDITY; EPIDEMIOLOGY; MULTICENTER	Surgical treatment of acute subdural hematoma (aSDH) is still matter of debate, especially in the elderly. A retrospective study to compare two different surgical approaches, namely standard (SC, craniotomy size > 8 cm) and limited craniotomy (LC, craniotomy size < 8 cm), was conducted in elderly patients with traumatic aSDH to identify the role of craniotomy size in terms of clinical and radiological outcome. Sixty-four patients aged 75 or older with aSDH as sole lesion were retrospectively analyzed. Data were collected pre- and postoperatively including clinical and radiological criteria. The primary outcome parameter was 30-day mortality. Secondary outcome parameters were radiological. The mean age was 79.2 (+/- 3.1) years with no difference between groups and almost equal distribution of craniotomy size. Mortality rate was significantly higher in the SC group in comparison to the LC group (68.4% vs. 31.6%; p = 0.045). The preoperative HD (p = 0.08) and the MLS (p = 0.09) were significantly higher in the SC group, whereas postoperative radiological evaluation showed no significant difference in HD or MLS. A limited craniotomy is sufficient for adequate evacuation of an aSDH in the elderly achieving the same radiological and clinical outcome.	[Pinggera, Daniel; Bauer, Marlies; Unterhofer, Michael; Thome, Claudius; Unterhofer, Claudia] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria		Pinggera, D (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria.	daniel.pinggera@tirol-kliniken.at	Bauer, Marlies/ABC-2537-2021	Bauer, Marlies/0000-0002-2338-8349	University of Innsbruck; Medical University of Innsbruck	Open access funding provided by University of Innsbruck and Medical University of Innsbruck.	Akbik OS, 2019, WORLD NEUROSURG, V126, pE1235, DOI 10.1016/j.wneu.2019.02.234; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bus S, 2019, BRIT J NEUROSURG, V33, P51, DOI 10.1080/02688697.2018.1522418; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; Hanko M, 2021, EUR J TRAUMA EMERG S, V47, P1635, DOI 10.1007/s00068-020-01367-4; Heyland DK, 2015, INTENS CARE MED, V41, P1911, DOI 10.1007/s00134-015-4028-2; JAMJOOM A, 1992, INJURY, V23, P518, DOI 10.1016/0020-1383(92)90149-M; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kim Hyunjun, 2018, Korean J Neurotrauma, V14, P14, DOI 10.13004/kjnt.2018.14.1.14; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kwon Young Sub, 2016, Korean J Neurotrauma, V12, P22, DOI 10.13004/kjnt.2016.12.1.22; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Oh Chang Hyun, 2016, Korean J Neurotrauma, V12, P11, DOI 10.13004/kjnt.2016.12.1.11; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; Unterhofer C, 2018, NEUROSURG REV, V41, P183, DOI 10.1007/s10143-017-0833-0; Unterhofer C, 2017, ACTA NEUROCHIR, V159, P1547, DOI 10.1007/s00701-017-3240-y; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17421	38	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.												10.1007/s10143-021-01548-8		APR 2021	7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RT2BT	WOS:000644270000003	33900496	hybrid			2022-02-06	
J	Berndt, N; Kovacs, R; Schoknecht, K; Rosner, J; Reiffurth, C; Maechler, M; Holzhutter, HG; Dreier, JP; Spies, C; Liotta, A				Berndt, Nikolaus; Kovacs, Richard; Schoknecht, Karl; Roesner, Joerg; Reiffurth, Clemens; Maechler, Mathilde; Holzhuetter, Hermann-Georg; Dreier, Jens P.; Spies, Claudia; Liotta, Agustin			Low neuronal metabolism during isoflurane-induced burst suppression is related to synaptic inhibition while neurovascular coupling and mitochondrial function remain intact	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Anaesthesia; burst suppression; cerebral blood flow; isoflurane; mitochondria	SPREADING DEPOLARIZATION; GAMMA-OSCILLATIONS; ANESTHETICS; OXYGEN; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; ISCHEMIA; PROPOFOL; K+	Deep anaesthesia may impair neuronal, vascular and mitochondrial function facilitating neurological complications, such as delirium and stroke. On the other hand, deep anaesthesia is performed for neuroprotection in critical brain diseases such as status epilepticus or traumatic brain injury. Since the commonly used anaesthetic propofol causes mitochondrial dysfunction, we investigated the impact of the alternative anaesthetic isoflurane on neuro-metabolism. In deeply anaesthetised Wistar rats (burst suppression pattern), we measured increased cortical tissue oxygen pressure (p(ti)O(2)), a similar to 35% drop in regional cerebral blood flow (rCBF) and burst-associated neurovascular responses. In vitro, 3% isoflurane blocked synaptic transmission and impaired network oscillations, thereby decreasing the cerebral metabolic rate of oxygen (CMRO2). Concerning mitochondrial function, isoflurane induced a reductive shift in flavin adenine dinucleotide (FAD) and decreased stimulus-induced FAD transients as Ca2+ influx was reduced by similar to 50%. Computer simulations based on experimental results predicted no direct effects of isoflurane on mitochondrial complexes or ATP-synthesis. We found that isoflurane-induced burst suppression is related to decreased ATP consumption due to inhibition of synaptic activity while neurovascular coupling and mitochondrial function remain intact. The neurometabolic profile of isoflurane thus appears to be superior to that of propofol which has been shown to impair the mitochondrial respiratory chain.	[Berndt, Nikolaus] Charite Univ Med Berlin, Inst Imaging Sci & Computat Modelling Cardiovasc, Berlin, Germany; [Kovacs, Richard; Roesner, Joerg; Reiffurth, Clemens; Maechler, Mathilde; Holzhuetter, Hermann-Georg; Dreier, Jens P.; Spies, Claudia; Liotta, Agustin] Free Univ Berlin, Berlin, Germany; [Kovacs, Richard; Roesner, Joerg; Reiffurth, Clemens; Maechler, Mathilde; Holzhuetter, Hermann-Georg; Dreier, Jens P.; Spies, Claudia; Liotta, Agustin] Humboldt Univ, Berlin, Germany; [Kovacs, Richard; Roesner, Joerg; Reiffurth, Clemens; Maechler, Mathilde; Holzhuetter, Hermann-Georg; Dreier, Jens P.; Spies, Claudia; Liotta, Agustin] Berlin Inst Hlth, Berlin, Germany; [Kovacs, Richard; Maechler, Mathilde; Liotta, Agustin] Charite Univ Med Berlin, Inst Neurophysiol, Berlin, Germany; [Schoknecht, Karl] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Roesner, Joerg] Charite Univ Med Berlin, Neurosci Res Ctr, Berlin, Germany; [Reiffurth, Clemens; Dreier, Jens P.] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Reiffurth, Clemens; Dreier, Jens P.; Liotta, Agustin] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany; [Holzhuetter, Hermann-Georg] Charite Univ Med Berlin, Inst Biochem, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Dreier, Jens P.] Tech Univ Berlin, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Einstein Ctr Neurosci, Berlin, Germany; [Spies, Claudia; Liotta, Agustin] Charite Univ Med Berlin, Dept Anesthesiol & Intens Care, Berlin, Germany; [Spies, Claudia; Liotta, Agustin] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany		Liotta, A (corresponding author), Charite, Dept Anesthesiol & Intens Care, Charite Pl 1, D-10117 Berlin, Germany.	agustin.liotta@charite.de		Kovacs, Richard/0000-0001-7870-4313; Liotta, Agustin/0000-0003-1205-5343; Berndt, Nikolaus/0000-0001-5594-9940; Reiffurth, Clemens/0000-0002-1372-1240; Holzhutter, Hermann-Georg/0000-0002-5054-6023	Charite - Universitatsmedizin Berlin; Berlin Institute of Health; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [408355133]; ERA-NET NEURON (EBio2); BMBFFederal Ministry of Education & Research (BMBF) [0101EW2004]; DFGGerman Research Foundation (DFG)European Commission [DR 323/5-1, DR 323/10-1]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The BIH Charite Clinician Scientist Program funded by the Charite - Universitatsmedizin Berlin and the Berlin Institute of Health supported AL (2014-2018). This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant no. 408355133 (AL/NB), DFG DR 323/5-1 (JPD), DFG DR 323/10-1 (JPD) and ERA-NET NEURON (EBio2), with funds from BMBF (0101EW2004) (JPD).	Andresen JM, 2014, CRIT CARE MED, V42, P2244, DOI 10.1097/CCM.0000000000000522; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bains R, 2009, ACTA ANAESTH SCAND, V53, P85, DOI 10.1111/j.1399-6576.2008.01823.x; Baumgart JP, 2015, P NATL ACAD SCI USA, V112, P11959, DOI 10.1073/pnas.1500525112; Berndt N, 2018, ARCH TOXICOL, V92, P3191, DOI 10.1007/s00204-018-2295-8; Berndt N, 2015, J CEREBR BLOOD F MET, V35, P1494, DOI 10.1038/jcbfm.2015.70; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Ching SN, 2012, P NATL ACAD SCI USA, V109, P3095, DOI 10.1073/pnas.1121461109; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Finsterer J, 2016, J CHILD NEUROL, V31, P1489, DOI 10.1177/0883073816661458; GHOSH JJ, 1954, NATURE, V174, P28, DOI 10.1038/174028a0; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI [10.2217/bmm.10.1, 10.2217/BMM.10.1]; Hesse S, 2019, BRIT J ANAESTH, V122, P622, DOI 10.1016/j.bja.2018.09.016; Holtkamp M, 2018, DRUGS, V78, P307, DOI 10.1007/s40265-017-0859-1; Huchzermeyer C, 2008, J NEUROSCI, V28, P1153, DOI 10.1523/JNEUROSCI.4105-07.2008; Huchzermeyer C, 2013, J CEREBR BLOOD F MET, V33, P263, DOI 10.1038/jcbfm.2012.165; Kajimoto M, 2014, J CEREBR BLOOD F MET, V34, P514, DOI 10.1038/jcbfm.2013.229; Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Kayser EB, 1999, ANESTHESIOLOGY, V90, P545, DOI 10.1097/00000542-199902000-00031; Koide M, 2012, P NATL ACAD SCI USA, V109, pE1387, DOI 10.1073/pnas.1121359109; Kuroda Y, 1996, ANESTHESIOLOGY, V84, P555, DOI 10.1097/00000542-199603000-00010; Lee K, 2018, NEUROTOXICOLOGY, V65, P28, DOI 10.1016/j.neuro.2018.01.007; Liotta A, 2012, J CEREBR BLOOD F MET, V32, P2076, DOI 10.1038/jcbfm.2012.116; Liotta A, 2011, J NEUROPHYSIOL, V105, P172, DOI 10.1152/jn.00186.2010; Marian M, 1999, NEUROCHEM RES, V24, P875, DOI 10.1023/A:1020910131237; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Miller MA, 2020, MILLERS ANESTHESIA; Mrkobrada M, 2019, LANCET, V394, P1022, DOI 10.1016/S0140-6736(19)31795-7; OLSEN KS, 1994, BRIT J ANAESTH, V72, P66, DOI 10.1093/bja/72.1.66; Reinsfelt B, 2003, ANESTH ANALG, V97, P1246, DOI 10.1213/01.ANE.0000086732.97924.BE; Schoknecht K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091925; Slupe AM, 2018, J CEREBR BLOOD F MET, V38, P2192, DOI 10.1177/0271678X18789273; Soehle M, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0051-7; Stecker MM, 2001, ANN THORAC SURG, V71, P22, DOI 10.1016/S0003-4975(00)02021-X; Tsurugizawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38977; van Alst TM, 2019, NEUROIMAGE, V195, P89, DOI 10.1016/j.neuroimage.2019.03.057; Watson PL, 2008, CRIT CARE MED, V36, P3171, DOI 10.1097/CCM.0b013e318186b9ce; Winkler MKL, 2012, EPILEPSIA, V53, P22, DOI 10.1111/j.1528-1167.2012.03699.x; Xie HY, 2020, J CEREBR BLOOD F MET, V40, P875, DOI 10.1177/0271678X19847123; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; Zeiler FA, 2017, J INTENSIVE CARE MED, V32, P130, DOI 10.1177/0885066615593939; Zhang YY, 2012, ANN NEUROL, V72, P630, DOI 10.1002/ana.23683; Zhang Z, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00296; Zimin PI, 2018, BRIT J ANAESTH, V120, P1019, DOI 10.1016/j.bja.2018.01.036	48	1	1	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2021	41	10					2640	2655	0271678X211010353	10.1177/0271678X211010353		APR 2021	16	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	WD1ZV	WOS:000680789900001	33899556	Green Published, hybrid			2022-02-06	
J	Bohnert, S; Wirth, C; Schmitz, W; Trella, S; Monoranu, CM; Ondruschka, B; Bohnert, M				Bohnert, Simone; Wirth, Christoph; Schmitz, Werner; Trella, Stefanie; Monoranu, Camelia-Maria; Ondruschka, Benjamin; Bohnert, Michael			Myelin basic protein and neurofilament H in postmortem cerebrospinal fluid as surrogate markers of fatal traumatic brain injury	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						CSF; Cerebrospinal fluid; Forensic neuropathology; Forensic neurotraumatology; Biomarker; Biofluid	NEURON-SPECIFIC ENOLASE; AXONAL INJURY; BIOCHEMICAL MARKERS; NERVOUS-SYSTEM; BIOMARKERS; SERUM; PROTEOLYSIS; S100B; ACCUMULATION; EXPRESSION	The aim of this study was to investigate if the biomarkers myelin basic protein (MBP) and neurofilament-H (NF-H) yielded informative value in forensic diagnostics when examining cadaveric cerebrospinal fluid (CSF) biochemically via an enzyme-linked immunosorbent assay (ELISA) and comparing the corresponding brain tissue in fatal traumatic brain injury (TBI) autopsy cases by immunocytochemistry versus immunohistochemistry. In 21 trauma and 19 control cases, CSF was collected semi-sterile after suboccipital puncture and brain specimens after preparation. The CSF MBP (p = 0.006) and NF-H (p = 0.0002) levels after TBI were significantly higher than those in cardiovascular controls. Immunohistochemical staining against MBP and against NF-H was performed on cortical and subcortical samples from also biochemically investigated cases (5 TBI cases/5 controls). Compared to the controls, the TBI cases showed a visually reduced staining reaction against MBP or repeatedly ruptured neurofilaments against NF-H. Immunocytochemical tests showed MBP-positive phagocytizing macrophages in CSF with a survival time of > 24 h. In addition, numerous TMEM119-positive microglia could be detected with different degrees of staining intensity in the CSF of trauma cases. As a result, we were able to document that elevated levels of MBP and NF-H in the CSF should be considered as useful neuroinjury biomarkers of traumatic brain injury.	[Bohnert, Simone; Wirth, Christoph; Trella, Stefanie; Bohnert, Michael] Univ Wurzburg, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany; [Schmitz, Werner] Biozentrum, Inst Biochem & Mol Biol 1, D-97074 Wurzburg, Germany; [Monoranu, Camelia-Maria] Univ Wurzburg, Inst Pathol, Dept Neuropathol, Josef Schneider Str 2, D-97080 Wurzburg, Germany; [Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Butenfeld 34, D-22529 Hamburg, Germany		Bohnert, S (corresponding author), Univ Wurzburg, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany.	simone.bohnert@uni-wuerzburg.de			Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bock W, 2006, SCHADEL HIRN VERLETZ; Bohnert S, 2021, INT J LEGAL MED, V135, P183, DOI 10.1007/s00414-020-02462-2; Bohnert S, 2020, INT J LEGAL MED, V134, P2167, DOI 10.1007/s00414-020-02384-z; Bohnert S, 2019, INT J LEGAL MED, V133, P1141, DOI 10.1007/s00414-019-02050-z; Bratzke H., 2011, RECHTSMEDIZIN, V21, P17; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Brodbeck K, 2019, RECHTSMEDIZIN, V29, P400, DOI 10.1007/s00194-019-00339-2; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; DEBER CM, 1991, CLIN BIOCHEM, V24, P113, DOI 10.1016/0009-9120(91)90421-A; Dettmeyer R.B., 2018, FORENSIC HISTOPATHOL; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; GARDINIER MV, 1992, J NEUROSCI RES, V33, P177, DOI 10.1002/jnr.490330123; GEDDES JW, 1995, NEUROBIOL AGING, V16, P651, DOI 10.1016/0197-4580(95)00062-J; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Harel A, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0139-16.2016; Hayashi T, 2015, INT J LEGAL MED, V129, P1085, DOI 10.1007/s00414-015-1245-8; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lassmann H, 1997, RES LEG MED, V17, P253; Li Y, 2015, J NEUROL SCI, V359, P280, DOI 10.1016/j.jns.2015.08.035; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Manivannan S, 2018, CLIN NEUROL NEUROSUR, V171, P6, DOI 10.1016/j.clineuro.2018.05.017; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Oerter S, 2019, INT J LEGAL MED, V133, P1107, DOI 10.1007/s00414-018-1893-6; Olczak M, 2018, FOLIA NEUROPATHOL, V56, P97, DOI 10.5114/fn.2018.76613; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Piek J., 2018, HDB SCHADELHIRN TRAU; Plemel JR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay6324; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Su E, 2012, NEUROCRIT CARE, V17, P401, DOI 10.1007/s12028-012-9767-0; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Trautz F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48145-w; Trautz F, 2018, INT J LEGAL MED, V132, P1103, DOI 10.1007/s00414-017-1767-3; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Vajtr D, 2012, Soud Lek, V57, P7; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	63	1	1	6	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2021	135	4					1525	1535		10.1007/s00414-021-02606-y		APR 2021	11	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	SS7YK	WOS:000643184500001	33895854	hybrid, Green Published			2022-02-06	
J	Draper, N; Kabaliuk, N; Stitt, D; Alexander, K				Draper, Nick; Kabaliuk, Natalia; Stitt, Danyon; Alexander, Keith			Potential of Soft-Shelled Rugby Headgear to Reduce Linear Impact Accelerations	JOURNAL OF HEALTHCARE ENGINEERING			English	Article							RECURRENT CONCUSSION; UNION PLAYERS; INJURY; SPORTS; EFFICACY; SEASON	The purpose of this study was to examine the potential of soft-shelled rugby headgear to reduce linear impact accelerations. A hybrid III head form instrumented with a 3-axis accelerometer was used to assess headgear performance on a drop test rig. Six headgear units were examined in this study: Canterbury Clothing Company (CCC) Ventilator, Kukri, 2(nd) Skull, N-Pro, and two Gamebreaker headgear units of different sizes (headgears 1-6, respectively). Drop heights were 238, 300, 610, and 912 mm with 5 orientations at each height (forehead, front boss, rear, rear boss, and side). Impact severity was quantified using peak linear acceleration (PLA) and head injury criterion (HIC). All headgear was tested in comparison to a no headgear condition (for all heights). Compared to the no headgear condition, all headgear significantly reduced PLA and HIC at 238 mm (16.2-45.3% PLA and 29.2-62.7% HIC reduction; P<0.0005, eta(2)(p) = 0.987-0.991). Headgear impact attenuation lowered significantly as the drop height increased (32.4-5.6% PLA and 50.9-11.7% HIC reduction at 912 mm). There were no significant differences in PLA or HIC reduction between headgear units 1-3. Post hoc testing indicated that headgear units 4-6 significantly outperformed headgear units 1-3 and additionally headgear units 5 and 6 significantly outperformed headgear 4 (P<0.05). The lowest reduction PLA and HIC was for impacts rear orientation for headgear units 1-4 (3.3 +/- 3.6%-11 +/- 5.8%). In contrast, headgear units 5 and 6 significantly outperformed all other headgear in this orientation (P<0.0005, eta(2)(p) = 0.982-0.990). Side impacts showed the greatest reduction in PLA and HIC for all headgear. All headgear units tested demonstrated some degree of reduction in PLA and HIC from a linear impact; however, units 4-6 performed significantly better than headgear units 1-3.	[Draper, Nick] Univ Canterbury, Sch Hlth Sci, Christchurch, New Zealand; [Kabaliuk, Natalia; Stitt, Danyon; Alexander, Keith] Univ Canterbury, Dept Mech Engn, Christchurch, New Zealand		Draper, N (corresponding author), Univ Canterbury, Sch Hlth Sci, Christchurch, New Zealand.	nick.draper@canterbury.ac.nz; natalia.kabaliuk@canterbury.ac.nz; danyonstitt@gmail.com; keith.alexander@canterbury.ac.nz		Kabaliuk, Natalia/0000-0002-9899-3738; Stitt, Danyon/0000-0002-7139-3660; Alexander, Keith/0000-0001-9887-730X; Draper, Nick/0000-0002-4466-3792			ACC, 2015, SPORT CONC NZ; Administration N.H.T.S, 1997, E C REG, P49; [Anonymous], 2019, GAMEBREAKER; [Anonymous], 2020, GAMEBREAKER D30; [Anonymous], 2019, SKULL N SOFT SHELL H; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Candy S, 2017, BRAIN INJURY, V31, P1521, DOI 10.1080/02699052.2017.1363407; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Eppinger R., 1998, DEV IMPROVED INJURY; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Frizzell ERA, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000361; Fuller CW, 2017, BRIT J SPORT MED, V51, P1272, DOI 10.1136/bjsports-2016-097301; Gaffaney C., 2014, COUNTING COST CONCUS; Ganly M, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000464; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hecimovich M, 2018, J SPORTS MED, V1, P8; Hecimovich MD, 2017, J PAEDIATR CHILD H, V53, P246, DOI 10.1111/jpc.13405; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hume P, 2017, BRIT J SPORT MED, V51, P333, DOI [10.1136/bjsports-2016-097372.125, DOI 10.1136/BJSPORTS-2016-097372.125]; King A., 2003, P IRCOBI C LISB PORT; King D, 2019, J SCI MED SPORT, V22, P532, DOI 10.1016/j.jsams.2018.10.015; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2017, ARC J RES SPORTS MED, V2, P9; King D, 2019, SPORTS MED, V49, P1559, DOI 10.1007/s40279-019-01151-4; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Knouse CL, 2003, J ATHL TRAINING, V38, P330; Ma R, 2016, MED SCI SPORT EXER, V48, P1957, DOI 10.1249/MSS.0000000000000997; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; NOCSAE, 2017, IMP ATT TESTS; NZSSSC, 2017, NZSSSC REPR CENS; P McLellan C, 2013, J ATHLETIC ENHANCEME, V2, P1, DOI [10.4172/2324-9080.1000126, DOI 10.4172/2324-9080.1000126]; Penta F, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8071174; Pettersen JA, 2002, BRIT J SPORT MED, V36, P19, DOI 10.1136/bjsm.36.1.19; Rugby W., 2014, HDB SPECIFICATIONS R; Rugby W., 2019, WORLD RUGBY LAW 4 HE; Rugby W., 2017, GLOBAL RUGBY PARTICI; Schick DM, 2008, BRIT J SPORT MED, V42, P447, DOI 10.1136/bjsm.2008.046672; Silver D, 2018, J NEUROL SCI, V388, P40, DOI 10.1016/j.jns.2018.02.046; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Versace J, 1971, SAE TECHNICAL PAPER; Whyte T, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043140	51	1	1	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2040-2295	2040-2309		J HEALTHC ENG	J. Healthc. Eng.	APR 24	2021	2021								5567625	10.1155/2021/5567625			10	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	SW8XD	WOS:000664797800001	33981403	Green Published, gold			2022-02-06	
J	de Oliveira, AJM; Solla, DJF; de Oliveira, KF; Amaral, BS; Andrade, AF; Kolias, AG; Paiva, WS				de Oliveira, Adilson J. M.; Solla, Davi J. F.; de Oliveira, Klever F.; Amaral, Bruno S.; Andrade, Almir F.; Kolias, Angelos G.; Paiva, Wellingson S.			Postoperative neutrophil-to-lymphocyte ratio variation is associated with chronic subdural hematoma recurrence	NEUROLOGICAL SCIENCES			English	Article						Hematoma; Subdural; Chronic; Inflammation; Neutrophil-lymphocyte ratio; Neurosurgery		Introduction Chronic subdural haematoma (CSDH) is one of the most common neurosurgical pathologies. The recurrence of chronic subdural haematomas is an important concern, considering that elderly patients are the most affected and reoperations in these patients may represent a risk of neurological and clinical complications. In accordance with the inflammatory theory regarding CSDH and its recurrence, we aimed to evaluate the role of an inflammatory marker, neutrophil-to-lymphocyte ratio (NLR), as a risk factor and prognostic variable for CSDH recurrence. Methods We performed a cohort study of adult patients operated for post-traumatic CSDH traumatic CSDH between January 2015 and December 2019 in our neurotrauma unit, whose data was retrospectively retrieved. We excluded patients with previous inflammatory or infectious diseases as well as use of anticoagulant/antiplatelet medications. Neutrophil and lymphocyte counts were obtained 24 h preoperatively and 48-72 h postoperatively. The primary endpoint was symptomatic recurrence of CSDH up to 1 year after the surgery. An independent sample was used to validate the findings. Results The testing sample comprised 160 patients (59.4% male, mean age 69.3 +/- 14.3 years, recurrence rate 22.5%). Postoperative neutrophil count and NLR were higher in those who recurred, as well as the neutrophils (median 1.15 vs 0.96, p = 0.022) and NLR (median 1.29 vs 0.79, p = 0.001) postoperative-to-preoperative ratios. Preoperative laboratory parameters or other baseline variables were not associated with recurrence. Postoperative NLR ratio (each additional unit, OR 2.53, 95% CI 1.37-4.67, p = 0.003) was independently associated with recurrence. The best cut-off for the postoperative NLR ratio was 0.995 (AUC-ROC 0.67, sensitivity 63.9%, specificity 76.6%). Postoperative NLR ratio >= 1 (i.e. a post-operative NLR that does not decrease compared to the preoperative value) was associated with recurrence (OR 4.59, 95% CI 2.00-10.53, p < 0.001). The validation sample analysis (66 patients) yielded similar results (AUC-ROC 0.728, 95% CI 0.594-0.862, p = 0.002) and similar cut-off (>= 1.05, sensitivity 77.8%, specificity 66.7%). Conclusion NLR ratio can be a useful parameter for the prediction of post-traumatic CSDH recurrence. This hypothesis was validated in an independent sample and the accuracy was moderate.	[de Oliveira, Adilson J. M.; Solla, Davi J. F.; de Oliveira, Klever F.; Amaral, Bruno S.; Andrade, Almir F.; Paiva, Wellingson S.] Univ Sao Paulo, Hosp Clin, Div Neurosurg, Dept Neurol,Neurotrauma Unit,Med Sch, Sao Paulo, Brazil; [de Oliveira, Adilson J. M.] Clin Girassol, Neurocience Ctr, Comandante Gika St 225, Luanda 01419000, Angola; [Solla, Davi J. F.; Kolias, Angelos G.; Paiva, Wellingson S.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Kolias, Angelos G.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England		de Oliveira, AJM (corresponding author), Univ Sao Paulo, Hosp Clin, Div Neurosurg, Dept Neurol,Neurotrauma Unit,Med Sch, Sao Paulo, Brazil.; de Oliveira, AJM (corresponding author), Clin Girassol, Neurocience Ctr, Comandante Gika St 225, Luanda 01419000, Angola.	adilsonvalmont@gmail.com	Paiva, Wellingson S/G-5517-2013	Paiva, Wellingson S/0000-0002-5165-7040			Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Deng QW, 2021, NEUROL SCI, V42, P2397, DOI 10.1007/s10072-020-04827-2; Dilektasli E, 2016, J TRAUMA ACUTE CARE, V81, P882, DOI 10.1097/TA.0000000000000980; Dong CH, 2018, CLIN BIOCHEM, V52, P131, DOI 10.1016/j.clinbiochem.2017.11.008; Edlmann E, 2020, ACTA NEUROCHIR, V162, P763, DOI 10.1007/s00701-020-04218-8; Edlmann E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42087-z; Edlmann E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0881-y; Faria SS, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.702; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Glancz LJ, 2020, ACTA NEUROCHIR, V162, P1455, DOI 10.1007/s00701-020-04356-z; Guha D, 2016, J NEUROSURG, V124, P750, DOI 10.3171/2015.2.JNS141889; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hara Mutsuya, 2009, Journal of Medical and Dental Sciences, V56, P101; Inci I, 2020, NEUROL SCI, V41, P1233, DOI 10.1007/s10072-019-04208-4; Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; Kocaturk O, 2019, NEUROL SCI, V40, P139, DOI 10.1007/s10072-018-3604-y; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; de Morais ANLR, 2021, NEUROSURG REV, V44, P3023, DOI 10.1007/s10143-021-01484-7; SARTI C, 1991, STROKE, V22, P848, DOI 10.1161/01.STR.22.7.848; SATO S, 1975, J NEUROSURG, V43, P569, DOI 10.3171/jns.1975.43.5.0569; Tao CY, 2017, NEUROCRIT CARE, V26, P393, DOI 10.1007/s12028-016-0332-0; Tao CY, 2017, BIOMARK MED, V11, P33, DOI 10.2217/bmm-2016-0187; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Yang WY, 2017, NEUROSURG CLIN N AM, V28, P205, DOI 10.1016/j.nec.2016.11.002; Ying AN, 2020, NEUROL SCI, V41, P2215, DOI 10.1007/s10072-020-04324-6; Zhang YD, 2020, CLIN NEUROL NEUROSUR, V191, DOI 10.1016/j.clineuro.2020.105738	33	1	1	2	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JAN	2022	43	1					427	434		10.1007/s10072-021-05241-y		APR 2021	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YA0JA	WOS:000642829500001	33891187				2022-02-06	
J	Elbin, RJ; Eagle, SR; Marchetti, GF; Anderson, M; Schatz, P; Womble, MN; Stephenson, K; Covassin, T; Collins, MW; Mucha, A; Kontos, AP				Elbin, R. J.; Eagle, Shawn R.; Marchetti, Gregory F.; Anderson, Morgan; Schatz, Philip; Womble, Melissa N.; Stephenson, Katie; Covassin, Tracey; Collins, Michael W.; Mucha, Anne; Kontos, Anthony P.			Using change scores on the vestibular ocular motor screening (VOMS) tool to identify concussion in adolescents	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Sports; mild traumatic brain injury; sports-related concussion		Objective To develop clinical cutoffs using change scores for the VOMS individual items and an overall VOMS change score that identified concussion in adolescent athletes. Methods Change score clinical cutoffs were calculated from a sample of adolescents (13-18 years) with SRC (n = 147) and a sample of uninjured adolescents CONTROL (n = 147). Receiver operating characteristic (ROC) curves, with area under the curve (AUC), based on Youden's J statistic were used to identify optimal cutoffs for identifying SRC from CONTROLS using VOMS individual item change scores, an overall VOMS change scores, and NPC distance (cm). Results AUC values for VOMS item change scores ranged from .55 to .71. Optimal change score cutoffs were >= 1 for VOMS items and >= 3 for overall VOMS change score. The optimal cutoff for NPC distance was >= 3 cm. A ROC analysis revealed a three-factor model (AUC = .76) for identifying SRC that included vertical vesibular ocular reflex (VVOR), visual motion sensitivity (VMS), and NPC distance items. The AUC (.73) for the overall VOMS change score was higher than any individual VOMS AUC values. Conclusions This study supports an alternate scoring approach and clinical interpretation of VOMS items involving change scores that account for pretest symptoms.	[Elbin, R. J.; Stephenson, Katie] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA; [Eagle, Shawn R.; Collins, Michael W.; Mucha, Anne; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA USA; [Marchetti, Gregory F.] Duquesne Univ, Rangos Sch Hlth Sci, Pittsburgh, PA 15219 USA; [Anderson, Morgan; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Womble, Melissa N.] Inova Sports Med Concuss Program, Fairfax, VA USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, 155 Stadium Dr, Fayetteville, AR 72701 USA.	rjelbin@uark.edu		Schatz, Philip/0000-0002-6222-6545; Anderson, Morgan/0000-0001-9170-6663; Stephenson, Katie/0000-0002-4590-8122	National Football League through the University of Pittsburgh; Brainscope, Inc. through the University of Arkansas; Inova Healthcare	Dr. Collins is a former shareholder and board-member of ImPACT Applications (relationship ended 12/16/19). Drs. Collins and Kontos receive book royalties from APA Books. Dr. Womble has received payment from ImPACT Applications for providing continuing education talks. Dr. Philip Schatz is a member of ImPACT Applications Inc. scientific advisory board. All other authors have no conflicts of interest to disclose. Drs. Collins and Kontos have funding for research from the National Football League through the University of Pittsburgh. Drs. Elbin and Womble have funding for research from Brainscope, Inc. through the University of Arkansas and Inova Healthcare.	Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Elbin RJ, 2019, J ATHL TRAINING, V54, P939, DOI 10.4085/1062-6050-347-18; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2021, CLIN J SPORT MED, V31, pE188, DOI 10.1097/JSM.0000000000000767; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kontos A. P., 2018, CONCUSSION CLIN PROF; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Sinnott AM, 2019, J SCI MED SPORT, V22, P1292, DOI 10.1016/j.jsams.2019.08.004; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Whitney SL, 2020, BRAIN INJURY, V34, P842, DOI 10.1080/02699052.2020.1755055; Worts PR, 2019, AM J SPORT MED, V47, pNP13, DOI 10.1177/0363546518817763; Yorke A.M., 2017, SPORTS HLTH MULTIDIS, V9, DOI [https://doi.org/10.1177/141738116678411, DOI 10.1177/141738116678411]	32	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1911806		APR 2021	7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	RS5WG	WOS:000643848500001	33896282				2022-02-06	
J	Mazarati, A; Medel-Matus, JS; Shin, D; Jacobs, JP; Sankar, R				Mazarati, Andrey; Medel-Matus, Jesus-Servando; Shin, Don; Jacobs, Jonathan P.; Sankar, Raman			Disruption of intestinal barrier and endotoxemia after traumatic brain injury: Implications for post-traumatic epilepsy	EPILEPSIA			English	Article						fluid percussion injury; fluorescein isothiocyanate&#8211; labeled dextran; intestinal permeability; lipopolysaccharide; rat		Objective Traumatic brain injury (TBI) may lead to the disruption of the intestinal barrier (IB), and to the escape of products of commensal gut bacteria, including lipopolysaccharide (LPS), into the bloodstream. We examined whether lateral fluid percussion injury (LFPI) and post-traumatic epilepsy (PTE) are associated with the increased intestinal permeability and endotoxemia, and whether these events in turn are associated with PTE. Methods LFPI was delivered to adult male Sprague-Dawley rats. Before, 1 week, and 7 months after LFPI, the IB permeability was examined by measuring plasma concentration of fluorescein isothiocyanate-labeled dextran (FD4) upon its enteral administration. Plasma LPS concentration was measured in the same animals, using enzyme-linked immunosorbent assay. PTE was examined 7 months after LFPI, with use of video-EEG (electroencephalography) monitoring. Results One week after LFPI, the IB disruption was detected in 14 of 17 and endotoxemia - in 10 of 17 rats, with a strong positive correlation between FD4 and LPS levels, and between plasma levels of each of the analytes and the severity of neuromotor deficit. Seven months after LFPI, IB disruption was detected in 13 of 15 and endotoxemia in 8 of 15 rats, with a strong positive correlation between plasma levels of the two analytes. Five of 15 LFPI rats developed PTE. Plasma levels of both FD4 and LPS were significantly higher in animals with PTE than among the animals without PTE. The analysis of seven rats, which were examined repeatedly at 1 week and at 7 months, confirmed that late IB disruption and endotoxemia were not due to lingering of impairments occurring shortly after LFPI. Significance LFPI leads to early and remote disruption of IB and a secondary endotoxemia. Early and late perturbations may occur in different subjects. Early changes reflect the severity of acute post-traumatic motor dysfunction, whereas late changes are associated with PTE.	[Mazarati, Andrey; Medel-Matus, Jesus-Servando; Shin, Don; Sankar, Raman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Mazarati, Andrey; Sankar, Raman] Univ Calif Los Angeles, Childrens Discovery & Innovat Inst, Los Angeles, CA USA; [Mazarati, Andrey; Jacobs, Jonathan P.] Univ Calif Los Angeles, Microbiome Ctr, Los Angeles, CA USA; [Jacobs, Jonathan P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Jacobs, Jonathan P.] VA Greater Los Angeles Healthcare Syst, Div Gastroenterol Hepatol & Parenteral Nutr, Los Angeles, CA USA; [Sankar, Raman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Mazarati, A (corresponding author), Univ Calif Los Angeles, Neurol Div, D Geffen Sch Med, Dept Pediat, BOX 951752,22-474 MDCC, Los Angeles, CA 90095 USA.	mazarati@ucla.edu			Department of Defense Epilepsy Research Program [W81XWH-19-1-0430]; Sudha Neelakantan and Venky Harinarayan Charitable Fund endowment	The work was supported by the Department of Defense Epilepsy Research Program grant W81XWH-19-1-0430 to AM, and by Sudha Neelakantan and Venky Harinarayan Charitable Fund endowment to Epilepsy Research Laboratories and to AM. The authors are grateful to Dr. Aristea Galanopoulou and her laboratory personnel for advising on LFPI procedures.	AOKI K, 1978, ACTA MED OKAYAMA, V32, P207; Auvin S, 2010, EPILEPSIA, V51, P34, DOI 10.1111/j.1528-1167.2010.02606.x; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Bingham D, 2013, J NEUROIMMUNOL, V256, P28, DOI 10.1016/j.jneuroim.2012.12.009; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Citraro R, 2021, EPILEPSIA, V62, P529, DOI 10.1111/epi.16813; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; Eslami M, 2020, NEUROL RES, V42, P91, DOI 10.1080/01616412.2019.1709139; Eslami M, 2015, J NEUROIMMUNOL, V289, P143, DOI 10.1016/j.jneuroim.2015.11.003; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Gil-Cardoso K, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800720; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Medel-Matus JS, 2021, EPILEPSIA OPEN, V6, P413, DOI 10.1002/epi4.12472; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Munford RS, 2016, J LEUKOCYTE BIOL, V100, P687, DOI 10.1189/jlb.3RU0316-151R; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Ono Tomonori, 2018, Epilepsia Open, V3, P90, DOI 10.1002/epi4.12260; Pan PF, 2019, NEUROL SCI, V40, P1105, DOI 10.1007/s10072-019-03739-0; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Sayyah M, 2003, NEUROSCIENCE, V122, P1073, DOI 10.1016/j.neuroscience.2003.08.043; Scott KA, 2017, BRAIN BEHAV IMMUN, V65, P20, DOI 10.1016/j.bbi.2017.02.004; Seemann S, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0370-8; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tache Y, 2015, J NEUROGASTROENTEROL, V21, P8, DOI 10.5056/jnm14162; Tamai H, 2000, ALCOHOL CLIN EXP RES, V24, P390, DOI 10.1111/j.1530-0277.2000.tb04629.x; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Wang LR, 2015, J IMMUNOL METHODS, V421, P44, DOI 10.1016/j.jim.2014.12.015	50	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	JUN	2021	62	6					1472	1481		10.1111/epi.16909		APR 2021	10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SK5YU	WOS:000642813700001	33893636				2022-02-06	
J	Shi, W; Dong, PF; Kuss, MA; Gu, LX; Kievit, F; Kim, HJ; Duan, B				Shi, Wen; Dong, Pengfei; Kuss, Mitchell A.; Gu, Linxia; Kievit, Forrest; Kim, Hyung Joon; Duan, Bin			Design and Evaluation of an In Vitro Mild Traumatic Brain Injury Modeling System Using 3D Printed Mini Impact Device on the 3D Cultured Human iPSC Derived Neural Progenitor Cells	ADVANCED HEALTHCARE MATERIALS			English	Article						3D printing; iPSC derived neural progenitor cells; microglia; neuroinflammation; repetitive mild traumatic brain injury		Despite significant progress in understanding the disease mechanism of traumatic brain injury (TBI), promising preclinical therapeutics have seldom been translated into successful clinical outcomes, partially because the model animals have physiological and functional differences in the central nervous system (CNS) compared to humans. Human relevant models are thus urgently required. Here, an in vitro mild TBI (mTBI) modeling system is reported based on 3D cultured human induced pluripotent stem cells (iPSC) derived neural progenitor cells (iPSC-NPCs) to evaluate consequences of single and repetitive mTBI using a 3D printed mini weight-drop impact device. Computational simulation is performed to understand the single/cumulative effects of weight-drop impact on the NPC differentiated neurospheres. Experimental results reveal that neurospheres show reactive astrogliosis and glial scar formation after repetitive (10 hits) mild impacts, while no astrocyte activation is found after one or two mild impacts. A 3D co-culture model of human microglia cells with neurospheres is further developed. It is found that astrocyte response is promoted even after two mild impacts, possibly caused by the chronic neuroinflammation after microglia activation. The in vitro mTBI modeling system recapitulates several hallmarks of the brain impact injury and might serve as a good platform for future drug screening.	[Shi, Wen; Kuss, Mitchell A.; Kim, Hyung Joon; Duan, Bin] Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA; [Shi, Wen; Kuss, Mitchell A.; Duan, Bin] Univ Nebraska Med Ctr, Div Cardiol, Dept Internal Med, Omaha, NE 68198 USA; [Dong, Pengfei; Gu, Linxia] Florida Inst Technol, Dept Biomed & Chem Engn & Sci, Melbourne, FL 32901 USA; [Kievit, Forrest] Univ Nebraska Lincoln, Dept Biol Syst Engn, Lincoln, NE 68583 USA; [Kim, Hyung Joon] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Duan, Bin] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE 68198 USA; [Duan, Bin] Univ Nebraska Lincoln, Dept Mech Engn, Lincoln, NE 68588 USA		Duan, B (corresponding author), Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA.; Duan, B (corresponding author), Univ Nebraska Med Ctr, Div Cardiol, Dept Internal Med, Omaha, NE 68198 USA.; Duan, B (corresponding author), Univ Nebraska Med Ctr, Dept Surg, Omaha, NE 68198 USA.; Duan, B (corresponding author), Univ Nebraska Lincoln, Dept Mech Engn, Lincoln, NE 68588 USA.	bin.duan@unmc.edu		DONG, PENGFEI/0000-0002-0954-8094; Kievit, Forrest/0000-0002-9847-783X	Mary & Dick Holland Regenerative Medicine Program start-up grant; Mary & Dick Holland Regenerative Medicine Program pilot project grant; University of Nebraska Collaboration Initiative Seed Grant; National Institute of Neurological Disorders and Stroke of the National Institute of Health [R01NS109488]	This work has been supported by Mary & Dick Holland Regenerative Medicine Program start-up grant, Mary & Dick Holland Regenerative Medicine Program pilot project grant, and University of Nebraska Collaboration Initiative Seed Grant (B.D.) and grant funding from the National Institute of Neurological Disorders and Stroke of the National Institute of Health (R01NS109488) to F.K. The authors would like to thank Dr. Peng Jiang at Rutgers University for providing the neural progenitor cells.	Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Aisiku IP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1470-7; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; [Anonymous], 2020, J NEUROTRAUM, V37, P93; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bang S, 2019, BIOMICROFLUIDICS, V13, DOI 10.1063/1.5120555; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cairns DM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay8828; Chen C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5430; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Ciechanowska A, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151911; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dello Russo C, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1288-0; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Durnaoglu S, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/212487; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Flower O., 2012, EMERG MED INT, V2012; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Gardner AJ, 2019, J ORTHOP SPORT PHYS, V49, P768, DOI 10.2519/jospt.2019.9105; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Goshi N, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01819-z; Gunhanlar N, 2018, MOL PSYCHIATR, V23, P1336, DOI 10.1038/mp.2017.56; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hofman MA, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00015; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Hoogenboom WS, 2019, PHARMACOL THERAPEUT, V198, P109, DOI 10.1016/j.pharmthera.2019.02.016; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Kim C, 2015, BMB REP, V48, P256, DOI 10.5483/BMBRep.2015.48.5.100; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Koza L, 2019, NEURAL REGEN RES, V14, P1701, DOI 10.4103/1673-5374.257520; Kumaria A, 2017, ATLA-ALTERN LAB ANIM, V45, P201, DOI 10.1177/026119291704500405; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156166; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer A.R, 2017, REV, V89, P623; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mobini S, 2019, BIOMATERIALS, V198, P146, DOI 10.1016/j.biomaterials.2018.05.012; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Pasquesi SA, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00016; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Qi DJ, 2018, ACS APPL MATER INTER, V10, P21825, DOI 10.1021/acsami.8b03962; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schiavone P, 2009, MED IMAGE ANAL, V13, P673, DOI 10.1016/j.media.2009.04.001; Schiweck J, 2018, FRONT CELLULAR NEURO, V12, P12; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sensharma P, 2017, MAT SCI ENG C-MATER, V77, P1302, DOI 10.1016/j.msec.2017.03.264; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Sharif-Alhoseini M, 2017, SPINAL CORD, V55, P714, DOI 10.1038/sc.2016.187; Shi W, 2020, CARBOHYD POLYM, V233, DOI 10.1016/j.carbpol.2019.115803; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Tian A, 2020, J NEUROSCI, V40, P1186, DOI 10.1523/JNEUROSCI.0519-19.2019; Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu SH, 2017, J MATER CHEM B, V5, P3870, DOI [10.1039/C7TB00721C, 10.1039/c7tb00721c]; Wu YY, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.180177; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu RJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15411-9; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yoon H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180697; Zhang WH, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab906e; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2	135	1	2	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	JUN	2021	10	12							2100180	10.1002/adhm.202100180		APR 2021	15	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	SW6CN	WOS:000642398600001	33890428				2022-02-06	
J	Kim, H; Triplet, EM; Radulovic, M; Bouchal, S; Kleppe, LS; Simon, WL; Yoon, H; Scarisbrick, IA				Kim, Ha Neui; Triplet, Erin M.; Radulovic, Maja; Bouchal, Samantha; Kleppe, Laurel S.; Simon, Whitney L.; Yoon, Hyesook; Scarisbrick, Isobel A.			The thrombin receptor modulates astroglia-neuron trophic coupling and neural repair after spinal cord injury	GLIA			English	Article						astroglia; brain derived neurotrophic factor; growth cone; myelin; protease activated receptor 1; spinal cord trauma; synapse; TrkB		Excessive activation of the thrombin receptor, protease activated receptor 1 (PAR1) is implicated in diverse neuropathologies from neurodegenerative conditions to neurotrauma. PAR1 knockout mice show improved outcomes after experimental spinal cord injury (SCI), however information regarding the underpinning cellular and molecular mechanisms is lacking. Here we demonstrate that genetic blockade of PAR1 in female mice results in improvements in sensorimotor co-ordination after thoracic spinal cord lateral compression injury. We document improved neuron preservation with increases in Synapsin-1 presynaptic proteins and GAP43, a growth cone marker, after a 30 days recovery period. These improvements were coupled to signs of enhanced myelin resiliency and repair, including increases in the number of mature oligodendrocytes, their progenitors and the abundance of myelin basic protein. These significant increases in substrates for neural recovery were accompanied by reduced astrocyte (Serp1) and microglial/monocyte (CD68 and iNOS) pro-inflammatory markers, with coordinate increases in astrocyte (S100A10 and Emp1) and microglial (Arg1) markers reflective of pro-repair activities. Complementary astrocyte-neuron co-culture bioassays suggest astrocytes with PAR1 loss-of-function promote both neuron survival and neurite outgrowth. Additionally, the pro-neurite outgrowth effects of switching off astrocyte PAR1 were blocked by inhibiting TrkB, the high affinity receptor for brain derived neurotrophic factor. Altogether, these studies demonstrate unique modulatory roles for PAR1 in regulating glial-neuron interactions, including the capacity for neurotrophic factor signaling, and underscore its position at neurobiological intersections critical for the response of the CNS to injury and the capacity for regenerative repair and restoration of function.	[Kim, Ha Neui; Triplet, Erin M.; Radulovic, Maja; Bouchal, Samantha; Kleppe, Laurel S.; Simon, Whitney L.; Yoon, Hyesook; Scarisbrick, Isobel A.] Rehabil Med Res Ctr, Dept Phys Med & Rehabil, Rochester, MN USA; [Kim, Ha Neui; Triplet, Erin M.; Radulovic, Maja; Yoon, Hyesook; Scarisbrick, Isobel A.] Mayo Clin, Grad Sch Biomed Sci, Dept Physiol & Biomed Engn, Rochester, MN USA; [Triplet, Erin M.; Scarisbrick, Isobel A.] Mayo Clin, Neurosci Program, Grad Sch Biomed Sci, Rochester, MN USA		Scarisbrick, IA (corresponding author), Mayo Clin Rochester, Ctr Regenerat Med, Dept Phys Med & Rehabil, Neurosci Program, 642B Guggenheim Bldg,200 First St,SW, Rochester, MN 55905 USA.	scarisbrick.isobel@mayo.edu		Kim, Haneui/0000-0002-5651-4727; Triplet, Erin/0000-0002-5303-4576	Center for Scientific ReviewUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS052741-10, T32 GM 65841]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [G-1508-05951, RG-1901-33209]	Center for Scientific Review, Grant/Award Numbers: R01NS052741-10, T32 GM 65841; National Multiple Sclerosis Society, Grant/Award Numbers: G-1508-05951, RG-1901-33209	Allen M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35497; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Burda JE, 2013, GLIA, V61, P1456, DOI 10.1002/glia.22534; Charsar BA, 2019, FASEB J, V33, P13775, DOI 10.1096/fj.201901730R; Choi CI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27613-9; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Citron BA, 2016, BRAIN RES, V1643, P10, DOI 10.1016/j.brainres.2016.04.071; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Duncan GJ, 2020, GLIA, V68, P227, DOI 10.1002/glia.23706; Eftekhari R, 2018, BIOL CHEM, V399, P1023, DOI 10.1515/hsz-2018-0001; Festoff BM, 2000, MOL MED, V6, P410, DOI 10.1007/BF03401784; Festoff BW, 2004, J NEUROTRAUM, V21, P907, DOI 10.1089/0897715041526168; French SL, 2015, BLOOD REV, V29, P179, DOI 10.1016/j.blre.2014.10.006; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Hamill CE, 2007, MOL PHARMACOL, V72, P653, DOI 10.1124/mol.107.038158; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Joshi M, 2002, J NEUROTRAUM, V19, P191, DOI 10.1089/08977150252806956; Junge CE, 2004, EXP NEUROL, V188, P94, DOI 10.1016/j.expneurol.2004.02.018; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kim HN, 2015, J NEUROCHEM, V135, P577, DOI 10.1111/jnc.13285; Kim W, 2015, MOL CELL BIOL, V35, P3684, DOI 10.1128/MCB.00764-15; Lee PR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0901-y; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lubetzki C, 2020, LANCET NEUROL, V19, P678, DOI 10.1016/S1474-4422(20)30140-X; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Mannaioni G, 2008, J BIOL CHEM, V283, P20600, DOI 10.1074/jbc.M803015200; McCoy KL, 2012, CELL SIGNAL, V24, P1351, DOI 10.1016/j.cellsig.2012.01.011; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; Nobuta H, 2012, ANN NEUROL, V72, P750, DOI 10.1002/ana.23670; PESTRONK A, 1980, EXP NEUROL, V70, P65, DOI 10.1016/0014-4886(80)90006-0; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Pukos N, 2019, GLIA, V67, P2178, DOI 10.1002/glia.23702; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Radulovic Maja, 2013, J Neuropathol Exp Neurol, V72, P1072, DOI 10.1097/NEN.0000000000000007; Rajput PS, 2014, NEUROSCIENCE, V281, P229, DOI 10.1016/j.neuroscience.2014.09.038; Sachan V, 2019, CELL DEATH DIFFER, V26, P1942, DOI 10.1038/s41418-018-0264-7; Saeed MA, 2017, INFLAMM BOWEL DIS, V23, P593, DOI 10.1097/MIB.0000000000001045; Scarisbrick IA, 2008, CURR TOP MICROBIOL, V318, P133; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 1999, J NEUROSCI, V19, P7757; Scarisbrick IA, 2012, BIOL CHEM, V393, P355, DOI 10.1515/hsz-2011-0241; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Shavit-Stein E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103419; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Stassart RM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00467; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Vance KM, 2015, J NEUROSCI, V35, P776, DOI 10.1523/JNEUROSCI.3105-14.2015; Vandell AG, 2008, J NEUROCHEM, V107, P855, DOI 10.1111/j.1471-4159.2008.05658.x; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Vergnolle N, 2004, J CLIN INVEST, V114, P1444, DOI 10.1172/JCI200421689; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Le VB, 2018, BRIT J PHARMACOL, V175, P388, DOI 10.1111/bph.14084; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Whetstone WD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170512; Wilson JR, 2014, SPINE J, V14, P1192, DOI 10.1016/j.spinee.2013.08.005; Yoon H, 2020, J NEUROSCI, V40, P1483, DOI 10.1523/JNEUROSCI.2029-19.2019; Yoon H, 2018, BIOL CHEM, V399, P1041, DOI 10.1515/hsz-2018-0122; Yoon H, 2017, GLIA, V65, P2070, DOI 10.1002/glia.23215; Yoon H, 2016, BIOL CHEM, V397, P1277, DOI 10.1515/hsz-2016-0239; Yoon H, 2015, GLIA, V63, P846, DOI 10.1002/glia.22788; Yoon H, 2013, J NEUROCHEM, V127, P283, DOI 10.1111/jnc.12293; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5	70	1	1	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	SEP	2021	69	9					2111	2132		10.1002/glia.24012		APR 2021	22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TG2SF	WOS:000642264900001	33887067				2022-02-06	
J	Caccese, JB; Santos, FV; Yamaguchi, FK; Buckley, TA; Jeka, JJ				Caccese, Jaclyn B.; Santos, Fernando V.; Yamaguchi, Felipe K.; Buckley, Thomas A.; Jeka, John J.			Persistent Visual and Vestibular Impairments for Postural Control Following Concussion: A Cross-Sectional Study in University Students	SPORTS MEDICINE			English	Article								Objective To examine how concussion may impair sensory processing for control of upright stance. Methods Participants were recruited from a single university into 3 groups: 13 participants (8 women, 21 +/- 3 years) between 2 weeks and 6 months post-injury who initiated a return-to-play progression (under physician management) by the time of testing (recent concussion group), 12 participants (7 women, 21 +/- 1 years) with a history of concussion (concussion history group, > 1 year post-injury), and 26 participants (8 women, 22 +/- 3 years) with no concussion history (control group). We assessed sensory reweighting by simultaneously perturbing participants' visual, vestibular, and proprioceptive systems and computed center of mass gain relative to each modality. The visual stimulus was a sinusoidal translation of the visual scene at 0.2 Hz, the vestibular stimulus was +/- 1 mA binaural monopolar galvanic vestibular stimulation (GVS) at 0.36 Hz, the proprioceptive stimulus was Achilles' tendon vibration at 0.28 Hz. Results The recent concussion (95% confidence interval 0.078-0.115, p = 0.001) and the concussion history (95% confidence interval 0.056-0.094, p = 0.038) groups had higher gains to the vestibular stimulus than the control group (95% confidence interval 0.040-0.066). The recent concussion (95% confidence interval 0.795-1.159, p = 0.002) and the concussion history (95% confidence interval 0.633-1.012, p = 0.018) groups had higher gains to the visual stimulus than the control group (95% confidence interval 0.494-0.752). There were no group differences in gains to the proprioceptive stimulus or in sensory reweighting. Conclusion Following concussion, participants responded more strongly to visual and vestibular stimuli during upright stance, suggesting they may have abnormal dependence on visual and vestibular feedback. These findings may indicate an area for targeted rehabilitation interventions.	[Caccese, Jaclyn B.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA; [Santos, Fernando V.] Bertec Corp, Columbus, OH 43219 USA; [Yamaguchi, Felipe K.; Buckley, Thomas A.; Jeka, John J.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19713 USA; [Yamaguchi, Felipe K.; Buckley, Thomas A.; Jeka, John J.] Univ Delaware, Interdisciplinary Biomech & Movement Sci Program, Newark, DE 19713 USA		Caccese, JB (corresponding author), Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, 453 W 10th Ave, Columbus, OH 43210 USA.	jaclyn.caccese@osumc.edu		Caccese, Jaclyn/0000-0003-2329-3603; Santos, Fernando/0000-0002-8637-792X	NIH-NINDS R01 [NS102157-01]	This study was supported by the NIH-NINDS R01 (NS102157-01) Grant, "Behavioral-and bio-markers of subconcussion with controlled human head impact."	Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Allison LK, 2018, J NEUROL PHYS THER, V42, P84, DOI 10.1097/NPT.0000000000000214; Boshra R, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa063; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Caccese JB, 2020, J NEUROTRAUM, V37, P2656, DOI 10.1089/neu.2020.7001; Caccese JB, 2020, INT J SPORTS MED, V41, P616, DOI 10.1055/a-1141-3553; Caccese JB, 2018, CLIN J SPORT MED; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Eagle SR, 2020, J SPORT SCI, V38, P1799, DOI 10.1080/02640414.2020.1756675; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2020, GAIT POSTURE, V79, P53, DOI 10.1016/j.gaitpost.2020.04.013; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hwang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088132; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Jeka JJ, 2010, J MOTOR BEHAV, V42, P197, DOI 10.1080/00222895.2010.481693; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karmali F, 2018, J NEUROPHYSIOL, V119, P509, DOI 10.1152/jn.00710.2017; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kuo AD, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S07; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Murray NG, 2019, SEMIN SPEECH LANG, V40, P48, DOI 10.1055/s-0038-1676451; Oldham JR, 2020, MED SCI SPORT EXER, V52, P2279, DOI 10.1249/MSS.0000000000002385; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pasma JH, 2014, NEUROSCIENCE, V267, P157, DOI 10.1016/j.neuroscience.2014.02.030; PETERKA RJ, 1995, EXP BRAIN RES, V105, P101; Peterka RJ, 2018, HAND CLINIC, V159, P27, DOI 10.1016/B978-0-444-63916-5.00002-1; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Schmidt JD, 2018, PEDIATR NEUROL, V81, P19, DOI 10.1016/j.pediatrneurol.2017.12.017; SLOANE PD, 1989, AM J OTOLARYNG, V10, P422, DOI 10.1016/0196-0709(89)90038-0; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Speers RA, 2002, GAIT POSTURE, V16, P20, DOI 10.1016/S0966-6362(02)00003-6; TEASDALE N, 1991, EXP BRAIN RES, V85, P691; Teel EF, 2016, CLIN J SPORT MED, V26, P162, DOI 10.1097/JSM.0000000000000210; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wood TA, 2019, AM J PHYS MED REHAB, V98, P566, DOI 10.1097/PHM.0000000000001152	58	1	1	0	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	OCT	2021	51	10					2209	2220		10.1007/s40279-021-01472-3		APR 2021	12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	UX4BC	WOS:000642067800001	33881749				2022-02-06	
J	Ryu, J; Stone, P; Lee, S; Payne, B; Gorse, K; Lafrenaye, A				Ryu, Jane; Stone, Phillip; Lee, Sabrina; Payne, Brighton; Gorse, Karen; Lafrenaye, Audrey			Buprenorphine alters microglia and astrocytes acutely following diffuse traumatic brain injury	SCIENTIFIC REPORTS			English	Article							SUSTAINED-RELEASE BUPRENORPHINE; INTRACRANIAL-PRESSURE; OPIOID RECEPTOR; INCISIONAL PAIN; AXONAL INJURY; ACTIVATION; MODEL; RATS; PHARMACOKINETICS; ANALGESIA	Traumatic brain injury (TBI) is a common phenomenon, accounting for significant cost and adverse health effects. While there is information about focal pathologies following TBI, knowledge of more diffuse processes is lacking, particularly regarding how analgesics affect this pathology. As buprenorphine is the most commonly used analgesic in experimental TBI models, this study investigated the acute effects of the opioid analgesic buprenorphine (Bup-SR-Lab) on diffuse neuronal/glial pathology, neuroinflammation, cell damage, and systemic physiology. We utilized a model of central fluid percussion injury (CFPI) in adult male rats treated with a single subcutaneous bolus of Bup-SR-Lab or saline 15 min post-injury. Microscopic assessments were performed at 1 day post-injury. Cell impermeable dextran was infused intraventricularly prior to sacrifice to assess neuronal membrane disruption. Axonal injury was assessed by investigating labeling of the anterogradely transported amyloid precursor protein. Neuroinflammation was assessed by analyzing Iba-1+microglial and GFAP+astrocyte histological/morphological features as well as cytokine levels in both regions of interest (ROIs). Myelin pathology was assessed by evaluating the expression of myelin basic protein (MBP) and the propensity of MBP+myelin debris. Acute physiologic data showed no difference between groups except for reduction in weight loss following cFPI in Bup treated animals compared to saline. There were no discernable differences in axonal injury or membrane disruption between treatment groups. Cytokine levels were consistent between Bup and saline treated animals, however, microglia and astrocytes revealed region specific histological changes at 1d following Bup treatment. Myelin integrity and overall MBP expression showed no differences between Bup and saline treated animals, but there were significant regional differences in MBP expression between the cortex and thalamus. These data suggest effects of Bup treatment on weight following CFPI and potential regional specificity of Bup-associated microglial and astrocyte alterations, but very little change in other acute pathology at 1-day post-injury. Overall, this preliminary study indicates that use of Bup-SR-Lab in preclinical work does have effects on acute glial pathology, however, longer term studies will be needed to assess potential effects of Bup treatment on more chronic pathological progressions.	[Ryu, Jane; Stone, Phillip; Gorse, Karen; Lafrenaye, Audrey] Virginia Commonwealth Univ, 1101 E Marshall St,Box 980709, Richmond, VA 23298 USA; [Lee, Sabrina] Godwin High Sch, Henrico, VA USA; [Payne, Brighton] Univ Mary Washington, Fredericksburg, VA USA		Lafrenaye, A (corresponding author), Virginia Commonwealth Univ, 1101 E Marshall St,Box 980709, Richmond, VA 23298 USA.	Audrey.lafrenaye@vcuhealth.org			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS096143]	The authors would like to recognize Judy Williamson, Frances White and Susan Walker for invaluable technical assistance. This work was supported by NINDS grant 1R01NS096143.	Akiyama K, 2002, J NEUROSCI RES, V68, P19, DOI 10.1002/jnr.10188; Benson C., 2014, ENCY NEUROLOGICAL SC, V2nd, P998, DOI [10.1016/B978-0-12-385157-4.00326-2, DOI 10.1016/B978-0-12-385157-4.00326-2]; BOAS RA, 1985, BRIT J ANAESTH, V57, P192, DOI 10.1093/bja/57.2.192; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brown S.M., 2011, ARE BIOLOGICALLY ACT; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Carranza-Aguilar CJ, 2020, CELL MOL NEUROBIOL, DOI 10.1007/s10571-020-00957-5; Carroll FI, 2013, J MED CHEM, V56, P2178, DOI 10.1021/jm301783x; Chum HH, 2014, J AM ASSOC LAB ANIM, V53, P193; Clement T, 2020, GLIA, V68, P528, DOI 10.1002/glia.23736; Cooper CS, 2009, J AM ASSOC LAB ANIM, V48, P279; Corkrum M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060586; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Dahan A, 2005, BRIT J ANAESTH, V94, P825, DOI 10.1093/bja/aei145; Dahan A, 2006, BRIT J ANAESTH, V96, P627, DOI 10.1093/bja/ael051; DeClue AE, 2014, VET J, V200, P270, DOI 10.1016/j.tvjl.2014.02.019; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dooley SB, 2017, AM J VET RES, V78, P321, DOI 10.2460/ajvr.78.3.321; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000410; Elkader A, 2005, CLIN PHARMACOKINET, V44, P661, DOI 10.2165/00003088-200544070-00001; Falcon E, 2016, NEUROPSYCHOPHARMACOL, V41, P2344, DOI 10.1038/npp.2016.38; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Felix NM, 2017, IRAN J BASIC MED SCI, V20, P368, DOI 10.22038/IJBMS.2017.8576; Foley PL, 2011, J AM ASSOC LAB ANIM, V50, P198; Franchi S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02914; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gerhold KJ, 2015, J NEUROSCI, V35, P9580, DOI 10.1523/JNEUROSCI.0731-14.2015; Gorse KM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00778; Greenwald MK, 2014, DRUG ALCOHOL DEPEN, V144, P1, DOI 10.1016/j.drugalcdep.2014.07.035; Guarnieri M, 2012, LAB ANIMAL, V41, P337, DOI 10.1038/laban.152; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hernandez ML, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01238; Ilback NG, 2008, LAB ANIM-UK, V42, P149, DOI 10.1258/la.2007.06002e; Jantzie LL, 2020, BRAIN BEHAV IMMUN, V84, P45, DOI 10.1016/j.bbi.2019.11.007; Johnson RA, 2016, J AM ASSOC LAB ANIM, V55, P306; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; JONES MKS, 1995, NEUROSCI LETT, V185, P91; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kendall LV, 2014, J AM ASSOC LAB ANIM, V53, P478; Lafrenaye AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70266-w; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Li Z, 2020, J PAIN RES, V13, P1803, DOI 10.2147/JPR.S255221; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Martin-Flores M, 2017, J AM ASSOC LAB ANIM, V56, P155; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Murphy A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02445; Muscat SM, 2021, NEUROBIOL AGING, V98, P214, DOI 10.1016/j.neurobiolaging.2020.11.008; National Institutes of Health, 2013, OFF LAB AN WELF, V2002; National Research Council, 2011, GUIDE LABORATORY ANI; Ortiz-Prado E, 2020, NEUROEPIDEMIOLOGY, V54, P33, DOI 10.1159/000502580; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prado GR, 2020, NEUROSCI INSIGHTS, V15, DOI 10.1177/2633105520946090; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Sanchez ES, 2008, GLIA, V56, P1017, DOI 10.1002/glia.20675; Seymour TL, 2016, J AM ASSOC LAB ANIM, V55, P300; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Staib-Lasarzik I, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0531-7; Sun J, 2017, EUR CYTOKINE NETW, V28, P85, DOI 10.1684/ecn.2017.0392; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Velazquez A, 2015, BRAIN INJURY, V29, P1126, DOI 10.3109/02699052.2015.1018325; Vestal-Laborde AA, 2014, DEV NEUROSCI-BASEL, V36, P409, DOI 10.1159/000365074; VILLIGER JW, 1981, LIFE SCI, V29, P2699, DOI 10.1016/0024-3205(81)90529-4; Web Soil Survey, 2019, HOME; Welsh Christopher, 2005, Psychiatry (Edgmont), V2, P29; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wu FX, 2019, ANESTH ANALG, V128, P1328, DOI 10.1213/ANE.0000000000003365; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	1	1	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 21	2021	11	1							8620	10.1038/s41598-021-88030-z			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RT0YP	WOS:000644194200056	33883663	Green Published, gold, Green Submitted			2022-02-06	
J	Wang, Z; Winans, NJ; Zhao, ZR; Cosgrove, ME; Gammel, T; Saadon, JR; Mani, R; Ravi, B; Fiore, SM; Mikell, CB; Mofakham, S				Wang, Zhe; Winans, Nathan J.; Zhao, Zirun; Cosgrove, Megan E.; Gammel, Theresa; Saadon, Jordan R.; Mani, Racheed; Ravi, Bharadwaj; Fiore, Susan M.; Mikell, Charles B.; Mofakham, Sima			Agitation Following Severe Traumatic Brain Injury Is a Clinical Sign of Recovery of Consciousness	FRONTIERS IN SURGERY			English	Article						severe traumatic brain injury; coma; posttraumatic agitation; recovery of consciousness; antipsychotics		Objective: Severe traumatic brain injury (sTBI) often results in disorders of consciousness. Patients emerging from coma frequently exhibit aberrant behaviors such as agitation. These non-purposeful combative behaviors can interfere with medical care. Interestingly, agitation is associated with arousal and is often among the first signs of neurological recovery. A better understanding of these behaviors may shed light on the mechanisms driving the return of consciousness in sTBI patients. This study aims to investigate the association between posttraumatic agitation and the recovery of consciousness. Methods: A retrospective chart review was conducted in 530 adult patients (29.1% female) admitted to Stony Brook University Hospital between January 2011 and December 2019 with a diagnosis of sTBI and Glasgow Coma Scale (GCS) <= 8. Agitation was defined as a Richmond Agitation Sedation Scale (RASS) > +1, or any documentation of equivalently combative and violent behaviors in daily clinical notes. The ability to follow verbal commands was used to define the recovery of consciousness and was assessed daily. Results: Of 530 total sTBI patients, 308 (58.1%) survived. Agitation was present in 169 of all patients and 162 (52.6%) of surviving patients. A total of 273 patients followed commands, and 159 of them developed agitation. Forty patients developed agitation on hospital arrival whereas 119 developed agitation later during their hospital course. Presence of in-hospital agitation positively correlated with command-following (r = 0.315, p < 0.001). The time to develop agitation and time to follow commands showed positive correlation (r = 0.485, p < 0.001). These two events occurred within 3 days in 54 (44.6%) patients, within 7 days in 81 (67.8%) patients, and within 14 days in 96 (80.2%) patients. In 71 (59.7%) patients, agitation developed before command-following; in 36 (30.2%) patients, agitation developed after command-following; in 12 (10.1%) patients, agitation developed on the same day as command-following. Conclusion: Posttraumatic agitation in comatose patients following sTBI is temporally associated with the recovery of consciousness. This behavior indicates the potential for recovery of higher neurological functioning. Further studies are required to identify neural correlates of posttraumatic agitation and recovery of consciousness after sTBI.	[Wang, Zhe; Winans, Nathan J.; Zhao, Zirun; Cosgrove, Megan E.; Gammel, Theresa; Saadon, Jordan R.; Mani, Racheed; Fiore, Susan M.; Mikell, Charles B.; Mofakham, Sima] SUNY Stony Brook, Renaissance Sch Med, Dept Neurol Surg, Stony Brook, NY 11794 USA; [Winans, Nathan J.] Columbia Univ, Dept Neurol Surg, Med Ctr, New York, NY USA; [Ravi, Bharadwaj] SUNY Stony Brook, Dept Neurobiol, Renaissance Sch Med, Stony Brook, NY USA		Mofakham, S (corresponding author), SUNY Stony Brook, Renaissance Sch Med, Dept Neurol Surg, Stony Brook, NY 11794 USA.	sima.mofakham@stonybrookmedicine.edu			Growing Convergence Research program (NSF) [2021002]; Office of the Vice President for Research at Stony Brook University; Renaissance School of Medicine at Stony Brook University [63845]	This work was supported by the Growing Convergence Research program (NSF Award 2021002). A SEED grant funding from the Office of the Vice President for Research at Stony Brook University. A FUSION-TRO award (63845) from the Renaissance School of Medicine at Stony Brook University.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Arciniegas DB, 2008, CRIT CARE CLIN, V24, P737, DOI 10.1016/j.ccc.2008.06.001; Asmar S, 2020, J TRAUMA ACUTE CARE, V89, P775, DOI 10.1097/TA.0000000000002866; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Deb S, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2601-z; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Ganau M, 2018, MINERVA ANESTESIOL, V84, P632, DOI 10.23736/S0375-9393.18.12294-2; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gramish JA, 2017, CLIN NEUROPHARMACOL, V40, P212, DOI 10.1097/WNF.0000000000000242; Herling Suzanne Forsyth, 2018, Cochrane Database Syst Rev, V11, pCD009783, DOI 10.1002/14651858.CD009783.pub2; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mahmood S, 2018, WORLD J EMERG MED, V9, P105, DOI 10.5847/wjem.j.1920-8642.2018.02.004; Maldonado JR, 2018, INT J GERIATR PSYCH, V33, P1428, DOI 10.1002/gps.4823; Martens G, 2020, ANN PHYS REHABIL MED, V63, P263, DOI 10.1016/j.rehab.2019.10.004; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Nikooie R, 2019, ANN INTERN MED, V171, P485, DOI 10.7326/M19-1860; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Phyland RK, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04553-2; Pouwels C G J G, 2019, Tijdschr Psychiatr, V61, P862; Rosati DL, 2002, AM J PHYS MED REHAB, V81, P90, DOI 10.1097/00002060-200202000-00003; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604; Wilson MP, 2012, WEST J EMERG MED, V13, P26, DOI 10.5811/westjem.2011.9.6866; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB	36	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	APR 21	2021	8								627008	10.3389/fsurg.2021.627008			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	RX1XO	WOS:000647014300001	33968974	Green Published, gold			2022-02-06	
J	Duhaut, DE; Heurteaux, C; Gandin, C; Ichai, C; Quintard, H				Duhaut, David Emmanuel; Heurteaux, Catherine; Gandin, Carine; Ichai, Carole; Quintard, Herve			The Antiedematous Effect of Exogenous Lactate Therapy in Traumatic Brain Injury: A Physiological and Mechanistic Approach	NEUROCRITICAL CARE			English	Article						Lactate sodium; Brain edema; Aquaporin; K&#8211; Cl transporter		Background Sodium lactate (SL) has been described as an efficient therapy in treating raised intracranial pressure (ICP). However, the precise mechanism by which SL reduces intracranial hypertension is not well defined. An antiedematous effect has been proposed but never demonstrated. In this context, the involvement of chloride channels, aquaporins, or K-Cl cotransporters has also been suggested, but these mechanisms have never been assessed when using SL. Methods In a rat model of traumatic brain injury (TBI), we compared the effect of SL versus mannitol 20% on ICP, cerebral tissue oxygen pressure, and brain water content. We attempted to clarify the involvement of chloride channels in the antiedematous effects associated with lactate therapy in TBI. Results An equimolar single bolus of SL and mannitol significantly reduced brain water content and ICP and improved cerebral tissue oxygen pressure 4 h after severe TBI. The effect of SL on brain water content was much longer than that of mannitol and persisted at 24 h post TBI. Western blot and immunofluorescence staining analyses performed 24 h after TBI revealed that SL infusion is associated with an upregulation of aquaporin 4 and K-Cl cotransporter 2. Conclusions SL is an effective therapy for treating brain edema after TBI. This study suggests, for the first time, the potential role of chloride channels in the antiedematous effect induced by exogenous SL.	[Duhaut, David Emmanuel] CHU Nice, Hosp Pasteur 2, Intens Care Unit, Nice, France; [Duhaut, David Emmanuel; Heurteaux, Catherine; Gandin, Carine; Ichai, Carole; Quintard, Herve] Inst Pharmacol Mol & Cellulaire, UMR7275, Valbonne, France; [Quintard, Herve] Hop Univ Geneve, Intens Care Unit, Geneva, Switzerland		Quintard, H (corresponding author), Hop Univ Geneve, Intens Care Unit, Geneva, Switzerland.	herve.quintard@hcuge.ch			Universite de Geneve	Open Access funding provided by Universite de Geneve.	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bisri Tatang, 2016, Asian J Neurosurg, V11, P151, DOI 10.4103/1793-5482.145375; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Carteron L, 2018, CRIT CARE MED, V46, P1649, DOI 10.1097/CCM.0000000000003274; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glykys J, 2017, TRENDS NEUROSCI, V40, P276, DOI 10.1016/j.tins.2017.03.006; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2015, TRENDS MOL MED, V21, P513, DOI 10.1016/j.molmed.2015.05.008; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; Millet A, 2018, BRIT J ANAESTH, V120, P1295, DOI 10.1016/j.bja.2018.01.025; Mongin AA, 2016, PFLUG ARCH EUR J PHY, V468, P421, DOI 10.1007/s00424-015-1765-6; Oddo M, 2018, INTENS CARE MED, V44, P449, DOI 10.1007/s00134-018-5086-z; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Schilte C, 2015, CRIT CARE MED, V43, P2212, DOI 10.1097/CCM.0000000000001137; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Somasetia DH, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0466-4; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Zhu L, 2005, J NEUROPHYSIOL, V93, P1557, DOI 10.1152/jn.00616.2004	41	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2021	35	3					747	755		10.1007/s12028-021-01219-y		APR 2021	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	XS0FS	WOS:000641663800001	33880700	hybrid, Green Published			2022-02-06	
J	Nonaka, M; Taylor, WW; Bukalo, O; Tucker, LB; Fu, AH; Kim, Y; McCabe, JT; Holmes, A				Nonaka, Mio; Taylor, William W.; Bukalo, Olena; Tucker, Laura B.; Fu, Amanda H.; Kim, Yeonho; McCabe, Joseph T.; Holmes, Andrew			Behavioral and Myelin-Related Abnormalities after Blast-Induced Mild Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						blast; fear learning; mTBI; myelin; nodes of Ranvier		In civilian and military settings, mild traumatic brain injury (mTBI) is a common consequence of impacts to the head, sudden blows to the body, and exposure to high-energy atmospheric shockwaves from blast. In some cases, mTBI from blast exposure results in long-term emotional and cognitive deficits and an elevated risk for certain neuropsychiatric diseases. Here, we tested the effects of mTBI on various forms of auditory-cued fear learning and other measures of cognition in male C57BL/6J mice after single or repeated blast exposure (blast TBI; bTBI). bTBI produced an abnormality in the temporal organization of cue-induced freezing behavior in a conditioned trace fear test. Spatial working memory, evaluated by the Y-maze task performance, was also deleteriously affected by bTBI. Reverse-transcription quantitative real-time polymerase chain reaction (RT-qPCR) analysis for glial markers indicated an alteration in the expression of myelin-related genes in the hippocampus and corpus callosum 1-8 weeks after bTBI. Immunohistochemical and ultrastructural analyses detected bTBI-related myelin and axonal damage in the hippocampus and corpus callosum. Together, these data suggest a possible link between blast-induced mTBI, myelin/axonal injury, and cognitive dysfunction.	[Nonaka, Mio; Taylor, William W.; Bukalo, Olena; Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, NIH, 5625 Fishers Lane Room 2N09, Rockville, MD 20852 USA; [Tucker, Laura B.; Fu, Amanda H.; Kim, Yeonho; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Tucker, Laura B.; Fu, Amanda H.; Kim, Yeonho; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Preclin Studies Core, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Nonaka, M (corresponding author), NIAAA, Lab Behav & Genom Neurosci, NIH, 5625 Fishers Lane Room 2N09, Rockville, MD 20852 USA.	nonaka@m.u-tokyo.ac.jp	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399; Nonaka, Mio/0000-0002-3492-6659	Nebraska Research Initiative (NRI); University of Nebraska Foundation; Office of the Vice-Chancellor for Research; NIAAA Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Henry Jackson Foundation for the Advancement of Military Medicine; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [306136-16.01-6085a5]; Uehara Memorial FoundationUehara Memorial Foundation; Japan Society for Promotion of Science (RPD program)	The EMCF is supported by state funds from the Nebraska Research Initiative (NRI) and the University of Nebraska Foundation, and institutionally by the Office of the Vice-Chancellor for Research.; A.H. is supported by the NIAAA Intramural Research Program, and A.H. and J.T.M. are funded by the Henry Jackson Foundation for the Advancement of Military Medicine and the Department of Defense in the Center for Neuroscience and Regenerative Medicine (306136-16.01-6085a5). M.N. is supported by the Uehara Memorial Foundation and Japan Society for Promotion of Science (RPD program).	Aggarwal S, 2011, DEV CELL, V21, P445, DOI 10.1016/j.devcel.2011.08.001; Arancibia-Carcamo IL, 2017, ELIFE, V6, DOI 10.7554/eLife.23329; Aravind A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00990; Auer F, 2018, CURR BIOL, V28, P549, DOI 10.1016/j.cub.2018.01.017; Badea A, 2018, NEUROIMAGE-CLIN, V18, P60, DOI 10.1016/j.nicl.2018.01.007; Baker W.E., 1973, EXPLOSIONS AIR; Barak B, 2019, NAT NEUROSCI, V22, P700, DOI 10.1038/s41593-019-0380-9; Bekku Y, 2010, J NEUROSCI, V30, P3113, DOI 10.1523/JNEUROSCI.5598-09.2010; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Blaze J, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00160; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Bukalo O, 2021, BEHAV BRAIN RES, V396, DOI 10.1016/j.bbr.2020.112913; Bukalo O, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500251; Burman MA, 2014, J NEUROSCI METH, V222, P111, DOI 10.1016/j.jneumeth.2013.11.005; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Corne R, 2019, PROG NEURO-PSYCHOPH, V88, P276, DOI 10.1016/j.pnpbp.2018.07.023; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dennis EL, 2018, I S BIOMED IMAGING, P1386, DOI 10.1109/ISBI.2018.8363830; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Dutta DJ, 2018, P NATL ACAD SCI USA, V115, P11832, DOI 10.1073/pnas.1811013115; Elder G.A., 2021, J NEUROTRAUM, DOI [10.1089/neu.2020.7398, DOI 10.1089/NEU.2020.7398]; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Feyder M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08.004.2007, 10.3389/neuro.08/004.2007]; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Green AJ, 2017, LANCET, V390, P2481, DOI 10.1016/S0140-6736(17)32346-2; GUNDUZCINAR O, 2018, MOL PSYCHIATR, V36, P1, DOI DOI 10.1038/S41380-017-0003-3; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; HILDEBRAND C, 1986, J NEUROCYTOL, V15, P681, DOI 10.1007/BF01625187; Hubler Z, 2018, NATURE, V560, P372, DOI 10.1038/s41586-018-0360-3; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Jaiswal S, 2019, BRAIN RES, V1723, DOI 10.1016/j.brainres.2019.146400; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kontos Anthony P, 2015, J Trauma Acute Care Surg, V79, pS146, DOI 10.1097/TA.0000000000000667; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Marinelli C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00027; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mendez MF, 2013, BRAIN INJURY, V27, P10, DOI 10.3109/02699052.2012.722252; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miyata S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23084; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Najm FJ, 2015, NATURE, V522, P216, DOI 10.1038/nature14335; Nawarawong NN, 2019, EUR J NEUROSCI, V50, P2101, DOI 10.1111/ejn.14281; Pan S, 2020, NAT NEUROSCI, V23, P487, DOI 10.1038/s41593-019-0582-1; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Ratliff WA, 2019, EXP NEUROL, V315, P9, DOI 10.1016/j.expneurol.2019.01.020; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Ritzel D.V., 2011, DJJD; ROSENBLUTH J, 1966, J CELL BIOL, V28, P73, DOI 10.1083/jcb.28.1.73; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sanderson DJ, 2009, LEARN MEMORY, V16, P379, DOI 10.1101/lm.1339109; Sangobowale M, 2018, NEUROSCI LETT, V682, P16, DOI 10.1016/j.neulet.2018.06.010; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwartz I, 2008, BRAIN INJURY, V22, P255, DOI 10.1080/02699050801941763; Seo DO, 2015, J NEUROSCI, V35, P11330, DOI 10.1523/JNEUROSCI.0483-15.2015; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Silva AI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11119-7; Singewald N, 2019, PSYCHOPHARMACOLOGY, V236, P21, DOI 10.1007/s00213-018-5054-x; Singh AK, 2016, RADIOGRAPHICS, V36, P295, DOI 10.1148/rg.2016150114; Steadman PE, 2020, NEURON, V105, P150, DOI 10.1016/j.neuron.2019.10.013; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; TRAPP BD, 1988, J NEUROCHEM, V51, P859, DOI 10.1111/j.1471-4159.1988.tb01822.x; Vu PA, 2018, BRAIN RES, V1700, P138, DOI 10.1016/j.brainres.2018.08.034; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Wang F, 2020, NAT NEUROSCI, V23, P481, DOI 10.1038/s41593-020-0588-8; Weiss C, 2020, SHOCK, V53, P744, DOI 10.1097/SHK.0000000000001424; Welliver RR, 2018, J NEUROSCI, V38, P6921, DOI 10.1523/JNEUROSCI.1862-17.2018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	100	1	1	9	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2021	38	11					1551	1571		10.1089/neu.2020.7254		APR 2021	21	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SL0LA	WOS:000641797500001	33605175				2022-02-06	
J	Piantino, J; Schwartz, DL; Luther, M; Newgard, C; Silbert, L; Raskind, M; Pagulayan, K; Kleinhans, N; Iliff, J; Peskind, E				Piantino, Juan; Schwartz, Daniel L.; Luther, Madison; Newgard, Craig; Silbert, Lisa; Raskind, Murray; Pagulayan, Kathleen; Kleinhans, Natalia; Iliff, Jeffrey; Peskind, Elaine			Link between Mild Traumatic Brain Injury, Poor Sleep, and Magnetic Resonance Imaging: Visible Perivascular Spaces in Veterans	JOURNAL OF NEUROTRAUMA			English	Article						all sleep disorders; brain trauma; glymphatic; MRI; perivascular spaces		Impaired clearance of perivascular waste in the brain may play a critical role in morbidity after mild traumatic brain injury (mTBI). We aimed to determine the effect of mTBI on the burden of magnetic resonance imaging (MRI)-visible perivascular spaces (PVSs) in a cohort of U.S. military veterans and whether sleep modulates this effect. We also investigated the correlation between PVS burden and severity of persistent post-concussive symptoms. Fifty-six Iraq/Afghanistan veterans received 3 Tesla MRI as part of a prospective cohort study on military blast mTBI. White matter PVS burden (i.e., number and volume) was calculated using an established automated segmentation algorithm. Multi-variate regression was used to establish the association between mTBIs sustained in the military and PVS burden. Covariates included age, blood pressure, number of impact mTBIs outside the military, and blast exposures. Correlation coefficients were calculated between PVS burden and severity of persistent post-concussive symptoms. There was a significant positive relationship between the number of mTBIs sustained in the military and both PVS number and volume (p = 0.04). A significant interaction was found between mTBI and poor sleep on PVS volume (p = 0.04). A correlation was found between PVS number and volume, as well as severity of postconcussive symptoms (p = 0.03). Further analysis revealed a moderate correlation between PVS number and volume, as well as balance problems (p < 0.001). In Iraq/Afghanistan veterans, mTBI is associated with an increase in PVS burden. Further, an interaction exists between mTBI and poor sleep on PVS burden. Increased PVS burden, which may indicate waste clearance dysfunction, is associated with persistent post-concussive symptom severity.	[Piantino, Juan; Luther, Madison] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Dept Pediat, Div Child Neurol, Portland, OR 97239 USA; [Schwartz, Daniel L.; Silbert, Lisa] Oregon Hlth & Sci Univ, Layton Aging & Alzheimers Dis Ctr, Neurol, Portland, OR 97239 USA; [Schwartz, Daniel L.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97239 USA; [Newgard, Craig] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Dept Emergency Med, Portland, OR 97239 USA; [Silbert, Lisa] Portland VA Med Ctr, Neurol, Portland, OR USA; [Raskind, Murray; Pagulayan, Kathleen; Iliff, Jeffrey; Peskind, Elaine] Vet Affairs Puget Sound Hlth Care Syst, Vet Affairs Northwest Network Mental Illness Res, Seattle, WA USA; [Raskind, Murray; Pagulayan, Kathleen; Iliff, Jeffrey; Peskind, Elaine] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Kleinhans, Natalia] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98195 USA; [Iliff, Jeffrey] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA		Piantino, J (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Div Child Neurol, Doernbecher Childrens Hosp,CDRC P, 707 Southwest Gaines St, Portland, OR 97239 USA.	piantino@ohsu.edu	Pagulayan, Kati/AAR-9225-2020		National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL150217-01]; Department of Veterans Affairs Rehabilitation Research and Development Service Merit ReviewUS Department of Veterans Affairs [B77421]; National Institute of Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG066518]	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI; K23HL150217-01), Department of Veterans Affairs Rehabilitation Research and Development Service Merit Review grant B77421, and National Institute of Aging (NIA; AG066518).	Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Belanger HG, 2017, J HEAD TRAUMA REHAB, V32, P46, DOI 10.1097/HTR.0000000000000208; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; BENHAIEMSIGAUX N, 1987, STROKE, V18, P1087, DOI 10.1161/01.STR.18.6.1087; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Boespflug EL, 2018, RADIOLOGY, V286, P632, DOI 10.1148/radiol.2017170205; Brown R, 2018, CARDIOVASC RES, V114, P1462, DOI 10.1093/cvr/cvy113; Buysse D J, 1989, Psychiatry Res, V28, P193; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Charidimou A, 2014, NEUROLOGY, V82, P57, DOI 10.1212/01.wnl.0000438225.02729.04; Christensen J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63022-7; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Ding J, 2017, JAMA NEUROL, V74, P1105, DOI 10.1001/jamaneurol.2017.1397; Francis F, 2019, INT J STROKE, V14, P359, DOI 10.1177/1747493019830321; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; HEIER LA, 1989, AM J NEURORADIOL, V10, P929; HIRABUKI N, 1994, AM J NEURORADIOL, V15, P277; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holfelder K, 2011, HISTOL HISTOPATHOL, V26, P1007, DOI 10.14670/HH-26.1007; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Iliff Jeffrey J, 2012, Sci Transl Med, V4, p147ra111, DOI 10.1126/scitranslmed.3003748; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; JUNGREIS CA, 1988, RADIOLOGY, V169, P101, DOI 10.1148/radiology.169.1.3420242; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lundgaard I, 2017, J CEREBR BLOOD F MET, V37, P2112, DOI 10.1177/0271678X16661202; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Opel RA, 2019, J CEREBR BLOOD F MET, V39, P2258, DOI 10.1177/0271678X18791632; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Parrington L, 2019, J ATHL TRAINING, V54, P429, DOI 10.4085/1062-6050-46-18; Patankar TF, 2005, AM J NEURORADIOL, V26, P1512; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Potter GM, 2015, CEREBROVASC DIS, V39, P224, DOI 10.1159/000375153; Promjunyakul N, 2015, NEUROIMAGE-CLIN, V8, P224, DOI 10.1016/j.nicl.2015.04.012; PULLICINO PM, 1995, STROKE, V26, P1598, DOI 10.1161/01.STR.26.9.1598; Ramirez J, 2015, J ALZHEIMERS DIS, V43, P415, DOI 10.3233/JAD-132528; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schwartz DL, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116126; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	52	1	1	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2021	38	17					2391	2399		10.1089/neu.2020.7447		APR 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UK1GM	WOS:000642474400001	33599176				2022-02-06	
J	Roberts, I; Brenner, A; Shakur-Still, H				Roberts, Ian; Brenner, Amy; Shakur-Still, Haleema			Tranexamic Acid Treatment for Trauma Victims	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						hemorrhage; trauma; traumatic brain injury; tranexamic acid; fibrinolysis		Worldwide, traumatic injury is responsible for over 5 million deaths per year, the majority due to exsanguination and head injury. The antifibrinolytic drug tranexamic acid is the only drug proven to reduce deaths after traumatic injury. Several large randomized controlled trials have provided high-quality evidence of its effectiveness and safety in trauma patients. Early tranexamic acid reduces deaths on the day of the injury in polytrauma patients and patients with isolated traumatic brain injury by around 20%. Treatment is time critical; for patients to benefit, tranexamic acid must be given as soon as possible after injury. Intramuscular administration is well tolerated and rapidly absorbed, with the potential to reduce time to treatment. Because the proportional reduction in bleeding death with tranexamic acid does not vary by baseline risk, a wide range of trauma patients stands to benefit. There are far more low-risk trauma patients than high-risk patients, with a substantial proportion of bleeding deaths in the low-risk group. As such, treatment should not be limited to patients with severe traumatic hemorrhage. We must give paramedics and physicians the confidence to treat a far wider range of trauma patients while emphasizing the importance of early treatment.	[Roberts, Ian; Brenner, Amy; Shakur-Still, Haleema] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England		Roberts, I (corresponding author), London Sch Hyg & Trop Med, Room 814,Keppel St, London WC1E 7HT, England.	Ian.Roberts@lshtm.ac.uk	Brenner, Amy/ABB-8133-2021		MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); NIHRNational Institute for Health Research (NIHR); Wellcome TrustWellcome TrustEuropean Commission; Charitable Trusts	I.R. reports grants from MRC, NIHR, Wellcome Trust, and Charitable Trusts, during the conduct of the study.	Ageron FX, 2020, BRIT J ANAESTH, V124, P676, DOI 10.1016/j.bja.2020.01.020; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Brenner A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03243-4; ClinicalTrials.gov, STUD TRAN AC AIR GRO; Clinicaltrials.gov, PERIOPERATIVE ISCHEM; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; Grassin-Delyle S, 2021, BRIT J ANAESTH, V126, P201, DOI 10.1016/j.bja.2020.07.058; Gruen RL, 2013, MED J AUSTRALIA, V199, P310, DOI 10.5694/mja13.10747; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Marsden MER, 2019, EMERG MED J, V36, P395, DOI 10.1136/emermed-2018-208118; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Okamoto S., 1962, AMINO METHYL CYCLOHE; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0685-8; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	26	1	1	1	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	JUL	2021	47	05					520	526		10.1055/s-0041-1725097		APR 2021	7	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	TC0DV	WOS:000641548400006	33878785				2022-02-06	
J	Mejia-Lancheros, C; Lachaud, J; Aubry, T; Wiens, K; O'Campo, P; Stergiopoulos, V; Hwang, SW				Mejia-Lancheros, Cilia; Lachaud, James; Aubry, Tim; Wiens, Kathryn; O'Campo, Patricia; Stergiopoulos, Vicky; Hwang, Stephen W.			Multi-trajectory group profiles of well-being and associated predictors among adults experiencing homelessness and mental illness: findings from the At Home/Chez Soi study, Toronto site	SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY			English	Article						Homeless person; Metal illness; Housing stability; Quality of life; Well-being status		Purpose To conduct a multi-dimensional and time-patterned analysis to identify distinct well-being trajectory profiles over a 6-year follow-up period among adults experiencing homelessness and mental illness. Methods Data from 543 participants of the At Home Chez Soi study's Toronto site were examined over a 6-year follow-up period, including measures of quality of life, community functioning, housing stability, and substance use. Well-being trajectories were identified using Group-Based Trajectory Modelling. Multinomial regression was used to identify predictor variables that were associated with each well-being trajectory profile. Results Four well-being profiles were identified: low well-being, moderate well-being, good well-being, and high well-being. Factors associated with a greater likelihood of following a better well-being profile included receiving Housing First, reporting female gender and non-white ethnicity, having post-secondary studies, and reporting a high resilience level. Concurrently, factors associated with a lower likelihood of better well-being profiles were having a history of chronic homelessness, experiences of discrimination in the healthcare setting, having comorbid mental disorders and a high level of symptom severity, and reporting a history of traumatic brain injury and childhood adversity. Conclusions Individuals experiencing homelessness follow distinct well-being profiles associated with their socio-demographic characteristics, health status, trauma history, resilience capabilities, and access to housing and support services. This work can inform integrated housing and support services to enhance the well-being trajectories of individuals experiencing homelessness.	[Mejia-Lancheros, Cilia; Lachaud, James; Wiens, Kathryn; O'Campo, Patricia; Hwang, Stephen W.] Unity Hlth Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, 30 Bonds St, Toronto, ON M5B 1W8, Canada; [Aubry, Tim] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [O'Campo, Patricia] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Stergiopoulos, Vicky] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Stergiopoulos, Vicky] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Div Gen Internal Med, Dept Med, Toronto, ON, Canada		Mejia-Lancheros, C (corresponding author), Unity Hlth Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, 30 Bonds St, Toronto, ON M5B 1W8, Canada.	Cilia.Mejia-Lancheros@unityhealth.to	Aubry, Tim/ABB-9932-2021	Aubry, Tim/0000-0002-6204-3773; Mejia-Lancheros, Cilia/0000-0003-1131-8439	Mental Health Commission of Canada; Ontario Ministry of Health and Long-Term Care (HSRF) [259]; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR MOP-130405]; St. Michael's Hospital Research Training Centre Scholarship; Fellowship Award in Research and Knowledge Translation on Urban Housing and Health from the Canadian Institutes of Health Research-Institute of Population and PublicCanadian Institutes of Health Research (CIHR) [201910RAT-435231-65841]; Canada Mortgage and Housing Corporation	The Toronto site of the AH/CS study was funded by the Mental Health Commission of Canada, Ontario Ministry of Health and Long-Term Care (HSRF #259), and the Canadian Institute of Health Research (CIHR MOP-130405). The present study also received funding from St. Michael's Hospital Research Training Centre Scholarship awarded (2019) to Dr. Cilia Mejia-Lancheros. Dr. James Lachaud's work was supported by a Fellowship Award in Research and Knowledge Translation on Urban Housing and Health (201910RAT-435231-65841) from the Canadian Institutes of Health Research-Institute of Population and Public in partnership with Canada Mortgage and Housing Corporation. The funding institutions had no role in the study design, collection, analysis, and interpretation of the data or the preparation, revision, or approval of the present manuscript. The views expressed in this publication are the views of the authors.	Adair CE, 2017, CAN J PSYCHIAT, V62, P30, DOI 10.1177/0706743716645302; [Anonymous], 2010, NATL POPULATION HLTH; Aubry T, 2016, PSYCHIAT SERV, V67, P275, DOI 10.1176/appi.ps.201400587; Aubry T, 2015, CAN J PSYCHIAT, V60, P467, DOI 10.1177/070674371506001102; Aubry T, 2012, AM J COMMUN PSYCHOL, V49, P142, DOI 10.1007/s10464-011-9444-z; Austin EL, 2008, WOMEN HEALTH ISS, V18, P26, DOI 10.1016/j.whi.2007.08.005; BARKER S, 1994, COMMUNITY MENT HLT J, V30, P459, DOI 10.1007/BF02189063; Baxter AJ, 2019, J EPIDEMIOL COMMUN H, V73, P379, DOI 10.1136/jech-2018-210981; Bird M, 2017, J SOC DISTRESS HOMEL, V26, P9, DOI 10.1080/10530789.2016.1274570; Biswas-Diener R, 2006, SOC INDIC RES, V76, P185, DOI 10.1007/s11205-005-8671-9; Boothroyd RA, 2008, ADM POLICY MENT HLTH, V35, P370, DOI 10.1007/s10488-008-0179-6; Brown M, 2017, AM J COMMUN PSYCHOL, V59, P306, DOI 10.1002/ajcp.12140; Brown RT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221020; Coleman J, 2017, SOC WORK PUBLIC HLTH, V32, P154, DOI 10.1080/19371918.2016.1160345; Conrad K J, 2001, Ment Health Serv Res, V3, P141, DOI 10.1023/A:1011571531303; Dennis ML, 2006, AM J ADDICTION, V15, P80, DOI 10.1080/10550490601006055; Dodge R. A. P., 2012, INT J WELLBEING, V2, P222, DOI [10.5502/ijw.v2i3.4, 10.5502/ijw., DOI 10.5502/IJW.V2I3.4]; Duke A, 2019, ISSUES MENT HEALTH N, V40, P605, DOI 10.1080/01612840.2019.1565875; Eddings W, 2012, STATA J, V12, P353, DOI 10.1177/1536867X1201200301; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; FEANTSA, 2019, MAG FEANTSA 1 18; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferguson KM, 2015, SOC SCI MED, V135, P47, DOI 10.1016/j.socscimed.2015.04.028; Fleury MJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245088; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Gentil L, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00010; Gleason K, 2017, AM J COMMUN PSYCHOL, V59, P158, DOI 10.1002/ajcp.12128; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hahn RA, 2015, INT J HEALTH SERV, V45, P657, DOI 10.1177/0020731415585986; Herzog JI, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00420; Hughes NR, 2017, HEALTH CARE ANAL, V25, P90, DOI 10.1007/s10728-014-0283-6; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-787; Ito K, 2014, PSYCHIAT CLIN NEUROS, V68, P145, DOI 10.1111/pcn.12108; Jones BL, 2013, SOCIOL METHOD RES, V42, P608, DOI 10.1177/0049124113503141; Jones MM, 2016, WORLD MED HEALTH POL, V8, P139, DOI 10.1002/wmh3.189; Kertesz SG, 2005, MED CARE, V43, P574, DOI 10.1097/01.mlr.0000163652.91463.b4; Lehman AF, 1996, SOC PSYCH PSYCH EPID, V31, P78, DOI 10.1007/BF00801903; Lindert J, 2015, EUR J PUBLIC HEALTH, V25, P731, DOI 10.1093/eurpub/cku193; Linton MJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010641; Liu M, 2020, AM J PREV MED, V58, P807, DOI 10.1016/j.amepre.2019.12.017; Mejia-Lancheros C, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113463; Mejia-Lancheros C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229385; Monnat SM, 2015, SOCIOL QUART, V56, P723, DOI 10.1111/tsq.12107; Montgomery AE, 2017, WOMEN HEALTH ISS, V27, P256, DOI 10.1016/j.whi.2017.03.014; Nagin DS, 2018, STAT METHODS MED RES, V27, P2015, DOI 10.1177/0962280216673085; Nagin DS, 2005, GROUP BASED MODELING, DOI [10.4159/9780674041318, DOI 10.4159/9780674041318]; National Alliance to End Homelessness, 2019, STATE HOMELESSNESS; Nayyar D, 2015, CAN J CARDIOL, V31, P1130, DOI 10.1016/j.cjca.2015.04.011; Nilsson SF, 2019, J URBAN HEALTH, V96, P741, DOI 10.1007/s11524-019-00377-x; NORTH CS, 1994, SOC WORK, V39, P639; Padgett DK, 2016, PSYCHIAT SERV, V67, P609, DOI 10.1176/appi.ps.201500126; Patanwala M, 2018, J GEN INTERN MED, V33, P635, DOI 10.1007/s11606-017-4229-1; Patterson ML, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003442; Paul S, 2018, INT J SOC PSYCHIATR, V64, P189, DOI 10.1177/0020764017748986; Rich AR, 2005, EVAL PROGRAM PLANN, V28, P69, DOI 10.1016/j.evalprogplan.2004.05.003; Riley ED, 2007, J URBAN HEALTH, V84, P415, DOI 10.1007/s11524-006-9153-3; Roy E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2802-x; Rukmana D, 2020, HOUS POLICY DEBATE, V30, P291, DOI 10.1080/10511482.2019.1684334; Rutenfrans-Stupar M, 2019, SOC INDIC RES, V145, P329, DOI 10.1007/s11205-019-02099-8; Rutenfrans-Stupar M, 2019, J SOC DISTRESS HOMEL, V28, P44, DOI 10.1080/10530789.2018.1563267; Schmidt R, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.29778; Shankar S, 2019, QUAL HEALTH RES, V29, P1850, DOI 10.1177/1049732318798353; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Statistics Canada, 2008, CANADIAN COMMUNITY H; Stergiopoulos V, 2019, LANCET PSYCHIAT, V6, P915, DOI 10.1016/S2215-0366(19)30371-2; Stergiopoulos V, 2015, JAMA-J AM MED ASSOC, V313, P905, DOI 10.1001/jama.2015.1163; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Tsemberis S., 2015, PATHWAYS MODEL END H; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; Vaishnavi S, 2007, PSYCHIAT RES, V152, P293, DOI 10.1016/j.psychres.2007.01.006; Weiss MJS, 1998, AM J PREV MED, V14, P356; Western M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163345; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Winetrobe H, 2017, WOMEN HEALTH ISS, V27, P286, DOI 10.1016/j.whi.2016.12.011; Woodhall-Melnik J, 2018, CHILD ABUSE NEGLECT, V80, P216, DOI 10.1016/j.chiabu.2018.03.027	78	1	1	2	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-7954	1433-9285		SOC PSYCH PSYCH EPID	Soc. Psychiatry Psychiatr. Epidemiol.	JAN	2022	57	1					67	81		10.1007/s00127-021-02093-x		APR 2021	15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	YH1DZ	WOS:000640830200001	33866385	Green Published, hybrid			2022-02-06	
J	Qu, XG; Zhang, ZH; Xu, XY; Wang, JH; Lei, C; Zhou, GS; Wu, W; Huang, L; Chen, X; Yu, S; Wang, T				Qu, Xingguang; Zhang, Zhaohui; Xu, Xiaoyun; Wang, Jiahui; Lei, Chao; Zhou, Gaosheng; Wu, Wen; Huang, Lin; Chen, Xing; Yu, Su; Wang, Tao			Selective sphingosine-1-phosphate receptor 1 modulation ameliorates TBI-induced neurological deficit after CCI	NEUROSCIENCE LETTERS			English	Article						TBI; RP101075; Neurological deficit; Cognitive dysfunction		Background and Purpose: The inflammatory response after traumatic brain injury (TBI) can contribute to secondary brain injury. RP101075, a sphingosine-1-phosphate receptor modulator, can attenuate various inflammatory responses. Here, we hypothesized that consecutive administration of RP101075 over 3 days could broadly suppress the TBI-induced inflammatory response and ameliorate the outcomes of TBI. Methods and Results: Young C57/BL6 mice were subjected to a controlled cortical impact (CCI) model. RP101075-treated mice exhibited significantly reduced scores on the modified neurological severity score (mNSS) test on days 3, 7, 14, and 21 after TBI, in comparison to TBI mice that received the vehicle. RP101075-treated mice had a remarkably decreased percentage of foot faults on the foot fault test on days 7, 14, and 21 after surgery, in comparison to TBI mice that received the vehicle. Using the wet brain weight/dry brain weight method, we found that RP101075 attenuated brain edema at 3 days post-TBI. According to the results of the Morris water maze (MWM), TBI mice treated with RP101075 exhibited reduced latency time and an increased percentage of target quadrant time from day 24 to day 25 after TBI, in comparison to TBI mice that received the vehicle. In addition, flow cytometry and immunohistochemistry showed that RP101075 markedly decreased the number of infiltrated T cells, B cells and NK cells at 3 days after TBI. Analysis of Western blot data showed that RP101075 lowered the expression of proinflammatory factors on day 3 after TBI. Conclusions: Our study demonstrated that consecutive administration of RP101075 over 3 days suppressed the TBI-induced inflammatory response and ameliorated neurological deficits after TBI. Thus, this procedure may be a potential treatment strategy for TBI in the clinical setting.	[Qu, Xingguang; Zhang, Zhaohui; Xu, Xiaoyun; Wang, Jiahui; Lei, Chao; Zhou, Gaosheng; Wu, Wen; Huang, Lin; Chen, Xing] China Three Gorges Univ, Dept Crit Care Med, Coll Clin Med Sci 1, Yichang 443003, Hubei, Peoples R China; [Yu, Su; Wang, Tao] China Three Gorges Univ, Coll Clin Med Sci 1, Inst Neurol, Yichang 443003, Hubei, Peoples R China		Yu, S; Wang, T (corresponding author), China Three Gorges Univ, Coll Clin Med Sci 1, Inst Neurol, Yichang 443003, Hubei, Peoples R China.	qxg1976@163.com; zhangzhaohui0316@163.com; 1215914091@qq.com; 120450983@qq.com; 429539473@qq.com; 353475700@qq.com; fly5wing@126.com; kawayirain@126.com; 87291593@qq.com; yususpring@163.com; taowang0210@whu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801068]; Yichang medical and health research project [A20 2-018]	This work was supported by the National Natural Science Foundation of China grant 81801068 and Yichang medical and health research project A20 2-018.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cohen JA, 2016, LANCET NEUROL, V15, P373, DOI 10.1016/S1474-4422(16)00018-1; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Olson A, 2014, J CROHNS COLITIS, V8, pS213, DOI 10.1016/S1873-9946(14)60476-1; Scott FL, 2016, BRIT J PHARMACOL, V173, P1778, DOI 10.1111/bph.13476; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soares HD, 1995, J NEUROSCI, V15, P8223; Subei AM, 2015, CNS DRUGS, V29, P565, DOI 10.1007/s40263-015-0261-z; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tran JQ, 2018, CLIN PHARM DRUG DEV, V7, P263, DOI 10.1002/cpdd.383; Zhang Z, 2008, NEUROPATH APPL NEURO, V34, P330, DOI 10.1111/j.1365-2990.2007.00893.x; Zhang ZY, 2007, J CELL MOL MED, V11, P307, DOI 10.1111/j.1582-4934.2007.00019.x	26	1	1	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 17	2021	750								135748	10.1016/j.neulet.2021.135748			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RC3GP	WOS:000632692200012	33610668	hybrid			2022-02-06	
J	Wang, WZ; Wang, JB; Tang, Q; Zhu, XW; Zhu, R; Cui, DD; Wei, CZ; Liu, XJ; Liu, XX; Ran, SS; Pan, YZ; Yu, JT				Wang, Wenzhu; Wang, Jingbo; Tang, Qing; Zhu, Xiwen; Zhu, Rui; Cui, Dandan; Wei, Chunzhu; Liu, Xinjie; Liu, Xingxing; Ran, Shanshan; Pan, Yuzheng; Yu, Jintao			CX3CR1 deficiency aggravates brain white matter injury and affects expression of the CD36/15LO/NR4A1 signal	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						TBI; CX3CR1(GFP/GFP); The fractional anisotropy (FA); White matter injury		Objective: To study the effects of CX3CR1 on white matter injury, neurofunction, recognition, and expression of the CD36/15LO/NR4A1 signal in mice with traumatic brain injury (TBI). Methods: CX3CR1(GFP/GFP), CX3CR1(GFP/+) and C57BL/6 male mice were randomly divided into 3 groups. We used a controlled cortical impact (CCI) to establish a TBI model and T2wt MRI to detect the TBI lesion. FA and DTI allowed for quantitative evaluation of the structural integrity of white matter tracts. Several behavior tests were used to investigate nerve function; a computer-based tracing system was used to trace and analyze dendrites and cell bodies of microglia and astrocytes in the peri-lesional brain areas. We also used RT-PCR and western blot to detect the effect of CX3CL1/CX3CR1 axis on CD36/15LO/NR4A1 signal. Results: The fractional anisotropy (FA) at the corpus callosum area of brain was decreased at 3 days post TBI, the average lesion volume CX3CR1(GFP/GFP) group was increased, and the neurologic deficit scores of mice of Cx3Cr1(GFP/+) and wild-type groups were significantly increased compared to Cx3Cr1(GFP/GFP) group mice. In the Corner turn test, TBI induced impairments in forelimb function that were more severe than Cx3Cr11(GFP/+) and wild-type TBI mice. We operated the Y-maze at 3 days post-TBI and the NOR test at 28 days after TBI. There was a significant TBI effect induced in decreased percentage entries into the novel arm in Cx3Cr1(GFP/+) and wild-type TBI mice, compared with Cx3Cr1(GFP/GFP); Cx3Cr1(GFP/+). Wild-type mice showed decreased exploration time in new objects compared with Cx3Cr1(GFP/GFP). Those two behavior tests demonstrated that Cx3Cr1 knock-out increased the damage caused by TBI to memory. In the tail suspension and force swimming tests, there was no significant difference between those three groups. CD36 increased in Cx3Cr1(GFP/GFP) compared with the other three groups at 3 days after TBI. TBI inhibited the expression of NR4A1 at 3 d after damage. Cx3Cr1 deficiency can induce high expression of 15LO, this was unaffected by TBI. Conclusion: CX3CR1 deletion can enhance white matter injury. It increased the expression of CD36 and 15LO and increased expression of NR4A1. The lack of CX3CR1 can affect the recovery of nerve function. (C) 2021 Published by Elsevier Inc.	[Wang, Wenzhu; Tang, Qing; Zhu, Xiwen; Zhu, Rui; Cui, Dandan; Wei, Chunzhu; Liu, Xinjie; Liu, Xingxing; Ran, Shanshan] Huazhong Univ Sci & Technol, Union Hosp, Dept Integrated Tradit & Western Med, Tongji Med Coll, Wuhan, Peoples R China; [Wang, Jingbo; Pan, Yuzheng] Guangxi Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Guangxi, Peoples R China; [Yu, Jintao] Huazhong Univ Sci & Technol, Union Hosp, Dept Otolaryngol, Tongji Med Coll, Wuhan, Peoples R China		Pan, YZ (corresponding author), Guangxi Med Univ, Dept Tradit Chinese Med, Affiliated Hosp 1, Guangxi, Peoples R China.; Yu, JT (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Otolaryngol, Tongji Med Coll, Wuhan, Peoples R China.	2016xh0089@hust.edu.cn; pyz79298@sina.com; jintaoyu@hust.edu.cn		wang, wenzhu/0000-0001-6066-5053	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81904023, 81600807]; Union hospital, Tongji Medical College, Huazhong University of Science and Technology	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by grants from the National Nature Science Foundation of China (81904023; 81600807), grant from the Union hospital, Tongji Medical College, Huazhong University of Science and Technology.	Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chang CF, 2017, NEUROBIOL DIS, V103, P54, DOI 10.1016/j.nbd.2017.03.016; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Giannopoulos PF, 2013, AGING CELL, V12, P1082, DOI 10.1111/acel.12136; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Grizenkova J, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-44; Honda M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15068-4; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Joshi YB, 2015, TRENDS PHARMACOL SCI, V36, P181, DOI 10.1016/j.tips.2015.01.005; KatrinPalumbo-Zerr P.Z., 2014, NAT MED, V21, P150; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Li Q, 2017, J CEREBR BLOOD F MET, V37, P3110, DOI 10.1177/0271678X17709186; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; McBride DW, 2015, BEHAV BRAIN RES, V290, P161, DOI 10.1016/j.bbr.2015.05.001; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mecca C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010318; Milior G, 2016, BRAIN BEHAV IMMUN, V55, P114, DOI 10.1016/j.bbi.2015.07.024; Neil S.N., 2020, TRAUMATIC DIFFUSE AX, P1; Pawelec P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102277; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Suzuki M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-78; Wang Q, 2016, DEFICIENCY DELAYS AC, V30, P380; Yang J., 2017, SCI REP-UK, V7; Zhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097423	35	1	1	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	APR 16	2021	549						47	53		10.1016/j.bbrc.2021.02.053			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	RB1KK	WOS:000631875100008	33662668				2022-02-06	
J	Amiresmaili, S; Shahrokhi, N; Khaksari, M; AsadiKaram, G; Aflatoonian, MR; Shirazpour, S; Amirkhosravi, L; Mortazaeizadeh, A				Amiresmaili, Sedigheh; Shahrokhi, Nader; Khaksari, Mohammad; AsadiKaram, Gholamreza; Aflatoonian, Mohammad Reza; Shirazpour, Sara; Amirkhosravi, Ladan; Mortazaeizadeh, Abbas			The Hepatoprotective mechanisms of 17 beta-estradiol after traumatic brain injury in male rats: Classical and non-classical estrogen receptors	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						Traumatic brain injury; 17?-estradiol; Hepatoprotection; Oxidative stress; Estrogen receptors		Protective effects of estrogen (E2) on traumatic brain injury (TBI) have been determined. In this study, the hepatoprotective effects of E2 after TBI through its receptors and oxidative stress regulation have been evaluated. Diffuse TBI induced by the Marmarou method in male rats. G15, PHTPP, MPP, and ICI182?780 as selective antagonists of E2 were injected before TBI. The results indicated that TBI induces a significant increase in liver enzymes [Alkaline phosphatase (ALP), Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Glutamyl transferase (GGT)], and oxidants levels [Malondialdehyde (MDA), Nitric oxide (NO)] and decreases in antioxidant biomarkers [Glutathione peroxidase (GPx) and Superoxide dismutase (SOD)] in the brain and liver, and plasma. We also found that E2 significantly preserved levels of these biomarkers and enzymatic activity. All antagonists inhibited the effects of E2 on increasing SOD and GPx. Also, the effects of E2 on brain MDA levels were inhibited by all antagonists, but in the liver, only ICI + G15 + E2 + TBI group was affected. The impacts of E2 on brain and liver and plasma NO levels were inhibited by all antagonists. The current findings demonstrated that E2 probably improved liver injury after TBI by modulating oxidative stress. Also, both classic (ER?, ER?) and non-classic [G protein-coupled estrogen receptor (GPER)] receptors are affected in the protective effects of E2.	[Amiresmaili, Sedigheh] Bam Univ Med Sci, Dept Physiol, Bam, Iran; [Amiresmaili, Sedigheh; AsadiKaram, Gholamreza] Kerman Univ Med Sci, Physiol Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Shahrokhi, Nader; Shirazpour, Sara] Kerman Univ Med Sci, Neurosci Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Khaksari, Mohammad; Amirkhosravi, Ladan] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Aflatoonian, Mohammad Reza] Bam Univ Med Sci, Nano BioElectrochem Res Ctr, Bam, Iran; [Mortazaeizadeh, Abbas] Kerman Univ Med Sci, Pathol & Stem Cells Res Ctr, Kerman, Iran		Shahrokhi, N (corresponding author), Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran.; Shahrokhi, N (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran.	nshahrokhi@kmu.ac.ir	Haddad, Mohammad Khaksari/AAB-9025-2019; Amirkhosravi, Ladan/AAW-9036-2021	Haddad, Mohammad Khaksari/0000-0003-0770-4281; 	Research Center of Bam University of Medical Sciences (Bam, Iran); Research Center of Bam University of Medical Sciences	This study was financially supported by the Research Center of Bam University of Medical Sciences (Bam, Iran) . The Research Center of Bam University of Medical Sciences financially approved this study.	Abbasi-Jorjandi M, 2020, ENVIRON POLLUT, V267, DOI 10.1016/j.envpol.2020.115424; Amiresmaili S, 2020, BIOCHEM PHARMACOL, V178, DOI 10.1016/j.bcp.2020.114044; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Arefin S, 2014, MATURITAS, V78, P123, DOI 10.1016/j.maturitas.2014.04.002; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bandegi AR, 2014, ADV PHARM BULL, V4, P493, DOI 10.5681/apb.2014.073; Bellanti F, 2013, REDOX BIOL, V1, P340, DOI 10.1016/j.redox.2013.05.003; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Chen BC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051298; Cheong RY, 2014, ENDOCRINOLOGY, V155, P1418, DOI 10.1210/en.2013-1943; Chhavi N, 2014, PEDIATR GASTROENTERO, V17, P162, DOI 10.5223/pghn.2014.17.3.162; Davis AM, 2006, MOL REPROD DEV, V73, P1034, DOI 10.1002/mrd.20520; Tran DN, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081614; Eckhoff DE, 2002, SURGERY, V132, P302, DOI 10.1067/msy.2002.125718; Elzer JG, 2010, J CEREBR BLOOD F MET, V30, P935, DOI 10.1038/jcbfm.2009.258; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fernandez-Perez L., 2013, FRONT ENDOCRINOL LAU, V4, P1, DOI [10.3389/fendo.2013.00066, DOI 10.3389/FENDO.2013.00066]; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Fox A, 2014, J REHABIL RES DEV, V51, P869, DOI 10.1682/JRRD.2013.10.0233; Fukuda T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005413; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Handa RJ, 2012, J NEUROENDOCRINOL, V24, P160, DOI 10.1111/j.1365-2826.2011.02206.x; Hekimoglu A, 2010, ARCH GYNECOL OBSTET, V281, P23, DOI 10.1007/s00404-009-1044-x; Hsieh DJY, 2015, CELL PHYSIOL BIOCHEM, V36, P274, DOI 10.1159/000374070; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Kajta M, 2013, NEUROSCIENCE, V238, P345, DOI 10.1016/j.neuroscience.2013.02.005; Keshavarzi Z, 2011, IRAN J BASIC MED SCI, V14, P231; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2015, BRAIN RES, V1618, P1, DOI 10.1016/j.brainres.2015.05.017; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Kurt AH, 2015, ONCOL LETT, V10, P3177, DOI 10.3892/ol.2015.3711; Lee MY, 2008, CELL RES, V18, P491, DOI 10.1038/cr.2008.42; Lin FS, 2012, SHOCK, V37, P183, DOI 10.1097/SHK.0b013e31823f1918; LUM G, 1972, CLIN CHEM, V18, P358; Luo CL, 2019, FREE RADICAL BIO MED, V130, P215, DOI 10.1016/j.freeradbiomed.2018.10.402; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Nizamutdinov D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40112; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Paydar P, 2018, INT J CANCER MANAG, V11, DOI 10.5812/ijcm.83370; Pratap UP, 2016, BRAIN RES BULL, V124, P238, DOI 10.1016/j.brainresbull.2016.05.015; Ramezani A, 2011, PHARMACOL BIOCHEM BE, V100, P144, DOI 10.1016/j.pbb.2011.07.010; Sa-Pereira I, 2018, BRAIN BEHAV IMMUN, V69, P486, DOI 10.1016/j.bbi.2018.01.008; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shen SQ, 2007, J SURG RES, V140, P67, DOI 10.1016/j.jss.2006.10.022; Shimizu T, 2007, J HEPATOL, V46, P1047, DOI 10.1016/j.jhep.2007.01.019; Sobocanec S, 2015, LIFE SCI, V130, P57, DOI 10.1016/j.lfs.2015.03.014; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Vasconsuelo A, 2011, STEROIDS, V76, P1223, DOI 10.1016/j.steroids.2011.08.001; Verslype C, 2004, ACTA CLIN BELG, V59, P285, DOI 10.1179/acb.2004.042; Villapol S, 2016, NEURAL REGEN RES, V11, P226, DOI 10.4103/1673-5374.177720; Vink R, 2003, ACT NEUR S, V86, P257; Wang H, 2012, CARDIOVASC RES, V94, P96, DOI 10.1093/cvr/cvs090; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Wang SL, 2015, J MOL NEUROSCI, V55, P141, DOI 10.1007/s12031-014-0384-6; Washington IM, 2012, AM COLL LAB, P57, DOI 10.1016/B978-0-12-380920-9.00003-1; Weniger M, 2016, SHOCK, V46, P4, DOI 10.1097/SHK.0000000000000670; Yamada J, 2006, ATHEROSCLEROSIS, V189, P198, DOI 10.1016/j.atherosclerosis.2005.11.036; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P3246, DOI 10.1016/j.fct.2010.08.034; Yu HP, 2009, SHOCK, V31, P227, DOI 10.1097/SHK.0b013e31818347e7; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596; Yucel A., 2012, J EXP INTEGR MED, V2, P1; Zhao PW, 2012, BIOL PHARM BULL, V35, P1947, DOI 10.1248/bpb.b12-00325	72	1	1	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	APR 15	2021	213								111987	10.1016/j.ecoenv.2021.111987			13	Environmental Sciences; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Toxicology	RB8ZN	WOS:000632394700002	33582408	gold			2022-02-06	
J	Bullock, GS; Murray, E; Vaughan, J; Kluzek, S				Bullock, Garrett S.; Murray, Elizabeth; Vaughan, Jake; Kluzek, Stefan			Temporal trends in incidence of time-loss injuries in four male professional North American sports over 13 seasons	SCIENTIFIC REPORTS			English	Article							NATIONAL-BASKETBALL-ASSOCIATION; CONCUSSION INCIDENCE; PREVENTION; EPIDEMIOLOGY; PLAYERS; SYSTEM; ISSUES; RISKS; RATES; KNEE	Sports-related injuries increase healthcare cost burden, and in some instances have harmful long term physical and psychological implications. There is currently a lack of comprehensive data on temporal injury trends across professional North American sports. The purpose of this study was to compare temporal trends, according to incidence and time-loss injuries, by body part in professional baseball, basketball, football, and ice hockey. Public injury data from Major League Baseball, National Basketball Association, National Football League, and National Hockey League from 2007 to December 2019 were extracted and used. A mean of 62.49 injuries per 100 players per season was recorded for all professional sports. The groin/hip/thigh reported the greatest season proportional injury incidence for baseball, football, and ice hockey, with the groin/hip/thigh as the third highest injury incidence in basketball. When stratifying by more specific body part groupings, the knee demonstrated the greatest injury proportional incidence for basketball, football, and ice hockey, with the knee as the third highest proportional injury incidence for baseball. There was an increased in basketball ankle injuries following 2011-2012 season. Football and ice hockey reported the greatest concussion proportion incidence, with football demonstrating an increase in concussions over time, and a substantial increase in concussions from the 2014 to 2015 season. These publicly extracted data and findings can be used as a shared resource for professional baseball, basketball, football, and ice hockey for future individual and across sport collaborations concerning resource allocation and decision making in order to improve player health.	[Bullock, Garrett S.; Kluzek, Stefan] Univ Oxford, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Oxford, England; [Bullock, Garrett S.; Kluzek, Stefan] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, B4495, Oxford OX3 7LD, England; [Bullock, Garrett S.] Wake Forest Sch Med, Dept Orthopaed Surg, Winston Salem, NC 27101 USA; [Murray, Elizabeth; Vaughan, Jake; Kluzek, Stefan] Univ Nottingham, Nottingham, England		Bullock, GS (corresponding author), Univ Oxford, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Oxford, England.; Bullock, GS (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, B4495, Oxford OX3 7LD, England.; Bullock, GS (corresponding author), Wake Forest Sch Med, Dept Orthopaed Surg, Winston Salem, NC 27101 USA.	garrettbullock@gmail.com		Kluzek, Stefan/0000-0002-0696-7541	Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis-Sports Grant [HFR02510]	Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis-Sports Grant (HFR02510).	Bahr R, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120902908; BRUNNER MC, 1989, INVEST RADIOL, V24, P72, DOI 10.1097/00004424-198901000-00015; Cai H, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2956-7; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Chalmers DJ, 2002, INJURY PREV, V8, pIV22, DOI 10.1136/ip.8.suppl_4.iv22; Cornell DJ, 2017, J STRENGTH COND RES, V31, P575, DOI 10.1519/JSC.0000000000001538; Cumps E, 2007, J SPORT SCI MED, V6, P204; Dahm Diane L, 2016, Am J Orthop (Belle Mead NJ), V45, pE54; Deitch JR, 2006, AM J SPORT MED, V34, P1077, DOI 10.1177/0363546505285383; Dick R, 2007, J ATHL TRAINING, V42, P221; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Emery CA, 2007, CLIN J SPORT MED, V17, P17, DOI 10.1097/JSM.0b013e31802e9c05; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Filbay SR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017785; Fleisig GS, 1999, J BIOMECH, V32, P1371, DOI 10.1016/S0021-9290(99)00127-X; Flynn E., 2016, WHAT IS NFLS CONCUSS; Foreman TK, 2006, PHYS THER SPORT, V7, P101, DOI 10.1016/j.ptsp.2006.02.001; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Gary G., 2017, BR J SPORTS MED, V51, pA64, DOI [10.1136/bjsports-2016-097270.167, DOI 10.1136/BJSPORTS-2016-097270.167]; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Landers RN, 2016, PSYCHOL METHODS, V21, P475, DOI 10.1037/met0000081; McKay CD, 2014, BRIT J SPORT MED, V48, P57, DOI 10.1136/bjsports-2013-092860; Meeuwisse WH, 2003, AM J SPORT MED, V31, P379, DOI 10.1177/03635465030310030901; National Basketball Association, 2020, NBA RULES HIST 2020; Neale T., 2009, NFL I NEW CONCUSSION; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P207, DOI 10.2147/OAJSM.S7715; Patel BH, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119854199; Peterson JG, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120913020; Posner M, 2011, AM J SPORT MED, V39, P1676, DOI 10.1177/0363546511411700; Riva D, 2016, J STRENGTH COND RES, V30, P461, DOI 10.1519/JSC.0000000000001097; Rothenberg Paul, 2016, Am J Orthop (Belle Mead NJ), V45, P368; Sadigursky D, 2017, BMC SPORTS SCI MED R, V9, DOI 10.1186/s13102-017-0083-z; Seagrave RA, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114535351; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; Starkey C, 2000, J ATHL TRAINING, V35, P161; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X	39	1	1	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 15	2021	11	1							8278	10.1038/s41598-021-87920-6			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RP6NY	WOS:000641844600034	33859331	gold, Green Published			2022-02-06	
J	Escarcega, JD; Knutsen, AK; Okamoto, RJ; Pham, DL; Bayly, PV				Escarcega, J. D.; Knutsen, A. K.; Okamoto, R. J.; Pham, D. L.; Bayly, P., V			Natural oscillatory modes of 3D deformation of the human brain in vivo	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Brain mechanics; Dynamic mode decomposition; Tagged MRI; Oscillations; Natural frequency		Natural modes and frequencies of three-dimensional (3D) deformation of the human brain were identi-fied from in vivo tagged magnetic resonance images (MRI) acquired dynamically during transient mild acceleration of the head. Twenty 3D strain fields, estimated from tagged MRI image volumes in 19 adult subjects, were analyzed using dynamic mode decomposition (DMD). These strain fields represented dynamic, 3D brain deformations during constrained head accelerations, either involving rotation about the vertical axis of the neck or neck extension. DMD results reveal fundamental oscillatory modes of deformation at damped frequencies near 7 Hz (in neck rotation) and 11 Hz (in neck extension). Modes at these frequencies were found consistently among all subjects. These characteristic features of 3D human brain deformation are important for understanding the response of the brain in head impacts and provide valuable quantitative criteria for the evaluation and use of computer models of brain mechanics. (c) 2021 Elsevier Ltd. All rights reserved.	[Escarcega, J. D.; Okamoto, R. J.; Bayly, P., V] Washington Univ, Mech Engn & Mat Sci, 1 Brookings Dr,Box 1185, St Louis, MO 63130 USA; [Knutsen, A. K.; Pham, D. L.] Henry M Jackson Fdn Adv Mil Med, Ctr Neurosci & Regenerat Med, Bethesda, MD USA		Escarcega, JD (corresponding author), Washington Univ, Mech Engn & Mat Sci, 1 Brookings Dr,Box 1185, St Louis, MO 63130 USA.	jescarcega@wustl.edu		Escarcega, Jordan/0000-0001-7163-4105	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01/R56 NS055951, U01 NS112120]; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense	We acknowledge support from NIH grants R01/R56 NS055951 and U01 NS112120 and the Department of Defense in the Center for Neuroscience and Regenerative Medicine.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Bayly PV, 2008, J MECH PHYS SOLIDS, V56, P2036, DOI 10.1016/j.jmps.2007.10.012; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chan DD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040230; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Craig R. R., 2006, FUNDAMENTALS STRUCTU; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Gomez AD, 2019, IEEE T BIO-MED ENG, V66, P1456, DOI 10.1109/TBME.2018.2874591; Guertler CA, 2018, J BIOMECH, V69, P10, DOI 10.1016/j.jbiomech.2018.01.016; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Knutsen A.K., 2020, BRAIN MULTIPHYSICS; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Laksari K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0331; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Okamoto RJ, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519840444; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schmid PJ, 2010, J FLUID MECH, V656, P5, DOI 10.1017/S0022112010001217; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Tu JH, 2014, J COMPUT DYN, V1, P391; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V84, P88, DOI 10.1016/j.jmbbm.2018.04.009; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y	35	1	1	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	APR 15	2021	119								110259	10.1016/j.jbiomech.2021.110259			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	RL8CN	WOS:000639194100014	33618329				2022-02-06	
J	Khetani, S; Singh, A; Besler, B; Butterworth, S; Lijnse, T; Loughery, K; Smith, K; Hosseini, E; Narang, R; Karan, K; Debert, C; Sen, A; Murari, K; Sanati-Nezhad, A				Khetani, Sultan; Singh, Anupriya; Besler, Brendon; Butterworth, Savitri; Lijnse, Thomas; Loughery, Kenneth; Smith, Katrin; Hosseini, Ehsan; Narang, Rakesh; Karan, Kunal; Debert, Chantel; Sen, Arindom; Murari, Kartikeya; Sanati-Nezhad, Amir			mu Drop: Multi-analyte portable electrochemical-sensing device for blood-based detection of cleaved tau and neuron filament light in traumatic brain injury patients	BIOSENSORS & BIOELECTRONICS			English	Article						Traumatic brain injury (TBI); Cleaved-tau protein (C-Tau); Neuron filament protein (NFL); Electrochemical immuno-biosensor; Biomedical device		Over 27 million individuals are affected every year worldwide with central nervous system (CNS) injuries. These injuries include but are not limited to traumatic brain injury (TBI) and spinal cord injury (SCI). CNS injuries remain a significant public health concern which demands reliable tools for rapid, on-sight, on-field, and pointof-care diagnostic (POC) solutions. To address these challenges, we developed a low-cost, open-source, hand-held, portable, and POC detection technology, termed as MicroDrop (mu Drop), which can simultaneously detect up to eight target biomolecules and display results in both analog and digital formats. The data acquired is stored wirelessly in a cloud server for further investigation and statistical analysis. Multiplexing capability of mu Drop and immuno-biosensors detects and quantifies Cleaved-Tau Protein (C-Tau) and Neuron-Filament (NFL) proteins in the blood of TBI patients. Immuno-biosensors rapidly sense the two target proteins in less than 30 min, with mu Drop and a conventional potentiostat. C-Tau and NFL were selectively detected with mu Drop within the dynamic range of 10 pg/mL - 100 ng/mL and the sensitivity range of 47 mu A/pg mm(2) - 65 mu A/pg mm(2). Comparing the biosensing performance with enzyme-linked immunosorbent assays (ELISA) shows that the immuno-biosensors combined with mu Drop could successfully differentiate between clinical controls and injured patients.	[Khetani, Sultan; Singh, Anupriya; Narang, Rakesh; Sanati-Nezhad, Amir] Univ Calgary, Dept Mech & Mfg Engn, BioMEMS & Bioinspired Microfluid Lab, Calgary, AB T2N 1N4, Canada; [Khetani, Sultan; Singh, Anupriya; Lijnse, Thomas; Narang, Rakesh; Sen, Arindom; Murari, Kartikeya; Sanati-Nezhad, Amir] Univ Calgary, Biomed Engn Grad Program, Calgary, AB T2N 1N4, Canada; [Besler, Brendon; Butterworth, Savitri; Loughery, Kenneth; Smith, Katrin; Murari, Kartikeya] Univ Calgary, Dept Elect & Comp Engn, Schulich Sch Engn, Calgary, AB T2N 1N4, Canada; [Hosseini, Ehsan; Karan, Kunal; Sen, Arindom] Univ Calgary, Dept Chem & Petr Engn, Calgary, AB T2N 1N4, Canada; [Sen, Arindom; Sanati-Nezhad, Amir] Univ Calgary, Ctr Bioengn Res & Educ, Schulich Sch Engn, Calgary, AB T2N 1N4, Canada; [Sen, Arindom] Univ Calgary, Schulich Sch Engn, Pharmaceut Prod Res Facil, Calgary, AB T2N 1N4, Canada; [Debert, Chantel] Univ Calgary, Alberta Children Hosp Res Inst Child & Maternal H, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Debert, Chantel] Univ Calgary, Foothills Med Ctr, Dept Clin Neurosci, Div Phys Med & Rehabil, Calgary, AB T2H 2T9, Canada		Sanati-Nezhad, A (corresponding author), Dept Mech & Mfg Engn, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	amir.sanatinezhad@ucalgary.ca		Sen, Arindom/0000-0002-8994-8601; Debert, Chantel/0000-0002-2704-0438; Murari, Kartikeya/0000-0001-5626-2008; Singh, Anupriya/0000-0003-4345-2683; Lijnse, Thomas/0000-0003-4049-5215; Hosseini, Ehsan/0000-0002-4868-1234; Besler, Brendon/0000-0001-8227-4328	Natural Sciences and Engineering Research of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research ChairNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; Alberta Prion Research Institute (APRI); Alberta Innovates BioSolutions (AIBS); Microsystems Hub, University of Calgary; CMC - Microsystems, Canada; Hotchkiss Brain Institute, Canada	The authors acknowledge Natural Sciences and Engineering Research of Canada (NSERC); Canada Research Chair; Alberta Prion Research Institute (APRI); Alberta Innovates BioSolutions (AIBS); Microsystems Hub, University of Calgary, and CMC - Microsystems, Canada for supporting this research. The Hotchkiss Brain Institute, Canada provided financial support for the collection of blood from the patients with TBI, through a larger study called University of Calgary acute neurorehabilitation initiative. The authors would also like to thank Mark Piitz, Drs. Sean Dukelow, Chester Ho and Patrick Whelan for their help and support in the UCAN study.	Ainla A, 2018, ANAL CHEM, V90, P6240, DOI 10.1021/acs.analchem.8b00850; Boulet-Audet M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30526; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Dryden MDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140349; Du X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14037-w; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gorodkiewicz E, 2011, MICROCHIM ACTA, V175, P177, DOI 10.1007/s00604-011-0656-6; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Khetani S, 2020, APPL MATER TODAY, V20, DOI 10.1016/j.apmt.2020.100721; Khetani S, 2020, ACS APPL MATER INTER, V12, P6910, DOI 10.1021/acsami.9b20826; Khetani S, 2019, BIOSENS BIOELECTRON, V145, DOI 10.1016/j.bios.2019.111715; Khetani S, 2018, BIOTECHNOL BIOENG, V115, P2504, DOI 10.1002/bit.26787; Khetani S, 2018, ACS SENSORS, V3, P844, DOI 10.1021/acssensors.8b00076; Khetani S, 2017, SENSOR ACTUAT B-CHEM, V247, P163, DOI 10.1016/j.snb.2017.02.169; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Mo JW, 2001, ANAL CHEM, V73, P1196, DOI 10.1021/ac0010882; Molina A, 2016, MONOGR ELECTROCHEM, P1, DOI 10.1007/978-3-319-21251-7; National Spinal Cord Injury Statistical Center, 2010, J Spinal Cord Med, V33, P439; North SH, 2012, ANNU REV ANAL CHEM, V5, P35, DOI 10.1146/annurev-anchem-062011-143105; OSTERYOUNG RA, 1981, PHILOS T R SOC A, V302, P315, DOI 10.1098/rsta.1981.0170; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Safavieh M, 2017, NANOSCALE, V9, P1852, DOI 10.1039/c6nr06417e; Safavieh M, 2016, BIOSENS BIOELECTRON, V80, P230, DOI 10.1016/j.bios.2016.01.060; Salahandish R, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201900478; Salahandish R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37573-9; Salahandish R, 2018, BIOSENS BIOELECTRON, V120, P129, DOI 10.1016/j.bios.2018.08.025; Salahandish R, 2018, BIOSENS BIOELECTRON, V117, P104, DOI 10.1016/j.bios.2018.05.043; Salahandish R, 2018, IEEE SENS J, V18, P2513, DOI 10.1109/JSEN.2018.2789433; Sha R, 2017, ELECTROCHIM ACTA, V233, P44, DOI 10.1016/j.electacta.2017.03.043; Simsikova M, 2013, APPL SURF SCI, V282, P342, DOI 10.1016/j.apsusc.2013.05.130; Singh R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42771; Valente KP, 2017, DRUG DISCOV TODAY, V22, P1654, DOI 10.1016/j.drudis.2017.06.010; Vedadghavami A, 2017, ACTA BIOMATER, V62, P42, DOI 10.1016/j.actbio.2017.07.028; Wang X, 2018, J AM CHEM SOC, V140, P18132, DOI 10.1021/jacs.8b11185; Xiong K, 2017, MAT SCI ENG C-MATER, V81, P386, DOI 10.1016/j.msec.2017.08.044; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	42	1	1	6	13	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	APR 15	2021	178								113033	10.1016/j.bios.2021.113033			10	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	QL6PS	WOS:000621207100002	33517230				2022-02-06	
J	Iverson, GL; Merz, ZC; Terry, DP				Iverson, Grant L.; Merz, Zachary C.; Terry, Douglas P.			Examining the Research Criteria for Traumatic Encephalopathy Syndrome in Middle-Aged Men From the General Population Who Played Contact Sports in High School	FRONTIERS IN NEUROLOGY			English	Article						assessment; head injury; traumatic brain injury; chronic pain; depression; concussion	MECHANICAL TURK; DIAGNOSIS; INJURY	Objective: There are no validated or agreed upon diagnostic clinical criteria for chronic traumatic encephalopathy or traumatic encephalopathy syndrome. This study examines the leading research criteria for traumatic encephalopathy syndrome (TES) in middle-aged men in the general population. Method: Participants were 409 men between the ages of 35 and 55 recruited through an online crowdsourcing platform. Participants provided demographic information, medication history, concussion history, contact sport history, current medication use, and current symptoms. Research criteria for TES were applied to the sample. Results: Over half of the total sample met TES symptom criteria (56.2%), without applying the neurotrauma exposure criteria. Those with 4+ prior concussions had higher rates of meeting TES criteria compared to those with 0-3 prior concussions, but the results were not statistically significant (69.8 vs. 54.6%; chi(2) = 3.58, p = 0.06). Exposure to contact sports was not related to higher rates of TES (ps >= 0.55). In a binary logistic regression predicting the presence of mild or greater TES, significant predictors were sleep difficulties [Odds ratio (OR) = 6.68], chronic pain (OR = 3.29), and age (OR = 1.04). Neurotrauma exposure was not a significant predictor (p = 0.66). When analyzing those with no prior concussions or contact sport histories (n = 126), 45.2% met symptom criteria for mild or greater TES; chronic pain and sleep difficulties were associated with a higher prevalence of meeting criteria for TES in this subgroup (ps < 0.001). Conclusions: Men who participated in contact sports in high school or college were not more likely to meet criteria for TES than men who participated in non-contact sports or no sports. In a multivariable model, sleep problems and chronic pain were predictive of meeting the symptom criteria for TES, but the repetitive neurotrauma exposure criterion was not a significant predictor of meeting the TES symptom criteria.	[Iverson, Grant L.; Terry, Douglas P.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA 02129 USA; [Iverson, Grant L.; Terry, Douglas P.] MassGen Hosp Children, Sports Concuss Program, Boston, MA 48118 USA; [Iverson, Grant L.; Terry, Douglas P.] A Red Sox Fdn, Home Base, Charlestown, MA 02129 USA; [Iverson, Grant L.; Terry, Douglas P.] Massachusetts Gen Hosp Program, Charlestown, MA 02129 USA; [Merz, Zachary C.] Moses Cone Mem Hosp, LeBauer Dept Neurol, Greensboro, NC USA		Iverson, GL (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Spaulding Res Inst, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), MassGen Hosp Children, Sports Concuss Program, Boston, MA 48118 USA.; Iverson, GL (corresponding author), A Red Sox Fdn, Home Base, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Massachusetts Gen Hosp Program, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu			National Football League	The authors declare that this study received funding, in part, from the National Football League for a program of research entitled The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects. In addition, unrestricted philanthropic support was provided by ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, the National Rugby League, and the Spaulding Research Institute. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Arditte KA, 2016, PSYCHOL ASSESSMENT, V28, P684, DOI 10.1037/pas0000217; Carroll EJ, 1936, AM J MED SCI, V191, P706, DOI 10.1097/00000441-193619150-00014; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Gosling SD, 2015, ANNU REV PSYCHOL, V66, P877, DOI 10.1146/annurev-psych-010814-015321; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Grashow R, 2020, ANN NEUROL, V88, P106, DOI 10.1002/ana.25747; HARVEY PKP, 1974, LANCET, V2, P928; Iverson GL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00739; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2020, J NEUROPSYCH CLIN N, V32, P139, DOI 10.1176/appi.neuropsych.19010021; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Laffey M, 2018, NEUROREHABILITATION, V43, P431, DOI 10.3233/NRE-182452; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moszczynski AJ, 2018, NEUROLOGY, V90, pE380, DOI 10.1212/WNL.0000000000004899; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839	35	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 14	2021	12								632618	10.3389/fneur.2021.632618			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RU0IK	WOS:000644835500001	33935940	gold, Green Published			2022-02-06	
J	Matuk, R; Pereira, M; Baird, J; Dooner, M; Cheng, Y; Wen, SC; Rao, S; Quesenberry, P; Raukar, NP				Matuk, Rani; Pereira, Mandy; Baird, Janette; Dooner, Mark; Cheng, Yan; Wen, Sicheng; Rao, Shyam; Quesenberry, Peter; Raukar, Neha P.			The role of salivary vesicles as a potential inflammatory biomarker to detect traumatic brain injury in mixed martial artists	SCIENTIFIC REPORTS			English	Article							SPORTS-RELATED CONCUSSION; EXOSOME-MEDIATED TRANSFER; FLUID BIOMARKERS; HEAD TRAUMA; EXPRESSION; CYCLOOXYGENASE-2; DEGRADATION; DYSFUNCTION; DAMAGE; PCR	Traumatic brain injury (TBI) is of significant concern in the realm of high impact contact sports, including mixed martial arts (MMA). Extracellular vesicles (EVs) travel between the brain and oral cavity and may be isolated from salivary samples as a noninvasive biomarker of TBI. Salivary EVs may highlight acute neurocognitive or neuropathological changes, which may be particularly useful as a biomarker in high impact sports. Pre and post-fight samples of saliva were isolated from 8 MMA fighters and 7 from controls. Real-time PCR of salivary EVs was done using the TaqMan Human Inflammatory array. Gene expression profiles were compared pre-fight to post-fight as well as pre-fight to controls. Largest signals were noted for fighters sustaining a loss by technical knockout (higher impact mechanism of injury) or a full match culminating in referee decision (longer length of fight), while smaller signals were noted for fighters winning by joint or choke submission (lower impact mechanism as well as less time). A correlation was observed between absolute gene information signals and fight related markers of head injury severity. Gene expression was also significantly different in MMA fighters pre-fight compared to controls. Our findings suggest that salivary EVs as a potential biomarker in the acute period following head injury to identify injury severity and can help elucidate pathophysiological processes involved in TBI.	[Matuk, Rani; Quesenberry, Peter] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Pereira, Mandy; Dooner, Mark; Cheng, Yan; Wen, Sicheng; Quesenberry, Peter] Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA; [Baird, Janette; Raukar, Neha P.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Rao, Shyam] Rhode Isl Hosp, Dept Med, Div Neurol Neurocrit Care, Providence, RI 02903 USA; [Raukar, Neha P.] Mayo Clin, Dept Emergency Med, Rochester, MN USA		Pereira, M (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA.	mpereira7@lifespan.org			National Heart, Lungs, and Blood Institute [T32HL116249]; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM119943]	This Project was supported by the National Heart, Lungs, and Blood Institute Grant #T32HL116249, Dr. P Quesenberry. Research reported in this publication was also supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM119943, Dr. P Quesenberry.	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Braughler J M, 1985, Cent Nerv Syst Trauma, V2, P269; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Cheng Y, 2020, NEURAL REGEN RES, V15, P676, DOI 10.4103/1673-5374.266924; Cheng Y, 2019, J CELL PHYSIOL, V234, P14377, DOI 10.1002/jcp.28139; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Jensen AR, 2017, SPORTS HEALTH, V9, P64, DOI 10.1177/1941738116664860; Ji M, 2016, J PHYS THER SCI, V28, P231, DOI [10.1589/jpts.28.231, 10.1589/jpts.28.1544]; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Karpman S, 2016, CLIN J SPORT MED, V26, P332, DOI 10.1097/JSM.0000000000000235; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lu LY, 2018, MOL MED REP, V17, P7339, DOI 10.3892/mmr.2018.8780; Lystad RP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967113518492; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McClain R, 2014, CLIN J SPORT MED, V24, P497, DOI 10.1097/JSM.0000000000000078; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Quesenberry PJ, 2010, ADV DRUG DELIVER REV, V62, P1141, DOI 10.1016/j.addr.2010.06.001; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rogelj B, 2006, J MOL NEUROSCI, V28, P103, DOI 10.1385/JMN:28:2:103; Rogelj B, 2004, REV NEUROSCIENCE, V15, P185; Santhana RL., 2016, INT J MED NANORES, V3, P13; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scoggin James F 3rd, 2010, Am J Orthop (Belle Mead NJ), V39, P247; Scoggin JF, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114522184; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Walrod B, 2011, CURR SPORT MED REP, V10, P288, DOI 10.1249/JSR.0b013e31822dc2c2; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yang HW, 2008, CURR PHARM DESIGN, V14, P1443, DOI 10.2174/138161208784480144; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93	54	1	1	4	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 14	2021	11	1							8186	10.1038/s41598-021-87180-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RN8LF	WOS:000640601800020	33854105	Green Published, gold			2022-02-06	
J	Riberholt, CG; Olsen, MH; Sondergaard, CB; Gluud, C; Ovesen, C; Jakobsen, JC; Mehlsen, J; Moller, K				Riberholt, Christian Gunge; Olsen, Markus Harboe; Sondergaard, Christian Baastrup; Gluud, Christian; Ovesen, Christian; Jakobsen, Janus Christian; Mehlsen, Jesper; Moller, Kirsten			Early Orthostatic Exercise by Head-Up Tilt With Stepping vs. Standard Care After Severe Traumatic Brain Injury Is Feasible	FRONTIERS IN NEUROLOGY			English	Article						early mobilization; traumatic brain injury; feasibility trial; head-up tilt; adverse events	MINIMALLY CONSCIOUS STATE; AROUSAL; MOBILIZATION; AWARENESS; TABLE; REST	Background: Intensive rehabilitation of patients after severe traumatic brain injury aims to improve functional outcome. The effect of initiating rehabilitation in the early phase, in the form of head-up mobilization, is unclear. Objective: To assess whether early mobilization is feasible and safe in patients with traumatic brain injury admitted to a neurointensive care unit. Methods: This was a randomized parallel-group clinical trial, including patients with severe traumatic brain injury (Glasgow coma scale <11 and admission to the neurointensive care unit). The intervention consisted of daily mobilization on a tilt-table for 4 weeks. The control group received standard care. Outcomes were the number of included participants relative to all patients with traumatic brain injury who were approached for inclusion, the number of conducted mobilization sessions relative to all planned sessions, as well as adverse events and reactions. Information on clinical outcome was collected for exploratory purposes. Results: Thirty-eight participants were included (19 in each group), corresponding to 76% of all approached patients [95% confidence interval (CI) 63-86%]. In the intervention group, 74% [95% CI 52-89%] of planned sessions were carried out. There was no difference in the number of adverse events, serious adverse events, or adverse reactions between the groups. Conclusions: Early head-up mobilization is feasible in patients with severe traumatic brain injury. Larger randomized clinical trials are needed to explore potential benefits and harms of such an intervention.	[Riberholt, Christian Gunge] Univ Copenhagen, Rigshosp, Dept Neurorehabil, Traumat Brain Injury Unit, Copenhagen, Denmark; [Riberholt, Christian Gunge; Olsen, Markus Harboe; Moller, Kirsten] Univ Copenhagen, Dept Clin Med, Fac Hlth Sci, Copenhagen, Denmark; [Olsen, Markus Harboe; Moller, Kirsten] Univ Copenhagen, Rigshosp, Dept Neuroanaesthesiol, Copenhagen, Denmark; [Sondergaard, Christian Baastrup] Copenhagen Univ Hosp, Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Gluud, Christian; Ovesen, Christian; Jakobsen, Janus Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit,Dept 7812, Copenhagen, Denmark; [Gluud, Christian; Jakobsen, Janus Christian] Univ Southern Denmark, Fac Heath Sci, Dept Reg Hlth Res, Odense, Denmark; [Ovesen, Christian] Bispebjerg & Frederiksberg Hosp, Dept Neurol, Copenhagen, Denmark; [Mehlsen, Jesper] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Surg Pathophysiol Unit, Copenhagen, Denmark		Riberholt, CG (corresponding author), Univ Copenhagen, Rigshosp, Dept Neurorehabil, Traumat Brain Injury Unit, Copenhagen, Denmark.; Riberholt, CG (corresponding author), Univ Copenhagen, Dept Clin Med, Fac Hlth Sci, Copenhagen, Denmark.	christian.riberholt@regionh.dk	Jakobsen, Janus Christian/N-2419-2013; Olsen, Markus/AAU-9570-2020; Gluud, Christian/AAY-1027-2021; Mehlsen, Jesper/AAA-5848-2022; Riberholt, Christian Gunge/AAC-9574-2019	Jakobsen, Janus Christian/0000-0002-3642-2120; Olsen, Markus/0000-0003-0981-0723; Gluud, Christian/0000-0002-8861-0799; Riberholt, Christian Gunge/0000-0002-6170-1869	Council of Danish Victims Fund [16-910-00043]; Research Fund of Rigshospitalet, Copenhagen University Hospital [R114-A4672]; Danish Physical Therapy Association [15242]	The trial has been funded by The Council of Danish Victims Fund (grant 16-910-00043), by the Research Fund of Rigshospitalet, Copenhagen University Hospital (R114-A4672), and the Danish Physical Therapy Association (15242). The funders had no influence on the design of the trial or interpretation of the results.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bernhardt J, 2016, NEUROLOGY, V86, P2138, DOI 10.1212/WNL.0000000000002459; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Elliott L, 2005, J NEUROL NEUROSUR PS, V76, P298, DOI 10.1136/jnnp.2004.047357; Frazzitta G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158030; Hart T, 2016, ARCH PHYS MED REHAB, V97, P2045, DOI 10.1016/j.apmr.2016.07.012; International Council for Harmonisation, 2016, INT ADD ICH E6 R1 GU; Jakobsen J.C, 2014, DAN MED J, V61, P1; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Kanikowska D, 2008, AVIAT SPACE ENVIR MD, V79, P1091, DOI 10.3357/ASEM.2301.2008; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Krewer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143180; Luther MS, 2008, CLIN REHABIL, V22, P1034, DOI 10.1177/0269215508092821; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Riberholt CG, 2020, EARLY ORTHOSTATIC EX; Riberholt C, 2018, BRAIN INJURY, V32, P252, DOI 10.1080/02699052.2017.1408144; Riberholt CG, 2013, DAN MED J, V60; Riberholt CG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237136; Riberholt CG, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3004-x; Riberholt CG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154831; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Stenger MB, 2012, EUR J APPL PHYSIOL, V112, P605, DOI 10.1007/s00421-011-2005-1; Thorlund K, 2011, USER MANUAL TRIAL SE; Wilson BA, 2013, BRAIN IMPAIR, V14, P475, DOI 10.1017/BrImp.2013.34	30	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 14	2021	12								626014	10.3389/fneur.2021.626014			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RT8IA	WOS:000644698300001	33935935	Green Published, gold			2022-02-06	
J	Mann, O; Peery, D; Segev, RB; Klainbart, S; Kelmer, E; Sobarzo, A; Shub, V; Rapoport, K; Shamir, MH; Chai, O				Mann, Ohad; Peery, Dana; Bader Segev, Ronnie; Klainbart, Sigal; Kelmer, Efrat; Sobarzo, Ariel; Shub, Vered; Rapoport, Kira; Shamir, Merav H.; Chai, Orit			CT findings and the prognostic value of the Koret CT score in cats with traumatic brain injury	JOURNAL OF FELINE MEDICINE AND SURGERY			English	Article						CT; traumatic brain injury; prognosis; intracranial haemorrhage		Objectives The aims of this study were to evaluate associations between abnormal head CT findings and outcome, and to examine the prognostic value of the Koret CT score (KCTS) in cats sustaining acute traumatic brain injury (TBI). Methods The medical records of cats hospitalised with TBI that underwent head CT scans within 72 h of admission were retrospectively reviewed. CT scans were evaluated independently by a radiologist and a neurologist who were blinded to the outcome. A KCTS and modified Glasgow Coma Scale (MGCS) were assigned to each cat and the association between abnormal CT findings, KCTS, MGCS and outcome were analysed. Results Fourteen cats were included in the study: nine (64.2%) survivors and five (35.7%) non-survivors. Of the nine cats that were discharged, one was a short-term survivor (10 days) and eight (57.1%) were long-term survivors (> 6 months). Abnormal CT findings included lateral ventricle asymmetry/midline shift (42.8%), intracranial haemorrhage (35.7%), caudotentorial lesions (14.2%) and cranial vault fractures (14.2%), all of which were depressed. Intracranial haemorrhage was found to be significantly and negatively associated with short-term (P = 0.005) and long-term (P = 0.023) survival. KCTS was significantly associated with short-term survival (P = 0.002) and long-term survival (P = 0.004). A KCTS cut-off value of 2 yielded a 100% sensitivity and 100% specificity for short-term survival and 100% sensitivity and 80% specificity for long-term survival. A MGCS cut-off value of > 13 was associated with a 100% sensitivity and 100% specificity for short-term survival, and with a 100% sensitivity and 80% specificity for long-term survival. Conclusions and relevance KCTS, performed up to 72 h from injury, can be used as an additional diagnostic tool for the prediction of survival in cats with TBI.	[Mann, Ohad; Bader Segev, Ronnie; Klainbart, Sigal; Kelmer, Efrat] Hebrew Univ Jerusalem, Koret Sch Vet Med, Teaching Hosp, Dept Emergency & Crit Care, POB 12, IL-76100 Rehovot, Israel; [Peery, Dana] Hebrew Univ Jerusalem, Koret Sch Vet Med, Teaching Hosp, Dept Radiol, Rehovot, Israel; [Sobarzo, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Sobarzo, Ariel] Ben Gurion Univ Negev, Hlth Fac, Preclin Res Ctr, Beer Sheva, Israel; [Shub, Vered] Ben Shemen Youth Village, Emergency & Specialist Vet Ctr, Beer Sheva, Israel; [Rapoport, Kira; Shamir, Merav H.; Chai, Orit] Hebrew Univ Jerusalem, Koret Sch Vet Med, Teaching Hosp, Dept Neurol & Neurosurg, Rehovot, Israel		Mann, O (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Teaching Hosp, Dept Emergency & Crit Care, POB 12, IL-76100 Rehovot, Israel.	ohadmann@gmail.com		Mann, Ohad/0000-0003-2690-0974	Hebrew University Teaching Hospital	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: this study was supported by a grant from the Hebrew University Teaching Hospital clinical study funding.	Adamantos S, 2011, J FELINE MED SURG, V13, P806, DOI 10.1016/j.jfms.2011.09.002; Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Caine A, 2019, J FELINE MED SURG, V21, P1111, DOI 10.1177/1098612X18819162; Chai O, 2017, AM J VET RES, V78, P1085, DOI 10.2460/ajvr.78.9.1085; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Dancer SC, 2019, VET RADIOL ULTRASOUN, V60, P648, DOI 10.1111/vru.12795; DEWEY CW, 1993, VET COMP ORTHOPAED, V6, P153; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; Dozeman ET, 2020, J VET EMERG CRIT CAR, V30, P28, DOI 10.1111/vec.12918; Garosi L, 2011, J FELINE MED SURG, V13, P815, DOI 10.1016/j.jfms.2011.09.003; Giannuzzi AP, 2017, OPEN VET J, V7, P306, DOI 10.4314/ovj.v7i4.3; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kirberger RM, 2019, J VET EMERG CRIT CAR, V29, P373, DOI 10.1111/vec.12863; Knight R, 2019, J FELINE MED SURG, V21, P1120, DOI 10.1177/1098612X18819183; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kuo KW, 2018, VET CLIN N AM-SMALL, V48, P111, DOI 10.1016/j.cvsm.2017.08.005; Lapsley J, 2019, J VET EMERG CRIT CAR, V29, P478, DOI 10.1111/vec.12885; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Platt SR, 2002, VET REC, V151, P243, DOI 10.1136/vr.151.8.243; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311; Yanai H, 2015, JAVMA-J AM VET MED A, V246, P1222, DOI 10.2460/javma.246.11.1222	26	1	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1098-612X	1532-2750		J FELINE MED SURG	J. Feline Med. Surg.	FEB	2022	24	2					91	97	1098612X211005306	10.1177/1098612X211005306		APR 2021	7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	YR0LS	WOS:000641913600001	33847537				2022-02-06	
J	Robertsen, A; Helseth, E; Forde, R				Robertsen, Annette; Helseth, Eirik; Forde, Reidun			Inter-physician variability in strategies linked to treatment limitations after severe traumatic brain injury; proactivity or wait-and-see	BMC MEDICAL ETHICS			English	Article						Decision-making; Ethics; Severe traumatic brain injury; Disorders of consciousness; Futile treatment		Background Prognostic uncertainty is a challenge for physicians in the neuro intensive care field. Questions about whether continued life-sustaining treatment is in a patient's best interests arise in different phases after a severe traumatic brain injury. In-depth information about how physicians deal with ethical issues in different contexts is lacking. The purpose of this study was to seek insight into clinicians' strategies concerning unresolved prognostic uncertainty and their ethical reasoning on the issue of limitation of life-sustaining treatment in patients with minimal or no signs of neurological improvement after severe traumatic brain injury in the later trauma hospital phase. Methods Interviews with 18 physicians working in a neurointensive care unit in a large Norwegian trauma hospital, followed by a qualitative thematic analysis focused on physicians' strategies related to treatment-limiting decision-making. Results A divide between proactive and wait-and-see strategies emerged. Notwithstanding the hospital's strong team culture, inter-physician variability with regard to ethical reasoning and preferred strategies was exposed. All the physicians emphasized the importance of team-family interactions. Nevertheless, their strategies differed: (1) The proactive physicians were open to consider limitations of life-sustaining treatment when the prognosis was grim. They initiated ethical discussions, took leadership in clarification and deliberation processes regarding goals and options, saw themselves as guides for the families and believed in the necessity to prepare families for both best-case and worst-case scenarios. (2) The "wait-and-see" physicians preferred open-ended treatment (no limitations). Neurologically injured patients need time to uncover their true recovery potential, they argued. They often avoided talking to the family about dying or other worst-case scenarios during this phase. Conclusions Depending on the individual physician in charge, ethical issues may rest unresolved or not addressed in the later trauma hospital phase. Nevertheless, team collaboration serves to mitigate inter-physician variability. There are problems and pitfalls to be aware of related to both proactive and wait-and-see approaches. The timing of best-interest discussions and treatment-limiting decisions remain challenging after severe traumatic brain injury. Routines for timely and open discussions with families about the range of ethically reasonable options need to be strengthened.	[Robertsen, Annette] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Res & Dev, Oslo, Norway; [Robertsen, Annette; Helseth, Eirik] Univ Oslo, Inst Clin Med, Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Forde, Reidun] Univ Oslo, Ctr Med Eth, Oslo, Norway		Robertsen, A (corresponding author), Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Res & Dev, Oslo, Norway.	annrobe@online.no					[Anonymous], 2019, PATIENT S RIGHTS LAW; Bar B, 2020, NEUROCRIT CARE, V32, P302, DOI 10.1007/s12028-019-00838-w; BMA British Medical Association, 2018, CLIN ASS NUTR HYDR C; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cochrane TI, 2009, AM J BIOETHICS, V9, P47, DOI 10.1080/15265160902718857; Creutzfeldt CJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3904; Fins JJ., 2015, RIGHTS COME MIND BRA, DOI [10.1017/CBO9781139051279, DOI 10.1017/CBO9781139051279]; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Granek L, 2016, J PSYCHOSOC ONCOL, V34, P39, DOI 10.1080/07347332.2015.1127306; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; Kitzinger C, 2019, BIOETHICS, V33, P896, DOI 10.1111/bioe.12583; Kitzinger J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI 10.1111/1467-9566.12020; Laurent A, 2017, CRIT CARE MED, V45, P2023, DOI 10.1097/CCM.0000000000002710; Lazaridis C, 2019, NEUROCRIT CARE, V30, P33, DOI 10.1007/s12028-018-0595-8; Lind R, 2011, INTENS CARE MED, V37, P1143, DOI 10.1007/s00134-011-2253-x; Lovstad M, 2018, BRAIN INJURY, V32, P1659, DOI 10.1080/02699052.2018.1539244; Magelssen M, 2020, J MED ETHICS, V46, P66, DOI 10.1136/medethics-2018-105190; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Michalsen A, 2019, CRIT CARE MED, V47, P1258, DOI 10.1097/CCM.0000000000003870; MOEN K, 2015, RES MED BIOL SCI PLA, P321; NEL, 2015, NEVR PROS VEG STAT M; Norwegian Directorate of Health, 2013, DECISION MAKING PROC; Perreira TA, 2019, J HEALTHC LEADERSH, V11, P101, DOI 10.2147/JHL.S214765; Piers RD, 2014, CHEST, V146, P267, DOI 10.1378/chest.14-0256; Robertsen A, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0648-9; Robertsen A, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0385-x; Rohaut B, 2018, BRIT J ANAESTH, V120, P5, DOI 10.1016/j.bja.2017.11.007; Royal College of Physicians, 2020, PROL DIS CONS FOLL S; Rubin MA, 2016, AM J RESP CRIT CARE, V193, P466, DOI 10.1164/rccm.201510-2086LE; Santhirapala R, 2019, BRIT J ANAESTH, V122, P306, DOI 10.1016/j.bja.2018.11.025; Schenker Y, 2013, J PALLIAT MED, V16, P243, DOI 10.1089/jpm.2012.0331; Schutz REC, 2018, J NEUROL SCI, V385, P232, DOI 10.1016/j.jns.2017.12.007; Schutz REC, 2017, J PALLIAT MED, V20, P170, DOI 10.1089/jpm.2016.0286; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Turgeon AF, 2019, CAN MED ASSOC J, V191, pE652, DOI 10.1503/cmaj.190154; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Van den Bulcke B, 2018, BMJ QUAL SAF, V27, P781, DOI 10.1136/bmjqs-2017-007390; Wade DT, 2018, J MED ETHICS, V44, P336, DOI 10.1136/medethics-2017-104244; White DB, 2016, JAMA-J AM MED ASSOC, V315, P2086, DOI 10.1001/jama.2016.5351; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012; Wilkinson D, 2016, BIOETHICS, V30, P109, DOI 10.1111/bioe.12162; Wilkinson D, 2009, BIOETHICS, V23, P503, DOI 10.1111/j.1467-8519.2009.01762.x; Wilkinson DJC, 2011, CURR OPIN ANESTHESIO, V24, P160, DOI 10.1097/ACO.0b013e328343c5af; Xafis V, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0024-0	47	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6939			BMC MED ETHICS	BMC Med. Ethics	APR 13	2021	22	1							43	10.1186/s12910-021-00612-8			9	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	RN5CJ	WOS:000640368900001	33849500	gold, Green Published, Green Submitted			2022-02-06	
J	Treble-Barna, A; Wade, SL; Pilipenko, V; Martin, LJ; Yeates, KO; Taylor, HG; Kurowski, BG				Treble-Barna, Amery; Wade, Shari L.; Pilipenko, Valentina; Martin, Lisa J.; Yeates, Keith Owen; Taylor, H. Gerry; Kurowski, Brad G.			Brain-Derived Neurotrophic Factor Val66Met and Behavioral Adjustment after Early Childhood Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						behavior; brain-derived neurotrophic factor; clinical outcomes; pediatric TBI		The present study examined the differential effect of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism on behavioral adjustment in children with traumatic brain injury (TBI) relative to children with orthopedic injury (OI). Participants were drawn from a prospective, longitudinal study of children who sustained a TBI (n = 69) or OI (n = 72) between 3 and 7 years of age. Parents completed the Child Behavior Checklist (CBCL) at the immediate post-acute period, 6, 12, and 18 months after injury, and an average of 3.5 and 7 years after injury. Longitudinal mixed models examined the BDNF Val66Met allele status (Met carriers vs. Val/Val homozygotes) x injury group (TBI vs. OI) interaction in association with behavioral adjustment. After adjusting for continental ancestry, socioeconomic status, time post-injury, and pre-injury functioning, the allele status x injury group interaction was statistically significant for Internalizing, Externalizing, and Total Behavior problems. Post hoc within-group analysis suggested a consistent trend of poorer behavioral adjustment in Met carriers relative to Val/Val homozygotes in the TBI group; in contrast, the opposite trend was observed in the OI group. These within-group differences, however, did not reach statistical significance. The results support a differential effect of the BDNF Val66Met polymorphism on behavioral adjustment in children with early TBI relative to OI, and suggest that the Met allele associated with reduced activity-dependent secretion of BDNF may impart risk for poorer long-term behavioral adjustment in children with TBI.	[Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave,KAU-910, Pittsburgh, PA 15213 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Pediat, Div Phys Med & Rehabil,Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Pilipenko, Valentina] Univ Cincinnati, Coll Med, Div Human Genet, Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Martin, Lisa J.] Univ Cincinnati, Coll Med, Div Human Genet, Dept Pediat,Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Div Pediat Rehabil Med, Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Abigail Wexner Res Inst, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA		Treble-Barna, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 Fifth Ave,KAU-910, Pittsburgh, PA 15213 USA.	amery.treble-barna@pitt.edu			National Institute for Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD00109716, K01 HD097030, R01 HD42729]; National Institute of Neurological Disorders and Stroke grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS096053]; National Center for Advancing Translational Sciences (NCATS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]; Ronald and Irene Ward Chair in Pediatric Brain Injury - Alberta Children's Hospital Foundation	This study was supported, in part, by the National Institute for Child Health and Human Development (NICHD) grants K12 HD00109716, K01 HD097030, and R01 HD42729. Additional support was provided by the National Institute of Neurological Disorders and Stroke grant 1R01NS096053 and grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences (NCATS). Keith Yeates is supported by the Ronald and Irene Ward Chair in Pediatric Brain Injury, funded by the Alberta Children's Hospital Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.	Achenbach T.M., 2000, MANUAL ASEBA SCH AGE, V4th; Aguilar JM, 2019, J HEAD TRAUMA REHAB, V34, P65, DOI 10.1097/HTR.0000000000000443; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown DT, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040195; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Conley YP, 2011, PM&R, V3, pS52, DOI 10.1016/j.pmrj.2011.04.004; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Finan JD, 2018, J ALZHEIMERS DIS, V65, P1055, DOI 10.3233/JAD-180585; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gabrys RL, 2019, CLIN J SPORT MED, V29, P494, DOI 10.1097/JSM.0000000000000550; Gagner C, 2021, J NEUROTRAUM, V38, P102, DOI 10.1089/neu.2019.6936; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Islam F, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0794-6; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kurowski BG, 2020, J HEAD TRAUMA REHAB, V35, P165, DOI 10.1097/HTR.0000000000000545; Kurowski BG, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00481; Kurowski BG, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000432; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Lawrence DW, 2014, BRAIN INJURY, V28, P841; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Madurski C, 2018, CRIT CARE MED, V46, P393, DOI 10.1097/01.ccm.0000528827.52141.9a; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Miguel PM, 2019, DEV MED CHILD NEUROL, V61, P1127, DOI 10.1111/dmcn.14182; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Narad ME, 2020, J HEAD TRAUMA REHAB, V35, pE271, DOI 10.1097/HTR.0000000000000550; Narad ME, 2019, J DEV BEHAV PEDIATR, V40, P451, DOI 10.1097/DBP.0000000000000681; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Narayanan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158838; Nestor PG, 2019, NEUROBIOL STRESS, V11, DOI 10.1016/j.ynstr.2019.100186; Notaras M, 2015, MOL PSYCHIATR, V20, P916, DOI 10.1038/mp.2015.27; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pinelis V G, 2015, Zh Nevrol Psikhiatr Im S S Korsakova, V115, P66, DOI 10.17116/jnevro20151158166-72; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thaler L, 2014, PROG NEURO-PSYCHOPH, V54, P43, DOI 10.1016/j.pnpbp.2014.04.010; Treble-Barna A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00460; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Tuerk C, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147061; Unternaehrer E, 2015, STRESS, V18, P451, DOI 10.3109/10253890.2015.1038992; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Walz NC, 2009, J PEDIATR REHAB MED, V2, P285, DOI 10.3233/PRM-2009-0094; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Weder N, 2014, J AM ACAD CHILD PSY, V53, P417, DOI 10.1016/j.jaac.2013.12.025; Wilson A, 2015, R PROJECT STAT COMPU; Yang JM, 2014, CELL REP, V7, P796, DOI 10.1016/j.celrep.2014.03.040; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583	76	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7466		APR 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RM9SK	WOS:000639996700001	33605167				2022-02-06	
J	Zhang, L; Levenson, CW; Salazar, VC; McCarthy, DM; Biederman, J; Zafonte, R; Bhide, PG				Zhang, Lin; Levenson, Cathy W.; Salazar, Valentina Cea; McCarthy, Deirdre M.; Biederman, Joseph; Zafonte, Ross; Bhide, Pradeep G.			Repetitive Mild Traumatic Brain Injury in a Perinatal Nicotine Exposure Mouse Model of Attention Deficit Hyperactivity Disorder	DEVELOPMENTAL NEUROSCIENCE			English	Article						Attention deficit hyperactivity disorder; Traumatic brain injury; Concussion; Attention; Working memory; Depression		Attention deficit hyperactivity disorder (ADHD) increases the risk for concussion or mild traumatic brain injury (mTBI). At the same time, recommendations for the management of ADHD include participation in sports and other organized physical activities, including those that carry an increased risk of mTBI. Very little work has been done to determine the extent to which untreated ADHD adversely impacts behavioral outcomes of repeated mild concussions. Here, we used a perinatal nicotine exposure (PNE) mouse model of ADHD combined with a closed-head, repetitive mTBI model. The PNE mouse model carries significant construct, face, and predictive validity as a preclinical model of ADHD. Two-month-old PNE and control mice were subjected to closed-head repetitive mTBI or sham procedure once daily for 5 days. Object-based attention, novel object recognition memory, spatial working memory, and depression-like behavior were analyzed 1 day and 2 weeks following repeated mTBI. Consistent with our previous reports, mice in the PNE group showed significant deficits in object-based attention and working memory prior to mTBI. These deficits persisted following the repeated mTBI. Repeated mTBI produced a transient attention deficit in the control group but did not exacerbate the attention deficit that is characteristic of the PNE group. Although neither PNE nor repetitive mTBI alone influenced immobility in the tail suspension test, when PNE mice were subjected to mTBI, there was a transient increase in this measurement suggesting a synergistic effect of ADHD and mTBI on depression-like behavior. Thus, our data using the PNE mouse model suggest that ADHD may be a risk factor for transient depression following repeated mTBI and that repeated mTBI may be a risk factor for transient attention deficit.	[Zhang, Lin; Levenson, Cathy W.; Salazar, Valentina Cea; McCarthy, Deirdre M.; Bhide, Pradeep G.] Florida State Univ, Coll Med, Dept Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA; [Biederman, Joseph] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Pediat Psychopharmacol, Boston, MA 02115 USA; [Zafonte, Ross] Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Zafonte, Ross] Harvard Med Sch, Charlestown, MA USA		Bhide, PG (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Ctr Brain Repair, Tallahassee, FL 32306 USA.	pradeep.bhide@med.fsu.edu		Bhide, Pradeep/0000-0003-4236-9415	Spaulding Rehabilitation Research Foundation; Jim and Betty Ann Rodgers Chair Funds; Florida State University	T This work was supported by a grant from the Spaulding Rehabilitation Research Foundation, The Jim and Betty Ann Rodgers Chair Funds, and a Planning Grant from the Florida State University.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alderson RM, 2013, NEUROPSYCHOLOGY, V27, P287, DOI 10.1037/a0032371; Alkam T, 2013, PSYCHOPHARMACOLOGY, V230, P451, DOI 10.1007/s00213-013-3175-9; Alkam T, 2011, BEHAV BRAIN RES, V220, P185, DOI 10.1016/j.bbr.2011.01.039; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Association AP., 2013, DIAGN STAT MAN MENT, V5th; Biederman J, 2006, J CLIN PSYCHIAT, V67, P148; Biederman J, 1998, J CLIN PSYCHIAT, V59, P4; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Brown A, 2012, J PSYCHIATR RES, V46, P476, DOI 10.1016/j.jpsychires.2012.01.008; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Caye A, 2019, MOL PSYCHIATR, V24, P390, DOI 10.1038/s41380-018-0116-3; Cook NE, 2020, J DEV BEHAV PEDIATR, V41, P571, DOI 10.1097/DBP.0000000000000808; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Cook Nathan E, 2016, PM R, V8, pS156, DOI 10.1016/j.pmrj.2016.07.032; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Danielson ML, 2018, J CLIN CHILD ADOLESC, V47, P199, DOI 10.1080/15374416.2017.1417860; Darkazalli A, 2016, RESTOR NEUROL NEUROS, V34, P433, DOI 10.3233/RNN-150628; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Faraone S., 2018, NEUROBIOLOGY MENTAL, P865; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Firth J, 2020, WORLD PSYCHIATRY, V19, P360, DOI 10.1002/wps.20773; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iaccarino MA, 2020, J ATTEN DISORD, V24, P309, DOI 10.1177/1087054718759752; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P1109, DOI 10.1093/arclin/acaa030; Iverson GL, 2021, CLIN J SPORT MED, V31, P438, DOI 10.1097/JSM.0000000000000773; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kaye S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00396; Kratochvil CJ, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00008; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Makris N, 2010, J ATTEN DISORD, V13, P407, DOI 10.1177/1087054709351671; Miklos M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114071; Ng QX, 2017, COMPLEMENT THER MED, V34, P123, DOI 10.1016/j.ctim.2017.08.018; Nowak MK, 2022, J ATTEN DISORD, V26, P125, DOI 10.1177/1087054720969977; Pagani LS, 2014, NEUROSCI BIOBEHAV R, V44, P195, DOI 10.1016/j.neubiorev.2013.03.008; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rowland AS, 2015, J ATTEN DISORD, V19, P741, DOI 10.1177/1087054713513799; Russell VA., 2011, CURR PROTOC NEUROSCI, V9, P35, DOI DOI 10.1002/0471142301.NS0935S54; Russell VA, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-9; Russell VA, 2007, J NEUROSCI METH, V161, P185, DOI 10.1016/j.jneumeth.2006.12.005; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; Semple BD, 2016, DEV NEUROSCI-BASEL, V38, P220, DOI 10.1159/000448089; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; Xu GF, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1471; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; Zhang L, 2021, CEREB CORTEX, V31, P483, DOI 10.1093/cercor/bhaa238; Zhang L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198064; Zhang MX, 2020, TOXICOLOGY, V431, DOI 10.1016/j.tox.2020.152367; Zhang-James Y, 2011, AM J MED GENET B, V156B, P835, DOI 10.1002/ajmg.b.31229; Zhu JM, 2017, INT J DEV NEUROSCI, V58, P26, DOI 10.1016/j.ijdevneu.2017.01.014; Zhu JM, 2014, J NEUROSCI, V34, P2768, DOI 10.1523/JNEUROSCI.4402-13.2014; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	64	1	1	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.	MAY	2021	43	1					63	72		10.1159/000515198		APR 2021	10	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Developmental Biology; Neurosciences & Neurology	SF2ST	WOS:000640282900001	33849015	Bronze			2022-02-06	
J	Toccalino, D; Wiseman-Hakes, C; Zalai, DM				Toccalino, Danielle; Wiseman-Hakes, Catherine; Zalai, Dora M.			Preliminary Validation of the Sleep and Concussion Questionnaire as an Outcome Measure for Sleep Following Brain Injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; sleep disturbance; insomnia		Background Sleep and wakefulness disturbances are common with traumatic brain injury (TBI); however, there are no condition-specific measures to evaluate sleep following TBI. Objective To assess the convergent validity of the Sleep and Concussion Questionnaire (SCQ), a condition-specific (TBI) measure is compared to polysomnography and existing self-report sleep questionnaires. Participants Included Thirty-two adults diagnosed with mild TBI, 3-24 months post-injury, average age, 38.9 years, predominantly female (63%) and with symptoms of chronic insomnia. Methods Participants underwent polysomnographic evaluation of sleep and completed the SCQ, Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), and the Fatigue Severity Scale (FSS). Correlations were assessed using Pearson's correlations. The sample was sufficiently powered (0.85) to detect a moderate to strong correlation of 0.5 or greater. Results SCQ sub-questions were meaningfully correlated with corresponding objective sleep parameters (time awake, number of awakenings, sleep efficiency, sleep onset latency, wake after sleep onset) as measured with polysomnography. Additional significant correlations were seen between total scores on the SCQ and ISI and between SCQ sub questions and total ESS scores. Conclusions This work provides initial evidence of the convergent validity of the SCQ with objective sleep parameters and existing self-report measures in patients after mild TBI.	[Toccalino, Danielle] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Wiseman-Hakes, Catherine] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Wiseman-Hakes, Catherine] Univ Hlth Network Toronto, Rehabil Inst, KITE Res Inst, Toronto, ON, Canada; [Zalai, Dora M.] Oakville Ctr Cognit Therapy, Oakville, ON, Canada		Wiseman-Hakes, C (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.	wisemc1@mcmaster.ca		Wiseman-Hakes, Catherine/0000-0001-8441-884X	Canadian Institutes of Health Research (CIHR) Frederick Banting Charles Best Canada Graduate Scholarship AwardCanadian Institutes of Health Research (CIHR); Youthdale Sleep Foundation	This work was funded by the Canadian Institutes of Health Research (CIHR) Frederick Banting Charles Best Canada Graduate Scholarship Award (DZ), and Youthdale Sleep Foundation.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Aoun R, 2019, NAT SCI SLEEP, V11, P131, DOI 10.2147/NSS.S182158; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bujang MA, 2017, ARCH OROFAC SCI, V12, P1; Cabin R.J., 2000, B ECOLOGICAL SOC AM, V81, P246; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Edinger J. D., 2004, DUKE STRUCTURED INTE; Hunt C, 2017, CAN J NEUROL SCI, V44, P676, DOI 10.1017/cjn.2017.222; Johns M., ESS MELBOURNE AUSTR; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Krabbe PFM, 2017, MEASUREMENT OF HEALTH AND HEALTH STATUS: CONCEPTS, METHODS AND APPLICATIONS FROM A MULTIDISCIPLINARY PERSPECTIVE, P113, DOI 10.1016/B978-0-12-801504-9.00007-6; KRUPP L, 1989, ARCH NEUROL-CHICAGO, V46; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; McInnes K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218423; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; MORIN CM, 2011, SLEEP, V34; Mukaka MM, 2012, MALAWI MED J, V24, P69; Ontario Neurotrauma Foundation, 2018, 3 EDITION GUIDELINES; Ontario Neurotrauma Foundation (ONF), 2013, GUIDELINES MANAGEMEN; R Development Core Team, 2012, R LANG ENV STAT COMP; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Revelle W., 2018, PSYCH PROCEDURES PER; Rundo JV, 2019, HAND CLINIC, V160, P381, DOI 10.1016/B978-0-444-64032-1.00025-4; Sampathkumar H, 2018, NEUROREHABILITATION, V43, P267, DOI 10.3233/NRE-182485; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Suzuki Y, 2017, SLEEP MED, V33, P36, DOI 10.1016/j.sleep.2016.06.033; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wiseman-Hakes C., 2017, BRAIN INJURY, V31, P719, DOI [10.1080/02699052, DOI 10.1080/02699052]; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P3, DOI DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Zalai Dora M, 2020, CMAJ Open, V8, pE142, DOI 10.9778/cmajo.20190137; Zhou Y, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8120223	39	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					743	750		10.1080/02699052.2021.1906949		APR 2021	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000639024700001	33843391				2022-02-06	
J	Fouche, PF; Meadley, B; St Clair, T; Winnall, A; Jennings, PA; Bernard, S; Smith, K				Fouche, Pieter F.; Meadley, Ben; St Clair, Toby; Winnall, Alison; Jennings, Paul A.; Bernard, Stephen; Smith, Karen			The association of ketamine induction with blood pressure changes in paramedic rapid sequence intubation of out-of-hospital traumatic brain injury	ACADEMIC EMERGENCY MEDICINE			English	Article						blood pressure; interrupted time series; paramedic; quazi&#8208; experiment; rapid sequence intubation; traumatic brain injury		Introduction Rapid sequence intubation (RSI) is used to secure the airway of traumatic brain injury (TBI) patients, with ketamine frequently used for induction. Studies show that ketamine-induction RSI might cause lower blood pressures when compared to etomidate. It is not clear if the results from that research can be extrapolated to systems that use different dosing regimens for ketamine RSI. Ambulance Victoria authorized the use of 1.5 mg/kg ketamine in January 2015 for head injury RSI induction by road-based paramedics. This study aims to examine whether systolic blood pressure changed when ketamine was introduced for prehospital head injury RSI. Methods This study was a retrospective analysis of out-of-hospital suspected TBI that received RSI by paramedics. Our analysis employs an interrupted time-series analysis (ITSA), which is a quasi-experimental method that tested whether hypotension and systolic blood pressures changed after the switch to ketamine induction in 2015. This ITSA utilized an ordinary least squares regression on complete observations using Newey-West standard errors. Results During the study period, paramedics performed RSI in 8,613 patients, and 1,759 (20.4%) had a TBI. Ketamine usage increased by 52.7% in January 2015 (p < 0.001) after road-based paramedics were authorized to use ketamine induction. This analysis found significant 5% increase in post-RSI hypotension (p = 0.046) after the introduction of ketamine, and thereafter the incidence of post-RSI hypotension increased steadily by 0.5% every 3 months (p = 0.004). Concurrently, changes in systolic blood pressure, as measured by the interval just before induction to the last measured on scene, show an average decrease of 7.8 mm Hg (p = 0.04) at the start of 2015 with the ketamine rollout. Conclusions This ITSA shows that postinduction hypotension and also decreases in systolic blood pressures became evident after the introduction of ketamine. Further research to investigate the association between ketamine induction and survival is needed.	[Fouche, Pieter F.] Monash Univ, Dept Paramed, Melbourne, Vic, Australia; [Meadley, Ben; St Clair, Toby; Jennings, Paul A.] Monash Univ, Dept Paramed, Ambulance Victoria, Melbourne, Vic, Australia; [St Clair, Toby] Monash Univ, Royal Childrens Hosp, Dept Trauma, Ambulance Victoria, Melbourne, Vic, Australia; [Winnall, Alison] Ambulance Victoria, Melbourne, Vic, Australia; [Jennings, Paul A.] Monash Univ, Ambulance Victoria, Dept Epidemiol & Prevent Med, Victoria, Melbourne, Vic, Australia; [Bernard, Stephen] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Ctr Res & Evaluat,Ambulance Victoria, Melbourne, Vic, Australia; [Smith, Karen] Monash Univ, Ambulance Victoria, Res & Evaluat, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Smith, Karen] Monash Univ, Ambulance Victoria, Res & Evaluat, Dept Paramed, Melbourne, Vic, Australia		Fouche, PF (corresponding author), Monash Univ, Dept Paramed, Melbourne, Vic, Australia.	Pieter.Fouche@monash.edu		StClair, Toby/0000-0002-3398-1242			[Anonymous], 2018, CLIN PRACTICE GUIDEL, P42; April MD, 2020, ACAD EMERG MED, V27, P1106, DOI 10.1111/acem.14063; Bernard Stephen, 2002, Emerg Med (Fremantle), V14, P406, DOI 10.1046/j.1442-2026.2002.00382.x; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Dewhirst Elisabeth, 2013, J Intensive Care Med, V28, P375, DOI 10.1177/0885066612448732; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Heffner A., 2011, CRITICAL CARE S1, V15, pP154, DOI DOI 10.1186/CC9574; Ishimaru T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53360-6; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Miller M, 2016, ANN EMERG MED, V68, P181, DOI 10.1016/j.annemergmed.2016.03.041; Mohr NM, 2020, ACAD EMERG MED, V27, P1140, DOI 10.1111/acem.14070; Montgomery JM, 2018, AM J POLIT SCI, V62, P760, DOI 10.1111/ajps.12357; PAGEL PS, 1992, ANESTHESIOLOGY, V76, P564, DOI 10.1097/00000542-199204000-00013; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Perkins ZB, 2013, INJURY, V44, P618, DOI 10.1016/j.injury.2012.03.019; Pollack Melanie A, 2020, Air Med J, V39, P111, DOI 10.1016/j.amj.2019.11.003; Price B, 2013, AM J EMERG MED, V31, P1124, DOI 10.1016/j.ajem.2013.03.041; Riley WT, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-10; Scherzer Daniel, 2012, J Pediatr Pharmacol Ther, V17, P142, DOI 10.5863/1551-6776-17.2.142; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Tarquinio KM, 2015, PEDIATR CRIT CARE ME, V16, P210, DOI 10.1097/PCC.0000000000000319; Upchurch CP, 2017, ANN EMERG MED, V69, P24, DOI 10.1016/j.annemergmed.2016.08.009; VELICER WF, 1983, EVALUATION REV, V7, P551, DOI 10.1177/0193841X8300700408	26	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	OCT	2021	28	10					1134	1141		10.1111/acem.14256		APR 2021	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	WM1WO	WOS:000638433800001	33759253				2022-02-06	
J	Rose, SC; Yeates, KO; Nguyen, JT; Ercole, PM; Pizzimenti, NM; McCarthy, MT				Rose, Sean C.; Yeates, Keith Owen; Nguyen, Joseph T.; Ercole, Patrick M.; Pizzimenti, Natalie M.; McCarthy, Matthew T.			Subconcussive Head Impacts and Neurocognitive Function Over 3 Seasons of Youth Football	JOURNAL OF CHILD NEUROLOGY			English	Article						cognition; concussion; neurobehavioral; neuropsychological; contact sports		Objective: To determine the association between repetitive subconcussive head impacts and neurobehavioral outcomes in youth tackle football players. Methods: Using helmet-based sensors, we measured head impacts for 3 consecutive seasons of play in 29 male players age 9-11. Cumulative impact g's were calculated. Players completed a battery of outcome measures before and after each season, including neuropsychological testing, vestibular-ocular sensitivity, and self- and parent-reported measures of symptoms and attention-deficit hyperactivity disorder (ADHD). Results: Average cumulative impact over 3 seasons was 13 900g. High-intensity hits predicted worse change for self-reported social adjustment (P = .001). Cumulative impact did not predict change in any of the outcome measures. History of ADHD, anxiety, and depression predicted worse change for self-reported symptoms and social adjustment, independent of head impacts. When players were stratified into 3 groups based on cumulative impact across all 3 seasons, differences in outcome measures existed prior to the start of the first season. These differences did not further increase over the course of the 3 seasons. Conclusion: Over 3 consecutive seasons of youth tackle football, we found no association between cumulative head impacts and neurobehavioral outcomes. Larger sample sizes and longer follow-up times would further assist in characterizing this relationship.	[Rose, Sean C.] Nationwide Childrens Hosp, Div Child Neurol, Columbus, OH USA; [Rose, Sean C.] Ohio State Univ, Columbus, OH 43210 USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Nguyen, Joseph T.; Ercole, Patrick M.] Sansom Consulting, San Antonio, TX USA; [Pizzimenti, Natalie M.] MORE Fdn, Brighton, MI USA; [McCarthy, Matthew T.] Summit Med Grp, Florham Pk, NJ USA		Rose, SC (corresponding author), Nationwide Childrens Hosp, 700 Childrens Dr, Columbus, OH 43205 USA.; Rose, SC (corresponding author), Ohio State Univ, Child Neurol, 700 Childrens Dr, Columbus, OH 43205 USA.	sean.rose@nationwidechildrens.org	Nguyen, Joseph/ABC-1527-2021	Nguyen, Joseph/0000-0003-1686-3911; Rose, Sean/0000-0001-5177-7715	MORE Foundation	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors report no conflicts of interest. Both Riddell and ElMindA provided grants and equipment to MORE Foundation to support this study. The study was investigator-initiated, and neither funder had a role in study design, interpretation of data, manuscript writing, or the decision to submit the manuscript for publication. Riddell processed the raw helmet impact data but did not have access to the results of the cognitive testing or other outcome measures. Riddell reviewed the final draft of the manuscript to confirm that the technical description of the helmet sensor technology in the manuscript is accurate.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2018, CLIN J SPORT MED, V28, P130, DOI 10.1097/JSM.0000000000000420; Bunford N, 2018, J ATTEN DISORD, V22, P66, DOI 10.1177/1087054714527793; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hair JF, 1995, MULTIVARIATE DATA AN; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Rivara FP., JAMA PEDIATR; Rose SC, 2019, J NEUROTRAUM, V36, P2803, DOI 10.1089/neu.2019.6519; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12	26	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2021	36	9					768	775	08830738211004490	10.1177/08830738211004490		APR 2021	8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	UI2AN	WOS:000640819700001	33834862				2022-02-06	
J	Tso, MK; Turgeon, P; Bosche, B; Lee, CK; Nie, T; D'Abbondanza, J; Ai, JL; Marsden, PA; Macdonald, RL				Tso, Michael K.; Turgeon, Paul; Bosche, Bert; Lee, Charles K.; Nie, Tian; D'Abbondanza, Josephine; Ai, Jinglu; Marsden, Philip A.; Macdonald, R. Loch			Gene expression profiling of brain endothelial cells after experimental subarachnoid haemorrhage	SCIENTIFIC REPORTS			English	Article							BASILAR ARTERY	Subarachnoid haemorrhage (SAH) is a type of hemorrhagic stroke that is associated with high morbidity and mortality. New effective treatments are needed to improve outcomes. The pathophysiology of SAH is complex and includes early brain injury and delayed cerebral ischemia, both of which are characterized by blood-brain barrier (BBB) impairment. We isolated brain endothelial cells (BECs) from mice subjected to SAH by injection of blood into the prechiasmatic cistern. We used gene expression profiling to identify 707 unique genes (2.8% of transcripts, 403 upregulated, 304 downregulated, 24,865 interrogated probe sets) that were significantly differentially expressed in mouse BECs after SAH. The pathway involving prostaglandin synthesis and regulation was significantly upregulated after SAH, including increased expression of the Ptgs2 gene and its corresponding COX-2 protein. Celecoxib, a selective COX-2 inhibitor, limited upregulation of Ptgs2 in BECs. In this study, we have defined the gene expression profiling of BECs after experimental SAH and provide further insight into BBB pathophysiology, which may be relevant to other neurological diseases such as traumatic brain injury, brain tumours, ischaemic stroke, multiple sclerosis, and neurodegenerative disorders.	[Tso, Michael K.] Univ Calgary, Div Neurosurg, Calgary, AB, Canada; [Tso, Michael K.; Bosche, Bert; Lee, Charles K.; Nie, Tian; D'Abbondanza, Josephine; Ai, Jinglu; Macdonald, R. Loch] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Neurosurg, Toronto, ON, Canada; [Tso, Michael K.; Bosche, Bert; Lee, Charles K.; Nie, Tian; D'Abbondanza, Josephine; Ai, Jinglu; Macdonald, R. Loch] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Turgeon, Paul; Marsden, Philip A.] Univ Toronto, Div Nephrol, Toronto, ON, Canada; [Bosche, Bert] MediClin Clin Reichshof, Dept Neurocrit Care Neurol & Neurosurg Stage Reha, Reichshof Eckenhagen, Germany; [Bosche, Bert] Univ Cologne, Inst Neurophysiol, Cologne, Germany; [Bosche, Bert] Univ Duisburg Essen, Dept Neurol, Essen, Germany; [Tso, Michael K.; Bosche, Bert; Lee, Charles K.; Nie, Tian; D'Abbondanza, Josephine; Ai, Jinglu; Macdonald, R. Loch] UCSF, Dept Neurol Surg, Fresno Campus, Fresno, CA 93701 USA		Macdonald, RL (corresponding author), Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Neurosurg, Toronto, ON, Canada.; Macdonald, RL (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Macdonald, RL (corresponding author), UCSF, Dept Neurol Surg, Fresno Campus, Fresno, CA 93701 USA.	rlochmacdonald@gmail.com		Nie, Tian/0000-0001-7426-0356	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Neurosurgery Research Education Foundation (NREF) AANS/CNS Cerebrovascular Section Research Fellowship; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [BO 4229/1-1, BO 4229/2-1]; CIHRCanadian Institutes of Health Research (CIHR); Physicians' Services Incorporated Foundation (PSIF); Heart & Stroke FoundationHeart & Stroke Foundation of Canada	MKT received the Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research (CIHR) and the Neurosurgery Research Education Foundation (NREF) AANS/CNS Cerebrovascular Section Research Fellowship. BB was supported by the Deutsche Forschungsgemeinschaft (DFG), Grants: BO 4229/1-1, BO 4229/2-1 (Novel strategies to protect the neurovascular unit). RLM received grant support from CIHR, Heart & Stroke Foundation, and Physicians' Services Incorporated Foundation (PSIF). RLM is chief scientific officer of Edge Therapeutics Inc. Dr. Andrew Baker, St. Michael's Hospital, provided guidance as a PhD program advisory committee member. Academic support was also received from members of Dr. Philip Marsden's lab and Dr. R. Loch Macdonald's lab. The Princess Margaret Genomics Centre assisted with performing the microarray hybridization and bioinformatics analysis. The St. Michael's Hospital core facility staff (Xiaofeng Lu, Cat Di Ciano, Pam Plante, Chris Spring) also provided training for the experiments described. Youdong Wang, research technician for Dr. Xiao-Yan Wen's lab, provided assistance with the whole brain fluorescent microscopy.	Akwii RG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050471; Andersohn F, 2006, STROKE, V37, P1725, DOI 10.1161/01.STR.0000226642.55207.94; Ayer R, 2011, ACTA NEUROCHIR SUPPL, V111, P145, DOI 10.1007/978-3-7091-0693-8_24; Bache S, 2017, STROKE, V48, P2391, DOI 10.1161/STROKEAHA.117.017804; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bosche B, 2020, TRANSL STROKE RES, V11, P337, DOI 10.1007/s12975-019-00735-6; Bosche B, 2015, STROKE, V46, pE126, DOI 10.1161/STROKEAHA.115.009131; Bosche B, 2010, ANN NEUROL, V67, P607, DOI 10.1002/ana.21943; Brueggemann Lioubov I, 2010, Mol Cell Pharmacol, V2, P15; Cooke DL, 2018, TRANSL STROKE RES, V9, P20, DOI 10.1007/s12975-017-0560-4; Dembo G, 2005, ANESTHESIOLOGY, V102, P409, DOI 10.1097/00000542-200502000-00026; Dinh YRT, 2001, NEUROSURGERY, V48, P626, DOI 10.1097/00006123-200103000-00037; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; Hirayama A, 2014, CIRC J, V78, P194, DOI 10.1253/circj.CJ-12-1573; Huntley MA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00355; Jiang JX, 2013, P NATL ACAD SCI USA, V110, P3591, DOI 10.1073/pnas.1218498110; Kikkawa Y, 2017, WORLD NEUROSURG, V108, P909, DOI 10.1016/j.wneu.2017.09.008; Kikkawa Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836397; Kleinloog R, 2016, STROKE, V47, P1286, DOI 10.1161/STROKEAHA.116.012541; Kurki MI, 2011, NEUROSURGERY, V68, P1667, DOI 10.1227/NEU.0b013e318210f001; Kurogi R, 2015, BRAIN RES, V1616, P26, DOI 10.1016/j.brainres.2015.04.049; Lai NS, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160480; Lee CI, 2012, MOL MED REP, V5, P118, DOI 10.3892/mmr.2011.614; Liu DH, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0188-x; Lublinsky S, 2019, EBIOMEDICINE, V43, P460, DOI 10.1016/j.ebiom.2019.04.054; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Munakata A, 2016, TRANSL STROKE RES, V7, P220, DOI 10.1007/s12975-016-0466-6; Nakaoka H, 2014, STROKE, V45, P2239, DOI 10.1161/STROKEAHA.114.005851; Nassiri F, 2016, NEUROCRIT CARE, V25, P351, DOI 10.1007/s12028-016-0266-6; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; Osuka K, 1998, STROKE, V29, P1219, DOI 10.1161/01.STR.29.6.1219; Osuka K, 2006, BRAIN RES, V1072, P1, DOI 10.1016/j.brainres.2005.12.003; Peng JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46577; Pera J, 2010, STROKE, V41, P224, DOI 10.1161/STROKEAHA.109.562009; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Pirlamarla P, 2016, TRENDS CARDIOVAS MED, V26, P675, DOI 10.1016/j.tcm.2016.04.011; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Sasahara A, 2008, NEUROSURG REV, V31, P283, DOI 10.1007/s10143-008-0135-7; Sherchan P, 2011, J NEUROTRAUM, V28, P2503, DOI 10.1089/neu.2011.1864; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stylli SS, 2017, J NEUROSURG, V126, P1131, DOI 10.3171/2016.1.JNS151454; Su XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144724; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Vikman P, 2006, J NEUROSURG, V105, P438, DOI 10.3171/jns.2006.105.3.438; Wang W, 2017, ONCOTARGET, V8, P2477, DOI 10.18632/oncotarget.13908; Xu J, 2017, NEUROCHEM RES, V42, P1267, DOI 10.1007/s11064-016-2168-6; Zheng BJ, 2015, MOL MED REP, V12, P967, DOI 10.3892/mmr.2015.3474	50	1	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	APR 9	2021	11	1							7818	10.1038/s41598-021-87301-z			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM3MY	WOS:000639568600008	33837224	gold, Green Published			2022-02-06	
J	Qiu, XC; Ping, SN; Kyle, M; Chin, L; Zhao, LR				Qiu, Xuecheng; Ping, Suning; Kyle, Michele; Chin, Lawrence; Zhao, Li-Ru			SCF plus G-CSF treatment in the chronic phase of severe TBI enhances axonal sprouting in the spinal cord and synaptic pruning in the hippocampus	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Stem cell factor; Granulocyte colony-stimulating factor; Corticospinal tract; Synaptic pruning		Traumatic brain injury (TBI) is a major cause of long-term disability in young adults. An evidence-based treatment for TBI recovery, especially in the chronic phase, is not yet available. Using a severe TBI mouse model, we demonstrate that the neurorestorative efficacy of repeated treatments with stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) (SCF + G-CSF) in the chronic phase is superior to SCF + G-CSF single treatment. SCF + G-CSF treatment initiated at 3 months post-TBI enhances contralesional corticospinal tract sprouting into the denervated side of the cervical spinal cord and re-balances the TBI-induced overgrown synapses in the hippocampus by enhancing microglial function of synaptic pruning. These neurorestorative changes are associated with SCF + G-CSF-improved somatosensory-motor function and spatial learning. In the chronic phase of TBI, severe TBI-caused microglial degeneration in the cortex and hippocampus is ameliorated by SCF + G-CSF treatment. These findings reveal the therapeutic potential and possible mechanism of SCF + G-CSF treatment in brain repair during the chronic phase of severe TBI.	[Qiu, Xuecheng; Ping, Suning; Kyle, Michele; Chin, Lawrence; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA; [Zhao, Li-Ru] Syracuse VA Med Ctr, VA Hlth Care Upstate New York, Syracuse, NY 13210 USA		Zhao, LR (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, 750 E Adams St, Syracuse, NY 13210 USA.; Zhao, LR (corresponding author), Syracuse VA Med Ctr, VA Hlth Care Upstate New York, Syracuse, NY 13210 USA.	ZHAOL@upstate.edu			Merit Review AwardUS Department of Veterans Affairs [I01RX002125]; United States Department of Veterans Affairs Rehabilitation Research & Development Service	This study was supported by Merit Review Award (I01RX002125 to L.R.Z.) from the United States Department of Veterans Affairs Rehabilitation Research & Development Service. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Basso L, 2017, P NATL ACAD SCI USA, V114, P11235, DOI 10.1073/pnas.1706053114; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; BRIDDELL RA, 1993, BLOOD, V82, P1720; Cain DP, 1996, BEHAV NEUROSCI, V110, P86, DOI 10.1037/0735-7044.110.1.86; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coronado VG., 2012, BRAIN INJURY MED PRI, P93; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cui LL, 2016, ASN NEURO, V8, DOI 10.1177/1759091416655010; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; De Coninck M, 2017, SOMATOSENS MOT RES, V34, P172, DOI 10.1080/08990220.2017.1372740; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Duarte RF, 2000, BLOOD, V96, P3422; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gao M, 2018, MOL NEUROBIOL, V55, P5913, DOI 10.1007/s12035-017-0814-x; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Giacino JTC, 2016, REHABILITATION ACCES; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Guo XZ, 2020, AGING DIS, V11, P1423, DOI 10.14336/AD.2020.0201; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Harris NG, 2013, J NEUROTRAUM, V30, P1137, DOI 10.1089/neu.2012.2785; Hess DA, 2002, BLOOD, V100, P869, DOI 10.1182/blood.V100.3.869; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hiraoka T, 2019, NEUROCASE, V25, P10, DOI 10.1080/13554794.2019.1599026; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/S0006-8993(96)00792-5; Kawaguchi Y, 2017, CEREB CORTEX, V27, P5755, DOI 10.1093/cercor/bhx252; Kennard JA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00009; Kim HJ, 2017, MOL PSYCHIATR, V22, P1576, DOI 10.1038/mp.2016.103; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Leon Carrion J., 2001, REV ESPANOLA NEUROPS, V3, P58; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miyanishi K, 2021, NEUROCHEM INT, V142, DOI 10.1016/j.neuint.2020.104901; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; National Data and Statistical Center, 2015, TRAUMATIC BRAIN INJU; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Oswald MJ, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00174; Peirson SN, 2018, J NEUROSCI METH, V300, P26, DOI 10.1016/j.jneumeth.2017.04.007; Qiu XC, 2020, EXP NEUROL, V330, DOI 10.1016/j.expneurol.2020.113335; Qiu XC, 2020, J NEUROTRAUM, V37, P950, DOI 10.1089/neu.2018.6170; Quiquempoix M, 2018, CELL REP, V24, P2799, DOI 10.1016/j.celrep.2018.08.038; Risher WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107591; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075562; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terashima T, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00837; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Turolla A, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/6565418; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xiong Y, 2019, NEURAL REGEN RES, V14, P1477, DOI 10.4103/1673-5374.255957; Zhang SC, 1997, J NEUROSCI RES, V47, P1; Zhang SC, 1998, J NEUROSCI RES, V53, P29; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001; Zysk M, 2019, J ALZHEIMERS DIS, V72, P161, DOI 10.3233/JAD-190572	87	1	1	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	APR 8	2021	9	1							63	10.1186/s40478-021-01160-3			25	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL7DK	WOS:000639128800001	33832542	gold, Green Published			2022-02-06	
J	Wei, G; Wang, JW; Wu, YB; Zheng, XX; Zeng, YL; Li, YS; Chen, XR				Wei, Guan; Wang, Jiawei; Wu, Yanbin; Zheng, Xiaoxin; Zeng, Yile; Li, Yasong; Chen, Xiangrong			Sirtuin 1 alleviates neuroinflammation-induced apoptosis after traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						neuroinflammation; neuronal apoptosis; NF&#8208; &#954; B; sirtuin 1; traumatic brain injury		Sirtuin 1 (SIRT1) plays a very important role in a wide range of biological responses, such as metabolism, inflammation and cell apoptosis. Changes in the levels of SIRT1 have been detected in the brain after traumatic brain injury (TBI). Further, SIRT1 has shown a neuroprotective effect in some models of neuronal death; however, its role and working mechanisms are not well understood in the model of TBI. This study aimed to address this issue. SIRT1-specific inhibitor (sirtinol) and activator (A3) were introduced to explore the role of SIRT1 in cell apoptosis. Results of the study suggest that SIRT1 plays an important role in neuronal apoptosis after TBI by inhibiting NF-kappa B, IL-6 and TNF-alpha deacetylation and the apoptotic pathway sequentially, possibly by alleviating neuroinflammation.	[Wei, Guan; Wang, Jiawei] Fujian Med Univ, Affiliated Hosp 2, Dept Emergency, Quanzhou, Peoples R China; [Wu, Yanbin; Zheng, Xiaoxin] Anxi Cty Hosp Tradit Chinese Med, Dept Neurosurg, Quanzhou, Peoples R China; [Zeng, Yile; Li, Yasong; Chen, Xiangrong] Fujian Med Univ, Affiliated Hosp 2, Dept Neurosurg, Quanzhou, Peoples R China		Li, YS; Chen, XR (corresponding author), 34 North Zhongshan Rd, Quanzhou 362000, Fujian, Peoples R China.	liyasong1861@126.com; xiangrong_chen281@163.com			Fujian Province Scientific Foundation [2018J01284, 2020J01223]; Quanzhou Scientific Foundation [2018N024S]	Fujian Province Scientific Foundation, Grant/Award Number: 2018J01284 and 2020J01223; Quanzhou Scientific Foundation, Grant/Award Number: 2018N024S	Agrawal R, 2016, J CEREBR BLOOD F MET, V36, P941, DOI 10.1177/0271678X15606719; Chandrasekaran K, 2019, BRAIN, V142, P3737, DOI 10.1093/brain/awz324; Chen HZ, 2016, CIRC RES, V119, P1076, DOI 10.1161/CIRCRESAHA.116.308895; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Deng ZH, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190189; Elesela S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008319; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Hong Q, 2018, KIDNEY INT, V93, P1330, DOI 10.1016/j.kint.2017.12.008; Latifkar A, 2019, DEV CELL, V49, P393, DOI 10.1016/j.devcel.2019.03.011; Leikin JB, 2019, DM-DIS MON, V65, DOI 10.1016/j.disamonth.2019.02.010; Lipphardt M, 2020, PFLUG ARCH EUR J PHY, V472, P991, DOI 10.1007/s00424-020-02407-z; Liu J, 2020, MOL CELL BIOCHEM, V472, P105, DOI 10.1007/s11010-020-03789-5; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Perovic M, 2020, NUTR NEUROSCI, DOI 10.1080/1028415X.2020.1769410; Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004; Ren MT, 2019, WORLD J GASTROENTERO, V25, P5800, DOI 10.3748/wjg.v25.i38.5800; Rizzi L, 2018, NEUROPEPTIDES, V71, P54, DOI 10.1016/j.npep.2018.07.001; Rubovitch V, 2019, J MOL NEUROSCI, V67, P613, DOI 10.1007/s12031-019-01271-6; Seo DY, 2019, INT NEUROUROL J, V23, pS82, DOI 10.5213/inj.1938214.107; Shabab T, 2017, INT J NEUROSCI, V127, P624, DOI 10.1080/00207454.2016.1212854; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Wang J, 2021, MOL NEUROBIOL, V58, P1052, DOI 10.1007/s12035-020-02171-2; Wang WT, 2019, BIOCHEM BIOPH RES CO, V518, P657, DOI 10.1016/j.bbrc.2019.08.100; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zhang XS, 2021, BRIT J PHARMACOL, V178, P1114, DOI 10.1111/bph.15346; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	28	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	MAY	2021	25	9					4478	4486		10.1111/jcmm.16534		APR 2021	9	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	RW6HC	WOS:000637784100001	33830639	gold, Green Published			2022-02-06	
J	Marincowitz, C; Paton, L; Lecky, F; Tiffin, P				Marincowitz, Carl; Paton, Lewis; Lecky, Fiona; Tiffin, Paul			Predicting need for hospital admission in patients with traumatic brain injury or skull fractures identified on CT imaging: a machine learning approach	EMERGENCY MEDICINE JOURNAL			English	Article; Early Access						trauma; research; trauma; head; imaging; CT; MRI	COMPUTED-TOMOGRAPHY; POOR	Background Patients with mild traumatic brain injury on CT scan are routinely admitted for inpatient observation. Only a small proportion of patients require clinical intervention. We recently developed a decision rule using traditional statistical techniques that found neurologically intact patients with isolated simple skull fractures or single bleeds <5 mm with no preinjury antiplatelet or anticoagulant use may be safely discharged from the emergency department. The decision rule achieved a sensitivity of 99.5% (95% CI 98.1% to 99.9%) and specificity of 7.4% (95% CI 6.0% to 9.1%) to clinical deterioration. We aimed to transparently report a machine learning approach to assess if predictive accuracy could be improved. Methods We used data from the same retrospective cohort of 1699 initial Glasgow Coma Scale (GCS) 13-15 patients with injuries identified by CT who presented to three English Major Trauma Centres between 2010 and 2017 as in our original study. We assessed the ability of machine learning to predict the same composite outcome measure of deterioration (indicating need for hospital admission). Predictive models were built using gradient boosted decision trees which consisted of an ensemble of decision trees to optimise model performance. Results The final algorithm reported a mean positive predictive value of 29%, mean negative predictive value of 94%, mean area under the curve (C-statistic) of 0.75, mean sensitivity of 99% and mean specificity of 7%. As with logistic regression, GCS, severity and number of brain injuries were found to be important predictors of deterioration. Conclusion We found no clear advantages over the traditional prediction methods, although the models were, effectively, developed using a smaller data set, due to the need to divide it into training, calibration and validation sets. Future research should focus on developing models that provide clear advantages over existing classical techniques in predicting outcomes in this population.	[Marincowitz, Carl; Lecky, Fiona] Univ Sheffield, Ctr Urgent & Emergency Care Res CURE, Hlth Serv Res Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Paton, Lewis] Univ York, Dept Hlth Sci, Alcuin Coll, York, N Yorkshire, England; [Tiffin, Paul] Univ York, Hull York Med Sch Dept Hlth Sci, York, N Yorkshire, England		Marincowitz, C (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England.	c.marincowitz@sheffield.ac.uk		Marincowitz, Carl/0000-0003-3043-7564	European Union Framework 7 Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (EC) [602150]; NHS Trusts 'Trauma Audit and Research Network; NIHR Career Development Fellowship [CDF-201508-11]; National Institute for Health ResearchNational Institute for Health Research (NIHR); University of YorkEuropean Commission; University of Sheffield	FL is supported by the European Union Framework 7 Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury ((EC grant 602150)) and NHS Trusts 'Trauma Audit and Research Network -www.tarn.ac.uk' (Grant Number Not Applicable/NA). CM is a National Institute for Health Research (NIHR) Clinical Lecturer in Emergency Medicine (Grant Number Not Applicable/NA). PT is funded in his research by an NIHR Career Development Fellowship (CDF-201508-11). This publication presents independent research funded by the National Institute for Health Research, University of Sheffield and University of York.	Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; De Fauw J, 2018, NAT MED, V24, P1342, DOI 10.1038/s41591-018-0107-6; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heus P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1099-2; Honaker J, 2011, J STAT SOFTW, V45, P1; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kaggle Forum, 2018, RANK KAGGL ALG COMP; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; Marincowitz Carl, 2018, Diagn Progn Res, V2, P6, DOI 10.1186/s41512-018-0027-4; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; NICE, 2014, CG 176 HEAD INJ TRIA; Niculescu-Mizil A, 2005, OBTAINING CALIBRATED, P413; R Core Team, 2019, R LANG ENV STAT COMP; Shah AD, 2019, J BIOMED SEMANT, V10, DOI 10.1186/s13326-019-0214-4; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; TIFFIN P, 1995, PSYCHOPHARMACOLOGY, V121, P494, DOI 10.1007/BF02246500	19	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.												10.1136/emermed-2020-210776		APR 2021	8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	XL6TC	WOS:000728275400001	33832924	Green Accepted			2022-02-06	
J	Zou, JR; Sun, HT; Xiang, Y				Zou, Jingrong; Sun, Haitao; Xiang, Yang			Correlation of serum cystatin C with inflammatory cytokines in patients with traumatic brain injury	SYNAPSE			English	Article						Cystatin C (Cys C); inflammatory cytokine; prognostic biomarker; traumatic brain injury (TBI)		Traumatic brain injury (TBI) is a world-wide leading health problem with high morbidity and mortality rates. Emerging studies have demonstrated that TBI is the consequence of a series of inflammatory responses in the body. The alteration of Cystatin C (Cys C) was reported in a variety of chronic inflammatory diseases and was also recommended as a biomarker for predicting renal diseases. In this study, we aimed to investigate the relationship between serum Cys C and TBI, and to evaluate the prognostic role of Cys C in TBI prediction. One hundred and seventy-six patients with TBI were recruited and 102 patients were finally analyzed, with 30 healthy control subjects. The concentrations of Cys C were significantly reduced in the healthy control group compared to the TBI group, and correlated with high GCS scores. The levels of hsCRP, counts of white blood cells, and levels of IL-6 and TNF-alpha were remarkably elevated in the TBI patients compared with the control group in a severity-dependent manner. Moreover, the concentration of Cys C was negatively correlated with TBI severity and positively correlated with inflammatory factors. In conclusion, serum Cys is an inflammatory cytokine-related factor and might indicate the severity of TBI thus serving as a prognostic biomarker.	[Zou, Jingrong; Sun, Haitao; Xiang, Yang] Wuxi Huishan Dist Peoples Hosp, Dept Emergency, 2 Zhanqian North Rd, Wuxi 214187, Jiangsu, Peoples R China		Xiang, Y (corresponding author), Wuxi Huishan Dist Peoples Hosp, Dept Emergency, 2 Zhanqian North Rd, Wuxi 214187, Jiangsu, Peoples R China.	xiangyang7615@163.com					Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Albrecht JS, 2020, J HEAD TRAUMA REHAB, V35, pE352, DOI 10.1097/HTR.0000000000000551; Bargnoux AS, 2019, ANN BIOL CLIN-PARIS, V77, P375, DOI 10.1684/abc.2019.1456; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Domej W, 2002, CLIN SCI, V102, P373, DOI 10.1042/CS20010168; Ferguson TW, 2015, CURR OPIN NEPHROL HY, V24, P295, DOI 10.1097/MNH.0000000000000115; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Huang XT, 2020, NEUROREPORT, V31, P293, DOI 10.1097/WNR.0000000000001397; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kim CY, 2013, J VASC INTERV RADIOL, V24, P1845, DOI 10.1016/j.jvir.2013.08.012; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; LEUNGTACK J, 1990, EXP CELL RES, V188, P16, DOI 10.1016/0014-4827(90)90272-C; Muslimovic Alma, 2015, Mater Sociomed, V27, P75, DOI 10.5455/msm.2015.27.75-78; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Okura T, 2010, CLIN EXP NEPHROL, V14, P584, DOI 10.1007/s10157-010-0334-8; Rokadia HK, 2012, LUNG, V190, P283, DOI 10.1007/s00408-012-9374-z; Shao HF, 2019, EUR REV MED PHARMACO, V23, P4341, DOI 10.26355/eurrev_201905_17940; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; SUN Q, 1989, EXP CELL RES, V180, P150, DOI 10.1016/0014-4827(89)90219-X; Takeyabu K, 1998, EUR RESPIR J, V12, P1033, DOI 10.1183/09031936.98.12051033; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; van der Laan SW, 2016, J AM COLL CARDIOL, V68, P934, DOI 10.1016/j.jacc.2016.05.092; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wang GN, 2014, CLIN BIOCHEM, V47, P176, DOI 10.1016/j.clinbiochem.2014.07.013; Werle B, 2003, BIOL CHEM, V384, P281, DOI 10.1515/BC.2003.031; Xu YK, 2015, IMMUNOL CELL BIOL, V93, P442, DOI 10.1038/icb.2014.121; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zi MT, 2018, IMMUNOL LETT, V196, P80, DOI 10.1016/j.imlet.2018.01.006	34	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-4476	1098-2396		SYNAPSE	Synapse	AUG	2021	75	8							e22201	10.1002/syn.22201		APR 2021	9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TB3BJ	WOS:000637514400001	33797795				2022-02-06	
J	Bradbury, KR; Williams, C; Leonard, S; Holding, E; Turner, E; Wagner, AE; Piantino, J; Luther, M; Hall, TA				Bradbury, Kathryn R.; Williams, Cydni; Leonard, Skyler; Holding, Emily; Turner, Elise; Wagner, Amanda E.; Piantino, Juan; Luther, Madison; Hall, Trevor A.			Emotional Aspects of Pediatric Post-Intensive Care Syndrome Following Traumatic Brain Injury	JOURNAL OF CHILD & ADOLESCENT TRAUMA			English	Article						Traumatic brain injury; Acute recovery; Post-intensive care syndrome; Emotional functioning		Children with traumatic brain injury (TBI) requiring neurocritical care are at risk for neurocognitive, emotional, physical, and psychosocial difficulties, collectively known as Post-Intensive Care Syndrome. Our study assessed parent-reported emotional functioning and identified risk factors for emotional sequelae in the acute recovery phase. Fifty-three children between 5 and 18 years old hospitalized for TBI were assessed 1-month following discharge. Relevant injury-, child-, and family-specific variables were collected. Emotional functioning was assessed using PROMIS Parent Proxy Report Short Forms for Anxiety and Depressive Symptoms. We used Chi-square tests to evaluate differences between children with and without elevations in anxiety and depressive symptoms. Logistic regression determined predictors of elevations in symptoms among significant variables. Parents frequently endorsed moderate or worse anxiety (45.2%) and depressive (32.1%) symptoms among children. Mechanism of injury and elevated parent post-traumatic stress disorder (PTSD) symptoms were associated with elevated anxiety and depressive symptoms, while direct family involvement in the accident/injury was associated only with elevated anxiety symptoms. Results from logistic regression indicated that only elevated parent PTSD symptoms were a significant predictor for child anxiety and depressive symptoms. Anxiety and depressive symptoms are prevalent in the acute recovery phase of TBI. Consistent with previous research, elevations in anxiety and depressive symptoms were more related to psychosocial factors than injury severity. High levels of parent PTSD symptoms and their relationship with children's internalizing symptoms highlight the need for mental health treatment for TBI patients and their families.	[Bradbury, Kathryn R.; Leonard, Skyler; Holding, Emily; Turner, Elise; Wagner, Amanda E.; Hall, Trevor A.] Oregon Hlth & Sci Univ, Inst Dev & Disabil, Dept Pediat, Div Pediat Psychol, Portland, OR 97239 USA; [Bradbury, Kathryn R.; Williams, Cydni; Leonard, Skyler; Holding, Emily; Turner, Elise; Wagner, Amanda E.; Piantino, Juan; Luther, Madison; Hall, Trevor A.] Doembecher Childrens Hosp, Portland, OR 97239 USA; [Bradbury, Kathryn R.] Childrens Neuropsychol Serv, 26 Chestnut St,Suite 2E, Andover, MA USA; [Williams, Cydni] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Crit Care, Portland, OR USA; [Williams, Cydni; Piantino, Juan; Luther, Madison; Hall, Trevor A.] Oregon Hlth & Sci Univ, Pediat Crit Care & Neurotrauma Recovery Program, Portland, OR USA; [Wagner, Amanda E.] Child Mind Inst, San Mateo, CA USA; [Piantino, Juan] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Neurol, Portland, OR USA		Bradbury, KR (corresponding author), Oregon Hlth & Sci Univ, Inst Dev & Disabil, Dept Pediat, Div Pediat Psychol, Portland, OR 97239 USA.; Bradbury, KR (corresponding author), Doembecher Childrens Hosp, Portland, OR 97239 USA.	kathryn.bradbury@gmail.com			Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL133115]	This work was supported by the Agency for Healthcare Research and Quality (grant number K12HS022981 to CW); and the National Heart, Lung, and Blood Institute (grant number K12HL133115 to JP).	Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Bertisch H, 2017, QUAL LIFE RES, V26, P1887, DOI 10.1007/s11136-017-1524-6; Bitsko RH, 2018, J DEV BEHAV PEDIATR, V39, P395, DOI 10.1097/DBP.0000000000000571; Cantwell DP, 1997, J AM ACAD CHILD PSY, V36, P610, DOI 10.1097/00004583-199705000-00011; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Dodd JN, 2018, PEDIATR NEUROL, V89, P58, DOI 10.1016/j.pediatrneurol.2018.09.007; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Hall TA, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1797176; Hartman ME, 2020, PEDIATR NEUROL, V108, P47, DOI 10.1016/j.pediatrneurol.2020.02.003; Irwin DE, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-22; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Kirkwood MW, 2017, CHILD NEUROPSYCHOL, V23, P273, DOI 10.1080/09297049.2015.1130219; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Manning JC, 2018, PEDIATR CRIT CARE ME, V19, P298, DOI 10.1097/PCC.0000000000001476; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McConnell B, 2020, J CHILD NEUROL, V35, P63, DOI 10.1177/0883073819876473; Nelson LP, 2012, PEDIATR CRIT CARE ME, V13, P338, DOI 10.1097/PCC.0b013e3182196a8f; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Cordts KMP, 2020, NEUROCRIT CARE, V33, P196, DOI 10.1007/s12028-019-00883-5; Prins A., 2015, PRIMARY CARE PTSD SC; Rennick JE, 2009, J CHILD HEALTH CARE, V13, P128, DOI 10.1177/1367493509102472; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stewart TC, 2013, J TRAUMA ACUTE CARE, V75, P836, DOI 10.1097/TA.0b013e3182a685b0; TEASDALE G, 1974, LANCET, V2, P81; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Williams Cydni N, 2019, Hosp Pediatr, V9, P958, DOI 10.1542/hpeds.2019-0173; Williams Cydni N, 2018, J Pediatr Intensive Care, V7, P173, DOI 10.1055/s-0038-1637005; Williams CN, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4090083; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	36	1	1	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1936-1521	1936-153X		J CHILD ADOLES TRAUM	J. Child Adolesc. Trauma	JUN	2021	14	2					177	187		10.1007/s40653-020-00332-y		APR 2021	11	Family Studies; Social Work	Emerging Sources Citation Index (ESCI)	Family Studies; Social Work	RZ4LE	WOS:000637893200001	33986904				2022-02-06	
J	Cicchino, JB; Kulie, PE; McCarthy, ML				Cicchino, Jessica B.; Kulie, Paige E.; McCarthy, Melissa L.			Injuries related to electric scooter and bicycle use in a Washington, DC, emergency department	TRAFFIC INJURY PREVENTION			English	Article						Micromobility; e-scooter; injury; bicycle; shared mobility	INFRASTRUCTURE; COHORT; RISK; BIKE	Objective E-scooter use has grown rapidly in the United States. Its rise in popularity has coincided with the promotion of cycling in many cities, but more needs to be known about how these transportation modes compare to determine if cycling should serve as an appropriate benchmark for policy decisions and safety expectations regarding e-scooters. Methods We examined characteristics of adults seeking treatment in a Washington, DC, emergency department (ED) for injuries associated with riding e-scooters during 2019 (n = 99) or bicycles during 2015-2017 (n = 337). Results E-scooter incidents less frequently involved moving vehicles (13.1% vs. 37.7%) or occurred on roads (24.5% vs. 50.7%) than cycling incidents. A smaller proportion of injured e-scooter riders were ages 30-49 (32.3% vs. 48.4%) and a larger proportion were 50 and older (34.3% vs. 22.6%) or female (45.5% vs. 29.1%). Distal lower extremity injuries were more common among e-scooter riders (13.1% vs. 3.0%; RR, 2.76; 95% CI, 1.79-3.54), and injuries to the proximal upper extremity (9.1% vs. 20.5%; RR, 0.49; 95% CI, 0.24-0.92) or chest, abdomen, and spine (3.0% vs. 14.0%; RR, 0.24; 95% CI, 0.07-0.70) were less common. Head injury rates were similar, but e-scooter riders more often experienced concussion with loss of consciousness (4.0% vs. 0.6%; RR, 3.03; 95% CI, 1.20-4.09) and were far less likely to wear helmets (2.0% vs. 66.4%). Estimated ED presentation rates per million miles traveled citywide were higher among e-scooter riders than cyclists (RR, 3.76; 95% CI, 3.08-4.59). Conclusions E-scooters and bicycles are both popular forms of micromobility, but the characteristics of riders injured on them, the ways in which they become injured, and the types of injuries they sustain differ substantially. E-scooter rider injury rates, though currently high, may decrease as they gain experience; however, if the number of new users continues to climb, they will persist in using the ED more often than cyclists per mile that they travel.	[Cicchino, Jessica B.] Insurance Inst Highway Safety, 4121 Wilson Blvd,6th Floor, Arlington, VA 22203 USA; [Kulie, Paige E.] George Washington Univ, Med Ctr, Dept Emergency Med, Washington, DC 20037 USA; [McCarthy, Melissa L.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA		Cicchino, JB (corresponding author), Insurance Inst Highway Safety, 4121 Wilson Blvd,6th Floor, Arlington, VA 22203 USA.	jcicchino@iihs.org		Cicchino, Jessica/0000-0003-4337-518X	Insurance Institute for Highway Safety	This work was supported by the Insurance Institute for Highway Safety.	Badeau A, 2019, AM J EMERG MED, V37, P1531, DOI 10.1016/j.ajem.2019.05.003; Cicchino JB, 2020, ACCIDENT ANAL PREV, V141, DOI 10.1016/j.aap.2020.105490; DAVIDSON J, 2005, EUR J EMERG MED, V12; DiGioia J, 2017, J SAFETY RES, V61, P105, DOI 10.1016/j.jsr.2017.02.015; DiMaggio CJ, 2020, INJURY PREV, V26, P524, DOI 10.1136/injuryprev-2019-043418; English KC, 2020, TRAFFIC INJ PREV, V21, P476, DOI 10.1080/15389588.2020.1804059; Gennarelli TA., 2008, ABBREVIATED INJURY S; Ling ZW, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9091662; Namiri NK, 2020, JAMA SURG, V155, P357, DOI 10.1001/jamasurg.2019.5423; National Association of City Transportation Officials, 2020, SHAR MICR US 2019; National Highway Traffic Safety Administration, 2020, TRAFF SAF FACTS; Nelson NG, 2011, AM J SPORT MED, V39, P404, DOI 10.1177/0363546510383478; Otte D, 2020, J TRANSP SAF SECUR, V12, P116, DOI 10.1080/19439962.2019.1662530; Poulos RG, 2015, ACCIDENT ANAL PREV, V78, P29, DOI 10.1016/j.aap.2015.02.009; Puzio TJ, 2020, TRAFFIC INJ PREV, V21, P175, DOI 10.1080/15389588.2019.1709176; Sanders RL, 2020, TRANSPORT RES A-POL, V139, P217, DOI 10.1016/j.tra.2020.07.009; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Thompson MJ, 2001, AM FAM PHYSICIAN, V63, P2007; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381; United States Census Bureau, AM COMMUNITY SURVEY; Watson HN., 2020, SAE TECHNICAL PAPER, DOI [10.4271/2020-01-0933, DOI 10.4271/2020-01-0933]; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	22	1	1	3	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	JUN 9	2021	22	5					401	406		10.1080/15389588.2021.1913280		APR 2021	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	SO3TO	WOS:000648183300001	33960868				2022-02-06	
J	Yeates, TM; Taylor, HG; Bigler, ED; Minich, NM; Tang, K; Cohen, DM; Bacevice, A; Mihalov, LK; Bangert, B; Zumberge, NA; Yeates, KO				Yeates, Taylor M.; Taylor, H. Gerry; Bigler, Erin D.; Minich, Nori M.; Tang, Ken; Cohen, Daniel M.; Bacevice, Ann; Mihalov, Leslie K.; Bangert, Barbara; Zumberge, Nicholas A.; Yeates, Keith Owen			Sex Differences in the Outcomes of Mild Traumatic Brain Injury in Children Presenting to the Emergency Department	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						concussion; outcome; pediatric; sex; traumatic brain injury		Sex differences after concussion have been studied largely in high school and college athletes, often without reference to comparison groups without concussion. This study sought to evaluate sex differences in outcomes among all children and adolescents presenting to the Emergency Department (ED) for either mild traumatic brain injury (TBI) or orthopedic injury (OI), regardless of mechanism of injury. The study involved a concurrent cohort, prospective study design with longitudinal follow-up. Participants were eight to 16 years old with mild TBI (n = 143) or OI (n = 73). They were recruited and completed an initial assessment at EDs at two children's hospitals. They returned for a post-acute assessment within two weeks of injury and for follow-up assessments at three and six months. Outcomes included child and parent proxy ratings of somatic and cognitive symptoms, and standardized tests of cognitive functioning and balance. Sex did not moderate group differences in balance, fluid or crystallized cognitive ability, or child or parent proxy ratings of somatic or cognitive symptoms. Both parents and children reported more somatic symptoms in girls than boys, but in both groups. Compared with the OI group, the mild TBI group showed significantly lower fluid cognitive ability at the post-acute assessment and significantly higher somatic and cognitive symptoms according to both child and parent proxy ratings across the first two weeks post-injury. The results suggest that sex does not moderate the outcomes of mild TBI in a pediatric ED population. Previous research pointing to sex differences after concussion may reflect the lack of comparison groups, as well as a focus on adolescents and young adults and sport-related concussion. Future research should investigate whether sex moderates the outcomes of pediatric mild TBI in adolescents but not in pre-adolescent children.	[Yeates, Taylor M.] Wright State Univ, Dept Populat & Publ Hlth Sci, Boonshoft Sch Med, Dayton, OH 45435 USA; [Taylor, H. Gerry; Cohen, Daniel M.; Mihalov, Leslie K.] Ohio State Univ, Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43210 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Minich, Nori M.; Bacevice, Ann] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Minich, Nori M.; Bacevice, Ann] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Tang, Ken] Childrens Hosp Eastern Ontario, Clin Res Unit, Res Inst, Ottawa, ON, Canada; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Radiol, Cleveland, OH USA; [Bangert, Barbara] Univ Hosp Hlth Syst, Dept Neurosurg, Cleveland, OH USA; [Zumberge, Nicholas A.] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Res Inst, Alberta Childrens Hosp, Calgary, AB, Canada		Yeates, TM (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Populat & Publ Hlth Sci, 3640 Colonel Glenn Hwy, Fairborn, OH 45324 USA.	yeates.2@wright.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01HD076885]	This work was supported by the National Institutes of Health grant R01HD076885.	Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; ANDREASON PJ, 1994, PSYCHIAT RES, V51, P175, DOI 10.1016/0165-1781(94)90037-X; [Anonymous], 1990, ABBREVIATED INJURY S; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beck JE, 2008, J PEDIATR PSYCHOL, V33, P547, DOI 10.1093/jpepsy/jsm113; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Esposito G, 1996, J NUCL MED, V37, P559; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Gray M, 2020, PHYS THER SPORT, V42, P68, DOI 10.1016/j.ptsp.2020.01.001; Green P, 2004, GREENS MED SYMPTOM V; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Harrell FE, 2015, SPRINGER SER STAT, P13, DOI 10.1007/978-3-319-19425-7_2; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson S.S., 2008, REPORT TRENDS PARTIC, V2008; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lyons TW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00690; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Oldham JR, 2020, J SCI MED SPORT, V23, P814, DOI 10.1016/j.jsams.2020.04.003; Patsimas T, 2020, J ATHL TRAINING, V55, P1020, DOI 10.4085/1062-6050-200-19; Pinheiro J. C., 2000, MIXED EFFECTS MODELS; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Romero-Acosta K, 2013, J MENT HEALTH, V22, P33, DOI 10.3109/09638237.2012.734655; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Sweeting H, 2003, SOC SCI MED, V56, P31, DOI 10.1016/S0277-9536(02)00010-2; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEASDALE G, 1974, LANCET, V2, P81; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Weintraub S, 2013, MONOGR SOC RES CHILD, V78, P1, DOI 10.1111/mono.12031; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yeates T.M., 2019, SEX DIFFERENCES OUTC	64	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2020.7470		APR 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ1VF	WOS:000637388800001	33678004	Green Submitted			2022-02-06	
J	Hiskens, MI; Vella, RK; Schneiders, AG; Fenning, AS				Hiskens, Matthew I.; Vella, Rebecca K.; Schneiders, Anthony G.; Fenning, Andrew S.			Minocycline improves cognition and molecular measures of inflammation and neurodegeneration following repetitive mTBI	BRAIN INJURY			English	Article						Concussion; animal models; neurobehavioral; rehabilitation		Objective To compare the neuroprotective effects of minocycline treatment in a murine model of mTBI on measures of spatial learning and memory, neuroinflammation, excitotoxicity, and neurodegeneration. Design Adult male C57BL/6 J mice were randomly assigned into vehicle control, vehicle with repetitive mTBI, minocycline without mTBI, or minocycline with repetitive mTBI groups. Methods A validated mouse model of repetitive impact-induced rotational acceleration was used to deliver 15 mTBIs across 23 days. Cognition was assessed via Morris water maze (MWM) testing, and mRNA analysis investigated MAPT, GFAP, AIF1, GRIA1, TARDBP, TNF, and NEFL genes. Assessment was undertaken 48 h and 3 months following final mTBI. Results In the chronic phase of recovery, MWM testing revealed impairment in the vehicle mTBI group compared to unimpacted controls (p < .01) that was not present in the minocycline mTBI group, indicating chronic neuroprotection. mRNA analysis revealed AIF1 elevation in the acute cortex (p < .01) and chronic hippocampus (p < .01) of the vehicle mTBI group, with minocycline treatment leading to improved markers of microglial activation and inflammation in the chronic stage of recovery. Conclusions These data suggest that minocycline treatment alleviated some mTBI pathophysiology and clinical features at chronic time-points.	[Hiskens, Matthew I.; Vella, Rebecca K.; Schneiders, Anthony G.; Fenning, Andrew S.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld 4701, Australia		Hiskens, MI (corresponding author), Cent Queensland Univ, Sch Hlth Med & Appl Sci, Rockhampton, Qld 4701, Australia.	m.hiskens@cqu.edu.au		Hiskens, Matthew/0000-0001-7054-1492	Australian Government Research Training SchemeAustralian Government	This project was supported by the Australian Government Research Training Scheme. The funding source was not involved in any of the following: study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication.	Adembri C, 2014, CRIT CARE MED, V42, pE570, DOI 10.1097/CCM.0000000000000414; Agoston DV, 2012, FRONT NEUROL, V3; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dafinca R, 2020, STEM CELL REP, V14, P892, DOI 10.1016/j.stemcr.2020.03.023; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Garrido-Mesa N, 2013, PHARMACOL RES, V67, P18, DOI 10.1016/j.phrs.2012.10.006; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hiskens M., 2021, TRAUMA CARE, V1, P23, DOI DOI 10.3390/TRAUMACARE1010003; Hiskens MI, 2020, BIOMARKERS, V25, P213, DOI 10.1080/1354750X.2020.1735521; Hiskens MI, 2019, J NEUROSCI RES, V97, P1194, DOI 10.1002/jnr.24472; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; IQBAL K, 1986, LANCET, V328; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Cabezas IL, 2014, NEUROLOGIA, V29, P305, DOI 10.1016/j.nrl.2012.10.006; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Garcia-Martinez EM, 2010, BIOCHEM PHARMACOL, V79, P239, DOI 10.1016/j.bcp.2009.07.028; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meythaler J, 2019, BRAIN INJURY, V33, P679, DOI 10.1080/02699052.2019.1566968; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot4085, 10.1101/pdb.prot4044, 10.1101/pdb.prot3723, 10.1101/pdb.prot4453, 10.1101/pdb.prot3966, 10.1101/pdb.prot3871, 10.1101/pdb.prot4022, 10.1101/pdb.prot4027, 10.1101/pdb.prot4056, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050]; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Sephton CF, 2012, BIOL CHEM, V393, P589, DOI 10.1515/hsz-2012-0115; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Shochat A, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.1.015001; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhang LJ, 2020, ARCH BIOCHEM BIOPHYS, V682, DOI 10.1016/j.abb.2020.108302	61	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					831	841		10.1080/02699052.2021.1909139		APR 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000636598000001	33818227				2022-02-06	
J	Rault, F; Terrier, L; Leclerc, A; Gilard, V; Emery, E; Derrey, S; Briant, AR; Gakuba, C; Gaberel, T				Rault, Frederick; Terrier, Laura; Leclerc, Arthur; Gilard, Vianney; Emery, Evelyne; Derrey, Stephane; Briant, Anais R.; Gakuba, Clement; Gaberel, Thomas			Decreased number of deaths related to severe traumatic brain injury in intensive care unit during the first lockdown in Normandy: at least one positive side effect of the COVID-19 pandemic	ACTA NEUROCHIRURGICA			English	Article						COVID-19; Traumatic brain injury; Lockdown; Intensive care unit; Outcome		Background The COVID-19 pandemic has led to severe containment measures to protect the population in France. The first lockdown modified daily living and could have led to a decrease in the frequency of severe traumatic brain injury (TBI). In the present study, we compared the frequency and severity of severe TBI before and during the first containment in Normandy. Methods We included all patients admitted in the intensive care unit (ICU) for severe TBI in the two tertiary neurosurgical trauma centres of Normandy during the first lockdown. The year before the containment served as control. The primary outcome was the number of patients admitted per week in ICU. We compared the demographic characteristics, TBI mechanisms, CT scan, surgical procedure, and mortality rate. Results The incidence of admissions for severe TBI in Normandy decreased by 33% during the containment. The aetiology of TBI significantly changed during the containment: there were less traffic road accidents and more TBI related to alcohol consumption. Patients with severe TBI during the containment had a better prognosis according to the impact score (p=0.04). We observed a significant decrease in the rate of short-term mortality related to severe TBI during the period of lockdown (p=0.02). Conclusions Containment related to the COVID-19 pandemic has resulted in a modification of the mechanisms of severe TBI in Normandy, which was associated with a decline in the rate of short-term death in intensive unit care.	[Rault, Frederick; Leclerc, Arthur; Emery, Evelyne; Gaberel, Thomas] Caen Univ Hosp, Dept Neurosurg, Ave Cote Nacre, F-14000 Caen, France; [Terrier, Laura; Gilard, Vianney; Derrey, Stephane] Rouen Univ Hosp, Dept Neurosurg, F-76000 Rouen, France; [Gilard, Vianney] Normandie Univ, UNIROUEN, Lab Microvascular Endothelium & Neonate Brain Les, INSERM,U1245, F-76000 Rouen, France; [Emery, Evelyne; Gakuba, Clement; Gaberel, Thomas] Normandie Univ, Inst Blood & Brain Caen Normandie, PhIND Physiopathol & Imaging Neurol Disorders, UNICAEN,INSERM,U1237, F-14000 Caen, France; [Emery, Evelyne; Gakuba, Clement; Gaberel, Thomas] Univ Caen Normandie, Med Sch, F-14000 Caen, France; [Briant, Anais R.] Unite Biostat & Rech Clin UBRC, Caen, France; [Gakuba, Clement] CHU Caen, Dept Anesthesiol & Crit Care Med, F-14000 Caen, France		Rault, F (corresponding author), Caen Univ Hosp, Dept Neurosurg, Ave Cote Nacre, F-14000 Caen, France.	rault-f@chu-caen.fr		Rault, Frederick/0000-0001-5291-0952; Leclerc, Arthur/0000-0002-7373-1109			Beauchamp T., 2001, PRINCIPLES BIOMEDICA, V5th; Bernat AL, 2020, NEUROCHIRURGIE, V66, P400, DOI 10.1016/j.neuchi.2020.06.127; Borsa S, 2020, ACTA NEUROCHIR, V162, P1227, DOI 10.1007/s00701-020-04333-6; Chibbaro S, 2020, NEUROCHIRURGIE, V66, P189, DOI [10.1016/j.neuchi.2020.05.001, 10.1016/j.neuchi/2020.05.001]; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hecht N, 2020, ACTA NEUROCHIR, V162, P1795, DOI 10.1007/s00701-020-04437-z; Hulsbergen AFC, 2020, ACTA NEUROCHIR, V162, P1485, DOI 10.1007/s00701-020-04375-w; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jayakumar N, 2020, WORLD NEUROSURG, V144, pE414, DOI 10.1016/j.wneu.2020.08.162; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; Luostarinen T, 2020, ACTA NEUROCHIR, V162, P2715, DOI 10.1007/s00701-020-04583-4; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Mathiesen T, 2020, ACTA NEUROCHIR, V162, P2221, DOI 10.1007/s00701-020-04482-8; Observatoire national interminist?riel de la s?curit? routi?re, 2020, BAR AVR 2020; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pichard R, 2020, INT ORTHOP, V44, P1497, DOI 10.1007/s00264-020-04654-2; Pieh C, 2021, PSYCHOSOM MED, V83, P328, DOI 10.1097/PSY.0000000000000871; Pinggera D, 2021, EUR J TRAUMA EMERG S, V47, P653, DOI 10.1007/s00068-020-01445-7; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Roger P, 2020, BILAN DEMOGRAPHIQUE; Rolland B, 2020, JMIR PUBLIC HLTH SUR, V6, P435, DOI 10.2196/19630; Salzberger B, 2020, INFECTION, V48, P151, DOI 10.1007/s15010-020-01409-4; Sant? publique France, 2020, COVID 19 POINT PID M; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 2021, ACTA NEUROCHIR, V163, P1051, DOI 10.1007/s00701-021-04724-3; SONNE NM, 1992, BRIT J NEUROSURG, V6, P125, DOI 10.3109/02688699209002914; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Venter A, 2021, SAMJ S AFR MED J, V111, P52, DOI [10.7196/SAMJ.2021.v111i1.15289, 10.7196/samj.2021.v111i1.15289]; WHO, 2020, 75 WHO; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zoia C, 2020, ACTA NEUROCHIR, V162, P1221, DOI 10.1007/s00701-020-04305-w	32	1	1	4	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2021	163	7					1829	1836		10.1007/s00701-021-04831-1		APR 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SQ8ZB	WOS:000636624900001	33813617	Green Published, Bronze			2022-02-06	
J	Champagne, AA; Coverdale, NS; Ross, A; Murray, C; Vallee, I; Cook, DJ				Champagne, Allen A.; Coverdale, Nicole S.; Ross, Andrew; Murray, Christopher; Vallee, Isabelle; Cook, Douglas J.			Characterizing changes in network connectivity following chronic head trauma in special forces military personnel: a combined resting-fMRI and DTI study	BRAIN INJURY			English	Article						Military personnel; resting-state fMRI; DTI; sub-concussive trauma; network connectivity; head injuries		Background Soldiers are exposed to significant repetitive head trauma, which may disrupt functional and structural brain connectivity patterns. Purpose/hypothesis Integrate resting-state functional MRI (rs-fMRI) and diffusion tensor imaging (DTI) to characterize changes in connectivity biomarkers within Canadian Special Operations Forces (CANSOF), hypothesizing that alterations in architectural organization of cortical hubs may follow chronic repetitive head trauma. Methods Fifteen CANSOFs with a history of chronic exposure to sub-concussive head trauma and concussive injuries (1.9 +/- 2.0 concussions (range: [0-6])), as well as an equal age-matched cohort of controls (CTLs) were recruited. BOLD-based rs-fMRI was combined with DTI to reconstruct functional and structural networks using independent component analyses and probabilistic tractography. Connectivity markers were computed based on the distance between functional seeds to assess for possible differences in injury susceptibility of short- and long-range connections. Results/discussion Significant hyper- and hypo-connectivity differences in cortical connections were observed suggesting that chronic head trauma may predispose soldiers to changes in the functional organization of brain networks. Significant structural alterations in axonal fibers directly connecting disrupted functional nodes were specific to hyper-connected long-range connections, suggesting a potential relationship between axonal injury and increases in neural recruitment following repetitive head trauma from high-exposure military duties.	[Champagne, Allen A.; Coverdale, Nicole S.; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Champagne, Allen A.] Queens Univ, Sch Med, Kingston, ON, Canada; [Ross, Andrew; Murray, Christopher] Performance Phen, Toronto, ON, Canada; [Vallee, Isabelle] Canadian Special Operat Forces Command, Ottawa, ON, Canada; [Cook, Douglas J.] Queens Univ, Dept Surg, Kingston, ON, Canada		Champagne, AA (corresponding author), Queens Univ, Sch Med, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.	a.champagne@queensu.ca			 [00000]	This work was supported with funding provided by Performance Phenomics Inc. (Toronto, ON, Canada); Performance Phenomics [00000];	Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beckmann CF, 2012, NEUROIMAGE, V62, P891, DOI 10.1016/j.neuroimage.2012.02.020; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BISWAL B, 1995, MAGNET RESON MED, V34; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Champagne AA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz021; Champagne AA, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102204; Champagne AA, 2020, J CEREBR BLOOD F MET, V40, P1453, DOI 10.1177/0271678X19862861; Champagne AA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101753; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Concussion in Sport Group, 2013, BR J SPORTS MED, V47; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeCicco JP, 2020, CLIN NEUROPSYCHOL, V34, P1215, DOI 10.1080/13854046.2020.1783367; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; Fisher RA, 1914, BIOMETRIKA, V10, P507; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Raizman R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65948-4; Reuveni I, 2016, HUM BRAIN MAPP, V37, P589, DOI 10.1002/hbm.23051; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Roby PR, 2020, ANN BIOMED ENG, V48, P1651, DOI 10.1007/s10439-020-02514-z; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Varkuti B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014801; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Vergara VM, 2017, NEUROIMAGE, V145, P365, DOI 10.1016/j.neuroimage.2016.03.038; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Xue C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120270; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang JY, 2012, TRENDS NEUROSCI, V35, P412, DOI 10.1016/j.tins.2012.04.010	58	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2021	35	7					760	768		10.1080/02699052.2021.1906951		APR 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ST8QM	WOS:000635863200001	33792439				2022-02-06	
J	van der Horn, HJ; Mangina, NR; Rakers, SE; Kok, JG; Timmerman, ME; Leemans, A; Spikman, JM; van der Naalt, J				van der Horn, Harm Jan; Mangina, Namrata R.; Rakers, Sandra E.; Kok, Jelmer G.; Timmerman, Marieke E.; Leemans, Alexander; Spikman, Jacoba M.; van Der Naalt, Joukje			White matter microstructure of the neural emotion regulation circuitry in mild traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						concussion; connectivity; diffusion MRI; symptoms; tractography		Emotion regulation is related to recovery after mild traumatic brain injury (mTBI). This longitudinal tractography study examined white matter tracts subserving emotion regulation across the spectrum of mTBI, with a focus on persistent symptoms. Four groups were examined: (a) symptomatic (n = 33) and (b) asymptomatic (n = 20) patients with uncomplicated mTBI (i.e., no lesions on computed tomography [CT]), (c) patients with CT-lesions in the frontal areas (n = 14), and (d) healthy controls (HC) (n = 20). Diffusion and conventional MRI were performed approximately 1- and 3-months post-injury. Whole-brain deterministic tractography followed by region of interest analyses was used to identify forceps minor (FM), uncinate fasciculus (UF), and cingulum bundle as tracts of interest. An adjusted version of the ExploreDTI Atlas Based Tractography method was used to obtain reliable tracts for every subject. Mean fractional anisotropy (FA), mean, radial and axial diffusivity (MD, RD, AD), and number of streamlines were studied per tract. Linear mixed models showed lower FA, and higher MD, and RD of the right UF in asymptomatic patients with uncomplicated mTBI relative to symptomatic patients and HC. Diffusion alterations were most pronounced in the group with frontal lesions on CT, particularly in the FM and UF; these effects increased over time. Within the group of patients with uncomplicated mTBI, there were no associations of diffusion measures with the number of symptoms nor with lesions on conventional MRI. In conclusion, mTBI can cause microstructural changes in emotion regulation tracts, however, no explanation was found for the presence of symptoms.	[van der Horn, Harm Jan; Mangina, Namrata R.; Rakers, Sandra E.; Kok, Jelmer G.; Spikman, Jacoba M.; van Der Naalt, Joukje] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Timmerman, Marieke E.] Univ Groningen, Dept Psychometr & Stat, Groningen, Netherlands; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands		van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen UMCG, Dept Neurol, Hanzepl 1,Poortweg 4,Postbus 30-001 AB51, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation (Hersenstichting) [Ps2012--06]	This study was funded by The Dutch Brain Foundation (Hersenstichting), grant no. Ps2012--06, to J.v.d.N.	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Coad BM, 2020, NEUROPSYCHOLOGIA, V145, DOI 10.1016/j.neuropsychologia.2017.11.006; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Dunst B, 2014, BRAIN COGNITION, V91, P71, DOI 10.1016/j.bandc.2014.08.006; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Folloni D, 2019, ELIFE, V8, DOI 10.7554/eLife.47175; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Kanaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038272; Karr JE, 2020, J CLIN EXP NEUROPSYC, V42, P1049, DOI 10.1080/13803395.2020.1841118; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King R, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101842; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; R Development Core Team, 2018, R LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Shamonin DP, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00050; Stephenson DD, 2020, J MAGN RESON IMAGING, V52, P1701, DOI 10.1002/jmri.27249; Tax CMW, 2014, NEUROIMAGE, V86, P67, DOI 10.1016/j.neuroimage.2013.07.067; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tenovuo O, 2021, J CLIN MED, V10, DOI 10.3390/jcm10010148; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; van der Horn HJ, 2020, HUM BRAIN MAPP, V41, P617, DOI 10.1002/hbm.24827; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; van der Horn HJ, 2017, J NEUROTRAUM, V34, P1035, DOI 10.1089/neu.2016.4659; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Verhage F, 1964, INTELLIGENCE AGE STU; Versace A, 2015, JAMA PSYCHIAT, V72, P367, DOI 10.1001/jamapsychiatry.2014.2170; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wallace EJ, 2020, HUM BRAIN MAPP, V41, P2187, DOI 10.1002/hbm.24939; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wu YC, 2020, NEUROLOGY, V95, pE781, DOI 10.1212/WNL.0000000000009930	57	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	MAY	2021	53	10					3463	3475		10.1111/ejn.15199		APR 2021	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	SK0MB	WOS:000636036600001	33759227	Green Published, hybrid			2022-02-06	
J	Bray, MJC; Richey, LN; Bryant, BR; Krieg, A; Jahed, S; Tobolowsky, W; LoBue, C; Peters, ME				Bray, Michael J. C.; Richey, Lisa N.; Bryant, Barry R.; Krieg, Akshay; Jahed, Sahar; Tobolowsky, William; LoBue, Christian; Peters, Matthew E.			Traumatic brain injury alters neuropsychiatric symptomatology in all-cause dementia	ALZHEIMERS & DEMENTIA			English	Article						acquired brain injury; all&#8208; cause dementia; Alzheimer&apos; s disease; anxiety; apathy; dementia; geriatric psychiatry; mild behavioral impairment; motor disturbances; neurodegeneration; neuropsychiatric symptoms; neuropsychiatry; traumatic brain injury		Introduction Traumatic brain injury (TBI) may alter the course of neuropsychiatric symptom (NPS) onset during dementia development. The connection among TBI, NPS, and dementia progression is of increasing interest to researchers and clinicians. Methods Incidence of NPS was examined in participants with normal cognition who progressed to all-cause dementia based on whether TBI history was present (n = 130) or absent (n = 849). Survival analyses were used to examine NPS incidence across 7.6 +/- 3.0 years of follow-up. Results Participants with TBI history had increased prevalence and incidence of apathy (44.7% vs 29.9%, P = .0062; HRadj. = 1.708, P = .0018) and motor disturbances (17.2% vs 9.5%, P = .0458; HRadj. = 2.023, P = .0168), controlling for demographics and type of dementia diagnosis. Earlier anxiety onset was associated with TBI (692 days prior to dementia diagnosis vs 161 days, P = .0265). Discussion History of TBI is associated with increased risk for and earlier onset of NPS in the trajectory of dementia development.	[Bray, Michael J. C.; Richey, Lisa N.; Bryant, Barry R.; Krieg, Akshay; Jahed, Sahar; Tobolowsky, William; Peters, Matthew E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, 5300 Alpha Commons Dr,Room 446, Baltimore, MD 21224 USA; [LoBue, Christian] Univ Texas Southwestern Med Ctr, Dept Psychiat, Dallas, TX USA		Bray, MJC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, 5300 Alpha Commons Dr,Room 446, Baltimore, MD 21224 USA.	mbray11@jhmi.edu	Bray, Michael Johnathan Charles/AAL-8925-2020	Bray, Michael Johnathan Charles/0000-0003-4650-1313; Krieg, Akshay/0000-0002-8281-5582	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG005146, P50 AG047266, P30 AG010129, P30 AG008017, P30 AG010161, P50 AG025688, P50 AG005133, P50 AG005138, P30 AG010133, P50 AG047366, P50 AG005681, U01 AG016976, P50 AG047270, P30 AG062429, P50 AG005136, P30 AG049638, P30 AG012300, P30 AG062421, P50 AG023501, P30 AG010124, P30 AG062428, P30 AG066444, P30 AG053760, P30 AG062422, P50 AG008702, P30 AG013846, P30 AG013854, P30 AG008051, P30 AG028383, P30 AG019610, P30 AG035982, P50 AG016573, P50 AG005142, P30 AG062715] Funding Source: Medline		Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Boulos ME, 2018, J NEUROSCI, V38, P7201, DOI 10.1523/JNEUROSCI.1011-18.2018; Bray MJC., 2019, INT REV PSYCHIATR, V2019, P1; Burhanullah MH, 2020, AM J GERIAT PSYCHIAT, V28, P64, DOI 10.1016/j.jagp.2019.03.023; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Ismail Z, 2016, ALZHEIMERS DEMENT, V12, P195, DOI 10.1016/j.jalz.2015.05.017; Joyce JM, 2020, INT REV PSYCHIATR, V32, P46, DOI 10.1080/09540261.2019.1656177; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Peters ME, 2015, AM J GERIAT PSYCHIAT, V23, P115, DOI 10.1016/j.jagp.2014.11.002; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P166, DOI 10.1176/appi.neuropsych.22.2.166; Rasmussen KL, 2018, ALZHEIMERS DEMENT, V14, P1589, DOI 10.1016/j.jalz.2018.07.223; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; Terpstra AR, 2017, NEUROREHAB NEURAL RE, V31, P1063, DOI 10.1177/1545968317736817; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015	20	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	APR	2021	17	4					686	691		10.1002/alz.12225			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RM8ZV	WOS:000639946100011	33470043				2022-02-06	
J	Brolin, K; Lanner, D; Halldin, P				Brolin, Karin; Lanner, Daniel; Halldin, Peter			Work-related traumatic brain injury in the construction industry in Sweden and Germany	SAFETY SCIENCE			English	Article						Traumatic brain injury; Construction; Occupation; Epidemiology; Falls; Helmet standards	DIFFUSE AXONAL INJURY; SLIPS; TRIPS; EPIDEMIOLOGY; IMPACTS; STATE; FALLS	Work-related traumatic brain injuries (wrTBIs) in the construction industry have been studied in North America but, to the best of our knowledge, not in Europe. This study analyzed sets of public data on head injuries occurring in the construction industry from the workers' compensation systems in Sweden and Germany, 2014 - 2018. The ratio of wrTBI varied from 11% to 61% of all head injuries, with higher ratios for more severe injuries. The average yearly incidence (per 100,000 FTE) of wrTBI resulting in more than four days absence from work was nine in Sweden and 117 in Germany, as compared to 22-212 in North American studies. A limitation of studies based on workers' compensation claims is that they underestimate the true burden of wrTBI. The most frequent events leading to wrTBI were falls, followed by loss of control, failure of material agents, and body movements without stress. Falls from a height caused 35% of all wrTBI with more than 14 days off work in Sweden and 57% of all new injury pensions granted in Germany. In North American studies, 52-78% of the wrTBI were caused by falls. This highlights the relevance of fall safety measures to reduce wrTBI in the construction industry, such as avoiding work at heights, use of safety nets, education, and etcetera. The energy absorption of safety helmets mainly protects the head excluding face of which 49-62% were wrTBI, indicating that helmet testing standards should evaluate protection against TBI as well as skull fractures.	[Brolin, Karin] Lightness By Design AB, Stadsgarden 10,11tr, S-11645 Stockholm, Sweden; [Lanner, Daniel; Halldin, Peter] MIPS AB, Kemistvagen 1B, S-18379 Taby, Sweden; [Halldin, Peter] Royal Inst Technol, Div Neuron Engn, S-10044 Stockholm, Sweden		Brolin, K (corresponding author), Lightness By Design AB, Stadsgarden 10,11tr, S-11645 Stockholm, Sweden.	karin.brolin@lightness.eu			MIPS AB, Sweden	Funding for this study was provided by MIPS AB, Sweden. Data was provided by the Swedish Work Environment Authority (Arbetsmiljoverket), and the German Social Accident Insurance (Deutsche Gesetzliche Unfallversicherung). We kindly thank Kjell Blom (AV) and Christoph Thomann (DGUV) for answering our questions and supporting with data.	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; AV, 2018, SWED WORK ENV AUTH R; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Colantonio A., 2010, CAN J PUBLIC HLTH S, V101, DOI [10.1007/0187115, DOI 10.1007/0187115]; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Davidsson J., 2009, P INT RES C BIOM IMP, P43; EU, 2008, EUROSTAT METHODOLOGI; EU, 2013, EUROSTAT METHODOLOGI; EU, 2001, N15EN FACTS EU; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Graff HJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026104; Guerrieri E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147382; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Kemmlert K, 2001, APPL ERGON, V32, P149, DOI 10.1016/S0003-6870(00)00051-X; Kemmlert K, 1998, SAFETY SCI, V28, P59, DOI 10.1016/S0925-7535(97)00071-4; Kica J, 2014, J SAFETY RES, V51, P49, DOI 10.1016/j.jsr.2014.09.003; Kim H, 2006, NEUROREHABILITATION, V21, P269; Kim SC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111063; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Konda S, 2015, INJURY PREV, V21, P115, DOI 10.1136/injuryprev-2014-041323; Kristman V.L., 2010, OPEN OCCUPAT HLTH SA, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Lipscomb HJ, 2006, APPL ERGON, V37, P267, DOI 10.1016/j.apergo.2005.07.008; Liu M, 2011, WORK, V39, P283, DOI 10.3233/WOR-2011-1176; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; Ono K, 1980, SAE TECHNICAL PAPER, DOI [10.4271/801303, DOI 10.4271/801303]; Otte D., 1999, CONTRIBUTION FINAL R; Paci M, 2017, CAN J NEUROL SCI, V44, P518, DOI 10.1017/cjn.2017.43; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Richter M., 2001, J TRAUMA ACUTE CARE, V51; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Sharma B, 2019, WORK, V62, P319, DOI 10.3233/WOR-192866; Terry DP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198128; Thibault L.E., 1972, SAE TECHNICAL PAPER, P720970, DOI [10.4271/720970, DOI 10.4271/720970]; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Wei Chia, 2012, Minn Med, V95, P55; Wei WL, 2010, BRAIN INJURY, V24, P1358, DOI 10.3109/02699052.2010.506635; Whyte T, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4043140; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	45	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-7535	1879-1042		SAFETY SCI	Saf. Sci.	APR	2021	136								105147	10.1016/j.ssci.2020.105147			11	Engineering, Industrial; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Operations Research & Management Science	RZ6TH	WOS:000648734200015		hybrid			2022-02-06	
J	Chong, SL; Dang, HX; Ming, MX; Mahmood, M; Zheng, CQS; Gan, CS; Lee, OPE; Ji, J; Chan, LCN; Ong, JSM; Kurosawa, H; Lee, JH				Chong, Shu-Ling; Dang, Hongxing; Ming, Meixiu; Mahmood, Maznisah; Zheng, Charles Q. S.; Gan, Chin Seng; Lee, Olive P. E.; Ji, Jian; Chan, Lawrence C. N.; Ong, Jacqueline S. M.; Kurosawa, Hiroshi; Lee, Jan Hau		Pediat Acute Critical Care Med As	Traumatic Brain Injury Outcomes in 10 Asian Pediatric ICUs: A Pediatric Acute and Critical Care Medicine Asian Network Retrospective Study	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						Asia; brain injuries; child; cognition; critical care outcomes; mortality; traumatic	HYPERTONIC SALINE; CHILDREN; HYPOTHERMIA; MORTALITY; IMPACT; ADULT; UNIT	Objectives: Traumatic brain injury remains an important cause of death and disability. We aim to report the epidemiology and management of moderate to severe traumatic brain injury in Asian PICUs and identify risk factors for mortality and poor functional outcomes. Design: A retrospective study of the Pediatric Acute and Critical Care Medicine Asian Network moderate to severe traumatic brain injury dataset collected between 2014 and 2017. Setting: Patients were from the participating PICUs of Pediatric Acute and Critical Care Medicine Asian Network. Patients: We included children less than 16 years old with a Glasgow Coma Scale less than or equal to 13. Interventions: None. Measurements and Main Results: We obtained data on patient demographics, injury circumstances, and PICU management. We performed a multivariate logistic regression predicting for mortality and poor functional outcomes. We analyzed 380 children with moderate to severe traumatic brain injury. Most injuries were a result of road traffic injuries (174 [45.8%]) and falls (160 [42.1%]). There were important differences in temperature control, use of antiepileptic drugs, and hyperosmolar agents between the sites. Fifty-six children died (14.7%), and 104 of 324 survivors (32.1%) had poor functional outcomes. Poor functional outcomes were associated with non-high-income sites (adjusted odds ratio, 1.90; 95% CI, 1.11-3.29), Glasgow Coma Scale less than 8 (adjusted odds ratio, 4.24; 95% CI, 2.44-7.63), involvement in a road traffic collision (adjusted odds ratio, 1.83; 95% CI, 1.04-3.26), and presence of child abuse (adjusted odds ratio, 2.75; 95% CI, 1.01-7.46). Conclusions: Poor functional outcomes are prevalent after pediatric traumatic brain injury in Asia. There is an urgent need for further research in these high-risk groups.	[Chong, Shu-Ling] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Chong, Shu-Ling; Lee, Jan Hau] Duke NUS Med Sch, Singapore, Singapore; [Dang, Hongxing] Chongqing Med Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Chongqing, Peoples R China; [Ming, Meixiu] Fudan Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Shanghai, Peoples R China; [Mahmood, Maznisah] Inst Paediat, Dept Paediat, Kuala Lumpur, Malaysia; [Zheng, Charles Q. S.] Singapore Clin Res Inst, Dept Epidemiol, Singapore, Singapore; [Gan, Chin Seng] Univ Malaya, Dept Paediat, Med Ctr, Kuala Lumpur, Malaysia; [Lee, Olive P. E.] Sarawak Gen Hosp, Dept Paediat, Sarawak, Malaysia; [Ji, Jian] Capital Med Univ, Beijing Childrens Hosp, Dept Pediat Intens Care Unit, Beijing, Peoples R China; [Chan, Lawrence C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Hong Kong, Peoples R China; [Ong, Jacqueline S. M.] Natl Univ Singapore Hosp, Khoo Teck Puat Natl Univ Childrens Med Inst, Singapore, Singapore; [Ong, Jacqueline S. M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Kurosawa, Hiroshi] Hyogo Prefectural Kobe Childrens Hosp, Dept Pediat Crit Care Med, Kobe, Hyogo, Japan; [Lee, Jan Hau] KK Womens & Childrens Hosp, Childrens Intens Care Unit, Singapore, Singapore		Chong, SL (corresponding author), KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore.; Chong, SL (corresponding author), Duke NUS Med Sch, Singapore, Singapore.	chong.shu-ling@kkh.com.sg	Gan, Chin Seng/B-2160-2012; Zheng, Qishi/R-9499-2016	Gan, Chin Seng/0000-0002-6758-4798; Zheng, Qishi/0000-0003-3368-4843; Lee, Olive Pei Ee/0000-0002-3372-7279	SingHealth Foundation Research GrantSingHealth [SHF/FG670P/2017]; KK Women's and Children's Hospital	This study was funded, in part, by SingHealth Foundation Research Grant (Grant Number SHF/FG670P/2017).; Dr. Chong's institution received funding from SingHealth Foundation Research Grant (Grant Number SHF/FG670P/2017). Dr. Zheng disclosed work for hire. Dr. Chan disclosed government work. Dr. Lee received funding from KK Women's and Children's Hospital. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Chong SL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015759; Chong SL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010618; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Ning PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164560; R Core Team, 2021, R LANG ENV STAT COMP; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Tasker RC, 2017, PEDIATR CRIT CARE ME, V18, P355, DOI 10.1097/PCC.0000000000001098; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Van Deynse H, 2019, BRAIN INJURY, V33, P1234, DOI 10.1080/02699052.2019.1641224; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Wilson MH, 2016, LANCET PUBLIC HEALTH, V1, pE44, DOI 10.1016/S2468-2667(16)30022-6; Wismans J, 2016, TRAFFIC INJ PREV, V17, P217, DOI 10.1080/15389588.2015.1066498; World Health Organization:, ROAD TRAFFIC INJURIE	40	1	1	5	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	APR	2021	22	4					401	411		10.1097/PCC.0000000000002575			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	RL9TW	WOS:000639306900014	33027240				2022-02-06	
J	Elsamadicy, AA; Koo, AB; David, WB; Lee, VC; Zogg, CK; Kundishora, AJ; Hong, CS; Reeves, BC; Sarkozy, M; Kahle, KT; DiLuna, M				Elsamadicy, Aladine A.; Koo, Andrew B.; David, Wyatt B.; Lee, Victor; Zogg, Cheryl K.; Kundishora, Adam J.; Hong, Christopher; Reeves, Benjamin C.; Sarkozy, Margot; Kahle, Kristopher T.; DiLuna, Michael			Post-traumatic seizures following pediatric traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Post-traumatic seizures; Pediatrics; Traumatic brain injury; Emergency department; Nationwide emergency department sample		Objectives: The aim of this study was to investigate the national impact of demographic, hospital, and inpatient risk factors on post-traumatic seizure (PTS) development in pediatric patients who presented to the ED following a traumatic brain injury (TBI). Patients and methods: The Nationwide Emergency Department Sample database years 2010?2014 was queried. Patients (<21 years old) with a primary diagnosis of TBI and subsequent secondary diagnosis of PTS were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification coding system. We identified demographic variables, hospital characteristics, pre-existing medical comorbidities, etiology of injuries, and type of injury. Univariate and multivariate logistic regression analyses were performed to identify the factors associated with post-traumatic seizures. Results: We identified 1,244,087 patients who sustained TBI, of which 10,340 (0.83%) developed PTS. Of the patients who had seizures, the youngest cohort aged 0-5 years had the greatest proportion of seizure development (p < 0.001). Compared to those TBI patients with loss of consciousness (LOC), patients encountering no LOC after TBI had the smallest proportion of seizures while Prolonged LOC with baseline return had the greatest proportion. On univariate analysis of the effect of in-hospital complication on rate of seizures, respiratory, renal and urinary, hematoma, septicemia, and other neurological complications were all significantly associated with seizure development. On multivariate regression, age 6?10 years (OR: 0.48, p < 0.001) 11?15 years (OR: 0.41, p < 0.001), and 16?20 years (OR: 0.51, p < 0.001) were independently associated with decreased risk of developing seizures. Extended LOC with baseline return (OR: 6.33, p < 0.001), extended LOC without baseline return (OR: 1.95, p = 0.009), and Other LOC (OR: 3.02, p < 0.001) were independently associated with increased risk of developing seizures. Subarachnoid hemorrhage (OR: 4.14, p < 0.001), subdural hemorrhage [OR: 7.72, p < 0.001), and extradural hemorrhage (OR: 3.13, p < 0.001) were all independently associated with increased risk of developing seizures. Conclusion: Out study demonstrates that various demographic, hospital, and clinical risk factors are associated with the development of seizures following traumatic brain injury. Enhancing awareness of these drivers may help provide greater awareness of patients likely to develop post-traumatic seizures such that this complication can be decreased in incidence so as to improve quality of care and decrease healthcare costs.	[Elsamadicy, Aladine A.; Koo, Andrew B.; David, Wyatt B.; Lee, Victor; Zogg, Cheryl K.; Kundishora, Adam J.; Hong, Christopher; Reeves, Benjamin C.; Sarkozy, Margot; Kahle, Kristopher T.; DiLuna, Michael] Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA		DiLuna, M (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, 333 Cedar St, New Haven, CT 06520 USA.	michael.diluna@yale.edu		Reeves, Benjamin/0000-0002-5924-6991; Lee, Victor/0000-0001-5075-0502			Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Ballard DW, 2019, ANN EMERG MED, V73, P440, DOI 10.1016/j.annemergmed.2018.11.011; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bertsimas D, 2019, JAMA PEDIATR, V173, P648, DOI 10.1001/jamapediatrics.2019.1068; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Mannix R, 2019, SEMIN PEDIATR NEUROL, V30, P35, DOI 10.1016/j.spen.2019.03.006; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Peterson AB, 2014, SURVEILLANCE REPORT; Rumalla K, 2018, J NEUROSURG-PEDIATR, V22, P684, DOI 10.3171/2018.6.PEDS1813; Sarmiento K, 2019, MMWR-MORBID MORTAL W, V68, P237, DOI 10.15585/mmwr.mm6810a2; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003	24	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2021	203								106556	10.1016/j.clineuro.2021.106556			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RH8HY	WOS:000636453700012	33636505				2022-02-06	
J	Fakhoury, M; Shakkour, Z; Kobeissy, F; Lawand, N				Fakhoury, Marc; Shakkour, Zaynab; Kobeissy, Firas; Lawand, Nada			Depression following traumatic brain injury: a comprehensive overview	REVIEWS IN THE NEUROSCIENCES			English	Article						animal models; antidepressant; depression; inflammation; post-traumatic depression; traumatic brain injury		Traumatic brain injury (TBI) represents a major health concern affecting the neuropsychological health; TBI is accompanied by drastic long-term adverse complications that can influence many aspects of the life of affected individuals. A substantial number of studies have shown that mood disorders, particularly depression, are the most frequent complications encountered in individualswith TBI. Post-traumatic depression (P-TD) is present in approximately 30% of individuals with TBI, with the majority of individuals experiencing symptoms of depression during the first year following head injury. To date, the mechanisms of P-TD are far from being fully understood, and effective treatments that completely halt this condition are still lacking. The aim of this review is to outline the current state of knowledge on the prevalence and risk factors of P-TD, to discuss the accompanying brain changes at the anatomical, molecular and functional levels, and to discuss current approaches used for the treatment of P-TD.	[Fakhoury, Marc; Lawand, Nada] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Lawand, Nada] Amer Univ Beirut, Fac Med, Dept Neurol, Beirut, Lebanon; [Fakhoury, Marc] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Beirut, Lebanon; [Shakkour, Zaynab; Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon		Lawand, N (corresponding author), Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon.; Lawand, N (corresponding author), Amer Univ Beirut, Fac Med, Dept Neurol, Beirut, Lebanon.	nl08@aub.edu.lb	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Shakkour, Zaynab/0000-0002-5436-1798; Fakhoury, Marc/0000-0002-9335-9308	Natural Science and Engineering Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC)	M.F. acknowledges financial support from the Natural Science and Engineering Council of Canada (NSERC) in form of a postdoctoral fellowship award.	Adembri C, 2014, CRIT CARE MED, V42, pE570, DOI 10.1097/CCM.0000000000000414; Ahmed S, 2017, INDIAN J PSYCHOL MED, V39, P114, DOI 10.4103/0253-7176.203129; Aisiku IP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1470-7; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Alexander MP, 2000, SEMIN NEUROL, V20, P427, DOI 10.1055/s-2000-13175; ALS-FRS-R, 2015, ALS FUNCTIONAL RATIN; Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2017, DEPRESSION OTHER COM; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Centers for Disease Control and Prevention, 2014, SURVEILLANCE REPORT; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Christensen B, 1994, ADV MED PSYCHOTHERAP, V7, P23; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Devoto C, 2017, CELL TRANSPLANT, V26, P1169, DOI 10.1177/0963689717714098; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Durish CL, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000343; Fakhoury M, 2016, MOL NEUROBIOL, V53, P2778, DOI 10.1007/s12035-015-9152-z; Fakhoury M, 2015, GEN HOSP PSYCHIAT, V37, P172, DOI 10.1016/j.genhosppsych.2015.01.005; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FDA, 2014, SELECTIVE SEROTONIN; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Global Burden of Disease and Injury Incidence and Prevalence CollaboratorsGlobal, 2018, LANCET, V392, P1789; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grunberg NE, 2013, CURR PROTOC NEUROSCI; Guillamondegui O., 2011, COMP EFFECTIVENESS R, V25; Guillamondegui O.D., 2011, AHRQ COMP EFFECTIVEN; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Hughes CE, 2018, FEBS J, V285, P2944, DOI 10.1111/febs.14466; INESS-ONF, 2015, CLIN PRACTISE GUIDEL; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2017, J NEUROPSYCH CLIN N, V29, P260, DOI 10.1176/appi.neuropsych.16100217; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kaiser RH, 2015, JAMA PSYCHIAT, V72, P603, DOI 10.1001/jamapsychiatry.2015.0071; Kant R, 1999, J NEUROPSYCH CLIN N, V11, P32, DOI 10.1176/jnp.11.1.32; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koulaeinejad N, 2019, IRAN J PHARM RES, V18, P1086, DOI 10.22037/ijpr.2019.1100677; Kovesdi E., 2012, FRONT NEUROL, V3, P1; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE47, DOI 10.1097/HTR.0000000000000439; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kumar RG, 2018, BRAIN INJURY, V32, P383, DOI 10.1080/02699052.2018.1427888; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Lecky F., 2017, CHANGING EPIDEMIOLOG; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Lin HL, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P307, DOI 10.1016/B978-0-12-802686-1.00019-5; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martino C, 2008, J ECT, V24, P92, DOI 10.1097/YCT.0b013e31814faae5; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McMillan T, 2002, NEUROPSYCHOL REHABIL, V12, P117, DOI 10.1080/09602010143000202; Mellergard P, 2011, NEUROSURGERY, V68, P12, DOI 10.1227/NEU.0b013e3181ef2a40; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P283, DOI 10.1097/HTR.0000000000000337; Newburn G, 1999, BRAIN INJURY, V13, P637; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Niciu MJ, 2014, J NEURAL TRANSM, V121, P907, DOI 10.1007/s00702-013-1130-x; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Park JM, 2020, NEUROL SCI, V41, P119, DOI 10.1007/s10072-019-04055-3; Piao CS, 2019, J CEREBR BLOOD F MET, V39, P58, DOI 10.1177/0271678X17742792; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; PUCILOWSKI O, 1993, PHYSIOL BEHAV, V54, P1215, DOI 10.1016/0031-9384(93)90351-F; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Rosenblat JD, 2018, J AFFECT DISORDERS, V227, P219, DOI 10.1016/j.jad.2017.10.042; Roy D, 2018, PSYCHOSOMATICS, V59, P47, DOI 10.1016/j.psym.2017.07.008; RUTHERFORD WH, 1977, LANCET, V1, P1; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silverberg ND, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2076-9; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Vuckovic MG, 2008, NEUROBIOL DIS, V32, P319, DOI 10.1016/j.nbd.2008.07.015; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Wheeler MA, 2003, CORTEX, V39, P827, DOI 10.1016/S0010-9452(08)70866-9; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wilson MS, 2002, AM J PHYS MED REHAB, V81, P364, DOI 10.1097/00002060-200205000-00009; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yamamoto T, 1999, ACT NEUR S, V75, P17; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yankelevitch-Yahav R, 2015, JOVE-J VIS EXP, DOI 10.3791/52587; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	156	1	1	4	5	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	APR	2021	32	3					289	303		10.1515/revneuro-2020-0037			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RJ0HJ	WOS:000637284000003	33661587	Bronze			2022-02-06	
J	Flanagan, SD; Proessl, F; Dunn-Lewis, C; Sterczala, AJ; Connaboy, C; Canino, MC; Beethe, AZ; Eagle, SR; Szivak, TK; Onate, JA; Volek, JS; Maresh, CM; Kaeding, CC; Kraemer, WJ				Flanagan, Shawn D.; Proessl, Felix; Dunn-Lewis, Courtenay; Sterczala, Adam J.; Connaboy, Chris; Canino, Maria C.; Beethe, Anne Z.; Eagle, Shawn R.; Szivak, Tunde K.; Onate, James A.; Volek, Jeff S.; Maresh, Carl M.; Kaeding, Christopher C.; Kraemer, William J.			Differences in brain structure and theta burst stimulation-induced plasticity implicate the corticomotor system in loss of function after musculoskeletal injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						human motor cortex; lower extremities; musculoskeletal injury; transcranial magnetic stimulation; use-dependent plasticity	TRANSCRANIAL MAGNETIC STIMULATION; CRUCIATE LIGAMENT RECONSTRUCTION; MOTOR CORTEX; CORTICAL PLASTICITY; EVOKED-POTENTIALS; MUSCLE ACTIVATION; SILENT PERIOD; EXCITABILITY; QUADRICEPS; MOVEMENTS	Traumatic musculoskeletal injury (MSI) may involve changes in corticomotor structure and function, but direct evidence is needed. To determine the corticomotor basis of MSI, we examined interactions among skeletomotor function, corticospinal excitability, corticomotor structure (cortical thickness and white matter microstructure), and intermittent theta burst stimulation (iTBS)-induced plasticity. Nine women with unilateral anterior cruciate ligament rupture (ACL) 3.2 +/- 1.1 yr prior to the study and 11 matched controls (CON) completed an MRI session followed by an offline plasticity-probing protocol using a randomized, sham-controlled, double-blind, cross-over study design. iTBS was applied to the injured (ACL) or nondominant (CON) motor cortex leg representation (M1(LEG)) with plasticity assessed based on changes in skeletomotor function and corticospinal excitability compared with sham iTBS. The results showed persistent loss of function in the injured quadriceps, compensatory adaptations in the uninjured quadriceps and both hamstrings, and injury-specific increases in corticospinal excitability. Injury was associated with lateralized reductions in paracentral lobule thickness, greater centrality of nonleg corticomotor regions, and increased primary somatosensory cortex leg area inefficiency and eccentricity. Individual responses to iTBS were consistent with the principles of homeostatic metaplasticity; corresponded to injury-related differences in skeletomotor function, corticospinal excitability, and corticomotor structure; and suggested that corticomotor adaptations involve both hemispheres. Moreover, iTBS normalized skeletomotor function and corticospinal excitability in ACL. The results of this investigation directly confirm corticomotor involvement in chronic loss of function after traumatic MSI, emphasize the sensitivity of the corticomotor system to skeletomotor events and behaviors, and raise the possibility that brain-targeted therapies could improve recovery. NEW & NOTEWORTHY Traumatic musculoskeletal injuries may involve adaptive changes in the brain that contribute to loss of function. Our combination of neuroimaging and theta burst transcranial magnetic stimulation (iTBS) revealed distinct patterns of iTBS-induced plasticity that normalized differences in muscle and brain function evident years after unilateral knee ligament rupture. Individual responses to iTBS corresponded to injury-specific differences in brain structure and physiological activity, depended on skeletomotor deficit severity, and suggested that corticomotor adaptations involve both hemispheres.	[Flanagan, Shawn D.; Volek, Jeff S.; Maresh, Carl M.; Kraemer, William J.] Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA; [Flanagan, Shawn D.; Proessl, Felix; Sterczala, Adam J.; Connaboy, Chris; Canino, Maria C.; Beethe, Anne Z.; Eagle, Shawn R.] Univ Pittsburgh, Dept Sports Med & Nutr, Neuromuscular Res Lab, Pittsburgh, PA 15260 USA; [Dunn-Lewis, Courtenay] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA USA; [Szivak, Tunde K.] Merrimack Coll, Dept Hlth Sci, N Andover, MA USA; [Onate, James A.] Ohio State Univ, Coll Med, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Kaeding, Christopher C.] Ohio State Univ, Dept Orthopaed, Sports Hlth & Performance Inst, Columbus, OH 43210 USA		Flanagan, SD (corresponding author), Ohio State Univ, Dept Human Sci, Columbus, OH 43210 USA.; Flanagan, SD (corresponding author), Univ Pittsburgh, Dept Sports Med & Nutr, Neuromuscular Res Lab, Pittsburgh, PA 15260 USA.	sdf29@pitt.edu	Connaboy, Christopher/AAH-4514-2020; Flanagan, Shawn/AAC-6018-2021	Connaboy, Christopher/0000-0002-9031-2192; Flanagan, Shawn/0000-0002-6531-4567; Proessl, Felix/0000-0002-9210-0222; Sterczala, Adam/0000-0002-0322-6836	Ohio State University doctoral fellowship; National Strength and Conditioning Association Doctoral Research Grant	This work was supported by an Ohio State University doctoral fellowship (S. D. Flanagan) and National Strength and Conditioning Association Doctoral Research Grant (S. D. Flanagan) .	ABE S, 1993, ARTHROSCOPY, V9, P394, DOI 10.1016/S0749-8063(05)80313-5; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Aflalo TN, 2006, P NATL ACAD SCI USA, V103, P2909, DOI 10.1073/pnas.0511139103; Aflalo TN, 2007, J NEUROSCI, V27, P2760, DOI 10.1523/JNEUROSCI.3147-06.2007; Ageberg Eva, 2002, J Electromyogr Kinesiol, V12, P205, DOI 10.1016/S1050-6411(02)00022-6; Ajuied A, 2014, AM J SPORT MED, V42, P2242, DOI 10.1177/0363546513508376; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Anderson AF, 2006, AM J SPORT MED, V34, P128, DOI 10.1177/0363546505280214; Ansdell P, 2020, EXP PHYSIOL, V105, P1132, DOI 10.1113/EP088629; Avanzino L, 2011, J NEUROSCI, V31, P3423, DOI 10.1523/JNEUROSCI.4893-10.2011; BALOGUN J A, 1992, Physiotherapy Theory and Practice, V8, P89, DOI 10.3109/09593989209108086; Baumeister J, 2011, J ORTHOP RES, V29, P1383, DOI 10.1002/jor.21380; Beck S, 2007, BRAIN RES, V1179, P51, DOI 10.1016/j.brainres.2007.08.048; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BRINKMAN J, 1973, BRAIN, V96, P653, DOI 10.1093/brain/96.4.653; Brownstein CG, 2018, EXP PHYSIOL, V103, P1251, DOI 10.1113/EP086982; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cassidy JM, 2017, TRANSL STROKE RES, V8, P33, DOI 10.1007/s12975-016-0467-5; Chen R, 1997, NEUROLOGY, V49, P881, DOI 10.1212/WNL.49.3.881; Chettouf S, 2020, NEUROSCI BIOBEHAV R, V113, P39, DOI 10.1016/j.neubiorev.2020.03.002; Chung SW, 2018, HUM BRAIN MAPP, V39, P783, DOI 10.1002/hbm.23882; Clark BC, 2014, J NEUROPHYSIOL, V112, P3219, DOI 10.1152/jn.00386.2014; Cohen J., 1988, STAT POWER ANAL BEHA, P567; Colomer-Poveda D, 2019, PHYS THER SPORT, V40, P143, DOI 10.1016/j.ptsp.2019.09.006; Courtney CA, 2011, CLIN NEUROPHYSIOL, V122, P1005, DOI 10.1016/j.clinph.2010.07.029; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 2004, J NEUROL NEUROSUR PS, V75, P555, DOI 10.1136/jnnp.2003.018127; Dodd KC, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00469; Elias LJ, 1998, NEUROPSYCHOLOGIA, V36, P37, DOI 10.1016/S0028-3932(97)00107-3; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Farthing JP, 2011, MED SCI SPORT EXER, V43, P1394, DOI 10.1249/MSS.0b013e318210783c; Flanagan SD, 2019, BRAIN STIMUL, V12, P1058, DOI 10.1016/j.brs.2019.03.004; Fling BW, 2013, HUM BRAIN MAPP, V34, P384, DOI 10.1002/hbm.21437; Giboin LS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00150; Goldsworthy MR, 2014, BRAIN STIMUL, V7, P864, DOI 10.1016/j.brs.2014.08.004; Granovsky Y, 2019, PAIN REP, V4, DOI 10.1097/PR9.0000000000000725; Graziano MSA, 2004, J NEUROPHYSIOL, V92, P395, DOI 10.1152/jn.01241.2003; Grooms DR, 2017, J ORTHOP SPORT PHYS, V47, P180, DOI 10.2519/jospt.2017.7003; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Heroux ME, 2006, KNEE SURG SPORT TR A, V14, P823, DOI 10.1007/s00167-006-0063-4; Hewett TE, 2013, AM J SPORT MED, V41, P216, DOI 10.1177/0363546512459638; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hortobagyi T, 2009, J APPL PHYSIOL, V106, P403, DOI 10.1152/japplphysiol.90701.2008; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iezzi E, 2010, EUR J NEUROSCI, V31, P585, DOI 10.1111/j.1460-9568.2010.07090.x; Joshi Anand A, 2012, Biomed Image Regist Proc, V7359, P180, DOI 10.1007/978-3-642-31340-0_19; Karabanov A, 2015, BRAIN STIMUL, V8, P993, DOI 10.1016/j.brs.2015.06.017; Kim HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146234; Kittelson AJ, 2014, EXP BRAIN RES, V232, P3991, DOI 10.1007/s00221-014-4079-6; Larson J, 2015, BRAIN RES, V1621, P38, DOI 10.1016/j.brainres.2014.10.034; Lavender A, 1999, KNEE SURG SPORT TR A, V7, P98, DOI 10.1007/s001670050129; Lefaucheur JP, 2020, CLIN NEUROPHYSIOL, V131, P474, DOI 10.1016/j.clinph.2019.11.002; Lepley AS, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102157; Lewis GN, 2018, PAIN MED, V19, P2166, DOI 10.1093/pm/pny108; List J, 2013, NEUROIMAGE, V83, P809, DOI 10.1016/j.neuroimage.2013.07.033; Long JY, 2016, J NEUROPHYSIOL, V115, P1196, DOI 10.1152/jn.00876.2015; LORENTZON R, 1989, AM J SPORT MED, V17, P423, DOI 10.1177/036354658901700318; Louboutin H, 2009, KNEE, V16, P239, DOI 10.1016/j.knee.2008.11.004; Miller RP, 1991, CLIN J PAIN, V7, P51, DOI DOI 10.1097/00002508-199103000-00053; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Muller-Dahlhaus F, 2015, NEUROSCIENTIST, V21, P185, DOI 10.1177/1073858414526645; Musahl V, 2019, NEW ENGL J MED, V380, P2341, DOI 10.1056/NEJMcp1805931; Neto T, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/3480512; Newbold DJ, 2020, NEURON, V107, P580, DOI 10.1016/j.neuron.2020.05.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Pamukoff DN, 2017, J ATHL TRAINING, V52, P422, DOI 10.4085/1062-6050-52.3.05; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Pennisi G, 2011, DEMENT GERIATR COGN, V31, P71, DOI 10.1159/000322798; Pijnenburg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100666; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Radhu N, 2013, CLIN NEUROPHYSIOL, V124, P1309, DOI 10.1016/j.clinph.2013.01.014; Ragert P, 2009, J NEUROPHYSIOL, V102, P766, DOI 10.1152/jn.00274.2009; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Rio E, 2016, SCAND J MED SCI SPOR, V26, P1072, DOI 10.1111/sms.12538; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Schilling KG, 2019, MAGN RESON IMAGING, V58, P82, DOI 10.1016/j.mri.2019.01.018; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Skarabot J, 2019, EXP PHYSIOL, V104, P635, DOI 10.1113/EP087557; Stefan K, 2008, NEUROIMAGE, V40, P265, DOI 10.1016/j.neuroimage.2007.11.037; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Teo JTH, 2011, CEREB CORTEX, V21, P1627, DOI 10.1093/cercor/bhq231; Thapa T, 2018, CLIN NEUROPHYSIOL, V129, P1090, DOI 10.1016/j.clinph.2018.01.060; Urbach D, 1999, MED SCI SPORT EXER, V31, P1691, DOI 10.1097/00005768-199912000-00001; Wang HLS, 2019, PEDIATR NEONATOL, V60, P297, DOI 10.1016/j.pedneo.2018.07.016; Webster KE, 2008, PHYS THER SPORT, V9, P9, DOI 10.1016/j.ptsp.2007.09.003; Yeh FC, 2017, MAGN RESON MED, V77, P603, DOI 10.1002/mrm.26143; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Zarzycki R, 2020, J ORTHOP SPORT PHYS, V50, P516, DOI 10.2519/jospt.2020.9329; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	99	1	1	3	4	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	APR	2021	125	4					1006	1021		10.1152/jn.00689.2020			16	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	RQ7UP	WOS:000642620400002	33596734				2022-02-06	
J	Goyal, N; Kumar, P				Goyal, Nishant; Kumar, Punit			Putting 'CSF-Shift Edema' Hypothesis to Test: Comparing Cisternal and Parenchymal Pressures After Basal Cisternostomy for Head Injury	WORLD NEUROSURGERY			English	Article						Adjuvant cisternostomy; Basal cisternostomy; Cisternal pressure; CSF-shift edema; Decompressive hemicraniectomy; Glasgow Coma Scale; Glymphatic pathway; Parenchymal pressure; Paravascular system		BACKGROUND: Increased brain edema in head injury is due to shift of cerebrospinal fluid (CSF) from cisterns at high pressure to brain parenchyma at low pressure. By opening basal cisterns and decreasing the increased cisternal pressure, basal cisternostomy (BC) results in reversal of CSF shift from parenchyma to cisterns, leading to decreased brain edema. Though the CSF-shift edema hypothesis is based on pressure difference between cisterns and brain parenchyma, the relationship of these pressures has not been studied. METHODS: A prospective clinical study was conducted from November 2018 to March 2020 including adult patients with head injury who were candidates for standard decompressive hemicraniectomy (DHC). All patients had neurological assessment and head computed tomography preoperatively and postoperatively. All patients underwent BC with DHC. Postoperatively, parenchymal and cisternal pressures and neurological condition were monitored hourly for 72 hours. RESULTS: Nine (5 men, 4 women) patients with head injury (mean age, 45.7 years; range, 25-72 years) underwent DHC-BC. Median Glasgow Coma Scale score of patients at admission was 8 (range, 4-14), and median midline shift on computed tomography was 8 mm (range, 7-12 mm). There was a significant difference between opening (25.70 +/- 10.48 mm Hg) and closing (11.30 +/- 5.95 mm Hg) parenchymal pressures (t(9) = 3.963, P = 0.003). Immediate postoperative cisternal pressure was 1-11 mm Hg and was lower than immediate postoperative parenchymal pressure in all except 1 patient. Postoperatively, if cisternal pressure remained low, parenchymal pressure also decreased, and patients showed clinical improvement. Patients showing increased cisternal pressure showed increased parenchymal pressure and clinical worsening. CONCLUSIONS: Our study supports the CSF-shift edema hypothesis. Following DHC-BC, cisternal pressure is lowered to near-atmospheric pressure, and its relationship to parenchymal pressure predicts the future course of patients by reversal or re-reversal of CSF shift.	[Goyal, Nishant; Kumar, Punit] All India Inst Med Sci, Dept Neurosurg, Rishikesh, India		Goyal, N (corresponding author), All India Inst Med Sci, Dept Neurosurg, Rishikesh, India.	drnishantgoyal@gmail.com					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock RM, SURG MANAGEMENT TRAU; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cherian Iype, 2018, Asian J Neurosurg, V13, P777, DOI 10.4103/ajns.AJNS_200_16; Cherian I, 2018, J NEUROSCI RES, V96, P744, DOI 10.1002/jnr.24145; Cherian Iype, 2016, Surg Neurol Int, V7, pS711; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Cherian I, 2016, CHIN J TRAUMATOL, V19, P7, DOI 10.1016/j.cjtee.2016.01.003; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Giammattei L, 2020, ACTA NEUROCHIR, V162, P469, DOI 10.1007/s00701-020-04222-y; Goyal N, 2020, INDIAN J NEUROTRAUM, V17, P3, DOI 10.1055/s-0039-1696865; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014	14	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						E252	E263		10.1016/j.wneu.2020.12.133			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900030	33412318				2022-02-06	
J	Guenther, TM; Spruce, MW; Bach, LM; Caples, CM; Beyer, CA; Grayson, JK; Meyers, FJ; Palmieri, TL; Brown, IE				Guenther, Timothy M.; Spruce, Marguerite W.; Bach, Lindsey M.; Caples, Connor M.; Beyer, Carl A.; Grayson, John K.; Meyers, Frederick J.; Palmieri, Tina L.; Brown, Ian E.			High Versus Low Volume Fluid Resuscitation Strategies in a Porcine Model (Sus scrofa) of Combined Thermal and Traumatic Brain Injury	SHOCK			English	Article						Combined burn injury and traumatic brain injury; modified Brooke formula; Parkland formula; resuscitation; thermal injury; traumatic brain injury	BURN INJURY; MANAGEMENT; MORTALITY; PRESSURE; FAILURE	Background: Combined burn and traumatic brain injury (TBI) treatment priorities may not align due to opposing fluid resuscitation paradigms used in treating burns and TBI. We developed a porcine model of combined thermal injury/TBI and compared an "aggressive" fluid resuscitation strategy using the Parkland formula and a "restrictive" resuscitation strategy using the modified Brooke formula. Methods: Twenty-eight swine were deeply anesthetized and received a 40% total body surface area full-thickness burn injury and TBI. Swine were then randomized to receive restrictive or aggressive resuscitation for 8 h after which time animals were euthanized and necropsy was performed. Volume of brain injury was assessed after analyzing segmental slices of brain tissue. Results: There were no differences between the restrictive and aggressive resuscitation groups in blood pressure, heart rate, central venous pressure, intra-cranial pressure (ICP), or serum lactate levels after 8 h of resuscitation. Urine output was higher in the aggressive resuscitation group. The restrictive group had a significantly higher serum blood urea nitrogen (BUN) compared with baseline and compared with the aggressive group. There was no significant difference in size of brain injury between groups. Conclusions: Both restrictive and aggressive resuscitation demonstrated adequate resuscitation at 8 h postinjury. Increased serum BUN in the restrictive group may be an indicator of early acute kidney injury, despite adequate urine output. Resuscitation strategy did not appear to affect ICP or the size of brain injury.	[Guenther, Timothy M.; Spruce, Marguerite W.; Bach, Lindsey M.; Caples, Connor M.; Beyer, Carl A.; Palmieri, Tina L.; Brown, Ian E.] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA; [Guenther, Timothy M.; Spruce, Marguerite W.; Bach, Lindsey M.; Caples, Connor M.; Beyer, Carl A.; Grayson, John K.] David Grant USAF Med Ctr, Clin Invest Facil, Travis Afb, CA USA; [Meyers, Frederick J.] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; [Palmieri, Tina L.] Shriners Hosp Children Northern Calif, Sacramento, CA USA		Guenther, TM (corresponding author), 2335 Stockton Blvd,North Addit 5th Floor, Sacramento, CA 95817 USA.	tmguenther@ucdavis.edu		Beyer, Carl/0000-0002-9785-8526	USAMRAA [W81XWH1820071]	USAMRAA Award #W81XWH1820071.	Abdullahi A, 2014, CELL MOL LIFE SCI, V71, P3241, DOI 10.1007/s00018-014-1612-5; Association AB, 2018, ADV BURN LIF SUPP CO; Belba M, 2005, Ann Burns Fire Disasters, V18, P61; Blaisdell LL, 2012, J BURN CARE RES, V33, P347, DOI 10.1097/BCR.0b013e3182343dab; Cancio LC., 2017, CARE PATIENTS BURNS, P329; Chiao HY, 2018, ANN PLAS SURG, V80, pS21, DOI 10.1097/SAP.0000000000001288; Chung KK, 2009, J TRAUMA, V67, P231, DOI 10.1097/TA.0b013e3181ac68cf; Clark AT, 2019, J BURN CARE RES, V40, P72, DOI 10.1093/jbcr/iry046; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Fatima Nida, 2019, Asian J Neurosurg, V14, P382, DOI 10.4103/ajns.AJNS_8_19; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Graybill JC., 2016, J AM COLLSURG, V223, P217; Gueugniaud P., 1997, ANN BURNS FIRE DISAS, V10, P72; Guilabert P, 2016, BRIT J ANAESTH, V117, P284, DOI 10.1093/bja/aew266; Haberal M, 2010, INDIAN J PLAST SURG, V43, pS29, DOI 10.4103/0970-0358.70715; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Infanger M, 2004, BURNS, V30, P305, DOI 10.1016/j.burns.2003.12.006; Ivy ME, 2000, J TRAUMA, V49, P387, DOI 10.1097/00005373-200009000-00001; Jain V, 2019, INDIAN J CRIT CARE M, V23, pS136, DOI 10.5005/jp-journals-10071-23191; Johnson MA, 2017, J TRAUMA ACUTE CARE, V83, P61, DOI [10.1097/TA.0000000000001372, 10.1097/TA.0000000000001518]; Langlois JA., 2006, CTR DIS CONTROL REPO, P7; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Navickis RJ, 2016, J BURN CARE RES, V37, pE268, DOI 10.1097/BCR.0000000000000201; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Palmieri TL, 2016, CRIT CARE CLIN, V32, P547, DOI 10.1016/j.ccc.2016.06.004; Pan JZ, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000014453, 10.1097/md.0000000000014453]; Paratz JD, 2014, SHOCK, V42, P295, DOI 10.1097/SHK.0000000000000204; Rajagopal R, 2017, WORLD NEUROSURG, V108, P529, DOI 10.1016/j.wneu.2017.09.013; Sheridan RL, 2012, NEW ENGL J MED, V367, P2027, DOI 10.1056/NEJMcpc1200088; Shin C, 1998, BURNS, V24, P39, DOI 10.1016/S0305-4179(97)00057-0; Steinvall I, 2008, CRIT CARE, V12, DOI 10.1186/cc7032; SWINDLE M. MICHAEL, 2015, SWINE LAB SURG ANEST; Taylor SL, 2014, BURNS, V40, P1106, DOI 10.1016/j.burns.2014.03.010; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Wardhana A, 2018, Ann Burns Fire Disasters, V31, P65; Wolf SE, 1997, ANN SURG, V225, P554, DOI 10.1097/00000658-199705000-00012; Zhu WM, 2016, J SPORT HEALTH SCI, V5, P77, DOI 10.1016/j.jshs.2016.01.019	41	1	1	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	APR	2021	55	4					536	544		10.1097/SHK.0000000000001658			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	SV3LX	WOS:000663725100014	32881757				2022-02-06	
J	Guo, HB; Zhou, XH; Li, XW; Yang, SX; Wang, YR				Guo, Hongbin; Zhou, Xuehui; Li, Xinwei; Yang, Shuxu; Wang, Yirong			Scenario for the use of effusion?peritoneal shunt necessary against subdural effusion secondary to decompressive craniectomy	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Cranioplasty; Decompressive craniectomy; Subdural effusion; Subdural hygroma; Surgery	TRAUMATIC BRAIN-INJURY; INTERHEMISPHERIC HYGROMA; EARLY CRANIOPLASTY; CLINICAL-FEATURES; RISK-FACTORS; HYDROCEPHALUS; COMPLICATIONS; MANAGEMENT	Objectives: This study aimed to summarize the surgical strategies for subdural effusion secondary to decompressive craniectomy (SESDC) and discuss the applicable scenarios of effusion?peritoneal shunt (EP shunt). Methods: A total of 53 consecutive patients with SESDC were screened out of 7569 cases. The SESDC was divided into five types, and the treatment methods of each type were analyzed and compared. According to the implementation strategy of cranioplasty (CP), patients were divided into CP-first and delayed-CP groups. The differences in surgical methods were compared between the two groups. Results: All patients with SESDC in this cohort had undergone cranioplasty. Subcutaneous puncture and aspiration (SPAA) proved ineffective. Only 2/30 patients in the CP-first group used EP shunt, while 6/19 patients in the delayed-CP group used EP shunt; the difference was statistically significant (P = 0.03). A significant difference was found in the use of EP shunt among type 1, type 2, and type 5 SESDC (?2 = 6.778, P = 0.034). Conclusions: CP combined with other treatments could cure most SESDC. EP shunt should be used preferentially in some specific scenarios in which CP cannot be performed first, rather than as a backup measure that can only be used when other preceding treatments fail.	[Guo, Hongbin; Zhou, Xuehui; Li, Xinwei; Yang, Shuxu; Wang, Yirong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurosurg, Xia Sha Campus, Hangzhou 310016, Peoples R China		Wang, YR (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurosurg, Xia Sha Campus, Hangzhou 310016, Peoples R China.	3198059@zju.edu.cn	Guo, Hongbin/ABA-7900-2021				Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Akins PT, 2019, WORLD NEUROSURG, V130, pE941, DOI 10.1016/j.wneu.2019.07.041; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Eguchi S, 2011, PEDIATR NEUROSURG, V47, P125, DOI 10.1159/000330543; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Jeon SW, 2011, J KOREAN NEUROSURG S, V49, P355, DOI 10.3340/jkns.2011.49.6.355; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kilincer C, 2010, MED PRIN PRACT, V19, P499, DOI 10.1159/000320313; Lu VM, 2021, NEUROSURG REV, V44, P129, DOI 10.1007/s10143-019-01223-z; Nalbach SV, 2012, J CLIN NEUROSCI, V19, P1222, DOI 10.1016/j.jocn.2012.01.016; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; Oreskovic D, 2017, PEDIATR NEUROSURG, V52, P417, DOI 10.1159/000452169; Paredes Igor, 2011, Surg Neurol Int, V2, P88, DOI 10.4103/2152-7806.82370; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Neto ARS, 2019, CLIN NEUROL NEUROSUR, V182, P73, DOI 10.1016/j.clineuro.2019.05.003; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wan Y, 2016, CLIN NEUROL NEUROSUR, V149, P87, DOI 10.1016/j.clineuro.2016.08.004; Wu RH, 2019, BMC SURG, V19, DOI 10.1186/s12893-019-0489-5; Xu GZ, 2014, J CRANIOFAC SURG, V25, P1836, DOI 10.1097/SCS.0b013e3182a21056; Yuan Q, 2015, BRAIN INJURY, V29, P971, DOI 10.3109/02699052.2015.1004760	29	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2021	203								106598	10.1016/j.clineuro.2021.106598			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RH8HU	WOS:000636453300017	33730617				2022-02-06	
J	Hammed, A; Mahfoud, M; Sulaiman, A				Hammed, Ali; Mahfoud, Moufid; Sulaiman, Alaa			Spontaneous migration of a falling bullet in the cerebellum reveals the importance of intraoperative skull X-ray	JOURNAL OF SURGICAL CASE REPORTS			English	Article						cranial gunshot wounds; falling bullet; migration; intraoperative X-ray	GUNSHOT WOUNDS; INJURIES; BRAIN	Cranial gunshot wounds (CGSWs) are the most lethal types of the cranial traumas and they are usually mortal. Falling bullets or gravitational bullets are the ones that move under the effect of the gravity force after the muzzle force diminished. CGSWs constitute a major clinical challenge for neurosurgeons dealing with trauma in both the military and civil experience. We report the case of a 21-year-old man with a falling bullet wound to the head. The decision of surgical treatment of a bullet injury is difficult if it is in close proximity to vital structures; removal of the bullet may cause significant neurological damage; however, migration can lead to a worsening of the neurological status of the patient. Before surgical removal of any intracranial bullet, as valuable information, it is recommended that a plain skull X-ray be obtained after final positioning of the head.	[Hammed, Ali; Mahfoud, Moufid; Sulaiman, Alaa] Tishreen Univ Hosp, Dept Neurosurg, Latakia, Syria		Hammed, A (corresponding author), Tishreen Univ Hosp, Dept Neurosurg, Latakia, Syria.	alihaamed9@gmail.com					[Anonymous], 2001, J TRAUMA, V51, pS16; Castillo-Rangel C, 2010, NEUROCIRUGIA, V21, P326; DREW JH, 1954, J NEUROSURG, V11, P386, DOI 10.3171/jns.1954.11.4.0386; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Ozdemir M, 2009, TURK NEUROSURG, V19, P73; Rammo RA, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.06.015; Rapp LG, 1999, NEUROL RES, V21, P475, DOI 10.1080/01616412.1999.11740961; Solmaz I, 2009, TURK NEUROSURG, V19, P216; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010; Vilvandre G, 1916, ARCH RADIOL ELECTROT, V21, P7	10	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2042-8812			J SURG CASE REP	J. Surg. Case Rep.	APR	2021		4							rjab105	10.1093/jscr/rjab105			3	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	TX9CK	WOS:000683382900041	33927852	Green Published, gold			2022-02-06	
J	Hanko, M; Grendar, M; Snopko, P; Opsenak, R; Sutovsky, J; Benco, M; Sorsak, J; Zelenak, K; Kolarovszki, B				Hanko, Martin; Grendar, Marian; Snopko, Pavol; Opsenak, Rene; Sutovsky, Juraj; Benco, Martin; Sorsak, Jakub; Zelenak, Kamil; Kolarovszki, Branislav			Random Forest-Based Prediction of Outcome and Mortality in Patients with Traumatic Brain Injury Undergoing Primary Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Machine learning; Outcome; Random forest; Traumatic brain injury		BACKGROUND: Various prognostic models are used to predict mortality and functional outcome in patients after traumatic brain injury with a trend to incorporate machine learning protocols. None of these models is focused exactly on the subgroup of patients indicated for decompressive craniectomy. Evidence regarding efficiency of this surgery is still incomplete, especially in patients undergoing primary decompressive craniectomy with evacuation of traumatic mass lesions. METHODS: In a prospective study with a 6-month follow-up period, we assessed postoperative outcome and mortality of 40 patients who underwent primary decompressive craniectomy for traumatic brain injuries during 2018-2019. The results were analyzed in relation to a wide spectrum of preoperatively available demographic, clinical, radiographic, and laboratory data. Random forest algorithms were trained for prediction of both mortality and unfavorable outcome, with their accuracy quantified by area under the receiver operating curves (AUCs) for out-of-bag samples. RESULTS: At the end of the follow-up period, we observed mortality of 57.5%. Favorable outcome (Glasgow Outcome Scale [GOS] score 4-5) was achieved by 30% of our patients. Random forest-based prediction models constructed for 6-month mortality and outcome reached a moderate predictive ability, with AUC = 0.811 and AUC = 0.873, respectively. Random forest models trained on handpicked variables showed slightly decreased AUC = 0.787 for 6-month mortality and AUC = 0.846 for 6-month outcome and increased out-of-bag error rates. CONCLUSIONS: Random forest algorithms show promising results in prediction of postoperative outcome and mortality in patients undergoing primary decompressive craniectomy. The best performance was achieved by Classification Random forest for 6-month outcome.	[Hanko, Martin; Snopko, Pavol; Opsenak, Rene; Sutovsky, Juraj; Benco, Martin; Kolarovszki, Branislav] Comenius Univ, Jessenius Fac Med Martin, Clin Neurosurg, Martin, Slovakia; [Sorsak, Jakub; Zelenak, Kamil] Comenius Univ, Jessenius Fac Med Martin, Clin Radiol, Martin, Slovakia; [Sorsak, Jakub; Zelenak, Kamil] Univ Hosp Martin, Martin, Slovakia; [Grendar, Marian] Comenius Univ, Jessenius Fac Med Martin, Bioinformat Ctr, Biomed Ctr Martin BioMed, Martin, Slovakia		Hanko, M (corresponding author), Comenius Univ, Jessenius Fac Med Martin, Clin Neurosurg, Martin, Slovakia.	m.hanko.to@gmail.com	Hanko, Martin/AAF-5292-2021	Hanko, Martin/0000-0002-6524-6517; Snopko, Pavol/0000-0001-5742-9869	 [UK/136/2019];  [UK/11/2020]	This work was supported by following grants: Dynamics and risk factors of progression in posttraumatic intracerebral haematomasea comparison of surgical and conservative treatment, UK/136/2019, UK/11/2020.	Abujaber A, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00738-5; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Albert Venencia, 2019, Hematol Oncol Stem Cell Ther, V12, P32, DOI 10.1016/j.hemonc.2018.09.005; Bhandari A, 2020, INSIGHTS IMAGING, V11, DOI 10.1186/s13244-020-00869-4; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Chan C. H., 2006, SMJ Singapore Medical Journal, V47, P928; Charry JD, 2017, WORLD NEUROSURG, V101, P554, DOI 10.1016/j.wneu.2017.02.051; Cooper DJ, 2020, J NEUROTRAUM, V37, P810, DOI 10.1089/neu.2019.6869; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Di Battista AP, 2016, SHOCK, V46, P96, DOI 10.1097/SHK.0000000000000642; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Gravesteijn BY, 2020, J CLIN EPIDEMIOL, V122, P95, DOI 10.1016/j.jclinepi.2020.03.005; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hale AT, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS17773; Hanko M, 2021, EUR J TRAUMA EMERG S, V47, P1635, DOI 10.1007/s00068-020-01367-4; Haveman ME, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2656-6; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Ishwaran Hemant, 2011, Statistical Analysis and Data Mining, V4, P115, DOI 10.1002/sam.10103; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Javorka K, 2001, LEKARSKAFYZIOLOGIA, P615; Jiang HT, 2020, PAK J MED SCI, V36, P770, DOI 10.12669/pjms.36.4.2045; Juran V, 2009, CESK SLOV NEUROL N, V72, P439; Kalagara S, 2019, J NEUROSURG-SPINE, V30, P344, DOI 10.3171/2018.8.SPINE1869; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Kwon Young Sub, 2016, Korean J Neurotrauma, V12, P22, DOI 10.13004/kjnt.2016.12.1.22; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Liao PZ, 2017, STAT BIOSCI, V9, P91, DOI 10.1007/s12561-016-9159-7; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matsuo K, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6276; Mracek J, 2011, ACTA NEUROCHIR, V153, P2259, DOI 10.1007/s00701-011-1132-0; Nakae R, 2019, ACTA NEUROCHIR, V161, P1943, DOI 10.1007/s00701-019-04010-3; Noyan MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75546-z; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Raj R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53889-6; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rajkomar A, 2019, NEW ENGL J MED, V380, P1347, DOI 10.1056/NEJMra1814259; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Sidey-Gibbons JAM, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0681-4; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tang ZJ, 2020, WORLD NEUROSURG, V134, pE298, DOI 10.1016/j.wneu.2019.10.053; Tapper Julius, 2017, Surg Neurol Int, V8, P141, DOI 10.4103/sni.sni_453_16; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; Wongvibulsin S, 2019, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-019-0863-0; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	61	1	1	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						E450	E458		10.1016/j.wneu.2021.01.002			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900051	33444843				2022-02-06	
J	Hardin, KY				Hardin, Kathryn Y.			Prospective Exploration of Cognitive-Communication Changes With Woodcock-Johnson IV Before and After Sport-Related Concussion	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: The purpose of this study was to evaluate changes in cognitive-communication performance using Woodcock-Johnson IV Tests (WJIV) from pre-injury baseline to post sport-related concussion. It was hypothesized that individual subtest performances would decrease postinjury in symptomatic individuals. Method: This prospective longitudinal observational nested cohort study of collegiate athletes assessed cognitive-communicative performance at preseason baseline and postinjury. Three hundred and forty-two male and female undergraduates at high risk for sport-related concussion participated in preseason assessments, and 18 individuals met criteria post injury. WJIV subtest domains included Word Finding, Speeded Reading Comprehension, Auditory Comprehension, Verbal Working Memory, Story Retell, and Visual Processing (letter and number). The power calculation was not met, and therefore data were conservatively analyzed with descriptive statistics and a planned subgroup analysis based on symptomatology. Results: Individual changes from baseline to postinjury were evaluated using differences in standard score performance. For symptomatic individuals, mean negative decreases in performance were found for Retrieval Fluency, Sentence Reading Fluency, Pattern Matchings, and all cluster scores postinjury. Individual performance declines also included decreases in story retell, verbal working memory, and visual processing. Conclusions: This study identified within-subject WJIV performance decline in communication domains post sport-related concussion and reinforces that cognitive-communication dysfunction should be considered in mild traumatic brain injury. Key cognitive-communication areas included speeded naming, reading, and verbal memory, though oral comprehension was not sensitive to change. Future clinical research across diverse populations is needed to expand these preliminary findings.	[Hardin, Kathryn Y.] Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA		Hardin, KY (corresponding author), Univ Colorado, Dept Speech Language & Hearing Sci, Boulder, CO 80309 USA.	hardink@colorado.edu		Hardin, Kathryn/0000-0001-9799-0220	University of Colorado Anschutz Colorado Clinical & Translational Sciences Institute; Clinical and Translational Science Award; National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute Grant [UL1 TR002535]; University of Colorado Boulder College of Arts & Sciences Dean's Fund for Excellence; CU Boulder CARTSS Scholar Fund; University of Colorado Speech-Language Hearing Clinic; Wardenburg Health Center; CU Club Sports	This work is supported by the University of Colorado Anschutz Colorado Clinical & Translational Sciences Institute and support from the Clinical and Translational Science Award. This work is supported by National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute Grant UL1 TR002535. Contents are the authors' sole responsibility and do not necessarily represent official National Institutes of Health views. Additional funding provided by the University of Colorado Boulder College of Arts & Sciences Dean's Fund for Excellence and the CU Boulder CARTSS Scholar Fund.; The authors would like to acknowledge Mary Dineen for her extensive support with data collection and graduate student support. Thanks to Gail Ramsberger, Theresa Hernandez, James Kelly, and Allan Prochazka for their input on neuroscience and support of this doctoral research and to Matthew McQueen for his assistance with statistical modeling. The author acknowledges the University of Colorado Speech-Language Hearing Clinic, Wardenburg Health Center, and CU Club Sports for their long-term support of this project as well as all of the athletes who participated in this study and the SLHS graduate students who collected data.	Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; American Speech-Language-Hearing Association, 2016, TRAUMATIC BRAIN INJU; American Speech-Language-Hearing Association, 2003, EVALUATING TREATING; ASHA Action Center, 2020, COD PAYM COGN EV TRE; Asken BM, 2017, J ATHL TRAINING, V52, P51, DOI 10.4085/1062-6050-51.12.27; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bartels C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-118; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; BEERS SR, 1994, J LEARN DISABIL, V27, P315, DOI 10.1177/002221949402700508; Bialunska A, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.874; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Brown J, 2019, TOP LANG DISORD, V39, P239, DOI 10.1097/TLD.0000000000000186; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Bureau of Labor Statistics U.S. Department of Labor, OCCUPATIONAL OUTLOOK; Chapman EH, 1999, J HEAD TRAUMA REHAB, V14, P521, DOI 10.1097/00001199-199912000-00002; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Constantinidou F, 2012, BRAIN INJURY, V26, P1549, DOI 10.3109/02699052.2012.698786; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dinnes C, 2018, COMMUN DISORD Q, V39, P490, DOI 10.1177/1525740117716416; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Gans R.E, 2017, J OTOLARYNGOLOGY ENT, V6; Gioia G. A., 2006, BRAIN INJURY, V23, P230; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Hardin K, 2020, J HEAD TRAUMA REHAB, V35, pE166; Hardin K. Y., IN PRESS; Hardin KY, 2019, SEMIN SPEECH LANG, V40, P65, DOI 10.1055/s-0038-1676452; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kegel NE, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P117, DOI 10.1007/978-0-387-89545-1_10; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; Langlois J. A., 2010, HEADS FACTS PHYS MIL; Larson JCG, 2015, ARCH CLIN NEUROPSYCH, V30, P192, DOI 10.1093/arclin/acv012; Ledbetter C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00825; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Lundine JP, 2019, AM J SPEECH-LANG PAT, V28, P1371, DOI 10.1044/2019_AJSLP-18-0295; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Mashima P., 2019, TOPICS LANGUAGE DISO, V39; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; McGrew K. S., 2014, TECHNICAL MANUAL; National Institute of Neurological Disorders and Stroke, 2013, NINDS COMM DAT EL TR; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Salvatore Anthony P, 2017, Concussion, V2, pCNC37, DOI 10.2217/cnc-2016-0024; Sander AM, 2009, CLIN NEUROPSYCHOL, V23, P1196, DOI 10.1080/13854040902845706; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; Speech-Language & Audiology Canada, 2019, ROL SPEECHL PATH CON; Stockbridge MD, 2020, BRAIN INJURY, V34, P567, DOI 10.1080/02699052.2020.1725836; TUPPER DE, 1990, J LEARN DISABIL, V23, P306, DOI 10.1177/002221949002300510; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	71	1	1	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		894	907		10.1044/2020_AJSLP-20-00110			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400004	33784181	Green Published			2022-02-06	
J	Hewetson, R; Cornwell, P; Shum, DHK				Hewetson, Ronelle; Cornwell, Petrea; Shum, David H. K.			Relationship and Social Network Change in People With Impaired Social Cognition Post Right Hemisphere Stroke	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article								Purpose: This article investigated relationship and social network change in the presence of a social cognition impairment post right hemisphere ( RH) stroke. Impaired emotion perception and inferential reasoning are sources of interpersonal difficulty in people with social cognition impairment after traumatic brain injury. People with an RH stroke have also been identified as vulnerable to interpersonal relationship change. However, the influence of impairments in particular domains of communication or cognition on relationship and social network maintenance is yet to be explored. Method: A multiple-case study methodology allowed for testing of theoretically developed propositions by exploring social networks and relationships within and between seven participant-proxy dyads. Purposeful recruitment was based on first-onset RH stroke and impaired social cognition, as determined by The Awareness of Social Inference Test. Results: Social network size reduction (71.4%, n = 5) and interpersonal relationship change (85.7%, n = 6) were attributed to altered communication style, impairments in social cognition, and reduced insight and/or motivation. The spouse emerged as a facilitator of social engagement. Conclusion: This study contributes to our understanding of the challenges experienced by people with impaired social cognition post RH stroke in maintaining relationships and their social networks.	[Hewetson, Ronelle; Cornwell, Petrea] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia; [Shum, David H. K.] Hong Kong Polytech Univ, Hong Kong, Peoples R China		Hewetson, R (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Qld, Australia.	r.hewetson@griffith.edu.au		Hewetson, Ronelle/0000-0003-1872-9943	Queensland Registration Board Legacy Fund - Speech Pathology Australia	The research was supported in part through a Queensland Registration Board Legacy Fund grant, awarded by Speech Pathology Australia.	Adams AG, 2019, NEUROSCI BIOBEHAV R, V102, P400, DOI 10.1016/j.neubiorev.2019.03.011; Alcala-Lopez D, 2018, CEREB CORTEX, V28, P2207, DOI 10.1093/cercor/bhx121; Barrett AM, 2009, BEHAV NEUROL, V22, P17, DOI 10.3233/BEN-2009-0250; Blake M. L., 2017, RIGHT HEMISPHERE DIS; Blake M. L., 2011, COGNITIVE COMMUNICAT; Blake ML, 2007, AM J SPEECH-LANG PAT, V16, P331, DOI 10.1044/1058-0360(2007/037); Borod Joan C, 2002, Appl Neuropsychol, V9, P23, DOI 10.1207/S15324826AN0901_4; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Cornwell B, 2014, J GERONTOL B-PSYCHOL, V69, pS75, DOI 10.1093/geronb/gbu037; Creswell J.W ., 2007, QUAL INQ; Dai CY, 2014, EUR J NEUROL, V21, P797, DOI 10.1111/ene.12413; Dalemans RJP, 2010, DISABIL REHABIL, V32, P1678, DOI 10.3109/09638281003649938; Dara Chinar, 2014, J Neurol Transl Neurosci, V2, P1037; Douglas JM, 2017, BRAIN IMPAIR, V18, P321, DOI 10.1017/BrImp.2017.20; Egbert N, 2006, HEALTH COMMUN, V20, P45, DOI 10.1207/s15327027hc2001_5; Ferre P., 2016, PERSPECTIVES ASHA SP, V1, P106, DOI [10.1044/persp1.SIG2.106., DOI 10.1044/PERSP1.SIG2.106]; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Haley WE, 2011, QUAL LIFE RES, V20, P799, DOI 10.1007/s11136-010-9810-6; Hewetson R, 2018, APHASIOLOGY, V32, P164, DOI 10.1080/02687038.2017.1315045; Hewetson R, 2017, TOP STROKE REHABIL, V24, P330, DOI 10.1080/10749357.2017.1289622; Hilari K, 2006, APHASIOLOGY, V20, P17, DOI 10.1080/02687030500279982; Hilari K, 2003, APHASIOLOGY, V17, P365, DOI 10.1080/02687030244000725; Hilari K, 2011, DISABIL REHABIL, V33, P211, DOI 10.3109/09638288.2010.508829; Jehkonen M, 2000, ACTA NEUROL SCAND, V102, P378, DOI 10.1034/j.1600-0404.2000.102006378.x; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kersten P, 2002, DISABIL REHABIL, V24, P860, DOI 10.1080/09638280210142167; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Le Dorze G, 2014, APHASIOLOGY, V28, P421, DOI 10.1080/02687038.2013.869305; Mackenzie C, 2008, EVID BASED COMMUN AS, V2, P235, DOI DOI 10.1080/17489530802615336; Malle B, 2001, INTENTIONS INTENTION; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2013, SOCIAL COMMUNICATION; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Merriam S.B., 2009, QUALITATIVE RES GUID, V4th ed.; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Mitchell RLC, 2015, NEUROPSYCHOLOGIA, V70, P1, DOI 10.1016/j.neuropsychologia.2015.02.018; Northcott S, 2018, GERONTOLOGIST, V58, P500, DOI 10.1093/geront/gnx011; Northcott S, 2011, INT J LANG COMM DIS, V46, P524, DOI 10.1111/j.1460-6984.2011.00079.x; Perry A, 2004, INT J QUAL HEALTH C, V16, P285, DOI 10.1093/intqhc/mzh059; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Quinn K, 2014, DISABIL REHABIL, V36, P185, DOI 10.3109/09638288.2013.783630; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P81, DOI 10.1080/02687030600798311; Sohlberg MM, 2019, INT J SPEECH-LANG PA, V21, P115, DOI 10.1080/17549507.2019.1583280; Tate R., 2011, MANUAL SYDNEY PSYCHO; Theadom A, 2019, NEUROPSYCHOLOGY, V33, P560, DOI 10.1037/neu0000516; Thomas G, 2011, QUAL INQ, V17, P511, DOI 10.1177/1077800411409884; Tsouna-Hadjis E, 2000, ARCH PHYS MED REHAB, V81, P881, DOI 10.1053/apmr.2000.4435; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Westerhof-Evers HJ, 2019, BRAIN INJURY, V33, P78, DOI 10.1080/02699052.2018.1531303; Yin RK., 2014, CASE STUDY RES DESIG, V5	57	1	1	2	4	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	APR	2021	30	2		S	SI		962	973		10.1044/2020_AJSLP-20-00047			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	RO4NT	WOS:000641022400009	33621120				2022-02-06	
J	Hu, J; Fung, FW; Jacobwitz, M; Parikh, DS; Vala, L; Donnelly, M; Topjian, AA; Abend, NS; Xiao, R				Hu, Jian; Fung, France W.; Jacobwitz, Marin; Parikh, Darshana S.; Vala, Lisa; Donnelly, Maureen; Topjian, Alexis A.; Abend, Nicholas S.; Xiao, Rui			Machine learning models to predict electroencephalographic seizures in critically ill children	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Seizure; Pediatric; Electroencephalogram; EEG monitoring; Machine learning	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CONTINUOUS VIDEO-EEG; ELECTROGRAPHIC SEIZURES; CONSENSUS STATEMENT; COMATOSE CHILDREN; ADULTS; COMMON; TERMINOLOGY; GUIDELINES	Objective: To determine whether machine learning techniques would enhance our ability to incorporate key variables into a parsimonious model with optimized prediction performance for electroencephalographic seizure (ES) prediction in critically ill children. Methods: We analyzed data from a prospective observational cohort study of 719 consecutive critically ill children with encephalopathy who underwent clinically-indicated continuous EEG monitoring (CEEG). We implemented and compared three state-of-the-art machine learning methods for ES prediction: (1) random forest; (2) Least Absolute Shrinkage and Selection Operator (LASSO); and (3) Deep Learning Important FeaTures (DeepLIFT). We developed a ranking algorithm based on the relative importance of each variable derived from the machine learning methods. Results: Based on our ranking algorithm, the top five variables for ES prediction were: (1) epileptiform discharges in the initial 30 minutes, (2) clinical seizures prior to CEEG initiation, (3) sex, (4) age dichotomized at 1 year, and (5) epileptic encephalopathy. Compared to the stepwise selection-based approach in logistic regression, the top variables selected by our ranking algorithm were more informative as models utilizing the top variables achieved better prediction performance evaluated by prediction accuracy, AUROC and F1 score. Adding additional variables did not improve and sometimes worsened model performance. Conclusion: The ranking algorithm was helpful in deriving a parsimonious model for ES prediction with optimal performance. However, application of state-of-the-art machine learning models did not substantially improve model performance compared to prior logistic regression models. Thus, to further improve the ES prediction, we may need to collect more samples and variables that provide additional information.	[Hu, Jian; Xiao, Rui] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Parikh, Darshana S.; Topjian, Alexis A.] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA; [Fung, France W.; Jacobwitz, Marin; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Pediat, Div Neurol, Philadelphia, PA 19104 USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fung, France W.; Abend, Nicholas S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Topjian, Alexis A.; Abend, Nicholas S.] Univ Penn, Dept Anesthesia & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Abend, Nicholas S.; Xiao, Rui] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Parikh, Darshana S.; Vala, Lisa; Donnelly, Maureen; Abend, Nicholas S.] Childrens Hosp Philadelphia, Dept Neurodiagnost, Philadelphia, PA 19104 USA		Xiao, R (corresponding author), Univ Penn, Dept Biostat Epidemiol & Informat, 423 Guardian Dr,Blockley Hall, Philadelphia, PA 19104 USA.	xiaor@email.chop.edu			NIH (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54-HD086984]; NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02NS096058]; Wolfson Foundation	Jian Hu - Reports no disclosures.; France W. Fung - Reports no disclosures.; Alexis A. Topjian - Reports no disclosures.; Rui Xiao - Funding from NIH (NICHD) U54-HD086984.; Darshana Parikh - Reports no disclosures.; Maureen Donnelly - Reports no disclosures.; Lisa Vala -Reports no disclosures.; Nicholas S. Abend - Funding from NIH (NINDS) K02NS096058 and the Wolfson Foundation.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P251, DOI 10.1097/WNP.0000000000000459; Abend NS, 2018, J CLIN NEUROPHYSIOL, V35, P246, DOI 10.1097/WNP.0000000000000458; Abend NS, 2015, J CLIN NEUROPHYSIOL, V32, P257, DOI 10.1097/WNP.0000000000000170; Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2013, SEIZURE-EUR J EPILEP, V22, P467, DOI 10.1016/j.seizure.2013.03.008; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Children's Hospital of Philadelphia, 2020, EEG MON CLIN PATHW; Fernandez IS, 2014, J PEDIATR-US, V164, P339, DOI 10.1016/j.jpeds.2013.09.032; Fukushima K., 1982, COMPET COOP NEURAL N, P267, DOI 10.1007/978-3-642-46466-9_18; Fung FW, 2020, EPILEPSIA, V61, P2754, DOI 10.1111/epi.16724; Fung FW, 2020, NEUROLOGY, V95, pE1599, DOI 10.1212/WNL.0000000000010421; Fung FW, 2020, EPILEPSIA, V61, P498, DOI 10.1111/epi.16448; Fung FW, 2019, EPILEPSIA, V60, P2095, DOI 10.1111/epi.16341; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Gwer S, 2012, ARCH DIS CHILD, V97, P343, DOI 10.1136/archdischild-2011-300935; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kane N, 2017, CLIN NEUROPHYS PRACT, V2, P170, DOI 10.1016/j.cnp.2017.07.002; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Ostendorf AP, 2016, PEDIATR CRIT CARE ME, V17, P667, DOI 10.1097/PCC.0000000000000791; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Piantino JA, 2013, PEDIATR CRIT CARE ME, V14, P601, DOI 10.1097/PCC.0b013e318291755a; Fernandez IS, 2017, EPILEPSIA, V58, P420, DOI 10.1111/epi.13653; Fernandez IS, 2018, SEIZURE-EUR J EPILEP, V54, P19, DOI 10.1016/j.seizure.2017.11.013; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Sansevere AJ, 2017, J CLIN NEUROPHYSIOL, V34, P421, DOI 10.1097/WNP.0000000000000379; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Shrikumar A., 2019, LEARNING IMPORTANT F; Struck AF, 2017, ANN NEUROL, V82, P177, DOI 10.1002/ana.24985; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vaewpanich J, 2016, EPILEPSY BEHAV, V62, P225, DOI 10.1016/j.yebeh.2016.07.012; Vlachy J, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00303; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; Williams RP, 2016, EPILEPSIA, V57, P786, DOI 10.1111/epi.13354; Yang A, 2015, SEIZURE-EUR J EPILEP, V25, P104, DOI 10.1016/j.seizure.2014.09.013	57	1	1	2	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	APR	2021	87						61	68		10.1016/j.seizure.2021.03.001			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RN0VQ	WOS:000640073600010	33714840				2022-02-06	
J	Huys, SEF; Van Gysel, A; Mommaerts, MY; Vander Sloten, J				Huys, Stijn E. F.; Van Gysel, Anke; Mommaerts, Maurice Y.; Vander Sloten, Jos			Evaluation of Patient-Specific Cranial Implant Design Using Finite Element Analysis	WORLD NEUROSURGERY			English	Article						Bone-implant interface; Cranium; Calcium phosphate; Finite element analysis; Patient-specific implant; Polyether ether ketone; Titanium		BACKGROUND: Various studies have investigated the load-bearing capacity of patient-specific cranial implants. However, little attention has been given to the evaluation of the design of ceramic-titanium (CeTi) implants. METHODS: A biomechanical evaluation of 3 patient-specific cranial implants was performed using finite element analysis. RESULTS: The results of the analyses allowed the identification of the implant regions as well as the magnitudes of the maximum stresses on, and displacements along, these regions after traumatic impact. The analyses also showed that polyether ether ketone cranial implants offer inferior brain and neurocranial protection due to their high flexibility and local peak stresses at the bone-screw interface. In contrast, CeTi implants were able to evenly distribute the stresses along the interface and thus reduced the risk of neurocranial fracture. The scaffold structure at the border of these implants reduced stress shielding and enhanced bone ingrowth. Moreover, brain injuries were less likely to occur, as the CeTi implant exhibits limited deflection. CONCLUSIONS: From the finite element analyses, CeTi cranial implants appear less likely to induce calvarial fractures with a better potential to protect the brain under impact loads.	[Huys, Stijn E. F.; Van Gysel, Anke; Vander Sloten, Jos] Katholieke Univ Leuven, Dept Mech Engn, Sect Biomech, Engn Sci, Leuven, Belgium; [Mommaerts, Maurice Y.] Vrije Univ Brussel, Univ Ziekenhuis Brussel, 3D Innovat Lab, Brussels, Belgium		Mommaerts, MY (corresponding author), Vrije Univ Brussel, Univ Ziekenhuis Brussel, 3D Innovat Lab, Brussels, Belgium.	mauricemommaerts@me.com	; Mommaerts, Maurice Y./N-9287-2014	Huys, Stijn/0000-0002-6121-901X; Mommaerts, Maurice Y./0000-0002-3522-8879			Aydin S, 2011, J NEUROSCI RURAL PRA, V2, P162, DOI 10.4103/0976-3147.83584; Bogu VP, 2017, ACTA BIOENG BIOMECH, V19, P125, DOI 10.5277/ABB-00547-2016-04; Boyd D, 2008, J MATER SCI-MATER M, V19, P1745, DOI 10.1007/s10856-007-3363-4; Clarkin OM, 2009, J MATER SCI-MATER M, V20, P1563, DOI 10.1007/s10856-009-3701-9; Diaz JM, 2017, IFMBE P, V60, P405; Ducic J, 2002, J ORAL MAXIL SURG, V60, P272, DOI 10.1053/joms.2002.30575; El Halabi F, 2011, J MECH BEHAV BIOMED, V4, P1819, DOI 10.1016/j.jmbbm.2011.05.039; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; FUJIWARA S, 1989, FORENSIC SCI INT, V43, P159, DOI 10.1016/0379-0738(89)90132-1; GORDON DS, 1974, BRIT MED J, V2, P478, DOI 10.1136/bmj.2.5917.478; Ilea A, 2019, J MATER SCI-MATER M, V30, DOI 10.1007/s10856-019-6227-9; Jonkergouw J, 2016, J CRANIO MAXILL SURG, V44, P1266, DOI 10.1016/j.jcms.2016.07.005; Khader BA, 2016, MAT SCI ENG C-MATER, V66, P315, DOI 10.1016/j.msec.2016.04.101; Kusakabe H, 2004, BIOMATERIALS, V25, P2957, DOI 10.1016/j.biomaterials.2003.09.090; Mommaerts MY, 2020, CRANIOMAX TRAUM REC, V13, P329, DOI 10.1177/1943387520927916; Nout E, 2018, ORAL MAXILLOFAC SURG, V22, P65, DOI 10.1007/s10006-017-0668-4; Piazza M, 2017, NEUROSURG CLIN N AM, V28, P257, DOI 10.1016/j.nec.2016.11.008; SAFI Y, 2010, SIMULIA COMM C SPETG, P1; Savaser BO, 2017, EPSTEM, V1, P22; Tsouknidas A, 2011, BIO-MED MATER ENG, V21, P139, DOI 10.3233/BME-2011-0663; Wang YR, 2007, ANN PLAS SURG, V58, P388, DOI 10.1097/01.sap.0000239352.89088.26	21	1	1	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2021	148						198	204		10.1016/j.wneu.2021.01.102			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RA9IO	WOS:000631732900113	33529765				2022-02-06	
J	Iverson, GL; Van Patten, R; Terry, DP; Levi, CR; Gardner, AJ				Iverson, Grant L.; Van Patten, Ryan; Terry, Douglas P.; Levi, Christopher R.; Gardner, Andrew J.			Predictors and Correlates of Depression in Retired Elite Level Rugby League Players	FRONTIERS IN NEUROLOGY			English	Article						retired athletes; sports; brain concussion; brain injury; depression; mental health		Background: There is considerable interest in determining whether later-in-life depression is associated with lifetime history of concussions or the duration of a career in professional contact and collision sports. Rugby league is a high-intensity collision sport involving a large number of tackles per game and a high rate of concussions. We examined predictors and correlates of depression in retired elite level rugby league players in Australia. Methods: Retired elite level rugby league players (N = 141, age: M = 52.6, SD = 13.8; Range = 30-89 years) completed the Depression, Anxiety, and Stress Scale (DASS), Brief Pain Inventory, Connor-Davidson Resilience Scale (CD-RISC), and Epworth Sleepiness Scale; they also reported on lifetime history of concussions. The DASS depression score was regressed on age, total number of self-reported concussions, years played professionally, CD-RISC score, BPI pain interference score, and ESS score. Results: The retired players reported a median of 15 total lifetime concussions [interquartile range (IQR) = 6-30], and a median of 8 years playing professional sports (IQR = 3.5-11). The proportion of the sample endorsing at least mild current depression was 29%. The DASS depression score was positively correlated with the DASS anxiety (r = 0.54) and DASS stress scores (r = 0.58). The CD-RISC score was negatively correlated with the depression score (r = -0.53). Depression scores were not significantly correlated with pain severity (r = 0.14), and were weakly correlated with life interference due to pain (r = 0.20) and years playing professional sports (r = -0.17). Depression scores were not significantly correlated with lifetime history of concussions (r = 0.14). A multiple regression model, with age, total number of self-reported concussions, years played professionally, the CD-RISC, Brief Pain Inventory-pain interference score, and Epworth Sleepiness Scale score as predictors was significant, with 35% of the variance in DASS depression accounted for. The two significant independent predictors of depression were lower resilience and greater life interference due to pain. Conclusions: This is the first large study of depression in retired rugby league players. Depression in these retired players was not meaningfully associated with lifetime history of concussions or number of years playing elite level collision sport. Depression was associated with current anxiety, stress, resilience, and life interference due to chronic pain.	[Iverson, Grant L.; Van Patten, Ryan; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Van Patten, Ryan; Terry, Douglas P.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] MassGen Hosp, Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Red Sox Fdn, Home Base, Charlestown, MA USA; [Iverson, Grant L.; Terry, Douglas P.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Levi, Christopher R.] Sydney Partnership Hlth Educ Res & Enterprise SPH, Sydney, NSW, Australia; [Levi, Christopher R.] Univ New South Wales, Sch Med Sci, Randwick, NSW, Australia; [Levi, Christopher R.; Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Levi, Christopher R.; Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia		Gardner, AJ (corresponding author), Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia.; Gardner, AJ (corresponding author), Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia.	Andrew.Gardner@newcastle.edu.au	Van+Patten, Ryan/AAZ-6757-2021	Gardner, Andrew/0000-0001-5031-5586	NSW Sporting Injuries Committee; Brain Foundation, Australia; Priority Research Centre for Stroke and Brain Injury; National Rugby League, ImPACT Applications, Inc.; Mooney-Reed Charitable Foundation; Spaulding Research Institute	This study was funded in part by the NSW Sporting Injuries Committee, the Brain Foundation, Australia, and the Priority Research Centre for Stroke and Brain Injury. Unrestricted philanthropic support was provided by the National Rugby League, ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, and the Spaulding Research Institute. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; ATKINSON JH, 1991, PAIN, V45, P111, DOI 10.1016/0304-3959(91)90175-W; Banks SM, 1996, PSYCHOL BULL, V119, P95, DOI 10.1037/0033-2909.119.1.95; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder EB, 2010, MOL PSYCHIATR, V15, P574, DOI 10.1038/mp.2009.141; Bodenmann G, 2013, CURR OPIN PSYCHIATR, V26, P464, DOI 10.1097/YCO.0b013e3283642de7; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Bulloch AG, 2009, DEPRESS ANXIETY, V26, P1172, DOI 10.1002/da.20618; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Carless D, 2009, QUAL RES SPORT EXERC, V1, P51, DOI 10.1080/19398440802567949; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Demetriou A, 2020, INT J SPORT EXERC PS, V18, P321, DOI 10.1080/1612197X.2018.1519839; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dooley D, 1996, ANNU REV PUBL HEALTH, V17, P449, DOI 10.1146/annurev.pu.17.050196.002313; Farmer AE, 2003, PSYCHOL MED, V33, P1169, DOI 10.1017/S0033291703008419; Fishbain DA, 1997, CLIN J PAIN, V13, P116, DOI 10.1097/00002508-199706000-00006; Friis RH, 2002, EUR PSYCHIAT, V17, P241, DOI 10.1016/S0924-9338(02)00682-X; Gaetz M, 2017, MED HYPOTHESES, V102, P130, DOI 10.1016/j.mehy.2017.03.023; Gallo WT, 2000, J GERONTOL B-PSYCHOL, V55, pS131, DOI 10.1093/geronb/55.3.S131; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gibson ES, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-116; Gonzalez G, 2019, ANN WORK EXPOS HEAL, V63, P359, DOI 10.1093/annweh/wxy107; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Gouttebarge V, 2021, NEUROCHIRURGIE, V67, P280, DOI 10.1016/j.neuchi.2020.01.001; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P252, DOI 10.1080/00913847.2017.1338497; Gouttebarge V, 2017, J SPORT SCI, V35, P2148, DOI 10.1080/02640414.2016.1258485; Gouttebarge V, 2016, J SPORT MED PHYS FIT, V56, P648; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Grant M., 1992, AUDIT ALCOHOL USE DI; Guell X, 2020, J NEUROTRAUM, V37, P1788, DOI 10.1089/neu.2019.6782; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Ilgen MA, 2008, GEN HOSP PSYCHIAT, V30, P521, DOI 10.1016/j.genhosppsych.2008.09.003; Iverson GL, 2020, ARCH CLIN NEUROPSYCH, V35, P332, DOI 10.1093/arclin/acz023; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jaremka LM, 2013, DEPRESS ANXIETY, V30, P288, DOI 10.1002/da.22078; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones ME, 2018, J SCI MED SPORT, V21, P558, DOI 10.1016/j.jsams.2017.10.013; Kendler KS, 2000, AM J PSYCHIAT, V157, P1243, DOI 10.1176/appi.ajp.157.8.1243; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kendler KS, 2001, AM J PSYCHIAT, V158, P587, DOI 10.1176/appi.ajp.158.4.587; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Kerr ZY, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114544107; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kilic O, 2017, EUR J SPORT SCI, V17, P1328, DOI 10.1080/17461391.2017.1381768; King D, 2010, INT J PERF ANAL SPOR, V10, P241, DOI 10.1080/24748668.2010.11868519; Laird KT, 2018, INT J GERIATR PSYCH, V33, P1596, DOI 10.1002/gps.4953; Laird KT, 2019, INT PSYCHOGERIATR, V31, P193, DOI 10.1017/S1041610217002873; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN; Mackinnon AL, 2019, INT J SPORTS MED, V40, P732, DOI 10.1055/a-0902-8601; Mak WWS, 2011, J COUNS PSYCHOL, V58, P610, DOI 10.1037/a0025195; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannes ZL, 2020, HEALTH PSYCHOL, V39, P452, DOI 10.1037/hea0000847; Mannes ZL, 2019, INT REV SPORT EXER P, V12, P265, DOI 10.1080/1750984X.2018.1469162; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martin LA, 2014, J APPL SPORT PSYCHOL, V26, P96, DOI 10.1080/10413200.2013.798371; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGillivray D, 2005, J SPORT SOC ISSUES, V29, P102, DOI 10.1177/0193723504268730; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Nicholas MK, 2019, PAIN, V160, P1156, DOI 10.1097/j.pain.0000000000001496; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Park S, 2013, INT REV SPORT EXER P, V6, P22, DOI 10.1080/1750984X.2012.687053; Ramirez-Maestre C, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0312-9; Richardson T, 2013, CLIN PSYCHOL REV, V33, P1148, DOI 10.1016/j.cpr.2013.08.009; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Russell ER, 2020, J NEUROL NEUROSUR PS, V91, P1256, DOI 10.1136/jnnp-2020-323315; Sanders G, 2017, EUR J SPORT SCI, V17, P1311, DOI 10.1080/17461391.2017.1371795; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schuring N, 2017, PHYSICIAN SPORTSMED, V45, P463, DOI 10.1080/00913847.2017.1386069; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stonnington CM, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0609-2; Sturgeon JA, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0317-4; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Terpstra AR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00712; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Turner AP, 2000, BRIT J SPORT MED, V34, P332, DOI 10.1136/bjsm.34.5.332; Turner RW, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988319876825; Wagnild G M, 1993, J Nurs Meas, V1, P165; Waugh CE, 2015, CLIN PSYCHOL REV, V41, P49, DOI 10.1016/j.cpr.2014.05.004; Weir DR., 2009, NATL FOOTBALL LEAGUE; Avila MPW, 2017, INT J GERIATR PSYCH, V32, P237, DOI 10.1002/gps.4619; Wilson KG, 2002, CLIN J PAIN, V18, P77, DOI 10.1097/00002508-200203000-00002; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; Wright DK, 2021, J NEUROTRAUM, V38, P983, DOI 10.1089/neu.2019.6886	119	1	1	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 1	2021	12								655746	10.3389/fneur.2021.655746			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RN4SQ	WOS:000640342900001	33868156	Green Published, gold			2022-02-06	
J	Jin, T; Lian, WJ; Xu, K; Liu, Y; Xu, ZN; Lu, RZ; Liu, MF				Jin, Tao; Lian, Weijie; Xu, Ke; Liu, Yan; Xu, Zhennan; Lu, Rongzhang; Liu, Mingfa			Effect of combination invasive intracranial pressure (ICP) monitoring and transcranial Doppler in the treatment of severe craniocerebral injury patients with decompressive craniectomy	ANNALS OF PALLIATIVE MEDICINE			English	Article						Invasive intracranial pressure (ICP); decompressive craniectomy; cranioplasty; transcranial Doppler (TCD); Glasgow Outcome Scale (GOS)	TRAUMATIC BRAIN-INJURY	Background: The aim of the present study was to explore the clinical effect and to predict the prognosis of severe craniocerebral injury patients with decompressive craniectomy by combining transcranial Doppler (TCD) and invasive intracranial pressure (ICP). Methods: A total of 60 severe craniocerebral injury patients with decompressive craniectomy, who were admitted to Shantou Central Hospital from June 2017 to March 2019, were enrolled in this retrospective study. Of these, 25 patients who had a Glasgow Coma Scale (GCS) score no greater 8 and no less than 6 underwent transcranial Doppler (TCD) before decompressive craniectomy, as well as ICP, after removing the skull and suturing the dura mater. The 60 patients were divided into 2 groups according to the following standards: (I) GCS score >= 8 on the 7th day postoperatively; (II) ICP continuously lower than 25 mmHg for the entire 7-day duration postoperatively; and (III) brain tissue consistently offset from the skull surface by 5 mm. The clinical outcome was determined based on the Glasgow Outcome Scale (GOS) 1, 3, and 6 months postoperatively. The TCD value, ICP, and prognosis were compared between the 2 groups. Results: The average postoperative ICP <19 mmHg in the first 24 h, mean blood flow velocity >56.33 cm/s, end-diastolic blood flow velocity > 40.28 cm/s, and resistance index <0.57 were statistically significant indicators to predict good prognosis. Conclusions: The use of TCD can predict the prognosis of severe craniocerebral injury patients.	[Jin, Tao; Lian, Weijie; Xu, Ke; Liu, Yan; Xu, Zhennan; Lu, Rongzhang; Liu, Mingfa] Sun Yat Sen Univ, Shantou Cent Hosp, Dept Neurosurg, Affiliated Shantou Hosp, Waima Rd 114, Shantou 515041, Peoples R China		Liu, MF (corresponding author), Sun Yat Sen Univ, Shantou Cent Hosp, Dept Neurosurg, Affiliated Shantou Hosp, Waima Rd 114, Shantou 515041, Peoples R China.	stlmfl163@sina.com			Science and Technology Bureau of Shantou City	This study was funded by the Science and Technology Bureau of Shantou City (No. Shanfuke2018-11-5).	Abraham P, 2017, ACTA NEUROCHIR, V159, P2279, DOI 10.1007/s00701-017-3363-1; Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Chang T, 2019, WORLD NEUROSURG, V126, pE116, DOI 10.1016/j.wneu.2019.02.005; Cook AM, 2020, NEUROCRIT CARE, V32, P647, DOI 10.1007/s12028-020-00959-7; Corallo F, 2017, INT J NEUROSCI, V127, P688, DOI 10.1080/00207454.2016.1235045; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Honda M, 2017, NEUROCRIT CARE, V27, P308, DOI 10.1007/s12028-017-0432-5; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Jasey N, 2018, BRAIN INJURY, V32, P318, DOI 10.1080/02699052.2017.1419283; Kolias AG, 2018, CURR TRAUMA REP, V4, P326, DOI 10.1007/s40719-018-0147-x; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; Stoner KE, 2016, WORLD NEUROSURG, V96, P101, DOI 10.1016/j.wneu.2016.08.095; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717	16	1	1	1	1	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	APR	2021	10	4					4472	4478		10.21037/apm-21-504			7	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	RW5PK	WOS:000646574100077	33894726	gold			2022-02-06	
J	Kaukas, L; Krieg, J; Collins-Praino, L; Corrigan, F				Kaukas, Lola; Krieg, Justin; Collins-Praino, Lyndsey; Corrigan, Frances			Effects of Remote Immune Activation on Performance in the 5-Choice Serial Reaction Time Task Following Mild Traumatic Brain Injury in Adolescence	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						prefrontal cortex; motivation; attention; traumatic brain injury; neuroinflammation		In adult pre-clinical models, traumatic brain injury (TBI) has been shown to prime microglia, exaggerating the central inflammatory response to an acute immune challenge, worsening depressive-like behavior, and enhancing cognitive deficits. Whether this phenomenon exists following mTBI during adolescence has yet to be explored, with age at injury potentially altering the inflammatory response. Furthermore, to date, studies have predominantly examined hippocampal-dependent learning domains, although pre-frontal cortex-driven functions, including attention, motivation, and impulsivity, are significantly affected by both adolescent TBI and acute inflammatory stimuli. As such, the current study examined the effects of a single acute peripheral dose of LPS (0.33 mg/kg) given in adulthood following mTBI in mid-adolescence in male Sprague-Dawley rats on performance in the 5-choice serial reaction time task (5-CSRTT). Only previously injured animals given LPS showed an increase in omissions and reward collection latency on the 5-CSRTT, with no effect noted in sham animals given LPS. This is suggestive of impaired motivation and a prolonged central inflammatory response to LPS administration in these animals. Indeed, morphological analysis of myeloid cells within the pre-frontal cortex, via IBA1 immunohistochemistry, found that injured animals administered LPS had an increase in complexity in IBA1+ve cells, an effect that was seen to a lesser extent in sham animals. These findings suggest that there may be ongoing alterations in the effects of acute inflammatory stimuli that are driven, in part by increased reactivity of microglial cells.	[Kaukas, Lola; Krieg, Justin; Collins-Praino, Lyndsey; Corrigan, Frances] Univ Adelaide, Adelaide Med Sch, Head Injury Lab, Adelaide, SA, Australia		Corrigan, F (corresponding author), Univ Adelaide, Adelaide Med Sch, Head Injury Lab, Adelaide, SA, Australia.	frances.corrigan@adelaide.edu.au		Corrigan, Frances/0000-0001-6150-8893	Neurosurgical Research Foundation	This work was supported by Neurosurgical Research Foundation.	Asinof SK, 2014, JOVE-J VIS EXP, DOI 10.3791/51574; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Belleau EL, 2019, BIOL PSYCHIAT, V85, P443, DOI 10.1016/j.biopsych.2018.09.031; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Biesmans S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9085273; Bluthe RM, 2002, NEUROPSYCHOPHARMACOL, V26, P86, DOI 10.1016/S0893-133X(01)00305-0; Bluthe RM, 2000, EUR J NEUROSCI, V12, P4447, DOI 10.1111/j.1460-9568.2000.01348.x; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chan SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74008-w; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Drouin-Ouellet J, 2011, GLIA, V59, P188, DOI 10.1002/glia.21086; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Felger JC, 2017, NEUROPSYCHOPHARMACOL, V42, P216, DOI 10.1038/npp.2016.143; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Fontainhas AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015973; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Hines DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060388; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Horrillo Daniel, 2011, Archives of Physiology and Biochemistry, V117, P140, DOI 10.3109/13813455.2011.577435; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Jett JD, 2017, NEUROSCIENCE, V346, P284, DOI 10.1016/j.neuroscience.2017.01.017; Kaukas L, 2021, BEHAV BRAIN RES, V402, DOI 10.1016/j.bbr.2020.113067; Kongsui R, 2015, NEUROSCIENCE, V310, P629, DOI 10.1016/j.neuroscience.2015.09.061; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Matsuzaki J, 2001, J NUTR, V131, P2139, DOI 10.1093/jn/131.8.2139; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Michely J, 2020, NEUROPSYCHOPHARMACOL, V45, P1448, DOI 10.1038/s41386-020-0669-0; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Norris GT, 2019, J EXP MED, V216, P60, DOI 10.1084/jem.20180199; Paine TA, 2011, NEUROPSYCHOPHARMACOL, V36, P1703, DOI 10.1038/npp.2011.51; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Relja B, 2020, EUR J TRAUMA EMERG S, V46, P751, DOI 10.1007/s00068-019-01235-w; Roth J, 2004, FRONT BIOSCI-LANDMRK, V9, P290, DOI 10.2741/1241; Savage JC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01340; Shin JA, 2015, BRAIN BEHAV IMMUN, V50, P221, DOI 10.1016/j.bbi.2015.07.008; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Siemsen B, 2020, BIORXIV PREPRINT, DOI [10.1101/566034, DOI 10.1101/566034]; Skandsen T, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00638; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Streit WJ, 2004, GLIA, V45, P208, DOI 10.1002/glia.10319; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Ta TT, 2019, P NATL ACAD SCI USA, V116, P4637, DOI 10.1073/pnas.1813562116; van Heesch F, 2014, EUR J PHARMACOL, V725, P55, DOI 10.1016/j.ejphar.2014.01.014; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wang D, 2016, CHIN J TRAUMATOL, V19, P193, DOI 10.1016/j.cjtee.2016.06.001; Webster KM, 2019, J COMP NEUROL, V527, P1102, DOI 10.1002/cne.24589; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Yegla B, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00296; Yeh KY, 2015, PHYTOTHER RES, V29, P260, DOI 10.1002/ptr.5247; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2	62	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	APR 1	2021	15								659679	10.3389/fnbeh.2021.659679			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	RN0SU	WOS:000640066100001	33867953	Green Published, gold			2022-02-06	
J	Kim, SK; Roche, MD; Fredericson, M; Dragoo, JL; Horton, BH; Avins, AL; Belanger, HG; Ioannidis, JPA; Abrams, GD				Kim, Stuart K.; Roche, Megan D.; Fredericson, Michael; Dragoo, Jason L.; Horton, Brandon H.; Avins, Andy L.; Belanger, Heather G.; Ioannidis, John P. A.; Abrams, Geoffrey D.			A Genome-wide Association Study for Concussion Risk	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						TRAUMATIC BRAIN INJURY; GENETIC TESTING; SPATA5; PLXNA4	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; INTELLECTUAL DISABILITY; GENETIC POLYMORPHISMS; ALZHEIMER-DISEASE; EPIDEMIOLOGY; PREDICTORS; RECOVERY; ALLELE; LOCI	Purpose This study aimed to screen the entire genome for genetic markers associated with risk for concussion. Methods A genome-wide association analyses was performed using data from the Kaiser Permanente Research Bank and the UK Biobank. Concussion cases were identified based on electronic health records from the Kaiser Permanente Research Bank and the UK Biobank from individuals of European ancestry. Genome-wide association analyses from both cohorts were tested for concussion using a logistic regression model adjusting for sex, height, weight, and race/ethnicity using allele counts for single nucleotide polymorphisms. Previously identified genes within the literature were also tested for association with concussion. Results There were a total of 4064 cases of concussion and 291,472 controls within the databases, with two single nucleotide polymorphisms demonstrating a genome-wide significant association with concussion. The first polymorphism, rs144663795 (P = 9.7 x 10(-11); OR = 2.91 per allele copy), is located within the intron of SPATA5. Strong, deleterious mutations in SPATA5 cause intellectual disability, hearing loss, and vision loss. The second polymorphism, rs117985931 (P = 3.97 x 10(-9); OR = 3.59 per allele copy), is located within PLXNA4. PLXNA4 plays a key role is axon outgrowth during neural development, and DNA variants in PLXNA4 are associated with risk for Alzheimer's disease. Previous investigations have identified five candidate genes that may be associated with concussion, but none showed a significant association in the current model (P < 0.05). Conclusion Two genetic markers were identified as potential risk factors for concussion and deserve further validation and investigation of molecular mechanisms.	[Kim, Stuart K.] Stanford Univ, Med Sch, Dept Dev Biol, Stanford, CA 94305 USA; [Roche, Megan D.; Fredericson, Michael; Abrams, Geoffrey D.] Stanford Univ, Dept Orthopaed Surg, Med Ctr, Stanford, CA 94305 USA; [Dragoo, Jason L.] UCHlth Steadman Hawkins Clin Denver Surg Ctr, Englewood, CO USA; [Horton, Brandon H.; Avins, Andy L.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Belanger, Heather G.] US Special Operat Command USSOCOM, Tampa, FL USA; [Belanger, Heather G.] St Michaels Inc, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA		Kim, SK (corresponding author), Stanford Univ, Med Sch, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5RO1AG025941, RC2 AG036607]; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); Wayne and Gladys Valley Foundation; Ellison Medical FoundationLawrence Ellison Foundation; Kaiser Permanente Community Benefits Program	This work was supported by grants from the NIH (5RO1AG025941 and RC2 AG036607), the Robert Wood Johnson Foundation, the Wayne and Gladys Valley Foundation, the Ellison Medical Foundation, and the Kaiser Permanente Community Benefits Program.	Abrahams S, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000465; Baldwin GT, 2018, HAND CLINIC, V158, P63, DOI 10.1016/B978-0-444-63954-7.00007-0; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buchert R, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0509-9; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Cochrane GD, 2018, CLIN J SPORT MED, V28, P125, DOI 10.1097/JSM.0000000000000443; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Cosgrave M, 2019, PHYS THER SPORT, V35, P99, DOI 10.1016/j.ptsp.2018.11.010; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Han Q, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00946; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hercher LS, 2016, J GENET COUNS, V25, P1267, DOI 10.1007/s10897-016-9965-6; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jorgenson E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10130; Jun G, 2014, ANN NEUROL, V76, P379, DOI 10.1002/ana.24219; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Kim SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170422; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kurata H, 2016, CLIN GENET, V90, P437, DOI 10.1111/cge.12813; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee YM, 2016, PHYSICIAN SPORTSMED, V44, P217, DOI 10.1080/00913847.2016.1216718; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; Mc Fie S, 2018, J SPORT SCI, V36, P2226, DOI 10.1080/02640414.2018.1448570; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKeithan Lydia, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030044; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Spinelli ED, 2007, NEUROSCIENCE, V144, P1266, DOI 10.1016/j.neuroscience.2006.10.057; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrell TR, 2018, BRIT J SPORT MED, V52, P192, DOI 10.1136/bjsports-2016-097419; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461	56	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	APR	2021	53	4					704	711		10.1249/MSS.0000000000002529			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	SK9FU	WOS:000656525300004	33017352				2022-02-06	
J	Li, YM; Wu, Q; Hu, E; Wang, Y; Lu, HM				Li, Youmei; Wu, Qian; Hu, En; Wang, Yang; Lu, Hongmei			Quantitative Mass Spectrometry Imaging of Metabolomes and Lipidomes for Tracking Changes and Therapeutic Response in Traumatic Brain Injury Surrounding Injured Area at Chronic Phase	ACS CHEMICAL NEUROSCIENCE			English	Article						Traumatic brain injury; quantitative mass spectrometry imaging; lipidomics; metabolomics; therapeutic response; chronic phase	RAT; INTEGRITY; RECOVERY; DISEASE; MODEL	Traumatic brain injury (TBI) is a complex disease process that may contribute to temporary or permanent disability. Tracking spatial changes of lipids and metabolites in the brain helps unveil the underlying mechanisms of the disease procession and therapeutic response. Here, the liquid microjunction surface sampling technique was used for mass spectrometry imaging of both lipids and metabolites in rat models of controlled cortical impact with and without XueFu ZhuYu decoction treatment, and the work was focused on the diffuse changes outside the injured area at chronic phase (14 days after injury). Quantitative information was provided for phosphotidylcholines and cerebrosides by adding internal standards in the sampling solvent. With principal component analysis for the imaging data, the midbrain was found to be the region with the largest diffuse changes following TBI outside the injured area. In detail, several phosphatidylcholines, phosphatidylethanolamines, phosphatidic acids, and diacylglycerols were found to be significantly up-regulated particularly in midbrain and thalamus after TBI and XFZY treatment. It is associated with the reported "self-repair" mechanisms at the chronic phase of TBI activated by neuroinflammation. Several glycosphingolipids were found to be increased in most of brain regions after TBI, which was inferred to be associated with neuroinflammation and oxidative stress triggered by TBI. Moreover, different classes of small matabolites were significantly changed after TBI, including fatty acids, amino acids, and purines. All these compounds were involved in 10 metabolic pathway networks, and 6 target proteins of XFZY were found related to the impacted pathways. These results shed light on the molecular mechanisms of TBI pathologic processes and therapeutic response.	[Li, Youmei; Wu, Qian; Lu, Hongmei] Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China; [Hu, En; Wang, Yang] Cent South Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Hunan, Peoples R China		Wu, Q; Lu, HM (corresponding author), Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China.	qianwu@csu.edu.cn; hongmeilu@csu.edu.cn		Wu, Qian/0000-0001-7522-1391	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [22074159, 21804142, 21873116, 21675174, 81973665]	Funding was provided by the National Natural Science Foundation of China (Grants 22074159, 21804142, 21873116, 21675174, and 81973665). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Barbacci DC, 2017, ACS CHEM NEUROSCI, V8, P2266, DOI 10.1021/acschemneuro.7b00189; Belarbi K, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00408-1; Caplan HW, 2020, ASN NEURO, V12, DOI 10.1177/1759091420911770; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gemperline E, 2014, BIOANALYSIS, V6, P525, DOI 10.4155/bio.13.341; Guo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05446-2; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartings JA, 2020, JAMA NEUROL, V77, P489, DOI 10.1001/jamaneurol.2019.4476; Hermans L, 2017, NEUROREHAB NEURAL RE, V31, P228, DOI 10.1177/1545968316675429; HerreraMarschitz M, 1996, J NEUROCHEM, V66, P1726; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Huang DN, 2020, ANAL BIOANAL CHEM, V412, P7017, DOI 10.1007/s00216-020-02837-9; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Lanekoff I, 2014, ANAL CHEM, V86, P1872, DOI 10.1021/ac403931r; Lazzarino G, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090850; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Li T, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.559618; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mallah K, 2019, ANAL CHEM, V91, P11879, DOI 10.1021/acs.analchem.9b02633; Mallah K, 2018, ANAL CHEM, V90, P10568, DOI 10.1021/acs.analchem.8b02682; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Salah NY, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155120; Schwartz SA, 2010, METHODS MOL BIOL, V656, P3, DOI 10.1007/978-1-60761-746-4_1; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Srivastava NK, 2019, MOL BIOL REP, V46, P1757, DOI 10.1007/s11033-019-04626-9; Tian H, 2017, ANAL CHEM, V89, P4611, DOI 10.1021/acs.analchem.7b00164; Tobias F, 2020, J PROTEOME RES, V19, P3620, DOI 10.1021/acs.jproteome.0c00443; Unsihuay D, 2021, ANNU REV PHYS CHEM, V72, P307, DOI 10.1146/annurev-physchem-061020-053416; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Van Berkel GJ, 2013, RAPID COMMUN MASS SP, V27, P1329, DOI 10.1002/rcm.6580; Van Berkel GJ, 2002, ANAL CHEM, V74, P6216, DOI 10.1021/ac020540+; van Vliet EA, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105080; Wang XP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-25; Wang Y, 2019, METABOLITES, V9, DOI 10.3390/metabo9100240; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Woischneck D, 2017, CLIN RADIOL, V72, DOI 10.1016/j.crad.2016.11.011; Wolahan SM, 2016, NEUROSURG CLIN N AM, V27, P465, DOI 10.1016/j.nec.2016.05.006; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Wu Q, 2020, J CHROMATOGR A, V1621, DOI 10.1016/j.chroma.2020.461086; Wu Q, 2020, J CHROMATOGR A, V1609, DOI 10.1016/j.chroma.2019.460436; Xia Z, 2020, ASN NEURO, V12, DOI 10.1177/1759091420910957; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Zhang W, 2009, CLIN EXP IMMUNOL, V157, P359, DOI 10.1111/j.1365-2249.2009.03971.x; Zheng F, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1520; Zhong YY, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8916938; Zhou D, 2020, J ETHNOPHARMACOL, V258, DOI 10.1016/j.jep.2020.112826; Zhou J, 2017, ONCOTARGET, V8, P72069, DOI 10.18632/oncotarget.18895; Zigmond E, 2009, AM J PHYSIOL-ENDOC M, V296, pE72, DOI 10.1152/ajpendo.90634.2008	62	1	1	11	19	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	APR 21	2021	12	8					1363	1375		10.1021/acschemneuro.1c00002		APR 2021	13	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	RS2FT	WOS:000643598600008	33793210				2022-02-06	
J	Mahan, MY; Rafter, DJ; Truwit, CL; Oswood, M; Samadani, U				Mahan, Margaret Y.; Rafter, Daniel J.; Truwit, Charles L.; Oswood, Mark; Samadani, Uzma			Evaluation of diffusion measurements reveals radial diffusivity indicative of microstructural damage following acute, mild traumatic brain injury	MAGNETIC RESONANCE IMAGING			English	Article						Mild traumatic brain injury; Diffusion tensor imaging; Radial diffusivity; Fractional anisotropy; Voxelwise tract-based spatial statistics		Purpose: Mild TBI, characterized by microstructural damage, often undetectable on conventional imaging techniques, is a pervasive condition that disturbs brain function and can potentially result in long-term deficits. Deciphering the underlying microstructural damage in mild TBI is crucial for establishing a reliable diagnosis and enabling effective therapeutics. Efforts to capture this damage have been extensive, but results have been inconsistent and incomplete. Methods: To that effect, we set out to examine the shape of the diffusion tensor in mild TBI during the acute phase of injury. We inspected diffusivity and geometric measurements describing the diffusion tensor's shape and compared mild TBI (N = 34, 20.4-66.6 yo) measurements with those from healthy control (N = 42, 20.7-67.2 yo) participants using voxelwise tract-based spatial statistics. Subsequently, to explore associations between the diffusion measurements in mild TBI, we performed nonparametric statistics and machine learning techniques. Results: Overall, mild TBI displayed a diffuse increase in D-lambda 2, D-lambda 3, D-radial, D-mean, and C-spherical, with a diffuse decrease in A(fractional), A(mode), and C-linear, in addition to no change in D-axial or C-planar. Most notably, our results provide evidence for D-radial as a potential biomarker for microstructural damage, specifically its main component D-lambda 2, based on their performance in discriminating between mild TBI and control groups. A(fractional) was also found to be important for discriminating between groups. Conclusion: Our results revealed the importance of a diffusion measurement often overlooked, D-radial, in assessing TBI and suggest differentiating diffusion measurements has the potential utility to detect variations in the underlying pathophysiology after injury.	[Mahan, Margaret Y.; Rafter, Daniel J.; Samadani, Uzma] Univ Minnesota, Dept Biomed Informat & Computat Biol, 101 Pleast St SE, Minneapolis, MN 55455 USA; [Truwit, Charles L.] Philips Global, Diagnost Imaging, 6655 Wedgwood Rd 105, Maple Grove, MN 55311 USA; [Oswood, Mark] Univ Minnesota, Dept Radiol, 420 Delaware St SE, Minneapolis, MN 55455 USA; [Truwit, Charles L.; Oswood, Mark] Hennepin Healthcare, Dept Radiol, 701 Pk Ave, Minneapolis, MN 55415 USA; [Samadani, Uzma] Minneapolis VA Med Ctr, Dept Neurosurg, 1 Vet Dr, Minneapolis, MN 55417 USA		Mahan, MY (corresponding author), Univ Minnesota, Dept Biomed Informat & Computat Biol, 101 Pleast St SE, Minneapolis, MN 55455 USA.	mahan027@umn.edu; chip.truwit@philips.com; mark.oswood@hcmed.org; uzma@samadani.com	Truwit, Charles/AAL-7140-2021	Truwit, Charles/0000-0001-8598-9812; Mahan, Margaret/0000-0002-7332-9523	State of Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant Program	This research was supported by funding from the State of Minnesota Spinal Cord Injury and Traumatic Brain Injury Research Grant Program administered by the Minnesota Office of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bhushan C, 2012, ASIAPAC SIGN INFO PR; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; de Groot M, 2013, NEUROIMAGE, V76, P400, DOI 10.1016/j.neuroimage.2013.03.015; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Faul M, 2015, HDB CLIN NEUROLOGY; Fjell AM, 2008, NEUROIMAGE, V42, P1654, DOI 10.1016/j.neuroimage.2008.06.005; Frieden T.R., 2015, CDC NIH REP C, P1, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Goodrich-Hunsaker NJ, 2018, J NEUROSCI RES, V96, P626, DOI 10.1002/jnr.24142; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; JONES C, 1979, AM J NURS, V79, P1551; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kurki TJI, 2013, J MAGN RESON IMAGING, V38, P46, DOI 10.1002/jmri.23901; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu ZX, 2010, PROC SPIE, V7628, DOI 10.1117/12.844748; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mahan M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0214775; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McKee A, 2015, HDB CLIN NEUROLOGY; McKinney W, 2010, P 9 PYTH SCI C, P56, DOI DOI 10.25080/MAJORA-92BF1922-00A; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mohammadian M, 2017, NEUROIMAGE-CLIN, V13, P174, DOI 10.1016/j.nicl.2016.11.016; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oliphant T.E, 2006, A GUIDE TO NUMPY; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prados F, 2010, J MAGN RESON IMAGING, V31, P1435, DOI 10.1002/jmri.22178; Salimi-Khorshidi G, 2011, NEUROIMAGE, V54, P2006, DOI 10.1016/j.neuroimage.2010.09.088; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Thomas AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178360; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Westin CF, 1997, P INT SOC MAG RESONM, V5, P1742; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yoshida S, 2013, PEDIATR RADIOL, V43, P15, DOI 10.1007/s00247-012-2496-x; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	98	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	APR	2021	77						137	147		10.1016/j.mri.2020.12.012			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	QF7HA	WOS:000617062100004	33359428	hybrid			2022-02-06	
J	Mete, M; Alpay, S; Aydemir, I; Unsal, UU; Collu, F; Ozel, HF; Duransoy, YK; Kutlu, N; Tuglu, MI				Mete, Mesut; Alpay, Suheda; Aydemir, Isil; Unsal, Ulkun Unlu; Collu, Fatih; Ozel, Hasan Fehmi; Duransoy, Yusuf Kurtulus; Kutlu, Necip; Tuglu, Mehmet Ibrahim			Therapeutic effects of Lacosamide in a rat model of traumatic brain injury: A histological, biochemical and electroencephalography monitoring study	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Electroencephalography; Lacosamide; Neuroprotective; Traumatic Brain Injury	FUNCTIONAL RECOVERY	Objective: Traumatic Brain Injury (TBI) is a major cause of death and disability worldwide, especially in children and young adults. TBI can be classified based on severity, mechanism or other features. Inflammation, apoptosis, oxidative stress, and ischemia are some of the important pathophys-iological mechanisms underlying neuronal loss after TBI. Lacosamide (LCM) is an anticonvulsant compound approved for the adjunctive treatment of partial-onset seizures and neuropathic pain. This study aimed to investigate possible neuroprotective effects of LCM in a rat model of TBI. Material and methods: Twenty-eight adult male, Wistar albino rats were used. The rats were divided into 4 groups. Group 1 was the control group (n=7). Group 2 was the trauma group (n=7) where rats were treated with 100 mg/kg saline intraperitoneally (IP) twice a day. Groups 3 and 4, rats were treated with 6 (group 3, n=7) or 20 (group 4, n=7) mg/kg Lacosamide IP twice a day. For each group, brain samples were collected 72 hours after injury. Brain samples and blood were evaluated with histopathological and biochemical methods. In addition, electroencephalograpy monitoring results were compared. Results: The immunoreactivity of both iNOS and eNOS (oxidative stress markers) were decreased with LCM treatment compared to trauma group. The results were statistically significant (*** P<0.001). The treatments of low (56,17 +/- 9,69) and high-dose LCM (43,91 +/- 9,09) were decreased the distribution of HIF-1 alpha compared to trauma group (P<0.01). The number of apoptotic cells were decreased with LCM treatment the difference between the trauma group and 20mg/kg LCM treated group (9,55 +/- 1,02) was statistically significant (***P<0.001). Malondialdehyde level was reduced with LCM treatment. MDA level was significantly higher in trauma group compared to LCM treated groups (*** P<0.001). The level of Superoxide dismutase in the trauma group was 1,86 U/ml, whereas it was 36,85 U/ml in 20mg/kg LCM treated group (*** P<0.001). Delta strength of EEG in 20mg/kg LCM treated group were similar to control group values after LCM treatment. Conclusion: No existing study has produced results suggesting that different doses of LCM has therapeutic effect against TBI, using EEG recording in addition to histological and biochemical evaluations in rats. (C) 2021 Elsevier Ltd. All rights reserved.	[Mete, Mesut; Duransoy, Yusuf Kurtulus] Celal Bayar Univ, Neurosurg Dept, Sch Med, Manisa, Turkey; [Alpay, Suheda; Kutlu, Necip] Manisa Celal Bayar Univ, Sch Med, Physiol Dept, Manisa, Turkey; [Aydemir, Isil] Nigde Omer Halisdemir Univ, Sch Med, Histol & Embryol Dept, Nigde, Turkey; [Unsal, Ulkun Unlu] Manisa Sehir Hosp, Neurosurg Clin, Manisa, Turkey; [Ozel, Hasan Fehmi] Manisa Celal Bayar Univ, Hlth Serv Vocat Sch, Manisa, Turkey; [Collu, Fatih] Manisa Celal Bayar Univ, Dept Biol, Fac Sci & Letters, Zool Sect, Manisa, Turkey; [Tuglu, Mehmet Ibrahim] Manisa Celal Bayar Univ, Sch Med, Histol & Embryol Dept, Manisa, Turkey		Mete, M (corresponding author), Celal Bayar Univ, Neurosurg Dept, Sch Med, Manisa, Turkey.	dr.mmete@hotmail.com; alpaysuheda@gmail.com; master_isil@yahoo.com; ulkununlu@hotmail.com; fatih.collu@gmail.com; fehmiozel@gmail.com; ykduransoy@hotmail.com; necip.kutlu@cbu.edu.tr; mituglu@yahoo.com	Unsal, Ulkun Unlu/B-9861-2016; OZEL, HASAN FEHMI/ABD-3296-2021	Unsal, Ulkun Unlu/0000-0001-5194-3138; OZEL, HASAN FEHMI/0000-0003-1676-0648; Collu, Fatih/0000-0001-6978-8404	Scientific Research Project of the Manisa Celal Bayar University, Turkey [2017196]	This work was supported by the Scientific Research Project of the Manisa Celal Bayar University, Turkey (Grant Number: 2017196) .	Alcantara-Montero A, 2016, REV NEUROLOGIA, V62, P223, DOI 10.33588/rn.6205.2015498; Arslan G, 2017, ACTA NEUROBIOL EXP, V77, P128, DOI 10.21307/ane-2017-045; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1113, DOI 10.1016/j.clinph.2006.01.020; Ben-Menachem E, 2007, EPILEPSIA, V48, P1308, DOI 10.1111/j.1528-1167.2007.01188.x; Beyreuther BK, 2007, CNS DRUG REV, V13, P21, DOI 10.1111/j.1527-3458.2007.00001.x; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; de Jongh A, 2001, CLIN NEUROPHYSIOL, V112, P378, DOI 10.1016/S1388-2457(00)00526-5; Demiroz S, 2019, TURK NEUROSURG, V29, P718, DOI 10.5137/1019-5149.JTN.25891-19.2; Doty P, 2007, NEUROTHERAPEUTICS, V4, P145, DOI 10.1016/j.nurt.2006.10.002; Finan JD, 2019, CLIN BIOMECH, V64, P114, DOI 10.1016/j.clinbiomech.2018.01.015; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Han MY, 2019, DRUG DES DEV THER, V13, P2923, DOI 10.2147/DDDT.S216156; Hoy SM, 2018, CNS DRUGS, V32, P473, DOI 10.1007/s40263-018-0523-7; Kim GH, 2017, J CLIN NEUROL, V13, P138, DOI 10.3988/jcn.2017.13.2.138; Lees G, 2006, NEUROPHARMACOLOGY, V50, P98, DOI 10.1016/j.neuropharm.2005.08.016; Leikin JB, 2019, DM-DIS MON, V65, DOI 10.1016/j.disamonth.2019.02.010; Licko T, 2013, EPILEPSIA, V54, P1176, DOI 10.1111/epi.12196; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mete M, 2018, TURK NEUROSURG, V28, P858, DOI 10.5137/1019-5149.JTN.21417-17.2; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nissinen J, 2006, EPILEPSIA, V47, P83; Numata M, 2013, INT J ONCOL, V42, P403, DOI 10.3892/ijo.2012.1723; de la Rosa JSO, 2018, SEIZURE-EUR J EPILEP, V56, P34, DOI 10.1016/j.seizure.2018.01.014; Owji S, 2020, CLIN ANAT, V33, P41, DOI 10.1002/ca.23447; Patyar S, 2010, NEUROSCIENCES, V15, P3; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Penolazzi B, 2008, PSYCHOPHYSIOLOGY, V45, P1025, DOI 10.1111/j.1469-8986.2008.00709.x; Pitkanen A, 2014, EPILEPSY RES, V108, P653, DOI 10.1016/j.eplepsyres.2014.02.001; Polat I, 2020, NEUROCHEM RES, V45, P1920, DOI 10.1007/s11064-020-03056-5; Puderbaugh M, 2020, NEUROPLASTICITY; Sharma S, 2020, ANN NEUROL, V87, P442, DOI 10.1002/ana.25675; Stohr T, 2006, EUR J PAIN, V10, P241, DOI 10.1016/j.ejpain.2005.04.002; Tutkun E, 2010, ACTA NEUROBIOL EXP, V70, P382; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Unsal UU, 2020, BIOTECH HISTOCHEM, V95, P233, DOI 10.1080/10520295.2019.1674919; Vieth J, 2001, BIOMAG 2000, P387; Wang B, 2013, NEUROCRIT CARE, V19, P125, DOI 10.1007/s12028-012-9808-8	37	1	1	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	APR	2021	52	4					713	723		10.1016/j.injury.2021.02.055			11	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	RS3IZ	WOS:000643674700012	33714548				2022-02-06	
J	Meyer, LJ; Riess, ML				Meyer, Luise J.; Riess, Matthias L.			Evaluation of In Vitro Neuronal Protection by Postconditioning with Poloxamer 188 Following Simulated Traumatic Brain Injury	LIFE-BASEL			English	Article						cell membrane stabilizer; compression injury; hypoxia reoxygenation injury; ischemia reperfusion injury; neurons; P188; tri-block copolymer	MEMBRANE PERMEABILIZATION; SURFACTANT POLOXAMER-188; BARRIER DAMAGE; CELL-DEATH; MODELS; RAT; NEUROPROTECTION; MITOCHONDRIAL; HEMORRHAGE; DECREASES	Traumatic brain injury (TBI) leads to morbidity and mortality worldwide. Reperfusion after ischemia adds detrimental injury to cells. Ischemia/reperfusion (I/R) injures cells in a variety of ways including cell membrane disruption. Hence, methods to improve endogenous membrane resealing capacity are crucial. Poloxamer (P) 188, an amphiphilic triblock copolymer, was found to be effective against I/R and mechanical injury in various experimental settings. The aim of this study was to establish an in vitro mouse neuronal TBI model and, further, to investigate if postconditioning with P188 directly interacts with neurons after compression and simulated I/R injury, when administered at the start of reoxygenation. Cellular function was assessed by cell number/viability, mitochondrial viability, membrane damage by lactated dehydrogenase (LDH) release and FM1-43 incorporation as well as apoptosis-activation by Caspase 3. Five hours hypoxia +/- compression with 2 h reoxygenation proved to be a suitable model for TBI. Compared to normoxic cells not exposed to compression, cell number and mitochondrial viability decreased, whereas membrane injury by LDH release/FM1-43 dye incorporation and Caspase 3 activity increased in cells exposed to hypoxic conditions with compression followed by reoxygenation. P188 did not protect neurons from simulated I/R and/or compression injury. Future research is indicated.	[Meyer, Luise J.; Riess, Matthias L.] Vanderbilt Univ, Dept Anesthesiol, Med Ctr, Nashville, TN 37232 USA; [Meyer, Luise J.] Univ Med Greifswald, Dept Anesthesiol, D-17475 Greifswald, Germany; [Riess, Matthias L.] TVHS VA Med Ctr, Anesthesiol, Nashville, TN 37212 USA; [Riess, Matthias L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA		Riess, ML (corresponding author), Vanderbilt Univ, Dept Anesthesiol, Med Ctr, Nashville, TN 37232 USA.; Riess, ML (corresponding author), TVHS VA Med Ctr, Anesthesiol, Nashville, TN 37212 USA.; Riess, ML (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	luise.j.meyer@gmail.com; matthias.riess@vanderbilt.edu		Riess, Matthias/0000-0001-8748-5757	US Department of Veterans Affairs Biomedical Laboratory RD ServiceUS Department of Veterans Affairs [I01 BX003482]	This work was supported in part by the US Department of Veterans Affairs Biomedical Laboratory R&D Service (I01 BX003482), and by institutional funds to M.L.R.	Adhikari U, 2016, J PHYS CHEM B, V120, P5823, DOI 10.1021/acs.jpcb.5b11448; Amaral E, 2011, METHODS MOL BIOL, V689, P137, DOI 10.1007/978-1-60761-950-5_8; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bao HJ, 2016, NEUROSCI LETT, V634, P7, DOI 10.1016/j.neulet.2016.09.052; Bartos Jason A, 2016, JACC Basic Transl Sci, V1, P224; Borgens RB, 2004, J NEUROSCI RES, V76, P141, DOI 10.1002/jnr.20053; Cadichon SB, 2007, J NEUROSURG, V106, P36, DOI 10.3171/ped.2007.106.1.36; Chen B, 2019, ACS APPL MATER INTER, V11, P4889, DOI 10.1021/acsami.8b21410; Curry DJ, 2004, NEUROSURGERY, V55, P943, DOI 10.1227/01.NEU.0000137890.29862.2C; Curry DJ, 2004, J NEUROSURG, V101, P91, DOI 10.3171/ped.2004.101.2.0091; Cyr AR, 2020, CRIT CARE CLIN, V36, P307, DOI 10.1016/j.ccc.2019.12.009; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; Dinet V, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01178; Ding WB, 2020, TOXICOLOGY, V436, DOI 10.1016/j.tox.2020.152437; Dong HL, 2019, NEUROCHEM INT, V126, P178, DOI 10.1016/j.neuint.2019.03.013; Douglas HF, 2017, FASEB J, V31; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Frim DM, 2004, NEUROREPORT, V15, P171, DOI 10.1097/00001756-200401190-00033; Glass TF, 2004, NEUROBIOL DIS, V17, P378, DOI 10.1016/j.nbd.2004.07.017; Gottlieb RA, 2011, J CARDIOVASC PHARM T, V16, P233, DOI 10.1177/1074248411409581; Gu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061641; Hackel B.J., 2017, Personal communication; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Houang EM, 2019, JACC-BASIC TRANSL SC, V4, P275, DOI 10.1016/j.jacbts.2019.01.009; Houang EM, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0177-7; Houang EM, 2017, MOL PHARMACEUT, V14, P2333, DOI 10.1021/acs.molpharmaceut.7b00197; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Inyang E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59888-2; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kanagaraj J, 2018, ANN BIOMED ENG, V46, P354, DOI 10.1007/s10439-017-1953-y; Kilinc D, 2007, P ANN INT IEEE EMBS, P5395, DOI 10.1109/IEMBS.2007.4353562; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kim M, 2017, BIOMACROMOLECULES, V18, P2090, DOI 10.1021/acs.biomac.7b00419; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Kumaria A, 2017, ATLA-ALTERN LAB ANIM, V45, P201, DOI 10.1177/026119291704500405; Lotze F.P., 2019, FASEB J, V33, p527.4, DOI [10.1096/fasebj.2019.33.1_supplement.527.4, DOI 10.1096/FASEBJ.2019.33.1_SUPPLEMENT.527.4]; Lotze FP, 2019, CIRCULATION, V140; Lullmann-Rauch R., 2015, TASCHENBUCH HISTOLOG, V5; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo CL, 2015, J MOL NEUROSCI, V56, P988, DOI 10.1007/s12031-015-0568-8; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Martindale JJ, 2014, J MOL CELL CARDIOL, V67, P26, DOI 10.1016/j.yjmcc.2013.12.008; Meyer L.J., 2021, ANESTH ANALG; Misra A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016011; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; Moore JC, 2017, CURR OPIN CRIT CARE, V23, P215, DOI 10.1097/MCC.0000000000000405; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Poellmann MJ, 2017, REGEN ENG TRANSL MED, V3, P111, DOI 10.1007/s40883-017-0031-1; Quinn M, 2008, EUR J NEUROSCI, V27, P43, DOI 10.1111/j.1460-9568.2007.05991.x; Riess M.L., 2015, ASA ABSTR; Salzman M.M., 2015, FASEB J, V29, p1026.5, DOI [10.1096/fasebj.29.1_supplement.1026.5, DOI 10.1096/FASEBJ.29.1_SUPPLEMENT.1026.5]; Salzman M.M., 2017, FASEB J, V31, DOI [10.1096/fasebj.31.1_supplement.1070.1, DOI 10.1096/FASEBJ.31.1_SUPPLEMENT.1070.1]; Salzman M.M., 2017, FASEB J, V31, DOI [10.1096/fasebj.31.1_supplement.1069.11, DOI 10.1096/FASEBJ.31.1_SUPPLEMENT.1069.11]; Salzman MM, 2020, PHARMACOL RES PERSPE, V8, DOI 10.1002/prp2.639; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Sharma J., 2020, COMMUNICATION; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Wang T, 2015, J MOL NEUROSCI, V55, P240, DOI 10.1007/s12031-014-0313-8; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844; Yildirim T, 2015, INT J NEUROSCI, V125, P941, DOI 10.3109/00207454.2014.979289; Zhang YL, 2018, J NEUROTRAUM, V35, P661, DOI 10.1089/neu.2017.5284	63	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-1729		LIFE-BASEL	Life-Basel	APR	2021	11	4							316	10.3390/life11040316			23	Biology; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Microbiology	RR6LM	WOS:000643207100001	33917288	gold, Green Published			2022-02-06	
J	Raso, MG; Arcuri, F; Liperoti, S; Mercurio, L; Mauro, A; Cusato, F; Romania, L; Serra, S; Pignolo, L; Tonin, P; Cerasa, A				Raso, Maria Girolama; Arcuri, Francesco; Liperoti, Stefano; Mercurio, Luca; Mauro, Aldo; Cusato, Francesco; Romania, Lidia; Serra, Sebastiano; Pignolo, Loris; Tonin, Paolo; Cerasa, Antonio			Telemonitoring of Patients With Chronic Traumatic Brain Injury: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						telerehabilitation; traumatic brain injury; medical complications; healthcare costs; coma recovery scale revised		Telehealth systems have shown success in the remote management of several neurological disorders, but there is a paucity of evidence in disorders of consciousness (DOC). In this study, we explore the effectiveness of a new telemonitoring system, for monitoring Vegetative State (VS) and Minimally Conscious State (MCS) patients. This was a prospective, mono-center randomized controlled study. We included only traumatic brain injury (TBI) patients who required long-term motor/cognitive assistance having a stable clinical condition. We examined their clinical evolution over similar to 4 years of the follow-up period. Twenty-two TBI patients were enrolled and equally divided into two groups: one telemonitored at home with our service and the second admitted to a standard long-stay hospitalization (LSH) program. Patients enrolled in the telehealth service (age: 49.9 +/- 20.4; 45% female; diagnosis: 36% VS/64% MCS) were demographically and clinically-matched with those admitted to the LSH program (age: 55.1 +/- 15; 18% female; diagnosis: 54% VS/46% MCS). Thirty-six percent of patients in the LSH program died before completing follow up evaluation with respect to 18% of death in the group of TBI patients telemonitored at home. At follow-up, patients in LSH and telemonitoring groups showed similar clinical progression, as measured by CRS-r, NCS, WHIM, and LCF scales, as well as by the number of medical complications (i.e., bedsores, infections). Finally, we estimated the total daily cost per patient. Severe TBI patients enrolled in the conventional LSH program cost 262euro every single day, whereas the cost per patient in the telehealth service resulted to be less expensive (93euro). Here, we highlight that our telehealth monitoring service is as efficacious as in-person usual care to manage a severe neurological disorder such as TBI in a cost-effective way.	[Raso, Maria Girolama; Arcuri, Francesco; Liperoti, Stefano; Mercurio, Luca; Mauro, Aldo; Cusato, Francesco; Romania, Lidia; Serra, Sebastiano; Pignolo, Loris; Tonin, Paolo; Cerasa, Antonio] St Anna Inst, Crotone, Italy; [Cerasa, Antonio] CNR, Inst Biomed Res & Innovat, Palermo, Italy		Cerasa, A (corresponding author), St Anna Inst, Crotone, Italy.; Cerasa, A (corresponding author), CNR, Inst Biomed Res & Innovat, Palermo, Italy.	antonio.cerasa76@gmail.com	Serra, Sebastiano/AAP-8391-2021		Italian Ministry of HealthMinistry of Health, Italy	This work has been funded by the Italian Ministry of Health (Grants Obiettivi di carattere prioritario di rilievo Nazionale del Ministero della Salute anno 2009).	Adams JL, 2020, CURR GERIATR REP, V9, P72, DOI 10.1007/s13670-020-00311-z; Beck CA, 2017, NEUROLOGY, V89, P1152, DOI 10.1212/WNL.0000000000004357; Bramanti Alessia, 2018, Innov Clin Neurosci, V15, P11; Calabro RS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013292; Chi NC, 2015, J TELEMED TELECARE, V21, P37, DOI 10.1177/1357633X14562734; Covelli V, 2016, ACTA NEUROL SCAND, V134, P352, DOI 10.1111/ane.12550; De Luca R, 2016, AGING CLIN EXP RES, V28, P753, DOI 10.1007/s40520-015-0463-8; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Hagen C., 1972, LEVELS COGNITIVE FUN; Kim H, 2017, J TELEMED TELECARE, V23, P149, DOI 10.1177/1357633X15615049; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Lindberg B, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/461829; Maresca G, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.563375; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Mistry H, 2012, J TELEMED TELECARE, V18, P1, DOI 10.1258/jtt.2011.110505; Ownsworth T, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000350; Powers JS, 2018, GERIATRICS-BASEL, V3, DOI 10.3390/geriatrics3020029; Rietdijk R, 2020, J TELEMED TELECARE, DOI 10.1177/1357633X20923824; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Takahashi PY, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-255; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Torrisi M, 2019, INT J REHABIL RES, V42, P344, DOI 10.1097/MRR.0000000000000369	27	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 1	2021	12								598777	10.3389/fneur.2021.598777			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RN4RC	WOS:000640338900001	33868141	gold, Green Published			2022-02-06	
J	Shope, C; Alshareef, M; Larrew, T; Bolling, C; Reagan, J; Yazdani, M; Spampinato, M; Eskandari, R				Shope, Chelsea; Alshareef, Mohammed; Larrew, Thomas; Bolling, Christopher; Reagan, Justin; Yazdani, Milad; Spampinato, Maria; Eskandari, Ramin			Utility of a pediatric fast magnetic resonance imaging protocol as surveillance scanning for traumatic brain	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						traumatic brain injury; pediatric trauma; magnetic resonance imaging; computed tomography; radiation; intracranial hemorrhage; surveillance imaging	HEAD-INJURY; MRI; CT; CHILDREN; HEMORRHAGE; ANESTHESIA; EXPOSURE; EVENTS; RISK	OBJECTIVE Traumatic brain injury (TBI) is a prevalent pediatric pathology in the modern emergency department. Computed tomography (CT) is utilized for detection of TBI and can result in cumulatively high radiation exposure. Recently, a fast brain magnetic resonance imaging (fbMRI) protocol has been employed for rapid imaging of hydrocephalus in pedi-atric patients. The authors investigate the utility of a modified trauma-focused fbMRI (t-fbMRI) protocol as an alternative to surveillance CT in the setting of acute TBI in pediatric patients, thus reducing radiation exposure while improving diag-nostic yield. METHODS A retrospective review was performed at the authors' institution for all pediatric patients who had undergone t-fbMRI within 72 hours of an initial CT scan, using a 1.5-or 3-T MR scanner for trauma indications. Forty patients met the study inclusion criteria. The authors performed a comparison of findings on the reads of CT and fbMRI, and a board-certified neuroradiologist conducted an independent review of both modalities. RESULTS T-fbMRI outperformed CT in specificity, sensitivity, and negative predictive value for all injury pathologies measured, except for skull fractures. T-fbMRI demonstrated a sensitivity of 100% in the detection of extraaxial bleed, intraventricular hemorrhage, and subarachnoid hemorrhage and had a sensitivity of 78% or greater for epidural hema-toma, subdural hematoma, and intraparenchymal hemorrhage. T-fbMRI yielded a specificity of 100% for all types of intracranial hemorrhages, with a corresponding negative predictive value that exceeded that for CT. CONCLUSIONS In pediatric populations, the t-fbMRI protocol provides a valid alternative to CT in the surveillance of TBI and intracranial hemorrhage. Although not as sensitive in the detection of isolated skull fractures, t-fbMRI can be used to monitor pathologies implicated in TBI patients while minimizing radiation exposure from traditional surveillance imaging.	[Shope, Chelsea] Med Univ South Carolina, Coll Med, Charleston, SC 29425 USA; [Alshareef, Mohammed; Larrew, Thomas; Eskandari, Ramin] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA; [Bolling, Christopher; Reagan, Justin; Yazdani, Milad; Spampinato, Maria] Med Univ South Carolina, Dept Radiol, Charleston, SC 29425 USA		Eskandari, R (corresponding author), Med Univ South Carolina, Charleston, SC 29425 USA.	eskandar@musc.edu					Argyropoulou MI, 2020, NEURORADIOLOGY, V62, P251, DOI 10.1007/s00234-019-02326-6; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Dremmen MHG, 2017, AM J NEURORADIOL, V38, P2187, DOI 10.3174/ajnr.A5405; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M, 2010, TRAUMATIC BRAIN INJU; Filippi CG, 2016, J PEDIATR NEURORADIO, V5, P32, DOI 10.1055/s-0036-1584416; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Flom L, 2016, PEDIATR RADIOL, V46, P519, DOI 10.1007/s00247-015-3500-z; Greenberg JK, 2019, J NEUROSURG-PEDIATR, V23, P227, DOI 10.3171/2018.7.PEDS18263; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Kabakus IM, 2019, PEDIATR EMERG CARE; Kralik SF, 2017, AM J NEURORADIOL, V38, P807, DOI 10.3174/ajnr.A5093; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Malviya S, 2000, BRIT J ANAESTH, V84, P743, DOI 10.1093/oxfordjournals.bja.a013586; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Mendoza D, 2016, J PEDIATR NEURORADIO, V5, P20, DOI 10.1055/s-0036-1584276; O'Leary JD, 2019, JAMA PEDIATR, V173, P29, DOI 10.1001/jamapediatrics.2018.3662; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Ryan ME, 2016, NEURORADIOLOGY, V58, P793, DOI 10.1007/s00234-016-1686-x; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; Vavilala MS, 2019, LANCET CHILD ADOLESC, V3, P23, DOI 10.1016/S2352-4642(18)30341-9; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Young AMH, 2018, PEDIATR RES, V83, P41, DOI 10.1038/pr.2017.215; Young JY, 2016, EMERG RADIOL, V23, P325, DOI 10.1007/s10140-016-1392-3	36	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2021	27	4					475	481		10.3171/2020.8.PEDS20496			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RI2KM	WOS:000636738500004	33545669				2022-02-06	
J	Tora, MS; Malcolm, JG; Mahmooth, Z; Pujari, A; Rindler, RS; Boulis, NM; Pradilla, G; Grossberg, JA; Ahmad, FU				Tora, Muhibullah S.; Malcolm, James G.; Mahmooth, Zayan; Pujari, Amit; Rindler, Rima S.; Boulis, Nicholas M.; Pradilla, Gustavo; Grossberg, Jonathan A.; Ahmad, Faiz U.			Complication Rates in Early Versus Late Cranioplasty-A 14-Year Single-Center Case Series	OPERATIVE NEUROSURGERY			English	Article						Cranioplasty; Complications; Hydrocephalus; Infection; Decompressive craniectomy; Traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; GRAFT INFECTION; FLAP PRESERVATION; EARLY SURGERY; SCALE; RISK	BACKGROUND: Cranioplasty (CP) following decompressive craniectomy (DC) is a common neurosurgical procedure for cranial cosmesis and protection. There is uncertainty regarding the complication rates and potential benefits related to the timing of CP. OBJECTIVE: To investigate the impact of the timing of CP on complication rates for different etiologies of DC. METHODS: A retrospective chart review was performed of all CP cases between 2004 and 2018 for traumatic and nontraumatic indications of DC. Demographics, clinical characteristics, and complications were collected. Early and late CP were defined as replacement of the bone flap at <= 90 and >90 d following DC, respectively. RESULTS: A total of 278 patients were included, receiving 81 early and 197 late CPs. When analyzing all patients, early CP was associated with a statistically significant higher odds of any complication (odds ratio [OR]: 3.25, P <.001), reoperation (OR: 2.57, P =.019), hydrocephalus (OR: 6.03, P =.003), and symptomatic extra-axial collections (OR: 9.22, P =.003). Subgroup analysis demonstrated statistically significant higher odds of these complications only for the CP trauma subgroup, but not the nontrauma subgroup. The odds of complications postCP demonstrated a statistically significant decrease of 4.4% for each week after DC (Unit Odds Ratio [U-OR]: 0.956, P =.0363). CONCLUSION: In our retrospective series, early CP was associated with higher odds of postoperative complications compared to late CP in the trauma subgroup. Greater care should be taken in preoperative planning and increased vigilance postoperatively for complications with this potentially more vulnerable subpopulation. Future prospective controlled trials are needed to elucidate optimal timing for CP.	[Tora, Muhibullah S.; Malcolm, James G.; Mahmooth, Zayan; Pujari, Amit; Rindler, Rima S.; Boulis, Nicholas M.; Pradilla, Gustavo; Grossberg, Jonathan A.; Ahmad, Faiz U.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA		Ahmad, FU (corresponding author), Emory Fac Off Bldg,49 Jesse Hill Dr SE,Room 4341, Atlanta, GA 30303 USA.	faiz.ahmad@emory.edu		Tora, Muhibullah/0000-0002-3300-6367			Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Goedemans T, 2020, J NEUROL, V267, P1312, DOI 10.1007/s00415-020-09695-6; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jiang JW, 2017, NEUROSURGERY, V80, pE216, DOI 10.1093/neuros/nyw103; Josephson SA, 2006, CEREBROVASC DIS, V22, P389, DOI 10.1159/000094857; Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Piedra MP, 2013, J NEUROSURG, V118, P109, DOI 10.3171/2012.10.JNS121037; Rosseto RS, 2015, WORLD NEUROSURG, V84, P431, DOI 10.1016/j.wneu.2015.03.045; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Songara A, 2016, WORLD NEUROSURG, V94, P303, DOI 10.1016/j.wneu.2016.07.003; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yeap MC, 2019, WORLD NEUROSURG, V128, pE841, DOI 10.1016/j.wneu.2019.05.005; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	26	1	1	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	APR	2021	20	4					389	396		10.1093/ons/opaa408			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RJ0VS	WOS:000637322300050	33469653				2022-02-06	
J	van Wijck, SF; Kongkaewpaisan, N; Han, K; Kokoroskos, N; Kongwibulwut, M; King, DR; van der Wilden, GM; Krijnen, P; Schipper, IB; Velmahos, GC				van Wijck, Suzanne F.; Kongkaewpaisan, Napaporn; Han, Kelsey; Kokoroskos, Nikolaos; Kongwibulwut, Manasnun; King, David R.; van der Wilden, Gwendolyn M.; Krijnen, Pieta; Schipper, Inger B.; Velmahos, George C.			Association between alcohol intoxication and mortality in severe traumatic brain injury in the emergency department: a retrospective cohort	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						alcohol; cohort study; intoxication; neurotrauma; traumatic brain injury		Background Acute alcohol intoxication is very common in patients with severe traumatic brain injury (TBI). Whether there is an independent association between alcohol intoxication and mortality is debated. This study hypothesized that alcohol intoxication is independently associated with less mortality after severe TBI (sTBI). Methods This retrospective observational cohort study included all patients with sTBI [head-Abbreviated Injury Score (AIS) >= 3, corresponding to serious head injury or worse] admitted from 1 January 2011 to 31 December 2016 in an academic level I trauma center. Patients were classified as with alcohol intoxication or without intoxication based on blood alcohol concentration or description of alcohol intoxication on admission. The primary endpoint was in-hospital mortality. Multivariable logistic regression analysis, including patient and injury characteristics, was used to assess independent association with alcohol intoxication. Results Of the 2865 TBI patients, 715 (25%) suffered from alcohol intoxication. They were younger (mean age 46 vs. 68 years), more often male (80 vs. 57%) and had a lower median Glasgow Coma Scale upon arrival (14 vs. 15) compared to the no-intoxication group. There was no difference in injury severity by head AIS or Rotterdam CT. Alcohol intoxication had an unadjusted association with in-hospital mortality [unadjusted odds ratio (OR) 0.51; 95% confidence interval (CI), 0.38-0.68]; however, there was no independent association after adjusting for potentially confounding patient and injury characteristics (adjusted OR 0.72; 95% CI, 0.48-1.09). Conclusion In this retrospective study, there was no independent association between alcohol intoxication and higher in-hospital mortality in emergency patients with sTBI.	[van Wijck, Suzanne F.; Kongkaewpaisan, Napaporn; Han, Kelsey; Kokoroskos, Nikolaos; Kongwibulwut, Manasnun; King, David R.; Velmahos, George C.] Massachusetts Gen Hosp, Dept Surg, Div Trauma Emergency Surg & Surg Crit Care, 165 Cambridge St, Boston, MA 02114 USA; [van Wijck, Suzanne F.; Kongkaewpaisan, Napaporn; Han, Kelsey; Kokoroskos, Nikolaos; Kongwibulwut, Manasnun; King, David R.; Velmahos, George C.] Harvard Med Sch, 165 Cambridge St, Boston, MA 02114 USA; [van Wijck, Suzanne F.; van der Wilden, Gwendolyn M.; Krijnen, Pieta; Schipper, Inger B.] Leiden Univ, Dept Trauma Surg, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands		van Wijck, SF (corresponding author), Leiden Univ, Dept Trauma Surg, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	suzannevanwijck@hotmail.com	Schipper, Inger/ABE-7796-2021	Schipper, Inger/0000-0001-9952-3079			Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mathias JL, 2018, NEUROPSYCHOL REHABIL, V28, P997, DOI 10.1080/09602011.2016.1224190; Mohseni S, 2016, BRAIN INJURY, V30, P1256, DOI 10.1080/02699052.2016.1183823; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Taylor AN., BRAIN NEUROTRAUMA MO; van Essen TA, 2019, ACTA NEUROCHIR, V161, P435, DOI 10.1007/s00701-018-3761-z	24	1	1	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	APR	2021	28	2					97	103		10.1097/MEJ.0000000000000754			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RL9PJ	WOS:000639295100007	32941201	Green Published, hybrid			2022-02-06	
J	Verbeek, AJM; de Valk, J; Schakenraad, D; Verbeek, JFM; Kroon, AA				Verbeek, Anna J. M.; de Valk, Janneke; Schakenraad, Ditmar; Verbeek, Jan F. M.; Kroon, Anna A.			E-bike and classic bicycle-related traumatic brain injuries presenting to the emergency department	EMERGENCY MEDICINE JOURNAL			English	Article							QUALITY-OF-LIFE; ELECTRIC BIKE; SAFETY; RIDERS	Background E-bike usage is increasingly popular and concerns about e-bike-related injuries and safety have risen as more injured e-bikers attend the emergency department (ED).Traumatic brain injury (TBI) is the main cause of severe morbidity and mortality in bicycle-related accidents. This study compares the frequency and severity of TBI after an accident with an e-bike or classic bicycle among patients treated in the ED. Methods This was a prospective cohort study of patients with bicycle-related injuries attending the ED of a level 1 trauma centre in the Netherlands between June 2016 and May 2017. The primary outcomes were frequency and severity of TBI (defined by the Abbreviated Injury Scale head score >= 1). Injury Severity Score, surgical intervention, hospitalisation and 30-day mortality were secondary outcomes. Independent risk factors for TBI were identified with multiple logistic regression. Results We included 834 patients, of whom there were 379 e-bike and 455 classic bicycle users. The frequency of TBI was not significantly different between the e-bike and classic bicycle group (respectively, n=56, 15% vs n=73, 16%; p=0.61). After adjusting for age, gender, velocity, anticoagulation use and alcohol intoxication the OR for TBI with an e-bike compared with classic bicycle was 0.90 (95% CI 0.56 to 1.45). Independent of type of bicycle, TBI was more likely if velocity was 26-45km/hour, OR 8.14 (95% CI 2.36 to 28.08), the patient was highly alcohol intoxicated, OR 7.02 (95% CI 2.88 to 17.08) or used anticoagulants, OR 2.18 (95% CI 1.20 to 3.97). TBI severity was similar in both groups (p=0.65): eight e-bike and seven classic bicycle accident victims had serious TBI. Conclusion The frequency and severity of TBI among patients treated for bicycle-related injuries at our ED was similar for e-bike and classic bicycle users. Velocity, alcohol intoxication and anticoagulant use were the main determinants of the risk of head injury regardless of type of bicycle used.	[Verbeek, Anna J. M.; de Valk, Janneke; Schakenraad, Ditmar; Kroon, Anna A.] Noordwest Ziekenhuisgrp, Dept Emergency Med, NL-1815 JD Alkmaar, Noord Holland, Netherlands; [Verbeek, Jan F. M.] Radboudumc, Dept Radiol & Nucl Med, Nijmegen, Gelderland, Netherlands		Verbeek, AJM (corresponding author), Noordwest Ziekenhuisgrp, Dept Emergency Med, NL-1815 JD Alkmaar, Noord Holland, Netherlands.	ajm.verbeek@nwz.nl		Verbeek, Jan/0000-0002-6880-561X			Airaksinen NK, 2018, INJURY, V49, P945, DOI 10.1016/j.injury.2018.03.002; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boele M, 2014, BEHAVIOUR ELECT CLAS; Crocker P, 2012, J EMERG MED, V43, P244, DOI 10.1016/j.jemermed.2011.05.029; de Guerre LEVM, 2020, EUR J TRAUMA EMERG S, V46, P413, DOI 10.1007/s00068-018-1033-5; Fishman E, 2018, SAFETY E BIKES NETHE; Gennarelli TA., 2008, ABBREVIATED INJURY S; Langford BC, 2015, ACCIDENT ANAL PREV, V82, P220, DOI 10.1016/j.aap.2015.05.016; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Papoutsi S, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/850236; Poos H P A M, 2017, Ned Tijdschr Geneeskd, V161, pD1520; Schepers JP, 2014, ACCIDENT ANAL PREV, V73, P174, DOI 10.1016/j.aap.2014.09.010; Schepers P, 2017, BICYCLE ACCIDENTS NE; Schleinitz K, 2017, SAFETY SCI, V92, P290, DOI 10.1016/j.ssci.2015.07.027; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Siman-Tov M, 2017, TRAFFIC INJ PREV, V18, P318, DOI 10.1080/15389588.2016.1246723; Stichting BOVAG-RAI Mobiliteit, 2018, MOB NUMB 2 WHEEL VEH; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; The Royal Society for the Prevention of Accidents, 2018, ROAD SAF FACTSH EL B; Weber T, 2014, ACCIDENT ANAL PREV, V73, P47, DOI 10.1016/j.aap.2014.07.020; Weiss R, 2018, Z ORTHOP UNFALLCHIR, V156, P78, DOI 10.1055/s-0043-120200	23	1	1	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	APR	2021	38	4					279	284		10.1136/emermed-2019-208811			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	RB1IB	WOS:000631868900007	33472871				2022-02-06	
J	Yamakawa, Y; Morioka, M; Negoto, T; Orito, K; Yoshitomi, M; Nakamura, Y; Takeshige, N; Yamamoto, M; Takeuchi, Y; Oda, K; Jono, H; Saito, H				Yamakawa, Yukako; Morioka, Motohiro; Negoto, Tetsuya; Orito, Kimihiko; Yoshitomi, Munetake; Nakamura, Yukihiko; Takeshige, Nobuyuki; Yamamoto, Masafumi; Takeuchi, Yasuharu; Oda, Kazutaka; Jono, Hirofumi; Saito, Hideyuki			A novel step-down infusion method of barbiturate therapy: Its safety and effectiveness for intracranial pressure control	PHARMACOLOGY RESEARCH & PERSPECTIVES			English	Article						barbiturate; cerebral perfusion pressure; intracranial pressure; step-down infusion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; PENTOBARBITAL COMA; PROPOFOL; HYPERTENSION; HYPOTHERMIA; MANAGEMENT; ICP	Intracranial pressure (ICP) has to be maintained quite constant, because increased ICP caused by cerebrovascular disease and head trauma is fatal. Although controlling ICP is clinically critical, only few therapeutic methods are currently available. Barbiturates, a group of sedative-hypnotic drugs, are recognized as secondary treatment for controlling ICP. We proposed a novel "step-down infusion" method, administrating barbiturate (thiamylal) after different time point from the start of treatment under normothermia, at doses of 3.0 (0-24 h), 2.0 (24-48 h), 1.5 (48-72 h), and 1.0 mg/kg/h (72-96 h), and evaluated its safety and effectiveness in clinical. In 22 patients with severe traumatic brain injury or severe cerebrovascular disease (Glasgow coma scale <= 8), thiamylal concentrations and ICP were monitored. The step-down infusion method under normothermia maintained stable thiamylal concentrations (<26.1 mu g/ml) without any abnormal accumulation/elevation, and could successfully keep ICP <20 mmHg (targeted management value: ICP <20 mmHg) in all patients. Moreover the mean value of cerebral perfusion pressure (CPP) was also maintained over 65 mmHg during all time course (targeted management value: CPP >65 mmHg), and no threatening changes in serum potassium or any hemodynamic instability were observed. Our novel "step-down infusion" method under normothermia enabled to maintain stable, safe thiamylal concentrations to ensure both ICP reduction and CPP maintenance without any serious side effects, may provide a novel and clinically effective treatment option for patients with increased ICP.	[Yamakawa, Yukako; Oda, Kazutaka; Jono, Hirofumi; Saito, Hideyuki] Kumamoto Univ Hosp, Dept Pharm, Kumamoto, Japan; [Morioka, Motohiro; Negoto, Tetsuya; Orito, Kimihiko; Yoshitomi, Munetake; Nakamura, Yukihiko; Takeshige, Nobuyuki; Yamamoto, Masafumi; Takeuchi, Yasuharu] Kurume Univ, Sch Med, Dept Neurosurg, Fukuoka, Japan		Jono, H (corresponding author), Kumamoto Univ Hosp, Dept Pharm, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hjono@kuh.kumamoto-u.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18 K08955, 16 K10745]	This study was supported by Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science (18 K08955 and 16 K10745).	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Beaudry F, 2005, J PHARMACEUT BIOMED, V39, P411, DOI 10.1016/j.jpba.2005.04.041; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS71; Brain Trauma Foundation The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P527; Bullock MR, 1996, J NEUROTRAUM, V13, P711; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Huang SJ, 2006, J CLIN NEUROSCI, V13, P818, DOI 10.1016/j.jocn.2005.11.034; KADAR D, 1982, CAN ANAESTH SOC J, V29, P16, DOI 10.1007/BF03007942; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KIERSEY D K, 1951, Br J Anaesth, V23, P141, DOI 10.1093/bja/23.3.141; Lee XP, 2013, FORENSIC TOXICOL, V31, P9, DOI 10.1007/s11419-012-0155-4; Leslie K, 2002, ANESTH ANALG, V94, P1298, DOI 10.1097/00000539-200205000-00045; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; Perez-Barcena J, 2008, CRIT CARE, V12, DOI 10.1186/cc6999; PITTMAN T, 1989, PEDIATR NEUROSCI, V15, P13, DOI 10.1159/000120433; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Ng Y, 2011, INTENS CARE MED, V37, P1285, DOI 10.1007/s00134-011-2240-2; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; STEEN PA, 1980, ANESTHESIOLOGY, V53, P183; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Zeiler FA, 2017, J INTENSIVE CARE MED, V32, P130, DOI 10.1177/0885066615593939	29	1	1	0	0	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	2052-1707			PHARMACOL RES PERSPE	Pharmacol. Res. Perspect.	APR	2021	9	2							e00719	10.1002/prp2.719			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	RP5LB	WOS:000641769400029	33617150	gold, Green Published			2022-02-06	
J	Yu, J; Meng, FX; He, FP; Chen, F; Bao, WX; Yu, YM; Zhou, JT; Gao, J; Li, JQ; Yao, Y; Ge, WP; Luo, BY				Yu, Jie; Meng, Fanxia; He, Fangping; Chen, Fei; Bao, Wangxiao; Yu, Yamei; Zhou, Jintao; Gao, Jian; Li, Jingqi; Yao, Yao; Ge, Woo-ping; Luo, Benyan			Metabolic Abnormalities in Patients with Chronic Disorders of Consciousness	AGING AND DISEASE			English	Article						chronic disorders of consciousness; targeted metabolomics; lipidomics; diagnosis; biomarkers; minimally conscious state (MCS); vegetative state (VS); Alzheimer's disease (AD)	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; VEGETATIVE STATE; CDP-CHOLINE; DIAGNOSIS; ASSOCIATION; BIOMARKERS; LIPIDOMICS; RELEVANCE; DEMENTIA	The vegetative state (VS) and minimally conscious state (MCS) are two major types of chronic disorders of consciousness (DoC). The assessment of these two consciousness states generally relies on the Coma Recovery Scale-Revised (CRS-R) score, but a high misdiagnosis rate limits the generalized use of this score. To identify metabolites in human plasma that can accurately distinguish VS from MCS patients, comprehensive plasma metabolic profiles were obtained with targeted metabolomics analysis and untargeted and targeted lipidomics analysis. Univariate and multivariate analyses were used to assess the significance of differences. Compared with healthy controls (HCs), the DoC groups, Emerged from Minimally Conscious State (EMCS) group and Alzheimer's disease (AD) group had significantly different metabolic profiles. Purine metabolism pathway differed the most between the DoC (MCS and VS) and HC groups. In this pathway, adenosine, ADP, and AMP, which are the derived products of ATP degradation, were decreased in the MCS and VS groups compared to healthy controls. More importantly, we identified certain lipids for which the levels were enriched in the VS or MCS groups. Specifically, phosphatidylcholine, (38:5)-H (PC(38:5)-H), and arachidonic acid (AA) differed substantially between the VS and MCS groups and may be used to distinguish these two groups of patients. Together, our findings suggest that metabolic profiling is significantly altered in patients with chronic DoC.	[Yu, Jie; Meng, Fanxia; He, Fangping; Bao, Wangxiao; Yu, Yamei; Zhou, Jintao; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Sch Med, Hangzhou 310003, Peoples R China; [Yu, Jie; Meng, Fanxia; He, Fangping; Bao, Wangxiao; Yu, Yamei; Zhou, Jintao; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Sch Med, Hangzhou 310003, Peoples R China; [Chen, Fei] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dept Neurosci, Dallas, TX 75390 USA; [Gao, Jian; Li, Jingqi] Zhejiang Armed Police Corps, Dept Rehabil, Hangzhou Hosp, Hangzhou 310051, Peoples R China; [Yao, Yao] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Ge, Woo-ping] Chinese Inst Brain Res, Beijing 102206, Peoples R China		Ge, WP (corresponding author), Chinese Inst Brain Res, Beijing 102206, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China.	woopingge@cibr.ac.cn; luobenyan@zju.edu.cn			Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2019-XZZX-001-01-02]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870817, 81671143, 81901068]	The authors thank the patients and volunteers for participating in this study. This work was supported by the Fundamental Research Funds for the Central Universities (2019-XZZX-001-01-02). This work was supported by grants from the Natural Science Foundation of China (No. 81870817; No. 81671143; No. 81901068).	Accorsi PA, 2017, J INTEGR NEUROSCI, V16, pS3, DOI 10.3233/JIN-170061; Afshin-Majd S, 2017, BIOMED PHARMACOTHER, V89, P1, DOI 10.1016/j.biopha.2017.02.007; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; AVRUCH L, 1976, CAN J BIOCHEM CELL B, V54, P657, DOI 10.1139/o76-095; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Chapple LAS, 2016, CLIN NUTR, V35, P1315, DOI 10.1016/j.clnu.2016.02.009; Chen M, 2018, NAT GENET, V50, P206, DOI 10.1038/s41588-017-0027-2; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; Chouraki V, 2017, ALZHEIMERS DEMENT, V13, P1327, DOI 10.1016/j.jalz.2017.04.009; COOPER J, 1995, BRIT J PSYCHIAT, V166, P4, DOI 10.1192/bjp.166.1.4; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Eberlin LS, 2014, P NATL ACAD SCI USA, V111, P10450, DOI 10.1073/pnas.1409778111; Erlbeck H, 2017, INT J PSYCHOPHYSIOL, V113, P8, DOI 10.1016/j.ijpsycho.2016.12.012; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Ferrari F, 2015, EUR J PHARMACOL, V756, P67, DOI 10.1016/j.ejphar.2015.03.011; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Gottle M, 2013, J NEUROCHEM, V127, P805, DOI 10.1111/jnc.12366; Gonzalez-Dominguez R, 2015, J PHARMACEUT BIOMED, V107, P75, DOI 10.1016/j.jpba.2014.10.010; Hayton S, 2017, CELL MOL LIFE SCI, V74, P4421, DOI 10.1007/s00018-017-2582-1; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; JENNETT B, 1972, LANCET, V1, P734; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kreilaus F, 2016, NEUROPATH APPL NEURO, V42, P535, DOI 10.1111/nan.12286; Leung W, 2015, G3-GENES GENOM GENET, V5, P719, DOI 10.1534/g3.114.015966; Luo CM, 2018, EBIOMEDICINE, V32, P50, DOI 10.1016/j.ebiom.2018.05.028; Machado C, 2002, NEUROLOGY, V59, P1473; Maegele M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614555142; MALDONADO VC, 1991, J NEUROL SCI, V103, pS15; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Nomura J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53965-x; Pasvogel AE, 2008, BIOL RES NURS, V10, P113, DOI 10.1177/1099800408323218; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; Prieto R, 2011, BRAIN RES, V1404, P39, DOI 10.1016/j.brainres.2011.06.006; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Proitsi P, 2017, ALZHEIMERS DEMENT, V13, P140, DOI 10.1016/j.jalz.2016.08.003; Qureshi MI, 2017, NEUROSCIENTIST, V23, P374, DOI 10.1177/1073858416673327; Riehl JR, 2017, NETW NEUROSCI, V1, P431, DOI [10.1162/NETN_a_00023, 10.1162/netn_a_00023]; Rosca MG, 2009, ADV DRUG DELIVER REV, V61, P1332, DOI 10.1016/j.addr.2009.06.009; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; SECADES JJ, 1995, METHOD FIND EXP CLIN, V17, P1; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Szpigel A, 2018, DIABETOLOGIA, V61, P399, DOI 10.1007/s00125-017-4462-5; Tacer KF, 2010, J STEROID BIOCHEM, V121, P619, DOI 10.1016/j.jsbmb.2010.02.026; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Xiong NX, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16810-8; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; YASUHARA M, 1974, CURR THER RES CLIN E, V16, P346	53	1	2	1	6	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	APR 1	2021	12	2					386	403		10.14336/AD.2020.0812			18	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	RC6LA	WOS:000632909000007	33815872	gold, Green Published			2022-02-06	
J	Zhang, Z; Bao, X; Li, D				Zhang, Zhuo; Bao, Xue; Li, Dan			Batroxobin inhibits astrocyte activation following nigrostriatal pathway injury	NEURAL REGENERATION RESEARCH			English	Article						astrocyte; brain; central nervous system; factor; injury; pathway	SPINAL-CORD-INJURY; GFAP EXPRESSION; GLIAL-CELLS; RAT-BRAIN; IN-VIVO; NEURONS; PROTECTS; REGENERATION; INFLAMMATION; MECHANISMS	Batroxobin is a thrombin-like serine protease from the venom of the Bothrops atrox and Bothrops moojeni snake species. Sirtuin 1 (Sirt1) has been shown to play an important role in neuroprotection after traumatic brain injury. However, its underlying mechanism of action remains poorly understood. The purpose of this study was to investigate whether the mechanism by which batroxobin participates in the activation of astrocytes is associated with Sirt1. Mouse models of nigrostriatal pathway injury were established. Immediately after modeling, mice were intraperitoneally administered 39 U/kg batroxobin. Batroxobin significantly reduced the expression of cleaved caspase-3 in both the substantia nigra and striatum, inhibited neuronal apoptosis, and promoted the recovery of rat locomotor function. These changes coincided with a remarkable reduction in astrocyte activation. Batroxobin also reduced Sirt1 expression and extracellular signal-regulated kinase activation in brain tissue. Intraperitoneal administration of the Sirt1-specific inhibitor EX527 (5 mg/kg) 30 minutes prior to injury could inhibit the abovementioned effects. In mouse astrocyte cultures, 1 ng/mL batroxobin attenuated interleukin-1 beta-induced activation of astrocytes and extracellular signal-regulated kinase. EX527 could also inhibit the effects of batroxobin. These findings suggest that batroxobin inhibits astrocyte activation after nigrostriatal pathway injury through the Sirt1 pathway. This study was approved by the Animal Ethics Committee of China Medical University, China (approval No. CMU2020037) on July 19, 2015.	[Zhang, Zhuo; Bao, Xue; Li, Dan] China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Liaoning, Peoples R China		Li, D (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Human Anat, Shenyang, Liaoning, Peoples R China.	dli01@cmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801239]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M651165]; Doctoral Start-up Foundation of Liaoning Province of China [20180540041]	This study was supported by the National Natural Science Foundation of China, No. 81801239 (to DL), China Postdoctoral Science Foundation, No. 2019M651165 (to DL) and Doctoral Start-up Foundation of Liaoning Province of China, No. 20180540041 (to DL).	Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Bell WR, 1997, DRUGS, V54, P18, DOI 10.2165/00003495-199700543-00005; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chang HM, 2009, J PINEAL RES, V47, P211, DOI 10.1111/j.1600-079X.2009.00704.x; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chong ZZ, 2008, CURR NEUROVASC RES, V5, P159, DOI 10.2174/156720208785425666; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Fan H, 2013, NEUROSCI BULL, V29, P501, DOI 10.1007/s12264-013-1354-7; Fidler IJ, 2011, SEMIN CANCER BIOL, V21, P107, DOI 10.1016/j.semcancer.2010.12.009; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Garcia A, 2005, BLOOD, V106, P3410, DOI 10.1182/blood-2005-05-1933; Guo LH, 2006, ACTA NEUROPATHOL, V112, P703, DOI 10.1007/s00401-006-0135-z; Guo WJ, 2011, J NEUROSCI RES, V89, P1723, DOI 10.1002/jnr.22725; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hinojosa-Godinez A, 2019, NEURAL REGEN RES, V14, P1787, DOI 10.4103/1673-5374.257537; Hodgkinson CR, 2008, THROMB HAEMOSTASIS, V100, P301, DOI 10.1160/TH08-03-0179; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kawano H, 2005, J NEUROSCI RES, V80, P191, DOI 10.1002/jnr.20441; Khuwaja Ali Khan, 2011, J Prev Med Public Health, V44, P210, DOI 10.3961/jpmph.2011.44.5.210; Kong LY, 1996, BRAIN RES, V729, P102, DOI 10.1016/S0006-8993(96)00417-9; Leonoudakis D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8302636; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Li D, 2016, BRAIN RES BULL, V127, P195, DOI 10.1016/j.brainresbull.2016.09.014; Li D, 2016, BRAIN RES, V1648, P90, DOI 10.1016/j.brainres.2016.07.008; Lv HD, 2015, BRAIN RES BULL, V115, P30, DOI 10.1016/j.brainresbull.2015.05.002; Paxions G., 2009, RAT BRAIN STEREOTAXI, V6th; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3; Sticozzi C, 2013, NEUROSCIENCE, V252, P367, DOI 10.1016/j.neuroscience.2013.07.061; Taherian A, 2015, IRAN J CANCER PREV, V8, DOI 10.17795/ijcp-3909; Tang YL, 2020, NEURAL REGEN RES, V15, P2262, DOI 10.4103/1673-5374.284996; Tovar-y-Romo LB, 2016, J NEUROCHEM, V136, P13, DOI 10.1111/jnc.13362; Yang Y, 2011, CELL MOL NEUROBIOL, V31, P437, DOI 10.1007/s10571-010-9637-2; Yoshioka N, 2010, J COMP NEUROL, V518, P3867, DOI 10.1002/cne.22431; Yu H, 2015, EXP THER MED, V9, P1631, DOI 10.3892/etm.2015.2368; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001	36	1	1	1	19	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2021	16	4					721	726		10.4103/1673-5374.295343			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	OM1ET	WOS:000585772900027	33063734	gold, Green Published			2022-02-06	
J	Appavu, B; Burrows, BT; Nickoles, T; Boerwinkle, V; Willyerd, A; Gunnala, V; Mangum, T; Marku, I; Adelson, PD				Appavu, Brian; Burrows, Brian T.; Nickoles, Todd; Boerwinkle, Varina; Willyerd, Anthony; Gunnala, Vishal; Mangum, Tara; Marku, Iris; Adelson, P. D.			Implementation of Multimodality Neurologic Monitoring Reporting in Pediatric Traumatic Brain Injury Management	NEUROCRITICAL CARE			English	Article						Traumatic Brain Injury; Pediatric Neurocritical Care; Quality Improvement; Multimodal Neurologic Monitoring; Hospital Complications		Background/Objective Multimodality neurologic monitoring (MMM) is an emerging technique for management of traumatic brain injury (TBI). An increasing array of MMM-derived biomarkers now exist that are associated with injury severity and functional outcomes after TBI. A standardized MMM reporting process has not been well described, and a paucity of evidence exists relating MMM reporting in TBI management with functional outcomes or adverse events. Methods Prospective implementation of standardized MMM reporting at a single pediatric intensive care unit (PICU) is described that included monitoring of intracranial pressure (ICP), cerebral oxygenation and electroencephalography (EEG). The incidence of clinical decisions made using MMM reporting is described, including timing of neuroimaging, ICP monitoring discontinuation, use of paralytic, hyperosmolar and pentobarbital therapies, neurosurgical interventions, ventilator and CPP adjustments and neurologic prognostication discussions. Retrospective analysis was performed on the association of MMM reporting with initial Glasgow Coma Scale (GCS) and Pediatric Risk of Mortality III (PRISM III) scores, duration of total hospitalization and PICU hospitalization, duration of mechanical ventilation and invasive ICP monitoring, inpatient complications, time with ICP > 20 mmHg, time with cerebral perfusion pressure (CPP) < 40 mmHg and 12-month Glasgow Outcome Scale-Extended Pediatrics (GOSE-Peds) scores. Association of outcomes with MMM reporting was investigated using the Wilcoxon rank-sum test or Fisher's exact test, as appropriate. Results Eighty-five children with TBI underwent MMM over 6 years, among which 18 underwent daily MMM reporting over a 21-month period. Clinical decision-making influenced by MMM reporting included timing of neuroimaging (100.0%), ICP monitoring discontinuation (100.0%), timing of extubation trials of surviving patients (100.0%), body repositioning (11.1%), paralytic therapy (16.7%), hyperosmolar therapy (22.2%), pentobarbital therapy (33.3%), provocative cerebral autoregulation testing (16.7%), adjustments in CPP thresholds (16.7%), adjustments in PaCO2 thresholds (11.1%), neurosurgical interventions (16.7%) and neurologic prognostication discussions (11.1%). The implementation of MMM reporting was associated with a reduction in ICP monitoring duration (p = 0.0017) and mechanical ventilator duration (p = 0.0018). No significant differences were observed in initial GCS or PRISM III scores, total hospitalization length, PICU hospitalization length, total complications, time with ICP > 20 mmHg, time with CPP < 40 mmHg, use of tier 2 therapy, or 12-month GOS-E Peds scores. Conclusion Implementation of MMM reporting in pediatric TBI management is feasible and can be impactful in tailoring clinical decisions. Prospective work is needed to understand the impact of MMM and MMM reporting systems on functional outcomes and clinical care efficacy.	[Appavu, Brian; Burrows, Brian T.; Boerwinkle, Varina; Mangum, Tara; Marku, Iris; Adelson, P. D.] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosci, 1919 E Thomas Rd,Ambulatory Bldg B,3rd Floor, Phoenix, AZ 85016 USA; [Appavu, Brian; Boerwinkle, Varina; Mangum, Tara; Marku, Iris; Adelson, P. D.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, 550 E Van Buren St, Phoenix, AZ 85004 USA; [Nickoles, Todd] Phoenix Childrens Hosp, Dept Surg, 1919 E Thomas Rd, Phoenix, AZ 85016 USA; [Willyerd, Anthony; Gunnala, Vishal] Phoenix Childrens Hosp, Dept Crit Care Med, 1919 E Thomas Rd, Phoenix, AZ 85016 USA		Appavu, B (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Neurosci, 1919 E Thomas Rd,Ambulatory Bldg B,3rd Floor, Phoenix, AZ 85016 USA.	bappavu@phoenixchildrens.com		Appavu, Brian/0000-0002-5396-2559	United States Department of Defense Congressionally Directed Medical Research Programs Epilepsy Research Program [W81XWH-19-1-0514]	This work was funded in part by the United States Department of Defense Congressionally Directed Medical Research Programs Epilepsy Research Program (W81XWH-19-1-0514).	Appavu B, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01261; Appavu B, 2019, J NEUROSURG-PEDIATR, V23, P661, DOI 10.3171/2019.2.PEDS18384; ARIES M, 2002, CRIT CARE MED, V30, P733, DOI DOI 10.1097/00003246-200204000-00002; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Centers for Disease Control and Prevention, 2020, PNEUM VENT ASS VAP N; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hellyer Thomas P, 2016, J Intensive Care Soc, V17, P238, DOI 10.1177/1751143716644461; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Pollack MM, 2013, PEDIATR CRIT CARE ME, V14, P448, DOI 10.1097/PCC.0b013e31828a7270; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rivera Lara Lucia, 2018, Continuum (Minneap Minn), V24, P1776, DOI 10.1212/CON.0000000000000671; Varsos GV, 2014, NEUROCRIT CARE, V20, P142, DOI 10.1007/s12028-013-9868-4; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1	24	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2021	35	1					3	15		10.1007/s12028-021-01190-8		MAR 2021	13	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TJ4CL	WOS:000635493400001	33791948	Green Published, Bronze			2022-02-06	
J	McDaid, J; Briggs, CA; Barrington, NM; Peterson, DA; Kozlowski, DA; Stutzmann, GE				McDaid, John; Briggs, Clark A.; Barrington, Nikki M.; Peterson, Daniel A.; Kozlowski, Dorothy A.; Stutzmann, Grace E.			Sustained Hippocampal Synaptic Pathophysiology Following Single and Repeated Closed-Head Concussive Impacts	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						Ca2+; CTE; concussion; hippocampus; LTP; synaptic transmission; tau		Traumatic brain injury (TBI), and related diseases such as chronic traumatic encephalopathy (CTE) and Alzheimer's (AD), are of increasing concern in part due to enhanced awareness of their long-term neurological effects on memory and behavior. Repeated concussions, vs. single concussions, have been shown to result in worsened and sustained symptoms including impaired cognition and histopathology. To assess and compare the persistent effects of single or repeated concussive impacts on mediators of memory encoding such as synaptic transmission, plasticity, and cellular Ca2+ signaling, a closed-head controlled cortical impact (CCI) approach was used which closely replicates the mode of injury in clinical cases. Adult male rats received a sham procedure, a single impact, or three successive impacts at 48-hour intervals. After 30 days, hippocampal slices were prepared for electrophysiological recordings and 2-photon Ca2+ imaging, or fixed and immunostained for pathogenic phospho-tau species. In both concussion groups, hippocampal circuits showed hyper-excitable synaptic responsivity upon Schaffer collateral stimulation compared to sham animals, indicating sustained defects in hippocampal circuitry. This was not accompanied by sustained LTP deficits, but resting Ca2+ levels and voltage-gated Ca2+ signals were elevated in both concussion groups, while ryanodine receptor-evoked Ca2+ responses decreased with repeat concussions. Furthermore, pathogenic phospho-tau staining was progressively elevated in both concussion groups, with spreading beyond the hemisphere of injury, consistent with CTE. Thus, single and repeated concussions lead to a persistent upregulation of excitatory hippocampal synapses, possibly through changes in postsynaptic Ca2+ signaling/regulation, which may contribute to histopathology and detrimental long-term cognitive symptoms.	[McDaid, John; Briggs, Clark A.; Barrington, Nikki M.; Peterson, Daniel A.; Stutzmann, Grace E.] Rosalind Franklin Univ Med & Sci, Ctr Neurodegenerat Dis & Therapeut, N Chicago, IL 60064 USA; [Barrington, Nikki M.; Peterson, Daniel A.; Stutzmann, Grace E.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA; [Peterson, Daniel A.; Stutzmann, Grace E.] Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, N Chicago, IL 60064 USA; [Kozlowski, Dorothy A.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Kozlowski, Dorothy A.] Depaul Univ, Neurosci Program, Chicago, IL 60604 USA		Stutzmann, GE (corresponding author), Rosalind Franklin Univ Med & Sci, Ctr Neurodegenerat Dis & Therapeut, N Chicago, IL 60064 USA.; Stutzmann, GE (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA.; Stutzmann, GE (corresponding author), Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, N Chicago, IL 60064 USA.	grace.stutzmann@rosalindfranklin.edu			DePaul-RFUMS pilot awards	Funding was obtained from DePaul-RFUMS pilot awards to DP, DK, and GS.	Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Albayram O, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0124-4; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arai M, 2019, J NEUROCHEM, V151, P795, DOI 10.1111/jnc.14803; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Avila J, 2004, NEUROTOX RES, V6, P477, DOI 10.1007/BF03033284; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Borde M, 2000, HIPPOCAMPUS, V10, P198; Briggs CA, 2017, BIOCHEM BIOPH RES CO, V483, P988, DOI 10.1016/j.bbrc.2016.09.088; Bruno AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.011; CDC, 2014, SURV REP TRAUM BRAIN; Chakroborty S, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0307-7; Chakroborty S, 2015, J NEUROSCI, V35, P6893, DOI 10.1523/JNEUROSCI.4002-14.2015; Chakroborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052056; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; DAVIES SN, 1989, PROC R SOC SER B-BIO, V236, P373, DOI 10.1098/rspb.1989.0028; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Di Vergouwen M, 2007, J CEREBR BLOOD F MET, V27, P1293, DOI 10.1038/sj.jcbfm.9600431; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FRANDSEN A, 1991, J NEUROCHEM, V56, P1075, DOI 10.1111/j.1471-4159.1991.tb02031.x; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Giacomello M, 2013, PRION, V7, P76, DOI 10.4161/pri.23581; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; Gurkoff GG, 2013, BRAIN RES, V1515, P98, DOI 10.1016/j.brainres.2013.03.043; Hazra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064318; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; HUANG YY, 1993, J NEUROSCI, V13, P568; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; HUBER KM, 1995, NEUROREPORT, V6, P1281, DOI 10.1097/00001756-199506090-00013; Huijbers W, 2019, J NEUROSCI, V39, P548, DOI 10.1523/JNEUROSCI.1397-18.2018; Huijbers W, 2015, BRAIN, V138, P1023, DOI 10.1093/brain/awv007; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; JAFFE DB, 1994, J NEUROBIOL, V25, P220, DOI 10.1002/neu.480250303; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; Koenig JB, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126506; Lacampagne A, 2017, ACTA NEUROPATHOL, V134, P749, DOI 10.1007/s00401-017-1733-7; Langham J, 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD000565, DOI 10.1002/14651858.CD000565]; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McInnes K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218423; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morimoto S, 2009, BIOCHEM BIOPH RES CO, V390, P87, DOI 10.1016/j.bbrc.2009.09.071; Niebauer M, 1999, NEUROPHARMACOLOGY, V38, P1343, DOI 10.1016/S0028-3908(99)00059-3; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Regehr WG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005702; Sandler VM, 1999, J NEUROSCI, V19, P4325; Schrank S, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a035212; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shen IH, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6122; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Stutzmann GE, 2005, PHYSIOLOGY, V20, P15, DOI 10.1152/physiol.00028.2004; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2003, J NEUROSCI, V23, P758; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1990, ACT NEUR S, V51, P315; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Titus DJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223180; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weber JT, 2002, J NEUROTRAUM, V19, P1433, DOI 10.1089/089771502320914660; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Wilson SM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00135; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yamada K, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0052-5; Zhang BL, 2011, CHINESE MED J-PEKING, V124, P740, DOI 10.3760/cma.j.issn.0366-6999.2011.05.020; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhang H, 2015, J ALZHEIMERS DIS, V45, P561, DOI 10.3233/JAD-142427; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	106	1	1	3	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	MAR 31	2021	15								652721	10.3389/fncel.2021.652721			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RM4BU	WOS:000639608400001	33867941	gold, Green Published			2022-02-06	
J	Brett, BL; Kramer, MD; Whyte, J; McCrea, MA; Stein, MB; Giacino, JT; Sherer, M; Markowitz, AJ; Manley, GT; Nelson, LD				Brett, Benjamin L.; Kramer, Mark D.; Whyte, John; McCrea, Michael A.; Stein, Murray B.; Giacino, Joseph T.; Sherer, Mark; Markowitz, Amy J.; Manley, Geoffrey T.; Nelson, Lindsay D.		TRACK-TBI Investigators	Latent Profile Analysis of Neuropsychiatric Symptoms and Cognitive Function of Adults 2 Weeks After Traumatic Brain Injury Findings From the TRACK-TBI Study	JAMA NETWORK OPEN			English	Article								IMPORTANCE Heterogeneity across patients with traumatic brain injury (TBI) presents challenges for clinical care and intervention design. Identifying distinct clinical phenotypes of TBI soon after injury may inform patient selection for precision medicine clinical trials. OBJECTIVE To investigate whether distinct neurobehavioral phenotypes can be identified 2 weeks after TBI and to characterize the degree to which early neurobehavioral phenotypes are associated with 6-month outcomes. DESIGN, SETTING, AND PARTICIPANTS This prospective cohort study included patients presenting to 18 US level 1 trauma centers within 24 hours of TBI from 2014 to 2019 as part of the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. Data were analyzed from January 28, 2020, to January 11, 2021. EXPOSURES TBI. MAIN OUTCOMES AND MEASURES Latent profiles (LPs) were derived from common dimensions of neurobehavioral functioning at 2 weeks after injury, assessed through National Institutes of Health TBI Common Data Elements (ie, Brief Symptom Inventory-18, Patient Health Questionnaire-9 Depression checklist, Posttraumatic Stress Disorder Checklist for DSM-5, PROMIS Pain Intensity scale, Insomnia Severity Index, Rey Auditory Verbal Learning Test, Wechsler Adult Intelligence Scale-Fourth Edition Coding and Symbol Search subtests, Trail Making Test, and NIH Toolbox Cognitive Battery Pattern Comparison Processing Speed, Dimensional Change Card Sort, Flanker Inhibitory Control and Attention, and Picture Sequence Memory subtests). Six-month outcomes were the Satisfaction With Life Scale (SWLS), Quality of Life after Brain Injury-Overall Scale (QOLIBRI-OS), Glasgow Outcome Scale-Extended (GOSE), and Rivermead Post-Concussion Symptoms Questionnaire (RPQ). RESULTS Among 1757 patients with TBI included, 1184 (67.4%) were men, and the mean (SD) age was 39.9 (17.0) years. LP analysis revealed 4 distinct neurobehavioral phenotypes at 2 weeks after injury: emotionally resilient (419 individuals [23.8%]), cognitively impaired (368 individuals [20.9%]), cognitively resilient (620 individuals [35.3%]), and neuropsychiatrically distressed (with cognitive weaknesses; 350 individuals [19.9%]). Adding LP group to models including demographic characteristics, medical history, Glasgow Coma Scale score, and other injury characteristics was associated with significantly improved estimation of association with 6-month outcome (GOSE R-2 increase = 0.09-0.19; SWLS R-2 increase = 0.12-0.22; QOLIBRI-OS R-2 increase = 0.14-0.32; RPQ R-2 = 0.13-0.34). CONCLUSIONS AND RELEVANCE In this cohort study of patients with TBI presenting to US level-1 trauma centers, qualitatively distinct profiles of symptoms and cognitive functioning were identified at 2 weeks after TBI. These distinct phenotypesmay help optimize clinical decision-making regarding prognosis, as well as selection and stratification for randomized clinical trials.	[Brett, Benjamin L.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, TIRR Mem Hermann, Houston, TX 77030 USA; [Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Badjatia, Neeraj/0000-0003-1509-9034; Hemphill, Claude/0000-0003-4019-7525	US National Institute for Neurological Disorders and Stroke (NINDS) [U01 NS1365885]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS110856]; US Department of Defense TBI Endpoints Development (TED) Initiative [W81XWH-14-2-0176]; NINDS under the National Institutes of Health [L30NS113158-01]; One Mind; Neurotrauma Sciences	The study was funded by the US National Institute for Neurological Disorders and Stroke (NINDS) (grant No. U01 NS1365885), One Mind, and Neurotrauma Sciences. This secondary data analysis project was supported by NINDS grant No. R01 NS110856 and grant No. W81XWH-14-2-0176 from the US Department of Defense TBI Endpoints Development (TED) Initiative. Dr Brettwas supported by award No. L30NS113158-01 from NINDS under the National Institutes of Health.	Agtarap S, 2021, ASSESSMENT, V28, P1656, DOI 10.1177/1073191120913941; Agtarap SD, 2021, J NEUROTRAUM, V38, P546, DOI 10.1089/neu.2020.7055; Ashley EA, 2015, JAMA-J AM MED ASSOC, V313, P2119, DOI 10.1001/jama.2015.3595; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins LM., 2009, BEHAV HLTH SCI, DOI [10.1002/9780470567333, DOI 10.1002/9780470567333]; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nelson LD, 2018, J INT NEUROPSYCH SOC, V24, P793, DOI 10.1017/S1355617718000462; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Peppel LD, 2020, J NEUROTRAUM, V37, P1587, DOI 10.1089/neu.2019.6735; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Riley WT, 2015, TRANSL BEHAV MED, V5, P243, DOI 10.1007/s13142-015-0320-5; Schmidt M., 1996, REY AUDITORY VERBAL; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6	57	1	1	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	MAR 30	2021	4	3							e213467	10.1001/jamanetworkopen.2021.3467			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RH1JD	WOS:000635982400004	33783518	gold, Green Published			2022-02-06	
J	Cook, NE; Karr, JE; Iverson, GL				Cook, Nathan E.; Karr, Justin E.; Iverson, Grant L.			Children with ADHD Have a Greater Lifetime History of Concussion: Results from the ABCD Study	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						attention-deficit; hyperactivity disorder; children; mild traumatic brain injury		This case-control study using baseline data from the population cohort Adolescent Brain Cognitive Development (ABCD) Study(R) compared lifetime history of concussion between children with and without attention-deficit/hyperactivity disorder (ADHD). We hypothesized that children with ADHD would have a greater lifetime history of concussion than children without ADHD. Children were recruited from schools across the United States, sampled to provide strong generalizability to the US population. The current sample included 10,585 children (age: mean = 9.9; standard deviation = 0.6; range 9-10 years; 48.9% girls; 64.6% White), including 1085 with ADHD and 9500 without ADHD. The prevalence of prior concussion among children with ADHD was 7.2% (95% CI: 6.6-7.8%) compared with 3.2% (3.1-3.3%) among children without ADHD, meaning current ADHD status was associated with twice the odds of experiencing a prior concussion [chi(2) = 44.54; p < 0.001; odds ratio = 2.34 (1.81-3.03)]. No significant differences were observed in proportion of boys and girls with ADHD who had a prior concussion history. The number of current ADHD symptoms were not meaningfully associated with prior concussion history. Lower socioeconomic status was associated with lower rates of reported concussion, but not differentially in association with ADHD. ADHD is associated with twice the lifetime prevalence of prior concussion before age 11 among children from the general U.S. population. Boys and girls with ADHD did not differ in proportions with prior concussion and concussion history was not related to the number of ADHD symptoms reported by parents.	[Cook, Nathan E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Cook, Nathan E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Cook, Nathan E.; Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, 101 Merrimac St,10th Floor,Room 1060, Boston, MA 02114 USA; [Karr, Justin E.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Iverson, Grant L.] Red Sox Fdn & Massachusetts Gen Hosp Program, Home Base, Charlestown, MA USA		Cook, NE (corresponding author), MassGen Hosp Children, Sports Concuss Program, 101 Merrimac St,10th Floor,Room 1060, Boston, MA 02114 USA.	necook@mgh.harvard.edu			Massachusetts General HospitalGeneral Electric	Dr. Nathan Cook acknowledges support from the Louis V. Gerstner III Research Scholar Award from Massachusetts General Hospital. Dr. Grant Iverson acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heinz Family Foundation, Boston Bolts, ImPACT~ Applications, Inc., National Rugby League, and the Spaulding Research Institute.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2019, KSADS COMP COMPUTER; Barch DM, 2018, DEV COGN NEUROS-NETH, V32, P55, DOI 10.1016/j.dcn.2017.10.010; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Cook NE, 2020, J DEV BEHAV PEDIATR, V41, P571, DOI 10.1097/DBP.0000000000000808; Cook NE, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00002; Cook NE, 2019, J PEDIATR-US, V214, P168, DOI 10.1016/j.jpeds.2019.07.048; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dufour SC, 2020, CORTEX, V131, P237, DOI 10.1016/j.cortex.2020.07.003; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Herguner A, 2015, DENT TRAUMATOL, V31, P140, DOI 10.1111/edt.12153; Iverson G.L., 2020, CLIN SPORT MED; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Russell AE, 2016, CHILD PSYCHIAT HUM D, V47, P440, DOI 10.1007/s10578-015-0578-3; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Thikkurissy S, 2012, PEDIATR DENT, V34, P28; Townsend L, 2020, J AM ACAD CHILD PSY, V59, P309, DOI 10.1016/j.jaac.2019.05.009; van Ierssel J., 2020, J SPORTS MED; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zucker RA, 2018, DEV COGN NEUROS-NETH, V32, P107, DOI 10.1016/j.dcn.2018.03.004	34	1	1	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2021.0019		MAR 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RH6LO	WOS:000636327800001	33626946				2022-02-06	
J	Hsueh, SC; Luo, W; Tweedie, D; Kim, DS; Kim, YK; Hwang, I; Gil, JE; Han, BS; Chiang, YH; Selman, W; Hoffer, BJ; Greig, NH				Hsueh, Shih Chang; Luo, Weiming; Tweedie, David; Kim, Dong Seok; Kim, Yu Kyung; Hwang, Inho; Gil, Jung-Eun; Han, Baek-Soo; Chiang, Yung-Hsiao; Selman, Warren; Hoffer, Barry J.; Greig, Nigel H.			N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge	ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE			English	Article						thalidomide; traumatic brain injury; neuroinflammation; tumor necrosis factor-alpha; cereblon; neurodegeneration	TUMOR-NECROSIS-FACTOR; ALPHA SYNTHESIS INHIBITOR; TNF-ALPHA; MICROGLIAL ACTIVATION; DISEASE PROGRESSION; PARKINSONS-DISEASE; PATHOLOGICAL LINK; NITRIC-OXIDE; LENALIDOMIDE; INFLAMMATION	Neuroinflammation contributes to delayed secondary cell death following traumatic brain injury (TBI), has the potential to chronically exacerbate the initial insult, and represents a therapeutic target that has largely failed to translate into human efficacy. Thalidomide-like drugs have effectively mitigated neuroinflammation across cellular and animal models of TBI and neurodegeneration but are complicated by adverse actions in humans. We hence developed N-adamantyl phthalimidine (NAP) as a new thalidomide-like drug to mitigate inflammation without binding to cereblon, a key target associated with the antiproliferative, antiangiogenic, and teratogenic actions seen in this drug class. We utilized a phenotypic drug discovery approach that employed multiple cellular and animal models and ultimately examined immunohistochemical, biochemical, and behavioral measures following controlled cortical impact (CCI) TBI in mice. NAP mitigated LPS-induced inflammation across cellular and rodent models and reduced oligomeric alpha-synuclein and amyloid-beta mediated inflammation. Following CCI TBI, NAP mitigated neuronal and synaptic loss, neuroinflammation, and behavioral deficits, and is unencumbered by cereblon binding, a key protein underpinning the teratogenic and adverse actions of thalidomide-like drugs in humans. In summary, NAP represents a new class of thalidomide-like drugs with anti-inflammatory actions for promising efficacy in the treatment of TBI and potentially longer-term neurodegenerative disorders.	[Hsueh, Shih Chang; Luo, Weiming; Tweedie, David; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Kim, Dong Seok] AevisBio Inc, Gaithersburg, MD 20878 USA; [Kim, Dong Seok; Kim, Yu Kyung; Hwang, Inho; Gil, Jung-Eun] Aevis Bio Inc, Daejeon 34141, South Korea; [Han, Baek-Soo] Korea Res Inst Biosci & Biotechnol, Res Ctr Biodef, Daejeon 305806, South Korea; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Neurosci Res Ctr, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan; [Selman, Warren; Hoffer, Barry J.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA		Greig, NH (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.	Greign@grc.nia.nih.gov			National Institute on Aging, National Institutes of Health, United StatesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2923-B-038-001-MY3, MOST 108-2321-B-038-008]; Taipei Medical University, Taipei, Taiwan [DP2-107-21121-01-N-05]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R56 AG057028]; Duane and Joyce Collins Neurosurgery Fund, Department of Neurological Surgery, Case Western Reserve University, Cleveland, OH	This research was supported in part by the following: (i) The Intramural Research Program, National Institute on Aging, National Institutes of Health, United States; (ii) Grants from (a) the Ministry of Science and Technology, Taiwan (MOST 104-2923-B-038-001-MY3 and MOST 108-2321-B-038-008), (b) DP2-107-21121-01-N-05, Taipei Medical University, Taipei, Taiwan, and (c) National Institutes of Health R56 AG057028; and (iii) The Duane and Joyce Collins Neurosurgery Fund, Department of Neurological Surgery, Case Western Reserve University, Cleveland, OH.	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Asatsuma-Okumura T, 2019, PHARMACOL THERAPEUT, V202, P132, DOI 10.1016/j.pharmthera.2019.06.004; Banjara M, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/8385961; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Batsaikhan B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030502; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Boi L, 2019, MOVEMENT DISORD, V34, P1818, DOI 10.1002/mds.27799; Boichenko I, 2018, ACS OMEGA, V3, P11163, DOI 10.1021/acsomega.8b00959; Boichenko I, 2016, J MED CHEM, V59, P770, DOI 10.1021/acs.jmedchem.5b01735; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Callizot N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215277; Callizot N, 2013, J NEUROSCI RES, V91, P706, DOI 10.1002/jnr.23193; Casu MA, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00031; Chamberlain Philip P, 2019, Drug Discov Today Technol, V31, P29, DOI 10.1016/j.ddtec.2019.02.004; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Clark IA, 2017, SEMIN IMMUNOPATHOL, V39, P505, DOI 10.1007/s00281-017-0628-y; Clark IA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0708-2; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; Degan D., 2018, J MED CHEM, V59, P770; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donovan KA, 2018, ELIFE, V7, DOI 10.7554/eLife.38430; Doyle HH, 2017, J NEUROSCI, V37, P3202, DOI 10.1523/JNEUROSCI.2906-16.2017; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Franco-Bocanegra DK, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060639; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gemechu Y, 2018, P NATL ACAD SCI USA, V115, P11802, DOI 10.1073/pnas.1814446115; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Greter M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00249; Gyengesi E, 2020, NAT REV NEUROL, V16, P131, DOI 10.1038/s41582-019-0307-9; Hartley T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0510; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Holstein SA, 2018, J CLIN ONCOL, V36, P2101, DOI 10.1200/JCO.2018.77.9637; Hsueh SC, 2019, CELL TRANSPLANT, V28, P1183, DOI 10.1177/0963689719854693; Ito T, 2016, INT J HEMATOL, V104, P293, DOI 10.1007/s12185-016-2073-4; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jung YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00313; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Klegeris Andis, 2005, Current Alzheimer Research, V2, P355, DOI 10.2174/1567205054367883; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kotla V, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-36; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lin CT, 2020, ELIFE, V9, DOI 10.7554/eLife.54726; Liu J, 2011, EUR J MED CHEM, V46, P1949, DOI 10.1016/j.ejmech.2011.01.047; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P409, DOI 10.1007/978-3-211-85578-2_80; Longhi L., 2013, J CEREB BLOOD FLOW M, V33; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Luo WM, 2018, BIOORGAN MED CHEM, V26, P1547, DOI 10.1016/j.bmc.2018.01.032; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Matyskiela ME, 2020, NAT STRUCT MOL BIOL, V27, P319, DOI 10.1038/s41594-020-0405-9; Matyskiela ME, 2018, NAT CHEM BIOL, V14, P981, DOI 10.1038/s41589-018-0129-x; Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778; MCBRIDE WG, 1978, LANCET, V1, P1362; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Millrine D, 2017, TRENDS MOL MED, V23, P348, DOI 10.1016/j.molmed.2017.02.006; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Mogi M, 2000, NEUROSCI LETT, V289, P165, DOI 10.1016/S0304-3940(00)01275-1; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Muhammad M, 2019, TUMOR NECROSIS FACTO; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Paganelli R, 2002, EXP GERONTOL, V37, P257, DOI 10.1016/S0531-5565(01)00191-7; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Park KM, 2008, J BIOL CHEM, V283, P33069, DOI 10.1074/jbc.M802209200; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pierce S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175882; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Sanchez-Alcazar JA, 2000, J BIOL CHEM, V275, P13353, DOI 10.1074/jbc.275.18.13353; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Soderstjerna E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105359; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stewart AK, 2014, SCIENCE, V343, P256, DOI 10.1126/science.1249543; Stimac A, 2017, MOLECULES, V22, DOI 10.3390/molecules22020297; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Valera E, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0320-x; Vargesson N, 2019, J HAND SURG-EUR VOL, V44, P88, DOI 10.1177/1753193418805249; Vargesson N, 2015, BIRTH DEFECTS RES C, V105, P140, DOI 10.1002/bdrc.21096; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Walker DG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020678; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; WHO, 2019, WHO TECH REP SER, V1021, P1; Wilcock DM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-84; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; Zeldis JB, 2011, ANN NY ACAD SCI, V1222, P76, DOI 10.1111/j.1749-6632.2011.05974.x; Zhan SQ, 2011, BBA-MOL BASIS DIS, V1812, P565, DOI 10.1016/j.bbadis.2010.11.003; Zhang CX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00083; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	129	1	1	0	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA		2575-9108		ACS PHARMACOL TRANSL	ACS Pharmacol. Transl. Sci.	APR 9	2021	4	2					980	1000		10.1021/acsptsci.1c00042		MAR 2021	21	Chemistry, Medicinal; Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	RL6FT	WOS:000639067200051	33860215				2022-02-06	
J	Hui, J; Aulakh, GK; Unniappan, S; Singh, B				Hui, Jasmine; Aulakh, Gurpreet Kaur; Unniappan, Suraj; Singh, Baljit			Loss of Nucleobindin-2/Nesfatin-1 increases lipopolysaccharide-induced murine acute lung inflammation	CELL AND TISSUE RESEARCH			English	Article						Nucleobindin-2; Nesfatin-1; Mouse; Lungs; Inflammation		NUCB2/nesfatin-1 is expressed in variety of tissues. Treatment with nesfatin-1 reduces inflammation in rat models of subarachnoid hemorrhage-induced oxidative brain damage and traumatic brain injury as well as myocardial injury. There is only one study showing anti-inflammatory actions of nesfatin-1 on acute lung inflammation. To more precisely determine the role of NUCB2/nesfatin-1 in acute lung inflammation, we conducted a study using NUCB2/nesfatin-1 knockout (NKO) mice as well as neutrophils isolated from the bone marrows of WT and NKO mice. Our findings suggest that the absence of NUCB2/nesfatin-1 significantly increases the accumulation of adherent neutrophils by approximately 3 times compared with WT within LPS-treated lungs. Integrating this with observations from both BALF and neutrophil cytokine expression, we propose that although neutrophils lacking NUCB2/nesfatin-1 individually secrete less pro-inflammatory cytokines compared with stimulated WT cells, the result of knocking out NUCB2/nesfatin-1 is net pro-inflammatory. No change was found in NUCB2/nesfatin-1 mRNA or protein expression comparing WT LPS and PBS-treated samples. Taken together, our results show that NUCB2/nesfatin-1 is constitutively expressed in mouse lungs and neutrophils and demonstrates anti-inflammatory properties in mouse lungs during acute lung injury, by inhibiting adherent neutrophil accumulation and inflammatory cytokine expression.	[Hui, Jasmine; Unniappan, Suraj; Singh, Baljit] Univ Saskatchewan, Dept Vet Biomed Sci, Western Coll Vet Med, Saskatoon, SK, Canada; [Aulakh, Gurpreet Kaur] Univ Saskatchewan, Western Coll Vet Med, Small Anim Clin Sci, Saskatoon, SK, Canada		Singh, B (corresponding author), Univ Saskatchewan, Dept Vet Biomed Sci, Western Coll Vet Med, Saskatoon, SK, Canada.	Baljit.singh@usask.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Saskatchewan Health Research Foundation; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; University of Saskatchewan through the Centennial Enhancement Chair in Comparative Endocrinology; Sylvia Fedoruk Centre for Nuclear Innovation Chair in Nuclear Imaging	Baljit Singh's laboratory is supported with a Discovery Grant from Natural Sciences and Engineering Research Council of Canada. Funding for the laboratory of Suraj Unniappan is supported by an open operating grant from the Canadian Institutes of Health Research, an establishment grant from the Saskatchewan Health Research Foundation, John Evans Leaders Fund from the Canada Foundation for Innovation and from the University of Saskatchewan through the Centennial Enhancement Chair in Comparative Endocrinology. Gurpreet Aulakh's work is supported through Sylvia Fedoruk Centre for Nuclear Innovation Chair in Nuclear Imaging.	BOHMER RH, 1992, CYTOMETRY, V13, P525, DOI 10.1002/cyto.990130512; Cabanski M, 2008, AM J RESP CELL MOL, V38, P26, DOI 10.1165/rcmb.2007-0010OC; Cao C, 2018, INT IMMUNOPHARMACOL, V54, P169, DOI 10.1016/j.intimp.2017.11.006; Chen DQ, 2019, NEUROPEPTIDES, V74, P34, DOI 10.1016/j.npep.2018.10.005; Chung Yiwa, 2013, Dev Reprod, V17, P461, DOI 10.12717/DR.2013.17.4.461; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; Eltom S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0087-0; He YT, 2020, EUR J PHARMACOL, V869, DOI 10.1016/j.ejphar.2019.172893; Hong SAY, 2020, AM J TRANSL RES, V12, P6740; Janardhan KS, 2012, CELL TISSUE RES, V348, P177, DOI 10.1007/s00441-011-1300-9; KANAI Y, 1993, BIOCHEM BIOPH RES CO, V196, P729, DOI 10.1006/bbrc.1993.2310; Kyriazopoulou E, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0930-5; Leivo-Korpela S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/232167; LEVIN J, 1970, NEW ENGL J MED, V283, P1313, DOI 10.1056/NEJM197012102832404; Lorenz E, 2001, AM J PHYSIOL-LUNG C, V281, pL1106, DOI 10.1152/ajplung.2001.281.5.L1106; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Monzon ME, 2011, AM J PHYSIOL-LUNG C, V300, pL204, DOI 10.1152/ajplung.00292.2010; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Ozsavci D, 2011, NEUROSURGERY, V68, P1699, DOI 10.1227/NEU.0b013e318210f258; Potera RM, 2019, INFLAMMATION, V42, P185, DOI 10.1007/s10753-018-0883-7; Prinz P, 2016, BIOCHEM BIOPH RES CO, V470, P521, DOI 10.1016/j.bbrc.2016.01.113; Scotece M, 2014, J ORTHOP RES, V32, P653, DOI 10.1002/jor.22585; Singh B, 2004, AM J PHYSIOL-LUNG C, V286, pL363, DOI 10.1152/ajplung.00003.2003; Stengel Andreas, 2012, Curr Gastroenterol Rep, V14, P480, DOI 10.1007/s11894-012-0291-3; Suratt BT, 2006, CLIN CHEST MED, V27, P579, DOI 10.1016/j.ccm.2006.06.005; Tang CH, 2012, PEPTIDES, V36, P39, DOI 10.1016/j.peptides.2012.04.014; Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x; Vrolyk V, 2019, CELL TISSUE RES, V378, P97, DOI 10.1007/s00441-019-03023-9; Walker F, 2008, BLOOD, V111, P3978, DOI 10.1182/blood-2007-10-119636; Wang ZZ, 2020, EUR REV MED PHARMACO, V24, P5071, DOI 10.26355/eurrev_202005_21200; World Health Organization, 2018, TOP 10 CAUS DEATH; Wright HL, 2014, RHEUMATOLOGY, V53, P1321, DOI 10.1093/rheumatology/keu035; Yoshimura T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00002; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	37	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	JUL	2021	385	1					87	103		10.1007/s00441-021-03435-6		MAR 2021	17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	TG7NP	WOS:000635088100006	33783610				2022-02-06	
J	Leng, Y; Byers, AL; Barnes, DE; Peltz, CB; Li, YX; Yaffe, K				Leng, Yue; Byers, Amy L.; Barnes, Deborah E.; Peltz, Carrie B.; Li, Yixia; Yaffe, Kristine			Traumatic Brain Injury and Incidence Risk of Sleep Disorders in Nearly 200,000 US Veterans	NEUROLOGY			English	Article							WAKE DISTURBANCES; DAMAGE; PATTERNS; SOLDIERS; INSOMNIA; AROUSAL; NEURONS; CARE	Objective To test the hypothesis that veterans with traumatic brain injury (TBI) have an increased subsequent risk of sleep disorders, we studied the longitudinal association between TBI and incident sleep disorders in nearly 200,000 veterans. Methods We performed a cohort study of all patients diagnosed with a TBI in the Veterans Health Administration system from October 1, 2001, to September 30, 2015, who were age-matched 1: 1 to veterans without TBI. Veterans with prevalent sleep disorders at baseline were excluded. Development of sleep disorders was defined as any inpatient or outpatient diagnosis of sleep apnea, hypersomnia, insomnia, or sleep-related movement disorders based on ICD-9 codes after the first TBI diagnosis or the random selection date for those without TBI. We restricted the analysis to those with at least 1 year of follow-up. We used Cox proportional hazards models to examine the association between TBI and subsequent risk of sleep disorders. Results The study included 98,709 veterans with TBI and 98,709 age-matched veterans without TBI (age 49 +/- 20 years). After an average follow-up of 5 (1-14) years, 23,127 (19.6%) veterans developed sleep disorders. After adjustment for demographics, education, income, and medical and psychiatric conditions, those who had TBI compared to those without TBI were 41% more likely to develop any sleep disorders (hazard ratio 1.41 [95% confidence interval 1.37-1.44]), including sleep apnea (1.28 [1.24-1.32]), insomnia (1.50 [1.45-1.55]), hypersomnia (1.50 [1.39-1.61]), and sleep-related movement disorders (1.33 [1.16-1.52]). The association was stronger for mild TBIs, did not differ appreciably by presence of posttraumatic stress disorder, and remained after a 2-year time lag. Conclusion In 197,418 veterans without sleep disorders, those with diagnosed TBI had an increased risk of incident sleep disorders over 14 years. Improved prevention and long-term management strategies for sleep are needed for veterans with TBI.	[Leng, Yue; Byers, Amy L.; Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Byers, Amy L.; Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Byers, Amy L.; Barnes, Deborah E.; Peltz, Carrie B.; Li, Yixia; Yaffe, Kristine] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA		Leng, Y; Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Yaffe, K (corresponding author), San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA.	yue.leng@ucsf.edu; kristine.yaffe@ucsf.edu			US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans Affairs Chronic Effects of Neurotrauma ConsortiumUS Department of Veterans Affairs [W81XWH-13-2-0095]; National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1K99AG056598]; Global Brain Health Institute; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Society [GBHI ALZ UK-19-591,141]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155]; US Army Medical Research Acquisition Activity, Fort Detrick	This material is based on work supported by the US Army Medical Research and Material Command and the US Department of Veterans Affairs Chronic Effects of Neurotrauma Consortiumunder awardW81XWH-13-2-0095. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the US government or the US Department of Veterans Affairs, and no official endorsement should be inferred. Dr. Leng is supported by the National Institute on Aging (NIA) (1K99AG056598) and received funding from the Global Brain Health Institute, Alzheimer's Association, and Alzheimer's Society (GBHI ALZ UK-19-591,141). Support was provided by NIA grant K24AG031155 awarded to Dr. Yaffe.	Al-Ameri LT, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9010010; Albrecht JS, 2020, INT REV PSYCHIATR, V32, P31, DOI 10.1080/09540261.2019.1656176; Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, P178, DOI 10.1097/HTR.0000000000000266; Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; Armed Forces Health Surveillance Branch, SURV CAS DEF; Armed Forces Health Surveillance Center (AFHSC), 2013, MSMR, V20, P9; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; CROMPTON MR, 1971, LANCET, V1, P669; DelRosso LM, 2014, J CLIN SLEEP MED, V10, P443, DOI 10.5664/jcsm.3628; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Malkki Hemi, 2016, Nat Rev Neurol, V12, P312, DOI 10.1038/nrneurol.2016.72; Mantua J, 2018, SLEEP MED REV, V41, P61, DOI 10.1016/j.smrv.2018.01.004; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McKeon AB, 2019, NEUROREHABILITATION, V45, P163, DOI 10.3233/NRE-192804; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Stonesifer LD, 2008, NEW ENGL J MED, V358, P2178; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w	48	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 30	2021	96	13					E1792	E1799		10.1212/WNL.0000000000011656			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SL0VO	WOS:000656634600025	33658328	Green Published			2022-02-06	
J	Ma, YW; Liu, YH; Ruan, XL; Liu, XB; Zheng, J; Teng, H; Shao, LQ; Yang, CQ; Wang, D; Xue, YX				Ma, Yawen; Liu, Yunhui; Ruan, Xuelei; Liu, Xiaobai; Zheng, Jian; Teng, Hao; Shao, Lianqi; Yang, Chunqing; Wang, Di; Xue, Yixue			Gene Expression Signature of Traumatic Brain Injury	FRONTIERS IN GENETICS			English	Article						traumatic brain injury; biomarkers; neuroimmunology; bioinformatics; signature genes		Background: Traumatic brain injury (TBI) is a brain function change caused by external forces, which is one of the main causes of death and disability worldwide. The aim of this study was to identify early diagnostic markers and potential therapeutic targets for TBI. Methods: Differences between TBI and controls in GSE89866 and GSE104687 were analyzed. The two groups of differentially expressed genes (DEGs) were combined for coexpression analysis, and the modules of interest were performed using enrichment analysis. Hub genes were identified by calculating area under curve (AUC) values of module genes, PPI network analysis, and functional similarity. Finally, the difference in immune cell infiltration between TBI and control was calculated by ssGSEA. Results: A total of 4,817 DEGs were identified in GSE89866 and 1,329 DEGs in GSE104687. They were clustered into nine modules. The genes of modules 1, 4, and 7 had the most crosstalk and were identified as important modules. Enrichment analysis revealed that they were mainly associated with neurodevelopment and immune inflammation. In the PPI network constructed by genes with top 50 AUC values in module genes, we identified the top 10 genes with the greatest connectivity. Among them, down-regulated RPL27, RPS4X, RPL23A, RPS15A, and RPL7A had similar functions and were identified as hub genes. In addition, DC and Tem were significantly up-regulated and down-regulated between TBI and control, respectively. Conclusion: We found that hub genes may have a diagnostic role for TBI. Molecular dysregulation mechanisms of TBI are associated with neurological and immune inflammation. These results may provide new ideas for the diagnosis and treatment of TBI.	[Ma, Yawen; Ruan, Xuelei; Shao, Lianqi; Xue, Yixue] China Med Univ, Sch Life Sci, Dept Neurobiol, Shenyang, Peoples R China; [Ma, Yawen; Liu, Yunhui; Liu, Xiaobai; Zheng, Jian; Teng, Hao; Yang, Chunqing; Wang, Di] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China; [Ma, Yawen; Liu, Yunhui; Ruan, Xuelei; Liu, Xiaobai; Zheng, Jian; Teng, Hao; Shao, Lianqi; Yang, Chunqing; Wang, Di; Xue, Yixue] Key Lab Neurooncol Liaoning Prov, Shenyang, Peoples R China		Xue, YX (corresponding author), China Med Univ, Sch Life Sci, Dept Neurobiol, Shenyang, Peoples R China.; Xue, YX (corresponding author), Key Lab Neurooncol Liaoning Prov, Shenyang, Peoples R China.	xugangyi7186@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81872503, 81802514, 81802507]	This work was supported by grants from the Natural Science Foundation of China (81872503, 81802514, and 81802507).	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Castranio EL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0569-2; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Royes LFF, 2019, NEUROSCI BIOBEHAV R, V102, P345, DOI 10.1016/j.neubiorev.2019.05.012; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gu C, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165921; Gu C, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2020.140444; Harper MM, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03374; Hildebrand F, 2006, AM J PATHOL, V169, P784, DOI 10.2353/ajpath.2006.060010; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin HY, 2018, EBIOMEDICINE, V27, P71, DOI 10.1016/j.ebiom.2017.10.033; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mayer AR, 2019, NEUROSCI BIOBEHAV R, V104, P160, DOI 10.1016/j.neubiorev.2019.06.024; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rana A, 2019, CURR NEUROPHARMACOL, V17, P614, DOI 10.2174/1570159X16666180911121847; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Shi X, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00559; Shi X, 2018, EBIOMEDICINE, V38, P217, DOI 10.1016/j.ebiom.2018.11.008; Shigemizu D, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00654-x; Sulima SO, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030229; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	43	1	1	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-8021		FRONT GENET	Front. Genet.	MAR 30	2021	12								646436	10.3389/fgene.2021.646436			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM1KI	WOS:000639418700001	33859672	gold, Green Published			2022-02-06	
J	Mumtaz, S; Cymerman, J; Komath, D				Mumtaz, Shadaab; Cymerman, James; Komath, Deepak			Cycling-Related Injuries During COVID-19 Lockdown: A North London Experience	CRANIOMAXILLOFACIAL TRAUMA & RECONSTRUCTION			English	Article; Early Access						trauma; cycling; helmet; COVID-19; lockdown; facial injuries; head injury	BICYCLE; TRAUMA	Objectives: There has been a notable surge in cycling injuries during the COVID-19(SARS-CoV-2 virus) pandemic. Cycling in general increased during lockdown as a leisure & fitness activity along with reduction in the use of public transport for commuting. We investigated the bicycle-related maxillofacial injuries & associations presenting through our emergency department(ED) which covers more than 1.6 million of London population. Study Design/Methods: A retrospective observational study was undertaken in the Barnet General Hospital ("hub") which receives all maxillofacial referrals from 6 "spoke" hospitals & other urgent primary/community care practices in North London area between 16 March 2020 & 16 July 2020. All data corresponding to cycling injuries during the lockdown period was analyzed wih the aid of trauma database/trust-wide electronic patient records. Results: Twenty-two patients (6.7%) with cycling-related injuries out of a total of 322 patients who attended during the 4 months study period with maxillofacial emergencies were identified. Average age of patient cohort was 35.4 years, mainly consisting of adult males (77%). Seven patients had minor head injury and 1 patient suffered traumatic brain injury. About 59% patients did not wear a protective helmet & 3 patients had heavy alcohol/recreational drug intoxication during the accidents. Four patients needed inpatient admission and treatment under general anesthesia. Conclusions: Based on our humble study, we advocate the need for robust road & personal safety measures with mandatory government legislations, policing of drug intoxication & encouragement of physical & mental health improvement measures during these unprecedented times & beyond.	[Mumtaz, Shadaab; Cymerman, James; Komath, Deepak] Royal Free London Fdn Trust, Dept Oral & Maxillofacial Surg, London, England		Mumtaz, S (corresponding author), Royal Free London NHS Fdn Trust, Dept Oral & Maxillofacial Surg, London NW3 2QG, England.	shadaab@me.com	Mumtaz, Shadaab/T-5880-2019	Mumtaz, Shadaab/0000-0003-1916-5924			Airaksinen NK, 2018, INJURY, V49, P945, DOI 10.1016/j.injury.2018.03.002; Boffano P, 2013, OR SURG OR MED OR PA, V116, P275, DOI 10.1016/j.oooo.2013.03.004; BONER C, 2014, J SAFETY RES, V51, P15; Bram JT, 2020, J PEDIATR ORTHOPED, V40, P373, DOI 10.1097/BPO.0000000000001600; Broe MP, 2018, SURG-J R COLL SURG E, V16, P202, DOI 10.1016/j.surge.2017.07.004; Cook R, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m453; Department for Transport, 2019, REP ROAD CAS GREAT B REP ROAD CAS GREAT B; Ding HL, 2020, ACCIDENT ANAL PREV, V144, DOI 10.1016/j.aap.2020.105652; Dinu M, 2019, SPORTS MED, V49, P437, DOI 10.1007/s40279-018-1023-0; Embree TE, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0282; Esmaeilikia M, 2018, J AUSTRALAS COLL ROA, V29, P30; Fitzpatrick DG, 2018, INT J ORAL MAX SURG, V47, P1121, DOI 10.1016/j.ijom.2018.03.005; Goodman A, 2014, J TRANSP HEALTH, V1, P5, DOI 10.1016/j.jth.2013.07.001; Gross I, 2018, J EMERG MED, V54, P793, DOI 10.1016/j.jemermed.2017.12.012; Highway Code, 2015, RULES CYCLISTS; Hoye A, 2018, ACCIDENT ANAL PREV, V120, P239, DOI 10.1016/j.aap.2018.08.001; Klemmer K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209090; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Olding J., 2020, SURG-J R COLL SURG E, V19; Olivier J, 2019, INT J EPIDEMIOL, V48, P1197, DOI 10.1093/ije/dyz003; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Patterson R, 2020, LANCET PLANET HEALTH, V4, pE186, DOI 10.1016/S2542-5196(20)30079-6; Scott LR, 2019, BRAIN INJURY, V33, P1597, DOI 10.1080/02699052.2019.1650201; Stier R, 2019, INT J ORAL MAX SURG, V48, P1235, DOI 10.1016/j.ijom.2019.02.018; Strotmeyer SJ, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-020-00249-y; Transport for London TfL, 2019, TRAVEL LONDON REPORT; Welsh C, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m336; Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425	28	1	1	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1943-3875	1943-3883		CRANIOMAX TRAUM REC	Craniomaxillofacial Trauma Reconstr.											19433875211007008	10.1177/19433875211007008		MAR 2021	5	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	RH8EQ	WOS:000636445100001					2022-02-06	
J	Selveindran, SM; Samarutilake, GDN; Rao, KMN; Pattisapu, JV; Hill, C; Kolias, AG; Pathi, R; Hutchinson, PJA; Sekhar, MVV				Selveindran, Santhani M.; Samarutilake, Gurusinghe D. N.; Rao, K. Madhu Narayana; Pattisapu, Jogi, V; Hill, Christine; Kolias, Angelos G.; Pathi, Rajesh; Hutchinson, Peter J. A.; Sekhar, M. V. Vijaya			An exploratory qualitative study of the prevention of road traffic collisions and neurotrauma in India: perspectives from key informants in an Indian industrial city (Visakhapatnam)	BMC PUBLIC HEALTH			English	Article						Road traffic collisions prevention; Neurotrauma prevention; India; Key informant perspectives	HELMET USE; FRAMEWORK ANALYSIS; SAFETY; NEUROSURGERY; HYDERABAD; ACCIDENTS; CAPACITY; CARE	Background Despite current preventative strategies, road traffic collisions (RTCs) and resultant neurotrauma remain a major problem in India. This study seeks to explore local perspectives in the context within which RTCs take place and identify potential suggestions for improving the current status. Methods Ten semi-structured interviews were carried out with purposively selected key informants from the city of Visakhapatnam, Andhra Pradesh. Participants were from one of the following categories: commissioning stakeholders; service providers; community or local patient group/advocacy group representatives. Transcripts from these interviews were analysed qualitatively using the Framework Method. Results Participants felt RTCs are a serious problem in India and a leading cause of neurotrauma. Major risk factors identified related to user behaviour such as speeding and not using personal safety equipment, and the user state, namely drink driving and underage driving. Other reported risk factors included poor infrastructure, moving obstacles on the road such as other vehicles, pedestrians and animals, overloaded vehicles and substandard safety equipment. Participants discussed how RTCs affect not only the health of the casualty, but are also a burden to the healthcare system, families, and the national economy. Although there are ongoing preventative strategies being carried out by both the government and the community, challenges to successful prevention emerged from the interviews which included resource deficiencies, inconsistent implementation, lack of appropriate action, poor governance, lack of knowledge and the mindset of the community and entities involved in prevention. Recommendations were given on how prevention of RTCs and neurotrauma might be improved, addressing the areas of education and awareness, research, the pre-hospital and trauma systems, enforcement and legislation, and road engineering, in addition to building collaborations and changing mindsets. Conclusions RTCs remain a major problem in India and a significant cause of neurotrauma. Addressing the identified gaps and shortfalls in current approaches and reinforcing collective responsibility towards road safety would be the way forward in improving prevention and reducing the burden.	[Selveindran, Santhani M.; Kolias, Angelos G.; Hutchinson, Peter J. A.] Cambridge Univ Hosp Trust, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England; [Selveindran, Santhani M.; Rao, K. Madhu Narayana; Hill, Christine; Kolias, Angelos G.; Hutchinson, Peter J. A.; Sekhar, M. V. Vijaya] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Samarutilake, Gurusinghe D. N.] Minist Hlth, Colombo, Sri Lanka; [Rao, K. Madhu Narayana; Pathi, Rajesh; Sekhar, M. V. Vijaya] King George Hosp, Dept Neurosurg, Visakhapatnam, Andhra Pradesh, India; [Pattisapu, Jogi, V] Univ Cent Florida, Dept Pediat Neurosurg, Coll Med, Orlando, FL 32816 USA; [Hill, Christine] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England		Selveindran, SM (corresponding author), Cambridge Univ Hosp Trust, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England.; Selveindran, SM (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	ss2604@medschl.cam.ac.uk			National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [RG89187]; UK Government	This research was commissioned by the National Institute for Health Research (NIHR) (Grant Number: RG89187) using UK aid from the UK Government. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.	Ackaah W, 2013, INJURY PREV, V19, P158, DOI 10.1136/injuryprev-2012-040348; Agrawal KP., 2016, DELHI ROLE MODEL U 1, P310; Ahmed I., 2013, ROAD INFRASTRUCTURE; Anup Kharde, 2018, International Journal of Medical Science and Public Health, V7, P969; Astbury NM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238645; Babhulkar S, 2019, OTA INT, V2; Balguri DS., 2019, CITY REPORT VISAKHAP; Bandyopadhyay S, 2020, FRONT SUSTAIN, V2, DOI [10.3389/frsc.2020.00010, DOI 10.3389/FRSC.2020.00010]; Bhavaraju SR, 2018, NEUROL INDIA, V66, P1133, DOI 10.4103/0028-3886.236967; BOEVER F, 1948, ARCH INT PHARMACOD T, V77, P1; Bora B, 2018, CURR SCI INDIA, V114, P1275, DOI 10.18520/cs/v114/i06/1275-1283; Bright T, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102165; Dandona R, 2020, LANCET PUBLIC HEALTH, V5, pE86, DOI 10.1016/S2468-2667(19)30246-4; Deme D., 2019, GLOB J APPL SCI TECH, V1, P103; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dewan MC, 2019, J NEUROSURG, V130, P1065, DOI 10.3171/2017.10.JNS17439; Directorate of Urban Land Transport Government of Karnataka, 2007, GUID ROAD SAF AUD; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Ganapathy K, 2015, NEUROL INDIA, V63, P142, DOI 10.4103/0028-3886.156274; Goel R, 2018, ACCIDENT ANAL PREV, V112, P105, DOI 10.1016/j.aap.2017.12.019; Gopalakrishnan S, 2012, J Family Med Prim Care, V1, P144, DOI 10.4103/2249-4863.104987; Gorea R., 2016, INT J ETHICS TRAUMA, V2, P6, DOI [10.18099/ijetv.v2i1.11129, DOI 10.18099/IJETV.V2I1.11129]; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gururaj G., 2017, BENGALARU NATL I MEN, V137; Hadaye RS, 2020, J FAM MED PRIM CARE, V9, P168, DOI 10.4103/jfmpc.jfmpc_904_19; Heydari S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226249; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; International Labour Organization and National Rural Roads Development Agency, 2015, MANAGING MAINTENANCE; Isaacs A. N., 2014, International Journal of Medicine and Public Health, V4, P318, DOI 10.4103/2230-8598.144055; Islam MI., 2019, INT J ENG MANAG RES, V9, DOI [10.31033/ijemr.9.5.23, DOI 10.31033/IJEMR.9.5.23]; Jacoby SF, 2017, INT J INJ CONTROL SA, V24, P493, DOI 10.1080/17457300.2016.1278235; Jimenez A, 2015, J SAFETY RES, V52, P29, DOI 10.1016/j.jsr.2014.12.005; Joint Working Group on Road Safety, 2020, ROAD SAF IND JOINT W; Karuppanagounder K, 2016, TRAFFIC INJ PREV, V17, P292, DOI 10.1080/15389588.2015.1055736; Kaul VK., 2015, WORLD AFFAIRS J INT, V19, P10; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Kirankumar MR., 2019, J CLIN SCI RES, V8, P132, DOI [10.4103/JCSR.JCSR_65_19, DOI 10.4103/JCSR.JCSR_65_19]; Kolawole, 2017, TRANSP LOGIST INT J, V17, P40; KPMG and Confederation of Indian Industries, 2019, ROADS HIGHW SECT CUR; Kumar A, 2019, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-019-4778-6; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marchini S, 2020, AMBIO, V49, P912, DOI 10.1007/s13280-019-01230-w; Mathur AK, 2017, J HEALTH MANAG, V19, P417, DOI 10.1177/0972063417717894; McKenna SA, 2013, ACTION RES-LONDON, V11, P113, DOI 10.1177/1476750312473342; Merali H., 2019, J GLOB HEALTH, DOI [10.7916/thejgh.v9i1.4952, DOI 10.7916/THEJGH.V9I1.4952]; Milakovich Jess, 2018, J Health Dispar Res Pract, V11, P115; Ministry of Law and Justice, 2019, MOT VEH AM ACT; Ministry of Road Transport and Highways, 2019, ROAD ACC IND 2018; Ministry of Road Transport and Highways, 2011, REP WORK GROUP 4ES R; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; Mohan G., 2011, STATE SECURITY COMMI; Mony Premkumar, 2002, Inj Control Saf Promot, V9, P137, DOI 10.1076/icsp.9.2.137.8700; Municipal Administration and Urban Development Department, 2016, DET ROADS EACH ULB A, DOI [1101300/http:/centralapp.cdma.ap.gov.in:8080/CDMAAPTaxesInfo/RoadDetails.jsp, DOI 1101300/HTTP:/CENTRALAPP.CDMA.AP.GOV.IN:8080/CDMAAPTAXESINFO/ROADDETAILS.JSP]; Murad MK, 2010, PREHOSP DISASTER MED, V25, P533, DOI 10.1017/S1049023X00008724; Njau B, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08651-3; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Oluwadiya KS, 2009, ACCIDENT ANAL PREV, V41, P294, DOI 10.1016/j.aap.2008.12.002; Pal R, 2019, J FAM MED PRIM CARE, V8, P775, DOI 10.4103/jfmpc.jfmpc_214_18; Parkinson S, 2016, QUAL RES PSYCHOL, V13, P109, DOI 10.1080/14780887.2015.1119228; Parsons JA., 2019, ENCY SURVEY RES METH, P406; Patel CR, 2012, PROCD SOC BEHV, V48, P527, DOI 10.1016/j.sbspro.2012.06.1031; PRS Legislative Research, 2017, VIT STAT OV ROAD ACC; Rahman, 2004, INVOLVEMENT IMPACT R; Raj A, 2018, INT J ACAD MED, V4, P89, DOI 10.4103/IJAM.IJAM_67_17; Ram Kodanda, 2019, World Neurosurg X, V2, P100020, DOI 10.1016/j.wnsx.2019.100020; Roberts H, 1997, ARCH DIS CHILD, V76, P487, DOI 10.1136/adc.76.6.487; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sharma M, 2014, PREHOSP DISASTER MED, V29, P307, DOI 10.1017/S1049023X14000296; Shrivastava SR, 2014, J NEUROSCI RURAL PRA, V5, pS33, DOI 10.4103/0976-3147.145198; Singh S., 2019, INT RES J ENG TECHNO, V6, P3324; Singh S, 2017, NDTV; Singh SK, 2017, TRANSP RES PROC, V25, DOI 10.1016/j.trpro.2017.05.484; Sleet DA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091921; Sorate RR, 2015, INT J RES ADVENT TEC, V12, P82; Sreedharan Jayadevan, 2010, J Inj Violence Res, V2, P49, DOI 10.5249/jivr.v2i1.26; Srinivasa Kumar PV., 2013, INT J RES HLTH SCI, V1, P80; Srivastava A., 2009, J ADM GOVERNANCE, P72; Tetali S, 2013, INJURY, V44, pS17, DOI 10.1016/S0020-1383(13)70208-0; Tropeano MP, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19507; Verster T, 2018, S AFR J SCI, V114, P63, DOI 10.17159/sajs.2018/20170427; Wadhwaniya S, 2017, PUBLIC HEALTH, V144, pS62, DOI 10.1016/j.puhe.2016.11.025; Ward DJ, 2013, J ADV NURS, V69, P2423, DOI 10.1111/jan.12127; WHO, 2004, WORLD REPORT ROAD TR; Witcher CSG, 2010, INT J QUAL METH, V9, P122, DOI 10.1177/160940691000900201; World Health Organisation, 2018, GLOB STAT REP ROAD S; World Health Organisation, 2017, SAV LIVES A ROAD SAF; World Health Organisation and Centers for Disease Control, 1995, STAND SURV NEUR; Zahiuddin, 2018, INT J CLIN BIOMEDICA, V4, P36, DOI [10.31878/ijcbr.2018.44.08, DOI 10.31878/IJCBR.2018.44.08]; Zeedyk MS, 2003, HEALTH EDUC RES, V18, P493, DOI 10.1093/her/cyf033	89	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	MAR 30	2021	21	1							618	10.1186/s12889-021-10686-z			19	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	RH5NC	WOS:000636264200002	33785012	Green Published, gold			2022-02-06	
J	Oyesanya, TO; Harris, G; Yang, Q; Byom, L; Cary, MP; Zhao, AT; Bettger, JP				Oyesanya, Tolu O.; Harris, Gabrielle; Yang, Qing; Byom, Lindsey; Cary, Michael P., Jr.; Zhao, Amy T.; Bettger, Janet Prvu			Inpatient rehabilitation facility discharge destination among younger adults with traumatic brain injury: differences by race and ethnicity	BRAIN INJURY			English	Article						[MeSH]; Brain Injuries; traumatic; rehabilitation; race Factors; patient Discharge; health Care Facilities; manpower; Services; outcome Assessment; Health Care		Objective : To determine the association of race and ethnicity with discharge destination among patients with traumatic brain injury (TBI) receiving inpatient rehabilitation facility (IRF) care. Design Secondary analysis using Uniform Data System for Medical Rehabilitation data. Methods : Patients (N = 99,614) diagnosed with TBI, age 18-64, admitted for IRF care between 2002 and 2018. Logistic regression was used to analyze data. Outcome : Discharge destination (home/community vs. subacute settings). Results : Most younger adults (age 18-64) with TBI were discharged home (89.24%) after IRF care vs. subacute (10.76%). Of those discharged home, 63.16% were white, 10.42% Black, 8.94% Hispanic/Latino, and 6.72% other races/ethnicities. After adjusting for covariates, patients who were Hispanic/Latino [OR = 1.26; 95% CI: 1.15, 1.37] and other race/ethnicities [OR = 1.10; 95% CI: 1.00, 1.21] (vs. White) had higher odds of discharge home vs. subacute. There was no difference in discharge destination for Black patients (vs. white). Predictors of discharge destination for groups stratified by race/ethnicity varied. Conclusions : Younger patients with TBI who were Hispanic/Latino or other races/ethnicities (vs. white) were more likely to go home vs. subacute. Findings can be used to inform IRF planning, resource allocation, and transitional care planning.	[Oyesanya, Tolu O.; Harris, Gabrielle; Yang, Qing; Cary, Michael P., Jr.; Zhao, Amy T.; Bettger, Janet Prvu] Duke Univ, Sch Nursing, 307 Trent Dr, Durham, NC 27710 USA; [Byom, Lindsey] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC 27515 USA; [Bettger, Janet Prvu] Duke Univ, Dept Orthoped, Sch Med, Durham, NC 27710 USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, 307 Trent Dr, Durham, NC 27710 USA.	tolu.oyesanya@duke.edu	Byom, Lindsey/AAC-5095-2019	Byom, Lindsey/0000-0002-2457-1735; Walker, Gabrielle/0000-0002-8977-3696; Oyesanya, Tolu/0000-0001-8821-4510; Yang, Qing/0000-0003-4844-4690	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P2CHD065702, U54MD012530]	This research was funded by the National Institutes of Health, Grant #P2CHD065702, PI Ottenbacher and Grant #U54MD012530; PI, Johnson, Investigator, Oyesanya	Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Boyd R, 2020, RACISM NEW STANDARD, DOI [DOI 10.1377/HBLOG20200630.939347, 10.1377/hblog2020063 0.939347/full/, DOI 10.1377/HBLOG20200630.939347/FULL]; Brickell TA, 2019, REHABIL PSYCHOL, V64, P307, DOI 10.1037/rep0000272; Brickell TA, 2018, BRAIN INJURY, V32, P1541, DOI 10.1080/02699052.2018.1503328; Brooks RT, 2017, J BLACK STUD, V48, DOI 10.1177/0021934717728454; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Burnett DM, 2000, BRAIN INJURY, V14, P713; C, 2020, MANAGEMENT SEVERE TR, P547; Callender L., 2017, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2017, TBI DAT STAT; Chan V, 2016, ARCH PHYS MED REHAB, V97, P772, DOI 10.1016/j.apmr.2016.01.011; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS1, DOI 10.1016/j.apmr.2017.04.013; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Glover LM, 2017, ETHNIC DIS, V27, P209, DOI 10.18865/ed.27.3.209; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Graham JE, 2018, ARCH PHYS MED REHAB, V99, P198, DOI 10.1016/j.apmr.2017.06.026; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Gujral IB, 2006, BRAIN INJURY, V20, P283, DOI 10.1080/02699050500488058; Haines KL, 2019, J SURG RES, V235, P131, DOI 10.1016/j.jss.2018.09.072; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; Hassan A, 2017, AM SURGEON, V83, P541; Janus TJ, 2013, J TRAUMA NURS, V20, P102, DOI 10.1097/JTN.0b013e318296003a; Johnson LW., 2020, CASES COMMUNICATION; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; Kersey J, 2019, J HEAD TRAUMA REHAB, V34, pE32, DOI 10.1097/HTR.0000000000000442; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Liu C, 2004, CLIN REHABIL, V18, P398, DOI 10.1191/0269215504cr741oa; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Odgaard L., 2016, J HEAD TRAUMA REHAB; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Ram P, 2020, CRIT CARE MED, V48, P31, DOI 10.1097/CCM.0000000000004043; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Taylor DM, 2018, NEPHROL DIAL TRANSPL, V33, P1545, DOI 10.1093/ndt/gfx293; Tozser T., 2018, ADV NEURODEV DISORD, V2, DOI [10.1007/s41252-018-0071-7, DOI 10.1007/S41252-018-0071-7]; Uniform Data System for Medical Rehabilitation, 2017, UDSPRO SYST; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; WAGNER A, 2000, J TRAUMA, V49	55	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					661	674		10.1080/02699052.2021.1895317		MAR 2021	14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000634123700001	33779428				2022-02-06	
J	Kant, A; Medhekar, NV; Bhandakkar, TK				Kant, Aayush; Medhekar, Nikhil V.; Bhandakkar, Tanmay K.			Spatial calcium kinetics after a traumatic brain injury	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Traumatic brain injury; Calcium kinetics; Finite element method		Accurate modelling of intracellular calcium ion ( Ca2+) concentration evolution is valuable as it is known to rapidly increase during a Traumatic Brain Injury. In the work presented here, our older non-spatial model dealing with the effect of mechanical stress upon the Ca2+ transportation in a neuron is spatialized by considering the brain tissue as a solid continuum with the Ca2+ activity occurring at every material point. Starting with one-dimensional representation, the brain tissue geometry is progressively made realistic and under the action of pressure or kinematic impulses, the effect of dimensionality and material behaviour on the correlation between the stress and concomitant Ca2+ concentration is investigated. The spatial calcium kinetics model faithfully captures the experimental observations concerning the Ca2+ concentration, load rate, magnitude and duration and most importantly shows that the critical location for primary injury may not be the most important location as far as secondary injury is concerned.	[Kant, Aayush; Medhekar, Nikhil V.] Monash Univ, Dept Mat Sci & Engn, Clayton, Vic 3800, Australia; [Kant, Aayush; Bhandakkar, Tanmay K.] Indian Inst Technol, Dept Mech Engn, Mumbai 400076, Maharashtra, India; [Kant, Aayush] Indian Inst Technol, IITB Monash Res Acad, Mumbai 400706, Maharashtra, India		Bhandakkar, TK (corresponding author), Indian Inst Technol, Dept Mech Engn, Mumbai 400076, Maharashtra, India.	aayush.kant@iitb.ac.in; nikhil.medhekar@monash.edu; tbhanda2@iitb.ac.in	Medhekar, Nikhil/B-3986-2008	Medhekar, Nikhil/0000-0003-3124-4430; Bhandakkar, Tanmay/0000-0001-8053-7702			Anderson RWG, 2000, THESIS; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Baker HL, 2002, BIOPHYS J, V82, P582, DOI 10.1016/S0006-3495(02)75423-4; Bandak F, 2001, P INT TECHN C ENH SA, P7; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chinn B, 1997, TECH REP SAE TECHNIC; Christensen R., 2012, THEORY VISCOELASTICI; COMSOL Multiphysics Reference Manual, 2019, COMS MULT, P1260; Coronado V, 2010, NATL CTR INJURY PREV, P2002; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Vilaca LMD, 2020, APPL MATH MODEL, V84, P425, DOI 10.1016/j.apm.2020.04.014; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Franklyn Melanie, 2005, Stapp Car Crash J, V49, P1; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Geddes DM, 2001, J BIOMECH ENG-T ASME, V123, P247, DOI 10.1115/1.1374201; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Janicki MA, 1984, TECH REP SAE TECHNIC; Jog CS., 2015, CONTINUUM MECH, DOI [10.1017/CBO9781316134054, DOI 10.1017/CBO9781316134054]; Kant A, 2018, BIOMECH MODEL MECHAN, V17, P169, DOI 10.1007/s10237-017-0952-0; KASS IS, 1986, J PHYSIOL-LONDON, V378, P313, DOI 10.1113/jphysiol.1986.sp016221; Kilinc D, 2008, THESIS DREXEL U; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Knowles BM, 2017, J BIOMECH, V59, P59, DOI 10.1016/j.jbiomech.2017.05.016; Kowalewski JM, 2006, MATH BIOSCI, V204, P232, DOI 10.1016/j.mbs.2006.03.001; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Misgeld T, 2014, NAT COMMUN, V5; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Pena A, 2005, ACT NEUR S, V95, P333; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	62	1	1	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	AUG	2021	20	4					1413	1430		10.1007/s10237-021-01453-5		MAR 2021	18	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	TR1WT	WOS:000633753800001	33772677				2022-02-06	
J	Park, E; Lyon, JG; Alvarado-Velez, M; Betancur, MI; Mokarram, N; Shin, JH; Bellamkonda, RV				Park, Eunyoung; Lyon, Johnathan G.; Alvarado-Velez, Melissa; Betancur, Martha I.; Mokarram, Nassir; Shin, Jennifer H.; Bellamkonda, Ravi V.			Enriching neural stem cell and anti-inflammatory glial phenotypes with electrical stimulation after traumatic brain injury in male rats	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						astrocyte; electrical stimulation; microglia; neural stem cell; RRID; AB_10013382; RRID; AB_10893200; RRID; AB_1523910; RRID; AB_2282664; RRID; AB_2291300; RRID; AB_2571567; RRID; AB_2650601; RRID; AB_2734747; RRID; AB_312800; RRID; RGD_734476; RRID; SCR_002285; RRID; SCR_002798; RRID; SCR_008520; traumatic brain injury		Traumatic brain injury (TBI) by an external physical impact results in compromised brain function via undesired neuronal death. Following the injury, resident and peripheral immune cells, astrocytes, and neural stem cells (NSCs) cooperatively contribute to the recovery of the neuronal function after TBI. However, excessive pro-inflammatory responses of immune cells, and the disappearance of endogenous NSCs at the injury site during the acute phase of TBI, can exacerbate TBI progression leading to incomplete healing. Therefore, positive outcomes may depend on early interventions to control the injury-associated cellular milieu in the early phase of injury. Here, we explore electrical stimulation (ES) of the injury site in a rodent model (male Sprague-Dawley rats) to investigate its overall effect on the constituent brain cell phenotype and composition during the acute phase of TBI. Our data showed that a brief ES for 1 hr on day 2 of TBI promoted anti-inflammatory phenotypes of microglia as assessed by CD206 expression and increased the population of NSCs and Nestin(+) astrocytes at 7 days post-TBI. Also, ES effectively increased the number of viable neurons when compared to the unstimulated control group. Given the salience of microglia and neural stem cells for healing after TBI, our results strongly support the potential benefit of the therapeutic use of ES during the acute phase of TBI to regulate neuroinflammation and to enhance neuroregeneration.	[Park, Eunyoung; Shin, Jennifer H.] Korea Adv Inst Sci & Technol, Dept Mech Engn, 291 Daehak Ro, Daejeon 34141, South Korea; [Lyon, Johnathan G.; Betancur, Martha I.; Mokarram, Nassir; Bellamkonda, Ravi V.] Duke Univ, Pratt Sch Engn, Dept Biomed Engn, 305 Teer Bldg,Box 90271, Durham, NC 27708 USA; [Alvarado-Velez, Melissa] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA		Shin, JH (corresponding author), Korea Adv Inst Sci & Technol, Dept Mech Engn, 291 Daehak Ro, Daejeon 34141, South Korea.; Bellamkonda, RV (corresponding author), Duke Univ, Pratt Sch Engn, Dept Biomed Engn, 305 Teer Bldg,Box 90271, Durham, NC 27708 USA.	j_shin@kaist.ac.kr; ravi@duke.edu		Lyon, Johnathan/0000-0002-0926-231X	KAIST; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079739-05]	KAIST-funded Global Singularity Research Program 2020; National Institute of Neurological Disorders and Stroke, Grant/Award Number: R01NS079739-05	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Chen C, 2019, BIOMATER RES, V23, DOI 10.1186/s40824-019-0176-8; Choi JY, 2017, EXP NEUROBIOL, V26, P33, DOI 10.5607/en.2017.26.1.33; Covacu R, 2017, NEUROSCIENTIST, V23, P27, DOI 10.1177/1073858415616559; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Gabel S, 2016, MOL NEUROBIOL, V53, P5041, DOI 10.1007/s12035-015-9428-3; Hahm SC, 2015, NEUROREHAB NEURAL RE, V29, P370, DOI 10.1177/1545968314545172; Hofer AS, 2019, CURR OPIN NEUROL, V32, P828, DOI 10.1097/WCO.0000000000000750; Huang YH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00586; Huffman WJ, 2019, BRAIN STIMUL, V12, P19, DOI 10.1016/j.brs.2018.10.005; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Iwasa SN, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0382-19.2019; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Liu A, 2015, ELIFE, V4, DOI 10.7554/eLife.04803; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lopez-Alvarez VM, 2019, NEUROMODULATION, V22, P509, DOI 10.1111/ner.12927; Mc Lean NA, 2016, GLIA, V64, P1546, DOI 10.1002/glia.23021; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Mokarram N, 2017, P NATL ACAD SCI USA, V114, pE5077, DOI 10.1073/pnas.1705757114; Mokarram N, 2011, IEEE T BIO-MED ENG, V58, P1900, DOI 10.1109/TBME.2010.2103075; Mukhatyar V, 2014, ANN BIOMED ENG, V42, P1436, DOI 10.1007/s10439-013-0960-x; Nakagomi T, 2015, STEM CELLS, V33, P1962, DOI 10.1002/stem.1977; National Center for Injury Prevention and Control (U.S.) , 2003, REPORT C MILD TRAUMA; Otto KJ, 2020, SCIENCE, V367, P1303, DOI 10.1126/science.abb0216; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Posel C, 2016, JOVE-J VIS EXP, DOI 10.3791/53658; Sakuma R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0523-9; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Shimada IS, 2012, J NEUROSCI, V32, P7926, DOI 10.1523/JNEUROSCI.4303-11.2012; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Vay SU, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1261-y; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Xiang Y, 2014, NEURAL REGEN RES, V9, P243, DOI 10.4103/1673-5374.128215; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Zhu R, 2019, EXP NEUROL, V319, DOI 10.1016/j.expneurol.2019.112963; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	45	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2021	99	7					1864	1884		10.1002/jnr.24834		MAR 2021	21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TI0TT	WOS:000633499900001	33772860	hybrid, Green Published, Green Submitted			2022-02-06	
J	Wettervik, TS; Lenell, S; Enblad, P; Lewen, A				Svedung Wettervik, Teodor; Lenell, Samuel; Enblad, Per; Lewen, Anders			Pre-injury antithrombotic agents predict intracranial hemorrhagic progression, but not worse clinical outcome in severe traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Anticoagulants; Antiplatelet; Antithrombotics; Clinical outcome; Hemorrhagic progression; Traumatic brain injury		Background The incidence of traumatic brain injury (TBI) patients of older age with comorbidities, who are pre-injury treated with antithrombotic agents (antiplatelets and/or anticoagulants), has increased. In this study, our aim was to investigate if pre-injury antithrombotic treatment was associated with worse intracranial hemorrhagic/injury progression and clinical outcome in patients with severe TBI. Methods In this retrospective study, including 844 TBI patients treated at our neurointensive care at Uppsala University Hospital, Sweden, 2008-2018, 159 (19%) were pre-injury treated with antithrombotic agents. Demography, admission status, radiology, treatment, and outcome variables were evaluated. Significant intracranial hemorrhagic/injury evolution was defined as hemorrhagic progression seen on the second computed tomography (CT), emergency neurosurgery after the initial CT, or death following the initial CT. Results Patients with pre-injury antithrombotics were significantly older and with a higher Charlson comorbidity index. They were more often injured by falls and more frequently developed acute subdural hematomas. Sixty-eight (8%) patients were pre-injury treated with monotherapy of antiplatelets, 67 (8%) patients with anticoagulants, and 24 (3%) patients with a combination of antithrombotics. Pre-injury anticoagulants, but not antiplatelets, were independently associated with significant intracranial hemorrhagic/injury evolution in a multiple regression analysis. However, neither anticoagulants nor antiplatelets were associated with mortality and unfavorable outcome in multiple regression analyses. Conclusions Only anticoagulants were associated with intracranial hemorrhagic/injury progression, but no antithrombotic agent correlated with worse clinical outcome. Management, including early anticoagulant reversal, availability of emergency neurosurgery, and neurointensive care, may be important aspects for reducing the adverse effects of pre-injury antithrombotics.	[Svedung Wettervik, Teodor; Lenell, Samuel; Enblad, Per; Lewen, Anders] Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se		Svedung Wettervik, Teodor/0000-0002-4556-5721; Lenell, Samuel/0000-0001-8914-5086	Uppsala University; Department of Neuroscience, Uppsala University	Open access funding provided by Uppsala University. The study was funded by the Department of Neuroscience, Uppsala University.	Adelborg K, 2016, HEART, V102, P1883, DOI 10.1136/heartjnl-2016-309402; Barletta JF, 2020, NEUROCRIT CARE, V33, P405, DOI 10.1007/s12028-019-00899-x; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Burger W, 2005, J INTERN MED, V257, P399, DOI 10.1111/j.1365-2796.2005.01477.x; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Dunham CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109473; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Frontera JA, 2016, CRIT CARE MED, V44, P2251, DOI 10.1097/CCM.0000000000002057; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lenell S, 2019, ACTA NEUROCHIR, V161, P1243, DOI 10.1007/s00701-019-03893-6; Lenell S, 2015, ACTA NEUROCHIR, V157, P417, DOI 10.1007/s00701-014-2329-9; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mathieu F, 2020, J NEUROTRAUM, V37, P2069, DOI 10.1089/neu.2019.6911; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Otley CC, 2003, MAYO CLIN PROC, V78, P1392, DOI 10.4065/78.11.1392; Powers AY, 2018, J CRIT CARE, V48, P243, DOI 10.1016/j.jcrc.2018.09.014; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Scotti P, 2020, J NEUROSURG, V133, P486, DOI 10.3171/2019.4.JNS19252; Shin SS, 2020, NEUROCRIT CARE, V32, P407, DOI 10.1007/s12028-019-00898-y; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sumiyoshi K, 2017, BRAIN INJURY, V31, P1445, DOI 10.1080/02699052.2017.1377349; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tollefsen MH, 2018, WORLD NEUROSURG, V114, pE209, DOI 10.1016/j.wneu.2018.02.167; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	40	1	1	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2021	163	5					1403	1413		10.1007/s00701-021-04816-0		MAR 2021	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RO5GJ	WOS:000633286100001	33770261	hybrid, Green Published			2022-02-06	
J	Philippi, CL; Velez, CS; Wade, BSC; Drennon, AM; Cooper, DB; Kennedy, JE; Bowles, AO; Lewis, JD; Reid, MW; York, GE; Newsome, MR; Wilde, EA; Tate, DF				Philippi, Carissa L.; Velez, Carmen S.; Wade, Benjamin S. C.; Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.; Bowles, Amy O.; Lewis, Jeffrey D.; Reid, Matthew W.; York, Gerald E.; Newsome, Mary R.; Wilde, Elisabeth A.; Tate, David F.			Distinct patterns of resting-state connectivity in US service members with mild traumatic brain injury versus posttraumatic stress disorder	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; Posttraumatic stress disorder; Resting-state functional connectivity; Default mode network; Frontoparietal network		Mild traumatic brain injury (mTBI) is highly prevalent in military populations, with many service members suffering from long-term symptoms. Posttraumatic stress disorder (PTSD) often co-occurs with mTBI and predicts worse clinical outcomes. Functional neuroimaging research suggests there are both overlapping and distinct patterns of resting-state functional connectivity (rsFC) in mTBI versus PTSD. However, few studies have directly compared rsFC of cortical networks in military service members with these two conditions. In the present study, U.S. service members (n = 137; ages 19-59; 120 male) underwent resting-state fMRI scans. Participants were divided into three study groups: mTBI only, PTSD only, and orthopedically injured (OI) controls. Analyses investigated group differences in rsFC for cortical networks: default mode (DMN), frontoparietal (FPN), salience, somatosensory, motor, auditory, and visual. Analyses were family-wise error (FWE) cluster-corrected and Bonferroni-corrected for number of network seeds regions at the whole brain level (p(FWE) < 0.002). Both mTBI and PTSD groups had reduced rsFC for DMN and FPN regions compared with OI controls. These group differences were largely driven by diminished connectivity in the PTSD group. rsFC with the middle frontal gyrus of the FPN was increased in mTBI, but decreased in PTSD. Overall, these results suggest that PTSD symptoms may have a more consistent signal than mTBI. Our novel findings of opposite patterns of connectivity with lateral prefrontal cortex highlight a potential biomarker that could be used to differentiate between these conditions.	[Philippi, Carissa L.; Velez, Carmen S.] Univ Missouri St Louis, Dept Psychol Sci, St Louis, MO 63121 USA; [Velez, Carmen S.; Wade, Benjamin S. C.; Wilde, Elisabeth A.; Tate, David F.] Univ Utah, Salt Lake City, UT 84112 USA; [Wade, Benjamin S. C.] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA; [Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.; Reid, Matthew W.] San Antonio VA Polytrauma Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX USA; [Bowles, Amy O.; Lewis, Jeffrey D.] Brooke Army Med Ctr, San Antonio, TX USA; [Bowles, Amy O.; Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [York, Gerald E.] Alaska Radiol Associates, Anchorage, AK USA; [Newsome, Mary R.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Newsome, Mary R.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX USA		Philippi, CL (corresponding author), Univ Missouri St Louis, Dept Psychol Sci, St Louis, MO 63121 USA.; Tate, DF (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	philippic@umsl.edu; David.Tate@hsc.utah.edu		Philippi, Carissa/0000-0003-3741-3661; Wade, Benjamin/0000-0003-2461-6101	Defense and Veterans Brain Injury Centers; U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]	This work was supported in part by the Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Materiel Command (USAMRMC; W81XWH-13-2-0025) and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835).	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P393, DOI 10.1097/HTR.0000000000000378; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carp J, 2012, NEUROIMAGE, V63, P289, DOI 10.1016/j.neuroimage.2012.07.004; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Ciric R, 2017, NEUROIMAGE, V154, P174, DOI 10.1016/j.neuroimage.2017.03.020; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Disner SG, 2018, HUM BRAIN MAPP, V39, P837, DOI 10.1002/hbm.23886; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246; DVBIC, 2018, DOD WORLDW TBI NUMB; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fenster RJ, 2018, NAT REV NEUROSCI, V19, P535, DOI 10.1038/s41583-018-0039-7; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gilmore CS, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.454; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Khazaee A, 2016, BRAIN IMAGING BEHAV, V10, P799, DOI 10.1007/s11682-015-9448-7; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Koch SBJ, 2016, DEPRESS ANXIETY, V33, P592, DOI 10.1002/da.22478; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Miller DR, 2017, BIOL PSYCHIAT-COGN N, V2, P363, DOI 10.1016/j.bpsc.2016.12.006; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Misaki M, 2018, NEUROIMAGE-CLIN, V17, P285, DOI 10.1016/j.nicl.2017.10.032; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mueller-Pfeiffer C, 2013, NEUROIMAGE-CLIN, V3, P531, DOI 10.1016/j.nicl.2013.08.009; Nicholson AA, 2019, PSYCHOL MED, V49, P2049, DOI 10.1017/S0033291718002866; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Olson EA, 2019, BIOL PSYCHIAT-COGN N, V4, P390, DOI 10.1016/j.bpsc.2018.09.012; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Philippi CL, 2015, J NEUROSCI, V35, P6068, DOI 10.1523/JNEUROSCI.5010-14.2015; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raji CA, 2015, BRAIN IMAGING BEHAV, V9, P527, DOI 10.1007/s11682-015-9385-5; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rowland JA, 2017, BRAIN CONNECT, V7, P45, DOI 10.1089/brain.2015.0406; Sacca V, 2019, BRAIN IMAGING BEHAV, V13, P1103, DOI 10.1007/s11682-018-9926-9; Santhanam P, 2019, BRAIN RES, V1711, P77, DOI 10.1016/j.brainres.2019.01.015; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096834; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27131; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu HR, 2014, COMPR PSYCHIAT, V55, P1688, DOI 10.1016/j.comppsych.2014.06.009	73	1	1	1	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2021	15	5					2616	2626		10.1007/s11682-021-00464-1		MAR 2021	11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WE0VC	WOS:000631746100003	33759113				2022-02-06	
J	Attilio, PJ; Snapper, DM; Rusnak, M; Isaac, A; Soltis, AR; Wilkerson, MD; Dalgard, CL; Symes, AJ				Attilio, Peter J.; Snapper, Dustin M.; Rusnak, Milan; Isaac, Akira; Soltis, Anthony R.; Wilkerson, Matthew D.; Dalgard, Clifton L.; Symes, Aviva J.			Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; angiotensin; RNA seq; hippocampus; candesartan; transcriptomic (RNA-Seq)	POSTTRAUMATIC-STRESS-DISORDER; ANXIETY-LIKE BEHAVIOR; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; GENE-EXPRESSION; 1A RECEPTORS; ANG-II; MICROGLIA; SYSTEM; ACTIVATION	Traumatic brain injury (TBI) results in complex pathological reactions, where the initial lesion is followed by secondary inflammation and edema. Our laboratory and others have reported that angiotensin receptor blockers (ARBs) have efficacy in improving recovery from traumatic brain injury in mice. Treatment of mice with a subhypotensive dose of the ARB candesartan results in improved functional recovery, and reduced pathology (lesion volume, inflammation and gliosis). In order to gain a better understanding of the molecular mechanisms through which candesartan improves recovery after controlled cortical impact injury (CCI), we performed transcriptomic profiling on brain regions after injury and drug treatment. We examined RNA expression in the ipsilateral hippocampus, thalamus and hypothalamus at 3 or 29 days post injury (dpi) treated with either candesartan (0.1 mg/kg) or vehicle. RNA was isolated and analyzed by bulk mRNA-seq. Gene expression in injured and/or candesartan treated brain region was compared to that in sham vehicle treated mice in the same brain region to identify genes that were differentially expressed (DEGs) between groups. The most DEGs were expressed in the hippocampus at 3 dpi, and the number of DEGs reduced with distance and time from the lesion. Among pathways that were differentially expressed at 3 dpi after CCI, candesartan treatment altered genes involved in angiogenesis, interferon signaling, extracellular matrix regulation including integrins and chromosome maintenance and DNA replication. At 29 dpi, candesartan treatment reduced the expression of genes involved in the inflammatory response. Some changes in gene expression were confirmed in a separate cohort of animals by qPCR. Fewer DEGs were found in the thalamus, and only one in the hypothalamus at 3 dpi. Additionally, in the hippocampi of sham injured mice, 3 days of candesartan treatment led to the differential expression of 384 genes showing that candesartan in the absence of injury had a powerful impact on gene expression specifically in the hippocampus. Our results suggest that candesartan has broad actions in the brain after injury and affects different processes at acute and chronic times after injury. These data should assist in elucidating the beneficial effect of candesartan on recovery from TBI.	[Attilio, Peter J.; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA; [Attilio, Peter J.; Snapper, Dustin M.; Rusnak, Milan; Isaac, Akira; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA; [Soltis, Anthony R.; Wilkerson, Matthew D.; Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Amer Genome Ctr, Bethesda, MD 20814 USA; [Wilkerson, Matthew D.; Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA.; Symes, AJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA.	aviva.symes@usuhs.edu		Dalgard, Clifton/0000-0003-2025-8239	Tri-Service Nursing Research Program [TSN-75-N17-C03]; Department of Defense CNRM translational award	This work was funded by a Tri-Service Nursing Research Program Grant #TSN-75-N17-C03 to PA and a Department of Defense CNRM translational award to AJS. The opinions and assertions contained herein are the private opinions of the authors and are not to be construed as reflecting the views of the Uniformed Services University of the Health Sciences, the United States Department of Defense, or the United States Department of the Army.	An JB, 2010, HYPERTENS RES, V33, P831, DOI 10.1038/hr.2010.79; Armstead WM, 2020, J NEUROTRAUM, V37, P2372, DOI 10.1089/neu.2018.6119; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bali A, 2013, PHARMACOL RES, V76, P49, DOI 10.1016/j.phrs.2013.07.004; Basters A, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180250; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Benicky J, 2009, CELL MOL NEUROBIOL, V29, P781, DOI 10.1007/s10571-009-9368-4; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bihl JC, 2015, VASC PHARMACOL, V73, P115, DOI 10.1016/j.vph.2015.08.007; Boal AH, 2016, HYPERTENSION, V68, P1132, DOI 10.1161/HYPERTENSIONAHA.116.08188; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chiu T, 2003, AM J PHYSIOL-GASTR L, V285, pG1, DOI 10.1152/ajpgi.00419.2002; Colafella KMM, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.05.020; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cole WR., 2016, TRANSLATIONAL RES TR, DOI DOI 10.1201/B18959-20; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Dab H, 2012, PHARM BIOL, V50, P1219, DOI 10.3109/13880209.2012.664554; Davies NM, 2011, J ALZHEIMERS DIS, V26, P699, DOI 10.3233/JAD-2011-110347; Davis CK, 2021, NEUROBIOL DIS, V147, DOI 10.1016/j.nbd.2020.105143; de Kloet AD, 2015, AM J PHYSIOL-REG I, V309, pR444, DOI 10.1152/ajpregu.00078.2015; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; DePaula-Silva AB, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1545-x; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DiCarlo LM, 2017, J COMP NEUROL, V525, P3360, DOI 10.1002/cne.24282; Dosch M, 2019, ELIFE, V8, DOI 10.7554/eLife.42670; Elkahloun AG, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-015-0167-5; Ellwanger DC, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017742118; Figaji AA, 2017, CHILD NERV SYST, V33, P1651, DOI 10.1007/s00381-017-3562-3; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Freund M, 2012, CELL TISSUE RES, V348, P29, DOI 10.1007/s00441-012-1354-3; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Giza C, 2018, HAND CLINIC, V158, P51, DOI 10.1016/B978-0-444-63954-7.00006-9; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Grant G., 2016, TRANSLATIONAL RES TR; Guan WH, 2011, TRANSL STROKE RES, V2, P179, DOI 10.1007/s12975-010-0061-1; Ho JK, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0255-9; Honke N, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.326; Hurt RC, 2015, GENES BRAIN BEHAV, V14, P526, DOI 10.1111/gbb.12235; Ichkova A, 2017, NEUROCHEM INT, V111, P93, DOI 10.1016/j.neuint.2017.03.022; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Janatpour ZC, 2020, NEURAL REGEN RES, V15, P1025, DOI 10.4103/1673-5374.270304; Janatpour ZC, 2019, J NEUROTRAUM, V36, P3115, DOI 10.1089/neu.2019.6376; Kamphuis W, 2015, GLIA, V63, P1036, DOI 10.1002/glia.22800; Kangussu LM, 2013, BEHAV BRAIN RES, V257, P25, DOI 10.1016/j.bbr.2013.09.003; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Kasukawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023228; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kawahara K, 2016, GLIA, V64, P1938, DOI 10.1002/glia.23034; Kehoe PG, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt3; Kehoe PG, 2018, J ALZHEIMERS DIS, V62, P1443, DOI 10.3233/JAD-171119; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khoury NM, 2012, J CLIN PSYCHIAT, V73, P849, DOI 10.4088/JCP.11m07316; Krause EG, 2011, J NEUROSCI, V31, P15009, DOI 10.1523/JNEUROSCI.0892-11.2011; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Laskowski R.A., 2015, BRAIN NEUROTRAUMA MO, DOI [10.1201/b18126-6, DOI 10.1201/B18126-6]; Lefevre-Dognin C, 2021, NEUROCHIRURGIE, V67, P218, DOI 10.1016/j.neuchi.2020.02.002; Lenkei Z, 1998, NEUROSCIENCE, V82, P827; Lenkei Z, 1997, FRONT NEUROENDOCRIN, V18, P383, DOI 10.1006/frne.1997.0155; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; MAKITA S, 1995, LIFE SCI, V56, pPL383, DOI 10.1016/0024-3205(95)98582-Z; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Maria NSS, 2019, EXP NEUROL, V318, P78, DOI 10.1016/j.expneurol.2019.04.016; Marvar PJ, 2014, BIOL PSYCHIAT, V75, P864, DOI 10.1016/j.biopsych.2013.08.024; McCarthy CA, 2013, CLIN EXP PHARMACOL P, V40, P571, DOI 10.1111/1440-1681.12099; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miller AJ, 2019, CLIN AUTON RES, V29, P231, DOI 10.1007/s10286-018-0572-5; Miura S, 2011, J RENIN-ANGIO-ALDO S, V12, P1, DOI 10.1177/1470320310370852; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Nishimura Y, 2000, BRAIN RES, V871, P29, DOI 10.1016/S0006-8993(00)02377-5; Nylocks KM, 2015, AM J MED GENET B, V168, P307, DOI 10.1002/ajmg.b.32313; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Pavel J, 2008, ANN NY ACAD SCI, V1148, P360, DOI 10.1196/annals.1410.006; Pawlikowski M, 1999, CELL MOL LIFE SCI, V55, P506, DOI 10.1007/s000180050307; Pernomian L, 2015, EUR J PHARMACOL, V764, P173, DOI 10.1016/j.ejphar.2015.07.007; Regenhardt RW, 2014, CLIN SCI, V126, P195, DOI 10.1042/CS20130324; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Ronning KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41141-0; Saavedra JM, 2017, PHARMACOL RES, V125, P91, DOI 10.1016/j.phrs.2017.06.017; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Saavedra JM, 2006, J HYPERTENS, V24, pS131, DOI 10.1097/01.hjh.0000220418.09021.ee; Saavedra JM, 2016, CELL MOL NEUROBIOL, V36, P259, DOI 10.1007/s10571-015-0327-y; Saavedra JM, 2012, CELL MOL NEUROBIOL, V32, P667, DOI 10.1007/s10571-011-9754-6; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schmid U, 2008, CANCER RES, V68, P9239, DOI 10.1158/0008-5472.CAN-08-1310; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Schweitzer AD, 2019, RADIOGRAPHICS, V39, P1571, DOI 10.1148/rg.2019190076; Shanab AY, 2015, ANGIOGENESIS, V18, P137, DOI 10.1007/s10456-014-9451-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh VP, 2008, AM J PHYSIOL-HEART C, V294, pH1675, DOI 10.1152/ajpheart.91493.2007; SSET EC, 2010, INT J STROKE, V5, P423, DOI DOI 10.1111/J.1747-4949.2010.00473.X; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; Svingos AM, 2019, J CLIN EXP NEUROPSYC, V41, P775, DOI 10.1080/13803395.2019.1620695; Thone-Reineke C, 2006, J HYPERTENS, V24, pS115; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2015, AM J HYPERTENS, V28, P289, DOI 10.1093/ajh/hpu197; Villapol S, 2013, J NEUROTRAUM, V30, pA11; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wang L, 2016, PHYSIOL GENOMICS, V48, P667, DOI 10.1152/physiolgenomics.00029.2016; Wang L, 2016, NEUROPHARMACOLOGY, V105, P114, DOI 10.1016/j.neuropharm.2015.12.026; Weber KT, 1997, CIRCULATION, V96, P4065; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Wolfe LF, 2018, NEUROREHABILITATION, V43, P257, DOI 10.3233/NRE-182583; Wright JW, 2004, PROG NEUROBIOL, V72, P263, DOI 10.1016/j.pneurobio.2004.03.003; Wu CY, 2013, MOL CELL BIOCHEM, V382, P47, DOI 10.1007/s11010-013-1717-4; Wu GM, 2017, METHODS MOL BIOL, V1558, P235, DOI 10.1007/978-1-4939-6783-4_11; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xu Y, 2015, BRAIN BEHAV IMMUN, V50, P298, DOI 10.1016/j.bbi.2015.07.015; Yu Z, 2019, BIOL PSYCHIAT, V86, P899, DOI 10.1016/j.biopsych.2019.05.027; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhu Y, 2018, SCIENCE, V362, P1267, DOI 10.1126/science.aat8077; Zhuang S, 2016, J CLIN NEUROSCI, V33, P32, DOI 10.1016/j.jocn.2016.02.036	124	1	1	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAR 22	2021	15								636259	10.3389/fnins.2021.636259			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RI1LS	WOS:000636671800001	33828448	gold, Green Published			2022-02-06	
J	Gao, X; Wu, DW; Li, X; Su, BH; Sun, ZF; Nie, BB; Zhang, XL; Wei, YX				Gao, Xing; Wu, Dawei; Li, Xiang; Su, Baihan; Sun, Zhifu; Nie, Binbin; Zhang, Xiaoli; Wei, Yongxiang			Altered glucose metabolism of the olfactory-related cortices in anosmia patients with traumatic brain injury	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Post-traumatic olfactory dysfunction; Positron emission tomography; Olfactory cortex; F-18-fluordeoxyglucose		Purpose Impaired brain cortices contribute significantly to the pathophysiological mechanisms of post-traumatic olfactory dysfunction (PTOD). This study aimed to use F-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) to measure cerebral cortices' metabolism activity and then to explore their associations with olfaction in patients with PTOD. Methods Ethics committee-approved prospective studies included 15 patients with post-traumatic anosmia and 11 healthy volunteers. Olfactory function was assessed using the Sniffin' Sticks. Participants underwent F-18-FDG PET/CT scan and the image data were collected for the voxel-based whole brain analysis. Furthermore, the standardized uptake value ratio (SUVR) of the whole brain regions was measured and correlated with olfactory function. Results Patients with post-traumatic anosmia showed significantly reduced glucose metabolism in bilateral rectus, bilateral superior and medial orbitofrontal cortex (OFC), bilateral thalamus, left hippocampus and parahippocampus and left superior temporal pole (all p < 0.001). In contrast, patients with post-traumatic anosmia had significantly increased glucose metabolism in the bilateral insula (all p < 0.001). SUVR values among a total of 17 cerebral cortices including frontal, limbic, and temporal regions were significantly and positively correlated with olfactory function. The cerebral cortices with the top three correlations were the right middle frontal OFC (r = 0.765, p = 0.001), right caudate (r = 0.652, p = 0.010) and right putamen (r = 0.623, p = 0.002). Conclusion Patients with post-traumatic anosmia presented with distinct patterns of brain metabolism and key cortices that highly associated with the retained olfactory function were identified. The preliminary results further support the potential use of PET imaging for precisely assessing brain metabolism in patients with PTOD.	[Gao, Xing; Wu, Dawei; Su, Baihan; Sun, Zhifu; Wei, Yongxiang] Capital Med Univ, Beijing Anzhen Hosp, Smell & Taste Ctr, Dept Otolaryngol, Beijing, Peoples R China; [Li, Xiang] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, Vienna, Austria; [Nie, Binbin] Chinese Acad Sci, Beijing Engn Res Ctr Radiog Tech & Equipment, Inst High Energy Phys, Beijing, Peoples R China; [Zhang, Xiaoli] Capital Med Univ, Beijing Anzhen Hosp, Dept Nucl Med, Beijing, Peoples R China; [Wei, Yongxiang] Affiliated Childrens Hosp, Capital Inst Pediat, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China		Wei, YX (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Smell & Taste Ctr, Dept Otolaryngol, Beijing, Peoples R China.; Wei, YX (corresponding author), Affiliated Childrens Hosp, Capital Inst Pediat, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China.	entweiyx@163.com		Li, Xiang/0000-0002-0016-6233	Beijing Hospitals Authority Youth Program [QML20190617]; Beijing Science and Technology Nova Program [Z201100006820086]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82000954]; Beijing Hospitals Authority' Mission Plan [SML20190601]; Beijing Scholars Program [051]; Beijing Hospitals Authority Clinical Medicine Development [XMLX202136]	This study was supported by Beijing Hospitals Authority Youth Program (QML20190617), Beijing Science and Technology Nova Program (Z201100006820086), Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support (XMLX202136), Natural Science Foundation of China (82000954), Beijing Hospitals Authority' Mission Plan (SML20190601), and Beijing Scholars Program (No. 051).	Ahmedy F, 2020, EUR ARCH OTO-RHINO-L, V277, P1343, DOI 10.1007/s00405-020-05823-0; Brand G, 2001, NEUROSCI BIOBEHAV R, V25, P159, DOI 10.1016/S0149-7634(01)00005-7; Bratt M, 2018, BRAIN INJURY, V32, P1021, DOI 10.1080/02699052.2018.1469043; Caminiti F, 2013, BRAIN INJURY, V27, P1715, DOI 10.3109/02699052.2013.823667; Chiaravalloti A, 2015, EUR J NUCL MED MOL I, V42, P733, DOI 10.1007/s00259-014-2969-2; Courtiol E, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00049; Fan LY, 2015, J CHIN MED ASSOC, V78, P299, DOI 10.1016/j.jcma.2014.11.009; Fjaeldstad A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42534; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Han PF, 2018, J NEUROTRAUM, V35, P2632, DOI 10.1089/neu.2017.5393; Han PF, 2019, BRAIN TOPOGR, V32, P987, DOI 10.1007/s10548-019-00729-5; Hummel T, 2017, RHINOLOGY, V54, P7, DOI 10.4193/Rhino16.248; Hummel T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00125; Iannilli E, 2007, BRAIN RES, V1139, P235, DOI 10.1016/j.brainres.2006.12.082; Joshi A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71245-x; Korshunov KS, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00275; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kubota S, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.556519; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lian TH, 2019, J ALZHEIMERS DIS, V70, P411, DOI 10.3233/JAD-181217; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lohle M, 2020, J NEURAL TRANSM, V127, P9, DOI 10.1007/s00702-019-02122-9; Lotsch J, 2016, NEUROIMAGE-CLIN, V11, P99, DOI 10.1016/j.nicl.2016.01.011; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Meunier D, 2014, NEUROIMAGE, V95, P264, DOI 10.1016/j.neuroimage.2014.03.041; Meyer JH, 2020, LANCET PSYCHIAT, V7, P1064, DOI 10.1016/S2215-0366(20)30255-8; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Moon WJ, 2018, AM J NEURORADIOL, V39, P2320, DOI 10.3174/ajnr.A5873; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Oh YS, 2018, PARKINSONISM RELAT D, V56, P47, DOI 10.1016/j.parkreldis.2018.06.022; Rice L, 2017, EUR J RADIOL, V94, P16, DOI 10.1016/j.ejrad.2017.07.014; Rolls ET, 2016, BRAIN COGNITION, V110, P4, DOI 10.1016/j.bandc.2015.07.002; Schofield P, 2019, HAND CLINIC, V164, P409, DOI 10.1016/B978-0-444-63855-7.00023-X; Seubert J, 2015, HUM BRAIN MAPP, V36, P1662, DOI 10.1002/hbm.22728; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Soudry Y, 2011, EUR ANN OTORHINOLARY, V128, P18, DOI 10.1016/j.anorl.2010.09.007; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Whitcroft KL, 2019, JAMA OTOLARYNGOL, V145, P846, DOI 10.1001/jamaoto.2019.1728; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yang L, 2010, OTOLARYNG HEAD NECK, V143, P554, DOI 10.1016/j.otohns.2010.05.010; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; Zhou GY, 2019, ELIFE, V8, DOI 10.7554/eLife.47177	45	1	1	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	DEC	2021	278	12					4813	4821		10.1007/s00405-021-06754-0		MAR 2021	9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	WO4VD	WOS:000630995100001	33744988				2022-02-06	
J	Szymski, D; Krutsch, V; Achenbach, L; Gerling, S; Pfeifer, C; Alt, V; Krutsch, W; Loose, O				Szymski, Dominik; Krutsch, Volker; Achenbach, Leonard; Gerling, Stephan; Pfeifer, Christian; Alt, Volker; Krutsch, Werner; Loose, Oliver			Epidemiological analysis of injury occurrence and current prevention strategies on international amateur football level during the UEFA Regions Cup 2019	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Amateur; Football; Soccer; Tournament; Epidemiology; Prevention; Risk factors		Introduction Football is the most popular sport worldwide and results in a high frequency of injuries. So far, mainly injuries in professional football have been investigated, and the literature lacks data regarding detailed injury epidemiology and current prevention data in amateur football tournaments. Materials and methods A prospective cohort study investigated an international amateur football tournament, the UEFA Regions' Cup, which took place in 2019 in Germany. Injury epidemiology, current prevention strategies of the teams and the implementation of the UEFA concussion protocol were investigated in detail by means of standardized injury definitions and data samples for football (Fuller et al., Scand J Med Sci Sports 16:83-92, https://doi.org/10.1111/j.1600-0838.2006.00528.x, 2006). Results 138 player of 8 teams participated in this study, while 39 players were excluded. Overall injury incidence was 12.5 per 1000 h total football exposure, 43.5 per 1000 h for match exposure. No injuries were registered during training. Injury prevalence was 14.1% per player and 1.1 injuries per match were registered. The lower extremity was predominantly affected by injuries (71.4%) and the majority of injuries (78.6%) were non-severe injury types like contusions (50%) and sprains (18.2%). Two head injuries, one contusion and one skin lesion, were handled by the guidelines of the UEFA concussion protocol. 44.4% of the players indicated at least one previous injury before tournament, 45.3% of them during the last two football seasons before start of the tournament. Injury prevention performance was included in all participating teams during the tournament by warm up or training strategies (100%). During the warm-up program just 5 exercises of the FIFA 11 +program was detected by this investigation in participating teams to be done by more half of the teams. Running exercises were the most frequently performed exercises, while trunk muscle exercises were less represented (14.3%). Conclusion This study presents for the first time epidemiological injury and prevention data of the UEFA Regions Cup. Injury incidence was higher compared to injury reports of regular seasons, but lower compared to other amateur football tournaments. Currently used prevention programs revealed trunk muscle exercises as often neglected.	[Szymski, Dominik; Pfeifer, Christian; Alt, Volker; Krutsch, Werner; Loose, Oliver] Univ Med Ctr Regensburg, Dept Trauma Surg, Regensburg, Germany; [Krutsch, Volker] Paracelsus Med Univ Nuernberg, Dept Otorhinolaryngol, Nurnberg, Germany; [Achenbach, Leonard] Univ Med Ctr Wuerzburg, Dept Trauma Surg, Wurzburg, Germany; [Gerling, Stephan] Clin St Hedwig, Clin Paediat, Regensburg, Germany; [Krutsch, Werner] SportDocsFranken, Nurnberg, Germany; [Loose, Oliver] Klinikum Stuttgart, Olga Hosp, Dept Orthoped Surg, Stuttgart, Germany		Loose, O (corresponding author), Univ Med Ctr Regensburg, Dept Trauma Surg, Regensburg, Germany.; Loose, O (corresponding author), Klinikum Stuttgart, Olga Hosp, Dept Orthoped Surg, Stuttgart, Germany.	oliverloose@web.de	Szymski, Dominik/AAC-4020-2022	Szymski, Dominik/0000-0002-1739-8524; Achenbach, Leonard/0000-0002-9053-0624; Loose, Oliver/0000-0001-8498-5772	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	Achenbach L, 2018, KNEE SURG SPORT TR A, V26, P1901, DOI 10.1007/s00167-017-4758-5; Agel J, 2016, CLIN J SPORT MED, V26, P518, DOI 10.1097/JSM.0000000000000290; Aman M, 2018, SCAND J MED SCI SPOR, V28, P1147, DOI 10.1111/sms.12956; Angele, STIFT FORD ARTHROSK; Barengo NC, 2014, INT J ENV RES PUB HE, V11, P11986, DOI 10.3390/ijerph111111986; Beynnon BD, 2014, AM J SPORT MED, V42, P1806, DOI 10.1177/0363546514540862; Bizzini M, 2015, BRIT J SPORT MED, V49, P577, DOI 10.1136/bjsports-2015-094765; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Dvorak J, 2000, AM J SPORT MED, V28, pS3; Dvorak J, 2000, AM J SPORT MED, V28, pS1; Dvorak J, 2009, F MARC FOOTBALL MED; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gouttebarge V, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000490; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Hagglund M, 2009, BRIT J SPORT MED, V43, P483, DOI 10.1136/bjsm.2008.056937; Henke T, 2014, BUNDESGESUNDHEITSBLA, V57, P628, DOI 10.1007/s00103-014-1964-x; Herman K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-75; Herrero H, 2014, AM J SPORT MED, V42, P78, DOI 10.1177/0363546513507767; Hewett Timothy E, 2010, N Am J Sports Phys Ther, V5, P234; Junge A, 2006, AM J SPORT MED, V34, P565, DOI 10.1177/0363546505281807; Junge A, 2004, AM J SPORT MED, V32, p80S, DOI 10.1177/0363546503261245; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Koch M, 2016, ARCH ORTHOP TRAUM SU, V136, P353, DOI 10.1007/s00402-015-2350-3; Krutsch V, 2020, ARCH ORTHOP TRAUM SU, V140, P457, DOI 10.1007/s00402-019-03261-0; Krutsch W, 2020, ARTHROSKOPIE, V33, P282, DOI 10.1007/s00142-020-00390-2; Krutsch W, 2018, SPORTVERLETZ SPORTSC, V32, P111, DOI 10.1055/s-0583-3792; Krutsch W, 2016, KNEE SURG SPORT TR A, V24, P2271, DOI 10.1007/s00167-014-3357-y; Krutsch W, 2015, ARCH ORTHOP TRAUM SU, V135, P659, DOI 10.1007/s00402-015-2178-x; Longo UG, 2012, AM J SPORT MED, V40, P996, DOI 10.1177/0363546512438761; Loose O, 2019, KNEE SURG SPORT TR A, V27, P978, DOI 10.1007/s00167-018-5119-8; Loose O, 2018, ARCH ORTHOP TRAUM SU, V138, P985, DOI 10.1007/s00402-018-2937-6; Luig P, 2018, VBG SPORTREPORT 2018; Lundblad M, 2019, KNEE SURG SPORT TR A, V27, P3692, DOI 10.1007/s00167-019-05491-6; Moses B, 2012, RES SPORTS MED, V20, P157, DOI 10.1080/15438627.2012.680633; Nouni-Garcia R, 2019, EUR J SPORT SCI, V19, P1150, DOI 10.1080/17461391.2019.1577495; Peterson L, 2000, AM J SPORT MED, V28, pS51; Sadigursky D, 2017, BMC SPORTS SCI MED R, V9, DOI 10.1186/s13102-017-0083-z; Silvers-Granelli HJ, 2017, CLIN ORTHOP RELAT R, V475, P2447, DOI 10.1007/s11999-017-5342-5; van Beijsterveldt AMC, 2015, J SCI MED SPORT, V18, P145, DOI 10.1016/j.jsams.2014.02.004; van der Horst N, 2017, BRIT J SPORT MED, V51, P1583, DOI 10.1136/bjsports-2016-097206; Walden M, 2006, BRIT J SPORT MED, V40, P158, DOI 10.1136/bjsm.2005.021055; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571	45	1	1	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	FEB	2022	142	2					271	280		10.1007/s00402-021-03861-9		MAR 2021	10	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	YL0TK	WOS:000630618800001	33740068	Green Published, hybrid			2022-02-06	
J	DeSimone, JC; Davenport, EM; Urban, J; Xi, Y; Holcomb, JM; Kelley, ME; Whitlow, CT; Powers, AK; Stitzel, JD; Maldjian, JA				DeSimone, Jesse C.; Davenport, Elizabeth M.; Urban, Jillian; Xi, Yin; Holcomb, James M.; Kelley, Mireille E.; Whitlow, Christopher T.; Powers, Alexander K.; Stitzel, Joel D.; Maldjian, Joseph A.			Mapping default mode connectivity alterations following a single season of subconcussive impact exposure in youth football	HUMAN BRAIN MAPPING			English	Article						concussion; connectivity; fMRI; football; subconcussion; youth		Repetitive head impact (RHI) exposure in collision sports may contribute to adverse neurological outcomes in former players. In contrast to a concussion, or mild traumatic brain injury, "subconcussive" RHIs represent a more frequent and asymptomatic form of exposure. The neural network-level signatures characterizing subconcussive RHIs in youth collision-sport cohorts such as American Football are not known. Here, we used resting-state functional MRI to examine default mode network (DMN) functional connectivity (FC) following a single football season in youth players (n = 50, ages 8-14) without concussion. Football players demonstrated reduced FC across widespread DMN regions compared with non-collision sport controls at postseason but not preseason. In a subsample from the original cohort (n = 17), players revealed a negative change in FC between preseason and postseason and a positive and compensatory change in FC during the offseason across the majority of DMN regions. Lastly, significant FC changes, including between preseason and postseason and between in- and off-season, were specific to players at the upper end of the head impact frequency distribution. These findings represent initial evidence of network-level FC abnormalities following repetitive, non-concussive RHIs in youth football. Furthermore, the number of subconcussive RHIs proved to be a key factor influencing DMN FC.	[DeSimone, Jesse C.; Davenport, Elizabeth M.; Holcomb, James M.; Maldjian, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Adv Neurosci Imaging Res ANSIR, Dallas, TX 75390 USA; [DeSimone, Jesse C.; Davenport, Elizabeth M.; Xi, Yin; Holcomb, James M.; Maldjian, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Urban, Jillian; Kelley, Mireille E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Salem, NC USA; [Urban, Jillian; Kelley, Mireille E.; Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Wake Forest Sch Biomed Engn, Virginia Tech, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol, Neuroradiol, Winston Salem, NC USA; [Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Clin & Translat Sci Inst, Winston Salem, NC USA; [Powers, Alexander K.] Wake Forest Sch Med, Dept Neurosurg, Winston Salem, NC USA; [Stitzel, Joel D.] Wake Forest Sch Med, Childress Inst Pediat Trauma, Winston Salem, NC USA		Maldjian, JA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joseph.maldjian@utsouthwestern.edu		DeSimone, Jesse/0000-0002-3823-8765	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082453, R01 NS091602]	National Institute of Neurological Disorders and Stroke, Grant/Award Numbers: R01 NS082453, R01 NS091602	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun Vince D, 1800, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Chrisman SPD, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2402; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DeSimone JC., 2021, HUM BRAIN MAPP, P1; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kroshus E, 2021, HEALTH PROMOT PRACT, V22, P829, DOI 10.1177/1524839920945255; Kullmann S, 2012, HUM BRAIN MAPP, V33, P1052, DOI 10.1002/hbm.21268; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Manning KY, 2020, NEUROLOGY, V95, pE402, DOI 10.1212/WNL.0000000000009821; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Straathof M, 2019, J CEREBR BLOOD F MET, V39, P189, DOI 10.1177/0271678X18809547; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Urban JE, 2019, J NEUROTRAUM, V36, P275, DOI 10.1089/neu.2018.5699; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	99	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUN 1	2021	42	8					2529	2545		10.1002/hbm.25384		MAR 2021	17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	RV9SP	WOS:000630042700001	33734521	Green Published, gold			2022-02-06	
J	Bamatraf, AA; Chong, MC; Mazlan, M; Che, CC; Fauziningtyas, R; Nursalam, N				Awadh Bamatraf, Amena; Chong, Mei Chan; Mazlan, Mazlina; Che, Chong Chin; Fauziningtyas, Rista; Nursalam, Nursalam			Informal carer's knowledge of traumatic brain injury questionnaire: Initial development and validation	NURSING OPEN			English	Article						carers; head injury; instrument development; psychometric properties		Aim: To develop and psychometrically test the instrument for measuring the knowledge of traumatic brain injury of informal carers. Design: Instrument development. Method: Focus group discussions were conducted among informal carers and healthcare specialists in March 2017. The content validity was determined by the mean of the item content validity index. A reliability test was performed by the Kuder-Richardson 20 and Pearson's correlation coefficient among 40 informal carers of patients with a traumatic brain injury in the rehabilitation medicine department of a tertiary hospital from August-September 2017. Results: The final 34-item questionnaire covers the nature of traumatic brain injury, the consequences of traumatic brain injury, the rehabilitation process, and the role of the caregiver. The item content means ranged from 0.8-1.00, and the difficulty of knowledge items ranged from 0.18-0.98. The internal consistency reliability and correlation coefficient were 0.70 arid 0.84, respectively.	[Awadh Bamatraf, Amena; Chong, Mei Chan; Che, Chong Chin] Univ Malaya, Fac Med, Dept Nursing Sci, Kuala Lumpur 50603, Malaysia; [Mazlan, Mazlina] Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia; [Fauziningtyas, Rista; Nursalam, Nursalam] Univ Airlangga, Fac Nursing, Surabaya, Indonesia		Chong, MC (corresponding author), Univ Malaya, Fac Med, Dept Nursing Sci, Kuala Lumpur 50603, Malaysia.	mcchong@um.edu.my	Mazlan, Mazlina/A-1015-2011; Fauziningtyas, Rista/R-2721-2019; Chan, Chong Mei/B-8394-2010; Che, Chong Chin/AAD-8778-2020	Mazlan, Mazlina/0000-0002-4012-1873; Fauziningtyas, Rista/0000-0002-1948-3909; Chan, Chong Mei/0000-0002-8599-3018; 			Allen M., 2017, SAGE ENCY COMMUNICAT, V1-4; [Anonymous], 2012, FACT SHEET SEL CAR S; Bamatraf AA, 2021, NURS OPEN, V8, P2722, DOI 10.1002/nop2.833; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Chamroonsawasdi K, 2017, BEHAV SCI-BASEL, V7, DOI 10.3390/bs7020020; Glen S., 2014, FACTOR ANAL EASY DEF; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Hudson, 2016, J AGING RES HEALTHCA, V1, P21, DOI DOI 10.14302/ISSN.2474-7785.JARH-16-1128; Lee K.F., 2014, MALAYS J PSYCHIAT, V23, P45; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; LoBiondo-Wood G, 2014, NURSING RES E BOOK M, V8th; Mavis I, 2013, BRAIN INJURY, V27, P587, DOI 10.3109/02699052.2013.772236; Mukaka MM, 2012, MALAWI MED J, V24, P69; Polit D.F., 2017, NURSING RES GENERATI, V10; Samartkit N, 2010, PAC RIM INT J NURS R, V14, P297; Shaji KS, 2012, INDIAN J PSYCHOL MED, V34, P303, DOI 10.4103/0253-7176.108191; Sullivan Karen, 2004, Top Stroke Rehabil, V11, P19; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644; Yusoff M.S.B., 2014, DIFFICULTY INDEX DIS	20	1	1	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2054-1058			NURS OPEN	NURS. OPEN	SEP	2021	8	5					2722	2731		10.1002/nop2.833		MAR 2021	10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	TZ7QD	WOS:000629600800001	33729702	gold, Green Published			2022-02-06	
J	Lv, SY; Zhao, WB; Rajah, GB; Dandu, C; Cai, LP; Cheng, Z; Duan, HL; Dai, QQ; Geng, XK; Ding, YC				Lv, Shuyu; Zhao, Wenbo; Rajah, Gary B.; Dandu, Chaitu; Cai, Lipeng; Cheng, Zhe; Duan, Honglian; Dai, Qingqing; Geng, Xiaokun; Ding, Yuchuan			Rapid Intervention of Chlorpromazine and Promethazine for Hibernation-Like Effect in Stroke: Rationale, Design, and Protocol for a Prospective Randomized Controlled Trial	FRONTIERS IN NEUROLOGY			English	Article						acute ischemic stroke (AIS); phenothiazine; neuroprotection; intravenous thrombolysis; rt-PA	TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; NEUROPROTECTION; THROMBOLYSIS; REPERFUSION; HYPOTHERMIA; PREVENTION; DAMAGE; DRUGS	Background: Following an acute ischemic stroke (AIS), rapidly initiated reperfusion therapies [i. e., intravenous thrombolysis (IVT) and endovascular treatment (EVT)] demonstrate robust clinical efficacy. However, only a subset of these patients can benefit from these therapies due to their short treatment windows and potential complications. In addition, many patients despite successful reperfusion still have unfavorable outcomes. Thus, neuroprotection strategies are urgently needed for AIS patients. Chlorpromazine and promethazine (C+P) have been employed in clinical practice for antipsychotic and sedative purposes. A clinical study has also shown a neuroprotective effect of C+P on patients with cerebral hemorrhage and subarachnoid hemorrhage. The safety, feasibility, and preliminary efficacy of intravenous administration of C+P in AIS patients within 24 h of onset will be elucidated. Methods: A prospective randomized controlled trial is proposed with AIS patients. Participants will be randomly allocated to an intervention group and a control group with a 1:1 ratio (n = 30) and will be treated with standard therapies according to the current stroke guidelines. Participants allocated to the intervention group will receive intravenous administration of C+P (chlorpromazine 50 mg and promethazine 50 mg) within 24 h of symptom onset. The primary outcome is safety (mainly hypotension), while the secondary outcomes include changes in functional outcome and infarction volume. Discussions: This study on Rapid Intervention of Chlorpromazine and Promethazine for Hibernation-like Effect in Stroke (RICHES) will be the first prospective randomized controlled trial to ascertain the safety, feasibility, and preliminary efficacy of intravenous C+P as a neuroprotection strategy in AIS patients. These results will provide parameters for future studies, provide insights into treatment effects, and neuroprotection with phenothiazine in AIS.	[Lv, Shuyu; Geng, Xiaokun] Capital Med Univ, Luhe Inst Neurosci, Beijing, Peoples R China; [Lv, Shuyu; Cai, Lipeng; Cheng, Zhe; Duan, Honglian; Dai, Qingqing; Geng, Xiaokun] Capital Med Univ, Beijing Luhe Hosp, Dept Neurol, Beijing, Peoples R China; [Zhao, Wenbo; Geng, Xiaokun] Capital Med Univ, China Amer Inst Neurosci, Xuanwu Hosp, Beijing, Peoples R China; [Rajah, Gary B.; Dandu, Chaitu; Geng, Xiaokun; Ding, Yuchuan] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA; [Rajah, Gary B.] Munson Med Ctr, Dept Neurosurg, Traverse City, MI USA; [Ding, Yuchuan] John D Dingell VA Med Ctr, Dept Res & Dev Ctr, Detroit, MI USA		Geng, XK (corresponding author), Capital Med Univ, Luhe Inst Neurosci, Beijing, Peoples R China.; Geng, XK (corresponding author), Capital Med Univ, Beijing Luhe Hosp, Dept Neurol, Beijing, Peoples R China.; Geng, XK (corresponding author), Capital Med Univ, China Amer Inst Neurosci, Xuanwu Hosp, Beijing, Peoples R China.; Geng, XK (corresponding author), Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA.	xgeng@ccmu.edu.cn		Zhao, Wenbo/0000-0001-7141-6394	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [82072549, 82001277]; Science and Technology Plan of Beijing Tongzhou District [KJ2020CX002]	This study was supported partially by the National Natural Science Foundation of China (82072549 and 82001277), and Science and Technology Plan of Beijing Tongzhou District (KJ2020CX002).	Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Cai LP, 2017, MOL NEUROBIOL, V54, P1263, DOI 10.1007/s12035-016-9695-7; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Cerebrovascular Disease Research Group Department of Neurology Peking Union Medical College Hospital, 1960, CHIN J NEUROPSYCHOL, V3, P146; CHIEN KR, 1977, AM J PATHOL, V88, P539; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P197, DOI 10.1177/1545968309331863; Dong Q, 2017, STROKE VASC NEUROL, V2, P147, DOI 10.1136/svn-2017-000074; Drew KL, 2007, J NEUROCHEM, V102, P1713, DOI 10.1111/j.1471-4159.2007.04675.x; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Einarson A, 2009, J PSYCHIATR PRACT, V15, P183, DOI 10.1097/01.pra.0000351878.45260.94; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Forreider B, 2017, PROG NEUROBIOL, V157, P174, DOI 10.1016/j.pneurobio.2016.03.002; Frerichs KU, 1999, ACT NEUR S, V73, P57; Guan LF, 2019, CURR NEUROVASC RES, V16, P232, DOI 10.2174/1567202616666190624122727; Han Y, 2019, NEUROL RES, V41, P697, DOI 10.1080/01616412.2019.1609160; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; JAYACHANDRAN S, 1985, UROLOGY, V25, P386, DOI 10.1016/0090-4295(85)90495-9; Kuczynski AM, 2019, BRAIN CIRC, V5, P43, DOI 10.4103/bc.bc_5_19; Lacasse H, 2006, ANN PHARMACOTHER, V40, P1966, DOI 10.1345/aph.1H241; Leng TD, 2019, BRAIN CIRC, V5, P8, DOI 10.4103/bc.bc_36_18; Li FW, 2019, CELL TRANSPLANT, V28, P145, DOI 10.1177/0963689718819443; Li HJ, 2014, EUR J PHARMACOL, V735, P38, DOI 10.1016/j.ejphar.2014.04.017; Liu SM, 2015, NEUROL RES, V37, P454, DOI 10.1179/1743132815Y.0000000031; Lopez-Munoz Francisco, 2005, Ann Clin Psychiatry, V17, P113, DOI 10.1080/10401230591002002; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; SADANAGA K K, 1989, Journal of Neurotrauma, V6, P153, DOI 10.1089/neu.1989.6.153; Sader AA, 2002, J CARDIOVASC SURG, V43, P827; Shen Fanxia, 2019, Aging Dis, V10, P12, DOI 10.14336/AD.2018.0205; Shetty AK, 2019, AGING DIS, V10, P470, DOI 10.14336/AD.2019.0330; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Songarj P, 2015, NEUROSCI LETT, V584, P253, DOI 10.1016/j.neulet.2014.10.037; Stone CR, 2019, NEUROL RES, V41, P679, DOI 10.1080/01616412.2019.1603592; Tong YN, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9120378; Wu SM, 2019, LANCET NEUROL, V18, P394, DOI 10.1016/S1474-4422(18)30500-3; Zhang, 2020, NAT MED, V37, P1579, DOI [10.1038/s41591-020-0897-1, 10.1007/s12325-020-01273-6, DOI 10.1038/S41591-020-0897-1]; Zhao WB, 2020, BRAIN CIRC, V6, P11, DOI 10.4103/bc.bc_58_19; Zhu HM, 2019, J NEUROSURG SCI, V63, P265, DOI 10.23736/S0390-5616.19.04665-4; ZIVIN JA, 1989, BRAIN RES, V482, P189, DOI 10.1016/0006-8993(89)90560-X	40	1	1	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 17	2021	12								621476	10.3389/fneur.2021.621476			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RF8MJ	WOS:000635092100001	33815250	Green Published, gold			2022-02-06	
J	Appel, D; Hummel, R; Weidemeier, M; Endres, K; Golz, C; Schafer, MKE				Appel, Dominik; Hummel, Regina; Weidemeier, Martin; Endres, Kristina; Goelz, Christina; Schafer, Michael K. E.			Pharmacologic Inhibition of ADAM10 Attenuates Brain Tissue Loss, Axonal Injury and Pro-inflammatory Gene Expression Following Traumatic Brain Injury in Mice	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						traumatic brain injury; ADAM10 (a disintegrin and metalloprotease 10); GI254023X; neuroprotection; neuroinflammation; axonal injury		The alpha-secretase A disintegrin and metalloprotease 10 (ADAM10) regulates various physiological and pathophysiological processes. Despite its broad functional implications during development, plasticity, and disease, no pharmacological approaches to inhibit ADAM10 in acute brain injury have been reported. Here, we examined the effects of the ADAM10 inhibitor GI254023X on the neurological and histopathological outcome after experimental traumatic brain injury (TBI). C57BL/6N mice were subjected to the controlled cortical impact (CCI) model of TBI or sham procedure and received GI254023X or vehicle during the acute phase of injury (n = 40, 100 mg/kg, 25% DMSO, 0.1 M Na2CO3, intraperitoneal, 30 min and 24 h after TBI). GI254023X treatment did not improve neurological deficits from 1 to 7 days post-injury (dpi) but animals treated with GI254023X exhibited smaller brain lesions compared to vehicle treatment. Determination of brain mRNA expression by quantitative PCR showed that TBI-induced up-regulation of Adam10 and Adam17 was not influenced by GI254023X but the up-regulation of the matrix metalloproteinase genes Mmp2 and Mmp9 was attenuated. GI254023X treatment further increased the T cell marker Cd247 but did not affect blood brain barrier integrity, as assessed by Occludin mRNA expression and IgG brain extravasation. However, in agreement with neuroprotective effects of ADAM10 inhibition, GI254023X treatment attenuated axonal injury, as indicated by decreased generation of spectrin breakdown products (SBDPs) and decreased immunostaining using anti-non-phosphorylated neurofilament (SMI-32). Interestingly, reduced axonal injury in GI254023X-treated animals coincided with subtle mRNA dysregulation in the glutamate receptor subunit genes Gria1 and Grin2b. Quantitative PCR also revealed that GI254023X mitigated up-regulation of the pro-inflammatory markers Il6, Tnfa, and Lcn2 but not the up-regulation of the pan-microglia marker Aif1, the M2 microglia marker Arg1 and the reactive astrocyte marker Gfap. Taken together, the ADAM10 inhibitor GI254023X attenuates brain tissue loss, axonal injury and pro-inflammatory gene expression in the CCI model of TBI. These results suggest that ADAM10 may represent a therapeutic target in the acute phase of TBI.	[Appel, Dominik; Hummel, Regina; Weidemeier, Martin; Goelz, Christina; Schafer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Endres, Kristina; Schafer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany; [Endres, Kristina] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany; [Schafer, Michael K. E.] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Mainz, Germany		Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Mainz, Germany.	Michael.Schaefer@unimedizinmainz.de	Endres, Kristina/K-4960-2015		Mainz Research School of Translational Biomedicine (TransMed) of the University Medical Center, Johannes Gutenberg-University Mainz, Germany; Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [SCHA1261/4-3]	This study was supported by the Mainz Research School of Translational Biomedicine (TransMed) of the University Medical Center, Johannes Gutenberg-University Mainz, Germany and by the Deutsche Forschungsgemeinschaft (SCHA1261/4-3 to MS).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Akamatsu Y, 2020, NEUROTHERAPEUTICS, V17, P446, DOI 10.1007/s13311-020-00840-7; Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brummer T, 2018, FASEB J, V32, P3560, DOI 10.1096/fj.201700823RR; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; Claasen AM, 2009, NEUROSCI LETT, V460, P92, DOI 10.1016/j.neulet.2009.05.040; Clement AB, 2008, NEUROSCIENCE, V152, P459, DOI 10.1016/j.neuroscience.2007.10.060; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corbett GT, 2015, P NATL ACAD SCI USA, V112, P8445, DOI 10.1073/pnas.1504890112; Del Turco D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084962; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dreymueller D, 2017, PLATELETS, V28, P354, DOI 10.1080/09537104.2016.1203396; Endres K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00056; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Guilherme MD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00182; Gunner G, 2019, NAT NEUROSCI, V22, P1075, DOI 10.1038/s41593-019-0419-y; Hsia HE, 2019, CELL MOL LIFE SCI, V76, P3055, DOI 10.1007/s00018-019-03173-7; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Hummel R, 2020, BRIT J PHARMACOL, V177, P5208, DOI 10.1111/bph.15259; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kramer TJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1550-0; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; Lai YJ, 2014, ANN RHEUM DIS, V73, P1575, DOI 10.1136/annrheumdis-2013-203561; Lambrecht BN, 2018, NAT REV IMMUNOL, V18, P745, DOI 10.1038/s41577-018-0068-5; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Meng T, 2017, MOL THER-NUCL ACIDS, V7, P439, DOI 10.1016/j.omtn.2017.05.004; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Mizuno S, 2018, J ORTHOP RES, V36, P2259, DOI 10.1002/jor.23878; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; Prox J, 2013, J NEUROSCI, V33, P12915, DOI 10.1523/JNEUROSCI.5910-12.2013; Pruessmeyer J, 2014, BLOOD, V123, P4077, DOI 10.1182/blood-2013-09-511543; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Schafer MKE, 2018, MATRIX BIOL, V68-69, P571, DOI 10.1016/j.matbio.2017.10.002; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sepult C, 2019, ONCOGENE, V38, P3521, DOI 10.1038/s41388-018-0669-2; Shackleton B, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0038-x; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sun LQ, 2017, ONCOTARGET, V8, P59181, DOI 10.18632/oncotarget.19469; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; Toshkezi G, 2018, J NEUROSURG, V129, P1286, DOI 10.3171/2017.7.JNS17878; Tsang JYS, 2018, EBIOMEDICINE, V38, P89, DOI 10.1016/j.ebiom.2018.11.012; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vezzoli E, 2019, J CLIN INVEST, V129, P2390, DOI 10.1172/JCI120616; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Yang H, 2019, CELL BIOL INT, V43, P863, DOI 10.1002/cbin.11154; Zhang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071913; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	64	1	1	3	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	MAR 15	2021	9								661462	10.3389/fcell.2021.661462			12	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	RE6NP	WOS:000634268500001	33791311	gold, Green Published			2022-02-06	
J	Bruijel, J; van Heugten, CM; Murray, J; Grima, N; Ymer, L; Walters, EM; Sinclair, K; Stapert, SZ; Vermeeren, A; Ponsford, JL				Bruijel, Jessica; van Heugten, Caroline M.; Murray, Jade; Grima, Natalie; Ymer, Lucy; Walters, Elizabeth M.; Sinclair, Kelly; Stapert, Sven Z.; Vermeeren, Annemiek; Ponsford, Jennie L.			The bidirectional relationship between sleep and physical activity following traumatic brain injury	JOURNAL OF SLEEP RESEARCH			English	Article						actigraphy; exercise; multilevel modelling; physical activity; sleep; traumatic brain injury		Sleep and physical activity are both modifiable behavioural factors that are associated with better health and are potentially related. Following traumatic brain injury, damage to the brain caused by an external force, sleep disturbances are common. Exploring bidirectional relationships between sleep and physical activity might provide insight into whether increasing physical activity could decrease these sleep disturbances. The current study, therefore, examined inter- and intra-individual temporal associations between sleep and daytime physical activity in 64 people with traumatic brain injury reporting sleep problems or fatigue (47 males; mean age, 40 years). Sleep and physical activity were measured using actigraphy with corroborating sleep diaries over 14 consecutive days. Multilevel models were used to examine inter- and intra-individual associations between physical activity and sleep. Inter-individual variations showed that earlier bedtimes, earlier wake-up times and lower sleep efficiency were associated with more physical activity. Intra-individual temporal variations showed no significant association of daytime physical activity with sleep duration or continuity. However, shorter sleep time and less wake after sleep onset than usual were associated with more time spent in light-intensity activity the next day. Therefore, sleep may have more of an influence on physical activity than physical activity has on sleep in people with traumatic brain injury. In conclusion, the results do not confirm a potential beneficial effect of physical activity on sleep but suggest that improving sleep quality might be relevant to support of a physically active lifestyle in people with traumatic brain injury. Further research is necessary to confirm these results.	[Bruijel, Jessica; van Heugten, Caroline M.; Stapert, Sven Z.; Vermeeren, Annemiek] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands; [Bruijel, Jessica; van Heugten, Caroline M.; Stapert, Sven Z.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [van Heugten, Caroline M.] Maastricht Univ Med Ctr, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Murray, Jade; Grima, Natalie; Ymer, Lucy; Walters, Elizabeth M.; Ponsford, Jennie L.] Monash Univ, Turner Inst Brain & Mental Hlth, Sch Psychol Sci, Clayton, Vic, Australia; [Grima, Natalie; Ymer, Lucy; Sinclair, Kelly; Ponsford, Jennie L.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Stapert, Sven Z.] Zuyderland Med Ctr, Dept Clin & Med Psychol, Sittard Geleen, Netherlands		Bruijel, J (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands.	jessica.bruijel@maastrichtuniversity.nl		Bruijel, Jessica/0000-0002-2656-5152	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1028733]	National Health and Medical Research Council, Grant/Award Number: 1028733	Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Atoui S, 2021, SLEEP MED REV, V57, DOI 10.1016/j.smrv.2021.101426; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Bernard P, 2016, HEALTH PSYCHOL, V35, P1307, DOI 10.1037/hea0000408; Best JR, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12769; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bruijel J, 2021, J SLEEP RES, V30, DOI 10.1111/jsr.13334; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Chennaoui M, 2015, SLEEP MED REV, V20, P59, DOI 10.1016/j.smrv.2014.06.008; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Driver S, 2016, BRAIN IMPAIR, V17, P55, DOI 10.1017/BrImp.2015.20; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Hamilton M, 2015, BRAIN INJURY, V29, P1572, DOI 10.3109/02699052.2015.1075145; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Horne J, 2013, SLEEP MED, V14, P1208, DOI 10.1016/j.sleep.2013.05.019; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kline CE, 2014, AM J LIFESTYLE MED, V8, P375, DOI 10.1177/1559827614544437; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lambiase MJ, 2014, MED SCI SPORT EXER, V46, P2301, DOI 10.1249/MSS.0000000000000361; Lambiase MJ, 2013, MED SCI SPORT EXER, V45, P2362, DOI 10.1249/MSS.0b013e31829e4cea; Lee P, 2019, GAIT POSTURE, V68, P141, DOI 10.1016/j.gaitpost.2018.11.023; Loprinzi PD, 2011, MENTAL HLTH PHYS ACT, P65, DOI [DOI 10.1016/J.MHPA.2011.08.001, 10.1016/j.mhpa.2011.08.001]; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McGlinchey EL, 2014, MENT HEALTH PHYS ACT, V7, P183, DOI 10.1016/j.mhpa.2014.05.003; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Morin C.M., 2012, OXFORD HDB SLEEP SLE, P1, DOI [10.1093/oxfordhb/9780195376203.001.0001, DOI 10.1093/OXFORDHB/9780195376203.001.0001]; Morris TP, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00135; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ramsey J, 2018, BRAIN INJURY, V32, P1518, DOI 10.1080/02699052.2018.1500715; Shechter A, 2014, SLEEP MED, V15, P1586, DOI 10.1016/j.sleep.2014.07.010; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Tang NKY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092158; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	1	1	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1105	1365-2869		J SLEEP RES	J. Sleep Res.	OCT	2021	30	5							e13334	10.1111/jsr.13334		MAR 2021	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UQ1FE	WOS:000628845700001	33719114	hybrid, Green Published			2022-02-06	
J	Saglam, E; Zirh, S; Aktas, CC; Muftuoglu, SF; Bilginer, B				Saglam, Emre; Zirh, Selim; Aktas, Canan Cakir; Muftuoglu, Sevda Fatma; Bilginer, Burcak			Papaverine provides neuroprotection by suppressing neuroinflammation and apoptosis in the traumatic brain injury via RAGE-NF-< kappa > B pathway	JOURNAL OF NEUROIMMUNOLOGY			English	Article								The receptor for advanced glycation end products (RAGE)-Nuclear Factor kappa B (NF-kappa B) signal pathway may represent a new target for the treatment of traumatic brain injury (TBI). The aim of the study is to investigate effects of papaverine on secondary signaling mechanisms through this pathway in mice TBI model. Immunohistochemically, while the number of RAGE and NF-kappa B positive cells, apoptotic cells increased, the number of NeuN positive cells reduced in TBI.Papaverine reduced the number of RAGE positive cells on glia and the number of NF-kappa B positive cells on both neuron and glia. At the same time, it decreased the number of microglia labeled with P2RY12 increased due to TBI. It also increased the NeuN positive cells and mitigated the brain edema. Results of this study showed that papaverine reduced TBI-induced neuroinflammation and apoptosis, also provided neuroprotection via the RAGENF-kappa B signal path, which is one of the possible mechanisms in TBI.	[Saglam, Emre; Bilginer, Burcak] Hacettepe Univ, Dept Neurosurg, Fac Med, Ankara, Turkey; [Zirh, Selim; Muftuoglu, Sevda Fatma] Hacettepe Univ, Dept Histol & Embryol, Fac Med, Ankara, Turkey; [Aktas, Canan Cakir] Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey		Saglam, E (corresponding author), Hacettepe Univ, Dept Neurosurg, Fac Med, Ankara, Turkey.	dremresa@gmail.com	ZIRH, Selim/AAP-4024-2020	ZIRH, Selim/0000-0002-7962-6078; Saglam, Emre/0000-0002-7118-2572	Scientific Research Projects Coordination Center of the Hacettepe University [THD-2018-17407]	This work was supported by the Scientific Research Projects Coordination Center of the Hacettepe University (project no: THD-2018-17407) Ankara, Turkey.	Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Dang YL, 2016, DRUG DES DEV THER, V10, P851, DOI 10.2147/DDDT.S97380; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; El-Far AHAM, 2018, ONCOL LETT, V15, P4627, DOI 10.3892/ol.2018.7902; Gao YJ, 2002, LIFE SCI, V70, P2675, DOI 10.1016/S0024-3205(02)01525-4; Han X, 2010, PHYTOCHEMISTRY, V71, P1305, DOI 10.1016/j.phytochem.2010.04.022; Huang H, 2017, J BUON, V22, P112; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Knott EP, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040696; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lee YY, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1649-3; Liu JK, 2005, NEUROCRIT CARE, V2, P124, DOI 10.1385/NCC:2:2:124; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McConkey DJ, 1996, STEM CELLS, V14, P619, DOI 10.1002/stem.140619; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Swanson MEV, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68086-z; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; Zhou T, 2019, J MOL NEUROSCI, V68, P111, DOI 10.1007/s12031-019-01289-w	36	1	1	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	MAR 15	2021	352								577476	10.1016/j.jneuroim.2021.577476			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	RN7II	WOS:000640526200007	33476858				2022-02-06	
J	Sun, JP; Li, XY; Gu, XY; Du, HL; Zhang, GS; Wu, JL; Wang, F				Sun, Jianping; Li, Xiaoyu; Gu, Xiaoyu; Du, Hailong; Zhang, Gengshen; Wu, Jianliang; Wang, Feng			Neuroprotective effect of hydrogen sulfide against glutamate-induced oxidative stress is mediated via the p53/glutaminase 2 pathway after traumatic brain injury	AGING-US			English	Article						traumatic brain injury; hydrogen sulfide; glutamate; oxidative stress; p53	INDUCED CELL-DEATH; AUTOPHAGY; CONTRIBUTES; DEFICITS; MODEL	Several reports suggest that hydrogen sulfide (H2S) exerts multiple biological and physiological effects on the pathogenesis of traumatic brain injury (TBI). However, the exact molecular mechanism involved in this effect is not yet fully known. In this study, we found that H2S alleviated TBI-induced motor and spatial memory deficits, brain pathology, and brain edema. Moreover, sodium hydrosulfide (NaHS), an H2S donor, treatment markedly increased the expression of Bcl-2, while inhibited the expression of Bax and Cleaved caspase-3 in TBI-challenged rats. Tunnel staining also demonstrated these results. Treatment with NaHS significantly reduced the glutamate and glutaminase 2 (GLS-2) protein levels, and glutamate-mediated oxidative stress in TBI-challenged rats. Furthermore, we demonstrated that H2S treatment inhibited glutamate-mediated oxidative stress through the p53/GLS-2 pathway. Therefore, our results suggested that H2S protects brain injury induced by TBI through modulation of the glutamate-mediated oxidative stress in the p53/GLS-2 pathway-dependent manner.	[Sun, Jianping; Gu, Xiaoyu; Du, Hailong; Zhang, Gengshen; Wu, Jianliang; Wang, Feng] Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China; [Li, Xiaoyu] Hebei Med Univ, Dept Thyroid & Breast Surg, Hosp 2, Shijiazhuang, Hebei, Peoples R China		Wang, F (corresponding author), Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China.	wffw008@zcmu.edu.cn			Key research project of Health Commission of Hebei Province of China [20200892]	This work was supported by grants from the Key research project of Health Commission of Hebei Province of China (No. 20200892).	Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Chan SJ, 2017, NEUROCHEM INT, V105, P1, DOI 10.1016/j.neuint.2016.11.015; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Fridman EA, 2019, BRAIN, V142, P1887, DOI 10.1093/brain/awz118; Garzon F, 2018, J ALZHEIMERS DIS, V65, P1469, DOI 10.3233/JAD-180668; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hong MY, 2012, CHINESE MED J-PEKING, V125, P2019, DOI 10.3760/cma.j.issn.0366-6999.2012.11.032; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Jembrek MJ, 2018, TOXICOLOGY, V406, P58, DOI 10.1016/j.tox.2018.05.014; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Johanssen T, 2015, NEUROBIOL DIS, V81, P176, DOI 10.1016/j.nbd.2015.02.008; Kamat PK, 2016, MOL NEUROBIOL, V53, P2451, DOI 10.1007/s12035-015-9212-4; Karimi SA, 2017, BRAIN RES BULL, V134, P177, DOI 10.1016/j.brainresbull.2017.07.014; Kim JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163433; Kumar M, 2018, CNS NEUROL DISORD-DR, V17, P654, DOI 10.2174/1871527317666180605072018; Li QQ, 2019, INT J BIOCHEM CELL B, V107, P154, DOI 10.1016/j.biocel.2018.12.018; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; MacMullin P, 2020, CEREB CORTEX, V30, P6108, DOI 10.1093/cercor/bhaa157; Maiden MJ, 2020, AM J RESP CRIT CARE, V201, P167, DOI 10.1164/rccm.201903-0673OC; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Murray NM, 2020, JAMA NEUROL, V77, P411, DOI 10.1001/jamaneurol.2019.4672; Vincenzi F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051242; Wang LG, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170942; Wang WT, 2019, BIOCHEM BIOPH RES CO, V518, P657, DOI 10.1016/j.bbrc.2019.08.100; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Zhang JX, 2019, INT J BIOCHEM CELL B, V117, DOI 10.1016/j.biocel.2019.105636; Zhang M, 2018, NEUROCHEM RES, V43, P2435, DOI 10.1007/s11064-018-2671-z; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241	33	1	1	2	3	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	MAR 15	2021	13	5					7180	7189					10	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	QX8BK	WOS:000629567800011	33640879	gold, Green Published			2022-02-06	
J	Wilson, T; Wisborg, T; Vindenes, V; Jamt, RG; Furuhaugen, H; Bogstrand, ST				Wilson, Thomas; Wisborg, Torben; Vindenes, Vigdis; Jamt, Ragnhild G.; Furuhaugen, Havard; Bogstrand, Stig Tore			Psychoactive substances have major impact on injuries in rural arctic Norway - A prospective observational study	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						alcohol; arctic; AUDIT&#8208; C; drugs; injury; intoxication; narcotics; psychoactive; rural; trauma		Background Rural areas have increased injury mortality with a high pre-hospital death rate. Knowledge concerning the impact of psychoactive substances on injury occurrence is lacking for rural arctic Norway. These substances are also known to increase pre-, per- and postoperative risk. The aim was by prospective observational design to investigate the prevalence and characteristics of psychoactive substance use among injured patients in Finnmark county. Methods From January 2015 to August 2016, patients >= 18 years admitted to hospitals in Finnmark due to injury were approached when competent. Blood was analysed for ethanol, sedatives, opioids, hypnotics and illicit substances in consenting patients, who completed a questionnaire gathering demographic factors, self-reported use/behaviour and incident circumstances. Results In 684 injured patients who consented to participation (81% consented), psychoactive substances were detected in 35.7%, alcohol being the most prevalent (23%). Patients in whom substances were detected were more often involved in violent incidents (odds ratio 8.92 95% confidence interval 3.24-24.61), indicated harmful use of alcohol (odds ratio 3.56, 95% confidence interval 2.34-5.43), reported the incident being a fall (odds ratio 2.21, 95% confidence interval 1.47-3.33) and presented with a reduced level of consciousness (odds ratio 3.91, 95% confidence interval 1.58-9.67). Subgroup analysis revealed significant associations between testing positive for a psychoactive substance and being diagnosed with a head injury or traumatic brain injury. Conclusion A significant proportion of injured patients had used psychoactive substances prior to admission. Use was associated with violence, falls, at-risk alcohol consumption, decreased level of consciousness on admittance and head injury.	[Wilson, Thomas; Wisborg, Torben] Arctic Univ Norway, Univ Tromso, Tromso, Norway; [Wilson, Thomas; Vindenes, Vigdis; Jamt, Ragnhild G.; Furuhaugen, Havard; Bogstrand, Stig Tore] Oslo Univ Hosp, Sect Drug Abuse Res, Dept Forens Sci, Oslo, Norway; [Wilson, Thomas; Wisborg, Torben] Finnmark Hosp Trust, Hammerfest Hosp, Dept Anaesthesia & Intens Care, Hammerfest, Norway; [Wisborg, Torben] Oslo Univ Hosp, Div Emergencies & Crit Care, Norwegian Natl Advisory Unit Trauma, Oslo, Norway; [Bogstrand, Stig Tore] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway		Wilson, T (corresponding author), Univ Tromso, Fac Hlth Sci, POB 6050, N--9037 Tromso, Norway.	thomas.wilson@finnmarkssykehuset.no		Wilson, Thomas/0000-0003-4197-3362; Wisborg, Torben/0000-0002-7213-8012; Furuhaugen, Havard/0000-0002-8870-0428	Norwegian Ministry of Foreign Affairs	This project received funding for data acquisition from the Norwegian Ministry of Foreign Affairs as part of a larger study exploring relationships between injuries and the use of alcohol, illicit and psychoactive medicinal substances in the Barents region through the Norwegian health department`s project "Surveillance of alcohol and drug related traffic injuries in Murmansk Oblast and Finnmark county". Finnmark Hospital Trust has facilitated data acquisition through support by emergency department nurses and laboratory services, and funded part of the statistical analysis via research grants. Blood samples were analysed by the Department of Forensic Sciences at Oslo University Hospital, formerly the Norwegian Institute of Public Health. This department has also supported statistical analysis through research grants and a ph.d. grant to Thomas Wilson.	[Anonymous], 2019, INJ NORW; [Anonymous], 2018, FOLK; Aziz H, 2015, J TRAUMA ACUTE CARE, V79, P463, DOI 10.1097/TA.0000000000000777; Baeseman Zachary J, 2009, WMJ, V108, P359; Bakke HK, 2011, WORLD J SURG, V35, P1615, DOI 10.1007/s00268-011-1102-y; Bakke HK, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-14; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Bogstrand ST, 2013, DRUG ALCOHOL DEPEN, V127, P187, DOI 10.1016/j.drugalcdep.2012.06.029; Bogstrand ST, 2011, DRUG ALCOHOL DEPEN, V117, P132, DOI 10.1016/j.drugalcdep.2011.01.007; Byrne JP., 2019, JAMA SURG; Cohen E, 2007, DRUG ALCOHOL DEPEN, V86, P214, DOI 10.1016/j.drugalcdep.2006.06.008; Cordovilla-Guardia S, 2017, NURS RES, V66, P399, DOI 10.1097/NNR.0000000000000231; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Dixit D, 2016, PHARMACOTHERAPY, V36, P797, DOI 10.1002/phar.1770; Eliasen M, 2013, ANN SURG, V258, P930, DOI 10.1097/SLA.0b013e3182988d59; Eliassen E, 2014, J CHROMATOGR B, V971, P72, DOI 10.1016/j.jchromb.2014.09.018; Fatovich DM, 2011, J TRAUMA, V71, P1816, DOI 10.1097/TA.0b013e318238bd4c; Fatovich DM, 2009, J TRAUMA, V67, P910, DOI 10.1097/TA.0b013e3181815a26; Gjerde H, 2011, ACCIDENT ANAL PREV, V43, P1197, DOI 10.1016/j.aap.2010.12.034; Goodson CM, 2014, ALCOHOL CLIN EXP RES, V38, P2664, DOI 10.1111/acer.12529; Hernandez M, 2005, CURR OPIN ANESTHESIO, V18, P315, DOI 10.1097/01.aco.0000169241.21680.0b; Holter JA, 2019, ACTA ANAESTH SCAND, V63, P1089, DOI 10.1111/aas.13384; Holton A, 2019, AGE AGEING, V48, P824, DOI 10.1093/ageing/afz112; Jamt REG, 2017, TRAFFIC INJ PREV, V18, P681, DOI 10.1080/15389588.2017.1283027; Jarman MP, 2018, JAMA SURG, V153, P535, DOI 10.1001/jamasurg.2017.6133; Jarman MP, 2016, SURGERY, V160, P1551, DOI 10.1016/j.surg.2016.06.020; Jonsdottir GM, 2017, ACTA ANAESTH SCAND, V61, P408, DOI 10.1111/aas.12869; Kabashi S, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.107588; Keeves J., 2019, INJURY; Kristoffersen L, 2006, FORENSIC SCI INT, V161, P151, DOI 10.1016/j.forsciint.2006.03.034; Kuitunen-Paul S, 2018, J EPIDEMIOL COMMUN H, V72, P856, DOI 10.1136/jech-2017-210078; Lund HME, 2011, J CHROMATOGR B, V879, P3367, DOI 10.1016/j.jchromb.2011.09.002; MacLeod JBA, 2011, INJURY, V42, P922, DOI 10.1016/j.injury.2010.01.098; Maerz AH, 2019, J TRAUMA ACUTE CARE, V87, P147, DOI 10.1097/TA.0000000000002280; McPeake JM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0909-6; Menendez ME, 2015, CLIN ORTHOP RELAT R, V473, P2402, DOI 10.1007/s11999-015-4173-5; Moden B, 2010, J EPIDEMIOL COMMUN H, V64, P440, DOI 10.1136/jech.2009.098947; Norwegian Institute of Public Health, CAUS DEATH REG 2016; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; O'Brien Mary Claire, 2013, J Caffeine Res, V3, P59, DOI 10.1089/jcr.2013.0004; Peek-Asa C, 2004, AM J PUBLIC HEALTH, V94, P1689, DOI 10.2105/AJPH.94.10.1689; Puljula J, 2016, ANN SURG, V263, P1235, DOI 10.1097/SLA.0000000000001392; Raatiniemi L, 2016, ACTA ANAESTH SCAND, V60, P668, DOI 10.1111/aas.12682; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Riuttanen A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74753-y; Ronning TH., 2019, TIDSSKR LAEGEFOREN, V139; Rood PPM, 2016, EUR J EMERG MED, V23, P147, DOI 10.1097/MEJ.0000000000000186; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Schuckit MA, 2014, NEW ENGL J MED, V371, P2109, DOI 10.1056/NEJMra1407298; Statistics Norway, 2018, RE CRIM 2017; Statistics Norway, 2020, FAT INJ TRAFF ACC PO; Stephenson MT, 2003, DRUG ALCOHOL DEPEN, V72, P279, DOI 10.1016/j.drugalcdep.2003.08.003; Tetrault JM, 2008, CRIT CARE CLIN, V24, P767, DOI 10.1016/j.ccc.2008.05.005; Trauma ACoS-Co, 2007, ALC SCREEN BRIEF INT; Uljas E, 2020, ACTA ANAESTH SCAND, V64, P216, DOI 10.1111/aas.13484; Vitesnikova J, 2014, INJURY, V45, P1440, DOI 10.1016/j.injury.2014.01.004; von Elm E, 2007, BMJ-BRIT MED J, V335, P806; Wade D, 2014, ALCOHOL CLIN EXP RES, V38, P294, DOI 10.1111/acer.12247; Wilson T, 2021, ACTA ANAESTH SCAND, V65, P824, DOI 10.1111/aas.13807; Woods C, 2019, AUSTRALAS EMERG CARE, V22, P22, DOI 10.1016/j.auec.2018.11.001; Zhang XY, 2019, ACCIDENT ANAL PREV, V123, P222, DOI 10.1016/j.aap.2018.11.023	61	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JUL	2021	65	6					824	833		10.1111/aas.13807		MAR 2021	10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	SL7HL	WOS:000628855700001	33638866	Green Published, hybrid			2022-02-06	
J	Cardoso, FD; Tavares, CDO; Araujo, BHS; Mansur, F; Lopes-Martins, RAB; da Silva, SG				Cardoso, Fabrizio dos Santos; de Souza Oliveira Tavares, Cristiane; Araujo, Bruno Henrique Silva; Mansur, Fernanda; Lopes-Martins, Rodrigo Alvaro Brandao; Gomes da Silva, Sergio			Improved Spatial Memory And Neuroinflammatory Profile Changes in Aged Rats Submitted to Photobiomodulation Therapy	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Photobiomodulation; Brain; Aging; Cognitive function; Learning; Cytokine	LEVEL LASER THERAPY; MONOCYTE CHEMOATTRACTANT PROTEIN-1; COGNITIVE IMPAIRMENT; ACHILLES TENDINITIS; BRAIN-INJURY; 650 NM; INFLAMMATION; EXPRESSION; ACTIVATION; INTERLEUKIN-6	Recent evidences have shown the therapeutic potential of transcranial photobiomodulation on traumatic brain injury and Alzheimer's disease. Despite the promising benefits in the brain, little is known about the laser's effects in the absence of pathological conditions. We submitted young (4 months old) and aged (20 months old) rats to transcranial low-level laser and evaluated their exploratory activity and habituation in open field, anxiety in elevated plus maze, spatial memory in Barnes maze, and aversive memory in a step-down inhibitory avoidance task. Additionally, the levels of a panel of inflammatory cytokines and chemokines were quantified in two different brain regions: the cerebral cortex and the hippocampus. Young and aged rats submitted to transcranial laser exhibited better cognitive performance in Barnes maze than did control rats. Transcranial laser therapy decreased cortical levels of GM-CSF, IL-10, MCP-1, LIX, and TNF alpha in young rats and IL-5 in aged rats. High levels of IL-6, IL-10, and TNF-alpha were found in the cerebral cortex of aged rats submitted to transcranial laser. In the hippocampus, a decrease in IP-10 and fractalkine levels was observed in the aged rats from the laser group when compared to the aged rats from the control group. Our data indicate that transcranial photobiomodulation improves spatial learning and memory and alters the neuroinflammatory profile of young and aged rats' brains.	[Cardoso, Fabrizio dos Santos; de Souza Oliveira Tavares, Cristiane; Gomes da Silva, Sergio] Univ Mogi das Cruzes, Nucleo Pesquisas Tecnol, Ave Candido Xavier de Almeida & Souza 200, BR-08780911 Sao Paulo, SP, Brazil; [Araujo, Bruno Henrique Silva] Ctr Nacl Pesquisa Energia & Mat CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Mansur, Fernanda] Hosp Israelita Albert Einstein, Ctr Expt Res, Sao Paulo, SP, Brazil; [Lopes-Martins, Rodrigo Alvaro Brandao] Univ Brasil UB, Lab Biophoton & Expt Therapeut Hlth & Esthet, Sao Paulo, SP, Brazil; [Gomes da Silva, Sergio] Ctr Univ UNIFAMINAS UNIFAMINAS, Muriae, MG, Brazil; [Gomes da Silva, Sergio] Fundacao Cristiano Varella FCV, Hosp Canc Muriae, Muriae, MG, Brazil		da Silva, SG (corresponding author), Univ Mogi das Cruzes, Nucleo Pesquisas Tecnol, Ave Candido Xavier de Almeida & Souza 200, BR-08780911 Sao Paulo, SP, Brazil.; da Silva, SG (corresponding author), Ctr Univ UNIFAMINAS UNIFAMINAS, Muriae, MG, Brazil.; da Silva, SG (corresponding author), Fundacao Cristiano Varella FCV, Hosp Canc Muriae, Muriae, MG, Brazil.	sergio.silva@fcv.org.br	Lopes-Martins, Rodrigo A B/E-2013-2013; Torres, Bruno/P-9975-2019	Lopes-Martins, Rodrigo A B/0000-0002-4533-1335; Torres, Bruno/0000-0003-0012-4217; Gomes da Silva, Sergio/0000-0002-9650-809X; dos Santos Cardoso, Fabrizio/0000-0002-7547-8880	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/16443-0]; Centros de Pesquisa, Inovacao e Difusao (CEPID) [2013/08028-1]	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Centros de Pesquisa, Inovacao e Difusao (CEPID; #2013/08028-1), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; #2017/16443-0).	Albertini R, 2004, J PHOTOCH PHOTOBIO B, V74, P101, DOI 10.1016/j.jphotobiol.2004.03.002; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Ataie-Kachoie P, 2014, J CLIN PATHOL, V67, P932, DOI 10.1136/jclinpath-2014-202493; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bjordal JM, 2006, PHOTOMED LASER SURG, V24, P158, DOI 10.1089/pho.2006.24.158; Bjordal JM, 2006, BRIT J SPORT MED, V40, P76, DOI 10.1136/bjsm.2005.020842; Blalock EM, 2003, J NEUROSCI, V23, P3807; Cardoso FD, 2017, HIPPOCAMPUS, V27, P899, DOI 10.1002/hipo.22740; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Council for International Organizations of Medical Sciences, 1985, ALTERN LAB ANIM, V12, pii; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Cardoso FD, 2021, MOL NEUROBIOL, V58, P2256, DOI 10.1007/s12035-020-02247-z; El Massri N, 2018, NEUROBIOL AGING, V66, P131, DOI 10.1016/j.neurobiolaging.2018.02.019; Godbout JP, 2009, IMMUNOL ALLERGY CLIN, V29, P321, DOI 10.1016/j.iac.2009.02.007; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hanzel CE, 2014, NEUROBIOL AGING, V35, P2249, DOI 10.1016/j.neurobiolaging.2014.03.026; Heneka MT, 2006, CLIN NEUROSCI RES, V6, P247, DOI 10.1016/j.cnr.2006.09.005; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Jurgens HA, 2012, EXP NEUROL, V233, P40, DOI 10.1016/j.expneurol.2010.11.014; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Krzyszton CP, 2008, AM J PHYSIOL-REG I, V295, pR1109, DOI 10.1152/ajpregu.90302.2008; Lai WJ, 2013, J PROTEOME RES, V12, P832, DOI 10.1021/pr300895r; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Liva SM, 2001, NEUROCHEM RES, V26, P629, DOI 10.1023/A:1010983119125; Lopes-Martins RAB, 2005, PHOTOMED LASER SURG, V23, P377, DOI 10.1089/pho.2005.23.377; Lopes-Martins RAB, 2006, PHOTOMED LASER SURG, V24, P197, DOI 10.1089/pho.2006.24.197; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Marcos RL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1447, DOI 10.1111/j.1751-1097.2011.00999.x; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Olazaran J, 2004, NEUROLOGY, V63, P2348, DOI 10.1212/01.WNL.0000147478.03911.28; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Rozzini L, 2007, INT J GERIATR PSYCH, V22, P356, DOI 10.1002/gps.1681; Salehpour F, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00074; Salehpour F, 2017, NEUROBIOL AGING, V58, P140, DOI 10.1016/j.neurobiolaging.2017.06.025; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Scholtzova H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0101-2; Shang DS, 2016, J CEREBR BLOOD F MET, V36, P1978, DOI 10.1177/0271678X16660983; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Shim DSC, 2012, IMMUNOL CELL BIOL, V90, P553, DOI 10.1038/icb.2011.69; Shin JH, 2014, BBA-GENE REGUL MECH, V1839, P826, DOI 10.1016/j.bbagrm.2014.06.019; Shinhmar H, 2020, J GERONTOL A-BIOL, V75, pE49, DOI 10.1093/gerona/glaa155; Sivapathasuntharam C, 2017, NEUROBIOL AGING, V52, P66, DOI 10.1016/j.neurobiolaging.2017.01.001; Terao Y, 2009, NEUROSCI RES, V64, P75, DOI 10.1016/j.neures.2009.01.017; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Wu J, 2013, NEUROBIOL AGING, V34, P2843, DOI 10.1016/j.neurobiolaging.2013.06.003; Xu ZQ, 2017, MOL NEUROBIOL, V54, P4551, DOI 10.1007/s12035-016-9983-2; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; Yao X, 2014, PHARMACOL THERAPEUT, V141, P125, DOI 10.1016/j.pharmthera.2013.09.004; Ye SM, 2001, NEUROIMMUNOMODULAT, V9, P183, DOI 10.1159/000049025	60	1	1	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.												10.1007/s10571-021-01069-4		MAR 2021	12	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	QV1BO	WOS:000627712000002	33704604				2022-02-06	
J	Zhu, XF; Long, ZY; Bao, TT; Liu, L; Yang, KL				Zhu, Xiaofei; Long, Zhiyong; Bao, Tingting; Liu, Liang; Yang, Kailin			Exploring the mechanism of Radix Rhei Et Rhizome intervention in intracerebral hemorrhage based on systematic pharmacology and proteomics strategy	BIOSCIENCE REPORTS			English	Article							CHINESE HERBAL PRESCRIPTIONS; PROTEIN-INTERACTION NETWORKS; TRAUMATIC BRAIN-INJURY; RAT MODEL; PYRUVATE-CARBOXYLASE; BREAST-CANCER; RHUBARB; PREDICTION; DECOCTION; CHRYSOPHANOL	Objective: To explore the mechanism of Radix Rhei Et Rhizome (Dahuang, DH) intervention in intracerebral hemorrhage (ICH) based on systematic pharmacology and proteomics strategy. Methods: The systematic pharmacological strategies were utilized to find the bioactive compounds of Radix Rhei Et Rhizome, predict its potential targets, and collect ICH's disease genes; then, the Cytoscape 3.7.1 software was applied for network construction and network topology analysis. After that, in-depth analysis of the proteomics data of Radix Rhei Et Rhizome intervention in ICH was performed to complement and validate the results of systematic pharmacological predictions. Results: A total of three major networks were constructed in the present study: (1) compound-compound target network of Radix Rhei Et Rhizome, (2) DH-ICH PPI network, (3) proteomics proteins' PPI network. These three major networks have been analyzed by network topology, and several small networks derived (such as signaling pathway networks). The enrichment analysis showed that Radix Rhei Et Rhizome can intervene in several biological process (such as inflammation, smooth muscle proliferation, platelet activation, blood pressure regulation, angiogenesis, hypoxia, and inflammatory response of leukocytes), signaling pathway (such as FoxO signaling pathway, complement and coagulation cascades, cGMP-PKG signaling pathway, and Rap1 signaling pathway), and reactome pathway (such as signaling by interleukins, interleukin-4 and interleukin-13 signaling, nuclear receptor transcription pathway, and platelet activation). Conclusion: Radix Rhei Et Rhizome may intervene in ICH-related biological process, signaling pathway, and reactome pathway found in this research so as to achieve the effect of treating ICH related injuries.	[Zhu, Xiaofei] Cent South Univ, Xiangya Hosp, Inst Integrat Med, Dept Integrated Tradit Chinese & Western Med, Changsha 410008, Peoples R China; [Long, Zhiyong] Shantou Univ, Guangdong Prov, Med Coll, Shantou, Peoples R China; [Long, Zhiyong] Shantou Univ, Guangdong Gen Hosp, Dept Phys Med & Rehabil, Med Coll, Shantou, Guangdong, Peoples R China; [Bao, Tingting] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Bao, Tingting] Beijing Univ Chinese Med, Sch Clin Med, Xiyuan Hosp, Beijing, Peoples R China; [Liu, Liang] Peoples Hosp Ningxiang City, Ningxiang 410600, Hunan, Peoples R China; [Yang, Kailin] Capital Med Univ, Grad Coll, Beijing, Peoples R China		Liu, L (corresponding author), Peoples Hosp Ningxiang City, Ningxiang 410600, Hunan, Peoples R China.; Yang, KL (corresponding author), Capital Med Univ, Grad Coll, Beijing, Peoples R China.	liuliang.ningxiang@hotmail.com; yang.cardiology@ccmu.edu.cn		yang, kai lin/0000-0002-1442-8644			Ano R, 2004, BIOORGAN MED CHEM, V12, P257, DOI 10.1016/j.bmc.2003.10.002; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bao TT, 2019, MED SCI MONITOR, V25, P8152, DOI 10.12659/MSM.917393; Beez T, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0994-z; Belousov AB, 2017, BMC CELL BIOL, V18, DOI 10.1186/s12860-016-0120-x; Cao YJ, 2017, CHIN MED-UK, V12, DOI 10.1186/s13020-017-0158-5; Chen FP, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-91; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Gao X.Y., 2010, J PHARM ANAL, V30, P1636; Gross BA, 2019, JAMA-J AM MED ASSOC, V321, P1295, DOI 10.1001/jama.2019.2413; Gu JW, 2000, CHINESE MED J-PEKING, V113, P529; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hardy SD, 2017, ONCOTARGET, V8, P103302, DOI 10.18632/oncotarget.21871; Hu Gui-xiang, 2009, Journal of Zhejiang University (Science), V36, P304, DOI 10.3785/j.issn.1008-9497.2009.03.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Li G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42842; Li MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42484; Li X, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3790728; Libring S, 2020, CANCERS, V12, DOI 10.3390/cancers12051270; Liu T, 2019, J ETHNOPHARMACOL, V232, P244, DOI 10.1016/j.jep.2018.11.032; Lu Jian-Sheng, 2005, Zhongguo Zhong Yao Za Zhi, V30, P1939; Lu L, 2014, COMPLEMENT THER MED, V22, P1060, DOI 10.1016/j.ctim.2014.10.002; Ma Y, 2014, NEUROCHEM RES, V39, P1809, DOI 10.1007/s11064-014-1395-y; Metodiewa D, 1997, BIOCHEM MOL BIOL INT, V41, P1067; Morotti A, 2016, EMERG MED CLIN N AM, V34, P883, DOI 10.1016/j.emc.2016.06.010; Ren JX, 2013, NEURAL REGEN RES, V8, P2039, DOI 10.3969/j.issn.1673-5374.2013.22.003; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Sansing LH, 2016, SEMIN NEUROL, V36, P223, DOI 10.1055/s-0036-1583296; Shinde A, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0204-5; Shinde A, 2019, CANCER RES, V79, P1831, DOI 10.1158/0008-5472.CAN-18-2636; Shinde A, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1008-9; Shinde A, 2018, MOL CANCER RES, V16, P1579, DOI 10.1158/1541-7786.MCR-18-0151; Shinde A, 2016, TOXICOL RES-UK, V5, P248, DOI 10.1039/c5tx00211g; Stelzer G., 2016, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/cpbi.5, 10.1002/cpbi.5]; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang Yu-ping, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P152; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Uzunalli Gozde, 2019, Oncotarget, V10, P6334, DOI 10.18632/oncotarget.27274; Walters WP, 2002, ADV DRUG DELIVER REV, V54, P255, DOI 10.1016/S0169-409X(02)00003-0; Wang X, 2017, NUCLEIC ACIDS RES, V45, pW356, DOI 10.1093/nar/gkx374; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang Y, 2016, EXP THER MED, V12, P250, DOI 10.3892/etm.2016.3330; Wilmanski T, 2017, CANCER LETT, V411, P171, DOI 10.1016/j.canlet.2017.09.045; Xu X, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1655-x; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Yang KL, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00825; Yang KL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54408-3; Yang KL, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109253; Yang ZY, 2018, PHARMACOGN MAG, V14, P134, DOI 10.4103/pm.pm_218_17; Yuan M.G., 2007, CHIN J TRADITIONAL C, V35, P1766; Zeng LT, 2017, J ETHNOPHARMACOL, V199, P68, DOI 10.1016/j.jep.2017.01.045; Zhang HX, 2004, J CHROMATOGR B, V812, P175, DOI 10.1016/j.jchromb.2004.08.010; Zhang N, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/370530; Zhao YM, 2016, NEUROSCI LETT, V630, P16, DOI 10.1016/j.neulet.2016.07.036; Zhou XP, 2011, IMMUNOPHARM IMMUNOT, V33, P594, DOI 10.3109/08923973.2010.549135	56	1	1	6	9	PORTLAND PRESS LTD	LONDON	1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	MAR 10	2021	41	3								10.1042/BSR20201910			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RF1OL	WOS:000634615700001	32803256	Green Published, gold			2022-02-06	
J	Alsalaheen, B; Almeida, A; Eckner, J; Freeman, J; Ichesco, I; Popovich, M; Streicher, N; Lorincz, M				Alsalaheen, Bara; Almeida, Andrea; Eckner, James; Freeman, Jeremiah; Ichesco, Ingrid; Popovich, Michael; Streicher, Nicholas; Lorincz, Matthew			Do male and female adolescents report symptoms differently after concussion?	BRAIN INJURY			English	Article						sex; sport Concussion Assessment Tool; SCAT5; mTBI; mild Traumatic Brain Injury		We investigated sex-based differences in the presence and severity of aggregated symptom indicators as well as individual concussion symptoms. Materials and Methods: A cross-sectional examination of sex differences in symptoms reported by adolescents upon initial concussion evaluation at a concussion clinic. Nine hundred and eighty-six adolescents completed the Sport Concussion Assessment Tool (SCAT5) symptom checklist. Chi-square and Mann-Whitney U tests were used for differences in the presence and severity of symptoms, respectively. Sex differences in global indices of symptom distress were compared. Results: Females endorsed more symptoms (Female: Median (M)=15, Interquartile range (IQR):9-18 vs. Male: M=11, IQR: 6-15, p<0.001) and a greater total symptom score (Female: M=37, IQR:16-45 vs. Male: M=20, IQR:8-39). After False Discovery Rate (FDR) adjustment, females endorsed the presence of 21 of 22 individual symptoms more frequently than males (p <= 0.039), with greater symptom severity for 20 of 22 individual symptoms (p <= 0.036). Moderate ESs were observed for sex-based differences in the total symptom score and the global severity index. Small ESs was observed for differences in most individual symptoms. Conclusions: The greater frequency and severity of concussion symptoms reported by female adolescents highlights the importance of considering sex as a modifier for the management of concussion.	[Alsalaheen, Bara] Univ Michigan Flint, Dept Phys Therapy, 303 E Kearsley St, Flint, MI 48502 USA; [Almeida, Andrea; Freeman, Jeremiah; Popovich, Michael; Streicher, Nicholas; Lorincz, Matthew] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Eckner, James] Univ Michigan, Ann Arbor, MI 48109 USA; [Ichesco, Ingrid] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA		Alsalaheen, B (corresponding author), Univ Michigan Flint, Dept Phys Therapy, 303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu					Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P829, DOI 10.2519/jospt.2019.8869; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bangasser DA, 2010, MOL PSYCHIATR, V15, P896, DOI 10.1038/mp.2010.66; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Cohen J, 1998, STAT POWER ANAL BEHA; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Gonzalez L, 2020, INJURY EPIDEMIOL, V7, DOI 10.1186/s40621-019-0228-5; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Verma Rohit, 2011, Ind Psychiatry J, V20, P4, DOI 10.4103/0972-6748.98407; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	40	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					698	704		10.1080/02699052.2021.1896034		MAR 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000626925700001	33689531				2022-02-06	
J	Hammond, FM; Zafonte, RD; Tang, Q; Jang, JH				Hammond, Flora M.; Zafonte, Ross D.; Tang, Qing; Jang, Jeong Hoon			Carbamazepine for Irritability and Aggression after Traumatic Brain Injury: A Randomized, Placebo-Controlled Study	JOURNAL OF NEUROTRAUMA			English	Article						aggression; agitation; brain injuries; carbamazepine; irritability		This study tested the hypothesis that carbamazepine (CBZ) reduces irritability/aggression among individuals >6 months post-traumatic brain injury (TBI). Seventy individuals were enrolled in a parallel-group, randomized, double-blind, placebo-controlled, forced-titration trial of CBZ (n = 35) versus placebo (n = 35). Participants were randomly assigned to receive CBZ or placebo 42 days with outcome assessed at baseline and Day 42. Dose was titrated up to 400 mg CBZ or placebo equivalent two times daily. Symptoms of irritability and aggression were measured using the Neuropsychiatric Inventory Irritability (NPI-I) and Aggression (NPI-A) domains as a composite measure (NPI-I/A). Global impression of change was recorded from participant, observer, and study clinician. The CBZ group did not differ significantly from the placebo group (p = 0.60 and 0.59 for NPI-I/A observer and participant ratings, respectively). High placebo effects were observed with minimal clinically important difference in observer NPI-I/A 57% in CBZ group and 77% in placebo group (p = 0.09). Findings were similar for participant ratings. Eighteen of 35 had therapeutic CBZ level >= 4. Therapeutic sample analysis revealed similar high placebo response and non-significant differences except clinician ratings favoring CBZ. Non-serious adverse events occurred more frequently in the CBZ group with greater nervous system effects. CBZ up to 400 mg two times daily was not superior to placebo at reducing irritability/aggression according observers and participants. Large placebo effects may have masked the detection of differences. Clinician rating metrics suggest benefit, and thus, CBZ should remain a treatment option for the experienced brain injury clinician. Data are provided that may aid treatment decisions.	[Hammond, Flora M.; Tang, Qing; Jang, Jeong Hoon] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Atrium Hlth, Dept Phys Med & Rehabil, Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Zafonte, Ross D.] Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp,Harvard Med Sch, Boston, MA USA		Hammond, FM (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133A20016]	The research reported in this article was supported by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number H133A20016). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS).	Andrade C, 2015, J CLIN PSYCHIAT, V76, pE330, DOI 10.4088/JCP.15f09870; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barratt E S, 1991, J Neuropsychiatry Clin Neurosci, V3, pS35; Bird EL, 2013, HEALTH PSYCHOL, V32, P829, DOI 10.1037/a0032078; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; ChathamShowalter PE, 1996, J NEUROPSYCH CLIN N, V8, P96; Citrome L, 2013, INT J CLIN PRACT, V67, P407, DOI 10.1111/ijcp.12142; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dougherty DM, 1999, PSYCHIAT RES, V85, P315, DOI 10.1016/S0165-1781(99)00011-6; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Fleminger S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003299.pub2; GALBRAITH S, 1985, BRIT MED J, V291, P1668, DOI 10.1136/bmj.291.6510.1668; Gould KR, 2019, NEUROPSYCHOL REHABIL, V29, P376, DOI 10.1080/09602011.2017.1307767; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hammond FM, 2017, J HEAD TRAUMA REHAB, V32, P308, DOI 10.1097/HTR.0000000000000342; Hammond FM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000136; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hicks AJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01169; Kamper SJ, 2009, J MAN MANIP THER, V17, P163, DOI 10.1179/jmt.2009.17.3.163; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Leucht S, 2006, NEUROPSYCHOPHARMACOL, V31, P406, DOI 10.1038/sj.npp.1300873; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Malec JF, 2018, ARCH PHYS MED REHAB, V99, P603, DOI 10.1016/j.apmr.2017.06.038; Malec JF, 2018, ARCH PHYS MED REHAB, V99, P281, DOI 10.1016/j.apmr.2017.07.020; McCarthy RJ, 2018, COLLABRA-PSYCHOL, V4, DOI 10.1525/collabra.104; Miciak M, 2012, SCAND J CARING SCI, V26, P394, DOI 10.1111/j.1471-6712.2011.00923.x; MUNTANER C, 1990, DRUG ALCOHOL DEPEN, V25, P1, DOI 10.1016/0376-8716(90)90133-Y; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P286, DOI 10.1097/HTR.0000000000000277; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Neumann DR, 2011, J HEAD TRAUMA REHAB, V26, P375, DOI 10.1097/HTR.0b013e3181f8d52d; Polich G, 2018, J NEUROTRAUM, V35, P1205, DOI 10.1089/neu.2017.5506; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Raine A, 1998, BEHAV SCI LAW, V16, P319, DOI 10.1002/(SICI)1099-0798(199822)16:3<319::AID-BSL311>3.0.CO;2-G; Sabaz M., CHALLENGING BEHAV PR; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; SNAITH RP, 1985, BRIT J PSYCHIAT, V147, P127, DOI 10.1192/bjp.147.2.127; Spahn JM, 2010, J AM DIET ASSOC, V110, P879, DOI 10.1016/j.jada.2010.03.021; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Williamson D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029604	51	1	1	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2238	2246		10.1089/neu.2020.7530		MAR 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000628690600001	33563104				2022-02-06	
J	Martinez-Molina, N; Siponkoski, ST; Kuusela, L; Laitinen, S; Holma, M; Ahlfors, M; Jordan-Kilkki, P; Ala-Kauhaluoma, K; Melkas, S; Pekkola, J; Rodriguez-Fornells, A; Laine, M; Ylinen, A; Rantanen, P; Koskinen, S; Cowley, BU; Sarkamo, T				Martinez-Molina, Noelia; Siponkoski, Sini-Tuuli; Kuusela, Linda; Laitinen, Sari; Holma, Milla; Ahlfors, Mirja; Jordan-Kilkki, Paivi; Ala-Kauhaluoma, Katja; Melkas, Susanna; Pekkola, Johanna; Rodriguez-Fornells, Antoni; Laine, Matti; Ylinen, Aarne; Rantanen, Pekka; Koskinen, Sanna; Cowley, Benjamin Ultan; Sarkamo, Teppo			Resting-State Network Plasticity Induced by Music Therapy after Traumatic Brain Injury	NEURAL PLASTICITY			English	Article							FUNCTIONAL CONNECTIVITY; EXECUTIVE FUNCTION; COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE; AMYLOID-BETA; DEFAULT; HUBS; NEUROPLASTICITY; DYSFUNCTION; PERCEPTION	Traumatic brain injury (TBI) is characterized by a complex pattern of abnormalities in resting-state functional connectivity (rsFC) and network dysfunction, which can potentially be ameliorated by rehabilitation. In our previous randomized controlled trial, we found that a 3-month neurological music therapy intervention enhanced executive function (EF) and increased grey matter volume in the right inferior frontal gyrus (IFG) in patients with moderate-to-severe TBI (N = 40). Extending this study, we performed longitudinal rsFC analyses of resting-state fMRI data using a ROI-to-ROI approach assessing within-network and between-network rsFC in the frontoparietal (FPN), dorsal attention (DAN), default mode (DMN), and salience (SAL) networks, which all have been associated with cognitive impairment after TBI. We also performed a seed-based connectivity analysis between the right IFG and whole-brain rsFC. The results showed that neurological music therapy increased the coupling between the FPN and DAN as well as between these networks and primary sensory networks. By contrast, the DMN was less connected with sensory networks after the intervention. Similarly, there was a shift towards a less connected state within the FPN and SAL networks, which are typically hyperconnected following TBI. Improvements in EF were correlated with rsFC within the FPN and between the DMN and sensorimotor networks. Finally, in the seed-based connectivity analysis, the right IFG showed increased rsFC with the right inferior parietal and left frontoparietal (Rolandic operculum) regions. Together, these results indicate that the rehabilitative effects of neurological music therapy after TBI are underpinned by a pattern of within- and between-network connectivity changes in cognitive networks as well as increased connectivity between frontal and parietal regions associated with music processing.	[Martinez-Molina, Noelia; Siponkoski, Sini-Tuuli; Sarkamo, Teppo] Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Mus Ageing & Rehabil Team, Helsinki, Finland; [Kuusela, Linda] Univ Helsinki, Dept Phys, Helsinki, Finland; [Kuusela, Linda; Pekkola, Johanna] Helsinki Univ Cent Hosp, HUS Med Imaging Ctr, Dept Radiol, Helsinki, Finland; [Kuusela, Linda; Pekkola, Johanna] Univ Helsinki, Helsinki, Finland; [Laitinen, Sari] Espoo Hosp, Espoo, Finland; [Holma, Milla] Mus Therapy Cooperat Instrumental, Helsinki, Finland; [Ahlfors, Mirja] Private Mus Therapy, Espoo, Finland; [Jordan-Kilkki, Paivi] Dial Partner Oy, Espoo, Finland; [Ala-Kauhaluoma, Katja] Ludus Assessment & Intervent Serv, Helsinki, Finland; [Melkas, Susanna; Ylinen, Aarne] Univ Helsinki, Dept Neurol, Helsinki, Finland; [Melkas, Susanna; Ylinen, Aarne] Helsinki Univ Hosp, Helsinki, Finland; [Rodriguez-Fornells, Antoni] Bellvitge Biomed Res Inst, Cognit & Brain Plastic Grp, Barcelona, Spain; [Rodriguez-Fornells, Antoni] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [Rodriguez-Fornells, Antoni] Catalan Inst Res & Adv Studies, Barcelona, Spain; [Laine, Matti] Abo Akad Univ, Dept Psychol, Turku, Finland; [Ylinen, Aarne] Tampere Univ Hosp, Tampere, Finland; [Rantanen, Pekka] Helsinki Univ Hosp, Dept Phys & Rehabil Med, Helsinki, Finland; [Rantanen, Pekka] Kanta Hame Cent Hosp, Hameenlinna, Finland; [Koskinen, Sanna] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Cowley, Benjamin Ultan] Univ Helsinki, Fac Educ Sci, Helsinki, Finland; [Cowley, Benjamin Ultan] Univ Helsinki, Fac Arts, Dept Digital Humanities, Cognit Sci, Helsinki, Finland		Martinez-Molina, N (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Mus Ageing & Rehabil Team, Helsinki, Finland.	noelia.martinezmolina@gmail.com	Cowley, Benjamin Ultan/A-6271-2019	Cowley, Benjamin Ultan/0000-0001-8828-2994; Koskinen, Sanna/0000-0002-3453-5084; Siponkoski, Sini-Tuuli/0000-0001-8078-3620; Melkas, Susanna/0000-0003-0564-9637; Martinez-Molina, Noelia/0000-0001-7699-5540	Academy of FinlandAcademy of FinlandEuropean Commission [277693, 299044, 306625]; University of Helsinki [313/51/2013]; Social Insurance Institution of Finland [18/26/2013]; Yrjo Johansson Foundation [6464]; Finnish Association of People with Physical Disabilities and Helsinki Uusimaa Hospital district [461/13/01/00/2015, 154/13/01/2016]	Financial support was provided by the Academy of Finland (grants no. 277693, 299044, and 306625), University of Helsinki (grant no. 313/51/2013), Social Insurance Institution of Finland (grant no. 18/26/2013), Yrjo Johansson Foundation (grant no. 6464), and the Finnish Association of People with Physical Disabilities and Helsinki Uusimaa Hospital district (grants nos. 461/13/01/00/2015 and 154/13/01/2016). We would like to thank the multi-disciplinary team of experts participating in the planning and data collection: music therapist Esa Ala-Ruona participated in planning of the intervention; Professor Mari Tervaniemi and neurologist Anne Vehmas took part in the initial planning of the study; research nurse Veera Lotvonen recruited the participants with the help of neuropsychologists Jaana Sarajuuri and Titta Ilvonen. Above all, we want to thank the patients with TBI and their family members who participated in the study.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Andersen SM, 2010, NEUROIMAGE, V53, P78, DOI 10.1016/j.neuroimage.2010.06.003; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bashwiner DM, 2020, NEUROIMAGE, V218, DOI 10.1016/j.neuroimage.2020.116940; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Belfi AM, 2017, NEUROPSYCHOLOGIA, V97, P29, DOI 10.1016/j.neuropsychologia.2017.01.030; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bharath RD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00513; Bianco R, 2016, NEUROIMAGE, V142, P444, DOI 10.1016/j.neuroimage.2016.08.025; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burgess PW, 2017, J INT NEUROPSYCH SOC, V23, P755, DOI 10.1017/S1355617717000704; Carpentier SM, 2016, J COGNITIVE NEUROSCI, V28, P1603, DOI 10.1162/jocn_a_00988; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cheung VKM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22144-9; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; de la Tremblaye PB, 2019, NEUROPHARMACOLOGY, V145, P13, DOI 10.1016/j.neuropharm.2018.02.032; Deco G, 2014, NEURON, V84, P892, DOI 10.1016/j.neuron.2014.08.034; Dixon ML, 2018, P NATL ACAD SCI USA, V115, pE1598, DOI 10.1073/pnas.1715766115; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Griffis JC, 2019, CELL REP, V28, P2527, DOI 10.1016/j.celrep.2019.07.100; Habibi A, 2018, ANN NY ACAD SCI, V1423, P73, DOI 10.1111/nyas.13606; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Han K, 2018, NEUROIMAGE-CLIN, V18, P262, DOI 10.1016/j.nicl.2018.01.030; Han KW, 2018, HUM BRAIN MAPP, V39, P2955, DOI 10.1002/hbm.24052; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hutchison RM, 2012, FRONT NEUROANAT, V6, P1, DOI 10.3389/fnana.2012.00029; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jaschke AC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00103; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Li LC, 2013, NEUROIMAGE, V80, P462, DOI 10.1016/j.neuroimage.2013.04.024; Lynch C, 2016, J MUSIC THER, V53, P279, DOI 10.1093/jmt/thw008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mah LWY, 2005, J NEUROPSYCH CLIN N, V17, P66, DOI 10.1176/appi.neuropsych.17.1.66; Martin N, 2012, APHASIOLOGY, V26, P462, DOI 10.1080/02687038.2011.619516; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Moradzadeh L, 2015, COGNITIVE SCI, V39, P992, DOI 10.1111/cogs.12183; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Myers N, 2014, BRAIN, V137, P2052, DOI 10.1093/brain/awu103; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nieto-Castanon A., 2020, HDB UNCTIONAL CONNEC; Nijhuis EHJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065511; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Putkinen V, 2015, ANN NY ACAD SCI, V1337, P153, DOI 10.1111/nyas.12656; Raglio A, 2015, WORLD J PSYCHIATR, V5, P68, DOI 10.5498/wjp.v5.i1.68; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Royal I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155291; Sachs M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187254; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Sarkamo T, 2013, WIRES COGN SCI, V4, P441, DOI 10.1002/wcs.1237; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Siponkoski ST, 2020, J NEUROTRAUM, V37, P618, DOI 10.1089/neu.2019.6413; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Strong JV, 2019, AGING NEUROPSYCHOL C, V26, P367, DOI 10.1080/13825585.2018.1448356; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Thaut MH, 2009, CORTEX, V45, P44, DOI 10.1016/j.cortex.2007.09.009; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; Vik BMD, 2018, BRAIN INJURY, V32, P634, DOI 10.1080/02699052.2018.1431842; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wechsler D., 2008, WECHSLER MEMORY SCAL; Wechsler D., 2012, WECHSLER ADULT INTEL; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zamorano AM, 2017, HUM BRAIN MAPP, V38, P4834, DOI 10.1002/hbm.23682; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zuk Jennifer, 2014, PLoS One, V9, pe99868, DOI 10.1371/journal.pone.0099868; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	108	1	1	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.	MAR 9	2021	2021								6682471	10.1155/2021/6682471			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RB1MO	WOS:000631880700001	33763126	Green Published, gold, Green Submitted			2022-02-06	
J	Schultz, R; Tate, RL; Perdices, M				Schultz, Regina; Tate, Robyn L.; Perdices, Michael			Neuropsychological recovery during the first 12 months after severe traumatic brain injury: A longitudinal study with monthly assessments	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury; Cognition disorders; Neuropsychological recovery; Practice effects; Psychometric tests		Neuropsychologists are commonly asked practical questions about cognitive recovery in the first year following moderate-to-severe traumatic brain injury (TBI), however guiding evidence to provide answers is limited. The design of this longitudinal study rectifies methodological problems in the literature by taking serial assessments on a monthly basis from 3- to 12-months post-trauma in a severe TBI sample (n = 23), and using four alternate forms of a brief yet sensitive cognitive assessment battery. Fifteen variables sampling seven cognitive domains were used: orientation, attention, processing speed, executive function, memory, language and visuospatial function. A matched control group (n = 23) was used to establish equivalence of the four alternate forms (no statistically significant differences), document practice effects (no statistically significant differences), and provide a comparison standard of cognitive functioning against which to interpret the TBI recovery curves. Twenty-one of 23 consenting TBI participants continued with the serial assessments. Hierarchical growth model analyses typically revealed linear recovery trajectories over the first 12 months. However, by 12-months post-trauma, a significant proportion (up to 36%) had residual mild to severe impairments in various cognitive domains. These results provide detailed information about patterns of cognitive recovery that also have direct clinical application.	[Schultz, Regina] Agcy Clin Innovat, Sydney, NSW, Australia; [Tate, Robyn L.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Med Sch Northern, Kolling Inst Med Res, Sydney, NSW, Australia; [Perdices, Michael] Royal North Shore Hosp, Dept Neurol, Sydney, NSW, Australia		Tate, RL (corresponding author), Royal North Shore Hosp, Kolling Inst Med Res, John Walsh Ctr Rehabil Res, Level 12, St Leonards, NSW, Australia.	robyn.tate@sydney.edu.au					Attix DK, 2009, CLIN NEUROPSYCHOL, V23, P21, DOI 10.1080/13854040801945078; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bell KR, 2008, AM J PHYS MED REHAB, V87, P330, DOI 10.1097/PHM.0b013e318168d092; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benton A., 1994, CONTRIBUTIONS NEUROP; Benton AL, 1994, MULTILINGUAL APHASIA; Bird CM, 2003, BRIT J CLIN PSYCHOL, V42, P407, DOI 10.1348/014466503322528946; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Code, 2014, SOCIAL COMMUNICATION, P1; COHEN MJ, 2000, ARCH CLIN NEUROPSYCH, V15; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; CORRIGAN JD, 1997, ARCH PHYS MED REHAB, V78; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Field A., 2009, DISCOVERING STAT USI, V3rd ed; Fisher JP., 1992, HUNDRED PICTURES NAM; FLEISCHMANN U M, 1991, Clinical Gerontologist, V10, P73, DOI 10.1300/J018v10n03_07; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Golden C.J., 1978, STROOP COLOR WORD TE; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Ingram F, 1997, NEUROPSY NEUROPSY BE, V10, P144; KERSEL DA, 2001, BRAIN INJURY, V15; Knight J.A., 2003, HDB REY OSTERRIETH C; Lacritz L H, 2001, Appl Neuropsychol, V8, P180, DOI 10.1207/S15324826AN0803_8; LASS NJ, 1975, J COMMUN DISORD, V8, P193, DOI 10.1016/0021-9924(75)90011-8; Lemay S, 2004, CLIN NEUROPSYCHOL, V18, P284, DOI 10.1080/13854040490501718; Lo AHY, 2012, J NEUROPSYCHOL, V6, P212, DOI 10.1111/j.1748-6653.2011.02023.x; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Macquarie Dictionary, 2008, MACQUARIE DICT PUBLI; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; May CP, 1998, J EXP PSYCHOL HUMAN, V24, P363, DOI 10.1037/0096-1523.24.2.363; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Morgan S.F., 1992, NEUROPSYCHOLOGY, V6, P327, DOI 10.1037/0894-4105.6.4.327; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Qualls CE, 2000, ARCH CLIN NEUROPSYCH, V15, P159, DOI 10.1016/S0887-6177(98)00043-2; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reeve CL, 2007, INT J TEST, V7, P225, DOI 10.1080/15305050701193595; Ruff R, 1996, ARCH CLIN NEUROPSYCH, V11, P313, DOI 10.1016/0887-6177(95)00031-3; RUFF R, 1986, PERCEPT MOTOR SKILL, V62; Schultz, 2008, 5 S NEUR REH IG FALL; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Slade PD, 2008, PSYCHOL ASSESSMENT, V20, P361, DOI 10.1037/a0012950; Smith A., 1991, SYMBOL DIGIT MODALIT; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stern RA, 2003, NEUROPSYCHOLOGICAL A; The Psychological Corporation, 1997, WAIS IIIWMS 3 TECHNI; Trahan DE, 1998, ASSESSMENT, V5, P227, DOI 10.1177/107319119800500303; VERPLOEG RD, 1997, APPL NEUROPSYCHOL, V4, DOI DOI 10.1207/s15324826an0404_6; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570	62	1	1	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1882507		MAR 2021	33	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	QU0UO	WOS:000627000600001	33685355				2022-02-06	
J	Brawman-Mintzer, O; Tang, XC; Bizien, M; Harvey, PD; Horner, MD; Arciniegas, DB; Raskind, M; Johnson-Greene, L; Martineau, RJ; Hamner, M; Rodriguez-Suarez, M; Jorge, RE; McGarity, S; Wortzel, HS; Wei, YL; Sindowski, T; Mintzer, J; Kindy, AZ; Donovan, K; Reda, D				Brawman-Mintzer, Olga; Tang, X. Charlene; Bizien, Marcel; Harvey, Philip D.; Horner, Michael D.; Arciniegas, David B.; Raskind, Murray; Johnson-Greene, Lisa; Martineau, R. Jared; Hamner, Mark; Rodriguez-Suarez, Mercedes; Jorge, Ricardo E.; McGarity, Suzanne; Wortzel, Hal S.; Wei, Yongliang; Sindowski, Tom; Mintzer, Jacobo; Kindy, Arianne Z.; Donovan, Keaveny; Reda, Domenic			Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; cognitive function; neurotransmitters; traumatic brain injury		Cognitive impairment is common in veterans with histories of traumatic brain injury (TBI). Cholinergic deficits have been hypothesized as contributors to this impairment. We report the effects of cholinesterase inhibitor rivastigmine transdermal patch treatment in veterans with TBI and post-traumatic memory impairment. Our objective was to evaluate the efficacy and safety of a 9.5 mg/24 h (10 cm(2)) rivastigmine patch in veterans of military conflicts with persistent moderate to severe memory impairment at least 12 weeks after TBI. This randomized, outpatient, double-blind, placebo-controlled 12-week trial with an exploratory double-blind phase of an additional 14 weeks was conducted at 5 VA Medical Centers, among veterans with closed, non-penetrating TBI who met or exceeded modified American Congress of Rehabilitation Medicine criteria for mild TBI with verbal memory deficits, as assessed by the Hopkins Verbal Learning Test, Revised (HVLT-R). Patients were randomized 1:1 to rivastigmine or matching placebo patches after a 1-week single-blind, placebo run-in phase. At randomization, patients received 4.6 mg/24 h rivastigmine patches or matching placebo increased to a 9.5 mg/24 h patch after 4 weeks. The primary efficacy outcome measure was the proportion of participants who had at least a five-word improvement on the HVLT-R Total Recall Index (Trials 1-3). A total of 3671 participants were pre-screened, of whom 257 (7.0%) were screened; 96 (37%) randomized, and 94 included in study analyses. Responder rates were 40.8% (20 of 49) and 51.1% (23 of 45) in the rivastigmine and placebo groups, respectively (p = 0.41). A mixed-effect model including treatment, time, and treatment-by-time interaction indicated no significant difference in treatment effect over time between the groups (p = 0.24). Overall, there were no significant differences in changes for all secondary outcomes between the rivastigmine and placebo groups. The most commonly observed adverse events were application site reactions. This trial provides the largest sample to date of veterans with TBI and post-traumatic memory deficits enrolled in a pharmacological trial. Trial Registration: clinicaltrials.gov Identifier: NCT01670526.	[Brawman-Mintzer, Olga; Horner, Michael D.; Hamner, Mark; Mintzer, Jacobo; Donovan, Keaveny] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Brawman-Mintzer, Olga; Horner, Michael D.; Hamner, Mark] Med Univ South Carolina, 171 Ashley Ave, Charleston, SC 29425 USA; [Tang, X. Charlene; Wei, Yongliang; Sindowski, Tom; Reda, Domenic] Edward Hines Jr VA Hosp, Cooperat Studies Program, Hines, IL USA; [Bizien, Marcel] Clin Res Pharm Coordinat Ctr, Cooperat Studies Program, Albuquerque, NM USA; [Harvey, Philip D.; Johnson-Greene, Lisa; Rodriguez-Suarez, Mercedes] Miami VA Healthcare Syst, Miami, FL USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Aurora, CO USA; [Raskind, Murray] VA Puget Sound Healthcare Syst, Seattle, WA USA; [Martineau, R. Jared] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Jorge, Ricardo E.] Michael E DeBakey VA Hlth Syst, Houston, TX USA; [McGarity, Suzanne] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Wortzel, Hal S.] Rocky Mt MIRECC Suicide Prevent, Denver, CO USA; [Kindy, Arianne Z.] Roper St Francis Healthcare, Charleston, SC USA		Brawman-Mintzer, O (corresponding author), Med Univ South Carolina, 171 Ashley Ave, Charleston, SC 29425 USA.	mintzero@musc.edu		, Domenic/0000-0003-1831-4270	VA Cooperative Studies Program (CSP), Cooperative Clinical Trial Award (CCTA) Program [0001]	This study was supported by the VA Cooperative Studies Program (CSP), Cooperative Clinical Trial Award (CCTA) Program [grant number CCTA #0001].	Arciniegas D, 2014, BRAIN INJURY, V28, P781; Arciniegas David B, 2004, Phys Med Rehabil Clin N Am, V15, P177, DOI 10.1016/S1047-9651(03)00104-9; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Green P., 2005, MED SYMPTOM VALIDITY; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Guy W., 1976, PUBLICATION ADM, V76-338; Hernandez-Tejada MA, 2017, NEW THERAPEUTICS FOR TRAUMATIC BRAIN INJURY: PREVENTION OF SECONDARY BRAIN DAMAGE AND ENHANCEMENT OF REPAIR AND REGENERATION, P273, DOI 10.1016/B978-0-12-802686-1.00017-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mausbach BT, 2011, SCHIZOPHR RES, V132, P165, DOI 10.1016/j.schres.2011.07.022; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Orsillo S.M., 2001, PRACTITIONERS GUIDE, P255, DOI DOI 10.1007/0-306-47628-2_20; Parent MB, 2004, LEARN MEMORY, V11, P9, DOI 10.1101/lm.69104; Posner K, 2007, CNS SPECTRUMS, V12, P156, DOI 10.1017/S1092852900020678; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Roy A, 2007, BIOMETRICS, V63, P699, DOI 10.1111/j.1541-0420.2007.00769.x; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Traeger J, 2020, CRIT CARE NURS Q, V43, P172, DOI 10.1097/CNQ.0000000000000301; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 2011, WECHSLER ABBREVIATED; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Zouris JM, 2006, MIL MED, V171, P246, DOI 10.7205/MILMED.171.3.246	50	1	1	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					1943	1952		10.1089/neu.2020.7146		MAR 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000627169800001	33514274				2022-02-06	
J	Sweeny, M; Perez, OH; Inness, EL; Danells, C; Chandra, T; Foster, E; Comper, P; Bayley, M; Mochizuki, G				Sweeny, Michelle; Habib Perez, Olinda; Inness, Elizabeth L.; Danells, Cynthia; Chandra, Tharshini; Foster, Evan; Comper, Paul; Bayley, Mark; Mochizuki, George			The Toronto concussion study: a cross-sectional analysis of balance deficits following acute concussion in community-dwelling adults	BRAIN INJURY			English	Article						Balance; concussion; adult; BESS; forceplate; SCAT		Objective: To characterize balance deficits in community-dwelling adults following acute concussion. Design: Cross-sectional observational study. Methods: Individuals with acute concussion (n=100) and healthy controls (n=20) completed the BESS (Balance Error Scoring System) and quiet standing trials on forceplates with the eyes open, closed, or during a cognitive dual task. BESS score and centre-of-pressure root mean square and high-frequency power (0.4-3Hz) were used to characterize group differences. In a secondary analysis, participants were subdivided based on self-reported symptoms of balance problems and dizziness using the SCAT-3 (Sport Concussion Assessment Tool - Third Edition) Symptom Checklist. Results: In comparing individuals with concussion and controls, BESS score (16.0 +/- 6.0 vs 12.6 +/- 3.8; F(1,116) = 5.814, p = .017) and anteroposterior [F(1.78, 204.2) = 11.93, p F(1, 114) = 10.05, p = .002] high-frequency power revealed significant group differences. Dividing individuals based on self-reported symptoms revealed significant differences in mediolateral high frequency power, such that participants reporting balance and dizziness problems as well as those participants not reporting balance or dizziness symptoms following concussion were less stable than controls. Conclusions: Deficits in clinical and posturographic measures of balance occur in community-dwelling adults with concussion. These measures do not align with self-reported balance symptoms. Future research and clinical practice aimed at careful selection of optimized balance assessment is recommended.	[Sweeny, Michelle; Habib Perez, Olinda; Inness, Elizabeth L.; Danells, Cynthia; Chandra, Tharshini; Foster, Evan; Comper, Paul; Bayley, Mark; Mochizuki, George] Univ Hlth Network, Univ Ctr, Toronto Rehabil Inst, Toronto, ON, Canada; [Sweeny, Michelle; Inness, Elizabeth L.; Comper, Paul; Mochizuki, George] Univ Toronto, Rehabil Sci Inst, Fac Med, Toronto, ON, Canada; [Inness, Elizabeth L.; Danells, Cynthia] Univ Toronto, Dept Phys Therapy, Fac Med, Toronto, ON, Canada; [Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Div Phys Med & Rehabil, Fac Med, Toronto, ON, Canada; [Mochizuki, George] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada		Mochizuki, G (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Rm 341 Bethune Coll,4700 Keele St, Toronto, ON M3J 1P3, Canada.	gmochizu@yorku.ca		Bayley, Mark/0000-0001-7860-9463; Inness, Elizabeth L./0000-0002-9217-4619	Hull-Ellis Concussion and Research Clinic; Toronto Rehab Foundation	We have no conflicts of interest to disclose. The authors acknowledge funding from the Hull-Ellis Concussion and Research Clinic and the Toronto Rehab Foundation	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cushman D, 2018, BRAIN INJURY, V32, P569, DOI 10.1080/02699052.2018.1432891; Daniels KAJ, 2019, J BIOMECH, V97, DOI 10.1016/j.jbiomech.2019.109400; Dierijck JK, 2018, INT J PSYCHOPHYSIOL, V132, P74, DOI 10.1016/j.ijpsycho.2018.03.005; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; FITZPATRICK RC, 1992, J PHYSIOL-LONDON, V458, P69, DOI 10.1113/jphysiol.1992.sp019406; GATEV P, 1999, J PHYSIOL-LONDON, V1; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HAYMAN M, 1942, ARCH NEURO PSYCHIATR, V341; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Inness EL, 2019, J HEAD TRAUMA REHAB, V34, pE37, DOI 10.1097/HTR.0000000000000431; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mayer AR, 2020, HUM BRAIN MAPP; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P., 2013, BRIT J SPORT MED, V47, P259, DOI DOI 10.1136/BJSPORTS-2013-092459.8; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MCILROY W, 1997, CLIN BIOMECH, V12; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Perez OH, 2018, PHYS THER, V98, P786, DOI 10.1093/ptj/pzy065; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Purkayastha S, 2019, PM&R, V11, P1184, DOI 10.1002/pmrj.12129; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Reilly N, 2020, EXP BRAIN RES, V238, P2783, DOI 10.1007/s00221-020-05934-4; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rochefort C, 2017, J SCI MED SPORT, V20, P970, DOI 10.1016/j.jsams.2017.04.008; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Schinkel-Ivy A, 2016, CLIN NEUROPHYSIOL, V127, P2463, DOI 10.1016/j.clinph.2016.02.021; Sweeny M, 2020, BRAIN INJURY, V34, P1384, DOI 10.1080/02699052.2020.1802665; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wallace J, 2020, AM J SPORT MED, V48, P2774, DOI 10.1177/0363546520946753; WELCH P, 1967, IEEE T ACOUST SPEECH; ZATSIORSKY V, 1999, MOTOR CONTROL, V3; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	47	1	1	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					587	595		10.1080/02699052.2021.1891288		MAR 2021	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000630309100001	33734923				2022-02-06	
J	Button, EB; Cheng, WH; Barron, C; Cheung, H; Bashir, A; Cooper, J; Gill, J; Stukas, S; Baron, DC; Robert, J; Rowe, EM; Cripton, PA; Wellington, CL				Button, Emily B.; Cheng, Wai Hang; Barron, Carlos; Cheung, Honor; Bashir, Asma; Cooper, Jennifer; Gill, Jasmine; Stukas, Sophie; Baron, David C.; Robert, Jerome; Rowe, Elyn M.; Cripton, Peter A.; Wellington, Cheryl L.			Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury	ALZHEIMERS RESEARCH & THERAPY			English	Article						GFAP; Plasma biomarker; TBI; CHIMERA; Immunoassay	HIGH-DENSITY-LIPOPROTEINS; C-TERMINAL HYDROLASE-L1; BIOENGINEERED VESSELS; AMYLOID ANGIOPATHY; ALZHEIMERS-DISEASE; MOUSE MODEL; BIOMARKERS; DEPOSITION; DYSFUNCTION; METABOLISM	Background Glial fibrillary acidic protein (GFAP) has emerged as a promising fluid biomarker for several neurological indications including traumatic brain injury (TBI), a leading cause of death and disability worldwide. In humans, serum or plasma GFAP levels can predict brain abnormalities including hemorrhage on computed tomography (CT) scans and magnetic resonance imaging (MRI). However, assays to quantify plasma or serum GFAP in preclinical models are not yet available. Methods We developed and validated a novel sensitive GFAP immunoassay assay for mouse plasma on the Meso Scale Discovery immunoassay platform and validated assay performance for robustness, precision, limits of quantification, dilutional linearity, parallelism, recovery, stability, selectivity, and pre-analytical factors. To provide proof-of-concept data for this assay as a translational research tool for TBI and Alzheimer's disease (AD), plasma GFAP was measured in mice exposed to TBI using the Closed Head Impact Model of Engineered Rotational Acceleration (CHIMERA) model and in APP/PS1 mice with normal or reduced levels of plasma high-density lipoprotein (HDL). Results We performed a partial validation of our novel assay and found its performance by the parameters studied was similar to assays used to quantify human GFAP in clinical neurotrauma blood specimens and to assays used to measure murine GFAP in tissues. Specifically, we demonstrated an intra-assay CV of 5.0%, an inter-assay CV of 7.2%, a lower limit of detection (LLOD) of 9.0 pg/mL, a lower limit of quantification (LLOQ) of 24.8 pg/mL, an upper limit of quantification (ULOQ) of at least 16,533.9 pg/mL, dilution linearity of calibrators from 20 to 200,000 pg/mL with 90-123% recovery, dilution linearity of plasma specimens up to 32-fold with 96-112% recovery, spike recovery of 67-100%, and excellent analyte stability in specimens exposed to up to 7 freeze-thaw cycles, 168 h at 4 degrees C, 24 h at room temperature (RT), or 30 days at - 20 degrees C. We also observed elevated plasma GFAP in mice 6 h after TBI and in aged APP/PS1 mice with plasma HDL deficiency. This assay also detects GFAP in serum. Conclusions This novel assay is a valuable translational tool that may help to provide insights into the mechanistic pathophysiology of TBI and AD.	[Button, Emily B.; Cheng, Wai Hang; Barron, Carlos; Cheung, Honor; Bashir, Asma; Cooper, Jennifer; Gill, Jasmine; Stukas, Sophie; Baron, David C.; Robert, Jerome; Rowe, Elyn M.; Wellington, Cheryl L.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada; [Button, Emily B.; Cheng, Wai Hang; Barron, Carlos; Cheung, Honor; Bashir, Asma; Cooper, Jennifer; Gill, Jasmine; Stukas, Sophie; Baron, David C.; Robert, Jerome; Rowe, Elyn M.; Wellington, Cheryl L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada; [Cripton, Peter A.; Wellington, Cheryl L.] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada; [Cripton, Peter A.; Wellington, Cheryl L.] Univ British Columbia, Sch Biomed Engn, Vancouver, BC V6T 1Z3, Canada		Wellington, CL (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.; Wellington, CL (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Z3, Canada.; Wellington, CL (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC V5Z 1M9, Canada.; Wellington, CL (corresponding author), Univ British Columbia, Sch Biomed Engn, Vancouver, BC V6T 1Z3, Canada.	wcheryl@mail.ubc.ca		Cheung, Honor/0000-0002-9780-2522; Cheng, Wai Hang/0000-0002-3408-9184	Weston Brain Institute [TR140070, TR192003]; Cure Alzheimer Fund	Operating funding for this work was provided by the Weston Brain Institute, Transformational Grants TR140070 and TR192003. Cure Alzheimer Fund supported the development of the APOE3 targeted replacement mice used in this study.	Abdelhak A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33158-8; Anderson TN, 2020, J TRAUMA ACUTE CARE, V89, P80, DOI 10.1097/TA.0000000000002706; Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; [Anonymous], MESOSCALEDISCOVERY E; [Anonymous], QUANTERIX QUANTERIX; [Anonymous], SPECIES CROSS REACTI; [Anonymous], FDA AUTHORIZES MARKE; Asken BM, 2020, J NEUROTRAUM, V37, P1537, DOI 10.1089/neu.2019.6831; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Bashir A, 2020, EXP NEUROL, V324, DOI 10.1016/j.expneurol.2019.113116; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Button EB, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0497-9; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Elahi FM, 2020, ALZHEIMERS DEMENT, V16, P681, DOI 10.1016/j.jalz.2019.09.004; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gordon SM, 2015, J PROTEOME RES, V14, P2686, DOI 10.1021/acs.jproteome.5b00213; Hampel H, 2018, NAT REV NEUROL, V14, P639, DOI 10.1038/s41582-018-0079-7; Huynh TPV, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0337-1; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Katsanos AH, 2017, STROKE, V48, P2586, DOI 10.1161/STROKEAHA.117.018409; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lewis LM, 2020, J NEUROTRAUM, V37, P2624, DOI 10.1089/neu.2020.7071; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Luger S, 2017, CLIN CHEM, V63, P377, DOI 10.1373/clinchem.2016.263335; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McNamara EH, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113409; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Namjoshi DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146540; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Oeckl P, 2019, J ALZHEIMERS DIS, V67, P481, DOI 10.3233/JAD-180325; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pattinson CL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13191; Plump AS, 1997, J LIPID RES, V38, P1033; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Riwanto M, 2013, J LIPID RES, V54, P3227, DOI 10.1194/jlr.R037762; Robert J, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00366-8; Robert J, 2017, ELIFE, V6, DOI 10.7554/eLife.29595; Robert J, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0201-0; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Sweeney MD, 2020, ALZHEIMERS DEMENT, V16, P821, DOI 10.1002/alz.12061; Sweeney MD, 2019, ALZHEIMERS DEMENT, V15, P158, DOI 10.1016/j.jalz.2018.07.222; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Verberk IMW, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00682-7; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zetterberg H, 2021, MOL PSYCHIATR, V26, P296, DOI 10.1038/s41380-020-0721-9; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	56	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1758-9193		ALZHEIMERS RES THER	Alzheimers Res. Ther.	MAR 7	2021	13	1							58	10.1186/s13195-021-00793-9			27	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QS7KI	WOS:000626074300001	33678186	Green Published			2022-02-06	
J	Anderson, MC; Evans, E; Zonfrillo, MR; Thomas, KS				Anderson, Marie C.; Evans, Emily; Zonfrillo, Mark R.; Thomas, Kali S.			Rural/urban differences in discharge from rehabilitation in older adults with traumatic brain injury	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						brain injuries; rural health service; skilled nursing facilities; urban health service		Background/Objectives Rates of traumatic brain injury (TBI) among older adults and treatment of this population in nursing homes are increasing. The objective of this study is to examine differences in the quality of care and outcomes of older adults with TBI in rural and urban settings by (1) comparing the rates of successful community discharge; and (2) reasons for not achieving successful discharge among patients in rural and urban environments. Design Retrospective national cohort study of skilled nursing facility (SNF) patients using Medicare inpatient claims linked with Minimum Data Set assessments. Demographic, health, and facility characteristics were compared between rural and urban settings using descriptive statistics. Logistic regression with state random effects was used to identify characteristics that predicted successful discharge. Setting U.S. skilled nursing facilities (n = 11,771). Participants Medicare beneficiaries aged 66 and older discharged to a SNF following hospitalization for TBI between 2011 and 2015 (n = 61,021). Measurements Successful community discharge defined as discharge from SNF within 100 days of admission and remaining in the community for >= 30 days without dying or admission to an inpatient healthcare facility. Results Unadjusted rates of successful discharge were significantly lower for patients in rural settings compared with patients in urban settings (52.1% vs 58.5%, p < 0.01). Patients in rural settings had lower adjusted odds (odds ratio 0.84, 95% confidence interval = 0.80-0.89) of successful discharge. Reasons for not discharging successfully differed between rural and urban settings with rural patients less likely to discharge from SNF within 100 days though also less likely to be rehospitalized within 30 days of SNF discharge. Conclusion Given the low overall rate of successful community discharge and worse outcomes among rural patients, further research to explore interventions to improve SNF care and discharge planning in this population is warranted.	[Anderson, Marie C.] Brown Univ, Warren Alpert Med Sch, 222 Richmond St,Box G-9034B, Providence, RI 02903 USA; [Evans, Emily; Thomas, Kali S.] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Warren Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02912 USA; [Thomas, Kali S.] Providence VA Med Ctr, Providence, RI USA		Anderson, MC (corresponding author), Brown Univ, Warren Alpert Med Sch, 222 Richmond St,Box G-9034B, Providence, RI 02903 USA.	marie_anderson@brown.edu			Foundation for Physical Therapy Research funded Center on Health Services Training and Research; Department of Veterans AffairsUS Department of Veterans Affairs; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG059210-01]	Foundation for Physical Therapy Research funded Center on Health Services Training and Research; Department of Veterans Affairs; Agency for Healthcare Research and Quality; National Institute on Aging, Grant/Award Number: R21AG059210-01	Anderson M., 2021, JOINT COMMITMENT ACT, P1; Anderson TJ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1053-3; Bowblis JR, 2013, HEALTH SERV RES, V48, P47, DOI 10.1111/j.1475-6773.2012.01431.x; Brown JB, 2019, J NEUROSCI RURAL PRA, V10, P10, DOI 10.4103/jnrp.jnrp_310_18; Burke Robert E, 2017, Am J Accountable Care, V5, P16; Centers for Medicare & Medicaid Services (CMS) HHS, 2016, Fed Regist, V81, P51969; Cornell PY, 2019, J HEALTH ECON, V66, P208, DOI 10.1016/j.jhealeco.2019.05.008; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Faul M, 2010, TRAUMATIC BRAIN INJU; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Ingram Deborah D, 2014, Vital Health Stat 2, P1; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; Kaufman BG, 2016, J RURAL HEALTH, V32, P35, DOI 10.1111/jrh.12128; Kosar CM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.18738; Leland NE, 2015, MED CARE, V53, P879, DOI 10.1097/MLR.0000000000000419; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Siconolfi D, 2019, J AM MED DIR ASSOC, V20, P503, DOI 10.1016/j.jamda.2019.01.120; Stagg V., 2006, CHARLSON STATA MODUL; Teno JM., 2018, SURGERY, VS0039, P30102; Thomas KS, 2019, J GERONTOL A-BIOL, V74, P219, DOI 10.1093/gerona/gly044; Thomas KS, 2017, MED CARE, V55, pE68, DOI 10.1097/MLR.0000000000000334; Thomas KS, 2012, J AM GERIATR SOC, V60, P1895, DOI 10.1111/j.1532-5415.2012.04146.x	23	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	JUN	2021	69	6					1601	1608		10.1111/jgs.17065		MAR 2021	8	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	SO8MQ	WOS:000625748500001	33675540				2022-02-06	
J	Ishii, D; Osaki, H; Yozu, A; Ishibashi, K; Kawamura, K; Yamamoto, S; Miyata, M; Kohno, Y				Ishii, Daisuke; Osaki, Hironobu; Yozu, Arito; Ishibashi, Kiyoshige; Kawamura, Kenta; Yamamoto, Satoshi; Miyata, Mariko; Kohno, Yutaka			Ipsilesional spatial bias after a focal cerebral infarction in the medial agranular cortex: A mouse model of unilateral spatial neglect	BEHAVIOURAL BRAIN RESEARCH			English	Article						Attention; Stroke; Photothrombotic ischemia; Radial arm maze; Spontaneous recovery	DORSOMEDIAL PREFRONTAL CORTEX; FRONTAL EYE FIELD; POSTERIOR PARIETAL CORTEX; ATTENTION; LESIONS; RECOVERY; DORSAL; RATS; AGE	Unilateral spatial neglect is a disorder of higher brain function that occurs after a brain injury, such as stroke, traumatic brain injury, brain tumor, and surgical procedures etc., and leads to failure to attend or respond to stimuli presented to the side contralateral to the lesioned cerebral hemisphere. Because patients with this condition often have other symptoms due to the presence of several brain lesions, it is difficult to evaluate the recovery mechanisms and effect of training on unilateral spatial neglect. In this study, a mouse model of unilateral spatial neglect was created to investigate whether the size of the lesion is related to the severity of ipsilesional spatial bias and the recovery process. Focal infarction was induced in the right medial agranular cortex (AGm) of mice via photothrombosis. After induction of cerebral infarction, ipsilesional spatial bias was evaluated for 9 consecutive days. The major findings were as follows: (1) unilateral local infarction of the AGm resulted in ipsilateral bias during internally guided decision-making; (2) the lesion size was correlated with the degree of impairment rather than slight differences in the lesion site; and (3) mice with anterior AGm lesions experienced lower recovery rates. These findings suggest that recovery from ipsilesional spatial bias requires neural plasticity within the anterior AGm. This conditional mouse model of ipsilesional spatial bias may be used to develop effective treatments for unilateral spatial neglect in humans.	[Ishii, Daisuke; Yozu, Arito; Kohno, Yutaka] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Ibaraki, Japan; [Ishii, Daisuke] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan; [Osaki, Hironobu; Miyata, Mariko] Tokyo Womens Med Univ, Sch Med, Dept Physiol Neurophysiol, Tokyo, Japan; [Yozu, Arito] Univ Tokyo, Dept Precis Engn, Tokyo, Japan; [Ishibashi, Kiyoshige] Ibaraki Prefectural Univ, Dept Phys Therapy, Hlth Sci Hosp, Ibaraki, Japan; [Kawamura, Kenta; Yamamoto, Satoshi] Ibaraki Prefectural Univ Hlth Sci, Dept Phys Therapy, Ibaraki, Japan		Ishii, D (corresponding author), Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Ibaraki, Japan.	d-ishii@umin.ac.jp		Yamamoto, Satoshi/0000-0002-4074-099X	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [18K17725, 15K21387, 17H05912, 18K14854, 19H05730, 1962-1]; Ibaraki Prefectural University of Health Sciences	This work was supported by JSPS KAKENHI (No. 18K17725 to Dr. Ishii; Nos. 15K21387, 17H05912, and 18K14854 to Dr. Osaki; and No. 19H05730 to Dr. Yozu) and a Grant-in-Aid for Project Research (No. 1962-1 to Dr. Kohno) from the Ibaraki Prefectural University of Health Sciences.	Bartolomeo P, 1998, NEUROPSYCHOLOGIA, V36, P227, DOI 10.1016/S0028-3932(97)00104-8; Bartolomeo P, 2019, BRAIN, V142, P840, DOI 10.1093/brain/awz043; Bartolomeo P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00110; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Burcham KJ, 1997, BEHAV BRAIN RES, V86, P41, DOI 10.1016/S0166-4328(96)02241-3; CALVANIO R, 1987, NEUROLOGY, V37, P1179, DOI 10.1212/WNL.37.7.1179; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; CORWIN JV, 1986, EXP NEUROL, V94, P683, DOI 10.1016/0014-4886(86)90247-5; CROWNE DP, 1986, BEHAV BRAIN RES, V22, P227, DOI 10.1016/0166-4328(86)90067-7; CROWNE DP, 1983, PSYCHOL BULL, V93, P232, DOI 10.1037/0033-2909.93.2.232; CROWNE DP, 1982, BEHAV BRAIN RES, V6, P25, DOI 10.1016/0166-4328(82)90079-1; CROWNE DP, 1983, SCIENCE, V220, P527, DOI 10.1126/science.6836298; Ebbesen CL, 2018, J NEUROSCI, V38, P9402, DOI 10.1523/JNEUROSCI.1671-18.2018; Erlich JC, 2015, ELIFE, V4; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; Franklin K., 2019, PAXINOS FRANKLINS MO; Fukui A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60662-7; Gillen R, 2005, ARCH PHYS MED REHAB, V86, P763, DOI 10.1016/j.apmr.2004.10.029; HEILMAN KM, 1979, ANN NEUROL, V5, P166, DOI 10.1002/ana.410050210; Hoff EI, 2007, BEHAV BRAIN RES, V178, P62, DOI 10.1016/j.bbr.2006.12.001; Kato J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63617-0; KING V, 1990, BEHAV BRAIN RES, V37, P169, DOI 10.1016/0166-4328(90)90092-S; KING VR, 1993, BEHAV BRAIN RES, V54, P117, DOI 10.1016/0166-4328(93)90070-7; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Marsh EB, 2008, CORTEX, V44, P1215, DOI 10.1016/j.cortex.2006.02.002; Medina J, 2009, J COGNITIVE NEUROSCI, V21, P2073, DOI 10.1162/jocn.2008.21160; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; Saevarsson S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00778; Saevarsson S, 2013, APPL NEUROPSYCH-ADUL, V20, P292, DOI 10.1080/09084282.2012.710682; Sato TR, 2019, ELIFE, V8, DOI 10.7554/eLife.50855; Suarez A, 2020, CORTEX, V126, P73, DOI 10.1016/j.cortex.2019.12.030; Van Vleet TM, 2000, PSYCHOBIOLOGY, V28, P57; VARGO JM, 1989, BEHAV NEUROSCI, V103, P1017, DOI 10.1037/0735-7044.103.5.1017; VARGO JM, 1988, EXP NEUROL, V102, P199, DOI 10.1016/0014-4886(88)90094-5; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Yamamoto T, 2019, J NEUROSCI, V39, P8484, DOI 10.1523/JNEUROSCI.0077-19.2019; Yang NYH, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00187	40	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 5	2021	401								113097	10.1016/j.bbr.2020.113097			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	PT4ST	WOS:000608605600010	33385423				2022-02-06	
J	Hynes, C; Scullion, L; Lawler, C; Steel, R; Boland, P				Hynes, Celia; Scullion, L.; Lawler, C.; Steel, R.; Boland, P.			The impact of in-service physical injury or illness on the mental health of military veterans	BMJ MILITARY HEALTH			English	Article; Early Access						qualitative research; depression & mood disorders; orthopaedic & trauma surgery	TRAUMATIC BRAIN-INJURY; PERSONNEL; FORCES	Background Each year approximately 2000 UK service personnel are medically discharged with physical and/or psychological injury or illness. While there is much research on both psychological injury and physical injury, the challenges of transition relating to the intersection between the two has received less attention. This article reports on the first phase of a 2-year funded study with the aim to understand the lived experiences of veterans who have been discharged from service with a physical injury or illness and the impacts of this on their mental health. Methods Using a qualitative methodology, 22 veterans who had been discharged from service within the last 8 years were interviewed to identify key aspects of their experience of the transition process. Results The article highlights two key themes: how some veterans adjusted to life with a physical injury or condition; and, the intersections that became apparent between physical injury and mental health. The challenges that veterans faced were shaped by the transition process and by the way in which the medical discharge process was conducted. Conclusions Consideration of improvements to the medical discharge process could influence better outcomes for those who have left with a physical injury or illness and later find themselves struggling with mental health issues.	[Hynes, Celia; Steel, R.; Boland, P.] Univ Cent Lancashire, Sch Community Hlth & Midwifery, Preston PR1 2HE, Lancs, England; [Scullion, L.] Univ Salford, Sch Hlth & Soc, Sustainable Housing & Urban Studies Unit SHUSU, Salford, Lancs, England; [Lawler, C.] Univ Salford, Sch Hlth & Soc, Salford Social Prescribing Hub, Salford, Lancs, England		Hynes, C (corresponding author), Univ Cent Lancashire, Sch Community Hlth & Midwifery, Preston PR1 2HE, Lancs, England.	chynes1@uclan.ac.uk		Lawler, Cormac/0000-0003-2453-7761	Forces in Mind Trust; Charitable Trust	This research is funded by the Forces in Mind Trust (understanding the transition to civilian life for ex-service personnel with physical conditions as a direct result of service or acquired while in service), a Charitable Trust founded by a 35 pound million endowment from the Big Lottery Fund (now The National Lottery Community Fund).	Bergman B P, 2000, J R Army Med Corps, V146, P204; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Brunger H, 2013, J AGGRESS CONFL PEAC, V5, DOI 10.1108/17596591311313681; Buckman JEJ, 2013, EUR J PUBLIC HEALTH, V23, P410, DOI 10.1093/eurpub/cks042; Caddick N, 2018, QUAL RES SPORT EXERC, V10, P429, DOI 10.1080/2159676X.2017.1333033; Christensen J, 2018, DISABIL REHABIL, V40, P2553, DOI 10.1080/09638288.2017.1342281; Desmond DM, 2006, SOC SCI MED, V62, P208, DOI 10.1016/j.socscimed.2005.05.011; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Gaunaurd IA, 2013, J REHABIL RES DEV, V50, P969, DOI 10.1682/JRRD.2013.02.0035; Hawley CA, 2015, J HEAD TRAUMA REHAB, V30, pE47, DOI 10.1097/HTR.0000000000000023; Heaver L., 2018, LIFTING LID TRANSITI; Help for Heroes, 2019, IMPR MED DISCH PROC; Kelsall HL, 2014, PAIN, V155, P685, DOI 10.1016/j.pain.2013.12.025; Krueger CA, 2012, J TRAUMA ACUTE CARE, V73, pS438, DOI 10.1097/TA.0b013e318275469c; Mason J., 2002, QUALITATIVE RES; MOD, 2014, ANN MED DISCH UK REG; Petrovic ZK, 2019, J NERV MENT DIS, V207, P53, DOI 10.1097/NMD.0000000000000928; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Samele C., 2013, MENTAL HLTH SERVING; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scullion L., 2018, SUPPORT SERVICE LEAV; Sharma J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0558-6; Sharp ML, 2019, J MIL VETERAN FAM HL, V5, P75, DOI 10.3138/jmvfh.2018-0051; Sharp ML, 2015, EPIDEMIOL REV, V37, P144, DOI 10.1093/epirev/mxu012; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309	26	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2633-3767	2633-3775		BMJ MILITARY HEALTH	BMJ Military Health												10.1136/bmjmilitary-2020-001759		MAR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XJ7LC	WOS:000726963500001	33664089	Green Submitted, Green Accepted			2022-02-06	
J	Liebert, A; Kiat, H				Liebert, Ann; Kiat, Hosen			The history of light therapy in hospital physiotherapy and medicine with emphasis on Australia: Evolution into novel areas of practice	PHYSIOTHERAPY THEORY AND PRACTICE			English	Article						Physiotherapy; history; phototherapy; photobiomodulation; light therapy		Objective: The objective of this narrative review was to investigate the history of light therapy in hospital settings, with reference to physiotherapy and particularly in an Australian context.Types of articles and search method:a review of available literature was conducted on PubMed, Medline and Google Scholar using keywords light therapy, photobiomodulation, physiotherapy, low-level laser, heliotherapy. Physiotherapy textbooks from Sydney University Library were searched. Historical records were accessed from the San Hospital library. Interviews were conducted with the San Hospital Chief Librarian and a retired former Head Physiotherapist from Royal Prince Alfred Hospital.Summary: Historically, light treatment has been used in both medical and physiotherapy practice. From its roots in ancient Egypt, India, and Greece, through to medieval times, the modern renaissance in 'light as therapy ' was begun by Florence Nightingale who, in the 1850s, advocated the use of clean air and an abundance of sunlight to restore health. Modern light therapy (phototherapy) had a marked uptake in use in medicine in Scandinavia, America, and Australia from 1903, following the pioneering work of Niels Finsen in the late 19th century, which culminated in Dr Finsen receiving the Nobel Prize for Medicine for the treatment of tuberculosis scarring with ultraviolet (UV) light, and treatment of smallpox scarring with red light. Treatment with light, especially UVB light, has been widely applied by physiotherapists in hospitals for dermatological conditions since the 1950s, particularly in Australia, Scandinavia, USA, England and Canada. In parallel, light treatment in hospitals for hyperbilirubinemia was used for neonatal jaundice. Since the 1980s light was also used in the medical specialties of ophthalmology, dermatology, and cardiology. In more recent years in physiotherapy, light was mostly used as an adjunct to the management of orthopedic/rheumatological conditions. Since the 1990s, there has been global use of light, in the form of photobiomodulation for the management of lymphedema, including in supportive cancer care. Photobiomodulation in the form of low-level laser has been used by physiotherapists and pain doctors since the 1990s in the management of chronic pain. The use of light as therapy is exemplified by its use in the San Hospital in Sydney, where light therapy was introduced in 1903 (after Dr. John Harvey Kellogg visited Niels Finsen in Denmark) and is practiced by nurses, physiotherapists and doctors until the present day. The use of light has expanded into new and exciting practices including supportive cancer care, and treatment of depression, oral mucositis, retinopathy of prematurity, and cardiac surgery complications. Light is also being used in the treatment of neurological diseases, such as Parkinson's disease, traumatic brain injury, and multiple sclerosis. The innovative uses of light in physiotherapy treatment would not be possible without the previous experience of successful application of light treatment.Conclusion: Light therapy has had a long tradition in medicine and physiotherapy. Although it has fallen somewhat out of favour over the past decades, there has been a renewed interest using modern techniques in recent times. There has been continuous use of light as a therapy in hospitals in Australia, most particularly the San Hospital in Sydney where it has been in use for almost 120 years.	[Liebert, Ann] Fox Valley Med Ctr, Photobiomodulat Therapy Clin, Wahroonga, NSW, Australia; [Kiat, Hosen] Sydney Adventist Hosp, Cardiac Hlth Inst Wahroonga, Wahroonga, NSW, Australia		Liebert, A (corresponding author), Fox Valley Med Ctr, Photobiomodulat Clin, 187 Fox Valley Rd, Wahroonga, NSW 2076, Australia.	ann.liebert@sydney.edu.au		Kiat, Hosen/0000-0002-2899-118X			Alfredo PP, 2018, CLIN REHABIL, V32, P173, DOI 10.1177/0269215517723162; Ancoli-Israel Sonia, 2003, Behav Sleep Med, V1, P22, DOI 10.1207/S15402010BSM0101_4; Askalsky P, 2019, NEUROPSYCH DIS TREAT, V15, P3255, DOI 10.2147/NDT.S188906; Beauchemin KM, 1998, J ROY SOC MED, V91, P352, DOI 10.1177/014107689809100703; Bicknell B, 2019, LASER MED SCI, V34, P317, DOI 10.1007/s10103-018-2594-6; Blivet Guillaume, 2018, Alzheimers Dement (N Y), V4, P54, DOI 10.1016/j.trci.2017.12.003; Briones E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003712.pub3; BROWN AK, 1985, PEDIATRICS, V75, P393; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Castro R, 2011, CRIT CARE, V15, DOI 10.1186/cc10000; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Cieslinska A., 2017, AUTISM PARADIGMS REC, P43; Connor JT., 1999, MAT CULTURE REV, V49, P60; De Scheerder IK, 2001, LASER SURG MED, V28, P212, DOI 10.1002/lsm.1040; De Scheerder IK, 2001, J CLIN LASER MED SUR, V19, P261, DOI 10.1089/10445470152611991; Derkacz A, 2013, LASER MED SCI, V28, P763, DOI 10.1007/s10103-012-1142-z; Derkacz A, 2010, AM J CARDIOL, V106, P1113, DOI 10.1016/j.amjcard.2010.06.017; Doan L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/504691; Downes A., 1877, P ROYAL SOC B, V26, P488, DOI [DOI 10.1098/RSPL.1877.0068, 10.1098/rspl.1877.0068]; El Massri N, 2018, NEUROBIOL AGING, V66, P131, DOI 10.1016/j.neurobiolaging.2018.02.019; Ferraresi C, 2016, J BIOPHOTONICS, V9, P1273, DOI 10.1002/jbio.201600176; Figueiro MG, 2014, CLIN INTERV AGING, V9, P1527, DOI 10.2147/CIA.S68557; Finsen N R, 1895, Br Med J, V2, P1412; Finsen NR, 1903, BRIT MED J, V1903, P1297; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Ganeshan V, 2019, NEUROSCIENCE, V400, P85, DOI 10.1016/j.neuroscience.2018.12.050; Gardener H, 2010, MOVEMENT DISORD, V25, P1560, DOI 10.1002/mds.23339; Gifford L S, 1987, Aust J Physiother, V33, P3, DOI 10.1016/S0004-9514(14)60579-1; Hallett K., 2015, AMLA C LOW LEV LAS T; Hamblin MR, 2018, PHOTOMED LASER SURG, V36, P241, DOI 10.1089/pho.2017.4401; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hamilton C, 2018, NEURAL REGEN RES, V13, P1738, DOI 10.4103/1673-5374.238613; Hart PH., 2009, NEUROIMMUNOLOGY SKIN, P125; Hart Prue H, 2018, Mult Scler J Exp Transl Clin, V4, p2055217318773112, DOI 10.1177/2055217318773112; Helmy ZM, 2019, LASER MED SCI, V34, P1115, DOI 10.1007/s10103-018-02701-4; Honigsmann H, 2012, PHOTOCH PHOTOBIO SCI, V12, P16, DOI 10.1039/c2pp25120e; Holick MF, 2008, CLIN J AM SOC NEPHRO, V3, P1548, DOI 10.2215/CJN.01350308; Horvath KA, 2001, CIRCULATION, V104, pI81; Johnstone DM, 2015, NEURAL REGEN RES, V10, P349, DOI 10.4103/1673-5374.153673; Kellogg J. H., 1910, LIGHT THERAPEUTICS P; Kendell RE, 2002, SCHIZOPHR RES, V54, P193, DOI 10.1016/S0920-9964(01)00264-X; Khan I, 2015, ADV WOUND CARE, V4, P724, DOI 10.1089/wound.2014.0623; Khoo NK, 2014, J LASERS MED SCI, V5, P86; Kiat H., 2017, LASER LED LIGHT THER, VAutumn; La Touche R, 2008, REV NEUROLOGIA, V46, P714, DOI 10.33588/rn.4612.2008066; Laakso E. Liisa, 1994, Laser Therapy, V6, P133; Liebert A., 2019, 17 INT ISLA C MED LA; Liebert A., 2017, PROCEEDINGS, V0048; Liebert A, 2018, PHOTOMED LASER SURG, V36, P515, DOI 10.1089/pho.2018.4527; Liebert A, 2019, PHOTOBIOMOD PHOTOMED, V37, P681, DOI 10.1089/photob.2019.4628; Liebert A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42386; Liebert A, 2013, PHYSIOTHER THEOR PR, V29, P616, DOI 10.3109/09593985.2013.783894; Liebert AD, 2016, J EXP NEUROSCI, V10, P1, DOI 10.4137/JEN.S33444; Liebert AD, 2014, MED HYPOTHESES, V82, P275, DOI 10.1016/j.mehy.2013.12.009; Lubomski M, 2020, J NEUROL, V267, P2507, DOI 10.1007/s00415-019-09320-1; Lushington K, 2002, J BIOL RHYTHM, V17, P377, DOI 10.1177/074873002129002582; Martinez-Martin P, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0009-1; McGonigle TA, 2017, AM J PATHOL, V187, P2046, DOI 10.1016/j.ajpath.2017.06.003; MESTER E, 1968, ACTA CHIR HUNG, V9, P349; Mitrofanis J, 2017, NEURAL REGEN RES, V12, P574, DOI 10.4103/1673-5374.205092; Moskvin SV, 2017, J LASERS MED SCI, V8, P56, DOI 10.15171/jlms.2017.11; Najafi M, 2014, J Biomed Phys Eng, V4, P163; Natoli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072135; Nightingale F., 1859, NOTES NURSING WHAT I; Nuhu JM, 2014, HONG KONG PHYSIOTHER, V32, P44, DOI 10.1016/j.hkpj.2014.02.002; Nussbaum E., 2011, 16 INT WCTP C JUN 20; Oron U, 2001, CIRCULATION, V103, P296; Palm T., 1890, PRACTITIONER; PETER RU, 1994, J AM ACAD DERMATOL, V30, P719, DOI 10.1016/S0190-9622(08)81501-0; Piller NB, 1998, LYMPHOLOGY, V31, P74; Robijns J, 2019, CURR OPIN ONCOL, V31, P291, DOI 10.1097/CCO.0000000000000511; RPeter RU, 2002, MIL MED, V167, P110, DOI [10.1093/milmed/167.suppl_1.110, DOI 10.1093/MILMED/167.SUPPL_1.110]; Sandhu A, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2013-000019; SATLIN A, 1992, AM J PSYCHIAT, V149, P1028; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Schwarz R., 2006, JH KELLOGG PIONEER H; Sellentin R, 2011, J MIL VETERANS HEALT, V19, P20; Smoot B, 2015, J CANCER SURVIV, V9, P287, DOI 10.1007/s11764-014-0411-1; Stausholm MB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031142; Stone J, 2013, PROCEEDINGS OF THE 9TH WORLD ASSOCIATION FOR LASER THERAPY CONGRESS (WALT), P17; Valdemar B., 1899, BMJ-BRIT MED J, V2, P825, DOI [10.1136/bmj.2.2022.825, DOI 10.1136/BMJ.2.2022.825]; VanSomeren EJW, 1997, BIOL PSYCHIAT, V41, P955, DOI 10.1016/S0006-3223(97)89928-3; Vassao PG, 2020, PHOTOBIOMOD PHOTOMED, V38, P206, DOI 10.1089/photob.2019.4751; Whelan HT., 2002, TECHN BIOST 2 INT C, P32; Willis GL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00741; WirzJustice A, 1996, J AFFECT DISORDERS, V37, P109, DOI 10.1016/0165-0327(95)00081-X; Woloshyn Tania Anne, 2017, SOAKING RAYS LIGHT T; Wu XM, 2016, J PHOTOCH PHOTOBIO B, V157, P89, DOI 10.1016/j.jphotobiol.2016.02.007; Zadik Y, 2019, SUPPORT CARE CANCER, V27, P3969, DOI 10.1007/s00520-019-04890-2; Zycinski P, 2007, KARDIOL POL, V65, P13	90	1	1	5	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0959-3985	1532-5040		PHYSIOTHER THEOR PR	Physiother. Theory Pract.	MAR 4	2021	37	3			SI		389	400		10.1080/09593985.2021.1887060			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	RC3AS	WOS:000632676600004	33678141				2022-02-06	
J	Siponkoski, ST; Koskinen, S; Laitinen, S; Holma, M; Ahlfors, M; Jordan-Kilkki, P; Ala-Kauhaluoma, K; Martinez-Molina, N; Melkas, S; Laine, M; Ylinen, A; Zasler, N; Rantanen, P; Lipsanen, J; Sarkamo, T				Siponkoski, Sini-Tuuli; Koskinen, Sanna; Laitinen, Sari; Holma, Milla; Ahlfors, Mirja; Jordan-Kilkki, Paivi; Ala-Kauhaluoma, Katja; Martinez-Molina, Noelia; Melkas, Susanna; Laine, Matti; Ylinen, Aarne; Zasler, Nathan; Rantanen, Pekka; Lipsanen, Jari; Sarkamo, Teppo			Effects of neurological music therapy on behavioural and emotional recovery after traumatic brain injury: A randomized controlled cross-over trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Early Access						Traumatic brain injury; Music therapy; Randomized controlled trial; Executive functioning; Behavioural regulation		Traumatic brain injury (TBI) causes deficits in executive function (EF), as well as problems in behavioural and emotional self-regulation. Neurological music therapy may aid these aspects of recovery. We performed a cross-over randomized controlled trial where 40 persons with moderate-severe TBI received a 3-month neurological music therapy intervention (2 times/week, 60 min/session), either during the first (AB, n = 20) or second (BA, n = 20) half of a 6-month follow-up period. The evidence from this RCT previously demonstrated that music therapy enhanced general EF and set shifting. In the current study, outcome was assessed with self-report and caregiver-report questionnaires performed at baseline, 3-month, 6-month, and 18-month stages. The results showed that the self-reported Behavioural Regulation Index of the Behaviour Rating Inventory of Executive Function (BRIEF-A) improved more in the AB than BA group from baseline to 3-month stage and the effect was maintained in the 6-month follow-up. No changes in mood or quality of life questionnaires were observed. However, a qualitative content analysis of the feedback revealed that many participants experienced the intervention as helpful in terms of emotional well-being and activity. Our results suggest that music therapy has a positive effect on everyday behavioural regulation skills after TBI.	[Siponkoski, Sini-Tuuli; Martinez-Molina, Noelia; Sarkamo, Teppo] Univ Helsinki, Dept Psychol & Logoped, Mus Aging & Rehabil Team, Cognit Brain Res Unit, Helsinki, Finland; [Koskinen, Sanna; Lipsanen, Jari] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Laitinen, Sari] Espoo Hosp, Espoo, Finland; [Holma, Milla] Mus Therapy Cooperat InstruMental, Helsinki, Finland; [Jordan-Kilkki, Paivi] Dial Partner Oy, Espoo, Finland; [Ala-Kauhaluoma, Katja] Assessment & Intervent Serv, Ludus Oy Tutkimus & Kuntoutuspalvelut, Helsinki, Finland; [Melkas, Susanna; Ylinen, Aarne] Univ Helsinki, Neurol, Helsinki, Finland; [Melkas, Susanna; Ylinen, Aarne] Helsinki Univ Hosp, Helsinki, Finland; [Laine, Matti] Abo Akad Univ, Dept Psychol, Helsinki, Finland; [Ylinen, Aarne] Tampere Univ Hosp, Tampere, Finland; [Ylinen, Aarne] Validia Rehabil Helsinki, Helsinki, Finland; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Tree Life, Richmond, VA USA; [Rantanen, Pekka] Helsinki Univ Hosp, Dept Phys & Rehabil Med, Helsinki, Finland; [Rantanen, Pekka] Kanta Hame Cent Hosp, Dept Phys & Rehabil Med, Hameenlinna, Finland		Siponkoski, ST (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Mus Aging & Rehabil Team, Cognit Brain Res Unit, Helsinki, Finland.	sini-tuuli.siponkoski@helsinki.fi		Koskinen, Sanna/0000-0002-3453-5084; Siponkoski, Sini-Tuuli/0000-0001-8078-3620; Lipsanen, Jari Olavi/0000-0003-0746-2745; Melkas, Susanna/0000-0003-0564-9637; Martinez-Molina, Noelia/0000-0001-7699-5540	Academy of FinlandAcademy of FinlandEuropean Commission [277693, 299044, 306625]; University of Helsinki [313/51/2013]; Social Insurance Institution of Finland [18/26/2013]; Yrjo Johansson Foundation [6464]; Finnish Association of People with Physical Disabilities and Helsinki Uusimaa Hospital district [461/13/01/00/2015, 154/13/01/2016]	Financial support was provided by the Academy of Finland [grant numbers 277693, 299044, 306625]; University of Helsinki [grant number 313/51/2013]; Social Insurance Institution of Finland [grant number 18/26/2013]; Yrjo Johansson Foundation [grant number 6464]; and the Finnish Association of People with Physical Disabilities and Helsinki Uusimaa Hospital district [grant numbers 461/13/01/00/2015 and 154/13/01/2016].	[Anonymous], 2016, IBM SPSS STAT WINDOW; Assarroudi A, 2018, J RES NURS, V23, P42, DOI 10.1177/1744987117741667; Baker F, 2005, BRAIN INJURY, V19, P519, DOI 10.1080/02699050400005150; Baker F, 2001, J MUSIC THER, V38, P170, DOI 10.1093/jmt/38.3.170; Baker F., 2004, BRIT J MUSIC THER, V18, P1359, DOI [10.1177/135945750401800204, DOI 10.1177/135945750401800204]; Baker FA, 2019, CLIN REHABIL, V33, P1045, DOI 10.1177/0269215519831417; Baker FA, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00299; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Beck A. T., 2005, BECK DEPRESSION INVE; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dwan K, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4378; Egeland J, 2010, CHILD NEUROPSYCHOL, V16, P326, DOI 10.1080/09297041003601462; Formisano R, 2001, Ann Ist Super Sanita, V37, P627; Froutan R, 2020, COMPLEMENT THER CLIN, V40, DOI 10.1016/j.ctcp.2020.101216; Gilbert SJ, 2008, CURR BIOL, V18, pR110, DOI 10.1016/j.cub.2007.12.014; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Guetin S., 2009, Annals of Physical and Rehabilitation Medicine, V52, P30, DOI 10.1016/j.annrmp.2008.08.009; Haynes W., 2013, ENCY SYST BIOL, P78, DOI [10.1007/978-1-4419-9863-7_1215, DOI 10.1007/978-1-4419-9863-7_1215]; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huque MH, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0615-6; Jacobson LA, 2020, CLIN NEUROPSYCHOL, V34, P243, DOI 10.1080/13854046.2019.1571634; Jentzsch I, 2014, NEUROPSYCHOLOGIA, V52, P117, DOI 10.1016/j.neuropsychologia.2013.09.025; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Keller PE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0394; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Koshimori Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01245; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Lynch C, 2016, J MUSIC THER, V53, P279, DOI 10.1093/jmt/thw008; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; Magee WL, 2002, J MUSIC THER, V39, P20, DOI 10.1093/jmt/39.1.20; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Martin N, 2012, APHASIOLOGY, V26, P462, DOI 10.1080/02687038.2011.619516; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mueller C., 2013, THESIS COLORADO STAT; Nayak, 2003, NORD J MUSIC THER, V12, P139, DOI [1, DOI 10.1080/08098130309478084]; Nayak S, 2000, REHABIL PSYCHOL, V45, P274, DOI 10.1037/0090-5550.45.3.274; Pool J, 2012, BRIEF GROUP MUSIC TH; Prigatano GP, 2011, TOP STROKE REHABIL, V18, P30, DOI 10.1310/tsr1801-30; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Raglio A, 2015, WORLD J PSYCHIATR, V5, P68, DOI 10.5498/wjp.v5.i1.68; Roddy C, 2020, NEUROPSYCHOL REHABIL, V30, P166, DOI 10.1080/09602011.2018.1448288; Rodriguez-Fornells A, 2012, ANN NY ACAD SCI, V1252, P282, DOI 10.1111/j.1749-6632.2011.06425.x; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Saarikallio S., 2007, PSYCHOL, V35, P88, DOI [DOI 10.1177/0305735607068889, 10.1177/0305735607068889]; Saarikallio S, 2011, PSYCHOL MUSIC, V39, P307, DOI 10.1177/0305735610374894; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2; Schneider S, 2010, MUSIC PERCEPT, V27, P271, DOI 10.1525/MP.2010.27.4.271; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Siponkoski ST, 2020, J NEUROTRAUM, V37, P618, DOI 10.1089/neu.2019.6413; Spitz G, 2017, J NEUROTRAUM, V34, P807, DOI 10.1089/neu.2016.4527; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Thabane L, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-92; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Toplak ME, 2013, J CHILD PSYCHOL PSYC, V54, P131, DOI 10.1111/jcpp.12001; Traumatic Brain Injury, 2008, CURR CAR GUID FINN M; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; van Ginkel JR, 2020, J PERS ASSESS, V102, P297, DOI 10.1080/00223891.2018.1530680; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Vik BMD, 2018, BRAIN INJURY, V32, P634, DOI 10.1080/02699052.2018.1431842; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110	87	1	1	5	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.												10.1080/09602011.2021.1890138		MAR 2021	33	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	QR2VH	WOS:000625071700001	33657970	Green Published, hybrid			2022-02-06	
J	Wilber, CG; Leddy, JJ; Bezherano, I; Bromley, L; Edwards, AE; Willer, BS; Haider, MN				Wilber, Charles G.; Leddy, John J.; Bezherano, Itai; Bromley, Lacey; Edwards, Amanda E.; Willer, Barry S.; Haider, Mohammad N.			Rehabilitation of Concussion and Persistent Postconcussive Symptoms	SEMINARS IN NEUROLOGY			English	Article						concussion; persistent post concussion symptoms; post-concussion syndrome; cervicogenic headache; active rehabilitation		Concussion and persistent postconcussive symptoms (PPCS) are encountered by clinicians in sports medicine, pediatrics, neurology, physiatry, emergency medicine, and primary care. Clinical management may require a multidisciplinary approach. This article presents a structured method for the diagnosis of concussion and PPCS in the outpatient setting, which includes a history, physical examination, and additional tests as clinically indicated to help identify underlying symptom generators. Treatment for concussion and PPCS should be individualized, based on predominant signs and symptoms, and can include subsymptom threshold aerobic exercise, cervical physical therapy, vestibulo-ocular rehabilitation, behavioral and cognitive psychotherapy, and some symptom-specific pharmacological therapies.	[Wilber, Charles G.; Leddy, John J.; Bezherano, Itai; Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Orthopaed & Sports Med, UBMD, Buffalo, NY USA; [Bromley, Lacey] Dyouville Coll, Sch Hlth Profess, Dept Phys Therapy, Buffalo, NY USA; [Bromley, Lacey] Bennett Rehabil Inst, Buffalo, NY USA; [Edwards, Amanda E.] SUNY Buffalo, Dept Athlet, UB Counseling Serv, Buffalo, NY USA; [Willer, Barry S.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY USA; [Haider, Mohammad N.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Program Neurosci, PhD Program Biomed Sci, Buffalo, NY USA		Haider, MN (corresponding author), 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	haider@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award number 1R01NS094444 and the National Center for Advancing Translational Sciences of the NIH under award number UL1TR001412 to the University at Buffalo, State University of New York. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Acharya U Rajendra, 2007, ADV CARDIAC SIGNAL P; Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Brassil HE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0200-y; Briere J, 2016, PSYCHOL TRAUMA-US, V8, P439, DOI 10.1037/tra0000107; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Campos E., 2002, PHYSL OCULAR MOVEMEN, P52; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Connery AK, 2016, PHYS MED REH CLIN N, V27, P475, DOI 10.1016/j.pmr.2015.12.001; Coupe M, 2009, RESP PHYSIOL NEUROBI, V169, pS10, DOI 10.1016/j.resp.2009.04.009; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dessy AM, 2015, CONT NEUROSURGERY, V37, P1; Du W., 2018, CLIN J SPORT MED, DOI 10.1097/JSM.0000000000000687; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Gauvin-Lepage J, 2020, CLIN J SPORT MED, V30, P423, DOI 10.1097/JSM.0000000000000634; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hammond FM, 2012, BRAIN INJURY MED PRI; Hinds Andrea, 2016, Concussion, V1, pCNC15, DOI 10.2217/cnc-2016-0002; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Jaffee MS, 2013, MANAGEMENT ADULTS TR; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kelly J, 2000, STANDARDIZED ASSESSM, P2; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Klatt B.N., 2015, PHYS MED REHABIL INT, V2; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Luedtke K, 2016, MANUAL THER, V23, P17, DOI 10.1016/j.math.2016.02.010; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; Morey L.C., 2007, PERSONALITY ASSESSME; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Ontario Neurotrauma Foundation, 2013, ONT NEUR FDN GUID CO; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Petrelli T, 2017, PAED CHILD HEALT-CAN, V22, P2, DOI 10.1093/pch/pxw011; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Register-Mihalik JK, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0724-2; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Sellbom M, 2006, J PERS ASSESS, V86, P196, DOI 10.1207/s15327752jpa8602_09; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Silver JM, 2019, TXB TRAUMATIC BRAIN; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Slavin-Mulford J, 2012, J PERS ASSESS, V94, P593, DOI 10.1080/00223891.2012.681817; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Snyder JJ, 2009, PSYCHIAT RES, V170, P256, DOI 10.1016/j.psychres.2008.11.008; Stroth S, 2009, NEUROPSYCHOL REHABIL, V19, P223, DOI 10.1080/09602010802091183; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Trojian TH, 2017, CURR SPORT MED REP, V16, P247, DOI 10.1249/JSR.0000000000000387; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	95	1	1	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	APR	2021	41	02					124	131		10.1055/s-0041-1725134		MAR 2021	8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RJ9NH	WOS:000625284600002	33663005				2022-02-06	
J	Feller, CN; Goldenberg, M; Asselin, PD; Merchant-Borna, K; Abar, B; Jones, CMC; Mannix, R; Kawata, K; Bazarian, JJ				Feller, Christina N.; Goldenberg, May; Asselin, Patrick D.; Merchant-Borna, Kian; Abar, Beau; Jones, Courtney Marie Cora; Mannix, Rebekah; Kawata, Keisuke; Bazarian, Jeffrey J.			Classification of Comprehensive Neuro-Ophthalmologic Measures of Postacute Concussion	JAMA NETWORK OPEN			English	Article							SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; SACCADIC EYE-MOVEMENTS; SMOOTH-PURSUIT; DYSFUNCTION; IMPACT; SYNCHRONIZATION; PERFORMANCE; TESTS; RISK	IMPORTANCE Symptom-based methods of concussion diagnosis in contact sports result in underdiagnosis and repeated head injury exposure, increasing the risk of long-term disability. Measures of neuro-ophthalmologic (NO) function have the potential to serve as objective aids, but their diagnostic utility is unknown. OBJECTIVE To identify NO measures that accurately differentiate athletes with and without concussion. DESIGN, SETTING, AND PARTICIPANTS This cohort studywas conducted among athletes with and without concussion who were aged 17 to 22 years between 2016 and 2017. Eye movements and cognitive function were measured a median of 19 days after injury among patients who had an injury meeting the study definition of concussion while playing a sport (retrospectively selected from a concussion clinic), then compared with a control group of participants without concussion (enrolled from 104 noncontact collegiate athlete volunteers without prior head injury). Data analysis was conducted from November 2019 through May 2020. EXPOSURE Concussion. MAIN OUTCOMES AND MEASURES Classification accuracy of clinically important discriminator eye-tracking (ET) metrics. Participants' eye movements were evaluated with a 12-minute ET procedure, yielding 42metrics related to smooth pursuit eyemovement (SPEM), saccades, dynamic visual acuity, and reaction time. Clinically important discriminator metricswere defined as those with significantly different group differences and area under the receiver operator characteristic curves (AUROCs) of at least 0.70. RESULTS A total of 34 participants with concussions (mean [SD] age, 19.7 [2.4] years; 20[63%] men) and 54 participants without concussions (mean [SD] age, 20.8 [2.2] years; 31 [57%] men) completed the study. Six ETmetrics (ie, simple reaction time, discriminate reaction time, discriminate visual reaction speed, choice visual reaction speed, and reaction time on 2 measures of dynamic visual acuity 2) were found to be clinically important; allwere measures of reaction time, and nonewere related to SPEM. Combined, these 6metrics had an AUROC of 0.90(95% CI, 0.80-0.99), a sensitivity of 77.8%, and a specificity of 92.6%. The 6metrics remained significant on sensitivity testing. CONCLUSIONS AND RELEVANCE In this study, ET measures of slowed visual reaction time had high classification accuracy for concussion. Accurate, objective measures of NO function have the potential to improve concussion recognition and reduce the disability associated with underdiagnosis.	[Feller, Christina N.; Asselin, Patrick D.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Feller, Christina N.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Goldenberg, May] Univ Rochester, Rochester, NY USA; [Asselin, Patrick D.; Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Merchant-Borna, Kian; Abar, Beau; Jones, Courtney Marie Cora; Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA; [Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA		Bazarian, JJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, 265 Crittenden Blvd,Box 655C, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu					Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bin Zahid A, 2020, CLIN J SPORT MED, V30, P433, DOI 10.1097/JSM.0000000000000639; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Cochrane GD, 2019, OPTOMETRY VISION SCI, V96, P256, DOI 10.1097/OPX.0000000000001364; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hunfalvay Melissa, 2020, Concussion, V5, pCNC69, DOI 10.2217/cnc-2019-0013; Hunfalvay Melissa, 2019, Concussion, V4, pCNC60, DOI 10.2217/cnc-2019-0001; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kellar D, 2018, NEUROIMAGE-CLIN, V18, P413, DOI 10.1016/j.nicl.2018.01.025; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Lange B, 2018, OPTOM VIS PERFORMANC, V6, P167; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAPIDOT MB, 1987, J GERONTOL, V42, P329, DOI 10.1093/geronj/42.3.329; Lempke LB, 2020, SPORTS MED, V50, P1341, DOI 10.1007/s40279-020-01281-0; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Mack DJ, 2017, BEHAV RES METHODS, V49, P2146, DOI 10.3758/s13428-016-0848-4; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00611; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Murray N., 2017, VIS DEV REHABIL, V3, P23; Murray NG, 2020, J NEUROTRAUM, V37, P340, DOI 10.1089/neu.2019.6595; Murray NP, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.2; Nagib S, 2019, J SPORT REHABIL, V28, P764, DOI 10.1123/jsr.2018-0021; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Samadani U., 2015, CONCUSSION, V1, pCNC2; Samadani Uzma, 2016, Concussion, V1, pCNC2, DOI 10.2217/cnc.15.2; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Simundic Ana-Maria, 2009, EJIFCC, V19, P203; Slobounov S, 2014, BRIT J SPORT MED, V48, P75, DOI 10.1136/bjsports-2013-092362; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; US Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Voss HU, 2007, BIOL CYBERN, V96, P309, DOI 10.1007/s00422-006-0116-2; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Webb B, 2018, J NEUROTRAUM, V35, P1874, DOI 10.1089/neu.2018.5673; Zaslow T, 2020, ORTHOP J SPORTS MED, V20, DOI [10.1177/ 2325967120S00150, DOI 10.1177/2325967120S00150]; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	55	1	1	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	MAR 3	2021	4	3							e210599	10.1001/jamanetworkopen.2021.0599			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR7RW	WOS:000625413100005	33656530	Green Published, gold			2022-02-06	
J	Schroder, A; Lawrence, T; Voets, N; Garcia-Gonzalez, D; Jones, M; Pena, JM; Jerusalem, A				Schroder, Anna; Lawrence, Tim; Voets, Natalie; Garcia-Gonzalez, Daniel; Jones, Mike; Pena, Jose-Maria; Jerusalem, Antoine			A Machine Learning Enhanced Mechanistic Simulation Framework for Functional Deficit Prediction in TBI	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						traumatic brain injury; resting state functional magnetic resonance imaging; default mode network; finite element simulation; machine learning	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; DIFFUSE AXONAL INJURY; FINITE-ELEMENT MODELS; CONNECTIVITY; IMPACT; DYSFUNCTION; DISRUPTION; HEAD	Resting state functional magnetic resonance imaging (rsfMRI), and the underlying brain networks identified with it, have recently appeared as a promising avenue for the evaluation of functional deficits without the need for active patient participation. We hypothesize here that such alteration can be inferred from tissue damage within the network. From an engineering perspective, the numerical prediction of tissue mechanical damage following an impact remains computationally expensive. To this end, we propose a numerical framework aimed at predicting resting state network disruption for an arbitrary head impact, as described by the head velocity, location and angle of impact, and impactor shape. The proposed method uses a library of precalculated cases leveraged by a machine learning layer for efficient and quick prediction. The accuracy of the machine learning layer is illustrated with a dummy fall case, where the machine learning prediction is shown to closely match the full simulation results. The resulting framework is finally tested against the rsfMRI data of nine TBI patients scanned within 24 h of injury, for which paramedical information was used to reconstruct in silico the accident. While more clinical data are required for full validation, this approach opens the door to (i) on-the-fly prediction of rsfMRI alterations, readily measurable on clinical premises from paramedical data, and (ii) reverse-engineered accident reconstruction through rsfMRI measurements.	[Schroder, Anna; Garcia-Gonzalez, Daniel; Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Oxford, England; [Lawrence, Tim; Voets, Natalie] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Jones, Mike] Cardiff Univ, Inst Med Engn & Med Phys, Cardiff, Wales; [Pena, Jose-Maria] Lurtis Ltd, Oxford, England; [Schroder, Anna] UCL, Dept Med Phys & Biomed Engn, London, England; [Garcia-Gonzalez, Daniel] Univ Carlos III Madrid, Dept Continuum Mech & Struct Anal, Leganes, Spain		Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Oxford, England.; Voets, N (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.; Pena, JM (corresponding author), Lurtis Ltd, Oxford, England.	natalie.voets@ndcn.ox.ac.uk; jm.penya@lurtis.com; antoine.jerusalem@eng.ox.ac.uk	Garcia-Gonzalez, Daniel/K-7349-2017	Garcia-Gonzalez, Daniel/0000-0003-4692-3508; Pena, Jose Maria/0000-0002-3303-0455	University of Oxford; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N020987/1]; NIHR Oxford Biomedical Research CentreNational Institute for Health Research (NIHR); University of Oxford Wellcome Centre for Integrative Neuroimaging	AS, J-MP, and AJ acknowledge funding from the University of Oxford University Challenge Seed Fund. DG-G and AJ also acknowledge funding from the EPSRC Healthcare Technologies Challenge Award No. EP/N020987/1. Finally, TL acknowledge funding from the NIHR Oxford Biomedical Research Centre and NV, from the University of Oxford Wellcome Centre for Integrative Neuroimaging.	Ami O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215721; Baker RE, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0660; Berthelson, 2017, INT J BIOMED BIOL EN, V11, P568; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dixit P, 2017, ARCH COMPUT METHOD E, V24, P979, DOI 10.1007/s11831-016-9196-x; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Garcia-Gonzalez D, 2018, J MECH PHYS SOLIDS, V112, P209, DOI 10.1016/j.jmps.2017.12.001; Garcia-Gonzalez D, 2017, J MECH BEHAV BIOMED, V69, P342, DOI 10.1016/j.jmbbm.2017.01.012; Garcia-Gonzalez D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28271-7; GURDJIAN ES, 1947, AM J SURG, V73, P269, DOI 10.1016/0002-9610(47)90321-8; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; Ikels K., 1996, P 15 INT TECHN C ENH, P1273; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Khalili-Mahani N, 2012, HUM BRAIN MAPP, V33, P1003, DOI 10.1002/hbm.21265; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Li XR, 2020, BEHAV RES METHODS, V52, P2657, DOI 10.3758/s13428-020-01360-0; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Menon D, 2008, BMJ-BRIT MED J, V336, P397, DOI 10.1136/bmj.39461.616991.80; Minaee S, 2019, IEEE T MED IMAGING, V38, P2545, DOI 10.1109/TMI.2019.2905917; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; National Institute for Health and Care Excellence, 2019, HEAD INJ ASS EARL MA; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pappachan B, 2012, J MAXILLOFAC ORAL SU, V11, P224, DOI 10.1007/s12663-011-0289-7; Patton D.A., 2017, HEAD IMPACT BIOMECHA, DOI [10.1007/978-3-319-30808-1_185-1, DOI 10.1007/978-3-319-30808-1_185-1]; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Royal College of Physicians Surgeons of Glasgow, 1974, GLASG STRUCT APPR AS; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Siddiqui Zaigham Faraz, 2015, Brain Inform, V2, P33; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; van der Horn HJ, 2017, J NEUROTRAUM, V34, P3262, DOI 10.1089/neu.2017.5185; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Voets NL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16046-5; Voets NL, 2012, BRAIN, V135, P2350, DOI 10.1093/brain/aws137; Wang F, 2020, TRAFFIC INJ PREV, V21, P102, DOI 10.1080/15389588.2019.1680837; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wong TT, 2015, PATTERN RECOGN, V48, P2839, DOI 10.1016/j.patcog.2015.03.009; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhang T, 2009, J MACH LEARN RES, V10, P555; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	70	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	MAR 3	2021	9								587082	10.3389/fbioe.2021.587082			19	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	QX4ZT	WOS:000629357100001	33748080	gold, Green Published, Green Accepted			2022-02-06	
J	Sultana, S; Burkovskiy, I; Zhou, J; Kelly, MM; Lehmann, C				Sultana, Saki; Burkovskiy, Ian; Zhou, Juan; Kelly, Melanie M.; Lehmann, Christian			Effect of Cannabinoid 2 Receptor Modulation on the Peripheral Immune Response in Central Nervous System Injury-Induced Immunodeficiency Syndrome	CANNABIS AND CANNABINOID RESEARCH			English	Article						AM630; cannabinoid 2 receptor; CNS injury; HU308; immunosuppression; intravital microscopy		Introduction: Acute central nervous system (CNS) injury, such as stroke, spinal cord injury, or traumatic brain injury can result in dysregulated immune response, and the condition is known as CNS injury-induced immunodeficiency syndrome (CIDS). The endocannabinoid system is an important homeostatic regulator in the CNS and immune system. Activation of cannabinoid 2 receptors (CB2R) on immune cells has been reported to dampen inflammation, suggesting a potential role of CB2R in the peripheral immune response following CNS injury. In this study, we have investigated the effect of CB2R modulation on the peripheral immune response during CIDS. Materials and Methods: Experimental CNS injury was induced in C57BL/6 mice through intracerebral injection of the vasopressor peptide, endothelin-1. A selective CB2R agonist (HU308) was used as an early treatment before the onset of CIDS and AM630, a selective CB2R antagonist, was administered as a later-phase therapy to combat the systemic immunodeficiency following the CNS injury. The peripheral immune response to endotoxin was studied 24 h after the CNS injury using intravital microscopy to examine leukocyte activation within the intestinal microcirculation in mice. Brain infarct size, and plasma levels of cytokines and soluble adhesion molecules were measured as additional parameters for the assessment of treatment outcomes. Results: Our results showed that early CB2R activation with HU308 reduced brain injury size and restored leukocyte response to endotoxin in the peripheral microcirculation. Late CB2R inhibition with AM630 also improved the peripheral leukocyte response to endotoxin and did not exacerbate the extent of brain injury. Discussion: CB2R activation has the potential to mitigate CNS injury as an early treatment by limiting neuroinflammation and preventing the development of CIDS. At the later stage with already-established CIDS, treatment may require dampening CB2R activation to improve the patient's outcome.	[Sultana, Saki; Burkovskiy, Ian; Zhou, Juan; Lehmann, Christian] Dalhousie Univ, Dept Anesthesia Pain Management & Perioperat Med, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada; [Kelly, Melanie M.; Lehmann, Christian] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Lehmann, Christian] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada		Sultana, S (corresponding author), Dalhousie Univ, Dept Anesthesia Pain Management & Perioperat Med, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	saki.sultana@dal.ca					Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Biernaskie J, 2001, MAGNET RESON MED, V46, P827, DOI 10.1002/mrm.1263; Bollaerts I, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9478542; Burkovskiy I, 2016, MICROCIRCULATION, V23, P283, DOI 10.1111/micc.12276; Chugh C, 2019, INDIAN J CRIT CARE M, V23, pS140, DOI 10.5005/jp-journals-10071-23192; Craft RM, 2013, LIFE SCI, V92, P476, DOI 10.1016/j.lfs.2012.06.009; Dhopeshwarkar A, 2014, MOL PHARMACOL, V86, P430, DOI 10.1124/mol.114.094649; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Felger JC, 2010, BRAIN BEHAV IMMUN, V24, P724, DOI 10.1016/j.bbi.2009.11.002; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; HEINEL LA, 1994, BRAIN RES BULL, V34, P137, DOI 10.1016/0361-9230(94)90010-8; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Hughes PM, 2003, J NEUROPATH EXP NEUR, V62, P1276, DOI 10.1093/jnen/62.12.1276; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kim T, 2019, NEUROCHEM INT, V127, P22, DOI 10.1016/j.neuint.2019.01.012; Klein T W, 2001, Pain Res Manag, V6, P95; Kumar KP, 2018, CELL TISSUE RES, V371, P551, DOI 10.1007/s00441-017-2753-2; Learoyd AE, 2017, TRANSL STROKE RES, V8, P541, DOI 10.1007/s12975-017-0553-3; Lehmann C, 2014, MED HYPOTHESES, V82, P736, DOI 10.1016/j.mehy.2014.03.015; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Miller LK, 2011, PHARMACOL REV, V63, P461, DOI 10.1124/pr.110.003491; Murta V, 2013, MOL CELL NEUROSCI, V53, P6, DOI 10.1016/j.mcn.2012.06.004; Ni X, 2004, MULT SCLER J, V10, P158, DOI 10.1191/1352458504ms1009oa; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Rieder SA, 2010, IMMUNOBIOLOGY, V215, P598, DOI 10.1016/j.imbio.2009.04.001; ROBINSON MJ, 1990, NEUROSCI LETT, V118, P269, DOI 10.1016/0304-3940(90)90644-O; SHARKEY J, 1993, J CEREBR BLOOD F MET, V13, P865, DOI 10.1038/jcbfm.1993.108; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Vogelgesang A, 2014, ACTA NEUROL SCAND, V129, P1, DOI 10.1111/ane.12165; Vogelgesang A, 2011, J NEUROIMMUNOL, V231, P105, DOI 10.1016/j.jneuroim.2010.09.023; Wei Y, 2009, MOL VIS, V15, P1243; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Yu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132487; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhou J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020388; Zou SL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030833	46	1	1	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2578-5125	2378-8763		CANNABIS CANNABINOID	Cannabis Cannabinoid Res.	AUG 1	2021	6	4					327	339		10.1089/can.2020.0130		MAR 2021	13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	TY5JY	WOS:000626129300001	33998888				2022-02-06	
J	Almeida, CA; Torres-Espin, A; Huie, JR; Sun, DM; Noble-Haeusslein, LJ; Young, W; Beattie, MS; Bresnahan, JC; Nielson, JL; Ferguson, AR				Almeida, Carlos A.; Torres-Espin, Abel; Huie, J. Russell; Sun, Dongming; Noble-Haeusslein, Linda J.; Young, Wise; Beattie, Michael S.; Bresnahan, Jacqueline C.; Nielson, Jessica L.; Ferguson, Adam R.			Excavating FAIR Data: the Case of the Multicenter Animal Spinal Cord Injury Study (MASCIS), Blood Pressure, and Neuro-Recovery	NEUROINFORMATICS			English	Article; Early Access						Data science; Metascience; Neurotrauma; Reproducibility; Spinal contusion; Motor recovery; Autonomic; Hemodynamics		Meta-analyses suggest that the published literature represents only a small minority of the total data collected in biomedical research, with most becoming 'dark data' unreported in the literature. Dark data is due to publication bias toward novel results that confirm investigator hypotheses and omission of data that do not. Publication bias contributes to scientific irreproducibility and failures in bench-to-bedside translation. Sharing dark data by making it Findable, Accessible, Interoperable, and Reusable (FAIR) may reduce the burden of irreproducible science by increasing transparency and support data-driven discoveries beyond the lifecycle of the original study. We illustrate feasibility of dark data sharing by recovering original raw data from the Multicenter Animal Spinal Cord Injury Study (MASCIS), an NIH-funded multi-site preclinical drug trial conducted in the 1990s that tested efficacy of several therapies after a spinal cord injury (SCI). The original drug treatments did not produce clear positive results and MASCIS data were stored in boxes for more than two decades. The goal of the present study was to independently confirm published machine learning findings that perioperative blood pressure is a major predictor of SCI neuromotor outcome (Nielson et al., 2015). We recovered, digitized, and curated the data from 1125 rats from MASCIS. Analyses indicated that high perioperative blood pressure at the time of SCI is associated with poorer health and worse neuromotor outcomes in more severe SCI, whereas low perioperative blood pressure is associated with poorer health and worse neuromotor outcome in moderate SCI. These findings confirm and expand prior results that a narrow window of blood-pressure control optimizes outcome, and demonstrate the value of recovering dark data for assessing reproducibility of findings with implications for precision therapeutic approaches.	[Almeida, Carlos A.; Torres-Espin, Abel; Huie, J. Russell; Beattie, Michael S.; Bresnahan, Jacqueline C.; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurol Surg, Weill Inst Neurosci, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Sun, Dongming; Young, Wise] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, New Brunswick, NJ USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Neurol, Austin, TX 78712 USA; [Noble-Haeusslein, Linda J.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Nielson, Jessica L.] Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN 55812 USA; [Nielson, Jessica L.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55812 USA; [Ferguson, Adam R.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA		Ferguson, AR (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Weill Inst Neurosci, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA.; Nielson, JL (corresponding author), Univ Minnesota, Dept Psychiat & Behav Sci, Minneapolis, MN 55812 USA.; Nielson, JL (corresponding author), Univ Minnesota, Inst Hlth Informat, Minneapolis, MN 55812 USA.; Ferguson, AR (corresponding author), San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA.	jnielson@umn.edu; adam.ferguson@ucsf.edu			Wings for Life Foundation; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088475, UG3/UH3NS106899]; NIH/NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH116156]; NIH/NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002494]; Department of Veterans AffairsUS Department of Veterans Affairs [1I01RX002245, I01RX002787]; Craig H. Neilsen Foundation;  [NS032000]	Supported by Wings for Life Foundation (ARF); NIH/NINDS: R01NS088475 (ARF); UG3/UH3NS106899 (ARF); JLN supported by NIH/NIMH: R01MH116156 and NIH/NCATS: UL1TR002494; Department of Veterans Affairs: 1I01RX002245 (ARF), I01RX002787 (ARF); and Craig H. Neilsen Foundation (ARF). Original MASCIS data collection was funded by NS032000 (WY). The authors would like to thank Hadi Askari, Sean P. O'Leary, and Patricia Morton for help with data recovery.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; Biering-Sorensen F, 2005, SPINAL CORD, V43, P587, DOI 10.1038/sj.sc.3101815; Callahan A, 2017, EXP NEUROL, V295, P135, DOI 10.1016/j.expneurol.2017.05.012; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; Catapano JS, 2016, WORLD NEUROSURG, V96, P72, DOI 10.1016/j.wneu.2016.08.053; Centers for Disease Control and Prevention, 2020, HIGH BLOOD PRESS FAC; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; CMAJ, 2014, CAN MED ASSOC J, V170, P437; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dakson A, 2017, SPINAL CORD, V55, P1033, DOI 10.1038/sc.2017.52; Ehsanian R, 2020, SPINAL CORD, V58, P377, DOI 10.1038/s41393-019-0370-5; Ercan I, 2017, ACTA VET-BEOGRAD, V67, P33, DOI 10.1515/acve-2017-0004; Ercan I, 2015, UHOD-ULUSLAR HEMATOL, V25, P130, DOI 10.4999/uhod.15942; FADEN AI, 1989, BRAIN RES, V486, P228, DOI 10.1016/0006-8993(89)90509-X; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Ferguson AR, 2014, NAT NEUROSCI, V17, P1442, DOI 10.1038/nn.3838; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fouad K, 2020, J NEUROTRAUM, V37, P831, DOI 10.1089/neu.2019.6674; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Hadley MN, 2002, NEUROSURGERY, V50, pS1; Hawkins BE, 2020, J NEUROTRAUM, V37, P2414, DOI 10.1089/neu.2018.6192; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Hawryluk GWJ, 2020, JAMA NEUROL, V77, P1150, DOI 10.1001/jamaneurol.2020.1310; Hook MA, 2004, J NEUROTRAUM, V21, P109, DOI 10.1089/089771504772695995; HUERTA MF, 1993, TRENDS NEUROSCI, V16, P436, DOI 10.1016/0166-2236(93)90069-X; Huie JR, 2018, CURR OPIN NEUROL, V31, P702, DOI 10.1097/WCO.0000000000000614; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Kepler CK, 2015, SPINAL CORD, V53, P763, DOI 10.1038/sc.2015.76; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lemmon VP, 2014, J NEUROTRAUM, V31, P1354, DOI 10.1089/neu.2014.3400; Ludecke D, 2020, COLLECTION CONVENIEN; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mueck L, 2013, NAT NANOTECHNOL, V8, P693, DOI 10.1038/nnano.2013.204; Neff EP, 2018, LAB ANIMAL, V47, P45, DOI 10.1038/laban.1405; Nielson JL, 2021, J NEUROTRAUM, V38, P2530, DOI 10.1089/neu.2019.6702; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Nielson JL, 2014, J NEUROTRAUM, V31, P1789, DOI 10.1089/neu.2014.3399; NIH Office of Extramural Research, 2019, NIH GRANTS POL STAT; Nout YS, 2012, J NEUROTRAUM, V29, P990, DOI 10.1089/neu.2011.1845; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; R Core Team, 2019, R LANG ENV STAT COMP; Readdy WJ, 2016, NEUROSURGERY, V79, P708, DOI 10.1227/NEU.0000000000001249; Rocher L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10933-3; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; RStudio Team, 2018, RSSTUDIO INT DEV R; Sabit B, 2018, J INTENSIVE CARE MED, V33, P3, DOI 10.1177/0885066616672643; Shah A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00011; Simundic A-M., 2009, BIOCHEM MEDICA, V19, P430; Squair JW, 2019, NEUROLOGY, V93, pE1205, DOI 10.1212/WNL.0000000000008125; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Young W, 2002, PROG BRAIN RES, V137, P231; Yue JK, 2020, WORLD NEUROSURG, V133, pE391, DOI 10.1016/j.wneu.2019.09.044; Yue JK, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17396	66	1	1	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics												10.1007/s12021-021-09512-z		MAR 2021	14	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Neurosciences & Neurology	QQ2ZB	WOS:000624392700001	33651310	hybrid			2022-02-06	
J	Liu, RK; Hicks, SD				Liu, Ruikang; Hicks, Steven D.			Discrepancies in child and parent reporting of concussion symptoms	BRAIN INJURY			English	Article						Mild traumatic brain injury; scales; youth; pediatric; SCAT		Objective: To assess discrepancies between child and parent symptom reports following concussion. Methods: Prospective cohort study involving 61 patients, age 7-21 years, diagnosed with a concussion within the previous 14 days. Children/parents completed the Child SCAT-3 symptom inventory at enrollment and 4 weeks post-injury. A within-subjects t-test was used to compare differences in child/parent response for each of 20 individual symptoms, 4 symptom domains, and total symptom severity. Pearson correlations were used to measure agreement between child/parent responses. A repeated measures analysis of variance assessed the effect of time on child/parent symptom discrepancy. Results: At enrollment, children reported higher symptom severity for 'distracted easily' (adj. p = .015) and 'confused' (adj. p = .015). There was moderate-to-high (r > 0.3) agreement between children and parents for more individual symptoms at enrollment (18/20) than at 4 weeks post-injury (14/20). Age had no effect (p > .05) on the discrepancy between child/parent reports. Conclusions: Although there was moderate-to-strong agreement between child/parent reports of concussion symptoms, discrepancies in individual cognitive symptom reports exist, in both children and adolescents. Therefore, collection of parent scales may provide useful information when tracking cognitive symptoms in adolescent patients, who may under-report or under-recognize cognitive deficits.	[Liu, Ruikang; Hicks, Steven D.] Penn State Hershey, Dept Pediat, 500 Univ Dr,Suite P1307,POB 850, Hershey, PA 17033 USA		Liu, RK (corresponding author), Penn State Hershey, Dept Pediat, 500 Univ Dr,Suite P1307,POB 850, Hershey, PA 17033 USA.	rliu@pennstatehealth.psu.edu			Children's Miracle Network; Gerber Foundation [5295]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2 TR002015, UL1 TR002014]	This study was funded by the Children's Miracle Network, the Gerber Foundation [ID#5295], and the National Center for Advancing Translational Sciences [KL2 TR002015, UL1 TR002014].	Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; BROGLIO S, 2009, CLIN J SPORT MED, V19; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; COLLINS M, 1999, JAMA-J AM MED ASSOC, V282; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Hardin AP, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2151; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Jones KM, 2018, BRAIN INJURY, V32, P1397, DOI 10.1080/02699052.2018.1496477; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2013, J PEDIATR-US, V163, P1192, DOI 10.1016/j.jpeds.2013.05.061; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; O'Neill JA, 2017, REHABIL PSYCHOL, V62, P300, DOI 10.1037/rep0000155; Pieper P, 2015, J PEDIATR HEALTH CAR, V29, P343, DOI 10.1016/j.pedhc.2015.01.008; Plourde V, 2019, CHILD NEUROPSYCHOL, V25, P44, DOI 10.1080/09297049.2018.1432585; Porter S., 2015, BMJ OPEN SPORT EXERC, V1, DOI [10.1136/bmjsem-2015-000029, DOI 10.1136/BMJSEM-2015-000029]; Rowhani-Rahbar A, 2016, J NEUROTRAUM, V33, P784, DOI 10.1089/neu.2015.4100; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	32	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2021	35	6					675	681		10.1080/02699052.2021.1894483		MAR 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	SB4DP	WOS:000623984800001	33646888				2022-02-06	
J	Ashkenazi, SS; Sacher, Y; Vakil, E				Ashkenazi, Simone Schwizer; Sacher, Yaron; Vakil, Eli			New Insights in Implicit Sequence Learning of Adults With Traumatic Brain Injury: As Measured by an Ocular Serial Reaction Time (O-SRT) Task	NEUROPSYCHOLOGY			English	Article						implicit sequence learning; procedural learning; eye tracking; SRT; TBI		Objective: We investigated the effect of traumatic brain injury (TBI) on implicit sequence learning (ISL) and its relation with demographic, clinical, and working memory (WM) capacity using an eye-tracked variant of the standard serial reaction time (RT; SRT) task. Besides RT, this ocular SRT (O-SRT) task enables generation of correct anticipations (CA) and stucks, reflecting other critical aspects of ISL. Method: ISL was tested in 26 individuals with TBI and 28 healthy controls using the O-SRT task. Mixed analyses of variance were conducted to analyze RT and CA in three phases: learning, interference, and recovery from interference. The average number of stucks was compared with an independent-samples t test. Finally, Pearson correlation analyses of ISL with demographic, clinical, and WM capacity measures were performed. Results: Based on RT, ISL was impaired in the TBI group. However, CA demonstrated improved learning, but with deficits in the interference and recovery from interference phases. Stucks were more frequent in the TBI group, which affected RT and CA measures. Neither demographic nor clinical factors were associated with ISL. Verbal, but not spatial, WM capacity was impaired in the TBI group, and spatial WM capacity positively correlated with ISL in controls only. Conclusion: We suggest that the high TBI group stuck rate can be attributed to lack of initiative and/or conservative response bias associated with TBI, and view it as a main cause leading to deficits in ISL. Unlike controls, the TBI group could not muster their relatively preserved spatial WM capacity to support their ISL performance.	[Ashkenazi, Simone Schwizer; Vakil, Eli] Bar Ilan Univ, Dept Psychol, IL-5290002 Ramat Gan, Israel; [Ashkenazi, Simone Schwizer; Vakil, Eli] Bar Ilan Univ, Susan Gonda Goldschmied Multidisciplinary Brain R, Ramat Gan, Israel; [Sacher, Yaron] Loewenstein Hosp & Rehabil Ctr, Brain Injury Rehabil, Raanana, Israel		Ashkenazi, SS (corresponding author), Bar Ilan Univ, Dept Psychol, IL-5290002 Ramat Gan, Israel.	simone.schwizer@gmail.com		Vakil, Eli/0000-0003-4715-8828; Schwizer Ashkenazi, Simone/0000-0002-8211-9624	Israeli Ministry of Defense, Rehabilitation Department [203003-846]	This work was supported by the Israeli Ministry of Defense, Rehabilitation Department (Grant 203003-846). The authors report no conflicts of interest.	Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Beigi M, 2016, NEUROPSYCHOLOGIA, V93, P53, DOI 10.1016/j.neuropsychologia.2016.09.019; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bo J, 2011, EXP BRAIN RES, V214, P73, DOI 10.1007/s00221-011-2807-8; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; CAMPBELL KB, 1990, ELECTROEN CLIN NEURO, P202; Clegg BA, 1998, TRENDS COGN SCI, V2, P275, DOI 10.1016/S1364-6613(98)01202-9; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FERRARO FR, 1993, BRAIN COGNITION, V21, P163, DOI 10.1006/brcg.1993.1013; Gabriel A, 2013, J INT NEUROPSYCH SOC, V19, P264, DOI 10.1017/S1355617712001270; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Gofer-Levi M, 2014, RES DEV DISABIL, V35, P1952, DOI 10.1016/j.ridd.2014.04.017; Gudjonsson G, 2017, CORTEX, V87, P156, DOI 10.1016/j.cortex.2016.06.013; Janacsek K, 2013, CORTEX, V49, P2001, DOI 10.1016/j.cortex.2013.02.012; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Korman M, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00010; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Kumari V, 2015, PSYCHOPHARMACOLOGY, V232, P3135, DOI 10.1007/s00213-015-3959-1; Little DM, 2014, ALZHEIMERS DEMENT, V10, pS188, DOI 10.1016/j.jalz.2014.04.002; Lukacs A, 2015, COGNITIVE SCI, V39, P383, DOI 10.1111/cogs.12143; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Moretti R, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00289; MUTTER SA, 1994, J CLIN EXP NEUROPSYC, V16, P271, DOI 10.1080/01688639408402638; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Oddy M, 2008, J CLIN EXP NEUROPSYC, V30, P568, DOI 10.1080/13803390701555598; Palmisano S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00023; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Pedersen A, 2009, PSYCHIAT RES, V169, P1, DOI 10.1016/j.psychres.2008.06.001; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Reber A. S., 1993, IMPLICIT LEARNING TA; Rigon A, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00251; Robertson EM, 2001, CEREB CORTEX, V11, P628, DOI 10.1093/cercor/11.7.628; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Skidmore Elizabeth R, 2015, Curr Phys Med Rehabil Rep, V3, P99; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2004, J CLIN EXP NEUROPSYC, V26, P653, DOI 10.1080/13803390490504335; Vakil E, 2002, BRAIN COGNITION, V50, P304, DOI 10.1016/S0278-2626(02)00515-8; Vakil E, 2001, J CLIN EXP NEUROPSYC, V23, P207, DOI 10.1076/jcen.23.2.207.1209; Vakil E, 2017, Q J EXP PSYCHOL, V70, P579, DOI 10.1080/17470218.2016.1172095; Vakil E, 2014, J CLIN EXP NEUROPSYC, V36, P447, DOI 10.1080/13803395.2014.901299; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Virag M, 2015, EXP BRAIN RES, V233, P2081, DOI 10.1007/s00221-015-4279-8; Waltzman D., 2017, J BEHAV BRAIN SCI, V7, P325, DOI [10.4236/jbbs.2017.78024, DOI 10.4236/JBBS.2017.78024]; Wechsler D., 1997, WECHSLER MEMORY SCAL, V14; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	60	1	1	1	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2021	35	2					172	184		10.1037/neu0000710			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	RF1GS	WOS:000634595600003	33211511				2022-02-06	
J	Biese, KM; Stamm, JM; Wichman, DM; Hetzel, SJ; Post, EG; Bell, DR				Biese, Kevin M.; Stamm, Julie M.; Wichman, Daniel M.; Hetzel, Scott J.; Post, Eric G.; Bell, David R.			Association of lower extremity injuries and injury mechanism with previous concussion history in adolescent athletes	PHYSICAL THERAPY IN SPORT			English	Article						Youth; Sports injuries; Injury risk; Female	SPORTS-RELATED CONCUSSION; MUSCULOSKELETAL INJURY; HIGH-SCHOOL; NEUROMUSCULAR CONTROL; SUBSEQUENT INJURY; RISK; RECOVERY; SPECIALIZATION; STABILITY; BALANCE	Objective: Determine the association between concussion and subsequent contact, non-contact, and overuse lower extremity (LE) injuries in a cohort of adolescent athletes. Secondarily, to identify this association between males and females. Study design: Cross-sectional. Setting: Summer athletic events with participants ages 12-18. Main outcome: Anonymous survey included sport-related injuries (injury month/year) and participants classified injuries as a contact, non-contact, overuse injury, or concussion. Multivariable logistic regression analyses were used to examine associations between a concussion event and a subsequent LE injury while controlling for age and any previous LE injury. Results: A concussion was reported in 219 athletes (Female = 96, 44%) and were matched with 219 non concussed athletes (438 total participants). Concussion was not association with a specific injury mechanism but was significant for any subsequent LE injury (OR = 1.58 95%CI = [1.03-2.41]; p < 0.05). Concussed females were more likely to report any subsequent LE injury compared to non-concussed female athletes (2.49[1.31, 4.74]; p < 0.01). This relationship was not observed between concussed and non-concussed males (1.11[0.62-1.99]; p > 0.5). Conclusion: A history of concussion was associated with any subsequent LE injury, but not associated with a specific mechanism of injury. The association with concussion and a subsequent LE injury was different between males and females. (C) 2020 Elsevier Ltd. All rights reserved.YY	[Biese, Kevin M.; Stamm, Julie M.; Wichman, Daniel M.; Bell, David R.] Univ Wisconsin, Dept Kinesiol, Madison, WI USA; [Hetzel, Scott J.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Post, Eric G.] Indiana State Univ, Dept Appl Med & Rehabil, Terre Haute, IN 47809 USA		Biese, KM (corresponding author), Dept Kinesiol, 1300 Univ Ave, Madison, WI 53706 USA.	kbiese@wisc.edu		Stamm, Julie/0000-0001-5448-5099	Wisconsin Center of Education Research; University of Wisconsin-Madison; Sports Medicine Classic Fund [233No58]	This study was funded by the Wisconsin Center of Education Research, which is internal funding from the University of Wisconsin-Madison, and the Sports Medicine Classic Fund [233No58] for their financial support of this project.	Alawna M, 2020, PHYS THER SPORT, V46, P145, DOI 10.1016/j.ptsp.2020.08.015; Avedesian JM, 2020, J APPL BIOMECH, V36, P313, DOI 10.1123/jab.2020-0034; Baker RL, 2016, PHYS MED REH CLIN N, V27, P53, DOI 10.1016/j.pmr.2015.08.001; Bell DR, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0657; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Biese KM, 2020, J SCI MED SPORT, V23, P721, DOI 10.1016/j.jsams.2020.01.012; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2020, MED SCI SPORT EXER, V52, P1256, DOI 10.1249/MSS.0000000000002269; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DiCesare CA, 2019, J ATHL TRAINING, V54, P1105, DOI 10.4085/1062-6050-407-18; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Eagle SR, 2019, MED SCI SPORT EXER, V51, P1619, DOI 10.1249/MSS.0000000000001974; Fehr SD, 2019, CLIN J SPORT MED, V29, P11, DOI 10.1097/JSM.0000000000000494; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harada GK, 2019, AM J SPORT MED, V47, P3256, DOI 10.1177/0363546519872502; Herman DC, 2019, J ATHL TRAINING, V54, P1089, DOI 10.4085/1062-6050-412-18; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2020, MED SCI SPORT EXER, V52, P1015, DOI 10.1249/MSS.0000000000002225; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; Knollman-Porter K, 2019, TOP LANG DISORD, V39, P257, DOI 10.1097/TLD.0000000000000187; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Marion SD, 2003, DEV NEUROPSYCHOL, V23, P399, DOI 10.1207/S15326942DN2303_6; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McGuine TA, 2017, AM J SPORT MED, V45, P2706, DOI 10.1177/0363546517710213; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Noyes FR, 2014, ARTHROSCOPY, V30, P245, DOI 10.1016/j.arthro.2013.10.009; Nyberg G, 2015, CURR RES CONCUSSION, V2, P109; Padua DA, 2015, J ATHL TRAINING, V50, P589, DOI 10.4085/1062-6050-50.1.10; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Post EG, 2017, AM J SPORT MED, V45, P1405, DOI 10.1177/0363546517690848; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Schlingermann BE, 2018, J STRENGTH COND RES, V32, P1993, DOI 10.1519/JSC.0000000000002108; Smith CA, 2015, MED SCI SPORT EXER, V47, P136, DOI 10.1249/MSS.0000000000000380; Sullivan L., 2018, INT J ADOLESCENT MED, V1; Tiemeier H, 2010, NEUROIMAGE, V49, P63, DOI 10.1016/j.neuroimage.2009.08.016; White HL, 2012, INJURY PREV, V18, P33, DOI 10.1136/injuryprev-2011-040006; Williams J, 2016, APPL NEUROPSYCH-CHIL, V5, P35, DOI 10.1080/21622965.2014.939271; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	57	1	1	0	2	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAR	2021	48						76	82		10.1016/j.ptsp.2020.12.018			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	QH1KJ	WOS:000618034700010	33387901				2022-02-06	
J	Bruneau, DA; Cronin, DS				Bruneau, David A.; Cronin, Duane S.			Brain response of a computational head model for prescribed skull kinematics and simulated football helmet impact boundary conditions	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Helmet protection; Human body model; Brain deformation; Anthropometric testing device; Impact biomechanics; Concussion; American Football; Muscle activation		Computational human body models (HBM) present a novel approach to predict brain response in football impact scenarios, with prescribed kinematic boundary conditions for the HBM skull typically used at present. However, computational optimization of helmets requires simulation of the coupled helmet and HBM model; which is much more complex and has not been assessed in the context of brain deformation and existing simplified approaches. In the current study, two boundary conditions and the resulting brain deformations were compared using a HBM head model: (1) a prescribed skull kinematics (PK) boundary condition using measured head kinematics from experimental impacts; and (2) a novel detailed simulation of a HBM head and neck, helmet and linear impactor (HBM-S). While lateral and rear impacts exhibited similar levels of maximum principal strain (MPS) in the brain tissue using both boundary conditions, differences were noted in the frontal orientation (at 9.3 m/s, MPS was 0.39 for PK, 0.54 for HBM-S). Importantly, both PK and HBM-S boundary conditions produced a similar distribution of MPS throughout the brain for each impact orientation considered. Within the corpus callosum and thalamus, high MPS was associated with lateral impacts and lower values with frontal and rear impacts. The good correspondence of both boundary conditions is encouraging for future optimization of helmet designs. A limitation of the PK approach is the need for experimental head kinematics data, while the HBM-S can predict brain response for varying impact conditions and helmet configurations, with potential as a tool to improve helmet protection performance.	[Bruneau, David A.; Cronin, Duane S.] Univ Waterloo, Dept MME, 200 Univ Ave West, Waterloo, ON, Canada		Cronin, DS (corresponding author), Univ Waterloo, Dept Mech Engn, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	duane.cronin@uwaterloo.ca		Bruneau, David/0000-0002-8612-1959	Football Research, Inc. (FRI); National Football League (NFL); Biomechanical Consulting and Research, LLC (Biocore) in the USA	The research presented was made possible by a grant from Football Research, Inc. (FRI), the National Football League (NFL), and Biomechanical Consulting and Research, LLC (Biocore) in the USA. The authors acknowledge the contributions of the NFLPA. The views expressed are solely those of the authors and do not represent those of FRI, the NFL, Biocore, or any of their affiliates or funding sources.	Barker JB, 2021, J BIOMECH ENG-T ASME, V143, DOI 10.1115/1.4047866; Barker JB, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036464; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Bruneau DA, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4043667; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Corrales MA, 2020, ANN BIOMED ENG, V48, P121, DOI 10.1007/s10439-019-02359-1; Cronin D., 2018, USER MANUAL FINITE E; Danelson KA, 2015, ACCIDENT ANAL PREV, V85, P125, DOI 10.1016/j.aap.2015.09.010; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Eckersley CP, 2019, J SCI MED SPORT, V22, P667, DOI 10.1016/j.jsams.2019.01.009; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Fice JB, 2011, ANN BIOMED ENG, V39, P2152, DOI 10.1007/s10439-011-0315-4; Funk J.R., 2017, LINEAR IMPACTOR HELM; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gennarelli T.A., 2015, IRCOBI C 2015, P1131, DOI [10.2353/ajpath.2009.080794, DOI 10.2353/AJPATH.2009.080794]; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giudice J.S., 2018, ANN BIOMED ENG, P1; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2011, MED ENG PHYS, V33, P1147, DOI 10.1016/j.medengphy.2011.05.004; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2018, COMPUT METHOD BIOMEC, V21, P264, DOI 10.1080/10255842.2018.1445229; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rousseau P., 2010, TITLE ESTIMATING INF; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; White NA, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4028133; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; YOGANANDAN N, 1989, Journal of Biomechanical Engineering, V111, P250; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	48	1	1	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	MAR	2021	115								104299	10.1016/j.jmbbm.2020.104299			12	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	QH9ZW	WOS:000618635800008	33465751				2022-02-06	
J	Castillo, RC; Carlini, AR; Doukas, WC; Hayda, RA; Frisch, HM; Andersen, RC; D'Alleyrand, JC; Mazurek, MT; Ficke, JR; Keeling, JJ; Pasquina, PF; Wain, HJ; MacKenzie, EJ				Castillo, Renan C.; Carlini, Anthony R.; Doukas, William C.; Hayda, Roman A.; Frisch, Harold M.; Andersen, Romney C.; D'Alleyrand, Jean-Claude; Mazurek, Michael T.; Ficke, James R.; Keeling, John J.; Pasquina, Paul F.; Wain, Harold J.; MacKenzie, Ellen J.			Pain, Depression, and Posttraumatic Stress Disorder Following Major Extremity Trauma Among United States Military Serving in Iraq and Afghanistan: Results From the Military Extremity Trauma and Amputation/Limb Salvage Study	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						PTSD; chronic pain; orthopaedic trauma; veteran	MENTAL-HEALTH PROBLEMS; COMORBID CHRONIC PAIN; COPING STRATEGIES; COMBAT; PREVALENCE; SYMPTOMS; VETERANS; VALIDITY; OUTCOMES; FREEDOM	Objectives: Assess the burden and co-occurrence of pain, depression, and posttraumatic stress disorder (PTSD) among service members who sustained a major limb injury, and examine whether these conditions are associated with functional outcomes. Design: A retrospective cohort study. Setting: Four U.S. military treatment facilities: Walter Reed Army Medical Center, National Naval Medical Center, Brooke Army Medical Center, and Naval Medical Center San Diego. Patients/Participants: Four hundred twenty-nine United States service members who sustained a major limb injury while serving in Afghanistan or Iraq met eligibility criteria upon review of their medical records. Intervention: Not applicable. Main Outcome Measurements: Outcomes assessed were: function using the short musculoskeletal functional assessment; PTSD using the PTSD Checklist and diagnostic and statistical manual criteria; pain using the chronic pain grade scale. Results: Military extremity trauma and amputation/limb salvage patients without pain, depression, or PTSD, were, on average, about one minimally clinically important difference (MCID) from age- and gender-adjusted population norms. In contrast, patients with low levels of pain and no depression or PTSD were, on average, one to 2 MCIDs from population norms. Military extremity trauma and amputation/limb salvage patients with either greater levels of pain, and who experience PTSD, depression, or both, were 4 to 6 MCIDs from population norms. Regression analyses adjusting for injury type (upper or lower limb, salvage or amputation, and unilateral or bilateral), age, time to interview, military rank, presence of a major upper limb injury, social support, presence of mild traumatic brain injury/concussion, and combat experiences showed that higher levels of pain, depression, and PTSD were associated with lower one-year functional outcomes. Conclusions: Major limb trauma sustained in the military results in significant long-term pain and PTSD. Overall, the results are consistent with the hypothesis that pain, depression, and PTSD are associated with disability in this population.	[Castillo, Renan C.; Carlini, Anthony R.; Mazurek, Michael T.; MacKenzie, Ellen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 415 North Washington St, Baltimore, MD 21231 USA; [Doukas, William C.; Mazurek, Michael T.] UHC Orthopedics, Bridgeport, WV USA; [Hayda, Roman A.; Mazurek, Michael T.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA; [Frisch, Harold M.; Mazurek, Michael T.] Mission Hosp, Orthopaed Trauma Serv, Asheville, NC USA; [Andersen, Romney C.; D'Alleyrand, Jean-Claude; Mazurek, Michael T.; Keeling, John J.; Pasquina, Paul F.; Wain, Harold J.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Andersen, Romney C.; Mazurek, Michael T.] Riverside Hlth Syst, Newport News, VA USA; [D'Alleyrand, Jean-Claude; Mazurek, Michael T.] Uniformed Serv Univ Hlth Sci, Norman M Rich Dept Surg, Bethesda, MD 20814 USA; [Mazurek, Michael T.; Ficke, James R.] San Antonio Mil Med Ctr, Dept Orthopaed & Rehabil, Ft Sam Houston, TX USA		Castillo, RC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 415 North Washington St, Baltimore, MD 21231 USA.	rcastill@jhu.edu			Military Amputee Research Program of the United States Army Medical Research Acquisition Activity (USAMRAA) [W81XWH-06-1-0361]	This study was funded in part by the Military Amputee Research Program of the United States Army Medical Research Acquisition Activity (USAMRAA) (W81XWH-06-1-0361).	Alschuler KN, 2012, EUR J PAIN, V16, P312, DOI 10.1016/j.ejpain.2011.06.010; ASHBURN MA, 1989, MIL MED, V154, P86; Barei DP, 2007, J ORTHOP TRAUMA, V21, P738, DOI 10.1097/BOT.0b013e31815bb30f; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; BENEDIKT RA, 1986, AM J PSYCHIAT, V143, P908; Bosse MJ, 2002, NEW ENGL J MED, V347, P1924, DOI 10.1056/NEJMoa012604; Busse JW, 2009, J CLIN EPIDEMIOL, V62, P1210, DOI 10.1016/j.jclinepi.2009.01.014; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Castillo RC, 2006, PAIN, V124, P321, DOI 10.1016/j.pain.2006.04.020; Castillo RC, 2016, TECH ORTHOP, V31, P228, DOI 10.1097/BTO.0000000000000200; Castillo RC, 2013, PAIN, V154, P2860, DOI 10.1016/j.pain.2013.08.025; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Doukas WC, 2013, J BONE JOINT SURG AM, V95A, P138, DOI 10.2106/JBJS.K.00734; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Frey K., 2018, 055 2018 MIL HLTH SY; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Gros DF, 2012, PSYCHIAT RES, V196, P267, DOI 10.1016/j.psychres.2011.10.022; Gros DF, 2010, J NERV MENT DIS, V198, P885, DOI 10.1097/NMD.0b013e3181fe7410; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; Maruish M., 2004, USE PSYCHOL TESTING, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Masini BD, 2009, J ORTHOP TRAUMA, V23, P261, DOI 10.1097/BOT.0b013e31819dfa04; McCarthy ML, 2003, J BONE JOINT SURG AM, V85A, P1689, DOI 10.2106/00004623-200309000-00006; Mitchell SL, 2019, J BONE JOINT SURG AM, V101, P1470, DOI 10.2106/JBJS.18.00970; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; NEWCOMB A, 2011, J TRAUMA, V70, P1557; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Piero Nicole, 2010, Adv NPs PAs, V1, P41; Poundja J, 2006, J TRAUMA STRESS, V19, P747, DOI 10.1002/jts.20151; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; Sherbourne CD, 2009, J GEN INTERN MED, V24, P620, DOI 10.1007/s11606-009-0956-2; Spiro A, 2006, J AMBUL CARE MANAG, V29, P71, DOI 10.1097/00004479-200601000-00008; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474; Wegener ST, 2011, PAIN, V152, P1349, DOI 10.1016/j.pain.2011.02.020; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	47	1	1	3	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	MAR	2021	35	3					E96	E102		10.1097/BOT.0000000000001921			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	SL0ZH	WOS:000656644400005	33079837				2022-02-06	
J	Chico-Fernandez, M; Barea-Mendoza, JA; Perez-Barcena, J; Garcia-Saez, I; Quintana-Diaz, M; Marina, L; Mayor-Garcia, DM; Servia-Goixart, L; Jimenez-Moragas, JM; Llompart-Pou, JA				Chico-Fernandez, Mario; Barea-Mendoza, Jesus A.; Perez-Barcena, Jon; Garcia-Saez, Iker; Quintana-Diaz, Manuel; Marina, Luis; Mayor-Garcia, Dolores M.; Servia-Goixart, Luis; Jimenez-Moragas, Jose M.; Llompart-Pou, Juan A.			Concomitant Traumatic Brain Injury and Hemorrhagic Shock: Outcomes Using the Spanish Trauma ICU Registry (RETRAUCI)	AMERICAN SURGEON			English	Article						severe trauma; traumatic brain injury; hemorrhagic shock; outcomes		Background To compare the main outcomes of trauma patients with and without traumatic brain injury (TBI), hemorrhagic shock, and the combination of both using data from the Spanish trauma intensive care unit (ICU) registry (RETRAUCI). Methods Patients admitted to the participating ICUs from March 2015 to May 2019 were included in the study. The main outcomes were analyzed according to the presence of TBI, hemorrhagic shock, and/or both. Comparison of groups with quantitative variables was performed using the Kruskal-Wallis test, and differences between groups with categorical variables were compared using the Chi-square test or Fisher's exact test as appropriate. A P value Results Overall, 310 patients (3.98%) were presented with TBI and hemorrhagic shock. Patients with TBI and hemorrhagic shock received more red blood cell (RBC) concentrates, fresh frozen plasma (FFP), a higher ratio FFP/RBC, and had a higher incidence of trauma-induced coagulopathy (60%) (P < .001). These patients had higher mortality (P < .001). Intracranial hypertension was the leading cause of death (50.4%). Conclusions Concomitant TBI and hemorrhagic shock occur in nearly 4% of trauma ICU patients. These patients required a higher amount of RBC concentrates and FFP and had an increased mortality.	[Chico-Fernandez, Mario; Barea-Mendoza, Jesus A.] Hosp Univ 12 Octubre, Serv Med Intens, UCI Trauma & Emergencias, Madrid, Spain; [Perez-Barcena, Jon; Llompart-Pou, Juan A.] Hosp Univ Son Espases, Inst Invest Sanitaria Illes Balears IdISBa, Serv Med Intens, Palma De Mallorca, Spain; [Garcia-Saez, Iker] Hosp Univ Donostia, Serv Med Intens, Donostia San Sebastian, Spain; [Quintana-Diaz, Manuel] Hosp Univ La Paz, Serv Med Intens, Madrid, Spain; [Marina, Luis] Hosp Virgen Salud, Serv Med Intens, Toledo, Spain; [Mayor-Garcia, Dolores M.] Complejo Hosp Torrecardenas, Serv Med Intens, Almeria, Spain; [Servia-Goixart, Luis] Univ Lleida, Hosp Univ Arnau de Vilanova, Serv Med Intens, IRBLleida, Lleida, Spain; [Jimenez-Moragas, Jose M.] Hosp Univ Puerta Mar, Serv Med Intens, Cadiz, Spain		Llompart-Pou, JA (corresponding author), Hosp Univ Son Espases, Serv Med Intens, Carretera Valldemossa 79, Palma De Mallorca 07120, Illes Balears, Spain.	juanantonio.llompart@ssib.es	Goixart, Lluis Servia/C-6561-2011	Goixart, Lluis Servia/0000-0001-9513-1465; Barea-mendoza, Jesus A/0000-0002-1858-525X	Fundacion Mutua MadrilenaInstituto de Salud Carlos III [AP117892013]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: RETRAUCI was supported by a grant for the development of an electronic web-based system awarded to Dr Chico-Fernandez (Fundacion Mutua Madrilena, reference number AP117892013).	Bardes JM, 2018, J TRAUMA ACUTE CARE, V84, P893, DOI 10.1097/TA.0000000000001882; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Caplan HW, 2019, CURR SURG REP, V7, DOI 10.1007/s40137-019-0237-x; Fernandez MC, 2019, MED INTENSIVA, V43, P497, DOI 10.1016/j.medin.2018.07.007; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P327, DOI 10.1016/j.medin.2015.07.011; Eastridge BJ, 2019, TRANSFUSION, V59, P1423, DOI 10.1111/trf.15161; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Hu Y, 2015, J SURG RES, V195, P284, DOI 10.1016/j.jss.2015.01.038; Hussmann B, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0221-x; Leibowitz A, 2019, EUR J TRAUMA EMERG S, V45, P263, DOI 10.1007/s00068-018-0908-9; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Meledeo MA, 2017, J TRAUMA ACUTE CARE, V82, pS33, DOI 10.1097/TA.0000000000001431; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0229-2; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Sims CA, 2019, JAMA SURG, V154, P994, DOI 10.1001/jamasurg.2019.2884; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Van PY, 2017, CURR OPIN CRIT CARE, V23, P498, DOI 10.1097/MCC.0000000000000455; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	22	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	MAR	2021	87	3					370	375		10.1177/0003134820949990			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RK4JS	WOS:000638264300007	32993317				2022-02-06	
J	Dagro, A; Wilkerson, J				Dagro, Amy; Wilkerson, Justin			A computational investigation of strain concentration in the brain in response to a rapid temperature rise	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury (TBI); Thermal expansion and mechanics of brain tissue; Pulsed high power microwave bioeffects	AUDITORY SYSTEM RESPONSE; MICROWAVE HEARING; MECHANICAL-PROPERTIES; WHITE-MATTER; THRESHOLDS; DEFORMATION; DENSITY; TISSUES; DAMAGE; MODEL	Following the mysterious health attacks on U.S. diplomats in Cuba in 2016, the cause of concussion-like symptoms concurrent with strange noises heard by the diplomats remains undetermined. A wide range of possible causes of the sensations have been proposed: pulsed microwave exposure, infrasound acoustic devices, pesticides/neurotoxins, and even mass hysteria (psychogenic illness). Here, we numerically examine the pulsed microwave exposure hypothesis and the simulated mechanical response of brain tissue. A computational model is used to examine the influence of various spatially varying temperature gradients and pulse durations on the mechanical response of brain tissue. We show that a stress-focusing effect due to a rapid temperature increase may result in brain tissue strains larger than the initially applied thermal strains.	[Dagro, Amy] US Army Res Lab, CCDC, Aberdeen Proving Ground, MD 21005 USA; [Wilkerson, Justin] Texas A&M Univ, J Mike Walker Dept Mech Engn 66, College Stn, TX USA		Dagro, A (corresponding author), US Army Res Lab, CCDC, Aberdeen Proving Ground, MD 21005 USA.	amy.m.dagro.civ@mail.mil; wilkerson@tamu.edu		Dagro, Amy/0000-0002-3250-3732			Alexander S.L., 2016, STRUCTURAL INFLUENCE; Alexander SL, 2020, J MECH BEHAV BIOMED, V102, DOI 10.1016/j.jmbbm.2019.103492; Alexander SL, 2019, J MECH BEHAV BIOMED, V90, P689, DOI 10.1016/j.jmbbm.2018.10.035; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Barnes F.S., 2018, BIOL MED ASPECTS ELE; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; CHOU CK, 1982, J ACOUST SOC AM, V71, P1321, DOI 10.1121/1.387852; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Dagro A.M., 2013, PRELIMINARY INVESTIG; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Dohrmann CR, 2000, INT J NUMER METH ENG, V47, P1549, DOI 10.1002/(SICI)1097-0207(20000330)47:9<1549::AID-NME842>3.3.CO;2-B; Duck FA., 2013, PHYS PROPERTIES TISS; Elder JA, 2003, BIOELECTROMAGNETICS, pS162, DOI 10.1002/bem.10163; FOSTER KR, 1974, SCIENCE, V185, P256, DOI 10.1126/science.185.4147.256; Frey A.H., 1988, MOD BIOELECTR, P785; FREY AH, 1979, SCIENCE, V206, P232, DOI 10.1126/science.482939; FREY AH, 1962, J APPL PHYSIOL, V17, P689, DOI 10.1152/jappl.1962.17.4.689; FREY AH, 1965, PSYCHOL BULL, V63, P322, DOI 10.1037/h0021698; FREY AH, 1961, AEROSPACE MED, V32, P1140; Ganpule S, 2018, SHOCK WAVES, V28, P127, DOI 10.1007/s00193-017-0791-z; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; GUY AW, 1975, ANN NY ACAD SCI, V247, P194, DOI 10.1111/j.1749-6632.1975.tb35996.x; GUY AW, 1982, RADIO SCI, V17, pS169, DOI 10.1029/RS017i05Sp0169S; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hammerand D.C., 2007, CONSTITUTIVE MODELS; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hasgall P., 2018, ITIS DATABASE THERMA, DOI [DOI 10.13099/VIP21000-04-0, 10.13099/VIP21000-04-0]; Hata T, 1997, J THERM STRESSES, V20, P819, DOI 10.1080/01495739708956130; HATA T, 1995, J THERM STRESSES, V18, P437, DOI 10.1080/01495739508946312; Hetnarski RB, 2009, SOLID MECH APPL, V158, P1; Holzapfel GA., 2002, MECCANICA, V37, P489, DOI DOI 10.1023/A:1020843529530; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; KASTELLA KG, 1971, BIOPHYS J, V11, P521, DOI 10.1016/S0006-3495(71)86232-X; KELL GS, 1975, J CHEM PHYS, V62, P3496, DOI 10.1063/1.430986; King A.I., 2018, BIOMECHANICS IMPACT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lin J.C., 1978, MICROWAVE AUDITORY E; Lin J.C., 2011, ELECTROMAGNETIC FIEL; LIN JC, 1977, IEEE T MICROW THEORY, V25, P605, DOI 10.1109/TMTT.1977.1129167; LIN JC, 1977, RADIO SCI, V12, P237, DOI 10.1029/RS012i06Sp00237; Mann-Nachbar P., 1970, THERMAL SHOCK FOLLOW; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; MENDEZ J, 1960, METABOLISM, V9, P472; Miller K, 2010, ACTA BIOENG BIOMECH, V12, P25; MILLER RB, 1994, IEEE T PLASMA SCI, V22, P701, DOI 10.1109/27.338285; Muller HH, 2012, BIOMED OPT EXPRESS, V3, P1025, DOI 10.1364/BOE.3.001025; OBRIEN JS, 1965, J LIPID RES, V6, P537; OLSEN RG, 1983, IEEE T BIO-MED ENG, V30, P289, DOI 10.1109/TBME.1983.325118; PAL S, 1989, BIOMECHANICS ///, P52; Peters GWM, 1997, BIORHEOLOGY, V34, P127, DOI 10.1016/S0006-355X(97)00009-7; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021; SEIP R, 1995, IEEE T BIO-MED ENG, V42, P828, DOI 10.1109/10.398644; Shen F, 2006, J BIOMECH ENG-T ASME, V128, P797, DOI 10.1115/1.2264393; Shigley J.E., 2011, SHIGLEYS MECH ENG DE; Swanson RL, 2018, JAMA-J AM MED ASSOC, V319, P1125, DOI 10.1001/jama.2018.1742; SWANSON SR, 1985, COMPUT STRUCT, V21, P81, DOI 10.1016/0045-7949(85)90231-7; Swarup B, 2007, PHYS WORLD, V20, P8; Tumolo J., 2019, HEARING J, V72, P22; Vogel EW, 2020, ANN BIOMED ENG, V48, P1196, DOI 10.1007/s10439-019-02437-4; Watanabe Y, 2000, IEEE T MICROW THEORY, V48, P2126, DOI 10.1109/22.884204; WHITE RM, 1963, J APPL PHYS, V34, P3559, DOI 10.1063/1.1729258; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527; Zhang J., 2007, BIOMECHANICAL RESPON; Zhou Z., 2019, STAPP CAR CRASH J, V63; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Ziriax J., 2008, MODELING EXPOSURE EL	76	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	MAR	2021	115								104228	10.1016/j.jmbbm.2020.104228			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	QI1KA	WOS:000618731000001	33316549				2022-02-06	
J	Dahl, HM; Andelic, N; Lovstad, M; Holthe, IL; Hestnes, M; Diseth, TH; Myhre, MC				Dahl, Hilde Margrete; Andelic, Nada; Lovstad, Marianne; Holthe, Ingvil Laberg; Hestnes, Morten; Diseth, Trond H.; Myhre, Mia Cathrine			Epidemiology of traumatic brain injury in children 15 years and younger in South-Eastern Norway in 2015-16. Implications for prevention and follow-up needs	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Head injury; traumatic brain injury; Pediatric brain injury; Pediatric traumatic brain injury; Intracranial injury epidemiology		Objective: This retrospective study aimed to describe the volume, severity, and injury mechanism of all hospital-admitted pediatric traumatic brain injury (pTBI) at Oslo University Hospital (OUH), emphasizing consequences for prevention and factors indicating a need for follow-up programs. Method: Data were extracted from the OUH Trauma registry on 176 children, 0-15 years old, admitted to OUH in 2015 and 2016 with a pTBI diagnosis. The dataset contains demographic data, injury mechanism, type, and severity (Glasgow coma scale, GCS; abbreviated injury scale, AIS; injury severity score, ISS), ICD-10 diagnosis codes, level of treatment, and destination of discharge. Results: 79.5% had mild, 9% moderate, and 11.4% severe TBI. The incidence of hospital-treated pTBI in Oslo was 29 per 100,000 per year. The boy: girl ratio was 1.9:1, but in the young teenage group (14-15 years), the ratio was 1:1. Intracranial injury (ICI) identified on CT/MRI was associated with extended hospital stays, with a median of 6 days compared to 1 day for patients without ICI. 27% of the patients assessed as mild TBI at admission had ICI. Children below eight years of age had a higher incidence of moderate and severe ICI from trauma (53% v.s. 28% in children > eight years). Conclusion: The injury characteristics of hospital-treated pTBI are in line with other European countries, but we find the boy-girl ratio different as young teenage girls seem to be catching up with the boys. ICI and length of stay should be considered when deciding which patients need follow-up and rehabilitation. ? 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Dahl, Hilde Margrete] Oslo Univ Hosp, Dept Clin Neurosci Children, Sect Child Neurol, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Andelic, Nada] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Inst Hlth & Soc, Oslo, Norway; [Lovstad, Marianne; Holthe, Ingvil Laberg] Univ Oslo, Dept Psychol, Fac Social Sci, Oslo, Norway; [Lovstad, Marianne; Holthe, Ingvil Laberg] Sunnaas Rehabil Hosp Trust, Dept Res, Nesoddtangen, Norway; [Hestnes, Morten] Oslo Univ Hosp, Div Emergencies & Crit Care, Dept Res & Dev, Oslo, Norway; [Hestnes, Morten] Oslo Univ Hosp, Oslo Univ Hosp Trauma Registry, Oslo, Norway; [Dahl, Hilde Margrete; Diseth, Trond H.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Diseth, Trond H.] Oslo Univ Hosp, Dept Clin Neurosci Children, Sect Psychosomat & CL Child Psychiat, Oslo, Norway; [Myhre, Mia Cathrine] Norwegian Ctr Violence & Traumat Stress Studies, Oslo, Norway; [Myhre, Mia Cathrine] Oslo Univ Hosp, Dept Neonatal Intens Care, Oslo, Norway		Dahl, HM (corresponding author), Oslo Univ Hosp, Dept Clin Neurosci Children, Oslo, Norway.	dahlhildemargrete@gmail.com; NADAND@ous-hf.no; Marianne.Lovstad@sunnaas.no; ingvild.laberg.holthe@sunnaas.no; uxmohe@ous-hf.no; trond.diseth@ous-hf.no; m.c.myhre@nkvts.no		Dahl, Hilde Margrete/0000-0003-2634-2589			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Beck B, 2019, ARCH DIS CHILD, V104, P256, DOI 10.1136/archdischild-2018-315565; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown JB, 2017, J TRAUMA ACUTE CARE, V82, P995, DOI 10.1097/TA.0000000000001440; Collins NC, 2013, EMERG MED J, V30, P675, DOI 10.1136/emermed-2011-200496; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Hansen C, 2019, PEDIATR NEUROL, V90, P31, DOI 10.1016/j.pediatrneurol.2018.09.015; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Myhre MC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000740; Olsen M, 2019, EUR J PAEDIATR NEURO, V23, P500, DOI 10.1016/j.ejpn.2019.01.009; Peden M, 2009, WORLD REPORT CHILD I; Renaud MI, 2020, J HEAD TRAUMA REHAB, V35, pE490, DOI 10.1097/HTR.0000000000000583; Riemann L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00345; Rogers S, 2017, J NURSING ED PRACTIC, V7, P23, DOI [10.5430/jnep. v7n11p23, DOI 10.5430/JNEP.V7N11P23]; Sor-Ost H, S E NORWAY REGIONAL; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Wilson ML, 2017, EUR J PAEDIATR NEURO, V21, P374, DOI 10.1016/j.ejpn.2016.10.008	29	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAR	2021	31						70	77		10.1016/j.ejpn.2021.02.002			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	RF7ZR	WOS:000635058900011	33647532				2022-02-06	
J	Dymek, M; Ptak, M; Ratajczak, M; Fernandes, FAO; Kwiatkowski, A; Wilhelm, J				Dymek, Mateusz; Ptak, Mariusz; Ratajczak, Monika; Fernandes, Fabio A. O.; Kwiatkowski, Artur; Wilhelm, Johannes			Analysis of HIC and Hydrostatic Pressure in the Human Head during NOCSAE Tests of American Football Helmets	BRAIN SCIENCES			English	Article						brain injury; finite element head model; American football; helmet; helmet testing; biomechanics; head injury criterion; concussion; NOCSAE		Brain damage is a serious economic and social burden. Contact sports such as American football, are one of the most common sources of concussions. The biomechanical response of the head-helmet system caused by dynamic loading plays a major role. The literature has focused on measuring the resultant kinematics that act on the head and helmet during tackles. However, few studies have focused on helmet validation tests, supported by recent findings and emerging numerical approaches. The future of helmet standards could benefit from insights at the level of injury mechanisms, using numerical tools to assess the helmets. Therefore, in this work, a numerical approach is employed to investigate the influence of intracranial pressure (ICP) on brain pathophysiology during and after helmeted impacts, which are common in American football. The helmeted impacts were performed at several impact locations according to the NOCSAE standard (configurations A, AP, B, C, D, F, R, UT). In order to evaluate the ICP levels, the alpha HEAD finite element head and brain model was combined with a Hybrid III-neck structure and then coupled with an American football helmet to simulate the NOCSAE impacts. In addition, the ICP level was analyzed together with the resulting HIC value, since the latter is commonly used, in this application and others, as the injury criterion. The obtained results indicate that ICP values exceed the common threshold of head injury criteria and do not correlate with HIC values. Thus, this work raises concern about applying the HIC to predict brain injury in American football direct head impacts, since it does not correlate with ICP predicted with the FE head model.	[Dymek, Mateusz; Ptak, Mariusz] Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland; [Ratajczak, Monika] Univ Zielona Gora, Fac Mech Engn, Ul Szafrana 4, PL-65516 Zielona Gora, Poland; [Fernandes, Fabio A. O.] Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Campus Santiago, P-3810193 Aveiro, Portugal; [Kwiatkowski, Artur] Prov Specialist Hosp Legnica, Dept Neurosurg, Ul Iwaszkiewicza 5, PL-59220 Legnica, Poland; [Wilhelm, Johannes] CFturbo GmbH, Unterer Kreuzweg 1, D-01097 Dresden, Germany		Dymek, M; Ptak, M (corresponding author), Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland.	mateusz.dymek@pwr.edu.pl; mariusz.ptak@pwr.edu.pl; m.ratajczak@iizp.uz.zgora.pl; fabiofernandes@ua.pt; artur.kwiatkowski@szpital.legnica.pl; johannes.wilhelm@cfturbo.com	Ptak, Mariusz/B-1493-2013; Fernandes, Fabio A.O./H-2680-2012; Dymek, Mateusz/AAY-3591-2021; Wilhelm, Johannes/O-8330-2016	Ptak, Mariusz/0000-0001-8081-8336; Fernandes, Fabio A.O./0000-0001-9751-8807; Dymek, Mateusz/0000-0001-7809-6848; Wilhelm, Johannes/0000-0001-5114-5400; Ratajczak, Monika/0000-0001-6980-315X	National Centre for Research and Development of PolandNational Centre for Research & Development, Poland [LIDER/8/0051/L-8/16/NCBR/2017]	This research was co-funded by the National Centre for Research and Development of Poland, grant number LIDER/8/0051/L-8/16/NCBR/2017. www.aheadproject.org (accessed on 1 February 2021).	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; [Anonymous], 2019, STANDARD PERFORMANCE; Arnason A, 2004, AM J SPORT MED, V32, p5S, DOI 10.1177/0363546503258912; Bailey AM, 2020, ANN BIOMED ENG, V48, P2566, DOI 10.1007/s10439-020-02626-6; Bailey AM, 2020, ANN BIOMED ENG, V48, P2531, DOI 10.1007/s10439-020-02627-5; Barker J., 2008, P INT RES C BIOM IMP; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boston University Research: CTE Center, FREQUENTLY ASKED QUE; Bustamante MC, 2019, J DYNAM BEHAV MAT, V5, P117, DOI 10.1007/s40870-019-00189-9; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Champagne AA, 2021, BRAIN IMAGING BEHAV, V15, P133, DOI 10.1007/s11682-019-00240-2; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cogoluenhes L., 2019, Computer Methods in Biomechanics and Biomedical Engineering, V22, P273, DOI 10.1080/10255842.2020.1714910; Corrales MA, 2020, ANN BIOMED ENG, V48, P121, DOI 10.1007/s10439-019-02359-1; Costa JMC, 2020, J MECH BEHAV BIOMED, V111, DOI 10.1016/j.jmbbm.2020.103976; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Duggins P, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3316; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fernandes FAO, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25010012; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giudice J., 2018, FINITE ELEMENT MODEL; Giudice JS, 2020, ANN BIOMED ENG, V48, P1524, DOI 10.1007/s10439-020-02472-6; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Greenberg M., 2019, GREENBERG HDB NEUROS, V53; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hardy, 2003, P INT RES C BIOM IMP; Hazay M, 2018, ACTA POLYTECH CTU PR, V18, P6, DOI 10.14311/APP.2018.18.0006; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Horanin-Dusza M., 2009, THESIS MED U WROCLAW; Hoshizaki TB, 2009, AM SOC TEST MATER, V1516, P107, DOI 10.1520/JAI101883; Jamroziak K, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9132702; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Johnston JM, 2015, SPORTS ENG, V18, P11, DOI 10.1007/s12283-014-0160-4; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Kawasaki T, 2018, AM J SPORT MED, V46, P656, DOI 10.1177/0363546517740567; Ken Belson, NEW YORK TIMES; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S., 2002, THESIS KTH ROYAL I T THESIS KTH ROYAL I T; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Lamb L, 2009, P I MECH ENG H, V223, P1021, DOI 10.1243/09544119JEIM573; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; M Fahlstedt M., 2018, FINITE ELEMENT MODEL; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; O'Keeffe E, 2020, J NEUROTRAUM, V37, P347, DOI 10.1089/neu.2019.6483; Pellman EJ., 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.13, DOI 10.3171/FOC.2006.21.4.13]; Post A, 2018, COMPUT METHOD BIOMEC, V21, P264, DOI 10.1080/10255842.2018.1445229; Prasad P., 1985, SAE TRANSACTIONS, V94, P106; Ptak M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9051000; Ratajczak M, 2019, MATERIALS, V12, DOI 10.3390/ma12020271; Russman A., 2015, NEUROLOGY, V84, P1526; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schoell Samantha L, 2015, Stapp Car Crash J, V59, P359; Schwarz A, NEW YORK TIMES; Sybilski K, 2019, ACTA BIOENG BIOMECH, V21, P169, DOI [10.37190/ABB-01421-2019-02, 10.5277/ABB-01421-2019-02]; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tierney GJ, 2020, J BIOMECH, V110, DOI 10.1016/j.jbiomech.2020.109969; Tierney GJ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9040726; Varela MM, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072492; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Wilhelm J, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10134467; Wilhelm J, 2017, SCI J MARIT UNIV SZC, V50, P98, DOI 10.17402/222; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Wu S, 2020, J AM MED INFORM ASSN, V27, P457, DOI 10.1093/jamia/ocz200; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	71	1	1	5	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAR	2021	11	3							287	10.3390/brainsci11030287			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RD4IB	WOS:000633442700001	33669105	Green Published, gold			2022-02-06	
J	Elzanie, AS; Park, KE; Irgebay, Z; Choi, J; Zellner, EG				Elzanie, Ashraf S.; Park, Kitae E.; Irgebay, Zhazira; Choi, James; Zellner, Elizabeth G.			Zygoma Fractures Are Associated With Increased Morbidity and Mortality in the Pediatric Population	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Facial; fracture; pediatric; surgery; trauma	EMERGENCY-DEPARTMENT VISITS; FACIAL FRACTURES; UNITED-STATES; PATTERNS; OUTCOMES; CHILDREN; INJURY	Background: Trauma involving the facial bones has been shown to be associated with high severity in previous studies. Characteristics of facial fractures in adults have been well described in the adult population, less so in the pediatric literature. Our investigation aims to define these epidemiological measures and risk factors for poor outcomes using the most recent data. Methods: The 2016 Trauma Quality Improvement Program data bank was examined to study facial fracture pattern, mechanism of injury, and demographic descriptive data to characterize pediatric trauma patients. Multivariable regression analysis was performed to assess risk factors for morbidity and mortality in pediatric facial fracture patients. Results: Of 51,168 total pediatric trauma patients, 2917 (5.7%) presented with facial fractures. Motor vehicle trauma was the most common mechanism of injury. Maxillary/malar fractures was the most common fracture type overall. Mandibular fractures were most common in the 0 to 1 age category while nasal bone fractures were more common in older patients. Patients with mandible fractures experienced the highest rate of operative management. Zygoma fracture was highly associated with concomitant traumatic brain injury. Multivariable regression analysis showed that fracture of the zygoma, concomitant traumatic brain injury, and cervical spine injury were risk factors for increased mortality. Conclusion: Facial fractures are a rare but significant form of trauma in the pediatric population. Our data suggests a slight change in fracture patterns compared to previous studies. Zygoma fractures, traumatic brain injury, and cervical spine injury are risk factors of increased mortality that clinicians should be aware of.	[Elzanie, Ashraf S.; Choi, James; Zellner, Elizabeth G.] New York Med Coll, Dept Surg, Valhalla, NY USA; [Park, Kitae E.; Irgebay, Zhazira] New York Med Coll, Sch Med, New York, NY USA		Zellner, EG (corresponding author), 100 Woods Rd,Ambulatory Care Pavil,Third Floor, Valhalla, NY 10595 USA.	Elizabeth.Zellner@wmchealth.org					Alcala-Galiano A, 2008, RADIOGRAPHICS, V28, P441, DOI 10.1148/rg.282075060; Allareddy V, 2014, J ORAL MAXIL SURG, V72, P1756, DOI 10.1016/j.joms.2014.03.015; Ashrafullah, 2018, J Oral Biol Craniofac Res, V8, P82, DOI 10.1016/j.jobcr.2017.09.006; Bergeron JM., 2019, ZYGOMATIC ARCH FRACT; Chan KH, 2016, LARYNGOSCOPE, V126, P485, DOI 10.1002/lary.25457; Chao MT, 2009, CRANIOMAX TRAUM REC, V2, P103, DOI 10.1055/s-0029-1215873; Cole P, 2009, CRANIOMAX TRAUM REC, V2, P77, DOI 10.1055/s-0029-1202592; Dobitsch AA, 2019, SURG J-NY, V5, pE146, DOI 10.1055/s-0039-1697627; Farkkila EM, 2020, INT J ORAL MAX SURG, V49, P75, DOI 10.1016/j.ijom.2019.06.024; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Gebran SG, 2019, J CRANIOFAC SURG, V30, P2189, DOI 10.1097/SCS.0000000000005789; Grunwaldt L, 2011, PLAST RECONSTR SURG, V128, P1263, DOI 10.1097/PRS.0b013e318230c8cf; Haug RH, 2000, ORAL SURG ORAL MED O, V90, P126, DOI 10.1067/moe.2000.107974; Hoppe IC, 2014, J CRANIO MAXILL SURG, V42, P1408, DOI 10.1016/j.jcms.2014.04.002; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Kaura Sameer, 2018, Ann Maxillofac Surg, V8, P78, DOI 10.4103/ams.ams_73_17; Kuhnel Thomas S, 2015, GMS Curr Top Otorhinolaryngol Head Neck Surg, V14, pDoc06, DOI 10.3205/cto000121; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mohseni S, 2018, INJURY, V49, P27, DOI 10.1016/j.injury.2017.11.021; Nathens AB, 2012, SURG CLIN N AM, V92, P441, DOI 10.1016/j.suc.2012.01.003; Odom EB, 2016, PLAST RECONSTR SURG, V138, p282E, DOI 10.1097/PRS.0000000000002385; Oleck NC, 2019, ANN PLAS SURG, V82, pS195, DOI 10.1097/SAP.0000000000001861; Pullos Alissa N, 2019, Atlas Oral Maxillofac Surg Clin North Am, V27, P113, DOI 10.1016/j.cxom.2019.05.003; Reich W, 2019, INT J PEDIATR OTORHI, V119, P151, DOI 10.1016/j.ijporl.2019.01.028; Roccia F., 2014, J ORAL MAXILLOFAC RE, V5, P5; Rottgers SA, 2011, J CRANIOFAC SURG, V22, P1260, DOI 10.1097/SCS.0b013e31821c6ab7; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Ul Haq Muhammad Ehsan, 2018, Eur J Dent, V12, P247, DOI 10.4103/ejd.ejd_370_17; Vyas RM, 2008, J CRANIOFAC SURG, V19, P339, DOI 10.1097/SCS.0b013e31814fb5e3; Wang HW, 2018, J CRANIOFAC SURG, V29, P1809, DOI 10.1097/SCS.0000000000004964; Wasicek PJ, 2019, J CRANIOFAC SURG, V30, P2052, DOI 10.1097/SCS.0000000000005862; Xu J, 2018, DEATHS FINAL DATA 20; Yang CS, 2017, TRAFFIC INJ PREV, V18, P724, DOI 10.1080/15389588.2017.1309650; Zimmermann C E, 2006, Int J Oral Maxillofac Surg, V35, P2, DOI 10.1016/j.ijom.2005.09.014	34	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR-APR	2021	32	2					559	563		10.1097/SCS.0000000000006948			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	ST2HB	WOS:000662269900067	33704980				2022-02-06	
J	Gamero, M; Kim, WS; Hong, S; Vorobiev, D; Morgan, CD; Park, SI				Gamero, Milenka; Kim, Woo Seok; Hong, Sungcheol; Vorobiev, Daniel; Morgan, Clinton D.; Park, Sung Il			Multimodal Sensing Capabilities for the Detection of Shunt Failure	SENSORS			English	Article						shunt device; multimodal sensors; pressure and flow rate		Hydrocephalus is a medical condition characterized by the abnormal accumulation of cerebrospinal fluid (CSF) within the cavities of the brain called ventricles. It frequently follows pediatric and adult congenital malformations, stroke, meningitis, aneurysmal rupture, brain tumors, and traumatic brain injury. CSF diversion devices, or shunts, have become the primary therapy for hydrocephalus treatment for nearly 60 years. However, routine treatment complications associated with a shunt device are infection, obstruction, and over drainage. Although some (regrettably, the minority) patients with shunts can go for years without complications, even those lucky few may potentially experience one shunt malfunction; a shunt complication can require emergency intervention. Here, we present a soft, wireless device that monitors distal terminal fluid flow and transmits measurements to a smartphone via a low-power Bluetooth communication when requested. The proposed multimodal sensing device enabled by flow sensors, for measurements of flow rate and electrodes for measurements of resistance in a fluidic chamber, allows precision measurement of CSF flow rate over a long time and under any circumstances caused by unexpected or abnormal events. A universal design compatible with any modern commercial spinal fluid shunt system would enable the widespread use of this technology.	[Gamero, Milenka; Kim, Woo Seok; Hong, Sungcheol; Vorobiev, Daniel; Park, Sung Il] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Morgan, Clinton D.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Park, Sung Il] Texas A&M Univ, Ctr Remote Hlth Sci & Technol, College Stn, TX 77843 USA; [Park, Sung Il] Texas A&M Univ, Inst Neurosci, College Stn, TX 77843 USA		Park, SI (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.; Park, SI (corresponding author), Texas A&M Univ, Ctr Remote Hlth Sci & Technol, College Stn, TX 77843 USA.; Park, SI (corresponding author), Texas A&M Univ, Inst Neurosci, College Stn, TX 77843 USA.	mgamero@tamu.edu; wooseok.kim@tamu.edu; hyhaerong@tamu.edu; dansparrow99@tamu.edu; Clinton.Morgan@BarrowBrainAndSpine.com; sipark@tamu.edu		Kim, Woo Seok/0000-0002-3075-1847; Hong, Sungcheol/0000-0003-2168-2971; Gamero, Milenka/0000-0002-7466-9642; Park, Sung Il/0000-0003-0001-8967	interdisciplinary X-Grants Program, part of the President's Excellence Fund at Texas AM University; Brain & Behavior Research FoundationNARSAD; National Science Foundation Engineering Research Center for Precise Advanced Technologies and Health Systems for Underserved Populations PATHS-UP [EEC-1648451]	This work was supported by grants from the interdisciplinary X-Grants Program, part of the President's Excellence Fund at Texas A&M University (S. Park), 2018 NARSARD Young Investigator Awards (S. Park) from Brain & Behavior Research Foundation and National Science Foundation Engineering Research Center for Precise Advanced Technologies and Health Systems for Underserved Populations PATHS-UP (EEC-1648451; S. Park).	Alkharabsheh A.R., 2010, P 2010 DEV E SYST EN; Aschoff A, 1999, NEUROSURG REV, V22, P67, DOI 10.1007/s101430050035; Bork T, 2010, BIOMED MICRODEVICES, V12, P607, DOI 10.1007/s10544-010-9413-6; Browd SR, 2006, PEDIATR NEUROL, V34, P171, DOI 10.1016/j.pediatrneurol.2005.05.021; Browd SR, 2006, PEDIATR NEUROL, V34, P83, DOI 10.1016/j.pediatrneurol.2005.05.020; Caruso M. J., 1998, Sensors, V15, P34; Cheng XL, 2016, NANO ENERGY, V22, P453, DOI 10.1016/j.nanoen.2016.02.037; CHIBA Y, 1980, J NEUROSURG, V52, P700, DOI 10.3171/jns.1980.52.5.0700; Clark TM, 2015, IEEE SENS J, V15, P6027, DOI 10.1109/JSEN.2015.2451655; De Keulenaer BL, 2009, INTENS CARE MED, V35, P969, DOI 10.1007/s00134-009-1445-0; Drake JM, 2000, CHILD NERV SYST, V16, P800, DOI 10.1007/s003810000351; Garne E, 2010, EUR J PAEDIATR NEURO, V14, P150, DOI 10.1016/j.ejpn.2009.03.005; Gimenez A, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0294; Gomez C, 2012, SENSORS-BASEL, V12, P11734, DOI 10.3390/s120911734; Hameed MQ, 2019, NEUROSURGERY, V85, P240, DOI 10.1093/neuros/nyy246; Hanak BW, 2017, PEDIATR NEUROSURG, V52, P381, DOI 10.1159/000452840; HARA M, 1983, J NEUROSURG, V58, P557, DOI 10.3171/jns.1983.58.4.0557; ISHIWATA Y, 1989, J NEUROSURG, V70, P143, DOI 10.3171/jns.1989.70.1.0143; Jetzki S, 2012, IEEE T BIOMED CIRC S, V6, P356, DOI 10.1109/TBCAS.2012.2183131; Jones HC, 2000, NEUROL RES, V22, P89; Kim WS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20421-8; Kim WS, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10062001; Kim WS, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20133639; Kraemer MR, 2017, J NEUROSURG-PEDIATR, V20, P216, DOI 10.3171/2017.2.PEDS16265; Krishnan SR, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0239-1; Krishnan SR, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat8437; Lenfeldt N, 2012, NEUROLOGY, V79, P237, DOI 10.1212/WNL.0b013e31825fdf8a; Lo Presti A, 2015, J NEUROSURG-PEDIATR, V15, P223, DOI 10.3171/2014.7.PEDS14222; Lutz Barry R, 2013, Surg Neurol Int, V4, pS38, DOI 10.4103/2152-7806.109197; Madsen JR, 2011, NEUROSURGERY, V68, P198, DOI 10.1227/NEU.0b013e3181fe2db6; Malm J, 2004, ACTA NEUROL SCAND, V110, P154, DOI 10.1111/j.1600-0404.2004.00302.x; Mickle AD, 2019, NATURE, V565, P361, DOI 10.1038/s41586-018-0823-6; MORI K, 1990, CHILD NERV SYST, V6, P198, DOI 10.1007/BF01850971; MURTAGH F, 1967, J AMER MED ASSOC, V202, P1010, DOI 10.1001/jama.202.11.1010; Neff S, 2005, J NEUROSURG, V103, P366, DOI 10.3171/ped.2005.103.4.0366; Persson EK, 2005, ACTA PAEDIATR, V94, P726, DOI 10.1080/08035250510027336; Qin CC, 2017, ANAL CHEM, V89, P8170, DOI 10.1021/acs.analchem.7b02034; Siekkinen M, 2012, 2012 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P232, DOI 10.1109/WCNCW.2012.6215496; dos Santos MPS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41540-3; Song EM, 2019, APL MATER, V7, DOI 10.1063/1.5094415; Song EM, 2018, ACS NANO, V12, P10317, DOI 10.1021/acsnano.8b05552; Stein SC, 2008, J NEUROSURG-PEDIATR, V1, P40, DOI 10.3171/PED-08/01/040; Stone JJ, 2013, J NEUROSURG-PEDIATR, V11, P15, DOI 10.3171/2012.9.PEDS1298; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Xu Jordan, 2019, Surg Neurol Int, V10, P254, DOI 10.25259/SNI_324_2019; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5	46	1	1	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	MAR	2021	21	5							1747	10.3390/s21051747			10	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	QW4QM	WOS:000628636000001	33802445	gold, Green Published			2022-02-06	
J	Gardner, AJ				Gardner, Andrew J.			Reliability of Using the Proposed International Consensus Video Signs of Potential Concussion for National Rugby League Head Impact Events	NEUROSURGERY			English	Article						Rugby league; Head impact events; Concussion; On-field video signs; Sensitivity; Specificity; Positive predictive value; Negative predictive value		BACKGROUND: Consensus on the definition of extant video signs of concussion have recently been proposed by representatives of international sporting codes for global consistency across professional leagues. OBJECTIVE: To review the reliability of the proposed international consensus video signs of concussion in National Rugby League (NRL) head impact events (HIEs). METHODS: The video signs of concussion were coded for every HIE during the 2019 NRL season. Coding was conducted blinded to the concussion status. Frequency, sensitivity, specificity, and a receiver operating characteristic curve were calculated. RESULTS: There were 943 HIEs identified over the 2019 NRL season, of which 106 resulted in a diagnosed concussion. The most frequently observed video sign in concussed athletes was blank/vacant look (54%), which was also the most sensitive video sign (0.54, CI: 0.44-0.63), while the most specific was tonic posturing (0.99, CI: 0.99-1.00). In 43.4% of diagnosed concussions none of the 6 video signs were present. The 6 video signs demonstrated a "fair" ability to discriminate between concussion and nonconcussion HIEs (area under the curve = 0.76). CONCLUSION: International consensus agreement between collision sports for extant video signs of concussion and the definition of those extant video signs are clinically important. The selection of signs requires rigorous assessment to examine their predictive value across all sports and within individual sports, and to determine further video signs to compliment and improve the identification of possible concussion events within various sports. The current study demonstrated that, for NRL-related HIEs, the diagnostic accuracy of video signs varies.	[Gardner, Andrew J.] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Hunter Bldg,Univ Dr, Callaghan, NSW 2308, Australia; [Gardner, Andrew J.] Hunter New England Local Hlth Dist Sports Concuss, Waratah, NSW, Australia		Gardner, AJ (corresponding author), Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Hunter Bldg,Univ Dr, Callaghan, NSW 2308, Australia.	Andrew.Gardner@newcastle.edu.au		Gardner, Andrew/0000-0001-5031-5586	Rugby League Research Committee (RLRC)	The author is grateful to the Chief Medical Officer of the National Rugby League, Dr Paul Bloomfield, for his support reviewing and coding all HIEs, and the Rugby League Research Committee (RLRC) for their support and endorsement of the video analysis research program. The author is grateful to Dr Christopher Oldmeadow (Hunter Medical Research Institute) for his statistical support and Dr Gordon Fuller for his feedback on the draft manuscript.	Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Davis GA, NEUROSURGERY; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Davis GA, 2019, BRIT J SPORT MED, V53, P1264, DOI 10.1136/bjsports-2019-100628; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2020, NEUROSURGERY, V87, P530, DOI 10.1093/neuros/nyaa072; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Gardner AJ, 2016, INT J SPORTS MED, V37, P267, DOI 10.1055/s-0035-1565203; Gardner AJ, 2020, NEUROSURGERY, V87, pE298, DOI 10.1093/neuros/nyaa158; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Hawk-Eye, HOM WORLD ATHL; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Kindschi K, 2015, CLIN J SPORT MED, V25, P201; Kindschi Kari, 2017, BMJ Open Sport Exerc Med, V3, pe000165, DOI 10.1136/bmjsem-2016-000165; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Kohler R, 2017, BR J SPORTS MED, V51, pA78; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Tape TG, AREA ROC CURVE; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Zuckerman SL, 2020, PHYSICIAN SPORTSMED, V48, P424, DOI 10.1080/00913847.2020.1731379	30	1	1	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2021	88	3					538	543		10.1093/neuros/nyaa437			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RJ0UU	WOS:000637319900047	33027812				2022-02-06	
J	Guatta, R; Delaidelli, A; May, AT; Jannelli, G; Moiraghi, A; Schaller, K; Bartoli, A				Guatta, Ramona; Delaidelli, Alberto; May, Adrien Thomas; Jannelli, Gianpaolo; Moiraghi, Alessandro; Schaller, Karl; Bartoli, Andrea			Isolated subarachnoid hemorrhage in mild traumatic brain injury: is a repeat CT scan necessary? A single-institution retrospective study	ACTA NEUROCHIRURGICA			English	Article						Mild traumatic brain injury; Traumatic subarachnoid hemorrhage; CT scan		Background Traumatic brain injury (TBI) with isolated subarachnoid hemorrhage (iSAH) is a common finding in the emergency department. In many centers, a repeat CT scan is routinely performed 24 to72 h following the trauma to rule out further radiological progression. The aim of this study is to assess the clinical utility of the repeat CT scan in clinical practice. Methods We reviewed the medical charts of all patients who presented to our institution with mild TBI (mTBI) and isolated SAH between January 2015 and October 2017. CT scan at admission and control after 24 to 72 h were examined for each patient in order to detect any possible change. Neurological deterioration, antiplatelet/anticoagulant therapy, coagulopathy, SAH location, associated injuries, and length of stay in hospital were analyzed. Results Of the 649 TBI patients, 106 patients met the inclusion criteria. Fifty-four patients were females and 52 were males with a mean age of 68.2 years. Radiological iSAH progression was found in 2 of 106 (1.89) patients, and one of them was under antiplatelet therapy. No neurological deterioration was observed. Ten of 106 (9.4%) patients were under anticoagulation therapy, and 28 of 106 (26.4%) were under antiplatelet therapy. Conclusion ISAH in mTBI seems to be a radiological stable entity over 72 h with no neurological deterioration. The clinical utility of a repeat head CT in such patients is questionable, considering its radiation exposure and cost. Regardless of anticoagulation/antiplatelet therapy, neurologic observation and symptomatic treatment solely could be a reasonable alternative.	[Guatta, Ramona; May, Adrien Thomas; Jannelli, Gianpaolo; Moiraghi, Alessandro; Schaller, Karl; Bartoli, Andrea] Geneva Univ Hosp, Div Neurosurg, Dept Clin Neurosci, Geneva, Switzerland; [Delaidelli, Alberto] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada		Guatta, R (corresponding author), Geneva Univ Hosp, Div Neurosurg, Dept Clin Neurosci, Geneva, Switzerland.	guattaramona@gmail.com; adelaidelli@bccrc.ca; adrien.may@hcuge.ch; gianpaolo.jannelli@hcuge.ch; alessandro.moiraghi@sfits.ch; karl.schaller@hcuge.ch; andrea.bartoli@hcuge.ch	Moiraghi, Alessandro/ABA-1943-2021	Moiraghi, Alessandro/0000-0003-4569-5304			Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Durham SR, 2006, J NEUROSURG, V105, P365, DOI 10.3171/ped.2006.105.5.365; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Khaldi A, 2010, J NEUROSURG, V113, P1021, DOI 10.3171/2009.11.JNS081048; Kreitzer N, 2014, ACAD EMERG MED, V21, P1084, DOI 10.1111/acem.12479; Kumar A, 2018, WORLD NEUROSURG, V113, P399, DOI 10.1016/j.wneu.2018.02.010; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Nagesh M, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19527; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Pauwels EKJ, 2011, ACTA RADIOL, V52, P767, DOI 10.1258/ar.2011.100496; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Rice TW, 2012, CRIT CARE MED, V40, P778, DOI 10.1097/CCM.0b013e318236f168; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thome C, 2018, HEALTH PHYS, V114, P328, DOI 10.1097/HP.0000000000000810; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d	28	1	1	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2021	163	11					3209	3216		10.1007/s00701-020-04622-0		MAR 2021	8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WH5PL	WOS:000623957500001	33646445				2022-02-06	
J	Jackson, DB; Testa, A; Vaughn, MG				Jackson, Dylan B.; Testa, Alexander; Vaughn, Michael G.			Traumatic Brain Injury and School Readiness Among Preschool-Aged Children in the United States	PEDIATRIC NEUROLOGY			English	Article						TBI; School readiness; Preschool; Children; United States		Background: The aim of this study is to examine the association between traumatic brain injury (TBI) and school readiness using a nationally representative sample of preschool-aged children in the United States. Methods: Using data on 15,402 preschool-aged children (ages three to five years) from the 2016 to 2018 cohorts of the National Survey of Children's Health, this study investigates the association between lifetime measure of TBI in children and four domains of school readiness: early learning skills, self-regulation, social-emotional development, and physical health/motor development. Results: Among this sample of preschool-aged children, 252 (1.64%) had experienced a TBI during their lifetime. Within school readiness domains, TBI was associated with a 62% to 99% increase in the rate of needs support/at-risk items and a 129% to 322% increase in the rate of at-risk items, contingent on the exact domain examined. Additional analyses reveal that, net of covariates, TBI reduced the predicted probability of being on-track across all four domains from approximately 0.424 for children with no history of TBI to 0.224 for children with a history of TBI. Conclusions: A history of TBI was associated with reductions in school readiness within and across domains. Facilitating better communication between parents, pediatricians, and schools about both TBI and responses to TBI may result in the implementation of services and individualized, tailored instructional approaches that can improve educational outcomes. (C) 2020 Elsevier Inc. All rights reserved.	[Jackson, Dylan B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Testa, Alexander] Univ Texas San Antonio, Coll Hlth Community & Policy, San Antonio, TX USA; [Vaughn, Michael G.] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO 63103 USA		Jackson, DB (corresponding author), Johns Hopkins Univ, Dept Populat Family & Reprod Hlth, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	dylan.jackson@jhu.edu					Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Centers for Disease Control and Prevention, 2015, REPORT C TRAUMATIC B; Centers for Disease Control and Prevention, 2018, REPORT C MANAGEMENT; Child Trends, CHILD TRENDS DATABAN; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gelineau-Morel RN, 2019, PEDIATR REV, V40, P468, DOI 10.1542/pir.2018-0257; Ghandour RM, 2019, CHILD INDIC RES, V12, P1389, DOI 10.1007/s12187-018-9586-8; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Kagan SL, 1995, RECONSIDERING CHILDR; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Lombard KJ, 2019, J TRAUMA NURS, V26, P89, DOI 10.1097/JTN.0000000000000427; Peterson AB, 2014, SURVEILLANCE REPORT; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Williams PG, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1766; Williams PG, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2293	27	1	1	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAR	2021	116						2	6		10.1016/j.pediatrneurol.2020.11.016			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	QJ7DJ	WOS:000619846700002	33388544				2022-02-06	
J	Kahn, MB; Williams, G; Mentiplay, BF; Bower, KJ; Olver, J; Clark, RA				Kahn, Michelle B.; Williams, Gavin; Mentiplay, Benjamin F.; Bower, Kelly J.; Olver, John; Clark, Ross A.			Upper Limb Associated Reactions The Relationship Between Movement Kinematics and Muscle Activity in Seated Versus Walking Testing	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Surface Electromyography; Muscle Activation; Maximal Voluntary Isometric Contraction; Neurological; Acquired Brain Injury; Stroke; Traumatic Brain Injury		Objective The aims of this study were to (1) evaluate the relationships between stationary and dynamic associated reaction (AR) tests in people with acquired brain injury using surface electromyography (sEMG) muscle activity and three-dimensional motion analysis kinematic measures and (2) assess the test-retest reliability of sEMG and seated tests of ARs. Design Forty-two adults with acquired brain injury underwent AR testing with seated contralateral maximal voluntary isometric contraction tests and walking (self-selected and fast speeds). Associated reaction measurements included biceps brachii sEMG, elbow goniometry, and three-dimensional motion analysis kinematics during walking. Pearson correlations evaluated the relationships between seated and dynamic walking AR tests and between muscle activity and kinematic measures. Chronic participants were reassessed 1 wk later for reliability. Results A strong (r = 0.65) and moderate (r = 0.53) relationship existed for biceps brachii sEMG during seated and walking tests at self-selected and fast walk, respectively. A weak to moderate relationship existed between biceps brachii sEMG and kinematics during walking and between seated and walking measures of ARs (r = 0.23-0.53). All tests had strong to very strong test-retest reliability (intraclass correlation coefficients, >0.78). Conclusion Seated contralateral maximal voluntary isometric contraction tests correlate only weakly to moderately with AR walking kinematics and moderately to strongly with biceps brachii activation during walking. Moderate relationships exist between sEMG and kinematics, indicating that they may provide different information for ARs.	[Kahn, Michelle B.; Williams, Gavin] Epworth Healthcare, Dept Physiotherapy, Epworth Rehabil, Melbourne, Vic, Australia; [Kahn, Michelle B.; Clark, Ross A.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sunshine Coast, Australia; [Williams, Gavin; Bower, Kelly J.] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia; [Mentiplay, Benjamin F.] La Trobe Univ, La Trobe Sport & Exercise Med Res Ctr, Melbourne, Vic, Australia; [Olver, John] Epworth Monash Rehabil Unit EMReM, Melbourne, Vic, Australia		Kahn, MB (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	Michelle.Kahn@epworth.org.au; gavin.williams@epworth.org.au; B.Mentiplay@latrobe.edu.au; bower@unimelb.edu.au; john.olver@epworth.org.au; rclark@usc.edu.au	Mentiplay, Benjamin/A-2279-2019	Mentiplay, Benjamin/0000-0002-4360-8310; Olver, John/0000-0001-7069-1191	National Health and Medical Research Council R.D. Wright Biomedical Fellowship [1090415]; Royal Automobile Club of Victoria, Epworth Research Institute; Physiotherapy Research Fund for a large doctoral project on assessment of associated reactions	Supported by grants awarded to M. B. Kahn from the Royal Automobile Club of Victoria, Epworth Research Institute, and Physiotherapy Research Fund for a large doctoral project on assessment of associated reactions. R. A. Clark is supported by a National Health and Medical Research Council R.D. Wright Biomedical Fellowship (number 1090415).	Bakheit AM, 2010, INT J REHABIL RES, V33, P199, DOI 10.1097/MRR.0b013e328332f5e0; Bhakta BB, 2001, CLIN REHABIL, V15, P195, DOI 10.1191/026921501671342614; Bhakta BB, 2008, J REHABIL MED, V40, P36, DOI 10.2340/16501977-0120; Bobath B., 1990, ADULT HEMIPLEGIA EVA; Bohannon RW, 2004, PERCEPT MOTOR SKILL, V99, P813, DOI 10.2466/pms.99.3.813-817; Boissy P, 1997, ARCH PHYS MED REHAB, V78, P1117, DOI 10.1016/S0003-9993(97)90138-6; Bruening DA, 2015, GAIT POSTURE, V41, P540, DOI 10.1016/j.gaitpost.2014.12.011; Casanova J., 1992, GRIP STRENGTH CLIN A, V2nd, P41; Clark R., PHYS FUNCTION ASSESS; Davies PM., 2000, STEPS FOLLOW COMPREH; Dvir Z, 1996, CLIN REHABIL, V10, P155, DOI DOI 10.1177/026921559601000212; Evans JD, 1996, STRAIGHTFORWARD STAT; Faturi FM, 2019, TOP STROKE REHABIL, V26, P73, DOI 10.1080/10749357.2018.1517511; Frykberg GE, 2014, GAIT POSTURE, V40, P64, DOI 10.1016/j.gaitpost.2014.02.006; Halaki M., 2012, COMPUTATIONAL INTELL; Heywood S, 2018, J ELECTROMYOGR KINES, V42, P74, DOI 10.1016/j.jelekin.2018.05.010; Ives JC, 2003, CLIN BIOMECH, V18, P543, DOI 10.1016/S0268-0033(03)00089-5; Kahn MB, 2020, GAIT POSTURE, V81, P273, DOI 10.1016/j.gaitpost.2020.08.110; Kahn MB, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0637-2; Kahn MB, 2020, CLIN REHABIL, V34, P252, DOI 10.1177/0269215519888782; Kahn MB, 2016, BRAIN INJURY, V30, P252, DOI 10.3109/02699052.2015.1117657; LAZARUS JAC, 1992, ARCH PHYS MED REHAB, V73, P1044; Mackey AH, 2005, GAIT POSTURE, V22, P1, DOI 10.1016/j.gaitpost.2004.06.002; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Portney LG., 2014, FDN CLIN RES PEARSON, V3rd; Rab G, 2002, GAIT POSTURE, V15, P113, DOI 10.1016/S0966-6362(01)00155-2; Reid S, 2010, GAIT POSTURE, V32, P10, DOI 10.1016/j.gaitpost.2010.02.015; Riad J, 2013, J PEDIATR ORTHOPED, V33, P298, DOI 10.1097/BPO.0b013e31827d0b5b; Simon SR, 2004, J BIOMECH, V37, P1869, DOI 10.1016/j.jbiomech.2004.02.047; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Smith, 1997, SCI ENG GUIDE DIGITA	31	1	1	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2021	100	3					235	242		10.1097/PHM.0000000000001551			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	QI4OE	WOS:000618957900015	33595935				2022-02-06	
J	Kerr, WT; Zhang, XR; Hill, CE; Janio, EA; Chau, AM; Braesch, CT; Le, JM; Hori, JM; Patel, AB; Allas, CH; Karimi, AH; Dubey, I; Sreenivasan, SS; Gallardo, NL; Bauirjan, J; Hwang, ES; Davis, EC; D'Ambrosio, SR; Al Banna, M; Cho, AY; Dewar, SR; Engel, J; Feusner, JD; Stern, JM				Kerr, Wesley T.; Zhang, Xingruo; Hill, Chloe E.; Janio, Emily A.; Chau, Andrea M.; Braesch, Chelsea T.; Le, Justine M.; Hori, Jessica M.; Patel, Akash B.; Allas, Corinne H.; Karimi, Amir H.; Dubey, Ishita; Sreenivasan, Siddhika S.; Gallardo, Norma L.; Bauirjan, Janar; Hwang, Eric S.; Davis, Emily C.; D'Ambrosio, Shannon R.; Al Banna, Mona; Cho, Andrew Y.; Dewar, Sandra R.; Engel, Jerome, Jr.; Feusner, Jamie D.; Stern, John M.			Epilepsy, dissociative seizures, and mixed: Associations with time to video-EEG	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Functional seizures; Drug resistant epilepsy; Healthcare triage; Psychogenic nonepileptic seizures (PNES; PNEA)	PSYCHOGENIC NONEPILEPTIC SEIZURES; QUALITY-OF-LIFE; TEMPORAL-LOBE EPILEPSY; SUDDEN UNEXPECTED DEATH; DIAGNOSTIC DELAY; RISK-FACTORS; SURGERY; HEALTH; DISPARITIES; PREDICTORS	Purpose: Video-electroencephalographic monitoring (VEM) is a core component to the diagnosis and evaluation of epilepsy and dissociative seizures (DS)-also known as functional or psychogenic seizures-but VEM evalu-ation often occurs later than recommended. To understand why delays occur, we compared how patient-reported clinical factors were associated with time from first seizure to VEM (TVEM) in patients with epilepsy, DS or mixed. Methods: We acquired data from 1245 consecutive patients with epilepsy, VEM-documented DS or mixed epilepsy and DS. We used multivariate log-normal regression with recursive feature elimination (RFE) to evaluate which of 76 clinical factors interacting with patients' diagnoses were associated with TVEM. Results: The mean and median TVEM were 14.6 years and 10 years, respectively (IQR 3-23 years). In the multivariate RFE model, the factors associated with longer TVEM in all patients included unemployment and not student status, more antiseizure medications (current and past), concussion, and ictal behavior suggestive of temporal lobe epilepsy. Average TVEM was shorter for DS than epilepsy, particularly for patients with depres-sion, anxiety, migraines, and eye closure. Average TVEM was longer specifically for patients with DS taking more medications, more seizure types, non-metastatic cancer, and with other psychiatric comorbidities. Conclusions: In all patients with seizures, trials of numerous antiseizure medications, unemployment and non-student status was associated with longer TVEM. These associations highlight a disconnect between Interna-tional League Against Epilepsy practice parameters and observed referral patterns in epilepsy. In patients with dissociative seizures, some but not all factors classically associated with DS reduced TVEM.	[Kerr, Wesley T.; Zhang, Xingruo; Allas, Corinne H.; Karimi, Amir H.; Dubey, Ishita; Sreenivasan, Siddhika S.; Bauirjan, Janar; Al Banna, Mona; Dewar, Sandra R.; Engel, Jerome, Jr.; Stern, John M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Kerr, Wesley T.; Janio, Emily A.; Chau, Andrea M.; Braesch, Chelsea T.; Le, Justine M.; Hori, Jessica M.; Patel, Akash B.; Allas, Corinne H.; Karimi, Amir H.; Dubey, Ishita; Sreenivasan, Siddhika S.; Gallardo, Norma L.; Hwang, Eric S.; Davis, Emily C.; D'Ambrosio, Shannon R.; Cho, Andrew Y.; Engel, Jerome, Jr.; Feusner, Jamie D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Hill, Chloe E.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA		Kerr, WT (corresponding author), 710 Westwood Plaza,Suite 1-240,Box 951769, Los Angeles, CA 90095 USA.	WesleyTk@g.UCLA.edu	Kerr, Wesley T/I-6301-2019	Kerr, Wesley T/0000-0002-5546-5951; Karimi, Amir/0000-0003-3560-9433; Dubey, Ishita/0000-0001-9871-333X; ZHANG, XINGRUO/0000-0002-2369-9454; Chau, Andrea/0000-0003-3768-7013; Janio, Emily/0000-0002-2221-0805	NIHRNational Institute for Health Research (NIHR) [25NS065723]; UCLA-California Institute of Technology Medical Scientist Training Program (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM08042]; Neuroimaging Training Program (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T90 DA022768, R90 DA022768, R90 DA023422]; William M. Keck FoundationW.M. Keck Foundation [R01 NS033310, P20 NS080181]	This work was supported by NIHR 25NS065723, the UCLA-California Institute of Technology Medical Scientist Training Program (NIH T32 GM08042), the Neuroimaging Training Program (NIH T90 DA022768, R90 DA022768 & R90 DA023422), the William M. Keck Foundation, and research grants to JE (R01 NS033310 & P20 NS080181).	Abe C, 2020, EPILEPSY BEHAV, V102, DOI 10.1016/j.yebeh.2019.106649; Alessi R, 2014, SEIZURE-EUR J EPILEP, V23, P906, DOI 10.1016/j.seizure.2014.07.016; Allen SE, 2018, EPILEPSY RES, V140, P56, DOI 10.1016/j.eplepsyres.2017.12.012; Anderson DG, 2017, EPILEPSY BEHAV, V69, P37, DOI 10.1016/j.yebeh.2017.01.005; Asadi-Pooya AA, 2020, EPILEPSY BEHAV, V104, DOI 10.1016/j.yebeh.2019.106895; Asadi-Pooya AA, 2017, EPILEPSY BEHAV, V75, P143, DOI 10.1016/j.yebeh.2017.08.005; Asranna A, 2019, NEUROL-CLIN PRACT, V9, P297, DOI [10.1212/CPJ.0000000000000628, 10.1212/CPJ.000000000000628]; Baroni G, 2016, SEIZURE-EUR J EPILEP, V37, P35, DOI 10.1016/j.seizure.2016.02.003; Beghi M, 2020, EPILEPSY BEHAV, V109, DOI 10.1016/j.yebeh.2020.107084; Benbadis SR, 2019, NEUROL-CLIN PRACT, V9, P284, DOI 10.1212/CPJ.0000000000000625; Berg AT, 2004, CNS SPECTRUMS, V9, P136, DOI 10.1017/S109285290000849X; Bjellvi J, 2019, NEUROLOGY, V93, pE159, DOI 10.1212/WNL.0000000000007753; Blair Robert D G, 2012, Epilepsy Res Treat, V2012, P751510, DOI 10.1155/2012/751510; Bodde NMG, 2012, CLIN NEUROL NEUROSUR, V114, P217, DOI 10.1016/j.clineuro.2011.10.019; Burneo JG, 2016, NEUROLOGY, V86, P72, DOI 10.1212/WNL.0000000000002249; Chuttoo Lauren, 2019, Nurs Stand, DOI 10.7748/ns.2019.e11331; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Davis RG, 2008, J TRAUMA STRESS, V21, P218, DOI 10.1002/jts.20313; DeGiorgio CM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00473; Dewar SR, 2015, EPILEPSY BEHAV, V44, P171, DOI 10.1016/j.yebeh.2014.12.027; Dickman SL, 2017, LANCET, V389, P1431, DOI 10.1016/S0140-6736(17)30398-7; Drees C, 2017, NEUROL-CLIN PRACT, V7, P205, DOI 10.1212/CPJ.0000000000000357; Engel, 2020, EPILEPSY BEHAV; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Engel J, 2013, EPILEPSY CURR, V13, P198, DOI 10.5698/1535-7597-13.5.198; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Englot DJ, 2012, NEUROLOGY, V78, P1200, DOI 10.1212/WNL.0b013e318250d7ea; Englot DJ, 2015, EPILEPSY RES, V118, P68, DOI 10.1016/j.eplepsyres.2015.09.012; Erba G, 2016, EPILEPSIA, V57, P777, DOI 10.1111/epi.13351; Erba G, 2012, EPILEPSY BEHAV, V24, P352, DOI 10.1016/j.yebeh.2012.04.126; Filipcic IS, 2018, PSYCHIAT DANUB, V30, pS152; Flores EJ, 2019, J AM COLL RADIOL, V16, P596, DOI 10.1016/j.jacr.2018.12.045; Fong JS, 2011, EPILEPSIA, V52, P1393, DOI 10.1111/j.1528-1167.2011.03091.x; Golding L, 2020, PHYSICIAN SPORTSMED, V48, P247, DOI 10.1080/00913847.2020.1713708; Goldstein LH, 2020, LANCET PSYCHIAT, V7, P491, DOI 10.1016/S2215-0366(20)30128-0; Griffith K, 2017, HEALTH AFFAIR, V36, P1503, DOI 10.1377/hlthaff.2017.0083; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hakimi AS, 2008, EPILEPSY BEHAV, V13, P96, DOI 10.1016/j.yebeh.2008.02.003; Hamiwka L, 2011, EPILEPSIA, V52, P870, DOI 10.1111/j.1528-1167.2011.03074.x; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Hill CE, 2018, EPILEPSY BEHAV, V86, P1, DOI 10.1016/j.yebeh.2018.07.003; Hingray C, 2018, EPILEPSIA, V59, P203, DOI 10.1111/epi.13952; Holper S, 2020, EMERG MED AUSTRALAS, V32, P430, DOI 10.1111/1742-6723.13420; Hurst DL, 1996, SEIZURE-EUR J EPILEP, V5, P47, DOI 10.1016/S1059-1311(96)80062-8; Jennum P, 2019, EPILEPSY BEHAV, V98, P59, DOI 10.1016/j.yebeh.2019.06.024; Jette N, 2016, LANCET NEUROL, V15, P982, DOI 10.1016/S1474-4422(16)30127-2; Jobst BC, 2015, JAMA-J AM MED ASSOC, V313, P285, DOI 10.1001/jama.2014.17426; Jones SG, 2010, PSYCHOSOM MED, V72, P487, DOI 10.1097/PSY.0b013e3181d96550; Kanner AM, 2012, EPILEPSY BEHAV, V24, P156, DOI 10.1016/j.yebeh.2012.01.007; KAPUR J, 1995, EPILEPSIA, V36, P1126, DOI 10.1111/j.1528-1157.1995.tb00471.x; Karakis I, 2014, SEIZURE-EUR J EPILEP, V23, P47, DOI 10.1016/j.seizure.2013.09.011; Kerr WT, 2020, EPILEPSY BEHAV, V113, DOI 10.1016/j.yebeh.2020.107525; Kerr WT, 2020, EPILEPSY BEHAV, V105, DOI 10.1016/j.yebeh.2020.107002; Kerr WT, 2014, INT WORKSHOP PATTERN; Kerr WT, 2019, SEIZURE-EUR J EPILEP, V67, P45, DOI 10.1016/j.seizure.2019.02.021; Kerr WT, 2018, EPILEPSY BEHAV, V80, P75, DOI 10.1016/j.yebeh.2017.11.035; Kerr WT, 2017, EPILEPSIA, V58, P1852, DOI 10.1111/epi.13888; Kerr WT, 2017, EPILEPSY BEHAV, V69, P69, DOI 10.1016/j.yebeh.2016.11.002; Kerr WT, 2016, SEIZURE-EUR J EPILEP, V40, P123, DOI 10.1016/j.seizure.2016.06.015; Kerr WT, 2012, EPILEPSIA, V53, pe189, DOI 10.1111/j.1528-1167.2012.03653.x; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lafrance WC, 2015, EPILEPSY BEHAV, V45, P136, DOI 10.1016/j.yebeh.2015.02.021; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2006, NEUROLOGY, V66, P1620, DOI 10.1212/01.wnl.0000224953.94807.be; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Libbon R, 2019, EPILEPSY BEHAV, V98, P117, DOI 10.1016/j.yebeh.2019.06.032; Liu SY, 2007, BRAIN DEV-JPN, V29, P69, DOI 10.1016/j.braindev.2006.06.009; Mansouri A, 2015, EPILEPSY RES TREAT; Mathern GW, 1999, EPILEPSIA, V40, P1740, DOI 10.1111/j.1528-1157.1999.tb01592.x; McIntosh AM, 2012, EPILEPSIA, V53, P970, DOI 10.1111/j.1528-1167.2012.03430.x; Nayback AM, 2008, J PSYCHOSOC NURS MEN, V46, P43; OBrien TJ, 2018, MORTALITY PATIENTS P; Papacostas S S, 2006, Electromyogr Clin Neurophysiol, V46, P323; Perez DL, 2016, CNS SPECTRUMS, V21, P239, DOI 10.1017/S109285291600002X; Rawlings GH, 2017, SEIZURE-EUR J EPILEP, V50, P83, DOI 10.1016/j.seizure.2017.06.006; Rawlings GH, 2017, EPILEPSY BEHAV, V68, P153, DOI 10.1016/j.yebeh.2016.10.035; Razvi S, 2012, EPILEPSY BEHAV, V23, P7, DOI 10.1016/j.yebeh.2011.10.009; Reuber M, 2002, NEUROLOGY, V58, P493, DOI 10.1212/WNL.58.3.493; Rhoades JA., 2001, STAT BRIEF MEDICAL E; Roberts JI, 2015, NEUROLOGY, V84, P159, DOI 10.1212/WNL.0000000000001127; Robson Catherine, 2017, Wellcome Open Res, V2, P55, DOI 10.12688/wellcomeopenres.12133.2; Rommelfanger KS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00106; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB., 1987, MULTIPLE IMPUTATION; Salinsky M, 2019, EPILEPSY BEHAV, V94, P72, DOI 10.1016/j.yebeh.2019.02.010; Schiltz NK, 2013, EPILEPSY RES, V107, P172, DOI 10.1016/j.eplepsyres.2013.08.003; Seneviratne U, 2014, J NEUROL NEUROSUR PS, V85, P466, DOI 10.1136/jnnp-2013-306618; Seneviratne U, 2012, EPILEPSIA, V53, pe63, DOI 10.1111/j.1528-1167.2011.03382.x; Sheikh SR, 2020, NEUROLOGY, V95, pE1404, DOI 10.1212/WNL.0000000000010185; Struck AF, 2011, EPILEPSY BEHAV, V22, P293, DOI 10.1016/j.yebeh.2011.06.022; Szaflarski Jerzy P, 2003, Med Sci Monit, V9, pCR113; Tatekawa H, 2020, SEIZURE-EUR J EPILEP, V75, P43, DOI 10.1016/j.seizure.2019.12.014; Tomson T, 2008, LANCET NEUROL, V7, P1021, DOI 10.1016/S1474-4422(08)70202-3; Tonini C, 2004, EPILEPSY RES, V62, P75, DOI 10.1016/j.eplepsyres.2004.08.006; Trainor D, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107482; Vakharia VN, 2018, ANN NEUROL, V83, P676, DOI 10.1002/ana.25205; WALCZAK TS, 1995, EPILEPSIA, V36, P1131, DOI 10.1111/j.1528-1157.1995.tb00472.x; Wardrope A, 2020, NEUROL-CLIN PRACT, V10, P96, DOI 10.1212/CPJ.0000000000000726; Wardrope A, 2018, SEIZURE-EUR J EPILEP, V61, P139, DOI 10.1016/j.seizure.2018.08.012; Wheeler SM, 2017, OBSTET GYN CLIN N AM, V44, P1, DOI 10.1016/j.ogc.2016.10.001; Widjaja E, 2011, EPILEPSY RES, V94, P61, DOI 10.1016/j.eplepsyres.2011.01.005; Yerdelen D, 2016, NEUROSCIENCES, V21, P47, DOI 10.17712/nsj.2016.1.2015595; Zupanc ML, 2010, PEDIATR NEUROL, V42, P12, DOI 10.1016/j.pediatrneurol.2009.07.018	104	1	1	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	MAR	2021	86						116	122		10.1016/j.seizure.2021.02.002			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RB3XH	WOS:000632047100021	33601302				2022-02-06	
J	Kramer, SA; Wagner, BK; Robles, I; Moeller, SJ; Bowman, AS; Kieffer, JD; Arruda, AG; Cressman, MD; Pairis-Garcia, MD				Kramer, Scott A.; Wagner, Brooklyn K.; Robles, Ivelisse; Moeller, Steve J.; Bowman, Andrew S.; Kieffer, Justin D.; Arruda, Andreia Goncalves; Cressman, Michael D.; Pairis-Garcia, Monique D.			Validating the effectiveness of alternative euthanasia techniques using penetrating captive bolt guns in mature swine (Sus scrofa domesticus)	JOURNAL OF ANIMAL SCIENCE			English	Article						euthanasia; mature swine; penetrating captive bolt		Euthanasia of mature swine is challenging. Temporal and behind-the-ear locations are two sites that have been identified as alternatives to the more commonly used frontal placement. In stage one, the effectiveness of two penetrating captive bolt gun styles (cylinder or pistol) was evaluated using frontal, temporal, and behind-the-ear placement in anesthetized mature swine (n = 36; weight: 267 +/- 41 kg). For stage one, when evaluating treatment efficacy by sex, the cylinder-style equipment was 100% effective in achieving death when applied to all cranial locations (frontal, temporal, and behind-theear) for sows; however, the pistol-style equipment was only 100% effective when applied at the behind-the-ear location for sows. For boars, the cylinder-style equipment was 100% effective when applied to the frontal and behind-the-ear location, but the pistol-style equipment was not effective for any cranial location in boars. Therefore, the pistol-frontal, pistoltemporal, pistol-behind-the-ear, and cylinder-temporal were not included for boars, and pistol-frontal and pistol-temporal were not included for sows in stage two. In stage two, commercial, mixed-breed, mature swine (n = 42; weight: 292 +/- 56 kg) were randomly assigned to one of four treatments based on the inclusion criteria described in stage one. A three-point traumatic brain injury (TBI) score (0 = normal; 1= some abnormalities; 2 = grossly abnormal, unrecognizable) was used to evaluate six neuroanatomical structures (cerebral cortex, cerebellum, hypothalamus, thalamus, pons, and brain stem), and the presence of hemorrhage was also noted. All treatments were 100% effective in stage two. A significant interaction between gun style and placement was determined on predicting total TBI as the cylinder style produced a higher total TBI score compared with the pistol type of the magnitude of +2.8 (P < 0.01). The cylinder style tended to produce a greater TBI score than the pistol in the temporal location (+1.2; P = 0.08). No difference was noted for TBI score behind-the-ear between the cylinder- and pistol-style gun (P > 0.05). TBI tended to be less in boars compared with sows (-0.6; P = 0.08). Hemorrhage was observed in frontal, parietal, occipital, and temporal lobes. This study demonstrated that the cylinder-style captive bolt gun more effectively resulted in brain trauma and death compared with a pistol-style gun and the behind-the-ear and temporal placement showed promise as an alternative placement site for euthanizing mature pigs on-farm.	[Kramer, Scott A.] USDA, Anim & Plant Hlth Inspect Serv, Streetsboro, OH 44241 USA; [Wagner, Brooklyn K.; Robles, Ivelisse; Pairis-Garcia, Monique D.] North Carolina State Univ, Coll Vet Med, Raleigh, NC 27606 USA; [Moeller, Steve J.; Kieffer, Justin D.; Cressman, Michael D.] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Bowman, Andrew S.; Arruda, Andreia Goncalves] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA		Pairis-Garcia, MD (corresponding author), North Carolina State Univ, Coll Vet Med, Raleigh, NC 27606 USA.	pairis-garcia@ncsu.edu	Bowman, Andrew/V-5035-2019	Bowman, Andrew/0000-0002-0738-8453; Pairis-Garcia, Monique/0000-0002-6005-5666	National Pork Board/Pork Checkoff for wholly funding this project [20-097]	We would like to acknowledge the National Pork Board/Pork Checkoff for wholly funding this project (grant 20-097).	Ackerman S., 1992, DISCOVERING BRAIN, P13; Adams D. B., 2008, SPECIFYING RISK ANIM, P81; American Dairy Science Association American Society of Animal Science and Poultry Science Association, 2010, GUIDE CARE USE AGR A, V3rd; Anderson K, 2019, TRANSL ANIM SCI, V3, P1405, DOI 10.1093/tas/txz097; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bjarkam CR, 2017, JOVE-J VIS EXP, DOI 10.3791/55511; Finnie JW, 2003, AUST VET J, V81, P153, DOI 10.1111/j.1751-0813.2003.tb11078.x; Gemus-Benjamin M. S., 2015, MSU PORK Q, V20, P1; Humane Slaughter Association (HSA), 2013, CAPTIVE BOLT STUNNIN, V2013; Miller D., 2020, AM VET MEDICAL ASS A, V2020; Mullins CR, 2017, ANIM WELFARE, V26, P449, DOI 10.7120/09627286.26.4.449; National Pork Board, 2019, COMMON SWINE IND AUD; National Pork Board, 2011, ON FARM EUTH SWIN RE; Pairis-Garcia MD, 2014, J SWINE HEALTH PROD, V22, P16; Ramirez A., 2009, J. Appl. Anim. Welfare Sci., V12, P151, DOI 10.1080/10888700902720318; Shearer J., 2016, P 2016 AM ASS SWIN V, P14; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Woods J., 2012, THESIS IOWA STATE U; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	19	1	1	3	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0021-8812	1525-3163		J ANIM SCI	J. Anim. Sci.	MAR	2021	99	3							skab052	10.1093/jas/skab052			8	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	RX0HG	WOS:000646900000013	33587140				2022-02-06	
J	Lagace-Legendre, C; Boucher, V; Robert, S; Tardif, PA; Ouellet, MC; de Guise, E; Boulard, G; Fremont, P; Emond, M; Moore, L; Le Sage, N				Lagace-Legendre, Corinne; Boucher, Valerie; Robert, Sebastien; Tardif, Pier-Alexandre; Ouellet, Marie-Christine; de Guise, Elaine; Boulard, Genevieve; Fremont, Pierre; Emond, Marcel; Moore, Lynne; Le Sage, Natalie			Persistent Postconcussion Symptoms: An Expert Consensus-Based Definition Using the Delphi Method	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; consensus; Delphi; mild traumatic brain injury; mTBI; persistent symptoms; postconcussion symptoms		Objective: To provide an expert consensus definition of persistent postconcussion symptoms following a mild traumatic brain injury (mTBI). Participants: Canadian healthcare professionals caring for patients with mTBI. Design: Online Delphi process. Main Measures: A first Delphi round documented important dimensions or criteria to consider when defining persistent symptoms. Expert opinions were then resubmitted in 4 subsequent Delphi rounds and their relevance was rated using a 9-point Likert scale. An item with a median rating of 7 or more and a sufficient level of agreement were considered consensual. Results: After 5 rounds, consensus was reached on a set of criteria that can be summarized as follows: presence of any symptom that cannot be attributed to a preexisting condition and that appeared within hours of an mTBI, that is still present every day 3 months after the trauma, and that has an impact on at least one sphere of a person's life. Conclusion: This Delphi consensus proposes a set of criteria that support a more uniform definition of persistent symptoms in mild TBI among clinicians and researchers. This definition may help clinicians better identify persistent postconcussion symptoms and improve patient management.	[Lagace-Legendre, Corinne; Boucher, Valerie; Tardif, Pier-Alexandre; Ouellet, Marie-Christine; Emond, Marcel; Moore, Lynne; Le Sage, Natalie] CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optim Sante, Quebec City, PQ, Canada; [Lagace-Legendre, Corinne; Boucher, Valerie; Robert, Sebastien; Fremont, Pierre; Emond, Marcel; Moore, Lynne; Le Sage, Natalie] Univ Laval, Fac Med, Quebec City, PQ, Canada; [Boucher, Valerie; Ouellet, Marie-Christine; Emond, Marcel; Le Sage, Natalie] Univ Laval, Ctr Rech Soins & Serv Premiere Ligne, CERSSPL, Quebec City, PQ, Canada; [Ouellet, Marie-Christine] Ctr Interdisciplinaire Rech Readaptat & Integrat, Quebec City, PQ, Canada; [de Guise, Elaine] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Boulard, Genevieve] Clin Neuropsychol, Quebec City, PQ, Canada		Le Sage, N (corresponding author), CHU Quebec, Hop Enfant Jesus, 1401,18e Rue,H-610, Quebec City, PQ G1J 1Z4, Canada.	corinne.lagace-legendre.1@ulaval.ca; valerie.boucher23@icloud.com; sebrobert99@hotmail.com; Pier-Alexandre.Tardif@crchudequebec.ulaval.ca; marie-christine.ouellet@psy.ulaval.ca; elaine.de.guise@umontreal.ca; genevieve.boulard.neuro@gmail.com; pierre.fremont@fmed.ulaval.ca; marcelemond1@me.com; lynne.moore@fmed.ulaval.ca; natalie.lesage@fmed.ulaval.ca	Le Sage, Natalie/G-7063-2016	Le Sage, Natalie/0000-0003-4762-8156; Fremont, Pierre/0000-0003-2810-8382; Boucher, Valerie/0000-0002-3117-2177	Fondation du CHA [702/8642]	This study was funded by the Fondation du CHA (702/8642). The authors thank all of the professionals who answered the Delphi surveys.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th; American Psychiatric Association A, 1994, DIAGNOSTIC STAT MANU; Beattie E, 2004, EMERG MED J, V21, P47, DOI 10.1136/emj.2003.001123; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Campbell SM, 2000, BRIT MED J, V321, P425, DOI 10.1136/bmj.321.7258.425; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan RCK, 2005, BRAIN INJURY, V19, P1117, DOI 10.1080/026990500150088; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dwyer B, 2018, HAND CLINIC, V158, P163, DOI 10.1016/B978-0-444-63954-7.00017-3; Fayol P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P497, DOI 10.1016/j.annrmp.2008.06.003; Fitch K., 2001, DTIC DOCUMENT; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2004, STUD NEUROPSYCHOL DE, P323; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lakhani BK, 2020, EYE, V34, P335, DOI 10.1038/s41433-019-0540-x; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Linstone H.A., 1975, DELPHI METHOD TECHNI; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Normand SLT, 1998, INT J QUAL HEALTH C, V10, P247, DOI 10.1093/intqhc/10.3.247; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Ontario Neurotrauma Foundation, 2018, GUIDELINES CONCUSSIO, V3rd ed.; Ontario Neurotrauma Foundation, 2013, GUIDELINES CONCUSSIO; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Sinha IP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000393; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	53	1	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		96	102		10.1097/HTR.0000000000000613			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100006	32826417	hybrid			2022-02-06	
J	Laratta, S; Giannotti, L; Tonin, P; Calabro, RS; Cerasa, A				Laratta, Stefania; Giannotti, Lucia; Tonin, Paolo; Calabro, Rocco Salvatore; Cerasa, Antonio			Marital Stability and Quality of Couple Relationships after Acquired Brain Injury: A Two-Year Follow-Up Clinical Study	HEALTHCARE			English	Article						marital stability; acquired brain injury; spouses; religiosity; educational level	DEPRESSIVE SYMPTOMS; COGNITIVE RESERVE; STROKE; CAREGIVERS; BURDEN; MARRIAGE; SURVIVAL; HEALTH; LIFE	Couple relationships after acquired brain injury (ABI) could be vulnerable to emotional distress. Previous evidence has demonstrated significant marital dissatisfaction in the first period after a traumatic event, while long-term evaluations are lacking. In this study, we evaluated the impact of a series of demographic and clinical factors on marital stability after two years from the injury. Thirty-five patients (29% female) with mild/moderate ABI (57% vascular, 43% traumatic) and their partners were enrolled. The couples completed a series of psychological questionnaires assessing marital adjustment (Dyadic Adjustment Scale, DAS) and family functioning (Family Relationship Index, FRI) at discharge from the intensive rehabilitation unit and after 2 years. Demographics (i.e., educational level, job employment and religion commitment) and clinical variables (i.e., the Barthel index, aetiology and brain lesion localization) were considered as predictive factors. Regression analyses revealed that the DAS and FRI values are differently influenced by demographic and clinical factors in patients and caregivers. Indeed, the highest educational level corresponds to better DAS and FRI values for patients. In the spouses, the variability of the DAS values was explained by aetiology (the spouses of traumatic ABI patients had worse DAS values), whereas the variability in the FRI values was explained by religious commitment (spending much time on religious activities was associated with better FRI values). Our data suggest that some clinical and demographic variables might be important for protecting against marital dissatisfaction after an ABI.	[Laratta, Stefania; Giannotti, Lucia; Tonin, Paolo; Cerasa, Antonio] S Anna Inst, I-88900 Crotone, Italy; [Calabro, Rocco Salvatore] IRCCS Ctr Neuro Bonino Pulejo, I-98124 Messina, Italy; [Cerasa, Antonio] Natl Res Council IRIB CNR, Inst Biomed Res & Innovat, I-87050 Mangone, Italy		Cerasa, A (corresponding author), S Anna Inst, I-88900 Crotone, Italy.; Cerasa, A (corresponding author), Natl Res Council IRIB CNR, Inst Biomed Res & Innovat, I-87050 Mangone, Italy.	s.laratta@isakr.it; lucia.giannotti@libero.it; p.tonin@isakr.it; roccos.calabro@irccsme.ity; a.cerasa@unicz.it	cerasa, antonio/E-8614-2011	cerasa, antonio/0000-0002-8022-4770; LARATTA, STEFANIA/0000-0003-0819-0374			Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Anderson S, 2018, AGEING SOC, V38, P2241, DOI 10.1017/S0144686X17000526; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Ayotte BJ, 2010, J GERONTOL B-PSYCHOL, V65, P438, DOI 10.1093/geronb/gbq033; Bijttebier P, 2000, HEART LUNG, V29, P278, DOI 10.1067/mhl.2000.107918; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Corallo F, 2019, J RELIG HEALTH, V58, P1444, DOI 10.1007/s10943-019-00840-8; Gentili P., 2002, MINERVA PSICHIATRICA, V43, P107, DOI DOI 10.1016/J.CELL.2012.08.029; George LK, 2002, PSYCHOL INQ, V13, P190, DOI 10.1207/S15327965PLI1303_04; Gholamzadeh Sakineh, 2014, Iran J Nurs Midwifery Res, V19, P478; Hammond FM, 2011, J HEAD TRAUMA REHAB, V26, P69, DOI 10.1097/HTR.0b013e318205174d; Hanks RA, 2020, REHABIL PSYCHOL, V65, P347, DOI 10.1037/rep0000304; Jaracz K, 2015, PATIENT EDUC COUNS, V98, P1011, DOI 10.1016/j.pec.2015.04.008; Karney BR., 2007, FAMILIES STRESS ASSE; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Kim D, 2017, OCCUP THER INT, DOI 10.1155/2017/1686143; King KB, 2012, HEALTH PSYCHOL, V31, P55, DOI 10.1037/a0025061; Kitzmuller G, 2012, J NEUROSCI NURS, V44, pE1, DOI 10.1097/JNN.0b013e31823ae4a1; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KuDreholt I., 2011, J DIVORCE REMARRIAGE, V52, P401, DOI [10.1080/10502556.2011.592423, DOI 10.1080/10502556.2011.592423]; Liu Q, 2018, J NEUROL, V265, P942, DOI 10.1007/s00415-018-8793-z; Margola D, 2019, EUR J PSYCHOL ASSESS, V35, P335, DOI 10.1027/1015-5759/a000427; Marshall CA, 2019, BRAIN INJURY, V33, P255, DOI 10.1080/02699052.2018.1553308; Martin SC, 2016, J FAM NURS, V22, P224, DOI 10.1177/1074840716640605; Nir Z, 2009, J NEUROSCI NURS, V41, P92, DOI 10.1097/JNN.0b013e318193456b; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Pierce LL, 2008, WESTERN J NURS RES, V30, P606, DOI 10.1177/0193945907310560; Quinn K, 2014, DISABIL REHABIL, V36, P185, DOI 10.3109/09638288.2013.783630; Riley Gerard A, 2016, Concussion, V1, pCNC18, DOI 10.2217/cnc-2016-0012; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Thomeer MB, 2016, J HEALTH SOC BEHAV, V57, P59, DOI 10.1177/0022146516628179; Tooth L, 2005, BRAIN INJURY, V19, P963, DOI 10.1080/02699050500110785; Turner B, 2010, BRAIN IMPAIR, V11, P281, DOI 10.1375/brim.11.3.281; Yoon KH, 2018, AGING MENT HEALTH, V22, P141, DOI 10.1080/13607863.2016.1232366; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007	39	1	1	3	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9032		HEALTHCARE-BASEL	Healthcare	MAR	2021	9	3							283	10.3390/healthcare9030283			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	RD8AH	WOS:000633693000001	33806697	gold, Green Published			2022-02-06	
J	Latchoumane, CFV; Betancur, MI; Simchick, GA; Sun, MK; Forghani, R; Lenear, CE; Ahmed, A; Mohankumar, R; Balaji, N; Mason, HD; Archer-Hartmann, SA; Azadi, P; Holmes, PV; Zhao, Q; Bellamkonda, RV; Karumbaiah, L				Latchoumane, Charles-Francois, V; Betancur, Martha, I; Simchick, Gregory A.; Sun, Min Kyoung; Forghani, Rameen; Lenear, Christopher E.; Ahmed, Aws; Mohankumar, Ramya; Balaji, Nivedha; Mason, Hannah D.; Archer-Hartmann, Stephanie A.; Azadi, Parastoo; Holmes, Philip, V; Zhao, Qun; Bellamkonda, Ravi, V; Karumbaiah, Lohitash			Engineered glycomaterial implants orchestrate large-scale functional repair of brain tissue chronically after severe traumatic brain injury	SCIENCE ADVANCES			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; FIBROBLAST GROWTH FACTOR-2; CEREBRAL-BLOOD-FLOW; CLOSED-HEAD-INJURY; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; UP-REGULATION; MOTOR CORTEX; NEUROGENESIS; RECOVERY	Severe traumatic brain injury (sTBI) survivors experience permanent functional disabilities due to significant volume loss and the brain's poor capacity to regenerate. Chondroitin sulfate glycosaminoglycans (CS-GAGs) are key regulators of growth factor signaling and neural stem cell homeostasis in the brain. However, the efficacy of engineered CS (eCS) matrices in mediating structural and functional recovery chronically after sTBI has not been investigated. We report that neurotrophic factor functionalized acellular eCS matrices implanted into the rat M1 region acutely after sTBI significantly enhanced cellular repair and gross motor function recovery when compared to controls 20 weeks after sTBI. Animals subjected to M2 region injuries followed by eCS matrix implantations demonstrated the significant recovery of "reach-to-grasp" function. This was attributed to enhanced volumetric vascularization, activity-regulated cytoskeleton (Arc) protein expression, and perilesional sensorimotor connectivity. These findings indicate that eCS matrices implanted acutely after sTBI can support complex cellular, vascular, and neuronal circuit repair chronically after sTBI.	[Latchoumane, Charles-Francois, V; Sun, Min Kyoung; Forghani, Rameen; Lenear, Christopher E.; Ahmed, Aws; Mohankumar, Ramya; Balaji, Nivedha; Mason, Hannah D.; Zhao, Qun; Karumbaiah, Lohitash] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Latchoumane, Charles-Francois, V; Lenear, Christopher E.; Ahmed, Aws; Karumbaiah, Lohitash] Univ Georgia, Coll Agr & Environm Sci, Edgar L Rhodes Ctr ADS, Athens, GA 30602 USA; [Betancur, Martha, I; Bellamkonda, Ravi, V] Duke Univ, Pratt Sch Engn, Dept Biomed Engn, 101 Sci Dr, Durham, NC 27705 USA; [Simchick, Gregory A.; Zhao, Qun] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Simchick, Gregory A.; Zhao, Qun] Univ Georgia, Bioimaging Res Ctr, Athens, GA 30602 USA; [Sun, Min Kyoung; Holmes, Philip, V; Karumbaiah, Lohitash] Univ Georgia, Biomed & Hlth Sci Inst, Div Neurosci, Athens, GA 30602 USA; [Archer-Hartmann, Stephanie A.; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Holmes, Philip, V] Univ Georgia, Psychol Dept, Athens, GA 30602 USA		Karumbaiah, L (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.; Karumbaiah, L (corresponding author), Univ Georgia, Coll Agr & Environm Sci, Edgar L Rhodes Ctr ADS, Athens, GA 30602 USA.; Karumbaiah, L (corresponding author), Univ Georgia, Biomed & Hlth Sci Inst, Div Neurosci, Athens, GA 30602 USA.	lohitash@uga.edu		Karumbaiah, Lohitash/0000-0001-7969-417X; Forghani, Rameen/0000-0002-1926-9240; Archer-Hartmann, Stephanie/0000-0001-8752-7363; Latchoumane, Charles-Francois Vincent/0000-0001-7018-0439; Sun, Min Kyoung/0000-0003-4389-9880; Simchick, Gregory/0000-0001-9326-7203; Betancur, Martha I./0000-0002-3082-1235; Lenear, Christopher/0000-0003-3378-5150	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1NS099596, R24GM137782]; Regenerative Engineering and Medicine (REM) research center; Alliance for Regenerative Rehabilitation Research and Training (AR3T) technology development grant	This work was supported by an NIH (RO1NS099596) award to L.K. and partially supported by a Georgia Partners in Regenerative Medicine seed grant from the Regenerative Engineering and Medicine (REM) research center to R.V.B. and L.K. and an Alliance for Regenerative Rehabilitation Research and Training (AR3T) technology development grant to L.K. and C.-F.V.L. P.A. acknowledges NIH support (R24GM137782) for this work.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Ances BM, 2000, J CEREBR BLOOD F MET, V20, P921, DOI 10.1097/00004647-200006000-00004; Baker EW, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1214; Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dayer AG, 2007, BRAIN, V130, P2962, DOI 10.1093/brain/awm200; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Fouda AY, 2017, MOL NEUROBIOL, V54, P661, DOI 10.1007/s12035-015-9675-3; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hao P, 2017, BIOMATERIALS, V140, P88, DOI 10.1016/j.biomaterials.2017.04.014; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040; ICHISE M, 1994, J NUCL MED, V35, P217; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Karumbaiah L, 2015, BIOCONJUGATE CHEM, V26, P2336, DOI 10.1021/acs.bioconjchem.5b00397; Karumbaiah L, 2012, BIOMATERIALS, V33, P5983, DOI 10.1016/j.biomaterials.2012.05.021; Kermani P, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00455; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kim SY, 2018, J NEUROSCI, V38, P93, DOI 10.1523/JNEUROSCI.1295-17.2017; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kurihara D, 2012, J BIOL CHEM, V287, P13822, DOI 10.1074/jbc.M111.314070; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; MARGOLIS RU, 1972, J NEUROCHEM, V19, P2325, DOI 10.1111/j.1471-4159.1972.tb01286.x; Martinez-Ramos C, 2015, NEUROSCI LETT, V598, P96, DOI 10.1016/j.neulet.2015.05.021; McCrary MR, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.201900285; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Mizumoto S, 2013, GLYCOCONJUGATE J, V30, P619, DOI 10.1007/s10719-012-9463-5; Modo M, 2019, BRAIN RES BULL, V150, P136, DOI 10.1016/j.brainresbull.2019.05.013; Monfils MH, 2006, EUR J NEUROSCI, V24, P739, DOI 10.1111/j.1460-9568.2006.04939.x; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Nih LR, 2018, NAT MATER, V17, P642, DOI 10.1038/s41563-018-0083-8; Nih LR, 2016, CURR OPIN BIOTECH, V40, P155, DOI 10.1016/j.copbio.2016.04.021; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; PRAYER L, 1993, ACTA RADIOL, V34, P593; Ramanathan D, 2006, P NATL ACAD SCI USA, V103, P11370, DOI 10.1073/pnas.0601065103; Ramanathan DS, 2018, NAT MED, V24, P1257, DOI 10.1038/s41591-018-0058-y; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; Seo JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074405; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Simchick G., 2016, P 24 ANN M ISMRM SIN; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; Sirko S, 2010, METHOD ENZYMOL, V479, P37, DOI 10.1016/S0076-6879(10)79003-0; Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309; Sugerman D., 2012, BRAIN INJURY MED, P45; Tang MM, 2017, BRAIN BEHAV IMMUN, V66, P322, DOI 10.1016/j.bbi.2017.05.013; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang LN, 2015, CONTRAST MEDIA MOL I, V10, P43, DOI 10.1002/cmmi.1601; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Woodbury ME, 2014, J NEUROIMMUNE PHARM, V9, P92, DOI 10.1007/s11481-013-9501-5; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Yu PP, 2018, TRENDS NEUROSCI, V41, P47, DOI 10.1016/j.tins.2017.10.005; Zhang L, 2013, TISSUE ENG PT A, V19, P1909, DOI [10.1089/ten.tea.2012.0622, 10.1089/ten.TEA.2012.0622]; Zhou L., 2018, STEM CELLS INT, V2018, P1	80	1	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	MAR	2021	7	10							eabe0207	10.1126/sciadv.abe0207			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QW4HG	WOS:000628612000004	33674306	Green Published, gold			2022-02-06	
J	Lempke, LB; Lynall, RC; Hoffman, NL; Devos, H; Schmidt, JD				Lempke, Landon B.; Lynall, Robert C.; Hoffman, Nicole L.; Devos, Hannes; Schmidt, Julianne D.			Slowed driving-reaction time following concussion-symptom resolution	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Mild traumatic brain injury; Motor vehicle; Neurocognitive function; Response time; Return to driving	TRAUMATIC BRAIN-INJURY; PERFORMANCE; EPIDEMIOLOGY; RELIABILITY; PREDICTORS; ABILITY; TESTS; SPORT; RISK; AGE	Background: Concussed patients have impaired reaction time (RT) and cognition following injury that may linger and impair driving performance. Limited research has used direct methods to assess driving-RT post-concussion. Our study compared driving RT during simulated scenarios between concussed and control individuals and examined driving-RT's relationship with traditional computerized neurocognitive testing (CNT) domains. Methods: We employed a cross-sectional study among 14 concussed (15.9 +/- 9.8 days post-concussion, mean +/- SD) individuals and 14 healthy controls matched for age, sex, and driving experience. Participants completed a driving simulator and CNT (CNS Vital Signs) assessment within 48 h of symptom resolution. A driving-RT composite (ms) was derived from 3 simulated driving scenarios: stoplight (green to yellow), evasion (avoiding approaching vehicle), and pedestrian (person running in front of vehicle). The CNT domains included verbal and visual memory; CNT-RT (simple-, complex-, Stroop-RT individually); simple and complex attention; motor, psychomotor, and processing speed; executive function; and cognitive flexibility. Independent t tests and Hedge d effect sizes assessed driving-RT differences between groups, Pearson correlations (r) examined driving RT and CNT domain relationships among cohorts separately, and p values were controlled for false discovery rate via Benjamini-Hochberg procedures (a = 0.05). Results: Concussed participants demonstrated slower driving-RT composite scores than controls (mean difference = 292.86 ms; 95% confidence interval (CI): 70.18-515.54; p = 0.048; d = 0.99). Evasion-RT (p = 0.094; d = 0.81), pedestrian-RT (p = 0.292; d = 0.31), and stoplight-RT (p = 0.292; d = 0.59) outcomes were not statistically significant after false-discovery rate corrections but demonstrated medium to large effect sizes for concussed deficits. Among concussed individuals, driving-RT outcomes did not significantly correlate with CNT domains (r-range = -0.51 to 0.55; p > 0.050). No correlations existed between driving-RT outcomes and CNT domains among control participants either (r-range = -0.52 to 0.72; p > 0.050). Conclusion: Slowed driving-RT composite scores and large effect sizes among concussed individuals when asymptomatic signify lingering impairment and raise driving-safety concerns. Driving-RT and CNT-RT measures correlated moderately but not statistically, which indicates that CNT-RT is not an optimal surrogate for driving RT.	[Lempke, Landon B.; Lynall, Robert C.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Hoffman, Nicole L.] Illinois State Univ, Sch Kinesiol & Recreat, Normal, IL 61790 USA; [Devos, Hannes] Univ Kansas, Dept Phys Therapy & Rehabil Sci, Lab Adv Rehabil Res Simulat, Med Ctr, Kansas City, KS 66160 USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA.	schmidtj@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	Office of the Vice President of Research at the University of Georgia	We thank Diana Robertson (University of Georgia) for her assistance in data processing. This study was funded by the Office of the Vice President of Research at the University of Georgia.	Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein JPK, 2018, PM&R, V10, P1153, DOI 10.1016/j.pmrj.2018.05.008; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Boufous S, 2011, TRAFFIC INJ PREV, V12, P475, DOI 10.1080/15389588.2011.591856; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Cohen J., 2013, STAT POWER ANAL BEHA; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Lempke LB, 2020, SPORTS MED, V50, P1341, DOI 10.1007/s40279-020-01281-0; Lempke LB, 2020, MED SCI SPORT EXER, V52, P1650, DOI 10.1249/MSS.0000000000002300; Lempke LB, 2020, J ATHL TRAINING, V55, P17, DOI 10.4085/1062-6050-322-18; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Lucas JA, 2019, BRIT J SPORT MED, V53, P495, DOI 10.1136/bjsports-2018-099118; MacDonald J, 2018, J PEDIATR-US, V194, P177, DOI 10.1016/j.jpeds.2017.10.032; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKay A, 2016, J HEAD TRAUMA REHAB, V31, pE44, DOI 10.1097/HTR.0000000000000209; McKerral M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00144; McKnight AJ, 1999, ACCIDENT ANAL PREV, V31, P445, DOI 10.1016/S0001-4575(98)00082-7; Neyens DM, 2015, HUM FACTORS, V57, P1472, DOI 10.1177/0018720815594057; Preece MHW, 2016, BRAIN INJURY, V30, P1096, DOI 10.3109/02699052.2016.1165868; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch JE, 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2015, DOI 10.1136/BMJSEM-2015]; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Ross PE, 2015, ARCH PHYS MED REHAB, V96, P440, DOI 10.1016/j.apmr.2014.09.027; Schmidt JD, 2018, J NEUROTRAUM, V35, P2418, DOI 10.1089/neu.2018.5707; Schmidt JD, 2019, BRAIN INJURY, V33, P1652, DOI 10.1080/02699052.2019.1664765; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; WASSERMAN S, 1988, J EDUC STAT, V13, P75; WITZ K, 1990, J EDUC STAT, V15, P84; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	45	1	1	0	1	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	MAR	2021	10	2					145	153		10.1016/j.jshs.2020.09.005			9	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	QY5AT	WOS:000630052900006	32961301	Green Published, gold			2022-02-06	
J	Lolk, K; Dreier, JW; Christensen, J				Lolk, Kasper; Dreier, Julie W.; Christensen, Jakob			Repeated traumatic brain injury and risk of epilepsy: a Danish nationwide cohort study	BRAIN			English	Article						epilepsy; co-morbidity; epidemiology; traumatic brain injury; concussion	CIVIL REGISTRATION SYSTEM; LONG-TERM RISK; HEAD-INJURY; POSTTRAUMATIC SEIZURES; CONCUSSION	Traumatic brain injury is associated with increased risk of epilepsy, but the importance of repeated traumatic brain injuries has not yet been established. We performed a nationwide population-based cohort study of 2476905 individuals born in Denmark between 1977 and 2016. We estimated hazard ratios (HRs) and the cumulative incidence of epilepsy following traumatic brain injury using Cox and competing risk regression, respectively. To estimate the cumulative incidence of epilepsy in the population without traumatic brain injury, we matched 10 controls for each subject with traumatic brain injury on year of birth, sex, and date of brain insult in the index person. In the cohort, traumatic brain injury was sustained by 167051 subjects (71162 females and 95889 males), and 37200 individuals developed epilepsy (17905 females and 19295 males). Compared with subjects without traumatic brain injury, the relative risk of epilepsy increased after a first traumatic brain injury [HR 2.04, 95% confidence interval (CI) 1.96-2.13] and even more after a second traumatic brain injury (HR 4.45, 95% CI 4.09-4.84). The risk increased with the severity of the first and the second traumatic brain injury, most notably after severe traumatic brain injuries. Females were more likely than males to develop epilepsy after mild traumatic brain injury (HR 2.13, 95% CI 2.00-2.28 versus HR 1.77, 95% CI 1.66-1.88; P<0.0001); in contrast, males were more likely than females to develop epilepsy after severe traumatic brain injury (HR 5.00, 95% CI 4.31-5.80 versus 3.21, 95% CI 2.56-4.03; P=0.0012). The risk remained increased for decades after the traumatic brain injury. This knowledge may inform efforts to prevent the development of post-traumatic epilepsy.	[Lolk, Kasper; Dreier, Julie W.; Christensen, Jakob] Aarhus Univ, Natl Ctr Register Based Res, Dept Econ & Business Econ, Aarhus BSS, Aarhus, Denmark; [Lolk, Kasper; Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark; [Dreier, Julie W.] Aarhus Univ, Ctr Integrated Register Based Res, Aarhus, Denmark		Lolk, K (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Dept Econ & Business Econ, Aarhus BSS, Aarhus, Denmark.	Lolk@econ.au.dk		Christensen, Jakob/0000-0002-9385-6435; Lolk, Kasper/0000-0003-2639-7969; Dreier, Julie Werenberg/0000-0002-9339-4170	Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited [NNF16OC0 019126, NNF17OC0029860]; Central Denmark Region; Danish Epilepsy Association	This study was supported by the Novo Nordisk Foundation (grant numbers: NNF16OC0 019126 and NNF17OC0029860), the Central Denmark Region, and the Danish Epilepsy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg KM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3908; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bishop Y.M., 1975, DISCRETE MULTIVARIAT; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Christensen J, 2007, EPILEPSY RES, V76, P60, DOI 10.1016/j.eplepsyres.2007.06.012; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Engel J., 2012, SEIZURE EPILEPSY, V2nd; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Firkin AL, 2015, EPILEPSIA, V56, P1534, DOI 10.1111/epi.13127; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Galili SF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017735; Gerds TA, 2019, Product-Limit Estimation for Censored Event History Analysis; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Holden E Wayne, 2005, Dis Manag, V8, P1, DOI 10.1089/dis.2005.8.1; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Mateu NC, 2020, SCAND J PUBLIC HEALT, V48, P331, DOI 10.1177/1403494819852826; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Musliner KL, 2019, ACTA PSYCHIAT SCAND, V139, P548, DOI 10.1111/acps.13028; Ohneberg K, 2019, STAT MED, V38, P4390, DOI 10.1002/sim.8305; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Ottman R, 1996, EPILEPSIA, V37, P353, DOI 10.1111/j.1528-1157.1996.tb00571.x; Pedersen CB, 2006, DAN MED BULL, V53, P441; PHILLIPS G, 1954, J NEUROL NEUROSUR PS, V17, P1, DOI 10.1136/jnnp.17.1.1; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SCHAUMANN BA, 1994, EPILEPSIA, V35, P48, DOI 10.1111/j.1528-1157.1994.tb02911.x; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Therneau Terry M, 2021, CRAN; Wennberg R, 2018, CAN J NEUROL SCI, V45, P275, DOI 10.1017/cjn.2017.300; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zollman FS., MANUAL TRAUMATIC BRA	42	1	1	2	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	MAR	2021	144		3				875	884		10.1093/brain/awaa448			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6YS	WOS:000649448200029	33439977				2022-02-06	
J	Lundine, JP; Todis, B; Gau, JM; McCart, M; Wade, SL; Yeates, KO; Glang, A				Lundine, Jennifer P.; Todis, Bonnie; Gau, Jeff M.; McCart, Melissa; Wade, Shari L.; Yeates, Keith Owen; Glang, Ann			Return to School Following TBI: Educational Services Received 1 Year After Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; child; education; hospitals; program development; rehabilitation; school health services; special education		Background: Many children who experience a traumatic brain injury (TBI) return to school without receiving needed support services. Objective: To identify services received and predictors of formal special education services (ie, Individualized Education Plan [IEP]) for students with TBI 1 year after returning to school. Setting and Participants: A total of 74 students with TBI recruited from children's hospitals in Colorado, Ohio, and Oregon. Design: Secondary analysis of previously reported randomized control trials with surveys completed by caregivers when students returned to school (T1) and 1 year later (T2). This study reports data collected at T2. Results: While 45% of students with TBI reported an IEP 1 year after returning to school, nearly 50% of students received informal or no services. Male students, those who sustained a severe TBI, and students whose parents reported domain-specific concerns were more likely to receive special education services at 1 year. In a multivariate model, sex remained the only significant predictor of IEP services at T2. Conclusions: Females and students with less severe or less visible deficits were less likely to receive special education services. While transition services may help students obtain special education for the first year after TBI, identifying students with TBI who have subtle or later-developing deficits remains a challenge.	[Lundine, Jennifer P.] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies & Inpatient Rehabil Program, Columbus, OH USA; [Todis, Bonnie; McCart, Melissa; Glang, Ann] Univ Oregon, Dept Psychol, Ctr Brain Injury Res & Training, Eugene, OR 97403 USA; [Gau, Jeff M.] Univ Oregon, Ctr Human Dev, Eugene, OR 97403 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Rehabil Med, Cincinnati, OH 45229 USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Lundine, JP (corresponding author), Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA.	lundine.4@osu.edu; todisb@cbirt.org; jeffg@ori.edu; mccart@uoregon.edu; shari.wade@cchmc.org; kyeates@ucalgary.ca; aglang@uoregon.edu	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A060075]	This work was supported by the National Institute on Disability and Rehabilitation Research (now National Institute on Disability, Independent Living, and Rehabilitation Research) [grant number H133A060075].	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Cermak CA, 2019, J HEAD TRAUMA REHAB, V34, pE13, DOI 10.1097/HTR.0000000000000419; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cook L. G., 2011, SIG 2 PERSPECTIVES N, V21, P33, DOI DOI 10.1044/NNSLD21.1.33; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Foster L, 2013, BRAIN INJURY, V27, P485, DOI 10.3109/02699052.2012.750747; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gioia GA, 2016, J HEAD TRAUMA REHAB, V31, P397, DOI 10.1097/HTR.0000000000000205; Glang A, 2018, BRAIN INJURY, V32, P608, DOI 10.1080/02699052.2018.1433329; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hibel J, 2010, SOCIOL EDUC, V83, P312, DOI 10.1177/0038040710383518; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Lipsey M.W., 2001, PRACTICAL META ANAL; Nagele DA., 2019, PHYS DISABIL ED RELA, V38, P10, DOI [10.14434/pders.v38i1.26850, DOI 10.14434/PDERS.V38I1.26850]; National Center for Education Statistics Common Core of Data (CCD), 2019, STAT NONF SURV PUBL; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Shaw SR, 2008, PSYCHOL SCHOOLS, V45, P74, DOI 10.1002/pits.20280; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Todis B, 2018, NEUROREHABILITATION, V42, P269, DOI 10.3233/NRE-172383; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	43	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		E89	E96		10.1097/HTR.0000000000000591			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100005	32769832				2022-02-06	
J	Martindale, SL; Lad, SS; Ord, AS; Nagy, KA; Crawford, CD; Taber, KH; Rowland, JA				Martindale, Sarah L.; Lad, Sagar S.; Ord, Anna S.; Nagy, Kristina A.; Crawford, Cameron D.; Taber, Katherine H.; Rowland, Jared A.			Sleep moderates symptom experience in combat veterans	JOURNAL OF AFFECTIVE DISORDERS			English	Article						PTSD; Traumatic brain Injury; Depression; Neurobehavioral symptoms; Sleep		Background: Though sleep disturbance has shown to negatively affect outcomes related to post-deployment conditions, it is unclear whether and how sleep disturbance affects mental health symptoms beyond these conditions. We evaluated the independent and moderating effects of sleep quality on posttraumatic stress disorder (PTSD), depressive, and neurobehavioral symptoms beyond mild traumatic brain injury (TBI) and PTSD diagnosis. Methods: Participants were 274 US combat veterans who deployed after 9/11. All completed diagnostic TBI and PTSD interviews and self-report measures of sleep quality, as well as PTSD, depressive, and neurobehavioral symptoms. Only those who passed symptom validity were included in analyses. Hierarchical regression evaluated the contribution of sleep quality to outcomes beyond PTSD and mild TBI. Moderation analyses evaluated interactions between mild TBI, PTSD, and sleep quality on symptom outcomes. Results: Mild TBI was only significantly associated with PTSD (p = .006) and neurobehavioral (p = .003) symptoms. PTSD diagnosis was associated with PTSD (p < .001), depressive (p < .001), and neurobehavioral symptoms (p < .001) beyond mild TBI. Sleep quality explained additional significant variance in all three outcome measures (p < .001), and also significantly moderated the effects of PTSD diagnosis on neurobehavioral symptoms (Delta R-2 = .01, p = .023). Limitations: Sleep was evaluated subjectively and therefore must be interpreted in this context. Conclusions: These results provide support that sleep quality is an independent contributing factor to health outcomes in post-deployment veterans and should be considered in etiology of complaints.	[Martindale, Sarah L.; Lad, Sagar S.; Ord, Anna S.; Nagy, Kristina A.; Crawford, Cameron D.; Taber, Katherine H.; Rowland, Jared A.] WG Bill Hefner VA Healthcare Syst, Salisbury, NC 28144 USA; [Martindale, Sarah L.; Rowland, Jared A.] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Taber, Katherine H.] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Taber, Katherine H.] Baylor Coll Med, Houston, TX 77030 USA		Martindale, SL (corresponding author), WG Bill Hefner VA Healthcare Syst, Salisbury, NC 28144 USA.; Martindale, SL (corresponding author), Wake Forest Sch Med, Winston Salem, NC 27101 USA.	Sarah.Martindale-Supak@va.gov	Martindale, Sarah L/O-8553-2018; Rowland, Jared A./AAN-3030-2021	Martindale, Sarah L/0000-0002-0059-3454; Rowland, Jared A./0000-0002-3655-3411; Lad, PsyD, Sagar/0000-0002-1278-8355; Ord, Anna/0000-0003-3373-2016			Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boyko EJ, 2013, DIABETES CARE, V36, P3154, DOI 10.2337/DC13-0042; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chakravorty S, 2014, J CLIN PSYCHOPHARM, V34, P350, DOI 10.1097/JCP.0000000000000130; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clum GA, 2001, J NERV MENT DIS, V189, P618, DOI 10.1097/00005053-200109000-00008; Freeman D, 2017, LANCET PSYCHIAT, V4, P749, DOI 10.1016/S2215-0366(17)30328-0; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Hardy MS, 2020, J NEUROPSYCH CLIN N, V32, P252, DOI 10.1176/appi.neuropsych.19090202; Hayes, 2018, INTRO MEDIATION MODE; Kanady JC, 2018, J CLIN SLEEP MED, V14, P1193, DOI 10.5664/jcsm.7224; Koffel EA, 2015, SLEEP MED REV, V19, P6, DOI 10.1016/j.smrv.2014.05.001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Livingston WS, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00059; Martindale S.L., Rehabil. Psychol, V62, P563; Martindale SL, 2020, MIL PSYCHOL, V32, P212, DOI 10.1080/08995605.2020.1724595; Martindale SL, 2018, ARCH PHYS MED REHAB, V99, P2485, DOI 10.1016/j.apmr.2018.04.029; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rosen RC, 2019, J TRAUMA STRESS, V32, P936, DOI 10.1002/jts.22462; Rowland JA, 2020, J NEUROTRAUM, V37, P1797, DOI 10.1089/neu.2019.6972; Siebern AT, 2011, PSYCHOL RES BEHAV MA, V4, P21, DOI 10.2147/PRBM.S10041; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Swinkels CM, 2013, SLEEP, V36, P1019, DOI 10.5665/sleep.2800; Talbot L., 2018, MILITARY VETERAN MEN; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Troxel WM, 2015, SLEEP MILITARY PROMO; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Wisdom NM, 2010, ARCH CLIN NEUROPSYCH, V25, P118, DOI 10.1093/arclin/acp110	39	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	MAR 1	2021	282						236	241		10.1016/j.jad.2020.12.161			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	QI9FX	WOS:000619295400033	33418372	Bronze			2022-02-06	
J	Mousessian, AS; da Silva, CPN; Oba-Shinjo, SM; Kolias, AG; Paiva, WS; Marie, SKN				Mousessian, Adaliana Sorg; Nunes da Silva, Clarisse Pereira; Oba-Shinjo, Sueli Mieko; Kolias, Angelos G.; Paiva, Wellingson Silva; Nagahashi Marie, Suely Kazue			CXCR7, CXCR4, and Their Ligand Expression Profile in Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						CXCR7; CXCR4; CXCL12; CXCL11; Gene expression; Protein expression; Traumatic brain injury	MARROW STROMAL CELLS; I-TAC; CHEMOKINE RECEPTOR; STEM-CELLS; T-CELLS; CXCL12; MIGRATION; ANGIOGENESIS; NEUROINFLAMMATION; INJECTION	OBJECTIVE: Traumatic brain injury (TBI) is a health problem worldwide, and therapeutic strategies to enhance brain tissue repair to lessen neurologic sequels are imperative. We aimed to analyze the impact of the inflammatory process in TBI through CXCR4 and CXCR7 chemokine receptors and their ligands' CXCL11 and CXCL12 expression profile in search for potential new druggable targets. METHODS: Twelve pericontusional tissues from severe TBI patients submitted to surgical treatment, and 20 control brain tissues from normal autopsy were analyzed for expression profile by real-time quantitative-polymerase chain reaction. CXCR7 and CXCR4 protein expressions were analyzed by immunohistochemistry. The findings were correlated with the clinical evolution. RESULTS: Increased gene expression of both receptors and their ligands was observed in TBI compared with controls, presenting high sensitivity and specificity to differentiate TBI from normal control (area under the curve ranging from 0.85 to 0.98, P < 0.001). In particular, CXCR7 expression highly correlated with CXCR4 and both ligands' expressions in TBI. Higher immunoreactions for CXCR7 and CXCR4 were identified in neurons and endothelial cells of TBI samples compared with controls. The patients presenting upregulated chemokine expression levels showed a trend toward favorable clinical evolution at up to 6 months of follow-up. CONCLUSIONS: The neuroprotective trend of CXCR4, CXCR7, CXCL11, and CXCL12 in TBI observed in this initial analysis warrants further studies with more patients, analyzing the involved signaling pathways for the development of new therapeutic strategies for TBI.	[Mousessian, Adaliana Sorg; Nunes da Silva, Clarisse Pereira; Oba-Shinjo, Sueli Mieko; Nagahashi Marie, Suely Kazue] Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Lab Mol & Cellular Biol, Sao Paulo, Brazil; [Paiva, Wellingson Silva] Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Div Neurosurg, Sao Paulo, Brazil; [Kolias, Angelos G.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England		Mousessian, AS (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Lab Mol & Cellular Biol, Sao Paulo, Brazil.	adaliana.m@usp.br	Paiva, Wellingson S/G-5517-2013; Shinjo, Sueli/C-4017-2012	Paiva, Wellingson S/0000-0002-5165-7040; Shinjo, Sueli/0000-0002-1650-5973			[Anonymous], 1998, NIH Consens Statement, V16, P1; Berahovich RD, 2014, IMMUNOLOGY, V141, P111, DOI 10.1111/imm.12176; Bogoslovsky T, 2011, STROKE, V42, P618, DOI 10.1161/STROKEAHA.110.596007; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chen KQ, 2018, CELL MOL IMMUNOL, V15, P324, DOI 10.1038/cmi.2017.134; Chen TJ, 2016, CLIN CHIM ACTA, V454, P6, DOI 10.1016/j.cca.2015.12.033; Cheng X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00590; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Corti S, 2011, GROWTH J CELLULAR MO, V15, P1645; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; Dziembowska M, 2005, GLIA, V50, P258, DOI 10.1002/glia.20170; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Guyon A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00065; He L, 2006, J IMMUNOL, V177, P3644, DOI 10.4049/jimmunol.177.6.3644; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Lee KM, 2014, EMBO J, V33, P2564, DOI 10.15252/embj.201488887; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Liu SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055290; Ma JH, 2015, NEUROL RES, V37, P50, DOI 10.1179/1743132814Y.0000000399; Mandel M, 2013, SENSORS-BASEL, V13, P6477, DOI 10.3390/s130506477; Marion DW, 2006, NEUROSURGERY, V58, P655; Noh H, 2014, NEUROCHEM INT, V69, P35, DOI 10.1016/j.neuint.2014.02.008; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Salmaggi A, 2002, J INTERF CYTOK RES, V22, P631, DOI 10.1089/10799900260100114; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sun WF, 2014, INFLAMM RES, V63, P287, DOI 10.1007/s00011-013-0699-8; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Volin MV, 1998, BIOCHEM BIOPH RES CO, V242, P46, DOI 10.1006/bbrc.1997.7890; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zajkowska J, 2011, ADV MED SCI-POLAND, V56, P311, DOI 10.2478/v10039-011-0033-z; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08840-y; Zhang Y, 2018, AGING DIS, V9, P287, DOI 10.14336/AD.2017.1112; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	54	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2021	147						E16	E24		10.1016/j.wneu.2020.11.022			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QT7BH	WOS:000626743400004	33189916				2022-02-06	
J	Pena, A; Dumkrieger, G; Berisha, V; Ross, K; Chong, CD; Schwedt, TJ				Pena, Austin; Dumkrieger, Gina; Berisha, Visar; Ross, Katherine; Chong, Catherine D.; Schwedt, Todd J.			Headache Characteristics and Psychological Factors Associated with Functional Impairment in Individuals with Persistent Posttraumatic Headache	PAIN MEDICINE			English	Article						Posttraumatic Headache; Mild Traumatic Brain Injury; Concussion; Pain Catastrophizing; Depression		Objective. Persistent posttraumatic headache (PPTH), one of the most common symptoms following mild traumatic brain injury, is often associated with substantial functional disability. The objective of this study was to assess the contribution of demographics, headache characteristics, and psychological symptoms to disability associated with PPTH. Methods. Participants completed the State-Trait Anxiety Inventory (STAI), the Beck Depression Inventory (BDI), the Pain Catastrophizing Scale (PCS), and the Migraine Disability Assessment (MIDAS) questionnaire. Two linear regression models were formulated to interrogate the relationships between 1) demographics and headache characteristics with the MIDAS questionnaire and 2) demographics, headache characteristics, and psychological symptoms with the MIDAS questionnaire. A two-way stepwise regression using the Akaike information criterion was performed to find a parsimonious model describing the relationships between demographics, headache characteristics, and psychological measures with the MIDAS questionnaire. Results. Participants included 58 patients with PPTH and 39 healthy controls (HCs). The median MIDAS score among those with PPTH was 48.0 (first quartile [1Q] = 20.0, third quartile [3Q] = 92.0), indicative of severe disability. Compared with the HCs, those with PPTH had higher scores on the BDI, STAI, and PCS. Older age predicted lower MIDAS scores (age: B=-0.11, P<0.01), whereas higher headache frequency, greater headache intensity, and higher trait anxiety scores predicted higher MIDAS scores in individuals with PPTH (headache frequency: B=0.07, P<0.001; headache intensity: B=0.51, P=0.04; trait anxiety score: B=1.11, P=0.01). Conclusions. Individuals with PPTH had substantial psychological symptoms and headache-related disability. Disability was partially explained by age, headache frequency and intensity, and trait anxiety. Holistic management of patients with PPTH to address headaches and psychological symptoms might reduce headache-associated disability.	[Pena, Austin] Mayo Clin, Mayo Clin Sch Med, Phoenix, AZ 85054 USA; [Dumkrieger, Gina; Chong, Catherine D.; Schwedt, Todd J.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Berisha, Visar] Arizona State Univ, Phoenix, AZ USA; [Ross, Katherine] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA		Schwedt, TJ (corresponding author), Mayo Clin, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	schwedt.todd@mayo.edu			Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program [W81XWH-15-1-0286, W81XWH-19-10534]; US Army Medical Research Acquisition Activity, Fort Detrick, MD	This study was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0286 and W81XWH-19-10534. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, is the awarding and administering acquisition office.	[Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Baker VB, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01107-4; Basler HD, 1996, INT J REHABILITATION, V2, P235; Beck A.T., 1987, MANUAL BECK DEPRESSI; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bond DS, 2015, HEADACHE, V55, P923, DOI 10.1111/head.12597; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; Carasco M, 2016, ADOLESC HEALTH MED T, V7, P59, DOI 10.2147/AHMT.S97925; Chong CD, 2017, HEADACHE, V57, P1522, DOI 10.1111/head.13193; Dindo L, 2012, BEHAV RES THER, V50, P537, DOI 10.1016/j.brat.2012.05.007; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Ford S, 2008, HEADACHE, V48, P523, DOI 10.1111/j.1526-4610.2008.00859.x; Heckman BD, 2009, PAIN, V146, P56, DOI 10.1016/j.pain.2009.06.019; Holroyd KA, 2007, CEPHALALGIA, V27, P1156, DOI 10.1111/j.1468-2982.2007.01420.x; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Kelman L, 2006, HEADACHE, V46, P1161, DOI 10.1111/j.1526-4610.2006.00444.x; Lanteri-Minet M, 2005, PAIN, V118, P319, DOI 10.1016/j.pain.2005.09.010; Llesuy JR, 2012, DEPRESSION NEUROLOGI, P103; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Marshall GN, 2010, J ABNORM PSYCHOL, V119, P143, DOI 10.1037/a0018009; Orr SL, 2017, J CHILD NEUROL, V32, P717, DOI 10.1177/0883073817702025; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Russo A, 2014, NEUROL SCI, V35, pS153, DOI 10.1007/s10072-014-1758-9; Sauro KM, 2010, HEADACHE, V50, P383, DOI 10.1111/j.1526-4610.2009.01544.x; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Sciruicchio V, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00114; Seng EK, 2019, HEADACHE, V59, P1448, DOI 10.1111/head.13657; Seng EK, 2018, HEADACHE, V58, P859, DOI 10.1111/head.13325; Spielberger C., 1983, MIND GARDEN, V70, P49; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stewart WF, 2000, PAIN, V88, P41, DOI 10.1016/S0304-3959(00)00305-5; Stewart WF, 2003, HEADACHE, V43, P258, DOI 10.1046/j.1526-4610.2003.03050.x; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tatrow K, 2003, HEADACHE, V43, P755, DOI 10.1046/j.1526-4610.2003.03133.x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Yavuz BG, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-53	43	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	MAR	2021	22	3					670	676		10.1093/pm/pnaa405			7	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	RJ0VZ	WOS:000637323000014	33432362				2022-02-06	
J	Perez Garcia, G; De Gasperi, R; Sosa, MAG; Perez, GM; Otero-Pagan, A; Pryor, D; Abutarboush, R; Kawoos, U; Hof, PR; Dickstein, DL; Cook, DG; Gandy, S; Ahlers, ST; Elder, GA				Perez Garcia, Georgina; De Gasperi, Rita; Gama Sosa, Miguel A.; Perez, Gissel M.; Otero-Pagan, Alena; Pryor, Dylan; Abutarboush, Rania; Kawoos, Usmah; Hof, Patrick R.; Dickstein, Dara L.; Cook, David G.; Gandy, Sam; Ahlers, Stephen T.; Elder, Gregory A.			Laterality and region-specific tau phosphorylation correlate with PTSD-related behavioral traits in rats exposed to repetitive low-level blast	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Animal model; Behavior; Blast; Laterality; Rat; Tau; Traumatic brain injury		Military veterans who experience blast-related traumatic brain injuries often suffer from chronic cognitive and neurobehavioral syndromes. Reports of abnormal tau processing following blast injury have raised concerns that some cases may have a neurodegenerative basis. Rats exposed to repetitive low-level blast exhibit chronic neurobehavioral traits and accumulate tau phosphorylated at threonine 181 (Thr181). Using data previously reported in separate studies we tested the hypothesis that region-specific patterns of Thr181 phosphorylation correlate with behavioral measures also previously determined and reported in the same animals. Elevated p-tau Thr181 in anterior neocortical regions and right hippocampus correlated with anxiety as well as fear learning and novel object localization. There were no correlations with levels in amygdala or posterior neocortical regions. Particularly striking were asymmetrical effects on the right and left hippocampus. No systematic variation in head orientation toward the blast wave seems to explain the laterality. Levels did not correlate with behavioral measures of hyperarousal. Results were specific to Thr181 in that no correlations were observed for three other phospho-acceptor sites (threonine 231, serine 396, and serine 404). No consistent correlations were linked with total tau. These correlations are significant in suggesting that p-tau accumulation in anterior neocortical regions and the hippocampus may lead to disinhibited amygdala function without p-tau elevation in the amygdala itself. They also suggest an association linking blast injury with tauopathy, which has implications for understanding the relationship of chronic blast-related neurobehavioral syndromes in humans to neurodegenerative diseases.	[Perez Garcia, Georgina; De Gasperi, Rita; Perez, Gissel M.; Otero-Pagan, Alena; Pryor, Dylan; Gandy, Sam] James J Peters Dept Vet Affairs Med Ctr, Res & Dev Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA; [Perez Garcia, Georgina; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, One Gustave Levy Pl, New York, NY 10029 USA; [De Gasperi, Rita; Gama Sosa, Miguel A.; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA; [Gama Sosa, Miguel A.] James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA; [Abutarboush, Rania; Kawoos, Usmah; Ahlers, Stephen T.] Naval Med Res Ctr, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Abutarboush, Rania; Kawoos, Usmah] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Nash Family Dept Neurosci & Friedman Brain Inst, One Gustave Levy Pl, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, One Gustave Levy, New York, NY 10029 USA; [Hof, Patrick R.; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Mt Sinai Alzheimers Dis Res Ctr, One Gustave Levy Pl, New York, NY 10029 USA; [Hof, Patrick R.; Gandy, Sam; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, One Gustave Levy Pl, New York, NY 10029 USA; [Dickstein, Dara L.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Dickstein, Dara L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Cook, David G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA; [Cook, David G.] Univ Washington, Dept Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Barbara & Maurice Deane Ctr Wellness & Cognit Hlt, 5 East 98th St, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, Mt Sinai NFL Neurol Care Ctr, 5 East 98th St, New York, NY 10029 USA; [Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Neurol Serv 3E16, 130 West Kingsbridge Rd, Bronx, NY 10468 USA		Elder, GA (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, One Gustave Levy Pl, New York, NY 10029 USA.	gregory.elder@va.gov			Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service AwardsUS Department of Veterans Affairs [1I01RX000996, 1I01RX002660, 1I21RX003019, 1I01RX000684, 1I01RX002333]; Department of Veterans Affairs Office of Research and Development Medical Research ServiceUS Department of Veterans Affairs [1I01BX004067, 1I01BX002311]; Alzheimer's Drug Discovery Foundation; Department of DefenseUnited States Department of Defense [0000B999.0000.000.A1503];  [P50AG005138];  [P30AG066514]	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Awards 1I01RX000996 (GE), 1I01RX002660 (GE), 1I21RX003019 (GE), 1I01RX000684 (SG), and 1I01RX002333 (SG), the Department of Veterans Affairs Office of Research and Development Medical Research Service 1I01BX004067 (GE) and 1I01BX002311 (DC), Department of Defense work unit number 0000B999.0000.000.A1503 (STA), the Alzheimer's Drug Discovery Foundation (SG) and by P50AG005138 and P30AG066514 to Mary Sano (SG, PRH). The funding agencies played no role in the design of the study and collection, analysis, and interpretation of data or in writing the manuscript.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Almeida FB, 2019, NEUROSCIENCE, V397, P56, DOI 10.1016/j.neuroscience.2018.11.029; Arun P, 2015, NEUROSCI LETT, V609, P152, DOI 10.1016/j.neulet.2015.10.036; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Baradaran R, 2020, INT J DEV NEUROSCI, V80, P303, DOI 10.1002/jdn.10026; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Belcheva I, 2007, LATERALITY, V12, P475, DOI 10.1080/13576500701453983; Berridge CW, 2003, ASYMMETRICAL BRAIN, P69; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Bugay V, 2020, J NEUROTRAUM, V37, P248, DOI 10.1089/neu.2018.6333; BUTLER RW, 1990, AM J PSYCHIAT, V147, P1308; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; CASTELLANO MA, 1987, PHYSIOL BEHAV, V40, P607, DOI 10.1016/0031-9384(87)90105-3; Cernak I, 2017, BRAIN INJURY, V31, P1168, DOI 10.1080/02699052.2016.1274779; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DENENBERG VH, 1981, BEHAV BRAIN SCI, V4, P1, DOI 10.1017/S0140525X00007330; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Dujardin S, 2019, ADV EXP MED BIOL, V1184, P305, DOI 10.1007/978-981-32-9358-8_23; Dumurgier J, 2017, J ALZHEIMERS DIS, V60, P1451, DOI [10.3233/JAD-170511, 10.3233/jad-170511]; Elder G.A., 2021, J NEUROTRAUM, DOI [10.1089/neu.2020.7398, DOI 10.1089/NEU.2020.7398]; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Engel C., 2019, 7 DEP DEF STAT SCI M, DOI [10.7249/CF380.1, DOI 10.7249/CF380.1]; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Farhang S, 2014, SYNAPSE, V68, P387, DOI 10.1002/syn.21746; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Geyer M A, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0807s03; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hami J, 2014, CELL MOL NEUROBIOL, V34, P215, DOI 10.1007/s10571-013-0005-x; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Howell D. C., 2012, STAT METHODS PSYCHOL, V8 th; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hugdahl K, 2011, WIRES COGN SCI, V2, P461, DOI 10.1002/wcs.122; Iacono D, 2020, J NEUROPATH EXP NEUR, V79, P144, DOI 10.1093/jnen/nlz122; Jablonski SA, 2013, BEHAV BRAIN RES, V256, P140, DOI 10.1016/j.bbr.2013.07.055; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Laubach M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0315-18.2018; Liberzon I, 2016, NEURON, V92, P14, DOI 10.1016/j.neuron.2016.09.039; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Liu MD, 2014, CHIN J TRAUMATOL, V17, P317, DOI 10.3760/cma.j.issn.1008-1275.2014.06.003; Logsdon AF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66113-7; Logsdon AF, 2017, ARCH NEUROSCI, V4, DOI 10.5812/archneurosci.44254; Lopes S, 2016, P NATL ACAD SCI USA, V113, pE3755, DOI 10.1073/pnas.1600953113; Lucke-Wold BP, 2017, J NEUROTRAUM, V34, pS62, DOI 10.1089/neu.2016.4680; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Lucke-Wold BP, 2016, J NEUROSURG, V124, P687, DOI 10.3171/2015.3.JNS141802; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Morgan CA, 1996, AM J PSYCHIAT, V153, P64; Murphy EK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74296-2; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P631, DOI 10.1017/S1355617716000448; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0357-17.2018; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Perez-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep21275; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Sadeghi L, 2017, J PROTEOMICS, V154, P22, DOI 10.1016/j.jprot.2016.11.023; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Shi QX, 2020, BRAIN RES BULL, V157, P149, DOI 10.1016/j.brainresbull.2020.02.002; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Sims R, 2020, NAT NEUROSCI, V23, P311, DOI 10.1038/s41593-020-0599-5; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Strigo IA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.116; Sullivan RM, 2014, PROG NEURO-PSYCHOPH, V54, P59, DOI 10.1016/j.pnpbp.2014.05.002; Tashev R, 2015, ACTA NEUROBIOL EXP, V75, P48; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Thijssen EH, 2020, NAT MED, V26, P387, DOI 10.1038/s41591-020-0762-2; Tronson NC, 2012, TRENDS NEUROSCI, V35, P145, DOI 10.1016/j.tins.2011.10.003; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vieweg WVR, 2006, AM J MED, V119, P383, DOI 10.1016/j.amjmed.2005.09.027; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Winer JA, 2002, HEARING RES, V168, P181, DOI 10.1016/S0378-5955(02)00489-6; Yolken RH, 2014, P NATL ACAD SCI USA, V111, P16106, DOI 10.1073/pnas.1418895111; Yuan WH, 2019, J NEUROTRAUM, V36, P721, DOI 10.1089/neu.2018.5737; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012	109	1	1	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	MAR 1	2021	9	1							33	10.1186/s40478-021-01128-3			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QR7KF	WOS:000625393100002	33648608	gold, Green Published			2022-02-06	
J	Pirruccio, K; Parisien, RL; Olsen, C; Kelly, JD				Pirruccio, Kevin; Parisien, Robert L.; Olsen, Corey; Kelly, John D.			Wrestling-related concussions and closed head injuries predominantly occur in high school age athletes	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Wrestling; Sports; Epidemiology; Delayed diagnosis	STATES HIGH-SCHOOL; UNITED-STATES; EMERGENCY-DEPARTMENTS; EPIDEMIOLOGY; FOOTBALL; DISLOCATIONS; PLAYERS	BACKGROUND: Sports-related concussions (SRC) and closed head injuries (CHI) have recently garnered national attention given mounting concern for long-term neurological sequelae resulting from repetitive head trauma. Despite historically dangerous techniques in wrestling that involve impacts to the head, there is a paucity of epidemiologic data in regard to wrestling-related concussions (WRCs) in the United States (USA). METHODS: The National Electronic Injury Surveillance System (NEISS) database was queried (2000-2018) to report national estimates and demographic characteristics of patients 6-25 years of age presenting to US emergency departments (EDs) with WRCs and CHIs. RESULTS: The average annual number of patients presenting to US EDs with WRCs or CHIs was 3465 (95% confidence interval [CI]: 2489-4441). Over one-third of patients were between 15 (17.7%; 95% CI: 15.8%-49.7%) and 16 (17.0%; 95% CI: 14.9%-19.1%) years of age, which comprised the peak age groups during which such head injuries were sustained. The vast majority of patients were male (96.3%; 95% CI: 94.8%-97.7%). Lastly, 6.2% (95% CI: 4.3-8.2%) of patients did not present to the ED on the same day that the injury was sustained. CONCLUSIONS: Due to the unique nature and culture of the sport, wrestlers may be more likely to attribute SRC or CHI symptoms to normal training-related fatigue, which can lead to underreporting or delayed diagnosis. It is therefore imperative that appropriate safety initiatives and concussion awareness campaigns be implemented in youth wrestling to decrease the incidence of SRCs at local and national levels.	[Pirruccio, Kevin] Univ Penn, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA; [Parisien, Robert L.; Kelly, John D.] Univ Penn, Dept Orthoped Surg, Philadelphia, PA 19104 USA; [Olsen, Corey] Philadelphia Coll Osteopath Med, Philadelphia, PA USA		Pirruccio, K (corresponding author), Univ Penn, Perelman Sch Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	kevin.pirruccio@pennmedicine.upenn.edu					[Anonymous], 2014, CONC REC DIAGN AC MA; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Casson IR, 2019, J ALZHEIMERS DIS, V69, P935, DOI 10.3233/JAD-190115; Chaabene H, 2017, J STRENGTH COND RES, V31, P1411, DOI 10.1519/JSC.0000000000001738; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Ferry B, 2020, CONCUSSION; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hewett TE, 2005, MED SPORT SCI, V48, P152, DOI 10.1159/000084288; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kerr HA, 2013, CLIN SPORT MED, V32, P273, DOI 10.1016/j.csm.2012.12.008; Kroshus E, 2018, J ATHL TRAINING, V53, P1143, DOI 10.4085/1062-6050-154-17; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; May T, 2020, 2 IMPACT SYNDROME; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Misch MR, 2020, EMERG MED CLIN N AM, V38, P207, DOI 10.1016/j.emc.2019.09.010; Myers RJ, 2010, WEST J EMERG MED, V11, P442; NEISS, 2000, NAT EL JUR SURV SYST; Pappas E, 2007, J SPORT SCI MED, V6, P58; Pirruccio K, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119835894; Pirruccio K, 2019, JAMA SURG, V154, P458, DOI 10.1001/jamasurg.2019.0061; Schroeder T., NEISS SAMPLE DESIGN; SNOOK GA, 1980, AM J SPORT MED, V8, P450, DOI 10.1177/036354658000800616; StataCorp LP, 2018, STAT IC 15 1 WIND; Stoneback JW, 2012, J BONE JOINT SURG AM, V94A, P240, DOI 10.2106/JBJS.J.01663; Thomas RE, 2018, PHYSICIAN SPORTSMED, V46, P168, DOI 10.1080/00913847.2018.1445406; US Consumer Product Safety Commission, 2017, NAT EL INJ SURV SYST; VanItallie TB, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.07.007; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Zacchilli MA, 2010, J BONE JOINT SURG AM, V92A, P542, DOI 10.2106/JBJS.I.00450	35	1	1	1	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	MAR	2021	61	3					407	412		10.23736/S0022-4707.20.11194-0			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QR6CY	WOS:000625305500010	32880134				2022-02-06	
J	Rodriguez, A; Burgos-Florez, F; Posada, JD; Cervera, E; Zucolotto, V; Sanjuan, H; Sanjuan, M; Villalba, PJ				Rodriguez, Alexander; Burgos-Florez, Francisco; Posada, Jose D.; Cervera, Eliana; Zucolotto, Valtencir; Sanjuan, Homero; Sanjuan, Marco; Villalba, Pedro J.			Electrochemical Immunosensor for the Quantification of S100B at Clinically Relevant Levels Using a Cysteamine Modified Surface	SENSORS			English	Article						biosensor; gold electrodes; electrochemical impedance spectroscopy; brain injuries; S-100B; biomarker	TRAUMATIC BRAIN-INJURY; BIOMARKER; PROTEIN	Neuronal damage secondary to traumatic brain injury (TBI) is a rapidly evolving condition, which requires therapeutic decisions based on the timely identification of clinical deterioration. Changes in S100B biomarker levels are associated with TBI severity and patient outcome. The S100B quantification is often difficult since standard immunoassays are time-consuming, costly, and require extensive expertise. A zero-length cross-linking approach on a cysteamine self-assembled monolayer (SAM) was performed to immobilize anti-S100B monoclonal antibodies onto both planar (AuEs) and interdigitated (AuIDEs) gold electrodes via carbonyl-bond. Surface characterization was performed by atomic force microscopy (AFM) and specular-reflectance FTIR for each functionalization step. Biosensor response was studied using the change in charge-transfer resistance (Rct) from electrochemical impedance spectroscopy (EIS) in potassium ferrocyanide, with [S100B] ranging 10-1000 pg/mL. A single-frequency analysis for capacitances was also performed in AuIDEs. Full factorial designs were applied to assess biosensor sensitivity, specificity, and limit-of-detection (LOD). Higher Rct values were found with increased S100B concentration in both platforms. LODs were 18 pg/mL(AuES) and 6 pg/mL(AuIDEs). AuIDEs provide a simpler manufacturing protocol, with reduced fabrication time and possibly costs, simpler electrochemical response analysis, and could be used for single-frequency analysis for monitoring capacitance changes related to S100B levels.	[Rodriguez, Alexander; Burgos-Florez, Francisco; Cervera, Eliana; Sanjuan, Homero; Villalba, Pedro J.] Univ Norte, Biotechnol Res Grp, Barranquilla 081007, Colombia; [Burgos-Florez, Francisco; Sanjuan, Marco] Univ Norte, Rat Use Energy & Preservat Environm Grp UREMA, Barranquilla 081007, Colombia; [Posada, Jose D.] Stanford Univ, Sch Med, Redwood City, CA 94063 USA; [Zucolotto, Valtencir] Univ Sao Paulo, Sao Carlos Inst Phys, Gnano Nanomed & Nanotoxicol Grp, BR-13566590 Sao Carlos, SP, Brazil		Villalba, PJ (corresponding author), Univ Norte, Biotechnol Res Grp, Barranquilla 081007, Colombia.	alexandersanjuan@uninorte.edu.co; fjburgos@uninorte.edu.co; jdposada@stanford.edu; edcervera@uninorte.edu.co; zuco@ifsc.usp.br; hsanjuan@uninorte.edu.co; msanjuan@uninorte.edu.co; villalbap@uninorte.edu.co	Posada, Jose/AAB-5284-2022	Posada, Jose/0000-0003-3864-0241; Villalba, Pedro/0000-0003-3015-0299; Zucolotto, Valtencir/0000-0003-4307-3077; Rodriguez Sanjuan, Alexander/0000-0001-6424-7254	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias [757-2016]; Gobernacion del Atlantico; Universidad del Norte	This research was funded by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) grant number 757-2016 and by Gobernacion del Atlantico call number 809-2018. The APC was funded by Universidad del Norte.	Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Cardinell Brittney A., 2019, Critical Reviews in Biomedical Engineering, V47, P193, DOI 10.1615/CritRevBiomedEng.2019026108; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Ding S., 2018, THESIS; Ding SW, 2017, ACS SENSORS, V2, P210, DOI 10.1021/acssensors.6b00581; Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2; Harpaz Dorin, 2019, Sensors (Basel), V19, DOI 10.3390/s19112533; Hassanain WA, 2020, J ELECTROCHEM SOC, V167, DOI 10.1149/1945-7111/ab82fb; Khetani S, 2017, SENSOR ACTUAT B-CHEM, V247, P163, DOI 10.1016/j.snb.2017.02.169; Kim C, 2015, NANOSCALE, V7, P17820, DOI 10.1039/c5nr05608j; Kuo YC, 2018, BIOSENS BIOELECTRON, V103, P130, DOI 10.1016/j.bios.2017.11.065; Kurzatkowska K, 2016, J ELECTROANAL CHEM, V767, P76, DOI 10.1016/j.jelechem.2016.02.012; Lee HS, 2009, CURR APPL PHYS, V9, pE270, DOI 10.1016/j.cap.2009.07.003; Lian Y, 2015, BIOSENS BIOELECTRON, V65, P314, DOI 10.1016/j.bios.2014.10.017; Liu Y, 2013, ELECTROANAL, V25, P1050, DOI 10.1002/elan.201200525; Lo J, 2021, ARCH PHYS MED REHAB, V102, P115, DOI 10.1016/j.apmr.2020.04.001; Mathew AS, 2018, MOL DIAGN THER, V22, P729, DOI 10.1007/s40291-018-0365-5; Mikula E, 2014, SENSORS-BASEL, V14, P10650, DOI 10.3390/s140610650; Moscote-Salazar Luis Rafael, 2016, Bull Emerg Trauma, V4, P8; Mozafari J, 2020, ARCH ACAD EMERG MED, V8; Peterson AB, 2019, SURVEILLANCE REPORT; Rodriguez A., 2019, NEURONAL GLIAL BIOMA, P67; Rodriguez A., 2020, CRIT CARE EMERG SURG, V7, P106, DOI [10.5005/jp-journals-10030-1288, DOI 10.5005/JP-JOURNALS-10030-1288]; Rodríguez Alexander, 2020, Biomed., V40, P89, DOI 10.7705/biomedica.4786; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Shukri WNW, 2016, J NANOPHOTONICS, V10, DOI 10.1117/1.JNP.10.046007; Sidhu RK, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20205773; Stevic P., 2018, RCA 1 CLEANING STAND; Tabrizi MA, 2019, MICROCHIM ACTA, V186, DOI 10.1007/s00604-018-3159-x; Varshney M, 2009, BIOSENS BIOELECTRON, V24, P2951, DOI 10.1016/j.bios.2008.10.001; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wu L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64200-3	33	1	1	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	MAR	2021	21	6							1929	10.3390/s21061929			18	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Instruments & Instrumentation	SF4NJ	WOS:000652734300001	33801798	Green Published, gold			2022-02-06	
J	Rosker, ZM; Kristjansson, E; Vodicar, M; Rosker, J				Rosker, Ziva Majcen; Kristjansson, Eythor; Vodicar, Miha; Rosker, Jernej			Postural balance and oculomotor control are influenced by neck kinaesthetic functions in elite ice hockey players	GAIT & POSTURE			English	Article						Sports; Cervical spine; Postural adaptations; Vision; Biomechanics; Eye movement control	EYE; MUSCLES; HEAD; DISTURBANCES; TRUNK; SPINE; PAIN	Background: Research indicates that neck kinaesthetic awareness plays an important role in oculomotor and balance control, however the relationship has not been studied in athletes. As performance in ice hockey demands visual perception acuity during skating, while constantly shifting between unilateral and bilateral stances in sports specific posture more in-depth relationship should be studied. Research question: What is the relationship between neck kinaesthetic awareness, postural balance and eye movement control in professional ice hockey players and non-trained individuals? Methods: In this observational study, centre-of-pressure was measured using force plate in twenty-eight hockey players and thirty non-trained participants during different stances in eyes-opened and eyes-closed conditions. Butterfly test and Head-to-Neutral Relocation test were performed to assess neck kinaesthesia. Horizontal smooth pursuit eye movements were measured using video-oculography. Linear regression was used to determine the relationship between neck kinaesthesia, body sway and oculomotor control. Results: Time-on-target in Butterfly test was able to predict low to medium proportions of variance in amplitude and velocity parameters for single leg stances in hockey players (R2 = .220?.698). Head-to-Neutral Relocation test was able to predict low to medium proportion of variance in average eye movement velocity during first 100 milliseconds of smooth pursuit initiation for both groups (R2 = .262?.541). Significance: Findings from our study suggest that cervical spine afferent input plays an important role in maintaining unilateral postural balance in hockey players, with less evidence presented in controls. Sports specific posture or upper body loading could lead to adaptations in neck proprioception, not frequently considered when searching for balance related injury risk factors or performance deficits. Our study suggests, that in addition to balance control, neck kinaesthesia can also affect oculomotor performance which was present in both groups. This is especially evident when initiating changes in eye movement direction.	[Rosker, Ziva Majcen] Univ Ljubljana, Fac Sport, Gortanova 22, SI-1000 Ljubljana, Slovenia; [Kristjansson, Eythor] Univ Hosp, Landspitali, IS-101 Reykjavik, Iceland; [Vodicar, Miha] Univ Med Ctr Ljubljana, Dept Orthopaed Surg, Njegoseva 4, SI-1000 Ljubljana, Slovenia; [Rosker, Jernej] Univ Primorska, Fac Hlth Sci, Polje 42, SI-6310 Koper, Izola, Slovenia		Rosker, ZM (corresponding author), Zvezna Ulica 9, SI-3000 Celje, Slovenia.	ziva.majcen-rosker@fsp.uni-lj.si; eythork@simnet.is; miha.vodicar@kclj.si; jernej.rosker@fvz.upr.si		Majcen Rosker, Ziva/0000-0002-0442-0219			Bexander CSM, 2019, PM&R, V11, P944, DOI 10.1002/pmrj.12059; Bogduk N, 2000, CLIN BIOMECH, V15, P633, DOI 10.1016/S0268-0033(00)00034-6; Danna-Dos-Santos A, 2008, J MOTOR BEHAV, V40, P179, DOI 10.3200/JMBR.40.3.179-185; de Vries J, 2015, MANUAL THER, V20, P736, DOI 10.1016/j.math.2015.04.015; de Zoete RMJ, 2020, BRAZ J PHYS THER, V24, P69, DOI 10.1016/j.bjpt.2018.10.013; DUTIA MB, 1991, PROG NEUROBIOL, V37, P165, DOI 10.1016/0301-0082(91)90026-W; Fooken J, 2016, J VISION, V16, DOI 10.1167/16.14.1; Forbes PA, 2018, HAND CLINIC, V159, P61, DOI 10.1016/B978-0-444-63916-5.00004-5; Hlavenka TM, 2017, APPL ERGON, V62, P28, DOI 10.1016/j.apergo.2017.02.006; Janssen M, 2013, EUR J APPL PHYSIOL, V113, P3049, DOI 10.1007/s00421-013-2739-z; Janssen M, 2015, SPINE, V40, pE1052, DOI 10.1097/BRS.0000000000001016; Kristjansson E, 2010, SPINE, V35, pE1298, DOI 10.1097/BRS.0b013e3181e7fc0a; Lebeau JC, 2016, J SPORT EXERCISE PSY, V38, P441, DOI 10.1123/jsep.2015-0123; Liu JX, 2003, J HISTOCHEM CYTOCHEM, V51, P175, DOI 10.1177/002215540305100206; Liu LD, 2017, NEURON, V95, P436, DOI 10.1016/j.neuron.2017.06.024; Mcilreavy L, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.5.7; Morrison S, 2015, J NEUROPHYSIOL, V114, P1773, DOI 10.1152/jn.00059.2015; NODA T, 1993, ACTA OTO-LARYNGOL, P191; Ono S, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14187; Palidis DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172061; Peterka RJ, 2018, HAND CLINIC, V159, P27, DOI 10.1016/B978-0-444-63916-5.00002-1; Pettorossi VE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00895; Poltavski D, 2015, J SPORT SCI, V33, P597, DOI 10.1080/02640414.2014.951952; ROLL R, 1991, EXP BRAIN RES, V85, P423; Rosker J, 2011, GAIT POSTURE, V33, P452, DOI 10.1016/j.gaitpost.2010.12.023; Thomas NM, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00216; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Walsh M, 2018, GAIT POSTURE, V66, P278, DOI 10.1016/j.gaitpost.2018.09.009; Yard EE, 2006, J ATHL TRAINING, V41, P441	30	1	1	3	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	MAR	2021	85						145	150		10.1016/j.gaitpost.2021.01.024			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	RT5LO	WOS:000644501700021	33578306				2022-02-06	
J	Shavit-Stein, E; Gerasimov, A; Aharoni, S; Gofrit, SG; Pikus, E; Pick, CG; Maggio, N				Shavit-Stein, Efrat; Gerasimov, Alexandra; Aharoni, Shay; Gofrit, Shany G.; Pikus, Ellen; Pick, Chaim G.; Maggio, Nicola			Unexpected role of stress as a possible resilience mechanism upon mild traumatic brain injury (mTBI) in mice	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Stress; Head trauma; Cognitive; Behavior; NMDA; GABA		Introduction: Mild traumatic brain injury (mTBI) is common and associated with cognitive impairment. Stress and mTBI are known to modulate the neural function. The present study aims at exploring the effect of prior stress exposure on cognitive function following mTBI. Methods: Eight weeks old male ICR mice were subjected to either stress induced by forced swimming stress alone, stress followed by an immediate mTBI, or stress followed by 30 min break and then mTBI. We had two control groups: SHAM group a control group which was not exposed to stress nor to mTBI and control mTBI group a control group which was exposed only to TBI with no stress. Mice were weighed prior and at 12, 24 h and 1 week following interventions. Motor evaluation was conducted by rotarod. Behavioral changes were evaluated using open field, Y maze, elevated plus maze and staircase tests, at 12 h and 1 week following interventions. Brain levels of NMDAR subunits (R1, R2A, R2B), GABA(B)R1, glucocorticoid and mineralocorticoid receptors (GR, MR) were evaluated using western blot. Results: Stress alone, mTBI alone, and stress followed by immediate mTBI resulted in a significant weight loss compared to control (p < 0.05). Stress 30 min prior to mTBI had a protective effect on weight (p = 0.14 compared to control). The stress and mTBI alone groups showed reduced time at the center of the open field arena 1 week after intervention (p < 0.05 for both). Time in the novel arm of the Y maze was significantly shorter in the mTBI and stress followed by delayed mTBI (p = 0.02). Immediate stress prior to mTBI had normalized times in the novel arm (p = 0.95 compared to control). Combination of stress and mTBI significantly modified NMDAR subunits levels (increased NMDAR1, p < 0.008, decreased NMDAR2Ap = 0.02) as well as increased MR levels (p = 0.04). Conclusion: Exposure to stress prior to mTBI may improve the cognitive consequences of mTBI. These data may point towards a novel, unexpected role of stress as a possible resilience mechanism in the setting of mTBI.	[Shavit-Stein, Efrat; Maggio, Nicola] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-6997801 Tel Aviv, Israel; [Shavit-Stein, Efrat; Gerasimov, Alexandra; Aharoni, Shay; Gofrit, Shany G.; Pikus, Ellen; Maggio, Nicola] Chaim Sheba Med Ctr, Dept Neurol, IL-5266202 Ramat Gan, Israel; [Pikus, Ellen] Tel Aviv Univ, Sackler Sch Med NY State, Amer Program, IL-6997801 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-6997801 Tel Aviv, Israel; [Pick, Chaim G.; Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, IL-6997801 Tel Aviv, Israel; [Maggio, Nicola] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52626202 Ramat Gan, Israel		Shavit-Stein, E; Maggio, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-6997801 Tel Aviv, Israel.	efrat.shavitstein@sheba.health.gov.il; Nicola.maggio@sheba.health.gov.il					Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Barnett S.A, 2007, RAT STUDY BEHAV, DOI [10.1002/1098-2337(1976)2:23.0.co;2-m, DOI 10.1002/1098-2337(1976)2:23.0.CO;2-M]; Ben Shimon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188524; Carvajal FJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2701526; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hashikawa-Hobara N, 2015, SCI REP-UK, V5, DOI 10.1038/srep12559; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Joels M, 2009, NAT REV NEUROSCI, V10, P459, DOI 10.1038/nrn2632; Kelly JP, 1997, NEUROLOGY, V48, P581; Lesniak A, 2016, NEUROPHARMACOLOGY, V101, P506, DOI 10.1016/j.neuropharm.2015.10.014; Maggio N, 2012, FRONT CELL NEUROSCI, V6, P1, DOI 10.3389/fncel.2012.00012; Maggio N, 2011, BIOL PSYCHIAT, V69, P748, DOI 10.1016/j.biopsych.2010.11.026; Maggio N, 2010, THESCIENTIFICWORLDJO, V10, P462, DOI 10.1100/tsw.2010.48; Maggio N, 2009, J NEUROSCI, V29, P8633, DOI 10.1523/JNEUROSCI.1901-09.2009; Nasca C, 2015, P NATL ACAD SCI USA, V112, P14960, DOI 10.1073/pnas.1516016112; Ohman L, 2007, SCAND J WORK ENV HEA, V33, P223; OLeary O.F., 2020, STRESS RESILIENCE, DOI [10.1016/C2016-0-03233-3, DOI 10.1016/C2016-0-03233-3]; Pacheco A, 2017, FRONT MOL NEUROSCI, V10, P1, DOI 10.3389/fnmol.2017.00244; Pan K., 2017, INNOV AGING, V1, P432, DOI [10.1093/geroni/igx004.1552, DOI 10.1093/GERONI/IGX004.1552]; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Segal M, 2010, HIPPOCAMPUS, V20, P1332, DOI 10.1002/hipo.20751; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Stein ES, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00299; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Vartanian O, 2017, MIL PSYCHOL, V29, P345, DOI 10.1037/mil0000159; Vos P.E., Eur. J. Neurol., V9, P207; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weiss R, 2016, J AUTOIMMUN, V73, P92, DOI 10.1016/j.jaut.2016.06.011; Weizman R, 1999, BRAIN RES, V839, P58, DOI 10.1016/S0006-8993(99)01664-9; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	40	1	1	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAR	2021	111								103586	10.1016/j.mcn.2020.103586			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QR1IN	WOS:000624970500005	33358995	hybrid			2022-02-06	
J	Shen, SC; Zhang, M; Ma, M; Rasam, S; Poulsen, D; Qu, J				Shen, Shichen; Zhang, Ming; Ma, Min; Rasam, Sailee; Poulsen, David; Qu, Jun			Potential Neuroprotective Mechanisms of Methamphetamine Treatment in Traumatic Brain Injury Defined by Large-Scale IonStar-Based Quantitative Proteomics	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; methamphetamine; large-scale proteomics; mass spectrometry; IonStar		Although traumatic brain injury (TBI) causes hospitalizations and mortality worldwide, there are no approved neuroprotective treatments, partly due to a poor understanding of the molecular mechanisms underlying TBI neuropathology and neuroprotection. We previously reported that the administration of low-dose methamphetamine (MA) induced significant functional/cognitive improvements following severe TBI in rats. We further demonstrated that MA mediates neuroprotection in part, via dopamine-dependent activation of the PI3K-AKT pathway. Here, we further investigated the proteomic changes within the rat cortex and hippocampus following mild TBI (TM), severe TBI (TS), or severe TBI plus MA treatment (TSm) compared to sham operated controls. We identified 402 and 801 altered proteins (APs) with high confidence in cortical and hippocampal tissues, respectively. The overall profile of APs observed in TSm rats more closely resembled those seen in TM rather than TS rats. Pathway analysis suggested beneficial roles for acute signaling through IL-6, TGF beta, and IL-1 beta. Moreover, changes in fibrinogen levels observed in TSm rats suggested a potential role for these proteins in reducing/preventing TBI-induced coagulopathies. These data facilitate further investigations to identify specific pathways and proteins that may serve as key targets for the development of neuroprotective therapies.	[Shen, Shichen; Zhang, Ming; Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14214 USA; [Shen, Shichen; Zhang, Ming; Ma, Min; Rasam, Sailee; Qu, Jun] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA; [Ma, Min] Roswell Park Comprehens Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14203 USA; [Rasam, Sailee] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Biochem, Buffalo, NY 14203 USA; [Poulsen, David] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosurg, Buffalo, NY 14203 USA		Qu, J (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14214 USA.; Qu, J (corresponding author), New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA.; Poulsen, D (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurosurg, Buffalo, NY 14203 USA.	ShichenS@buffalo.edu; MZhang25@buffalo.edu; MinMa@buffalo.edu; SaileeSu@buffalo.edu; DavidPou@buffalo.edu; JunQu@buffalo.edu		Ma, Min/0000-0002-4203-5215; Poulsen, David/0000-0002-7793-2813	NeuroTrauma Sciences [1149921/1/82786]	This research was funded by NeuroTrauma Sciences, grant number 1149921/1/82786.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; [Anonymous], 2015, C TRAUM BRAIN INJ US; Bai W, 2018, BIOCHEM BIOPH RES CO, V498, P795, DOI 10.1016/j.bbrc.2018.03.060; Ding GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061241; Divolis G, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz028; Fang XX, 2013, CELL MOL NEUROBIOL, V33, P241, DOI 10.1007/s10571-012-9891-6; Griffiths DR, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1767; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00198; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Liu Z, 2011, NEUROTOX RES, V19, P484, DOI 10.1007/s12640-010-9215-x; Mallah K, 2019, MOL CELL PROTEOMICS, V18, P1669, DOI 10.1074/mcp.RA119.001604; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Ning C, 2014, FASEB J, V28, P2725, DOI 10.1096/fj.13-247833; Pascovici D, 2016, PROTEOMICS, V16, P2448, DOI 10.1002/pmic.201600044; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rau TF, 2014, EXP NEUROL, V253, P31, DOI 10.1016/j.expneurol.2013.12.001; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Sadygov RG, 2006, ANAL CHEM, V78, P8207, DOI 10.1021/ac060923y; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Shen SC, 2018, ANAL CHEM, V90, P10350, DOI 10.1021/acs.analchem.8b02172; Shen SC, 2018, EXPERT REV PROTEOMIC, V15, P541, DOI 10.1080/14789450.2018.1490646; Shen XM, 2018, P NATL ACAD SCI USA, V115, pE4767, DOI 10.1073/pnas.1800541115; Shen XM, 2017, J PROTEOME RES, V16, P2445, DOI 10.1021/acs.jproteome.7b00061; Shen XM, 2015, J PROTEOME RES, V14, P4147, DOI 10.1021/acs.jproteome.5b00200; Song C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-59; Song H, 2018, J PROTEOME RES, V17, P858, DOI 10.1021/acs.jproteome.7b00618; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Toffolo K, 2019, NEUROPHARMACOLOGY, V145, P199, DOI 10.1016/j.neuropharm.2018.08.028; Wang XQ, 2009, NEUROSCI LETT, V450, P122, DOI 10.1016/j.neulet.2008.11.051; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Wohlgehagen E., 2015, MOD RES INFLAMM, V4, P9, DOI DOI 10.4236/MRI.2015.42002; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhao ZA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.98	41	1	1	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	MAR	2021	22	5							2246	10.3390/ijms22052246			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	QV9PB	WOS:000628293000001	33668155	gold, Green Published			2022-02-06	
J	Silverberg, ND; Otamendi, T; Panenka, WJ; Archambault, P; Babul, S; MacLellan, A; Li, LDC				Silverberg, Noah D.; Otamendi, Thalia; Panenka, William J.; Archambault, Patrick; Babul, Shelina; MacLellan, Anna; Li, Linda C.		Canadian TBI Res Consortium	De-implementing Prolonged Rest Advice for Concussion in Primary Care Settings: A Pilot Stepped Wedge Cluster Randomized Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain concussion; brain injuries; implementation science; practice guideline; primary healthcare; rest		Objective: To evaluate the feasibility and preliminary efficacy of a de-implementation intervention to support return-to-activity guideline use after concussion. Setting: Community. Participants: Family physicians in community practice (n = 21 at 5 clinics). Design: Pilot stepped wedge cluster randomized trial with qualitative interviews. Training on new guidelines for return to activity after concussion was provided in education outreach visits. Main Measures: The primary feasibility outcomes were recruitment, retention, and postencounter form completion (physicians prospectively recorded what they did for each new patient with concussion). Efficacy indicators included a knowledge test and guideline compliance based on postencounter form data. Qualitative interviews covered Theoretical Domains Framework elements. Results: Recruitment, retention, and postencounter form completion rates all fell below feasibility benchmarks. Family physicians demonstrated increased knowledge about the return-to-activity guideline (M = 8.8 true-false items correct out of 10 after vs 6.3 before) and improved guideline adherence (86% after vs 25% before) after the training. Qualitative interviews revealed important barriers (eg, beliefs about contraindications) and facilitators (eg, patient handouts) to behavior change. Conclusions: Education outreach visits might facilitate de-implementation of prolonged rest advice after concussion, but methodological changes will be necessary to improve the feasibility of a larger trial. The qualitative findings highlight opportunities for refining the intervention.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Otamendi, Thalia] Univ British Columbia, Rehabil Sci, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Babul, Shelina] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Li, Linda C.] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Silverberg, Noah D.; MacLellan, Anna] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Panenka, William J.] BC Mental Hlth & Subst Use Serv Res Inst, Vancouver, BC, Canada; [Panenka, William J.] British Columbia Prov Neuropsychiat Program, Vancouver, BC, Canada; [Archambault, Patrick] Univ Laval, Dept Family Med & Emergency Med, Quebec City, PQ, Canada; [Archambault, Patrick] Ctr Integre Sante & Serv Sociaux Chaudiere Appala, Ste Marie, ON, Canada; [Archambault, Patrick] Ctr Rech Integree Syst Apprenant Sante & Serv Soc, Levis, PQ, Canada; [Archambault, Patrick] Univ Laval, Ctr Rech Soins & Serv Premiere Ligne, Quebec City, PQ, Canada; [Archambault, Patrick] Univ Laval, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [Babul, Shelina] BC Childrens Hosp, Injury Res & Prevent Unit, Vancouver, BC, Canada; [Li, Linda C.] Arthrit Res Canada, Richmond, BC, Canada		Silverberg, ND (corresponding author), GF Strong Rehabil Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca; totamendi@gmail.com; willpanenka@gmail.com; patrick.m.archambault@gmail.com; sbabul@bcchr.ca; maclellananna@outlook.com; lli@arthritisresearch.ca	Li, Linda C./P-8485-2015	Li, Linda C./0000-0001-6280-0511; Panenka, William/0000-0001-7143-6512; Babul, Shelina/0000-0002-0227-2574	Vancouver Coastal Health Research Institute through an Innovation and Translational Research Grant; CIHR Embedded Clinician Scientist AwardCanadian Institutes of Health Research (CIHR) [370937]	The Vancouver Coastal Health Research Institute provided funding for this study through an Innovation and Translational Research Grant. Dr Noah Silverberg received research salary support from the Vancouver Coastal Health Research Institute and Michael Smith Foundation for Health Research. Dr Patrick Archambault has received a CIHR Embedded Clinician Scientist Award (#370937).	ANDREASSEN J, 1957, ACTA MED SCAND, V158, P239; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BIRKIMER JC, 1979, J APPL BEHAV ANAL, V12, P535, DOI 10.1901/jaba.1979.12-535; Brownson RC, 2018, J PUBLIC HEALTH MAN, V24, P102, DOI 10.1097/PHH.0000000000000673; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Craton N, 2014, CURR SPORT MED REP, V13, P201, DOI 10.1249/JSR.0000000000000072; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Gagliardi AR, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007047; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kovacs E, 2018, J GEN INTERN MED, V33, P1142, DOI 10.1007/s11606-018-4435-5; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Mold James W, 2005, Ann Fam Med, V3 Suppl 1, pS12, DOI 10.1370/afm.303; Ontario Neurotrauma Foundation, 2013, GUID CONC TRAUM BRAI; Prasad V, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-1; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-139; Rao DP, 2018, HEALTH PROMOT CHRON, V38, P147, DOI 10.24095/hpcdp.38.3.05; Roman BR, 2014, ANN INTERN MED, V161, P149, DOI 10.7326/M14-0212; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Silverberg ND., 2017, SPORT CONCUSSION COM; Silverberg ND, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00362; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Ubel PA, 2015, HEALTH AFFAIR, V34, P239, DOI 10.1377/hlthaff.2014.0983; Young HML, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193756	44	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		79	86		10.1097/HTR.0000000000000609			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100003	32898029				2022-02-06	
J	Simpson, TS; Peterson, RL; Patrick, KE; Forster, JE; McNally, KA				Simpson, Tess S.; Peterson, Robin L.; Patrick, Kristina E.; Forster, Jeri E.; McNally, Kelly A.			Concussion Symptom Treatment and Education Program: A Feasibility Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; intervention; pediatric; rehabilitation; traumatic brain injury		Objective: To evaluate the feasibility and potential benefits of a manualized, brief cognitive-behavioral therapy-based intervention program for children and adolescents with persistent postconcussive symptoms. Setting: Two outpatient pediatric concussion programs in the United States. Participants: Patients aged 8 to 17 years who sustained concussions between 2 and 12 months prior to enrollment. Design: Pre-/postretrospective study. Main Measures: SCAT-3; HBI; PedsQL 4.0 Generic Core Scales; and RCADS. Results: Thirty children and adolescents completed the treatment program. Self- and parent-reported postconcussive symptoms, quality of life, and internalizing symptoms significantly improved with treatment. Mixed-effects models revealed a significant decline in self-reported postconcussive symptoms across treatment sessions, a = -2.07, SE = 0.25, P < .001. The largest change occurred between sessions 2 and 3, following the session focusing on concussion psychoeducation and sleep hygiene (estimated mean change between sessions 2 and 3 = -4.72, P < .0001). Conclusions: Our findings indicate that a 6-session manualized cognitive behavioral intervention is feasible to initiate in an outpatient clinic 1 to 12 months following a pediatric mild traumatic brain injury. With a manualized format, clinicians at most levels of training should be able to implement this treatment manual and flexibly adapt as needed when working with children and adolescents who are experiencing delayed symptom recovery following concussion.	[Simpson, Tess S.; Peterson, Robin L.; Forster, Jeri E.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Simpson, Tess S.; Peterson, Robin L.; Forster, Jeri E.] Childrens Hosp Colorado, Aurora, CO USA; [Patrick, Kristina E.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA USA; [Patrick, Kristina E.] Seattle Childrens Hosp, Seattle, WA USA; [Forster, Jeri E.] Rocky Mt Reg Vet Affairs VA Med Facil, Rocky Mt Mental Illness Res Educ & Clin Ctr Vet S, Aurora, CO USA; [McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [McNally, Kelly A.] Nationwide Childrens Hosp, Columbus, OH USA		Simpson, TS (corresponding author), Childrens Hosp Colorado, Dept Phys Med & Rehabil, 13123 E 16th Ave, Aurora, CO 80045 USA.	tess.simpson@childrenscolorado.org; robin.peterson@childrenscolorado.org; kristina.e.patrick@gmail.com; JERI.FORSTER@CUANSCHUTZ.EDU; kelly.mcnally@nationwidechildrens.org					Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McNally KA, 2018, CHILD NEUROPSYCHOL, V24, P396, DOI 10.1080/09297049.2017.1280143; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Palermo TM., 2015, COGNITIVE BEHAV THER, V5th ed.; Peterson RL, 2015, J NEUROPSYCH CLIN N, V27, P280, DOI 10.1176/appi.neuropsych.14120373; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Scheenen ME, 2017, J NEUROTRAUM, V34, P2713, DOI 10.1089/neu.2016.4885; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Simpson TS., 2017, CLIN PRACT PEDIAT PS, V5, P248; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tomfohr-Madsen L, 2020, J HEAD TRAUMA REHAB, V35, pE103, DOI 10.1097/HTR.0000000000000504; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	41	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		E79	E88		10.1097/HTR.0000000000000592			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100002	32769833				2022-02-06	
J	Smith, DH; Dolle, JP; Ameen-Ali, KE; Bretzin, A; Cortes, E; Crary, JF; Dams-O'Connor, K; Diaz-Arrastia, R; Edlow, BL; Folkerth, R; Hazrati, LN; Hinds, SR; Iacono, D; Johnson, VE; Keene, CD; Kofler, J; Kovacs, GG; Lee, EB; Manley, G; Meaney, D; Montine, T; Okonkwo, DO; Perl, DP; Trojanowski, JQ; Wiebe, DJ; Yaffe, K; McCabe, T; Stewart, W				Smith, Douglas H.; Dolle, Jean-Pierre; Ameen-Ali, Kamar E.; Bretzin, Abigail; Cortes, Etty; Crary, John F.; Dams-O'Connor, Kristen; Diaz-Arrastia, Ramon; Edlow, Brian L.; Folkerth, Rebecca; Hazrati, Lili-Naz; Hinds, Sidney R.; Iacono, Diego; Johnson, Victoria E.; Keene, C. Dirk; Kofler, Julia; Kovacs, Gabor G.; Lee, Edward B.; Manley, Geoffrey; Meaney, David; Montine, Thomas; Okonkwo, David O.; Perl, Daniel P.; Trojanowski, John Q.; Wiebe, Douglas J.; Yaffe, Kristine; McCabe, Thomas; Stewart, William			COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI)	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Traumatic brain injury; Chronic traumatic encephalopathy; Neurodegenerative disease; Dementia; Concussion		Efforts to characterize the late effects of traumatic brain injury (TBI) have been in progress for some time. In recent years much of this activity has been directed towards reporting of chronic traumatic encephalopathy (CTE) in former contact sports athletes and others exposed to repetitive head impacts. However, the association between TBI and dementia risk has long been acknowledged outside of contact sports. Further, growing experience suggests a complex of neurodegenerative pathologies in those surviving TBI, which extends beyond CTE. Nevertheless, despite extensive research, we have scant knowledge of the mechanisms underlying TBI-related neurodegeneration (TReND) and its link to dementia. In part, this is due to the limited number of human brain samples linked to robust demographic and clinical information available for research. Here we detail a National Institutes for Neurological Disease and Stroke Center Without Walls project, the COllaborative Neuropathology NEtwork Characterizing ouTcomes of TBI (CONNECT-TBI), designed to address current limitations in tissue and research access and to advance understanding of the neuropathologies of TReND. As an international, multidisciplinary collaboration CONNECT-TBI brings together multiple experts across 13 institutions. In so doing, CONNECT-TBI unites the existing, comprehensive clinical and neuropathological datasets of multiple established research brain archives in TBI, with survivals ranging minutes to many decades and spanning diverse injury exposures. These existing tissue specimens will be supplemented by prospective brain banking and contribute to a centralized route of access to human tissue for research for investigators. Importantly, each new case will be subject to consensus neuropathology review by the CONNECT-TBI Expert Pathology Group. Herein we set out the CONNECT-TBI program structure and aims and, by way of an illustrative case, the approach to consensus evaluation of new case donations.	[Smith, Douglas H.; Dolle, Jean-Pierre; Johnson, Victoria E.] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ameen-Ali, Kamar E.; Stewart, William] Univ Glasgow, Queen Elizabeth Univ Hosp, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Bretzin, Abigail; Wiebe, Douglas J.] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cortes, Etty] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Cortes, Etty; Crary, John F.] Icahn Sch Med, Neuropathol Brain Bank & Res Core, Ronald M Loeb Ctr Alzheimers Dis, Dept Pathol, New York, NY USA; [Cortes, Etty; Crary, John F.] Icahn Sch Med, Neuropathol Brain Bank & Res Core, Ronald M Loeb Ctr Alzheimers Dis, Dept Neurosci, New York, NY USA; [Cortes, Etty; Crary, John F.] Icahn Sch Med Mt Sinai, Dept Pathol, Fishberg Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, 175 Cambridge St Suite 300, Boston, MA 02114 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Edlow, Brian L.] Harvard Med Sch, Charlestown, MA USA; [Folkerth, Rebecca] NYU, Sch Med, Dept Forens Med, New York, NY USA; [Hazrati, Lili-Naz] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Hazrati, Lili-Naz] Hosp Sick Children, Dept Pathol, Toronto, ON, Canada; [Hazrati, Lili-Naz] Canadian Concuss Ctr, Toronto, ON, Canada; [Hinds, Sidney R.] Uniformed Serv Univ USU, Brain Tissue Repository & Neuropathol Core, Ctr Neurosci & Regenerat Med CNRM, Bethesda, MD USA; [Hinds, Sidney R.] Chron Effects NeuroTrauma Consortium CENC, Ft Detrick, MD USA; [Iacono, Diego] Henry M Jackson Fdn Adv Mil Med HJF, Bethesda, MD USA; [Keene, C. Dirk] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Kofler, Julia] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Kovacs, Gabor G.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis CRND, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON, Canada; [Kovacs, Gabor G.] Univ Toronto, Dept Lab Med & Pathobiol, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON, Canada; [Kovacs, Gabor G.] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Kovacs, Gabor G.] Univ Hlth Network, Krembil Brain Inst, Toronto, ON, Canada; [Lee, Edward B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Manley, Geoffrey] Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,Rm M779, San Francisco, CA 94143 USA; [Manley, Geoffrey] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Rm 101, San Francisco, CA USA; [Meaney, David] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Montine, Thomas] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Perl, Daniel P.] Uniformed Serv Univ USU, DoD USU Brain Tissue Repository & Neuropathol Cor, F Edward Hebert Sch Med, Bethesda, MD USA; [Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol Epidemiol & Biostat, San Francisco, CA 94143 USA; [McCabe, Thomas] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland; [Stewart, William] Queen Elizabeth Univ Hosp, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Queen, Scotland		Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA.; Stewart, W (corresponding author), Univ Glasgow, Queen Elizabeth Univ Hosp, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	smithdou@pennmedicine.upenn.edu; william.stewart@glasgow.ac.uk	Ameen-Ali, Kamar/AAU-1781-2021; Lee, Edward/AAU-8436-2021; Kovacs, Gabor G./A-7468-2013	Ameen-Ali, Kamar/0000-0002-7583-4099; Bretzin, Abigail/0000-0003-3730-2849; Kovacs, Gabor G./0000-0003-3841-5511; Stewart, William/0000-0003-2199-2582	U.S. National Institutes of Health, National Institute of Neurologic Disorders and Stroke [NS115322]	Funding provided to the CWOW CONNECT-TBI group was from the U.S. National Institutes of Health, National Institute of Neurologic Disorders and Stroke (Grant #NS115322: D.H.S, W.S). The opinions or assertions contained here are the private views of the authors and are not to be construed as official or as reflecting the views of any sponsor.	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; KUKULL WA, 1990, NEUROLOGY, V40, P1364, DOI 10.1212/WNL.40.9.1364; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; Nelson PT, 2019, BRAIN, V142, P1503, DOI 10.1093/brain/awz099; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; Skrobot OA, 2016, BRAIN, V139, P2957, DOI 10.1093/brain/aww214; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Tribett T, 2019, J FORENSIC SCI, V64, P1248, DOI 10.1111/1556-4029.14001; Walhovd KB, 2010, NEUROBIOL AGING, V31, P1107, DOI 10.1016/j.neurobiolaging.2008.08.013; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	30	1	1	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	MAR 1	2021	9	1							32	10.1186/s40478-021-01122-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QR7KF	WOS:000625393100001	33648593	Green Accepted, gold, Green Published			2022-02-06	
J	Spiteri, C; Ponsford, J; Williams, G; Kahn, M; McKay, A				Spiteri, Courtney; Ponsford, Jennie; Williams, Gavin; Kahn, Michelle; McKay, Adam			Factors Affecting Participation in Physical Therapy During Posttraumatic Amnesia	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Fatigue; Pain; Rehabilitation	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; AGITATED BEHAVIOR; INPATIENT REHABILITATION; PATIENT; SCALE; RELIABILITY; OUTCOMES; DISTURBANCES; ENGAGEMENT	Objectives: To examine the effect of agitation, cognitive impairment, fatigue, and pain on physical therapy participation and outcomes during posttraumatic amnesia (PTA) after traumatic brain injury (TBI). Design: Prospective longitudinal study. Setting: Inpatient rehabilitation hospital. Participants: Participants (N= 77) with moderate-to-severe TBI who were deemed to be experiencing PTA using the Westmead Post-Traumatic Amnesia Scale. Interventions: Not applicable. Main Outcome Measures: The Pittsburgh Rehabilitation Participation Scale and time in therapy (min) were recorded twice daily after routine physical therapy sessions during PTA. The FIM-motor (select items related to physical therapy) score rated on admission and after emergence from PTA was used to calculate FIM-motor change. Results: Agitation was associated with lower participation in therapy. The presence of agitation and pain both predicted lower FIM-motor change at emergence from PTA. Higher levels of cognitive impairment and fatigue were also associated with lower participation and less time in therapy. Conclusions: The presence of agitation, fatigue, pain, and cognitive impairment impede rehabilitation success during PTA. This study strengthens the case for implementing environmental and behavioral recommendations, such as conducting therapy earlier in the day within a familiar space (ie, on the ward) and tailoring session duration to patient needs. This is with the aim of minimizing fatigue, agitation, and pain, while promoting cognitive recovery and arousal during PTA to maximize physical gains. Further research is warranted to examine the factors associated with rehabilitation success across other therapeutic disciplines. (C) 2020 by the American Congress of Rehabilitation Medicine	[Spiteri, Courtney; Ponsford, Jennie; McKay, Adam] Monash Univ, Turner Inst Brain & Mental Hlth, Clayton, Vic, Australia; [Spiteri, Courtney; Ponsford, Jennie; McKay, Adam] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Williams, Gavin; Kahn, Michelle] Epworth Healthcare, Richmond, Vic, Australia		Spiteri, C (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	Courtney.baxter@monash.edu			Monash University as part of the Doctorate of Psychology (Clinical Neuropsychology)	Supported by the Monash University as part of the Doctorate of Psychology (Clinical Neuropsychology) Research funding.	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Buffum MD, 2001, GERIATR NURS, V22, P80, DOI 10.1067/mgn.2001.115196; Christensen AL, 1998, J HEAD TRAUMA REHAB, V13, P79, DOI 10.1097/00001199-199810000-00009; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Joe GW, 2002, J SUBST ABUSE TREAT, V22, P183, DOI 10.1016/S0740-5472(02)00232-5; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Maclean N, 2000, SOC SCI MED, V50, P495; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McKay A, 2020, NEUROPSYCHOL REHABIL, V30, P579, DOI 10.1080/09602011.2018.1479276; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Montgomery P, 1997, Rehabil Nurs, V22, P20; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Raina KD, 2016, J HEAD TRAUMA REHAB, V31, pE41, DOI 10.1097/HTR.0000000000000196; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Symonds CP, 1943, LANCET, V1, P7; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2019, NEUROPSYCHOL REHABIL, V29, P1655, DOI 10.1080/09602011.2018.1441033; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Zachrisson O, 2002, J PSYCHOSOM RES, V52, P501, DOI 10.1016/S0022-3999(01)00315-4; Zieber CG, 2005, INT J PALLIAT NURS, V11, P71, DOI 10.12968/ijpn.2005.11.2.17673	56	1	1	2	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2021	102	3					378	385		10.1016/j.apmr.2020.06.024			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	RC1JV	WOS:000632559000005	32745545				2022-02-06	
J	Strack, JE; Torres, VA; Pennington, ML; Cardenas, MN; Dupree, J; Meyer, EC; Dolan, S; Kruse, MI; Synett, SJ; Kimbrel, NA; Gulliver, SB				Strack, J. E.; Torres, V. A.; Pennington, M. L.; Cardenas, M. N.; Dupree, J.; Meyer, E. C.; Dolan, S.; Kruse, M., I; Synett, S. J.; Kimbrel, N. A.; Gulliver, S. B.			Psychological distress and line-of-duty head injuries in firefighters	OCCUPATIONAL MEDICINE-OXFORD			English	Article						Depression; firefighter; head injury; post-traumatic stress disorder	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; BECK-DEPRESSION-INVENTORY; TBI IDENTIFICATION METHOD; MAJOR DEPRESSION; SYMPTOMS; PTSD; RISK; RELIABILITY; VETERANS	Background Head injuries are common injury in the fire service; however, very little data exist on the risks this may pose to the development of post-traumatic stress disorder (PTSD) and depression in this high-risk population. Aims Our study aimed to compare levels of PTSD and depression symptoms in firefighters with a line-of-duty head injury, non-line-of-duty head injury and no head injury. Methods In this cross-sectional study, we assessed current PTSD and depression symptoms as well as retrospective head injuries. Results Seventy-six per cent of the total sample reported at least one head injury in their lifetime. Depression symptoms were significantly more severe among firefighters with a line-of-duty head injury compared to those with no head injury, but not compared to those who sustained a non-line-of-duty head injury. Depression symptoms did not differ between firefighters with a non-line-of-duty head injury and those with no head injury. PTSD symptoms were significantly more severe among firefighters with a line-of-duty head injury compared to both firefighters with no head injury and those with a non-line-of-duty head injury. Conclusions We found that firefighters who reported at least one line-of-duty head injury had significantly higher levels of PTSD and depression symptoms than firefighters who reported no head injuries. Our findings also suggest head injuries sustained outside of fire service could have less of an impact on the firefighter's PTSD symptom severity than head injuries that occur as a direct result of their job.	[Strack, J. E.; Pennington, M. L.; Cardenas, M. N.; Dupree, J.; Meyer, E. C.; Gulliver, S. B.] Baylor Scott & White Hlth, Warriors Res Inst, 2201 MacArthur Dr,Suite 2200, Waco, TX 76708 USA; [Torres, V. A.] Univ Mississippi, University Pk, MS 38677 USA; [Meyer, E. C.; Gulliver, S. B.] Texas A&M Univ, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Temple, TX 76508 USA; [Meyer, E. C.; Dolan, S.] Baylor Univ, Dept Psychol & Neurosci, Waco, TX 76706 USA; [Kruse, M., I] Austin Fire Dept, Austin, TX 78702 USA; [Kruse, M., I] Austin Travis Cty Emergency Med Serv, Austin, TX 78702 USA; [Synett, S. J.] US Dept Vet Affairs, Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO 80045 USA; [Kimbrel, N. A.] Durham Vet Affairs Med Ctr, Durham, NC 27705 USA; [Kimbrel, N. A.] VA Midatlant Mental Illness Res Educ & Clin Ctr, Durham, NC 27707 USA; [Kimbrel, N. A.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27701 USA		Strack, JE (corresponding author), Baylor Scott & White Hlth, Warriors Res Inst, 2201 MacArthur Dr,Suite 2200, Waco, TX 76708 USA.	jordanerstrack@gmail.com			Research Mentorship Award (RMA) grant from Baylor Scott White [150278]	This research was supported by a Research Mentorship Award (RMA) grant from Baylor Scott & White (150278) and approved by the Institutional Review Boards for the Protection of Human Research Subjects at Baylor Scott & White.	Beck AT, 1997, BEHAV RES THER, V35, P785, DOI 10.1016/S0005-7967(97)00025-9; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Chen YS, 2007, QUAL LIFE RES, V16, P1289, DOI 10.1007/s11136-007-9248-7; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Evarts B., 2019, US FIRE DEP PROFILE; Evarts B., 2018, US FIREFIGHTER INJUR; Fischer H., 2013, US MILITARY CASUALTY; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacGregor AJ, 2013, INJURY, V44, P1458, DOI 10.1016/j.injury.2012.10.009; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; McKinlay A, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000284; Meyer EC, 2012, PSYCHOL SERV, V9, P1, DOI 10.1037/a0026414; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Peterson AB, 2014, SURVEILLANCE REPORT; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Tak S, 2007, J URBAN HEALTH, V84, P153, DOI 10.1007/s11524-006-9155-1; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Torres VA, 2020, WORKPLACE HEALTH SAF, V68, P468, DOI 10.1177/2165079920922576; Weathers F.W., 1993, ANN M INT SOC TRAUM; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	29	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480	1471-8405		OCCUP MED-OXFORD	Occup. Med.-Oxf.	MAR	2021	71	2					99	104		10.1093/occmed/kqab013			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	UU2VH	WOS:000698658500012	33598694				2022-02-06	
J	Thompson, S; Hays, K; Weintraub, A; Ketchum, JM; Kowalski, RG				Thompson, Sarah; Hays, Kaitlin; Weintraub, Alan; Ketchum, Jessica M.; Kowalski, Robert G.			Rhythmic Auditory Stimulation and Gait Training in Traumatic Brain Injury: A Pilot Study	JOURNAL OF MUSIC THERAPY			English	Article						brain injury; music therapy; neurorehabilitation		Rhythmic auditory stimulation (RAS) has been well researched with stroke survivors and individuals who have Parkinson's disease, but little research exists on RAS with people who have experienced traumatic brain injury (TBI). This pilot study aimed to (1) assess the feasibility of the study design and (2) explore potential benefits. This single-arm clinical trial included 10 participants who had a 2-week control period between baseline and pretreatment. Participants had RAS daily for a 2-week treatment period and immediately completed post-treatment assessments. Participants then had a 1-week control period and completed follow-up assessment. The starting cadence was evaluated each day of the intervention period due to the variation in daily functioning in this population. All 10 participants were 1-20 years post-TBI with notable deviations in spatial-temporal aspects of gait including decreased velocity, step symmetry, and cadence. All participants had a high risk of falling as defined by achieving less than 22 on the Functional Gait Assessment (FGA). The outcome measures included the 10-m walk test, spatial and temporal gait parameters, FGA, and Physical Activity Enjoyment Scale. There were no adverse events during the study and gait parameters improved. After the intervention, half of the participants achieved a score of more than 22 on the FGA, indicating that they were no longer at high risk of experiencing falls.	[Thompson, Sarah] Rehabil Rhythms, 2222 S Fraser St,2, Aurora, CO 80014 USA; [Thompson, Sarah; Hays, Kaitlin; Weintraub, Alan; Ketchum, Jessica M.; Kowalski, Robert G.] Craig Hosp, Englewood, CO USA; [Kowalski, Robert G.] Univ Colorado, Dept Neurol, Sch Med, Aurora, CO USA		Thompson, S (corresponding author), Rehabil Rhythms, 2222 S Fraser St,2, Aurora, CO 80014 USA.			Thompson, Sarah/0000-0001-5267-6027	Craig Hospital Foundation	This study was supported by the Craig Hospital Foundation.	Acuna SA, 2018, GAIT POSTURE, V62, P510, DOI 10.1016/j.gaitpost.2018.04.012; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Cha Y, 2014, J PHYS THER SCI, V26, P479, DOI 10.1589/jpts.26.479; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conklyn D, 2010, NEUROREHAB NEURAL RE, V24, P835, DOI 10.1177/1545968310372139; Crasta JE, 2018, NEUROPSYCHOLOGIA, V117, P102, DOI 10.1016/j.neuropsychologia.2018.05.017; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; Lin JH, 2010, STROKE, V41, P2021, DOI 10.1161/STROKEAHA.110.589739; Magee WL, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006787.pub3; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Mullen SP, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-103; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Murrock CJ, 2016, ISSUES MENT HEALTH N, V37, P164, DOI 10.3109/01612840.2015.1088904; Prassas S, 1997, GAIT POSTURE, V6, P218, DOI 10.1016/S0966-6362(97)00010-6; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sejdic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043104; Spaulding SJ, 2013, ARCH PHYS MED REHAB, V94, P562, DOI 10.1016/j.apmr.2012.10.026; Steiner WA, 2002, PHYS THER, V82, P1098, DOI 10.1093/ptj/82.11.1098; Suh JH, 2014, NEUROREHABILITATION, V34, P193, DOI 10.3233/NRE-131008; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; Thaut M. H., 2014, HDB NEUROLOGIC MUSIC; Thaut MH, 1997, J NEUROL SCI, V151, P207, DOI 10.1016/S0022-510X(97)00146-9; Thaut MH, 1998, HUM MOVEMENT SCI, V17, P839, DOI 10.1016/S0167-9457(98)00031-1; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Tyson S, 2009, CLIN REHABIL, V23, P1018, DOI 10.1177/0269215509339004; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]; WHO, 2001, INT CLASS FUNCT DIS; Williams G, 2015, J HEAD TRAUMA REHAB, V30, pE13, DOI 10.1097/HTR.0000000000000038; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069	47	1	1	1	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-2917	2053-7395		J MUSIC THER	J. Music Ther.	SPR	2021	58	1					70	94		10.1093/jmt/thaa016			25	Music; Rehabilitation	Social Science Citation Index (SSCI)	Music; Rehabilitation	RJ0QE	WOS:000637307300006	33095230	Bronze			2022-02-06	
J	Walton, SR; Broshek, DK; Kranz, S; Malin, SK; Hertel, J; Resch, JE				Walton, Samuel R.; Broshek, Donna K.; Kranz, Sibylle; Malin, Steven K.; Hertel, Jay; Resch, Jacob E.			Mood, Psychological, and Behavioral Factors of Health-Related Quality of Life Throughout Recovery From Sport Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; appetite; concussion; fatigue; health-related quality of life; resilience; sleep disturbance; stigma		Objective: To measure alterations in mood, psychological, and behavioral factors in collegiate athletes throughout recovery from sport concussion (SC) compared with matched controls. Setting: University research laboratory. Participants: Twenty (55% female) division I collegiate athletes with SC (19.3 +/- 1.08 years old, 1.77 +/- 0.11 m, 79.6 +/- 23.37 kg) and 20 (55% female) uninjured matched controls (20.8 +/- 2.17 years old, 1.77 +/- 0.10 m, 81.9 +/- 23.45 kg). Design: Longitudinal case control. Main Measures: Self-reported concussion-related symptoms, anxiety, resilience, stigma, sleep disturbance, fatigue, and appetite were assessed at 3 time points in the SC group: T-1 (<= 72 hours of SC), T-2 (7 days after T-1), and T-F (after symptom resolution). Control participants were evaluated at similar intervals. Group and group-by-sex differences were assessed using repeated-measures analyses of variance. Post hoc analyses were performed with Tukey's honestly significant difference (HSD) and paired-sample t tests. Results: The SC group had greater sleep disturbance than controls at T-1 (P = .001; d = 1.21) and endorsed greater stigma at all time points (P <= .03; d >= 0.80). Stigma (F-(2) = 3.68; P = 0.03; eta(2)(p) = 0.12), sleep disturbance (F-(2) = 5.27; P = .008; eta(2)(p) = 0.15), and fatigue (F-(2) = 3.46; P = .04; eta(2)(p) = 0.11) improved throughout recovery in those with SC only. No differences were observed between males and females (P > .05). Conclusion: Sleep disturbance and stigma were negatively affected by SC, highlighting potential areas for clinical interventions to maximize recovery in males and females.	[Walton, Samuel R.; Broshek, Donna K.; Kranz, Sibylle; Malin, Steven K.; Hertel, Jay; Resch, Jacob E.] Univ North Carolina Chapel Hill, Exercise & Sport Sci Work, 2207 Stallings Evans Sports Ctr Campus,Box 8700, Chapel Hill, NC 27599 USA		Walton, SR (corresponding author), Univ North Carolina Chapel Hill, Exercise & Sport Sci Work, 2207 Stallings Evans Sports Ctr Campus,Box 8700, Chapel Hill, NC 27599 USA.	swaltonatc@gmail.com; dkb6v@virginia.edu; sibylle.kranz@virginia.edu; skm6n@virginia.edu; jnh7g@virginia.edu; jer6x@virginia.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815; Walton, Samuel/0000-0003-2647-5701			Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan PW, 2002, CLIN PSYCHOL-SCI PR, V9, P35, DOI 10.1093/clipsy/9.1.35; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Curvis W, 2018, NEUROPSYCHOL REHABIL, V28, P527, DOI 10.1080/09602011.2016.1175359; Durish CL, 2019, J INT NEUROPSYCH SOC, V25, P346, DOI 10.1017/S1355617718001169; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hoffman NL, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy222; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Howell DR, 2019, J CHILD NEUROL, V34, P256, DOI 10.1177/0883073818824000; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Mattes RD, 2015, WORLD REV NUTR DIET, V111, P19, DOI 10.1159/000362292; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Petchprapai N, 2017, J NURS RES, V25, P51, DOI 10.1097/jnr.0000000000000119; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; The Technical Cooperation Program, 2008, INT MIL TEST ASS ANN; Todd R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192125; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; Walton SR, 2020, SPORTS HEALTH, V12, P382, DOI 10.1177/1941738120923869	35	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		128	136		10.1097/HTR.0000000000000604			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100014	32769824				2022-02-06	
J	Weber, MW; Nie, JZ; Espinosa, JA; Delfino, KR; Michael, AP				Weber, Matthew W.; Nie, Jeffrey Z.; Espinosa, Jose A.; Delfino, Kristin R.; Michael, Alex P.			Assessing the efficacy of mild traumatic brain injury management	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Mild traumatic brain injury; Head computed tomography; Management of traumatic brain injury; Healthcare utilization		Objective: Intracranial hemorrhage (ICH) is frequently found on computed tomography (CT) after mild traumatic brain injury (mTBI) prompting transfer to centers with neurosurgical coverage and repeat imaging to confirm hemorrhage stability. Studies suggest routine repeat imaging has little utility in patients with minimal ICH, no anticoagulant/antiplatelet use, and no neurological decline. Additionally, it is unclear which mTBI patients benefit from transfer for neurosurgery consultation. The authors sought to assess the clinical utility and cost effectiveness of routine repeat head CTs and transfer to tertiary centers in patients with low-risk, mTBI. Methods: Retrospective evaluation of patients receiving a neurosurgical consultation for TBI during a 4-year period was performed at a level 1 trauma center. Patients were stratified according to risk for neurosurgical intervention based on their initial clinical evaluation and head CT. Only patients with low-risk, mTBI were included. Results: Of 531 patients, 119 met inclusion criteria. Eighty-eight (74.0 %) received two or more CTs. Direct cost of repeat imaging was $273,374. Thirty-seven (31.1 %) were transferred to our facility from hospitals without neurosurgical coverage, costing $61,384. No patient had neurosurgical intervention or mTBI-related in-hospital mortality despite enlarging ICH on repeat CT in three patients. Two patients had mTBI related 30-day readmission for seizure without ICH expansion. Conclusion: Routine repeat head CT or transfer of low-risk, mTBI patients to a tertiary center did not result in neurosurgical intervention. Serial neurological examinations may be a safe, cost-effective alternative to repeat imaging for select mTBI patients. A large prospective analysis is warranted for further evaluation.	[Weber, Matthew W.; Nie, Jeffrey Z.; Espinosa, Jose A.; Michael, Alex P.] Southern Illinois Univ, Sch Med, Div Neurosurg, 421 N 9th St, Springfield, IL 62702 USA; [Delfino, Kristin R.] Southern Illinois Univ, Sch Med, Clin Res Ctr, 201 E Madison,POB 19664, Springfield, IL 62794 USA		Weber, MW (corresponding author), Southern Illinois Univ, Sch Med, Div Neurosurg, 421 N 9th St, Springfield, IL 62702 USA.	mweber96@siumed.edu; jnie31@siumed.edu; jespinosa@siumed.edu; kdelfino84@siumed.edu; amichael@siumed.edu	Nie, Jeffrey/AAU-1475-2021	Nie, Jeffrey/0000-0001-5213-4252; Weber, Matthew/0000-0002-3606-5346; Delfino, Kristin/0000-0003-0075-1472			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2003, REPORT C MILD TRAUMA; Arnold MR, 2020, AM J EMERG MED, V38, P1097, DOI 10.1016/j.ajem.2019.158379; Bernard AM, 1996, ACAD MED, V71, P262, DOI 10.1097/00001888-199603000-00019; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Capron GK, 2017, AM J SURG, V214, P1182, DOI 10.1016/j.amjsurg.2017.09.002; Harbrecht BG, 2010, J TRAUMA, V68, P1367, DOI 10.1097/TA.0b013e3181d990da; Hernandez-Boussard T, 2017, J PATIENT SAF, V13, P187, DOI 10.1097/PTS.0000000000000148; Huynh T, 2006, AM SURGEON, V72, P1162; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2015, ANN SURG, V262, P440, DOI 10.1097/SLA.0000000000001418; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; LUND E, 1982, NEURORADIOLOGY, V22, P181, DOI 10.1007/BF00341246; Marin JR, 2017, BRAIN INJURY, V31, P24, DOI 10.1080/02699052.2016.1217351; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Nickoloff EL, 2001, AM J ROENTGENOL, V177, P285, DOI 10.2214/ajr.177.2.1770285; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Peterson AB, 2014, SURVEILLANCE REPORT; Reljic T, 2014, J NEUROTRAUM, V31, P78, DOI 10.1089/neu.2013.2873; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Rosen Claire B, 2018, Trauma Surg Acute Care Open, V3, pe000129, DOI 10.1136/tsaco-2017-000129; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; World Health Organization, 2006, NEUROLOGICAL DISORDE, P164; Yun BJ, 2017, AM J EMERG MED, V35, P1281, DOI 10.1016/j.ajem.2017.03.071	32	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAR	2021	202								106518	10.1016/j.clineuro.2021.106518			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RC7IS	WOS:000632970600003	33601271				2022-02-06	
J	Wettervik, TS; Howells, T; Hillered, L; Rostami, E; Lewen, A; Enblad, P				Wettervik, Teodor Svedung; Howells, Timothy; Hillered, Lars; Rostami, Elham; Lewen, Anders; Enblad, Per			Autoregulatory or Fixed Cerebral Perfusion Pressure Targets in Traumatic Brain Injury: Determining Which Is Better in an Energy Metabolic Perspective	JOURNAL OF NEUROTRAUMA			English	Article						cerebral microdialysis; neurointensive care; optimal cerebral perfusion pressure; pressure autoregulation; traumatic brain injury		Current guidelines in traumatic brain injury (TBI) recommend a cerebral perfusion pressure (CPP) within the fixed interval of 60-70 mm Hg. However, the autoregulatory, optimal CPP target (CPPopt) might yield better cerebral blood flow (CBF) regulation. In this study, we investigated fixed versus autoregulatory CPP targets in relation to cerebral energy metabolism and clinical outcome after TBI. Ninety-eight non-craniectomized patients with severe TBI treated in the neurointensive care unit, Uppsala University Hospital, Sweden, 2008-2018, were included. Data from cerebral microdialysis (MD), intracranial pressure (ICP), pressure autoregulation, CPP and CPPopt55-15 (a variant of CPPopt based on filtered slow waves from 15-55 sec range) were analyzed the first 10 days. The good monitoring time (GMT %) below/within/above the fixed and autoregulatory CPP targets were calculated. CPPopt55-15 was >70 mm Hg 74% of the time the first 10 days. Higher GMT (%) Delta CPPopt55-15 +/- 10 mm Hg correlated with lower lactate/pyruvate ratio (LPR) on day 1 and lower cerebral glycerol on days 6-10, and predicted favorable clinical outcome. Higher GMT (%) CPP within 60-70 mm Hg correlated with lower cerebral glucose on days 2-10 and higher LPR on days 6-10, but predicted favorable clinical outcome. Higher GMT (%) CPP >70 mm Hg had the opposite associations; that is, with higher cerebral glucose and lower LPR, but unfavorable clinical outcome. Autoregulatory CPP targets may be beneficial, because patients with CPP values close to the optimal CPP had both better cerebral energy metabolism and better clinical outcome, but this needs to be evaluated in randomized trials.	[Wettervik, Teodor Svedung; Howells, Timothy; Hillered, Lars; Rostami, Elham; Lewen, Anders; Enblad, Per] Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se			Department of Neuroscience/Neurosurgery, Uppsala University, Sweden	The research was supported by the Department of Neuroscience/Neurosurgery, Uppsala University, Sweden.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Diringer MN, 2011, TRANSL STROKE RES, V2, P517, DOI 10.1007/s12975-011-0119-8; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; GRAHAM DI, 1971, LANCET, V1, P265; Grande PO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00315; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Johnson U, 2017, ACTA NEUROCHIR, V159, P1065, DOI 10.1007/s00701-017-3139-7; Johnson U, 2014, NEUROCRIT CARE, V21, P259, DOI 10.1007/s12028-014-9954-2; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zeiler FA, 2020, J NEUROTRAUM, V37, P1306, DOI 10.1089/neu.2019.6726	37	1	1	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					1969	1978		10.1089/neu.2020.7290		MAR 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000624602200001	33504257				2022-02-06	
J	Yamal, JM; Aisiku, IP; Hannay, HJ; Brito, FA; Robertson, CS				Yamal, Jose-Miguel; Aisiku, Imoigele P.; Hannay, H. Julia; Brito, Frances A.; Robertson, Claudia S.			Disability Rating Scale in the First Few Weeks After a Severe Traumatic Brain Injury as a Predictor of 6-Month Functional Outcome	NEUROSURGERY			English	Article						Traumatic brain injury; Closed head injury; Intracranial pressure; Disability Rating Scale; Prognostic		BACKGROUND: An early acute marker of long-term neurological outcome would be useful to help guide clinical decision making and therapeutic effectiveness after severe traumatic brain injury (TBI). We investigated the utility of the Disability Rating Scale (DRS) as early as 1 wk after TBI as a predictor of favorable 6-mo Glasgow Outcome Scale extended (GOS-E). OBJECTIVE: To determine the predictability of a favorable 6-mo GOS-E using the DRS measured during weeks 1 to 4 of injury. METHODS: The study is a sub analysis of patients enrolled in the Epo Severe TBI Trial (n = 200) to train and validate L1-regularized logistic regression models. DRS was collected at weeks 1 to 4 and GOS-E at 6 mo. RESULTS: The average area under the receiver operating characteristic curve was 0.82 for the model with baseline demographic and injury severity variables and week 1 DRS and increased to 0.88 when including weekly DRS until week 4. CONCLUSION: This study suggests that week 1 to 4 DRS may be predictors of favorable 6-mo outcome in severe TBI patients and thus useful both for clinical prognostication as well as surrogate endpoints for adaptive clinical trials.	[Yamal, Jose-Miguel; Brito, Frances A.] Univ Texas Houston, Dept Biostat & Data Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Aisiku, Imoigele P.] Harvard Med Sch, Dept Emergency Med, Brigham & Womens Hosp, Boston, MA USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX 77204 USA; [Hannay, H. Julia] Univ Houston, Texas Inst Measurement Evaluat & Stat TIMES, Houston, TX 77204 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Hannay, HJ (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77204 USA.; Yamal, JM (corresponding author), Univ Texas Houston, Coordinating Ctr Clin Trials, Dept Biostat & Data Sci, Sch Publ Hlth, 1200 Pressler,RAS E80, Houston, TX 77030 USA.	Jose-Miguel.Yamal@uth.tmc.edu; Julia.Hannay@times.uh.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]	This study was supported by the National Institute of Neurological Disorders and Stroke (grant #P01-NS38660).	Benoit JS, 2019, J INT NEUROPSYCH SOC, V25, P293, DOI 10.1017/S1355617718001078; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Faul M, TRAUMATIC BRAIN INJU; Gajewski BJ, 2016, PHARM STAT, V15, P396, DOI 10.1002/pst.1755; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; McCauley SR, 2013, J NEUROTRAUM, V30, P1506, DOI 10.1089/neu.2013.2925; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Osier ND, 2018, J NEUROTRAUM, V35, P2684, DOI 10.1089/neu.2017.5268; Pallmann P, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1017-7; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Roy D, 2020, J NEUROPSYCH CLIN N, V32, P132, DOI 10.1176/appi.neuropsych.18120379; Rubin ML, 2019, J NEUROTRAUM, V36, P2417, DOI 10.1089/neu.2018.6217; Shih WCJ, 2006, BIOMETRICAL J, V48, P656, DOI 10.1002/bimj.200610241; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zhao S, 2016, J NEUROTRAUM, V33, P2055, DOI 10.1089/neu.2015.4036	30	1	1	1	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2021	88	3					619	626		10.1093/neuros/nyaa474			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RJ0UU	WOS:000637319900056	33369651	Green Published			2022-02-06	
J	Zachar-Tirado, R; Chen, ZQ; Donders, J				Zachar-Tirado, Rachel; Chen, Ziqi; Donders, Jacobus			Clinical Utility of the Patient Health Questionnaire-Adolescent in Adolescents With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adolescents; depression; suicidal thoughts; traumatic brain injury		Objective: To determine the clinical utility of the Patient Health Questionnaire-Adolescent (PHQ-A) in screening for depressive disorders in adolescents following traumatic brain injury (TBI). Design: Retrospective analysis of data collected as a part of routine clinical care over a period of 4 years. Setting: Regional rehabilitation facility. Participants: Adolescents (n = 101) with mild to moderate-severe TBI who were referred for an outpatient neuropsychological evaluation within 1 to 12 months postinjury. Main Outcome Measures: PHQ-A, PHQ-A_2 (2-item version), and Processing Speed Index (PSI) from the Wechsler scales of intelligence. Results: Both premorbid depressive disorder and PHQ-A scores predicted a postinjury diagnosis of depressive disorder, with a combined sensitivity of 0.91 and specificity of 0.59. PHQ-A_2 did not reach acceptable levels of sensitivity in predicting suicidal thoughts. PHQ-A scores did not add significantly to the prediction of PSI results after accounting for TBI severity. Conclusions: PHQ-A has clinical utility as a screening instrument for depressive disorders in outpatient adolescents with TBI when the cutoff for clinically significant concern is set at more than 4 and premorbid psychiatric history is also taken into account.	[Zachar-Tirado, Rachel; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA; [Chen, Ziqi] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	Rachel.Zachar-Tirado@maryfreebed.com; zc23@students.calvin.edu; Jacobus.Donders@maryfreebed.com			Mary Free Bed Guild Fund [60]	This research was supported in part by a grant from the Mary Free Bed Guild Fund (project #60).	Allgaier AK, 2012, DEPRESS ANXIETY, V29, P906, DOI 10.1002/da.21971; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Austin PC, 2017, STAT METHODS MED RES, V26, P796, DOI 10.1177/0962280214558972; Barrera M, 2008, J PSYCHOSOC ONCOL, V26, P1, DOI 10.1300/J077v26n01_01; Baune BT, 2014, PSYCHIAT RES, V218, P261, DOI 10.1016/j.psychres.2014.04.052; Boyer KM, 2006, J INT NEUROPSYCH SOC, V12, P305, DOI 10.1017/S1355617706060425; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Catroppa C., 2016, NEW FRONTIERS PEDIAT; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Donders J, 2019, J INT NEUROPSYCH SOC, V25, P355, DOI 10.1017/S1355617719000109; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Donders J, 2017, BRAIN INJURY, V31, P1871, DOI 10.1080/02699052.2017.1334962; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Dueweke AR, 2018, FAM SYST HEALTH, V36, P281, DOI 10.1037/fsh0000350; Durish CL, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000343; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Favre T, 2009, CHILD NEUROPSYCHOL, V15, P85, DOI 10.1080/09297040802577311; Glenn CR, 2017, J CHILD PSYCHOL PSYC, V58, P1319, DOI 10.1111/jcpp.12769; Gorman S, 2016, NEUROPSYCHOLOGY, V30, P263, DOI 10.1037/neu0000214; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Johnson JG, 2002, J ADOLESCENT HEALTH, V30, P196, DOI 10.1016/S1054-139X(01)00333-0; Klimkeit EI, 2011, ARCH CLIN NEUROPSYCH, V26, P662, DOI 10.1093/arclin/acr051; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; Mayes SD, 2007, CHILD NEUROPSYCHOL, V13, P469, DOI 10.1080/09297040601112773; Nrugham L, 2008, J AFFECT DISORDERS, V111, P83, DOI 10.1016/j.jad.2008.02.010; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Pennello G, 2016, J BIOPHARM STAT, V26, P1083, DOI 10.1080/10543406.2016.1226335; Peterson RL, 2013, J HEAD TRAUMA REHAB, V28, pE1, DOI 10.1097/HTR.0b013e318263f5ba; Pratt LA, 2014, GEN HOSP PSYCHIAT, V36, P119, DOI 10.1016/j.genhosppsych.2013.09.007; Puig O, 2012, EUR CHILD ADOLES PSY, V21, P315, DOI 10.1007/s00787-012-0262-0; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Roy A, 2017, J ABNORM CHILD PSYCH, V45, P69, DOI 10.1007/s10802-016-0160-x; Schwartz-Stav O, 2006, EUR CHILD ADOLES PSY, V15, P352, DOI 10.1007/s00787-006-0541-8; Selby EA, 2013, J CLIN CHILD ADOLESC, V42, P481, DOI 10.1080/15374416.2012.736356; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Sinclair M, 2013, ADV MENT HEALTH INTE, V7, P93, DOI 10.1108/20441281311310199; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Strang JF, 2012, RES AUTISM SPECT DIS, V6, P406, DOI 10.1016/j.rasd.2011.06.015; Tham SW, 2013, J PAIN, V14, P1242, DOI 10.1016/j.jpain.2013.05.007; Travers BG, 2014, NEUROPSYCHOLOGIA, V53, P137, DOI 10.1016/j.neuropsychologia.2013.11.008; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2014, WECHSLER INTELLIGENC, V5th; Winardi W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129796	52	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2021	36	2			SI		E118	E125		10.1097/HTR.0000000000000610			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RH9OM	WOS:000636539100011	32898027				2022-02-06	
J	Zhang, YX; Wang, ZY; Peng, JH; Gerner, ST; Yin, SG; Jiang, Y				Zhang, Yuxuan; Wang, Zhaoyang; Peng, Jianhua; Gerner, Stefan T.; Yin, Shigang; Jiang, Yong			Gut microbiota-brain interaction: An emerging immunotherapy for traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						TBI; CNS; Immune response; GBA; Immunotherapy	VAGUS NERVE-STIMULATION; IMMUNE-SYSTEM; BACTERIAL PEPTIDOGLYCANS; CLINICAL-TRIALS; T-CELLS; INFLAMMATION; HEALTH; EFFECTOR; BARRIER; AXIS	Individuals suffering from traumatic brain injury (TBI) often experience the activation of the immune system, resulting in declines in cognitive and neurological function after brain injury. Despite decades of efforts, approaches for clinically effective treatment are sparse. Evidence on the association between current therapeutic strategies and clinical outcomes after TBI is limited to poorly understood mechanisms. For decades, an increasing number of studies suggest that the gut-brain axis (GBA), a bidirectional communication system between the central nervous system (CNS) and the gastrointestinal tract, plays a critical role in systemic immune response following neurological diseases. In this review, we detail current knowledge of the immune pathologies of GBA after TBI. These processes may provide a new therapeutic target and rehabilitation strategy developed and used in clinical treatment of TBI patients.	[Zhang, Yuxuan; Wang, Zhaoyang; Peng, Jianhua; Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Dept Neurosurg, Luzhou 646000, Peoples R China; [Peng, Jianhua; Yin, Shigang; Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Lab Neurol Dis & Brain Funct, Luzhou 646000, Peoples R China; [Peng, Jianhua; Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Sichuan Clin Res Ctr Neurosurg, Luzhou 646000, Peoples R China; [Gerner, Stefan T.] Univ Hosp Erlangen Nuremberg, Dept Neurol, D-91054 Erlangen, Germany; [Yin, Shigang; Jiang, Yong] Southwest Med Univ, Affiliated Hosp, Academician Expert Workstn Sichuan Prov, Luzhou 646000, Peoples R China		Yin, SG; Jiang, Y (corresponding author), Southwest Med Univ, Affiliated Hosp, Lab Neurol Dis & Brain Funct, Luzhou 646000, Peoples R China.	sgyin@swmu.edu.cn; jiangyong@swmu.edu.cn	Gerner, Stefan T./ABH-8328-2020	Gerner, Stefan T./0000-0001-6020-8290; Peng, Jianhua/0000-0003-3348-9538	Young Elite Scientist Sponsorship Program by the China Association for Science and Technology; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771278, 81801176, 81971132]; Sichuan Science and Technology Program [2019JDTD0004]	This work was supported by grants from the Young Elite Scientist Sponsorship Program by the China Association for Science and Technology, and the National Natural Science Foundation of China (81771278, 81801176, 81971132); the Sichuan Science and Technology Program (2019JDTD0004).	Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Arentsen T, 2017, MOL PSYCHIATR, V22, P257, DOI 10.1038/mp.2016.182; Arroyo DS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00770; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Borody T, 2015, EXPERT REV GASTROENT, V9, P1379, DOI 10.1586/17474124.2015.1086267; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Browning KN, 2003, AM J PHYSIOL-GASTR L, V284, pG8, DOI 10.1152/ajpgi.00322.2002; Brunkhorst R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070124; Caricilli Andrea Moro, 2014, World J Gastrointest Pathophysiol, V5, P18, DOI 10.4291/wjgp.v5.i1.18; Carlson AL, 2018, BIOL PSYCHIAT, V83, P148, DOI 10.1016/j.biopsych.2017.06.021; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI [10.1007/s00213-010-1832-9, 10.1007/s00213-010-2097-z]; Chen KQ, 2017, J AUTOIMMUN, V85, P64, DOI 10.1016/j.jaut.2017.06.012; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Cresci GA, 2015, NUTR CLIN PRACT, V30, P734, DOI 10.1177/0884533615609899; Cryan JF, 2020, LANCET NEUROL, V19, P179, DOI 10.1016/S1474-4422(19)30356-4; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dominguez-Bello MG, 2019, GUT, V68, P1108, DOI 10.1136/gutjnl-2018-317503; Dopkins N, 2018, IMMUNOLOGY, V154, P178, DOI 10.1111/imm.12903; Durgan DJ, 2019, STROKE, V50, P2270, DOI 10.1161/STROKEAHA.119.025140; Elkind MSV, 2020, NEUROLOGY, V95, pE1091, DOI 10.1212/WNL.0000000000010038; Elkins J, 2017, LANCET NEUROL, V16, P217, DOI 10.1016/S1474-4422(16)30357-X; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fakhoury M, 2016, MOL NEUROBIOL, V53, P2778, DOI 10.1007/s12035-015-9152-z; Farhadi A, 2003, J GASTROEN HEPATOL, V18, P479, DOI 10.1046/j.1440-1746.2003.03032.x; Fasano A, 2012, CLIN GASTROENTEROL H, V10, P1096, DOI 10.1016/j.cgh.2012.08.012; Forsythe P, 2014, ADV EXP MED BIOL, V817, P115, DOI 10.1007/978-1-4939-0897-4_5; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Glimcher LH, 2000, GENE DEV, V14, P1693; Gonzalez-Santana A, 2020, TRENDS MOL MED, V26, P729, DOI 10.1016/j.molmed.2020.05.003; Gu SC, 2018, J STROKE CEREBROVASC, V27, P1178, DOI 10.1016/j.jstrokecerebrovasdis.2017.11.031; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Hoover DB, 2017, PHARMACOL THERAPEUT, V179, P1, DOI 10.1016/j.pharmthera.2017.05.002; Hornig M, 2013, CURR OPIN RHEUMATOL, V25, P488, DOI 10.1097/BOR.0b013e32836208de; Howard Benjamin M, 2017, Trauma Surg Acute Care Open, V2, pe000108, DOI 10.1136/tsaco-2017-000108; Hu B., 2018, BRAIN CIRCULATION, V4; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kelsen J, 2019, J NEUROTRAUM, V36, P3253, DOI 10.1089/neu.2018.6369; Kim HJ, 2009, J NEUROCHEM, V110, P1226, DOI 10.1111/j.1471-4159.2009.06212.x; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Lattanzi S, 2019, TRANSL STROKE RES, V10, P137, DOI 10.1007/s12975-018-0649-4; Lattanzi S, 2018, J NEUROL SCI, V387, P98, DOI 10.1016/j.jns.2018.01.038; Lee N, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.36; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Li Y, 2000, GASTROENTEROLOGY, V118, P1197, DOI 10.1016/S0016-5085(00)70373-8; Liu ZH, 2013, AM J CLIN NUTR, V97, P117, DOI 10.3945/ajcn.112.040949; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Ma YY, 2019, J NUTR, V149, P1543, DOI 10.1093/jn/nxz105; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Maurer-Spurej E, 2007, J PSYCHIATR NEUROSCI, V32, P23; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Moschetta A., 2014, PLOS ONE, V9; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nishio J, 2012, CELL MOL LIFE SCI, V69, P3635, DOI 10.1007/s00018-012-0993-6; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Oami T, 2019, CURR OPIN CRIT CARE, V25, P145, DOI 10.1097/MCC.0000000000000582; Ogawa S, 2014, J CLIN PSYCHIAT, V75, pE906, DOI 10.4088/JCP.13r08908; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Patel JJ, 2016, CURR OPIN CRIT CARE, V22, P339, DOI 10.1097/MCC.0000000000000331; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Pitt T, 2011, ALLERGY ASTHMA CL IM, V7, DOI [10.1186/1710-1492-7-S1-S1, 10.1186/1710-1492-7-S1-S10]; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Powell N, 2017, NAT REV GASTRO HEPAT, V14, P143, DOI 10.1038/nrgastro.2016.191; Raybould HE, 2010, AUTON NEUROSCI-BASIC, V153, P41, DOI 10.1016/j.autneu.2009.07.007; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Rice MW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00875; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schrijver IA, 2001, BRAIN, V124, P1544, DOI 10.1093/brain/124.8.1544; Sellebjerg F, 2016, THER ADV NEUROL DISO, V9, P31, DOI 10.1177/1756285615615257; Sharma A, 2019, INT REV NEUROBIOL, V146, P1, DOI 10.1016/bs.irn.2019.06.005; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Simon DW, 2020, BRAIN RES, V1747, DOI 10.1016/j.brainres.2020.147056; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Simpson CA, 2021, CLIN PSYCHOL REV, V83, DOI 10.1016/j.cpr.2020.101943; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Tang YL, 2020, NEUROREHAB NEURAL RE, V34, P831, DOI 10.1177/1545968320948065; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Tosoni G, 2019, CURR OPIN PHARMACOL, V48, P107, DOI 10.1016/j.coph.2019.08.003; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Veltkamp R, 2016, NEUROTHERAPEUTICS, V13, P791, DOI 10.1007/s13311-016-0458-y; Wan W, 2020, J INT MED RES, V48, DOI 10.1177/0300060520948717; Wang SG, 2018, NEUROSCI BIOBEHAV R, V95, P191, DOI 10.1016/j.neubiorev.2018.09.002; Wang YJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02781; Wang ZF, 2020, CURR MED CHEM, V27, P2979, DOI 10.2174/0929867326666190308133732; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhou L, 2014, NEURAL REGEN RES, V9, P1585, DOI 10.4103/1673-5374.141783; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; 2015, ANT SPORT NUTR, P1	132	1	1	2	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2021	337								113585	10.1016/j.expneurol.2020.113585			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QD1UA	WOS:000615311200016	33370556				2022-02-06	
J	Zink, F; Vogt, J; Wachter, U; Hartert, J; Horchler, M; Zhang, XM; Hezel, F; Kapapa, T; Datzmann, T; Hoffmann, A; Wepler, M; Calzia, E; Radermacher, P; Hartmann, C				Zink, Fabian; Vogt, Josef; Wachter, Ulrich; Hartert, Jens; Horchler, Mirco; Zhang, Xiaomin; Hezel, Felix; Kapapa, Thomas; Datzmann, Thomas; Hoffmann, Andrea; Wepler, Martin; Calzia, Enrico; Radermacher, Peter; Hartmann, Clair			Effects of Acute Subdural Hematoma-Induced Brain Injury On Energy Metabolism in Peripheral Blood Mononuclear Cells	SHOCK			English	Article						ASDH; energy metabolism; metabolic flux analysis; oxygen radicals; PBMCs	MASS ISOTOPOMER DISTRIBUTIONS; GLUTAMINE-METABOLISM; OXIDATIVE STRESS; IMMUNE-RESPONSE; MITOCHONDRIAL; LYMPHOCYTES; MODEL	In activated immune cells, differentiation and function are determined by cell type-specific modifications of metabolic patterns. After traumatic brain injury both immune cell activation and suppression were reported. Therefore, we sought to explore immune cell energy metabolism in a long-term, resuscitated porcine model of acute subdural hematoma (ASDH)-induced acute brain injury devoid of impaired systemic hemodynamics and oxygen transport. Before and up to 50 h after induction of ASDH, peripheral blood mononuclear cells (PBMCs) were separated by density gradient centrifugation, and cell metabolism was analyzed using high-resolution respirometry for mitochondrial respiration and electron spin resonance for reactive oxygen species production. After incubation with stable isotope-labeled 1,2-C-13(2)-glucose or C-13(5)-glutamine, distinct labeling patterns of intermediates of glycolysis or tricarboxylic acid (TCA) cycle and (CO2)-C-13 production were measured by gas chromatography-mass spectroscopy. Principal component analysis was followed by a varimax rotation on the covariance across all measured variables and all measured time points. After ASDH induction, average PBMC metabolic activity remained unaffected, possibly because strict adherence to intensive care unit guidelines limited trauma to ASDH induction without any change in parameters of systemic hemodynamics, oxygen transport, and whole-body metabolism. Despite decreased glycolytic activity fueling the TCA cycle, the principal component analysis indicated a cell type-specific activation pattern with biosynthetic and proliferative characteristics.	[Zink, Fabian; Vogt, Josef; Wachter, Ulrich; Horchler, Mirco; Zhang, Xiaomin; Hezel, Felix; Hoffmann, Andrea; Calzia, Enrico; Radermacher, Peter; Hartmann, Clair] Ulm Univ Hosp, Inst Anesthesiol Pathophysiol & Proc Dev, Ulm, Germany; [Hartert, Jens; Datzmann, Thomas; Wepler, Martin; Hartmann, Clair] Ulm Univ Hosp, Dept Anesthesiol, Ulm, Germany; [Kapapa, Thomas] Ulm Univ Hosp, Dept Neurosurg, Ulm, Germany		Zink, F (corresponding author), Helmholtzstr 8-1, D-89081 Ulm, Germany.	fabian.zink@uni-ulm.de			DFGGerman Research Foundation (DFG)European Commission [GRK2203, CRC1149]	The presented research was supported by DFG by the research training group GRK2203 ``PULMOSENS'' (FZ) and the collaborative research center CRC1149 ``Danger Response, Disturbance Factors, and Regenerative Potential after Acute Trauma'' (CH, PR).	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Datzmann T, 2021, J NEUROSURG, V134, P223, DOI 10.3171/2019.9.JNS191789; Dikalov SI, 2011, FREE RADICAL RES, V45, P417, DOI 10.3109/10715762.2010.540242; Donnelly RP, 2015, MOL IMMUNOL, V68, P513, DOI 10.1016/j.molimm.2015.07.034; Douguet L, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1484979; Draper N.R., 1998, APPL REGRESSION ANAL; Durocher M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1433-4; Fehske H., 2008, COMPUTATIONAL MANY P; Forina M., 1998, J CHEMOM, V3, P115; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Hartmann C, 2019, SHOCK, V51, P68, DOI 10.1097/SHK.0000000000001115; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Jacobs R, 1999, INT J IMMUNOPHARMACO, V21, P445, DOI 10.1016/S0192-0561(99)00025-9; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kim J, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8605471; Kleikers PWM, 2012, J MOL MED, V90, P1391, DOI 10.1007/s00109-012-0963-3; Knoller E, 2016, CRIT CARE MED, V44, pE264, DOI 10.1097/CCM.0000000000001412; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Lawley D.N., 1971, FACTOR ANAL STAT MET; Li P, 2015, SCI REP-UK, V5, DOI 10.1038/srep10229; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Macintyre AN, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-5; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Pearce EJ, 2018, NAT REV IMMUNOL, V18, P81, DOI 10.1038/nri.2017.139; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Rantanen A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-266; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sumi C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192796; Theorell A, 2017, BIOTECHNOL BIOENG, V114, P2668, DOI 10.1002/bit.26379; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Vogt JA, 1997, AM J PHYSIOL-CELL PH, V272, pC2049, DOI 10.1152/ajpcell.1997.272.6.C2049; Walsh KB, 2019, METAB BRAIN DIS, V34, P763, DOI 10.1007/s11011-019-00399-z; Wang FL, 2018, EBIOMEDICINE, V30, P303, DOI 10.1016/j.ebiom.2018.02.009; Weiss SL, 2015, PEDIATR CRIT CARE ME, V16, pE4, DOI 10.1097/PCC.0000000000000277; Wiechert W, 2001, MATH BIOSCI, V169, P173, DOI 10.1016/S0025-5564(00)00059-6; Zhang X., 2020, INTENSIVE CARE MED E; Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048	50	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	MAR	2021	55	3					407	417		10.1097/SHK.0000000000001642			11	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	SW2DE	WOS:000664328700016	32826816				2022-02-06	
J	Zivanovic, N; Virani, S; Rajaram, AA; Lebel, C; Yeates, KO; Brooks, BL				Zivanovic, Nikola; Virani, Shane; Rajaram, Alysha A.; Lebel, Catherine; Yeates, Keith Owen; Brooks, Brian L.			Cortical Volume and Thickness in Youth Several Years After Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric concussion; cortical thickness; cortical volume; long-term; magnetic resonance imaging; postconcussion syndrome		Objective: The long-term effects of pediatric concussion on brain morphometry remain poorly delineated. This study used magnetic resonance imaging (MRI) to investigate cortical volume and thickness in youth several years after concussion. Methods: Participants aged 8-19 years old with a history of concussion (n = 37) or orthopedic injury (n = 20) underwent MRI, rated their postconcussion symptoms, and completed cognitive testing on average 2.6 years (SD = 1.6) after injury. FreeSurfer was used to obtain cortical volume and thickness measurements as well as determine any significant correlations between brain morphometry, postconcussion symptoms (parent and self-report), and cognitive functioning. Results: No significant group differences were found for either cortical volume or thickness. Youth with a history of concussion had higher postconcussion symptom scores (both parent and self-report Postconcussion Symptom Inventory) than the orthopedic injury group, but symptom ratings did not significantly correlate with cortical volume or thickness. Across both groups, faster reaction time on a computerized neurocognitive test battery (CNS Vital Signs) was associated with a thinner cortex in the left pars triangularis of the inferior frontal gyrus and the left caudal anterior cingulate. Better verbal memory was associated with a thinner cortex in the left rostral middle frontal gyrus. Conclusion: Findings do not support differences in cortical volume or thickness approximately 2.5 years postconcussion in youth, suggesting either long-term cortical recovery or no cortical differences as a result of injury. Further research using a longitudinal study design and larger samples is needed.	[Zivanovic, Nikola; Rajaram, Alysha A.; Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Virani, Shane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Virani, Shane; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB, Canada; [Virani, Shane; Lebel, Catherine; Yeates, Keith Owen; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Rajaram, Alysha A.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Lebel, Catherine] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Lebel, Catherine; Yeates, Keith Owen; Brooks, Brian L.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen; Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca	Yeates, Keith/AAJ-4223-2020	Zivanovic, Nikola/0000-0001-6482-6416			Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2018, INT J PSYCHOPHYSIOL, V132, P99, DOI 10.1016/j.ijpsycho.2018.07.474; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fuchs E, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/541870; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA., 2008, J INT NEUROPSYCHOL S, P204; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Karama S, 2009, INTELLIGENCE, V37, P145, DOI 10.1016/j.intell.2008.09.006; Kumar Ashutosh, 2019, Innov Clin Neurosci, V16, P30; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Plourde V, 2018, ARCH CLIN NEUROPSYCH, V33, P247, DOI 10.1093/arclin/acx067; Plourde V, 2017, J INT NEUROPSYCH SOC, V23, P304, DOI 10.1017/S1355617717000066; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Singh P, 2016, NEURAL REGEN RES, V11, P920, DOI 10.4103/1673-5374.184487; Sohn MN, 2020, J INT NEUROPSYCH SOC, V26, P763, DOI 10.1017/S1355617720000223; Sophie Su Y., 2016, TRANSLATIONAL RES TR; Squeglia LM, 2013, J INT NEUROPSYCH SOC, V19, P962, DOI 10.1017/S1355617713000878; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Ware AL, 2020, J NEUROTRAUM, V37, P1892, DOI 10.1089/neu.2019.6850; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	52	1	1	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAR	2021	36	3					186	194		10.1177/0883073820962930			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	PY6BV	WOS:000612128900003	33059521				2022-02-06	
J	Allonsius, F; De Kloet, AJ; Van Markus-Doornbosch, F; Meesters, JJL; Kromme, CH; Vlieland, TPMV; van der Holst, M				Allonsius, F.; De Kloet, A. J.; Van Markus-Doornbosch, F.; Meesters, J. J. L.; Kromme, C. H.; Vliet Vlieland, T. P. M.; van der Holst, M.			Parent-reported family impact in children and young adults with acquired brain injury in the outpatient rehabilitation setting	BRAIN INJURY			English	Article						Family impact; acquired brain injury; rehabilitation; pediatric		Purpose: To increase knowledge/awareness on family impact (FI) after acquired brain injury (ABI) in rehabilitation settings, it is essential to investigate the associations between patient-functioning and impact on families. This has been explored in hospital-based cohorts, but not in rehabilitation settings. Methods: A cross-sectional, multi-center study among parents of children/young adults (aged 57-<24 years) with ABI referred to rehabilitation was performed. Patient/injury/family-characteristics were noted, and parents completed the PedsQL (TM) Family-Impact-Module and PedsQL (TM) generic-core-4.0 to assess FI and health-related quality of life (HRQoL). Univariate- and multivariable-regression analyses were performed to investigate associations between HRQoL/patient/injury/family-related factors and FI. Results: 246 families participated; patients' median age was 14 year (IQR 117-<16), 65 had non-traumatic-brain-injury (nTBI) (26%), 127 were female. FI was found to be considerable (median FIM-score 71.9, IQR:60-85). Especially referral to rehabilitation >6 months after onset, diminished patients' mental/emotional health and HRQoL (child/family factors), and premorbid problems were associated with higher FI. Conclusions: In this rehabilitation cohort, pediatric ABI caused considerably higher FI than in hospital-based studies with referral to rehabilitation >6 months, diminished child/family factors and presence of premorbid problems increasing FI. Assessing and monitoring FI and its associated factors enables professionals to individualize treatment, psychoeducation, support and follow-up.	[Allonsius, F.; De Kloet, A. J.; Van Markus-Doornbosch, F.; Meesters, J. J. L.; Kromme, C. H.; Vliet Vlieland, T. P. M.; van der Holst, M.] Basalt Rehabil, Dept Innovat Qual & Res, Leiden, Netherlands; [Allonsius, F.; De Kloet, A. J.; Van Markus-Doornbosch, F.; Meesters, J. J. L.; Kromme, C. H.; Vliet Vlieland, T. P. M.; van der Holst, M.] Basalt Rehabil, Dept Innovat Qual & Res, The Hague, Netherlands; [De Kloet, A. J.; Meesters, J. J. L.] The Hague Univ Appl Sci, Ctr Expertsie Hlth Innovat, The Hague, Netherlands; [Allonsius, F.; Van Markus-Doornbosch, F.; Meesters, J. J. L.; Vliet Vlieland, T. P. M.; van der Holst, M.] Leiden Univ, Med Ctr, Dept Orthoped Rehabil & Phys Therapy, NL-2333 ZA Leiden, Netherlands		Allonsius, F (corresponding author), Leiden Univ, Med Ctr, Dept Orthoped Rehabil & Phys Therapy, NL-2333 ZA Leiden, Netherlands.; Allonsius, F (corresponding author), Basalt Rehabil Ctr, Dept Innovat Qual & Res, NL-2543 SW The Hague, Netherlands.	f.allonsius@basaltrevalidatie.nl	van der Holst, Menno/AAL-5791-2021; Allonsius, Florian/AAL-9788-2021; Vlieland, Thea Vliet/AAJ-8119-2020	van der Holst, Menno/0000-0002-0797-5711; Allonsius, Florian/0000-0001-9911-7070; Vlieland, Thea Vliet/0000-0001-6322-3859; de Kloet, Arend/0000-0001-9066-5601	Hersenstichting [PZ2015.01.10]; Revalidatiefonds [R2014.124]	This work was supported by the Hersenstichting [PZ2015.01.10]; Revalidatiefonds [R2014.124].	Amram O, 2015, INT J ENV RES PUB HE, V12, P15594, DOI 10.3390/ijerph121215009; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; [Anonymous], 2020, STATPEARLS INTERNET; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BARTKO J, 1966, PSYCHOL REP, V19; BEDELL G, 2004, NEUROREHABILITATION, V19; Bemister TB, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-182; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Cuschieri S, 2019, SAUDI J ANAESTH, V13, P31, DOI 10.4103/sja.SJA_543_18; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; de Kloet AJ, 2015, J DEV BEHAV PEDIATR, V36, P342, DOI 10.1097/DBP.0000000000000169; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dixon, 2004, HEALTH QUAL LIFE OUT, V2, DOI 10.1186/1477-7525-2-55; Fisher A, 2019, DISABIL REHABIL, V41, P854, DOI 10.1080/09638288.2017.1407966; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Hansson H, 2013, PEDIATR BLOOD CANCER, V60, P865, DOI 10.1002/pbc.24474; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hileli I, 2014, PEDIATR BLOOD CANCER, V61, P265, DOI 10.1002/pbc.24712; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Lambregts SAM, 2018, BRAIN INJURY, V32, P230, DOI 10.1080/02699052.2017.1406990; Lambregts SAM, 2018, DEV NEUROREHABIL, V21, P465, DOI 10.1080/17518423.2018.1460770; Leickly FE, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.5.e8; Limbers CA, 2011, J ATTEN DISORD, V15, P392, DOI 10.1177/1087054709356191; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Medrano GR, 2013, QUAL LIFE RES, V22, P2899, DOI 10.1007/s11136-013-0422-9; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Neuner B, 2011, ANN NEUROL, V70, P70, DOI 10.1002/ana.22381; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; RIVARA J, 1996, ARCH PHYS MED REHAB, V77; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; van Markus-Doornbosch F, 2020, DEV NEUROREHABIL, V23, P328, DOI 10.1080/17518423.2019.1692948; Varni JW, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-26; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077	43	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2021	35	5					563	573		10.1080/02699052.2021.1891287		FEB 2021	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO8QM	WOS:000630410600001	33734919	hybrid			2022-02-06	
J	Oates, AJ; Sidpra, J; Mankad, K				Oates, Adam J.; Sidpra, Jai; Mankad, Kshitij			Parenchymal brain injuries in abusive head trauma	PEDIATRIC RADIOLOGY			English	Article						Abusive head trauma; Brain; Child abuse; Computed tomography; Infants; Magnetic resonance imaging; Parenchyma; Shaken baby syndrome; Trauma; Traumatic brain injury		The consequences of abusive head trauma (AHT) can be devastating for both the individual child and for wider society. Death is undoubtedly a very real possibility, but even for those children who survive, there is often very significant morbidity with the potential for gross motor and cognitive impairment, behavioural problems, blindness and epilepsy, which can greatly affect their quality of life. Caring for such children places a vast financial and infrastructural burden on society that frequently extends well into adulthood. While few struggle to have any sympathy for the perpetrator, frequently the infant's father, it should be noted that a single solitary and momentary loss of complete control can have horrific and unforeseen consequences. A number of papers within this edition describe features of AHT and include descriptions of skull fractures and extra-axial haemorrhage, along with mimics of such phenomena. However, in this review we concentrate our attention on the myriad of parenchymal findings that can occur. Such parenchymal injuries include hypoxic-ischaemic damage, clefts, contusion and focal haemorrhage. We offer our perspectives on current thinking on these entities and put them in the context of the immensely important question - how do we recognise abusive head trauma?	[Oates, Adam J.] Birmingham Childrens Hosp, Dept Radiol, Birmingham, W Midlands, England; [Sidpra, Jai] UCL, Med Sch, London, England; [Mankad, Kshitij] Great Ormond St Hosp Sick Children, Dept Radiol, Great Ormond St, London WC1N 3JH, England		Mankad, K (corresponding author), Great Ormond St Hosp Sick Children, Dept Radiol, Great Ormond St, London WC1N 3JH, England.	kshitij.mankad@gosh.nhs.uk		Sidpra, Jai/0000-0003-1985-5503			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Ammermann H, 2007, J NEUROL SCI, V260, P65, DOI 10.1016/j.jns.2007.03.026; Barnes PD, 2010, SEMIN PEDIATR NEUROL, V17, P7, DOI 10.1016/j.spen.2010.01.005; BIRD CR, 1987, RADIOLOGY, V163, P373, DOI 10.1148/radiology.163.2.3562816; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; Duhaime AC, 2019, J NEUROSURG-PEDIATR, V24, P481, DOI 10.3171/2019.7.PEDS18394; Edwards GA, 2015, J FORENSIC LEG MED, V35, P33, DOI 10.1016/j.jflm.2015.06.012; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Giza CC, 2001, J ATHL TRAINING, V36, P228; Greeley CS, 2010, SEMIN PEDIATR NEUROL, V17, P275, DOI 10.1016/j.spen.2010.09.001; Greenberg David P, 2005, Pediatr Infect Dis J, V24, pS39, DOI 10.1097/01.inf.0000160911.65632.e1; HORI A, 1991, ARCH NEUROL-CHICAGO, V48, P871, DOI 10.1001/archneur.1991.00530200113030; Hughes J, 2016, ARCH DIS CHILD, V101, P310, DOI 10.1136/archdischild-2014-306803; Ichord RN, 2007, J NEUROTRAUM, V24, P106, DOI 10.1089/neu.2006.0087; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Kleinman P., 2015, DIAGNOSTIC IMAGING C, P453, DOI 10.1017/CBO9780511862366.028; Kleinman PK, 2015, DIAGNOSTIC IMAGING C, DOI [10.1017/CBO9780511862366, DOI 10.1017/CBO9780511862366]; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Lopez-Guerrero AL, 2012, CHILD NERV SYST, V28, P2033, DOI 10.1007/s00381-012-1864-z; Matschke J, 2015, INT J LEGAL MED, V129, P105, DOI 10.1007/s00414-014-1060-7; Orman G, 2020, J NEUROIMAGING, V30, P15, DOI 10.1111/jon.12670; Orru' E, 2018, J NEUROIMAGING, V28, P608, DOI 10.1111/jon.12555; Oualha M, 2013, INTENS CARE MED, V39, P1306, DOI 10.1007/s00134-013-2930-z; Palifka LA, 2016, AM J NEURORADIOL, V37, P163, DOI 10.3174/ajnr.A4519; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Royal College of Paediatrics and Child Health, 2019, CHILD PROTECTION EVI; Sanchez T, 2010, EMERG RADIOL, V17, P413, DOI 10.1007/s10140-010-0877-8; Siskas N, 2003, NEURORADIOLOGY, V45, P283, DOI 10.1007/s00234-002-0887-7; Society & College of Radiographers Royal College of Radiologists, 2018, RADIOLOGICAL INVESTI; Talbert DG, 2006, MED HYPOTHESES, V67, P786, DOI 10.1016/j.mehy.2006.04.028; Teixeira Sara Reis, 2018, Top Magn Reson Imaging, V27, P503, DOI 10.1097/RMR.0000000000000169; Thomas AG, 2013, ARCH DIS CHILD, V98, P787, DOI 10.1136/archdischild-2013-304267; van Zandwijk JP, 2019, FORENSIC SCI MED PAT, V15, P423, DOI 10.1007/s12024-019-00093-7; Vester MEM, 2019, FORENSIC SCI MED PAT, V15, P408, DOI 10.1007/s12024-019-0082-3; WATTS CC, 1969, AM J DIS CHILD, V118, P518, DOI 10.1001/archpedi.1969.02100040520019	41	1	1	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	MAY	2021	51	6			SI		898	910		10.1007/s00247-021-04981-5		FEB 2021	13	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	SD6SY	WOS:000622662900001	33638693				2022-02-06	
J	Podolsky-Gondim, GG; Cardoso, R; Zucoloto, EL; Grisi, L; Medeiros, M; De Souza, SN; Santos, MV; Colli, BO				Podolsky-Gondim, Guilherme G.; Cardoso, Rodrigo; Zucoloto Junior, Edson Luis; Grisi, Luca; Medeiros, Mateus; De Souza, Stephanie Naomi; Santos, Marcelo, V; Colli, Benedicto O.			Traumatic Brain Injury in the Elderly: Clinical Features, Prognostic Factors, and Outcomes of 133 Consecutive Surgical Patients	CUREUS			English	Article						elderly; geriatric trauma; head injury; subdural hematoma; traumatic brain injury; anticoagulants	PREINJURY WARFARIN USE; INTRACRANIAL HEMORRHAGE; ANTIPLATELET AGENTS; MORTALITY; RISK; ANTICOAGULATION; EPIDEMIOLOGY; REVERSAL	Objective With the aging of the global population, an increase in the proportion of elderly patients presenting with traumatic brain injury (TBI) is expected. This population presents several distinctive characteristics that impact management and outcome of TBI, such as comorbidities, frailty, and preinjury use of medications specially antiplatelets and anticoagulants. The purpose of this study was to assess the general characteristics and prognostic factors of elderly patients with TBI that were surgically managed at a single institution. Methods The authors performed a retrospective review of all elderly patients (age >= 65 years) with a history of TBI that underwent cranial neurosurgical procedures at their institution, between 2015 and 2019. Clinical characteristics, laboratory tests, and radiological scans, as well as surgeries, performed, outcome, and prognostic factors were analyzed, comprising 133 consecutive cases overall. Results The mean age of patients was 76.6 +/- 7.3 years, ranging from 65 years to 97 years. There was a predominance of males (71.4%) and the most frequent mechanism of injury was fall (80.4%). Mild TBI comprised 57.1% of the cases, followed by severe TBI in 25.6%. Frequent signs and symptoms were impaired consciousness (69.9%), focal motor deficits (32.3%), and gait disturbances (12.8%). The majority had reported comorbidities upon admission (79.7%), with cardiac disease (79.2%) and diabetes (24.5%) as the most frequent. Preinjury anticoagulation was reported in 18.8% and use of antiplatelet drugs in 17.3%. The most common finding in the head CT was chronic subdural hematoma (48.1%), followed by acute subdural hematoma (37.6%). Coagulation was found to be altered in 12.8% of the patients. The most common neurosurgical procedure performed was trephination for hematoma evacuation (56.3%), followed by craniotomy (21.2%). Blood product transfusion was needed in 61.7% of the patients. Overall mortality was 42.1%, with the majority in the first month after admission (83.9%). Unfavorable outcome (Glasgow Outcome Scale <5) at discharge was identified in 73% of the patients. Identified prognostic factors were TBI severity, absent pupillary reactivity, acute intracranial bleeding on head CT, basal cisterns obliteration, altered coagulation status, and need for blood transfusion. Conclusions TBI severity, pupillary reactivity, coagulation status, need for blood products transfusion and acute bleeding, as well as basal cisterns obliteration found in head CT, are factors that influenced the outcome in this series of elderly patients with TBI that need surgical management. It is paramount to observe the particularities of this population in this context, to optimize outcomes, avoid complications and ultimately generate awareness focused on prevention.	[Podolsky-Gondim, Guilherme G.; Cardoso, Rodrigo; Zucoloto Junior, Edson Luis; Grisi, Luca; Medeiros, Mateus; De Souza, Stephanie Naomi; Colli, Benedicto O.] Univ Sao Paulo, Ribeirao Preto Clin Hosp, Ribeirao Preto Med Sch, Div Neurosurg,Dept Surg & Anat, Ribeirao Preto, Brazil; [Santos, Marcelo, V] Univ Sao Paulo, Ribeirao Preto Clin Hosp, Ribeirao Preto Med Sch, Div Pediat Neurosurg,Dept Surg & Anat, Ribeirao Preto, Brazil		Podolsky-Gondim, GG (corresponding author), Univ Sao Paulo, Ribeirao Preto Clin Hosp, Ribeirao Preto Med Sch, Div Neurosurg,Dept Surg & Anat, Ribeirao Preto, Brazil.	podolsky@usp.br	Podolsky-Gondim, Guilherme Gozzoli/AAL-1611-2021	Podolsky-Gondim, Guilherme Gozzoli/0000-0002-9608-2607			American College of Surgeons, 2013, ACS TQIP GER TRAUM M; [Anonymous], 2017, 2017 NATL POPULATION; Bergeron E, 2006, J TRAUMA, V60, P268, DOI 10.1097/01.ta.0000197651.00482.c5; Blazer DG, 2009, AM J PSYCHIAT, V166, P1162, DOI 10.1176/appi.ajp.2009.09010016; Bradburn E, 2012, J TRAUMA ACUTE CARE, V73, P435, DOI 10.1097/TA.0b013e31825c7cf4; Callaway DW, 2007, EMERG MED CLIN N AM, V25, P837, DOI 10.1016/j.emc.2007.06.005; Callaway DW, 2009, J TRAUMA, V66, P1040, DOI 10.1097/TA.0b013e3181895e9e; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hirano Elcio S., 2007, Medicina (Ribeirao Preto), V40, P352; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; Jacobs David G, 2003, Curr Opin Crit Care, V9, P535, DOI 10.1097/00075198-200312000-00012; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kirsch MJ, 2004, J TRAUMA, V57, P1230, DOI 10.1097/01.TA.0000150839.69648.17; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Mangram AJ, 2012, J TRAUMA ACUTE CARE, V72, P119, DOI 10.1097/TA.0b013e318241f0ba; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x	28	1	1	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	FEB 27	2021	13	2							e13587	10.7759/cureus.13587			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QR0XE	WOS:000624939600006	33815990	Green Published, gold			2022-02-06	
J	Wang, ML; Wei, XE; Yu, MM; Li, WB				Wang, Ming-Liang; Wei, Xiao-Er; Yu, Meng-Meng; Li, Wen-Bin			Cognitive impairment in mild traumatic brain injury: a diffusion kurtosis imaging and volumetric study	ACTA RADIOLOGICA			English	Article						Mild traumatic brain injury; diffusion kurtosis imaging; voxel-based morphometry; tract-based spatial statistics; subcortical nuclei; cognitive impairment	OPTIMIZATION; REGISTRATION; OUTCOMES; ROBUST; MRI	Background A significant number of patients with mild traumatic brain injury (mTBI) would experience cognitive deficit. Purpose To investigate the brain structural changes in sub-acute mTBI by diffusion kurtosis imaging (DKI) and volumetric analysis, and to assess the relationship between brain structural changes and cognitive functions. Material and Methods A total of 23 patients with sub-acute mTBI and 24 control participants were recruited. All the participants underwent examinations of neuropsychological tests, DKI, and magnetic resonance imaging (MRI)-based morphological scans. Images were investigated using whole brain-based analysis and further regions of interest-based analysis for subcortical nuclei. The neuropsychological tests were compared between the mTBI and the control group. Correlation analysis was performed to examine the relationship between gray matter (GM) volume, DKI parameters, and cognitive functions. Results Compared with control participants, mTBI patients performed worse in the domains of verbal memory, attention and executive function (P < 0.05). No regional GM volume differences were observed between the mTBI and control groups (P > 0.05). Using DKI, patients with mTBI showed lower mean kurtosis (MK) in widespread white matter (WM) regions and several subcortical nuclei (P < 0.05), and higher mean diffusivity (MD) in the right pallidum (P < 0.05). Lower MK value of multiple WM regions and several subcortical nuclei correlated with cognitive impairment (P < 0.05). Conclusion DKI was sensitive in detecting brain microstructural changes in patients with sub-acute mTBI showing lower MK value in widespread WM regions and several subcortical nuclei, which were statistically associated with cognitive deficits.	[Wang, Ming-Liang; Wei, Xiao-Er; Yu, Meng-Meng; Li, Wen-Bin] Shanghai Jiao Tong Univ, Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Radiol, Sch Med, Shanghai, Peoples R China; [Li, Wen-Bin] Kashgar Prefecture Second Peoples Hosp, Imaging Ctr, Kashgar, Peoples R China		Li, WB (corresponding author), 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	liwenbin@sjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81901727, 81271540, 81301213]; Natural Science Foundation of Xinjiang Province [2016D01C083]; Shanghai key discipline of medical imaging [2017ZZ02005]	The author(s) received the following financial support for the research, authorship, and/or publication of this article: This study is supported by National Natural Science Foundation of China (Nos. 81901727, 81271540, 81301213), Natural Science Foundation of Xinjiang Province (No. 2016D01C083), 2018 Youth Medical Talents - Medical Imaging Practitioner Program, and Shanghai key discipline of medical imaging (No. 2017ZZ02005).	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hart MG, 2017, NEUROIMAGE-CLIN, V15, P194, DOI 10.1016/j.nicl.2017.04.026; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Karlsen RH, 2019, J NEUROSCI RES, V97, P568, DOI 10.1002/jnr.24383; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Little DM, 2014, ALZHEIMERS DEMENT, V10, pS188, DOI 10.1016/j.jalz.2014.04.002; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mueller A, 2017, TRENDS COGN SCI, V21, P474, DOI 10.1016/j.tics.2017.03.009; Muftuler LT, 2020, J NEUROTRAUM, V37, P2081, DOI 10.1089/neu.2020.6993; Patel JB, 2020, AM J NEURORADIOL, V41, P92, DOI 10.3174/ajnr.A6346; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Strauss SB, 2016, AM J NEURORADIOL, V37, P1983, DOI 10.3174/ajnr.A4851; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang ML, 2018, NEUROSCIENCE, V392, P180, DOI 10.1016/j.neuroscience.2018.09.030; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zi W, 2014, ACTA NEUROL SCAND, V130, P178, DOI 10.1111/ane.12262	40	1	1	2	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	APR	2022	63	4					504	512	0284185121998317	10.1177/0284185121998317		FEB 2021	9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	YR9QR	WOS:000680701800001	33641452				2022-02-06	
J	Brown-Taylor, L; Jaramillo, C; Eapen, BC; Kretzmer, T; Gavin, LP; Cooper, T; Pugh, MJ				Brown-Taylor, Lindsey; Jaramillo, Carlos; Eapen, Blessen C.; Kretzmer, Tracy; Gavin, Lindsey P.; Cooper, Tyler; Pugh, Mary J.			Accumulation of Good Intentions: How Individual Practice Guidelines Lead to Polypharmacy in the Treatment of Patients with Polytrauma	PM&R			English	Article								Polytrauma clinical triad (PCT) is the comorbid occurrence of traumatic brain injury (TBI), posttraumatic stress disorder (PTSD), and pain after trauma. No clinical practice guidelines for postacute care of patients with PCT currently exist; instead, clinical practice guidelines have been published for the three conditions (TBI, PTSD, and pain) as distinct clinical entities. Using multiple, individual practice guidelines for a patient with PCT may lead to unintended prescription of multiple and potentially adversely interacting medications (ie, polypharmacy). Polypharmacy, especially that which includes central nervous system-acting medications, may lead to overdose, suicidality, and chronic symptomatology. Current individual guidelines for each condition of PCT do not address how to coordinate care for the polytraumatic diagnosis. The purpose of this Practice Management piece is to describe the unintended consequences of polypharmacy in patients with PCT and to discuss mitigation approaches including rational prescribing, nonpharmacologic alternatives, and interdisciplinary coordination.	[Brown-Taylor, Lindsey; Pugh, Mary J.] Decis Enhancement & Analyt Sci IDEAS Ctr Innovat, Salt Lake City, UT 84112 USA; [Jaramillo, Carlos] South Texas Vet Hlth Care Syst, San Antonio Polytrauma Ctr, San Antonio, TX USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Kretzmer, Tracy] James A Haley Vet Hosp, Tampa, FL USA; [Gavin, Lindsey P.; Cooper, Tyler; Pugh, Mary J.] Univ Utah, Sch Med, Salt Lake City, UT USA		Brown-Taylor, L (corresponding author), Decis Enhancement & Analyt Sci IDEAS Ctr Innovat, Salt Lake City, UT 84112 USA.	lindsey.brown.taylor@utah.edu		Brown-Taylor, Lindsey/0000-0003-1479-8968			Adams RS, 2019, J HEAD TRAUMA REHAB, V34, P167, DOI 10.1097/HTR.0000000000000481; Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Aronson JK, 2004, BRIT J CLIN PHARMACO, V57, P229, DOI 10.1111/j.1365-2125.2004.02090.x; Braun BJ, 2016, EFORT OPEN REV, V1, P146, DOI 10.1302/2058-5241.1.160002; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; Eide Richard P 3rd, 2018, MSMR, V25, P2; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Gardner Annette L, 2018, Fed Pract, V35, P40; Geller AI, 2012, PM&R, V4, P198, DOI 10.1016/j.pmrj.2012.02.012; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Oldak S, 2019, ONCOLOGIST, V24, P1201, DOI 10.1634/theoncologist.2018-0807; Peixoto C, 2018, J PAIN RES, V11, P1927, DOI 10.2147/JPR.S165077; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0270-1; Piggott KL, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m261; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; The diagnosis and treatment of low back pain work group, 2017, VA DOD CLIN PRACT GU; The Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; The Management of Posttraumatic Stress Disorder Work Group, 2017, VA DOD CLIN PRACT GU; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458	21	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2021	13	10					1169	1175		10.1002/pmrj.12526		FEB 2021	7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	WC5YZ	WOS:000624128800001	33247558				2022-02-06	
J	van der Eerden, AW; van den Heuvel, TL; Perlbarg, V; Vart, P; Vos, PE; Puybasset, L; Galanaud, D; Platel, B; Manniesing, R; Goraj, BM				van der Eerden, A. W.; van den Heuvel, T. L.; Perlbarg, V.; Vart, P.; Vos, P. E.; Puybasset, L.; Galanaud, D.; Platel, B.; Manniesing, R.; Goraj, B. M.			Traumatic Cerebral Microbleeds in the Subacute Phase Are Practical and Early Predictors of Abnormality of the Normal-Appearing White Matter in the Chronic Phase	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							BRAIN-INJURY; AXONAL INJURY; RELIABILITY; METRICS; LESIONS; TRACTS; DTI	BACKGROUND AND PURPOSE: In the chronic phase after traumatic brain injury, DTI findings reflect WM integrity. DTI interpretation in the subacute phase is less straightforward. Microbleed evaluation with SWI is straightforward in both phases. We evaluated whether the microbleed concentration in the subacute phase is associated with the integrity of normal-appearing WM in the chronic phase. MATERIALS AND METHODS: Sixty of 211 consecutive patients 18 years of age or older admitted to our emergency department ?24 hours after moderate to severe traumatic brain injury matched the selection criteria. Standardized 3T SWI, DTI, and T1WI were obtained 3 and 26?weeks after traumatic brain injury in 31 patients and 24 healthy volunteers. At baseline, microbleed concentrations were calculated. At follow-up, mean diffusivity (MD) was calculated in the normal-appearing WM in reference to the healthy volunteers (MDz). Through linear regression, we evaluated the relation between microbleed concentration and MDz in predefined structures. RESULTS: In the cerebral hemispheres, MDz at follow-up was independently associated with the microbleed concentration at baseline (left: B = 38.4 [95% CI 7.5?69.3], P?=?.017; right: B?=?26.3 [95% CI 5.7?47.0], P?=?.014). No such relation was demonstrated in the central brain. MDz in the corpus callosum was independently associated with the microbleed concentration in the structures connected by WM tracts running through the corpus callosum (B?=?20.0 [95% CI 24.8?75.2], P?<?.000). MDz in the central brain was independently associated with the microbleed concentration in the cerebral hemispheres (B?=?25.7 [95% CI 3.9?47.5], P?=?.023). CONCLUSIONS: SWI-assessed microbleeds in the subacute phase are associated with DTI-based WM integrity in the chronic phase. These associations are found both within regions and between functionally connected regions.	[van der Eerden, A. W.; van den Heuvel, T. L.; Platel, B.; Manniesing, R.; Goraj, B. M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands; [van der Eerden, A. W.] Erasmus MC, Dept Radiol & Nucl Med, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Perlbarg, V.] Sorbonne Univ, Lab Imagerie Biomed, INSERM, CNRS, Paris, France; [Perlbarg, V.] BrainTale SAS, Paris, France; [Vart, P.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, Nijmegen, Netherlands; [Vos, P. E.] Santiz Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands; [Puybasset, L.] Hop La Pitie Salpetriere, AP HP, Dept Neurosurg ICU, Paris, France; [Galanaud, D.] Hop La Pitie Salpetriere, AP HP, Dept Neuroradiol, Paris, France; [Goraj, B. M.] Med Ctr Postgrad Educ, Dept Diagnost Imaging, Warsaw, Poland		van der Eerden, AW (corresponding author), Erasmus MC, Dept Radiol & Nucl Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.vandereerden@erasmusmc.nl	; Platel, Bram/D-2132-2009; Manniesing, Rashindra/G-9728-2015	Perlbarg, Vincent/0000-0002-3438-2479; Platel, Bram/0000-0002-1936-6825; PUYBASSET, Louis/0000-0002-6849-1825; Manniesing, Rashindra/0000-0002-4616-6298	Trauma Regio Oost, Radboudumc, Nijmegen; Stichting Fonds Catharine van Tussenbroek	This is an investigator-initiated study supported by Trauma Regio Oost, Radboudumc, Nijmegen, and by Stichting Fonds Catharine van Tussenbroek (travel grant). The funding organizations did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; and the decision to submit the manuscript for publication.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; [Anonymous], MNI ICBM 152 NONLINE; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Chen YJ, 2017, J NEUROIMAGING, V27, P272, DOI 10.1111/jon.12404; Cicuendez M, 2017, ACTA NEUROCHIR, V159, P25, DOI 10.1007/s00701-016-3000-4; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Domin M, 2019, BRAIN STRUCT FUNCT, V224, P1447, DOI 10.1007/s00429-019-01849-1; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Haller S, 2018, RADIOLOGY, V287, P11, DOI 10.1148/radiol.2018170803; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Ma CC, 2014, J CLIN NEUROSCI, V21, P1388, DOI 10.1016/j.jocn.2013.11.032; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Yokoyama K, 2008, AM J NEURORADIOL, V29, P1159, DOI 10.3174/ajnr.A1001; Zhang JQ, 2013, NEUROSCI LETT, V551, P47, DOI 10.1016/j.neulet.2013.07.003	34	1	1	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2021	42	5					861	867		10.3174/ajnr.A7028		FEB 2021	7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	SA2MM	WOS:000644232000001	33632731				2022-02-06	
J	Chen, YF; Herrold, AA; Gallagher, V; Martinovich, Z; Bari, S; Vike, NL; Vesci, B; Mjaanes, J; McCloskey, LR; Reilly, JL; Breiter, HC				Chen, Yufen; Herrold, Amy A.; Gallagher, Virginia; Martinovich, Zoran; Bari, Sumra; Vike, Nicole L.; Vesci, Brian; Mjaanes, Jeffrey; McCloskey, Leanne R.; Reilly, James L.; Breiter, Hans C.			Preliminary Report: Localized Cerebral Blood Flow Mediates the Relationship between Progesterone and Perceived Stress Symptoms among Female Collegiate Club Athletes after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain perfusion; concussion; female; mild traumatic injury; progesterone; sport injury		Female athletes are under-studied in the field of concussion research, despite evidence of higher injury prevalence and longer recovery time. Hormonal fluctuations caused by the natural menstrual cycle (MC) or hormonal contraceptive (HC) use impact both post-injury symptoms and neuroimaging findings, but the relationships among hormone, symptoms, and brain-based measures have not been jointly considered in concussion studies. In this preliminary study, we compared cerebral blood flow (CBF) measured with arterial spin labeling between concussed female club athletes 3-10 days after mild traumatic brain injury (mTBI) and demographic, HC/MC matched controls (CON). We tested whether CBF statistically mediates the relationship between progesterone serum levels and post-injury symptoms, which may support a hypothesis for progesterone's role in neuroprotection. We found a significant three-way relationship among progesterone, CBF, and perceived stress score (PSS) in the left middle temporal gyrus for the mTBI group. Higher progesterone was associated with lower (more normative) PSS, as well as higher (more normative) CBF. CBF mediates 100% of the relationship between progesterone and PSS (Sobel p value = 0.017). These findings support a hypothesis for progesterone having a neuroprotective role after concussion and highlight the importance of controlling for the effects of sex hormones in future concussion studies.	[Chen, Yufen] Northwestern Univ, Feinberg Sch Med, Ctr Translat Imaging, Dept Radiol, Chicago, IL 60611 USA; [Gallagher, Virginia; Martinovich, Zoran; Bari, Sumra; Vike, Nicole L.; Reilly, James L.; Breiter, Hans C.] Northwestern Univ, Feinberg Sch Med, Warren Wright Adolescent Ctr, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [McCloskey, Leanne R.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Herrold, Amy A.] Edward Hines Jr VA Hosp, Hines, IL USA; [Vesci, Brian; Mjaanes, Jeffrey] Northwestern Univ, Northwestern Hlth Serv Sports Med, Evanston, IL USA; [Breiter, Hans C.] Massachusetts Gen Hosp, Lab Neuroimaging & Genet, Dept Psychiat, Boston, MA 02114 USA; [Breiter, Hans C.] Harvard Med Sch, Boston, MA 02115 USA		Chen, YF (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Translat Imaging, Neuroimaging, 710 N Fairbanks Court,LC 0-300, Chicago, IL 60611 USA.	yfchen@northwestern.edu			Eleanor Wood-Prince Grant Initiative: A Project of the Woman's Board of Northwestern Memorial Hospital; National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS106840]; Clinical and Translational Science Award (CTSA) grant from the NIH [UL1TR001422]; Warren Wright Adolescent Center (WWAC); Northwestern Memorial Hospital; WWAC; VA RR&D Career Development Award [RX000949]	Funding was provided in part by the Eleanor Wood-Prince Grant Initiative: A Project of the Woman's Board of Northwestern Memorial Hospital, the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under Award Number F31NS106840, and data collection via REDCap was supported in part by a Clinical and Translational Science Award (CTSA) grant from the NIH under Award Number UL1TR001422. Funding for scanning was supplied by the Warren Wright Adolescent Center (WWAC), Northwestern Memorial Hospital, and the WWAC provided space and/or salary for V.G., S.B., N.L.V., J.L.R., and H.C.B. A.A.H. was supported by VA RR&D Career Development Award RX000949. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Acord-Vira A, 2019, J POSTSECOND EDUC DI, V32, P35; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Andreano JM, 2010, NEUROIMAGE, V53, P1286, DOI 10.1016/j.neuroimage.2010.07.011; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Bain CAL, 2004, HUM REPROD, V19, P2411, DOI 10.1093/humrep/deh396; Bari S, 2019, BRAIN IMAGING BEHAV, V13, P735, DOI 10.1007/s11682-018-9861-9; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Birdsill AC, 2013, OBESITY, V21, P1313, DOI 10.1002/oby.20170; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Breiter H., 2020, IMPLEMENTING ALGORIT, DOI [10.1101/2020.02.29.971275, DOI 10.1101/2020.02.29.971275]; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Cai J, 2015, NEUROSCI LETT, V600, P238, DOI 10.1016/j.neulet.2015.06.023; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056733; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Chen Y., CONCUSSION NEUROIMAG, V1, DOI [10.1093/texcom/tgaa078, DOI 10.1093/TEXCOM/TGAA078]; Chen YF, 2019, J ORTHOP SPORT PHYS, V49, P811, DOI 10.2519/jospt.2019.8884; Cheslock J., 2007, WHOS PLAYING COLL SP; Churchill NW, 2019, NEUROLOGY, V93, pE1980, DOI 10.1212/WNL.0000000000008523; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Constantini Naama W, 2005, Clin Sports Med, V24, pe51, DOI 10.1016/j.csm.2005.01.003; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Craig MC, 2008, HORM BEHAV, V53, P503, DOI 10.1016/j.yhbeh.2007.11.005; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Daniels Kimberly, 2013, Natl Health Stat Report, P1; Davey J, 2016, NEUROIMAGE, V137, P165, DOI 10.1016/j.neuroimage.2016.05.051; De Bondt T, 2013, EUR RADIOL, V23, P57, DOI 10.1007/s00330-012-2572-5; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Gasic GP, 2009, AM J MED GENET B, V150B, P762, DOI 10.1002/ajmg.b.30944; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gingnell M, 2012, HORM BEHAV, V62, P400, DOI 10.1016/j.yhbeh.2012.07.005; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Hamer J, 2020, J NEUROTRAUM, V37, P1197, DOI 10.1089/neu.2019.6800; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Herrold AA, 2019, MIL MED, V184, P138, DOI 10.1093/milmed/usy306; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Herzberg SD, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117718781; Hu WT, 2010, NEUROLOGY, V75, P881, DOI 10.1212/WNL.0b013e3181f11e35; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Joseph JE, 2012, NEUROIMAGE, V59, P2923, DOI 10.1016/j.neuroimage.2011.09.067; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kay J, 2019, NEUROLOGY, V93, pS14, DOI 10.1212/01.wnl.0000580968.75648.4b; Khaksari M, 2018, TRANSL STROKE RES, V9, P393, DOI 10.1007/s12975-017-0588-5; Konrad C, 2008, J NEURAL TRANSM, V115, P1327, DOI 10.1007/s00702-008-0073-0; Krause DN, 2011, ACTA PHYSIOL, V203, P181, DOI 10.1111/j.1748-1716.2011.02323.x; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Mozolic JL, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.016.2010; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Pedersen ER, 2012, PSYCHOL ADDICT BEHAV, V26, P672, DOI 10.1037/a0027945; Peltonen GL, 2016, AM J PHYSIOL-REG I, V311, pR222, DOI 10.1152/ajpregu.00106.2016; Pennington B., 2008, NEW YORK TIMES; Perlis RH, 2008, ARCH GEN PSYCHIAT, V65, P882, DOI 10.1001/archgenpsychiatry.2008.3; Petersen N, 2014, NEUROIMAGE, V90, P24, DOI 10.1016/j.neuroimage.2013.12.016; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Robinson SM, 2014, PSYCHOL ADDICT BEHAV, V28, P154, DOI 10.1037/a0030992; Sankar SB, 2019, NEUROBIOL DIS, V124, P544, DOI 10.1016/j.nbd.2018.12.018; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Somerson JS, 2019, JBJS REV, V7, DOI 10.2106/JBJS.RVW.18.00198; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Viswanathan V, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/jnhum.2015.00176, 10.3389/fnhum.2015.00176]; Wang Y, 2019, BRAIN IMAGING BEHAV, V13, P1375, DOI 10.1007/s11682-018-9946-5; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Weis S, 2008, J NEUROSCI, V28, P13401, DOI 10.1523/JNEUROSCI.4392-08.2008; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu YW, 2016, NEUROIMAGE, V132, P542, DOI 10.1016/j.neuroimage.2016.03.004; Yun JY, 2017, J AFFECT DISORDERS, V214, P53, DOI 10.1016/j.jad.2017.01.043	97	1	1	3	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1809	1820		10.1089/neu.2020.7217		FEB 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000623960300001	33470158				2022-02-06	
J	Miles, SR; Hammond, FM; Neumann, D; Silva, MA; Tang, XY; Kajankova, M; Dillahunt-Aspillaga, C; Nakase-Richardson, R				Miles, Shannon R.; Hammond, Flora M.; Neumann, Dawn; Silva, Marc A.; Tang, Xinyu; Kajankova, Maria; Dillahunt-Aspillaga, Christina; Nakase-Richardson, Risa			Evolution of Irritability, Anger, and Aggression after Traumatic Brain Injury: Identifying and Predicting Subgroups	JOURNAL OF NEUROTRAUMA			English	Article						aggression; anger; irritable mood; rehabilitation; post-traumatic stress disorder; traumatic brain injury		The current prospective, multi-center, longitudinal cohort study examined how veterans/service members (V/SM) changed in their irritability, anger, and aggression (IAA) scores from admission to discharge in post-acute rehabilitation settings. The goals were to identify trajectory subgroups, and explore if there were different predictors of the subgroups. V/SM (n = 346) from five Veterans Affairs TBI Model Systems Polytrauma Rehabilitation Centers participated. The sample was mostly men (92%) and identified as white (69%), black (13%), and other races (18%). Median age was 28 years, and 78% had sustained a severe TBI. Staff rated IAA at admission and discharge using the Mayo-Portland Adaptability Inventory-4 item#15. Four IAA trajectory subgroups were identified: (1) no IAA at admission or discharge (n = 89, 25.72%), (2) resolved IAA (n = 61, 17.63%), (3) delayed onset IAA (n = 31, 8.96%), and (4) persistent IAA (n = 165, 47.69%). Greater post-traumatic stress disorder (PTSD) symptoms were the only consistent predictor of belonging to all the subgroups who had IAA compared with the no IAA subgroup. We conclude that IAA had different trajectories after a TBI. The majority of V/SM had persistent impairment from IAA, a quarter of the sample had no impairment from IAA, and fewer participants had resolving or worsening IAA. Findings emphasize the importance of educating providers and family of the different ways and times that IAA can manifest after TBI. Timely diagnosis and treatment of PTSD symptoms during and after rehabilitation are critical treatment targets.	[Miles, Shannon R.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL USA; [Miles, Shannon R.; Silva, Marc A.] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Silva, Marc A.; Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Pulm & Sleep Med Div, Tampa, FL 33620 USA; [Hammond, Flora M.; Neumann, Dawn] Indiana Univ Sch Med, Rehabil Hosp Indiana, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Tang, Xinyu] Tampa VA Res & Educ Fdn Inc, Tampa, FL USA; [Kajankova, Maria] Icahn Sch Med Mt Sinai, Brain Injury Res Ctr, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Rehabil & Mental Hlth Counseling Program, Coll Behav & Community Sci, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, TBI Ctr Excellence, Tampa, FL USA		Miles, SR (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd 117, Tampa, FL 33612 USA.	shannon.miles@va.gov	Miles, Shannon/AAS-2173-2021	Miles, Shannon/0000-0001-8925-1321	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research [NIDILRR]); VHA Central Office VA TBI Model System Program of Research, Subcontract from General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; NIDILRRUnited States Department of Health & Human Services [90DRTB0002]	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is a funded collaboration between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research [NIDILRR]). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency, and NIDILRR (grant 90DRTB0002 to Indiana University).The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official position of HIDILLR, ACL, HHS, Departments of Veterans Affairs and Defense or of any other federal agency, policy, or decision unless so designated by other official documentation.	Alderman N, 2007, BRAIN INJURY, V21, P891, DOI 10.1080/02699050701543560; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P314, DOI 10.1097/HTR.0b013e3182562f04; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Centers for Disease Control and Prevention, 2006, BEHAV RISK FACTOR SU; Centers for Disease Control and Prevention, 2019, SURVEILLANCE REPORT; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Elmer J, 2019, RESUSCITATION, V137, P197, DOI 10.1016/j.resuscitation.2019.02.030; Flaherty JM, 2018, J CLIN PSYCHOL, V74, P1281, DOI 10.1002/jclp.22595; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Greve KW, 2001, BRAIN INJURY, V15, P255; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hammond FM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000136; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kelly G, 2008, BRAIN IMPAIR, V9, P293, DOI 10.1375/brim.9.3.293; Kerr K, 2011, BRAIN INJURY, V25, P729, DOI 10.3109/02699052.2011.580315; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Miles SR, 2020, ARCH PHYS MED REHAB, V101, P81, DOI 10.1016/j.apmr.2019.07.018; Miles SR, 2016, PSYCHOL TRAUMA-US, V8, P464, DOI 10.1037/tra0000132; Miles SR, 2016, J INTERPERS VIOLENCE, V31, P1795, DOI 10.1177/0886260515570746; Nagin DS, 2018, STAT METHODS MED RES, V27, P2015, DOI 10.1177/0962280216673085; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Orth U, 2006, J CONSULT CLIN PSYCH, V74, P698, DOI 10.1037/0022-006X.74.4.698; Ragsdale KA, 2018, BEHAV THER, V49, P617, DOI 10.1016/j.beth.2017.09.008; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Ropacki S, 2018, ARCH PHYS MED REHAB, V99, P952, DOI 10.1016/j.apmr.2017.12.035; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tonkonogy J M, 1991, J Neuropsychiatry Clin Neurosci, V3, P189; U.S. Department of Veterans Affairs Office of Health Equity, RACIAL ETHNIC MINORI; Visscher AJM, 2011, J CLIN NURS, V20, P3414, DOI 10.1111/j.1365-2702.2011.03800.x; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Zayfert C, 2005, J TRAUMA STRESS, V18, P637, DOI 10.1002/jts.20072	41	1	1	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1827	1833		10.1089/neu.2020.7451		FEB 2021	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000624025000001	33470179				2022-02-06	
J	Raguz, M; Predrijevac, N; Dlaka, D; Oreskovic, D; Rotim, A; Romic, D; Almahariq, F; Marcinkovic, P; Deletis, V; Kostovic, I; Chudy, D				Raguz, Marina; Predrijevac, Nina; Dlaka, Domagoj; Oreskovic, Darko; Rotim, Ante; Romic, Dominik; Almahariq, Fadi; Marcinkovic, Petar; Deletis, Vedran; Kostovic, Ivica; Chudy, Darko			Structural changes in brains of patients with disorders of consciousness treated with deep brain stimulation	SCIENTIFIC REPORTS			English	Article							AUTOMATED 3-D EXTRACTION; VEGETATIVE STATE; ELECTRICAL-STIMULATION; RETICULAR-FORMATION; THALAMIC CONTRIBUTIONS; HIPPOCAMPAL-FORMATION; NUCLEUS-ACCUMBENS; CEREBRAL-CORTEX; AROUSAL; INTRALAMINAR	Disorders of consciousness (DOC) are one of the major consequences after anoxic or traumatic brain injury. So far, several studies have described the regaining of consciousness in DOC patients using deep brain stimulation (DBS). However, these studies often lack detailed data on the structural and functional cerebral changes after such treatment. The aim of this study was to conduct a volumetric analysis of specific cortical and subcortical structures to determine the impact of DBS after functional recovery of DOC patients. Five DOC patients underwent unilateral DBS electrode implantation into the centromedian parafascicular complex of the thalamic intralaminar nuclei. Consciousness recovery was confirmed using the Rappaport Disability Rating and the Coma/Near Coma scale. Brain MRI volumetric measurements were done prior to the procedure, then approximately a year after, and finally 7 years after the implementation of the electrode. The volumetric analysis included changes in regional cortical volumes and thickness, as well as in subcortical structures. Limbic cortices (parahippocampal and cingulate gyrus) and paralimbic cortices (insula) regions showed a significant volume increase and presented a trend of regional cortical thickness increase 1 and 7 years after DBS. The volumes of related subcortical structures, namely the caudate, the hippocampus as well as the amygdala, were significantly increased 1 and 7 years after DBS, while the putamen and nucleus accumbens presented with volume increase. Volume increase after DBS could be a result of direct DBS effects, or a result of functional recovery. Our findings are in accordance with the results of very few human studies connecting DBS and brain volume increase. Which mechanisms are behind the observed brain changes and whether structural changes are caused by consciousness recovery or DBS in patients with DOC is still a matter of debate.	[Raguz, Marina; Predrijevac, Nina; Dlaka, Domagoj; Oreskovic, Darko; Romic, Dominik; Almahariq, Fadi; Marcinkovic, Petar; Chudy, Darko] Dubrava Univ Hosp, Dept Neurosurg, Avenija Gojka Suska 6, Zagreb 10000, Croatia; [Raguz, Marina; Oreskovic, Darko; Almahariq, Fadi; Kostovic, Ivica; Chudy, Darko] Univ Zagreb, Ctr Excellence Basic Clin & Translat Neurosci, Croatian Inst Brain Res, Sch Med, Zagreb, Croatia; [Rotim, Ante] Sestre Milosrdnice Univ Hosp Ctr, Dept Neurosurg, Zagreb, Croatia; [Deletis, Vedran] Albert Einstein Coll Med, New York, NY USA; [Chudy, Darko] Univ Zagreb, Sch Med, Dept Surg, Zagreb, Croatia		Raguz, M (corresponding author), Dubrava Univ Hosp, Dept Neurosurg, Avenija Gojka Suska 6, Zagreb 10000, Croatia.; Raguz, M (corresponding author), Univ Zagreb, Ctr Excellence Basic Clin & Translat Neurosci, Croatian Inst Brain Res, Sch Med, Zagreb, Croatia.	marinaraguz@gmail.com			Croatian Science Fundation [CSF-IP-2020-02-4308]; European Union through the European Regional Development Fund, Operational Program Competitiveness and Cohesion, Grant [KK.01.1.1.01.0007]; Adris Foundation Grant "Application analysis of a robotic system for stereotactic neuronavigation"	This research was supported by the Croatian Science Fundation project CSF-IP-2020-02-4308, the European Union through the European Regional Development Fund, Operational Program Competitiveness and Cohesion, Grant agreement No. KK.01.1.1.01.0007, CoRE-Neuro. In addition, this research was supported by the Adris Foundation Grant "Application analysis of a robotic system for stereotactic neuronavigation", leader Assistant Professor Darko Chudy, M.D., Ph.D.	Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Annen J, 2018, ANN NEUROL, V83, P842, DOI 10.1002/ana.25214; Bayne T, 2016, TRENDS COGN SCI, V20, P405, DOI 10.1016/j.tics.2016.03.009; Beaumont JG, 2005, NEUROPSYCHOL REHABIL, V15, P184, DOI 10.1080/09602010443000489; Behrendt RP, 2013, REV NEUROSCIENCE, V24, P239, DOI 10.1515/revneuro-2012-0088; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bezchlibnyk YB, 2017, BRAIN STIMUL, V10, P315, DOI 10.1016/j.brs.2016.11.013; Block N, 2007, BEHAV BRAIN SCI, V30, P481, DOI 10.1017/S0140525X07002786; Boucher M, 2009, MED IMAGE ANAL, V13, P203, DOI 10.1016/j.media.2008.09.001; Bregant T, 2013, EUR J PAEDIATR NEURO, V17, P608, DOI 10.1016/j.ejpn.2013.05.005; CALVET J, 1959, Rev Otoneuroophtalmol, V31, P443; Casanova MF, 2009, J AUTISM DEV DISORD, V39, P751, DOI 10.1007/s10803-008-0681-4; Casanova MF, 2002, J CHILD NEUROL, V17, P515, DOI 10.1177/088307380201700708; Cavdar S, 2008, J ANAT, V212, P249, DOI 10.1111/j.1469-7580.2008.00858.x; Chang YM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00035; Chudy D, 2018, J NEUROSURG, V128, P1189; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd ed.; Corbetta M, 2006, P 12 ANN M ORG HUM B; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Crick F, 2004, NEUROSURGERY, V55, P273, DOI 10.1227/01.NEU.0000129279.26534.76; DANDY WE, 1946, B JOHNS HOPKINS HOSP, V79, P34; Das G D, 1969, Ergeb Anat Entwicklungsgesch, V41, P3; Delacour J, 1997, BEHAV BRAIN RES, V85, P127, DOI 10.1016/S0166-4328(96)00161-1; Eckert U, 2012, HUM BRAIN MAPP, V33, P2627, DOI 10.1002/hbm.21389; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; GREEN JD, 1956, ELECTROEN CLIN NEURO, V8, P245, DOI 10.1016/0013-4694(56)90117-1; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; HALGREN E, 1978, BRAIN, V101, P83, DOI 10.1093/brain/101.1.83; Hamani C, 2011, EXP NEUROL, V232, P100, DOI 10.1016/j.expneurol.2011.08.023; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; JAYARAMAN A, 1985, J COMP NEUROL, V231, P396, DOI 10.1002/cne.902310309; JENNETT B, 1972, LANCET, V1, P734; Jessberger S, 2016, F1000RES, V12, P5, DOI [10.12688/f1000research.7459.1, DOI 10.12688/F1000RESEARCH.7459.1]; Johnson LSM, 2011, J MED ETHICS, V37, P175, DOI 10.1136/jme.2010.038877; JONES EG, 1974, J COMP NEUROL, V154, P349, DOI 10.1002/cne.901540402; Kerr AL, 2011, J COMMUN DISORD, V44, P538, DOI 10.1016/j.jcomdis.2011.04.011; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; KOSTOVIC I, 1980, J NEUROCYTOL, V9, P219, DOI 10.1007/BF01205159; Kretschmer E, 1940, Z GESAMTE NEUROL PSY, V169, P576, DOI 10.1007/BF02871384; Laureys S, 2017, COMA DISORDERS CONSC, DOI [10.1007/978-3-319-55964-3, DOI 10.1007/978-3-319-55964-3]; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LEISE EM, 1990, BRAIN RES REV, V15, P1, DOI 10.1016/0165-0173(90)90009-D; LEONTOVICH TA, 1963, J COMP NEUROL, V121, P347, DOI 10.1002/cne.901210305; Levitt JG, 2003, CEREB CORTEX, V13, P728, DOI 10.1093/cercor/13.7.728; Lu-Emerson C, 2010, NEUROREHABILITATION, V26, P35, DOI 10.3233/NRE-2010-0534; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MACCHI G, 1984, EXP BRAIN RES, V54, P225; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; Manjon JV, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00030; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCLARDY T, 1969, CONFIN NEUROL, V31, P219; Metzger CD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00024; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Mogensen J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00625; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Mota B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00127; NEWMAN J, 1995, CONSCIOUS COGN, V4, P172, DOI 10.1006/ccog.1995.1024; Okubo Y, 2011, J PHYSIOL-LONDON, V589, P481, DOI 10.1113/jphysiol.2010.199539; Overgaard M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01719; Overgaard M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0209; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; RAMONMOLINER E, 1966, J COMP NEUROL, V126, P311, DOI 10.1002/cne.901260301; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Robbins S.M, 2004, THESIS MCGILL U; Rubeaux M, 2015, PROC SPIE, V9287, DOI 10.1117/12.2071146; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Sankar T, 2015, BRAIN STIMUL, V8, P645, DOI 10.1016/j.brs.2014.11.020; Santuy A, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0377-17.2017; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2009, ARCH NEUROL-CHICAGO, V66, P697, DOI 10.1001/archneurol.2009.79; Seidel K, 2020, NEUROPHYSIOLOGY NEUR, V2, P515, DOI [10.1016/B978-0-12-815000-9.00036-8, DOI 10.1016/B978-0-12-815000-9.00036-8]; Sharma Nikhil, 2013, Handb Clin Neurol, V110, P3, DOI 10.1016/B978-0-444-52901-5.00001-0; Sherif T., 2014, NEUROINFORMATICS, V21, P54, DOI [10.3389/fninf.2014.00054, DOI 10.3389/FNINF.2014.00054]; Singh V, 2005, P 11 ANN M ORG HUM B; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; SU HS, 1990, J COMP NEUROL, V297, P582, DOI 10.1002/cne.902970410; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Tsubokawa T, 1990, Brain Inj, V4, P315; Turner DA, 2011, J NEUROPATH EXP NEUR, V70, P167, DOI 10.1097/NEN.0b013e31820e1152; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Vanhoecke J, 2017, BRAIN STIMUL, V10, P1013, DOI 10.1016/j.brs.2017.08.006; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; Yamamoto T, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.04.010; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x; Young GB, 1999, ARCH NEUROL-CHICAGO, V56, P153, DOI 10.1001/archneur.56.2.153; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263; Zijdenbos A, 1998, LECT NOTES COMPUTER	99	1	1	5	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	FEB 23	2021	11	1							4401	10.1038/s41598-021-83873-y			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT6WQ	WOS:000626731000024	33623134	Green Published, gold			2022-02-06	
J	Schaffert, J; Didehbani, N; LoBue, C; Hart, J; Rossetti, H; Lacritz, L; Cullum, CM				Schaffert, Jeff; Didehbani, Nyaz; LoBue, Christian; Hart, John; Rossetti, Heidi; Lacritz, Laura; Cullum, C. Munro			Frequency and Predictors of Traumatic Encephalopathy Syndrome in a Prospective Cohort of Retired Professional Athletes	FRONTIERS IN NEUROLOGY			English	Article						traumatic encephalopathy syndrome; chronic traumatic encephalopathy; concussion and sports; dementia; athletes		Traumatic encephalopathy syndrome (TES) is proposed to represent the long-term impact of repetitive head-injury exposure and the clinical manifestation of chronic traumatic encephalopathy (CTE). This study aimed to evaluate the frequency of TES in a cohort of retired professional contact sport athletes, compare the frequency of TES to clinical consensus diagnoses, and identify predictors that increase the likelihood of TES diagnosis. Participants were 85 retired professional contact sport athletes from a prospective cohort at the University of Texas Southwestern Medical Center and the University of Texas at Dallas. Participants ranged in age from 23 to 79 (M = 55.95, SD = 13.82) and obtained 7 to 19 years of education (M = 16.08, SD = 1.03). Retirees were either non-Hispanic white (n = 62) or African-American (n = 23). Retired athletes underwent a standard clinical evaluation, which included a clinical interview, neurological exam, neuroimaging, neuropsychological testing, and consensus diagnosis of normal, mild cognitive impairment, or dementia. TES criteria were applied to all 85 athletes, and frequencies of diagnoses were compared. Fourteen predictors of TES diagnosis were evaluated using binary logistic regressions, and included demographic, neuropsychological, depression symptoms, and head-injury exposure variables. A high frequency (56%) of TES was observed among this cohort of retired athletes, but 54% of those meeting criteria for TES were diagnosed as cognitively normal via consensus diagnosis. Games played in the National Football League (OR = 0.993, p = 0.087), number of concussions (OR = 1.020, p = 0.532), number of concussions with loss of consciousness (OR = 1.141 p = 0.188), and years playing professionally (OR = 0.976, p = 0.627) were not associated with TES diagnosis. Degree of depressive symptomatology, as measured by the total score on the Beck Depression Inventory-II, was the only predictor of TES diagnosis (OR = 1.297, p < 0.001). Our results add to previous findings underscoring the risk for false positive diagnosis, highlight the limitations of the TES criteria in clinical and research settings, and question the relationship between TES and head-injury exposure. Future research is needed to examine depression in retired professional athletes.	[Schaffert, Jeff; Didehbani, Nyaz; LoBue, Christian; Rossetti, Heidi; Lacritz, Laura; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Didehbani, Nyaz; Hart, John] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [LoBue, Christian; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA; [Hart, John] Univ Texas Dallas, Sch Behav & Brain Sci, Callier Ctr, Dallas, TX USA; [Hart, John; Lacritz, Laura; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA		Cullum, CM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.; Cullum, CM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosurg, Dallas, TX 75390 USA.; Cullum, CM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA.	munro.cullum@utsouthwestern.edu			state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders; Alzheimer's Association Research Grant [2019-AARG643558]; US Army Medical Research and Development Program [W81XWH-20-1-0493]; Texas Institute for Brain Injury and Repair (TIBIR), a state-funded initiative as part of the Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center; University of Texas at Dallas; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [5K23AG030006]	This study was made possible, in part, by the Texas Alzheimer's Research and Care Consortium (TARCC) funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders. This work was supported in part by an Alzheimer's Association Research Grant (2019-AARG643558) and the US Army Medical Research and Development Program (W81XWH-20-1-0493). Support was also provided by the Texas Institute for Brain Injury and Repair (TIBIR), a state-funded initiative as part of the Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center. This study was additionally supported by The University of Texas at Dallas, and in part by grant 5K23AG030006 from the National Institute on Aging.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Brett BL, 2019, J ALZHEIMERS DIS, V68, P591, DOI 10.3233/JAD-181058; Brett BL, 2019, J NEUROPSYCH CLIN N, V31, P17, DOI 10.1176/appi.neuropsych.18040080; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denney DA, 2019, J CLIN EXP NEUROPSYC, V41, P565, DOI 10.1080/13803395.2019.1588229; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Fields L, 2020, ARCH CLIN NEUROPSYCH, V35, P233, DOI 10.1093/arclin/acz008; Gil F, 2016, INT REV PSYCHIATR, V28, P572, DOI 10.1080/09540261.2016.1212821; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Heaton R. K., 2004, REVISED COMPREHENSIV; Hunsinger Benbow D., 2020, WABASH FOOTBALL PLAY; Iverson GL, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00739; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2019, J NEUROPSYCH CLIN N, V31, P328, DOI 10.1176/appi.neuropsych.18110280; Iverson GL, 2020, J NEUROPSYCH CLIN N, V32, P139, DOI 10.1176/appi.neuropsych.19010021; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kalmar JH, 2009, J INT NEUROPSYCH SOC, V15, P476, DOI 10.1017/S1355617709090584; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lyketsos Constantine G, 2011, Alzheimers Dement, V7, P532, DOI 10.1016/j.jalz.2011.05.2410; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; MEYERS J, 1995, MEYERS SCORING SYSTE; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2020, NEUROLOGY, V94; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Palmer BW, 1998, ARCH CLIN NEUROPSYCH, V13, P503, DOI 10.1016/S0887-6177(97)00037-1; Randolph C, 2018, ARCH CLIN NEUROPSYCH, V33, P644, DOI 10.1093/arclin/acy063; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Schaffert J, 2020, INT REV PSYCHIATR, V32, P71, DOI 10.1080/09540261.2019.1658572; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Wechsler, 1997, WECHSLER ADULT INTEL; Wolfson DI, 2020, BRAIN INJURY, V34, P528, DOI 10.1080/02699052.2020.1725843	41	1	1	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 23	2021	12								617526	10.3389/fneur.2021.617526			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QT2WV	WOS:000626452900001	33708171	Green Published, gold			2022-02-06	
J	Zhou, Z; Domel, AG; Li, XG; Grant, G; Kleiven, S; Camarillo, D; Zeineh, M				Zhou, Zhou; Domel, August G.; Li, Xiaogai; Grant, Gerald; Kleiven, Svein; Camarillo, David; Zeineh, Michael			White Matter Tract-Oriented Deformation Is Dependent on Real-Time Axonal Fiber Orientation	JOURNAL OF NEUROTRAUMA			English	Article						embedded element approach; finite element analysis; tract-oriented strain; traumatic axonal injury; white matter tracts		Traumatic axonal injury (TAI) is a critical public health issue with its pathogenesis remaining largely elusive. Finite element (FE) head models are promising tools to bridge the gap between mechanical insult, localized brain response, and resultant injury. In particular, the FE-derived deformation along the direction of white matter (WM) tracts (i.e., tract-oriented strain) has been shown to be an appropriate predictor for TAI. The evolution of fiber orientation in time during the impact and its potential influence on the tract-oriented strain remains unknown, however. To address this question, the present study leveraged an embedded element approach to track real-time fiber orientation during impacts. A new scheme to calculate the tract-oriented strain was proposed by projecting the strain tensors from pre-computed simulations along the temporal fiber direction instead of its static counterpart directly obtained from diffuse tensor imaging. The results revealed that incorporating the real-time fiber orientation not only altered the direction but also amplified the magnitude of the tract-oriented strain, resulting in a generally more extended distribution and a larger volume ratio of WM exposed to high deformation along fiber tracts. These effects were exacerbated with the impact severities characterized by the acceleration magnitudes. Results of this study provide insights into how best to incorporate fiber orientation in head injury models and derive the WM tract-oriented deformation from computational simulations, which is important for furthering our understanding of the underlying mechanisms of TAI.	[Zhou, Zhou; Domel, August G.; Camarillo, David] Stanford Univ, Dept Bioengn, 213 Quarry Rd, Stanford, CA 94305 USA; [Grant, Gerald; Camarillo, David] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Grant, Gerald] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Zeineh, Michael] Stanford Univ, Dept Radiol, 213 Quarry Rd, Stanford, CA 94305 USA; [Camarillo, David] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Li, Xiaogai; Kleiven, Svein] KTH Royal Inst Technol, Neuron Engn, Stockholm, Sweden		Zhou, Z (corresponding author), Stanford Univ, Dept Bioengn, 213 Quarry Rd, Stanford, CA 94305 USA.; Zeineh, M (corresponding author), Stanford Univ, Dept Radiol, 213 Quarry Rd, Stanford, CA 94305 USA.	zhouz@stanford.edu; mzeineh@stanford.edu			Taube Stanford Children's Concussion Initiative	Drs. Michael Zeineh, Gerald Grant, and David Camarillo received funding from the Pac-12 Conference's Student-Athlete Health and Well-Being Initiative and Taube Stanford Children's Concussion Initiative.	Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2020, ARCH COMPUT METHOD E, V27, P1187, DOI 10.1007/s11831-019-09352-w; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen, 2019, GOOGLE PATENTS; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; De Alvarenga V, 2019, J NEUROTRAUM, V36, pA4, DOI 10.1089/neu.2018.6143; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C., 2017, DEV ANISOTROPIC FINI, P2017; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hajiaghamemar M, 2021, J NEUROTRAUM, V38, P144, DOI 10.1089/neu.2019.6791; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hallquist J.O., 2020, LS DYNA KEYWORD USER; Hao H, 2007, J BIOMECH ENG-T ASME, V129, P511, DOI 10.1115/1.2746372; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven, 2005, P IRCOBI C PRAG CZEC, P21; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S., 2006, SCAND J FORENS SCI, V2, P73; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Li XR, 2020, BEHAV RES METHODS, V52, P2657, DOI 10.3758/s13428-020-01360-0; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mikula S, 2012, NAT METHODS, V9, P1198, DOI [10.1038/nmeth.2213, 10.1038/NMETH.2213]; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Montanino A., 2020, DEFINITION AXONAL IN, P2020; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tamura A, 2007, STAPP CAR CRASH JO, V51, P139; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z	90	1	1	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1730	1745		10.1089/neu.2020.7412		FEB 2021	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000623697100001	33446060	Green Submitted			2022-02-06	
J	Kopruszinski, CM; Turnes, JM; Swiokla, J; Weinstein, TJ; Schwedt, TJ; Dodick, DW; Anderson, T; Navratilova, E; Porreca, F				Kopruszinski, Caroline M.; Turnes, Joelle M.; Swiokla, Juliana; Weinstein, Troy J.; Schwedt, Todd J.; Dodick, David W.; Anderson, Trent; Navratilova, Edita; Porreca, Frank			CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache	CEPHALALGIA			English	Article						Mild traumatic brain injury (mTBI); concussion; post-traumatic headache (PTH); persistent post-traumatic headache (PPTH); diffuse noxious inhibitory controls (DNIC); conditioned pain modulation (CPM); CGRP; fremanezumab	MILD TRAUMATIC BRAIN; CONDITIONED PAIN MODULATION; INDUCED ANALGESIA; INJURY; STEM	Aim Determine the role of calcitonin-gene related peptide in promoting post-traumatic headache and dysregulation of central pain modulation induced by mild traumatic brain injury in mice. Methods Mild traumatic brain injury was induced in lightly anesthetized male C57BL/6J mice by a weight drop onto a closed and unfixed skull, which allowed free head rotation after the impact. We first determined possible alterations in the diffuse noxious inhibitory controls, a measure of net descending pain inhibition called conditioned pain modulation in humans at day 2 following mild traumatic brain injury. Diffuse noxious inhibitory control was assessed as the latency to a thermally induced tail-flick that served as the test stimulus in the presence of right forepaw capsaicin injection that provided the conditioning stimulus. Post-traumatic headache-like behaviors were assessed by the development of cutaneous allodynia in the periorbital and hindpaw regions after mild traumatic brain injury. We then determined if intraperitoneal fremanezumab, an anti-calcitonin-gene related peptide monoclonal antibody or vehicle administered 2 h after sham or mild traumatic brain injury induction could alter cutaneous allodynia or diffuse noxious inhibitory control responses on day 2 post mild traumatic brain injury. Results In naive and sham mice, capsaicin injection into the forepaw elevated the latency to tail-flick, reflecting the antinociceptive diffuse noxious inhibitory control response. Periorbital and hindpaw cutaneous allodynia, as well as a loss of diffuse noxious inhibitory control, was observed in mice 2 days after mild traumatic brain injury. Systemic treatment with fremanezumab blocked mild traumatic brain injury-induced cutaneous allodynia and prevented the loss of diffuse noxious inhibitory controls in mice subjected to a mild traumatic brain injury. Interpretation Sequestration of calcitonin-gene related peptide in the initial stages following mild traumatic brain injury blocked the acute allodynia that may reflect mild traumatic brain injury-related post-traumatic headache and, additionally, prevented the loss of net descending inhibition within central pain modulation pathways. As loss of conditioned pain modulation has been linked to multiple persistent pain conditions, dysregulation of descending modulatory pathways may contribute to the persistence of post-traumatic headache. Additionally, evaluation of the conditioned pain modulation/diffuse noxious inhibitory controls response may serve as a biomarker of vulnerability for chronic/persistent pain. These findings suggest that early anti-calcitonin-gene related peptide intervention has the potential to be effective both for the treatment of mild traumatic brain injury-induced post-traumatic headache, as well as inhibiting mechanisms that may promote post-traumatic headache persistence.	[Kopruszinski, Caroline M.; Swiokla, Juliana; Weinstein, Troy J.; Navratilova, Edita; Porreca, Frank] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Turnes, Joelle M.] Univ Fed Parana, Dept Pharmacol, Curitiba, Parana, Brazil; [Schwedt, Todd J.; Dodick, David W.; Porreca, Frank] Mayo Clin, Dept Neurol, Phoenix, AZ USA; [Anderson, Trent] Univ Arizona, Coll Med, Dept Biomed Sci, Phoenix, AZ USA		Porreca, F (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ 85724 USA.	frankp@medadmin.arizona.edu		Navratilova, Edita/0000-0002-1497-125X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS106902]; Coordination for the Improvement of Higher Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This research was supported in part by NIH1R01NS106902. Coordination for the Improvement of Higher Education Personnel (CAPES) provided doctorate and interuniversity exchange doctorate fellowships for JMT.	[Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Ashina H, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01136-z; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Avona A, 2019, J NEUROSCI, V39, P4323, DOI 10.1523/JNEUROSCI.0364-19.2019; Bannister K, 2017, J PHYSIOL-LONDON, V595, P4159, DOI 10.1113/JP274165; Bree D, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0720-6; Carey C, 2019, PAIN MED, V20, P2198, DOI 10.1093/pm/pnz058; Ceriani CEJ, 2019, HEADACHE, V59, P1597, DOI 10.1111/head.13661; Charles A, 2019, LANCET, V394, P1765, DOI 10.1016/S0140-6736(19)32504-8; Da Silva JT, 2018, BEHAV BRAIN RES, V349, P91, DOI 10.1016/j.bbr.2018.04.055; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Damien J, 2018, INT REV NEUROBIOL, V139, P255, DOI 10.1016/bs.irn.2018.07.024; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Gear RW, 1999, J NEUROSCI, V19, P7175, DOI 10.1523/JNEUROSCI.19-16-07175.1999; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Hoeger Bement M, 2020, EUR J PAIN, V24, P752, DOI 10.1002/ejp.1523; Huang IH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143527; Hughes SW., 2019, PAIN REP, V4, P1; Irvine KA, 2018, J NEUROTRAUM, V35, P1495, DOI 10.1089/neu.2017.5411; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Itomi Y, 2016, EUR J PHARMACOL, V784, P61, DOI 10.1016/j.ejphar.2016.05.011; Jang SH., 2016, MEDICINE, V95, P1; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lockwood S, 2020, J NEURAL TRANSM, V127, P541, DOI 10.1007/s00702-019-02077-x; Nation KM, 2018, PAIN, V159, P919, DOI 10.1097/j.pain.0000000000001167; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Nir RR, 2015, CURR OPIN SUPPORT PA, V9, P131, DOI 10.1097/SPC.0000000000000126; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Phelps CE, 2019, PAIN, V160, P1614, DOI 10.1097/j.pain.0000000000001553; Potvin S, 2016, PAIN, V157, P1704, DOI 10.1097/j.pain.0000000000000573; Sahbaie P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55739-x; Sahbaie P, 2018, J PAIN, V19, P1392, DOI 10.1016/j.jpain.2018.06.004; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Stroman PW, 2016, J NEUROTRAUM, V33, P1450, DOI 10.1089/neu.2015.4257; Suplita RL, 2005, NEUROPHARMACOLOGY, V49, P1201, DOI 10.1016/j.neuropharm.2005.07.007; Szarka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133223; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; Yarnitsky D, 2014, PAIN, V155, P663, DOI 10.1016/j.pain.2013.11.005; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429; Yoen H., 2020, KOREAN J RADIOL, V21; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z	46	1	1	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2021	41	6					749	759	0333102420981688	10.1177/0333102420981688		FEB 2021	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ5HW	WOS:000649129000001	33615840				2022-02-06	
J	Morgan, RE; Dunkel, B; Spiro, S; Beltran, E				Morgan, R. E.; Dunkel, B.; Spiro, S.; Beltran, E.			Computed tomographic and magnetic resonance imaging of a coup contrecoup traumatic brain injury in a horse	EQUINE VETERINARY EDUCATION			English	Article; Early Access						horse; trauma; head; coup; contrecoup		A 3-year-old Thoroughbred mare found recumbent in the field was referred for further assessment with suspicion of a skull fracture. Neurological examination identified compulsive tight circling to the left, and hypermetria in all four limbs. The mare was obtunded, with a mild head tilt to the right, absent menace response of the right eye and decreased facial sensation on the right. Standing computed tomographic examination revealed a subtle depression fracture of the dorsal calvarium and moderate intra-axial midline shift consistent with a traumatic brain injury (TBI). Despite supportive treatment, the mare deteriorated and was subjected to euthanasia. Post-mortem high field magnetic resonance imaging revealed findings consistent with a small cerebral contusion adjacent to the fracture site, and moderate to severe ipsilateral cerebral oedema within the caudal cerebrum and rostral brainstem, consistent with a coup contrecoup TBI. Brainstem lesions indicate a poor prognosis and support the decision for euthanasia. This is the first report of the imaging findings of a coup contrecoup TBI in a horse.	[Morgan, R. E.; Dunkel, B.; Beltran, E.] Equine Referral Hosp, Royal Vet Coll, Hatfield, Herts, England; [Spiro, S.] Zool Soc London, Wildlife Hlth Serv, London, England		Morgan, RE (corresponding author), Equine Referral Hosp, Royal Vet Coll, Hatfield, Herts, England.	rmorgan@rvc.ac.uk					Asha'ari ZA, 2011, J LARYNGOL OTOL, V125, P781, DOI 10.1017/S0022215111000545; Banga MS, 2017, INDIAN J NEUROSURG, V6, P103, DOI 10.1055/s-0037-1601361; Bansal Mayank, 2018, Asian J Neurosurg, V13, P348, DOI 10.4103/ajns.AJNS_229_16; Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Beltran E, 2012, J SMALL ANIM PRACT, V53, P101, DOI 10.1111/j.1748-5827.2011.01166.x; Brooks DE, 2014, EQUINE VET EDUC, V26, P527, DOI 10.1111/eve.12214; Cepeda S, 2016, J NEUROTRAUM, V33, P1034, DOI 10.1089/neu.2015.4153; CUMMINGS JF, 1969, ANN NY ACAD SCI, V167, P293, DOI 10.1111/j.1749-6632.1969.tb20452.x; De Zani D, 2013, EQUINE VET EDUC, V25, P493, DOI 10.1111/eve.12003; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Goncalves R, 2011, VET J, V188, P39, DOI 10.1016/j.tvjl.2010.03.024; HERRON MA, 1978, AM J VET RES, V39, P1137; Holbourn AHS, 1943, LANCET, V2, P438; Humble SS, 2018, J TRAUMA ACUTE CARE, V85, P155, DOI 10.1097/TA.0000000000001852; Lanksch W., 1982, DIAGNOSIS BRAIN EDEM, P43; Lindenberg R., 1993, GUIDELINES APPL PATH, P585; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Scrivani PV, 2013, EQUINE VET EDUC, V25, P499, DOI 10.1111/eve.12085; Wykes V., 2015, SURG OXFORD, V33, P355, DOI [10.1016/j.mpsur.2015.06.001, DOI 10.1016/J.MPSUR.2015.06.001]	20	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0957-7734	2042-3292		EQUINE VET EDUC	Equine Vet. Educ.												10.1111/eve.13441		FEB 2021	6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	QJ3NE	WOS:000619598100001		hybrid			2022-02-06	
J	Flynn, S; Leete, J; Shahim, P; Pattinson, C; Guedes, VA; Lai, C; Devoto, C; Qu, BX; Greer, K; Moore, B; van der Merwe, A; Ekanayake, V; Gill, J; Chan, L				Flynn, Spencer; Leete, Jacqueline; Shahim, Pashtun; Pattinson, Cassandra; Guedes, Vivian A.; Lai, Chen; Devoto, Christina; Qu, Bao-Xi; Greer, Kisha; Moore, Brian; van der Merwe, Andre; Ekanayake, Vindhya; Gill, Jessica; Chan, Leighton			Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							POSTCONCUSSION SYNDROME; AMYLOID-BETA; SATISFACTION; BIOMARKER; SCALE; TAU	Traumatic brain injury (TBI) is linked to long-term symptoms in a sub-set of patients who sustain an injury, but this risk is not universal, leading us and others to question the nature of individual variability in recovery trajectories. Extracellular vesicles (EVs) are a promising, novel avenue to identify blood-based biomarkers for TBI. Here, our aim was to determine if glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) measured 1-year postinjury in EVs could distinguish patients from controls, and whether these biomarkers relate to TBI severity or recovery outcomes. EV GFAP and EV NfL were measured using an ultrasensitive assay in 72 TBI patients and 20 controls. EV GFAP concentrations were elevated in moderate and severe TBI compared to controls (p's<0.001) and could distinguish controls from moderate (AUC=0.86) or severe TBI (AUC=0.88). Increased EV GFAP and EV NfL levels were associated with lower 1-year Glasgow Outcome Scale-Extended (GOS-E) score (p's<0.05). These findings suggest that blood-derived EV concentrations of GFAP and NfL drawn even 1 year after injury are higher in TBI patients compared to controls, and are related to injury severity and poor recovery outcomes, suggesting that TBIs alter the activity of these biomarkers, likely contributing to individual variability in recovery.	[Flynn, Spencer; Shahim, Pashtun; Chan, Leighton] Natl Inst Hlth Clin Ctr, Dept Rehabil Med, Bethesda, MD 20892 USA; [Leete, Jacqueline; Pattinson, Cassandra; Guedes, Vivian A.; Lai, Chen; Devoto, Christina; Qu, Bao-Xi; Greer, Kisha; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Shahim, Pashtun; Moore, Brian; van der Merwe, Andre; Ekanayake, Vindhya; Gill, Jessica; Chan, Leighton] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Moore, Brian; van der Merwe, Andre; Ekanayake, Vindhya] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA		Shahim, P (corresponding author), Natl Inst Hlth Clin Ctr, Dept Rehabil Med, Bethesda, MD 20892 USA.; Shahim, P (corresponding author), Ctr Neurosci & Regenerat Med, Bethesda, MD USA.	pashtun-poh.shahim@nih.gov		de Alvarenga Guedes, Vivian/0000-0001-8478-2465; Flynn, Spencer/0000-0001-5854-3751	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Intramural Research Program of the National Institutes of Nursing Research; Intramural Research Program of the Clinical Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Henry M. Jackson Foundation for the Advancement of Military Medicine [HU0001-17-2-0029]; Medstar Health Research Institute [NCT00888563]	Open Access funding provided by the National Institutes of Health (NIH). This work was supported by the Intramural Research Program of the National Institutes of Nursing Research, the Intramural Research Program of the Clinical Center of the National Institutes of Health, the Center for Neuroscience and Regenerative Medicine, by Grant HU0001-17-2-0029 from the Henry M. Jackson Foundation for the Advancement of Military Medicine, and by Medstar Health Research Institute Grant NCT00888563. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Falker C, 2016, J NEUROCHEM, V137, P88, DOI 10.1111/jnc.13514; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Guedes VA, 2020, NEUROLOGY, V94, pE2412, DOI 10.1212/WNL.0000000000009577; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Idland AV, 2017, NEUROBIOL AGING, V49, P138, DOI 10.1016/j.neurobiolaging.2016.09.012; JENNETT B, 1975, LANCET, V1, P480; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Menke RAL, 2015, ANN CLIN TRANSL NEUR, V2, P748, DOI 10.1002/acn3.212; Mondello S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040977; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pattinson CL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13191; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pawlitzki M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01037; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Shahim P, 2020, NEUROLOGY, V95, pE610, DOI 10.1212/WNL.0000000000009983; Shahim P, 2020, NEUROLOGY, V95, pE623, DOI 10.1212/WNL.0000000000009985; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI 10.1586/EPR.09.17; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winston CN, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01005; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	36	1	1	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	FEB 16	2021	11	1							3896	10.1038/s41598-021-82875-0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT6VI	WOS:000626727200047	33594224	gold, Green Published			2022-02-06	
J	Meier, TB; Espana, LY; Kirk, AJ; Nader, AM; Powell, JE; Nelson, LD; Mayer, AR; Brett, BL				Meier, Timothy B.; Espana, Lezlie Y.; Kirk, Alexander J.; Nader, Amy M.; Powell, Jennifer E.; Nelson, Lindsay D.; Mayer, Andrew R.; Brett, Benjamin L.			Association of Previous Concussion with Hippocampal Volume and Symptoms in Collegiate-Aged Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; hippocampus; mild traumatic brain injury; repetitive head impacts		There is concern that previous concussion and contact-sport exposure may have negative effects on brain structure and function. Accurately quantifying previous concussion is complicated by the fact that multiple definitions exist, with recent definitions allowing for diagnosis based on the presence of symptoms alone (Concussion in Sport Group criteria; CISG) rather than the presence of acute injury characteristics such as alterations in mental status (American Congress of Rehabilitation Medicine criteria; ACRM). The goals of the current work were to determine the effects of previous concussion and contact-sport exposure on gray matter structure and clinical measures in healthy, young-adult athletes and determine the extent to which these associations are influenced by diagnostic criteria used to retrospectively quantify concussions. One-hundred eight collegiate-aged athletes were enrolled; 106 athletes were included in final analyses (age, 21.37 +/- 1.69; 33 female). Participants completed a clinical battery of self-report and neurocognitive measures and magnetic resonance imaging to quantify subcortical volumes and cortical thickness. Semistructured interviews were conducted to measure exposure to contact sports and the number of previous concussions based on CISG and ACRM criteria. There was a significant association of concussion-related and psychological symptoms with previous concussions based on ACRM (ps < 0.05), but not CISG, criteria. Hippocampal volume was inversely associated with the number of previous concussions for both criteria (ps < 0.05). Findings provide evidence that previous concussions are associated with smaller hippocampal volumes and greater subjective clinical symptoms in otherwise healthy athletes and highlight the importance of diagnostic criteria used to quantify previous concussion.	[Meier, Timothy B.; Espana, Lezlie Y.; Kirk, Alexander J.; Nader, Amy M.; Powell, Jennifer E.; Nelson, Lindsay D.; Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Mind Res Network,Dept Psychol, Lovelace Biomed & Environm Res Inst,Neurol Dept, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat,Dept Psychol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM 87131 USA		Meier, TB (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu		Espana, Lezlie/0000-0002-6466-4653	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102225]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; National Institute of Neurological Disorders and Stroke under the National Institutes of Health [L30NS113158]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS102225. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The REDCap electronic database and the Adult Translational Research Unit used for this project were supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award Number UL1TR001436. B.L.B. acknowledges support from the National Institute of Neurological Disorders and Stroke under the National Institutes of Health under Award Number L30NS113158. This research was completed, in part, with computational resources and technical support provided by the Research Computing Center at the Medical College of Wisconsin.	Adler CM, 2018, CLIN J SPORT MED, V28, P100, DOI 10.1097/JSM.0000000000000391; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Alsalaheen B, 2017, SPORTS HEALTH, V9, P324, DOI 10.1177/1941738117713974; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Caccese JB, 2020, SPORTS MED, V50, P1377, DOI 10.1007/s40279-020-01261-4; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz280; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Janowitz D, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.102; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerr ZY, 2015, J NEUROTRAUM, V32, P1083, DOI 10.1089/neu.2014.3666; Lancaster MA, 2016, CLIN NEUROPSYCHOL, V30, P321, DOI 10.1080/13854046.2016.1138504; Lee AL, 2002, BIPOLAR DISORD, V4, P117, DOI 10.1034/j.1399-5618.2002.01144.x; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marsland AL, 2015, BRAIN BEHAV IMMUN, V48, P195, DOI 10.1016/j.bbi.2015.03.015; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Parivash SN, 2019, J NEUROTRAUM, V36, P2762, DOI 10.1089/neu.2018.6357; Radoi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212541; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Wicklund A, 2021, CLIN J SPORT MED, V31, pE467, DOI 10.1097/JSM.0000000000000813; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	58	1	1	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2021	38	10					1358	1367		10.1089/neu.2020.7143		FEB 2021	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RZ6DB	WOS:000620266800001	33397203				2022-02-06	
J	Logan, MW; McNeeley, S; Morgan, MA				Logan, Matthew William; McNeeley, Susan; Morgan, Mark Alden			The Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder on Prison Adjustment and Recidivism among Military Veterans: Evidence from Minnesota	PSYCHIATRIC QUARTERLY			English	Article						Military veterans; Prison; TBI; PTSD; Recidivism; Institutional adjustment		The prevalence of, and link between, mental health disorders-such as traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD)-and antisocial behavior is well-documented among the military veteran population. Studies also show that TBI and PTSD account for variation in prison-based and re-entry outcomes. Despite this body of research, comparatively fewer studies have explicitly focused on how these factors affect prison adjustment for inmates with prior military experience. We used administrative data provided by the Minnesota Department of Corrections (MnDOC) and employed a series of survival analyses to examine how prior diagnoses of TBI and PTSD (among other risk factors) influence metrics of institutional adjustment and recidivism among a sample of military veterans. Our results indicate that the effects of TBI, PTSD, and other indicators of criminogenic risk are relevant when examining the experiences of justice-involved military veterans-especially with respect recidivism-based outcomes. The implications of our results are discussed and directions for future research are given.	[Logan, Matthew William] Texas State Univ, Sch Criminal Justice & Criminol, San Marcos, TX 78666 USA; [McNeeley, Susan] Minnesota Dept Correct, St Paul, MN USA; [Morgan, Mark Alden] Univ Cincinnati, Cincinnati, OH USA		Logan, MW (corresponding author), Texas State Univ, Sch Criminal Justice & Criminol, San Marcos, TX 78666 USA.	mwl39@txstate.edu		Logan, Matt/0000-0003-3329-7042			[Anonymous], 2004, NBC NEWS; Beckham JC, 2000, AGGRESS VIOLENT BEH, V5, P451, DOI 10.1016/S1359-1789(98)00018-4; Beckham JC, 1998, J TRAUMA STRESS, V11, P777, DOI 10.1023/A:1024453618638; Bronson J., 2015, VETERANS PRISON JAIL; Brooke E.J., 2020, CORRECTIONS, V5, P292, DOI [10.1080/23774657.2018.1542284, DOI 10.1080/23774657.2018.1542284]; Burke C, 2019, VETERANS MOVING FORW; Cochran JC, 2014, JUSTICE Q, V31, P1044, DOI 10.1080/07418825.2012.736526; DeLisi M, 2010, YOUTH VIOLENCE JUV J, V8, P107, DOI 10.1177/1541204009349399; Drapela LA, 2019, JUSTICE Q, V36, P1023, DOI 10.1080/07418825.2018.1481221; Elbogen EB, 2014, AM J PSYCHIAT, V171, P749, DOI 10.1176/appi.ajp.2014.13101316; Elbogen EB, 2010, CLIN PSYCHOL REV, V30, P595, DOI 10.1016/j.cpr.2010.03.009; Fahmy C, 2020, J CRIM JUST, V67, DOI 10.1016/j.jcrimjus.2020.101658; Felson RB, 2012, CRIM JUSTICE BEHAV, V39, P125, DOI 10.1177/0093854811428565; Fontana A, 2005, J NERV MENT DIS, V193, P203, DOI 10.1097/01.nmd.0000154835.92962.e5; FOY DW, 1984, J CONSULT CLIN PSYCH, V52, P79, DOI 10.1037/0022-006X.52.1.79; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Grieger, 2006, PRIM PSYCHIAT, V13, P51; Grossman D., 1996, KILLING PSYCHOL COST; Hill G., 1985, PREDICTION CRIMINOLO, P96; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hotopf M, 2006, JAMA-J AM MED ASSOC, V296, P574, DOI 10.1001/jama.296.5.574; Logan M.W., 2017, CRIMINAL JUSTICE POL, V28, P814, DOI [10.1177/0887403415623033, DOI 10.1177/0887403415623033]; Logan MW, 2017, J CRIM JUST, V52, P90, DOI 10.1016/j.jcrimjus.2017.08.007; Matheson FI, 2020, BRAIN INJURY, V34, P757, DOI 10.1080/02699052.2020.1753114; McCallum K, 2018, J FORENSIC PRACT, V20, P229, DOI 10.1108/JFP-12-2017-0055; Mcneeley S, 2021, CRIM JUSTICE BEHAV, V48, P195, DOI 10.1177/0093854820959394; Morgan MA, 2019, AM J CRIM JUSTICE, V44, P746, DOI 10.1007/s12103-018-9458-2; Olver ME, 2014, PSYCHOL ASSESSMENT, V26, P156, DOI 10.1037/a0035080; Prescan, 2013, CORRECTIONS FORUM, V22, P37; Sappington AA, 1996, INT J OFFENDER THER, V40, P54, DOI 10.1177/0306624X96401007; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; SIGAFOOS CE, 1994, INT J OFFENDER THER, V38, P117, DOI 10.1177/0306624X9403800204; Smith, 2008, FED PROBAT, V72, P1; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Trulson CR, 2011, CRIME DELINQUENCY, V57, P709, DOI 10.1177/0011128709340224; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wooldredge JD, 1999, CRIM JUSTICE BEHAV, V26, P235, DOI 10.1177/0093854899026002005	37	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-2720	1573-6709		PSYCHIAT QUART	Psychiatr. Q.	SEP	2021	92	3					1147	1158		10.1007/s11126-021-09883-1		FEB 2021	12	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	UD4FJ	WOS:000618166600001	33587259				2022-02-06	
J	Pratile, T; Marshall, C; DeMatteo, C				Pratile, Taylor; Marshall, Cameron; DeMatteo, Carol			Examining how time from sport-related concussion to initial assessment predicts return-to-play clearance	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Concussion; sport-related concussion return-to-play; recovery; discharge		Objective: (i) To analyze data of adolescents who have sustained a sport-related concussion (SRC) through the use of Complete Concussion Management Inc. (CCMI) concussion database system; and (ii) to determine an optimal time to assess and manage an athlete with an SRC by prospectively analyzing data from CCMI concussion database system. Method: A cohort of patients, ages 8-18 years, who sustained an SRC, assessed 30 days or less from injury and were treated at partnered CCMI clinics across Canada were prospectively followed. The primary outcome measure was recovery, defined as CCMI discharge, which includes an athlete having completed all return-to-school and return-to-play steps and passed the Gapski-Goodman test without symptom exacerbation. Results: 1213 athletes (482 female) were included for analysis. Days between injury and initial assessment (p = 0.00), male sex (p = 0.00), and previous concussion history (p = 0.00) were significant predictors of time to discharge. A log-rank test revealed a significant difference (p = 0.00) in time to discharge with athletes assessed <10 days of injury discharged at a mean of 23.5 days (95% CI, 22.5, 24.5) and those assessed at day 10 to 30 were discharged at a mean of 37.1 days (95% CI, 33.7, 40.5). Athletes who were assessed at 0 to 9 days from injury were two times more likely to be discharged sooner compared to those athletes assessed 10 to 30 days from injury (HR 2.03, p = 0.00). Conclusion: Time from SRC to initial assessment significantly predicted time to discharge, with those being evaluated earlier experiencing a faster discharge. The results aid in establishing recommended timelines for evaluation following an SRC in order to prevent or mitigate athletes experiencing a prolonged recovery and encourage timely access to care and a quicker return to life post-concussive injury.	[Pratile, Taylor; DeMatteo, Carol] McMaster Univ, Dept Rehabil Sci, Hamilton, ON, Canada; [Marshall, Cameron] Complete Concuss Management Inc, Dept Res, Oakville, ON, Canada		Pratile, T (corresponding author), McMaster Univ, Fac Sci, Sch Rehabil Sci, 1400 Main St West,Room 403, Hamilton, ON L8S 1C7, Canada.	taylor.pratile@gmail.com					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Bezherano I, 2021, CLIN J SPORT MED, V31, P465, DOI 10.1097/JSM.0000000000000809; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Dobney DM., 2018, J HEAD TRAUMA REHAB, V33; Downey RI., 2018, BRAIN INJURY, V32; Eagle SR, 2020, AM J SPORT MED, V48, P2544, DOI 10.1177/0363546520937291; Eagle SR, 2020, J NEUROSURG-PEDIATR, V26, P165, DOI 10.3171/2020.2.PEDS2025; Ewing-Cobbs L, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0939; Government of Canada, 2019, SPORT RECR REL CONC; Iaccarino MA, 2018, NEUROL-CLIN PRACT, V8, P403, DOI 10.1212/CPJ.0000000000000525; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Koerte IK, 2020, J NEUROIMAGING, V30, P387, DOI 10.1111/jon.12726; Kontos AP., 2020, JAMA NEUROL, V77; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Leddy JJ., 2019, JAMA PEDIATR, V173; Leddy JJ., 2011, CLIN J SPORT MED, V21; Leddy JJ., 2018, CURR SPORTS MED REP, V17; Marshall CM., 2019, PHYS SPORTSMED, V47; Matveev R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6232-9; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mrazik M., 2017, EC PSYCHIAT PSYCHOL; Quatman-Yates C, 2018, ARCH PHYS MED REHAB, V99, P994, DOI 10.1016/j.apmr.2017.11.012; Schneider KJ., 2017, BR J SPORTS MED, V51; Sufrinko AM., 2017, AM J SPORT MED, V45; Thomas DJ., 2018, CLIN J SPORT MED, V28; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek RL., 2017, J PEDIAT, V181	30	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2021.1879603		FEB 2021	9	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	QH0GT	WOS:000617957200001	33475440				2022-02-06	
J	Gao, M; Dong, Q; Wang, WJ; Yang, ZJ; Guo, LL; Lu, YZ; Ding, BY; Chen, LH; Zhang, JN; Xu, RX				Gao, Mou; Dong, Qin; Wang, Wenjia; Yang, Zhijun; Guo, Lili; Lu, Yingzhou; Ding, Boyun; Chen, Lihua; Zhang, Jianning; Xu, Ruxiang			Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury	STEM CELL RESEARCH & THERAPY			English	Article						Induced neural stem cell; Crry; Closed head injury; Transplantation; Complement		BackgroundRecently, growing evidence has indicated an important role of the complement system, a crucial component of immunity, in mediating neuroinflammation and promoting neuronal apoptosis following closed head injury (CHI). We previously reported that transplanted induced neural stem cells (iNSCs) pre-treated with CHI mouse serum could enhance complement receptor type 1-related protein y (Crry) expression and ameliorate complement-mediated damage in mouse CHI models. However, the mechanism underlying the elevated levels of Crry expression remains elusive.MethodsCHI models were established using a standardized weight-drop device. We collected CHI mouse serum at 12h post-trauma. RT-QPCR assay, western blot analysis, complement deposition assay, Akt inhibition assay, flow cytometry, cell transplantation, and functional assay were utilized to clarify the mechanism of Crry expression in iNSCs receiving CHI mouse serum treatment.ResultsWe observed dramatic increases in the levels of Crry expression and Akt activation in iNSCs receiving CHI mouse serum treatment. Remarkably, Akt inhibition led to the reduction of Crry expression in iNSCs. Intriguingly, the treatment of iNSC-derived neurons with recombinant complement receptor 2-conjugated Crry (CR2-Crry), which inhibits all complement pathways, substantially enhanced Crry expression and Akt activation in neurons after CHI mouse serum treatment. In subsequent in vitro experiments of pre-treatment of iNSCs with CR2-Crry, we observed significant increases in the levels of Crry expression and Akt activation in iNSCs and iNSC-derived astrocytes and neurons post-treatment with CHI mouse serum. Additionally, an in vivo study showed that intracerebral-transplanted iNSCs pre-treated with CR2-Crry markedly enhanced Crry expression in neurons and protected neurons from complement-dependent damage in the brains of CHI mice.ConclusionINSCs receiving CR2-Crry pre-treatment increased the levels of Crry expression in iNSCs and iNSC-derived astrocytes and neurons and attenuated complement-mediated injury following CHI.	[Gao, Mou; Guo, Lili; Chen, Lihua; Xu, Ruxiang] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Neurosurg, Chengdu 610072, Peoples R China; [Gao, Mou; Zhang, Jianning] Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China; [Dong, Qin] Capital Med Univ, Fu Xing Hosp, Dept Neurol, Beijing 100038, Peoples R China; [Wang, Wenjia] Peoples Liberat Army Gen Hosp, Dept ENT HN, Hainan Hosp, Sanya 572013, Peoples R China; [Yang, Zhijun; Ding, Boyun; Xu, Ruxiang] Peoples Liberat Army Gen Hosp, Dept Neurosurg, Med Ctr 7, Beijing, Peoples R China; [Lu, Yingzhou] Capital Med Univ, Fu Xing Hosp, Dept Obstet, Beijing 100038, Peoples R China		Chen, LH; Xu, RX (corresponding author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Neurosurg, Chengdu 610072, Peoples R China.; Zhang, JN (corresponding author), Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing 100853, Peoples R China.	zljp824gk@163.com; jnzhang2018@163.com; jzprofxu@126.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81671189, 81971295, 82001293]; Military Medical Innovation Project of the Army [16CXZ001]	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (Nos. 81671189, 81971295, 82001293) and the Military Medical Innovation Project of the Army (No. 16CXZ001).	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Alawieh A, 2016, IMMUNOL REV, V274, P270, DOI 10.1111/imr.12470; Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gao M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0172-7; Gao M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45989; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Gwon SY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-207; Hajishengallis G, 2017, NAT IMMUNOL, V18, P1288, DOI 10.1038/ni.3858; Hajishengallis G, 2016, IMMUNOL REV, V274, P233, DOI 10.1111/imr.12467; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Jacob A, 2007, LAB INVEST, V87, P1186, DOI 10.1038/labinvest.3700686; Jimenez-Perianez A, 2005, J LEUKOCYTE BIOL, V78, P1386, DOI 10.1189/jlb.1104642; Killedar SY, 2006, LAB INVEST, V86, P1243, DOI 10.1038/labinvest.3700487; Kim H, 2014, CYTOTHERAPY, V16, P357, DOI 10.1016/j.jcyt.2013.10.011; Kim MY, 2010, NEUROSCIENCE, V170, P8, DOI 10.1016/j.neuroscience.2010.07.020; Lai BQ, 2016, BIOMATERIALS, V109, P40, DOI 10.1016/j.biomaterials.2016.08.005; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Marshall KM, 2014, J EXP MED, V211, P1793, DOI 10.1084/jem.20131902; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46; Mollinari C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0891-4; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Shahbazi E, 2016, STEM CELL REP, V6, P539, DOI 10.1016/j.stemcr.2016.02.013; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Yao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137211	42	1	1	2	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1757-6512		STEM CELL RES THER	Stem Cell Res. Ther.	FEB 12	2021	12	1							128	10.1186/s13287-021-02186-z			15	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	QJ5UM	WOS:000619755400013	33579360	Green Submitted, Green Published, gold			2022-02-06	
J	Wijenberg, M; Rauwenhoff, J; Stapert, S; Verbunt, J; van Heugten, C				Wijenberg, Melloney; Rauwenhoff, Johanne; Stapert, Sven; Verbunt, Jeanine; van Heugten, Caroline			Do fear and catastrophizing about mental activities relate to fear-avoidance behavior in a community sample? An experimental study	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Post-concussion-like symptoms; fear-avoidance model; catastrophizing brain injury; experiment		Introduction: Healthy people often experience headache, cognitive failures, or mental fatigue. Some people even experience these symptoms on a level comparable to patients with mild spectrum brain injuries. In these individuals, the fear-avoidance model explains symptoms as a consequence of catastrophizing and fear-avoidance toward mental activities. This experimental study investigated in healthy adults whether fear-avoidance and catastrophizing about mental activities are related to fear-avoidance behavior (i.e., behavioral avoidance of mental activities) according to the fear-avoidance model. Method: A randomized crossover within-subject design was used with two measurements and 80 participants. Participants were exposed to three demanding cognitive tasks and their simplified counterparts. Post-concussion symptoms, catastrophizing, fear-avoidance, behavioral avoidance (time spent working on cognitive tasks), exposure to mental activity, depression, heart rate, and state-trait anxiety were assessed. Results: Significant correlations between the variables of the fear-avoidance model were found. Furthermore, catastrophizers spent less time on difficult tasks compared to easy tasks. Both catastrophizing and female sex predicted time spent on difficult tasks, whereas only female sex predicted time spent on easy tasks. Conclusions: This study found that, according to the fear-avoidance model, catastrophizing is related to behavioral avoidance of cognitively challenging tasks in a community sample.	[Wijenberg, Melloney; Stapert, Sven; van Heugten, Caroline] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Wijenberg, Melloney; Rauwenhoff, Johanne; van Heugten, Caroline] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Rauwenhoff, Johanne; van Heugten, Caroline] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Stapert, Sven] Zuyderland Med Ctr, Dept Clin & Med Psychol, Sittard Geleen, Netherlands; [Verbunt, Jeanine] Adelante, Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Verbunt, Jeanine] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Maastricht, Netherlands		Stapert, S (corresponding author), Maastricht Univ, POB 616, NL-6200 MD Maastricht, Netherlands.	s.stapert@maastrichtuniversity.nl		Rauwenhoff, Johanne/0000-0002-0064-6560; Verbunt, Jeanine/0000-0002-9060-9455			Aaronson LS, 2003, WESTERN J NURS RES, V25, P419, DOI 10.1177/0193945903025004007; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Beck A.T., 1996, MANUAL BECK DEPRESSI, DOI DOI 10.1037/T00742-000; BERG EA, 1948, J GEN PSYCHOL, V391; Bernstein EE, 2019, DEPRESS ANXIETY, V36, P950, DOI 10.1002/da.22935; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CIMA RF, 2012, LANCET, V379; Cook AJ, 2006, PAIN, V121, P195, DOI 10.1016/j.pain.2005.11.018; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Doherty, 2011, PRACTICAL ASPECTS EC; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Forsyth JP, 2001, APPL PREV PSYCHOL, V10, P243, DOI 10.1016/S0962-1849(01)80002-0; Goubert L, 2004, CLIN J PAIN, V20, P103, DOI 10.1097/00002508-200403000-00007; Harris AM, 2009, J GEN INTERN MED, V24, P155, DOI 10.1007/s11606-008-0845-0; Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2; Houben RMA, 2005, J BEHAV MED, V28, P415, DOI 10.1007/s10865-005-9011-x; IVERSON G, 2003, APPL NEUROPSYCHOL, V10; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee AR, 2016, COMPUT HUM BEHAV, V55, P51, DOI 10.1016/j.chb.2015.08.011; Leeuw M, 2007, J PAIN, V8, P840, DOI 10.1016/j.jpain.2007.05.013; Leising D, 2009, J RES PERS, V43, P707, DOI 10.1016/j.jrp.2009.03.009; Lejuez C.W., 2003, BEHAV THERAPIST; Leung L, 2012, INDIAN J PSYCHOL MED, V34, P204, DOI 10.4103/0253-7176.106012; Lundberg M, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/494196; Merckelbach, 2010, GEK EXPT PSYCHOPATHO, DOI [10.1007/978-90-313-7640-7, DOI 10.1007/978-90-313-7640-7]; Moroz M, 2019, BEHAV RES THER, V112, P18, DOI 10.1016/j.brat.2018.11.006; Nock MK, 2008, J CONSULT CLIN PSYCH, V76, P28, DOI 10.1037/0022-006X.76.1.28; Osman A, 2000, J BEHAV MED, V23, P351, DOI 10.1023/A:1005548801037; Pincus T., 2002, SPINE, V27, DOI 10.1097/00007632-200203010-00017; RISKIND JH, 2006, J SOC CLIN PSYCHOL, V25; Roelofs J, 2004, EUR J PAIN, V8, P495, DOI 10.1016/j.ejpain.2003.11.016; Roelofs J, 2007, PAIN, V131, P181, DOI 10.1016/j.pain.2007.01.008; Rossi V, 2012, ANXIETY STRESS COPIN, V25, P603, DOI 10.1080/10615806.2011.582948; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Snell DL, 2020, J NEUROTRAUM, V37, P1566, DOI 10.1089/neu.2019.6729; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Trost Z, 2011, PAIN, V152, P1540, DOI 10.1016/j.pain.2011.02.038; Van der Does A.J.W., 2002, NEDERLANDSE VERSIE B; Van der Ploeg H.M., 1980, HANDLEIDING BIJ ZELF; van Mierlo ML, 2014, INT J STROKE, V9, P341, DOI 10.1111/ijs.12149; Verbunt JA, 2010, PAIN, V149, P428, DOI 10.1016/j.pain.2010.01.020; Vlaeyen J.W., 1995, PAIN, V62, DOI 10.1016/0304-3959(94)00279-n; Vlaeyen JWS, 2016, PAIN, V157, P1588, DOI 10.1097/j.pain.0000000000000574; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Vrijsen JN, 2014, COGNITIVE THER RES, V38, P217, DOI 10.1007/s10608-013-9563-y; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Wideman TH, 2013, PAIN, V154, P2262, DOI 10.1016/j.pain.2013.06.005; Wijenberg MLM, 2020, J NEUROTRAUM, V37, P2639, DOI 10.1089/neu.2020.7135; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wijenberg MLM, 2016, J BEHAV MED, V39, P815, DOI 10.1007/s10865-016-9749-3; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9; Wood, 2017, NEUROBEHAVIOURAL DIS, P167; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021; Zenger M, 2013, J SOC CLIN PSYCHOL, V32, P97, DOI 10.1521/jscp.2013.32.1.97	64	1	1	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 2	2021	43	1					66	77		10.1080/13803395.2021.1874881		FEB 2021	12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	QP1SH	WOS:000616860500001	33567961	hybrid			2022-02-06	
J	Allen, JW; Trofimova, A; Ahluwalia, V; Smith, JL; Abidi, SA; Peters, MAK; Rajananda, S; Hurtado, JE; Gore, RK				Allen, J. W.; Trofimova, A.; Ahluwalia, V.; Smith, J. L.; Abidi, S. A.; Peters, M. A. K.; Rajananda, S.; Hurtado, J. E.; Gore, R. K.			Altered Processing of Complex Visual Stimuli in Patients with Postconcussive Visual Motion Sensitivity	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; MOTOR SCREENING VOMS; VESTIBULAR REHABILITATION; ROBUST; VERTIGO; DIZZINESS; ACCURATE; BALANCE; OPTIMIZATION	BACKGROUND AND PURPOSE: Vestibular symptoms are common after concussion. Vestibular Ocular Motor Screening identifies vestibular impairment, including postconcussive visual motion sensitivity, though the underlying functional brain alterations are not defined. We hypothesized that alterations in multisensory processing are responsible for postconcussive visual motion sensitivity, are detectable on fMRI, and correlate with symptom severity. MATERIALS AND METHODS: Twelve patients with subacute postconcussive visual motion sensitivity and 10 healthy control subjects underwent vestibular testing and a novel fMRI visual-vestibular paradigm including 30-second ?neutral? or ?provocative? videos. The presence of symptoms/intensity was rated immediately after each video. fMRI group-level analysis was performed for a ?provocative-neutral? condition. Z-statistic images were nonparametrically thresholded using clusters determined by Z?>?2.3 and a corrected cluster significance threshold of P?=?.05. Symptoms assessed on Vestibular Ocular Motor Screening were correlated with fMRI mean parameter estimates using Pearson correlation coefficients. RESULTS: Subjects with postconcussive visual motion sensitivity had significantly more Vestibular Ocular Motor Screening abnormalities and increased symptoms while viewing provocative videos. While robust mean activation in the primary and secondary visual areas, the parietal lobe, parietoinsular vestibular cortex, and cingulate gyrus was seen in both groups, selective increased activation was seen in subjects with postconcussive visual motion sensitivity in the primary vestibular/adjacent cortex and inferior frontal gyrus, which are putative multisensory visual-vestibular processing centers. Moderate-to-strong correlations were found between Vestibular Ocular Motor Screening scores and fMRI activation in the left frontal eye field, left middle temporal visual area, and right posterior hippocampus. CONCLUSIONS: Increased fMRI brain activation in visual-vestibular multisensory processing regions is selectively seen in patients with postconcussive visual motion sensitivity and is correlated with Vestibular Ocular Motor Screening symptom severity, suggesting that increased visual input weighting into the vestibular network may underlie postconcussive visual motion sensitivity.	[Allen, J. W.; Trofimova, A.; Smith, J. L.] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Allen, J. W.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Abidi, S. A.] Emory Univ, Sch Med, Atlanta, GA USA; [Allen, J. W.; Gore, R. K.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Allen, J. W.; Gore, R. K.] Emory Univ, Atlanta, GA 30322 USA; [Ahluwalia, V.] Georgia State Univ, Georgia Tech Ctr Adv Brain Imaging, Atlanta, GA 30303 USA; [Peters, M. A. K.; Rajananda, S.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Hurtado, J. E.; Gore, R. K.] Shepherd Ctr, Atlanta, GA USA		Allen, JW (corresponding author), 1364 Clifton Rd NE,Suite BG20, Atlanta, GA 30322 USA.	jwallen@emory.edu		Allen, Jason/0000-0002-5274-1105; Smith, Jeremy/0000-0003-0841-5297; Trofimova, Anna/0000-0002-3110-7914	Georgia State/Georgia Tech Center for Advanced Brain Imaging Neural Engineering Center Seed Grant; Emory University Department of Radiology and Imaging Sciences Seed Grant	This work was supported by the Georgia State/Georgia Tech Center for Advanced Brain Imaging Neural Engineering Center Seed Grant and the Emory University Department of Radiology and Imaging Sciences Seed Grant.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Alkathiry AA, 2019, SPORTS HEALTH, V11, P479, DOI 10.1177/1941738119865262; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalman O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152309; Andersson JLR, 2007, TRO7JA2 FMRIB; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brandt T, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00047; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Bronstein AM, 2013, SEMIN NEUROL, V33, P219, DOI 10.1055/s-0033-1354602; BRONSTEIN AM, 1995, J NEUROL NEUROSUR PS, V59, P472, DOI 10.1136/jnnp.59.5.472; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Corso PS., 2006, INCIDENCE EC BURDEN, P208; Cousins S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105426; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; Della-Justina HM, 2015, EXP BRAIN RES, V233, P237, DOI 10.1007/s00221-014-4107-6; Dieterich M, 2015, ANN NY ACAD SCI, V1343, P10, DOI 10.1111/nyas.12585; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363, DOI 10.1007/3-540-45103-x_50; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Gattu R, 2016, BRAIN INJURY, V30, P1501, DOI 10.1080/02699052.2016.1219056; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hendershot KA., 2016, P NAT S NEUR SOC LEX; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hurtado JE, 2020, PHYSIOTHER THEOR PR, DOI 10.1080/09593985.2020.1815259; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Kirsch V, 2018, NEUROIMAGE, V178, P224, DOI 10.1016/j.neuroimage.2018.05.018; Kontos AP, 2017, MIL MED, V182, P99, DOI 10.7205/MILMED-D-16-00177; Lee JO, 2018, HUM BRAIN MAPP, V39, P3340, DOI 10.1002/hbm.24080; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Sethuraman KN, 2014, ACAD EMERG MED, V21, P1386, DOI 10.1111/acem.12536; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Wright WG, 2005, J VESTIBUL RES-EQUIL, V15, P185; Xu L., 2010, TRAUMATIC BRAIN INJU, P208	50	1	1	3	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2021	42	5					930	937		10.3174/ajnr.A7007		FEB 2021	8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	SA2MM	WOS:000644201100001	33574098				2022-02-06	
J	Abdollahzadeh, A; Belevich, I; Jokitalo, E; Sierra, A; Tohka, J				Abdollahzadeh, Ali; Belevich, Ilya; Jokitalo, Eija; Sierra, Alejandra; Tohka, Jussi			DeepACSON automated segmentation of white matter in 3D electron microscopy	COMMUNICATIONS BIOLOGY			English	Article							BRAIN-INJURY; AXONS	Tracing the entirety of ultrastructures in large three-dimensional electron microscopy (3D-EM) images of the brain tissue requires automated segmentation techniques. Current segmentation techniques use deep convolutional neural networks (DCNNs) and rely on high-contrast cellular membranes and high-resolution EM volumes. On the other hand, segmenting low-resolution, large EM volumes requires methods to account for severe membrane discontinuities inescapable. Therefore, we developed DeepACSON, which performs DCNN-based semantic segmentation and shape-decomposition-based instance segmentation. DeepACSON instance segmentation uses the tubularity of myelinated axons and decomposes under-segmented myelinated axons into their constituent axons. We applied DeepACSON to ten EM volumes of rats after sham-operation or traumatic brain injury, segmenting hundreds of thousands of long-span myelinated axons, thousands of cell nuclei, and millions of mitochondria with excellent evaluation scores. DeepACSON quantified the morphology and spatial aspects of white matter ultrastructures, capturing nanoscopic morphological alterations five months after the injury. With DeepACSON, Abdollahzadeh et al. combines existing deep learning-based methods for semantic segmentation and a novel shape decomposition technique for the instance segmentation. The pipeline is used to segment low-resolution 3D-EM datasets allowing quantification of white matter morphology in large fields-of-view.	[Abdollahzadeh, Ali; Sierra, Alejandra; Tohka, Jussi] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Belevich, Ilya; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, Helsinki, Finland		Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland.	alejandra.sierralopez@uef.fi	; Jokitalo, Eija/C-8375-2009	Belevich, Ilya/0000-0003-2190-4909; Jokitalo, Eija/0000-0002-4159-6934; TOHKA, JUSSI/0000-0002-1048-5860; Sierra Lopez, Alejandra/0000-0001-5399-2056; Abdollahzadeh, Ali/0000-0001-6234-2012	Academy of FinlandAcademy of FinlandEuropean Commission [316258, 323385]; Biocenter Finland; University of Helsinki	This work was supported by the Academy of Finland (grant #316258 to J.T. and grant #323385 to A.S.) and Biocenter Finland and the University of Helsinki (I.B., E.J., and SBEM imaging). We would like to thank Maarit Pulkkinen for her help with the animal handling, and Mervi Lindman and Antti Salminen for help preparing the samples for SBEM. We would like to thank Andrea Behanova for developing gACSON, the segmentation evaluation software. The authors acknowledge CSC-IT Center for Science, Finland, for computational resources.	ABDOLLAHZADEH A, 2019, SCI, V9, DOI DOI 10.1038/S41598-019-42648-2; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Berning M, 2015, NEURON, V87, P1193, DOI 10.1016/j.neuron.2015.09.003; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Dabov K, 2006, PROC SPIE, V6064, DOI 10.1117/12.643267; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dorkenwald S, 2017, NAT METHODS, V14, P435, DOI 10.1038/nmeth.4206; Falk T, 2019, NAT METHODS, V16, P67, DOI 10.1038/s41592-018-0261-2; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/bfb0056195; Funke J, 2019, IEEE T PATTERN ANAL, V41, P1669, DOI 10.1109/TPAMI.2018.2835450; Funke J, 2012, PROC CVPR IEEE, P1004, DOI 10.1109/CVPR.2012.6247777; Ginsburger K, 2019, NEUROIMAGE, V193, P10, DOI 10.1016/j.neuroimage.2019.02.055; Giusti A, 2013, IEEE IMAGE PROC, P4034, DOI 10.1109/ICIP.2013.6738831; Haberl MG, 2018, NAT METHODS, V15, P677, DOI 10.1038/s41592-018-0106-z; Hassouna MS, 2005, PROC CVPR IEEE, P458; He K., 2016, CVPR, P770, DOI DOI 10.1109/CVPR.2016.90; He KM, 2015, PROC CVPR IEEE, P5353, DOI 10.1109/CVPR.2015.7299173; Hildebrand DGC, 2017, NATURE, V545, P345, DOI 10.1038/nature22356; Januszewski M, 2018, NAT METHODS, V15, P605, DOI 10.1038/s41592-018-0049-4; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamiya K, 2017, NEUROIMAGE-CLIN, V14, P663, DOI 10.1016/j.nicl.2017.03.003; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Kwong MT, 2019, COMPUT METHOD APPL M, V346, P1025, DOI 10.1016/j.cma.2018.09.006; Langkvist M, 2014, PATTERN RECOGN LETT, V42, P11, DOI 10.1016/j.patrec.2014.01.008; Lee HH, 2019, BRAIN STRUCT FUNCT, V224, P1469, DOI 10.1007/s00429-019-01844-6; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Maggioni M, 2013, IEEE T IMAGE PROCESS, V22, P119, DOI 10.1109/TIP.2012.2210725; Maitin-Shepard J.B., 2016, 30 C NEUR INF PROC S, V29, P1966; Maniates-Selvin JT, 2020, RECONSTRUCTION MOTOR, DOI [10.1101/2020.01.10.902478, DOI 10.1101/2020.01.10.902478]; McDonald JH., 2014, HDB BIOL STAT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Meirovitch Y., 2016, ARXIV161202120; Meirovitch Y, 2019, PROC CVPR IEEE, P8417, DOI 10.1109/CVPR.2019.00862; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mikula S, 2012, NAT METHODS, V9, P1198, DOI [10.1038/nmeth.2213, 10.1038/NMETH.2213]; Mockus J., 1978, GLOBAL OPTIMIZATION, V2, P117, DOI DOI 10.1007/978-94-009-0909-0_80394.90090; Nunez-Iglesias J, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00034; Nunez-Iglesias J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071715; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Palombo M, 2019, NEUROIMAGE, V188, P391, DOI 10.1016/j.neuroimage.2018.12.025; Paszke A., 2019, P ADV NEURAL INF PRO, P8024, DOI DOI 10.1038/S41591-021-01287-9; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reniers D, 2008, IEEE T VIS COMPUT GR, V14, P355, DOI [10.1109/TVCG.2008.23, 10.1109/TC.2007.70786]; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Salo RA, 2018, NEUROIMAGE, V172, P404, DOI 10.1016/j.neuroimage.2018.01.087; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Sierra A., 2020, SEGMENTATION WHITE M, DOI [10.23729/bad417ca-553f-4fa6-ae0a-22eddd29a230, DOI 10.23729/BAD417CA-553F-4FA6-AE0A-22EDDD29A230]; Snoek J., 2012, ADV NEURAL INFORM PR, P2951; Soderholm J, 2001, BIOTECHNIQUES, V31, P306, DOI 10.2144/01312st01; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tohka J, 2020, DEEPACSON SOFTWARE V, DOI [10.1038/s42003-021-01699-w, DOI 10.1038/S42003-021-01699-W]; Tohka J, CYLINDRICAL SHAPE DE; Tohka J., GACSON SOFTWARE VISU, DOI [10.5281/zenodo.3693563, DOI 10.5281/ZENODO.3693563]; van Kaick O, 2014, ACM T GRAPHIC, V34, DOI 10.1145/2611811; WALLACE DL, 1983, J AM STAT ASSOC, V78, P569, DOI 10.2307/2288118; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P2, DOI 10.1167/iovs.02-0333; Wanner AA, 2015, J MICROSC-OXFORD, V259, P137, DOI 10.1111/jmi.12244; Zeng T, 2017, BIOINFORMATICS, V33, P2555, DOI 10.1093/bioinformatics/btx188; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019; Zhou Y, 2015, ACM T GRAPHIC, V34, DOI 10.1145/2816795.2818074	68	1	1	2	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY		2399-3642		COMMUN BIOL	Commun. Biol.	FEB 10	2021	4	1							179	10.1038/s42003-021-01699-w			14	Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	QK1BU	WOS:000620115700002	33568775	gold, Green Published			2022-02-06	
J	Krenz, U; Timmermann, D; Gorbunova, A; Lendt, M; Schmidt, S; von Steinbuechel, N				Krenz, Ugne; Timmermann, Dagmar; Gorbunova, Anastasia; Lendt, Michael; Schmidt, Silke; von Steinbuechel, Nicole			Health-related quality of life after pediatric traumatic brain injury: A qualitative comparison between children's and parents' perspectives	PLOS ONE			English	Article								Background Pediatric traumatic brain injury (TBI) may cause a wide range of symptoms, which can negatively affect the quality of life of patients and their entire families. No internationally and simultaneously developed disease-specific instrument exists for assessing pediatric health-related quality of life (HRQoL) after TBI. The aim of the current project is to provide original material from small group interviews with individuals after TBI concerning what they state is relevant for their HRQoL. This material is required for a further study to generate items for age-adapted questionnaires assessing the TBI-specific HRQoL of children and adolescents (C&A): the QOLIBRI-Kiddy/Kid/Ado and proxy versions (Quality of Life after Brain Injury-Kiddy/Kids/Adolescents/Proxy) for individuals aged 6-17 and their parents. Methods The semi-structured interviews were conducted with separate small groups of C&A (n = 19), divided into three age groups (5-7y, 8-12y, 13-17y), after mild, moderate, and severe TBI, and with groups of the corresponding parents (n = 26). All interviews lasted for about 60 minutes, were recorded and transcribed verbatim. The statements were investigated by qualitative analyses and sorted into categories relevant to the HRQoL of C&A after TBI. Only descriptive group comparisons but no pairwise comparisons between children and corresponding parents were performed. Results The analyses led to 32 subcategories, which were assigned to six main theoretically based HRQoL categories. Many agreements exist between the C&A's and parents' perspectives within the main categories, however their focus on HRQoL differs, especially concerning age-related contents. Parents of the youngest participant group already focus on topics such as autonomy, whereas this only becomes relevant for C&A from the age of eight years on. Interestingly, even 5-year-old children were able to discuss their HRQoL, which indicates the importance of a self-report instrument. Conclusions Results obtained from this qualitative study identify the content of the HRQoL dimensions important for C&A after TBI and their parents. Both, differences and similarities in the children's and the parents' views were investigated, to get a first insight in valid dimensions for the prospective questionnaires to be developed. In a future study, items for the questionnaires will be deducted from the small group interview material and psychometrically tested in C&A after TBI from Germany. This study will address whether all statements were assigned to the suitable dimensions and whether differences between C&A and parents persist.	[Krenz, Ugne; Timmermann, Dagmar; Gorbunova, Anastasia; von Steinbuechel, Nicole] Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany; [Lendt, Michael] St Mauritius Therapeut Clin, Neuropediat, Meerbusch, Germany; [Schmidt, Silke] Ernst Moritz Arndt Univ Greifswald, Dept Hlth & Prevent, Greifswald, Germany		Krenz, U (corresponding author), Georg August Univ, Dept Med Psychol & Med Sociol, Gottingen, Germany.	ugne.krenz@med.uni-goettingen.de		Krenz, Ugne/0000-0002-0518-8781	Dr. Senckenbergische Stiftung Frankfurt am Main, Germany; Dr. Christ'sche Stiftung Frankfurt am Main, Germany; UniscientiaStiftung, Vaduz, Lichtenstein; Goettingen University	The authors declare no competing financial interests. This work was funded by Dr. Senckenbergische Stiftung Frankfurt am Main, Germany (no grant number available) and Dr. Christ'sche Stiftung Frankfurt am Main, Germany (no grant number available), and UniscientiaStiftung, Vaduz, Lichtenstein (no grant number available). The publication was supported by the Open Access Publication Funds of the Goettingen University. The funders had no role in study design, data collection, data analysis, decision to publish, and writing the manuscript. URLs sponsors websites: Senckenbergische Stiftung: http://www.senckenbergische-stiftung.de/Dr.Christ'sche Stiftung Frankfurt am Main, Germany: https://www.ckh-stiftung.de/UniscientiaStiftung, Vaduz, Lichtenstein: foundation has no URL.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Bohn B, 2014, TRAUMA BERUFSKRANKH, V16, P425, DOI 10.1007/s10039-014-2101-7; Coghill D, 2009, J CHILD PSYCHOL PSYC, V50, P544, DOI 10.1111/j.1469-7610.2009.02008.x; Davis E, 2007, QUAL LIFE RES, V16, P863, DOI 10.1007/s11136-007-9187-3; Dorn SD, 2010, ALIMENT PHARM THER, V31, P666, DOI 10.1111/j.1365-2036.2009.04220.x; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Gesellschaft fur Neonatologie und padiatrische Intensivmedizin e. V ed, 2011, LEITLINIE SCHADEL HI; Gothwal VK, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.4.15; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Heary CM, 2002, J PEDIATR PSYCHOL, V27, P47, DOI 10.1093/jpepsy/27.1.47; Holbrook TL, 2007, J TRAUMA, V62, P577, DOI 10.1097/TA.0b013e318031aa97; Horner SD, 2000, RES NURS HEALTH, V23, P510, DOI 10.1002/1098-240X(200012)23:6<510::AID-NUR9>3.0.CO;2-L; Landolt MA, 2009, AUST NZ J PSYCHIAT, V43, P746, DOI 10.1080/00048670903001919; Langlois JA, 2000, SUMMARY RECOMMENDATI; Lendt M, 2014, MONATSSCHR KINDERH, V162, P420, DOI 10.1007/s00112-014-3114-9; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Marra CA, 2005, SOC SCI MED, V60, P1571, DOI 10.1016/j.socscimed.2004.08.034; Martin-Herz SP, 2012, CLIN CHILD FAM PSYCH, V15, P192, DOI 10.1007/s10567-012-0115-x; Mayring P., 2010, HDB QUALITATIVE FORS, V11th, DOI [10.1007/978-3-531-92052-8_42, DOI 10.1007/978-3-531-92052-8_42]; Messing-Juenger M., 2018, HDB SCHAEDEL HIRN TR, P288; Morgan D.L., 1996, FOCUS GROUPS QUALITA; Morgan M., 2002, QUAL RES, V2, P5, DOI [DOI 10.1177/1468794102002001636, https://doi.org/10.1177/1468794102002001636]; Rajmil L, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-101; Ravens-Sieberer U., 2000, BUNDESGESUNDHEITSBLA, V43, P198, DOI [10.1007/s001030050035, DOI 10.1007/S001030050035]; Ravens-Sieberer U, 2006, PHARMACOECONOMICS, V24, P1199, DOI 10.2165/00019053-200624120-00005; Rothe K, 2014, TRAUMA BERUFSKRANKH, V16, P190, DOI 10.1007/s10039-013-2013-y; Skjerning H, 2014, QUAL LIFE RES, V23, P1883, DOI 10.1007/s11136-014-0623-x; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stewart DW., 2014, FOCUS GROUPS THEORY; Theunissen NCM, 1998, QUAL LIFE RES, V7, P387, DOI 10.1023/A:1008801802877; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-2; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 1998, NEUE HERAUSFORDERUNG, P50; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Warschburger P, 2003, QUAL LIFE RES, V12, P291, DOI 10.1023/A:1023233308653; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; Witzel A., 2012, PROBLEM CTR INTERVIE; World Health Organization, CONST WHO 1948	47	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2021	16	2							e0246514	10.1371/journal.pone.0246514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QH4UN	WOS:000618271700038	33566806	Green Published, gold			2022-02-06	
J	Varner, C; Thompson, C; de Wit, K; Borgundvaag, B; Houston, R; McLeod, S				Varner, Catherine; Thompson, Cameron; de Wit, Kerstin; Borgundvaag, Bjug; Houston, Reaves; McLeod, Shelley			Predictors of persistent concussion symptoms in adults with acute mild traumatic brain injury presenting to the emergency department	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Mild traumatic brain injury; Concussion; Persistent concussion symptoms		Objective To identify risk factors associated with persistent concussion symptoms in adults presenting to the emergency department (ED) with acute mild traumatic brain injury (TBI). Methods This was a secondary analysis of a randomized controlled trial conducted in three Canadian EDs whereby the intervention had no impact on recovery or healthcare utilization outcomes. Adult (18-64 years) patients with a mild TBI sustained within the preceding 48 h were eligible for enrollment. The primary outcome was the presence of persistent concussion symptoms at 30 days, defined as the presence of >= 3 symptoms on the Rivermead Post-concussion Symptoms Questionnaire. Results Of the 241 patients who completed follow-up, median (IQR) age was 33 (25 to 50) years, and 147 (61.0%) were female. At 30 days, 49 (20.3%) had persistent concussion symptoms. Using multivariable logistic regression, headache at ED presentation (OR: 7.7; 95% CI 1.6 to 37.8), being under the influence of drugs or alcohol at the time of injury (OR: 5.9; 95% CI 1.8 to 19.4), the injury occurring via bike or motor vehicle collision (OR: 2.9; 95% CI 1.3 to 6.0), history of anxiety or depression (OR: 2.4; 95% CI 1.2 to 4.9), and numbness or tingling at ED presentation (OR: 2.4; 95% CI 1.1 to 5.2), were found to be independently associated with persistent concussion symptoms at 30 days. Conclusions Five variables were found to be significant predictors of persistent concussion symptoms. Although mild TBI is mostly a self-limited condition, patients with these risk factors should be considered high risk for developing persistent concussion symptoms and flagged for early outpatient follow-up.	[Varner, Catherine; Borgundvaag, Bjug; McLeod, Shelley] Univ Toronto, Fac Med, Toronto, ON, Canada; [Varner, Catherine; Thompson, Cameron; Borgundvaag, Bjug; Houston, Reaves; McLeod, Shelley] Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [Varner, Catherine; Borgundvaag, Bjug; McLeod, Shelley] Univ Toronto, Dept Family & Community Med, 206-600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Varner, Catherine; Thompson, Cameron; Borgundvaag, Bjug; McLeod, Shelley] Sinai Hlth Syst, Toronto, ON, Canada; [de Wit, Kerstin] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada		Varner, C (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Varner, C (corresponding author), Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada.; Varner, C (corresponding author), Univ Toronto, Dept Family & Community Med, 206-600 Univ Ave, Toronto, ON M5G 1X5, Canada.; Varner, C (corresponding author), Sinai Hlth Syst, Toronto, ON, Canada.	catherine.varner@sinaihealth.ca	McLeod, Shelley/AAE-9636-2019	McLeod, Shelley/0000-0003-2686-6307; Varner, Catherine/0000-0002-9696-1329	Workplace Safety and Insurance Board of Ontario; Canadian Association of Emergency Physicians	This project was supported by grants from the Workplace Safety and Insurance Board of Ontario and the Canadian Association of Emergency Physicians.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; CDC, INJURY PREVENTION CO; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Delaney, 2011, BRAIN INJURY, V23, P531; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Madhok DY, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050269; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod, 2020, ACAD EMERG MED, V22, P6; Plass AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210138; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Velikonja, 2018, STANDARDS HIGH QUALI; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257	24	1	1	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	MAY	2021	23	3					365	373		10.1007/s43678-020-00076-6		FEB 2021	9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	RY2LR	WOS:000616021200002	33555602				2022-02-06	
J	Raikes, AC; Dailey, NS; Forbeck, B; Alkozei, A; Killgore, WDS				Raikes, Adam C.; Dailey, Natalie S.; Forbeck, Brittany; Alkozei, Anna; Killgore, William D. S.			Daily Morning Blue Light Therapy for Post-mTBI Sleep Disruption: Effects on Brain Structure and Function	FRONTIERS IN NEUROLOGY			English	Article						concussion; phototherapy; daytime sleepiness; fatigue; gray matter volume; functional connectivity		Background: Mild traumatic brain injuries (mTBIs) are associated with novel or worsened sleep disruption. Several studies indicate that daily morning blue light therapy (BLT) is effective for reducing post-mTBI daytime sleepiness and fatigue. Studies demonstrating changes in brain structure and function following BLT are limited. The present study's purpose is to identify the effect of daily morning BLT on brain structure and functional connectivity and the association between these changes and self-reported change in post-mTBI daytime sleepiness. Methods: A total of 62 individuals recovering from a mTBI were recruited from two US cities to participate in a double-blind placebo-controlled trial. Eligible individuals were randomly assigned to undergo 6 weeks of 30 min daily morning blue or placebo amber light therapy (ALT). Prior to and following treatment all individuals completed a comprehensive battery that included the Epworth Sleepiness Scale as a measure of self-reported daytime sleepiness. All individuals underwent a multimodal neuroimaging battery that included anatomical and resting-state functional magnetic resonance imaging. Atlas-based regional change in gray matter volume (GMV) and region-to-region functional connectivity from baseline to post-treatment were the primary endpoints for this study. Results: After adjusting for pre-treatment GMV, individuals receiving BLT had greater GMV than those receiving amber light in 15 regions of interest, including the right thalamus and bilateral prefrontal and orbitofrontal cortices. Improved daytime sleepiness was associated with greater GMV in 74 ROIs, covering many of the same general regions. Likewise, BLT was associated with increased functional connectivity between the thalamus and both prefrontal and orbitofrontal cortices. Improved daytime sleepiness was associated with increased functional connectivity between attention and cognitive control networks as well as decreased connectivity between visual, motor, and attention networks (all FDR corrected p < 0.05). Conclusions: Following daily morning BLT, moderate to large increases in both gray matter volume and functional connectivity were observed in areas and networks previously associated with both sleep regulation and daytime cognitive function, alertness, and attention. Additionally, these findings were associated with improvements in self-reported daytime sleepiness. Further work is needed to identify the personal characteristics that may selectively identify individuals recovering from a mTBI for whom BLT may be optimally beneficial.	[Raikes, Adam C.] Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ 85721 USA; [Dailey, Natalie S.; Forbeck, Brittany; Alkozei, Anna; Killgore, William D. S.] Univ Arizona, Social Cognit & Affect Neurosci Lab, Tucson, AZ USA		Raikes, AC (corresponding author), Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ 85721 USA.	raikes.ressarch@gmail.com	Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727; Dailey, Natalie S./0000-0003-4800-4118	US Army Medical Research and Development Command (USAMRDC) [W81XWH-11-10056, W81XWH-14-1-0571]	This work was funded by multiple grants to WK from the US Army Medical Research and Development Command (USAMRDC) including W81XWH-11-10056 and W81XWH-14-1-0571. The content, opinions, interpretations, conclusions, and recommendations are solely the responsibility of the authors and do not necessarily represent the views of Partners Healthcare, the University of Arizona College of Medicine, the Department of Defense, or the US Army Medical Research and Development Command.	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Alkozei A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184884; Alkozei A, 2016, SLEEP, V39, P1671, DOI 10.5665/sleep.6090; Alkozei A, 2016, NEUROSCI LETT, V616, P5, DOI 10.1016/j.neulet.2016.01.034; Altena E, 2010, BIOL PSYCHIAT, V67, P182, DOI 10.1016/j.biopsych.2009.08.003; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bajaj S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00616; Banks SD, 2016, ARCH PHYS MED REHAB, V97, P1254, DOI 10.1016/j.apmr.2016.03.013; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brooks BL, 2019, J NEUROTRAUM, V36, P2391, DOI 10.1089/neu.2018.6257; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; Cirelli C, 2019, SCIENCE, V366, P189, DOI 10.1126/science.aay5304; Ciric R, 2017, NEUROIMAGE, V154, P174, DOI 10.1016/j.neuroimage.2017.03.020; Clark AL, 2018, J HEAD TRAUMA REHAB, V33, P382, DOI 10.1097/HTR.0000000000000377; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Combs PR, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967118817515; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Dai XJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00266; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW TBI NUMB; Dewan K, 2011, SLEEP, V34, P593, DOI 10.1093/sleep/34.5.593; Dobney DM, 2019, DISABIL REHABIL, V41, P727, DOI 10.1080/09638288.2017.1400595; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Elmenhorst D, 2007, J NEUROSCI, V27, P2410, DOI 10.1523/JNEUROSCI.5066-06.2007; Esteban O., 2020, NIPY NIPYPE 1; Esteban O, 2019, NAT METHODS, V16, P111, DOI 10.1038/s41592-018-0235-4; Evans AC, 2012, NEUROIMAGE, V62, P911, DOI 10.1016/j.neuroimage.2012.01.024; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Fonov V., 2009, NEUROIMAGE, V47, pS102; Fortin JP, 2018, NEUROIMAGE, V167, P104, DOI 10.1016/j.neuroimage.2017.11.024; Fortin JP, 2017, NEUROIMAGE, V161, P149, DOI 10.1016/j.neuroimage.2017.08.047; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Hoffman NL, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy222; Howell DR, 2019, J CHILD NEUROL, V34, P256, DOI 10.1177/0883073818824000; Iyer KK, 2020, J NEUROTRAUM, V37, P2647, DOI 10.1089/neu.2020.7200; Iyer KK, 2019, ANN CLIN TRANSL NEUR, V6, P954, DOI 10.1002/acn3.764; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; Kerr Z, 2016, BRAIN INJURY, V30, P504; Killgore WDS, 2020, EXPERT REV NEUROTHER, V20, P1081, DOI 10.1080/14737175.2020.1814147; Killgore WDS, 2020, NEUROSCI LETT, V735, DOI 10.1016/j.neulet.2020.135242; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; Killgore WDS, 2015, NEUROREPORT, V26, P779, DOI 10.1097/WNR.0000000000000418; Klein A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005350; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lanczos C., 1964, J SOC IND APPL MAT B, V1, P76, DOI [10.1137/0701007, DOI 10.1137/0701007]; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; Ludwig R, 2020, PM&R, V12, P500, DOI 10.1002/pmrj.12309; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Mantua J, 2018, SLEEP MED REV, V41, P61, DOI 10.1016/j.smrv.2018.01.004; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; Markiewicz C.J., 2018, NAT METHODS, DOI 10.1101/306951; Master CL, 2020, JAMA OPHTHALMOL, V138, P1135, DOI 10.1001/jamaophthalmol.2020.3466; Meyer J, 2020, BRAIN INJURY, V34, P1435, DOI 10.1080/02699052.2020.1802780; Mohajer B, 2020, HUM BRAIN MAPP, V41, P3034, DOI 10.1002/hbm.24995; Munivenkatappa A, 2016, BRAIN INJURY, V30, P388, DOI 10.3109/02699052.2015.1089599; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Oyegbile TO, 2020, BEHAV SLEEP MED, V18, P241, DOI 10.1080/15402002.2019.1578223; Pattinson CL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13191; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Puentes-Mestril C, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00061; R Core Team, 2021, R LANG ENV STAT COMP; Raikes AC, 2020, J HEAD TRAUMA REHAB, V35, pE405, DOI 10.1097/HTR.0000000000000579; Raikes AC, 2019, SLEEP MED, V58, P66, DOI 10.1016/j.sleep.2019.03.008; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Stoffers Diederick, 2012, Front Neurol, V3, P105, DOI 10.3389/fneur.2012.00105; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Vandewalle G, 2007, CEREB CORTEX, V17, P2788, DOI 10.1093/cercor/bhm007; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2013, J COGNITIVE NEUROSCI, V25, P2072, DOI 10.1162/jocn_a_00450; Vandewalle G, 2011, J BIOL RHYTHM, V26, P249, DOI 10.1177/0748730411401736; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Williams WP, 2016, PHARMACOTHERAPY, V36, P1028, DOI 10.1002/phar.1822; Wiseman-Hakes C, 2019, ASN NEURO, V11, DOI 10.1177/1759091418822405; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yu MC, 2018, HUM BRAIN MAPP, V39, P4213, DOI 10.1002/hbm.24241; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	112	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 5	2021	12								625431	10.3389/fneur.2021.625431			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QJ1RI	WOS:000619467100001	33633674	Green Published, gold			2022-02-06	
J	Janigro, D; Bailey, DM; Lehmann, S; Badaut, J; O'Flynn, R; Hirtz, C; Marchi, N				Janigro, Damir; Bailey, Damian M.; Lehmann, Sylvain; Badaut, Jerome; O'Flynn, Robin; Hirtz, Christophe; Marchi, Nicola			Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts	FRONTIERS IN NEUROLOGY			English	Article						neurovascular unit; blood biomarkers; saliva; concussion; epilepsy; neurodegeneration; traumatic brain injury; extreme sports		Within the neurovascular unit (NVU), the blood-brain barrier (BBB) operates as a key cerebrovascular interface, dynamically insulating the brain parenchyma from peripheral blood and compartments. Increased BBB permeability is clinically relevant for at least two reasons: it actively participates to the etiology of central nervous system (CNS) diseases, and it enables the diagnosis of neurological disorders based on the detection of CNS molecules in peripheral body fluids. In pathological conditions, a suite of glial, neuronal, and pericyte biomarkers can exit the brain reaching the peripheral blood and, after a process of filtration, may also appear in saliva or urine according to varying temporal trajectories. Here, we specifically examine the evidence in favor of or against the use of protein biomarkers of NVU damage and BBB permeability in traumatic head injury, including sport (sub)concussive impacts, seizure disorders, and neurodegenerative processes such as Alzheimer's disease. We further extend this analysis by focusing on the correlates of human extreme physiology applied to the NVU and its biomarkers. To this end, we report NVU changes after prolonged exercise, freediving, and gravitational stress, focusing on the presence of peripheral biomarkers in these conditions. The development of a biomarker toolkit will enable minimally invasive routines for the assessment of brain health in a broad spectrum of clinical, emergency, and sport settings.	[Janigro, Damir] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA; [Janigro, Damir] FloTBI Inc, Cleveland, OH USA; [Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Cardiff, Wales; [Lehmann, Sylvain; O'Flynn, Robin; Hirtz, Christophe] Univ Montpellier, CHU Montpellier, INSERM, IRMB,INM,UFR Odontol,CNRS, Montpellier, France; [Badaut, Jerome] Univ Bordeaux, Brain Mol Imaging Lab, INCIA, CNRS UMR 5287, Bordeaux, France; [Marchi, Nicola] Univ Montpellier, Inst Funct Genom, Dept Neurosci, UMR 5203 CNRS U1191 INSERM,Cerebrovasc & Gila Res, Montpellier, France		Marchi, N (corresponding author), Univ Montpellier, Inst Funct Genom, Dept Neurosci, UMR 5203 CNRS U1191 INSERM,Cerebrovasc & Gila Res, Montpellier, France.	nicola.marchi@igf.cnrs.fr	Hirtz, Christophe/AAD-1662-2022; Hirtz, Christophe/R-9255-2017; Marchi, Nicola/J-8607-2016; Lehmann, Sylvain/P-1301-2017	Hirtz, Christophe/0000-0002-7313-0629; Hirtz, Christophe/0000-0002-7313-0629; Marchi, Nicola/0000-0001-9124-0226; Lehmann, Sylvain/0000-0001-6117-562X	ANR-Hepatobrain; ANR-EpicyteFrench National Research Agency (ANR); ERaNet Neu-Vasc; ANSES Epidemicmac; MUSE-iSite University of Montpellier; Royal Society Wolfson Research Fellowship [WM170007]; Royal Society International Exchanges Award [IES/R2/192137]; Japan Society for the Promotion of Science Research FellowshipMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [JSPS/OF317]	NM was supported by ANR-Hepatobrain, ANR-Epicyte, ERaNet Neu-Vasc, ANSES Epidemicmac, MUSE-iSite University of Montpellier. DB was supported by a Royal Society Wolfson Research Fellowship (#WM170007), Royal Society International Exchanges Award (IES/R2/192137), and Japan Society for the Promotion of Science Research Fellowship (#JSPS/OF317).	Abbott NJ, 2018, ACTA NEUROPATHOL, V135, P387, DOI 10.1007/s00401-018-1812-4; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; Al-Rawi NH, 2009, CLIN CHEM LAB MED, V47, P1519, DOI 10.1515/CCLM.2009.345; Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Andersson JPA, 2009, J APPL PHYSIOL, V107, P809, DOI 10.1152/japplphysiol.91434.2008; Aqrawi LA, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1228-x; Arango-Lievano M, 2018, CELL REP, V23, P1045, DOI 10.1016/j.celrep.2018.03.110; Atici Y, 2012, SEIZURE-EUR J EPILEP, V21, P175, DOI 10.1016/j.seizure.2011.11.003; Ayatollahi Hossein, 2007, Urol J, V4, P238; Bailey DM, 2009, J PHYSIOL-LONDON, V587, P73, DOI 10.1113/jphysiol.2008.159855; Bailey DM, 2020, NEUROSCIENCE, V441, P142, DOI 10.1016/j.neuroscience.2020.05.048; Bailey DM, 2019, EXP PHYSIOL, V104, P1769, DOI 10.1113/EP088005; Bailey DM, 2018, FREE RADICAL BIO MED, V124, P104, DOI 10.1016/j.freeradbiomed.2018.05.090; Bailey DM, 2017, HIGH ALT MED BIOL, V18, P73, DOI 10.1089/ham.2016.0081; Bailey DM, 2017, CIRCULATION, V135, P166, DOI 10.1161/CIRCULATIONAHA.116.024226; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Bailey DM, 2011, EXP PHYSIOL, V96, P1196, DOI 10.1113/expphysiol.2011.060178; Bailey DM, 2009, AM J PHYSIOL-REG I, V297, pR1283, DOI 10.1152/ajpregu.00366.2009; Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; Bailey DM, 2006, J CEREBR BLOOD F MET, V26, P99, DOI 10.1038/sj.jcbfm.9600169; Bain AR, 2018, FASEB J, V32, P2305, DOI 10.1096/fj.201701031R; Bak TH, 2011, NAT REV NEUROL, V7, P10, DOI 10.1038/nrneurol.2010.177; Banks WA, 2016, NAT REV DRUG DISCOV, V15, P275, DOI 10.1038/nrd.2015.21; Bargerstock E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101477; Barthelemy NR, 2020, J EXP MED, V217, DOI 10.1084/jem.20200861; Bastin P, 2018, ANN BIOL CLIN-PARIS, V76, P393, DOI 10.1684/abc.2018.1355; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Brown BM, 2013, MOL PSYCHIATR, V18, P875, DOI 10.1038/mp.2012.107; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Byrne ML, 2013, BRAIN BEHAV IMMUN, V34, P164, DOI 10.1016/j.bbi.2013.08.010; Calik M, 2014, NEUROSCI LETT, V558, P58, DOI 10.1016/j.neulet.2013.10.040; Calik M, 2013, SEIZURE-EUR J EPILEP, V22, P99, DOI 10.1016/j.seizure.2012.10.012; Calverley TA, 2020, J PHYSIOL-LONDON, V598, P2513, DOI 10.1113/JP275021; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Castagnola M, 2017, ACTA OTORHINOLARYNGO, V37, P94, DOI 10.14639/0392-100X-1598; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Cohen AD, 2019, MOL CELL NEUROSCI, V97, P3, DOI 10.1016/j.mcn.2018.12.004; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; del Rio MS, 1999, ADV EXP MED BIOL, V474, P145; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Dezayee Zhian Mahmood Ibrahim, 2016, Indian J Dent Res, V27, P388, DOI 10.4103/0970-9290.191887; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dubayle D, 2020, NPJ MICROGRAVITY, V6, DOI 10.1038/s41526-019-0094-z; Ebersole JL, 2017, J PERIODONTAL RES, V52, P419, DOI 10.1111/jre.12406; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Enright Noelle, 2018, Epilepsia Open, V3, P427, DOI 10.1002/epi4.12275; ERNSTING J, 1963, J PHYSIOL-LONDON, V169, P292, DOI 10.1113/jphysiol.1963.sp007257; Falcone Tatiana, 2015, Clin Schizophr Relat Psychoses, V9, P65, DOI 10.3371/CSRP.FACA.030813; Fazio V, 2004, ANN THORAC SURG, V78, P46, DOI 10.1016/j.athoracsur.2003.11.042; Friedman Alon, 2011, Cardiovasc Psychiatry Neurol, V2011, P431470, DOI 10.1155/2011/431470; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Gazzolo D, 2005, CLIN BIOCHEM, V38, P229, DOI 10.1016/j.clinbiochem.2004.12.006; Gazzolo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115194; Giannoni P, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00003; Giannoni P, 2018, CLIN SCI, V132, P361, DOI 10.1042/CS20171634; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Gillick K, 2018, RESUSCITATION, V128, P24, DOI 10.1016/j.resuscitation.2018.04.010; Gozt A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10010023; Grassl N, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0293-0; Gresle MM, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/315406; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Gulati G, 2016, CLIN RHEUMATOL, V35, P2989, DOI 10.1007/s10067-016-3339-1; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Harris JL, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00202, 10.3389/fnagi.2015.00202]; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Henshall DC, 2016, LANCET NEUROL, V15, P1368, DOI 10.1016/S1474-4422(16)30246-0; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Hirtz C, 2005, J PHYSIOL BIOCHEM, V61, P469, DOI 10.1007/BF03168453; Hirtz C, 2016, BIOANALYSIS, V8, P43, DOI 10.4155/bio.15.228; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Holshouser B, 2019, J NEUROTRAUM, V36, P1352, DOI 10.1089/neu.2018.5919; Hu S, 2006, J DENT RES, V85, P1129, DOI 10.1177/154405910608501212; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Janigro D, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00528; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jickling GC, 2011, NEUROTHERAPEUTICS, V8, P349, DOI 10.1007/s13311-011-0050-4; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones CMC, 2020, BRAIN INJURY, V34, P407, DOI 10.1080/02699052.2020.1725123; Kaczor-Urbanowicz KE, 2018, BIOINFORMATICS, V34, P1, DOI 10.1093/bioinformatics/btx504; Kaczor-Urbanowicz KE, 2017, EXP BIOL MED, V242, P459, DOI 10.1177/1535370216681550; Kallenberg K, 2008, J CEREBR BLOOD F MET, V28, P1635, DOI 10.1038/jcbfm.2008.55; Kallenberg K, 2007, J CEREBR BLOOD F MET, V27, P1064, DOI 10.1038/sj.jcbfm.9600404; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Karikari TK, 2020, LANCET NEUROL, V19, P422, DOI 10.1016/S1474-4422(20)30071-5; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Khurshid Z, 2018, ADV CLIN CHEM, V86, P23, DOI 10.1016/bs.acc.2018.05.002; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kjeld T, 2015, SCAND J MED SCI SPOR, V25, pe253, DOI 10.1111/sms.12309; Klement W, 2019, EPILEPSIA, V60, P1399, DOI 10.1111/epi.16019; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Korfias S, 2006, BRAIN INJURY, V20, P867, DOI 10.1080/02699050600832395; La Fratta I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21474-y; Lakin WD, 2007, AVIAT SPACE ENVIR MD, V78, P932, DOI 10.3357/ASEM.2060.2007; Lakshmi P V S Deepa, 2015, Contemp Clin Dent, V6, P443, DOI 10.4103/0976-237X.169844; Lee ARG, 2020, NPJ MICROGRAVITY, V6, DOI 10.1038/s41526-020-0097-9; Lee YC, 2019, CURR PHARM DESIGN, V25, P4560, DOI 10.2174/1381612825666191210154535; Leuzy A, 2019, MOL PSYCHIATR, V24, P1112, DOI 10.1038/s41380-018-0342-8; Li Y, 2004, J DENT RES, V83, P199, DOI 10.1177/154405910408300303; Li Y, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00221; Liang KG, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00456; Librizzi L, 2018, NEUROSCI LETT, V667, P75, DOI 10.1016/j.neulet.2017.01.013; Liebner S, 2018, ACTA NEUROPATHOL, V135, P311, DOI 10.1007/s00401-018-1815-1; Lindblad C, 2020, J NEUROTRAUM, V37, P1381, DOI 10.1089/neu.2019.6741; Linsenmaier U, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150827; Loo JA, 2010, J DENT RES, V89, P1016, DOI 10.1177/0022034510380414; Maas AIR, 2018, LANCET NEUROL, V17, P737, DOI 10.1016/S1474-4422(18)30275-8; Malkiewicz MA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1403-x; Malon RSP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/962903; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Marchi N, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-37; Marchi N, 2014, TRENDS NEUROSCI, V37, P55, DOI 10.1016/j.tins.2013.11.002; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marchi N, 2012, EPILEPSIA, V53, P1877, DOI 10.1111/j.1528-1167.2012.03637.x; Marchi Nicola, 2011, Cardiovasc Psychiatry Neurol, V2011, P482415, DOI 10.1155/2011/482415; Marchi N, 2011, EPILEPSIA, V52, P1627, DOI 10.1111/j.1528-1167.2011.03080.x; Markopoulos AK, 2001, J PERIODONTAL RES, V36, P88, DOI 10.1034/j.1600-0765.2001.360204.x; Marlatt MW, 2012, DEV NEUROBIOL, V72, P943, DOI 10.1002/dneu.22009; Humberto JSM, 2018, BRAZ ORAL RES, V32, DOI 10.1590/1807-3107bor-2018.vol32.0082; Matsuzawa Y, 1992, HIGH ALTITUDE MED, P300; Mayeux Richard, 2004, NeuroRx, V1, P182, DOI 10.1602/neurorx.1.2.182; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Meier TB, 2020, ANN NEUROL, V87, P907, DOI 10.1002/ana.25725; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Michetti F, 2011, CLIN BIOCHEM, V44, P245, DOI 10.1016/j.clinbiochem.2010.10.007; Mikkonen K, 2012, SEIZURE-EUR J EPILEP, V21, P144, DOI 10.1016/j.seizure.2011.10.006; Monbailliu T, 2017, BIOMARK MED, V11, P503, DOI 10.2217/bmm-2016-0232; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Montagne A, 2020, NATURE, V581, P70, DOI 10.1038/s41586-020-2247-3; Montagne A, 2019, ALZHEIMERS DEMENT, V15, P1568, DOI 10.1016/j.jalz.2019.07.012; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neyraud E, 2006, J PROTEOME RES, V5, P2474, DOI 10.1021/pr060189z; Nicholson C, 2017, BIOPHYS J, V113, P2133, DOI 10.1016/j.bpj.2017.06.052; Noe Francesco M, 2019, Epilepsia Open, V4, P30, DOI 10.1002/epi4.12302; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; O'Connor A, 2021, MOL PSYCHIATR, V26, P5967, DOI 10.1038/s41380-020-0838-x; Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Palmio J, 2008, EPILEPSY RES, V81, P155, DOI 10.1016/j.eplepsyres.2008.05.006; Palmqvist S, 2020, JAMA-J AM MED ASSOC, V324, P772, DOI 10.1001/jama.2020.12134; Papa L, 2019, J NEUROTRAUM, V36, P1343, DOI 10.1089/neu.2018.6072; Papa L, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000473; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Patel N, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0219-1; Pay JB, 2019, CLIN BIOCHEM, V68, P1, DOI 10.1016/j.clinbiochem.2019.04.006; Peters SA, 2008, CLIN PHARMACOKINET, V47, P261, DOI 10.2165/00003088-200847040-00004; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Pollak TA, 2018, LANCET PSYCHIAT, V5, P79, DOI 10.1016/S2215-0366(17)30293-6; Porte Y, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00064; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Prestgaard E, 2019, STROKE, V50, P155, DOI 10.1161/STROKEAHA.118.021798; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Pulido RS, 2020, NEURON, V108, DOI 10.1016/j.neuron.2020.09.002; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rantonen PJF, 2000, ACTA ODONTOL SCAND, V58, P299, DOI 10.1080/00016350050217163; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Risso FM, 2012, J MATERN-FETAL NEO M, V25, P101, DOI 10.3109/14767058.2012.715024; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI 10.1089/neu.2009-0928; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Ruber T, 2018, BRAIN, V141, P2952, DOI 10.1093/brain/awy242; Rundgren Malin, 2014, BMC Res Notes, V7, P726, DOI 10.1186/1756-0500-7-726; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Sagare AP, 2011, J ALZHEIMERS DIS, V24, P25, DOI 10.3233/JAD-2010-101248; Sanchez Garcia P, 1989, An Med Interna, V6, P5; Schepici G, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040245; Schoonman GG, 2008, J CEREBR BLOOD F MET, V28, P198, DOI 10.1038/sj.jcbfm.9600513; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shaw LM, 2018, ALZHEIMERS DEMENT, V14, P1505, DOI 10.1016/j.jalz.2018.07.220; Shelhamer M, 2016, J APPL PHYSIOL, V120, P1442, DOI 10.1152/japplphysiol.01046.2015; SHIP JA, 1990, J GERONTOL, V45, pM61, DOI 10.1093/geronj/45.2.M61; Siqueira WL, 2011, PROTEOM CLIN APPL, V5, P575, DOI 10.1002/prca.201100046; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Sonesson M, 2011, EUR J ORAL SCI, V119, P15, DOI 10.1111/j.1600-0722.2010.00794.x; Stein TP, 2002, NUTRITION, V18, P867, DOI 10.1016/S0899-9007(02)00938-3; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Sun Y, 2015, IEEE T NANOBIOSCI, V14, P167, DOI 10.1109/TNB.2015.2395143; Sweeney MD, 2020, ALZHEIMERS DEMENT, V16, P821, DOI 10.1002/alz.12061; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Tari AR, 2019, LANCET PUBLIC HEALTH, V4, pE565, DOI 10.1016/S2468-2667(19)30183-5; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Tiwari Manjul, 2011, J Nat Sci Biol Med, V2, P53, DOI 10.4103/0976-9668.82322; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080211; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wei F, 2012, CHIN J DENT RES, V15, P7; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Willie CK, 2015, J CEREBR BLOOD F MET, V35, P66, DOI 10.1038/jcbfm.2014.170; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Wong David T W, 2012, J Am Dent Assoc, V143, p19S; World malaria situation, 1990, WORLD HLTH STAT Q, V43, P68; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yan WH, 2009, PROTEOM CLIN APPL, V3, P116, DOI 10.1002/prca.200800140; Yeung C, 2021, PEDIATR EMERG CARE, V37, pE1373, DOI 10.1097/PEC.0000000000002050; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang J., 2016, TRANSLATIONAL RES TR; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; Zonner SW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00327	250	1	1	4	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 4	2021	11								577312	10.3389/fneur.2020.577312			20	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QI5IG	WOS:000619010400001	33613412	Green Published, gold			2022-02-06	
J	Jones, KM; Ameratunga, S; Starkey, NJ; Theadom, A; Barker-Collo, S; Ikeda, T; Feigin, VL				Jones, Kelly M.; Ameratunga, Shanthi; Starkey, Nicola J.; Theadom, Alice; Barker-Collo, Suzanne; Ikeda, Takayoshi; Feigin, Valery L.		BIONIC Study Grp	Psychosocial functioning at 4-years after pediatric mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; children; behavioral adjustment; emotional adjustment; social competence; participation		Objective: Behavioral and emotional difficulties are reported following pediatric mild traumatic brain injury (TBI). But few studies have used a broad conceptual approach to examine children's long-term psychosocial outcomes. This study examines children's psychosocial outcomes at 4-years after mild TBI and associated factors. Methods: Parents of 93 children (<16 years) with mild TBI completed subscales of age-appropriate versions of the Strengths and Difficulties Questionnaire, the Behavior Rating Inventory of Executive Function, the Pediatric Quality of Life Inventory, and the Adolescent Scale of Participation questionnaire at 4-years post-injury. Results: Mean group-level scores were statistically significantly higher for hyperactivity/inattention and lower for emotional functioning than published norms. Levels of participation were greater compared to those observed in normative samples. More than 19% met published criteria for clinically significant hyperactivity/inattention, emotional functioning problems, peer relationship problems, and social functioning difficulties. Lower family socio-economic status and greater parental anxiety and depression were associated with overall psychosocial difficulties. Conclusions: Findings indicate that as a group, children with mild TBI are characterized by elevated rates of behavioral, emotional, and social difficulties at 4-years post-injury. Parent mental health may be an untapped opportunity to support children's psychosocial development following mild TBI, with replication required in larger samples.	[Jones, Kelly M.; Theadom, Alice; Feigin, Valery L.] Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Clin Sci, Natl Inst Stroke & Appl Neurosci, Private Bag 92006, Auckland 1142, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland, New Zealand; [Starkey, Nicola J.] Univ Waikato, Sch Psychol, Div Arts Psychol & Social Sci, Hamilton, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Ikeda, Takayoshi] Auckland Univ Technol, Fac Hlth & Environm Sci, Dept Biostat & Epidemiol, Auckland, New Zealand		Jones, KM (corresponding author), Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Clin Sci, Natl Inst Stroke & Appl Neurosci, Private Bag 92006, Auckland 1142, New Zealand.	kelly.jones@aut.ac.nz		Theadom, Alice/0000-0003-0351-6216; Feigin, Valery L./0000-0002-6372-1740	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192, 13/408]	This research was funded by the Health Research Council of New Zealand [project grants 09/063A, 11/192, 13/408].	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Bornstein MH, 2010, DEV PSYCHOPATHOL, V22, P717, DOI 10.1017/S0954579410000416; Calkins SD., 2007, EMERGENCE SELF REGUL; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J. David, 2004, Journal of Rehabilitation Medicine Supplement, P28; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; CAVELL T, 1990, J CLIN CHILD PSYCHOL, V19; Coie JDE., 1990, RECENT ADV STUDY PEE; Eisenberg N, 2002, MINN SYM CHILD PSYCH, V32, P133; Eley T. C., 2004, ANXIETY DISORDERS CH, P71; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Golos A, 2016, NEUROREHABILITATION, V38, P311, DOI 10.3233/NRE-161322; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; IBM Corp, IBM SPSS STAT WINDOW; Jimenez N, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2462; Jones KM, 2019, BRAIN INJURY, V33, P884, DOI 10.1080/02699052.2019.1606445; Jones KM, 2018, J PRIM HEALTH CARE, V10, P81, DOI 10.1071/HC17038; Keenan HT, 2019, J NEUROTRAUM, V36, P282, DOI 10.1089/neu.2018.5687; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kendler KS, 2008, PSYCHOL MED, V38, P1567, DOI 10.1017/S003329170800384X; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Landry SH, 2003, DEV NEUROPSYCHOL, V24, P559, DOI 10.1207/S15326942DN242&3_04; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Mellor D, 2005, AUST PSYCHOL, V40, P215, DOI 10.1080/00050060500243475; Ministry of Health, 2018, SOC EM BEH DIFF NZ C; Muller-Nix C, 2004, EARLY HUM DEV, V79, P145, DOI 10.1016/j.earlhumdev.2004.05.002; Olsson CA, 2013, J HAPPINESS STUD, V14, P1069, DOI 10.1007/s10902-012-9369-8; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Parker J., 2006, DEV PSYCHOPATHOL, P419, DOI DOI 10.1002/9780470939383.CH12; PARKER S, 1988, PEDIATR CLIN N AM, V35, P1227; Pink B.N., 2006, AUSTR NZ STANDARD CL; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Renaud MI, 2020, EUR J PAEDIATR NEURO, V25, P145, DOI 10.1016/j.ejpn.2019.11.008; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Ryan NP, 2019, J NEUROTRAUM, V36, P2895, DOI 10.1089/neu.2018.6308; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; SHORES E, 1986, MED J AUSTRALIA, V144; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Valmaggia L., 2019, SYSTEMATIC REV, V33, P1272; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; World Health Organisation,, 2007, INT CLASS FUNCT DIS; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zamani A, 2019, EXP NEUROL, V314, P34, DOI 10.1016/j.expneurol.2019.01.007; ZIGMUND A, 1983, ACTA PSYCHIAT SCAND, V67	72	1	1	2	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2021	35	4					416	425		10.1080/02699052.2021.1878553		FEB 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ4BK	WOS:000614920500001	33539250				2022-02-06	
J	Lu, HY; Huang, APH; Kuo, LT				Lu, Hsueh-Yi; Huang, Abel Po-Hao; Kuo, Lu-Ting			Prognostic value of variables derived from heart rate variability in patients with traumatic brain injury after decompressive surgery	PLOS ONE			English	Article							GLASGOW COMA SCALE; ISCHEMIC-STROKE; MORTALITY; SCORE; PREDICTOR; DEATH	Measurement of heart rate variability can reveal autonomic nervous system function. Changes in heart rate variability can be associated with disease severity, risk of complications, and prognosis. We aimed to investigate the prognostic value of heart rate variability measurements in patients with moderate-to-severe traumatic brain injury after decompression surgery. We conducted a prospective study of 80 patients with traumatic brain injury after decompression surgery using a noninvasive electrocardiography device for data collection. Assessment of heart rate variability parameters included the time and frequency domains. The correlations between heart rate variability parameters and one-year mortality and functional outcomes were analyzed. Time domain measures of heart rate variability, using the standard deviation of the RR intervals and the square root of the mean squared differences of successive RR intervals, were statistically significantly lower in the group of patients with unfavorable outcomes and those that died. In frequency domain analysis, very low-frequency and total power were significantly higher in patients with favorable functional outcomes. High-frequency, low-frequency, and total power were statistically significantly higher in patients who survived for more than one year. Multivariate analysis using a model combining age and the Glasgow Coma Scale score with variables derived from heart rate variability substantially improved the prognostic value for predicting long-term outcome. These findings reinforced the concept that traumatic brain injury impacts the brain-heart axis and cardiac autonomic modulation even after decompression surgery, and variables derived from heart rate variability may be useful predictors of outcome.	[Lu, Hsueh-Yi] Natl Yunlin Univ Sci & Technol, Dept Ind Engn & Management, Touliu, Yunlin County, Taiwan; [Huang, Abel Po-Hao; Kuo, Lu-Ting] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan		Kuo, LT (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.	kuoluting@gmail.com	Kuo, Lu-Ting/AAU-3205-2021	HUANG, ABEL PO-HAO/0000-0002-5689-6761; Kuo, Lu-Ting/0000-0002-1405-8700			Bauer A, 2017, INT J CARDIOL, V237, P19, DOI 10.1016/j.ijcard.2017.03.087; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Camm AJ, 1996, EUR HEART J, V17, P354; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; Dang BQ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1582182; De Raedt S, 2015, J NEUROL SCI, V348, P24, DOI 10.1016/j.jns.2014.12.007; Dismuke Clara E, 2015, Glob J Health Sci, V7, P156, DOI 10.5539/gjhs.v7n6p156; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Ernst G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00240; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Graff B, 2013, J HYPERTENS, V31, P1629, DOI 10.1097/HJH.0b013e328361e48b; Haji-Michael PG, 2000, CRIT CARE MED, V28, P2578, DOI 10.1097/00003246-200007000-00066; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; JENNETT B, 1975, LANCET, V1, P480; Johnston Brian W, 2020, J Intensive Care Soc, V21, P148, DOI 10.1177/1751143719853744; Lakusic Nenad, 2003, Acta Med Croatica, V57, P269; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Machado-Ferrer Y, 2013, CLIN NEUROPHYSIOL, V124, P589, DOI 10.1016/j.clinph.2012.09.008; Morris JA, 2007, J AM COLL SURGEONS, V204, P885, DOI 10.1016/j.jamcollsurg.2007.01.019; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Proctor KG, 2007, J TRAUMA, V63, P33, DOI 10.1097/01.ta.0000251593.32396.df; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapenne T, 2000, ANESTH ANALG, V91, P329, DOI 10.1097/00000539-200008000-00018; Riganello F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132336; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Takabatake N, 2001, AM J RESP CRIT CARE, V163, P1314, DOI 10.1164/ajrccm.163.6.2004175; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tobaldini E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060852; Vistisen ST, 2014, BRAIN INJURY, V28, P196, DOI 10.3109/02699052.2013.860477; Werdan K, 2009, CAN J PHYSIOL PHARM, V87, P266, DOI 10.1139/Y09-012; Yang CCH, 2000, AM J PHYSIOL-HEART C, V278, pH1269, DOI 10.1152/ajpheart.2000.278.4.H1269; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	40	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2021	16	2							e0245792	10.1371/journal.pone.0245792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF5UW	WOS:000616960200053	33539419	Green Published, gold			2022-02-06	
J	Oehr, LE; Yang, JYM; Chen, J; Maller, JJ; Seal, ML; Anderson, JFI				Oehr, Lucy E.; Yang, Joseph Yuan-Mou; Chen, Jian; Maller, Jerome J.; Seal, Marc L.; Anderson, Jacqueline F. I.			Investigating White Matter Tract Microstructural Changes at Six-Twelve Weeks following Mild Traumatic Brain Injury: A Combined Diffusion Tensor Imaging and Neurite Orientation Dispersion and Density Imaging Study	JOURNAL OF NEUROTRAUMA			English	Article						diffusion-tensor imaging; mild traumatic brain injury; neurite orientation dispersion and density imaging; tractography; white matter tract		Using diffusion-weighted imaging (DWI), research has demonstrated changes suggestive of damage to white matter tracts (WMT) following mild traumatic brain injury (mTBI). Yet due to the predominant use of the diffusion tensor imaging (DTI) model, which has numerous well-established limitations, it has not yet been possible to clearly examine the nature of changes to WMT microstructure following mTBI. This study used a second DWI-based technique, neurite orientation dispersion and density imaging (NODDI), in combination with DTI to measure microstructural changes within the corpus callosum, three long association and one projection WMTs at 6-12 weeks following mTBI, compared with matched trauma controls (TC). Between-groups differences were identified across all WMT for the DTI metric fractional anisotropy (FA), and the NODDI metrics orientation dispersion index (ODI) and isotropic volume fraction (ISO). No statistically significant between-groups differences were found for other DTI and NODDI metrics. Our study revealed that reduced FA was accompanied by increased ODI, suggesting that mTBI results in reduced coherence of axonal fiber bundles within the studied WMTs. These between-groups differences in WMT microstructure were found at 6-12 weeks post-injury, which suggests that structural recovery is not yet complete towards end of the typical 3-month recovery period.	[Oehr, Lucy E.; Anderson, Jacqueline F. I.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Yang, Joseph Yuan-Mou] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Yang, Joseph Yuan-Mou] Murdoch Childrens Res Inst, Dept Neurosci Res, Melbourne, Vic, Australia; [Chen, Jian; Seal, Marc L.] Murdoch Childrens Res Inst, Dept Dev Imaging, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Maller, Jerome J.] Gen Elect Healthcare, Melbourne, Vic, Australia; [Maller, Jerome J.] Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Anderson, Jacqueline F. I.] Alfred Hosp, Dept Psychol, Melbourne, Vic, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	jfande@unimelb.edu.au		Yang, Joseph Yuan-Mou/0000-0003-4081-7157	University of MelbourneUniversity of Melbourne; Murdoch Childrens Research Institute; Royal Children's Hospital; University of Melbourne Department of Paediatrics; Victorian Government's Operational Infrastructure Support Program; Royal Children's Hospital Foundation	This work was supported by the University of Melbourne [2017 MRGSS]. Imaging analysis was conducted within the Developmental Imaging research group, Murdoch Childrens Research Institute at the Children's MRI Centre, Royal Children's Hospital, Melbourne Victoria. This was supported by the Murdoch Childrens Research Institute, Royal Children's Hospital, The University of Melbourne Department of Paediatrics and the Victorian Government's Operational Infrastructure Support Program. This work was also part funded by a grant from the University of Melbourne, and the Royal Children's Hospital Foundation to Dr. Joseph Yuan-Mou Yang (RCH1000).	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; By S, 2017, NEUROIMAGE-CLIN, V15, P333, DOI 10.1016/j.nicl.2017.05.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Fitzgerald, 2018, NEUROPSYCHOL REHABIL, P1; Genc S, 2017, NEUROIMAGE, V148, P373, DOI 10.1016/j.neuroimage.2017.01.023; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grussu F, 2015, NEUROIMAGE, V111, P590, DOI 10.1016/j.neuroimage.2015.01.045; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Kamiya K, 2020, J NEUROSCI METH, V346, DOI 10.1016/j.jneumeth.2020.108908; Martino J, 2013, BRAIN STRUCT FUNCT, V218, P105, DOI 10.1007/s00429-012-0386-5; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; Melonakos ED, 2011, PSYCHIAT RES-NEUROIM, V193, P65, DOI 10.1016/j.pscychresns.2011.01.009; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; O'Donnell LJ, 2015, SCHIZOPHR RES, V161, P133, DOI 10.1016/j.schres.2014.09.007; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Rabinowitz AR, 2014, ANNU REV PSYCHOL, V65, P301, DOI 10.1146/annurev-psych-010213-115103; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sterne, 2003, ESSENTIAL MED STAT; Tabachnick B.G., 2014, USING MULTIVARIATE S, V6th; Timmers I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167884; Tournier J.D., 2010, P INT SOC MAGNETIC R, P1670; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wedeen, HIGH ANGULAR RESOLUT; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	50	1	1	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2021	38	16					2255	2263		10.1089/neu.2020.7310		FEB 2021	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TY0QY	WOS:000616390100001	33307950				2022-02-06	
J	Rizzo, JR; Hudson, TE; Martone, J; Dai, WW; Ihionu, O; Chaudhry, Y; Selesnick, I; Balcer, LJ; Galetta, SL; Rucker, JC				Rizzo, John-Ross; Hudson, Todd E.; Martone, John; Dai, Weiwei; Ihionu, Oluchi; Chaudhry, Yash; Selesnick, Ivan; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.			How sandbag-able are concussion sideline assessments? A close look at eye movements to uncover strategies	BRAIN INJURY			English	Article						Concussion; king-Devick; rapid Automatized Naming Tasks; saccades; inter-saccadic Interval; sandbagging		Background: Sideline diagnostic tests for concussion are vulnerable to volitional poor performance ("sandbagging") on baseline assessments, motivated by desire to subvert concussion detection and potential removal from play. We investigated eye movements during sandbagging versus best effort on the King-Devick (KD) test, a rapid automatized naming (RAN) task. Methods: Participants performed KD testing during oculography following instructions to sandbag or give best effort. Results: Twenty healthy participants without concussion history were included (mean age 27 +/- 8 years). Sandbagging resulted in longer test times (89.6 +/- 39.2 s vs 48.2 +/- 8.5 s, p < .001), longer inter-saccadic intervals (459.5 +/- 125.4 ms vs 311.2 +/- 79.1 ms, p < .001) and greater numbers of saccades (171.4 +/- 47 vs 138 +/- 24.2, p < .001) and reverse saccades (wrong direction for reading) (21.2% vs 11.3%, p < .001). Sandbagging was detectable using a logistic model with KD times as the only predictor, though more robustly detectable using eye movement metrics. Conclusions: KD sandbagging results in eye movement differences that are detectable by eye movement recordings and suggest an invalid test score. Objective eye movement recording during the KD test shows promise for distinguishing between best effort and post-injury performance, as well as for identifying sandbagging red flags.	[Rizzo, John-Ross; Hudson, Todd E.] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Rizzo, John-Ross; Hudson, Todd E.; Martone, John; Ihionu, Oluchi; Chaudhry, Yash; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Rizzo, John-Ross] NYU, Tandon Sch Engn, Dept Mech & Aerosp Engn, New York, NY USA; [Rizzo, John-Ross] NYU, Tandon Sch Engn, Dept Biomed Engn, New York, NY USA; [Dai, Weiwei; Selesnick, Ivan] NYU, Tandon Sch Engn, Dept Elect & Comp Engn, New York, NY USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA		Rucker, JC (corresponding author), Dept Neurol, 222 East 41st St,14th Floor, New York, NY 10017 USA.; Rucker, JC (corresponding author), Dept Ophthalmol, 222 East 41st St,14th Floor, New York, NY 10017 USA.	janet.rucker@nyulangone.org		Rucker, Janet/0000-0002-0397-0999; Rizzo, John-Ross/0000-0002-4084-0085	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K12HDOO1097]; NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K12HDOO1097]; NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training Program (JRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Empire Clinical Research Investigator Program (ECRIP); NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	5K12HDOO1097 NICHD and NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training Program (JRR). Empire Clinical Research Investigator Program (ECRIP);Empire Clinical Research Investigator Program (ECRIP).;NICHD and NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training Program [5K12HDOO1097];	Akhand O, 2019, J NEURO-OPHTHALMOL, V39, P68, DOI 10.1097/WNO.0000000000000726; Akhand O, 2018, J NEUROL SCI, V387, P199, DOI 10.1016/j.jns.2018.02.031; Anderson MN, 2020, BRAIN INJURY, V34, P369, DOI 10.1080/02699052.2020.1724332; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cobbs L, 2017, J NEUROL SCI, V372, P393, DOI 10.1016/j.jns.2016.10.044; Dahan N, 2020, J NEUROL SCI, V415, DOI 10.1016/j.jns.2020.116953; Dai WW, 2017, J VISION, V17, DOI 10.1167/17.9.10; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; DM T., 2013, NEUROL CLIN PRACT, V3, DOI 10.1212/CPJ.0b013e3182a1ba22; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Fallon S, 2019, J NEUROL SCI, V402, P52, DOI 10.1016/j.jns.2019.04.036; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Gelman A., 2013, BAYESIAN DATA ANAL, DOI DOI 10.1201/B16018; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Horn AKE, 2003, ANN NY ACAD SCI, V1004, P19, DOI 10.1196/annals.1303.003; HORN AKE, 1995, J COMP NEUROL, V359, P350, DOI 10.1002/cne.903590212; Jamali M, 2019, ELIFE, V8, DOI 10.7554/eLife.45573; KEATING EG, 1986, BEHAV BRAIN RES, V22, P191, DOI 10.1016/0166-4328(86)90064-1; KM G, 2011, J NEURO-OPHTHALMOL, V76; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kulp MT, 1996, OPTOMETRY VISION SCI, V73, P283, DOI 10.1097/00006324-199604000-00011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; MCCREA M, 1997, BRIT J SPORT MED, V48; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; OHTSUKA K, 1991, NEUROSCI RES, V10, P290, DOI 10.1016/0168-0102(91)90086-E; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; PIERROTDESEILLIGNY C, 1991, J NEUROL NEUROSUR PS, V54, P1106, DOI 10.1136/jnnp.54.12.1106; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Roos JCP, 2008, EXP BRAIN RES, V187, P283, DOI 10.1007/s00221-008-1304-1; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Swets JA., 1954, SIGNAL DETECTION THE; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; TE H., 2021, BAYESIAN DATA ANAL B; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	48	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2021	35	4					426	435		10.1080/02699052.2021.1878554		FEB 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ4BK	WOS:000614445600001	33529094				2022-02-06	
J	Wang, PF; Pan, BG; Tian, J; Yang, L; Chen, ZS; Yang, LJ; Fan, ZZ				Wang, Pengfei; Pan, Baogen; Tian, Jun; Yang, Lei; Chen, Zeshang; Yang, Lijun; Fan, Zhenzeng			Ac-FLTD-CMK inhibits pyroptosis and exerts neuroprotective effect in a mice model of traumatic brain injury	NEUROREPORT			English	Article						Ac-FLTD-CMK; neuroinflammation; pyroptosis; traumatic brain injury		Pyroptosis has been reported to contribute to the traumatic brain injury (TBI) process. Ac-FLTD-CMK is a newly synthesized pyroptosis inhibitor. However, whether Ac-FLTD-CMK inhibits pyroptosis and plays a neuroprotective role after TBI is unknown. The present study aimed to determine the effects of Ac-FLTD-CMK on TBI in a mouse model. Male C57BL/6 mice were randomly divided into sham, TBI + vehicle, and TBI + Ac-FLTD-CMK groups. TBI was induced using a weight-drop apparatus. Intraventricular injection of Ac-FLTD-CMK was performed 30 min after TBI. Caspase-1, caspase-11, gasdermin-D (GSDMD), and caspase-3 expression in the peri-contusional cortex were assessed by western blotting. Interleukin-1 beta (IL-1 beta) and interleukin-18 (IL-18) expression in the peri-contusional cortex were measured using ELISA. Behavioral experiments, brain water content, Evans blue extravasation, lactate dehydrogenase (LDH) release, and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling staining were also performed. The results showed that Ac-FLTD-CMK administration significantly downregulated caspase-1 p20, caspase-11 p20, GSDMD N-terminal, IL-1 beta, and IL-18 expression; reduced LDH release; alleviated neuronal death; attenuated brain edema and blood-brain barrier damage; and improved neurobehavioral function. These findings indicate that Ac-FLTD-CMK treatment suppresses pyroptosis and protects mice against TBI.	[Wang, Pengfei; Chen, Zeshang; Yang, Lijun; Fan, Zhenzeng] Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Wang, Pengfei; Pan, Baogen] Hebei Med Univ, Dept Neurosurg, Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China; [Tian, Jun] Hebei Med Univ, Dept Neurosurg, Hosp Shijiazhuang 1, Shijiazhuang, Hebei, Peoples R China; [Yang, Lei] Hebei Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Shijiazhuang, Hebei, Peoples R China		Fan, ZZ (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping Rd, Shijiazhuang 050000, Hebei, Peoples R China.	Fanzhenzeng@126.com			Health Committee Research Program of Hebei [20200003]	This study is supported by Health Committee Research Program of Hebei [Grant No. 20200003] and The government funding of clinical medical talents (There is no grant number for this fund).	Aachoui Y, 2015, CELL HOST MICROBE, V18, P320, DOI 10.1016/j.chom.2015.07.016; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Audia JP, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0692-z; Cheng Y, 2020, NEURAL REGEN RES, V15, P676, DOI 10.4103/1673-5374.266924; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Ding JJ, 2017, CELL, V168, P544, DOI 10.1016/j.cell.2017.01.008; Draganov D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16222; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Kang R, 2018, CELL HOST MICROBE, V24, P97, DOI 10.1016/j.chom.2018.05.009; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lei A, 2016, TRENDS IMMUNOL, V37, P569, DOI 10.1016/j.it.2016.07.004; Liang HS, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105771; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; Lueptow LM, 2017, JOVE-J VIS EXP, DOI 10.3791/55718; Maltez VI, 2015, IMMUNITY, V43, P987, DOI 10.1016/j.immuni.2015.10.010; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Misaghi S, 2006, CELL DEATH DIFFER, V13, P163, DOI 10.1038/sj.cdd.4401716; Palacios-Macapagal D, 2017, J IMMUNOL, V199, P847, DOI 10.4049/jimmunol.1601162; Platnich JM, 2018, CELL REP, V25, P1525, DOI 10.1016/j.celrep.2018.09.071; Poh L, 2019, BRAIN BEHAV IMMUN, V75, P34, DOI 10.1016/j.bbi.2018.09.001; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Yang J, 2018, P NATL ACAD SCI USA, V115, P6792, DOI 10.1073/pnas.1800562115; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Zhang J, 2017, NEUROCHEM INT, V111, P23, DOI 10.1016/j.neuint.2017.05.020; Zhang MK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0295-2	37	1	1	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	FEB 3	2021	32	3					188	197		10.1097/WNR.0000000000001580			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RL9QJ	WOS:000639297700002	33470761				2022-02-06	
J	Knopp, RC; Jastaniah, A; Dubrovskyi, O; Gaisina, I; Tai, L; Thatcher, GRJ				Knopp, Rachel C.; Jastaniah, Ammar; Dubrovskyi, Oleksii; Gaisina, Irina; Tai, Leon; Thatcher, Gregory R. J.			Extending the Calpain-Cathepsin Hypothesis to the Neurovasculature: Protection of Brain Endothelial Cells and Mice from Neurotrauma	ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE			English	Article						calpain-1; cathepsin-B; brain endothelial cells; TBI; oxidative stress	FOCAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; BARRIER BREAKDOWN; INHIBITOR; PATHOLOGY; INJURY; NEUROPROTECTION; SPECTRIN; ENOS	The calpain-cathepsin hypothesis posits a key role for elevated calpain-1 and cathepsin-B activity in the neurodegeneration underlying neurotrauma and multiple disorders including Alzheimer's disease (AD). AD clinical trials were recently halted on alicapistat, a selective calpain-1 inhibitor, because of insufficient exposure of neurons to the drug. In contrast to neuroprotection, the ability of calpain-1 and cathepsin-B inhibitors to protect the blood-brain barrier (BBB), is understudied. Since cerebrovascular dysfunction underlies vascular dementia, is caused by ischemic stroke, and is emerging as an early feature in the progression of AD, we studied protection of brain endothelial cells (BECs) by selective and nonselective calpain-1 and cathepsin-B inhibitors. We show these inhibitors protect both neurons and murine BECs from ischemia-reperfusion injury. Cultures of primary BECs from ALDH2(-/-) mice that manifest enhanced oxidative stress were sensitive to ischemia, leading to reduced cell viability and loss of tight junction proteins; this damage was rescued by calpain-1 and cathepsin-B inhibitors. In ALDH2(-/-) mice 24 h after mild traumatic brain injury (mTBI), BBB damage was reflected by significantly increased fluorescein extravasation and perturbation of tight junction proteins, eNOS, MMP-9, and GFAP. Both calpain and cathepsin-B inhibitors alleviated BBB dysfunction caused by mTBI. No clear advantage was shown by selective versus nonselective calpain inhibitors in these studies. The lack of recognition of the ability of calpain inhibitors to protect the BBB may have led to the premature abandonment of this therapeutic approach in AD clinical trials and requires further mechanistic studies of cerebrovascular protection by calpain-1 inhibitors.	[Knopp, Rachel C.; Jastaniah, Ammar; Dubrovskyi, Oleksii; Gaisina, Irina] Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60612 USA; [Gaisina, Irina] Univ Illinois, UICtr Drug Discovery UIC, Chicago, IL 60612 USA; [Tai, Leon] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Thatcher, Gregory R. J.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA		Thatcher, GRJ (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	grjthatcher@arizona.edu	Knopp, Rachel/AAD-6940-2022	Knopp, Rachel/0000-0002-1091-3829; Thatcher, Gregory/0000-0002-7757-1739	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR002003, T32AG57468]	NIH UL1TR002003 (UICentre), NIH T32AG57468 (RCK).	Abdullahi W, 2018, AM J PHYSIOL-CELL PH, V315, pC343, DOI 10.1152/ajpcell.00095.2018; Alluri H, 2016, J BIOL CHEM, V291, P26958, DOI 10.1074/jbc.M116.735365; Austin SA, 2013, J NEUROCHEM, V127, P691, DOI 10.1111/jnc.12334; Averna M, 2008, J BIOL CHEM, V283, P29069, DOI 10.1074/jbc.M803638200; Bernstein HG, 2018, NEURAL REGEN RES, V13, P2100, DOI 10.4103/1673-5374.241457; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Chu J, 2017, MOL PSYCHIATR, V22, P1002, DOI 10.1038/mp.2016.214; CRESPI MD, 1986, BIOCHEM BIOPH RES CO, V136, P521, DOI 10.1016/0006-291X(86)90471-7; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Di Domenico F, 2017, FREE RADICAL BIO MED, V111, P253, DOI 10.1016/j.freeradbiomed.2016.10.490; Fa M, 2016, J ALZHEIMERS DIS, V49, P707, DOI 10.3233/JAD-150618; Frederick JR, 2008, CRIT CARE MED, V36, pS481, DOI 10.1097/CCM.0b013e31818a8ec8; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/neu.2013.2944, 10.1089/NEU.2013.2944]; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jantos K, 2019, BIOORG MED CHEM LETT, V29, P1968, DOI 10.1016/j.bmcl.2019.05.034; Jastaniah A, 2020, CHEMMEDCHEM, V15, P2280, DOI 10.1002/cmdc.202000385; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Kling A, 2017, J MED CHEM, V60, P7123, DOI 10.1021/acs.jmedchem.7b00731; Knopp RC, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101486; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Lochhead JJ, 2012, AM J PHYSIOL-HEART C, V302, pH582, DOI 10.1152/ajpheart.00889.2011; Lon HK, 2019, CLIN PHARM DRUG DEV, V8, P290, DOI 10.1002/cpdd.598; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Maiuolo J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092693; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; McCaffrey G, 2009, J NEUROCHEM, V110, P58, DOI 10.1111/j.1471-4159.2009.06113.x; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Medeiros R, 2012, AM J PATHOL, V181, P616, DOI 10.1016/j.ajpath.2012.04.020; Metzger RR, 2018, J NEUROSURG-PEDIATR, V22, P369, DOI 10.3171/2018.4.PEDS17593; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Pijet B, 2018, MOL NEUROBIOL, V55, P9294, DOI 10.1007/s12035-018-1061-5; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Pratico D, 2004, J ALZHEIMERS DIS, V6, P171; Schiefer IT, 2013, J MED CHEM, V56, P6054, DOI 10.1021/jm4006719; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Siklos M, 2015, ACTA PHARM SIN B, V5, P506, DOI 10.1016/j.apsb.2015.08.001; Tasca CI, 2015, METHODS MOL BIOL, V1254, P197, DOI 10.1007/978-1-4939-2152-2_15; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Wang FX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00376; Weekman EM, 2016, J ALZHEIMERS DIS, V49, P893, DOI 10.3233/JAD-150759; Yamashima T, 2016, AGEING RES REV, V32, P169, DOI 10.1016/j.arr.2016.05.008; Yamazaki Y, 2019, BRAIN, V142, P1077, DOI 10.1093/brain/awz011; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	53	1	1	0	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA		2575-9108		ACS PHARMACOL TRANSL	ACS Pharmacol. Transl. Sci.	FEB 12	2021	4	1					372	385		10.1021/acsptsci.0c00217		FEB 2021	14	Chemistry, Medicinal; Pharmacology & Pharmacy	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy	QJ6MW	WOS:000619803700030	33615187				2022-02-06	
J	Amooei, M; Meshkati, Z; Nasiri, R; Dakhili, AB				Amooei, Maryam; Meshkati, Zohreh; Nasiri, Rozita; Dakhili, Amir Bahador			Cognitive decline prevention in offspring of Pb+2 exposed mice by maternal aerobic training and Cur/CaCO3@Cur supplementations: In vitro and in vivo studies	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						Lead (Pb+2); Aerobic exercise; Curcumin; CaCO3@Cur; Cytotoxicity; Behavioral tasks	INDUCED OXIDATIVE STRESS; TRAUMATIC BRAIN-INJURY; PHYSICAL-EXERCISE; ALZHEIMERS-DISEASE; LEAD-EXPOSURE; OLDER-ADULTS; MOUSE MODEL; PARKINSONS-DISEASE; TREADMILL EXERCISE; VITAMIN-E	Heavy metals are considered contaminants that hazardously influence the healthy life of humans and animals as they are widely used in industry. Contact of youngsters and women at ages of parturition with lead (Pb+2) is a main related concern, which passes through the placental barricade and its better absorption in the intestine leads to flaws in the fetal developfment. However, the metals threaten animal and human life, in particular throughout developmental stages. Products existing in the nature have a major contribution to innovating chemo-preventives. As a naturally available polyphenol and necessary curcuminoid, curcumin (Cur) is a derivative of the herb Curcuma longa (L.) rhizome, which globally recognized as "wonder drug of life"; however, Cur has a limited clinical use as it is poorly dissolved in water. Therefore, to enhance its clinically relevant parameters, curcumin-loaded calcium carbonate (CaCO3@Cur) was synthesized by one step coprecipitation method as a newly introduced in this research. Initially, its structure was physio chemically characterized using FT-IR, FESEM and DLS equipment and then the cytotoxicity of lead when it was pretreated with Cur/CaCO3@Cur were assessed by MTT assay. Both Cur and CaCO3@Cur diminished the toxic effects of Pb+2 while the most protective effect on the Pb+2 cytotoxicity was achieved by pre-incubation of cells with CaCO3@Cur. Besides, the morphological changes of Pb+2-treated cells that were pre-incubated with or without Cur/CaCO3@Cur were observed by normal and florescent microscopes. A non-pharmacologic method that lowers the hazard of brain damage is exercise training that is capable of both improving and alleviating memory. In the current study, the role of regular aerobic training and CaCO3@Cur was assessed in reducing the risk of brain damage induced by lead nitrate contact. To achieve the mentioned goal, pregnant Balb/C mice were assigned to five groups (six mice/group) at random: negative and positive controls, aerobic training group and Cur and CaCO3@Cur treated (50 mg/kg/b.wt) trained groups that exposed to Pb+2 (2 mg/kg) by drinking water during breeding and pregnancy. With the completion of study, offspring were subjected to the behavioral tasks that was tested by step-through ORT, DLB, MWM and YM tests. As a result, having regular aerobic training and CaCO3@Cur co-administration with lead nitrate could reverse the most defected behavioral indicators; yet, this was not visible for both sexes and it seems that gender can also be a source of different effects in the animal's body. In fact, having regular aerobic training along with CaCO3@Cur supplementation during pregnancy may be encouraging protecting potential agents towards the toxicity of Pb+2 that could be recommended in the areas with high pollution of heavy metals.	[Amooei, Maryam; Meshkati, Zohreh] Islamic Azad Univ, Isfahan Khorasgan Branch, Dept Phys Educ & Sport Sci, Esfahan, Iran; [Nasiri, Rozita] Iran Natl Elite Fdn, Tehran 9311114578, Iran; [Nasiri, Rozita] Univ Isfahan, Fac Biol Sci & Technol, Dept Cell & Mol Biol & Microbiol, Esfahan, Iran; [Dakhili, Amir Bahador] Tech & Vocat Univ TVU, Fac Shahid Chamran Branch, Dept Phys Educ & Sport Sci, Kerman, Iran		Meshkati, Z (corresponding author), Islamic Azad Univ, Isfahan Khorasgan Branch, Dept Phys Educ & Sport Sci, Esfahan, Iran.	zmeshkati@gmail.com	Meshkati, Zohreh/AAN-6787-2021		physical education and sport sciences faculty and the Transgenesis center of excellence of Islamic Azad University, Esfahan (Khorasgan) branch of Iran	We are grateful to the physical education and sport sciences faculty and the Transgenesis center of excellence of Islamic Azad University, Esfahan (Khorasgan) branch of Iran for their supports and facilities provided through the study.	Abdel-Wahab BA, 2014, AUSTIN J PHARM THER, V2, P8; Afarinesh M., 2004, J RAFSANJAN U MED SC, V3, P141; Agarwal NB, 2011, PHYTOMEDICINE, V18, P756, DOI 10.1016/j.phymed.2010.11.007; Agarwal R, 2010, J APPL TOXICOL, V30, P457, DOI 10.1002/jat.1517; Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Ahmad I, 2003, PAK J MED RES, V42, P256; AI XQ, 2010, J NANOSCI NANOTECHNO, V10, DOI DOI 10.1186/1471-2458-10-112; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Ali HM, 2018, PHARMACOL REP, V70, P804, DOI 10.1016/j.pharep.2018.02.009; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Archer T, 2011, ACTA NEUROL SCAND, V123, P221, DOI 10.1111/j.1600-0404.2010.01412.x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baker LD, 2010, J ALZHEIMERS DIS, V22, P569, DOI 10.3233/JAD-2010-100768; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Banerjee AK, 2003, MOL CELL BIOCHEM, V253, P307, DOI 10.1023/A:1026032404105; Baranowska-Bosiacka I, 2013, TOXICOLOGY, V303, P187, DOI 10.1016/j.tox.2012.10.027; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bilandzic N, 2009, SCI TOTAL ENVIRON, V407, P4243, DOI 10.1016/j.scitotenv.2009.04.009; Bogden JD, 1997, ENVIRON HEALTH PERSP, V105, P1284, DOI 10.2307/3433737; Bokara KK, 2008, BIOMETALS, V21, P9, DOI 10.1007/s10534-007-9088-5; Bokara KK, 2009, J APPL TOXICOL, V29, P452, DOI 10.1002/jat.1423; Boyanapalli Sarandeep S S, 2015, Curr Pharmacol Rep, V1, P129; Broocks A, 2003, EUR NEUROPSYCHOPHARM, V13, P153, DOI 10.1016/S0924-977X(02)00177-3; Bruening K, 1999, ENVIRON HEALTH PERSP, V107, P431, DOI 10.2307/3434623; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; Cechetti F, 2012, NEUROBIOL LEARN MEM, V97, P90, DOI 10.1016/j.nlm.2011.09.008; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Celiktas O. Y., 2007, Food Chemistry, V100, P553, DOI 10.1016/j.foodchem.2005.10.011; Chen X, 2015, MOLECULES, V20, P14293, DOI 10.3390/molecules200814293; Chhunchha B, 2013, AM J PHYSIOL-CELL PH, V304, pC636, DOI 10.1152/ajpcell.00345.2012; Chourbaji S, 2006, NEUROBIOL DIS, V23, P587, DOI 10.1016/j.nbd.2006.05.001; CLAPP JF, 1995, MED SCI SPORT EXER, V27, P170; Clark CS, 2009, ENVIRON RES, V109, P930, DOI 10.1016/j.envres.2009.07.002; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Collett GP, 2004, CARCINOGENESIS, V25, P2183, DOI 10.1093/carcin/bgh233; Cory-Slechta DA, 2008, BASIC CLIN PHARMACOL, V102, P218, DOI 10.1111/j.1742-7843.2007.00189.x; Danafar H, 2017, PHARM DEV TECHNOL, V22, P642, DOI 10.3109/10837450.2016.1146296; Danafar H, 2016, JUNDISHAPUR J NAT PH, V11, DOI 10.17795/jjnpp-36758; Dey PM, 2000, TOXICOLOGY, V146, P137, DOI 10.1016/S0300-483X(00)00171-2; El-Shenawy SMA, 2008, PHARMACOL REP, V60, P199; Ellerkamp V, 2016, ANTICANCER RES, V36, P3363; Eugenia D., 2009, Lucrari Stiintifice - Universitatea de Stiinte Agricole a Banatului Timisoara, Medicina Veterinara, V42, P295; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Finkelstein Y, 1998, BRAIN RES REV, V27, P168, DOI 10.1016/S0165-0173(98)00011-3; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Florea AM, 2006, BIOMETALS, V19, P419, DOI 10.1007/s10534-005-4451-x; Garcia-Capdevila S, 2009, BEHAV BRAIN RES, V202, P162, DOI 10.1016/j.bbr.2009.03.020; Garcia-Mesa Y, 2011, J ALZHEIMERS DIS, V24, P421, DOI 10.3233/JAD-2011-101635; Gibbons TE, 2014, BEHAV BRAIN RES, V272, P131, DOI 10.1016/j.bbr.2014.05.049; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; Hamadouche N, 2009, AM J SCI RES, P38; Hamadouche NA, 2013, ARCH BIOL SCI, V65, P1435, DOI 10.2298/ABS1304435H; Han JM, 2007, BRAIN RES, V1185, P68, DOI 10.1016/j.brainres.2007.09.044; Hiramatsu K, 2016, NUTR RES, V36, P143, DOI 10.1016/j.nutres.2015.09.018; Hopkins ME, 2010, NEUROBIOL LEARN MEM, V94, P278, DOI 10.1016/j.nlm.2010.06.006; Hosseini SM, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0858-9; Hosseinzadeh S, 2013, PHARM BIOL, V51, P240, DOI 10.3109/13880209.2012.717230; Hu SX, 2015, EXPERT REV NEUROTHER, V15, P629, DOI 10.1586/14737175.2015.1044981; Ismail EH, 2014, J SCI RES, V6, P509, DOI [DOI 10.3329/JSR.V6I3.18750, 10.3329/jsr, DOI 10.3329/JSR]; Jedrziewski MK, 2010, ALZHEIMERS DEMENT, V6, P448, DOI 10.1016/j.jalz.2010.02.004; Kang W., 2000, OVEREXPRESSION PROEN; Katzung B.G., 2010, BASIC CLIN PHARM; Kilikdar D., 2011, PROTECTIVE EFFECT AQ; Kim IW, 2005, CRYST GROWTH DES, V5, P513, DOI 10.1021/cg049721q; Kim TW, 2016, J EXERC REHABIL, V12, P156, DOI 10.12965/jer.1632644.322; Koo HM, 2013, J PHYS THER SCI, V25, P1103, DOI 10.1589/jpts.25.1103; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kumar VM, 2017, ENVIRON SCI POLLUT R, V24, P1544, DOI 10.1007/s11356-016-7923-3; Lau YS, 2011, EUR J NEUROSCI, V33, P1264, DOI 10.1111/j.1460-9568.2011.07626.x; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lautenschlager NT, 2012, BBA-MOL BASIS DIS, V1822, P474, DOI 10.1016/j.bbadis.2011.07.010; Leem YH, 2009, J NEUROSCI RES, V87, P2561, DOI 10.1002/jnr.22075; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Letchford K, 2008, J PHARM SCI-US, V97, P1179, DOI 10.1002/jps.21037; Li Y, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00339; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; Liu HL, 2011, BEHAV BRAIN RES, V218, P308, DOI 10.1016/j.bbr.2010.12.030; Liu JX, 2010, NEUROCHEM RES, V35, P473, DOI 10.1007/s11064-009-0083-9; Liu WN, 2012, PSYCHONEUROENDOCRINO, V37, P1057, DOI 10.1016/j.psyneuen.2011.12.003; Loumbourdis NS, 2003, ARCH TOXICOL, V77, P527, DOI 10.1007/s00204-003-0487-2; LUEPTOW LM, 2017, JOVE-J VIS EXP, V126, DOI DOI 10.3791/55718; MAHAFFEY KR, 1990, ENVIRON HEALTH PERSP, V89, P75, DOI 10.2307/3430900; Mahjoub S, 2016, J CLIN NEUROL, V12, P414, DOI 10.3988/jcn.2016.12.4.414; Manogaran E, 2015, J PHARM SCI RES, V7, P189; Massadeh AM, 2007, BIOL TRACE ELEM RES, V120, P227, DOI 10.1007/s12011-007-8017-3; Mehdizadeh H, 2017, PROG NEURO-PSYCHOPH, V79, P426, DOI 10.1016/j.pnpbp.2017.07.022; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Nasiri M, 2016, RSC ADV, V6, P84217, DOI 10.1039/c6ra14918a; Nasiri R, 2020, NANOTECHNOLOGY, V31, DOI 10.1088/1361-6528/ab6fd4; Nasiri R, 2017, RSC ADV, V7, P40074, DOI 10.1039/c7ra06389j; Ogonovszky H, 2005, NEUROCHEM INT, V46, P635, DOI 10.1016/j.neuint.2005.02.009; Cruz JFO, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3651; Ozbeyli D, 2017, CLIN EXP HEALTH SCI, V7, P27, DOI 10.5152/clinexphealthsci.2017.230; Paillard T, 2015, J CLIN NEUROL, V11, P212, DOI 10.3988/jcn.2015.11.3.212; Pan J, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-16; Pang TYC, 2013, NEUROPHARMACOLOGY, V64, P515, DOI 10.1016/j.neuropharm.2012.06.029; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Park JW, 2013, INT J NEUROSCI, V123, P253, DOI 10.3109/00207454.2012.755969; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Payne M, 2008, CAN MED ASSOC J, V179, P253, DOI 10.1503/cmaj.071483; Payton F, 2007, J NAT PROD, V70, P143, DOI 10.1021/np060263s; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Plate KM, 2013, J AM ASSOC LAB ANIM, V52, P524; Plowman SA., 2013, EXERCISE PHYSL HLTH, V4; Posser T, 2007, ARCH TOXICOL, V81, P407, DOI 10.1007/s00204-007-0177-6; Prasad S, 2014, BIOTECHNOL ADV, V32, P1053, DOI 10.1016/j.biotechadv.2014.04.004; Prasanthi RPJ, 2010, INT J DEV NEUROSCI, V28, P161, DOI 10.1016/j.ijdevneu.2009.12.002; Radak Z, 2010, J ALZHEIMERS DIS, V20, P777, DOI 10.3233/JAD-2010-091531; Rao FZ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081269; Revilla S, 2014, NEUROPHARMACOLOGY, V81, P55, DOI 10.1016/j.neuropharm.2014.01.037; Reza B, 2008, INDIAN J PHARMACOL, V40, P69, DOI 10.4103/0253-7613.41041; Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x; Sahu BD, 2016, LIFE SCI, V144, P8, DOI 10.1016/j.lfs.2015.11.018; Saleh H. A., 2018, Biomedical & Pharmacology Journal, V11, P871, DOI 10.13005/bpj/1444; Salem N.A., 2016, J HEAVY MET TOXIC DI, V1; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Shahandeh M, 2011, NEW ARMEN MED J, V5, P4; Shahandeh M, 2013, NEURAL REGEN RES, V8, P714, DOI 10.3969/j.issn.1673-5374.2013.08.006; SHALLIE PD, 2010, J NEUROSCI BEHAV HLT, V2, P23; Sharifi A. M., 2003, Toxicology Letters (Shannon), V144, ps140, DOI 10.1016/S0378-4274(03)90520-0; Sharifi AM, 2010, CELL MOL NEUROBIOL, V30, P769, DOI 10.1007/s10571-010-9504-1; Sharifi AM, 2002, NEUROSCI LETT, V329, P45, DOI 10.1016/S0304-3940(02)00576-1; Shi HS, 2012, INT J NANOMED, V7, P2601, DOI 10.2147/IJN.S31439; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Soto-Urquieta MG, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-74; Souza LC, 2013, NEUROTOX RES, V24, P148, DOI 10.1007/s12640-012-9373-0; Souza MA, 2009, EPILEPSIA, V50, P811, DOI 10.1111/j.1528-1167.2008.01908.x; Stranahan AM, 2012, CURR ALZHEIMER RES, V9, P86; Tandon SK, 2002, ENVIRON RES, V90, P61, DOI 10.1006/enrs.2002.4386; Tavakoli-Nezhad M, 2001, NEUROTOXICOLOGY, V22, P259, DOI 10.1016/S0161-813X(01)00010-9; Tuzmen MN, 2015, TOXICOL MECH METHOD, V25, P120, DOI 10.3109/15376516.2014.997947; Um HS, 2008, INT J MOL MED, V22, P529, DOI 10.3892/ijmm_00000052; Um HS, 2011, NEUROSCI RES, V69, P161, DOI 10.1016/j.neures.2010.10.004; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; Vidoni ED, 2012, NEUROBIOL AGING, V33, P1624, DOI 10.1016/j.neurobiolaging.2011.03.016; Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610; Wang YZ, 2019, J GEOTECH GEOENVIRON, V145, DOI 10.1061/(ASCE)GT.1943-5606.0002079; Wang ZS, 2006, CHEM MATER, V18, P2912, DOI 10.1021/cm0603102; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Wonga T.S., 2017, CHEM ENG, V56; Wu J. Y., 2013, Journal of Agricultural Science and Applications, V2, P8, DOI 10.14511/jasa.2013.020102; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang JQ, 2014, PATHOL RES PRACT, V210, P357, DOI 10.1016/j.prp.2014.02.005; Yin MM, 2013, BEHAV BRAIN RES, V253, P297, DOI 10.1016/j.bbr.2013.07.040; Yousif W. H., 2010, Iraqi Journal of Veterinary Sciences, V24; Yuede CM, 2009, NEUROBIOL DIS, V35, P426, DOI 10.1016/j.nbd.2009.06.002; Zaremba CM, 1998, CHEM MATER, V10, P3813, DOI 10.1021/cm970785g; Zhu DZ, 2011, J EXP NANOSCI, V6, P622, DOI 10.1080/17458080.2010.518167	156	1	1	1	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	FEB	2021	209								111785	10.1016/j.ecoenv.2020.111785			18	Environmental Sciences; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Toxicology	PY1PI	WOS:000611821500002	33348254	gold			2022-02-06	
J	Barreiro-Iglesias, A				Barreiro-Iglesias, Anton			Role of cyclooxygenases and prostaglandins in adult brain neurogenesis	PROSTAGLANDINS & OTHER LIPID MEDIATORS			English	Article						Prostaglandin; Cyclooxygenases; Adult neurogenesis; Dentate gyrus; EP receptors	NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; PROLIFERATION; DIFFERENTIATION; REGENERATION; APOPTOSIS; CELECOXIB	The telencephalon of adult mammals shows constitutive neurogenesis, and disease or traumatic injuries alter the rate of neurogenesis in the adult brain. Understanding the molecular signals that control adult brain neurogenesis is of crucial importance for the development of therapies to promote regeneration in the injured or diseased brain. Here, I reviewed our current knowledge on the role of cyclooxygenases and prostaglandins in controlling adult brain neurogenesis. Current data indicate that cyclooxygenase-2 derived prostaglandin E2 acting through EP receptors promotes neurogenesis in adult neurogenic niches of the telencephalon and that manipulations of this signalling pathway could be used to promote neurogenesis under pathological conditions. In this review article, I also propose new research directions to increase our knowledge on the role of this signalling pathway in neurogenesis.	[Barreiro-Iglesias, Anton] Univ Santiago de Compostela, Fac Biol, Dept Funct Biol, CIBUS, Campus Vida, Santiago De Compostela 15782, Spain		Barreiro-Iglesias, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Funct Biol, CIBUS, Campus Vida, Santiago De Compostela 15782, Spain.	anton.barreiro@usc.es	Barreiro-Iglesias, Anton/G-5281-2010	Barreiro-Iglesias, Anton/0000-0002-7507-080X			Egeland M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.68; Ganz J, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019018; Goncalves MB, 2010, BRIT J PHARMACOL, V159, P1118, DOI 10.1111/j.1476-5381.2009.00618.x; Guo JW, 2017, BIOMATERIALS, V145, P106, DOI 10.1016/j.biomaterials.2017.07.023; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Kumihashi K, 2001, NEUROREPORT, V12, P915, DOI 10.1097/00001756-200104170-00010; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim DA, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018820; Ling L, 2016, INT J NEUROSCI, V126, P469, DOI 10.3109/00207454.2015.1031226; Ma Y, 2017, PHARM BIOPROCESS, V5, P3; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nam SM, 2015, J VET SCI, V16, P245, DOI 10.4142/jvs.2015.16.3.245; Nam SM, 2013, NEUROCHEM RES, V38, P2559, DOI 10.1007/s11064-013-1169-y; Otsuki L, 2020, TRENDS NEUROSCI, V43, P213, DOI 10.1016/j.tins.2020.02.002; Peng L, 2018, AM J PATHOL, V188, P23, DOI 10.1016/j.ajpath.2017.09.004; Rai-Bhogal R, 2018, BIOCHEM BIOPHYS REP, V14, P43, DOI 10.1016/j.bbrep.2018.03.012; Sasaki T, 2003, J NEUROSCI RES, V72, P461, DOI 10.1002/jnr.10595; Shimamura M, 2013, J CEREBR BLOOD F MET, V33, P1207, DOI 10.1038/jcbfm.2013.69; Uchida K, 2002, ZOOL SCI, V19, P1211, DOI 10.2108/zsj.19.1211; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; Watanabe Y, 2017, TOXICOLOGY, V389, P55, DOI 10.1016/j.tox.2017.06.013; Wong CT, 2016, J NEUROSCI RES, V94, P759, DOI 10.1002/jnr.23759; Wong CT, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-19; Xia Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.69; Yagami T, 2016, MOL NEUROBIOL, V53, P4754, DOI 10.1007/s12035-015-9355-3	25	1	1	3	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1098-8823	2212-196X		PROSTAG OTH LIPID M	Prostaglandins Other Lipid Mediat.	FEB	2021	152								106498	10.1016/j.prostaglandins.2020.106498			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	PY8QF	WOS:000612305000007	33035690				2022-02-06	
J	Bilgi, K; Gopalakrishna, KN; Chakrabarti, D; Rao, GSU				Bilgi, Kanchan; Gopalakrishna, Kadarapura Nanjundaiah; Chakrabarti, Dhritiman; Rao, G. S. Umamaheswara			Outcome Prediction of TBI: Are There Parameters That Affect the IMPACT and CRASH Models?	WORLD NEUROSURGERY			English	Article						Neutrophil-to-lymphocyte ratio; Prognostic models; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; TO-LYMPHOCYTE RATIO; COAGULOPATHY; NEUTROPHIL	BACKGROUND: Abnormal hematologic parameters associated with unfavorable neurological outcomes in traumatic brain injury (TBI) have been studied in isolation. We aimed to study whether there are any additional parameters that improve standard prognostic models in TBI. METHODS: This prospective observational study conducted in a tertiary neurological care center included adult patients with moderate and severe isolated head injury. Laboratory and clinical parameters were noted at admission, and the Glasgow Outcome Score-Extended of patients was assessed after 6 months. Multiple logistic regression was conducted using fixed coefficients of IMPACT (International Mission for Prognosis and Analysis of Clinical Trials) and CRASH (Corticosteroid Randomisation After Significant Head Injury) prognostic models. The new composite models were compared with the original models. RESULTS: The study comprised 96 patients. Parameters with relatively good predictability for mortality were elevated international normalized ratio (area under the curve [AUC] 0.69, odds ratio 13.2), total leukocyte count (AUC 0.68, odds ratio 1.15), and transfusion of blood products (AUC 0.72, odds ratio 6.43). Addition of these led to a statistically small improvement in predictions of IMPACT and CRASH. Neutrophil-to-lymphocyte ratio was not a good predictor of mortality or morbidity (AUC 0.58 and 0.47, respectively). CONCLUSIONS: International normalized ratio, total leukocyte count, and blood transfusion were found to be predictors of mortality and unfavorable neurological outcome in TBI at 6 months. Their addition to the IMPACT and CRASH prognostic models resulted in a modest improvement in the prediction of outcome in TBI.	[Bilgi, Kanchan] Vikram Hosp, Dept Neuroanaesthesiol, Bengaluru, India; [Gopalakrishna, Kadarapura Nanjundaiah; Chakrabarti, Dhritiman; Rao, G. S. Umamaheswara] Natl Inst Mental Hlth & Neurosci, Dept Neuroanaesthesia & Neurocrit Care, Bengaluru, India		Bilgi, K (corresponding author), Vikram Hosp, Dept Neuroanaesthesiol, Bengaluru, India.	kanchanbilgi@gmail.com		Bilgi, Kanchan/0000-0003-1425-7133; KN, Gopalakrishna/0000-0001-6059-7206			Al-Dorzi HM, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/672639; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Gurkanlar D, 2009, TURK NEUROSURG, V19, P211; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Kisilevsky A, 2018, BRIT J ANAESTH, V120, P988, DOI 10.1016/j.bja.2017.11.108; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; R Development Core Team, 2012, R LANG ENV STAT COMP; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Tao CY, 2017, NEUROCRIT CARE, V26, P393, DOI 10.1007/s12028-016-0332-0; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang WM, 2018, MED SCI MONITOR, V24, P4413, DOI 10.12659/MSM.910845; Zhao JL, 2019, WORLD NEUROSURG, V124, pE411, DOI 10.1016/j.wneu.2018.12.107	23	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2021	146						E590	E596		10.1016/j.wneu.2020.10.134			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QJ6NI	WOS:000619804900092	33130284				2022-02-06	
J	Chen, CC; Chen, CPC; Chen, CH; Hsieh, YW; Chung, CY; Liao, CH				Chen, Chih-Chi; Chen, Carl P. C.; Chen, Chien-Hung; Hsieh, Yu-Wei; Chung, Chia-Ying; Liao, Chien-Hung			Predictors of In-Hospital Mortality for School-Aged Children with Severe Traumatic Brain Injury	BRAIN SCIENCES			English	Article						school-aged children; traumatic brain injury; predictors; mortality		Traumatic brain injury (TBI) is the leading cause of mortality in children. There are few studies focused on school-aged children with TBI. We conducted this study to identify the early predictors of in-hospital mortality in school-aged children with severe TBI. In this 10 year observational cohort study, a total of 550 children aged 7-18 years with TBI were enrolled. Compared with mild/moderate TBI, children with severe TBI were older; more commonly had injury mechanisms of traffic accidents; and more neuroimage findings of subarachnoid hemorrhage (SAH), subdural hemorrhage (SDH), parenchymal hemorrhage, cerebral edema, and less epidural hemorrhage (EDH). The in-hospital mortality rate of children with severe TBI in our study was 23%. Multivariate analysis showed that falls, being struck by objects, motor component of Glasgow coma scale (mGCS), early coagulopathy, and SAH were independent predictors of in-hospital mortality. We concluded that school-aged children with severe TBI had a high mortality rate. Clinical characteristics including injury mechanisms of falls and being struck, a lower initial mGCS, early coagulopathy, and SAH are predictive of in-hospital mortality.	[Chen, Chih-Chi; Chen, Carl P. C.; Chen, Chien-Hung; Chung, Chia-Ying] Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Dept Phys Med & Rehabil, 5 Fuhsing St, Taoyuan 333, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Sch Med, Dept Occupat Therapy, 259,Sec1,WenHua First Rd, Taoyuan 333, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Sch Med, Grad Inst Behav Sci, 259,Sec1,WenHua First Rd, Taoyuan 333, Taiwan; [Hsieh, Yu-Wei] Chang Gung Univ, Hlth Aging Res Ctr, 259,Sec1,WenHua First Rd, Taoyuan 333, Taiwan; [Liao, Chien-Hung] Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Dept Trauma & Emergency Surg, 5 Fuhsing St, Taoyuan 333, Taiwan		Liao, CH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Sch Med, Dept Trauma & Emergency Surg, 5 Fuhsing St, Taoyuan 333, Taiwan.	Claudia5477@gmail.com; Carlchendr@gmail.com; b9002052@cgmh.org.tw; Ywhsieh@mail.cgu.edu.tw; chiaying928@yahoo.com; surgymet@gmail.com		Hsieh, Yu-Wei/0000-0002-2564-8431; Chung, Chia-Ying/0000-0002-2146-6040	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST109-2622-B-182A-001-(NCRPG3J0012)]; Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPG3K0801]	This research was funded by the Ministry of Science and Technology, Taiwan, MOST109-2622-B-182A-001-(NCRPG3J0012), and Chang Gung Memorial Hospital, grant number CMRPG3K0801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker SN, 2014, J TRAUMA ACUTE CARE, V77, P304, DOI 10.1097/TA.0000000000000300; Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; [Anonymous], 2006, TRAUMATIC BRAIN INJU; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Bahloul Mabrouk, 2011, J Emerg Trauma Shock, V4, P29, DOI 10.4103/0974-2700.76831; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chen CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030390; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Chou R, 2017, ANN EMERG MED, V70, P143, DOI 10.1016/j.annemergmed.2016.11.032; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P1180, DOI 10.1136/jnnp.2007.135178; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fu YQ, 2017, BRAIN INJURY, V31, P396, DOI 10.1080/02699052.2016.1264629; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Harel O, 2007, EXP AGING RES, V33, P187, DOI 10.1080/03610730701239004; Heather NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082245; Hermanides J, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1883-y; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Ichikawa R, 2018, PEDIATR EMERG CARE, V34, P825, DOI 10.1097/PEC.0000000000001321; Irie F., 2010, INJURY, V41, pS30, DOI [10.1016/j.injury.2010.01.021, DOI 10.1016/J.INJURY.2010.01.021]; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Madley-Dowd P, 2019, J CLIN EPIDEMIOL, V110, P63, DOI 10.1016/j.jclinepi.2019.02.016; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Olsen M, 2019, EUR J PAEDIATR NEURO, V23, P500, DOI 10.1016/j.ejpn.2019.01.009; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Pin-on P, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013081; Podolsky-Gondim GG, 2018, CHILD NERV SYST, V34, P2455, DOI 10.1007/s00381-018-3989-1; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Sundberg J, 2011, AM J EMERG MED, V29, P1019, DOI 10.1016/j.ajem.2010.06.002; Suttipongkaset P, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0594; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Totapally A, 2017, J TRAUMA ACUTE CARE, V82, P362, DOI 10.1097/TA.0000000000001280; Trefan L, 2016, ARCH DIS CHILD, V101, P527, DOI 10.1136/archdischild-2015-308424; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Verchere J, 2013, LANCET NEUROL, V12, P426, DOI 10.1016/S1474-4422(13)70073-5; Wetzel RC, 2002, CRIT CARE MED, V30, pS468, DOI 10.1097/00003246-200211001-00012; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	54	1	1	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	FEB	2021	11	2							136	10.3390/brainsci11020136			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QN2IY	WOS:000622291200001	33494346	gold, Green Published			2022-02-06	
J	Dunn, JC; Eckhoff, MD; Nicholson, TC; Campbell, W; Kenney, K; Smith, J; Landau, M; Miller, M; Souza, J; Nesti, LJ				Dunn, John C.; Eckhoff, Michael D.; Nicholson, Tyler C.; Campbell, William; Kenney, Kimbra; Smith, Jonathan; Landau, Mark; Miller, Matthew; Souza, Jason; Nesti, Leon J.			Combat-Sustained Peripheral Nerve Injuries in the United States Military	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Combat trauma; nerve surgery; peripheral nerve injury		Purpose Combat-sustained peripheral nerve injuries (CSPNIs) are often the result of high-energy blast mechanisms and are increasing in frequency and severity among US forces engaged in contemporary warfare. The purpose of this study was to describe CSPNIs and report outcomes after evaluation in a military multidisciplinary peripheral nerve clinic. We hypothesized that a shorter time to evaluation by a multidisciplinary peripheral nerve team would improve outcomes. Methods The Peripheral Nerve Consortium (PNC) maintains an electronic database of all active duty service members who sustained a peripheral nerve injury (PNI) and were treated by the PNC between 2004 and 2009. This database was queried for service member demographic information, injury characteristics, wounding patterns, CSPNI description, surgical procedures, and Medical Research Council final motor and sensory outcome. Results Among the 104 service members treated by the PNC in the 6-year period reviewed, there were 138 PNIs. Average age was 27 years, time to initial evaluation by the PNC was 4 (+/- 7) months, and average follow-up was 18 (+/- 18) months. Associated injuries included fractures (31.1%), multiple PNIs (76.8%), vascular injury (30.4%), and traumatic brain injury (34.1%). There was no association between Sunderland classification and time to evaluation, mechanism of injury, or nerve injured. However, Sunderland classification was correlated with final motor and final sensory scores. Service members with better final sensory score (S1 or S2) had shorter time to initial evaluation than did patients with a final sensory score of S0 (<0.05). This did not hold true for final motor score. Conclusions Service members with more severe initial injuries had worse final outcomes. Although timely referral does not occur for most CSPNIs, a shorter time to presentation also led to improved sensory recovery. Complex combat-sustained PNIs may be best understood and treated within a multidisciplinary team. Copyright (C) 2021 by the American Society for Surgery of the Hand. All rights reserved.	[Dunn, John C.; Eckhoff, Michael D.; Nicholson, Tyler C.] William Beaumont Army Med Ctr, Dept Orthopaed, 5005 N Piedras St, El Paso, TX 79920 USA; [Campbell, William; Smith, Jonathan; Landau, Mark] Walter Reed Natl Mil Med Ctr, Dept Neurol, Bethesda, MD USA; [Kenney, Kimbra; Souza, Jason] Walter Reed Natl Mil Med Ctr, Dept Plast Surg, Bethesda, MD USA; [Miller, Matthew] Walter Reed Natl Mil Med Ctr, Dept Phys Med & Rehabil, Bethesda, MD USA; [Nesti, Leon J.] Uniformed Serv Univ Hlth Sci, Dept Surg, Clin & Expt Orthopaed, Bethesda, MD 20814 USA		Eckhoff, MD (corresponding author), William Beaumont Army Med Ctr, Dept Orthopaed, 5005 N Piedras St, El Paso, TX 79920 USA.	michael.d.eckhoff@gmail.com			Comprehensive Neuroscience Program [MDA90502-2-0007]; Comprehensive National Neuroscience Program [W81XWH-07-1-0679]; Peripheral Nerve Consortium of Walter Reed National Military Medical Center (Bethesda, MD); Uniformed Services University of the Health Sciences (Bethesda, MD) [HU0001-11-1-0004, HU0001-15-20003]; Henry M. Jackson Foundation for the Advancement of Military Medicine (Bethesda, MD);  [JPC-1 HU0001-17-2-0004]	The opinions and or assertions contained herein are the private views of the authors and are not to be construed as reflecting the official position or views of the Department of the Navy, Army, or Air Force, the Department of Defense, or the US Government. This material is based on the work supported by the Comprehensive Neuroscience Program (MDA90502-2-0007), Comprehensive National Neuroscience Program (W81XWH-07-1-0679), and JPC-1 HU0001-17-2-0004. This material is based on the work supported by the Peripheral Nerve Consortium of Walter Reed National Military Medical Center and Uniformed Services University of the Health Sciences (HU0001-11-1-0004 and HU0001-15-20003) (Bethesda, MD) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (Bethesda, MD).	Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Birch R, 2012, J BONE JOINT SURG BR, V94B, P529, DOI [10.1302/0301-620X.94B4.27488, 10.1302/0301-620X.94B4.28488]; Birch R, 2012, J BONE JOINT SURG BR, V94B, P523, DOI 10.1302/0301-620X.94B4.28483; BRISTOW WR, 1947, BRIT J SURG, V34, P333, DOI 10.1002/bjs.18003413602; Cho MS, 2012, J HAND SURG-AM, V37A, P2340, DOI 10.1016/j.jhsa.2012.08.028; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd ed.; Daniel WW, 2019, BIOSTATISTICS FDN AN, V11th; Dellon, 1988, SURG PERIPHERAL NERV; Dunn JC, 2016, ANN VASC SURG, V35, P30, DOI 10.1016/j.avsg.2016.01.040; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frazier C, 1927, MED DEP US ARMY WORL, V11, P1085; Hanigan W, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS103; KALLIO PK, 1993, J HAND SURG-BRIT EUR, V18B, P320, DOI 10.1016/0266-7681(93)90052-H; KALLIO PK, 1993, J HAND SURG-BRIT EUR, V18B, P97, DOI 10.1016/0266-7681(93)90205-T; MACKINNON SE, 1989, ANN PLAS SURG, V22, P257, DOI 10.1097/00000637-198903000-00013; Mitchell SW, 2007, CLIN ORTHOP RELAT R, P35, DOI 10.1097/BLO.0b013e31803df02c; NOVAK CB, 1992, J HAND SURG-AM, V17A, P59, DOI 10.1016/0363-5023(92)90114-5; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Roganovic Z, 2004, ACTA NEUROCHIR, V146, P1185, DOI 10.1007/s00701-004-0361-x; Roganovic Z, 2004, NEUROSURGERY, V55, P1120, DOI 10.1227/01.NEU.0000142353.92119.FE; Roganovic Z, 2005, SURG NEUROL, V63, P410, DOI 10.1016/j.surneu.2004.08.007; Samardzic MM, 1997, J TRAUMA, V43, P645, DOI 10.1097/00005373-199710000-00014; Schoenfeld AJ, 2013, J TRAUMA ACUTE CARE, V75, P287, DOI 10.1097/TA.0b013e31829a0970; Secer HI, 2007, J NEUROSURG, V107, P776, DOI 10.3171/JNS-07/10/0776; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Sunderland S., 1978, NERVES NERVE INJURIE; Thorburn SW, 1922, HIST GREAT WAR MED S, V2, P145; VASTAMAKI M, 1993, J HAND SURG-BRIT EUR, V18B, P323, DOI 10.1016/0266-7681(93)90053-I; Wang YR, 2013, HAND CLIN, V29, P349, DOI 10.1016/j.hcl.2013.04.004	31	1	1	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	FEB	2021	46	2								10.1016/j.jhsa.2020.08.004			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	RC2SR	WOS:000632655300011	33012612				2022-02-06	
J	Elkbuli, A; Ehrhardt, JD; Kinslow, K; McKenney, M				Elkbuli, Adel; Ehrhardt, John D., Jr.; Kinslow, Kyle; McKenney, Mark			Prophylactic Inferior Vena Cava Filters Outcomes in Severely Injured Trauma Patients	AMERICAN SURGEON			English	Article						inferior vena cava filters; trauma outcomes; injury severity; traumatic brain injury	BRAIN-INJURY; VENOUS THROMBOEMBOLISM; FOLLOW-UP; HIGH-RISK; THROMBOSIS; PREVENTION; MANAGEMENT; PLACEMENT; GUIDELINES; MORTALITY	Background Patients with major trauma and contraindications to anticoagulation are often considered candidates for a prophylactic inferior vena cava filter (IVCF). Prophylactic IVCFs are controversial in trauma and backed by varying levels of evidence. This study aims to analyze outcomes in severely injured patients who receive IVCFs. Methods A retrospective review of trauma patients aged >= 16 years with ISS >= 15 admitted to our level 1 trauma center from years 2013 through 2018. Patients were divided into 2 groups: prophylactic IVCF versus VTE chemoprophylaxis. The analysis evaluated demographics, stratified by ISS (15-24, 25-34, >= 35), and subgrouped those with AIS-Head >= 3. Adjusted outcome measures included DVT, PE, mortality, and ICU length-of-stay (ICU-LOS). Results The study sample included 413 patients with prophylactic IVCFs and 2487 on VTE chemoprophylaxis. IVCF placement was associated with higher severity injuries: ISS 28 versus 25 and lower GCS 10.0 versus 11.8, TBI prevalence 83% versus 68% (P < .001). Patients with IVCFs had increased ICU-LOS (23.2 days vs 12.2 days), DVT (14.8% vs 4.3%), and PE (5.8% vs 1.6%) for patients with ISS <35 (P < .001). ISS >= 35 was not associated with intergroup DVT or PE rate differences (P = .81 and .43). No intergroup mortality differences were observed, including after ISS stratification. Among patients with AIS-Head >= 3, prophylactic IVCF was associated with lower in-hospital mortality (8.4% vs 15.7%, P = .001). Conclusions Prophylactic IVCF placement was associated with higher rates of DVT and nonfatal PE, and prolonged ICU-LOS. Prophylactic IVCF placement was not associated with increased in-hospital mortality for severely injured trauma patients. Among patients with concomitant critical head injuries (AIS-Head >= 3), prophylactic IVCF placement was associated with lower in-hospital mortality than VTE chemoprophylaxis.	[Elkbuli, Adel; Ehrhardt, John D., Jr.; Kinslow, Kyle; McKenney, Mark] Kendall Reg Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, Miami, FL 33175 USA; [McKenney, Mark] Univ S Florida, Tampa, FL 33620 USA		Elkbuli, A (corresponding author), Kendall Reg Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, Miami, FL 33175 USA.	Adel.Elkbuli@hcahealthcare.com					Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castro-Ferreira R, 2018, ANN VASC SURG, V46, P380, DOI 10.1016/j.avsg.2017.06.131; Chow FCL, 2015, ANN VASC SURG, V29, P985, DOI 10.1016/j.avsg.2015.01.009; Committee on Trauma: Trauma Quality Improvement Program, 2015, BEST PRACT MAN TRAUM; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Gorman PH, 2009, J TRAUMA, V66, P707, DOI 10.1097/TA.0b013e318188beba; GREENFIELD LJ, 1973, SURGERY, V73, P599; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Haut ER, 2014, JAMA SURG, V149, P194, DOI 10.1001/jamasurg.2013.3970; Hemmila MR, 2015, ANN SURG, V262, P577, DOI 10.1097/SLA.0000000000001434; Ho KM, 2019, NEW ENGL J MED, V381, P328, DOI 10.1056/NEJMoa1806515; Langan EM, 1999, J VASC SURG, V30, P484, DOI 10.1016/S0741-5214(99)70075-3; Lopera JE, 2020, CATHETER CARDIO INTE, V95, P1, DOI 10.1002/ccd.28533; Mobin-Uddin K, 1969, Am Surg, V35, P889; MOBINUDDIN K, 1969, ARCH SURG-CHICAGO, V99, P711; Moore PS, 2010, J VASC SURG, V52, P118, DOI 10.1016/j.jvs.2009.09.067; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Rogers FB, 1998, ARCH SURG-CHICAGO, V133, P406, DOI 10.1001/archsurg.133.4.406; Saeed MJ, 2017, JAMA INTERN MED, V177, P1861, DOI 10.1001/jamainternmed.2017.5960; Sarosiek S, 2017, JAMA SURG, V152, P75, DOI 10.1001/jamasurg.2016.3091; Sarosiek S, 2013, JAMA INTERN MED, V173, P513, DOI 10.1001/jamainternmed.2013.343; Sim J, 2015, ANN SURG TREAT RES, V89, P215, DOI 10.4174/astr.2015.89.4.215; Spate K, 2008, INT J ANGIOL, V17, P23, DOI 10.1055/s-0031-1278275; Stone J, 2017, CARDIOVASC DIAGN THE, V7, pS276, DOI 10.21037/cdt.2017.09.01; Turner TE, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0452; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108	29	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2021	87	2					300	308		10.1177/0003134820950297			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QZ5KZ	WOS:000630766200024	32935995				2022-02-06	
J	ElSaadani, M; Ahmed, SM; Jacovides, C; Lopez, A; Johnson, VE; Kaplan, LJ; Schwab, CW; Smith, DH; Pascual, JL				ElSaadani, Mohamed; Ahmed, Syed M.; Jacovides, Christina; Lopez, Alfonso; Johnson, Victoria E.; Kaplan, Lewis J.; Schwab, C. William; Smith, Douglas H.; Pascual, Jose L.			Antithrombin III ameliorates post-traumatic brain injury cerebral leukocyte mobilization enhancing recovery of blood brain barrier integrity	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	79th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma / Clinical Congress of Acute Care Surgery	SEP 08-18, 2020	ELECTR NETWORK	Amer Assoc Surg Trauma		Antithrombin III; traumatic brain injury; neutrophil; blood brain barrier; murine		BACKGROUND Acute traumatic coagulopathy often accompanies traumatic brain injury (TBI) and may impair cognitive recovery. Antithrombin III (AT-III) reduces the hypercoagulability of TBI. Antithrombin III and heparinoids such as enoxaparin (ENX) demonstrate potent anti-inflammatory activity, reducing organ injury and modulating leukocyte (LEU) activation, independent of their anticoagulant effect. It is unknown what impact AT-III exerts on cerebral LEU activation and blood-brain barrier (BBB) permeability after TBI. We hypothesized that AT-III reduces live microcirculatory LEU-endothelial cell (EC) interactions and leakage at the BBB following TBI. METHODS CD1 mice (n = 71) underwent either severe TBI (controlled cortical impact (CCI), 6-m/s velocity, 1-mm depth, and 4-mm diameter) or sham craniotomy and then received either AT-III (250 IU/kg), ENX (1.5 mg/kg), or vehicle (saline) every 24 hours. Forty-eight hours post-TBI, cerebral intravital microscopy visualized in vivo penumbral microvascular LEU-EC interactions and microvascular leakage to assess BBB inflammation/permeability. Body weight loss and the Garcia neurological test (motor, sensory, reflex, balance) served as surrogates of clinical recovery. RESULTS Both AT-III and ENX similarly reduced in vivo penumbral LEU rolling and adhesion (p < 0.05). Antithrombin III also reduced live BBB leakage (p < 0.05). Antithrombin III animals demonstrated the least 48-hour body weight loss (8.4 +/- 1%) versus controlled cortical impact and vehicle (11.4 +/- 0.5%, p < 0.01). Garcia neurological test scores were similar among groups. CONCLUSION Antithrombin III reduces post-TBI penumbral LEU-EC interactions in the BBB leading to reduced neuromicrovascular permeability. Antithrombin III further reduced body weight loss compared with no therapy. Further study is needed to determine if these AT-III effects on neuroinflammation affect longer-term neurocognitive recovery after TBI.	[ElSaadani, Mohamed; Ahmed, Syed M.; Jacovides, Christina; Lopez, Alfonso; Kaplan, Lewis J.; Schwab, C. William; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, 51 N 39th St,Med Off Bldg,1st Fl Suite 120, Philadelphia, PA 19104 USA; [Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA		Pascual, JL (corresponding author), Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, 51 N 39th St,Med Off Bldg,1st Fl Suite 120, Philadelphia, PA 19104 USA.	MElSaadani@som.umaryland.edu; Moiz1491@gmail.com; Christina.Jacovides@pennmedicine.upenn.edu; Alfonso.Lopez@pennmedicine.upenn.edu; vje@pennmedicine.upenn.edu; Lewis.Kaplan@pennmedicine.upenn.edu; Charles.Schwab@pennmedicine.upenn.edu; Amy.Carthy@pennmedicine.upenn.edu; Jose.Pascual@pennmedicine.upenn.edu		Ahmed, Syed Moiz/0000-0003-3922-5525	GRIFOLS International	The authors declare no conflicts of interests. This work was supported by an investigator-sponsored research grant from GRIFOLS International.	Allingstrup M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub3; Arai M, 2004, SPINE, V29, P405, DOI 10.1097/01.BRS.0000090887.50981.8E; Bucur SZ, 1998, TRANSFUSION, V38, P481, DOI 10.1046/j.1537-2995.1998.38598297219.x; Campbell-Sills L, 2020, J HEAD TRAUMA REHAB, V35, P14, DOI 10.1097/HTR.0000000000000516; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gardner AJ., 2016, HDB CLIN NEUROLOGY, V138; Hagiwara S, 2008, INTENS CARE MED, V34, P361, DOI 10.1007/s00134-007-0887-5; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hoffmann JN, 2000, AM J PHYSIOL-CELL PH, V279, pC98, DOI 10.1152/ajpcell.2000.279.1.C98; Hoffmann JN, 2002, CRIT CARE MED, V30, P218, DOI 10.1097/00003246-200201000-00031; HORIE S, 1990, THROMB RES, V59, P895, DOI 10.1016/0049-3848(90)90113-Q; Iba T, 2018, THROMB RES, V171, P1, DOI 10.1016/j.thromres.2018.09.042; Kubes P, 2000, BRAIN PATHOL, V10, P127; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Lindemann S, 2003, BASIC RES CARDIOL, V98, P8, DOI 10.1007/s00395-003-0383-1; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Maeda A, 2011, PEDIATR INT, V53, P747, DOI 10.1111/j.1442-200X.2011.03350.x; Marks JA, 2012, J TRAUMA ACUTE CARE, V73, P351, DOI 10.1097/TA.0b013e3182592f76; Mizutani A, 2003, BLOOD, V101, P3029, DOI 10.1182/blood-2002-08-2406; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Neviere R, 2001, SHOCK, V15, P220, DOI 10.1097/00024382-200115030-00010; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Ostrovsky L, 1997, CIRCULATION, V96, P2302; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Rehberg S, 2013, CRIT CARE MED, V41, pE439, DOI 10.1097/CCM.0b013e318298ad3a; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Uchiba M, 1997, SEMIN THROMB HEMOST, V23, P583, DOI 10.1055/s-2007-996140; Uchiba M, 1996, AM J PHYSIOL-LUNG C, V270, pL921, DOI 10.1152/ajplung.1996.270.6.L921; Uchiba M, 1998, THROMB RES, V89, P233, DOI 10.1016/S0049-3848(98)00012-7; von Leden RE, 2019, EXP NEUROL, V317, P144, DOI 10.1016/j.expneurol.2019.03.004; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiedermann CJ, 2002, ACTA MED AUST, V29, P89, DOI 10.1046/j.1563-2571.2002.02012.x; YAMAUCHI T, 1989, BIOCHEM BIOPH RES CO, V163, P1404, DOI 10.1016/0006-291X(89)91135-2; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	44	1	1	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2021	90	2					274	280		10.1097/TA.0000000000003000			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	QH5QD	WOS:000618329200014	33093292				2022-02-06	
J	Fitzgerald, JM; Belleau, EL; Ehret, LE; Trevino, C; Brasel, KJ; Larson, C; deRoon-Cassini, T				Fitzgerald, Jacklynn M.; Belleau, Emily L.; Ehret, Lauren E.; Trevino, Colleen; Brasel, Karen J.; Larson, Christine; deRoon-Cassini, Terri			DACC Resting State Functional Connectivity as a Predictor of Pain Symptoms Following Motor Vehicle Crash: A Preliminary Investigation	JOURNAL OF PAIN			English	Article						Motor vehicle accident; traumatic injury; pain; functional magnetic resonance imaging; resting state; cingulate cortex		There is significant heterogeneity in pain outcomes following motor vehicle crashes (MVCs), such that a sizeable portion of individuals develop symptoms of chronic pain months after injury while others recover. Despite variable outcomes, the pathogenesis of chronic pain is currently unclear. Previous neuroimaging work implicates the dorsal anterior cingulate cortex (dACC) in adaptive control of pain, while prior resting state functional magnetic resonance imaging studies find increased functional connectivity (FC) between the dACC and regions involved in pain processing in those with chronic pain. Hyper-connectivity of the dACC to regions that mediate pain response may therefore relate to pain severity. The present study completed rsfMRI scans on N = 22 survivors of MVCs collected within 2 weeks of the incident to test whole-brain dACC-FC as a predictor of pain severity 6 months later. At 2 weeks, pain symptoms were predicted by positive connectivity between the dACC and the premotor cortex. Controlling for pain symptoms at 2 weeks, pain symptoms at 6 months were predicted by negative connectivity between the dACC and the precuneus. Previous research implicates the precuneus in the individual subjective awareness of pain. Given a relatively small sample size, approximately half of which did not experience chronic pain at 6 months, findings warrant replication. Nevertheless, this study provides preliminary evidence of enhanced dACC connectivity with motor regions and decreased connectivity with pain processing regions as immediate and prospective predictors of pain following MVC. Perspective: This article presents evidence of distinct neural vulnerabilities that predict chronic pain in MVC survivors based on whole-brain connectivity with the dorsal anterior cingulate cortex. ? 2020 by United States Association for the Study of Pain, Inc.	[Fitzgerald, Jacklynn M.] Marquette Univ, Dept Psychol, Cramer Hall 328N,POB 1881, Milwaukee, WI 53201 USA; [Belleau, Emily L.] McLean Hosp, Dept Psychiat, Belmont, MA USA; [Belleau, Emily L.] Harvard Med Sch, Boston, MA 02115 USA; [Ehret, Lauren E.] Rogers Behav Hlth, Minneapolis, MN USA; [Trevino, Colleen; deRoon-Cassini, Terri] Med Coll Wisconsin, Dept Surg, Div Trauma & Crit Care, Milwaukee, WI USA; [Brasel, Karen J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Larson, Christine] Univ Wisconsin Milwaukee, Dept Psychol, Milwaukee, WI USA		Fitzgerald, JM (corresponding author), Marquette Univ, Dept Psychol, Cramer Hall 328N,POB 1881, Milwaukee, WI 53201 USA.	jacklynn.fitzgerald@marquette.edu		Trevino, Colleen/0000-0002-7813-3642	Medical College of Wisconsin Injury Research Center - CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE001175]	This work was supported by funds obtained through the Medical College of Wisconsin Injury Research Center funded by the CDC (R49/CE001175).	An X, 1998, J COMP NEUROL, V401, P455; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beck JG, 2007, PROF PSYCHOL-RES PR, V38, P629, DOI 10.1037/0735-7028.38.6.629; Bolwerk A, 2013, J PAIN, V14, P1107, DOI 10.1016/j.jpain.2013.04.007; Bortsov AV, 2013, EUR J PAIN, V17, P1243, DOI 10.1002/j.1532-2149.2013.00285.x; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chang WJ, 2018, J PAIN, V19, P341, DOI 10.1016/j.jpain.2017.10.007; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; Connolly MR, 2019, J PAIN, V20, P394, DOI 10.1016/j.jpain.2018.08.007; Cook DB, 2004, J RHEUMATOL, V31, P364; Demirakca T, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8240894; DiMaggio C, 2016, INJURY, V47, P1393, DOI 10.1016/j.injury.2016.04.002; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Duckworth MP, 2005, CLIN J PAIN, V21, P251, DOI 10.1097/00002508-200505000-00008; Duenas M, 2016, J PAIN RES, V9, P457, DOI 10.2147/JPR.S105892; Dum RP, 2009, J NEUROSCI, V29, P14223, DOI 10.1523/JNEUROSCI.3398-09.2009; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fenton BW, 2015, PAIN, V22; FERRAZ MB, 1990, J RHEUMATOL, V17, P1022; Fitzgerald JM, 2018, HARVARD REV PSYCHIAT, V26, P116, DOI 10.1097/HRP.0000000000000185; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fuchs PN, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00035; Geuter S, 2017, ELIFE, V6, DOI 10.7554/eLife.24770; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Giesecke T, 2004, ARTHRITIS RHEUM-US, V50, P613, DOI 10.1002/art.20063; Goffaux P, 2014, BRAIN TOPOGR, V27, P366, DOI 10.1007/s10548-013-0291-0; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hong JY, 2014, J NEUROSCI, V34, P14252, DOI 10.1523/JNEUROSCI.1683-14.2014; Hu S, 2018, DRUG ALCOHOL DEPEN, V185, P173, DOI 10.1016/j.drugalcdep.2017.11.026; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Ichesco E, 2016, EUR J PAIN, V20, P1079, DOI 10.1002/ejp.832; Iwata K, 2005, J NEUROPHYSIOL, V94, P1980, DOI 10.1152/jn.00190.2005; Jahn A, 2016, J NEUROSCI, V36, P12385, DOI 10.1523/JNEUROSCI.2180-16.2016; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Jones GT, 2011, ARTHRIT CARE RES, V63, P696, DOI 10.1002/acr.20417; Kirino E, 2017, PSYCHIAT CLIN NEUROS, V71, P262, DOI 10.1111/pcn.12495; Kong J, 2010, BEHAV BRAIN RES, V211, P215, DOI 10.1016/j.bbr.2010.03.042; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Lieberman MD, 2015, P NATL ACAD SCI USA, V112, P15250, DOI 10.1073/pnas.1515083112; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mertens P, 2015, NEUROCHIRURGIE, V61, pS22, DOI 10.1016/j.neuchi.2014.09.001; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Morecraft RJ, 2007, J COMP NEUROL, V500, P134, DOI 10.1002/cne.21165; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Russo JF, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.3.FOCUS1543; Salomons TV, 2004, J NEUROSCI, V24, P7199, DOI 10.1523/JNEUROSCI.1315-04.2004; Schmidt-Wilcke T, 2014, NEUROIMAGE-CLIN, V6, P252, DOI 10.1016/j.nicl.2014.09.007; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Thompson JM, 2017, PAIN RES MANAG, V2017, DOI 10.1155/2017/8296501; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Trevino C, 2014, J TRAUMA NURS, V21, P50, DOI 10.1097/JTN.0000000000000032; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yu CS, 2011, NEUROIMAGE, V54, P2571, DOI 10.1016/j.neuroimage.2010.11.018	81	1	1	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900	1528-8447		J PAIN	J. Pain	FEB	2021	22	2					171	179		10.1016/j.jpain.2020.07.002			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RK3IW	WOS:000638194300005	32736035				2022-02-06	
J	Haney, LJ; Pugh, MJV; Copeland, LA; Wang, CP; MacCarthy, DJ; Amuan, ME; Shireman, PK				Haney, Lauren J.; Pugh, Mary Jo V.; Copeland, Laurel A.; Wang, Chen-Pin; MacCarthy, Daniel J.; Amuan, Megan E.; Shireman, Paula K.			Persistent Pain, Physical Dysfunction, and Decreased Quality of Life After Combat Extremity Vascular Trauma	ANNALS OF VASCULAR SURGERY			English	Article; Proceedings Paper	15th Annual Meeting of the Academic-Surgical-Congress (ASC) / 15th Annual Academic Surgical Congress of the Association-for-Academic-Surgery (AAS) and Society-of-University-Surgeons (SUS)	FEB 02-06, 2020	Assoc Acad Surg, Orlando, FL	Acad Surg Congress, Soc Univ Surg, Assoc Acad Surg	Assoc Acad Surg		INJURY; QUESTIONNAIRE; MILITARY; OUTCOMES; ADULTS; SCALE	Background: Combat-related extremity vascular injuries (EVI) have long-lasting impact on Iraq/Afghanistan veterans. The purpose of this study is to describe long-term functional outcomes in veterans with EVI using survey measures and identify modifiable factors that may be improved to reduce chronic pain and injury-related dysfunction. Methods: Veterans with upper and lower EVI undergoing an initial limb salvage attempt were identified using the Department of Defense Trauma Registry and validated with chart abstraction. Surveys measured pain; Short Musculoskeletal Function Assessment (SMFA) for self-reported bother and dysfunction; and Veterans RAND 12-Item Health Survey (VR-12) physical and mental component scores (PCS; MCS) for quality of life, depression, post-traumatic stress disorder, and the potentially modifiable factors of reintegration into civilian life, resilient coping, resilience, and family functioning. Results: Eighty-one patients responded with an average time since injury of 129 months (SD: 31; range 67-180 months). Mechanism of injury included 64% explosions and 31% gunshot wounds; 16% of the respondents were diagnosed with moderate/severe/penetrating traumatic brain injury. Limb salvage rates were 100% and 77% for upper and lower extremities, respectively (P = 0.004). Respondents screened positive for probable depression (55%) and post-traumatic stress disorder (51%). Compared with population norms, SMFA bother and dysfunction indices were higher (worse), MCS was lower (worse), and PCS was similar. The multivariable models adjusted for age, marital status and pain. The higher SMFA is part of the results of the multivariable models. MCS decreased with difficulty reintegrating into civilian life and was positively correlated with increased resilience and resilient coping. SMFA scores were greater for patients with high pain intensity and increased 6-11 points per point increase in difficulty with civilian-life reintegration. SMFA dysfunction was associated with better family functioning. Conclusions: EVI results in significant long-term disability with lasting deficits in physical function, frequent depressive symptoms, and below average self-reported quality of life. Strengthening modifiable factors including resiliency and resilient coping, and providing ongoing assistance to improve reintegration into civilian life, may ameliorate the functional disabilities and chronic pain experienced by veterans with EVI.	[Haney, Lauren J.; Wang, Chen-Pin; MacCarthy, Daniel J.; Shireman, Paula K.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Haney, Lauren J.; Wang, Chen-Pin; MacCarthy, Daniel J.; Shireman, Paula K.] Univ Texas Hlth San Antonio, Div Vasc & Endovasc Surg, Dept Surg, Long Sch Med, San Antonio, TX USA; [Haney, Lauren J.; Wang, Chen-Pin; MacCarthy, Daniel J.; Shireman, Paula K.] Univ Texas Hlth San Antonio, Dept Populat Hlth Sci, Long Sch Med, San Antonio, TX USA; [Pugh, Mary Jo V.] Univ Utah, Sch Med, Dept Internal Med, Div Epidemiol, Salt Lake City, UT USA; [Pugh, Mary Jo V.; Amuan, Megan E.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Copeland, Laurel A.] VA Cent Western Massachusetts Healthcare Syst, Leeds, MA USA; [Copeland, Laurel A.] Univ Massachusetts, Sch Med, Dept Populat & Quantitat Hlth Sci, Worcester, MA USA		Shireman, PK (corresponding author), UT Hlth San Antonio, 7703 Floyd Curl Dr,MC 7741, San Antonio, TX 78229 USA.	Shireman@uthscsa.edu	Copeland, Laurel/C-3763-2017	Copeland, Laurel/0000-0002-9478-0209; SHIREMAN, PAULA/0000-0002-9701-5422; Haney, Lauren/0000-0001-5836-3523	Veterans Health AdministrationUS Department of Veterans Affairs [HX001304/IIR 13-029]	The authors have no conflicts of interest to disclose. This work was supported by the Veterans Health Administration (HX001304/IIR 13-029). The views expressed are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	Aidinian G, 2010, J VASC SURG, V51, P214, DOI 10.1016/j.jvs.2009.06.054; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Barei DP, 2007, J ORTHOP TRAUMA, V21, P738, DOI 10.1097/BOT.0b013e31815bb30f; Clouse WD, 2006, ANN VASC SURG, V20, P429, DOI 10.1007/s10016-006-9090-3; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Coughlin S.S., 2011, SURVEY PRACTICE, V4, P1, DOI [10.29115/SP-2011-0004, DOI 10.29115/SP-2011-0004]; Defense Manpower Data Center, 2016, DOD SURV BURD TIG TE; Defense Manpower Data Center (DMDC) Research Surveys and Statistics Center (RSSC), BREIF LEAD IND MIL O; Doukas WC, 2013, J BONE JOINT SURG AM, V95A, P138, DOI 10.2106/JBJS.K.00734; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gifford SM, 2009, J VASC SURG, V50, P549, DOI 10.1016/j.jvs.2009.03.051; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Johnson TP., 2000, INCLUSION DISABLED P; Lee M, 2009, J NUTR HEALTH AGING, V13, P576, DOI 10.1007/s12603-009-0110-1; Melcer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170569; Patel JA, 2018, J VASC SURG, V68, P1872, DOI 10.1016/j.jvs.2018.04.038; Perkins ZB, 2018, J TRAUMA ACUTE CARE, V85, pS104, DOI 10.1097/TA.0000000000001956; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; Prins A, 2016, J GEN INTERN MED, V31, P1206, DOI 10.1007/s11606-016-3703-5; Rasmussen Todd E, 2006, Perspect Vasc Surg Endovasc Ther, V18, P91, DOI 10.1177/1531003506293374; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Sharrock AE, 2019, J VASC SURG, V70, P224, DOI 10.1016/j.jvs.2018.11.024; Shireman PK, 2015, BMC SURG, V15, DOI 10.1186/1471-2482-15-13; Swiontkowski MF, 1999, J BONE JOINT SURG AM, V81A, P1245, DOI 10.2106/00004623-199909000-00006; University of Minnesota, MFA SMFA RES; Vogt D., 2012, MANUAL DEPLOYMENT RI; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; White JM, 2011, ANN SURG, V253, P1184, DOI [10.1097/SLA.0b013e31820752e3, 10.2165/11537150-000000000-00000]	29	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	FEB	2021	71						167	180		10.1016/j.avsg.2020.08.104			14	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery; Cardiovascular System & Cardiology	RC0NM	WOS:000632500700020	32890646				2022-02-06	
J	Hellstrom, T; Andelic, N; de Lange, AMG; Helseth, E; Eiklid, K; Westlye, LT				Hellstrom, Torgeir; Andelic, Nada; de Lange, Ann-Marie G.; Helseth, Eirik; Eiklid, Kristin; Westlye, Lars T.			Apolipoprotein e4 Status and Brain Structure 12 Months after Mild Traumatic Injury: Brain Age Prediction Using Brain Morphometry and Diffusion Tensor Imaging	JOURNAL OF CLINICAL MEDICINE			English	Article						mild traumatic brain injury; APOE; brain-age gap; MRI	POST-CONCUSSION SYMPTOMS; WHITE-MATTER MICROSTRUCTURE; ALZHEIMERS-DISEASE; AXONAL INJURY; HEAD TRAUMA; E EPSILON-4; ATROPHY; CONSCIOUSNESS; ASSOCIATION; DISRUPTION	Background: Apolipoprotein E (APOE) e4 is associated with poor outcome following moderate to severe traumatic brain injury (TBI). There is a lack of studies investigating the influence of APOE e4 on intracranial pathology following mild traumatic brain injury (MTBI). This study explores the association between APOE e4 and MRI measures of brain age prediction, brain morphometry, and diffusion tensor imaging (DTI). Methods: Patients aged 16 to 65 with acute MTBI admitted to the trauma center were included. Multimodal MRI was performed 12 months after injury and associated with APOE e4 status. Corrections for multiple comparisons were done using false discovery rate (FDR). Results: Of included patients, 123 patients had available APOE, volumetric, and DTI data of sufficient quality. There were no differences between APOE e4 carriers (39%) and non-carriers in demographic and clinical data. Age prediction revealed high accuracy both for the DTI-based and the brain morphometry based model. Group comparisons revealed no significant differences in brain-age gap between e4 carriers and non-carriers, and no significant differences in conventional measures of brain morphometry and volumes. Compared to non-carriers, APOE e4 carriers showed lower fractional anisotropy (FA) in the hippocampal part of the cingulum bundle, which did not remain significant after FDR adjustment. Conclusion: APOE e4 carriers might be vulnerable to reduced neuronal integrity in the cingulum. Larger cohort studies are warranted to replicate this finding.	[Hellstrom, Torgeir; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, N-0318 Oslo, Norway; [de Lange, Ann-Marie G.; Westlye, Lars T.] Univ Oslo, Dept Psychol, Fac Social Sci, N-0317 Oslo, Norway; [de Lange, Ann-Marie G.] CHU Vaudois, Ctr Res Neurosci, LREN, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [de Lange, Ann-Marie G.] Univ Lausanne, CH-1011 Lausanne, Switzerland; [de Lange, Ann-Marie G.] Univ Oxford, Dept Psychiat, Oxford OX3 7JK, England; [Helseth, Eirik] Univ Oslo, Inst Clin Med, Fac Med, N-0318 Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, N-0424 Oslo, Norway; [Eiklid, Kristin] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Westlye, Lars T.] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT, N-0424 Oslo, Norway; [Westlye, Lars T.] Univ Oslo, KG Jebsen Ctr Neurodev Disorders, Fac Med, N-0318 Oslo, Norway		Hellstrom, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway.	torgeir.hellstrom@ous-hf.no; nadand@ous-hf.no; a.m.g.de.lange@psykologi.uio.no; ehelseth@ous-hf.no; k.l.eiklid@gmail.com; l.t.westlye@psykologi.uio.no	Hellstrom, Torgeir/AAY-6043-2021; Hellstrom, Torgeir/AAW-4301-2021	Hellstrom, Torgeir/0000-0003-0831-3274; Helseth, Eirik/0000-0001-5758-6485	Research Council of NorwayResearch Council of Norway; South-Eastern Norway Regional Health Authority; European Research Council under the European UnionEuropean Research Council (ERC) [802998]	This study is supported by the Research Council of Norway, the South-Eastern Norway Regional Health Authority, and the European Research Council under the European Union's Horizon 2020 research and Innovation program (ERCStG, Grant 802998).	Bartzokis G, 2006, ARCH GEN PSYCHIAT, V63, P63, DOI 10.1001/archpsyc.63.1.63; Beck D, 2021, NEUROIMAGE, V224, DOI 10.1016/j.neuroimage.2020.117441; Benjamini Y., 1995, J ROY STAT SOC, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Choo IH, 2010, NEUROBIOL AGING, V31, P772, DOI 10.1016/j.neurobiolaging.2008.06.015; Cole JH, 2020, NEUROBIOL AGING, V92, P34, DOI 10.1016/j.neurobiolaging.2020.03.014; Cole JH, 2020, ANN NEUROL, V88, P93, DOI 10.1002/ana.25746; Cole JH, 2019, MOL PSYCHIATR, V24, P266, DOI 10.1038/s41380-018-0098-1; Cole JH, 2017, TRENDS NEUROSCI, V40, P681, DOI 10.1016/j.tins.2017.10.001; Cole JH, 2017, NEUROIMAGE, V163, P115, DOI 10.1016/j.neuroimage.2017.07.059; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; De Lange AMG, 2020, NEUROIMAGE, V222, DOI 10.1016/j.neuroimage.2020.117292; de Lange AMG, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2020.102229; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Di Battista AP, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-0339-3; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Firbank MJ, 2007, NEUROIMAGE, V36, P1, DOI 10.1016/j.neuroimage.2007.02.027; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Han Laura K M, 1800, Mol Psychiatry, V26, P5124, DOI 10.1038/s41380-020-0754-0; Harris TC, 2019, ANN BIOMED ENG, V47, P1941, DOI 10.1007/s10439-018-02148-2; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Hellstrom T, 2016, BRAIN INJURY, V30, P1683, DOI 10.1080/02699052.2016.1199905; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; ISEKI E, 1989, ACTA NEUROPATHOL, V78, P131, DOI 10.1007/BF00688200; James H., 2019, BIOMARKERS HUMAN AGI; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaufmann T, 2019, NAT NEUROSCI, V22, P1617, DOI 10.1038/s41593-019-0471-7; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lenihan MW, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0541-5; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Li X, 2020, ELIFE, V9, DOI 10.7554/eLife.51507; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Major BP, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.549624; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Mueller SG, 2009, HIPPOCAMPUS, V19, P558, DOI 10.1002/hipo.20614; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Brien WT, 2021, J NEUROTRAUM, V38, P1350, DOI 10.1089/neu.2020.7479; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; Richard G, 2020, NEUROIMAGE-CLIN, V25, DOI 10.1016/j.nicl.2019.102159; Richard G, 2018, PEERJ, V6, DOI 10.7717/peerj.5908; Samatovicz RA, 2000, J HEAD TRAUMA REHAB, V15, P869, DOI 10.1097/00001199-200006000-00002; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Shafto MA, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0204-1; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2020, ELIFE, V9, DOI 10.7554/eLife.52677; Smith SM, 2019, NEUROIMAGE, V200, P528, DOI 10.1016/j.neuroimage.2019.06.017; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sullivan DR, 2019, J NEUROTRAUM, V36, P3264, DOI 10.1089/neu.2019.6489; Symons G.F., 2020, J CONCUSSION, V4, P1, DOI [10.1177/2059700220975609, DOI 10.1177/2059700220975609]; Taylor JR, 2017, NEUROIMAGE, V144, P262, DOI 10.1016/j.neuroimage.2015.09.018; Taylor WD, 2004, BIOL PSYCHIAT, V55, P201, DOI 10.1016/j.biopsych.2003.07.001; TEASDALE G, 1974, LANCET, V2, P81; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Villain N, 2008, J NEUROSCI, V28, P6174, DOI 10.1523/JNEUROSCI.1392-08.2008; Westlye LT, 2012, NEUROLOGY, V79, P1961, DOI 10.1212/WNL.0b013e3182735c9c; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wightman D.P., 2020, LARGEST GWAS 1126563, DOI [10.1101/2020.11. 20.20235275, DOI 10.1101/2020.11.20.20235275, 10.1101/2020.11.20.20235275]; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zhang J, 2019, J NEUROL NEUROSUR PS, V90, P98, DOI 10.1136/jnnp-2017-317691	79	1	1	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	FEB	2021	10	3							418	10.3390/jcm10030418			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QD1MS	WOS:000615292200001	33499167	gold, Green Published			2022-02-06	
J	Hogeveen, J; Krueger, F; Grafman, J				Hogeveen, Jeremy; Krueger, Frank; Grafman, Jordan			Association Between Alexithymia and Impaired Reward Valuation in Patients With Fronto-Insular Damage	EMOTION			English	Article						alexithymia; emotional awareness; reward valuation; lesion-symptom mapping; insula	POSTTRAUMATIC-STRESS-DISORDER; AGE-RELATED DIFFERENCES; DECISION-MAKING; GENERAL INTELLIGENCE; ANTERIOR INSULA; EMOTION; CORTEX; SYSTEM; NEUROSCIENCE; AUTISM	Humans compute the anticipated reward value of stimuli in their environment in order to behave in an adaptive, goal-directed manner. This reward valuation ability is vital, and its disruption in a range of clinical populations has profound peisonal and social consequences. However, research has often failed to consider the reward-related functions of a central component of human emotion: conscious emotional experience. Alexithymia-a condition characterized by diminished conscious awareness of one's emotions-offers a unique opportunity to examine the link between emotional awareness and reward valuation. In the present study, we measured both acquired alexithymia and reward valuation ability in a large sample of patients with traumatic brain injuries (N = 112). Behavioral analyses provided evidence for a negative association between alexithymia and reward valuation ability. This association remained significant after controlling for several covariates in the model (anxiety, depression, posttraumatic stress disorder, and IQ). Voxel-based lesionsymptom mapping was carried out to identify brain regions-of-interest (ROB) that, when damaged, lead to increased alexithymia and impaired reward valuation. Importantly, mediation models computed using the ROB identified through the voxel-based lesion-symptom mapping revealed a specific indirect effect of left frontoinsular damage on impaired valuation that was mediated by increased levels of alexithymia. This indirect effect was not observed for any of the other candidate ROIs. The present study identifies a network of brain regions likely to be involved in the integration of subjective feelings and reward processes critical for the adaptive control of goal-directed behavior.	[Hogeveen, Jeremy] Univ New Mexico, Dept Psychol, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA; [Hogeveen, Jeremy] Univ New Mexico, Psychol Clin Neurosci Ctr, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Mol Neurosci, Fairfax, VA 22030 USA; [Grafman, Jordan] Shirley Ryan AbilityLab, Cognit Neurosci Lab, Chicago, IL USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, Chicago, IL 60611 USA		Hogeveen, J (corresponding author), Univ New Mexico, Dept Psychol, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA.; Hogeveen, J (corresponding author), Univ New Mexico, Psychol Clin Neurosci Ctr, Logan Hall,1 Univ New Mexico,MSC03 2220, Albuquerque, NM 87131 USA.	jhogeveen@unm.edu		Hogeveen, Jeremy/0000-0001-9612-2085; Grafman, Jordan H./0000-0001-8645-4457	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Julius N. Frankel Foundation; Smart Family Foundation of New York; Therapeutic Cognitive Neuroscience Fund	We thank our Vietnam veterans for their participation in the study. We are grateful to V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants. The National Naval Medical Center and the National Institute of Neurological Disorders and Stroke provided their facilities and supported the research.; This work was supported by a grant from the Julius N. Frankel Foundation (to Jordan Grafman), the Smart Family Foundation of New York (to Jordan Grafman), and the Therapeutic Cognitive Neuroscience Fund (to Jordan Grafman). Questions regarding the Vietnam Head Injury Study can be directed to Jordan Grafman, e-mail: jgrafman@ northwestern.edu	Badura AS, 2003, J ANXIETY DISORD, V17, P349, DOI 10.1016/S0887-6185(02)00201-3; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Berridge KC, 2016, AM PSYCHOL, V71, P670, DOI 10.1037/amp0000059; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Bowen S, 2014, JAMA PSYCHIAT, V71, P547, DOI 10.1001/jamapsychiatry.2013.4546; Brewer R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150664; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Charpentier CJ, 2016, PSYCHOL SCI, V27, P763, DOI 10.1177/0956797616634654; Chen YC, 2014, NEUROBIOL AGING, V35, P827, DOI 10.1016/j.neurobiolaging.2013.10.080; Chhatwal J., 2016, PSYCHODYN PSYCHIAT, V44, P305, DOI [DOI 10.1521/PDPS.2016.44.2.305, 10.1521/pdps.2016.44.2.305]; Cook R, 2013, PSYCHOL SCI, V24, P723, DOI 10.1177/0956797612463582; Costa A, 2007, J INT NEUROPSYCH SOC, V13, P980, DOI 10.1017/S1355617707071329; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DAMASIO Antonio, 2003, LOOKING SPINOZA JOY; de Morree HM, 2016, J NEUROSURG ANESTH, V28, P153, DOI 10.1097/ANA.0000000000000207; Downar J, 2016, TRENDS COGN SCI, V20, P107, DOI 10.1016/j.tics.2015.10.007; Fellows LK, 2011, ANN NY ACAD SCI, V1239, P51, DOI 10.1111/j.1749-6632.2011.06229.x; Field AP, 2017, BEHAV RES THER, V98, P19, DOI 10.1016/j.brat.2017.05.013; Fishbein, 1980, PROGR SOCIAL PSYCHOL, P49; Fogley R, 2014, PSYCHIAT RES, V218, P1, DOI 10.1016/j.psychres.2014.04.020; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Gillebert CR, 2014, NEUROIMAGE-CLIN, V4, P540, DOI 10.1016/j.nicl.2014.03.009; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Grynberg D, 2010, PERS INDIV DIFFER, V49, P845, DOI 10.1016/j.paid.2010.07.013; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Guo CC, 2016, P NATL ACAD SCI USA, V113, pE2430, DOI 10.1073/pnas.1509184113; Hogeveen J, 2016, TRENDS NEUROSCI, V39, P694, DOI 10.1016/j.tins.2016.08.007; Hogeveen J, 2017, CEREB CORTEX, V27, P1401, DOI 10.1093/cercor/bhv317; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kimberg DY, 2007, J COGNITIVE NEUROSCI, V19, P1067, DOI 10.1162/jocn.2007.19.7.1067; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Laneri D, 2017, HUM BRAIN MAPP, V38, P4034, DOI 10.1002/hbm.23646; Lebreton M, 2009, NEURON, V64, P431, DOI 10.1016/j.neuron.2009.09.040; LeDoux JE, 2016, AM J PSYCHIAT, V173, P1083, DOI 10.1176/appi.ajp.2016.16030353; Lischke A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00229; Luminet O, 2006, J RES PERS, V40, P713, DOI 10.1016/j.jrp.2005.09.001; Mather M, 2018, CURR OPIN BEHAV SCI, V19, P98, DOI 10.1016/j.cobeha.2017.12.017; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Parker JDA, 2003, J PSYCHOSOM RES, V55, P269, DOI 10.1016/S0022-3999(02)00578-0; Paulus MP, 2012, TRENDS COGN SCI, V16, P476, DOI 10.1016/j.tics.2012.07.009; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; R Development Core Team, 2012, R LANG ENV STAT COMP; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Regenwetter M, 2011, PSYCHOL REV, V118, P42, DOI 10.1037/a0021150; Riva F, 2018, NEUROBIOL AGING, V65, P7, DOI 10.1016/j.neurobiolaging.2017.12.028; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Shah P, 2016, CORTEX, V81, P215, DOI 10.1016/j.cortex.2016.03.021; Sharp PB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26268-w; Silvers JA, 2017, CEREB CORTEX, V27, P3502, DOI 10.1093/cercor/bhw073; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Solomon M, 2011, AUTISM RES, V4, P109, DOI 10.1002/aur.177; Spielberger CD., 1970, STATE TRAIT ANXIETY; Stone LA, 2001, PSYCHOTHER PSYCHOSOM, V70, P92, DOI 10.1159/000056232; Su IW, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00570; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Tingley D, 2014, J STAT SOFTW, V59; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Walker GM, 2011, BRAIN LANG, V117, P110, DOI 10.1016/j.bandl.2010.09.008; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wechsler D., 2011, WECHSLER ABBREVIATED; Whitton AE, 2015, CURR OPIN PSYCHIATR, V28, P7, DOI 10.1097/YCO.0000000000000122; Wilcox RR., 2011, INTRO ROBUST ESTIMAT; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Witkiewitz K, 2019, ALCOHOL CLIN EXP RES, V43, P1296, DOI 10.1111/acer.14053; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	79	1	1	1	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1528-3542	1931-1516		EMOTION	Emotion	FEB	2021	21	1					137	147		10.1037/emo0000676			11	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	QB8BZ	WOS:000614363500011	31535883	Green Accepted			2022-02-06	
J	Hsu, HH; Lai, WH; Yu, HT; Xiao, SH; Tsai, YH; Wang, KC; Huang, SJ; Yang, CC				Hsu, Huan-Hsuan; Lai, Wen-Hsuan; Yu, Hsiu-Ting; Xiao, Sheng-Huang; Tsai, Yi-Hsin; Wang, Kuo-Chuan; Huang, Sheng-Jean; Yang, Chi-Cheng			Long-Term Presentation of Postconcussion Symptoms and Associated Factors: Analysis of Latent Class Modeling	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Mild traumatic brain injury; Postconcussion symptoms; Longitudinal; Latent class modeling	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYMPTOMS; HEAD-INJURY; QUESTIONNAIRE; IRRITABILITY; PREDICTION; RECOVERY; FATIGUE; IMPACT; ADULTS	Objective: Postconcussion symptoms (PCS) are commonly reported by patients with mild traumatic brain injury (MTBI). Although PCS significantly recovered by 3-month postinjury, a number of patients still experienced persistent PCS for >1 year. As few researchers investigated long-term PCS endorsement, the present study thus aims to show the latent structure of long-term PCS and further uncover its associating factors. Methods: In total, 110 patients with MTBI and 32 healthy participants were prospectively enrolled. PCS was evaluated at 2 weeks and long-term evaluations (mean = 2.90 years) after MTBI. In addition, cognitive functions, which include memory, executive function, and information processing, and emotional disturbances, which include depression, anxiety, and irritability, were also examined at 2-week postinjury. Results: Patients reported significantly more PCS at 2-week postinjury than healthy participants did, but PCS significantly improved at long-term evaluations when comparing with PCS at acute stage after MTBI. Both of PCS at 2 weeks and longterm evaluations can be further subdivided into subgroups based on the severity of PCS, in which specific PCS (e.g., fatigue, loss of energy, insomnia, slowness of information processing, irritability, and blurred vision) can be well differentiated among subgroups at long-term evaluations. Conclusions: This study directly showed the characteristics of long-term PCS and associating factors. It further evidenced that specific physical, cognitive, and emotional symptoms might be determinant to identify the subgroups of patients with long-term PCS endorsement.	[Hsu, Huan-Hsuan] Taichung Tzu Chi Hosp, Dept Neurol, Tanzih Township, Taiwan; [Lai, Wen-Hsuan] Yi Her Hosp, Div Rehabil, New Taipei, Taiwan; [Yu, Hsiu-Ting; Yang, Chi-Cheng] Natl Chengchi Univ, Dept Psychol, 64,Sec 2 Zhinan Rd, Taipei, Taiwan; [Xiao, Sheng-Huang] Taipei City Hosp, Ren Ai Branch, Taipei, Taiwan; [Tsai, Yi-Hsin] Far Eastern Mem Hosp, Dept Neurosurg, New Taipei, Taiwan; [Wang, Kuo-Chuan] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan; [Huang, Sheng-Jean] Taipei City Hosp, Taipei, Taiwan; [Yang, Chi-Cheng] Taipei City Hosp, Holist Mental Hlth Ctr, Taipei, Taiwan		Yang, CC (corresponding author), Natl Chengchi Univ, Dept Psychol, 64,Sec 2 Zhinan Rd, Taipei, Taiwan.	yangyang@nccu.edu.tw		YANG, CHI CHENG/0000-0002-4544-3978	Ministry of Science and Technology (MOST) in TaiwanMinistry of Science and Technology, Taiwan [MOST 107-2410-H-004-101]	Supported by the Ministry of Science and Technology (MOST) in Taiwan (MOST 107-2410-H-004-101).	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Alderman N, 2004, SCI PRACT NEUROPSYCH, P269; Barker-Collo S, 2019, BRAIN INJURY, V33, P618, DOI 10.1080/02699052.2019.1570339; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Chen HY, 2000, BECK DEPRESSION INVE; Chi H. T, 2005, CLASSIFICATION MEDIC; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; de Koning ME, 2017, NEUROLOGY, V89, P1908, DOI 10.1212/WNL.0000000000004604; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hua M-S, 1986, WORD SEQUENCE LEARNI; Hua MS, 1997, NEUROPSYCHOLOGY, V11, P156, DOI 10.1037/0894-4105.11.1.156; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kraus J., 1996, NAUROTRAUMA, P16; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Levin H. S, 1983, PACED AUDITORY SERIA; LEZAK MD, 2004, NEUROPSYCHOLOGICAL A, P611; Lin YC, 2000, BECK ANXIETY INVENTO; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Ma HP, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/4364592; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Silverberg ND, 2018, ARCH PHYS MED REHAB, V99, P250, DOI 10.1016/j.apmr.2017.07.006; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stein E, 2017, BRAIN INJURY, V31, P1736, DOI 10.1080/02699052.2017.1380843; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Thomas M, 2018, BRAIN IMPAIR, V19, P166, DOI 10.1017/Brimp.2017.26; Thurman DJ, 2001, HEAD TRAUMA, P327; Vermunt JeroenK., 2016, TECHNICAL GUIDE LATE; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2013, BRAIN INJURY, V27, P1008, DOI 10.3109/02699052.2013.794975; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Yang CC, 2011, BRAIN IMPAIR, V12, P200; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yuen K. M., 2012, MODIFIED CHECKLIST P	65	1	2	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2021	36	1					62	73		10.1093/arclin/acaa063			12	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	SA6UP	WOS:000649437300006	32839820				2022-02-06	
J	Huang, APH; Lai, DM; Hsu, YH; Tsai, HH; Su, CY; Hsu, SH				Huang, Abel Po-Hao; Lai, Dar-Ming; Hsu, Yi-Hua; Tsai, Hsin-Han; Su, Chia-Yi; Hsu, Shan-hui			An anti-inflammatory gelatin hemostatic agent with biodegradable polyurethane nanoparticles for vulnerable brain tissue	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Hemostatic; Surgery; Foreign body reaction; Anti-inflammatory; Polyurethane; Nanoparticle		Hemostasis plays a fundamental and critical role in all surgical procedures. However, the currently used topical hemostatic agents may at times undesirably induce inflammation, infection, and foreign body reaction and hamper the healing process. This may be serious in the central nervous system (CNS), especially for some neurosurgical diseases which have ongoing inflammation causing secondary brain injury. This study was aimed to develop a hemostatic agent with anti-inflammatory property by incorporating carboxyl-functionalized biodegradable polyurethane nanoparticles (PU NPs) and to evaluate its functionality using a rat neurosurgical model. PU NPs are specially-designed anti-inflammatory nanoparticles and absorbed by a commercially available hemostatic gelatin powder (Spongostan (TM)). Then, the gelatin was implanted to the injured rat cortex and released anti-inflammatory PU NPs. The time to hemostasis, the cerebral edema formation, and the brain's immune responses were examined. The outcomes showed that PU NP-contained gelatin attenuated the brain edema, suppressed the gene expression levels of pro-inflammatory M1 biomarkers (e.g., IL-1 beta level to be about 25%), elevated the gene expression levels of anti-inflammatory M2 biomarkers (e.g., IL-10 level to be about 220%), and reduced the activation of inflammatory cells in the implanted site, compared with the conventional gelatin. Moreover, PU NP-contained gelatin increased the gene expression level of neurotrophic factor BDNF by nearly 3-folds. We concluded that the PU NP-contained hemostatic agents are anti-inflammatory with neumprotective potential in vivo. This new hemostatic agent will be useful for surgery involving vulnerable tissue or organ (e.g., CNS) and also for diseases such as stroke, traumatic brain injury, and neumdegenerative diseases.	[Huang, Abel Po-Hao; Lai, Dar-Ming; Hsu, Yi-Hua; Tsai, Hsin-Han; Su, Chia-Yi] Natl Taiwan Univ Hosp & Coll Med, Dept Surg, Taipei, Taiwan; [Huang, Abel Po-Hao; Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan		Hsu, SH (corresponding author), Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	shhsu@ntu.edu.tw		HUANG, ABEL PO-HAO/0000-0002-5689-6761	Seventh Core Laboratory of NTUH; Ministry of Science and Technology, Taiwan, ROCMinistry of Science and Technology, Taiwan [MOST 105-2321-B-002-040, MOST 106-2321-B-002-041]	The authors thank the research support from Seventh Core Laboratory of NTUH. The authors also thank 7T animal MRI Core Lab of the Neurobiology and Cognitive Science Center, NTU for technical and facility support. This work was supported by Ministry of Science and Technology (MOST 105-2321-B-002-040, MOST 106-2321-B-002-041), Taiwan, ROC.	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Behrens AM, 2014, J BIOMED MATER RES A, V102, P4182, DOI 10.1002/jbm.a.35052; Behrens AM, 2014, ACTA BIOMATER, V10, P701, DOI 10.1016/j.actbio.2013.10.029; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Broekema FI, 2016, BIO-MED MATER ENG, V27, P149, DOI 10.3233/BME-161578; Broekema FI, 2011, J MATER SCI-MATER M, V22, P1081, DOI 10.1007/s10856-011-4276-9; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Cao YN, 2018, MOL PHARMACEUT, V15, P4550, DOI 10.1021/acs.molpharmaceut.8b00548; Carniglia L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158564; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503; Colon GP, 1996, J NEUROSURG, V85, P335, DOI 10.3171/jns.1996.85.2.0335; Ellis-Behnke R, 2011, WIRES NANOMED NANOBI, V3, P70, DOI 10.1002/wnan.110; Emmez H, 2010, TURK NEUROSURG, V20, P485, DOI 10.5137/1019-5149.JTN.3300-10.2; Ereth MH, 2008, NEUROSURGERY, V63, P369, DOI 10.1227/01.NEU.0000327031.98098.DD; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Gentile P, 2015, J MECH BEHAV BIOMED, V44, P53, DOI 10.1016/j.jmbbm.2014.12.017; Gonzalez-Paz RJ, 2013, J BIOMED MATER RES A, V101, P1036, DOI 10.1002/jbm.a.34407; Graber JJ, 2014, INTERDISCIP NEUROSUR, V1, P5, DOI 10.1016/j.inat.2014.01.002; Hangge P, 2017, CARDIOVASC DIAGN THE, V7, pS267, DOI 10.21037/cdt.2017.08.07; He Y, 2019, ACS BIOMATER SCI ENG, V5, P1113, DOI 10.1021/acsbiomaterials.8b01609; Heller HT, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160664; Henderson PW, 2010, J BIOMED MATER RES A, V93A, P776, DOI 10.1002/jbm.a.32586; Ho MY, 2019, WORLD NEUROSURG, V126, P475, DOI 10.1016/j.wneu.2019.03.030; Hsu SH, 2017, J BIOMED MATER RES A, V105, P1383, DOI 10.1002/jbm.a.36022; Huang YJ, 2018, ACS APPL MATER INTER, V10, P19436, DOI 10.1021/acsami.8b04718; Huang YJ, 2015, NANOSCALE, V7, P20352, DOI 10.1039/c5nr06379e; Ian Y, 2015, HDB BLEEDING COAGULA, P241; Jang SW, 2010, KOREAN J RADIOL, V11, P359, DOI 10.3348/kjr.2010.11.3.359; Kaymaz M, 2005, J CLIN NEUROSCI, V12, P445, DOI 10.1016/j.jocn.2004.02.027; Komatsu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102778; Kucinska-Lipka J, 2013, SCI WORLD J, DOI 10.1155/2013/450132; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lapierre F., 2012, EXPLICATIVE CASES CO, P505; Lei T, 2017, INT J CLIN EXP MED, V10, P3996; Lively S, 2012, TRANSL STROKE RES, V3, pS132, DOI 10.1007/s12975-012-0151-3; Luo TT, 2016, MAT SCI ENG C-MATER, V63, P352, DOI 10.1016/j.msec.2016.03.007; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Modery-Pawlowski CL, 2013, BIOMATERIALS, V34, P3031, DOI 10.1016/j.biomaterials.2012.12.045; Morral-Ruiz G., 2016, ADV POLYURETHANE BIO, P195, DOI [10.1016/B978-0-08-100614-6.00007-X., DOI 10.1016/B978-0-08-100614-6.00007-X]; Nogueira AB, 2014, NEUROSURGERY, V75, P678, DOI 10.1227/NEU.0000000000000512; Pereira Bruno Monteiro, 2018, Rev Col Bras Cir, V45, pe1900, DOI 10.1590/0100-6991e-20181900; Ribalta T, 2004, ARCH PATHOL LAB MED, V128, P749; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stagliano S, 2018, QUANT IMAG MED SURG, V8, P971, DOI 10.21037/qims.2018.09.04; Stroemer RP, 1997, J CEREBR BLOOD F MET, V17, P597; Teleanu DM, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9010096; Tschoe C, 2020, J STROKE, V22, P29, DOI 10.5853/jos.2019.02236; Wang AN, 2013, INT J PHARMACEUT, V441, P30, DOI 10.1016/j.ijpharm.2012.12.021; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Xi CY, 2018, CLIN APPL THROMB-HEM, V24, P279, DOI 10.1177/1076029617716770; Xu FF, 2015, CTS-CLIN TRANSL SCI, V8, P490, DOI 10.1111/cts.12299; Yang X, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00943; Yang Z, 2010, J R SOC INTERFACE, V7, pS411, DOI 10.1098/rsif.2010.0158.focus; Yao HHI, 2013, J CLIN NEUROSCI, V20, P349, DOI 10.1016/j.jocn.2012.09.005; Zeiler FA, 2015, ACTA NEUROCHIR, V157, P513, DOI 10.1007/s00701-015-2346-3	57	1	1	11	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	FEB	2021	121								111799	10.1016/j.msec.2020.111799			11	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	QI6YI	WOS:000619124600005	33579446				2022-02-06	
J	Hui, JY; Feng, JF; Tu, Y; Zhang, WT; Zhong, CL; Liu, M; Wang, YH; Long, LS; Chen, LG; Liu, JF; Mou, CH; Qiu, BH; Huang, XJ; Huang, QB; Zhang, N; Yang, XF; Yang, CH; Li, LH; Ma, R; Wu, X; Lei, J; Jiang, Y; Liu, L; Gao, GY; Jiang, JY				Hui, Jiyuan; Feng, Junfeng; Tu, Yue; Zhang, Weituo; Zhong, Chunlong; Liu, Min; Wang, Yuhai; Long, Liansheng; Chen, Ligang; Liu, Jinfang; Mou, Chaohui; Qiu, Binghui; Huang, Xianjian; Huang, Qibing; Zhang, Nu; Yang, Xiaofeng; Yang, Chaohua; Li, Lihong; Ma, Rong; Wu, Xiang; Lei, Jin; Jiang, Yong; Liu, Liang; Gao, Guoyi; Jiang, Jiyao		LTH-1 Trial Collaborators	Safety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension (LTH-1): A multicenter randomized controlled trial	ECLINICALMEDICINE			English	Article						Traumatic brain injury; Randomized controlled trial; Prolonged hypothermia; Efficacy; Safety	GLASGOW OUTCOME SCALE; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MANAGEMENT; HEAD; GUIDELINES	Background: Therapeutic hypothermia may need prolonged duration for the patients with severe traumatic brain injury (sTBI). Methods: The Long-Term Hypothermia trial was a prospective, multicenter, randomized, controlled clinical trial to examine the safety and efficacy in adults with sTBI. Eligible patients were 18-65, Glasgow Coma Scale score at 4 to 8, and initial intracranial pressure (ICP) >= 25 mm Hg, randomly assigned to the long-term mild hypothermia group (34-35 degrees C for 5 days) or normothermia group at 37 degrees C. The primary outcome was the Glasgow outcome scale (GOS) at 6 months. Secondary outcomes included ICP control, complications and laboratory findings, the length of ICU and hospital stay, and GOS at 6 months in patients with initial ICP >= 30 mm Hg. This trial is registered with ClinicalTrials.gov, NCT01886222. Findings: 302 patients were enrolled from June 25, 2013, to December 31, 2018, with 6 months follow-up in 14 hospitals, 156 in hypothermia group and 146 in normothermia group. There was no difference in favorable outcome (OR 1.55, 95%CI 0.91-2.64; P = 0.105) and in mortality (P = 0.111) between groups. In patients with an initial ICP >= 30 mm Hg, hypothermic treatment significantly increased favorable outcome over normothermia group (60.82%, 42.71%, respectively; OR 1.861, 95%CI 1.031; P =3.361; P = 0.039). Long-term mild hypothermia did not increase the incidences of complications. Interpretation: Long-term mild hypothermia did not improve the neurological outcomes. However, it may be a potential option in sTBI patients with initial ICP >= 30 mm Hg. (C) 2021 The Author(s). Published by Elsevier Ltd.	[Hui, Jiyuan; Feng, Junfeng; Ma, Rong; Wu, Xiang; Lei, Jin; Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Head Trauma, Head Trauma Ctr,Dept Neurosurg,Renji Hosp, Shanghai 200127, Peoples R China; [Gao, Guoyi] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Neurosurg, Sch Med, Shanghai 200080, Peoples R China; [Tu, Yue] Beijing Chaoyang Integrat Med Emergency Med Ctr, Neurol Intens Care Unit, Beijing, Peoples R China; [Zhang, Weituo] Shanghai Jiao Tong Univ, Clin Res Inst, Sch Med, Shanghai, Peoples R China; [Zhong, Chunlong; Liu, Min] Tongji Univ, Shanghai East Hosp, Dept Neurosurg, Sch Med, Shanghai, Peoples R China; [Wang, Yuhai] Taihu Hosp, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China; [Long, Liansheng] South Taihu Hosp, Dept Neurosurg, Huzhou, Peoples R China; [Chen, Ligang; Jiang, Yong; Liu, Liang] Southwest Med Univ, Dept Neurosurg, Affiliated Hosp, Luzhou, Peoples R China; [Liu, Jinfang] Cent South Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Peoples R China; [Mou, Chaohui] Taizhou First Peoples Hosp, Dept Neurosurg, Taizhou, Zhejiang, Peoples R China; [Qiu, Binghui] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Peoples R China; [Huang, Xianjian; Jiang, Jiyao] Shenzhen Second Peoples Hosp, Dept Neurosurg, Shenzhen, Peoples R China; [Huang, Qibing] Shandong Univ, Dept Neurosurg, Qilu Hosp, Jinan, Peoples R China; [Zhang, Nu] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, Wenzhou, Peoples R China; [Yang, Xiaofeng; Jiang, Jiyao] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Emergency & Trauma Ctr, Hangzhou, Peoples R China; [Yang, Chaohua] Sichuan Univ, Dept Neurosurg, West China Hosp, Chengdu, Peoples R China; [Li, Lihong] Tangdu Hosp, Dept Neurosurg, Xian, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Head Trauma, Head Trauma Ctr,Dept Neurosurg,Renji Hosp, Shanghai 200127, Peoples R China.; Gao, GY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Neurosurg, Sch Med, Shanghai 200080, Peoples R China.	gao3@sina.com; jiyaojiang@126.com			Shanghai municipal government; Shanghai Jiao Tong University/School of Medicine	This research was supported by grants Shanghai municipal government and Shanghai Jiao Tong University/School of Medicine. The sponsor of the study had no role in the data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Andrews PJD, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22450; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; [Anonymous], 1897, PRINCIPLES TREATMENT; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chinese Congress of Neurological Surgeons CNEC, 2009, CHIN J NEUROSURG, V25, P100; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0009; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, P3, DOI 10.1089/ther.2010.1500; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Injury G.B.D.T.B., 2019, LANCET NEUROL, V18, P56; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JY, 2013, THER HYPOTHERMIA TEM, V3, P120, DOI 10.1089/ther.2013.0008; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Lei J, 2015, CONTEMP CLIN TRIALS, V40, P9, DOI 10.1016/j.cct.2014.11.008; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; TEASDALE G, 1974, LANCET, V2, P81; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zhi DS, 1999, SURG NEUROL, V52, P393, DOI 10.1016/S0090-3019(99)00101-9	30	1	1	8	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2589-5370		ECLINICALMEDICINE	EClinicalMedicine	FEB	2021	32								100732	10.1016/j.eclinm.2021.100732			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV5TC	WOS:000645894000023	33681741	gold, Green Published			2022-02-06	
J	Jarvis, LM; Peterson, MJ; Caves, KM				Jarvis, Leighanne M.; Peterson, Matthew J.; Caves, Kevin M.			Development, Validity, and Reliability of a Novel Walking Speed Measurement Device: the GaitBox	GAIT & POSTURE			English	Article						Walking speed; gait; technology; functional status; older adults		Background: Gait speed is an important measure of health status for older adults and individuals with neurological conditions. Literature reports that measurements made by people are not as accurate as automatic timers. Research question: Is the GaitBox (GB), a device to measure walking speed (WS) automatically and accurately, a valid approach to walking speed measurement in a clinical setting? Methods: Two prospective validation studies were completed comparing the GB to human timers (HT) and the Sprint Timing System (STS). Subjects were recruited from convenience samples of healthy older adults (S1, N = 35, 72.4 +/- 7.4 years of age) and individuals with Spinal Cord Injury (SCI), Traumatic Brain Injury (TBI), or unknown / no diagnosis (S2, N = 44, 35.3 +/- 13.5 years of age). Subjects completed 4 timed walks. The GB, HT, and STS simultaneously measured WS across a 4 m or 10 m course. Protocol followed an adapted version of the NIH Walk Test. Subjects were instructed to walk at a normal pace. Validity and reliability were determined using Pearson correlations, absolute mean differences, Intraclass Correlation Coefficients (ICC's) and Bland-Altman plots. Results: WS measured in both studies demonstrated strong correlations between GB and STS (r = 0.98-0.99, p < 0.0001), excellent test-retest reliability GB ICC's (0.93-0.94), no systematic bias, and good precision. In S1 and S2, ICC's between GB and STS were excellent at 0.91 and 0.93, respectively. Significance: Considering the increased use of WS as a clinically relevant measure of mobility, functional decline, and recovery, accurate measurement of WS are important. These studies show the GB is a valid and reliable measurement tool within various populations completing the 4 m and 10 m walk tests at a usual speed. Additional populations and walking distances should be evaluated further. Due to its accuracy, the GaitBox is a valid alternative to HT in the clinic setting.	[Jarvis, Leighanne M.; Caves, Kevin M.] Duke Univ, Dept Head & Neck Surg & Commun Sci, Durham, NC USA; [Peterson, Matthew J.] Campbell Univ, Dept Clin Res, Buies Creek, NC 27506 USA; [Peterson, Matthew J.] Duke Univ, Dept Med, Durham, NC USA; [Caves, Kevin M.] Duke Univ, Dept Med Adjunct, Durham, NC USA; [Caves, Kevin M.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Jarvis, LM; Caves, KM (corresponding author), DUMC 3887 200 Trent Dr RM 155, Durham, NC 27710 USA.	Leighanne.davis@duke.edu; kevin.caves@duke.edu			National Institute on Disability, Independent Living and Rehabilitation Research in the U.S. Department of Health and Human Services [90RE5028]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30AG028716]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institute on Disability, Independent Living and Rehabilitation Research in the U.S. Department of Health and Human Services [grant number 90RE5028]; and the National Institutes of Health [grant number P30AG028716].	[Anonymous], SPRINT SYSTEM; [Anonymous], MULTIPLE SCLEROSIS F; Bethoux F, 2018, GAIT POSTURE, V61, P393, DOI 10.1016/j.gaitpost.2018.01.033; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Clark RA, 2019, J SCI MED SPORT, V22, P212, DOI 10.1016/j.jsams.2018.07.005; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gershon, 2012, NIH TOOLBOX TECHNICA; Goldberg A, 2011, AGING CLIN EXP RES, V23, P406, DOI 10.1007/BF03325236; Goldman MD, 2013, NEUROLOGY, V81, P1856, DOI 10.1212/01.wnl.0000436065.97642.d2; Graham JE, 2008, ARCH PHYS MED REHAB, V89, P865, DOI 10.1016/j.apmr.2007.11.029; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Guralnik JG, SHORT PHYS PERFORMAN; Hardy SE, 2007, J AM GERIATR SOC, V55, P1727, DOI 10.1111/j.1532-5415.2007.01413.x; Karpman C, 2014, RESP CARE, V59, P531, DOI 10.4187/respcare.02688; Lusardi MM, 2012, TOP GERIATR REHABIL, V28, P67, DOI 10.1097/TGR.0b013e31824385a4; Maggio M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153583; Middleton A, 2015, J AGING PHYS ACTIV, V23, P314, DOI 10.1123/japa.2013-0236; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Peters DM, 2014, PHYSIOTHER THEOR PR, V30, P183, DOI 10.3109/09593985.2013.845805; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; van Silfhout L, 2017, NEUROREHAB NEURAL RE, V31, P842, DOI 10.1177/1545968317723751; Youdas JW, 2010, PM&R, V2, P537, DOI 10.1016/j.pmrj.2010.02.008	26	1	1	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2021	84						52	57		10.1016/j.gaitpost.2020.11.009			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	QL0QW	WOS:000620787200009	33271417				2022-02-06	
J	Jeong, HS; Ha, S; Jeong, DH; O'Sullivan, DM; Lee, SY				Jeong, Hee Seong; Ha, Sunghe; Jeong, Dae Hyoun; O'Sullivan, David Michael; Lee, Sae Yong			Injury and Illness in World Taekwondo Junior Athletes: An Epidemiological Study	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						adolescent; epidemiology; risk factor; injury surveillance; martial art		Taekwondo has been reported to be one of the most injurious sports in the summer Olympics, however, there is a dearth of data about injury profiles for junior athletes. Therefore, we aimed to identify the incidence and profiles of the injuries and illnesses that occurred during the 2018 World Taekwondo Junior Championships and recorded using an online system. Among the 889 athletes, 67 injuries and four illnesses were reported, corresponding to an overall clinical incidence of 7.5 injuries (95% confidence interval [CI]: 5.7-9.3) and 0.5 illnesses (0.1-0.9) per 100 athletes. The most frequent injuries were lower extremity injuries (n = 33, 3.71% of all athletes), mostly in the foot/toe (n = 11, 1.2% of athletes), followed by head and trunk injuries, mostly in the face (n = 14, 1.6% of athletes), and upper extremity injuries, mostly in the fingers (n = 6, 0.7% of athlete). Contusions (n = 37, 4.2% of athlete) were the most frequent injury type, followed by ligament ruptures/sprains and laceration. The most common injury mechanism was contact during an opponent attack (n = 51, 5.7% of athlete). Three mild concussions none resulted in time loss (none required hospital transfer or had prolonged recovery). The respiratory system was the most affected by illness, with pain and fever as symptoms. Environmental factors were the most common cause of illness. This study shows that 7.5 per 100 athletes (38.5/1000 athlete-exposures and 6.9/1000 min-exposures) had new or recurrent injuries, whereas 0.5 per 100 athletes experienced illness. In conclusion, the data shows male athletes reported more injuries than females and the most common cause of injury was due to contact between athletes. Contusions, ligament rupture/sprains, laceration and fractures to the lower extremities, head, and trunk were the most common injury. Knowing these injury profiles of junior taekwondo athletes can help taekwondo stakeholders, especially medical staff to prepare accordingly to ensure the safety of the athletes.	[Jeong, Hee Seong; Lee, Sae Yong] Yonsei Univ, Dept Phys Educ, Seoul 03722, South Korea; [Jeong, Hee Seong; Ha, Sunghe; Lee, Sae Yong] Int Olymp Comm Res Ctr Korea, Seoul 03722, South Korea; [Ha, Sunghe] Natl Rehabil Ctr, Dept Clin Res Rehabil, Seoul 01022, South Korea; [Jeong, Dae Hyoun] Southern Illinois Univ, Sch Med, Dept Family & Community Med, Springfield, IL 62702 USA; [O'Sullivan, David Michael] Pusan Natl Univ, Div Sports Sci, Busan 46241, South Korea; [Lee, Sae Yong] Yonsei Univ, Inst Convergence Sci, Seoul 03722, South Korea		Lee, SY (corresponding author), Yonsei Univ, Dept Phys Educ, Seoul 03722, South Korea.; Lee, SY (corresponding author), Int Olymp Comm Res Ctr Korea, Seoul 03722, South Korea.; O'Sullivan, DM (corresponding author), Pusan Natl Univ, Div Sports Sci, Busan 46241, South Korea.; Lee, SY (corresponding author), Yonsei Univ, Inst Convergence Sci, Seoul 03722, South Korea.	hsj@yonsei.ac.kr; hasunghe7@gmail.com; djeong@siumed.edu; davidosullivan@pusan.ac.kr; sylee1@yonsei.ac.kr		O'Sullivan, David Michael/0000-0001-8265-9260; Jeong, Hee Seong/0000-0001-8318-7322; Ha, Sunghe/0000-0002-7197-561X	Yonsei University	This work was supported by the Yonsei University Research Grant of 2020.	Beis K, 2001, EUR J SPORT TRAUMA R, V23, P130; Bromley SJ, 2018, BRIT J SPORT MED, V52, P8, DOI 10.1136/bjsports-2016-097313; Caine DJ, 2009, EPIDEMIOLOGY INJURY; Dick R, 2007, J ATHL TRAINING, V42, P173; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fife GP, 2018, J SPORT SCI, V36, P1461, DOI 10.1080/02640414.2017.1398406; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Jeong H.S., 2020, BR J SPORTS MED, V54, pA54; Jeong Hee Seong, 2020, [Journal of Sport and Leisure Studies, 한국사회체육학회지], V82, P433, DOI 10.51979/KSSLS.2020.10.82.433; Jeong HS, 2019, J SPORT SCI MED, V18, P376; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kazemi M, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-22; Kim J, 2011, J LEISURE RES, V43, P545, DOI 10.1080/00222216.2011.11950249; Kim U.Y., 1997, TAEKWONDO TXB, V766, P17; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Kong S, 2021, J MENS HEALTH, V17, P16, DOI 10.31083/jomh.v17i1.200; Lystad RP, 2015, BIOL SPORT, V32, P213, DOI 10.5604/20831862.1150303; Lystad RP, 2013, J SPORT MED PHYS FIT, V53, P655; Lystad RP, 2013, BRIT J SPORT MED, V47, P441, DOI 10.1136/bjsports-2012-091666; Royuela CM, 2016, SPORTIS, V2, P164, DOI 10.17979/sportis.2016.2.2.1423; O'Sullivan DM, 2017, J NEUROSURG-PEDIATR, V19, P662, DOI 10.3171/2017.1.PEDS16432; Ok Koh Jae, 2015, [Journal of Korean Physical Education Association for Girls and Women, 한국여성체육학회지], V29, P13; Park SU, 2020, J MENS HEALTH, V16, pE1, DOI 10.22374/jomh.v16i1.163; Peabody J.W.P., 1996, J SPORT MED PHYS FIT, V3643, P8; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; Soligard T, 2019, BRIT J SPORT MED, V53, P1085, DOI 10.1136/bjsports-2018-100236; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Son B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145143; Thomas RE, 2017, PHYSICIAN SPORTSMED, V45, P372, DOI 10.1080/00913847.2017.1369193; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; World Taekwnodo, WTF REINFORCES COMMI; World Taekwnodo, POSTMATCH INJURY SUR; World Taekwnodo, WORLD TAEKWONDO COMP; World Taekwondo, 2016, WT NEWS; World Taekwondo, WT NEWS; 최춘길, 2010, [The Korean Journal of Sport, 한국스포츠학회], V8, P31	37	1	1	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2021	18	4							2134	10.3390/ijerph18042134			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QP0KR	WOS:000623526900001	33671704	gold, Green Published			2022-02-06	
J	Kruse, DW; Nobe, AS; Billimek, J				Kruse, David William; Nobe, Andrew Seiji; Billimek, John			Injury incidence and characteristics for elite, male, artistic USA gymnastics competitions from 2008 to 2018	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						gymnastics; injuries; concussion; injury prevention	OLYMPIC GAMES; SPORTS INJURIES; SURVEILLANCE	Objectives To determine the injury incidence and characteristics for elite, male, artistic USA gymnasts during gymnastics competitions, held in the USA, from 2008 to 2018. Methods Injury documentation performed by lead physician and certified athletic trainers at elite junior and senior USA Gymnastics competitions from 2008 to 2018 were reviewed and compiled into an excel database. Injury incidence was computed per 1000 registered gymnasts by competition setting as well as injury location, type, cause, severity, and setting. Results From 2008 to 2018, 180 injuries were reported in a total of 2102 gymnasts with injury incidence of 85.6 per 1000 gymnasts (95% CI 73.4 to 97.8). The most common injury site was at the ankle (16.7 per 1000 gymnasts, 95% CI 10.9 to 22.4), and muscle strain/rupture/tear was the most common type of injury (28.5 per 1000 gymnasts, 95% CI 21.2 to 35.9). The most common cause was contact with surface (56.1 per 1000 gymnasts, 95% CI 46.1 to 66.2), and the event where most injuries were sustained was the vault (21.9 per 1000 gymnasts, 95% CI 15.4 to 28.4). Incidence of time loss injuries was 38.5 per 1000 gymnasts (95% CI 30.1 to 47.0). Injury incidence was higher during competition (58.5 per 1000 gymnasts, 95% CI 48.2 to 68.8) than during training (27.1 per 1000 RG, 95% CI 19.9 to 34.3; RR 2.16, 95% CI 1.59 to 2.94, p<0.001); injury incidence was greater at Olympic Trials (RR 3.23, 95% CI 1.24 to 8.47, p=0.017) than at National Qualifier meets. We report concussion incidence in gymnastics (5.7 per 1000 gymnasts, 95% CI 2.3 to 9.2). Conclusions This is the largest injury study to date for male artistic gymnasts (180 injuries, 2102 gymnasts, 11 years).	[Kruse, David William] Orthopaed Specialty Inst, Primary Care Sports Med, Irvine, CA USA; [Nobe, Andrew Seiji; Billimek, John] Univ Calif Irvine, Dept Family Med, Irvine, CA USA		Kruse, DW (corresponding author), Orthopaed Specialty Inst, Irvine, CA 92868 USA.	krusedw@gmail.com		Kruse, David/0000-0002-3573-451X	USA Gymnastics	We would like to acknowledge USA Gymnastics for their support and the medical professionals who have provided excellent care for these injured athletes across many competitions.	Altman D.G., 1990, PRACTICAL STAT MED R; Bahr R, 2020, BRIT J SPORT MED, V54, P372, DOI 10.1136/bjsports-2019-101969; CAINE D, 1989, AM J SPORT MED, V17, P811, DOI 10.1177/036354658901700616; Caine D, 2003, PHYS THER SPORT, V4, P10, DOI 10.1016/S1466-853X(02)00070-6; Caine D., 2006, SPORTS MED TRAINING, V16, P501, DOI [10. 1080/15438629509512053, DOI 10.1080/15438629509512053]; Campbell R, 2019, BRIT J SPORT MED, V53, P1056, DOI 10.1136/bjsports-2018-099547; Edouard P, 2018, BRIT J SPORT MED, V52, P475, DOI 10.1136/bjsports-2017-097972; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Finch C F, 1999, J Sci Med Sport, V2, P42, DOI 10.1016/S1440-2440(99)80183-2; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Hart E, 2018, CURR SPORT MED REP, V17, P366, DOI 10.1249/JSR.0000000000000536; Hecht SS, 2009, CURR SPORT MED REP, V8, P113, DOI 10.1249/JSR.0b013e3181a61993; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kerr ZY, 2015, J ATHL TRAINING, V50, P870, DOI 10.4085/1062-6050-50.7.02; Kolt GS, 2010, EPIDEMIOLOGY INJURY, P144; Kruse D, 2009, CURR SPORT MED REP, V8, P20, DOI 10.1249/JSR.0b013e3181967ca6; Sheskin D, 2004, HDB PARAMETRIC NONPA; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; The Nielsen Company, 2017, YEAR SPORTS MED REP; Timpka T, 2014, BRIT J SPORT MED, V48, P483, DOI 10.1136/bjsports-2013-093241; Westermann RW, 2015, SPORTS HEALTH, V7, P161, DOI 10.1177/1941738114559705	22	1	1	4	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2021	55	3					163	+		10.1136/bjsports-2019-101297			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PZ5PZ	WOS:000612793600010	33055133				2022-02-06	
J	Launey, Y; Asehnoune, K; Lasocki, S; Dahyot-Fizelier, C; Huet, O; Le Pabic, E; Malejac, B; Seguin, P				Launey, Yoann; Asehnoune, Karim; Lasocki, Sigismond; Dahyot-Fizelier, Claire; Huet, Olivier; Le Pabic, Estelle; Malejac, Bastien; Seguin, Philippe		AtlanRea Grp	Risk factors for ventilator-associated pneumonia due to Staphylococcus aureus in patients with severe brain injury: A multicentre retrospective cohort study	ANAESTHESIA CRITICAL CARE & PAIN MEDICINE			English	Article						Brain injury; Ventilator-Associated pneumonia; Staphylococcus aureus		Background: The present study aims at identifying the risk factors for ventilator-associated pneumonia (VAP) Staphylococcus aureus (S. aureus) in patients with severe brain injury (SBI). Methods: In this multicentre, retrospective, observational study, patients >= 18 year old who had SBI (Glasgow coma scale GCS score < 9) who received mechanical ventilation for at least 48 h were analysed. The main objective was to identify risk factors for S. aureus VAP vs VAP due to other pathogens and to identify risk factors for S. aureus VAP vs patients who did not experience VAP. Results: Eight hundred and forty-seven patients with SBI were admitted in ICU after severe traumatic brain injury (n = 489, 58%), aneurysmal SAH (n = 156, 18%), stroke (n = 27, 3%), spontaneous intracranial haemorrhage (n = 80, 9%), arteriovenous malformation rupture (n = 25, 3%), and other causes (n = 70, 8%). Three hundred fifty of 847 patients (41%) had VAP with S. aureus (n = 161) or other pathogens (n = 189). In patients with VAP, the multivariate analysis shows that age per 10 years of ageing (OR 0.80, 95% CI [0.70; 0.90]; p < 0.001) and tobacco use (OR 0.54, 95% CI [0.33; 0.88]; p = 0.014) were protective factors against S. aureus. Age per 10 years of ageing remained a protective factor against S. aureus VAP vs no VAP (OR 0.80, 95% CI [0.73; 0.89], p < 0.001). Conclusions: In this retrospective study involving patients with SBI and who experienced VAP, increased age and tobacco use were protective factors against VAP due to S. aureus. Increased age remained protective against S. aureus in VAP vs no VAP analysis. (C) 2020 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Launey, Yoann; Malejac, Bastien; Seguin, Philippe] CHU Rennes, Dept Anesthesie Reanimat, 2 Rue Henri Le Guilloux, F-35033 Rennes, France; [Asehnoune, Karim] CHU Nantes, Dept Anesthesie Reanimat, Nantes, France; [Lasocki, Sigismond] CHU Angers, Dept Anesthesie Reanimat, Angers, France; [Dahyot-Fizelier, Claire] CHU Poitiers, Dept Anesthesie Reanimat, Poitiers, France; [Huet, Olivier] CHU Brest, Dept Anesthesie Reanimat, Brest, France; [Le Pabic, Estelle] CHU Rennes, CIC Inserm 1414, Rennes, France		Seguin, P (corresponding author), CHU Rennes, Serv Reanimat Chirurg, Hop Pontchaillou, 2 Rue Henri Le Guilloux, F-35033 Rennes, France.	philippe.seguin@chu-rennes.fr	Seguin, Philippe/P-9487-2019	Seguin, Philippe/0000-0002-7774-4257			[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Asehnoune K, 2012, ANESTHESIOLOGY, V117, P411, DOI 10.1097/ALN.0b013e31825f018d; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Choi Chong Seng, 2006, Journal of Microbiology Immunology and Infection, V39, P458; Cinotti R, 2014, EUR J CLIN MICROBIOL, V33, P823, DOI 10.1007/s10096-013-2020-8; Damas P, 2015, CRIT CARE MED, V43, P22, DOI 10.1097/CCM.0000000000000674; Durmaz R, 2001, MICROBIOLOGICA, V24, P143; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Geeraerts T, 2018, ANAESTH CRIT CARE PA, V37, P171, DOI 10.1016/j.accpm.2017.12.001; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kasuya Y, 2011, J CRIT CARE, V26, P273, DOI 10.1016/j.jcrc.2010.09.006; Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049; Lefrant J-Y, 2014, Ann Fr Anesth Reanim, V33, P202, DOI 10.1016/j.annfar.2014.01.008; Leone M, 2018, ANAESTH CRIT CARE PA, V37, P625, DOI 10.1016/j.accpm.2018.10.011; Leone M, 2018, ANAESTH CRIT CARE PA, V37, P83, DOI 10.1016/j.accpm.2017.11.006; Martin C, 2019, ANAESTH CRIT CARE PA, V38, P549, DOI 10.1016/j.accpm.2019.02.017; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Rabinstein Alejandro A, 2009, Neurocrit Care, V10, P414, DOI 10.1007/s12028-009-9218-8; Reizine F, 2019, J CRIT CARE, V50, P221, DOI 10.1016/j.jcrc.2018.12.010; RELLO J, 1992, CHEST, V102, P525, DOI 10.1378/chest.102.2.525; RELLO J, 1990, AM REV RESPIR DIS, V142, P1320, DOI 10.1164/ajrccm/142.6_Pt_1.1320; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Sirvent JM, 2000, INTENS CARE MED, V26, P1369, DOI 10.1007/s001340000611; Sollid JUE, 2014, INFECT GENET EVOL, V21, P531, DOI 10.1016/j.meegid.2013.03.020; Steiner T, 2014, INT J STROKE, V9, P838, DOI 10.1111/ijs.12369; Toulouse E, 2018, ANAESTH CRIT CARE PA, V37, P607, DOI 10.1016/j.accpm.2018.10.013	28	1	1	4	6	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2352-5568			ANAESTH CRIT CARE PA	Anaesth. Crit. Care Pain Med.	FEB	2021	40	1							100785	10.1016/j.accpm.2020.01.012			6	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	RV1ET	WOS:000645581000007	33249176	Bronze			2022-02-06	
J	Liu, SN; Shi, CQ; Ma, XY; Zhao, BY; Chen, XP; Tao, LY				Liu, Sinan; Shi, Chaoqun; Ma, Xuying; Zhao, Bingyang; Chen, Xiping; Tao, Luyang			Cognitive deficits and rehabilitation mechanisms in mild traumatic brain injury patients revealed by EEG connectivity markers	CLINICAL NEUROPHYSIOLOGY			English	Article						Event-related potentials; Event-related oscillations; Functional connectivity; mTBI; Go/NoGo task; Neuropsychological assessment		Objective: To explore the multiple specific biomarkers and cognitive compensatory mechanisms of mild traumatic brain injury (mTBI) patients at recovery stage. Methods: The experiment was performed in two sections. In Section I, using event-related potential, event-related oscillation and spatial phase-synchronization, we explored neural dynamics in 24 volunteered healthy controls (HC) and 38 patients at least 6 months post-mTBI (19 with epidural hematoma, EDH; 19 with subdural hematoma, SDH) during a Go/NoGo task. In Section II, according to the neuropsychological scales, patients were divided into sub-groups to assess these electroencephalography (EEG) indicators in identifying different rehabilitation outcomes of mTBI. Results: In Section I, mean amplitudes of NoGo-P3 and P3d were decreased in mTBI patients relative to HC, and NoGo-theta power in the non-injured hemisphere was decreased in SDH patients only. In Section II, patients with chronic neuropsychological defects exhibited more serious impairments of intra-hemispheric connectivity, whereas inter-hemispheric centro-parietal and frontal connectivity were enhanced in response to lesions. Conclusions: EEG distinguished mTBI patients from healthy controls, and estimated different rehabilitation outcomes of mTBI. The centro-parietal and frontal connectivity are the main compensatory mechanism for the recovery of mTBI patients. Significance: EEG measurements and network connectivity can track recovery process and mechanism of mTBI. (c) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.	[Liu, Sinan; Shi, Chaoqun; Ma, Xuying; Zhao, Bingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Dept Forens Sci, Suzhou 215021, Peoples R China		Chen, XP; Tao, LY (corresponding author), Soochow Univ, Dept Forens Sci, Suzhou 215021, Peoples R China.	xipingchen@suda.edu.cn; taoluyang@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81871536, 81971800]; Priority Academic Program Development of Jiangsu Higher Education Institutes (PAPD), China	This study was supported by grants 81530062, 81871536 and 81971800 from the National Natural Science Foundation of China. We also appreciate the support from the Priority Academic Program Development of Jiangsu Higher Education Institutes (PAPD), China.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Alexander MP, 2007, NEUROLOGY, V68, P1515, DOI 10.1212/01.wnl.0000261482.99569.fb; Allen C, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171369; Amoruso L, 2018, NEUROIMAGE, V177, P68, DOI 10.1016/j.neuroimage.2018.05.020; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Asanowicz D, 2012, BRAIN COGNITION, V79, P117, DOI 10.1016/j.bandc.2012.02.014; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bigler ED, 2015, BRAIN NEUROTRAUMA; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bush ALH, 2015, EAR HEARING, V36, P395, DOI 10.1097/AUD.0000000000000142; Candrian G, 2018, ANN PHYS REHABIL MED, V61, P18, DOI 10.1016/j.rehab.2017.07.246; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; D'Souza MM, 2020, Neuroradiol J, P186; Daviaux Y, 2016, NEUROSCIENCE, V339, P32, DOI 10.1016/j.neuroscience.2016.09.033; del Rio M, 2018, NEUROIMAGE, V176, P277, DOI 10.1016/j.neuroimage.2018.04.041; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Russo F, 2016, NEUROIMAGE, V126, P1, DOI 10.1016/j.neuroimage.2015.11.036; Diez I, 2017, NETW NEUROSCI, V1, P116, DOI [10.1162/NETN_a_00007, 10.1162/netn_a_00007]; Dodge Y, 2008, CONCISE ENCY STAT; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gao X, 2014, INT J PSYCHOPHYSIOL, V94, P399, DOI 10.1016/j.ijpsycho.2014.10.010; Gosselin A, 2019, INT J PSYCHOPHYSIOL, V141, P18, DOI 10.1016/j.ijpsycho.2019.04.007; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Harmony T, 2009, INT J PSYCHOPHYSIOL, V71, P9, DOI 10.1016/j.ijpsycho.2008.07.020; Hinkelmann K, 2015, NEUROBIOL AGING, V36, P919, DOI 10.1016/j.neurobiolaging.2014.09.008; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Kaltiainen H, 2018, BRAIN TOPOGR, V31, P1037, DOI 10.1007/s10548-018-0667-2; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Lewine JD, 2019, J CLIN NEUROPHYSIOL, V36, P298, DOI 10.1097/WNP.0000000000000588; Lin MY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00386; Longatti PL, 2004, STROKE, V35, pE35, DOI 10.1161/01.STR.0000113736.73632.F6; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; MOHR G, 1983, J NEUROSURG, V58, P482, DOI 10.3171/jns.1983.58.4.0482; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Osborn AG, 2009, DIAGNOSTIC IMAGING B, V2nd; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Rincon S, 2016, HAND CLINIC, V135, P447, DOI 10.1016/B978-0-444-53485-9.00022-2; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Rodrigo AH, 2014, NEUROIMAGE, V85, P423, DOI 10.1016/j.neuroimage.2013.01.059; Rommel AS, 2017, J AM ACAD CHILD PSY, V56, P40, DOI 10.1016/j.jaac.2016.10.006; Rose E, 2009, RES DEV DISABIL, V30, P496, DOI 10.1016/j.ridd.2008.07.009; Schiller B, 2014, CEREB CORTEX, V24, P2430, DOI 10.1093/cercor/bht095; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Soldatovic-Stajic B, 2014, EUR REV MED PHARMACO, V18, P1632; Stephan KE, 2008, NEUROIMAGE, V42, P1, DOI 10.1016/j.neuroimage.2008.04.167; Tenke CE, 2011, BIOL PSYCHIAT, V70, P388, DOI 10.1016/j.biopsych.2011.02.016; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wang BA, 2017, NEUROIMAGE, V159, P248, DOI 10.1016/j.neuroimage.2017.07.054; Wang P, 2019, NEUROIMAGE, V196, P114, DOI 10.1016/j.neuroimage.2019.04.001; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI DOI 10.1089/neu.2014.3492; Wang XQ, 2011, EPILEPSY BEHAV, V20, P471, DOI 10.1016/j.yebeh.2010.12.039; Yamanaka K, 2010, J COGNITIVE NEUROSCI, V22, P714, DOI 10.1162/jocn.2009.21258; Yin SF, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00017; Zhao WX, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.966	71	1	1	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	2021	132	2					554	567		10.1016/j.clinph.2020.11.034			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QG4GZ	WOS:000617547100028	33453686				2022-02-06	
J	Mackelprang, JL; Clifasefi, SL; Grazioli, VS; Collins, SE				Mackelprang, Jessica L.; Clifasefi, Seema L.; Grazioli, Veronique S.; Collins, Susan E.			Content Analysis of Health Concerns among Housing First Residents with a History of Alcohol Use Disorder	JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED			English	Article						Homelessness; Housing First; healthcare; alcohol use disorder; injury; health	TRAUMATIC BRAIN-INJURY; CHRONICALLY HOMELESS INDIVIDUALS; RANDOMIZED CONTROLLED-TRIAL; PALLIATIVE CARE; HARM REDUCTION; EXPERIENCING HOMELESSNESS; MANAGEMENT PROGRAM; MENTAL-ILLNESS; YOUNG-ADULTS; PEOPLE	Previous research has utilized survey and administrative data to document health problems among Housing First (HF) residents; however, little is known about residents' personal perspectives on their health. The purpose of this study was to utilize conventional content analysis to analyze health-related concerns among HF residents with histories of alcohol use disorder. Between June and December 2013, we interviewed 44 adults who had histories of chronic homelessness and alcohol use disorder and were residing in single-site HF in Seattle, Washington. Responses centered on five primary topics: alcohol-related harm, perceived health vulnerability, concern for fellow residents' health, end of life, and health and safety promotion. HF residents experience complex alcohol-exacerbated health difficulties and existing health services may not meet the needs of those whose health is particularly compromised. Considering that HF facilitates aging in place, end-of-life care and grief counseling should be integrated into HF services.	[Mackelprang, Jessica L.] Swinburne Univ Technol, Dept Psychol Sci, Sch Hlth Sci, 401-451 Burwood Rd, Melbourne, Vic 3122, Australia; [Clifasefi, Seema L.; Collins, Susan E.] Univ Washington, Harm Reduct Res & Treatment Ctr, Harborview Med Ctr, Psychiat & Behav Sci, Seattle, WA 98195 USA; [Grazioli, Veronique S.] Lausanne Univ, Dept Vulnerabil & Social Med, Ctr Primary Care & Publ Hlth, Chair Med Vulnerable Populat, Lausanne, Switzerland; [Collins, Susan E.] Washington State Univ, Pullman, WA 99164 USA		Mackelprang, JL (corresponding author), Swinburne Univ Technol, Dept Psychol Sci, Sch Hlth Sci, 401-451 Burwood Rd, Melbourne, Vic 3122, Australia.	jmackelprang@swin.edu.au	Mackelprang, Jessica L./AAT-4283-2021	Mackelprang, Jessica L./0000-0001-9135-7811	National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R34AA022077, K01AA021147]	is research was supported by grants from the National Institute on Alcohol Abuse and Alcoholism to Susan E. Collins (R34AA022077) and Seema L. Clifasefi (K01AA021147). We appreciate Nicole Torres for her assistance in the initial coding of study data. We also express our gratitude to the community members who shared their experiences and ideas for program enhancement as part of this project.	All Home, 2019, SEATTL KING COUNT PO; Aubry T, 2015, CAN J PSYCHIAT, V60, P467, DOI 10.1177/070674371506001102; Baggett TP, 2015, AM J PUBLIC HEALTH, V105, P1189, DOI 10.2105/AJPH.2014.302248; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Bird M, 2017, J SOC DISTRESS HOMEL, V26, P9, DOI 10.1080/10530789.2016.1274570; Brown RT, 2013, J HEALTH CARE POOR U, V24, P456, DOI 10.1353/hpu.2013.0077; Charmaz K., 2014, BROKERAGE CLOSURE IN; Clifasefi SL, 2020, J COMMUNITY PSYCHOL, V48, P763, DOI 10.1002/jcop.22291; Clifasefi SL, 2016, J COMMUNITY PSYCHOL, V44, P845, DOI 10.1002/jcop.21812; Clifasefi SL, 2013, INT J DRUG POLICY, V24, P291, DOI 10.1016/j.drugpo.2012.10.002; Collins CC, 2019, CHILD YOUTH SERV REV, V96, P34, DOI 10.1016/j.childyouth.2018.11.025; Collins S. E., 2011, HARM REDUCTION PRAGM, V2nd; Collins SE, 2019, INT J DRUG POLICY, V67, P24, DOI 10.1016/j.drugpo.2019.01.002; Collins SE, 2018, SUBST USE MISUSE, V53, P16, DOI 10.1080/10826084.2017.1322406; Collins SE, 2016, INT J DRUG POLICY, V27, P89, DOI 10.1016/j.drugpo.2015.08.003; Collins SE, 2015, SUBST ABUS, V36, P21, DOI 10.1080/08897077.2014.904838; Collins SE, 2013, AM J PUBLIC HEALTH, V103, pS269, DOI 10.2105/AJPH.2013.301312; Collins SE, 2012, INT J DRUG POLICY, V23, P111, DOI 10.1016/j.drugpo.2011.07.010; Collins SE, 2012, AM J PUBLIC HEALTH, V102, P511, DOI 10.2105/AJPH.2011.300403; Ehlers CL, 2013, DRUG ALCOHOL DEPEN, V133, P180, DOI 10.1016/j.drugalcdep.2013.05.011; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Golembiewski Elizabeth, 2017, Soc Sci (Basel), V6, DOI 10.3390/socsci6030096; Goodman A, 2017, SOC SCI MED, V178, P87, DOI 10.1016/j.socscimed.2017.01.053; Grazioli VS, 2017, INT J DRUG POLICY, V41, P65, DOI 10.1016/j.drugpo.2016.12.015; Grazioli VS, 2015, INT J DRUG POLICY, V26, P468, DOI 10.1016/j.drugpo.2014.10.009; Grenier A, 2016, CAN J AGING, V35, P28, DOI 10.1017/S0714980815000616; Henry M, 2019, 2019 ANN HOMELESS AS; Henwood BF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2552-1; Holmes A, 2017, AUSTRALAS PSYCHIATRY, V25, P56, DOI 10.1177/1039856216669916; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 2009, J URBAN HEALTH, V86, P791, DOI 10.1007/s11524-009-9388-x; Inouye SK, 2013, JAMA-J AM MED ASSOC, V309, P451, DOI 10.1001/jama.2012.214089; Kertesz SG, 2009, MILBANK Q, V87, P495, DOI 10.1111/j.1468-0009.2009.00565.x; Kirst M, 2015, DRUG ALCOHOL DEPEN, V146, P24, DOI 10.1016/j.drugalcdep.2014.10.019; Klop HT, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0320-6; Koopmans GT, 2007, SOC SCI MED, V64, P1216, DOI 10.1016/j.socscimed.2006.11.018; Krakowsky Y, 2013, AM J HOSP PALLIAT ME, V30, P268, DOI 10.1177/1049909112448925; Kushel MB, 2003, ARCH INTERN MED, V163, P2492, DOI 10.1001/archinte.163.20.2492; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Ly A, 2015, CAN J PSYCHIAT, V60, P475, DOI 10.1177/070674371506001103; Mackelprang JL, 2014, PREHOSP EMERG CARE, V18, P476, DOI 10.3109/10903127.2014.916020; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; MacKenzie M, 2019, J AM BOARD FAM MED, V32, P847, DOI 10.3122/jabfm.2019.06.190066; Malone DK, 2015, HOUS CARE SUPPORT, V18, P62, DOI 10.1108/HCS-05-2015-0007; Matthews S., 2019, STIGMA ADDICTION; Matthews S, 2017, J BIOETHIC INQ, V14, P275, DOI 10.1007/s11673-017-9784-y; McNeil R, 2013, MED EDUC, V47, P485, DOI 10.1111/medu.12132; McNeil R, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-14; McNeil R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-312; Milby JB, 2010, AM J PUBLIC HEALTH, V100, P913, DOI 10.2105/AJPH.2008.152975; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Nelson G, 2015, PSYCHIAT SERV, V66, P592, DOI 10.1176/appi.ps.201400201; Nikoo M, 2017, J HEAD TRAUMA REHAB, V32, pE19, DOI 10.1097/HTR.0000000000000262; Office of Community Planning and Development, 2007, DEF CHRON HOM TECHN; Padgett DK, 2020, GERONTOLOGIST, V60, P60, DOI 10.1093/geront/gnz040; Padgett DK, 2015, HOUSING 1 ENDING HOM, DOI [10.1093/acprof:oso/9780199989805.001.0001, DOI 10.1093/ACPROF:OSO/9780199989805.001.0001]; Parsell C, 2015, HOUSING STUD, V30, P1189, DOI 10.1080/02673037.2015.1009874; Podymow T, 2006, PALLIATIVE MED, V20, P81, DOI 10.1191/0269216306pm1103oa; Russolillo A, 2014, INT J HOUS POLICY, V14, P79, DOI 10.1080/14616718.2014.884881; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Solar O., 2010, WHO DOCUMENT PR; Somers JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168745; Song J, 2007, J GEN INTERN MED, V22, P435, DOI 10.1007/s11606-006-0046-7; Stergiopoulos V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3768-4; Topolovec-Vranic J, 2017, J PSYCHIATR RES, V87, P53, DOI 10.1016/j.jpsychires.2016.12.004; Tsemberis S., 2010, HOUSING 1 PATHWAYS M, DOI [10.1108/HCS-05-2015-0007, DOI 10.1108/HCS-05-2015-0007]; Urbanoski K, 2018, ADDICTION, V113, P137, DOI 10.1111/add.13928; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Wenzel SL, 2018, AM J COMMUN PSYCHOL, V61, P421, DOI 10.1002/ajcp.12237; Whittaker E, 2017, AUST NZ J PUBL HEAL, V41, P306, DOI 10.1111/1753-6405.12631	73	1	1	1	5	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	1049-2089	1548-6869		J HEALTH CARE POOR U	J. Health Care Poor Underserved	FEB	2021	32	1					463	486					24	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	QR5ZQ	WOS:000625296600036	33678708				2022-02-06	
J	Macks, C; Jeong, D; Lee, JS				Macks, Christian; Jeong, DaUn; Lee, Jeoung Soo			Local delivery of RhoA siRNA by PgP nanocarrier reduces inflammatory response and improves neuronal cell survival in a rat TBI model	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						Traumatic brain injury; Neuroinflammation; Secondary injury; RhoA; RNA interference (RNAi); PgP nanocarrier	TRAUMATIC BRAIN-INJURY; CHONDROITIN SULFATE PROTEOGLYCANS; KINASE INHIBITOR; GENE-THERAPY; ROCK; ASTROCYTES; EXPRESSION; FASUDIL; NEURODEGENERATION; DEGENERATION	Traumatic brain injury (TBI) is a leading cause of death and disability with complex pathophysiology including prolonged neuroinflammation, apoptosis, and glial scar formation. The upregulation of RhoA is a key factor in the pathological development of secondary injury following TBI. Previously, we developed a novel cationic, amphiphilic copolymer, poly (lactide-co-glycolide)-graftpolyethylenimine (PgP), as a nanocarrier for delivery of therapeutic nucleic acids. In a rat compression spinal cord injury model, delivery of siRNA targeting RhoA (siRhoA) by PgP resulted in RhoA knockdown; reduced astrogliosis and inflammation; and promoted axonal regeneration/sparing. Here, we evaluated the effect of RhoA knockdown by PgP/siRhoA nanoplexes in a rat controlled cortical impact TBI model. A single intraparenchymal injection of PgP/siRhoA nanoplexes significantly reduced RhoA expression, lesion volume, neuroinflammation, and apoptosis, and increased neuronal survival in the ipsilateral cortex. These results suggest that PgP/siRhoA nanoplexes can efficiently knockdown RhoA expression in the injured brain and reduce secondary injury. (c) 2020 Published by Elsevier Inc.	[Macks, Christian; Jeong, DaUn; Lee, Jeoung Soo] Clemson Univ, Dept Bioengn, 301 Rhodes Res Ctr, Clemson, SC 29634 USA		Lee, JS (corresponding author), Clemson Univ, Dept Bioengn, 301 Rhodes Res Ctr, Clemson, SC 29634 USA.	cmacks@g.clemson.edu; daun7014@gmail.com; ljspia@clemson.edu			National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P20GM10344407]; National Institute of Neurological Disorders and Strokes (NINDS) of the NIH [R01 NS111037025]	This work was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [grant number 5P20GM10344407] and partly supported by the National Institute of Neurological Disorders and Strokes (NINDS) of the NIH [grant number R01 NS111037025] .	Abeysinghe HCS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030288; Ahmad K, 2017, J INTENSIVE CRIT CAR, V3, P1; Alabed YZ, 2006, J NEUROCHEM, V96, P1616, DOI 10.1111/j.1471-4159.2006.03670.x; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Bye N, 2016, EXP NEUROL, V279, P86, DOI 10.1016/j.expneurol.2016.02.012; Chan CCM, 2007, GLIA, V55, P369, DOI 10.1002/glia.20466; Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011; Clark DA, 2020, NEW ZEAL J AGR RES, V63, P505, DOI 10.1080/00288233.2019.1577276; Costa-Mattioli M, 2017, SCI REP-UK, P1; Donovan FM, 1997, J NEUROSCI, V17, P5316; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fujimura M, 2011, TOXICOL APPL PHARM, V250, P1, DOI 10.1016/j.taap.2010.09.011; Gherardini L, 2014, CELL MOL LIFE SCI, V71, P1, DOI 10.1007/s00018-013-1310-8; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Gutekunst CA, 2016, NEUROSCIENCE, V339, P308, DOI 10.1016/j.neuroscience.2016.10.022; Gwak SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10982-y; Gwak SJ, 2017, BIOMATERIALS, V121, P155, DOI 10.1016/j.biomaterials.2017.01.003; Gwak SJ, 2016, ACTA BIOMATER, V35, P98, DOI 10.1016/j.actbio.2016.02.013; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kesherwani V, 2014, NEUROSCI LETT, V576, P45, DOI 10.1016/j.neulet.2014.05.053; Kim ID, 2012, MOL THER, V20, P829, DOI 10.1038/mt.2011.291; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; Lau CL, 2011, BRIT J PHARMACOL, V163, P533, DOI 10.1111/j.1476-5381.2011.01259.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macks C, 2018, J NEUROTRAUM, V11, P1; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; McKerracher L, 2012, INT REV NEUROBIOL, V105, P117, DOI 10.1016/B978-0-12-398309-1.00007-X; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Mulherkar S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010245; Otsuka S, 2011, J NEUROTRAUM, V28, P1063, DOI 10.1089/neu.2010.1568; Park HJ, 2013, J NEUROSCI METH, V213, P76, DOI 10.1016/j.jneumeth.2012.12.010; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Perez-Martinez FC, 2012, J ALZHEIMERS DIS, V31, P697, DOI 10.3233/JAD-2012-120661; Raad M, 2012, ELECTROPHORESIS, V33, P3659, DOI 10.1002/elps.201200470; Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Roser AE, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00094; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Scheiblich H, 2017, CELL MOL NEUROBIOL, V37, P461, DOI 10.1007/s10571-016-0379-7; Schonfeld LM, 2017, J NEUROTRAUM, V34, P505, DOI 10.1089/neu.2016.4440; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Sheikh AM, 2009, GLIA, V57, P898, DOI 10.1002/glia.20815; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sun HW, 2007, WORLD J GASTROENTERO, V13, P3517, DOI 10.3748/wjg.v13.i25.3517; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tonges L, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00039; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; Wang JF, 2016, INVEST OPHTH VIS SCI, V57, P3892, DOI 10.1167/iovs.16-19447; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yu JL, 2016, J MOL NEUROSCI, V58, P74, DOI 10.1007/s12031-015-0691-6	59	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	FEB	2021	32								102343	10.1016/j.nano.2020.102343			12	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Research & Experimental Medicine	SM6NF	WOS:000657718900003	33259960	Green Accepted			2022-02-06	
J	McArdle, D; DeMartini, A; Kim, S; Connaughton, D				McArdle, David; DeMartini, Anne; Kim, Sungwon; Connaughton, Daniel			'IT ISN'T MY AREA'. COACHES' AWARENESS OF CONCUSSION PROTOCOLS IN SCOTTISH YOUTH FOOTBALL	SCOTTISH AFFAIRS			English	Article						concussion; girls' football; coaches; interviews; Scotland	CONSENSUS STATEMENT; SPORT	This paper discusses an externally-funded project into Scottish coaches' awareness of the sports concussion prevention initiative, If in Doubt, Sit Them Out. It explores the short-term risks of concussion to youth participants in particular before analysing the data from interviews with ten coaches of girls' football. The coaches' apparent lack of awareness of the policy are highlighted and the possibility that the different resources in girls' and boys' football, and between girls' performance and girls' recreational participation, might impact on injury recognition and treatment, are explored. The paper highlights the need for further research into those areas, and the need to immediately address the apparently low levels of awareness of If in Doubt. With that in mind, proposals for both immediate and longer-term reform for its dissemination are introduced.	[McArdle, David] Stirling Univ, Law Sch, Stirling, Scotland; [DeMartini, Anne] Flagler Coll, Sport Management, St Augustine, FL USA; [Kim, Sungwon] St Johns Univ, Sport Management, New York, NY USA; [Connaughton, Daniel] Univ Florida, Sport Management, Gainesville, FL USA		McArdle, D (corresponding author), Stirling Univ, Law Sch, Stirling, Scotland.				Royal Society of Edinburgh Arts and Humanities Small Grant Award	This research was funded by a Royal Society of Edinburgh Arts and Humanities Small Grant Award. We would like to thank the funders, the grant referees and the reviewers of this paper. Special thanks, of course, to the interviewees.	Allen J. B., 2014, Managing Leisure, V19, P36, DOI 10.1080/13606719.2013.849502; [Anonymous], INTRO YOUTH ADULT CO; [Anonymous], 2020, INTRO CHILDRENS COAC; [Anonymous], 2017, BBC; [Anonymous], CLUB ACAD SCOTLAND; [Anonymous], 2020, SCOTTISH FA HEADING; [Anonymous], CONTINUING COACH DEV; [Anonymous], 1 AID; [Anonymous], CHILD WELLBEING; [Anonymous], 2018, CONCUSSION MANAGEMEN; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Auld Christopher, 2006, WORKING VOLUNTEERS S; Bey T, 2009, WEST J EMERG MED, V10, P6; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; DeMartini AL, 2021, INT J SPORTS SCI COA, V16, P554, DOI 10.1177/1747954120981197; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; FIFA, 2020, 5 SUBST OPT TEMP ALL; Findlay-King L, 2018, MANAG SPORT LEIS, V23, P277, DOI 10.1080/23750472.2018.1550369; Hampden Sports Clinic Sports, CONCUSSION; Hart Simon, 2015, INDEPENDENT; Kim S, 2017, J LEG ASP SPORT, V27, P162, DOI [10.1123/jlas. 2016-0007, DOI 10.1123/JLAS.2016-0007]; Kim S, 2021, J ADOLESCENT HEALTH, V68, P184, DOI 10.1016/j.jadohealth.2020.04.029; Macrae EHR, 2017, J SPORT MANAGE, V31, P15, DOI 10.1123/jsm.2016-0089; May T., 2020, STATPEARLS; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P1557, DOI 10.1136/bjsports-2017-098065; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Murrie Ewan, 2016, BBC NEWS; Rieger B, 2018, CUREUS, V10, DOI 10.7759/cureus.2268; Rowe N.F., 2019, SPORTS PARTICIPATION; Saldana J, 2016, CODING MANUAL QUALIT, V3rd; SHAW S, 2009, SPORT MANAGEMENT Q, V12, P26; Shedden Sam, 2020, SCOTSMAN; Slater Matt, 2015, BBC NEWS; Spindler G, 1992, HDB QUALITATIVE RES; SportScotland, 2005, MAK WOM GIRLS MOR AC; SportScotland, 2018, DOUBT SIT THEM OUT; Wigmore Tim, 2018, TELEGRAPH	39	1	1	2	3	EDINBURGH UNIV PRESS	EDINBURGH	THE TUN-HOLYROOD RD, 12 2F JACKSONS ENTRY, EDINBURGH EH8 8PJ, SCOTLAND	0966-0356	2053-888X		SCOTT AFF	Scott. Aff.	FEB	2021	30	1					53	73		10.3366/scot.2021.0352			21	Political Science	Emerging Sources Citation Index (ESCI)	Government & Law	QH2SG	WOS:000618126800003		Green Accepted			2022-02-06	
J	McIntyre, M; Amiri, M; Kumbhare, D				McIntyre, McKyla; Amiri, Mohammadreza; Kumbhare, Dinesh			Postconcussion Syndrome A Diagnosis of Past Diagnostic and Statistical Manual of Mental Disorders	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Postconcussion; DSM-IV; DSM-V		After concussion, a subset of patients have persistent symptoms that are functionally limiting and may be difficult to treat. These symptoms were previously captured in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) under the diagnosis of "Post-Concussion Syndrome." However, in the recently published fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, postconcussion syndrome has been eliminated. The elimination of "Post-Concussion Syndrome" moves the Diagnostic and Statistical Manual of Mental Disorders further away from congruence with the International Classification of Diseases (ICD-10) with respect to the classification of postconcussion symptomology. Although this change likely had the positive effect of reducing misdiagnoses of symptoms due to other causes, the authors highlight the potential issues surrounding the elimination of postconcussion syndrome in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This opinion piece also emphasizes the multiple diagnostic and therapeutic challenges that may result for those involved in the treatment of, or research regarding, concussion patients with persistent symptoms. Future revisions that provide clear clinical diagnostic criteria may be beneficial.	[McIntyre, McKyla; Amiri, Mohammadreza; Kumbhare, Dinesh] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Kumbhare, Dinesh] Univ Toronto, Dept Med, Div Phys Med & Rehabil, Toronto, ON, Canada		Kumbhare, D (corresponding author), 550 Univ Ave,Suite 7-131, Toronto, ON M5G 2A2, Canada.	Mckyla.mcintyre@uhn.ca; mohammadreza.amiri@uhn.ca; dinesh.kumbhare@uhn.ca	Amiri, Reza/C-3825-2013	Amiri, Reza/0000-0001-8579-8055; McIntyre, McKyla/0000-0002-8317-3200			American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Hon KL, 2019, SEMIN PEDIATR NEUROL, V30, P117, DOI 10.1016/j.spen.2019.03.017; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086	11	1	1	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2021	100	2					193	195		10.1097/PHM.0000000000001586			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	PR7XF	WOS:000607446300020	32889864				2022-02-06	
J	Mi, ZP; Liu, H; Rose, ME; Ma, XC; Reay, DP; Ma, J; Henchir, J; Dixon, CE; Graham, SH				Mi, Zhiping; Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Reay, Daniel P.; Ma, Jie; Henchir, Jeremy; Dixon, C. Edward; Graham, Steven H.			Abolishing UCHL1's hydrolase activity exacerbates TBI-induced axonal injury and neuronal death in mice	EXPERIMENTAL NEUROLOGY			English	Article						Ubiquitin carboxy terminal hydrolase L1; Traumatic brain injury; Ubiquitin proteasome pathway; Aging; Neurodegeneration; Axonal injury	TRAUMATIC BRAIN-INJURY; UBIQUITIN PROTEASOME SYSTEM; TERMINAL HYDROLASE; AUTOPHAGY; PROTEIN; UCH-L1; MODEL; L1; DEGRADATION; DELETION	Ubiquitin (Ub) C-terminal hydrolase L1 (UCHL1) is a multifunctional protein that is expressed in neurons throughout brain at high levels. UCHL1 deletion is associated with axonal degeneration, progressive sensory motor ataxia, and premature death in mice. UCHL1 has been hypothesized to play a role in the pathogenesis of neurodegenerative diseases and recovery after neuronal injury. UCHL1 hydrolyzes Ub from polyubiquitinated (poly-Ub) proteins, but also may ligate Ub to select neuronal proteins, and interact with cytoskeletal proteins. These and other mechanisms have been hypothesized to underlie UCHL1's role in neurodegeneration and response to brain injury. A UCHL1 knockin mouse containing a C90A mutation (C90A) devoid of hydrolase activity was constructed. The C90A mouse did not develop the sensory and motor deficits, degeneration of the gracile nucleus and tract, or premature death as seen in UCHL1 deficient mice. C90A and wild type (WT) mice were subjected to the controlled cortical impact (CCI) model of traumatic brain injury (TBI), and cell death, axonal injury and behavioral outcome were assessed. C90A mice exhibited decreased spared tissue volume, greater loss of CA1 hippocampal neurons and greater axonal injury as detected using anti-amyloid precursor protein (APP) antibody and anti-non-phosphorylated neurofilament H (SMI-32) antibody immunohistochemistry after CCI compared to WT controls. Poly-Ub proteins and Beclin-1 were elevated after CCI in C90A mice compared to WT controls. Vestibular motor deficits assessed using the beam balance test resolved by day 5 after CCI in WT mice but not in C90A mice. These results suggest that the hydrolase activity of UCHL1 does not account for the progressive neurodegeneration and premature death seen in mice that do not express full length UCHL1. The hydrolase activity of UCHL1 contributes to the function of the ubiquitin proteasome pathway (UPP), ameliorates activation of autophagy, and improves motor recovery after CCI. Thus, UCHL1 hydrolase activity plays an important role in acute injury response after TBI.	[Mi, Zhiping; Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Reay, Daniel P.; Ma, Jie; Henchir, Jeremy; Dixon, C. Edward; Graham, Steven H.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Res Off Bldg 30,Mail Code 151 Univ Dr, Pittsburgh, PA 15240 USA; [Mi, Zhiping; Liu, Hao; Rose, Marie E.; Reay, Daniel P.; Ma, Jie; Graham, Steven H.] Univ Pittsburgh, Dept Neurosurg, Sch Med, Pittsburgh, PA 15216 USA; [Ma, Xiecheng; Henchir, Jeremy; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15216 USA; [Ma, Xiecheng; Henchir, Jeremy; Dixon, C. Edward] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15216 USA		Graham, SH (corresponding author), VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Res Off Bldg 30,Mail Code 151 Univ Dr, Pittsburgh, PA 15240 USA.	Steven.Graham@va.gov			National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant [R01NS102195]	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke Grant R01NS102195 (to S.H.G. and C.E.D.).	Bett JS, 2015, BIOCHEM J, V466, P489, DOI 10.1042/BJ20141349; Bheda A, 2010, CELL CYCLE, V9, P980, DOI 10.4161/cc.9.5.10934; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Cai F, 2010, NEUROSCIENCE, V169, P1520, DOI 10.1016/j.neuroscience.2010.06.032; Cao GD, 2002, J NEUROSCI, V22, P5423; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Costes S, 2014, AUTOPHAGY, V10, P1004, DOI 10.4161/auto.28478; Coulombe J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00129; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dong CH, 2014, J NEUROSCI, V34, P3171, DOI 10.1523/JNEUROSCI.3291-13.2014; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feldmann LK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123048; Goldberg MP, 2003, STROKE, V34, P330, DOI 10.1161/01.STR.0000054048.22626.B9; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gubellini P, 1997, NEUROCHEM RES, V22, P93, DOI 10.1023/A:1027389623767; Huang QA, 2010, APOPTOSIS, V15, P1292, DOI 10.1007/s10495-010-0466-z; Kabuta T, 2008, AUTOPHAGY, V4, P827, DOI 10.4161/auto.6560; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Liu H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.323; Liu H, 2019, P NATL ACAD SCI USA, V116, P4643, DOI 10.1073/pnas.1821282116; Liu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178049; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Reinicke AT, 2019, P NATL ACAD SCI USA, V116, P7963, DOI 10.1073/pnas.1812413116; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Sakurai M, 2008, EUR J NEUROSCI, V27, P691, DOI 10.1111/j.1460-9568.2008.06047.x; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Vannucci SJ, 1998, J CEREBR BLOOD F MET, V18, P376, DOI 10.1097/00004647-199804000-00005; Walters BJ, 2008, MOL CELL NEUROSCI, V39, P539, DOI 10.1016/j.mcn.2008.07.028; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; YAMAZAKI K, 1988, P SOC EXP BIOL MED, V187, P209; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Zhang MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep07298	47	1	1	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2021	336								113524	10.1016/j.expneurol.2020.113524			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PS7NL	WOS:000608112900003	33159930				2022-02-06	
J	Monaco, MR; Brewer, BW; Van Raalte, JL; May, CN				Monaco, Matthew R.; Brewer, Britton W.; Van Raalte, Judy L.; May, Christine N.			How Many Concussions Would It Take for Athletes to Choose to Discontinue Participation in Their Primary Sport?	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						injury risk; sport ethic; athletic identity		The process by which athletes decide to continue or discontinue sport participation after concussion has not been explicated. Intercollegiate and club sport athletes (N = 394) completed an online survey that included assessments of demographic factors, the total number of concussions (and anterior cruciate ligament (ACL) tears) that would prompt sport retirement, concussion history, and athletic identity. On average, participants reported that they would retire from their primary sport after sustaining 3 to 4 concussions (and approximately 2 ACL tears). The total number of concussions reported was negatively correlated with the number of additional concussions it would take to precipitate sport retirement. Athletic identity was positively associated with the number of concussions that participants with a history of one or more concussions reported would prompt them to retire from their primary sport. The results provide information of potential utility to professionals implementing concussion education programs and working with athletes at risk of experiencing concussion.	[Monaco, Matthew R.; Brewer, Britton W.; Van Raalte, Judy L.; May, Christine N.] Springfield Coll, Dept Psychol, 263 Alden St, Springfield, MA 01109 USA; [Van Raalte, Judy L.] Wuhan Sports Univ, Coll Hlth Sci, 461 Luoyu Rd, Wuhan 430079, Peoples R China		Brewer, BW (corresponding author), Springfield Coll, Dept Psychol, 263 Alden St, Springfield, MA 01109 USA.	mmonaco@springfieldcollege.edu; bbrewer@springfieldcollege.edu; jvanraal@springfieldcollege.edu; christinemay811@gmail.com		May, Christine/0000-0002-4367-5310			Baranoff J, 2015, J SCI MED SPORT, V18, P250, DOI 10.1016/j.jsams.2014.04.002; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Brewer B.W., 2001, ACAD ATHLETIC J, V16, P103; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; Centers for Disease Control and Prevention, SYMPT TRAUM BRAIN IN; Cohen J., 2013, STAT POWER ANAL BEHA; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hilliard RC, 2017, J SPORT REHABIL, V26, P208, DOI 10.1123/jsr.2015-0134; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Kontos A.P., 2017, OXFORD RES ENCY PSYC; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Manuel JC, 2002, J ADOLESCENT HEALTH, V31, P391, DOI 10.1016/S1054-139X(02)00400-7; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay C, 2013, CLIN J SPORT MED, V23, P216, DOI 10.1097/JSM.0b013e31826a86c9; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; O'Rourke DJ, 2017, SPORT EXERC PERFORM, V6, P262, DOI 10.1037/spy0000097; Prochniak P., 2013, PSYCHOL PEDAGOGICAL, P23; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Sousa PL, 2017, KNEE SURG SPORT TR A, V25, P1356, DOI 10.1007/s00167-015-3697-2; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; University of Pittsburgh Medical Center, CONC FACTS STAT; Weinberg R, 2013, J CLIN SPORT PSYCHOL, V7, P41, DOI 10.1123/jcsp.7.1.41	27	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	FEB	2021	18	4							1582	10.3390/ijerph18041582			7	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	QP0PR	WOS:000623540400001	33567484	Green Published, gold			2022-02-06	
J	Morissette, SB; Ryan-Gonzalez, C; Yufik, T; DeBeer, BB; Kimbrel, NA; Sorrells, AM; Holleran-Steiker, L; Penk, WE; Gulliver, SB; Meyer, EC				Morissette, Sandra B.; Ryan-Gonzalez, Clark; Yufik, Tomas; DeBeer, Bryann B.; Kimbrel, Nathan A.; Sorrells, Audrey M.; Holleran-Steiker, Lori; Penk, Walter E.; Gulliver, Suzy B.; Meyer, Eric C.			The Effects of Posttraumatic Stress Disorder Symptoms on Educational Functioning in Student Veterans	PSYCHOLOGICAL SERVICES			English	Article						veteran; PTSD; higher education; educational functioning	MENTAL-HEALTH PROBLEMS; COLLEGE-STUDENTS; MEMORY; PTSD; ALCOHOL; AFGHANISTAN; ATTENTION; IRAQ; CONSEQUENCES; VALIDATION	Posttraumatic stress disorder (PTSD) occurs at high rates among student veterans and is known to negatively impact educational functioning; however, the unique effects of PTSD are less clear, given that PTSD is highly comorbid with many other conditions that could potentially affect educational functioning. The present study had two objectives: (a) to determine the impact of PTSD symptom severity on educational functioning after accounting for demographic variables, traumatic brain injury, and commonly co-occurring mental health conditions; and (b) to identify which symptom clusters of PTSD have the greatest impact on educational functioning. Educational functioning and other commonly occurring mental health conditions were assessed cross-sectionally among 90 student veterans. Traumatic brain injury and major depressive disorder (MDD) were initially associated with impaired educational functioning; however, after adding PTSD into the final model, only PTSD (beta = .44, p = .001) and MDD (beta = .31, p = .001) remained associated with educational impairment. Follow-up analyses indicated that the reexperiencing symptom cluster was most strongly associated with impaired educational functioning (beta = .28, p = .031). Overall, these results suggest that PTSD symptoms-especially reexperiencing symptoms-may be a driving force behind impaired educational impairment, even after accounting for other commonly co-occurring mental health conditions.	[Morissette, Sandra B.; Ryan-Gonzalez, Clark] Univ Texas San Antonio, Dept Psychol, One UTSA Circle, San Antonio, TX 78249 USA; [Yufik, Tomas] St Edwards Univ, Dept Psychol, Austin, TX 78704 USA; [DeBeer, Bryann B.; Meyer, Eric C.] Cent Texas Vet Hlth Care Syst, VISN Ctr Excellence Res Returning War Vet 17, Dept Vet Affairs, Waco, TX USA; [DeBeer, Bryann B.; Gulliver, Suzy B.; Meyer, Eric C.] Texas A&M Hlth Sci Ctr, Dept Psychiat & Behav Sci, Bryan, TX USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Midatlantic Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Sorrells, Audrey M.; Holleran-Steiker, Lori] Univ Texas Austin, Dept Special Educ, Austin, TX 78712 USA; [Penk, Walter E.] Texas A&M Univ, Hlth Sci Ctr, Dept Psychiat & Behav Sci, College Stn, TX 77843 USA; [Gulliver, Suzy B.] Baylor Scott & White Healthcare Syst, Warrior Res Inst, Waco, TX USA		Morissette, SB (corresponding author), Univ Texas San Antonio, Dept Psychol, One UTSA Circle, San Antonio, TX 78249 USA.	sandra.morissette@utsa.edu			VA Merit Awards [I01RX000304-01A1, I01RX000304-01A4]; Rehabilitation Research and Development Service of the VA Office of Research and Development	This work was supported by VA Merit Awards to Sandra B. Morissette (I01RX000304-01A1), and Sandra B. Morissette and Eric C. Meyer (I01RX000304-01A4), from the Rehabilitation Research and Development Service of the VA Office of Research and Development. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT, VIV; Astin A. W., 1985, ACHIEVING ED EXCELLE; Astin A. W., 2000, STUDENTS; Astin AW, 1998, J COLL STUDENT DEV, V39, P251; Bachrach RL, 2012, J CLIN PSYCHOL, V68, P843, DOI 10.1002/jclp.21874; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; Barry AE, 2012, DRUG-EDUC PREV POLIC, V19, P415, DOI 10.3109/09687637.2011.647123; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Born J, 2004, ANN NY ACAD SCI, V1032, P198, DOI 10.1196/annals.1314.020; Bovin MJ, 2018, PSYCHOL SERV, V15, P216, DOI 10.1037/ser0000220; Brancu M, 2016, PSYCHOL TRAUMA-US, V8, P222, DOI 10.1037/tra0000078; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Center for Behavioral Health Statistics and Quality, 2017, 2016 NAT SURV DRUG U; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; DeRoma V., 2009, COLL STUD J, V43, P325; DiRamio D, 2008, J STUD AFF RES PRACT, V45, P73; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Duncan RD, 2000, J INTERPERS VIOLENCE, V15, P987, DOI 10.1177/088626000015009005; Elliott M, 2011, J STUD AFF RES PRACT, V48, P279, DOI 10.2202/1949-6605.6293; Ellis HC, 1997, J EXP PSYCHOL GEN, V126, P131, DOI 10.1037/0096-3445.126.2.131; Ellison ML, 2012, PSYCHIATR REHABIL J, V35, P209, DOI 10.2975/35.3.2012.209.217; First M.B., 1996, STRUCTURED CLIN INTE; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Government Accountability Office, 2015, POST 9 11 GI BILL AD; Government Accountability Office, 2013, VA ED BEN STUD CHAR; Government Accountability Office, 2014, VET AFF BETT UND NEE; Hartley MT, 2010, AM J PSYCHIATR REHAB, V13, P295, DOI 10.1080/15487768.2010.523372; Hellawell SJ, 2002, BEHAV RES THER, V40, P1143, DOI 10.1016/S0005-7967(01)00080-8; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; INGRAM RE, 1984, COGNITIVE THER RES, V8, P443, DOI 10.1007/BF01173284; Johnston L. D., 2005, MONITORING FUTURE NA; KESSLER RC, 1995, AM J PSYCHIAT, V152, P1026; Kimbrel NA, 2015, PSYCHIAT RES, V226, P78, DOI 10.1016/j.psychres.2014.12.007; King D. W., 2003, MANUAL DEPLOYMENT RI; Komarraju M, 2010, J COLL STUDENT DEV, V51, P332, DOI 10.1353/csd.0.0137; Kranzler HR, 1996, ADDICTION, V91, P859, DOI 10.1111/j.1360-0443.1996.tb03580.x; Kuester A, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1386988; Kuh G., 2010, STUDENT SUCCESS COLL; Kuh G. D., 2003, CHANGE, V35, P24, DOI DOI 10.1080/00091380309604090; Kuh G. D., 2005, ASSESSING CONDITIONS; Kuh GD, 2008, J HIGH EDUC-UK, V79, P540, DOI 10.1353/jhe.0.0019; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; McNally R. J., 1987, J ANXIETY DISORDERS, V1, P105, DOI DOI 10.1016/0887-6185(87)90001-6; MCNALLY RJ, 1990, J ABNORM PSYCHOL, V99, P398, DOI 10.1037/0021-843X.99.4.398; MULTON KD, 1991, J COUNS PSYCHOL, V38, P30, DOI 10.1037/0022-0167.38.1.30; O'Keeffe, 2013, COLL STUDENT J, V47, P605, DOI DOI 10.1016/J.IJME.2014.01.003; Pascarella E. T., 1991, COLL AFFECTS STUDENT; Pascarella ET., 2005, COLL AFFECTS STUDENT; Read JP, 2012, J CONSULT CLIN PSYCH, V80, P426, DOI 10.1037/a0028210; Read JP, 2011, PSYCHOL TRAUMA-US, V3, P148, DOI 10.1037/a0021260; Read JP, 2006, J STUD ALCOHOL, V67, P169, DOI 10.15288/jsa.2006.67.169; Rein L., 2015, WASHINGTON POST; Rudd MD, 2011, PROF PSYCHOL-RES PR, V42, P354, DOI 10.1037/a0025164; Rumann CB, 2010, J HIGH EDUC, V81, P431, DOI 10.1353/jhe.0.0103; Ryan-Gonzalez C, 2019, J NEUROTRAUM, V36, P1584, DOI 10.1089/neu.2017.5590; Salzer MS, 2008, PSYCHIAT SERV, V59, P370, DOI 10.1176/ps.2008.59.4.370; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SEIBERT PS, 1991, MEM COGNITION, V19, P507, DOI 10.3758/BF03199574; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Southwell KH, 2018, J COLL STUD RETENT-R, V19, P394, DOI 10.1177/1521025116636133; Strayhorn TL, 2012, J COLL STUDENT DEV, V53, P783, DOI 10.1353/csd.2012.0078; Tanielian T., 2008, INVISIBLE WOUNDS WAR; U.S. Department of Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TRAU; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vance ML, 2009, J POSTSECOND EDUC DI, V22, P18; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Veterans Benefits Administration, 2017, 2016 ANN BEN REP; Walton GM, 2007, J PERS SOC PSYCHOL, V92, P82, DOI 10.1037/0022-3514.92.1.82; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Wenger J. W., 2018, EXAMINATION RECENT D, DOI [10.7249/RR1928, DOI 10.7249/RR1928]; Widome R, 2011, AM J HEALTH BEHAV, V35, P387, DOI 10.5993/AJHB.35.4.1; Woodson J., 2015, TRAUMATIC BRAIN INJU; ZEITLIN SB, 1991, BEHAV RES THER, V29, P451, DOI 10.1016/0005-7967(91)90129-Q	80	1	1	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	FEB	2021	18	1					124	133		10.1037/ser0000356			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	QV0QP	WOS:000627683200013	31192672				2022-02-06	
J	Notrica, DM; Kirsch, L; Misra, S; Kelly, C; Greenberg, J; Ortiz, JB; Rowe, RK; Lifshitz, J; Adelson, PD; Stottlemyre, RL; Cohen, A; Sayrs, LW				Notrica, David M.; Kirsch, Lisa; Misra, Shivani; Kelly, Cara; Greenberg, Jodie; Ortiz, J. Bryce; Rowe, Rachel K.; Lifshitz, Jonathan; Adelson, P. David; Stottlemyre, Rachael L.; Cohen, Aaron; Sayrs, Lois W.			Evaluating abusive head trauma in children < 5 years old: Risk factors and the importance of the social history	JOURNAL OF PEDIATRIC SURGERY			English	Article						Abusive head trauma; Traumatic brain injury; Pediatrics; Child abuse		Background: Abusive head trauma (AHT) is the leading cause traumatic death in children <= 5 years of age. AHT remains seriously under-surveilled, increasing the risk of subsequent injury and death. This study assesses the clinical and social risks associated with fatal and non-fatal AHT. Methods: A single-institution, retrospective review of suspected AHT patients <= 5 years of age between 2010 and 2016 using a prospective hospital forensic registry data yielded demographic, clinical, family, psycho-social and other follow-up information. Descriptive statistics were used to look for differences between patients with AHT and accidental head trauma. Logistic regression estimated the adjusted odds ratios (AOR) for AHT. A receiver operating characteristic (ROC) curve was created to calculate model sensitivity and specificity. Results: Forensic evaluations of 783 children age <= 5 years with head trauma met the inclusion criteria; 25 were fatal with median[IQR] age 23[4.5-39.0] months. Of 758 non-fatal patients, age was 7[3.0-11.0] months; 59.5% male; 435 patients (57.4%) presentedwith a skull fracture, 403 (53.2%) with intracranial hemorrhage. Ultimately 242 (31.9%) were adjudicated AHT, 335(44.2%) were accidental, 181 (23.9%) were undetermined. Clinical factors increasing the risk of AHT included multiple fractures (Exp(beta) = 9.9[p = 0.001]), bruising (Exp beta = 5.7 [p < 0.001]), subdural blood (Exp(beta)= 5.3[p = 0.001]), seizures (Exp(beta)= 4.9[p= 0.02]), lethargy/unresponsiveness (Exp(beta) = 2.24[p = 0.02]), loss of consciousness (Exp(beta) = 4.69[p = 0.001]), and unknown mechanism of injury (Exp(beta) = 3.9[p = 0.001]); skull fracture reduced the risk of AHT by half (Exp(beta) = 0.5[p = 0.011]). Social risks factors included prior police involvement (Exp(beta) = 5.9[p = 0.001]), substance abuse (Exp(beta) = 5.7[p=.001]), unknown number of adults in the home (Exp(beta)= 4.1[p= 0.001]) and intimate partner violence (Exp(beta) = 2.3[p = 0.02]). ROC area under the curve (AUC) = 0.90([95% CI = 0.86-0.93] p=.001) provides 73% sensitivity; 91% specificity. Conclusions: To improve surveillance of AHT, interviews should include and consider social factors including caregiver/household substance abuse, intimate partner violence, prior police involvement and household size. An unknown number of adults in home is associated with an increased risk of AHT. (C) 2020 Elsevier Inc. All rights reserved.	[Notrica, David M.; Kirsch, Lisa; Greenberg, Jodie; Adelson, P. David; Stottlemyre, Rachael L.; Sayrs, Lois W.] Phoenix Childrens Hosp, 1919 E Thomas Rd, Phoenix, AZ 85016 USA; [Notrica, David M.; Kirsch, Lisa; Ortiz, J. Bryce; Rowe, Rachel K.; Lifshitz, Jonathan; Adelson, P. David; Sayrs, Lois W.] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA; [Kelly, Cara] Arizona State Univ, Sch Social Work, Ctr Child Well Being, Tempe, AZ 85287 USA; [Ortiz, J. Bryce; Rowe, Rachel K.; Lifshitz, Jonathan; Adelson, P. David] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA; [Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ USA; [Cohen, Aaron] Valleywise Hlth Syst, Phoenix, AZ USA; [Misra, Shivani] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA		Sayrs, LW (corresponding author), Phoenix Childrens Hosp, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	lsayrs@phoenixchildrens.com		Rowe, Rachel/0000-0002-9034-3159			Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Berger RP, 2011, PEDIATRICS, V128, P637, DOI 10.1542/peds.2010-2185; Berger RP, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.0429; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Bonkowsky JL, 2008, PEDIATRICS, V122, P125, DOI 10.1542/peds.2007-3376; Chen CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030390; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Currie J, 2010, CHILD MALTREATMENT, V15, P111, DOI 10.1177/1077559509355316; Damashek A, 2013, CHILD ABUSE NEGLECT, V37, P735, DOI 10.1016/j.chiabu.2013.04.014; Dudley N, 2015, PEDIATRICS, V135, pE255, DOI 10.1542/peds.2014-3424; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Duhaime AC, 2019, J NEUROSURG-PEDIATR, V24, P481, DOI 10.3171/2019.7.PEDS18394; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; Erickson SJ, 2005, ARCH PEDIAT ADOL MED, V159, P1173, DOI 10.1001/archpedi.159.12.1173; Evans SE, 2008, AGGRESS VIOLENT BEH, V13, P131, DOI 10.1016/j.avb.2008.02.005; Featherstone B, 2019, CHILD YOUTH SERV REV, V97, P127, DOI 10.1016/j.childyouth.2017.06.009; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Ferguson NM, 2016, PEDIATR CRIT CARE ME, V17, P444, DOI 10.1097/PCC.0000000000000709; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Hymel KP, 2019, CHILD ABUSE NEGLECT, V88, P266, DOI 10.1016/j.chiabu.2018.11.015; Hymel KP, 2014, PEDIATRICS, V134, pE1537, DOI 10.1542/peds.2014-1329; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Kitzmann KM, 2003, J CONSULT CLIN PSYCH, V71, P339, DOI 10.1037/0022-006X.71.2.339; Kochar A, 2020, EMERG MED J, V37, P127, DOI 10.1136/emermed-2018-208154; Letson MM, 2016, CHILD ABUSE NEGLECT, V60, P36, DOI 10.1016/j.chiabu.2016.09.001; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Miller TR, 2018, PREV SCI, V19, P695, DOI 10.1007/s11121-017-0815-z; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Morad Y, 2010, CLIN EXP OPHTHALMOL, V38, P514, DOI 10.1111/j.1442-9071.2010.02291.x; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Notrica DM, 2020, J PEDIATR SURG, V55, P341, DOI 10.1016/j.jpedsurg.2019.10.010; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Palusci VJ, 2014, CHILD ABUSE NEGLECT, V38, P25, DOI 10.1016/j.chiabu.2013.08.014; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Rolfes MC, 2018, J PEDIATR NEUROL, V16, P39, DOI 10.1055/s-0037-1604212; Rosen N.G., 2020, 2020 W TRAUM ASS M S; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Springer KW, 2007, CHILD ABUSE NEGLECT, V31, P517, DOI 10.1016/j.chiabu.2007.01.003; Stith SM, 2009, AGGRESS VIOLENT BEH, V14, P13, DOI 10.1016/j.avb.2006.03.006; Van IJzendoorn R, 2019, J CHILD PSYCHOL PSYC	49	1	1	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	FEB	2021	56	2					390	396		10.1016/j.jpedsurg.2020.10.019			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	QF3TY	WOS:000616821600033	33220974				2022-02-06	
J	Osborne, CL; Juengst, SB; Smith, EE				Osborne, Candice L.; Juengst, Shannon B.; Smith, Emily E.			Identifying user-centered content, design, and features for mobile health apps to support long-term assessment, behavioral intervention, and transitions of care in neurological rehabilitation: An exploratory study	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Mobile health; stroke; traumatic brain injury		Introduction The use of mobile health technology has the potential to increase healthcare accessibility, promote self-management, provide education materials, and support self-monitoring of biometrics. This may be of particular benefit to those living in the community with chronic neurological conditions. The purpose of this research was to characterize perspectives of individuals with brain injury or stroke, their care partners, and neuro-rehabilitation clinicians to inform the design of mobile health app-based interventions that address the need for ongoing community-based health-related professional support. Methods Individuals with stroke or traumatic brain injury, their care partners, and clinicians were recruited from a large university hospital with a specialized neuro-rehabilitation program. Data were collected via semi-structured focus groups and were examined using descriptive statistics and content analysis. Results Five consistent themes emerged: (a) all-in-one app with customized features; (b) communication with healthcare providers; (c) cognitive strategies; (d) app accessibility; and (e) user education. The clinician focus group reiterated these consumer focus group themes, with one additional theme: (f) logistics of clinician time and effort to provide effective app-based services to patients. Conclusions Results have directly informed the ongoing development of a community-based mobile health app intervention, and may also inform the content and design of future mHealth technological development in this population.	[Osborne, Candice L.; Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Smith, Emily E.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA		Osborne, CL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA.	candice.osborne@utsouthwestern.edu					Anthes E, 2016, NATURE, V532, P20, DOI 10.1038/532020a; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Centers for Disease Control and Prevention, 2015, REPORT C TRAUMATIC B; Choi YH, 2015, TELEMED E-HEALTH, V21, P729, DOI 10.1089/tmj.2014.0207; De Joode EA, 2013, NEUROPSYCHOL REHABIL, V23, P133, DOI 10.1080/09602011.2012.726632; Denzin, 2009, RES ACT THEORETICAL, DOI [10.4324/9781315134543, DOI 10.4324/9781315134543]; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dobkin BH, 2016, CURR OPIN NEUROL, V29, P693, DOI 10.1097/WCO.0000000000000380; Dubey D, 2014, J STROKE, V16, P86, DOI 10.5853/jos.2014.16.2.86; Firth J, 2016, SCHIZOPHRENIA BULL, V42, P448, DOI 10.1093/schbul/sbv132; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Grant JS, 2004, INT J REHABIL RES, V27, P105, DOI 10.1097/01.mrr.0000127639.47494.e3; Graven C, 2011, DISABIL REHABIL, V33, P1501, DOI 10.3109/09638288.2010.542874; Hafsteinsdottir TB, 2011, PATIENT EDUC COUNS, V85, P14, DOI 10.1016/j.pec.2010.07.046; Juengst Shannon B, 2019, Arch Rehabil Res Clin Transl, V1, P100009, DOI 10.1016/j.arrct.2019.100009; Juengst SB, 2019, CURR PHYS MED REHAB, V7, P341, DOI 10.1007/s40141-019-00240-9; Krueger RA., 2014, FOCUS GROUPS PRACTIC, V5th; Lyon AR, 2016, CLIN PSYCHOL-SCI PR, V23, P180, DOI 10.1111/cpsp.12154; Matthew-Maich N, 2016, JMIR MHEALTH UHEALTH, V4, P164, DOI 10.2196/mhealth.5127; MITCHELL ES, 1986, ADV NURS SCI, V8, P18, DOI 10.1097/00012272-198604000-00004; Mohr DC, 2018, JAMA PSYCHIAT, V75, P113, DOI 10.1001/jamapsychiatry.2017.3838; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Nussbaum R, 2019, ARCH PHYS MED REHAB, V100, P115, DOI 10.1016/j.apmr.2018.07.439; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; Paul L, 2016, TOP STROKE REHABIL, V23, P170, DOI 10.1080/10749357.2015.1122266; Pavliscsak H, 2016, J AM MED INFORM ASSN, V23, P110, DOI 10.1093/jamia/ocv121; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Setiawan I Made Agus, 2019, JMIR Form Res, V3, pe12982, DOI 10.2196/12982; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Thurmond VA, 2001, J NURS SCHOLARSHIP, V33, P253, DOI 10.1111/j.1547-5069.2001.00253.x; Wang YF, 2017, ADV NUTR, V8, P449, DOI 10.3945/an.116.014100; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; World Health Organization Global Observatory for eHealth, 2011, MHEALTH NEW HORIZONS; World Stroke Organization, 2019, FACTS FIGURES STROKE	36	1	1	3	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	FEB	2021	84	2					101	110		10.1177/0308022620954115			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	QC0ON	WOS:000614534100005					2022-02-06	
J	Popovich, M; Sas, A; Almeida, AA; Freeman, J; Alsalaheen, B; Lorincz, M; Eckner, JT				Popovich, Michael; Sas, Andrew; Almeida, Andrea Ana; Freeman, Jeremiah; Alsalaheen, Bara; Lorincz, Matthew; Eckner, James T.			Symptom Provocation During Aerobic and Dynamic Supervised Exercise Challenges in Adolescents With Sport-Related Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; assessment; return to play	CLINICAL RECOVERY; UP-REGULATION; REHABILITATION; PLASTICITY; CHILDREN; RETURN	Context: Supervised exercise challenges (SECs) have been shown to be safe and beneficial in the early symptomatic period after concussion. Thus far, most in-clinic SECs studied have included a form of basic aerobic exercise only. An SEC that also includes dynamic forms of exercise mimics all steps of a standard return-to-play progression and may enhance the detection of concussion symptoms to guide in-clinic management decisions. Objective: To determine whether an SEC that includes a dynamic SEC (DSEC) uncovered symptoms that would not have been identified by an SEC involving an aerobic SEC (ASEC) alone in adolescent patients with sport-related concussion. Design: Retrospective case series. Setting: Multidisciplinary sport concussion clinic at a tertiary care center. Patients or Other Participants: A total of 65 adolescent athletes (mean age = 14.9 6 2.0 years, 72.3% males) who underwent an in-clinic SEC within 30 days of concussion. Main Outcome Measure(s): Presence of pre- exercise symptoms and symptom provocation during the SEC were recorded, with exercise-provoked symptoms categorized as occurring during ASEC or DSEC. Results: Of the total patient sample, 69.2% (n = 45/65) experienced symptom provocation at some point during the SEC. Symptoms were provoked in 20 patients during the ASEC, whereas 25 completed the ASEC without symptom provocation before becoming symptomatic during the subsequent DSEC and 20 completed the SEC without any symptom provocation. Of the 65 patients in the total sample, 46 were asymptomatic immediately before the SEC. Of these previously asymptomatic patients, 23.9% (n = 11/46) experienced symptom provocation during the ASEC, and an additional 37.0% (n = 17/46) remained asymptomatic during the ASEC but then developed symptoms during the DSEC. Conclusions: The ASEC alone may not detect symptom provocation in a significant proportion of concussion patients who otherwise would develop symptoms during a DSEC.	[Popovich, Michael; Almeida, Andrea Ana; Alsalaheen, Bara; Lorincz, Matthew] Univ Michigan, Dept Neurol, 2301 Commonwealth Blvd, Ann Arbor, MI 48105 USA; [Freeman, Jeremiah] Univ Michigan, Dept Sports Med & Phys Therapy, Ann Arbor, MI 48105 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48105 USA; [Sas, Andrew] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA		Popovich, M (corresponding author), Univ Michigan, Dept Neurol, 2301 Commonwealth Blvd, Ann Arbor, MI 48105 USA.	mipopovi@med.umich.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25 NS089450] Funding Source: Medline		Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Archer T, 2014, CNS NEUROL DISORD-DR, V13, P1640; Ardern CL, 2016, BRIT J SPORT MED, V50, P853, DOI 10.1136/bjsports-2016-096278; Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Dwyer B, 2018, SEMIN NEUROL, V38, P619, DOI 10.1055/s-0038-1673692; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kovacevic A, 2018, SLEEP MED REV, V39, P52, DOI 10.1016/j.smrv.2017.07.002; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marshall CM, 2019, PHYSICIAN SPORTSMED, V47, P158, DOI 10.1080/00913847.2018.1542258; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moran RN, 2019, J NEUROSURG-PEDIATR, V23, P465, DOI 10.3171/2018.10.PEDS18425; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Orr R, 2021, CLIN J SPORT MED, V31, P23, DOI 10.1097/JSM.0000000000000683; Popovich M, 2021, CLIN J SPORT MED, V31, P127, DOI 10.1097/JSM.0000000000000721; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; van Leeuwen RB, 2017, NEUROLOGIST, V22, P69, DOI 10.1097/NRL.0000000000000116	30	1	1	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2021	56	2					148	156		10.4085/1062-6050-0072.20			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	QK3AH	WOS:000620252800004	33428736	Green Published, gold			2022-02-06	
J	Porter, K; Quintana, C; Hoch, M				Porter, Ke'La; Quintana, Carolina; Hoch, Matthew			The Relationship Between Neurocognitive Function and Biomechanics: A Critically Appraised Topic	JOURNAL OF SPORT REHABILITATION			English	Article						head; brain; balance; posture	RELIABILITY; CONCUSSION	Clinical Scenario: Neurocognitive performance may put individuals at a greater risk for lower-extremity musculoskeletal injuries. Research has observed the relationship between lower-extremity musculoskeletal injury and baseline neurocognitive performance; however, the understanding of this relationship is lacking. Exploring this relationship may give further insight into musculoskeletal injury and provide innovative directions for musculoskeletal injury prevention. Clinical Question: Is there a relationship between neurocognitive performance and lower-extremity biomechanics during a jumping or cutting task in healthy adult athletes? Summary of Key Findings: The literature was searched for articles that examined the relationship of a baseline neurocognitive test and a biomechanical analysis following a sports-related task. A total of 3 cross-sectional articles were included. All 3 studies concluded that poorer neurocognitive performance was associated with biomechanical faults that are linked to increased risk or rate of lower-extremity musculoskeletal injury. Clinical Bottom Line: Based on the evidence included, there is a moderate-level evidence to support the relationship between neurocognition and lower-extremity biomechanics in healthy adult athletes. Strength of Recommendation: In accordance with the van Tulder approach, there is a moderate level of evidence due to consistent findings from a combination of high- and limited-quality articles.	[Porter, Ke'La; Quintana, Carolina; Hoch, Matthew] Univ Kentucky, Dept Athlet Training & Clin Nutr, Sports Med Res Inst, Coll Hlth Sci, Lexington, KY 40506 USA		Hoch, M (corresponding author), Univ Kentucky, Dept Athlet Training & Clin Nutr, Sports Med Res Inst, Coll Hlth Sci, Lexington, KY 40506 USA.	Matt.Hoch@uky.edu					Broglio SP, 2007, J ATHL TRAINING, V42, P509; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Herman DC, 2016, AM J SPORT MED, V44, P2347, DOI 10.1177/0363546516657338; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Monfort SM, 2019, AM J SPORT MED, V47, P1488, DOI 10.1177/0363546519834544; Munn J, 2010, J SCI MED SPORT, V13, P2, DOI 10.1016/j.jsams.2009.03.004; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shibata Satoshi, 2018, Phys Ther Res, V21, P44, DOI 10.1298/ptr.E9938; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Wilkerson GB, 2017, J SPORT REHABIL, V26, P26, DOI 10.1123/jsr.2015-0068	12	1	1	1	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	FEB	2021	30	2					327	332		10.1123/jsr.2020-0103			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	QA1YO	WOS:000613245200022	32791494	Bronze			2022-02-06	
J	Pushchina, EV; Zharikova, EI; Varaksin, AA				Pushchina, Evgeniya V.; Zharikova, Eva I.; Varaksin, Anatoly A.			Mechanical Brain Injury Increases Cells' Production of Cystathionine beta-Synthase and Glutamine Synthetase, but Reduces Pax2 Expression in the Telencephalon of Juvenile Chum Salmon, Oncorhynchus keta	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						adult neurogenesis; traumatic brain injury; glutamine synthetase; aNSCs; NPCs; radial glia; cystathionine &#946; -synthase; Pacific chum salmon; Paired Box2; sonic hedgehog signaling		The considerable post-traumatic brain recovery in fishes makes them a useful model for studying the mechanisms that provide reparative neurogenesis, which is poorly represented in mammals. After a mechanical injury to the telencephalon in adult fish, lost neurons are actively replaced due to the proliferative activity of neuroepithelial cells and radial glia in the neurogenic periventricular zone. However, it is not enough clear which signaling mechanisms are involved in the activation of adult neural stem cells (aNSC) after the injury (reactive proliferation) and in the production of new neurons (regenerative neurogenesis) from progenitor cells (NPC). In juvenile Pacific salmon, the predominant type of NSCs in the telencephalon are neuroepithelial cells corresponding to embryonic NSCs. Expression of glutamine synthetase (GS), a NSC molecular marker, was detected in the neuroepithelial cells of the pallium and subpallium of juvenile chum salmon, Oncorhynchus keta. At 3 days after a traumatic brain injury (TBI) in juvenile chum salmon, the GS expression was detected in the radial glia corresponding to aNSC in the pallium and subpallium. The maximum density of distribution of GS(+) radial glia was found in the dorsal pallial region. Hydrogen sulfide (H2S) is a proneurogenic factor that reduces oxidative stress and excitotoxicity effects, along with the increased GS production in the brain cells of juvenile chum salmon. In the fish brain, H2S producing by cystathionine beta-synthase in neurogenic zones may be involved in maintaining the microenvironment that provides optimal conditions for the functioning of neurogenic niches during constitutive neurogenesis. After injury, H2S can determine cell survivability, providing a neuroprotective effect in the area of injury and reducing the process of glutamate excitotoxicity, acting as a signaling molecule involved in changing the neurogenic environment, which leads to the reactivation of neurogenic niches and cell regeneration programs. The results of studies on the control of the expression of regulatory Sonic Hedgehog genes (Shh) and the transcription factors Paired Box2 (Pax2) regulated by them are still insufficient. A comparative analysis of Pax2 expression in the telencephalon of intact chum salmon showed the presence of constitutive patterns of Pax2 expression in neurogenic areas and non-neurogenic parenchymal zones of the pallium and subpallium. After mechanical injury, the patterns of Pax2 expression changed, and the amount of Pax2(+) decreased (p < 0.05) in lateral (Dl), medial (Dm) zones of the pallium, and the lateral zone (Vl) of the subpallium compared to the control. We believe that the decrease in the expression of Pax2 may be caused by the inhibitory effect of the Pax6 transcription factor, whose expression in the juvenile salmon brain increases upon injury.	[Pushchina, Evgeniya V.; Zharikova, Eva I.; Varaksin, Anatoly A.] Russian Acad Sci, Far East Branch, AV Zhirmunsky Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia		Pushchina, EV (corresponding author), Russian Acad Sci, Far East Branch, AV Zhirmunsky Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia.	puschina@mail.ru; eva_1213@mail.ru; anvaraksin@mail.ru	Varaksin, Anatoliy/AAN-1585-2021; Pushchina, Evgeniya/P-9789-2015	Pushchina, Evgeniya/0000-0003-0388-3147	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [20-34-90091]	The reported study was funded by the Russian Foundation for Basic Research (research project no. 20-34-90091) to EVP and EIZ.	Abe K, 1996, J NEUROSCI, V16, P1066; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Barbosa Joana S, 2016, Neurogenesis (Austin), V3, pe1148101, DOI 10.1080/23262133.2016.1148101; Bollaerts I, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9478542; Busse A, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-36; Ceci M, 2019, REV NEUROSCIENCE, V30, P45, DOI 10.1515/revneuro-2018-0020; Che XR, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00392; Dakubo GD, 2003, DEVELOPMENT, V130, P2967, DOI 10.1242/dev.00515; Docampo-Seara A, 2020, BRAIN STRUCT FUNCT, V225, P817, DOI 10.1007/s00429-020-02038-1; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; Than-Trong E, 2015, GLIA, V63, P1406, DOI 10.1002/glia.22856; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Giuffre A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6290931; Gopalakrishnan Priya, 2019, Pathophysiology, V26, P1, DOI 10.1016/j.pathophys.2018.10.005; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; KATSURA K, 1994, BIOCHEM SOC T, V22, P991, DOI 10.1042/bst0220991; Kimura H, 2019, NEUROCHEM INT, V126, P118, DOI 10.1016/j.neuint.2019.01.027; Kimura H, 2013, NEUROCHEM INT, V63, P492, DOI 10.1016/j.neuint.2013.09.003; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kumar A, 2017, J CLIN INVEST, V127, P4365, DOI 10.1172/JCI89885; Kyritsis N, 2014, TRENDS CELL BIOL, V24, P128, DOI 10.1016/j.tcb.2013.08.004; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; McDonald RP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27880-6; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Panthi S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9049782; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; Pirotte N, 2016, DEV BIOL, V409, P4, DOI 10.1016/j.ydbio.2015.09.025; Pushchina EV, 2019, RUSS J DEV BIOL+, V50, P39, DOI 10.1134/S1062360419020048; Pushchina EV, 2018, RUSS J DEV BIOL+, V49, P264, DOI [10.1134/S047514501805004X, 10.1134/S1062360418050041]; Pushchina EV, 2017, RUSS J DEV BIOL+, V48, P307, DOI 10.1134/S106236041705006X; Pushchina EV, 2011, NEUROCHEM J+, V5, P24, DOI 10.1134/S1819712411010090; Pushchina E.V., 2020, ONCORHYNCHUS KETA BR, V10, P65, DOI [10.3390/brainsci10020065, DOI 10.3390/BRAINSCI10020065]; Pushchina E.V., 2017, NEUROCHEMICAL ORG AD, P267; Pushchina EV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249638; Pushchina EV, 2020, NEURAL REGEN RES, V15, P1867, DOI 10.4103/1673-5374.280320; Pushchina EV, 2019, NEURAL REGEN RES, V14, P156, DOI 10.4103/1673-5374.243721; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; Sehgal R, 2009, DEV BIOL, V332, P429, DOI 10.1016/j.ydbio.2009.05.579; Soukkarieh C, 2007, DEV BIOL, V303, P800, DOI 10.1016/j.ydbio.2006.11.016; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Thompson JA, 2011, PROG NEUROBIOL, V95, P334, DOI 10.1016/j.pneurobio.2011.08.012; Van Houcke J, 2015, AGEING RES REV, V24, P358, DOI 10.1016/j.arr.2015.10.004; Wang JF, 2014, NEUROCHEM INT, V64, P37, DOI 10.1016/j.neuint.2013.11.002; Wang YP, 2002, NAT NEUROSCI, V5, P831, DOI 10.1038/nn911; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wong CED, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050286; Xiao LC, 2012, INT J MOL MED, V30, P1126, DOI 10.3892/ijmm.2012.1090; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zupanc GKH, 2013, CURR TOP MICROBIOL, V367, P193, DOI 10.1007/82_2012_297	61	1	1	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB	2021	22	3							1279	10.3390/ijms22031279			34	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	QD1WR	WOS:000615318100001	33525421	gold, Green Published			2022-02-06	
J	Readnower, RD; Hubbard, WB; Kalimon, OJ; Geddes, JW; Sullivan, PG				Readnower, Ryan D.; Hubbard, William Brad; Kalimon, Olivia J.; Geddes, James W.; Sullivan, Patrick G.			Genetic Approach to Elucidate the Role of Cyclophilin D in Traumatic Brain Injury Pathology	CELLS			English	Article						controlled cortical impact; mitochondrial bioenergetics; mitochondria; cyclosporin a; NIM811; mitochondrial permeability transition; Ppif; neuroprotection		Cyclophilin D (CypD) has been shown to play a critical role in mitochondrial permeability transition pore (mPTP) opening and the subsequent cell death cascade. Studies consistently demonstrate that mitochondrial dysfunction, including mitochondrial calcium overload and mPTP opening, is essential to the pathobiology of cell death after a traumatic brain injury (TBI). CypD inhibitors, such as cyclosporin A (CsA) or NIM811, administered following TBI, are neuroprotective and quell neurological deficits. However, some pharmacological inhibitors of CypD have multiple biological targets and, as such, do not directly implicate a role for CypD in arbitrating cell death after TBI. Here, we reviewed the current understanding of the role CypD plays in TBI pathobiology. Further, we directly assessed the role of CypD in mediating cell death following TBI by utilizing mice lacking the CypD encoding gene Ppif. Following controlled cortical impact (CCI), the genetic knockout of CypD protected acute mitochondrial bioenergetics at 6 h post-injury and reduced subacute cortical tissue and hippocampal cell loss at 18 d post-injury. The administration of CsA following experimental TBI in Ppif-/- mice improved cortical tissue sparing, highlighting the multiple cellular targets of CsA in the mitigation of TBI pathology. The loss of CypD appeared to desensitize the mitochondrial response to calcium burden induced by TBI; this maintenance of mitochondrial function underlies the observed neuroprotective effect of the CypD knockout. These studies highlight the importance of maintaining mitochondrial homeostasis after injury and validate CypD as a therapeutic target for TBI. Further, these results solidify the beneficial effects of CsA treatment following TBI.	[Readnower, Ryan D.; Hubbard, William Brad; Kalimon, Olivia J.; Geddes, James W.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA; [Readnower, Ryan D.; Hubbard, William Brad; Kalimon, Olivia J.; Geddes, James W.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40508 USA; [Hubbard, William Brad; Sullivan, Patrick G.] Lexington Vet Affairs Healthcare Syst, Lexington, KY 40502 USA		Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA.; Sullivan, PG (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40508 USA.; Sullivan, PG (corresponding author), Lexington Vet Affairs Healthcare Syst, Lexington, KY 40502 USA.	ryan.readnower@gmail.com; bradhubbard@uky.edu; olivia.kalimon@uky.edu; jgeddes@uky.edu; patsullivan@uky.edu		Hubbard, Brad/0000-0001-7018-0148; Sullivan, Patrick/0000-0001-7418-4760; Readnower, Ryan/0000-0001-5350-8754	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS051220, R01 NS062993]; Kentucky Spinal Cord and Head Injury Research Trust	This research was funded by NIH/NINDS R01 NS062993 (JWG and PGS), NIH/NINDS P30NS051220 and funding from the Kentucky Spinal Cord and Head Injury Research Trust.	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BERDEN JHM, 1985, LANCET, V1, P219; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Carroll J, 2019, P NATL ACAD SCI USA, V116, P12816, DOI 10.1073/pnas.1904005116; Centers for Disease Control and Prevention, TBI DATA STAT; CONNERN CP, 1992, BIOCHEM J, V284, P381, DOI 10.1042/bj2840381; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; DAVOLIO C, 1995, NEUROSCI LETT, V192, P29, DOI 10.1016/0304-3940(95)11600-2; DEGROEN PC, 1987, NEW ENGL J MED, V317, P861, DOI 10.1056/NEJM198710013171404; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Gainutdinov T, 2015, ARCH BIOCHEM BIOPHYS, V579, P40, DOI 10.1016/j.abb.2015.05.009; Gauba E, 2017, J ALZHEIMERS DIS, V55, P1351, DOI 10.3233/JAD-160822; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hazelton JL, 2009, J NEUROSCI RES, V87, P1250, DOI 10.1002/jnr.21921; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Hubbard W.B., 2021, CLIN BIOENERGETICS, P385, DOI [10.1016/B978-0-12-819621-2.00017-6, DOI 10.1016/B978-0-12-819621-2.00017-6]; Hubbard WB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45568-3; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Karch J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4597; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P209, DOI 10.1007/BF00691854; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Mnatsakanyan N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13766-2; Mouri A, 2010, HIPPOCAMPUS, V20, P293, DOI 10.1002/hipo.20625; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Neginskaya MA, 2019, CELL REP, V26, P11, DOI 10.1016/j.celrep.2018.12.033; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Springer JE, 2018, J NEUROTRAUM, V35, P492, DOI 10.1089/neu.2017.5167; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tanveer A, 1996, EUR J BIOCHEM, V238, P166, DOI 10.1111/j.1432-1033.1996.0166q.x; Urbani A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12331-1; Vekaria HJ, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104866; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Yonutas HM, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113243; Zhou WC, 2017, ELIFE, V6, DOI 10.7554/eLife.23781; Zhu YJ, 2015, J NEUROSCI METH, V254, P73, DOI 10.1016/j.jneumeth.2015.07.022	76	1	1	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	FEB	2021	10	2							199	10.3390/cells10020199			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	QN3VD	WOS:000622390600001	33498273	Green Published, gold			2022-02-06	
J	Resch, C; Hurks, P; de Kloet, A; van Heugten, C				Resch, Christine; Hurks, Petra; de Kloet, Arend; van Heugten, Caroline			Rationale and description of BrainLevel: Computerized repeated practice with strategy use instruction for children with acquired brain injury	CLINICAL REHABILITATION			English	Article						Cognitive rehabilitation; metacognition; training; traumatic brain injury; adolescence		Objective: In this paper, we provide the rationale behind and a description of BrainLevel, a new cognitive rehabilitation intervention for children with acquired brain injury. Rationale: Children with acquired brain injury frequently report cognitive problems and consequently problems in participation, psychosocial functioning, family functioning and quality of life. Computerized repeated practice of specific cognitive tasks (so-called 'brain training') improves performance on those specific or highly similar tasks, but rarely leads to better daily life functioning. Adding strategy use instruction as an intervention component, with the aim to transfer task-specific effects to other contexts, may yield positive effects on cognitive and daily life functioning of children with acquired brain injury. Description of the new intervention: In BrainLevel, computerized repeated practice is offered via the online training programme BrainGymmer. For the strategy use instruction, we developed a protocol to provide and practice function-specific and metacognitive strategies. The intervention period is 6 weeks, during which children train five times per week for 30 minutes per day at home with BrainGymmer. Additionally, they attend a weekly 45-minute strategy use instruction session on the basis of our protocol with a cognitive rehabilitation specialist. Discussion: BrainLevel is innovative in combining computerized repeated practice with strategy use instruction as cognitive rehabilitation for children with acquired brain injury. Currently, we are investigating the effectiveness of BrainLevel. In this paper, possible adaptations to tailor BrainLevel to other games or contexts, or to incorporate novel scientific insights, for example regarding optimal intervention duration and intensity, are discussed.	[Resch, Christine; Hurks, Petra; van Heugten, Caroline] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands; [Resch, Christine; van Heugten, Caroline] Limburg Brain Injury Ctr, Maastricht, Netherlands; [de Kloet, Arend] Hague Univ Appl Sci, The Hague, Netherlands; [de Kloet, Arend] Basalt Rehabil, The Hague, Netherlands; [van Heugten, Caroline] Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Maastricht, Netherlands		van Heugten, C (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, POB 616, NL-6200 MD Maastricht, Netherlands.	caroline.vanheugten@maastrichtuniversity.nl		Resch, Christine/0000-0003-2797-6137	Johanna Kinderfonds [2014/0039-1552]; Stichting Rotterdams Kinderrevalidatie Fonds Adriaanstichting [14.09.30-2014/0039]; Cornelia-Stichting [2014/0039-1552]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The development of the interventin was funded by Johanna Kinderfonds (Project ID: 2014/0039-1552), Cornelia-Stichting (Project ID: 2014/0039-1552), and Stichting Rotterdams Kinderrevalidatie Fonds Adriaanstichting (Project ID: 14.09.30-2014/0039).	Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Bangirana P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-96; Bosson MS, 2010, AUST J LEARN DIFFIC, V15, P13, DOI 10.1080/19404150903524523; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Diamond A, 2016, DEV COGN NEUROS-NETH, V18, P34, DOI 10.1016/j.dcn.2015.11.005; Dunning DL, 2014, MEM COGNITION, V42, P854, DOI 10.3758/s13421-014-0410-5; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Godin H., 2017, ED CHILD PSYCHOL, V34, P110; Hardy KK, 2013, PSYCHO-ONCOLOGY, V22, P1856, DOI 10.1002/pon.3222; Hardy KK, 2011, J PEDIATR ONCOL NURS, V28, P27, DOI 10.1177/1043454210377178; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Karbach J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00390; Keenan HT., 2007, PEDIATRICS, V119; Kesler SR, 2011, BRAIN INJURY, V25, P101, DOI 10.3109/02699052.2010.536194; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Limond J, 2014, CLIN NEUROPSYCHOL, V28, P181, DOI 10.1080/13854046.2013.873083; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; MEICHENBAUM DH, 1971, J ABNORM PSYCHOL, V77, P115, DOI 10.1037/h0030773; Peijnenborgh JCAW, 2016, NEUROPSYCHOL REHABIL, V26, P645, DOI 10.1080/09602011.2015.1026356; Prins PJM, 2011, CYBERPSYCH BEH SOC N, V14, P115, DOI 10.1089/cyber.2009.0206; Resch C, 2018, BRAIN INJURY, V32, P679, DOI 10.1080/02699052.2018.1458335; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Rossignoli-Palomeque T, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00565; van de Ven RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172993; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Verhelst H, 2017, GAMES HEALTH J, V6, P28, DOI 10.1089/g4h.2016.0043; Wang ZW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00217; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430	34	1	1	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JUN	2021	35	6					787	800	0269215521989652	10.1177/0269215521989652		FEB 2021	14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	SP2QU	WOS:000631239900001	33517763	Green Published, hybrid			2022-02-06	
J	Rosyidi, RM; Wardhana, DPW; Apriawan, T; Al Fauzi, A; Priyanto, B; Gunawan, K; Nugroho, SW; Prihastomo, KT; Nasution, MD; Ihwan, A				Rosyidi, Rohadi Muhammad; Wardhana, Dewa Putu Wisnu; Apriawan, Tedy; Al Fauzi, Asra; Priyanto, Bambang; Gunawan, Kevin; Nugroho, Setyo Widi; Prihastomo, Krisna Tsaniadi; Nasution, Muhammad Deni; Ihwan, Andi			Algorithm of traumatic brain injury management at Indonesia in the COVID 19 pandemic ERA. Retrospective cohort study	ANNALS OF MEDICINE AND SURGERY			English	Article						Covid 19; Traumatic brain injury; Management of neurotrauma		Objectives: COVID-19, a global pandemic, affects neurosurgical care in Indonesia. This study has objective to propose guideline and algorithm recommendation for the management of TBI patients during this pandemic, which can be used flexibly at neurosurgery centers, both in Indonesia and throughout the world. Methods: We performed retrospective Cohort analysis from TBI database at tertiary public general hospitals. All neurotrauma cases from mid-February until mid-August 2020 was included in this study. The chronology of COVID-19 pandemics impact in Indonesia was defined by early period from mid-February until end of May 2020, and late period are latter. All subjects undergone the screening and perioperative measures that based on our proposes scoring system and algorithm as follows. Results: There are many guidelines that explain screening methods in neurosurgery patients in general, as well as neurotrauma in particular. But here, we proposed our own scoring and screening algorithm that has been developed based on conditions in Indonesia. In total of 757 neurotrauma cases data were collected from the pandemic starts in Indonesia. Discussion: Screening is a crucial initial step in this pandemic period, not only for COVID patients, but also all patients who enter the emergency room. The use of PPE is a necessity in several neurosurgery centers, especially with high COVID-19 case rates. Conclusion: The management of neurotrauma patients with suspected and confirmed COVID-19 requires special attention, starting from admission of the patient in ER. Rapid scoring and screening are important and the highest level of PPE is mandatory during patient care.	[Rosyidi, Rohadi Muhammad; Priyanto, Bambang] Mataram Univ, West Nusa Tenggara Gen Hosp, Dept Neurosurg, Med Fac, Mataram, Indonesia; [Wardhana, Dewa Putu Wisnu] Udayana Univ, Udayana Univ Hosp, Dept Neurosurg, Med Fac, Bali, Indonesia; [Apriawan, Tedy; Al Fauzi, Asra] Airlangga Univ, Dr Soetomo Gen Hosp Med Ctr, Dept Neurosurg, Med Fac, Surabaya, East Java, Indonesia; [Gunawan, Kevin; Nugroho, Setyo Widi] Indonesia Univ, Cipto Mangunkusumo Natl Gen Hosp, Dept Neurosurg, Med Fac, Jakarta, Indonesia; [Prihastomo, Krisna Tsaniadi] Dr Kariadi Gen Hosp Med Ctr, Dept Neurosurg, Semarang, Center Java, Indonesia; [Nasution, Muhammad Deni] Sumatera Utara Univ, Dept Neurosurg, Med Fac, Medan, North Sumatera, Indonesia; [Ihwan, Andi] Hasanuddin Univ, Dept Neurosurg, Med Fac, Makassar, South Sulawesi, Indonesia		Rosyidi, RM (corresponding author), Mataram Univ, West Nusa Tenggara Gen Hosp, Dept Neurosurg, Med Fac, Mataram, Indonesia.	rha.ns2010@gmail.com		Dewa Putu, Wisnu Wardhana/0000-0001-9934-9859; Al Fauzi, Asra/0000-0002-5155-2476			Agha R, 2019, INT J SURG, V72, P156, DOI 10.1016/j.ijsu.2019.11.002; Anjorin A., 2020, ASIAN PAC J TROP MED, V13, P199, DOI [10.4103/1995-7645.281612., DOI 10.4103/1995-7645.281612]; Bhaskar S., 2020, FRONT NEUROL, V11, P1; Burke J.F., 2020, NEUROSURGERY, P1; Chen P, 2020, CHIN J TRAUMATOL, V23, P202, DOI 10.1016/j.cjtee.2020.05.006; Cozzi D., 2019, RADIOL MED, V2020; Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006; Emejulu JK, 2020, WORLD NEUROSURG, V138, pE705, DOI 10.1016/j.wneu.2020.03.036; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Li Y., 2020, AM J ROENTGENOL, V214, P1280, DOI [10.2214/AJR.20.22954, DOI 10.2214/AJR.20.22954, DOI 10.1556/084.2020.00001]; Li Y, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00312-5; Peeling R.W., 2020, LANCET INFECT DIS, V3099, P1; Rath G, 2016, PRACT GUIDEL ANESTH, V2014, P53, DOI DOI 10.5005/JP/BOOKS/12644_7; Royal College of Surgeons, 2020, GUID SURG WORK COVID, P3; Salazar LRM, 2020, J NEUROSCI RURAL PRA, V11, P474, DOI 10.1055/s-0040-1712553; Song C-Y, 2020, COVID 19 EARLY WARNI, DOI DOI 10.1101/2020.03.05.20031906; Tan YT, 2020, CURR MED SCI, V40, P281, DOI 10.1007/s11596-020-2173-5; The Society of British Neurological Surgeons, 2020, CLIN GUID MAN NEUR P; Unden J., 2020, BMC MED, V11, P24; Waller JV, 2020, AM J ROENTGENOL, V215, P834, DOI 10.2214/AJR.20.23418; World Health Organization (WHO), 2020, 17 WHO, V17	21	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	FEB	2021	62						98	103		10.1016/j.amsu.2021.01.008			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	QK4ZW	WOS:000620396100021	33520203	Green Accepted, Green Published, gold			2022-02-06	
J	Snyder, A; Sheridan, C; Tanner, A; Bickart, K; Sullan, M; Craske, M; Choe, M; Babikian, T; Giza, C; Asarnow, R				Snyder, Aliyah; Sheridan, Christopher; Tanner, Alexandra; Bickart, Kevin; Sullan, Molly; Craske, Michelle; Choe, Meeryo; Babikian, Talin; Giza, Christopher; Asarnow, Robert			Cardiorespiratory Functioning in Youth with Persistent Post-Concussion Symptoms: A Pilot Study	JOURNAL OF CLINICAL MEDICINE			English	Article						autonomic functioning; concussion; cardiorespiratory; brain injury; end-tidal CO2; post-concussion symptoms; mild traumatic brain injury		Dysregulation of the autonomic nervous system (ANS) may play an important role in the development and maintenance of persistent post-concussive symptoms (PPCS). Post-injury breathing dysfunction, which is influenced by the ANS, has not been well-studied in youth. This study evaluated cardiorespiratory functioning at baseline in youth patients with PPCS and examined the relationship of cardiorespiratory variables with neurobehavioral outcomes. Participants were between the ages of 13-25 in two groups: (1) Patients with PPCS (concussion within the past 2-16 months; n = 13) and (2) non-injured controls (n = 12). Capnometry was used to obtain end-tidal CO2 (EtCO2), oxygen saturation (SaO(2)), respiration rate (RR), and pulse rate (PR) at seated rest. PPCS participants exhibited a reduced mean value of EtCO2 in exhaled breath (M = 36.3 mmHg, SD = 2.86 mmHg) and an altered inter-correlation between EtCO2 and RR compared to controls. Neurobehavioral outcomes including depression, severity of self-reported concussion symptoms, cognitive catastrophizing, and psychomotor processing speed were correlated with cardiorespiratory variables when the groups were combined. Overall, results from this study suggest that breathing dynamics may be altered in youth with PPCS and that cardiorespiratory outcomes could be related to a dimension of neurobehavioral outcomes associated with poorer recovery from concussion.	[Snyder, Aliyah; Babikian, Talin; Asarnow, Robert] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Snyder, Aliyah; Sheridan, Christopher; Bickart, Kevin; Choe, Meeryo; Babikian, Talin; Giza, Christopher; Asarnow, Robert] UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA; [Sheridan, Christopher] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27101 USA; [Tanner, Alexandra; Craske, Michelle; Asarnow, Robert] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Bickart, Kevin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Bickart, Kevin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neuropsychiat, Los Angeles, CA 90095 USA; [Sullan, Molly] Univ Calif San Diego, Psychol Serv, Dept Psychiat, San Diego, CA 92093 USA; [Sullan, Molly] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Choe, Meeryo; Giza, Christopher] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA 90095 USA; [Choe, Meeryo; Giza, Christopher] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Giza, Christopher] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Snyder, A (corresponding author), Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA.; Snyder, A (corresponding author), UCLA Steve Tisch BrainSPORT Program, Los Angeles, CA 90095 USA.	asnyder@mednet.ucla.edu; casherid@wakehealth.edu; tannera@ucla.edu; kbickart@mednet.ucla.edu; msullan@health.ucsd.edu; craske@psych.ucla.edu; mchoe@mednet.ucla.edu; tbabikian@mednet.ucla.edu; cgiza@mednet.ucla.edu; rasarnow@mednet.ucla.edu			UCLA Brain Injury Research Center; UCLA Easton Labs for Brain Injury; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS09229]; Della Martin Foundation; UCLA Steve Tisch BrainSPORT Program	This research was funded by the UCLA Brain Injury Research Center, UCLA Steve Tisch BrainSPORT Program, UCLA Easton Labs for Brain Injury, and Stan and Patty Silver, NINDS NS09229, and the Della Martin Foundation.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Albalawi T, 2017, J NEUROTRAUM, V34, P2700, DOI 10.1089/neu.2017.5060; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Aydemir M, 2010, LUPUS, V19, P255, DOI 10.1177/0961203309351540; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; BLAU JN, 1983, BRIT MED J, V286, P1108, DOI 10.1136/bmj.286.6371.1108; Blom EH, 2014, PSYCHOPHYSIOLOGY, V51, P412, DOI 10.1111/psyp.12188; Boris JR, 2018, AUTON NEUROSCI-BASIC, V215, P97, DOI 10.1016/j.autneu.2018.05.004; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Coffman KE, 2019, EUR J APPL PHYSIOL, V119, P2033, DOI 10.1007/s00421-019-04190-x; Colasanti A, 2008, NEUROPSYCHOPHARMACOL, V33, P3103, DOI 10.1038/npp.2008.31; Corne S, 2003, AM J RESP CRIT CARE, V167, P1193, DOI 10.1164/rccm.2203019; Courtney R, 2009, INT J OSTEOPATH MED, V12, P78, DOI 10.1016/j.ijosm.2009.04.002; Dhokalia A, 1998, PSYCHOSOM MED, V60, P33, DOI 10.1097/00006842-199801000-00007; Dimitriadis Z, 2013, AM J PHYS MED REHAB, V92, P746, DOI 10.1097/PHM.0b013e31829e74f7; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Dony P, 2017, J CLIN ANESTH, V36, P123, DOI 10.1016/j.jclinane.2016.10.028; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fuller-Rowell TE, 2013, J AGING HEALTH, V25, P839, DOI 10.1177/0898264313491427; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Greenberg J, 2020, PSYCHOSOMATICS, V61, P49, DOI 10.1016/j.psym.2019.09.004; Griez E, 1998, J PSYCHOSOM RES, V45, P493, DOI 10.1016/S0022-3999(98)00027-0; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Hilz MJ, 2015, J NEUROTRAUM, V32, P1796, DOI 10.1089/neu.2014.3842; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Houtveen JH, 2002, PSYCHOPHYSIOLOGY, V39, P427, DOI 10.1017/S0048577202394022; Howard L, 2018, HEADACHE, V58, P62; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; IBM Corp, 2019, SPSS STAT VERSION 26; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL., 2012, PTSD MILD TRAUMATIC; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Jyotsna V.P., 2012, INDIAN J, V16, pS489, DOI [10.4103/2230-8210.95692, DOI 10.4103/2230-8210.95692]; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; KRAPF R, 1991, NEW ENGL J MED, V324, P1394, DOI 10.1056/NEJM199105163242003; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; Lampert R, 2005, AM HEART J, V150, P153, DOI 10.1016/j.ahj.2004.08.008; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; LI ST, 1975, J MOL BIOL, V98, P835, DOI 10.1016/S0022-2836(75)80015-5; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Masaoka Y, 1997, INT J PSYCHOPHYSIOL, V27, P153, DOI 10.1016/S0167-8760(97)00052-4; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; Meuret AE, 2008, J PSYCHIATR RES, V42, P560, DOI 10.1016/j.jpsychires.2007.06.005; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Oldenhof H, 2019, J CRIM JUST, V65, DOI 10.1016/j.jcrimjus.2018.05.011; Oneda B, 2010, HYPERTENS RES, V33, P708, DOI 10.1038/hr.2010.74; Papp LA, 1997, AM J PSYCHIAT, V154, P1557; Paulus MP, 2013, DEPRESS ANXIETY, V30, P315, DOI 10.1002/da.22076; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Poyhonen M, 2004, ACTA ANAESTH SCAND, V48, P93, DOI 10.1111/j.1399-6576.2004.00272.x; RAFFERTY GF, 1992, RESP MED, V86, P335, DOI 10.1016/S0954-6111(06)80033-8; Roberson-Nay R, 2015, J BEHAV THER EXP PSY, V47, P68, DOI 10.1016/j.jbtep.2014.10.013; Roth WT, 2005, INT J PSYCHOPHYSIOL, V58, P190, DOI 10.1016/j.ijpsycho.2005.01.015; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P., 2018, ENCY CLIN NEUROPSYCH, P2990, DOI [10.1007/978- 3-319-57111-9_210, DOI 10.1007/978-3-319-57111-9_210]; Shechter A, 2002, NEUROLOGY, V58, P422, DOI 10.1212/WNL.58.3.422; Siedlecki P, 2018, BRAIN INJURY, V32, P1824, DOI 10.1080/02699052.2018.1506945; Silverberg N., 2017, BRAIN INJURY, V31, P719; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Soleimanpour H, 2013, WEST J EMERG MED, V14, P590, DOI 10.5811/westjem.2013.4.14296; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sung CW, 2016, PSYCHOPHYSIOLOGY, V53, P455, DOI 10.1111/psyp.12575; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Teng HC, 2018, EUR J CARDIOVASC NUR, V17, P717, DOI 10.1177/1474515118778453; Thastum MM, 2018, NEUROREHABILITATION, V43, P155, DOI 10.3233/NRE-172391; Toschi-Dias E, 2017, J AFFECT DISORDERS, V214, P74, DOI 10.1016/j.jad.2017.03.017; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Wilhelm FH, 2001, BEHAV MODIF, V25, P513, DOI 10.1177/0145445501254003; Wilhelm FH, 2001, BIOL PSYCHIAT, V49, P596, DOI 10.1016/S0006-3223(00)01000-3; Williamson John B, 2013, Front Neuroeng, V6, P13, DOI 10.3389/fneng.2013.00013; Yuksel H, 2017, J INTEGR MED-JIM, V15, P456, DOI 10.1016/S2095-4964(17)60368-6	84	1	1	4	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	FEB	2021	10	4							561	10.3390/jcm10040561			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP8FB	WOS:000624065400001	33546148	Green Published			2022-02-06	
J	Tian, RF; Dong, JQ; Liu, WM; Zhang, J; Han, FF; Zhang, B; Xu, XJ; Niu, F; Liu, BY				Tian, Runfa; Dong, Jinqian; Liu, Weiming; Zhang, Ji; Han, Feifei; Zhang, Bin; Xu, Xiaojian; Niu, Fei; Liu, Baiyun			Prognostic Analysis of Emergency Decompressive Craniectomy for Patients with Severe Traumatic Brain Injury with Bilateral Fixed Dilated Pupils	WORLD NEUROSURGERY			English	Article						Aggressive treatment; Bilateral fixed dilated pupils; Decompressive craniectomy; Prognostic predictors; Severe traumatic brain injury		OBJECTIVE: For patients with severe traumatic brain injury (sTBI) with bilateral fixed dilated pupils (BFDP), the value of aggressively decompressive craniectomy (DC) treatment is still controversial. The objective of this study was to analyze and validate the outcome of DC in patients with sTBI with BFDP. - METHODS: We retrospectively collected data from 44 patients with sTBI with BFDP who underwent DC treatment from July 2011 to June 2018. Outcomes used as indicators were mortality and favorable outcome. The analysis was based on the Glasgow Outcome Scale score recorded at discharge, 6, and 12 months after trauma. RESULTS: The overall survival was 36.4% (16/44) at discharge and 25.0% (11/44) at 6 and 12 months, and the favorable outcome (Glasgow Outcome Scale score = 4-5) at discharge, 6, and 12 months after injury was 9.1% (4/44), 13.6% (6/44), and 20.5% (9/44), respectively. Sex (P= 0.046), preoperative Glasgow Coma Scale (GCS) score (P= 0.031), injuryesurgery intervals (P = 0.022), and tracheotomy (P = 0.017) were independent associations to 6 and 12 months follow-up survival, whereas only preoperative GCS score (odds ratio, 6.088; confidence interval, 1.172-31.612; P = 0.032) and injuryesurgery intervals (odds ratio, 0.241; confidence interval, 0.065-0.893; P = 0.033) were independent associations with 12 months follow-up favorable outcome. - CONCLUSIONS: BFDP indicates a grave prognostic sign after sTBI, but the higher preoperative GCS score and shorter injuryesurgery intervals in patients who underwent DC treatment might independently predict favorable outcome for patients with sTBI with BFDP, and patients might benefit more than expected if the DC treatment were applied more aggressively and positively.	[Tian, Runfa; Dong, Jinqian; Liu, Weiming; Liu, Baiyun] Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Tian, Runfa; Dong, Jinqian; Liu, Weiming; Zhang, Bin; Xu, Xiaojian; Niu, Fei; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Tian, Runfa; Dong, Jinqian; Liu, Weiming; Zhang, Bin; Xu, Xiaojian; Niu, Fei; Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Tian, Runfa; Dong, Jinqian; Liu, Weiming; Zhang, Bin; Xu, Xiaojian; Niu, Fei; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Zhang, Ji] Sun Yat Sen Univ, State Key Lab Oncol South China, Dept Neurosurg, Guangzhou, Peoples R China; [Han, Feifei] Xuzhou Med Univ, Clin Coll, Dept Diagnost, Xuzhou, Jiangsu, Peoples R China		Liu, BY (corresponding author), Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China.; Liu, BY (corresponding author), Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China.; Liu, BY (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.	liubaiyun1212@163.com	Liu, Weiming/E-7512-2015; Dong, Jinqian/AAP-2298-2021; Liu, Weiming/O-7968-2019	Liu, Weiming/0000-0002-6245-6287; Liu, Weiming/0000-0002-6245-6287	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801225, 81771327]	We express our sorrow to all the patients involved in the current research. These data are not just simple numbers but indicate disaster for whole families. In addition, we would like to acknowledge the assistance of Mengshi Yang, Fei Gao, and Shenghua Lu for their support of this study. This study was supported by National Natural Science Foundation of China (number 81801225 and number 81771327).	Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Chaudhuri K, 2009, INJURY, V40, P28, DOI 10.1016/j.injury.2008.09.004; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Engel DC, 2010, INJURY, V41, P901, DOI 10.1016/j.injury.2010.01.002; Goksu E, 2012, ULUS TRAVMA ACIL CER, V18, P231, DOI 10.5505/tjtes.2012.79059; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Helmy Adel, 2012, Acta Neurochir Suppl, V114, P295, DOI 10.1007/978-3-7091-0956-4_57; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Hyder AA, 2009, HEALTH POLICY, V89, P1, DOI 10.1016/j.healthpol.2008.05.001; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jamous M, 2010, EUR J TRAUMA EMERG S, V36, P465, DOI 10.1007/s00068-010-0002-4; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Li G, 2008, CHIN J TRAUMATOL, V11, P253, DOI 10.1016/S1008-1275(08)60052-8; Mao X, 2015, THER CLIN RISK MANAG, V11, P1627, DOI 10.2147/TCRM.S89820; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Scotter J, 2015, EMERG MED J, V32, P654, DOI 10.1136/emermed-2014-204260; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011	28	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2021	146						E1307	E1317		10.1016/j.wneu.2020.11.162			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QJ6NI	WOS:000619804900040	33307262				2022-02-06	
J	Tomblin, BT; Pritchard, NS; Filben, TM; Miller, LE; Miles, CM; Urban, JE; Stitzel, JD				Tomblin, Brian T.; Pritchard, N. Stewart; Filben, Tanner M.; Miller, Logan E.; Miles, Christopher M.; Urban, Jillian E.; Stitzel, Joel D.			Characterization of On-Field Head Impact Exposure in Youth Soccer	JOURNAL OF APPLIED BIOMECHANICS			English	Article						pediatric; nonconcussive impacts; concussion; head kinematics	CONCUSSION INCIDENCE; BRAIN-INJURY; ACCELERATION; CONTACT; SPORTS	The objective of this research was to characterize head impacts with a validated mouthpiece sensor in competitive youth female soccer players during a single season with a validated mouthpiece sensor. Participants included 14 youth female soccer athletes across 2 club-level teams at different age levels (team 1. ages 12-13 y; team 2, ages 14-15 y). Head impact and time-synchronized video data were collected for 66 practices and games. Video data were reviewed to characterize the type and frequency of contact experienced by each athlete. A total of 2216 contact scenarios were observed; heading the ball (n = 681, 30.7%) was most common. Other observed contact scenarios included collisions, dives, falls, and unintentional ball contact. Team 1 experienced a higher rate of headers per player per hour of play than team 2, while team 2 experienced a higher rate of collisions and dives. A total of 935 video-verified contact scenarios were concurrent with recorded head kinematics. While headers resulted in a maximum linear acceleration of 56.1g, the less frequent head-to-head collisions (n = 6) resulted in a maximum of 113.5g. The results of this study improve the understanding of head impact exposure in youth female soccer players and inform head impact exposure reduction in youth soccer.	[Tomblin, Brian T.; Pritchard, N. Stewart; Filben, Tanner M.; Miller, Logan E.; Miles, Christopher M.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA; [Tomblin, Brian T.; Pritchard, N. Stewart; Filben, Tanner M.; Miller, Logan E.; Miles, Christopher M.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Univ, Sch Biomed Engn & Sci, Virginia Tech, Winston Salem, NC 27101 USA; [Tomblin, Brian T.; Pritchard, N. Stewart; Filben, Tanner M.; Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC 27101 USA		Urban, JE (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC 27101 USA.; Urban, JE (corresponding author), Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC 27101 USA.	jurban@wakehealth.edu		Filben, Tanner/0000-0002-2572-0093	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091602-01A1, R01NS082453, R01NS094410]	The authors would like to thank the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for supporting this study. They would also like to thank Konstantia Strates for her efforts in study coordination. The National Institute of Neurological Disorders and Stroke of the National Institutes of Health, through award numbers R01NS091602-01A1, R01NS082453, and R01NS094410, supported members of the research team who contributed to this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The mouthpiece technology presented herein is patent pending. Dr. Stitzel and Dr. Urban are co-inventors of the mouthpiece technology.	Ambekar D, 2013, IEEE ENG MED BIO, P4167, DOI 10.1109/EMBC.2013.6610463; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Di Salvo V, 2008, J SPORT MED PHYS FIT, V48, P443; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Miller LE, 2020, RES SPORTS MED, V28, P55, DOI 10.1080/15438627.2019.1590833; Miller LE, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039165; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; O'Kane JW, 2016, PHYSICIAN SPORTSMED, V44, P190, DOI 10.1080/00913847.2016.1149423; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Quintero LM, 2020, J APPL BEHAV ANAL, V53, P237, DOI 10.1002/jaba.557; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; U.S. Soccer Federation, 2018, IMPL GUID US SOCC PL; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338	36	1	1	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	FEB	2021	37	1					36	42		10.1123/jab.2020-0071			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	PW8QP	WOS:000610933000007	33152691				2022-02-06	
J	Tsui, CT; MacGillivray, SR; Weber, SM; McAllister, L; Churchward, MA; Dennison, CR; Todd, KG				Tsui, Christopher T.; MacGillivray, Samantha R.; Weber, Savannah M.; McAllister, Lowell; Churchward, Matthew A.; Dennison, Christopher R.; Todd, Kathryn G.			Applying a novel 3D hydrogel cell culture to investigate activation of microglia due to rotational kinematics associated with mild traumatic brain injury	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						mTBI; Glia; Hydrogel; 3D cell culture; Rotational kinematics	LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; DIFFUSE AXONAL INJURY; NITRIC-OXIDE; POSSIBLE INVOLVEMENT; COGNITIVE DEFICITS; MURINE MODEL; HEAD IMPACT; MOUSE MODEL; RAT MODEL; NEURONS	Many investigations on mild traumatic brain injury (mTBI) aim to further understand how cells in the brain react to the mechanical forces associated with the injury. While it is known that rapid head rotation is a mechanism contributing to mTBI, establishing definitive thresholds for head rotation has proved challenging. One way to advance determining mechanisms and thresholds for injury is through in vitro models. Here, an apparatus has been designed that is capable of delivering rotational forces to three-dimensional (3D) hydrogel cell cultures. Using an in vitro model, we test the hypothesis that rotational kinematics can activate microglia suspended in a 3 dimensional mixed glia environment (absent neurons). The impact apparatus was able to deliver peak angular velocities of approximately 45 rad/s, a magnitude for angular velocity that in select literature is associated with diffuse brain injury. However, no measurable glial cell reactivity was observed in response to the rotational kinematics through any of the chosen metrics (nitric oxide, pro-inflammatory cytokine release and proportion of amoeboid activated microglia). The results generated from this study suggest that rotation of the glia alone did not cause activation in future work we will investigate the effect of neuronal contributions in activating glia.	[Tsui, Christopher T.; Weber, Savannah M.; Churchward, Matthew A.; Todd, Kathryn G.] Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB T6G 2G3, Canada; [Tsui, Christopher T.; Weber, Savannah M.; Churchward, Matthew A.; Todd, Kathryn G.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB T6G 2E1, Canada; [Tsui, Christopher T.; Todd, Kathryn G.] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada; [MacGillivray, Samantha R.; McAllister, Lowell; Dennison, Christopher R.] Univ Alberta, Biomed Instrumentat Lab, Dept Mech Engn, Edmonton, AB T6G 1H9, Canada		Todd, KG (corresponding author), Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB T6G 2G3, Canada.	cttsui@ualberta.ca; smacgill@ualberta.ca; smweber@ualberta.ca; lowellm@ualberta.ca; churchwa@ualberta.ca; cdenniso@ualberta.ca; kgtodd@ualberta.ca	Churchward, Matthew/AAG-5046-2021	Churchward, Matthew/0000-0001-5257-3271; Tsui, Christopher/0000-0001-5713-7137	Alberta Health Services; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Davey Endowment for Brain Research; Leaders Opportunity Fund	The authors would like to thank Kyle Koss for helpful discussions during the early stages of the study. The authors are grateful for financial support from Alberta Health Services, the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation, the Davey Endowment for Brain Research, and the Leaders Opportunity Fund.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; [Anonymous], 1583012013 ISO; Arciniegas D., 2006, MILD TRAUMATIC BRAIN; Au NPB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00128; Biasca N., 2005, EUR J TRAUMA, V31, P105, DOI [10.1007/s00068-005-1050-z, DOI 10.1007/S00068-005-1050-Z]; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Chang CH, 2013, 1ST INTERNATIONAL CONFERENCE ON ORANGE TECHNOLOGIES (ICOT 2013), P223, DOI 10.1109/ICOT.2013.6521197; Chen EYT, 2012, J BIOMED MATER RES A, V100A, P2006, DOI 10.1002/jbm.a.34201; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001; Churchward MA, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0085-7; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Das M, 2014, NANOMED-NANOTECHNOL, V10, P1539, DOI 10.1016/j.nano.2014.01.003; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; FAN L, 1995, MOL BRAIN RES, V30, P125; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; GALEA E, 1992, P NATL ACAD SCI USA, V89, P10945, DOI 10.1073/pnas.89.22.10945; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Gennarelli T.A., 1972, COMP TRANSLATIONAL R; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Griess P., 1879, BER DTSCH CHEM GES, V12, P426; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Hernandez F, 2019, J NEUROTRAUM, V36, P1125, DOI 10.1089/neu.2016.4758; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hiskens MI, 2019, J NEUROSCI RES, V97, P1194, DOI 10.1002/jnr.24472; Holbourn AHS, 1943, LANCET, V2, P438; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jeffery AF, 2014, BIOMACROMOLECULES, V15, P2157, DOI 10.1021/bm500318d; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kitamura Y, 1996, EUR J PHARMACOL, V306, P297, DOI 10.1016/0014-2999(96)00212-9; Koerte IK, 2015, FRONT NEUROSCI, V57, P277; Koss K, 2019, MOL NEUROBIOL, V56, P6409, DOI 10.1007/s12035-019-1529-y; Koss KM, 2017, JOVE-J VIS EXP, DOI 10.3791/56615; Koumlis S, 2018, EXP MECH, V58, P125, DOI 10.1007/s11340-017-0338-3; Koumlis S, 2015, EXP MECH, V55, P1441, DOI 10.1007/s11340-015-0052-y; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nash B, 2011, J ANAT, V219, P44, DOI 10.1111/j.1469-7580.2010.01330.x; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Ommaya A.K., 1967, SCALING EXPT DATA CE, DOI [10.4271/670906, DOI 10.4271/670906]; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Peterson SL, 2005, J BIOMED MATER RES A, V72A, P10, DOI 10.1002/jbm.a.30166; Polazzi E, 2001, GLIA, V36, P271, DOI 10.1002/glia.1115; Qin HL, 2017, MED SCI MONITOR, V23, P6099, DOI 10.12659/MSM.905429; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Society of Automotive Engineers, 2014, J211 SAE; Sosnoff JJ, 2008, EXP BRAIN RES, V187, P563, DOI 10.1007/s00221-008-1324-x; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Suk K, 2001, BRAIN RES, V900, P342, DOI 10.1016/S0006-8993(01)02326-5; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Thibault L.E., 1972, SAE TECHNICAL PAPER, P720970, DOI [10.4271/720970, DOI 10.4271/720970]; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Tuzgen S, 2003, NEUROL RES, V25, P31, DOI 10.1179/016164103101201085; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang MJ, 2002, EUR J NEUROSCI, V16, P2103, DOI 10.1046/j.1460-9568.2002.02290.x; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229	94	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	FEB	2021	114								104176	10.1016/j.jmbbm.2020.104176			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	PS8OO	WOS:000608183500006	33184015				2022-02-06	
J	Weston, NM; Rolfe, AT; Freelin, AH; Reeves, TM; Sun, D				Weston, N. M.; Rolfe, A. T.; Freelin, A. H.; Reeves, T. M.; Sun, D.			Traumatic brain injury modifies synaptic plasticity in newly-generated granule cells of the adult hippocampus	EXPERIMENTAL NEUROLOGY			English	Article						Neurogenesis; Traumatic brain injury; Dentate gyrus; Long-term potentiation; Recovery of function	LONG-TERM POTENTIATION; DENTATE GYRUS; ENHANCED NEUROGENESIS; COGNITIVE RECOVERY; STRUCTURAL-CHANGES; NEWBORN NEURONS; CRITICAL PERIOD; INTEGRATION; BORN; RATS	The hippocampus is vulnerable to traumatic brain injury (TBI), and hippocampal damage is associated with cognitive deficits that are often the hallmark of TBI. Recent studies have found that TBI induces enhanced neurogenesis in the dentate gyrus (DG) of the hippocampus, and this cellular response is related to innate cognitive recovery. However, cellular mechanisms of the role of DG neurogenesis in post-TBI recovery remain unclear. This study investigated changes in long-term potentiation (LTP) within the DG in relation to TBI-induced neurogenesis. Adult male rats received a moderate TBI or sham injury and were sacrificed for brain slice recordings at 30 or 60 days post-injury. Recordings were taken from the medial perforant path input to DG granule cells in the presence or absence of the GABAergic antagonist picrotoxin, reflecting activity of either all DG granule cells or predominately newborn granule cells, respectively. Measurements of LTP observed in the total granule cell population (with picrotoxin) showed a prolonged impairment which worsened between 30 and 60 days post-TBI. Under conditions which predominantly reflected the LTP elicited in newly born granule cells (no picrotoxin), a strikingly different pattern of post-TBI changes was observed, with a time-dependent cycle of functional impairment and recovery. At 30 days after injury this cell population showed little or no LTP, but by 60 days the capacity for LTP of the newly born granule cells was no different from that of sham controls. The time-frame of LTP improvements in the newborn cell population, comparable to that of behavioral recovery reported previously, suggests the unique functional properties of newborn granule cells enable them to contribute to restorative change following brain injury.	[Weston, N. M.; Rolfe, A. T.; Freelin, A. H.; Reeves, T. M.; Sun, D.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Med Ctr, Richmond, VA 23298 USA		Reeves, TM; Sun, D (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, MCV Campus Box 980709, Richmond, VA 23298 USA.	thomas.reeves@vcuhealth.org; dong.sun@vcuhealth.org		Freelin, Anne/0000-0001-9998-7914	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS101955, NS093985]	The authors were supported by funding from National Institute of Health, grant numbers: NS101955 (Sun, Reeves) and NS093985 (Sun).	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bortolotto Zuner A, 1800, Curr Protoc Neurosci, VChapter 6, DOI 10.1002/0471142301.ns0613s54; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; CHRISTIE BR, 1994, NEUROREPORT, V5, P385, DOI 10.1097/00001756-199401120-00003; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Drew LJ, 2016, HIPPOCAMPUS, V26, P763, DOI 10.1002/hipo.22557; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Griesbach Grace S, 2015, Handb Clin Neurol, V128, P681, DOI 10.1016/B978-0-444-63521-1.00042-X; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Ikrar T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00204; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lemaire V, 2012, J NEUROSCI, V32, P3101, DOI 10.1523/JNEUROSCI.4731-11.2012; LOMO T, 1971, EXP BRAIN RES, V12, P46; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Phillips LL, 2014, NEURAL REGEN RES, V9, P362, DOI 10.4103/1673-5374.128237; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Suarez-Pereira I, 2015, HIPPOCAMPUS, V25, P51, DOI 10.1002/hipo.22349; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Sun D, 2015, J NEUROTRAUM, V32, P495, DOI 10.1089/neu.2014.3545; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Toni N, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018903; Toth Z, 1997, J NEUROSCI, V17, P8106; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.0.CO;2-J; Wang WS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0160-16.2016; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	65	1	1	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2021	336								113527	10.1016/j.expneurol.2020.113527			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PS7NL	WOS:000608112900006	33188818				2022-02-06	
J	Wong, CK; Ziaks, L; Vargas, S; DeMattos, T; Brown, C				Wong, Christopher Kevin; Ziaks, Lauren; Vargas, Samantha; DeMattos, Tessia; Brown, Chelsea			Sequencing and Integration of Cervical Manual Therapy and Vestibulo-oculomotor Therapy for Concussion Symptoms: Retrospective Analysis	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						vestibular rehabilitation; vision therapy; manual therapy; cervicogenic headache; concussion	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; VESTIBULAR REHABILITATION; PROTRACTED RECOVERY; NECK PAIN; DIZZINESS; INTERVENTIONS; CONVERGENCE; BALANCE; RELIABILITY	Background After concussion many people have cervicogenic headache, visual dysfunction, and vestibular deficits that can be attributed to brain injury, cervical injury, or both. While clinical practice guidelines outline treatments to address the symptoms that arise from the multiple involved systems, no preferred treatment sequence for post-concussion syndrome has emerged. Purpose This study sought to describe the clinical and patient-reported outcomes for people with post-concussion symptoms after a protocol sequenced to address cervical dysfunction and benign paroxysmal positional vertigo within the first three weeks of injury, followed by integrated vision and vestibular therapy. Study Design Retrospective longitudinal cohort analysis Methods Records from a concussion clinic for 38 patients (25 male 13 female, aged 26.9 +/- 19.7 years) with post-concussion symptoms due to sports, falls, assaults, and motor vehicle accident injuries were analyzed. Musculoskeletal, vision, and vestibular system functions were assessed after pragmatic treatment including early cervical manual therapy and canalith repositioning treatment-when indicated-integrated with advanced vision and vestibular rehabilitation. Patient-reported outcomes included the Post-Concussion Symptom Scale (PCSS) for general symptoms; and for specific symptoms, the Dizziness Handicap Index (DHI), Convergence Insufficiency Symptom Scale (CISS), Activities-specific Balance Confidence scale (ABC), and the Brain Injury Vision Symptom Survey (BIVSS). Paired t-tests with Bonferroni correction to minimize familywise error (p<0.05) were used to analyze the clinical and patient-reported outcomes. Results After 10.4 +/- 4.8 sessions over 57.6 +/- 34.0 days, general symptoms improved on the PCSS (p=0.001, 95%CI=12.4-30.6); and specific symptoms on the DHI (p<0.001, 95%CI=14.5-33.2), CISS (p<0.002, 95%CI=7.1-18.3), ABC (p<0.024, 95%CI=-.3 - -.1), and BIVSS (p<0.001, 95%CI=13.4-28.0). Clinical measures improved including cervical range-of-motion (55.6% fully restored), benign paroxysmal positional vertigo symptoms (28/28, fully resolved), Brock string visual convergence (p<0.001, 95%CI=3.3-6.3), and score on the Balance Error Scoring System (p<0.001, 95%CI=5.5-11.6). Conclusion A rehabilitation approach for post-concussion syndrome that sequenced cervical dysfunction and benign paroxysmal positional vertigo treatment within the first three weeks of injury followed by integrated vision and vestibular therapy improved clinical and patient-reported outcomes.	[Wong, Christopher Kevin] Columbia Univ, Irving Med Ctr, Dept Rehabil & Regenerat Med, 617 West 168th St, New York, NY 10032 USA; [Ziaks, Lauren; Brown, Chelsea] Intermt Healthcare, Pk City Hosp, Park City, UT USA; [Vargas, Samantha; DeMattos, Tessia] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10032 USA		Wong, CK (corresponding author), Columbia Univ, Irving Med Ctr, Dept Rehabil & Regenerat Med, 617 West 168th St, New York, NY 10032 USA.						Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Argaet EC, 2019, CLIN NEUROPHYS PRACT, V4, P97, DOI 10.1016/j.cnp.2019.03.001; Bexander CSM, 2012, EXP BRAIN RES, V217, P67, DOI 10.1007/s00221-011-2973-8; Chaibi A, 2012, J HEADACHE PAIN, V13, P351, DOI 10.1007/s10194-012-0436-7; Dunning JR, 2012, J ORTHOP SPORT PHYS, V42, P5, DOI 10.2519/jospt.2012.3894; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Heick JD, 2018, INT J SPORTS PHYS TH, V13, P808, DOI 10.26603/ijspt20180808; Hilton MP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003162.pub3; Kim EH, 2010, INVEST OPHTH VIS SCI, V51, P4017, DOI 10.1167/iovs.09-4560; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Luedtke K, 2016, CEPHALALGIA, V36, P474, DOI 10.1177/0333102415597889; Lundblad M, 2017, INT J SPORTS PHYS TH, V12, P286; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Matuseviciene G, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018734; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; Mestre C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206674; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Reid SA, 2014, ARCH PHYS MED REHAB, V95, P1603, DOI 10.1016/j.apmr.2014.04.009; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Scheiman M., 2002, UNDERSTANDING MANAGI, V2nd; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Tiwari D, 2019, INT J SPORTS PHYS TH, V14, P282, DOI 10.26603/ijspt20190282; Treleaven J, 2006, AUST J PHYSIOTHER, V52, P67, DOI 10.1016/S0004-9514(06)70070-8; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Varatharajan S, 2016, EUR SPINE J, V25, P1971, DOI 10.1007/s00586-016-4376-9; Ziaks L, 2019, INTERNET J ALLIED HE, V17	40	1	1	2	2	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	FEB	2021	16	1					12	20		10.26603/001c.18825			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	QK9GD	WOS:000620685800003	33604130	gold, Green Published			2022-02-06	
J	Yeh, PC; Gilbert-Baffoe, E; Michael, A; Frontera, J				Yeh, Peter Chia; Gilbert-Baffoe, Ekua; Michael, Ashley; Frontera, Joel			Assessing Physical Medicine and Rehabilitation Residency Education Using the Neurological Assessment Competency Evaluation System	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Education; Spinal Cord Injury; Brain Injury; Evaluation System		Competent neurologic examination and clinical skills are essential components in the care for patients in acute hospital and rehabilitation settings. To enhance the evaluation and education of Physical Medicine and Rehabilitation residents, the authors developed an educational objective structured clinical examination, the Neurological Exam Assessment Competency Evaluation System, and gathered 2 yrs of baseline data. The Neurological Exam Assessment Competency Evaluation System consisted of nine 9-min examination stations, seven with written clinical scenario with instructions for junior residents to complete the appropriate examination (stations: Altered Mental Status, Mild Traumatic Brain Injury, Dementia, Stroke, Falls, and the International Standards for Neurological Classification of Spinal Cord Injury Sensory and Motor Examinations). Examinees provided written responses to posed questions for the other two stations-Modified Ashworth Scale and brachial plexus. The assessment tools for this examination were designed for residency programs to evaluate the basic competencies as outlined by the Accreditation Council for Graduate Medical Education and Physical Medicine and Rehabilitation milestones. Based on the feedback received from the examinees and examiners, the Neurological Exam Assessment Competency Evaluation System can serve as an educational objective structured clinical examination for the improvement of trainee core competencies.	[Yeh, Peter Chia; Gilbert-Baffoe, Ekua; Michael, Ashley] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX USA; [Frontera, Joel] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, UT Hlth, Houston, TX USA		Yeh, PC (corresponding author), Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, 7200 Cambridge St,Suite 10C, Houston, TX 77030 USA.						Accreditation Council for Graduate Medical Education, 2019, ACGME PROGRAM REQUIR; [Anonymous], 2014, J Grad Med Educ, V6, P207, DOI 10.4300/JGME-06-01s1-26; Button JH, 2007, AM J PHYS MED REHAB, V86, P926, DOI 10.1097/PHM.0b013e318152027b; Chawla Jasvinder P S, 2011, Front Neurol, V2, P17, DOI 10.3389/fneur.2011.00017; Feddock CA, 2007, AM J MED, V120, P374, DOI 10.1016/j.amjmed.2007.01.023; Goldstein EA, 2005, ACAD MED, V80, P423, DOI 10.1097/00001888-200505000-00003; Gottlieb M, 2021, AEM EDUC TRAIN, V5, DOI 10.1002/aet2.10519; HARDEN RM, 1975, BRIT MED J, V1, P447, DOI 10.1136/bmj.1.5955.447; JAIN SS, 1994, AM J PHYS MED REHAB, V73, P234, DOI 10.1097/00002060-199407000-00002; Jain SS, 1997, AM J PHYS MED REHAB, V76, P102, DOI 10.1097/00002060-199703000-00003; Kogan JR, 2009, JAMA-J AM MED ASSOC, V302, P1316, DOI 10.1001/jama.2009.1365; Lin L, 2013, AM J PHYS MED REHAB, V92, P258, DOI 10.1097/PHM.0b013e3182745ed9; Wijeratne Don Thiwanka, 2018, Can Med Educ J, V9, pe78; Willoughby Julian, 2015, AMA J Ethics, V17, P515, DOI 10.1001/journalofethics.2015.17.6.medu1-1506; Yang YR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208609; Zaman J, 2016, SOUTH MED J, V109, P754, DOI 10.14423/SMJ.0000000000000573	16	1	1	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2021	100	2S		1			S40	S44		10.1097/PHM.0000000000001649			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PS1UP	WOS:000607715500009	33252472				2022-02-06	
J	Huang, DD; Siaw-Debrah, F; Wang, H; Ye, S; Wang, KK; Wu, K; Zhang, Y; Wang, H; Yao, CJ; Chen, JY; Yan, L; Zhang, CL; Zhuge, QC; Yang, JJ				Huang, Dongdong; Siaw-Debrah, Felix; Wang, Hua; Ye, Sheng; Wang, Kankai; Wu, Ke; Zhang, Ying; Wang, Hao; Yao, Chaojie; Chen, Jiayu; Yan, Lin; Zhang, Chun-Li; Zhuge, Qichuan; Yang, Jianjing			Transplanting Rac1-silenced bone marrow mesenchymal stem cells promote neurological function recovery in TBI mice	AGING-US			English	Article						BMMSCs; NADPH; Rac1; TBI; neurological function recovery	TRAUMATIC BRAIN-INJURY; RESPIRATORY BURST OXIDASE; STROMAL CELLS; MOLECULAR-MECHANISMS; NADPH OXIDASES; UNITED-STATES; RHO GTPASES; NOX FAMILY; APOPTOSIS; PHOSPHORYLATION	Bone marrow mesenchymal stem cells (BMMSCs)-based therapy has emerged as a promising novel therapy for Traumatic Brain Injury (TBI). However, the therapeutic quantity of viable implanted BMMSCs necessary to initiate efficacy is still undetermined. Increased oxidative stress following TBI, which leads to the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase signaling pathway, has been implicated in accounting for the diminished graft survival and therapeutic effect. To prove this assertion, we silenced the expression of NADPH subunits (p22-phox, p47-phox, and p67-phox) and small GTPase Rac1 in BMMSCs using shRNA. Our results showed that silencing these proteins significantly reduced oxidative stress and cell death/apoptosis, and promoted implanted BMMSCs proliferation after TBI. The most significant result was however seen with Rac1 silencing, which demonstrated decreased expression of apoptotic proteins, enhanced in vitro survival ratio, reduction in TBI lesional volume and significant improvement in neurological function post shRac1-BMMSCs transplantation. Additionally, two RNA-seq hub genes (VEGFA and MMP-2) were identified to play critical roles in shRac1-mediated cell survival. In summary, we propose that knockdown of Rac1 gene could significantly boost cell survival and promote the recovery of neurological functions after BMMSCs transplantation in TBI mice.	[Huang, Dongdong; Siaw-Debrah, Felix; Wang, Hua; Ye, Sheng; Wang, Kankai; Wu, Ke; Zhang, Ying; Wang, Hao; Yao, Chaojie; Chen, Jiayu; Yan, Lin; Zhuge, Qichuan; Yang, Jianjing] Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China; [Huang, Dongdong; Siaw-Debrah, Felix; Wang, Hua; Ye, Sheng; Wang, Kankai; Wu, Ke; Zhang, Ying; Wang, Hao; Yao, Chaojie; Chen, Jiayu; Yan, Lin; Zhuge, Qichuan; Yang, Jianjing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou 325000, Peoples R China; [Zhang, Chun-Li] Univ Texas Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA		Zhuge, QC; Yang, JJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China.; Zhuge, QC; Yang, JJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou 325000, Peoples R China.	qc.zhuge@wmu.edu.cn; yangjianjing@wmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771262]; Zhejiang Health Science and Technology Project [2016RCA022]; Zhejiang Key Research and Development Project [2017C03027]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LQ20H090005]	This study was supported by the National Natural Science Foundation of China (No. 81771262), Zhejiang Health Science and Technology Project (2016RCA022), Zhejiang Key Research and Development Project (2017C03027), and Zhejiang Provincial Natural Science Foundation of China (LQ20H090005).	Amiri F, 2015, CELL STRESS CHAPERON, V20, P237, DOI 10.1007/s12192-014-0560-1; Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cuadrado A, 2014, J BIOL CHEM, V289, P15244, DOI 10.1074/jbc.M113.540633; Cui YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127309; DIEKMANN D, 1994, SCIENCE, V265, P531, DOI 10.1126/science.8036496; Dietrich J, 2019, STEM CELL RES, V38, DOI 10.1016/j.scr.2019.101477; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Feng Y, 2017, MOL MED REP, V16, P654, DOI 10.3892/mmr.2017.6619; Gu WD, 2012, NEUROL RES, V34, P172, DOI 10.1179/1743132811Y.0000000068; Guo SW, 2017, NEUROPSYCH DIS TREAT, V13, P2757, DOI 10.2147/NDT.S141534; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Hinz N, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0450-3; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; HOGE CW, 2004, US ARMY MED DEP J, V351, P13; Horie N, 2015, NEUROL MED-CHIR, V55, P107, DOI 10.2176/nmc.ra.2014-0271; Hu JN, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1210-4; Jamieson C, 2015, J CELL SCI, V128, P3933, DOI 10.1242/jcs.167742; Karabiyik C, 2018, BRAIN PATHOL, V28, P569, DOI 10.1111/bpa.12562; Kim GD, 2013, INT J ONCOL, V43, P600, DOI 10.3892/ijo.2013.1959; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P417, DOI 10.1167/iovs.10-6140; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Ma YH, 2012, J NEUROSCI RES, V90, P1873, DOI 10.1002/jnr.23088; Malgieri A, 2010, INT J CLIN EXP MED, V3, P248; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Pauwels K, 2009, CURR GENE THER, V9, P459, DOI 10.2174/156652309790031120; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Santabarbara-Ruiz P, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007926; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Smith DK, 2016, STEM CELL REP, V7, P955, DOI 10.1016/j.stemcr.2016.09.013; Stiehler M, 2016, STEM CELL RES, V16, P782, DOI 10.1016/j.scr.2016.03.013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Uetake Y, 2018, MOL BIOL CELL, V29, P2632, DOI 10.1091/mbc.E18-01-0026; Volpe G, 2019, J NEUROIMMUNOL, V331, P11, DOI 10.1016/j.jneuroim.2016.12.005; Wei L, 2017, PROG NEUROBIOL, V157, P49, DOI 10.1016/j.pneurobio.2017.03.003; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wei ZZ, 2015, CELL TRANSPLANT, V24, P391, DOI 10.3727/096368915X686887; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wu F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/293271; Wu K, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1428-1; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Yao MH, 2019, BIOMATER SCI-UK, V7, P4088, DOI 10.1039/c9bm00749k; Yuan L, 2014, J AGR FOOD CHEM, V62, P5390, DOI 10.1021/jf500903g; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015	60	1	1	1	1	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	JAN 31	2021	13	2					2822	2850		10.18632/aging.202334			29	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	QC2AV	WOS:000614637600001	33411679	Green Published, gold			2022-02-06	
J	Boltzmann, M; Schmidt, SB; Gutenbrunner, C; Krauss, JK; Stangel, M; Hoglinger, GU; Wallesch, CW; Rollnik, JD				Boltzmann, Melanie; Schmidt, Simone B.; Gutenbrunner, Christoph; Krauss, Joachim K.; Stangel, Martin; Hoeglinger, Guenter U.; Wallesch, Claus-W.; Rollnik, Jens D.			The influence of the CRS-R score on functional outcome in patients with severe brain injury receiving early rehabilitation	BMC NEUROLOGY			English	Article						Disorders of Consciousness (DoC); Coma Recovery Scale-Revised (CRS-R); Neurological Early Rehabilitation; Prognosis; Functional Outcome		BackgroundThe aim of the study was to determine the role of the Coma Recovery Scale-Revised (CRS-R) in the prediction of functional status at the end of neurological early rehabilitative treatment.MethodsPatients consecutively admitted to intensive or intermediate care units of a neurological rehabilitation center were enrolled in the study. Consciousness and functional status were assessed with the Coma Recovery Scale-Revised (CRS-R) and the Early Rehabilitation Barthel Index (ERBI), respectively. Both assessments were carried out weekly within the first month and at the end of early rehabilitation. Patient and clinical data were entered into a binary logistic regression model to predict functional status at discharge.Results327 patients (112 females, 215 males) with a median age of 63 years (IQR=53-75) and a median disease duration of 18 days (IQR=12-28) were included. Most patients suffered from stroke (59%), followed by traumatic brain injury (31%), and hypoxic ischemic encephalopathy (10%). Upon admission, 12% were diagnosed as comatose, 31% as unresponsive wakefulness syndrome (UWS), 35% as minimally conscious state (MCS) and 22% already emerged from MCS (eMCS). Of all patients undergoing complete early rehabilitative treatment (n=180), 72% showed improvements in level of consciousness (LOC). In this group, age, initial CRS-R score and gains in CRS-R score after four weeks independently predicted functional outcome at discharge.ConclusionsThe study confirms the relevance of the CRS-R score for functional outcome prediction. High CRS-R scores and young age facilitate functional improvements and increase the probability to continue treatment in subsequent rehabilitation phases. Moreover, results indicate that recovery might occur over a period of time that extends beyond acute care.	[Boltzmann, Melanie; Schmidt, Simone B.; Rollnik, Jens D.] Hannover Med Sch, BDH Clin Hessisch Oldendorf, Associated Inst, Inst Neurorehabilitat Res, Hessisch Oldendorf, Germany; [Gutenbrunner, Christoph] Hannover Med Sch, Dept Rehabil Med, Hannover, Germany; [Krauss, Joachim K.] Hannover Med Sch, Dept Neurosurg, Hannover, Germany; [Stangel, Martin] Hannover Med Sch, Sect Clin Neuroimmunol & Neurochem, Dept Neurol, Hannover, Germany; [Hoeglinger, Guenter U.] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Wallesch, Claus-W.] BDH Clin Elzach, Elzach, Germany		Boltzmann, M (corresponding author), Hannover Med Sch, BDH Clin Hessisch Oldendorf, Associated Inst, Inst Neurorehabilitat Res, Hessisch Oldendorf, Germany.	m.boltzmann@bdh-klinik-hessisch-oldendorf.de					Aubinet C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00665; Bagnato S, 2017, J NEUROTRAUM, V34, P535, DOI 10.1089/neu.2016.4418; Boltzmann M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4719279; Boly M, 2008, LANCET NEUROL, V7, P1013, DOI 10.1016/S1474-4422(08)70219-9; Bruno M-A., 2012, COMA DISORDERS CONSC, P11, DOI [DOI 10.1007/978-1-4471-2440-5_2, 10.1007/978-1-4471-2440-5_2]; Chang Eric Y, 2013, Crit Rev Phys Rehabil Med, V25, P203; Chatelle C, 2014, BRAIN INJURY, V28, P1202, DOI 10.3109/02699052.2014.920518; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hamilton JA, 2020, NEUROPSYCHOL REHABIL, V30, P266, DOI 10.1080/09602011.2018.1461656; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lucca LF, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1293-7; MAHONEY F I, 1965, Md State Med J, V14, P61; Maurer-Karattup P., 2010, NEUROL REHABIL, V16, P232; Pistoia F, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0374-3; Pohl M, 2010, REHABILITATION, V49, P22, DOI 10.1055/s-0029-1246153; Portaccio E, 2018, ARCH PHYS MED REHAB, V99, P914, DOI 10.1016/j.apmr.2018.01.015; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; Posner JB, 2007, PLUM POSNERS DIAGNOS; Rollnik JD, 2011, REHABILITATION, V50, P408, DOI 10.1055/s-0031-1273728; Rollnik JD, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-34; Rollnik JD, 2010, DTSCH ARZTEBL INT, V107, P286, DOI 10.3238/arztebl.2010.0286; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Schonle PW., 2000, INT HDB NEUROPSYCHOL, P327, DOI [10.1007/978-1-4757-5569-5_22, DOI 10.1007/978-1-4757-5569-5_22]; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Seminog OO, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1778; Sutton JA, 2017, BRAIN INJURY, V31, P1019, DOI 10.1080/02699052.2017.1300836; Thibaut A, 2020, J NEUROL, V267, P1245, DOI 10.1007/s00415-019-09628-y; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	38	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JAN 30	2021	21	1							44	10.1186/s12883-021-02063-5			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QE8MY	WOS:000616461000002	33514337	Green Published, gold			2022-02-06	
J	Iverson, GL; Karr, JE; Hong, Y; Yang, CC; Maxwell, B; Berkner, PD				Iverson, Grant L.; Karr, Justin E.; Hong, Yue; Yang, Chi-Cheng; Maxwell, Bruce; Berkner, Paul D.			Baseline preseason ImPACT(R) testing in Mandarin with adolescent student-athletes in the United States	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article; Early Access						Adolescent; brain concussion; cross-cultural comparison; neuropsychology		Researchers have examined differences on ImPACT(R) in baseline symptom reporting and neurocognitive performances based on the language of administration and racial/ethnic identity. This is the first study to examine differences between student-athletes tested in Mandarin versus English on ImPACT(R) during preseason baseline assessments conducted in high schools in the United States. Participants included 252 adolescent student-athletes who completed ImPACT(R) testing in the state of Maine in Mandarin and 252 participants who completed testing in English, matched on age, gender, and health and academic history. Participants were compared on neurocognitive composite scores and symptom ratings. Boys tested in Mandarin, but not girls, had modestly better neurocognitive performance on one of four composite scores (i.e., Visual Motor Speed, p < .001, d = .45). Although language groups did not differ in total symptom severity, boys tested in Mandarin endorsed multiple physical symptoms at higher rates than boys tested in English. These results suggest that the current ImPACT(R) neurocognitive normative data are reasonably appropriate for use with adolescents evaluated in Mandarin. There were some differences in the reporting of physical symptoms, with greater rates of symptom endorsement by boys tested in Mandarin than boys tested in English; but overall symptom severity ratings were comparable between the language groups.	[Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Res Inst, 79-96 Thirteenth St, Charlestown, MA 02129 USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Karr, Justin E.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Hong, Yue] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; [Hong, Yue] A Red Sox Fdn, Home Base, Charlestown, MA USA; [Hong, Yue] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Yang, Chi-Cheng] Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan; [Yang, Chi-Cheng] Taipei City Hosp, Holist Mental Hlth Ctr, Taipei, Taiwan; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Berkner, Paul D.] Univ New England, Hlth Serv, Biddeford, ME USA		Iverson, GL (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Harvard Med Sch, Spaulding Res Inst, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu		YANG, CHI CHENG/0000-0002-4544-3978; Karr, Justin/0000-0003-3653-332X; Iverson, Grant/0000-0001-7348-9570			Akutsu PD, 2006, PROF PSYCHOL-RES PR, V37, P407, DOI 10.1037/0735-7028.37.4.407; Bagayogo IP, 2013, ADV PSYCHOSOM MED, V33, P64, DOI 10.1159/000350057; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P216, DOI 10.1093/arclin/acx059; Brett BL, 2016, ARCH CLIN NEUROPSYCH, V31, P904, DOI 10.1093/arclin/acw055; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; Cohen J., 2013, STAT POWER ANAL BEHA; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Gregoire J, 2018, INT J TEST, V18, P101, DOI 10.1080/15305058.2017.1398166; Grover S, 2014, ASIAN J PSYCHIATR, V7, P77, DOI 10.1016/j.ajp.2013.11.014; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; Houck ZM, 2020, CLIN NEUROPSYCHOL, V34, P561, DOI 10.1080/13854046.2019.1666923; ImPACT Applications Inc, 2011, IMMEDIATE POSTCONCUS; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kuo BCH, 2004, J MULTICULT COUNS D, V32, P143, DOI 10.1002/j.2161-1912.2004.tb00367.x; Mason SJ, 2020, ARCH CLIN NEUROPSYCH, V35, P1131, DOI 10.1093/arclin/acaa047; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Peltonen K, 2019, CHILD NEUROPSYCHOL, V25, P336, DOI 10.1080/09297049.2018.1474865; Ryan C., 2013, AM COMMUNITY SURVEY; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Sirin SR, 2013, DEV PSYCHOL, V49, P736, DOI 10.1037/a0028398; Sue S., 2000, CONDUCTING PSYCHOL R; Tsushima WT, 2017, ARCH CLIN NEUROPSYCH, V32, P450, DOI 10.1093/arclin/acx025; Vartiainen MV, 2021, APPL NEUROPSYCH-ADUL, V28, P53, DOI 10.1080/23279095.2019.1592175; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; Womble MN, 2016, ARCH CLIN NEUROPSYCH, V31, P305, DOI 10.1093/arclin/acw011; Wong TM, 2004, APPL NEUROPSYCHOL, V11, P23, DOI 10.1207/s15324826an1101_4; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	48	1	1	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child												10.1080/21622965.2021.1881897		JAN 2021	11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	QH0ZJ	WOS:000618005900001	33583284				2022-02-06	
J	Grassi, DC; Zaninotto, AL; Feltrin, FS; Macruz, FBC; Otaduy, MCG; Leite, CC; Guirado, VMP; Paiva, WS; Andrade, CS				Grassi, Daphine Centola; Zaninotto, Ana Luiza; Feltrin, Fabricio Stewan; Macruz, Fabiola Bezerra Carvalho; Otaduy, Maria Concepcion Garcia; Leite, Claudia Costa; Guirado, Vinicius Monteiro Paula; Paiva, Wellingson Silva; Santos Andrade, Celi			Dynamic changes in white matter following traumatic brain injury and how diffuse axonal injury relates to cognitive domain	BRAIN INJURY			English	Article						Brain injury; white matter; MRI; DTI; tractography; cognition		Objective: The goal is to evaluate longitudinally with diffusion tensor imaging (DTI) the integrity of cerebral white matter in patients with moderate and severe DAI and to correlate the DTI findings with cognitive deficits. Methods: Patients with DAI (n = 20) were scanned at three timepoints (2, 6 and 12 months) after trauma. A healthy control group (n = 20) was evaluated once with the same high-field MRI scanner. The corpus callosum (CC) and the bilateral superior longitudinal fascicles (SLFs) were assessed by deterministic tractography with ExploreDTI. A neuropschychological evaluation was also performed. Results: The CC and both SLFs demonstrated various microstructural abnormalities in between-groups comparisons. All DTI parameters demonstrated changes across time in the body of the CC, while FA (fractional anisotropy) increases were seen on both SLFs. In the splenium of the CC, progressive changes in the mean diffusivity (MD) and axial diffusivity (AD) were also observed. There was an improvement in attention and memory along time. Remarkably, DTI parameters demonstrated several correlations with the cognitive domains. Conclusions: Our findings suggest that microstructural changes in the white matter are dynamic and may be detectable by DTI throughout the first year after trauma. Likewise, patients also demonstrated improvement in some cognitive skills.	[Grassi, Daphine Centola; Feltrin, Fabricio Stewan; Macruz, Fabiola Bezerra Carvalho; Otaduy, Maria Concepcion Garcia; Leite, Claudia Costa; Santos Andrade, Celi] Univ Sao Paulo, Fac Med, Dept Radiol, Av Dr Eneas De Carvalho Aguiar 255, BR-05403001 Sao Paulo, Brazil; [Grassi, Daphine Centola; Feltrin, Fabricio Stewan; Macruz, Fabiola Bezerra Carvalho; Otaduy, Maria Concepcion Garcia; Leite, Claudia Costa; Santos Andrade, Celi] Univ Sao Paulo, Fac Med, Hosp Clin, Lab Med Invest 44, Sao Paulo, Brazil; [Zaninotto, Ana Luiza] MGH Inst Hlth Profess MGHIHP, Speech & Feeding Disorders Lab, Boston, MA USA; [Zaninotto, Ana Luiza; Guirado, Vinicius Monteiro Paula; Paiva, Wellingson Silva] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Neurol, Sao Paulo, Brazil; [Feltrin, Fabricio Stewan] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA		Grassi, DC (corresponding author), Univ Sao Paulo, Fac Med, Dept Radiol, Av Dr Eneas De Carvalho Aguiar 255, BR-05403001 Sao Paulo, Brazil.	daphinecgrassi@gmail.com	Paiva, Wellingson S/G-5517-2013; Zaninotto, Ana Luiza C./I-4095-2016; Guirado, Vinicius Monteiro de Paula/AAG-7299-2019	Paiva, Wellingson S/0000-0002-5165-7040; Zaninotto, Ana Luiza C./0000-0003-0639-0612; Santos Andrade, Celi/0000-0003-0382-3232; Feltrin, Fabricio Stewan/0000-0001-6783-7655; Grassi, Daphine/0000-0001-5003-7619; Guirado, Vinicius Monteiro de Paula/0000-0002-7782-3609	FAPESP - Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/18136-1, 2016/05547-6, 2017/17065-9]	This work was supported by FAPESP - Sao Paulo Research Foundation under Grants [2015/18136-1, 2016/05547-6 and 2017/17065-9].	ADAMS J, 1989, HISTOPATHOLOGY, V15; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Armstrong RA, 2019, OPHTHAL PHYSL OPT, V39, P316, DOI 10.1111/opo.12636; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bell JM, 2015, J HEAD TRAUMA REHAB, V30, P148, DOI 10.1097/HTR.0000000000000143; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Leon AMC, 2018, J NEUROTRAUM, V35, P2365, DOI 10.1089/neu.2018.5691; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Fitsiori A, 2011, BRIT J RADIOL, V84, P5, DOI 10.1259/bjr/21946513; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Haris M, 2006, J MAGN RESON IMAGING, V24, P1259, DOI 10.1002/jmri.20778; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hashim E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00097; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jasey N, 2019, CURR PHYS MED REHAB, V7, P333, DOI 10.1007/s40141-019-00242-7; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kamali A, 2014, BRAIN STRUCT FUNCT, V219, P269, DOI 10.1007/s00429-012-0498-y; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim DS, 2015, J KOREAN NEUROSURG S, V58, P131, DOI 10.3340/jkns.2015.58.2.131; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lurito JT, 2001, NEUROIMAG CLIN N AM, V11, P355; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Patry BN, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P352, DOI 10.1007/0-387-25610-5_19; RAY S, 2002, HISTOL HISTOPATHOL, V17; Reid-Arndt SA, 2011, APPL NEUROPSYCHOL, V18, P291, DOI 10.1080/09084282.2011.595456; Ressel Volker, 2018, Eur Radiol Exp, V2, P33, DOI 10.1186/s41747-018-0066-1; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rulseh AM, 2013, J MAGN RESON IMAGING, V38, P1103, DOI 10.1002/jmri.24065; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith Douglas H, 2016, Bridge (Wash D C), V46, P79; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STROEMER R, 1995, STROKE, V26; SULLIVAN G, 2013, J NEUROPATH EXP NEUR, V72; Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang HJ, 2018, INT J IMMUNOPATH PH, V31, DOI 10.1177/2058738418801406; WANG J, 2008, ARCH NEUROL-CHICAGO, V65; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Yang XF, 2011, MED HYPOTHESES, V77, P60, DOI 10.1016/j.mehy.2011.03.023; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028	78	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					275	284		10.1080/02699052.2020.1859615		JAN 2021	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000612788800001	33507820				2022-02-06	
J	Russ, MK; Navarre, P; Stevens, JP				Russ, Matthias K.; Navarre, Pierre; Stevens, Jarrad P.			An Alternative Site for Pin Placement in External Fixation of Pelvic Fractures: Lateral Posterior Pelvic External Fixator Surgical Technique	FRONTIERS IN SURGERY			English	Article						pelvic fracture; polytrauma; external fixation; damage-control orthopedics; lateral posterior external fixator		Introduction: The application of an external fixator for unstable pelvic fractures is an important component of many resuscitation protocols. Moreover, certain pelvic fractures may be treated with an external fixator without requiring further internal fixation. We report our initial clinical results with an alternate pelvic external fixator site, the lateral posterior external fixator (LPEF), and describe the surgical technique. Methods and Materials: From 2010 to 2013, we identified 27 consecutive patients (mean age 44.6 years, range 18-80 years) treated by the same surgeon (MKR) with an LPEF in a level 1 trauma center. Retrospective data collection included mechanism of injury, surgical interventions, and complications. Results: The LPEF was used in 16 patients as acute pelvic stabilization and converted at a median of 2 days (interquartile range 1-3.5) to internal fixation, whereas in 10 patients, it was used as definitive treatment and removed at a median of 48 days (interquartile range 37-64). One patient died on day 14, secondary to his severe closed head injury. The only surgical complications were two wound infections (20%, 2/10 in the group of definitive LPEFs), which resolved without sequelae after the removal of the LPEF (at 36 and 50 days) and antibiotics, one case of loss of fixation leading to the removal of the LPEF at 71 days, and one patient who had hypergranulating external fixator sites and eventually healed without any cutaneous sequelae. All fractures consolidated in a good position. Discussion: The described techniques of pelvic external fixation include the anterosuperior (iliac wing), supra-acetabular (anteroinferior), and subcristal (anterior superior iliac spine) insertion sites. The reported infection rates in definitive pelvic fracture treatment range from 20 to 40%. Due to the localization of the insertion sites, the lateral femoral cutaneous nerve is potentially at risk with the last two techniques. On the other hand, the LPEF insertion site is quite safe, as it is anatomically far from any nerves and the inguinal region, and allows easy access for laparotomy. The results in this series suggest that the lateral posterior pelvic external fixator technique is an alternative to previous techniques with a low risk of complications.	[Russ, Matthias K.; Navarre, Pierre; Stevens, Jarrad P.] Alfred Hosp, Dept Orthopaed Surg, Melbourne, Vic, Australia; [Russ, Matthias K.] Cabrini Hosp, Orthopaed Surg, Melbourne, Vic, Australia; [Russ, Matthias K.] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Navarre, Pierre] Southland Hosp, Dept Orthopaed Surg, Invercargill, New Zealand; [Navarre, Pierre] Univ Otago, Dept Surg Sci, Dunedin, New Zealand; [Stevens, Jarrad P.] Knox Private Hosp, Knox Orthopaed Grp, Melbourne, Vic, Australia		Navarre, P (corresponding author), Alfred Hosp, Dept Orthopaed Surg, Melbourne, Vic, Australia.; Navarre, P (corresponding author), Southland Hosp, Dept Orthopaed Surg, Invercargill, New Zealand.; Navarre, P (corresponding author), Univ Otago, Dept Surg Sci, Dunedin, New Zealand.	navarre.pieffe@gmail.com					BURGESS AR, 1990, J TRAUMA, V30, P848, DOI 10.1097/00005373-199007000-00015; Cole PA, 2012, J ORTHOP TRAUMA, V26, P269, DOI 10.1097/BOT.0b013e3182410577; Cothren CC, 2007, J TRAUMA, V62, P834, DOI 10.1097/TA.0b013e31803c7632; Fangio P, 2005, J TRAUMA, V58, P978, DOI 10.1097/01.TA.0000163435.39881.26; FLINT L, 1990, ANN SURG, V211, P703, DOI 10.1097/00000658-199006000-00008; Gabbe BJ, 2011, INJURY, V42, P985, DOI 10.1016/j.injury.2011.06.003; Grimm MR, 1998, J TRAUMA, V44, P454, DOI 10.1097/00005373-199803000-00006; Grothaus MC, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000164526.08610.97; GYLLING SF, 1985, AM J SURG, V150, P721, DOI 10.1016/0002-9610(85)90416-7; Hak DJ, 2009, J AM ACAD ORTHOP SUR, V17, P447, DOI 10.5435/00124635-200907000-00005; Lindahl J, 1999, J BONE JOINT SURG BR, V81B, P955, DOI 10.1302/0301-620X.81B6.8571; MAJEED SA, 1990, J BONE JOINT SURG BR, V72, P612, DOI 10.1302/0301-620X.72B4.2380212; Mason WTM, 2005, INJURY, V36, P599, DOI 10.1016/j.injury.2004.11.016; MUCHA P, 1984, J TRAUMA, V24, P379, DOI 10.1097/00005373-198405000-00002; Palmer S, 1997, INJURY, V28, P649, DOI 10.1016/S0020-1383(97)00141-1; RIEMER BL, 1993, J TRAUMA, V35, P671, DOI 10.1097/00005373-199311000-00003; Smit WR., 2007, FRACTURES PELVIS ACE, P317, DOI [10.3109/9781420016383, DOI 10.3109/9781420016383]; Solomon LB, 2008, CLIN ANAT, V21, P674, DOI 10.1002/ca.20697; Solomon LB, 2009, J ORTHOP TRAUMA, V23, P365, DOI 10.1097/BOT.0b013e3181a2aec3; Young J. W., 1987, RADIOLOGIC MANAGEMEN; YOUNG JWR, 1986, RADIOLOGY, V160, P445, DOI 10.1148/radiology.160.2.3726125	21	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-875X			FRONT SURG	Front. Surg.	JAN 28	2021	7								621125	10.3389/fsurg.2020.621125			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QF3NC	WOS:000616803700001	33585549	gold, Green Published			2022-02-06	
J	Lehner, M; Jung, P; Olivieri, M; Schmittenbecher, PP				Lehner, M.; Jung, P.; Olivieri, M.; Schmittenbecher, P. -P.		Interdisziplinare Arbe	Multiple trauma care in childhood - practical and pragmatic summary of the new guideline	NOTFALL & RETTUNGSMEDIZIN			German	Article						Emergency room; Traumatic brain injury; Airway management; Imaging; Thorax; and abdominal Trauma		Children are not little adults; thus, the algorithms, drugs, and procedures from adult medicine cannot be directly applied to childhood. The proportion of seriously injured children and adolescents under the age of 16 is very low at 3-4% of all seriously injured persons. In this age group, in particular, standardized processes in prehospital care and in the emergency room with subsequent in-hospital treatment, are decisive in terms of overall survival. If we speak of "multiple trauma" in childhood, we continue to assume-contrary to the Berlin definition-multiple injuries of which one or a combination of injuries is potentially life-threatening. The guideline "Multiple trauma care in childhood" comprises a total of 71 guiding principles. Thereof, 16 can be recommended, 37 recommended and 18 strongly recommended aspects were concerted among the 22 representatives of the specialist societies and professional associations. The special features about prehospital care and transport as well as inhospital care in the emergency room are discussed. In particular prehospital airway management, care of severe traumatic brain injuries, anti fibrinolytic, graduated radiological diagnostics according to the ALARA (as low as reasonably achievable) principle, as well as the diagnosis and therapy of thoracic and abdominal trauma are dealt with. In addition to these aspects, it is important for effective emergency room care that employees in both prehospital care and care in the emergency room are regularly allowed to take part in established simulation training.	[Lehner, M.] Luzerner Kantonsspital, Kinderchirurg Klin, Kinderspital Luzern, Spitalstr 20, CH-6000 Luzern, Switzerland; [Jung, P.] Univ Klinikum Schleswig Holstein, Klin Kinder & Jugendmed, Lubeck, Germany; [Olivieri, M.] LMU Klinikum Munchen, Kinderklin, Dr von Haunerschen Kinderspital, Munich, Germany; [Olivieri, M.] LMU Klinikum Munchen, Kinderpoliklin, Dr von Haunerschen Kinderspital, Munich, Germany; [Schmittenbecher, P. -P.] Klinikum Karlsruhe, Kinderchirurg Klin, Karlsruhe, Germany		Lehner, M (corresponding author), Luzerner Kantonsspital, Kinderchirurg Klin, Kinderspital Luzern, Spitalstr 20, CH-6000 Luzern, Switzerland.	markus.lehner@luks.ch					Bollinger M, 2019, ANAESTHESIST, V68, P384, DOI 10.1007/s00101-019-0609-8; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Hoffmann F, 2016, PREHOSP EMERG CARE, V20, P493, DOI 10.3109/10903127.2016.1139216; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, NEUROSURGERY, V84, P1169, DOI 10.1093/neuros/nyz051; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Lehner M, 2018, ANAESTHESIST, V67, P914, DOI 10.1007/s00101-018-0500-z; Lehner M, 2018, NOTFALL RETTUNGSMED, V21, P90, DOI 10.1007/s10049-017-0385-4; Leonhard G, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0671-x; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Schmittenbecher, 2020, S2K LEITL POL KIND, P1; Schoneberg C, 2014, UNFALLCHIRURG, V117, P829, DOI 10.1007/s00113-014-2656-6; Stylianos S, 2005, CURR OPIN PEDIATR, V17, P402, DOI 10.1097/01.mop.0000163693.96101.84; Wang CH, 2014, CRIT CARE MED, V42, P954, DOI 10.1097/CCM.0000000000000050; Wyen H, 2010, EUR J TRAUMA EMERG S, V36, P300, DOI 10.1007/s00068-010-1124-4; Zundel S, 2014, ZBL CHIR, V139, P592, DOI 10.1055/s-0034-1383373	19	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	FEB	2021	24	1			SI		32	42		10.1007/s10049-020-00830-4		JAN 2021	11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	QC5MC	WOS:000611960400001					2022-02-06	
J	Hergert, DC; Robertson-Benta, C; Sicard, V; Schwotzer, D; Hutchison, K; Covey, DP; Quinn, DK; Sadek, JR; McDonald, J; Mayer, AR				Hergert, Danielle C.; Robertson-Benta, Cidney; Sicard, Veronik; Schwotzer, Daniela; Hutchison, Kent; Covey, Dan P.; Quinn, Davin K.; Sadek, Joseph R.; McDonald, Jacob; Mayer, Andrew R.			Use of Medical Cannabis to Treat Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cannabidiol; cannabinoids; medical cannabis; medical marijuana; THC; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; CLOSED-HEAD INJURY; MARIJUANA USE; CHRONIC PAIN; FUNCTIONAL CONNECTIVITY; LONGITUDINAL FMRI; ANXIETY DISORDERS; COGNITIVE CONTROL; HEALTH OUTCOMES; WORKING-MEMORY	There is not a single pharmacological agent with demonstrated therapeutic efficacy for traumatic brain injury (TBI). With recent legalization efforts and the growing popularity of medical cannabis, patients with TBI will inevitably consider medical cannabis as a treatment option. Pre-clinical TBI research suggests that cannabinoids have neuroprotective and psychotherapeutic properties. In contrast, recreational cannabis use has consistently shown to have detrimental effects. Our review identified a paucity of high-quality studies examining the beneficial and adverse effects of medical cannabis on TBI, with only a single phase III randomized control trial. However, observational studies demonstrate that TBI patients are using medical and recreational cannabis to treat their symptoms, highlighting inconsistencies between public policy, perception of potential efficacy, and the dearth of empirical evidence. We conclude that randomized controlled trials and prospective studies with appropriate control groups are necessary to fully understand the efficacy and potential adverse effects of medical cannabis for TBI.	[Hergert, Danielle C.; Robertson-Benta, Cidney; Sicard, Veronik; Mayer, Andrew R.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Pete & Nancy Domenici Hall, Albuquerque, NM USA; [Schwotzer, Daniela; Covey, Dan P.; McDonald, Jacob] Lovelace Biomed & Environm Res Inst, Albuquerque, NM USA; [Hutchison, Kent] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Quinn, Davin K.; Sadek, Joseph R.; Mayer, Andrew R.] Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; [Sadek, Joseph R.; Mayer, Andrew R.] Univ New Mexico, Hlth Sci Ctr, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Sadek, Joseph R.] New Mexico VA Hlth Care Syst, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Psychol Dept, Albuquerque, NM 87131 USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall, Albuquerque, NM 87106 USA.	amayer@mrn.org		Sicard, Veronik/0000-0003-2452-934X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 01 R01 NS098494-01A1, NIH 01 R01 NS098494-03S1A1]	This research was supported by grants from the National Institutes of Health (NIH; https://www.nih.gov; grant numbers NIH 01 R01 NS098494-01A1 and -03S1A1) to Andrew R. Mayer.	Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Angarita GA, 2016, ADDICT SCI CLIN PRAC, V11, DOI 10.1186/s13722-016-0056-7; Ashton CH, 2011, ACTA PSYCHIAT SCAND, V124, P250, DOI 10.1111/j.1600-0447.2011.01687.x; Babson KA, 2014, CURR ADDICT REPORTS, V1, P109, DOI 10.1007/s40429-014-0016-9; Babson KA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0775-9; Bar-Sela G, 2019, ANTI-CANCER DRUG, V30, P91, DOI 10.1097/CAD.0000000000000685; Barrus Daniel G, 2016, Methods Rep RTI Press, V2016, DOI 10.3768/rtipress.2016.op.0035.1611; Batalla A, 2014, CURR PHARM DESIGN, V20, P2168, DOI 10.2174/13816128113199990432; Batalla A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055821; Bedi G, 2010, PSYCHOPHARMACOLOGY, V212, P675, DOI 10.1007/s00213-010-1995-4; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Bigand T, 2019, NURS OUTLOOK, V67, P223, DOI 10.1016/j.outlook.2018.12.014; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Black N, 2019, LANCET PSYCHIAT, V6, P995, DOI 10.1016/S2215-0366(19)30401-8; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bloomfield MAP, 2019, PHARMACOL THERAPEUT, V195, P132, DOI 10.1016/j.pharmthera.2018.10.006; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonar EE, 2019, DRUG ALCOHOL DEPEN, V195, P193, DOI 10.1016/j.drugalcdep.2018.11.016; Bonn-Miller MO, 2017, JAMA-J AM MED ASSOC, V318, P1708, DOI 10.1001/jama.2017.11909; Bonn-Miller MO, 2014, AM J DRUG ALCOHOL AB, V40, P23, DOI 10.3109/00952990.2013.821477; Bonn-Miller MO, 2013, PSYCHOL TRAUMA-US, V5, P193, DOI 10.1037/a0026621; Borgwardt SJ, 2008, BIOL PSYCHIAT, V64, P966, DOI 10.1016/j.biopsych.2008.05.011; Bosker WM, 2012, ADDICTION, V107, P1837, DOI 10.1111/j.1360-0443.2012.03928.x; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Burggren AC, 2019, AM J DRUG ALCOHOL AB, V45, P563, DOI 10.1080/00952990.2019.1634086; Campbell G, 2019, EUR ARCH PSY CLIN N, V269, P135, DOI 10.1007/s00406-018-0960-9; Carone D.A., 2013, MILD TRAUMATIC BRAIN; Chandra S, 2019, EUR ARCH PSY CLIN N, V269, P5, DOI 10.1007/s00406-019-00983-5; Cheng H, 2014, J PSYCHOPHARMACOL, V28, P1030, DOI 10.1177/0269881114550354; Choi S, 2020, J CLIN NEUROPHYSIOL, V37, P39, DOI 10.1097/WNP.0000000000000617; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Colizzi Marco, 1800, Curr Addict Rep, V4, P62, DOI 10.1007/s40429-017-0142-2; Corroon JM, 2017, J PAIN RES, V10, P989, DOI 10.2147/JPR.S134330; Cousijn J, 2014, ADDICT BIOL, V19, P282, DOI 10.1111/adb.12111; Cranford JA, 2017, DRUG ALCOHOL DEPEN, V180, P227, DOI 10.1016/j.drugalcdep.2017.08.017; Crippa JA, 2009, HUM PSYCHOPHARM CLIN, V24, P515, DOI 10.1002/hup.1048; Cuttler C, 2018, J AFFECT DISORDERS, V235, P198, DOI 10.1016/j.jad.2018.04.054; Di Napoli M, 2016, CEREBROVASC DIS, V41, P248, DOI 10.1159/000443532; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Englund A, 2017, LANCET PSYCHIAT, V4, P643, DOI 10.1016/S2215-0366(17)30075-5; Englund A, 2013, J PSYCHOPHARMACOL, V27, P19, DOI 10.1177/0269881112460109; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedorova EV, 2019, DRUG ALCOHOL DEPEN, V198, P21, DOI 10.1016/j.drugalcdep.2019.01.026; Ferguson CJ, 2012, PSYCHOL METHODS, V17, P120, DOI 10.1037/a0024445; Fergusson DM, 2008, ADDICTION, V103, P969, DOI 10.1111/j.1360-0443.2008.02221.x; Filbey F, 2013, AM J DRUG ALCOHOL AB, V39, P382, DOI 10.3109/00952990.2013.841710; Filbey FM, 2018, NEUROPSYCHOPHARMACOL, V43, P700, DOI 10.1038/npp.2017.44; Gates PJ, 2014, SLEEP MED REV, V18, P477, DOI 10.1016/j.smrv.2014.02.005; Giles GM, 2019, BRAIN INJURY, V33, P129, DOI 10.1080/02699052.2018.1539762; Green B, 2003, DRUG ALCOHOL REV, V22, P453, DOI 10.1080/09595230310001613976; Greer GR, 2014, J PSYCHOACTIVE DRUGS, V46, P73, DOI 10.1080/02791072.2013.873843; Grenier K, 2020, CAN J NEUROL SCI, V47, P11, DOI 10.1017/cjn.2019.298; Gruber SA, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00983; Gruber SA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.201E00355; Hauser W, 2018, EUR J PAIN, V22, P455, DOI 10.1002/ejp.1118; Haney M, 2007, JAIDS-J ACQ IMM DEF, V45, P545, DOI 10.1097/QAI.0b013e31811ed205; Haney M, 2016, NEUROPSYCHOPHARMACOL, V41, P393, DOI 10.1038/npp.2015.251; Harding IH, 2012, NEUROPSYCHOPHARMACOL, V37, P1923, DOI 10.1038/npp.2012.39; Hawley LA, 2018, ARCH PHYS MED REHAB, V99, P1584, DOI 10.1016/j.apmr.2018.02.003; Hergert DC, 2020, PSYCHOSOMATICS, V61, P819, DOI 10.1016/j.psym.2020.01.006; Hill KP, 2017, CANNABIS CANNABINOID, V2, P96, DOI 10.1089/can.2017.0017; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hser YI, 2017, J SUBST ABUSE TREAT, V81, P53, DOI 10.1016/j.jsat.2017.07.012; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jang H, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.045007; Jikomes N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22755-2; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; Klumpers LE, 2012, NEUROIMAGE, V63, P1701, DOI 10.1016/j.neuroimage.2012.07.051; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Koppel BS, 2014, NEUROLOGY, V82, P1556, DOI 10.1212/WNL.0000000000000363; Kosiba JD, 2019, SOC SCI MED, V233, P181, DOI 10.1016/j.socscimed.2019.06.005; Lawrence DW, 2020, BRAIN INJURY, V34, P42, DOI 10.1080/02699052.2019.1679885; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Ligresti A, 2016, PHYSIOL REV, V96, P1593, DOI 10.1152/physrev.00002.2016; Lin LA, 2016, ADDICT BEHAV, V61, P99, DOI 10.1016/j.addbeh.2016.05.015; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lucas P, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0278-6; Lucas P, 2017, INT J DRUG POLICY, V42, P30, DOI 10.1016/j.drugpo.2017.01.011; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; MacCallum CA, 2018, EUR J INTERN MED, V49, P12, DOI 10.1016/j.ejim.2018.01.004; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Mammen G, 2017, ADDICTION, V112, P730, DOI 10.1111/add.13738; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Marconi A, 2016, SCHIZOPHRENIA BULL, V42, P1262, DOI 10.1093/schbul/sbw003; Martin-Santos R, 2012, CURR PHARM DESIGN, V18, P4966, DOI 10.2174/138161212802884780; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2018, BIOL PSYCHIAT-COGN N, V3, P294, DOI 10.1016/j.bpsc.2017.09.012; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McVige J, 2019, NEUROLOGY, V92; McVige J, 2018, NEUROLOGY, V91, pS18; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Morgan CJA, 2012, PSYCHOL MED, V42, P391, DOI 10.1017/S0033291711001322; Morgan CJA, 2010, BRIT J PSYCHIAT, V197, P285, DOI 10.1192/bjp.bp.110.077503; Moritz ED, 2019, MMWR-MORBID MORTAL W, V68, P985, DOI 10.15585/mmwr.mm6843e1; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nestor L, 2008, NEUROIMAGE, V40, P1328, DOI 10.1016/j.neuroimage.2007.12.059; Nguyen BM, 2014, AM SURGEON, V80, P979; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Otten R, 2017, ADDICT BIOL, V22, P1081, DOI 10.1111/adb.12372; Pacheco-Colon I, 2018, PSYCHOL ADDICT BEHAV, V32, P497, DOI 10.1037/adb0000380; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park JY, 2017, DRUG ALCOHOL DEPEN, V177, P1, DOI 10.1016/j.drugalcdep.2017.03.009; Pedersen W, 2010, ADDICTION, V105, P109, DOI 10.1111/j.1360-0443.2009.02719.x; Peres FF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00482; Perron BE, 2019, DRUG ALCOHOL DEPEN, V194, P401, DOI 10.1016/j.drugalcdep.2018.09.029; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Piper BJ, 2017, J PSYCHOPHARMACOL, V31, P569, DOI 10.1177/0269881117699616; Rabner J, 2016, AM J ADDICTION, V25, P91, DOI 10.1111/ajad.12338; Roitman P, 2014, CLIN DRUG INVEST, V34, P587, DOI 10.1007/s40261-014-0212-3; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Roy-Byrne P, 2015, AM J ADDICTION, V24, P599, DOI 10.1111/ajad.12270; Russell C, 2018, INT J DRUG POLICY, V52, P87, DOI 10.1016/j.drugpo.2017.11.008; Pazos MR, 2013, NEUROPHARMACOLOGY, V71, P282, DOI 10.1016/j.neuropharm.2013.03.027; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Sarvet AL, 2018, DRUG ALCOHOL DEPEN, V186, P10, DOI 10.1016/j.drugalcdep.2018.01.009; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Scott JC, 2018, JAMA PSYCHIAT, V75, P585, DOI 10.1001/jamapsychiatry.2018.0335; Sexton M, 2016, CANNABIS CANNABINOID, V1, P131, DOI 10.1089/can.2016.0007; Sharma Priyamvada, 2012, Iran J Psychiatry, V7, P149; Shetty T., 2014, AM ACAD NEUROL J S, V82, pSuppl; Shishko Ilona, 2018, Ment Health Clin, V8, P86, DOI 10.9740/mhc.2018.03.086; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Smith PA., 2017, J PAIN MANAGEMENT, V10, P397; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Swartz R, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-3; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Tomko RL, 2018, DRUG ALCOHOL DEPEN, V182, P1, DOI 10.1016/j.drugalcdep.2017.09.035; Troutt WD, 2017, J ALTERN COMPLEM MED, V23, P879, DOI 10.1089/acm.2016.0337; Turna J, 2019, J PSYCHIATR RES, V111, P134, DOI 10.1016/j.jpsychires.2019.01.024; Turner SE, 2017, PROG CHEM ORG NAT PR, V103, P61, DOI 10.1007/978-3-319-45541-9_3; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vandrey R, 2015, JAMA-J AM MED ASSOC, V313, P2491, DOI 10.1001/jama.2015.6613; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; Wadsworth E, 2020, SUBST USE MISUSE, V55, P582, DOI 10.1080/10826084.2019.1691594; Walsh Z, 2017, CLIN PSYCHOL REV, V51, P15, DOI 10.1016/j.cpr.2016.10.002; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wetherill RR, 2012, BRAIN RES, V1432, P66, DOI 10.1016/j.brainres.2011.11.013; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Wilkinson ST, 2015, J CLIN PSYCHIAT, V76, P1174, DOI 10.4088/JCP.14m09475; Wilson M, 2018, ADDICT BEHAV, V77, P225, DOI 10.1016/j.addbeh.2017.10.012; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Xiang T, 2018, PR IEEE SEN ARRAY, P336, DOI 10.1109/SAM.2018.8448749; Yanes JA, 2018, J PSYCHOPHARMACOL, V32, P283, DOI 10.1177/0269881117744995; Yoles E, 1996, J NEUROTRAUM, V13, P49, DOI 10.1089/neu.1996.13.49; Zhou D, 2017, PHARMAZIE, V72, P435, DOI 10.1691/ph.2017.7474	172	1	1	6	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					1904	1917		10.1089/neu.2020.7148		JAN 2021	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000613465200002	33256496				2022-02-06	
J	Nguyen, T; Al-Juboori, MH; Walerstein, J; Xiong, WH; Jin, XM				Nguyen, Tyler; Al-Juboori, Mohammed Haider; Walerstein, Jakub; Xiong, Wenhui; Jin, Xiaoming			Impaired Glutamate Receptor Function Underlies Early Activity Loss of Ipsilesional Motor Cortex after Closed-Head Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						calcium imaging; controlled cortical impact; neuroplasticity; optogenetic mapping; traumatic brain injury	D-ASPARTATE RECEPTORS; MECHANICAL INJURY; CORTICAL-NEURONS; CLINICAL-TRIALS; GENE-EXPRESSION; CALCIUM; NMDA; INHIBITION; BINDING; PATTERNS	Although mild traumatic brain injury (mTBI) accounts for the majority of TBI patients, the effects and cellular and molecular mechanisms of mTBI on cortical neural circuits are still not well understood. Given the transient and non-specific functional deficits after mTBI, it is important to understand whether mTBI causes functional deficits of the brain and the underlying mechanism, particularly during the early stage after injury. Here, we used in vivo optogenetic motor mapping to determine longitudinal changes in cortical motor map and in vitro calcium imaging to study how changes in cortical excitability and calcium signals may contribute to the motor deficits in a closed-head mTBI model. In channelrhodopsin 2 (ChR2)-expressing transgenic mice, we recorded electromyograms (EMGs) from bicep muscles induced by scanning blue laser on the motor cortex. There were significant decreases in the size and response amplitude of motor maps of the injured cortex at 2 h post-mTBI, but an increase in motor map size of the contralateral cortex in 12 h post-mTBI, both of which recovered to baseline level in 24 h. Calcium imaging of cortical slices prepared from green fluorescent calmodulin proteins-expressing transgenic mice showed a lower amplitude, but longer duration, of calcium transients of the injured cortex in 2 h post-mTBI. Blockade of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid or N-methyl-d-aspartate receptors resulted in smaller amplitude of calcium transients, suggesting impaired function of both receptor types. Imaging of calcium transients evoked by glutamate uncaging revealed reduced response amplitudes and longer duration in 2, 12, and 24 h after mTBI. Higher percentages of neurons of the injured cortex had a longer latency period after uncaging than that of the uninjured neurons. The results suggest that impaired glutamate neurotransmission contributes to functional deficits of the motor cortex in vivo, which supports enhancing glutamate neurotransmission as a potential therapeutic approach for the treatment of mTBI.	[Nguyen, Tyler; Walerstein, Jakub; Xiong, Wenhui; Jin, Xiaoming] Indiana Univ Sch Med, Indiana Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, 320 West 15th St,NB 500C, Indianapolis, IN 46202 USA; [Nguyen, Tyler; Walerstein, Jakub; Xiong, Wenhui; Jin, Xiaoming] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, 320 West 15th St,NB 500C, Indianapolis, IN 46202 USA; [Nguyen, Tyler] Indiana Univ Sch Med, Med Neurosci Program, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Al-Juboori, Mohammed Haider] Indiana Univ Sch Med, Indiana Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Al-Juboori, Mohammed Haider] Indiana Univ Sch Med, Dept Neurol Surg, Indianapolis, IN 46202 USA		Jin, XM (corresponding author), Indiana Univ Sch Med, Indiana Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, 320 West 15th St,NB 500C, Indianapolis, IN 46202 USA.; Jin, XM (corresponding author), Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, 320 West 15th St,NB 500C, Indianapolis, IN 46202 USA.	xijin@iupui.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS057940, NS089509]; Indiana Spinal Cord and Brain Injury Research Fund	This work was supported by grants from the NIH (NS057940 and NS089509) and by the Indiana Spinal Cord and Brain Injury Research Fund.	Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; ANTAL J, 1992, LIFE SCI, V51, P185, DOI 10.1016/0024-3205(92)90074-Y; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/nmeth.1303, 10.1038/NMETH.1303]; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Dixon C.E., 1993, J HEAD TRAUMA REHABI; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farin A, 2004, ACT NEUR S, V89, P101; Friedman LK, 2001, MOL BRAIN RES, V86, P34, DOI 10.1016/S0169-328X(00)00252-7; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Han XJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00210; Hansen KR, 2018, J NEUROTRAUM, V35, P1523, DOI 10.1089/neu.2017.5029; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Limbrick DD, 2001, BRAIN RES, V894, P56, DOI 10.1016/S0006-8993(00)03303-5; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Morris TA, 1999, J NEUROSCI, V19, P8234; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Omlor W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12670-z; Parsons JT, 1997, J NEUROCHEM, V68, P1124; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Qian J, 2019, J NEUROTRAUM, V36, P485, DOI 10.1089/neu.2018.5713; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Sun DA, 2002, EPILEPSIA, V43, P1296, DOI 10.1046/j.1528-1157.2002.09702.x; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	54	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2021	38	14					2018	2029		10.1089/neu.2020.7225		JAN 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TD0YA	WOS:000613464900001	33238833	Green Submitted			2022-02-06	
J	Chandran, R; Mehta, SL; Vemuganti, R				Chandran, Raghavendar; Mehta, Suresh L.; Vemuganti, Raghu			Antioxidant Combo Therapy Protects White Matter After Traumatic Brain Injury	NEUROMOLECULAR MEDICINE			English	Article						Secondary brain damage; Neurotrauma; Oxidative stress; Apocynin; TBHQ	OXIDATIVE STRESS	Following traumatic brain injury (TBI), increased production of reactive oxygen species (ROS) and the ensuing oxidative stress promotes the secondary brain damage that encompasses both grey matter and white matter. As this contributes to the long-term neurological deficits, decreasing oxidative stress during the acute period of TBI is beneficial. While NADPH oxidase (NOX2) is the major producer of ROS, transcription factor Nrf2 that induces antioxidant enzymes promotes efficient ROS disposal. We recently showed that treatment with an antioxidant drug combo of apocynin (NOX2 inhibitor) and TBHQ (Nrf2 activator) protects the grey matter in adult mice subjected to TBI. We currently show that this antioxidant combo therapy given at 2 h and 24 h after TBI also protects white matter in mouse brain. Thus, the better functional outcomes after TBI in the combo therapy treated mice might be due to a combination of sparing both grey matter and white matter. Hence, the antioxidant combo we tested is a potent therapeutic option for translation in future.	[Chandran, Raghavendar; Mehta, Suresh L.; Vemuganti, Raghu] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA; [Vemuganti, Raghu] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA		Vemuganti, R (corresponding author), Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA.; Vemuganti, R (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.	vemuganti@neurosurgery.wisc.edu		Vemuganti, Raghu/0000-0002-5714-270X	US Veterans Administration Merit Review Grant [BX004344]	Supported by a US Veterans Administration Merit Review Grant BX004344.	Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Davis CK, 2021, NEUROBIOL DIS, V147, DOI 10.1016/j.nbd.2020.105143; Di Pietro V, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030260; Guemez-Gamboa A, 2011, J NEUROPATH EXP NEUR, V70, P1020, DOI 10.1097/NEN.0b013e3182358e4e; Ismail H, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100943; Jarrahi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8100389; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Simpson DSA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080743; Sinke MRT, 2021, J NEUROTRAUM, V38, P1642, DOI 10.1089/neu.2020.7151; Traeger J, 2020, CRIT CARE NURS Q, V43, P172, DOI 10.1097/CNQ.0000000000000301; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003	11	1	1	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	SEP	2021	23	3					344	347		10.1007/s12017-021-08645-3		JAN 2021	4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC8QG	WOS:000610463500001	33486699				2022-02-06	
J	Mu, J; Wang, TT; Li, MY; Guan, T; Guo, Y; Zhang, XL; Zhang, GH; Kong, JM				Mu, Jiao; Wang, Tingting; Li, Meiyu; Guan, Teng; Guo, Ying; Zhang, Xiaoli; Zhang, Guohui; Kong, Jiming			Ketogenic diet protects myelin and axons in diffuse axonal injury	NUTRITIONAL NEUROSCIENCE			English	Article; Early Access						Ketogenic diet; diffuse axonal injury; myelination; axonal degeneration; mitochondrial mass; beta-hydroxybutryate		Background: Ketogenic diet (KD) has been identified as a potential therapy to enhance recovery after traumatic brain injury (TBI). Diffuse axonal injury (DAI) is a common type of traumatic brain injury that is characterized by delayed axonal disconnection. Previous studies showed that demyelination resulting from oligodendrocyte damage contributes to axonal degeneration in DAI. Aim: The present study tests a hypothesis that ketone bodies from the ketogenic diet confers protection for myelin and attenuates degeneration of demyelinated axon in DAI. Methods: A modified Marmarou's model of DAI was induced in adult rats. The DAI rats were fed with KD and analyzed with western blot, transmission electron microscope, ELISA test and immunohistochemistry. Meanwhile, a co-culture of primary oligodendrocytes and neurons was treated with ketone body beta-hydroxybutryate (beta HB) to test for its effects on the myelin-axon unit. Results: Here we report that rats fed with KD showed an increased fatty acid metabolism and ketonemia. This dietary intervention significantly reduced demyelination and attenuated axonal damage in rats following DAI, likely through inhibition of DAI-induced excessive mitochondrial fission and promoting mitochondrial fusion. In an in vitro model of myelination, the ketone body beta HB increased myelination significantly and reduced axonal degeneration induced by glucose deprivation (GD). beta HB robustly increased cell viability, inhibited GD-induced collapse of mitochondrial membrane potential and attenuated death of oligodendrocytes. Conclusion: Ketone bodies protect myelin-forming oligodendrocytes and reduce axonal damage. Ketogenic diet maybe a promising therapy for DAI.	[Mu, Jiao; Wang, Tingting; Li, Meiyu; Guo, Ying; Zhang, Guohui; Kong, Jiming] Hebei North Univ, Dept Forens Med, 11 Zuanshinan Rd, Zhangjiakou 075000, Hebei, Peoples R China; [Mu, Jiao; Guan, Teng; Guo, Ying] Beihang Univ, Sch Biol Sci & Med Engn, Dept Biomed Engn, Beijing, Peoples R China; [Mu, Jiao; Kong, Jiming] Univ Manitoba, Max Rady Coll Med, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zhang, Xiaoli] Hebei North Univ, Dept Life Sci, Res Ctr, Zhangjiakou, Peoples R China		Zhang, GH (corresponding author), Hebei North Univ, Dept Forens Med, 11 Zuanshinan Rd, Zhangjiakou 075000, Hebei, Peoples R China.; Kong, JM (corresponding author), Univ Manitoba, Fac Med, Dept Human Anat & Cell Sci, 745 Bannatyne, Winnipeg, MB R3E 0J9, Canada.	jiming.kong@umanitoba.ca; guohuizhang123@163.com		Kong, Jiming/0000-0002-2859-9831	ALS Canada/Brain Canada Foundation [45278]; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Hebei Natural Science FoundationNatural Science Foundation of Hebei Province [H2017405021]; Basic Scientific Research Project of Higher Education Institutions in Hebei Province [JYT-2019007]	This work was supported by ALS Canada/Brain Canada Foundation [grant number 45278]; Canadian Institutes of Health Research; Hebei Natural Science Foundation [grant number H2017405021]; a Basic Scientific Research Project of Higher Education Institutions in Hebei Province [grant number JYT-2019007].	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alizadeh A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00035; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Elamin M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00377; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Hasan-Olive MM, 2019, NEUROCHEM RES, V44, P22, DOI 10.1007/s11064-018-2588-6; Jahani-Asl A, 2010, BBA-MOL BASIS DIS, V1802, P162, DOI 10.1016/j.bbadis.2009.09.006; Lauritzen KH, 2016, NEUROBIOL AGING, V48, P34, DOI 10.1016/j.neurobiolaging.2016.08.005; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Luo FC, 2017, EXP NEUROL, V292, P21, DOI 10.1016/j.expneurol.2017.02.015; Masino SA., 2016, KETOGENIC DIET METAB, V1st ed; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; McNally MA, 2012, J NEUROCHEM, V121, P28, DOI 10.1111/j.1471-4159.2012.07670.x; Mu J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00217; Mu J, 2015, INT J CLIN EXP PATHO, V8, P4388; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Salim A, 2009, AM SURGEON, V75, P25; Sarkar Shamik, 2018, Critical Reviews in Biomedical Engineering, V46, P289, DOI 10.1615/CritRevBiomedEng.2018027249; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Stiefel KM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00202; Stikov N, 2015, DATA BRIEF, V4, P368, DOI 10.1016/j.dib.2015.05.019; Stumpf SK, 2019, ACTA NEUROPATHOL, V138, P147, DOI 10.1007/s00401-019-01985-2; Thomson CE, 2008, EUR J NEUROSCI, V28, P1518, DOI 10.1111/j.1460-9568.2008.06415.x; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Yang HJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00585; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Zhang YF, 2013, J CEREBR BLOOD F MET, V33, P1307, DOI 10.1038/jcbfm.2013.87; Zhu XH, 2012, NEUROIMAGE, V60, P2107, DOI 10.1016/j.neuroimage.2012.02.013	33	1	1	2	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.												10.1080/1028415X.2021.1875300		JAN 2021	14	Neurosciences; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Nutrition & Dietetics	PV7LV	WOS:000610166200001	33487123				2022-02-06	
J	Chen, DF; Kumari, P; Haider, HA; Ruiz, AR; Lega, J; Dhakar, MB				Chen, Denise F.; Kumari, Polly; Haider, Hiba A.; Ruiz, Andres Rodriguez; Lega, Julia; Dhakar, Monica B.			Association of Epileptiform Abnormality on Electroencephalography with Development of Epilepsy After Acute Brain Injury	NEUROCRITICAL CARE			English	Article						Acute brain injury; Seizures; Epileptiform abnormalities; Outcomes; Continuous electroencephalogram	CONTINUOUS EEG; SEIZURES; SCORE	Background/Objectives: Epileptiform abnormalities (EA) on continuous electroencephalography (cEEG) are associated with increased risk of acute seizures; however, data on their association with development of long-term epilepsy are limited. We aimed to investigate the association of EA in patients with acute brain injury (ABI): ischemic or hemorrhagic stroke, traumatic brain injury, encephalitis, or posterior reversible encephalopathy syndrome, and subsequent development of epilepsy. Methods: This was a retrospective, single-center study of patients with ABI who had at least 6 hours of cEEG during the index admission between 1/1/2017 and 12/31/2018 and at least 12 months of follow-up. We compared patients with EAs; defined as lateralized periodic discharges (LPDs), lateralized rhythmic delta activity (LRDA), generalized periodic discharges (GPDs), and sporadic interictal epileptiform discharges (sIEDs) to patients without EAs on cEEG. The primary outcome was the new development of epilepsy, defined as the occurrence of spontaneous clinical seizures following hospital discharge. Secondary outcomes included time to development of epilepsy and use of anti-seizure medications (ASMs) at the time of last follow-up visit. Results: One hundred and one patients with ABI met study inclusion criteria. Thirty-one patients (30.7%) had EAs on cEEG. The median (IQR) time to cEEG was 2 (1-5) days. During a median (IQR) follow-up period of 19.1 (16.2-24.3) months, 25.7% of patients developed epilepsy; the percentage of patients who developed epilepsy was higher in those with EAs compared to those without EAs (41.9% vs. 18.6%, p = 0.025). Patients with EAs were more likely to be continued on ASMs during follow-up compared to patients without EAs (67.7% vs. 38.6%, p = 0.009). Using multivariable Cox regression analysis, after adjusting for age, mental status, electrographic seizures on cEEG, sex, ABI etiology, and ASM treatment on discharge, patients with EAs had a significantly increased risk of developing epilepsy compared to patients without EA (hazard ratio 3.39; 95% CI 1.39-8.26; p = 0.007). Conclusions: EAs on cEEG in patients with ABI are associated with a greater than three-fold increased risk of new-onset epilepsy. cEEG findings in ABI may therefore be a useful risk stratification tool for assessing long-term risk of seizures and serve as a biomarker for new-onset epilepsy.	[Chen, Denise F.; Kumari, Polly; Haider, Hiba A.; Ruiz, Andres Rodriguez; Lega, Julia; Dhakar, Monica B.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Chen, Denise F.; Kumari, Polly; Haider, Hiba A.; Ruiz, Andres Rodriguez; Lega, Julia; Dhakar, Monica B.] Grady Mem Hosp, Atlanta, GA 30303 USA; [Dhakar, Monica B.] Brown Univ, Dept Neurol, Warren Alpert Med Sch, 593 Eddy St,APC 5, Providence, RI 02903 USA		Dhakar, MB (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.; Dhakar, MB (corresponding author), Grady Mem Hosp, Atlanta, GA 30303 USA.; Dhakar, MB (corresponding author), Brown Univ, Dept Neurol, Warren Alpert Med Sch, 593 Eddy St,APC 5, Providence, RI 02903 USA.	monicadhakar@gmail.com	Chen, Denise/AAA-6860-2021	Chen, Denise/0000-0002-9827-3351			Alvarez V, 2017, CLIN NEUROPHYSIOL, V128, P570, DOI 10.1016/j.clinph.2017.01.001; Andrade-Valenca LP, 2011, NEUROLOGY, V77, P524, DOI 10.1212/WNL.0b013e318228bee2; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Bentes Carla, 2018, Epilepsia Open, V3, P203, DOI 10.1002/epi4.12103; Haapaniemi E, 2014, STROKE, V45, P1971, DOI 10.1161/STROKEAHA.114.004686; Hill CE, 2019, NEUROLOGY, V92, pE9, DOI 10.1212/WNL.0000000000006689; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Husari KS, 2021, NEUROCRIT CARE, V34, P201, DOI 10.1007/s12028-020-01017-y; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Naidech AM, 2018, CRIT CARE MED, V46, P1480, DOI 10.1097/CCM.0000000000003272; Punia V, 2019, ANN CLIN TRANSL NEUR, V6, P2230, DOI 10.1002/acn3.50925; Punia V, 2018, EPILEPSIA, V59, P1612, DOI 10.1111/epi.14509; Punia V, 2018, J CLIN NEUROPHYSIOL, V35, P71, DOI 10.1097/WNP.0000000000000428; Punia V, 2015, EPILEPSY BEHAV, V49, P250, DOI 10.1016/j.yebeh.2015.06.026; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Rodriguez Ruiz A, 2017, JAMA NEUROL, V74, P181, DOI DOI 10.1001/jamaneurol.2016.4990; Struck AF, 2020, JAMA NEUROL, V77, P500, DOI 10.1001/jamaneurol.2019.4656; Struck AF, 2017, JAMA NEUROL, V74, P1419, DOI 10.1001/jamaneurol.2017.2459; Struck AF, 2017, ANN NEUROL, V82, P177, DOI 10.1002/ana.24985; Tabaeizadeh M, 2020, NEUROCRIT CARE, V32, P697, DOI 10.1007/s12028-020-00944-0; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2019, NEUROBIOL DIS, V123, P110, DOI 10.1016/j.nbd.2018.07.025; Zafar SF, 2018, CLIN NEUROPHYSIOL, V129, P2219, DOI 10.1016/j.clinph.2018.08.015	25	1	1	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	2					428	433		10.1007/s12028-020-01182-0		JAN 2021	6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WU3OH	WOS:000608927600002	33469863				2022-02-06	
J	Kendrick, D; das Nair, R; Kellezi, B; Morriss, R; Kettlewell, J; Holmes, J; Timmons, S; Bridger, K; Patel, P; Brooks, A; Hoffman, K; Radford, K				Kendrick, Denise; das Nair, Roshan; Kellezi, Blerina; Morriss, Richard; Kettlewell, Jade; Holmes, Jain; Timmons, Stephen; Bridger, Kay; Patel, Priya; Brooks, Adam; Hoffman, Karen; Radford, Kathryn		ROMTATE Study Team	Vocational rehabilitation to enhance return to work after trauma (ROWTATE): protocol for a non-randomised single-arm mixed-methods feasibility study	PILOT AND FEASIBILITY STUDIES			English	Article						Vocational rehabilitation; Work; Occupation; Trauma; Injury; Psychological outcomes	POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; PSYCHOLOGICAL MORBIDITY; INTERVENTIONS; DEPRESSION; RECOVERY; OUTCOMES; QUALITY; PREDICTORS; ANXIETY	Background: Traumatic injuries are common amongst working-age adults. Survivors often experience physical and psychological problems, reduced quality of life and difficulty returning to work. Vocational rehabilitation improves work outcomes for a range of conditions but evidence of effectiveness for those with traumatic injuries is lacking. This study assesses feasibility of delivering a vocational rehabilitation intervention to enhance return to work and improve quality of life and wellbeing in people with at least moderate trauma to inform design of a definitive randomised controlled trial (RCT). Methods: Non-randomised, single-arm, multi-centre mixed-methods feasibility study with nested case studies and qualitative study. The case studies comprise interviews, observations of clinical contacts and review of clinical records. The qualitative study comprises interviews and/or focus groups. Participants will be recruited from two UK major trauma centres. Participants will comprise 40 patients aged 16-69 with an injury severity score of > 8 who will receive the intervention and complete questionnaires. Interviews will be conducted with 10 patients and their occupational therapists (OTs), clinical psychologists (CPs), employers and commissioners of rehabilitation services. Fidelity will be assessed in up to six patients by observations of OT and CP-patient contacts, review of patient records and intervention case report forms. OT and CP training will be evaluated using questionnaires and competence to deliver the intervention assessed using a team objective structured clinical examination and written task. Patients participating in and those declining participation in the study will be invited to take part in interviews/focus groups to explore barriers and facilitators to recruitment and retention. Outcomes include recruitment and retention rates, intervention fidelity, OT and CP competence to deliver the intervention, experiences of delivering or receiving the intervention and factors likely to influence definitive trial delivery. Discussion: Effective vocational rehabilitation interventions to enhance return to work amongst trauma patients are urgently needed because return to work is often delayed, with detrimental effects on health, financial stability, healthcare resource use and wider society. This protocol describes a feasibility study delivering a complex intervention to enhance return to work in those with at least moderate trauma.	[Kendrick, Denise; Bridger, Kay] Sch Med, Univ Pk,Floor 13,Tower Bldg, Nottingham NG7 2RD, England; [das Nair, Roshan; Morriss, Richard] Jubilee Campus, Inst Mental Hlth, Sch Med, Wollaton Rd, Nottingham NG8 1BB, England; [Kellezi, Blerina] Nottingham Trent Univ, Sch Social Sci, Div Psychol, Burton St, Nottingham NG1 4BU, England; [Kettlewell, Jade; Timmons, Stephen] Nottingham Univ Business Sch, Ctr Hlth Innovat Leadership & Learning, Jubilee Campus, Wollaton Rd, Nottingham NG8 1BB, England; [Holmes, Jain; Radford, Kathryn] Queens Med Ctr, Sch Med, Med Sch, Nottingham NG7 2UH, England; [Patel, Priya; Hoffman, Karen] Queen Mary Univ London, Ctr Trauma Sci, Barts & London Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England; [Brooks, Adam] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Derby Rd, Nottingham NG7 2UH, England		Kendrick, D (corresponding author), Sch Med, Univ Pk,Floor 13,Tower Bldg, Nottingham NG7 2RD, England.	denise.kendrick@nottingham.ac.uk	Holmes, Jain/K-2125-2016	Holmes, Jain/0000-0003-2465-102X; Radford, Kate/0000-0001-6246-3180; Kendrick, Denise/0000-0003-3603-6542	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research ProgrammeNational Institute for Health Research (NIHR) [RP-PG-0617-20001]	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Reference number RP-PG-0617-20001). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.	Aarons Gregory A, 2004, Ment Health Serv Res, V6, P61, DOI 10.1023/B:MHSR.0000024351.12294.65; Beckett K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005668; Black C., 2008, REV HLTH BRIT WORK A; Brouwer S, 2011, J OCCUP REHABIL, V21, P244, DOI 10.1007/s10926-010-9262-4; Burton A.K., 2006, IS WORK GOOD YOUR HL; Cancelliere C, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0113-z; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Checkland P, 1999, SOFT SYSTEMS METHODO, P418; Cole DC, 2002, CAN MED ASSOC J, V166, P749; Cole E, 2016, ANN SURG, V264, P188, DOI 10.1097/SLA.0000000000001393; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Crowther R., 2001, COCHRANE DB SYST REV, P2; DEY I, 2007, QUALITATIVE RES PRAC, P80; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Eldridge SM, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5239; Escorpizo R, 2011, J OCCUP REHABIL, V21, P126, DOI 10.1007/s10926-011-9292-6; Herbert E, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3578-y; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hoefsmit N, 2012, J OCCUP REHABIL, V22, P462, DOI 10.1007/s10926-012-9359-z; Hou WH, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010002.pub3; Ilmarinen J, 2009, SCAND J WORK ENV HEA, V35, P1; International Committee of Medical Journal Editors, 2019, INT COMM MED J ED RE; Jacoby SF, 2017, INT J NURS STUD, V65, P54, DOI 10.1016/j.ijnurstu.2016.11.004; Karjalainen K, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002193; Kendrick D, 2017, QUAL LIFE RES, V26, P1233, DOI 10.1007/s11136-016-1439-7; Kendrick D, 2017, BRIT J GEN PRACT, V67, pE555, DOI 10.3399/bjgp17X691673; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; Kendrick D, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625139; Lerner D, 2001, MED CARE, V39, P72, DOI 10.1097/00005650-200101000-00009; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; MRC, 2006, DEV EVALUATING COMPL; Najarkolai AR, 2016, BALI MED J, V5, P111, DOI 10.15562/bmj.v5i3.304; National Audit Office, 2010, MAJ TRAUM CAR ENGL; National confidential enquiry into patient outcome and death, 2007, TRAUM WHO CAR REP NA; National Institute for Health and Care Excellence, 2016, 40 NICE; National Institute for Health Research. Research Design Service London, JUST SAMPL SIZ FEAS; National Peer Review Programme, 2015, NAT PEER REV REP MAJ; NCASRI Project Team, 2016, LEAD TURN STOK L 1 R; Nelson J, 2017, QUAL RES, V17, P554, DOI 10.1177/1468794116679873; Neugebauer E, 2006, EUR J TRAUMA, V32, P44, DOI 10.1007/s00068-006-0150-8; NHS Digital, HOSP EP STAT ENGL AD; Norlund A, 2009, J REHABIL MED, V41, P115, DOI 10.2340/16501977-0297; O'Donnell ML, 2008, CLIN PSYCHOL REV, V28, P387, DOI 10.1016/j.cpr.2007.07.008; O'Donnell ML, 2012, J TRAUMA STRESS, V25, P125, DOI 10.1002/jts.21677; Papasotiriou AN, 2017, SAF HEALTH WORK-KR, V8, P162, DOI 10.1016/j.shaw.2016.10.003; Radford K, 2017, HTA MONOGRAPH; Radford K, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2647; Rhodes C, 2017, 06152 HOUS COMM LIB; Roels EH, 2016, SPINAL CORD, V54, P2, DOI 10.1038/sc.2015.133; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Salbach NM, 2011, J EVAL CLIN PRACT, V17, P794, DOI 10.1111/j.1365-2753.2010.01478.x; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Shih RA, 2010, J TRAUMA, V69, P1560, DOI 10.1097/TA.0b013e3181e59c05; Spilman S.K., 2006, CRITICAL TRANSITIONS; Spreadborough S, 2018, CLIN REHABIL, V32, P410, DOI 10.1177/0269215517730862; Umberson D, 2005, J MARRIAGE FAM, V67, P1332, DOI 10.1111/j.1741-3737.2005.00220.x; VANTHIEL J, 1991, MED EDUC, V25, P224; Wald J, 2009, PSYCHOL INJ LAW, V2, P254, DOI 10.1007/s12207-009-9059-y; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Weiss Daniel S., 1997, P399; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS17, DOI 10.1016/j.apmr.2013.02.029; World Health Organisation, 2014, INJ VIOL FACTS; World Health Organization, 2007, INT CLASS FUNCT DIS; Yardley L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4055; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	71	1	1	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2055-5784		PILOT FEASIBILITY ST	Pilot Feasibility Stud.	JAN 20	2021	7	1							29	10.1186/s40814-021-00769-4			12	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	WD1MO	WOS:000704714000001	33472707	Green Accepted, gold, Green Published			2022-02-06	
J	Mansour, A; Loggini, A; Goldenberg, FD; Kramer, C; Naidech, AM; El Ammar, F; Vasenina, V; Castro, B; Das, P; Horowitz, PM; Karrison, T; Zakrison, T; Hampton, D; Rogers, SO; Lazaridis, C				Mansour, Ali; Loggini, Andrea; Goldenberg, Fernando D.; Kramer, Christopher; Naidech, Andrew M.; Ammar, Faten El; Vasenina, Valentina; Castro, Brandyn; Das, Paramita; Horowitz, Peleg M.; Karrison, Theodore; Zakrison, Tanya; Hampton, David; Rogers, Selwyn O.; Lazaridis, Christos			Coagulopathy as a Surrogate of Severity of Injury in Penetrating Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						coagulopathy; neurocritical care; penetrating brain injury	CIVILIAN GUNSHOT WOUNDS; HEAD; PREDICTORS; MORTALITY	Penetrating brain injury (PBI) is the most devastating type of traumatic brain injury. Development of coagulopathy in the acute setting of PBI, though common, remains of unclear significance as does its reversal. The aim of this study is to investigate the relationship between coagulopathy and clinical presentation, radiographical features, and outcome in civilian patients with PBI. Eighty-nine adult patients with PBI at a Level I trauma center in Chicago, Illinois who survived acute resuscitation and with available coagulation profile were analyzed. Coagulopathy was defined as international normalized ratio [INR] >1.3, platelet count <100,000 /mu L, or partial thromboplastin time >37 sec. Median age (interquartile range; IQR) of our cohort was 27 (21-35) years, and 74 (83%) were male. The intent was assault in 74 cases (83%). The mechanism of PBI was gunshot wound in all patients. Forty patients (45%) were coagulopathic at presentation. In a multiple regression model, coagulopathy was associated with lower Glasgow Coma Scale (GCS)-Motor score (odds ratio [OR], 0.67; confidence interval [CI], 0.48-0.94; p = 0.02) and transfusion of blood products (OR, 3.91; CI, 1.2-12.5; p = 0.02). Effacement of basal cisterns was the only significant radiographical features associated with coagulopathy (OR, 3.34; CI, 1.08-10.37; p = 0.04). Mortality was found to be significantly more common in coagulopathic patients (73% vs. 25%; p < 0.001). However, in our limited sample, reversal of coagulopathy at 24 h was not associated with a statistically significant improvement in outcome. The triad of coagulopathy, low post-resuscitation GCS, and radiographical effacement of basal cisterns identify a particularly ominous phenotype of PBI. The role, and potential reversal of, coagulopathy in this group warrants further investigation.	[Mansour, Ali; Loggini, Andrea; Goldenberg, Fernando D.; Kramer, Christopher; Ammar, Faten El; Lazaridis, Christos] Univ Chicago Med & Biol Sci, Neurosci Intens Care Unit, Dept Neurol, Chicago, IL USA; [Mansour, Ali; Goldenberg, Fernando D.; Kramer, Christopher; Vasenina, Valentina; Castro, Brandyn; Das, Paramita; Horowitz, Peleg M.; Lazaridis, Christos] Univ Chicago Med & Biol Sci, Dept Surg, Sect Neurosurg, Chicago, IL USA; [Karrison, Theodore] Univ Chicago Med & Biol Sci, Dept Surg, Sect Trauma & Acute Care Surg, Chicago, IL USA; [Naidech, Andrew M.; Zakrison, Tanya; Hampton, David; Rogers, Selwyn O.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Evanston, IL USA		Mansour, A (corresponding author), Univ Chicago, Dept Neurol, Neurosci Intens Care Unit, 5841 South Maryland Ave,MC 2030, Chicago, IL 60637 USA.	ali.mansour@uchospitals.edu	, Ali/ABE-6372-2021	, Ali/0000-0002-2658-074X; Hampton, David/0000-0002-9870-0835; Loggini, Andrea/0000-0001-5479-9442			Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Centers for Disease Control and Prevention, 2016, FAT INJ REP NAT REG; Cohen MJ, 2017, CRIT CARE CLIN, V33, P101, DOI 10.1016/j.ccc.2016.08.003; Deng HS, 2019, J NEUROTRAUM, V36, P322, DOI 10.1089/neu.2017.5591; Endo A, 2016, CRIT CARE MED, V44, pE797, DOI 10.1097/CCM.0000000000001731; Fletcher-Sandersjoo A, 2021, NEUROCRIT CARE, V34, P635, DOI 10.1007/s12028-020-01037-8; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Gonzalez E, 2017, CRIT CARE CLIN, V33, P119, DOI 10.1016/j.ccc.2016.09.002; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; Loggini A, 2020, J CRIT CARE, V56, P159, DOI 10.1016/j.jcrc.2019.12.026; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maragkos GA, 2018, J NEUROTRAUM, V35, P2605, DOI 10.1089/neu.2018.5682; Martin G, 2018, NEUROCRIT CARE, V28, P330, DOI 10.1007/s12028-017-0485-5; Mikati AG, 2019, NEUROSURGERY, V85, pE872, DOI 10.1093/neuros/nyz127; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Vajkoczy P, 1999, CLIN NEUROL NEUROSUR, V101, P175, DOI 10.1016/S0303-8467(99)00033-5; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	21	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2021	38	13					1821	1826		10.1089/neu.2020.7422		JAN 2021	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SU3SJ	WOS:000610621400001	33238820				2022-02-06	
J	Fino, PC; Weightman, MM; Dibble, LE; Lester, ME; Hoppes, CW; Parrington, L; Arango, J; Souvignier, A; Roberts, H; King, LA				Fino, Peter C.; Weightman, Margaret M.; Dibble, Leland E.; Lester, Mark E.; Hoppes, Carrie W.; Parrington, Lucy; Arango, Jorge; Souvignier, Alicia; Roberts, Holly; King, Laurie A.			Objective Dual-Task Turning Measures for Return-to-Duty Assessment After Mild Traumatic Brain Injury: The ReTURN Study Protocol	FRONTIERS IN NEUROLOGY			English	Article						concussion; gait; return to sport (RTS); inertial sensors; wearable sensors	SPORTS-RELATED CONCUSSION; MOBILITY ASSESSMENT-TOOL; QUALITY-OF-LIFE; COLLEGIATE FOOTBALL PLAYERS; PSYCHOMETRIC PROPERTIES; EXECUTIVE DYSFUNCTION; RECURRENT CONCUSSION; POSTURAL STABILITY; RETEST RELIABILITY; PHYSICAL-THERAPY	Determining readiness for duty after mild traumatic brain injury (mTBI) is essential for the safety of service members and their unit. Currently, these decisions are primarily based on self-reported symptoms, objective measures that assess a single system, or standardized physical or cognitive tests that may be insensitive or lack ecological validity for warrior tasks. While significant technological advancements have been made in a variety of assessments of these individual systems, assessments of isolated tasks are neither diagnostically accurate nor representative of the demands imposed by daily life and military activities. Emerging evidence suggests that complex tasks, such as dual-task paradigms or turning, have utility in probing functional deficits after mTBI. Objective measures from turning tasks in single- or dual-task conditions, therefore, may be highly valuable for clinical assessments and return-to-duty decisions after mTBI. The goals of this study are to assess the diagnostic accuracy, predictive capacity, and responsiveness to rehabilitation of objective, dual-task turning measures within an mTBI population. These goals will be accomplished over two phases. Phase 1 will enroll civilians at three sites and active-duty service members at one site to examine the diagnostic accuracy and predictive capacity of dual-task turning outcomes. Phase 1 participants will complete a series of turning tasks while wearing inertial sensors and a battery of clinical questionnaires, neurocognitive testing, and standard clinical assessments of function. Phase 2 will enroll active-duty service members referred for rehabilitation from two military medical treatment facilities to investigate the responsiveness to rehabilitation of objective dual-task turning measures. Phase 2 participants will complete two assessments of turning while wearing inertial sensors: a baseline assessment prior to the first rehabilitation session and a post-rehabilitation assessment after the physical therapist determines the participant has completed his/her rehabilitation course. A variable selection procedure will then be implemented to determine the best task and outcome measure for return-to-duty decisions based on diagnostic accuracy, predictive capacity, and responsiveness to rehabilitation. Overall, the results of this study will provide guidance and potential new tools for clinical decisions in individuals with mTBI.	[Fino, Peter C.] Univ Utah, Dept Hlth & Kinesiol, Salt Lake City, UT 84112 USA; [Weightman, Margaret M.] Allina Hlth, Courage Kenny Res Ctr, Minneapolis, MN USA; [Dibble, Leland E.] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT USA; [Lester, Mark E.; Hoppes, Carrie W.] Army Baylor Univ, Doctoral Program Phys Therapy, Ft Sam Houston, TX USA; [Lester, Mark E.] Texas State Univ, Dept Phys Therapy, Round Rock, TX USA; [Parrington, Lucy; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Arango, Jorge] Traumat Brain Injury Ctr Excellence, Ft Carson, CO USA; [Souvignier, Alicia] Evans Army Community Hosp, Ft Carson, CO USA; [Roberts, Holly] Madigan Army Med Ctr, Joint Base Lewis McChord, WA USA		Fino, PC (corresponding author), Univ Utah, Dept Hlth & Kinesiol, Salt Lake City, UT 84112 USA.	peter.fino@utah.edu			Department of Defense, through the Congressionally Directed Medical Research ProgramUnited States Department of Defense [W81XWH1820049]	This work was supported by the Assistant Secretary of Defense for Health Affairs endorsed by the Department of Defense, through the Congressionally Directed Medical Research Program under Award No.W81XWH1820049.	[Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1; Association A.P, 2013, DIAGN STAT MAN MENT; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bernardin D, 2012, EXP BRAIN RES, V223, P65, DOI 10.1007/s00221-012-3241-2; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conti C., 2014, 2014 3DTV C 3DTV CON, P1; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Courtine G, 2004, J NEUROPHYSIOL, V91, P1524, DOI 10.1152/jn.00817.2003; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Davidson SP, 2016, APPL ERGON, V56, P27, DOI 10.1016/j.apergo.2016.03.001; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Defense ASO, 2015, TRAUMATIC BRAIN INJU; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fino P, 2014, J BIOMECH, V47, P1395, DOI 10.1016/j.jbiomech.2014.01.032; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fino PC, 2019, J HEAD TRAUMA REHAB, V34, pE74, DOI 10.1097/HTR.0000000000000418; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fino PC, 2015, SENSORS-BASEL, V15, P10676, DOI 10.3390/s150510676; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hachana Y, 2013, J STRENGTH COND RES, V27, P2752, DOI 10.1519/JSC.0b013e3182890ac3; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hettich Thomas, 2010, J Spec Oper Med, V10, P48; Hudson TE, 2005, EXP BRAIN RES, V165, P283, DOI 10.1007/s00221-005-2313-y; Hurst H, 2004, J MANIP PHYSIOL THER, V27, P26, DOI 10.1016/j.jmpt.2003.11.003; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kelley AM, 2015, J HEAD TRAUMA REHAB, V30, pE11, DOI 10.1097/HTR.0000000000000060; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; King LA, 2012, J NEUROL PHYS THER, V36, P25, DOI 10.1097/NPT.0b013e31824620d1; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Kleffelgaard I, 2013, PHYS THER, V93, P900, DOI 10.2522/ptj.20120381; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Lennon A, 2018, J NEUROL PHYS THER, V42, P123, DOI 10.1097/NPT.0000000000000227; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Lieberman HR, 2005, AVIAT SPACE ENVIR MD, V76, pC7; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Palmer CJ, 2013, ERGONOMICS, V56, P1708, DOI 10.1080/00140139.2013.832805; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Paul SS, 2017, IEEE T NEUR SYS REH, V25, P2347, DOI 10.1109/TNSRE.2017.2740945; Paul SS, 2017, JAMA OTOLARYNGOL, V143, P1008, DOI 10.1001/jamaoto.2017.1443; Quatman-Yates CC, 2020, J ORTHOP SPORT PHYS, V50, pCPG1, DOI 10.2519/jospt.2020.0301; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Raphan T, 2001, ANN NY ACAD SCI, V942, P128; Raya MA, 2013, J REHABIL RES DEV, V50, P951, DOI 10.1682/JRRD.2012.05.0096; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Robitaille N, 2017, DISABIL REHABIL-ASSI, V12, P758, DOI 10.1080/17483107.2016.1229048; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Smith LB, 2014, AM J OCCUP THER, V68, P439, DOI 10.5014/ajot.2014.012393; Solomon D, 2006, EXP BRAIN RES, V173, P475, DOI 10.1007/s00221-006-0393-y; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; U.S.P.S. Association, 2019, USPSA COMP RUL; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Weightman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169104; Weightman MM, 2015, ASSESSMENT MILITARY; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Williams G, 2012, CLIN REHABIL, V26, P741, DOI 10.1177/0269215511429163; Williams G, 2010, BRAIN INJURY, V24, P1027, DOI 10.3109/02699052.2010.490517; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326; Yamaguchi T, 2013, GAIT POSTURE, V38, P209, DOI 10.1016/j.gaitpost.2012.11.007; Zaferiou AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188184	100	1	1	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 15	2021	11								544812	10.3389/fneur.2020.544812			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PZ3OW	WOS:000612649300001	33519659	gold, Green Published			2022-02-06	
J	Matovu, P; Kirya, M; Galukande, M; Kiryabwire, J; Mukisa, J; Ocen, W; Wilson, ML; Abio, A; Lule, H				Matovu, Paul; Kirya, Musa; Galukande, Moses; Kiryabwire, Joel; Mukisa, John; Ocen, William; Wilson, Michael Lowery; Abio, Anne; Lule, Herman			Hyperglycemia in severe traumatic brain injury patients and its association with thirty-day mortality: a prospective observational cohort study in Uganda	PEERJ			English	Article						Traumatic-brain-injury; Hyperglycemia; Prevalence; Mortality; Uganda	BLOOD-GLUCOSE; HYPOTHERMIA; ADMISSION; LEVEL	Background: Traumatic brain injury (TBI) is a growing public health concern that can be complicated with an acute stress response. This response may be assessed by monitoring blood glucose levels but this is not routine in remote settings. There is a paucity of data on the prevalence of hyperglycemia and variables associated with mortality after severe TBI in Uganda. Objective: We aimed to determine the prevalence of hyperglycemia in patients with severe TBI and variables associated with 30-day mortality at Mulago National Referral Hospital in Uganda. Methods: We consecutively enrolled a cohort 99 patients patients with severe TBI. Serum glucose levels were measured at admission and after 24 h. Other study variables included: mechanism of injury, CT findings, location and size of hematoma, and socio-demographics. The main outcome was mortality after 30 days of management and this was compared in patients with hyperglycemia more than 11.1 mmol/L to those without. Results: Most patients (92.9%) were male aged 18-30 years (47%). Road Traffic Collisions were the most common cause of severe TBI (64.7%) followed by assault (17.1%) and falls (8.1%). Nearly one in six patients were admitted with hyperglycemia more than 11.1 mmol/L. The mortality rate in severe TBI patients with hyperglycemia was 68.8% (OR 1.47; 95% CI [0.236-9.153]; P = 0.063) against 43.7% in those without hyperglycemia. The presence of hypothermia (OR 10.17; 95% CI [1.574-65.669]; P = 0.015) and convulsions (OR 5.64; 95% CI [1.541-19.554]; P = 0.009) were significant predictors of mortality. Conclusion: Hypothermia and convulsions at admission were major predictors of mortality in severe TBI. Early hyperglycemia following severe TBI appears to occur with a tendency towards high mortality. These findings justify routine glucose monitoring and could form the basis for establishing a blood sugar control protocol for such patients in remote settings.	[Matovu, Paul; Kirya, Musa; Galukande, Moses] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Gen Surg, Kampala, Uganda; [Kiryabwire, Joel] Mulago Natl Referral & Teaching Hosp, Dept Neurosurg, Kampala, Uganda; [Mukisa, John] Uganda Case Western Reserve Univ Res Collaborat, Clin Epidemiol Unit, Kampala, Uganda; [Ocen, William] Mulago Hosp Kampala, Dept Surg, Kampala, Uganda; [Ocen, William] Lira Univ, Dept Surg, Lira, Uganda; [Wilson, Michael Lowery] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Baden Wuerttemb, Germany; [Abio, Anne; Lule, Herman] Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neural Sci, Turku, Finland; [Abio, Anne; Lule, Herman] Univ Turku, Injury Epidemiol & Prevent Res Grp, Turku, Finland; [Lule, Herman] Kampala Int Univ Western Campus, Dept Surg, Directorate Res & Innovat, Kampala, Uganda		Wilson, ML (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Baden Wuerttemb, Germany.	michael.wilson@uni-heidelberg.de	Lule, Herman/AAJ-8762-2021	Lule, Herman/0000-0002-0647-9716; , Anne/0000-0002-4568-3509; mukisa, john/0000-0002-9208-0313	Alexander von Humboldt-Stiftung, Bonn, GermanyAlexander von Humboldt Foundation	Michael Lowery Wilson was supported by the Alexander von Humboldt-Stiftung, Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adatia K, 2021, NEUROCRIT CARE, V34, P312, DOI 10.1007/s12028-020-00994-4; Adeolu AA, 2010, J CLIN NEUROSCI, V17, P325, DOI 10.1016/j.jocn.2009.07.088; Adeolu AA, 2015, J NEUROSCI RURAL PRA, V6, P216, DOI 10.4103/0976-3147.153230; Ahmed AI, 2016, NEUROSURG CLIN N AM, V27, P489, DOI 10.1016/j.nec.2016.05.004; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Chalya Phillipo L, 2014, Tanzan J Health Res, V16, P280; Chalya Phillipo L, 2012, J Trauma Manag Outcomes, V6, P1, DOI 10.1186/1752-2897-6-1; Desai M, 2018, J NEUROSURG SCI, V62, P563, DOI 10.23736/S0390-5616.18.04476-4; Doherty J., 2017, CRITICAL AFRICAN STU, V9, P192, DOI [10.1080/21681392.2017.1317457, DOI 10.1080/21681392.2017.1317457]; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Haron RH, 2011, MALAYS J MED SCI, V18, P69; Hesdorffer DC, 2009, EPILEPSIA, V50, P1102, DOI 10.1111/j.1528-1167.2008.01945.x; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Hutchinson, 2018, SURGERY, V36, P613, DOI [10.1016/j.mpsur.2018.09.007, DOI 10.1016/J.MPSUR.2018.09.007]; James SL, 2020, INJURY PREV, V26, P96, DOI 10.1136/injuryprev-2019-043494; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kafaki SB, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMEDED.S40330; Keane Matthew, 2016, Emerg Nurse, V24, P19, DOI 10.7748/en.2016.e1569; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; Roehler DR, 2013, GLOB HEALTH PROMOT, V20, P37, DOI 10.1177/1757975913509657; Salehpour F, 2016, WORLD NEUROSURG, V87, P132, DOI 10.1016/j.wneu.2015.11.048; Salim A, 2009, AM SURGEON, V75, P25; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Singh A, 2015, INT J SCI RES, V4, P190; Siya A, 2019, TRAFFIC INJ PREV, V20, pS133, DOI 10.1080/15389588.2019.1658084; Ssebakumba MK, 2020, EGYPT J NEUROSURG, V35, DOI 10.1186/s41984-020-0073-4; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Uganda National Council for Science & Technology, 2014, NAT GUID RES INV HUM; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; World Health Organization, 2015, GLOB STAT REP ROAD S; Zia N, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000259	37	1	1	1	1	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	JAN 15	2021	9								e10589	10.7717/peerj.10589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PS7OS	WOS:000608116200004	33520442	Green Published, gold			2022-02-06	
J	Moschonas, EH; Leary, JB; Memarzadeh, K; Bou-Abboud, CE; Folweiler, KA; Monaco, CM; Cheng, JP; Kline, AE; Bondi, CO				Moschonas, Eleni H.; Leary, Jacob B.; Memarzadeh, Kimiya; Bou-Abboud, Carine E.; Folweiler, Kaitlin A.; Monaco, Christina M.; Cheng, Jeffrey P.; Kline, Anthony E.; Bondi, Corina O.			Disruption of basal forebrain cholinergic neurons after traumatic brain injury does not compromise environmental enrichment-mediated cognitive benefits	BRAIN RESEARCH			English	Article						BFCNs, beam-walking; Behavior; Controlled cortical impact; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; REDUCED EVOKED RELEASE; IGG-SAPORIN LESIONS; NUCLEUS BASALIS; MAZE PERFORMANCE; SPATIAL WORKING; HISTOLOGICAL BENEFITS; ATTENTIONAL SET; SEPTAL AREA; HEAD-INJURY	Environmental enrichment (EE) attenuates traumatic brain injury (TBI)-induced loss of medial septal (MS) choline acetyltransferase (ChAT)-cells and enhances spatial learning and memory vs. standard (STD) housing. Whether basal forebrain cholinergic neurons (BFCNs) are important mediators of EE-induced benefits after TBI requires further investigation. Anesthetized female rats were randomly assigned to intraseptal infusions of the immunotoxin 192-IgG-saporin (SAP; 0.22 mu g in 1.0 mu L) or vehicle (VEH; 1.0 mu L IgG) followed immediately by a cortical impact (2.8 mm deformation depth at 4 m/s) or sham injury and divided into EE and STD housing. Spatial learning and memory retention were assessed on post-operative days 14-19. MS ChAT(+) cells were quantified at 3 weeks. SAP significantly reduced ChAT(+) cells in both the EE and STD groups. Cognitive performance was improved in the EE groups, regardless of VEH or SAP infusion, vs. the STD-housed groups (p's < 0.05). No cognitive differences were revealed between the TBI + EE + SAP and TBI + EE + VEH groups (p > 0.05) or between the TBI + STD + SAP and TBI + STD + VEH groups (p > 0.05). These data show that despite significant MS ChAT+ cell loss, the EE-mediated benefit in cognitive recovery is not compromised.	[Moschonas, Eleni H.; Leary, Jacob B.; Memarzadeh, Kimiya; Bou-Abboud, Carine E.; Folweiler, Kaitlin A.; Monaco, Christina M.; Cheng, Jeffrey P.; Kline, Anthony E.; Bondi, Corina O.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15224 USA; [Moschonas, Eleni H.; Leary, Jacob B.; Memarzadeh, Kimiya; Bou-Abboud, Carine E.; Folweiler, Kaitlin A.; Monaco, Christina M.; Cheng, Jeffrey P.; Kline, Anthony E.; Bondi, Corina O.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Moschonas, Eleni H.; Kline, Anthony E.; Bondi, Corina O.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15224 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15224 USA		Bondi, CO (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Sch Med, Room 6124,4401 Penn Ave, Pittsburgh, PA 15224 USA.	bondico@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620, HD069620-S1, NS084967, NS110609, NS094950, NS099683]; Research Advisory Committee, Children's Hospital of Pittsburgh of UPMC	This work was supported, in part, by the National Institutes of Health grants NS060005, HD069620, HD069620-S1, NS084967 (AEK), NS110609, NS094950, NS099683 (COB), and the Research Advisory Committee, Children's Hospital of Pittsburgh of UPMC (COB).	Arciniegas D., 1995, BRAIN INJURY, V13, P1; Baxter MG, 1996, NEUROREPORT, V7, P1417, DOI 10.1097/00001756-199605310-00019; BERGERSWEENEY J, 1994, J NEUROSCI, V14, P4507; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; Chappell J, 1998, NEUROPHARMACOLOGY, V37, P481, DOI 10.1016/S0028-3908(98)00032-X; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; De Bartolo P, 2008, NEUROSCIENCE, V154, P444, DOI 10.1016/j.neuroscience.2008.03.069; de la Tremblaye PB, 2017, NEUROREHAB NEURAL RE, V31, P977, DOI 10.1177/1545968317739999; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Dornan WA, 1996, BEHAV BRAIN RES, V82, P93, DOI 10.1016/S0166-4328(97)81112-6; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Hartonian I, 2005, RESTOR NEUROL NEUROS, V23, P87; HEPLER DJ, 1985, J NEUROSCI, V5, P866; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Johnson DA, 2002, BRAIN RES, V943, P132, DOI 10.1016/S0006-8993(02)02623-9; KELSEY JE, 1988, BEHAV NEUROSCI, V102, P289; KELSEY JE, 1993, BEHAV NEUROSCI, V107, P565, DOI 10.1037/0735-7044.107.4.565; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Lehmann O, 2003, EUR J NEUROSCI, V18, P651, DOI 10.1046/j.1460-9568.2003.02745.x; Lehmann O, 2002, EUR J NEUROSCI, V15, P1991, DOI 10.1046/j.1460-9568.2002.02037.x; Menon DK, 2009, CRIT CARE MED, V37, pS129, DOI 10.1097/CCM.0b013e3181921225; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Paban V, 2011, NEUROBIOL AGING, V32, P470, DOI 10.1016/j.neurobiolaging.2009.03.010; Pang KCH, 2001, HIPPOCAMPUS, V11, P814, DOI 10.1002/hipo.1097; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shen JM, 1996, BEHAV NEUROSCI, V110, P1181, DOI 10.1037/0735-7044.110.5.1181; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Tait DS, 2008, BEHAV BRAIN RES, V187, P100, DOI 10.1016/j.bbr.2007.08.035; Tenovuo OS, 2006, CURR DRUG THER, V1, P187, DOI 10.2174/157488506776930932; Vuckovich JA, 2004, LEARN MEMORY, V11, P87, DOI 10.1101/lm.63504; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Waite JJ, 1996, LIFE SCI, V58, P1947, DOI 10.1016/0024-3205(96)00184-1; WAITE JJ, 1995, NEUROSCIENCE, V65, P463, DOI 10.1016/0306-4522(94)00479-O; Walsh TJ, 1996, BRAIN RES, V726, P69, DOI 10.1016/S0006-8993(96)00271-5; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102	58	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2021	1751								147175	10.1016/j.brainres.2020.147175			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PH7OW	WOS:000600598100005	33121921	Green Accepted			2022-02-06	
J	Sutar, S; Ganpule, SG				Sutar, Sunil; Ganpule, S. G.			Assessment of Compression Driven Shock Tube Designs in Replicating Free-Field Blast Conditions for Traumatic Brain Injury Studies	JOURNAL OF NEUROTRAUMA			English	Article						artifacts; computational model; free-field blast; implications for injury; shock tube	POSSIBLE DAMAGE MECHANISM; INTRACRANIAL-PRESSURE; RISK-ASSESSMENT; OVERPRESSURE; CAVITATION; RAT; EXPOSURE; MODELS; TBI	Compression driven shock tubes are indispensable in studies of blast-induced traumatic brain injury (bTBI). The ability of shock tubes in faithfully recreating free-field blast conditions is of enormous interest and has a direct impact on injury outcomes. Toward this end, the evolution of blast wave inside and outside of the compression driven shock tube has been studied using validated, finite element based shock tube models. Several shock tube configurations (uniform cross-section, transition, conical, suddenly expanded, and end plate) have been considered. The finite element modeling approach has been used to simulate the transient, dynamic response of blast wave propagation. The response is studied for longer durations (40-100 msec) compared with the existing literature. We demonstrate that locations inside and outside of the shock tube can generate free-field blast profile in some form, but with numerous caveats. Our results indicate that the locations inside the shock tube are affected by higher underpressure and corresponding kinetic energy yield compared with free-field blast. These effects can be minimized using optimized end plate configuration at the exit of the shock tube, yet this is accompanied by secondary loading that is not representative of the free-field blast. Blast wave profile can be tailored using transition, conical, and suddenly expanded sections. We observe oscillations in the blast wave profile for suddenly expanded configuration. Locations outside the shock tube are affected by jet-wind effects because of the sudden expansion, barring a narrow region at the exit. For the desired overpressure yield inferred in bTBI, obtaining positive phase durations of <1 msec inside the shock tube, which are sought for studies in rodents, is challenging. Overall, these results underscore that replicating free-field blast conditions using a shock tube involves tradeoffs that need to be weighed carefully and their effect on injury outcomes should be evaluated during laboratory bTBI investigations.	[Sutar, Sunil; Ganpule, S. G.] Indian Inst Technol Roorkee, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India		Ganpule, SG (corresponding author), Indian Inst Technol Roorkee, Dept Mech & Ind Engn, Roorkee 247667, Uttar Pradesh, India.	ganpule@me.iitr.ac.in			Department of Science and Technology (DST)Department of Science & Technology (India) [ECR-2017-000417]; Ministry of Human Resource Development	SG acknowledges financial support from the Department of Science and Technology (DST) under the grant ECR-2017-000417. SS acknowledges a fellowship from the Ministry of Human Resource Development.	Alay E, 2018, SHOCK WAVES, V28, P51, DOI 10.1007/s00193-017-0762-4; Anderson J., 2003, MODERN COMPRESSIBLE; Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Bakroon M., 2018, NUM METHODS GEOTECH, V8, P2018; Bentil SA, 2016, EXP MECH, V56, P759, DOI 10.1007/s11340-015-0122-1; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Bowen I.G., 1968, DA49146XZ372 LOV FDN, pDASA; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Eslaminejad A., 2017, FLUIDS ENG DIV SUMM; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P322, DOI 10.1098/rspa.1946.0046; Garimella HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190881; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Haniff S, 2017, SHOCK WAVES, V27, P929, DOI 10.1007/s00193-017-0765-1; Hyde D., 2004, CONWEP 2 1 0 8 COMPU; Iwaskiw AS, 2018, SHOCK WAVES, V28, P63, DOI 10.1007/s00193-017-0759-z; Jeon D, 2017, COMPUTATION, V5, DOI 10.3390/computation5030041; Jiang Z, 1999, SHOCK WAVES, V9, P1, DOI 10.1007/s001930050133; Kahali S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227125; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Karlos V, 2016, INT J PROT STRUCT, V7, P409, DOI 10.1177/2041419616659572; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kumar R, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00090; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LSTC, 2017, LS DYNA KEYW US MAN; Nguyen M, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2320699; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Ouellet S., 2017, J SHOCK WAVES, V27, P1; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Rafaels KA, 2010, J TRAUMA, V69, P368, DOI 10.1097/TA.0b013e3181e88122; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; Skotak M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00797; Skotak M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198968; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Sutar S, 2020, BIOMECH MODEL MECHAN, V19, P875, DOI 10.1007/s10237-019-01256-9; Swietek B, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5099633; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tasissa AF, 2016, P ROY SOC A-MATH PHY, V472, DOI 10.1098/rspa.2015.0611; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Teich M, 2010, INT J PROT STRUCT, V1, P219, DOI 10.1260/2041-4196.1.2.219; Wadley HNG, 2010, INT J IMPACT ENG, V37, P317, DOI 10.1016/j.ijimpeng.2009.06.006; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wiri S, 2016, SHOCK WAVES, V26, P279, DOI 10.1007/s00193-016-0644-1; Yu A.W., 2014, P 32 ANN NAT NEUR S; Zeng QH, 2014, J PHYS CONF SER, V510, DOI 10.1088/1742-6596/510/1/012047; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	61	1	1	4	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1717	1729		10.1089/neu.2020.7394		JAN 2021	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000610188500001	33108952				2022-02-06	
J	Grevfors, N; Lindblad, C; Nelson, DW; Svensson, M; Thelin, EP; Wahlin, RR				Grevfors, Niklas; Lindblad, Caroline; Nelson, David W.; Svensson, Mikael; Thelin, Eric Peter; Rubenson Wahlin, Rebecka			Delayed Neurosurgical Intervention in Traumatic Brain Injury Patients Referred From Primary Hospitals Is Not Associated With an Unfavorable Outcome	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; secondary referral hospital; pre-hospital management; human; neurosurgery	ACUTE SUBDURAL-HEMATOMA; PROGNOSTIC ANALYSIS; PREHOSPITAL TIME; GOLDEN HOUR; HEAD-INJURY; IMPACT; MORTALITY; EPIDEMIOLOGY; S100B; MILD	Background: Secondary transports of patients suffering from traumatic brain injury (TBI) may result in a delayed management and neurosurgical intervention, which is potentially detrimental. The aim of this study was to study the effect of triaging and delayed transfers on outcome, specifically studying time to diagnostics and neurosurgical management. Methods: This was a retrospective observational cohort study of TBI patients in need of neurosurgical care, 15 years and older, in the Stockholm Region, Sweden, from 2008 throughout 2014. Data were collected from pre-hospital and in-hospital charts. Known TBI outcome predictors, including the protein biomarker of brain injury S100B, were used to assess injury severity. Characteristics and outcomes of direct trauma center (TC) and those of secondary transfers were evaluated and compared. Functional outcome, using the Glasgow Outcome Scale, was assessed in survivors at 6-12 months after trauma. Regression models, including propensity score balanced models, were used for endpoint assessment. Results: A total of n = 457 TBI patients were included; n = 320 (70%) patients were direct TC transfers, whereas n = 137 (30%) were secondary referrals. In all, n = 295 required neurosurgery for the first 24 h after trauma (about 75% of each subgroup). Direct TC transfers were more severely injured (median Glasgow Coma Scale 8 vs. 13) and more often suffered a high energy trauma (31 vs. 2.9%) than secondary referrals. Admission S100B was higher in the TC transfer group, though S100B levels 12-36 h after trauma were similar between cohorts. Direct or indirect TC transfer could be predicted using propensity scoring. The secondary referrals had a shorter distance to the primary hospital, but had later radiology and surgery than the TC group (all p < 0.001). In adjusted multivariable analyses with and without propensity matching, direct or secondary transfers were not found to be significantly related to outcome. Time from trauma to surgery did not affect outcome. Conclusions: TBI patients secondary transported to a TC had surgical intervention performed hours later, though this did not affect outcome, presumably demonstrating that accurate pre-hospital triaging was performed. This indicates that for selected patients, a wait-and-see approach with delayed neurosurgical intervention is not necessarily detrimental, but warrants further research.	[Grevfors, Niklas; Nelson, David W.] Karolinska Univ Hosp, Div Perioperat Med & Intens Care PMI, Dept Anesthesiol, Stockholm, Sweden; [Lindblad, Caroline; Svensson, Mikael; Thelin, Eric Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Nelson, David W.] Karolinska Inst, Sect Anesthesiol & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Svensson, Mikael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden; [Thelin, Eric Peter] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Rubenson Wahlin, Rebecka] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden; [Rubenson Wahlin, Rebecka] Soder Sjukhuset, Dept Anesthesia & Intens Care, Stockholm, Sweden; [Rubenson Wahlin, Rebecka] Ambulanssjukvarden & Storstockholm AB, Ambulance Med Serv Stockholm, Stockholm, Sweden; [Rubenson Wahlin, Rebecka] Acad EMS, Stockholm, Sweden		Thelin, EP (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Thelin, EP (corresponding author), Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden.	Eric.thelin@ki.se	Thelin, Eric Peter/K-2144-2012; Lindblad, Caroline/AAJ-7911-2021	Thelin, Eric Peter/0000-0002-2338-4364; Lindblad, Caroline/0000-0003-4952-8597; Nelson, David/0000-0003-2530-8207; Rubenson Wahlin, Rebecka/0000-0003-3890-8236	Hjarnfonden (The Swedish Brain Foundation); Svenska Sallskapet for Medicinsk Forskning (Swedish Society for Medical Research); ALF	ET has received financial support from Hjarnfonden (The Swedish Brain Foundation), Svenska Sallskapet for Medicinsk Forskning (Swedish Society for Medical Research). ET and DN were supported by ALF. The funders had no role in the design or conduct of this research.	American College of Surgeons, 2012, ATLS ADV TRAUM LIF S; Bellander Bo-Michael, 2008, Lakartidningen, V105, P1834; Blow O, 1999, J TRAUMA, V47, P964, DOI 10.1097/00005373-199911000-00028; Brorsson C, 2011, ACTA ANAESTH SCAND, V55, P944, DOI 10.1111/j.1399-6576.2011.02451.x; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cnossen MC, 2019, J NEUROTRAUM, V36, P176, DOI 10.1089/neu.2018.5712; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Gravesteijn BY, 2021, PREHOSP EMERG CARE, V25, P629, DOI 10.1080/10903127.2020.1817210; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Harrell FE, 2018, rms: regression modeling strategies; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jivall L, 2000, EUREF S TROMS 2000 0; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Kim J, 2017, PREHOSP EMERG CARE, V21, P466, DOI 10.1080/10903127.2017.1294223; Konstantinidis A, 2011, J TRAUMA, V71, P1627, DOI 10.1097/TA.0b013e3182159e31; Lecky FE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016355; Leyrat C, 2019, STAT METHODS MED RES, V28, P3, DOI 10.1177/0962280217713032; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marcoux J, 2016, J NEUROSURG, V125, P642, DOI 10.3171/2015.6.JNS15175; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McHugh GS, 2007, J NEUROTRAUM, V24, P251, DOI 10.1089/neu.2006.0026; Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Nordgarden T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0524-z; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peitzman AB, 2002, THE TRAUMA MANUAL; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; Pingel R, 2014, SOME ASPECTS PROPENS; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; R Core Team, 2020, R LANG ENV STAT COMP; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; S. County Council, 2013, EMS MED STAT CAK NET; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; SLL Stockholms prehospitala centrum, 2006, MED RIKTL AMB; Smith RM, 2009, INJURY, V40, pS23, DOI 10.1016/j.injury.2009.10.033; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thelin EP, 2016, EUR J TRAUMA EMERG S, V42, P617, DOI 10.1007/s00068-015-0583-z; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; Tierney KJ, 2016, J NEUROSURG, V124, P538, DOI 10.3171/2015.4.JNS142440; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; van Buuren S, 2011, J STAT SOFTW, V45, P1; Venables W.N., 2002, MODERN APPL STAT S, V4th, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Voskens FJ, 2018, JAMA SURG, V153, P322, DOI 10.1001/jamasurg.2017.4472; Wahlin RR, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00194; Wiegele M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2352-6; Woodzin E., 2016, ABBREVIATED INJURY S; Zhang K, 2016, BRIT J NEUROSURG, V30, P251, DOI 10.3109/02688697.2016.1139052; Zhang ZH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.03.29	77	1	1	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 13	2021	11								610192	10.3389/fneur.2020.610192			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PY6IF	WOS:000612145900001	33519689	Green Published, gold			2022-02-06	
J	Hou, QH; Chen, HM; Liu, Q; Yan, XL				Hou, Qinhan; Chen, Hongmou; Liu, Quan; Yan, Xianlei			FGF10 Attenuates Experimental Traumatic Brain Injury through TLR4/MyD88/NF-kappa B Pathway	CELLS TISSUES ORGANS			English	Article						FGF10; Traumatic brain injury; Neuronal apoptosis; Neuroinflammation; TLR4/MyD88/NF-kappa B	NF-KAPPA-B; PATHOPHYSIOLOGY; REGENERATION; RECEPTORS; CYTOKINES; RATS; MICE	Traumatic brain injury (TBI) can induce neuronal apoptosis and neuroinflammation, resulting in substantial neuronal damage and behavioral disorders. Fibroblast growth factors (FGFs) have been shown to be critical mediators in tissue repair. However, the role of FGF10 in experimental TBI remains unknown. In this study, mice with TBI were established via weight-loss model and validated by increase of modified neurological severity scores (mNSS) and brain water content. Secondly, FGF10 levels were elevated in mice after TBI, whereas intraventricular injection of Ad-FGF10 decreased mNSS score and brain water content, indicating the remittance of neurological deficit and cerebral edema in TBI mice. In addition, neuronal damage could also be ameliorated by stereotactic injection of Ad-FGF10. Overexpression of FGF10 increased protein expression of Bcl-2, while it decreased Bax and cleaved caspase-3/PARP, and improved neuronal apoptosis in TBI mice. In addition, Ad-FGF10 relieved neuroinflammation induced by TBI and significantly reduced the level of interleukin 1 beta/6, tumor necrosis factor alpha, and monocyte chemoattractant protein-1. Moreover, Ad-FGF10 injection decreased the protein expression level of Toll-like receptor 4 (TLR4), MyD88, and phosphorylation of NF-kappa B (p-NF-kappa B), suggesting the inactivation of the TLR4/MyD88/NF-kappa B pathway. In conclusion, overexpression of FGF10 could ameliorate neurological deficit, neuronal apoptosis, and neuroinflammation through inhibition of the TLR4/MyD88/NF-kappa B pathway, providing a potential therapeutic strategy for brain injury in the future. (c) 2021 S. Karger AG, Basel	[Hou, Qinhan; Chen, Hongmou; Liu, Quan; Yan, Xianlei] Guangxi Med Univ, Dept Neurosurg, Affiliated Hosp 4, 1 Liushi Rd, Liuzhou City 545005, Guangxi, Peoples R China		Chen, HM (corresponding author), Guangxi Med Univ, Dept Neurosurg, Affiliated Hosp 4, 1 Liushi Rd, Liuzhou City 545005, Guangxi, Peoples R China.	lzgryyhqh@163.com			Guangxi Provincival Natural Scientific Foundation [2018GXNSFAA294026]; Science Research and Technology Development Plan of Liuzhou City [2016G020207]	This work was supported by the Guangxi Provincival Natural Scientific Foundation (Grant No. 2018GXNSFAA294026) and the Science Research and Technology Development Plan of Liuzhou City (Grant No. 2016G020207).	Boshoff EL, 2018, NEUROPHARMACOLOGY, V137, P156, DOI 10.1016/j.neuropharm.2018.04.017; Chen CH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005437; Chen J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.490; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Chen PQ, 2019, J INTEGR NEUROSCI, V18, P153, DOI 10.31083/j.jin.2019.02.120; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Feng Y, 2016, INT J MOL MED, V37, P921, DOI 10.3892/ijmm.2016.2495; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Grothe C, 2006, BRAIN RES REV, V51, P293, DOI 10.1016/j.brainresrev.2005.12.001; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hyakkoku K, 2010, NEUROSCIENCE, V171, P258, DOI 10.1016/j.neuroscience.2010.08.054; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li XK, 2016, SEMIN CELL DEV BIOL, V53, P155, DOI 10.1016/j.semcdb.2015.12.014; Li YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19869; Lin Q, 2011, INT IMMUNOPHARMACOL, V11, P1422, DOI 10.1016/j.intimp.2011.04.026; Maddaluno L, 2017, DEVELOPMENT, V144, P4047, DOI 10.1242/dev.152587; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Nacu E, 2016, NATURE, V533, P407, DOI 10.1038/nature17972; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rana A, 2020, BRAIN INJURY, V34, P1039, DOI 10.1080/02699052.2020.1772508; Rana A, 2019, CURR NEUROPHARMACOL, V17, P614, DOI 10.2174/1570159X16666180911121847; Shahror RA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6422; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan XH, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00556; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	34	1	1	2	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1422-6405	1422-6421		CELLS TISSUES ORGANS	Cells Tissues Organs	APR	2021	209	4-6					248	256		10.1159/000511381		JAN 2021	9	Anatomy & Morphology; Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Cell Biology; Developmental Biology	RW4ZE	WOS:000607674400001	33440393				2022-02-06	
J	Luu, D; Komisarow, J; Mills, BM; Vavilala, MS; Laskowitz, DT; Mathew, J; James, ML; Hernandez, A; Sampson, J; Fuller, M; Ohnuma, T; Raghunathan, K; Privratsky, J; Bartz, R; Krishnamoorthy, V				Luu, David; Komisarow, Jordan; Mills, Brianna M.; Vavilala, Monica S.; Laskowitz, Daniel T.; Mathew, Joseph; James, Michael L.; Hernandez, Adrian; Sampson, John; Fuller, Matt; Ohnuma, Tetsu; Raghunathan, Karthik; Privratsky, Jamie; Bartz, Raquel; Krishnamoorthy, Vijay			Association of Severe Acute Kidney Injury with Mortality and Healthcare Utilization Following Isolated Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Acute kidney injury; Healthcare utilization	HYPOXIA	Background/Objective: Traumatic brain injury (TBI) is a leading cause of morbidity, mortality, and disability in the USA. While cardiopulmonary dysfunction can result in poor outcomes following severe TBI, the impact of acute kidney injury (AKI) is poorly understood. We examined the association of severe AKI with hospital mortality and healthcare utilization following isolate severe TBI. Methods: We conducted a retrospective cohort study using the National Trauma Data Bank from 2007 to 2014. We identified a cohort of adult patients with isolated severe TBI and described the incidence of severe AKI, corresponding to Acute Kidney Injury Network stage 3 disease or greater. We examined the association of severe AKI with the primary outcome of hospital mortality using multivariable logistic regression models. In secondary analyses, we examined the association of severe AKI with dialysis catheter placement, tracheostomy and gastrostomy utilization, and hospital length of stay. Results: There were 37,851 patients who experienced isolated severe TBI during the study period. Among these patients, 787 (2.1%) experienced severe (Stage 3 or greater) AKI. In multivariable models, the development of severe AKI in the hospital was associated with in-hospital mortality (OR 2.03, 95% CI 1.64-2.52), need for tracheostomy (OR 2.10, 95% CI 1.52-2.89), PEG tube placement (OR 1.88, 95% CI 1.45-2.45), and increased hospital length of stay (p < 0.001). Conclusions: The overall incidence of severe AKI is relatively low (2.1%), but is associated with increased mortality and multiple markers of increased healthcare utilization following severe TBI.	[Luu, David; Mathew, Joseph; James, Michael L.; Fuller, Matt; Ohnuma, Tetsu; Raghunathan, Karthik; Privratsky, Jamie; Bartz, Raquel; Krishnamoorthy, Vijay] Duke Univ, Med Ctr, Dept Anesthesiol, DUMC 3094, Durham, NC 27710 USA; [Komisarow, Jordan; Sampson, John] Duke Univ, Dept Neurosurg, Durham, NC USA; [Mills, Brianna M.; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Pain Med, Seattle, WA 98195 USA; [Laskowitz, Daniel T.; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [Hernandez, Adrian] Duke Univ, Dept Med, Durham, NC USA; [Luu, David; Komisarow, Jordan; James, Michael L.; Fuller, Matt; Ohnuma, Tetsu; Raghunathan, Karthik; Privratsky, Jamie; Bartz, Raquel; Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Crit Care & Perioperat Populat Hlth Res CAPER Uni, Durham, NC USA; [Mills, Brianna M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Hernandez, Adrian; Raghunathan, Karthik; Krishnamoorthy, Vijay] Duke Univ, Populat Hlth Sci, Durham, NC USA		Krishnamoorthy, V (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, DUMC 3094, Durham, NC 27710 USA.	vijay.krishnamoorthy@duke.edu		Ohnuma, Tetsu/0000-0002-2303-6802; Komisarow, Jordan/0000-0003-3919-7931	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS109274]	Dr. Krishnamoorthy received funding from the National Institutes of Health (K23 NS109274).	Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Erdman MJ, 2017, NEUROHOSPITALIST, V7, P9, DOI 10.1177/1941874416665744; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Lee S, 2019, J NEUROSURG, V131, P1931, DOI 10.3171/2018.8.JNS18676; Lin CY, 2012, AASRI PROC, V1, P40, DOI 10.1016/j.aasri.2012.06.008; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Maguigan KL, 2017, J CLIN NEUROSCI, V39, P147, DOI 10.1016/j.jocn.2017.01.025; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; McDonald SJ, 2020, J NEUROTRAUM, V37, P770, DOI 10.1089/neu.2019.6885; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Ramtinfar S, 2016, INDIAN J CRIT CARE M, V20, P575, DOI 10.4103/0972-5229.192042; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Wiersema R, 2019, BMC NEPHROL, V21, DOI 10.1186/s12882-019-1645-y; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131	23	1	1	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2021	35	2					434	440		10.1007/s12028-020-01183-z		JAN 2021	7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WU3OH	WOS:000607523900002	33442812				2022-02-06	
J	Verberne, DPJ; Ponds, RWHM; Kroese, MEAL; Wijenberg, MLM; Barten, DG; Pasmans, R; Staals, J; van Heugten, CM				Verberne, Daan P. J.; Ponds, Rudolf W. H. M.; Kroese, Marielle E. A. L.; Wijenberg, Melloney L. M.; Barten, Dennis G.; Pasmans, Raphael; Staals, Julie; van Heugten, Caroline M.			Long-term psychosocial outcome following mild traumatic brain injury and minor stroke: a direct longitudinal comparison	JOURNAL OF NEUROLOGY			English	Article						Stroke; Brain injuries; traumatic; Longitudinal studies; Social participation; Emotional adjustment; Primary health care		Background and purpose Research suggests comparable long-term psychosocial outcomes following mild traumatic brain injury (mTBI) and minor stroke, but no direct comparison has been made. This study aimed to directly compare psychosocial outcome over time in persons with mTBI and minor stroke. Methods In this multicenter, prospective longitudinal cohort study, community-dwelling persons with mTBI (n = 182) and minor stroke (n = 48) were assessed at 6 weeks, 3, 6 and 12 months post-injury. Outcome measures included anxiety and depression symptoms (Hospital Anxiety and Depression Scale-HADS), cognitive problems in daily life (Checklist for Cognitive and Emotional Consequences of Stroke-CLCE-24) and quality of life (EuroQol-5D-5L-EQ-5D-5L). Multilevel growth curve modeling, controlled for demographic variables, was used to determine outcomes over time between groups. Proportions of persons reporting persistent psychosocial symptoms at 6 months post-injury were compared using Pearson's Chi-squared tests. Results Improvements in outcomes were observed in the first 6 months and effects stabilized to 12 months post-injury in both groups. Minor stroke cases reported significantly higher levels of HADS anxiety and a significantly reduced increase in EQ-5D-5L utility scores than mTBI cases, but differences were small in absolute numbers. No significant differences were observed between groups regarding HADS depression and CLCE-24 cognition scores. Proportions of persons reporting persistent psychosocial symptoms were equal between groups. Conclusions Psychosocial outcome is largely comparable following mTBI and minor stroke. Specific attention should be paid to anxiety symptoms and cognitive problems in daily life for which uniform aftercare seems appropriate.	[Verberne, Daan P. J.; Ponds, Rudolf W. H. M.; van Heugten, Caroline M.] Maastricht Univ, Maastricht Univ Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci MHeNs, PO 616 UNS 40,6200, NL-6200 MD Maastricht, Netherlands; [Verberne, Daan P. J.; Ponds, Rudolf W. H. M.; Wijenberg, Melloney L. M.; van Heugten, Caroline M.] Limburg Ctr Brain Injury, Maastricht, Netherlands; [Ponds, Rudolf W. H. M.] Adelante Rehabil Ctr Expertise Rehabil & Audiol, Dept Brain Injury Rehabil, Hoensbroek, Netherlands; [Ponds, Rudolf W. H. M.] Maastricht Univ, Dept Med Psychol, Med Ctr, Maastricht, Netherlands; [Kroese, Marielle E. A. L.] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, Maastricht, Netherlands; [Wijenberg, Melloney L. M.; van Heugten, Caroline M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Barten, Dennis G.] VieCuri Med Ctr, Dept Emergency Med, Venlo, Netherlands; [Pasmans, Raphael] Zuyderland Med Ctr, Dept Neurol, Heerlen, Netherlands; [Staals, Julie] Maastricht Univ, Dept Neurol, Med Ctr, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Maastricht Univ Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci MHeNs, PO 616 UNS 40,6200, NL-6200 MD Maastricht, Netherlands.; van Heugten, CM (corresponding author), Limburg Ctr Brain Injury, Maastricht, Netherlands.; van Heugten, CM (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl		ponds, rudolf/0000-0002-9748-4659			Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Broomfield NM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0198-8; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Bulloch AGM, 2015, GEN HOSP PSYCHIAT, V37, P507, DOI 10.1016/j.genhosppsych.2015.06.007; Carlsson GE, 2004, DISABIL REHABIL, V26, P1373, DOI 10.1080/09638280400000211; Carroll Linda J., 2004, Journal of Rehabilitation Medicine Supplement, P113; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Castor N, 2018, BRAIN INJURY, V32, P1803, DOI 10.1080/02699052.2018.1508748; Chun HYY, 2018, STROKE, V49, P556, DOI 10.1161/STROKEAHA.117.020078; Cieza A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-78; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010; Duits A, 2008, J NEUROL NEUROSUR PS, V79, P143, DOI 10.1136/jnnp.2007.114595; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Johnson CO, 2019, LANCET NEUROL, V18, P439, DOI 10.1016/S1474-4422(19)30034-1; Jonasson A, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1056; Kneebone II, 2016, DISABIL REHABIL, V38, P1836, DOI 10.3109/09638288.2015.1107764; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Materne M, 2018, BRAIN INJURY, V32, P1731, DOI 10.1080/02699052.2018.1517224; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morsund AH, 2019, ACTA NEUROL SCAND, V140, P281, DOI 10.1111/ane.13143; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; Satink T, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0739-4; Skoglund E, 2019, J REHABIL MED, V51, P660, DOI 10.2340/16501977-2595; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Strambo D, 2015, CEREBROVASC DIS, V39, P209, DOI 10.1159/000375151; Turner GM, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-1057-x; van Heugten C, 2007, CLIN NEUROL NEUROSUR, V109, P257, DOI 10.1016/j.clineuro.2006.10.002; van Rijsbergen MWA, 2015, J STROKE CEREBROVASC, V24, P1823, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.017; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Watkins CL, 2011, STROKE, V42, P1956, DOI 10.1161/STROKEAHA.110.602227; White J, 2016, FAM PRACT, V33, P382, DOI 10.1093/fampra/cmw011; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wolitzky-Taylor KB, 2008, CLIN PSYCHOL REV, V28, P1021, DOI 10.1016/j.cpr.2008.02.007; World Health Organization (WHO), 2015, WHO GLOBAL STRATEGY; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	1	1	1	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUN	2021	268	6					2132	2140		10.1007/s00415-020-10385-6		JAN 2021	9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SN4ZB	WOS:000607493500004	33439328	Green Published, hybrid			2022-02-06	
J	Vega-Garcia, A; Feria-Romero, I; Garcia-Juarez, A; Munguia-Madera, AC; Montes-Aparicio, AV; Zequeida-Munoz, E; Garcia-Albavera, E; Orozco-Suarez, S				Vega-Garcia, Angelica; Feria-Romero, Iris; Garcia-Juarez, Anais; Munguia-Madera, Ana Ch.; Montes-Aparicio, Alexia V.; Zequeida-Munoz, Esli; Garcia-Albavera, Estefany; Orozco-Suarez, Sandra			Cannabinoids: A New Perspective on Epileptogenesis and Seizure Treatment in Early Life in Basic and Clinical Studies	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						cannabinoids; epileptogenesis; neurodevelopment; neuroprotection; anti-inflammatory; pharmacokinetics	INDUCED CELL-DEATH; ENDOCANNABINOID SYSTEM; STATUS EPILEPTICUS; RAT HIPPOCAMPUS; INFLAMMATORY RESPONSE; CANNABIDIOL TREATMENT; FUNCTIONAL RECOVERY; PEDIATRIC EPILEPSY; PLANT CANNABINOIDS; NEONATAL SEIZURES	Neural hyperexcitability in the event of damage during early life, such as hyperthermia, hypoxia, traumatic brain injury, status epilepticus, or a pre-existing neuroinflammatory condition, can promote the process of epileptogenesis, which is defined as the sequence of events that converts a normal circuit into a hyperexcitable circuit and represents the time that occurs between the damaging event and the development of spontaneous seizure activity or the establishment of epilepsy. Epilepsy is the most common neurological disease in the world, characterized by the presence of seizures recurring without apparent provocation. Cannabidiol (CBD), a phytocannabinoid derived from the subspecies Cannabis sativa (CS), is the most studied active ingredient and is currently studied as a therapeutic strategy: it is an anticonvulsant mainly used in children with catastrophic epileptic syndromes and has also been reported to have anti-inflammatory and antioxidant effects, supporting it as a therapeutic strategy with neuroprotective potential. However, the mechanisms by which CBD exerts these effects are not entirely known, and the few studies on acute and chronic models in immature animals have provided contradictory results. Thus, it is difficult to evaluate the therapeutic profile of CBD, as well as the involvement of the endocannabinoid system in epileptogenesis in the immature brain. Therefore, this review focuses on the collection of scientific data in animal models, as well as information from clinical studies on the effects of cannabinoids on epileptogenesis and their anticonvulsant and adverse effects in early life.	[Vega-Garcia, Angelica] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City, DF, Mexico; [Feria-Romero, Iris; Munguia-Madera, Ana Ch.; Montes-Aparicio, Alexia V.; Orozco-Suarez, Sandra] Hosp Especialidades Dr Bernardo Sepulveda, Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Neurol,IMSS, Mexico City, DF, Mexico; [Garcia-Juarez, Anais] Univ Guadalajara, Ctr Univ Ciencias Biol & Agropecuarias, Div Ciencias Biol & Ambientales, Guadalajara, Jalisco, Mexico; [Zequeida-Munoz, Esli] Univ Autonoma Guerrero, Fac Med, Acapulco, Mexico; [Garcia-Albavera, Estefany] Univ Autonoma Estado Morelos, Fac Biol, Cuernavaca, Morelos, Mexico		Orozco-Suarez, S (corresponding author), Hosp Especialidades Dr Bernardo Sepulveda, Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Neurol,IMSS, Mexico City, DF, Mexico.	sorozco5@hotmail.com			IMSS health research fund [FIS/IMSS/PROT/PRIO/19/107]	This work was supported by the IMSS health research fund, FIS/IMSS/PROT/PRIO/19/107 number grant for the included experimental part and the correction of the English style.	Abu-Sawwa Renad, 2020, J Pediatr Pharmacol Ther, V25, P485, DOI 10.5863/1551-6776-25.6.485; Al-Muhtasib N, 2018, EPILEPSIA, V59, P333, DOI 10.1111/epi.13990; Alexandre J, 2020, ADDICT BIOL, V25, DOI 10.1111/adb.12824; Anderson LL, 2020, BRIT J PHARMACOL, V177, P4261, DOI 10.1111/bph.15181; Andre CM, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00463, 10.3389/fpls.2016.00019]; Armstrong C, 2009, EPILEPSIA, V50, P1657, DOI 10.1111/j.1528-1167.2009.02173.x; Arzimanoglou A, 2020, EPILEPTIC DISORD, V22, P1, DOI 10.1684/epd.2020.1141; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Auvin S, 2014, EPILEPTIC DISORD, V16, pS37, DOI 10.1684/epd.2014.0670; Balosso S, 2005, ANN NEUROL, V57, P804, DOI 10.1002/ana.20480; Baud O, 2019, ANESTH ANALG, V128, P718, DOI 10.1213/ANE.0000000000004032; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Benitez-Diaz P, 2003, DEV NEUROSCI-BASEL, V25, P366, DOI 10.1159/000073514; Berdyshev EV, 2000, CHEM PHYS LIPIDS, V108, P169, DOI 10.1016/S0009-3084(00)00195-X; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bhaskaran MD, 2010, EXP NEUROL, V223, P529, DOI 10.1016/j.expneurol.2010.01.021; Bih CI, 2015, NEUROTHERAPEUTICS, V12, P699, DOI 10.1007/s13311-015-0377-3; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Blair RE, 2004, J PHARMACOL EXP THER, V310, P871, DOI 10.1124/jpet.104.068478; Booz GW, 2011, FREE RADICAL BIO MED, V51, P1054, DOI 10.1016/j.freeradbiomed.2011.01.007; BORNHEIM LM, 1992, DRUG METAB DISPOS, V20, P241; Bouchard J, 2012, J NEUROSCI, V32, P18259, DOI 10.1523/JNEUROSCI.4008-12.2012; Bouchet CA, 2020, PHARMACOL THERAPEUT, V209, DOI 10.1016/j.pharmthera.2020.107495; Brusco A, 2008, SYNAPSE, V62, P944, DOI 10.1002/syn.20569; Burstein S, 2015, BIOORGAN MED CHEM, V23, P1377, DOI 10.1016/j.bmc.2015.01.059; Caiati MD, 2012, SCI REP-UK, V2, DOI 10.1038/srep00285; Capasso R, 2008, BRIT J PHARMACOL, V154, P1001, DOI 10.1038/bjp.2008.177; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chan PC, 1996, FUND APPL TOXICOL, V30, P109, DOI 10.1006/faat.1996.0048; Chen J, 2015, N-S ARCH PHARMACOL, V388, P451, DOI 10.1007/s00210-015-1088-3; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Chen K, 2007, J NEUROSCI, V27, P46, DOI 10.1523/JNEUROSCI.3966-06.2007; Chen YH, 2013, NEUROIMMUNOMODULAT, V20, P223, DOI 10.1159/000348440; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Claudet I, 2017, EUR J PEDIATR, V176, P553, DOI 10.1007/s00431-017-2872-5; Cock HR, 2002, PROG BRAIN RES, V135, P187; Correa F, 2007, NEUROIMMUNOMODULAT, V14, P182, DOI 10.1159/000110644; Coulter Douglas A, 2006, Epilepsy Curr, V6, P18, DOI 10.1111/j.1535-7511.2005.00082.x; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Devinsky O, 2018, NEUROLOGY, V90, pE1204, DOI 10.1212/WNL.0000000000005254; Devinsky O, 2018, EPILEPSY BEHAV, V86, P131, DOI 10.1016/j.yebeh.2018.05.013; Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Devinsky O, 2014, EPILEPSIA, V55, P791, DOI 10.1111/epi.12631; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Di Marzo V, 2015, NEUROTHERAPEUTICS, V12, P692, DOI 10.1007/s13311-015-0374-6; Dow-Edwards D, 2017, BRAIN RES, V1654, P157, DOI 10.1016/j.brainres.2016.08.037; El-Remessy AB, 2008, MOL VIS, V14, P2190; Elliott J, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0761-2; ElSohly MA, 2016, BIOL PSYCHIAT, V79, P613, DOI 10.1016/j.biopsych.2016.01.004; Etienne M., 2014, HDB CANNABIS, P144; Feng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21931; Fernandez-Ruiz J, 2000, TRENDS NEUROSCI, V23, P14, DOI 10.1016/S0166-2236(99)01491-5; Folbergrova J, 2010, NEUROCHEM INT, V56, P394, DOI 10.1016/j.neuint.2009.11.011; Forcelli PA, 2011, EPILEPSIA, V52, pE207, DOI 10.1111/j.1528-1167.2011.03297.x; Franco V, 2019, DRUGS, V79, P1435, DOI 10.1007/s40265-019-01171-4; Galanopoulou AS, 2008, CURR NEUROPHARMACOL, V6, P1, DOI 10.2174/157015908783769653; Gaston TE, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0882-y; Gaston TE, 2017, EPILEPSY BEHAV, V70, P313, DOI 10.1016/j.yebeh.2016.11.016; Geffrey AL, 2015, EPILEPSIA, V56, P1246, DOI 10.1111/epi.13060; Ghovanloo MR, 2018, J BIOL CHEM, V293, P16546, DOI 10.1074/jbc.RA118.004929; Glass HC, 2018, SEMIN FETAL NEONAT M, V23, P218, DOI 10.1016/j.siny.2018.02.001; Glass HC, 2012, PEDIATR NEUROL, V46, P111, DOI 10.1016/j.pediatrneurol.2011.11.006; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; GREENE ML, 1974, GASTROENTEROLOGY, V66, P365; HAGLID KG, 1994, MOL NEUROBIOL, V9, P259, DOI 10.1007/BF02816125; Harkany T, 2008, MOL CELL ENDOCRINOL, V286, pS84, DOI 10.1016/j.mce.2008.02.011; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hayakawa K, 2009, BIOL PHARM BULL, V32, P1538, DOI 10.1248/bpb.32.1538; Hayatbakhsh MR, 2007, J AM ACAD CHILD PSY, V46, P408, DOI 10.1097/chi.0b013e31802dc54d; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Hill AJ, 2014, NEUROSCI LETT, V566, P269, DOI 10.1016/j.neulet.2014.03.013; Huntsman RJ, 2020, J CLIN NEUROPHYSIOL, V37, P2, DOI 10.1097/WNP.0000000000000641; Jabs R, 1997, NEUROSCIENCE, V81, P847, DOI 10.1016/S0306-4522(97)00207-8; Jensen FE, 2009, CLIN PERINATOL, V36, P881, DOI 10.1016/j.clp.2009.08.001; Jiang JF, 2004, J NEUROCHEM, V90, P1036, DOI 10.1111/j.1471-4159.2004.02577.x; Jones NA, 2010, J PHARMACOL EXP THER, V332, P569, DOI 10.1124/jpet.109.159145; Joseph EK, 2006, PAIN, V121, P105, DOI 10.1016/j.pain.2005.12.010; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; Kaplan JS, 2017, P NATL ACAD SCI USA, V114, P11229, DOI 10.1073/pnas.1711351114; Karschner EL, 2011, CLIN CHEM, V57, P66, DOI 10.1373/clinchem.2010.152439; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kaushal S, 2016, EPILEPSIA, V57, P727, DOI 10.1111/epi.13365; Kawaguchi K, 2005, BRAIN RES, V1050, P130, DOI 10.1016/j.brainres.2005.05.038; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Klein BD, 2017, NEUROCHEM RES, V42, P1939, DOI 10.1007/s11064-017-2287-8; Knupp KG, 2019, SEIZURE-EUR J EPILEP, V72, P23, DOI 10.1016/j.seizure.2019.09.007; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kubova H, 2001, J NEUROSCI, V21, P3593, DOI 10.1523/JNEUROSCI.21-10-03593.2001; Kubova H, 2013, NEUROSCIENCE, V235, P232, DOI 10.1016/j.neuroscience.2012.12.055; Kubova Hana, 2012, Adv Tech Stand Neurosurg, V39, P3, DOI 10.1007/978-3-7091-1360-8_1; Kudin AP, 2002, EUR J NEUROSCI, V15, P1105, DOI 10.1046/j.1460-9568.2002.01947.x; Kurz JE, 2001, J NEUROCHEM, V78, P304, DOI 10.1046/j.1471-4159.2001.00426.x; Cheung KAK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236079; Laprairie RB, 2015, BRIT J PHARMACOL, V172, P4790, DOI 10.1111/bph.13250; Lattanzi S, 2019, DRUG TODAY, V55, P177, DOI 10.1358/dot.2019.55.3.2909248; Lattanzi S, 2018, DRUGS, V78, P1791, DOI 10.1007/s40265-018-0992-5; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Leo A, 2016, PHARMACOL RES, V107, P85, DOI 10.1016/j.phrs.2016.03.005; Li Y, 2015, NEUROSCIENCE, V311, P253, DOI 10.1016/j.neuroscience.2015.10.041; Liou GI, 2008, INVEST OPHTH VIS SCI, V49, P5526, DOI 10.1167/iovs.08-2196; Lorigados L., 2013, BIOTECNOL APPL, V30, P1, DOI DOI 10.2174/1381612811319380009; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Mahmoud E., 2014, HDB CANNABIS, P46; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Meador KJ, 2012, NEUROLOGY, V78, P1207, DOI 10.1212/WNL.0b013e318250d824; Mecha M, 2016, PHARMACOL THERAPEUT, V166, P40, DOI 10.1016/j.pharmthera.2016.06.011; MECHOULA.R, 1965, TETRAHEDRON, V21, P1223, DOI 10.1016/0040-4020(65)80064-3; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morgan NH, 2009, NEUROPHARMACOLOGY, V57, P356, DOI 10.1016/j.neuropharm.2009.07.017; Mori MA, 2017, PROG NEURO-PSYCHOPH, V75, P94, DOI 10.1016/j.pnpbp.2016.11.005; Murchison D, 2000, BRAIN RES, V854, P139, DOI 10.1016/S0006-8993(99)02297-0; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; OHLSSON A, 1986, BIOMED ENVIRON MASS, V13, P77, DOI 10.1002/bms.1200130206; Onaivi ES, 2012, J PSYCHOPHARMACOL, V26, P92, DOI 10.1177/0269881111400652; Pan H, 2009, J PHARMACOL EXP THER, V328, P708, DOI 10.1124/jpet.108.147181; Pandolfo P, 2011, EUR J PHARMACOL, V655, P38, DOI 10.1016/j.ejphar.2011.01.013; Patel M, 2003, NEUROSCIENCE, V118, P431, DOI 10.1016/S0306-4522(02)00979-X; Patel S, 2017, NEUROSCI BIOBEHAV R, V76, P56, DOI 10.1016/j.neubiorev.2016.12.033; Patra PH, 2019, EPILEPSIA, V60, P303, DOI 10.1111/epi.14629; Pazos MR, 2012, NEUROPHARMACOLOGY, V63, P776, DOI 10.1016/j.neuropharm.2012.05.034; Perez M, 2013, EUR J NEUROSCI, V38, P3424, DOI 10.1111/ejn.12341; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pertwee R. G., 2014, HDB CANNABIS, P167; Pitkanen A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022822; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Porter BE, 2013, EPILEPSY BEHAV, V29, P574, DOI 10.1016/j.yebeh.2013.08.037; Qu Y, 2003, EXP NEUROL, V184, P326, DOI 10.1016/j.expneurol.2003.07.001; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Ravizza T, 2005, EPILEPSIA, V46, P113, DOI 10.1111/j.1528-1167.2005.01006.x; Rice AC, 1998, BRAIN RES, V782, P240, DOI 10.1016/S0006-8993(97)01285-7; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Rosenberg EC, 2017, EPILEPSY BEHAV, V70, P319, DOI 10.1016/j.yebeh.2016.11.006; Ruhaak LR, 2011, BIOL PHARM BULL, V34, P774, DOI 10.1248/bpb.34.774; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Sanchez RM, 2001, J NEUROSCI, V21, P8154, DOI 10.1523/JNEUROSCI.21-20-08154.2001; Schonhofen P, 2018, CNS DRUGS, V32, P697, DOI 10.1007/s40263-018-0550-4; Sekar Krithiga, 2019, F1000Res, V8, DOI 10.12688/f1000research.16515.1; Semple BD, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00002; Shimada T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/901902; Silvestro S, 2019, MOLECULES, V24, DOI 10.3390/molecules24081459; Skowronska K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020309; SOFIA RD, 1976, EUR J PHARMACOL, V35, P7, DOI 10.1016/0014-2999(76)90295-8; Solowij N, 2011, PSYCHOPHARMACOLOGY, V216, P131, DOI 10.1007/s00213-011-2203-x; Specchio N, 2020, EPILEPTIC DISORD, V22, pS1, DOI 10.1684/epd.2019.1121; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Stott N. K., 2018, AM EP SOC ANN M NEW; Suchomelova L, 2015, NEUROSCIENCE, V305, P209, DOI 10.1016/j.neuroscience.2015.08.006; Sugaya Y, 2016, CELL REP, V16, P1405, DOI 10.1016/j.celrep.2016.06.083; Szaflarski JP, 2018, EPILEPSIA, V59, P1540, DOI 10.1111/epi.14477; Szczurowska E, 2013, PHYSIOL RES, V62, pS21, DOI 10.33549/physiolres.932662; Treat L, 2017, EPILEPSIA, V58, P123, DOI 10.1111/epi.13617; Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b; TURKANIS SA, 1979, EPILEPSIA, V20, P351, DOI 10.1111/j.1528-1157.1979.tb04815.x; Tyzio R, 1999, J NEUROSCI, V19, P10372; Tzadok M, 2016, SEIZURE-EUR J EPILEP, V35, P41, DOI 10.1016/j.seizure.2016.01.004; Vega-Garcia A, 2020, CURR PHARM DESIGN, V26, P1388, DOI 10.2174/1381612826666200320121813; Viviani B, 2003, J NEUROSCI, V23, P8692; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wang S, 2000, J PHARMACOL EXP THER, V292, P497; Wang T, 2008, CAN MED ASSOC J, V178, P1669, DOI 10.1503/cmaj.071178; Watanabe K, 2007, LIFE SCI, V80, P1415, DOI 10.1016/j.lfs.2006.12.032; Wheless JW, 2019, CNS DRUGS, V33, P593, DOI 10.1007/s40263-019-00624-4; Wong SS, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1818; Wright S., 2014, HDB OF CANNABIS, P483	178	1	1	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JAN 12	2021	14								610484	10.3389/fnbeh.2020.610484			18	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	PX6ZG	WOS:000611502100001	33510627	Green Published, gold			2022-02-06	
J	Asken, BM; Mantyh, WG; La Joie, R; Strom, A; Casaletto, KB; Staffaroni, AM; Apple, AC; Lindbergh, CA; Iaccarino, L; You, M; Grant, H; Fonseca, C; Windon, C; Younes, K; Tanner, J; Rabinovici, GD; Kramer, JH; Gardner, RC				Asken, Breton M.; Mantyh, William G.; La Joie, Renaud; Strom, Amelia; Casaletto, Kaitlin B.; Staffaroni, Adam M.; Apple, Alexandra C.; Lindbergh, Cutter A.; Iaccarino, Leonardo; You, Michelle; Grant, Harli; Fonseca, Corrina; Windon, Charles; Younes, Kyan; Tanner, Jeremy; Rabinovici, Gil D.; Kramer, Joel H.; Gardner, Raquel C.			Association of remote mild traumatic brain injury with cortical amyloid burden in clinically normal older adults	BRAIN IMAGING AND BEHAVIOR			English	Article						Traumatic brain injury; Concussion; Amyloid; PET; Aging; Neurodegenerative; Dementia	TERM SURVIVORS; BETA; HISTORY; RISK; ENCEPHALOPATHY; ACCUMULATION; IMPAIRMENT; PATHOLOGY; DISEASE	We investigated whether clinically normal older adults with remote, mild traumatic brain injury (mTBI) show evidence of higher cortical A beta burden. Our study included 134 clinically normal older adults (age 74.1 +/- 6.8 years, 59.7% female, 85.8% white) who underwent A beta positron emission tomography (A beta-PET) and who completed the Ohio State University Traumatic Brain Injury Identification questionnaire. We limited participants to those reporting injuries classified as mTBI. A subset (N = 30) underwent a second A beta-PET scan (mean 2.7 years later). We examined the effect of remote mTBI on A beta-PET burden, interactions between remote mTBI and age, sex, and APOE status, longitudinal A beta accumulation, and the interaction between remote mTBI and A beta burden on memory and executive functioning. Of 134 participants, 48 (36%) reported remote mTBI (0, N = 86; 1, N = 31, 2+, N = 17; mean 37 +/- 23 years since last mTBI). Effect size estimates were small to negligible for the association of remote mTBI with A beta burden (p = .94, eta(2) < 0.01), and for all interaction analyses. Longitudinally, we found a non-statistically significant association of those with remote mTBI (N = 11) having a faster rate of A beta accumulation (B = 0.01, p = .08) than those without (N = 19). There was no significant interaction between remote mTBI and A beta burden on cognition. In clinically normal older adults, history of mTBI is not associated with greater cortical A beta burden and does not interact with A beta burden to impact cognition. Longitudinal analyses suggest remote mTBI may be associated with more rapid cortical A beta accumulation. This finding warrants further study in larger and more diverse samples with well-characterized lifelong head trauma exposure.	[Asken, Breton M.; Mantyh, William G.; La Joie, Renaud; Strom, Amelia; Casaletto, Kaitlin B.; Staffaroni, Adam M.; Apple, Alexandra C.; Lindbergh, Cutter A.; Iaccarino, Leonardo; You, Michelle; Grant, Harli; Fonseca, Corrina; Windon, Charles; Younes, Kyan; Tanner, Jeremy; Kramer, Joel H.; Gardner, Raquel C.] Univ Calif San Francisco, Weill Inst Neurosci, Memory & Aging Ctr, Dept Neurol, 675 Nelson Rising Lane,Suite 190, San Francisco, CA 94158 USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, Memory & Aging Ctr, San Francisco, CA USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Dept Radiol, Weill Inst Neurosci, Memory & Aging Ctr, San Francisco, CA USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Dept Biomed Imaging, Weill Inst Neurosci, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Gardner, Raquel C.] San Francisco Vet Affairs Hlth, San Francisco, CA USA		Asken, BM (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, Memory & Aging Ctr, Dept Neurol, 675 Nelson Rising Lane,Suite 190, San Francisco, CA 94158 USA.	Breton.Asken@ucsf.edu	La Joie, Renaud/AAC-8569-2021	La Joie, Renaud/0000-0003-2581-8100; Mantyh, William/0000-0003-2096-2461; Asken, Breton/0000-0001-8419-142X	UCSF ADRC [NIA P50AG023501, P30AG062422]; NIH-NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG045611, R01(s) AG032289, AG048234, K23 AG058752, K23 AG061253, K99AG065501]; Larry L. Hillblom Network Grant [2014-A-004-NET]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS095755]; American Federation for Aging Research; Global Brain Health Institute; Larry L. Hillblom Fellowship [2018-A-025-FEL]; Alzheimer's AssociationAlzheimer's Association [AARF-16-443577]; Robert W. Katzman Fellowship Training Grant through the American Academy of Neurology; American Brain Foundation; Alzheimer's AssociationAlzheimer's Association	We thank the following funding sources that have supported our work: UCSF ADRC (NIA P50AG023501 and P30AG062422; PI: Bruce Miller), NIH-NIA (R01 AG045611) to GDR; NIH-NIA (R01(s) AG032289 and AG048234) and Larry L. Hillblom Network Grant (2014-A-004-NET) to JHK; NIH-NINDS (K23 NS095755), American Federation for Aging Research, and Global Brain Health Institute to RCG; NIH-NIA (K23 AG058752) to KBC; NIH-NIA (K23 AG061253) and Larry L. Hillblom Fellowship (2018-A-025-FEL) to AMS; NIH-NIA (K99AG065501) and Alzheimer's Association (AARF-16-443577) to RLJ; and the Robert W. Katzman Fellowship Training Grant through the American Academy of Neurology in conjunction with the American Brain Foundation and Alzheimer's Association to WGM.	Alosco ML, 2020, NEUROLOGY, V95, pE793, DOI 10.1212/WNL.0000000000010040; Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Arenaza-Urquijo EM, 2018, NEUROLOGY, V90, P695, DOI 10.1212/WNL.0000000000005303; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Gardner RC, 2020, J ALZHEIMERS DIS, V74, P699, DOI 10.3233/JAD-191138; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Grasset L, 2020, ALZHEIMERS DEMENT, V16, P853, DOI 10.1002/alz.12080; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Peltz CB, 2020, NEUROLOGY, V95, pE1126, DOI 10.1212/WNL.0000000000010087; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Schneider ALC, 2019, J NEUROTRAUM, V36, P2549, DOI 10.1089/neu.2018.6213; Stark SL, 2013, NEUROLOGY, V81, P437, DOI 10.1212/WNL.0b013e31829d8599; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; Visser-Keizer AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166995; Wang ML, 2017, NEUROSCI LETT, V655, P115, DOI 10.1016/j.neulet.2017.06.055; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Welmer AK, 2017, J GERONTOL A-BIOL, V72, P669, DOI 10.1093/gerona/glw141; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Zhu CW, 2019, J AM GERIATR SOC, V67, P269, DOI 10.1111/jgs.15638	38	1	1	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2021	15	5					2417	2425		10.1007/s11682-020-00440-1		JAN 2021	9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WE0VC	WOS:000607018500002	33432536				2022-02-06	
J	Sime, FB; Roberts, JA; Jeffree, RL; Pandey, S; Adiraju, S; Livermore, A; Butler, J; Parker, SL; Wallis, SC; Lipman, J; Cotta, MO				Sime, Fekade Bruck; Roberts, Jason A.; Jeffree, Rosalind L.; Pandey, Saurabh; Adiraju, Santosh; Livermore, Amelia; Butler, Jenie; Parker, Suzanne L.; Wallis, Steven C.; Lipman, Jeffrey; Cotta, Menino Osbert			Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance	CLINICAL PHARMACOKINETICS			English	Article							CRITICALLY-ILL PATIENTS; INTRAVENOUS-INFUSION; ORAL TABLETS; SAFETY; MONOTHERAPY; EFFICACY; PLACEBO	Background and Objective Patients with severe trauma exhibit augmented renal clearance, which can alter the dosing requirement of renally eliminated drugs. This study aimed to develop a population pharmacokinetic model for levetiracetam in patients with severe traumatic brain injury and aneurysmal subarachnoid hemorrhage, and use it to describe optimal dosing regimens. Methods This was a prospective open-label observational study. Critically ill adult patients with severe traumatic brain injury or aneurysmal subarachnoid hemorrhage without renal dysfunction and receiving levetiracetam were eligible. Serial levetiracetam plasma concentrations were analyzed to develop a population pharmacokinetic model and perform dosing simulations. Results A two-compartment model best described the concentration-time data from 30 patients. The mean +/- standard deviation parameter estimates were bioavailability (F) of 0.8 +/- 0.2, absorption rate constant of 2.4 +/- 2 h(-1), clearance 2.5 +/- 1.1 L/h, central volume of distribution 8.9 +/- 3.0 L/h, and transfer rate constraints of 1.8 +/- 1.1 h(-1) from central to peripheral compartments and 0.7 +/- 0.3 h(-1) from peripheral to central compartments. For the simulated intermittent dosing regimens, on average, the median trough concentration reduced by 50% for every 40-mL/min/1.73 m(2) increase in urinary creatinine clearance. Simulated doses of at least 6 g/day were required for some levels of augmented renal clearance. Conclusions Patients with severe traumatic brain injury and aneurysmal subarachnoid hemorrhage with augmented renal clearance are at risk of not achieving target levetiracetam plasma concentrations. We suggest dose titration guided by measured creatinine clearance, and/or, therapeutic drug monitoring if available, to minimize the risk of seizures.	[Sime, Fekade Bruck; Roberts, Jason A.; Pandey, Saurabh; Adiraju, Santosh; Parker, Suzanne L.; Wallis, Steven C.; Lipman, Jeffrey; Cotta, Menino Osbert] Univ Queensland, Clin Res Ctr, Bldg 71-918,Royal Brisbane & Womens Hosp Campus, Herston, Qld 4029, Australia; [Sime, Fekade Bruck; Roberts, Jason A.; Cotta, Menino Osbert] Univ Queensland, Ctr Translat Antiinfect Pharmacodynam, Sch Pharm, Brisbane, Qld, Australia; [Roberts, Jason A.] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia; [Roberts, Jason A.; Livermore, Amelia; Butler, Jenie; Lipman, Jeffrey] Royal Brisbane & Womens Hosp, Dept Intens Care, Brisbane, Qld, Australia; [Roberts, Jason A.; Lipman, Jeffrey] Univ Montpellier, Div Anesthesiol Crit Care Emergency & Pain Med, Univ Nimes Hosp, Nimes, France; [Jeffree, Rosalind L.] Royal Brisbane & Womens Hosp, Kenneth G Jamieson Dept Neurosurg, Brisbane, Qld, Australia; [Jeffree, Rosalind L.] Univ Queensland, Fac Med, Brisbane, Qld, Australia		Sime, FB; Cotta, MO (corresponding author), Univ Queensland, Clin Res Ctr, Bldg 71-918,Royal Brisbane & Womens Hosp Campus, Herston, Qld 4029, Australia.; Sime, FB; Cotta, MO (corresponding author), Univ Queensland, Ctr Translat Antiinfect Pharmacodynam, Sch Pharm, Brisbane, Qld, Australia.	f.sime@uq.edu.au; m.o.cotta@uq.edu.au	Parker, Suzanne/C-5348-2017; Sime, Fekade/I-3643-2019; Wallis, Steven/F-2046-2010; Jeffree, Rosalind/G-4705-2015	Parker, Suzanne/0000-0002-6124-7475; Sime, Fekade/0000-0003-4061-2063; Wallis, Steven/0000-0002-2392-9854; Jeffree, Rosalind/0000-0001-7663-2694	Royal Brisbane and Women's Hospital Foundation; Intensive Care Foundation, Australia	This work was supported by Grants from the Royal Brisbane and Women's Hospital Foundation and the Intensive Care Foundation, Australia.	Alsaadi TM, 2005, SEIZURE-EUR J EPILEP, V14, P139, DOI 10.1016/j.seizure.2004.12.006; Benedetti MS, 2003, EUR J CLIN PHARMACOL, V59, P621, DOI 10.1007/s00228-003-0655-6; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; Farrokh S, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2066-1; Johannessen SI, 2003, THER DRUG MONIT, V25, P347, DOI 10.1097/00007691-200306000-00016; Keur MB, 2010, F1000 MED REP, V2, P7, DOI DOI 10.3410/M2-7; Leppik IE, 2002, EPILIPSIA, V43, P1; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Lindholm D, 2002, EPILIPSIA, V43, P1; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Mink S, 2011, CLIN NEUROL NEUROSUR, V113, P644, DOI 10.1016/j.clineuro.2011.05.007; Mushtaq R, 2002, INT LEAGUE EP ANN M, P351; Nau KM, 2009, NEUROCRIT CARE, V11, P34, DOI 10.1007/s12028-009-9185-0; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Pigeolet E, 2007, CLIN PHARMACOKINET, V46, P503, DOI 10.2165/00003088-200746060-00004; Privitera M, 2001, EPILEPSIA, V42, P31, DOI 10.1046/j.1528-1157.2001.00007.x; Ramael S, 2006, CLIN THER, V28, P734, DOI 10.1016/j.clinthera.2006.05.004; Ramael S, 2006, EPILEPSIA, V47, P1128, DOI 10.1111/j.1528-1167.2006.00586.x; Rhee SJ, 2017, EPILEPSY RES, V132, P8, DOI 10.1016/j.eplepsyres.2017.02.011; Sime FB, 2015, CURR OPIN PHARMACOL, V24, P1, DOI 10.1016/j.coph.2015.06.002; Spencer DD, 2011, PHARMACOTHERAPY, V31, P934, DOI 10.1592/phco.31.10.934; Steinhoff BJ, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419873518; Toublanc N, 2015, CLIN DRUG INVEST, V35, P495, DOI 10.1007/s40261-015-0303-9; Toublanc N, 2014, DRUG METAB PHARMACOK, V29, P61, DOI 10.2133/dmpk.DMPK-13-RG-045; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2013, CRIT CARE, V17, DOI 10.1186/cc12544; Uges JWF, 2009, EPILEPSIA, V50, P415, DOI 10.1111/j.1528-1167.2008.01889.x	28	1	1	0	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0312-5963	1179-1926		CLIN PHARMACOKINET	Clin. Pharmacokinet.	MAY	2021	60	5					655	664		10.1007/s40262-020-00979-8		JAN 2021	10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	SA5ZX	WOS:000607024600001	33428169				2022-02-06	
J	Modica, LCM; Egnoto, MJ; Statz, JK; Carr, W; Ahlers, ST				Modica, L. T. Claire M.; Egnoto, Michael J.; Statz, Jonathan K.; Carr, Walter; Ahlers, Stephen T.			Development of a Blast Exposure Estimator from a Department of Defense-Wide Survey Study on Military Service Members	JOURNAL OF NEUROTRAUMA			English	Article						behavioral health; blast; military; overpressure		Long-term, repeated exposure to low-intensity blast overpressure is a potential causal factor of lasting outcomes reminiscent of post-concussion syndrome. Wearable blast sensor engineers are exploring elements of blast that are associated with outcomes. Currently, however, there are no devices that can truly record all blasts experienced by an individual. Military service members (n = 984) were surveyed about their lifelong exposure and behavioral health. Using heavy-arms-associated target outcomes, we calculated a generalized blast exposure value (GBEV) for each participant. A threshold of 200,000 GBEV units was established at which a participant was likely to report more intense symptomology. If repetitive, low-intensity blast exposure has even a subtle effect over time, operational readiness could be negatively impacted. A threshold of exposure can inform decisions about how to reduce detrimental exposure. The GBEV can be used to track ongoing exposure and potentially identify those who may be at risk for developing blast-related outcomes.	[Modica, L. T. Claire M.; Statz, Jonathan K.; Ahlers, Stephen T.] Naval Med Res Ctr, Silver Spring, MD USA; [Egnoto, Michael J.; Carr, Walter] Walter Reed Army Inst Res, Silver Spring, MD USA; [Egnoto, Michael J.] Katmai Govt Serv, Anchorage, AK USA; [Statz, Jonathan K.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Carr, Walter] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA		Modica, LCM (corresponding author), US Navy, Naval Med Res Ctr, Med Serv Corps, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	email@clairemodica.com		Modica, Claire/0000-0002-7033-7632	Joint Program Committee-5 Development of Exposure Standards to Repeated Blast Exposure program [603115HP.3730.001.A1118]	This work was supported by the Joint Program Committee-5 Development of Exposure Standards to Repeated Blast Exposure program, work unit #603115HP.3730.001.A1118. Dr. Carr was supported, in part, by an appointment to the Research Participation Program at the Walter Reed Army Institute of Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Army Medical Research and Development Command.	Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dawes J, 2008, INT J MARKET RES, V50, P61, DOI 10.1177/147078530805000106; Department of Defense, 2019, 2018 DEM PROG MIL CO, pDC; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kaplan D., 2014, NEUROBEHAVIORAL SYMP; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Sambandam R., 2006, QUIRKS MARKETING RES, V20, P22; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141	11	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2021	38	12					1654	1661		10.1089/neu.2020.7405		JAN 2021	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	SN7AR	WOS:000606619500001	33138683				2022-02-06	
J	Ratliff, WA; Saykally, JN; Keeley, KL; Driscoll, DC; Murray, KE; Okuka, M; Mervis, RF; Delic, V; Citron, BA				Ratliff, Whitney A.; Saykally, Jessica N.; Keeley, Kristen L.; Driscoll, David C.; Murray, Kathleen E.; Okuka, Maja; Mervis, Ronald F.; Delic, Vedad; Citron, Bruce A.			Sidestream Smoke Affects Dendritic Complexity and Astrocytes After Model Mild Closed Head Traumatic Brain Injury	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article; Early Access						Traumatic brain injury; Cigarette smoke; Oxidative stress; Mouse models; Astrocytes; Dendritic arbor	COGNITIVE DEFICITS; CIGARETTE-SMOKING; OXIDATIVE STRESS; IN-VITRO; EXPRESSION; HIPPOCAMPUS; EXPOSURE; RECOVERY; DISEASE; PERFORMANCE	Mild traumatic brain injuries can have long-term consequences that interfere with the life of the patient and impose a burden on our health care system. Oxidative stress has been identified as a contributing factor for the progression of neurodegeneration following TBI. A major source of oxidative stress for many veterans is cigarette smoking and second-hand smoke, which has been shown to have an effect on TBI recovery. To examine the potential influences of second-hand smoke during recovery from TBI, we utilized a mouse model of closed head injury, followed by repeated exposure to cigarette smoke and treatment with a neuroprotective antioxidant. We found that neither the mild injuries nor the smoke exposure produced axonal damage detectable with amino cupric silver staining. However, complexity in the dendritic arbors was significantly reduced after mild TBI plus smoke exposure. In the hippocampus, there were astrocytic responses, including Cyp2e1 upregulation, after the injury and tobacco smoke insult. This study provides useful context for the importance of lifestyle changes, such as reducing or eliminating cigarette smoking, during recovery from TBI.	[Ratliff, Whitney A.; Saykally, Jessica N.; Keeley, Kristen L.; Driscoll, David C.; Citron, Bruce A.] Bay Pines VA Healthcare Syst, Res & Dev 151, Lab Mol Biol, Bay Pines, FL 33744 USA; [Ratliff, Whitney A.; Saykally, Jessica N.; Keeley, Kristen L.; Citron, Bruce A.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Okuka, Maja] Univ S Florida, Morsani Coll Med, Dept Obstet & Gynecol, Tampa, FL 33612 USA; [Mervis, Ronald F.] NeuroStruct Analyt, Columbus, OH 43212 USA; [Murray, Kathleen E.; Delic, Vedad; Citron, Bruce A.] Res & Dev, VA New Jersey Hlth Care Syst, E Orange, NJ 07018 USA; [Murray, Kathleen E.; Delic, Vedad; Citron, Bruce A.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA		Citron, BA (corresponding author), Bay Pines VA Healthcare Syst, Res & Dev 151, Lab Mol Biol, Bay Pines, FL 33744 USA.; Citron, BA (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA.; Citron, BA (corresponding author), Res & Dev, VA New Jersey Hlth Care Syst, E Orange, NJ 07018 USA.; Citron, BA (corresponding author), Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.	bruce.citron@rutgers.edu	Ratliff, Whitney/L-3556-2016	Ratliff, Whitney/0000-0002-5461-7802	Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development)US Department of Veterans Affairs [I01RX001520]; Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program [W81XWH-16-1-0626]; Florida Department of Health James and Esther King Biomedical Research Program [4KB14]; Bay Pines Foundation	This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development (I01RX001520)), the Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program (W81XWH-16-1-0626), the Florida Department of Health James and Esther King Biomedical Research Program (4KB14), and The Bay Pines Foundation. The funding sources had no involvement in study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Adhami N, 2017, CLIN SCI, V131, P2409, DOI 10.1042/CS20171053; Bastian LA, 2010, J GEN INTERN MED, V25, P102, DOI 10.1007/s11606-009-1224-1; Brown DW, 2010, J GEN INTERN MED, V25, P147, DOI 10.1007/s11606-009-1160-0; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Cho H, 2016, EUR J NEUROL, V23, P110, DOI 10.1111/ene.12816; Cojocaru Inimioara Mihaela, 2013, Rom J Intern Med, V51, P97; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Gairola CG, 2006, MOL MECH TOBACCO IND, P121; Gjota-Ergin S, 2018, NEUROSCI LETT, V673, P104, DOI 10.1016/j.neulet.2018.02.059; Hatic H, 2012, J NEUROTRAUM, V29, P1188, DOI 10.1089/neu.2011.1806; Ho YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036752; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang JJ, 2013, REPROD TOXICOL, V35, P89, DOI 10.1016/j.reprotox.2012.07.003; Huang JJ, 2009, FERTIL STERIL, V92, P1456, DOI 10.1016/j.fertnstert.2008.07.1781; Huf F, 2019, ALCOHOL, V77, P101, DOI 10.1016/j.alcohol.2018.08.009; Kaisar MA, 2018, NEUROSCI LETT, V682, P1, DOI 10.1016/j.neulet.2018.05.045; Kaisar MA, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0389-5; Lee IN, 2012, METAB BRAIN DIS, V27, P197, DOI 10.1007/s11011-012-9294-x; Machaalani R, 2019, NEUROTOXICOLOGY, V74, P40, DOI 10.1016/j.neuro.2019.05.009; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morrison HW, 2016, NEUROSCIENCE, V339, P85, DOI 10.1016/j.neuroscience.2016.09.047; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Paulson JR, 2010, J PHARMACOL EXP THER, V332, P371, DOI 10.1124/jpet.109.157776; Ratliff WA, 2020, BRAIN RES, V1746, DOI 10.1016/j.brainres.2020.147019; Ratliff WA, 2020, J NEUROTRAUM, V37, P1910, DOI 10.1089/neu.2020.7005; Ratliff WA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59252-4; Ratliff WA, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0525-5; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Saykally JN, 2018, J NEUROTRAUM, V35, P139, DOI 10.1089/neu.2017.5070; Sherman SE, 2008, BMJ-BRIT MED J, V336, P1016, DOI 10.1136/bmj.39510.805266.BE; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Sivandzade F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01818-0; Sivandzade F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174225; Sivandzade F, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0497-5; Speck AE, 2011, NEUROCHEM RES, V36, P1056, DOI 10.1007/s11064-011-0447-9; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tindberg N, 1996, MOL PHARMACOL, V50, P1065; Tuon T, 2010, NEUROSCI LETT, V475, P16, DOI 10.1016/j.neulet.2010.03.030; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Wang ZY, 2020, J NEUROTRAUM, V37, P1221, DOI 10.1089/neu.2019.6742; Yu R, 2016, J ALZHEIMERS DIS, V50, P133, DOI 10.3233/JAD-150751; Zhang ZW, 2020, BRAIN RES, V1739, DOI 10.1016/j.brainres.2020.146818; Zhong YJ, 2012, TOXICOLOGY, V302, P275, DOI 10.1016/j.tox.2012.08.009; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	52	1	1	4	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.												10.1007/s10571-020-01036-5		JAN 2021	11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	PP9LI	WOS:000606174700001	33417143				2022-02-06	
J	Ruesch, A; Acharya, D; Schmitt, S; Yang, J; Smith, MA; Kainerstorfer, JM				Ruesch, Alexander; Acharya, Deepshikha; Schmitt, Samantha; Yang, Jason; Smith, Matthew A.; Kainerstorfer, Jana M.			Comparison of static and dynamic cerebral autoregulation under anesthesia influence in a controlled animal model	PLOS ONE			English	Article							DIFFUSE CORRELATION SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; BLOOD-FLOW; INTRACRANIAL-PRESSURE; GUIDELINES; MANAGEMENT	The brain's ability to maintain cerebral blood flow approximately constant despite cerebral perfusion pressure changes is known as cerebral autoregulation (CA) and is governed by vasoconstriction and vasodilation. Cerebral perfusion pressure is defined as the pressure gradient between arterial blood pressure and intracranial pressure. Measuring CA is a challenging task and has created a variety of evaluation methods, which are often categorized as static and dynamic CA assessments. Because CA is quantified as the performance of a regulatory system and no physical ground truth can be measured, conflicting results are reported. The conflict further arises from a lack of healthy volunteer data with respect to cerebral perfusion pressure measurements and the variety of diseases in which CA ability is impaired, including stroke, traumatic brain injury and hydrocephalus. To overcome these differences, we present a healthy non-human primate model in which we can control the ability to autoregulate blood flow through the type of anesthesia (isoflurane vs fentanyl). We show how three different assessment methods can be used to measure CA impairment, and how static and dynamic autoregulation compare under challenges in intracranial pressure and blood pressure. We reconstructed Lassen's curve for two groups of anesthesia, where only the fentanyl anesthetized group yielded the canonical shape. Cerebral perfusion pressure allowed for the best distinction between the fentanyl and isoflurane anesthetized groups. The autoregulatory response time to induced oscillations in intracranial pressure and blood pressure, measured as the phase lag between intracranial pressure and blood pressure, was able to determine autoregulatory impairment in agreement with static autoregulation. Static and dynamic CA both show impairment in high dose isoflurane anesthesia, while low isoflurane in combination with fentanyl anesthesia maintains CA, offering a repeatable animal model for CA studies.	[Ruesch, Alexander; Acharya, Deepshikha; Schmitt, Samantha; Yang, Jason; Smith, Matthew A.; Kainerstorfer, Jana M.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Schmitt, Samantha; Smith, Matthew A.; Kainerstorfer, Jana M.] Carnegie Mellon Univ, Neurosci Inst, Pittsburgh, PA 15213 USA; [Schmitt, Samantha; Smith, Matthew A.] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA		Kainerstorfer, JM (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.; Kainerstorfer, JM (corresponding author), Carnegie Mellon Univ, Neurosci Inst, Pittsburgh, PA 15213 USA.	jkainers@andrew.cmu.edu		Ruesch, Alexander/0000-0002-1890-4134; Smith, Matthew A/0000-0003-1192-9942	Center for Machine Learning and Health (CMLH); Pennsylvania Infrastructure Technology Alliance (PITA); American Heart Association (AHA)American Heart Association [17SDG33700047]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21-EB024675]	The authors acknowledge the financial support for the research, authorship, and publication through the Center for Machine Learning and Health (CMLH) to AR (https://www.cs.cmu.edu/cmlh-cfp), Pennsylvania Infrastructure Technology Alliance (PITA) to JK (https://dced.pa.gov/programs/pennsylvania-infrastructuretechnology-alliance-pita/), the American Heart Association (AHA) 17SDG33700047 to JK (https://pureresearch.americanheart.org/en/), and the National Institutes of Health (NIH) R21-EB024675 to JK (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanerud J, 2012, J CEREBR BLOOD F MET, V32, P1177, DOI 10.1038/jcbfm.2012.18; AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Balestreri M, 2005, ACT NEUR S, V95, P25; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Buckley EM, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011009; Buckley EM, 2009, OPT EXPRESS, V17, P12571, DOI 10.1364/OE.17.012571; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carp SA, 2010, BIOMED OPT EXPRESS, V1, P553, DOI 10.1364/BOE.1.000553; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P721, DOI 10.1136/jnnp.63.6.721; de Jong DLK, 2017, J PHYSIOL-LONDON, V595, P5623, DOI 10.1113/JP274304; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Fantini S, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031411; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; GRUBB RL, 1975, J NEUROSURG, V43, P385, DOI 10.3171/jns.1975.43.4.0385; Harary M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18020465; Intharakham K, 2019, J CEREBR BLOOD F MET, V39, P2105, DOI 10.1177/0271678X19871013; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Lalou AD, 2019, J NEUROSURG, V130, P154, DOI 10.3171/2017.7.JNS17216; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LASSEN NA, 1976, BRIT J ANAESTH, V48, P719, DOI 10.1093/bja/48.8.719; Loushin MK, 2005, CURR CLIN ONCOL, P171; Numan T, 2014, MED ENG PHYS, V36, P1487, DOI 10.1016/j.medengphy.2014.08.001; Patel PM., 2010, MILLERS ANESTHESIA, VEighth, DOI [10.1016/b978-0-443-06959-8.00013-3, DOI 10.1016/B978-0-443-06959-8.00013-3]; Payne S., 2016, CEREBRAL AUTOREGULAT, DOI [10.1007/978-3-319-31784-7, DOI 10.1007/978-3-319-31784-7]; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Ruesch A, 2020, BIOMED OPT EXPRESS, V11, P1462, DOI 10.1364/BOE.386612; Ruesch A, 2020, J CEREBR BLOOD F MET, V40, P2304, DOI 10.1177/0271678X19891359; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Summors AC, 1999, ANESTH ANALG, V88, P341, DOI 10.1097/00000539-199902000-00022; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; University of Minnesota, AN GUID NONH PRIM; University of Texas at Austin, NONH PRIM SPEC AN; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Xu W, 2016, CHILD NERV SYST, V32, P1371, DOI 10.1007/s00381-016-3143-x	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2021	16	1							e0245291	10.1371/journal.pone.0245291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY4OF	WOS:000630020100025	33418561	gold, Green Published			2022-02-06	
J	Mealings, M; Douglas, PJ; Olver, PJ				Mealings, Margaret; Douglas, Professor Jacinta; Olver, Professor John			The student journey: Living and learning following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; Education; Rehabilitation; Student Perspectives		Primary objective: In this research we set out to gain further understanding of the experiences of students participating in secondary and tertiary education following TBI: exploring academic and non-academic factors, as well as changes in experiences over time. Methods and procedures: A longitudinal, qualitative investigation was completed. 12 students (17-32 years) completed up to three in-depth interviews over a period of 4-15 months, capturing atotal of 30 time points. Data were analyzed using grounded theory methods. Main outcomes and results: Students' participation experiences were unique and varied with different timelines and outcomes, however they shared many similar critical points. We interpreted their experiences as a student journey traveling through four significant landscapes, "Choosing to study", "Studying", "Deciding what to do", "Making the next step." Journeys involved complex processes of living and learning. Moving along the pathway was not always smooth or straightforward. Conclusions: Students' experiences of returning to study following TBI can be interpreted as a complex journey of living and learning. Four important stages of the journey provide clinicians and educators with landscape features that can provide a structure for exploring supports to address both academic and non-academic factors to assist students in their study journey.	[Mealings, Margaret; Douglas, Professor Jacinta] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic, Australia; [Mealings, Margaret; Olver, Professor John] Epworth Healthcare, Epworth Rehabil, Richmond, Australia; [Douglas, Professor Jacinta] Summer Fdn, Res & Innovat Unit, Box Hill, Vic, Australia; [Olver, Professor John] Epworth Monash Rehabil Med Unit, Richmond, Australia		Mealings, M (corresponding author), Epworth Rehabil, Community Integrat Team, Richmond, Vic 3121, Australia.	Margaret.mealings@epworth.org.au		Douglas, Jacinta/0000-0003-0940-6624; Mealings, Margaret/0000-0001-8264-275X; Olver, John/0000-0001-7069-1191	Epworth Healthcare; Victorian Brain Injury Recovery Association/East Kew Branch of the Community Bendigo Bank Research Scholarship	This research was supported by scholarships awarded to the first author by Epworth Healthcare and Victorian Brain Injury Recovery Association/East Kew Branch of the Community Bendigo Bank Research Scholarship.	[Anonymous], 2011, NVIVO VERS 10 SOFTW; Brown J, 2017, NEUROREHABILITATION, V41, P483, DOI 10.3233/NRE-162065; Cahill SM, 2014, CAN J OCCUP THER, V81, P93, DOI 10.1177/0008417414533185; Charmaz K., 2014, BROKERAGE CLOSURE IN; Childers C, 2016, J POSTSECOND EDUC DI, V29, P389; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; D'Cruz K, 2016, SCAND J OCCUP THER, V23, P30, DOI 10.3109/11038128.2015.1057521; Davies S., 2016, CONTEM SCHL PSYCHOL, V20, P370, DOI [10.1007/s40688-016-0095-9, DOI 10.1007/S40688-016-0095-9]; Hartman LR, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615614307; Killi EM, 2014, NORD PSYCHOL, V66, P274, DOI 10.1080/19012276.2014.985068; Mayes R., 2018, URBAN REV, V50, DOI [10.1007/s11256-017-0433-x, DOI 10.1007/S11256-017-0433-X]; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2016, BRAIN INJURY, V30, P1656, DOI 10.1080/02699052.2016.1201592; Mealings M, 2020, NEUROPSYCHOL REHABIL, V30, P1255, DOI 10.1080/09602011.2019.1574231; Mealings M, 2017, INT J SPEECH-LANG PA, V19, P441, DOI 10.1080/17549507.2016.1221453; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; Mealings M, 2010, BRAIN IMPAIR, V11, P1, DOI 10.1375/brim.11.1.1; Minichiello V., 2004, HDB RES METHODS NURS, P59; Minton D, 2017, WORK, V58, P35, DOI 10.3233/WOR-172598; Nardone A, 2015, NEUROREHABILITATION, V37, P459, DOI 10.3233/NRE-151274; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Stagg K, 2019, DISABIL REHABIL, V41, P489, DOI 10.1080/09638288.2017.1396366; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; UNESCO . Institute for Statistics, 2019, SHAR POP ED ATT POP; Venville A, 2016, INT J DISABIL DEV ED, V63, P571, DOI 10.1080/1034912X.2016.1153050; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	30	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					315	334		10.1080/02699052.2020.1863466		JAN 2021	20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000605423800001	33405962				2022-02-06	
J	Lorente, L; Martin, MM; Perez-Cejas, A; Gonzalez-Rivero, AF; Ramos-Gomez, L; Sole-Violan, J; Caceres, JJ; Cabrera, J; Alvarez-Castillo, A; Ferrer-Moure, C; Jimenez, A				Lorente, Leonardo; Martin, Maria M.; Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.; Ramos-Gomez, Luis; Sole-Violan, Jordi; Caceres, Juan J.; Cabrera, Judith; Alvarez-Castillo, Andrea; Ferrer-Moure, Carmen; Jimenez, Alejandro			High Serum Soluble Fas Ligand Levels in Non-survivor Traumatic Brain Injury Patients	NEUROCRITICAL CARE			English	Article						sFasL; Patients; Mortality; Trauma; Injury; Brain	CEREBROSPINAL-FLUID; HEAD-INJURY; APOPTOSIS; DEATH; SEVERITY	Purpose Soluble Fas Ligand (sFasL) is one of the main ligands that activates the apoptosis extrinsic pathway. Higher expression of FasL in brain samples and higher cerebrospinal fluid FasL concentrations in traumatic brain injury (TBI) patients than in controls have been found. However, the potential association between blood sFasL concentrations and TBI mortality has not been reported. Therefore, the objective of this study was to determine whether that association exists. Methods We included patients with a severe isolated TBI, defined as < 9 points in Glasgow Coma Scale (GCS) and < 10 non-cranial aspects points in Injury Severity Score in this observational and prospective study performed in 5 Intensive Care Units. We measured serum sFasL concentrations on day 1 of TBI. Results We found that 30-day survivor (n = 59) in comparison to non-survivor patients (n = 24) had higher GCS (p = 0.001), lower age (p = 0.004), lower APACHE-II score (p < 0.001), lower intracranial pressure (ICP) (p = 0.01), lower computer tomography (CT) findings of high risk of death (p = 0.02) and lower serum sFasL concentrations (p < 0.001). The area under the curve for mortality prediction by serum sFasL levels was of 75% (95% CI = 63%-87%; p < 0.001). In Kaplan-Meier analysis was found that patients with serum sFasL levels > 29.2 pg/mL had a higher mortality rate (Hazard ratio = 6.2; 95% CI = 2.6-14.8; p < 0.001). Multiple logistic regression analysis found an association between serum sFasL levels and mortality after controlling for GCS, age and CT findings (OR = 1.055; 95% CI = 1.018-1.094; p = 0.004), and after controlling for APACHE-II, ICP and CT findings (OR = 1.048; 95% CI = 1.017-1.080; p = 0.002). Conclusions The association between serum sFasL levels and 30-day mortality in TBI patients was the major novel finding of our study; however, future validation could be interesting to confirm those results.	[Lorente, Leonardo; Cabrera, Judith; Alvarez-Castillo, Andrea] Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Perez-Cejas, Antonia; Gonzalez-Rivero, Agustin F.; Ferrer-Moure, Carmen] Hosp Univ Canarias, Lab Dept, Ofra S-N, Tenerife 38320, Spain; [Ramos-Gomez, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista Arriba S-N, Brena Alta 38713, La Palma, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Barranco Ballena S-N, Las Palmas Gran Canaria 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Santa Cruz Tenerife, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Alvarez Castillo, Andrea Carolina/0000-0003-4063-9370; Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [PI-18-00500]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported by a grant from Instituto de Salud Carlos III (PI-18-00500) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Glushakova Olena Y, 2017, Brain Circ, V3, P87, DOI 10.4103/bc.bc_27_16; Jiang WQ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020922; Kleinbaum D. G., 1998, APPL REGRESSION ANAL, P281; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lenzlinger PM, 2002, J NEUROIMMUNOL, V122, P167, DOI 10.1016/S0165-5728(01)00466-0; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Crespo ART, 2007, BRAIN INJURY, V21, P441, DOI 10.1080/02699050701311125; Qiu JH, 2002, J NEUROSCI, V22, P3504; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; TEASDALE G, 1974, LANCET, V2, P81; Ullah I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33296-z; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Yin XH, 2017, NEUROSCI RES, V124, P33, DOI 10.1016/j.neures.2017.05.003; Yin XH, 2016, BRAIN RES, V1637, P64, DOI 10.1016/j.brainres.2016.02.019; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje	24	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2021	35	1					249	254		10.1007/s12028-020-01158-0		JAN 2021	6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	TJ4CL	WOS:000605134900001	33403586				2022-02-06	
J	Meltzer, KJ; Juengst, SB				Meltzer, Karen J.; Juengst, Shannon B.			Associations between frequent pain or headaches and neurobehavioral symptoms by gender and TBI severity	BRAIN INJURY			English	Article						Traumatic brain injury; gender; pain; emotion; behavior		Objective: To investigate differences in frequent pain or headaches and associated neurobehavioral symptoms among men, women, and transgender individuals with and without a history of traumatic brain injury (TBI). Setting: Community Participants: English and Spanish-speaking adults (n = 2,862) with and without self-reported TBI Design: Cross-sectional study Main Measures: Behavioral Assessment Screening Tool (BAST) subscales for Negative Affect, Substance Abuse, Executive Function, Fatigue, Impulsivity, and one item for experiencing "frequent pain or headache." Results: Women reported more pain than men. Women with a mild TBI (mTBI) more often reported frequent headaches/pain than woman in general or those with mTBI alone. Women reporting frequent headache/pain reported more negative affect and fatigue than men with comparable TBI history. Individuals identifying as transgender/other without TBI had higher negative affect and fatigue than both men and women without TBI. Individuals with mTBI and frequent headache/pain reported more executive function problems than those with mTBI without headache/pain. Pain and moderate/severe TBI were associated with more executive function problems in men and women, but more so for women. Conclusion: Results suggest frequent headache/pain may differ between genders, particularly after mTBI. Pain, fatigue, executive function, and negative affect may be especially important in women's recovery from TBI.	[Meltzer, Karen J.; Juengst, Shannon B.] UT Southwestern Med Ctr, Dept Clin Rehabil Counseling, Dallas, TX 75390 USA; [Juengst, Shannon B.] UT Southwestern Med Ctr, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Juengst, SB (corresponding author), UT Southwestern Med Ctr, Dept Clin Rehabil Counseling, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu		Juengst, Shannon/0000-0003-4709-545X	National Institutes for Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) [R03HD09445]	This work was funded by the National Institutes for Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD). Grant no: [R03HD09445].	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; [Anonymous], 2019, PREVENTING INTIMATE; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; BAY E, 2009, J NEUROSCI NURS J AM, V41; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bay EH, 2014, J NEUROSCI NURS, V46, P142, DOI 10.1097/JNN.0000000000000048; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brown, 2009, HDB STUDY MENTAL HLT, P256, DOI [10.1017/CBO9780511984945.017, DOI 10.1017/CBO9780511984945017]; CDC, 2014, TBI US REP TRAUM BRA; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; CORRIGAN J, 2007, J HEAD TRAUMA REHAB, V22; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Higashi Robin T, 2019, Health Lit Res Pract, V3, pe243, DOI 10.3928/24748307-20190925-01; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; Juengst SB, 2017, J CLIN EXP NEUROPSYC, V39, P513, DOI 10.1080/13803395.2016.1240758; Koerte IK, 2020, J NEUROIMAGING, V30, P387, DOI 10.1111/jon.12726; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; LIOSSI C, 2009, J NEUROPSYCHIATRY CL, V21; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; NAMPIAPARAMPIL D, 2008, JAMA-J AM MED ASSOC, V300; National Institute of Neurologic Disorders and Stroke, WORKSH SUMM UND TRAU; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Osborne CL., 2019, DISABIL REHABIL; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Safer JD, 2016, CURR OPIN ENDOCRINOL, V23, P168, DOI 10.1097/MED.0000000000000227; Soendergaard PL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00051; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; St?lnacke, 2013, SEX DIFFERENCES SYMP; TBI, 2019, GET FACTS CONC TRAUM; Wagner, 2018, DISABIL REHABIL, V42, P1	45	1	1	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 5	2021	35	1					41	47		10.1080/02699052.2020.1857438		JAN 2021	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QU1AU	WOS:000604699600001	33395320	Green Accepted			2022-02-06	
J	Lloyd, O; Ownsworth, T; Fleming, J; Jackson, M; Zimmer-Gembeck, M				Lloyd, Owen; Ownsworth, Tamara; Fleming, Jennifer; Jackson, Megan; Zimmer-Gembeck, Melanie			Impaired Self-Awareness after Pediatric Traumatic Brain Injury: Protective Factor or Liability?	JOURNAL OF NEUROTRAUMA			English	Article						adolescents; children; metacognition; self-awareness; traumatic brain injury	BEHAVIOR PROBLEMS; VIDEO FEEDBACK; CHILDREN; DEFICITS; OUTCOMES; CHILDHOOD; PARENT; RATINGS; RECOMMENDATIONS; ADOLESCENTS	Children and adolescents with traumatic brain injury (TBI) can experience impaired self-awareness, or difficulty in accurately perceiving their personal abilities. This study aimed to identify the neuro-developmental and socio-environmental factors associated with self-awareness impairment and determine how self-awareness is associated with psychosocial functioning. Parents and their children age 8-16 years with TBI (n = 107, 65.4% male, mean [M] age = 12.66 years, standard deviation [SD] = 2.6 years) were consecutively recruited from an outpatient clinic over a 4-year period. Children completed the Paediatric Awareness Questionnaire (PAQ) to report their functional abilities, and the Beck Youth Inventories to report their self-concept, and anxiety and depression symptoms. Parents completed the PAQ and measures of family functioning, parenting style, and children's emotional and behavioral problems. Self-awareness impairments were defined as more negative parent-child discrepancy scores on the PAQ. Younger age at injury, more severe injury, and more family dysfunction were significantly associated with poorer self-awareness. Poorer self-awareness was associated with worse parent-rated child adaptive functioning and emotional and behavioral problems. However, poorer self-awareness was also significantly associated with more positive self-concept and fewer symptoms of depression and anxiety as rated by children. Overall, impaired self-awareness seems to be both a liability and a benefit depending on the reporter (parent or child) and outcome of interest (adaptive function/behavior or self-concept/mood).	[Lloyd, Owen; Ownsworth, Tamara; Jackson, Megan] Griffith Univ, Sch Appl Psychol, Messines Ridge Rd, Brisbane, Qld 4122, Australia; [Lloyd, Owen; Ownsworth, Tamara; Jackson, Megan] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Lloyd, Owen; Jackson, Megan] Queensland Childrens Hosp, Childrens Hlth Queensland, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia; [Lloyd, Owen] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Zimmer-Gembeck, Melanie] Griffith Univ, Sch Appl Psychol, Southport, Qld, Australia		Lloyd, O (corresponding author), Griffith Univ, Sch Appl Psychol, Messines Ridge Rd, Brisbane, Qld 4122, Australia.; Lloyd, O (corresponding author), Menzies Hlth Inst Queensland, Messines Ridge Rd, Brisbane, Qld 4122, Australia.	owen.lloyd@griffithuni.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094	Moving Ahead Centre of Research Excellence	This study was supported by a seed grant from the "Moving Ahead Centre of Research Excellence.'' There was no specific grant number.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson MN, 2019, DEV NEUROPSYCHOL, V44, P443, DOI 10.1080/87565641.2019.1667995; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Brown FL, 2015, BEHAV RES THER, V73, P58, DOI 10.1016/j.brat.2015.07.001; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Crowther JE, 2011, J HEAD TRAUMA REHAB, V26, P192, DOI 10.1097/HTR.0b013e318218dd22; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fivush R, 2011, ANNU REV PSYCHOL, V62, P559, DOI 10.1146/annurev.psych.121208.131702; Fleming JM, 1996, BRAIN INJURY, V10, P1; Geurten M, 2016, CLIN NEUROPSYCHOL, V30, P558, DOI 10.1080/13854046.2016.1178331; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Harter S., 2012, HDB SELF IDENTITY, P680; Hendry K, 2020, CHILD NEUROPSYCHOL, V26, P1005, DOI 10.1080/09297049.2020.1750577; Hoerold D, 2013, NEUROPSYCHOLOGIA, V51, P385, DOI 10.1016/j.neuropsychologia.2012.11.019; Krasny-Pacini A, 2015, DISABIL REHABIL, V37, P2092, DOI 10.3109/09638288.2014.998783; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lloyd O, 2018, CHILD NEUROPSYCHOL, V24, P702, DOI 10.1080/09297049.2017.1332173; Lloyd O, 2015, J HEAD TRAUMA REHAB, V30, P311, DOI 10.1097/HTR.0000000000000113; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Oakland, 2015, ADAPTIVE BEHAV ASSES; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Raj SP, 2014, J PEDIATR PSYCHOL, V39, P84, DOI 10.1093/jpepsy/jst075; Robinson C.C., 2001, HDB FAMILY MEASUREME; ROBINSON CC, 1995, PSYCHOL REP, V77, P819, DOI 10.2466/pr0.1995.77.3.819; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schmidt J, 2015, CAN J OCCUP THER, V82, P54, DOI 10.1177/0008417414550999; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schorr E, 2020, DISABIL REHABIL, V42, P2437, DOI 10.1080/09638288.2019.1602676; SIMPSON D, 1982, LANCET, V2, P450; Steer, 2005, BECK YOUTH INVENTORI; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wade M, 2018, PSYCHON B REV, V25, P2119, DOI 10.3758/s13423-018-1459-0; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wales L, 2019, BRAIN INJURY, V33, P633, DOI 10.1080/02699052.2019.1566838; Walsh F., 2003, NORMAL FAMILY PROCES, P581, DOI DOI 10.4324/9780203428436_CHAPTER_21; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Wolfe KR, 2015, J PEDIATR PSYCHOL, V40, P272, DOI 10.1093/jpepsy/jsu060; Yeates KO, 2017, J INT NEUROPSYCH SOC, V23, P806, DOI 10.1017/S1355617717000686; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	62	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					616	627		10.1089/neu.2020.7191		JAN 2021	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000606521000001	33107366				2022-02-06	
J	Zhuang, SJ; Liu, BG; Guo, SF; Xue, YZ; Wu, L; Liu, SQ; Zhang, CL; Ni, XY				Zhuang, Sujing; Liu, Baogui; Guo, Shifeng; Xue, Yanzhong; Wu, Lin; Liu, Shiqi; Zhang, Chunling; Ni, Xiuyan			Germacrone alleviates neurological deficits following traumatic brain injury by modulating neuroinflammation and oxidative stress	BMC COMPLEMENTARY MEDICINE AND THERAPIES			English	Article						Germacrone; Traumatic brain injury; NF-&#954; B; Inflammation	NF-KAPPA-B; INDUCED INFLAMMATION; MICROGLIA; NRF2; NEUROPROTECTION; TRANSCRIPTION; ACTIVATION; PROMOTES; PATHWAY	Background Germacrone (GM) is a terpenoid compound which is reported to have anti-inflammatory and anti-oxidative effects. However, its role in treating traumatic brain injury (TBI) remains largely unknown. Methods Male C57BL/6 mice were divided into the following groups: control group, TBI group [controlled cortical impact (CCI) model], CCI + 5 mg/kg GM group, CCI + 10 mg/kg GM group and CCI + 20 mg/kg GM group. GM was administered via intraperitoneal injection. The neurological functions (including motor coordination, spatial learning and memory abilities) and brain edema were measured. Nissl staining was used to detect the neuronal apoptosis. Colorimetric assays and enzyme linked immunosorbent assay (ELISA) kits were used to determine the expression levels of oxidative stress markers including myeloperoxidase (MPO), malondialdehyde (MDA) and superoxide dismutase (SOD), as well as the expressions of inflammatory markers, including tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6). Additionally, protein levels of Nrf2 and p-p65 were detected by Western blot assay. Results GM significantly ameliorated motor dysfunction, spatial learning and memory deficits of the mice induced by TBI and it also reduced neuronal apoptosis and microglial activation in a dose-dependent manner. Besides, GM treatment reduced neuroinflammation and oxidative stress compared to those in the CCI group in a dose-dependent manner. Furthermore, GM up-regulated the expression of antioxidant protein Nrf2 and inhibited the expression of inflammatory response protein p-p65. Conclusions GM is a promising drug to improve the functional recovery after TBI via repressing neuroinflammation and oxidative stress.	[Zhuang, Sujing; Guo, Shifeng; Xue, Yanzhong] Linyi Cent Hosp, Dept Neurol, Linyi 276400, Shandong, Peoples R China; [Liu, Baogui] Linyi Cent Hosp, Dept Anesthesiol, Linyi 276400, Shandong, Peoples R China; [Wu, Lin; Zhang, Chunling] Jining Med Univ, Affiliated Hosp, Dept Intens Care Unit 2, Jining 272000, Shandong, Peoples R China; [Liu, Shiqi] Jining Med Univ, Affiliated Hosp, Dept Gastrointestinal Surg, Jining 272000, Shandong, Peoples R China; [Ni, Xiuyan] Linyi Cent Hosp, Dept Radiotherapy, Linyi 276400, Shandong, Peoples R China		Ni, XY (corresponding author), Linyi Cent Hosp, Dept Radiotherapy, Linyi 276400, Shandong, Peoples R China.	mgpjfnuxiemu8211@163.com			Medical Research Project of Linyi Central Hospital [20170032]	This study is supported by the Medical Research Project of Linyi Central Hospital (Approval No. 20170032).	Abdalkader M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00466; An JF, 2014, CELL MOL BIOL, V60, P8; Cameron HA, 2015, ANNU REV PSYCHOL, V66, P53, DOI 10.1146/annurev-psych-010814-015006; Chen S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0963-x; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jeong YH, 2016, BIOMOL THER, V24, P581, DOI 10.4062/biomolther.2016.141; Kim JW, 2009, LIFE SCI, V84, P227, DOI 10.1016/j.lfs.2008.12.005; Li LT, 2013, BRAIN RES, V1497, P32, DOI 10.1016/j.brainres.2012.12.032; Lim MS, 2016, PHYTOTHER RES, V30, P2036, DOI 10.1002/ptr.5711; Liu WS, 2019, J CELL BIOCHEM, V120, P17015, DOI 10.1002/jcb.28963; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107; Singleton Q, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010063; Sun Y, 2019, EXP THER MED, V18, P3514, DOI 10.3892/etm.2019.7990; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Thanan R, 2015, INT J MOL SCI, V16, P193, DOI 10.3390/ijms16010193; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Wang B, 2012, FREE RADICAL BIO MED, V52, P928, DOI 10.1016/j.freeradbiomed.2011.12.006; Wang ZR, 2019, BIOCHEM BIOPH RES CO, V518, P560, DOI 10.1016/j.bbrc.2019.08.084; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Yin YT, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0993-4; Zhang F, 2018, TRANSL STROKE RES, V9, P174, DOI 10.1007/s12975-017-0549-z; Zhang JX, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-2865-1	31	1	1	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2662-7671		BMC COMPLEMENT MED	BMC Complement. Med. Ther.	JAN 5	2021	21	1							6	10.1186/s12906-020-03175-0			10	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	PS5IQ	WOS:000607955100002	33402180	Green Published, gold			2022-02-06	
J	Chen, VCH; Yang, YH; Lee, CTC; Chen, YL; Dewey, ME; Gossop, M				Chen, Vincent Chin-Hung; Yang, Yao-Hsu; Lee, Charles Tzu-Chi; Chen, Yi-Lung; Dewey, Michael E.; Gossop, Michael			Methylphenidate and TBI in ADHD and co-occurring epilepsy and mental disorders: a self-controlled case series study	EUROPEAN CHILD & ADOLESCENT PSYCHIATRY			English	Article; Early Access						ADHD medication; TBI; Self-controlled case series study	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; INJURY; RISK; MEDICATION; CHILDREN; ADOLESCENTS; DEPRESSION; STIMULANT	It is suggested that medication for attention-deficit hyperactivity disorder (ADHD) links to lower risk of traumatic brain injury (TBI). Little is known about whether the beneficial effect of methylphenidate is persistent in individuals with other comorbid mental disorders and epilepsy. We identified 90,634 participants who were less than 18 years old and diagnosed with ADHD from Taiwan's National Health Insurance Research Database (NHIRD) from January 1, 2000 to December 31, 2013. Cox proportional hazards models with hazard ratio (HR) and 95% confidence interval were conducted to compare the risks of TBI event between groups of ADHD-only and ADHD with co-occurring other mental disorders. Within-individual comparisons using a self-controlled case series study design were conducted using conditional Poisson regression models with relative incidence (RR) and 95% CI to examine the effect of methylphenidate on TBI with adjustment for medication of psychotropics and anticonvulsants. For children and adolescents with ADHD, we found comorbid mental disorders and epilepsy increase the risk of TBI, with HRs ranged from 1.21 to 1.75. For the effect of MPH, we found reduced risks for TBI in ADHD (RR = 0.83, 95% CI = 0.70-0.98). Similar results were found among individuals with co-occurring oppositional defiant disorders or conduct disorder, MDD, tic disorders and epilepsy. Methylphenidate treatment was linked to lower risk for TBI in patients with ADHD and the inverse association was persistent among those with other comorbid mental disorders and epilepsy.	[Chen, Vincent Chin-Hung] Chang Gung Mem Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Chiayi Branch, Dept Tradit Chinese Med, Chiayi, Taiwan; [Lee, Charles Tzu-Chi] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan; [Chen, Yi-Lung] Asia Univ, Dept Healthcare Adm, 500 Lioufeng Rd, Taichung 41354, Taiwan; [Chen, Yi-Lung] Asia Univ, Dept Psychol, Taichung, Taiwan; [Dewey, Michael E.] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Gossop, Michael] Kings Coll London, Inst Psychiat, Natl Addict Ctr, London, England		Chen, YL (corresponding author), Asia Univ, Dept Healthcare Adm, 500 Lioufeng Rd, Taichung 41354, Taiwan.; Chen, YL (corresponding author), Asia Univ, Dept Psychol, Taichung, Taiwan.	elong@asia.edu.tw	Yang, Yao-Hsu/A-3450-2019	Yang, Yao-Hsu/0000-0002-8080-0504; Chen, Yi-Lung/0000-0003-2934-5814	Chang Gung Memorial HospitalChang Gung Memorial Hospital [CLRPG6G0042, CLRPG6G0043]	This work was supported by grants from the Chang Gung Memorial Hospital (CLRPG6G0042, CLRPG6G0043).	Brikell I, 2019, EPILEPSIA, V60, P284, DOI 10.1111/epi.14640; Cairney J, 2014, DEV MED CHILD NEUROL, V56, P1040, DOI 10.1111/dmcn.12509; Castellanos FX, 1997, J AM ACAD CHILD PSY, V36, P589, DOI 10.1097/00004583-199705000-00008; Chang HK, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11857; Chang Z, 2019, BIOL PSYCHIAT, V86, P335, DOI 10.1016/j.biopsych.2019.04.009; Chang Z, 2017, JAMA PSYCHIAT, V74, P597, DOI 10.1001/jamapsychiatry.2017.0659; Chang Z, 2016, BIOL PSYCHIAT, V80, P916, DOI 10.1016/j.biopsych.2016.02.018; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen Q, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3769; Chen CCH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8714; Chen VCH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173762; Cohen R, 2013, J CHILD NEUROL, V28, P120, DOI 10.1177/0883073812440327; Cohen SC, 2015, J AM ACAD CHILD PSY, V54, P728, DOI 10.1016/j.jaac.2015.06.011; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Erskine HE, 2016, J AM ACAD CHILD PSY, V55, P841, DOI 10.1016/j.jaac.2016.06.016; Ghirardi L, 2020, J CHILD PSYCHOL PSYC, V61, P140, DOI 10.1111/jcpp.13136; Ghirardi L, 2020, J AM ACAD CHILD PSY, V59, P944, DOI 10.1016/j.jaac.2019.06.010; Golubchik P, 2017, INT CLIN PSYCHOPHARM, V32, P289, DOI 10.1097/YIC.0000000000000175; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Jory C, 2019, SEIZURE-EUR J EPILEP, V71, P66, DOI 10.1016/j.seizure.2019.06.013; Kutlu A, 2017, J CLIN PSYCHOPHARM, V37, P220, DOI 10.1097/JCP.0000000000000668; Lee MJ, 2016, J AFFECT DISORDERS, V189, P110, DOI 10.1016/j.jad.2015.09.015; Liao YT, 2018, EUR CHILD ADOLES PSY, V27, P279, DOI 10.1007/s00787-017-1042-7; Liou YJ, 2018, J ADOLESCENT HEALTH, V63, P233, DOI 10.1016/j.jadohealth.2018.02.012; LOWE TL, 1982, JAMA-J AM MED ASSOC, V247, P1729, DOI 10.1001/jama.247.12.1729; Man KKC, 2017, CNS DRUGS, V31, P1043, DOI 10.1007/s40263-017-0485-1; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Ng CH, 1997, AUST NZ J PSYCHIAT, V31, P382, DOI 10.3109/00048679709073848; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Raman SR, 2018, LANCET PSYCHIAT, V5, P824, DOI 10.1016/S2215-0366(18)30293-1; Ravi M, 2015, J CAN ACAD CHILD ADO, V25, P50; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Ruiz-Goikoetxea M, 2018, NEUROSCI BIOBEHAV R, V84, P63, DOI 10.1016/j.neubiorev.2017.11.007; SAVITZ DA, 1989, AM J EPIDEMIOL, V129, P1062, DOI 10.1093/oxfordjournals.aje.a115210; Sun SH, 2019, JAMA PSYCHIAT, V76, P1141, DOI 10.1001/jamapsychiatry.2019.1944; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Vaughan B, 2012, CHILD ADOL PSYCH CL, V21, P941, DOI 10.1016/j.chc.2012.07.005; Wolraich ML, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2528	39	1	1	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1018-8827	1435-165X		EUR CHILD ADOLES PSY	Eur. Child Adolesc. Psych.												10.1007/s00787-020-01694-2		JAN 2021	8	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	PN1AJ	WOS:000604218200004	33389157				2022-02-06	
J	Wan, ANN; Nasr, AS				Wan, Anna N.; Nasr, Annette S.			Return to learn: An ethnographic study of adolescent young adults returning to school post-concussion	JOURNAL OF CLINICAL NURSING			English	Article						adolescent health; concussion; education; neurology; neuroscience; post&#8208; concussion syndrome; qualitative approaches; school nursing	TRAUMATIC BRAIN-INJURY; CHILDREN; MANAGEMENT; EDUCATION; REST	Background and purpose The Centers for Disease Control and Prevention estimates that 3.8 million concussions occur in the United States each year. Concussion symptoms can negatively impact the academic performance of adolescents after they return to school. The purpose of this study was to better understand the perceptions of parent-adolescent dyads as male and female adolescents returned to learn after sustaining a concussion. Methods A qualitative ethnographic study of 10, English-speaking, parent-adolescent dyads was conducted, following the adolescents return to school after a recent concussion. Dyads were recruited from a Concussion Clinic in Menlo Park, California between October 2018 and October 2019. Adolescents were aged 14-16 years old. Each dyad participated in a semistructured interview. Interviews were subsequently transcribed and analysed using thematic analysis. This qualitative study design utilised COREQ (File S1). This study was approved by the Institutional Review Board and ethics committee. Conclusions Three categories were identified: adolescents feeling misunderstood by school staff about their injuries, adolescents feeling overwhelmed by their injuries, and academic accommodations lacking clarity and implementation. The overarching theme that emerged was clear: Parents and adolescents lacked consistent guidelines for the adolescents' return to learn after a concussion. Relevance to Clinical Practice Post-concussion syndrome as a result of head injury is a complex condition that requires a multidisciplinary approach to treatment. This treatment should be individualised and appropriately adjusted to provide the adolescent with the most optimal environment for recovery. This study provides data to suggest that more guidance from the medical provider or treatment team is needed for teachers and school administrators in order to create an ideal return to learn environment for the adolescent who is recovering from a head injury.	[Wan, Anna N.; Nasr, Annette S.] Stanford Childrens Hosp, Palo Alto, CA USA; [Nasr, Annette S.] Stanford Univ, Dept Pediat, Sch Med, Palo Alto, CA 94304 USA; [Nasr, Annette S.] Stanford Childrens Hosp, Dept Nursing Res & Evidence Based Practice, Palo Alto, CA USA		Wan, ANN (corresponding author), Stanford Childrens Hlth, Adult Headache & Pediat Concuss Clin, Palo Alto, CA 94304 USA.	annwan@stanfordchildrens.org		Wan, Anna/0000-0003-0465-5496	Stanford Children's Health Center for Professional Excellence and Inquiry	This study project was supported by the Stanford Children's Health Center for Professional Excellence and Inquiry	Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cruz Edward Venzon, 2013, Nurse Res, V20, P36; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DeSantis L, 2000, WESTERN J NURS RES, V22, P351, DOI 10.1177/019394590002200308; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Faul M, 2010, TRAUMATIC BRAIN INJU; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Glaser BG., 2017, DISCOVERY GROUNDED T; Hachem LD, 2016, CAN J NEUROL SCI, V43, P554, DOI 10.1017/cjn.2016.41; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Halstead ME, 2017, BRIT J SPORT MED, V51, P147, DOI 10.1136/bjsports-2016-096674; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Roper J., 2000, ETHNOGRAPHY NURSING; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schwandt T.A., 2007, SAGE DICT QUALITATIV; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Spradley J.P., 1979, ETHNOGRAPHIC INTERVI; Strauss A., 1990, BASICS QUALITATIVE R; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939	33	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	MAR	2021	30	5-6					793	802		10.1111/jocn.15617		JAN 2021	10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	QY6KY	WOS:000604048400001	33351994				2022-02-06	
J	Wilu, AW; Allain, P; Moustafa, AA; El Haj, M				Wilu Wilu, Amina; Allain, Philippe; Moustafa, Ahmed A.; El Haj, Mohamad			"To whom did I tell that information?": Relationship between destination memory and theory of mind in traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						communication; destination memory; social cognition; theory of mind; traumatic brain injury		Traumatic Brain Injury (TBI) has been widely associated with impairment of social cognition. We therefore investigated the relationship between the ability to infer and predict other's mental states (i.e., Theory of Mind, ToM) and the ability to remember to whom one has sent information (i.e., destination memory). We invited patients with TBI and control subjects, on a destination memory task, to tell proverbs to pictures of celebrities, so as to remember to which celebrity they had previously told the proverbs. Participants also performed affective (i.e., Reading the Mind in the Eyes) and cognitive (i.e., the false belief) tests of ToM. Results demonstrated lower destination memory, affective, and cognitive ToM performance in TBI patients than in control subjects. Critically, analysis demonstrated significant positive correlations between destination memory and first order and second cognitive order ToM in patients with TBI, but no significant correlations between destination memory and affective ToM in these patients. Our results demonstrate a relationship between difficulties of TBI patients to infer and predict cognitive states of interlocutors and difficulties to remember to which interlocutor information has been told.	[Wilu Wilu, Amina; El Haj, Mohamad] Ctr Hosp Tourcoing, Unite Geriatrie, Tourcoing, France; [Allain, Philippe] Univ Angers, Lab Psychol Pays Loire EA 4638, Angers, France; [Allain, Philippe] Ctr Hosp Univ Angers, Ctr Natl Reference Malad Neurogenet Adulte, Dept Neurol, Angers, France; [Moustafa, Ahmed A.] Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Moustafa, Ahmed A.] Western Sydney Univ, Marcs Inst Brain & Behav, Sydney, NSW, Australia; [Moustafa, Ahmed A.] Qatar Univ, Coll Arts & Sci, Dept Social Sci, Doha, Qatar; [El Haj, Mohamad] Univ Nantes, Lab Psychol Pays Loire EA 4638, Nantes, France; [El Haj, Mohamad] Inst Univ France, Paris, France		El Haj, M (corresponding author), Univ Nantes, LPPL Lab Psychol Pays Loire, Fac Psychol, Chemin Cens Tertre,BP 81227, F-44312 Nantes 3, France.	mohamad.elhaj@univ-nantes.fr	Moustafa, Ahmed/AAM-2836-2021	el haj, mohamad/0000-0001-7635-7557; ALLAIN, Philiooe/0000-0003-0668-0986			BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Bosco FM, 2018, J COMMUN DISORD, V75, P102, DOI 10.1016/j.jcomdis.2018.05.002; Bosco FM, 2018, ARCH CLIN NEUROPSYCH, V33, P875, DOI 10.1093/arclin/acy041; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Cohen J., 1992, CURR DIR PSYCHOL SCI, V1, P98, DOI [DOI 10.2307/20182143, DOI 10.1111/1467-8721.EP10768783]; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Desgranges B., 2012, REV NEUROPSYCHOL, V4, P216, DOI 10.3917/rne.043.0216; El Haj M, 2018, MEMORY, V26, P610, DOI 10.1080/09658211.2017.1387665; El Haj M, 2018, PSYCHOL RES-PSYCH FO, V82, P1027, DOI 10.1007/s00426-017-0891-5; El Haj M, 2018, PSYCHOL RES-PSYCH FO, V82, P600, DOI 10.1007/s00426-016-0840-8; El Haj M, 2018, BEHAV BRAIN SCI, V41, DOI 10.1017/S0140525X17001339; El Haj M, 2017, EXP AGING RES, V43, P355, DOI 10.1080/0361073X.2017.1333821; El Haj M, 2017, Q J EXP PSYCHOL, V70, P1166, DOI 10.1080/17470218.2016.1173079; El Haj M, 2017, PSYCHIAT RES, V248, P71, DOI 10.1016/j.psychres.2016.12.023; El Haj M, 2016, ALCOHOL CLIN EXP RES, V40, P1321, DOI 10.1111/acer.13070; El Haj M, 2015, CURR ALZHEIMER RES, V12, P796, DOI 10.2174/1567205012666150710112802; El Haj M, 2016, MEMORY, V24, P526, DOI 10.1080/09658211.2015.1021257; El Haj M, 2015, J ALZHEIMERS DIS, V48, P529, DOI 10.3233/JAD-150467; El Haj M, 2016, J NEUROPSYCHOL, V10, P77, DOI 10.1111/jnp.12057; El Haj M, 2015, AGING CLIN EXP RES, V27, P337, DOI 10.1007/s40520-014-0286-z; El Haj M, 2015, EXP AGING RES, V41, P204, DOI 10.1080/0361073X.2015.1001658; El Haj M, 2014, GERIATR PSYCHOL NEUR, V12, P432, DOI 10.1684/pnv.2014.0499; El Haj M, 2014, J CLIN EXP NEUROPSYC, V36, P127, DOI 10.1080/13803395.2013.869309; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Fleming J, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1758-6; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gopie N, 2010, PSYCHOL AGING, V25, P922, DOI 10.1037/a0019703; Gopie N, 2009, PSYCHOL SCI, V20, P1492, DOI 10.1111/j.1467-9280.2009.02472.x; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Laisney M, 2013, J NEUROPSYCHOL, V7, P107, DOI 10.1111/j.1748-6653.2012.02038.x; Leslie AM, 1998, DEVELOPMENTAL SCI, V1, P247, DOI 10.1111/1467-7687.00038; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ries M, 2006, NEUROPSYCHOLOGIA, V44, P2233, DOI 10.1016/j.neuropsychologia.2006.05.021; Rosema S, 2014, J NEUROTRAUM, V31, P899, DOI 10.1089/neu.2013.3226; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; SPIERS MV, 1994, BRAIN INJURY, V8, P463, DOI 10.3109/02699059409150998; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Turkstra LS, 2018, NEUROPSYCHOLOGIA, V111, P117, DOI 10.1016/j.neuropsychologia.2018.01.016; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van der Linden M.A., 2004, EVALUATION TROUBLES; Wilu AW, 2018, NEUROL SCI, V39, P1035, DOI 10.1007/s10072-018-3321-6; Wilu Wilu A., 2018, REV NEUROPSYCHOL, V10, P130, DOI [10.1684/nrp.2018.0458, DOI 10.1684/NRP.2018.0458]; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	77	1	1	2	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2021	28	1					1	11		10.1080/23279095.2019.1585350			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	PT0CM	WOS:000608289600002	30889969				2022-02-06	
J	Agimi, Y; Marion, D; Schwab, K; Stout, K				Agimi, Yll; Marion, Donald; Schwab, Karen; Stout, Katharine			Estimates of Long-Term Disability Among US Service Members With Traumatic Brain Injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities of daily living (ADL); long-term disability; SCTBIFR; traumatic brain injury; US military	UNITED-STATES; EPIDEMIOLOGY; TRENDS; ARMY; IRAQ	Background: Traumatic brain injury (TBI) is a significant health issue in the US military. The purpose of this study was to estimate the probability of long-term disability among hospitalized service members (SMs) with TBIs, using the South Carolina Traumatic Brain Injury and Follow-up Registry (SCTBIFR) model developed on civilian hospitalized patients. Methods: We identified military patients in military or civilian hospitals or theater level 3 to 5 military treatment facilities (MTFs) whose first TBI occurred between October 1, 2013, and September 30, 2015. TBI-related disability at 1-year post-hospital discharge was estimated using regression coefficients from the SCTBIFR. Results: Among the identified 4877 SMs, an estimated 65.6% of SMs with severe TBI, 56.2% with penetrating TBI, 31.4% with moderate TBI, and 12.0% with mild TBI are predicted to develop long-term disability. TBI patients identified at theater level 4 and 5 MTFs had an average long-term disability rate of 56.9% and 61.1%, respectively. In total, we estimate that 25.2% of all SMs hospitalized with TBI will develop long-term disability. Conclusion Applying SCTBIFR long-term probability estimates to US SMs with TBIs provides useful disability estimates to inform providers and health systems on the likelihood that particular subgroups of TBI patients will require continued support and long-term care.	[Agimi, Yll; Marion, Donald; Schwab, Karen; Stout, Katharine] Def & Vet Brain Injury Ctr, 1335 East West Hwy,4-214E, Silver Spring, MD 20910 USA; [Agimi, Yll; Marion, Donald] Gen Dynam Informat Technol, Falls Church, VA USA; [Schwab, Karen] 9Line LLC, Tampa, FL USA		Agimi, Y (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Hwy,4-214E, Silver Spring, MD 20910 USA.	yll.agimi@gmail.com; donald.w.marion.ctr@mail.mil; karen.a.schwab2.ctr@mail.mil; katharine.c.stout.civ@mail.mil	AGIMI, YLL/AAL-9337-2021		Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs; US Army Human Research Protection Program Office [DV-15-02]	This study was supported by Defense and Veterans Brain Injury Center (DVBIC). This study was approved by the US Army Human Research Protection Program Office (DV-15-02) and the US Army Medical Research andMateriel Command's Office of Research Protections, Institutional Review Board Office (ORP IRBO) (M-10436). No outside sources contributed to the funding of this study.	Agimi Y, 2019, MIL MED, V184, pE233, DOI 10.1093/milmed/usy313; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Armed Forces Health Surveillance Center, 2015, CAS DEF DAT AN HLTH; Centers for Disease Control and Prevention, 2015, TRAUM BRAIN INJ US F; Defense Manpower Data Center, 2008, ACT DUT SERV AG YEAR; Defense Manpower Data Center, 2013, CONT TRACK SYST DEPL; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Gubata ME, 2013, MIL MED, V178, P708, DOI 10.7205/MILMED-D-12-00542; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; National Center for Health Statistics, 2008, BAR INJ DIAGN MATR F; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Orman JA, 2012, J TRAUMA ACUTE CARE, V73, pS496, DOI 10.1097/TA.0b013e318275473c; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Regasa LE, 2018, J HEAD TRAUMA REHAB, V33, P123, DOI 10.1097/HTR.0000000000000380; Schulz-Heik RJ, 2017, BRAIN INJURY, V31, P1287, DOI 10.1080/02699052.2017.1307449; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Selassie A, 2004, S CAROLINA TRAUMATIC; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; US Department of Defense, 2015, TRAUM BRAIN INJ UPD; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Weiss H, 2010, PEDIATRICS, V126, P1141, DOI 10.1542/peds.2010-0271; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	28	1	1	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		1	9		10.1097/HTR.0000000000000573			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300001	32472830				2022-02-06	
J	Ahidjo, N; Ngarka, L; Etet, PFS; Njamnshi, WY; Nfor, LN; Mengnjo, MK; Atchou, JGB; Mouofo, EN; Tatah, GY; Zok, FDA; Ngadjui, BT; Ngwa, W; Njamnshi, AK				Ahidjo, Nene; Ngarka, Leonard; Etet, Paul F. Seke; Njamnshi, Wepnyu Y.; Nfor, Leonard N.; Mengnjo, Michel K.; Atchou, Jonas G. Basseguin; Mouofo, Edmond N.; Tatah, Godwin Y.; Zok, Faustin Dong A.; Ngadjui, Bonaventure T.; Ngwa, Wilfred; Njamnshi, Alfred K.			Garcinia kola improves cognitive and motor function of a rat model of acute radiation syndrome in the elevated plus maze	BRAIN COMMUNICATIONS			English	Article						Garcinia kola; Gamma radiation; anxiety-depression; acute radiation syndrome; motor and cognitive impairment	BRAIN; NEUROTOXICITY; ANTIOXIDANT; MORTALITY; KOLAVIRON; THERAPY; ANXIETY; DAMAGE	We reported recently that the elevated plus maze is a good tool for evaluating cognitive and motor functional changes in gammairradiated rats as a model for new drug evaluation and monitoring. The capacity of Garcinia kola to mitigate radiation-induced brain injury is currently unknown. We therefore assessed the effects of the neuroprotective medicinal plant Garcinia kola, on the cognitive and motor changes in this murine model of acute radiation syndrome. Wistar rats exposed once to an ionizing dose of Tc99m-generated Gamma radiation were treated with an ethyl acetate fraction of methanolic extract of Garcinia kola seeds (content of 100 mg/kg of extract) for 9 weeks. Cognitive and motor function indicators were assessed in the elevated plus maze in these animals and compared with irradiated control groups (vitamin C- and vehicle-treated groups) and the non-irradiated control rats. The irradiated control group displayed cachexia, shaggy and dirty fur, porphyrin deposits around eyes, decreased exploratory activity, reduced social interactions and a loss of thigmotaxis revealed by a marked decrease in rearing episodes and stretch attend posture episodes close to the walls of elevated plus maze closed arm, an increased central platform time, and decreases in open arm time and entries. This group further displayed a decrease in head dips and grooming episodes. Treatment with Garcinia kola, and in a lesser extent vitamin C, significantly prevented the body weight loss (P < 0.001) and mitigated the development of elevated plus maze signs of cognitive and motor affections observed in the irradiated control group (P < 0.05). Altogether, our data suggest for the first time that Garcinia kola seeds have protective properties against the development of cognitive and motor decline in the acute radiation syndrome-like context. Future studies are warranted to characterize the molecular mechanisms and neuronal networks of this action.	[Ahidjo, Nene; Ngarka, Leonard; Njamnshi, Wepnyu Y.; Nfor, Leonard N.; Mengnjo, Michel K.; Atchou, Jonas G. Basseguin; Mouofo, Edmond N.; Tatah, Godwin Y.; Njamnshi, Alfred K.] Univ Yaounde I, Fac Med & Biomed Sci, Neurosci Lab, Yaounde, Cameroon; [Ahidjo, Nene; Njamnshi, Wepnyu Y.; Njamnshi, Alfred K.] Brain Res Africa Initiat BRAIN, Geneva, Switzerland; [Ahidjo, Nene; Ngarka, Leonard; Etet, Paul F. Seke; Njamnshi, Wepnyu Y.; Nfor, Leonard N.; Mengnjo, Michel K.; Atchou, Jonas G. Basseguin; Tatah, Godwin Y.; Njamnshi, Alfred K.] Brain Res Africa Initiat BRAIN, POB 25625, Yaounde, Cameroon; [Ngarka, Leonard; Nfor, Leonard N.; Mengnjo, Michel K.; Njamnshi, Alfred K.] Yaounde Cent Hosp, Dept Neurol, Yaounde, Cameroon; [Etet, Paul F. Seke] Ctr Sustainable Hlth & Dev, Garoua, Cameroon; [Etet, Paul F. Seke] Univ Ngaoundere, Dept Physiol Sci & Biochem, Garoua, Cameroon; [Atchou, Jonas G. Basseguin] Yaounde Mil Hosp, Dept Psychiat, Yaounde, Cameroon; [Tatah, Godwin Y.] CH St Nazaire, Dept Neurol, St Nazaire, France; [Zok, Faustin Dong A.] Yaounde Gen Hosp, Radiotherapy Unit, Yaounde, Cameroon; [Ngadjui, Bonaventure T.] Univ Yaounde I, Fac Med & Biomed Sci, Dept Pharmacol & Tradit Med, Yaounde, Cameroon; [Ngwa, Wilfred] Harvard Med Sch, Dept Radiat Oncol, Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA		Njamnshi, AK (corresponding author), Brain Res Africa Initiat BRAIN, POB 25625, Yaounde, Cameroon.; Njamnshi, AK (corresponding author), Univ Yaounde I, Neurosci Lab, Fac Med, POB 25625, Yaounde, Cameroon.	alfred.njamnshi@brainafrica.org			Brain Research Africa Initiation (BRAIN), Cameroon	There was no specific funding for this work but all the equipment for the experiments including video recording and analysis were acquired and kindly made available to the Neuroscience lab (FMBS) by Brain Research Africa Initiation (BRAIN), Cameroon (www.brainafrica.org).	Abarikwu SO, 2014, BBA-GEN SUBJECTS, V1840, P2373, DOI 10.1016/j.bbagen.2014.03.006; Adedara IA, 2015, PHARM BIOL, V53, P695, DOI 10.3109/13880209.2014.937504; Behin A, 2004, SEMIN NEUROL, V24, P405, DOI 10.1055/s-2004-861535; BERAL V, 1988, BRIT MED J, V297, P757, DOI 10.1136/bmj.297.6651.757; Castanheira L, 2018, CURR TOP MED CHEM, V18, P1656, DOI 10.2174/1568026618666181115102518; Djague F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237076; Djiogue S, 2018, BEHAV BRAIN FUNCT, V14, DOI 10.1186/s12993-018-0146-7; Duran A, 2003, Neurologia, V18, P389; Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033118; Farahna M, 2017, J ETHNOPHARMACOL, V195, P159, DOI 10.1016/j.jep.2016.11.001; Farombi EO, 2013, J ETHNOPHARMACOL, V146, P536, DOI 10.1016/j.jep.2013.01.018; Farombi EO, 2018, PESTIC BIOCHEM PHYS, V145, P39, DOI 10.1016/j.pestbp.2018.01.002; Guignet M, 2020, NEUROBIOL DIS, V133, DOI 10.1016/j.nbd.2019.03.019; Happold C, 2008, J NEURO-ONCOL, V90, P357, DOI 10.1007/s11060-008-9674-6; Icheku Vincent, 2018, Ayu, V39, P132, DOI 10.4103/ayu.AYU_195_16; Kalaria RN, 2016, BBA-MOL BASIS DIS, V1862, P915, DOI 10.1016/j.bbadis.2016.01.015; Kelsey CR, 2010, NEURO-ONCOLOGY, V12, P145, DOI 10.1093/neuonc/nop040; Khan A, 2019, NEUROTOXICOLOGY, V72, P38, DOI 10.1016/j.neuro.2019.02.002; Kim JH, 2017, INT J MED SCI, V14, P97, DOI 10.7150/ijms.17681; Njamnshi AK, 2020, ADV BIOMED RES-INDIA, V9, DOI 10.4103/abr.abr_62_20; NORTON S, 1976, BRAIN RES, V116, P49, DOI 10.1016/0006-8993(76)90248-1; Okoko T, 2009, FOOD CHEM TOXICOL, V47, P2620, DOI 10.1016/j.fct.2009.07.023; Padurariu M, 2017, INT J VET SCI MED, V5, P98, DOI 10.1016/j.ijvsm.2017.08.003; Pasquier D, 2004, RADIOTHER ONCOL, V72, P1, DOI 10.1016/j.radonc.2004.04.005; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Pinz MP, 2018, BIOMED PHARMACOTHER, V105, P1006, DOI 10.1016/j.biopha.2018.06.049; Seke Etet Paul F, 2017, J Microsc Ultrastruct, V5, P206, DOI 10.1016/j.jmau.2017.05.005; Seke Etet PF, 2017, J COMPLEMENT INTEGR, V14, P2016; Song XY, 2017, PHYSIOL BEHAV, V179, P487, DOI 10.1016/j.physbeh.2017.07.023; Thabet NM, 2018, ARCH PHYSIOL BIOCHEM, V124, P185, DOI 10.1080/13813455.2017.1374978; Vuralli D, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0963-6; WILKINSON GS, 1987, AM J EPIDEMIOL, V125, P231, DOI 10.1093/oxfordjournals.aje.a114523; Zolotov V A, 1982, Med Radiol (Mosk), P53	33	1	1	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	3							fcab170	10.1093/braincomms/fcab170			8	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	XU5TR	WOS:000734327400042	34396117	Green Published, gold			2022-02-06	
J	Asmar, S; Chehab, M; Bible, L; Khurrum, M; Castanon, L; Ditillo, M; Joseph, B				Asmar, Samer; Chehab, Mohamad; Bible, Letitia; Khurrum, Muhammad; Castanon, Lourdes; Ditillo, Michael; Joseph, Bellal			The Emergency Department Systolic Blood Pressure Relationship After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Glasgow Coma Scale; Mortality; Resuscitation protocols	REDEFINING HYPOTENSION; HYPERTENSION; MORTALITY; ASSOCIATION; MANAGEMENT; CRITERIA; IMPACT	Background: Blood pressure alterations in patients with traumatic brain injury (TBI) have been shown to be associated with increased mortality. However, there is paucity of data describing the optimal emergency department (ED) systolic blood pressure (SBP) target during the initial evaluation. The aim of our study was to assess the association between SBP on presentation and mortality in patients with TBI. Methods: We performed a retrospective (2015-2016) review of the American College of Surgeons Trauma Quality Improvement Program database and included all adult (age >= 18y) trauma patients who had TBI on presentation. The outcome measure was in-hospital mortality at different ED-SBP values. A subanalysis by age and TBI severity in accordance with the Glasgow Coma Scale (GCS) was performed (mild (GCS >13), moderate (GCS 9-12), and severe (<= 8)). Multivariate logistic regression analysis was performed. Results: A total of 94,411 adult trauma patients with TBI were included. Mean age was 59 + /- 21y, 62% were male, and median GCS was 15 [14-15]. Mean SBP was 147 +/- 28 mmHg, and overall mortality was 8.6%. The lowest rate of mortality was noticed at ED SBP between 110 and 149 mmHg, whereas the highest mortality was at admission SBP 90 mmHg and SBP 190 mmHg. On regression analysis, SBP between 130 and 149 mmHg (odds ratio = 0.92; P = 0.68) was not associated with increased odds of mortality relative to SBP between 110 and 129 mmHg. On subanalysis based on severity of TBI (mild 80.9%, moderate 5.3%, and severe 13.8%), patients with SBP between 110 and 149 mmHg were less likely to die across all TBI groups. Conclusions: The optimal ED-SBP range for patients with TBI seems to be age and severity dependent. The optimum range might guide clinicians in developing resuscitation protocols for managing patients with TBI. Level of Evidence: Level III Prognostic. (c) 2020 Published by Elsevier Inc.	[Asmar, Samer; Chehab, Mohamad; Bible, Letitia; Khurrum, Muhammad; Castanon, Lourdes; Ditillo, Michael; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ 85721 USA		Joseph, B (corresponding author), Univ Arizona, Div Trauma Crit Care & Emergency Surg, Dept Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Chehab, Mohamad/0000-0002-3890-0691; Bible, Letitia/0000-0002-5417-4028			Barmparas G, 2014, J TRAUMA ACUTE CARE, V77, P592, DOI 10.1097/TA.0000000000000382; Bell J, 2014, HAARBAUER KRUPA J TR; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown JB, 2015, J TRAUMA ACUTE CARE, V78, P352, DOI 10.1097/TA.0000000000000523; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Davison DL, 2012, CHEST, V141, P793, DOI 10.1378/chest.11-0789; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Khalil M, 2014, J AM COLL SURGEONS, V219, pS67, DOI 10.1016/j.jamcollsurg.2014.07.156; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Krishnamoorthy V, 2017, J NEUROSURG ANESTH, V29, P382, DOI 10.1097/ANA.0000000000000370; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Lehmann R, 2009, ARCH SURG-CHICAGO, V144, P853, DOI 10.1001/archsurg.2009.153; Ley EJ, 2011, J TRAUMA, V71, P1689, DOI 10.1097/TA.0b013e31823cc5df; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Oyetunji TA, 2011, ARCH SURG-CHICAGO, V146, P865, DOI 10.1001/archsurg.2011.154; Peterson AB, 2019, URVEILLANCE REPORT T; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Sharma D, 2011, J NEUROSURG ANESTH, V23, P363, DOI 10.1097/01.ana.0000405613.27980.ea; Shibahashi K, 2018, WORLD NEUROSURG, V120, pE667, DOI 10.1016/j.wneu.2018.08.142; Shiozaki T, 2005, CURR HYPERTENS REP, V7, P450, DOI 10.1007/s11906-005-0040-1; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	33	1	1	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2021	257						493	500		10.1016/j.jss.2020.07.062			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PF5MA	WOS:000599097100053	32916502				2022-02-06	
J	Ataizi, ZS; Ozkoc, M; Kanbak, G; Karimkhani, H; Burukoglu Donmez, D; Ustunisik, N; Ozturk, B				Ataizi, Zeki Serdar; Ozkoc, Mete; Kanbak, Gungor; Karimkhani, Hadi; Burukoglu Donmez, Dilek; Ustunisik, Novber; Ozturk, Buket			Evaluation of the Neuroprotective Role of Boric Acid in Preventing Traumatic Brain Injury-Mediated Oxidative Stress	TURKISH NEUROSURGERY			English	Article						Boric acid; Catalase; Malondialdehyde; Oxidative stress; Rat; Traumatic brain injury	LIPID-PEROXIDATION; DIETARY BORON; ANTIOXIDANT; EDEMA; ASSAY	AIM: To investigate the possible neuroprotective effect of boric acid (BA) by examining the changes in catalase (CAT) activity and levels of CAT and malondialdehyde (MDA) in brain tissues from rats with closed head trauma. MATERIAL and METHODS: The study consisted of three groups: control, traumatic brain injury (TBI) and TBI + BA. Animals in the control and TBI groups received saline, while animals in the TBI + BA group received BA through daily oral gavage, for 14 days prior to TBI was performed using the modified Marmarou impact acceleration model. After 24 hours, animals were euthanized, and brain tissue obtained to measure the levels of MDA and to assess the activity of CAT. RESULTS: MDA levels and CAT activity were significantly higher in the TBI group versus the control group. However, they were significantly lower in the TBI + BA group compared to TBI alone. Similarly, edema and necrotic neurons were observed in the TBI group, but not in the control or TBI + BA groups. CONCLUSION: Based on biochemical and histopathological evidence, we determined that TBI induced lipid peroxidation and oxidative stress were inhibited by pre-treatment with BA.	[Ataizi, Zeki Serdar] Eskisehir Yunus Emre State Hosp, Dept Neurosurg, Eskisehir, Turkey; [Ozkoc, Mete; Kanbak, Gungor; Ustunisik, Novber] Eskisehir Osmangazi Univ, Grad Sch Hlth Sci, Dept Med Biochem, Eskisehir, Turkey; [Karimkhani, Hadi] Istanbul Medipol Univ, Grad Sch Hlth Sci, Dept Med Biochem, Istanbul, Turkey; [Burukoglu Donmez, Dilek] Eskisehir Osmangazi Univ, Grad Sch Hlth Sci, Dept Med Histol & Embryol, Eskisehir, Turkey; [Ozturk, Buket] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Biol, Eskisehir, Turkey		Ataizi, ZS (corresponding author), Eskisehir Yunus Emre State Hosp, Dept Neurosurg, Eskisehir, Turkey.	sataizi@gmail.com			Turkish Neurosurgical Society	Preparation for publication of this article is partly supported by Turkish Neurosurgical Society.	Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Beutler E, 1973, RED CELL METABOLISM, V3th; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brocardo PS, 2011, BRAIN RES REV, V67, P209, DOI 10.1016/j.brainresrev.2011.02.001; Bryan J, 1983, INTRO NEUROSURGERY, V4th; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; CLASEN RA, 1974, J NEUROSURG, V41, P576, DOI 10.3171/jns.1974.41.5.0576; COHEN G, 1984, NEUROTOXICOLOGY, V5, P77; Colak S, 2011, TOXICOL IND HEALTH, V27, P700, DOI 10.1177/0748233710395349; DeKosky ST, 2004, J NEUROTRAUM, V21, P491, DOI 10.1089/089771504774129838; Dohi K, 2007, ANTIOXID REDOX SIGN, V9, P281, DOI 10.1089/ars.2007.9.281; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Huh PW, 2000, EUR J PHARMACOL, V389, P79, DOI 10.1016/S0014-2999(99)00768-2; HUNT CD, 1994, ENVIRON HEALTH PERSP, V102, P35, DOI 10.2307/3431960; Hunt CD, 1999, J TRACE ELEM EXP MED, V12, P221, DOI 10.1002/(SICI)1520-670X(1999)12:3&lt;221::AID-JTRA6&gt;3.0.CO;2-X; Hunt CD, 2005, ENCY DIETARY SUPPLEM, V1st, P55; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Ince S, 2012, DRUG CHEM TOXICOL, V35, P285, DOI 10.3109/01480545.2011.607825; Ince S, 2010, J TRACE ELEM MED BIO, V24, P161, DOI 10.1016/j.jtemb.2010.01.003; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Long DM, 1972, STEROIDS BRAIN EDEMA, P87; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NIELSEN FH, 1991, FASEB J, V5, P2661, DOI 10.1096/fasebj.5.12.1916090; Nielsen FH, 2008, NUTR REV, V66, P183, DOI 10.1111/j.1753-4887.2008.00023.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pawa S, 2006, CHEM-BIOL INTERACT, V160, P89, DOI 10.1016/j.cbi.2005.12.002; Petty MA, 1996, EUR J PHARMACOL, V307, P149, DOI 10.1016/0014-2999(96)00235-X; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; SIES H, 1992, ANN NY ACAD SCI, V669, P7, DOI 10.1111/j.1749-6632.1992.tb17085.x; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-2; Sogut I, 2015, EXP THER MED, V9, P1023, DOI 10.3892/etm.2014.2164; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; SUN Y, 1988, CLIN CHEM, V34, P497; Tang J, 2016, BIOL TRACE ELEM RES, V170, P208, DOI 10.1007/s12011-015-0428-y; WEIR RJ, 1972, TOXICOL APPL PHARM, V23, P351, DOI 10.1016/0041-008X(72)90037-3; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014	42	1	1	1	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2021	31	4					493	499		10.5137/1019-5149.JTN.25692-18.4			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TI4WM	WOS:000672802600003					2022-02-06	
J	Bayir, O; Karagoz, T; Alpaslan Pinarli, F; Saribas, GS; Ozogul, C; Keseroglu, K; Saylam, G; Cadalli Tatar, E; Karahan, S; Ocal, B; Korkmaz, MH				Bayir, Omer; Karagoz, Tugba; Alpaslan Pinarli, Ferda; Saribas, Gulistan Sanem; Ozogul, Candan; Keseroglu, Kemal; Saylam, Guleser; Cadalli Tatar, Emel; Karahan, Sevilay; Ocal, Bulent; Korkmaz, Mehmet Hakan			Impact of fetal brain tissue derived mesenchymal stem cell and fibrin glue on facial nerve crash injury	TURKISH JOURNAL OF MEDICAL SCIENCES			English	Article						Facial nerve; facial nerve palsy; trauma; stem cell implantation; fetal brain tissue derived mesenchymal stem cells	PLATELET-RICH PLASMA; BONE-MARROW; REGENERATION; RECONSTRUCTION; RECOVERY; THERAPY	Background/aim: To evaluate the clinical and histopathological effects of fetal brain tissue derived mesenchymal stem cells (FBTMSC) and fibrin glue (FG) on the facial nerve (FN) regeneration in rats with traumatic FN injury. Materials and methods: Twenty-eight Sprague Dawley rats were included in the study and divided into 4 groups. Traumatic FN injury (FP) was created by a surgical clamp compression to the main trunk of left FN in all groups. In the control group (group 1) no treatment was applied, in group 2 (FBTMSC group) 2 x 10(6) FBTMSC was injected, in group 3 (FG group) only FG was applied, in group 4 (FBTMSC and FG groups) both FBTMSC and FG were applied to the injured section of the nerve. The FN functions were evaluated clinically, immediately after the procedure and at 3rd, 5th, and 8th weeks postoperatively. The FNs of all subjects were excised after the 8th week; then the rats were sacrificed. The presence of stem cells in the injured zone was assessed using bromo-deoxyuridine (BrdU), and apoptosis was determined by the TUNEL method. Results: After the damage, total FP was observed in all subjects. Statistically significant functional improvement was observed in group 4 compared to all other groups (P < 0.005). TUNEL-positive cell count was statistically significantly higher in the control group than the other groups (P < 0.001). TUNEL-positive cell count was statistically significantly lower in group 4 than the other groups. The proportion of BrdU-stained cells in group 4 (5%) was higher than group 2 (2%). Conclusion: Clinically and histopathologically FBTMSC applied with FG may play a promising role as a regenerative treatment in posttraumatic FP.	[Bayir, Omer; Keseroglu, Kemal; Saylam, Guleser; Cadalli Tatar, Emel; Ocal, Bulent] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept Otolaryngol Head & Neck Surg, Ankara, Turkey; [Karagoz, Tugba] Kaman State Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Kirsehir, Turkey; [Alpaslan Pinarli, Ferda] Myogen Lab & Hlth Serv, Ankara, Turkey; [Saribas, Gulistan Sanem] Ahi Evran Univ, Fac Med, Dept Histol & Embryol, Kirsehir, Turkey; [Ozogul, Candan] Univ Kyrenia, Fac Med, Dept Histol & Embryol, Girne, Northern Cyprus, Turkey; [Karahan, Sevilay] Hacettepe Univ, Fac Med, Dept Biostat, Ankara, Turkey; [Korkmaz, Mehmet Hakan] Yhldhrhm Beyazht Univ, Fac Med, Dept Otolaryngol Head & Neck Surg, Ankara, Turkey		Karagoz, T (corresponding author), Kaman State Hosp, Dept Otorhinolaryngol & Head & Neck Surg, Kirsehir, Turkey.	tugbakrgz@yahoo.com		Bayir, Omer/0000-0001-9445-6129			Aggarwal SK, 2012, J NEUROL SURG PART B, V73, P245, DOI 10.1055/s-0032-1312716; Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102; Angelov DN, 2005, ADV ANAT EMBRYOL CEL, V180, P1; Batioglu-Karaaltin A, 2016, HEAD NECK-J SCI SPEC, V38, pE2011, DOI 10.1002/hed.24371; Cho HH, 2010, LARYNGOSCOPE, V120, P907, DOI 10.1002/lary.20860; Lucena EED, 2014, J ORAL MAXIL SURG, V72, P1001, DOI 10.1016/j.joms.2013.11.006; ELLIS JC, 1985, ARCH OTOLARYNGOL, V111, P781; Faria Simone Damasceno de, 2006, Rev. Bras. Otorrinolaringol., V72, P341, DOI 10.1590/S0034-72992006000300008; Farrag TY, 2007, LARYNGOSCOPE, V117, P157, DOI 10.1097/01.mlg.0000249726.98801.77; Fathi SS, 2017, WORLD J STEM CELLS, V9, P144, DOI 10.4252/wjsc.v9.i9.144; GUNTINASLICHIUS O, 1994, EUR ARCH OTO-RHINO-L, V251, P410; Guo BF, 2009, OTOLARYNG HEAD NECK, V140, P159, DOI 10.1016/j.otohns.2008.10.039; Kerrebijn JDF, 1998, J OTOLARYNGOL, V27, P183; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Lerner MZ, 2014, LARYNGOSCOPE, V124, P2555, DOI 10.1002/lary.24798; Li Y, 2017, NEURAL REGEN RES, V12, P1544, DOI 10.4103/1673-5374.215267; Ma FK, 2017, ACTA BIOMATER, V50, P188, DOI 10.1016/j.actbio.2016.11.064; Matthes SM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/573169; Mattox D.E., 2015, CUMMINGS OTOLARYNGOL, V6th ed., P2617; Nelke KH, 2015, POSTEP HIG MED DOSW, V69, P996; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Reichenberger MA, 2016, MICROSURG, V36, P491, DOI 10.1002/micr.30018; Sameem M, 2011, PLAST RECONSTR SURG, V127, P2381, DOI 10.1097/PRS.0b013e3182131cf5; Sasaki R, 2011, J TISSUE ENG REGEN M, V5, P823, DOI 10.1002/term.387; Satar B, 2009, LARYNGOSCOPE, V119, P2221, DOI 10.1002/lary.20610; Schultz SS, 2005, CURR DRUG TARGETS, V6, P63, DOI 10.2174/1389450053345046; Shi Y, 2009, ACTA OTO-LARYNGOL, V129, P906, DOI 10.1080/00016480802468153; Tremp M, 2018, MUSCLE NERVE, V58, P566, DOI 10.1002/mus.26188; Vakharia KT, 2011, OTOLARYNG HEAD NECK, V144, P53, DOI 10.1177/0194599810390892; Volk GF, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-25; Wang Qinying, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P612; Wang TV, 2016, CURR OPIN OTOLARYNGO, V24, P285, DOI 10.1097/MOO.0000000000000292; Wang XM, 2011, BRAIN RES, V1383, P71, DOI 10.1016/j.brainres.2011.01.098; Yamamoto T, 2016, CELL TRANSPLANT, V25, P183, DOI 10.3727/096368915X688074; Zhang H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-67	37	1	1	5	6	TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL TURKEY	ANKARA	ATATURK BULVARI NO 221, KAVAKLIDERE, ANKARA, 00000, TURKEY	1300-0144	1303-6165		TURK J MED SCI	Turk. J. Med. Sci.		2021	51	3					1481	1490		10.3906/sag-2004-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TB9IJ	WOS:000668257500010	33244948	Green Published			2022-02-06	
J	Belchev, Z; Boulos, ME; Rybkina, J; Johns, K; Jeffay, E; Colella, B; Ozubko, J; Bray, MJC; Di Genova, N; Levi, A; Changoor, A; Worthington, T; Gilboa, A; Green, R				Belchev, Zorry; Boulos, Mary Ellene; Rybkina, Julia; Johns, Kadeen; Jeffay, Eliyas; Colella, Brenda; Ozubko, Jason; Bray, Michael Johnathan Charles; Di Genova, Nicholas; Levi, Adina; Changoor, Alana; Worthington, Thomas; Gilboa, Asaf; Green, Robin			Remotely delivered environmental enrichment intervention for traumatic brain injury: Study protocol for a randomised controlled trial	BMJ OPEN			English	Article						rehabilitation medicine; neurological injury; therapeutics		Introduction Individuals with moderate-severe traumatic brain injury (m-sTBI) experience progressive brain and behavioural declines in the chronic stages of injury. Longitudinal studies found that a majority of patients with m-sTBI exhibit significant hippocampal atrophy from 5 to 12 months post-injury, associated with decreased cognitive environmental enrichment (EE). Encouragingly, engaging in EE has been shown to lead to neural improvements, suggesting it is a promising avenue for offsetting hippocampal neurodegeneration in m-sTBI. Allocentric spatial navigation (ie, flexible, bird's eye view approach), is a good candidate for EE in m-sTBI because it is associated with hippocampal activation and reduced ageing-related volume loss. Efficacy of EE requires intensive daily training, prohibitive within most current health delivery systems. The present protocol is a novel, remotely delivered and self-administered intervention designed to harness principles from EE and allocentric spatial navigation to offset hippocampal atrophy and potentially improve hippocampal functions such as navigation and memory for patients with m-sTBI. Methods and analysis Eighty-four participants with chronic m-sTBI are being recruited from an urban rehabilitation hospital and randomised into a 16-week intervention (5 hours/week; total: 80 hours) of either targeted spatial navigation or an active control group. The spatial navigation group engages in structured exploration of different cities using Google Street View that includes daily navigation challenges. The active control group watches and answers subjective questions about educational videos. Following a brief orientation, participants remotely self-administer the intervention on their home computer. In addition to feasibility and compliance measures, clinical and experimental cognitive measures as well as MRI scan data are collected pre-intervention and post-intervention to determine behavioural and neural efficacy. Ethics and dissemination Ethics approval has been obtained from ethics boards at the University Health Network and University of Toronto. Findings will be presented at academic conferences and submitted to peer-reviewed journals.	[Belchev, Zorry; Jeffay, Eliyas; Gilboa, Asaf] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Belchev, Zorry; Jeffay, Eliyas; Levi, Adina; Gilboa, Asaf] Rotman Res Inst Baycrest, Toronto, ON, Canada; [Belchev, Zorry; Boulos, Mary Ellene; Rybkina, Julia; Johns, Kadeen; Jeffay, Eliyas; Colella, Brenda; Bray, Michael Johnathan Charles; Di Genova, Nicholas; Changoor, Alana; Worthington, Thomas; Gilboa, Asaf; Green, Robin] Toronto Rehabil Inst, KITE, Toronto, ON, Canada; [Boulos, Mary Ellene; Rybkina, Julia; Bray, Michael Johnathan Charles] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Ozubko, Jason] SUNY Coll Geneseo, Dept Psychol, Geneseo, NY 14454 USA; [Di Genova, Nicholas] McMaster Univ, Dept Comp & Software, Hamilton, ON, Canada; [Levi, Adina; Worthington, Thomas] York Univ, Dept Psychol, Toronto, ON, Canada; [Changoor, Alana] McMaster Univ, Fac Hlth Sci, Global Hlth Program, Hamilton, ON, Canada; [Green, Robin] Univ Toronto, Dept Psychiat, Toronto, ON, Canada		Belchev, Z (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.; Belchev, Z (corresponding author), Rotman Res Inst Baycrest, Toronto, ON, Canada.; Belchev, Z (corresponding author), Toronto Rehabil Inst, KITE, Toronto, ON, Canada.	zorrybelchev@gmail.com	Boulos, Mary Ellene/AAL-9435-2020; Bray, Michael Johnathan Charles/AAL-8925-2020	Boulos, Mary Ellene/0000-0001-5046-598X; Bray, Michael Johnathan Charles/0000-0003-4650-1313; Belchev, Zorry/0000-0002-9361-0865; Rybkina, Julia/0000-0001-5996-3512	Ontario Neurotrauma Foundation (ONF) [2017-ABI-INFRA-1035]; Canadian Centre for Aging & Brain Health Innovation (CABHI); Canadian Traumatic Brain Injury Research Consortium (CTRC); Branch Out Neurological Foundation; Canada Research ChairsCanada Research ChairsCGIAR [950-230647]	This work is supported and funded by the Ontario Neurotrauma Foundation (ONF; 2017-ABI-INFRA-1035), the Canadian Centre for Aging & Brain Health Innovation (CABHI), the Canadian Traumatic Brain Injury Research Consortium (CTRC), the Branch Out Neurological Foundation and the Canada Research Chairs (950-230647).	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; [Anonymous], 2010, J PHARMACOL PHARMACO, V1, P42; Beck A.T., 1996, MANUAL BECK DEPRESSI, DOI DOI 10.1037/T00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brunec IK, 2018, CURR BIOL, V28, P2129, DOI 10.1016/j.cub.2018.05.016; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council, TRIC POL STAT ETH CO; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Changoor A, 2020, NEUROLOGY, V94; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Corrow JC, 2016, CORTEX, V76, P89, DOI 10.1016/j.cortex.2016.01.003; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Creswell J.W., 2003, HDB MIXED METHODS SO, P209; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; GRAHAM DI, 2006, ADAMS GRAHAMS INTRO; Green REA, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00615; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Hirshhorn M, 2012, HIPPOCAMPUS, V22, P842, DOI 10.1002/hipo.20944; Howard LR, 2014, CURR BIOL, V24, P1331, DOI 10.1016/j.cub.2014.05.001; Iaria G, 2003, J NEUROSCI, V23, P5945; International Q, 1999, NVIVO QUAL DAT AN SO; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Konishi K, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00001; Lebowitz MS, 2012, J REHABIL RES DEV, V49, P1547, DOI 10.1682/JRRD.2011.07.0133; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Lithfous S, 2013, AGEING RES REV, V12, P201, DOI 10.1016/j.arr.2012.04.007; Lovden M, 2011, CEREB CORTEX, V21, P1435, DOI 10.1093/cercor/bhq230; Lovden M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.013; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Moreno-Jimenez EP, 2019, NAT MED, V25, P554, DOI 10.1038/s41591-019-0375-9; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; O'Neil-Pirozzi TM, 2016, BRAIN INJURY, V30, P1617, DOI 10.1080/02699052.2016.1199906; Ohnishi T, 2006, NEUROSCI RES, V55, P361, DOI 10.1016/j.neures.2006.04.009; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Persson J, 2013, BEHAV BRAIN RES, V256, P219, DOI 10.1016/j.bbr.2013.07.050; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Rey A., 1959, EXAMEN CLIN PSYCHOL, V2 ed; Rey A, 1958, LEXAMEN CLINIQUE PSY; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenbaum RS, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00196; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Scholz J, 2015, NEUROIMAGE, V109, P190, DOI 10.1016/j.neuroimage.2015.01.027; Sharma B, 2017, DISABIL REHABIL, V39, P1380, DOI 10.1080/09638288.2016.1195453; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Smith A., 1982, SYMBOL DIGITS MODALI; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Stark SM, 2013, NEUROPSYCHOLOGIA, V51, P2442, DOI 10.1016/j.neuropsychologia.2012.12.014; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tomaszczyk JC, 2018, J REHABIL MED, V50, P519, DOI 10.2340/16501977-2344; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Vieweg P, 2019, HIPPOCAMPUS, V29, P340, DOI 10.1002/hipo.23030; Vieweg P, 2015, CORTEX, V64, P343, DOI 10.1016/j.cortex.2014.12.007; Waller D, 2006, J EXP PSYCHOL LEARN, V32, P867, DOI 10.1037/0278-7393.32.4.867; Wechsler D, 1981, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; West GL, 2017, CURR DIR PSYCHOL SCI, V26, P152, DOI 10.1177/0963721416687342; WHO, 2015, WORLD HLTH STAT 2015; Wiener JM, 2020, BEHAV RES METHODS, V52, P630, DOI 10.3758/s13428-019-01264-8; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	73	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	2							e039767	10.1136/bmjopen-2020-039767			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QK8LG	WOS:000620630800017	33574141	Green Published, gold			2022-02-06	
J	Bodine, AJ; Heinemann, AW; Carpenter, J; Taylor, SM; Hansen, P; Lieber, RL; Sliwa, J				Bodine, Andrew J.; Heinemann, Allen W.; Carpenter, Julia; Taylor, Sally M.; Hansen, Piper; Lieber, Richard L.; Sliwa, James			Development of a Multidimensional, Multigroup Measure of Self-Care for Inpatient Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Outcome assessment; Health care; Psychometrics; Rehabilitation; Self care		Objective: To develop and evaluate a measure of clinician-observed and patient-performed self-care function for use during inpatient rehabilitation. Design: Retrospective analysis of self-care assessments collected by therapists using confirmatory factor analysis (CFA) followed by multidimensional item response theory (MIRT). Setting: Freestanding inpatient rehabilitation hospital in the Midwestern United States. Participants: Inpatients (N=7719) with stroke, traumatic brain injury, spinal cord injury, neurologic disorders, and musculoskeletal conditions. Interventions: Not applicable Main Outcome Measures: A total of 19 clinician-selected self-care measures including the FIM and patient-performed, clinician-rated measures of balance, upper extremity function, strength, changing body position, and swallowing. Clinicians completed assessments on admission and at least 1 interim assessment. Results: CFA was completed for 3 patient groups defined by their highest level of balance (sitting, standing, walking). We reduced the number of items by 47.5% while maintaining acceptable internal consistency; unidimensionality within each item set required development of testlets. A recursive analysis defined a self-care measure with sensitivity (Cohen d(max_min) =1.13; Cohen d(last_first.)=0.91) greater than the FIM self-care items (d(max_min.)=0.94; d(last_first .)=0.83). The CFA models provided good to acceptable fit (root mean square error of approximations 0.030.06). Most patients with admission FIM self-care ratings of total assistance (88%, 297 of 338) made improvements on the MIRT self-care measure that were undetected by the FIM; the FIM detected no change for 26% of these patients (78 of 297). The remaining 74% (219 of 297) improved on the MIRT-based measure an average of 14 days earlier than was detected by the FIM. Conclusions: This MIRT self-care measure possesses measurement properties that are superior to the FIM, particularly for patients near its floor or ceiling. Methods assure accommodation for multidimensionality and high levels of sensitivity. This self-care measure has the potential to improve monitoring of self-care and manage therapy effectively during inpatient rehabilitation. Archives of Physical Medicine and Rehabilitation 2021;102:97-105 (c) 2020 by the American Congress of Rehabilitation Medicine	[Bodine, Andrew J.] Shirley Ryan AbilityLab, Outcomes Management Syst & Analyt, Chicago, IL USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Carpenter, Julia; Taylor, Sally M.; Lieber, Richard L.; Sliwa, James] Shirley Ryan AbilityLab, Chicago, IL USA; [Taylor, Sally M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Hansen, Piper] Shirley Ryan AbilityLab, Staff Dev, Chicago, IL USA; [Lieber, Richard L.] Northwestern Univ, Physiol & Biomed Engn, Chicago, IL 60611 USA		Bodine, AJ (corresponding author), 355 E Erie St,Suite 26 North, Chicago, IL 60611 USA.	abodine@sralab.org	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326			Beninato M, 2016, PHYS THER, V96, P456, DOI 10.2522/ptj.20150167; BERG K, 1989, Physiotherapy Canada, V41, P304; Bergego C., 1995, Annales de Readaptation et de Medecine Physique, V38, P183, DOI 10.1016/0168-6054(96)89317-2; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cai L, 2010, PSYCHOMETRIKA, V75, P33, DOI 10.1007/s11336-009-9136-x; Canny ML, 2009, AM J OCCUP THER, V63, P506, DOI 10.5014/ajot.63.4.506; Centers for Medicare and Medicaid Services, INP REH FAC PSS; Centers for Medicare and Medicaid Services, CMS1671F; Centers for Medicare and Medicaid Services, IRF PAI IRF QRP MAN; Chalmers RP, 2016, J STAT SOFTW, V71, DOI 10.18637/jss.v071.i05; Chen HF, 2012, ARCH PHYS MED REHAB, V93, P1039, DOI 10.1016/j.apmr.2011.11.033; Chen WH, 1997, J EDUC BEHAV STAT, V22, P265, DOI 10.3102/10769986022003265; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; D'Aquila MA, 2004, CLIN REHABIL, V18, P102, DOI 10.1191/0269215504cr709oa; Dungan S, 2019, AM J SPEECH-LANG PAT, V28, P424, DOI 10.1044/2018_AJSLP-18-0072; Glas CAW, 2005, MML EAP ESTIMATION T; Gorman SL, 2014, REHABIL RES PRACT, V2014, DOI 10.1155/2014/593280; Gorman SL, 2010, J NEUROL PHYS THER, V34, P150, DOI 10.1097/NPT.0b013e3181f0065f; Hambleton RK., 1991, FUNDAMENTALS ITEM RE; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hsieh CL, 1998, AGE AGEING, V27, P107, DOI 10.1093/ageing/27.2.107; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Keith R A, 1987, Adv Clin Rehabil, V1, P6; La Porta F, 2012, ARCH PHYS MED REHAB, V93, P1209, DOI 10.1016/j.apmr.2012.02.020; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Mann G., 2002, MASA MANN ASSESSMENT; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; MATHIOWETZ V, 1985, OCCUP THER J RES, V5, P24, DOI 10.1177/153944928500500102; Matsumoto J, 2001, NEUROLOGY, V57, P1876, DOI 10.1212/WNL.57.10.1876; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; Muthen B. O, 2017, MPLUS USERS GUIDE VE; National Quality Forum, MEAS EV CRIT; Nijland R, 2010, J REHABIL MED, V42, P694, DOI 10.2340/16501977-0560; O'Neil KH, 1999, DYSPHAGIA, V14, P139, DOI 10.1007/PL00009595; PROMIS, INSTR DEV VAL SCI ST; Rehabilitation Institute of Chicago, 1998, FUNCTIONAL ASSESSMEN; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; STOCKING ML, 1983, APPL PSYCH MEAS, V7, P201, DOI 10.1177/014662168300700208; Torchiano M, 2017, PACKAGE EFFSIZE EFFI; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; Wang YC, 2011, J HAND THER, V24, P313, DOI 10.1016/j.jht.2011.05.001; Weeks JP, 2010, J STAT SOFTW, V35, P1; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	46	1	1	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2021	102	1					97	105		10.1016/j.apmr.2020.08.021			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	QA5ST	WOS:000613505800012	33035514				2022-02-06	
J	Brunner, M; Hemsley, B; Togher, L; Dann, S; Palmer, S				Brunner, Melissa; Hemsley, Bronwyn; Togher, Leanne; Dann, Stephen; Palmer, Stuart			Social Media and People With Traumatic Brain Injury: A Metasynthesis of Research Informing a Framework for Rehabilitation Clinical Practice, Policy, and Training	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							COMMUNICATION; PARTICIPATION	Purpose: The aim of the study was to investigate the experiences of people with traumatic brain injury (TBI) and rehabilitation professionals in use of social media after TBI. Design: Metasynthesis of a multilevel mixed-methods research design was used in the study. Method: A qualitative metasynthesis of (a) evidence in the literature regarding the use of communication technologies and social media after TBI, (b) Twitter data and network analysis, (c) interviews with people with TBI (n = 13), (d) focus groups with TBI rehabilitation professionals (n = 11), and (e) a review of current guidance on safe use of social media was conducted. Results: People with TBI adopt a trial-and-error approach to using social media. Their meaningful use and a sense of connection enable them to develop social media mastery. TBI rehabilitation professionals' concerns regarding potential risks associated with using social media might lead them to restrict social media use during rehabilitation. Conclusions: Access to proactive training in social media use and a supportive network of rehabilitation professionals, family, and friends can enable people with TBI to develop social media mastery through working collaboratively on social media goals. This metasynthesis of research culminates in an evidence-based protocol for assessing and supporting a person with TBI's social media goals to guide clinical practice and future research in the field.	[Brunner, Melissa; Hemsley, Bronwyn] Univ Technol Sydney, Grad Sch Hlth, Dept Speech Pathol, Ultimo, NSW, Australia; [Brunner, Melissa; Togher, Leanne] Univ Sydney, Fac Med & Hlth, Sydney Sch Hlth Sci, Dept Speech Pathol, Sydney, NSW, Australia; [Hemsley, Bronwyn] Univ Newcastle, Fac Educ & Arts, Callaghan, NSW, Australia; [Dann, Stephen] Australian Natl Univ, Coll Business & Econ, Canberra, ACT, Australia; [Palmer, Stuart] Univ Melbourne, Melbourne Ctr Study Higher Educ, Melbourne, Vic, Australia; [Palmer, Stuart] WorkSafe Victoria, Geelong, Vic, Australia		Brunner, M (corresponding author), Univ Technol Sydney, Grad Sch Hlth, Dept Speech Pathol, Ultimo, NSW, Australia.; Brunner, M (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney Sch Hlth Sci, Dept Speech Pathol, Sydney, NSW, Australia.	melissa.brunner@sydney.edu.au	Dann, Stephen/H-2505-2011; Hemsley, Bronwyn/A-7427-2010	Dann, Stephen/0000-0001-7946-3494; Palmer, Stuart/0000-0002-2517-0597; Hemsley, Bronwyn/0000-0002-6255-3140; Brunner, Melissa/0000-0001-6823-5189	Australian GovernmentAustralian GovernmentCGIAR; Australian Research CouncilAustralian Research Council; University of Newcastle; University of Technology Sydney	This research was funded through an Australian Government Research Training Program scholarship (first author) and a Discovery Early Career Research Award from the Australian Research Council (second author). The authors would like to acknowledge and thank the participants for their time and for sharing their experiences and University A [the University of Newcastle] and University B [the University of Technology Sydney] for administration of funding and support in the conduction of this research.	Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Braun V., 2019, HDB RES METHODS HLTH, P843, DOI [10.1007/978-981-10-2779-6_103-1, DOI 10.1007/978-981-10-5251-4_103]; Brunner M., 2019, P HAW INT C SYST SCI; Brunner M, 2020, BRAIN IMPAIR, V21, P1, DOI 10.1017/BrImp.2019.12; Brunner M, 2021, DISABIL REHABIL, V43, P1955, DOI 10.1080/09638288.2019.1685604; Brunner M, 2019, INT J LANG COMM DIS, V54, P221, DOI 10.1111/1460-6984.12405; Brunner M, 2018, BRAIN INJURY, V32, P49, DOI 10.1080/02699052.2017.1403047; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Callaway L, 2016, AUST OCCUP THER J, V63, P143, DOI 10.1111/1440-1630.12284; Creswell J. W., 2018, RES DESIGN QUALITATI; Dann S., 2015, MAXIMIZING COMMERCE, P313; Defense Health Agency, 2019, COGN REH SERV MEMB V; Doig E, 2015, SCAND J OCCUP THER, V22, P302, DOI 10.3109/11038128.2015.1017530; eSafety Commissioner, 2020, PROT VOIC RISK ONL R; eSafety Commissioner, 2019, ESAFETY INF; eSafety Commissioner, 2019, ONL SAF BAS; Flynn MA, 2019, BRAIN INJURY, V33, P1097, DOI 10.1080/02699052.2019.1616112; Forsman M., 2017, STEREOTYPES IMAGES B, P193; Hayes H, 2013, TRENDS ISS CRIME CRI, P1; Headley MG, 2020, J MIX METHOD RES, V14, P145, DOI 10.1177/1558689819844417; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Ketchum JM, 2020, J HEAD TRAUMA REHAB, V35, P254, DOI 10.1097/HTR.0000000000000566; Levack, 2015, REHABILITATION GOAL, P3; Magliano L, 1998, SOC PSYCH PSYCH EPID, V33, P405, DOI 10.1007/s001270050073; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Morgan DL, 2007, J MIX METHOD RES, V1, P48, DOI 10.1177/2345678906292462; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pew Research Center, 2017, ONLINE HARASSMENT 20; Prescott S, 2018, DISABIL REHABIL, V40, P2388, DOI 10.1080/09638288.2017.1336644; Scolere L, 2018, SOC MEDIA SOC, V4, DOI 10.1177/2056305118784768; Sensis, 2017, SENS SOC MED REP 201; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Taubner H, 2020, APHASIOLOGY, V34, P300, DOI 10.1080/02687038.2019.1594151; Togher L., 2010, 40 CLIN APH C ISL PA; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tracy S.J., 2013, QUALITATIVE RES METH; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M., 2006, BRAIN IMPAIR, V7, P246, DOI [10.1375/brim.7.3.246, DOI 10.1375/BRIM.7.3.246]; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	44	1	1	2	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	JAN	2021	30	1					19	33		10.1044/2020_AJSLP-20-00211			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	QB4IX	WOS:000614105200002	33332986				2022-02-06	
J	Bullock-Saxton, J; Lehn, A; Laakso, EL				Bullock-Saxton, Joanne; Lehn, Alexander; Laakso, E-Liisa			Exploring the Effect of Combined Transcranial and Intra-Oral Photobiomodulation Therapy Over a Four-Week Period on Physical and Cognitive Outcome Measures for People with Parkinson's Disease: A Randomized Double-Blind Placebo-Controlled Pilot Study	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Cognition; Parkinson's disease; photobiomodulation; physical functional performance	TRAUMATIC BRAIN-INJURY; LIGHT; PERFORMANCE; NEUROPROTECTION; CONNECTIVITY; STIMULATION; PENETRATION; RELIABILITY; LASERS; 810NM	Background: Neuroprotection against Parkinson's disease degeneration by photobiomodulation has been reported in animal models but no true placebo-controlled human studies have been published. Objective: To understand if photobiomodulation therapy can produce clinically significant differences in physical performance measures in people with Parkinson's disease; and what frequency of treatment is necessary to initiate clinical change. Methods: In a participant and assessor-blinded, randomized, placebo-controlled pilot study, 22 participants received either sham and/or active laser photobiomodulation (904 nm, 60 mW/diode, 50 Hz) for 33 s to each of 21 points at the cranium and intra-orally, on one, two or three times/week for 4 weeks. Two treatment phases were separated by a 4-week wash-out (Phase 2). Upper and lower limb physical outcome measures were assessed before and after each treatment phase. The Montreal Cognitive Assessment was evaluated prior to treatment Phase 1, and at the end of treatment Phase 3. Results: Montreal Cognitive Assessment remained stable between start and end of study. No measures demonstrated statistically significant changes. With regular treatment, the spiral (writing) test and the dynamic step test were most sensitive to change in a positive direction; and the 9-hole peg test demonstrated a minimum clinically important difference worthy of further investigation in a larger, adequately powered clinical trial. A placebo effect was noted. Conclusion: The results support the notion that combined transcranial and intra-oral photobiomodulation therapy needs to be applied at least 2 to 3 times per week for at least four weeks before some improvement in outcome measures becomes evident. Longer courses of treatment may be required.	[Bullock-Saxton, Joanne] Act Rehabil Physiotherapy, Brisbane, Qld, Australia; [Lehn, Alexander] Princess Alexandra Hosp, Dept Neurol, Brisbane, Qld, Australia; [Lehn, Alexander] Univ Queensland, Princess Alexandra Hosp, Clin Sch, Brisbane, Qld, Australia; [Laakso, E-Liisa] Brisbane & Menzies Hlth Inst, Mater Res Inst, Brisbane, Qld, Australia		Bullock-Saxton, J (corresponding author), Mater Med Ctr, Act Rehabil Physiotherapy, 293 Vulture St, South Brisbane, Qld 4001, Australia.	joanne.bullock-saxton@activerehab.com.au			Cromwell Property Group Foundation; Active Rehabilitation Foundation	Cromwell Property Group Foundation and Dolben Inc. for philanthropic funding to support clinical backfill of researcher time.; Active Rehabilitation Foundation for in-kind administrative support of the project.; Mr. John Fitzgerald and staff of Active Rehabilitation Physiotherapy Pty Ltd for in kind support of team members and resources, use of facilities and administrative assistance.; Dr. Ann Liebert and Dr. Dan Johnstone for valuable ongoing discussions regarding potential dosing parameters; in addition, we wish to acknowledge the work in animal models of Profs. Jonathan Stone and John Mitrofanis that assisted the protocol development for this project.; Irradia Australia for assistance in provision of intra-oral and placebo devices.; Authors' disclosures available online (https://www.j-alz.com/manuscript-disclosures/21-0170r1).	Abbruzzese G, 2016, PARKINSONISM RELAT D, V22, pS60, DOI 10.1016/j.parkreldis.2015.09.005; Anders JJ, 2016, PHOTOMED LASER SURG, V34, P418, DOI 10.1089/pho.2016.4137; Artusi CA, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7800; Bennell K, 2011, ARTHRIT CARE RES, V63, pS350, DOI 10.1002/acr.20538; Bullock-Saxton J, 2018, WORLD ASS LAS THER C; Calabresi P, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0184; Calabresi P, 2013, LANCET NEUROL, V12, P811, DOI 10.1016/S1474-4422(13)70118-2; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Costa-Ribeiro A, 2017, DEV NEUROREHABIL, V20, P121, DOI 10.3109/17518423.2015.1131755; Darlot F, 2016, ANN NEUROL, V79, P59, DOI 10.1002/ana.24542; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; Dorsey ER, 2018, LANCET NEUROL, V17, P939, DOI 10.1016/S1474-4422(18)30295-3; Earhart GM, 2011, J NEUROL PHYS THER, V35, P157, DOI 10.1097/NPT.0b013e318235da08; El Massri N, 2016, EXP BRAIN RES, V234, P3225, DOI 10.1007/s00221-016-4720-7; Ferrazzoli D, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00121; Fuhrer H, 2014, J NEURAL TRANSM, V121, P147, DOI 10.1007/s00702-013-1081-2; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hamilton C, 2018, NEURAL REGEN RES, V13, P1738, DOI 10.4103/1673-5374.238613; Hamilton CL, 2019, PHOTOBIOMOD PHOTOMED, V37, P615, DOI 10.1089/photob.2019.4663; Ho M. D., 2016, J INT NEUROPSYCH SOC, V22, P229; Horsager J, 2020, BRAIN, V143, P3077, DOI 10.1093/brain/awaa238; Jensen HB, 2016, MULT SCLER RELAT DIS, V7, P58, DOI 10.1016/j.msard.2016.03.007; Joensen J, 2012, PHOTOMED LASER SURG, V30, P688, DOI 10.1089/pho.2012.3306; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Johnstone DM, 2015, NEURAL REGEN RES, V10, P349, DOI 10.4103/1673-5374.153673; Loddo G, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00042; Maksimovich IV, 2019, PHOTOBIOMOD PHOTOMED, V37, P606, DOI 10.1089/photob.2019.4649; Massano J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008870; Monteiro RS, 2015, MED HYPOTHESES, V85, P537, DOI 10.1016/j.mehy.2015.07.011; Moro C, 2017, EXP BRAIN RES, V235, P3081, DOI 10.1007/s00221-017-5048-7; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Morris S, 2001, PHYS THER, V81, P810, DOI 10.1093/ptj/81.2.810; O'Donnell CM, 2021, J GERIATR PSYCH NEUR, DOI 10.1177/0891988720988906; O'Driscoll C, 2017, J ALZHEIMERS DIS, V58, P789, DOI 10.3233/JAD-161042; Pievani M, 2014, NAT REV NEUROL, V10, P620, DOI 10.1038/nrneurol.2014.178; Pitzschke A, 2015, PHYS MED BIOL, V60, P2921, DOI 10.1088/0031-9155/60/7/2921; Rascol O, 2002, LANCET, V359, P1589, DOI 10.1016/S0140-6736(02)08520-3; Rivera-Torres S, 2019, GERONTOL GERIATR MED, V5, DOI 10.1177/2333721418823604; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Salehpour F, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040610; Salehpour F, 2019, PHOTOBIOMOD PHOTOMED, V37, P581, DOI 10.1089/photob.2019.4676; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Santos L, 2019, BRAIN STIMUL, V12, P810, DOI 10.1016/j.brs.2019.02.009; Saunders-Pullman R, 2008, MOVEMENT DISORD, V23, P531, DOI 10.1002/mds.21874; Shaw VE, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/296875; Smithson F, 1998, PHYS THER, V78, P577, DOI 10.1093/ptj/78.6.577; Tomlinson CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002817.pub4; Vatansever D, 2016, BRAIN CONNECT, V6, P201, DOI 10.1089/brain.2015.0388; Videnovic A, 2017, JAMA NEUROL, V74, P411, DOI 10.1001/jamaneurol.2016.5192; Wright AA, 2011, J ORTHOP SPORT PHYS, V41, P319, DOI 10.2519/jospt.2011.3515; Xuan WJ, 2016, J BIOPHOTONICS, V9, P1263, DOI 10.1002/jbio.201500336; Yue L, 2015, PROC SPIE, V9321, DOI 10.1117/12.2077019	55	1	1	2	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2021	83	4					1499	1512		10.3233/JAD-210170			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WJ3SG	WOS:000708967100008	34092640				2022-02-06	
J	Butler, EK; Groner, JI; Vavilala, MS; Bulger, EM; Rivara, FP				Butler, Elissa K.; Groner, Jonathan I.; Vavilala, Monica S.; Bulger, Eileen M.; Rivara, Frederick P.			Surgeon choice in management of pediatric abdominal trauma	JOURNAL OF PEDIATRIC SURGERY			English	Article						Abdominal trauma; Hollow viscus injury; Children; Surgeon type; Non-operative management; Laparoscopy	SOLID-ORGAN INJURY; FREE FLUID; COMPUTED-TOMOGRAPHY; BLUNT TRAUMA; LAPAROSCOPY; LAPAROTOMY; OUTCOMES	Background: No guidelines exist for management of hemodynamically stable children with suspected hollow viscus injury. We sought to determine factors contributing to surgeon management of these patients. Methods: Surgeon members of the Eastern Association for the Surgery of Trauma and American Pediatric Surgical Association completed a survey on 3 blunt abdominal injury scenarios: (1) isolated, (2) with multisystem injury, and (3) with traumatic brain injury (TBI), and a penetrating injury scenario. Multivariable logistic regression was used to determine factors associated with initial management of observation vs. operation for blunt injury and observation vs. local wound exploration versus laparoscopy for penetrating injury. Results: Of 394 surgeons (response rate 223%), 50.3% were pediatric surgeons. For scenarios 1-3, 32.2%, 49.3%, and 60.7% of surgeons chose operation over observation, respectively. Compared to isolated blunt injury, surgeons were more likely to choose operation for patients with multisystem injury (aOR 220, 95%C1: 1.78-2.72) or TB1 (aOR 3.60, 95%Cl: 2.79-4.66). Pediatric surgeons were less likely to choose operation (aOR 0.32, 95%CI: 0.22-0.44). For penetrating injury, 39.1%, 295%, and 31.5% of surgeons chose observation, local wound explora-tion, and laparoscopy, respectively. Conclusions: Large variation exists in management of hemodynamically stable children with suspected hollow viscus injury. Although patient injury characteristics account for some variation, surgeon factors such as type of surgeon also play a role. Evidence-based practice guidelines should be developed to standardize care. Type of Study: Cross-Sectional Survey. (C) 2020 Elsevier Inc. All rights reserved.	[Butler, Elissa K.; Vavilala, Monica S.; Bulger, Eileen M.; Rivara, Frederick P.] Univ Washington, Harborview Injury Prevent & Res Ctr, 325 9th Ave Box 359960, Seattle, WA 98122 USA; [Butler, Elissa K.; Bulger, Eileen M.] Univ Washington, Dept Surg, 1959 NE Pacific St, Seattle, WA 98195 USA; [Butler, Elissa K.] SUNY Upstate Med Univ, Dept Surg, 750 East Adams St, Syracuse, NY 13210 USA; [Groner, Jonathan I.] Nationwide Childrens Hosp, Ctr Pediat Trauma Res, 700 Childrens Dr, Columbus, OH 43205 USA; [Groner, Jonathan I.] Nationwide Childrens Hosp, Dept Pediat Surg, 700 Childrens Dr, Columbus, OH 43205 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, 1959 NE Pacific St, Seattle, WA 98195 USA		Butler, EK (corresponding author), SUNY Upstate Med Univ, 750 East Adams St, Syracuse, NY 13210 USA.	butlere@upstate.edu			National Institutes of Health T-32 Pediatric Injury Research Training ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32HD057822-10]	Dr. Butler was supported by the National Institutes of Health T-32 Pediatric Injury Research Training Program [5T32HD057822-10].	Arbra CA, 2017, J TRAUMA ACUTE CARE, V83, P597, DOI 10.1097/TA.0000000000001533; Bege T, 2016, J VISC SURG, V153, P61, DOI 10.1016/j.jviscsurg.2016.04.007; Bekker W, 2019, ANN ROY COLL SURG, V101, P552, DOI 10.1308/rcsann.2019.0078; Butler EK, 2020, J SURG RES, V251, P303, DOI 10.1016/j.jss.2020.01.030; Cherkasov M, 2008, SURG ENDOSC, V22, P228, DOI 10.1007/s00464-007-9550-z; Fakhry SM, 2000, J TRAUMA, V48, P408, DOI 10.1097/00005373-200003000-00007; Gaines BA, 2010, SEMIN PEDIATR SURG, V19, P300, DOI 10.1053/j.sempedsurg.2010.08.001; Goedecke M, 2019, INNOV SURG SCI, V4, P100, DOI 10.1515/iss-2018-0004; Gonser-Hafertepen LN, 2014, J AM COLL SURGEONS, V219, P599, DOI 10.1016/j.jamcollsurg.2014.04.020; Jerby BL, 1997, J PEDIATR SURG, V32, P580, DOI 10.1016/S0022-3468(97)90711-9; Justin V, 2017, CURR TRAUMA REP, V3, P43, DOI 10.1007/s40719-017-0076-0; Lee PC, 2014, SURG INNOV, V21, P155, DOI 10.1177/1553350612474496; Li YL, 2015, WORLD J SURG, V39, P2862, DOI 10.1007/s00268-015-3212-4; Livingston DH, 2001, AM J SURG, V182, P6, DOI 10.1016/S0002-9610(01)00665-1; Lynch T, 2018, CURR PEDIATR REV, V14, P59, DOI 10.2174/1573396313666170815100547; Malinoski DJ, 2010, J TRAUMA, V69, P84, DOI 10.1097/TA.0b013e3181db37f5; Ng AKT, 2002, J TRAUMA, V52, P1134, DOI 10.1097/00005373-200206000-00019; Oyo-Ita A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007383.pub3; Pearson EG, 2017, SURG CLIN N AM, V97, P75, DOI 10.1016/j.suc.2016.08.005; Segui-Gomez M, 2003, J PEDIATR SURG, V38, P1162, DOI 10.1016/S0022-3468(03)00262-8; Shimizu T, 2019, ACUTE MED SURG, V6, P358, DOI 10.1002/ams2.421; Stylianos S, 2008, SEMIN PEDIATR SURG, V17, P110, DOI 10.1053/j.sempedsurg.2008.02.006	22	1	1	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	JAN	2021	56	1					146	152		10.1016/j.jpedsurg.2020.09.023			7	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	PT5WW	WOS:000608686400025	33139031	Green Accepted			2022-02-06	
J	Caldieraro, MA; Laufer-Silva, T; Cassano, P				Caldieraro, Marco Antonio; Laufer-Silva, Tatiana; Cassano, Paolo			Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; cognition disorders; depression; low-level light therapy; photobiomodulation	TRAUMATIC BRAIN-INJURY; LOW-LEVEL LASER; BIPHASIC DOSE-RESPONSE; LIGHT THERAPY; COGNITIVE PERFORMANCE; ANXIETY TREATMENTS; CANADIAN NETWORK; ISCHEMIC-STROKE; ADULTS; MANAGEMENT	Background: Major depressive disorder (MDD) is prevalent and has significant impact on individuals and society. Cognitive symptoms are frequent in MDD and insufficiently treated by antidepressant medications. Transcranial photobiomodulation (t-PBM) is a novel device therapy which shows promise as an antidepressant and pro-cognitive treatment. To date, despite the encouraging results, the optimal stimulation parameters of t-PBM to treat MDD are not established, and clinical studies are very heterogeneous in terms of these parameters. While the literature provides guidance on the appropriate fluence to achieve therapeutic results, little is known on the other parameters. Objective: To evaluate the relationship between different parameters and the antidepressant effect of t-PBM. Methods: We reviewed clinical studies on MDD and on depressive symptoms comorbid with other diseases. We calculated the standardized effect size of the change in symptoms severity before and after t-PBM and we performed a descriptive analysis of the reviewed papers. Results: The greatest effect sizes for the antidepressant effect were found in studies using pulse-wave t-PBM with high peak irradiance (but low average irradiance) over large skin surface. One well-designed and sufficiently powered, double-blind, sham-controlled trial indicated that t-PBM with low irradiance over a small skin surface is ineffective to treat depression. Conclusion: The use of t-PBM for Alzheimer's disease and for dementia is still at its inception; these dosimetry lessons from the use of t-PBM for depression might serve as guidance.	[Caldieraro, Marco Antonio; Laufer-Silva, Tatiana] Hosp Clin Porto Alegre HCPA, Ctr Pesquisa Expt CPE, Porto Alegre, RS, Brazil; [Caldieraro, Marco Antonio; Laufer-Silva, Tatiana] Hosp Clin Porto Alegre HCPA, Ctr Pesquisa Clin CPC, Porto Alegre, RS, Brazil; [Caldieraro, Marco Antonio; Laufer-Silva, Tatiana] Univ Fed Rio Grande do Sul, Fac Med, Dept Psiquiatria & Med Legal, Programa Posgrad Psiquiatria & Ciencias Comportam, Porto Alegre, RS, Brazil; [Cassano, Paolo] Harvard Med Sch, Boston, MA 02115 USA; [Cassano, Paolo] Massachusetts Gen Hosp, MGH Div Neuropsychiat, Boston, MA 02114 USA		Caldieraro, MA (corresponding author), Hosp Clin Porto Alegre, Serv Psiquiatria, Rua Ramiro Barcelos 2350 4 Andar, BR-90035903 Porto Alegre, RS, Brazil.	mcaldieraro@hcpa.edu.br	Caldieraro, Marco Antonio/U-7356-2019	Caldieraro, Marco Antonio/0000-0002-4355-9547			Allais G, 2003, NEUROL SCI, V24, pS138; Askalsky P, 2019, NEUROPSYCH DIS TREAT, V15, P3255, DOI 10.2147/NDT.S188906; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; Brunoni AR, 2017, NEW ENGL J MED, V376, P2523, DOI 10.1056/NEJMoa1612999; Caldieraro MA, 2019, J AFFECT DISORDERS, V243, P262, DOI 10.1016/j.jad.2018.09.048; Cassano Paolo, 2004, Ann Clin Psychiatry, V16, P15, DOI 10.1080/10401230490281618; Cassano P, 2019, PHOTOBIOMOD PHOTOMED, V37, P651, DOI 10.1089/photob.2019.4678; Cassano P, 2018, PHOTOMED LASER SURG, V36, P634, DOI 10.1089/pho.2018.4490; Cassano P, 2019, NEUROPHOTONICS, V6, DOI 10.1117/1.NPh.6.1.015004; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chaieb L, 2015, FRONT BEHAV NEUROSCI, V9, P1, DOI 10.3389/fnbeh.2015.00147; Chao LL, 2019, PHOTOBIOMODULATION P, V37, P133, DOI 10.1089/photob.2018.4555; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Correa MS, 2012, BIOL PSYCHOL, V89, P293, DOI 10.1016/j.biopsycho.2011.11.001; Chaves MED, 2014, AN BRAS DERMATOL, V89, P616, DOI 10.1590/abd1806-4841.20142519; Disner SG, 2016, BRAIN STIMUL, V9, P780, DOI 10.1016/j.brs.2016.05.009; Evans VC, 2014, J CLIN PSYCHIAT, V75, P1359, DOI 10.4088/JCP.13r08939; Ferraresi Cleber, 2012, Photonics Lasers Med, V1, P267; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gabel Charles Philip, 2018, Laser Ther, V27, P167, DOI 10.5978/islsm.27_18-OR-18; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Harkless LB, 2006, J DIABETES COMPLICAT, V20, P81, DOI 10.1016/j.jdiacomp.2005.06.002; Heiskanen V, 2018, PHOTOCH PHOTOBIO SCI, V17, P1003, DOI [10.1039/c8pp00176f, 10.1039/c8pp90049c]; Henderson TA, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00187; Hersant B, 2015, PHOTOMED LASER SURG, V33, P283, DOI 10.1089/pho.2014.3822; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Huisa BN, 2013, INT J STROKE, V8, P315, DOI 10.1111/j.1747-4949.2011.00754.x; Hunot Vivien M, 2007, Prim Care Companion J Clin Psychiatry, V9, P91; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Iosifescu D, 2020, 2020 VIRT M SOC BIOL; Iwashita T, 2003, J NEURO-ONCOL, V64, P265, DOI 10.1023/A:1025684903137; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Kennedy SH, 2016, CAN J PSYCHIAT, V61, P540, DOI 10.1177/0706743716659417; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Konstantinovic LM, 2013, LASER SURG MED, V45, P648, DOI 10.1002/lsm.22190; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Litscher D, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/575798; Luppa M, 2007, J AFFECT DISORDERS, V98, P29, DOI 10.1016/j.jad.2006.07.017; Machado MO, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1101-z; MacQueen GM, 2017, PSYCHIAT CLIN NEUROS, V71, P18, DOI 10.1111/pcn.12463; McIntyre RS, 2015, COMPR PSYCHIAT, V56, P279, DOI 10.1016/j.comppsych.2014.08.051; Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Olfson M, 2016, JAMA INTERN MED, V176, P1482, DOI 10.1001/jamainternmed.2016.5057; Papakostas GI, 2014, J CLIN PSYCHIAT, V75, P8, DOI 10.4088/JCP.13r08710; Parikh SV, 2016, CAN J PSYCHIAT, V61, P524, DOI 10.1177/0706743716659418; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Quah-Smith I, 2013, J AFFECT DISORDERS, V148, P179, DOI 10.1016/j.jad.2012.11.058; Quah-Smith Joo Im, 2005, Acupunct Med, V23, P103; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Rosa MA, 2012, NEUROPSYCHOPHARMACOL, V37, P102, DOI 10.1038/npp.2011.225; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Salehpour F, 2021, J ALZHEIMERS DIS, V83, P1431, DOI 10.3233/JAD-210029; Salehpour F, 2019, PHOTOBIOMOD PHOTOMED, V37, P581, DOI 10.1089/photob.2019.4676; Salehpour F, 2017, REV NEUROSCIENCE, V28, P441, DOI 10.1515/revneuro-2016-0087; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Sinyor M, 2010, CAN J PSYCHIAT, V55, P126, DOI 10.1177/070674371005500303; Sommer AP, 2014, PHOTOMED LASER SURG, V32, P59, DOI 10.1089/pho.2014.9866; Song PH, 2020, BRAIN RES BULL, V155, P155, DOI 10.1016/j.brainresbull.2019.12.007; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; YuanY, 2020, NEUROPHOTONICS, V7, P1; Yue L, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.8.088001; Zarei M, 2016, LASER MED SCI, V31, P363, DOI 10.1007/s10103-015-1818-2; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002; Zivin JA, 2014, INT J STROKE, V9, P950, DOI 10.1111/j.1747-4949.2012.00896.x	77	1	1	4	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2021	83	4					1453	1469		10.3233/JAD-210586			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WJ3SG	WOS:000708967100005	34487045				2022-02-06	
J	Campbell, KR; Parrington, L; Peterka, RJ; Martini, DN; Hullar, TE; Horak, FB; Chesnutt, JC; Fino, PC; King, LA				Campbell, Kody R.; Parrington, Lucy; Peterka, Robert J.; Martini, Douglas N.; Hullar, Timothy E.; Horak, Fay B.; Chesnutt, James C.; Fino, Peter C.; King, Laurie A.			Exploring persistent complaints of imbalance after mTBI: Oculomotor, peripheral vestibular and central sensory integration function	JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION			English	Article						Peripheral vestibular function; oculomotor function; central sensory integration; postural control; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS; BLAST EXPOSURE; EYE-MOVEMENTS; HEAD-INJURY; BALANCE; CONCUSSION; SYMPTOMS; DEPRESSION; DIZZINESS	BACKGROUND: Little is known on the peripheral and central sensory contributions to persistent dizziness and imbalance following mild traumatic brain injury (mTBI). OBJECTIVE: To identify peripheral vestibular, central integrative, and oculomotor causes for chronic symptoms following mTBI. METHODS: Individuals with chronic mTBI symptoms and healthy controls (HC) completed a battery of oculomotor, peripheral vestibular and instrumented posturography evaluations and rated subjective symptoms on validated questionnaires. We defined abnormal oculomotor, peripheral vestibular, and central sensory integration for balance measures among mTBI participants as falling outside a 10-percentile cutoff determined from HC data. A X-squared test associated the proportion of normal and abnormal responses in each group. Partial Spearman's rank correlations evaluated the relationships between chronic symptoms and measures of oculomotor, peripheral vestibular, and central function for balance control. RESULTS: The mTBI group (n = 58) had more abnormal measures of central sensory integration for balance than the HC (n = 61) group (mTBI: 41% - 61%; HC: 10%, p's < 0.001), but no differences on oculomotor and peripheral vestibular function (p > 0.113). Symptom seventies were negatively correlated with central sensory integration for balance scores (p's <0.048). CONCLUSIONS: Ongoing balance complaints in people with chronic mTBI are explained more by central sensory integration dysfunction rather than peripheral vestibular or oculomotor dysfunction.	[Campbell, Kody R.; Parrington, Lucy; Horak, Fay B.; Chesnutt, James C.; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Peterka, Robert J.; Hullar, Timothy E.] Vet Affairs Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Martini, Douglas N.] Univ Massachusetts, Dept Kinesiol, Amherst, MA USA; [Hullar, Timothy E.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97239 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, Portland, OR 97239 USA; [Fino, Peter C.] Univ Utah, Dept Hlth & Kinesiol, Salt Lake City, UT USA		Campbell, KR (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Neurol, 3222 SW Res Dr, Portland, OR 97239 USA.	campbeko@ohsu.edu			Defense for Health Affairs [W81XWH-15-0620]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002369]	This study was supported by the Assistant Secretary of Defense for Health Affairs under the Award Number W81XWH-15-0620 and by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award Number UL1TR002369. All interpretations and opinions are those of the author and are not necessarily endorsed by the Department of Defense. The authors would like to thank the research team that contributed to data collection and specifically audiologists SeanKempel, AuD, Daniel Putterman, AuD, and Marco Jurado, AuD. Study data were collected and managed using REDCap electronic data capture tools hosted at Oregon Health and Science University [20, 21]. REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed to support data capture for research studies, providing 1) an intuitive interface for validated data capture; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for data integration and interoperability with external sources.	Akdal G, 2009, HEADACHE, V49, P419, DOI 10.1111/j.1526-4610.2008.01256.x; Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alkathiry AA, 2019, SPORTS HEALTH, V11, P479, DOI 10.1177/1941738119865262; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; Bogle J.M., 2019, PERSPECTIVES ASHA SP, V4, P1349; Burch R, 2021, HEADACHE, V61, P60, DOI 10.1111/head.14024; Calzolari E, 2021, BRAIN, V144, P128, DOI 10.1093/brain/awaa386; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Chu SY, 2017, BRAIN INJURY, V31, P1674, DOI 10.1080/02699052.2017.1332783; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cohen J., 2013, STAT POWER ANAL BEHA; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; Dowiasch S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00046; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hebert JR, 2018, J HEAD TRAUMA REHAB, V33, P403, DOI 10.1097/HTR.0000000000000385; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hsu WC, 2008, ARCH OTOLARYNGOL, V134, P1099, DOI 10.1001/archotol.134.10.1099; I. NeuroCom International, 2008, BAL MAN SYST CLIN IN; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Leung FT, 2019, MUSCULOSKEL SCI PRAC, V39, P144, DOI 10.1016/j.msksp.2018.12.007; Mantokoudis G, 2015, AUDIOL NEURO-OTOL, V20, P39, DOI 10.1159/000362780; Marcus HJ, 2019, J NEUROL, V266, P2430, DOI 10.1007/s00415-019-09403-z; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meehan A, 2019, UNDERSEA HYPERBAR M, V46, P271; Meehan A, 2016, UNDERSEA HYPERBAR M, V43, P567; Murray NG, 2020, J NEUROTRAUM, V37, P340, DOI 10.1089/neu.2019.6595; NASHNER LM, 1982, J NEUROSCI, V2, P536; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterka RJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01045; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; T.B.I.W.G. Management of Concussion/m, 2016, VA DOD CLIN PRACT GU; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Wares JR, 2015, J REHABIL RES DEV, V52, P591, DOI 10.1682/JRRD.2014.08.0197; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wu YC, 2020, NEUROLOGY, V95, pE781, DOI 10.1212/WNL.0000000000009930; Zorzin L, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01128-z	56	1	1	4	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0957-4271	1878-6464		J VESTIBUL RES-EQUIL	J. Vestib. Res.-Equilib. Orientat.		2021	31	6					519	530		10.3233/VES-201590			12	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	WL3CE	WOS:000710286600008	34024798				2022-02-06	
J	Casper, ST				Casper, Stephen T.			The Intertwined History of Malingering and Brain Injury: An Argument for Structural Competency in Traumatic Brain Injury	JOURNAL OF LAW MEDICINE & ETHICS			English	Article						Concussion; Traumatic Brain Injury; Malingering; Structural Competency; Stigma	RAILWAY SPINE; CONCUSSION; TBI	Every year millions of people suffer minor brain injuries, many of which occur in collision sports. While there has been substantial commentary and debate about the nature of this public health crisis, it is clear that the scientific and clinical arguments reflect values preferences and judgments that are often invisible in documents which combine artful language with undue focus paid to sources of uncertainty at the cost of clarity and transparency. This essay gives a brief history of these patterns and proposes a remedy.	[Casper, Stephen T.] Clarkson Univ, Hist, Potsdam, NY 13676 USA		Casper, ST (corresponding author), Clarkson Univ, Hist, Potsdam, NY 13676 USA.						[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; [Anonymous], 1878, PALL MALL BUDGET BEI, P14; [Anonymous], 1878, PALL MALL BUDGET BEI, P15; [Anonymous], 1878, PALL MALL BUDGET BEI, P15; Bachynski K., 2019, NO GAME BOYS PLAY HI; Barr WB, 2020, CAN PSYCHOL, V61, P151, DOI 10.1037/cap0000210; Blumenthal Susanna L., 2016, LAW MODERN MIND CONS; Brock S., 1949, INJURIES BRAIN SPINA; Burnham JC, 2012, SOC HIST MED, V25, P761, DOI 10.1093/shm/hks018; Burstyn V., 1999, RITES MEN MANHOOD PO; CAPLAN EM, 1995, B HIST MED, V69, P387; Casper ST, 2020, SOC SCI MED, V245, DOI 10.1016/j.socscimed.2019.112688; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Cooter R., 1998, WAR MED MODERNITY, P125; Dagi T. F., 1997, HIST NEUROSURGERY IT, P289; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; EPSTEIN RA, 1982, GA L REV, V16, P775; Erichsen J.E., 1867, RAILWAY OTHER INJURI; FRIEDMAN LM, 1967, COLUMBIA LAW REV, V67, P50, DOI 10.2307/1121130; Halligan P.W., 2006, MALINGERING ILLNESS; Harrington R, 2003, SOC HIST MED, V16, P209, DOI 10.1093/shm/16.2.209; Lawton F., 1969, LATE EFFECTS HEAD IN, P435; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Malcolm D., 2019, CONCUSSION CRISIS SP, P2; Metzl JM, 2014, SOC SCI MED, V103, P126, DOI 10.1016/j.socscimed.2013.06.032; Micale M.S., 2011, TRAUMATIC PASTS; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Nichols A.H., 1886, BOSTON MED SURG J, VCXIV, P510; Nichols A.H., 1886, BOSTON MED SURG J, VCXIV, P511; Oppenheim Janet, 1991, SHATTERED NERVES DOC; Phelan SM, 2018, ARCH PHYS MED REHAB, V99, P2222, DOI 10.1016/j.apmr.2018.04.007; Poinsett A., 1964, EBONY, P34; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Sandel E., 2020, SHAKEN BRAIN SCI CAR; Schneider R., 1969, MED SCI SPORT, V1, P112; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Smith R., 1981, TRIAL MED INSANITY R, P161; WALKER AE, 1969, LATE EFFECTS HEAD IN; Weisz G, 2014, CHRONIC DISEASE IN THE TWENTIETH CENTURY: A HISTORY, P1	39	1	1	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics		2021	49	3			SI		365	371	PII S1073110521000553	10.1017/jme.2021.55			7	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	XB3YB	WOS:000721266600007	34665092	Bronze			2022-02-06	
J	Casper, ST; Bachynski, KE; Buckland, ME; Comrie, D; Gandy, S; Gates, J; Goldberg, DS; Henne, K; Hind, K; Morrison, D; Ortega, F; Pearce, AJ; Philpott-Jones, S; Sandel, E; Tatos, T; Tucker, S; Finkel, AM				Casper, Stephen T.; Bachynski, Kathleen E.; Buckland, Michael E.; Comrie, Don; Gandy, Sam; Gates, Judith; Goldberg, Daniel S.; Henne, Kathryn; Hind, Karen; Morrison, Daniel; Ortega, Francisco; Pearce, Alan J.; Philpott-Jones, Sean; Sandel, Elizabeth; Tatos, Ted; Tucker, Sally; Finkel, Adam M.			Toward Complete, Candid, and Unbiased International Consensus Statements on Concussion in Sport	JOURNAL OF LAW MEDICINE & ETHICS			English	Article						Concussion; Consensus Statements; Disclosure; Sports Medicine; Informed Consent	FOOTBALL; RISKS	Five international consensus statements on concussion in sports have been published. This commentary argues that there is a strong need for a new approach to them that foregrounds public health expertise and patient-centered guidance. Doing so will help players, parents and practitioners keep perspective about these potentially life-altering injuries especially when they recur.	[Casper, Stephen T.] Clarkson Univ, Honors Program, Potsdam, NY 13676 USA; [Bachynski, Kathleen E.] Muhlenberg Coll, Allentown, PA 18104 USA; [Buckland, Michael E.] Royal Prince Alfred Hosp, Dept Neuropathol, Camperdown, NSW, Australia; [Buckland, Michael E.] Univ Sydney, Sydney, NSW, Australia; [Comrie, Don] NeuroLabs Inc, Edinburgh, Midlothian, Scotland; [Gandy, Sam] Icahn Sch Med, New York, NY USA; [Gandy, Sam] Mt Sinai Ctr Cognit Hlth & NFL Neurol Care, New York, NY USA; [Gates, Judith; Tucker, Sally] Head Change, Newport, Shrops, England; [Goldberg, Daniel S.] Univ Colorado, Ctr Bioeth & Humanities, Anschutz Med Campus, Boulder, CO 80309 USA; [Henne, Kathryn] Australian Natl Univ, Sch Regulat & Global Governance, Canberra, ACT, Australia; [Hind, Karen] Univ Durham, Dept Sport & Exercise Sci, Fac Social Sci & Hlth, Durham, England; [Morrison, Daniel] Abilene Christian Univ, Dept Commun & Sociol, Abilene, TX 79699 USA; [Ortega, Francisco] Univ Rovira & Virgili, Barcelona Med Anthropol Res Ctr, ICREA Catalan Inst Res & Adv Studies, Tarragona, Spain; [Pearce, Alan J.] La Trobe Univ, Coll Sci Hlth & Engn, Melbourne, Vic, Australia; [Philpott-Jones, Sean] Hurkon Headwaters Hlth Network, Govt Relat & Grants Management, Queensbury, NY USA; [Sandel, Elizabeth] Univ Calif Davis, Davis, CA 95616 USA; [Sandel, Elizabeth] Paradigm, Walnut Creek, CA USA; [Tatos, Ted] Univ Utah, Salt Lake City, UT 84112 USA; [Tatos, Ted] EconONE Res, Los Angeles, CA USA; [Finkel, Adam M.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA		Casper, ST (corresponding author), Clarkson Univ, Honors Program, Potsdam, NY 13676 USA.		ORTEGA, FRANCISCO/E-9867-2016	ORTEGA, FRANCISCO/0000-0002-5039-9449	ERASMUS + strategic partnerships program [2019-1-IE01-KA202-051555]	Dr. Buckland is the director of the Australian Sports Brain Bank, part of the Concussion Legacy Foundation Global Brain Bank initiative. Dr. Casper reports personal fees from Shrader and Associates, personal fees from Zimmer Reed, other from Langfit and Gardner, and other from Rylands, outside the submitted work. Dr. Pearce reports grants from ERASMUS + strategic partnerships program (2019-1-IE01-KA202-051555), grants from Sports Health Check Charity, grants from Australian Football League (2015-2017), other from Impact Technologies (2015-2019), other from Samsung Inc (2016), personal fees from Various Legal firms, outside the submitted work. Dr. Sandel reports publication of a book, Shaken Brain: The Science, Care, and Treatment of Concussion, with royalties paid by Harvard University Press, 2020. The other authors have no conflicts to disclose.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Botkin JR, 2018, JAMA-J AM MED ASSOC, V320, P2307, DOI 10.1001/jama.2018.17525; Brand KP, 2020, SEMIN NEUROL, V40, P450, DOI 10.1055/s-0039-1688484; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Casper ST, 2018, HEADACHE, V58, P795, DOI 10.1111/head.13288; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; Fainaru-Wada M., 2014, LEAGUE DENIAL NFL CO; Finkel AM, 2019, HUM ECOL RISK ASSESS, V25, P564, DOI 10.1080/10807039.2018.1456899; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gillett G, 2018, CAMB Q HEALTHC ETHIC, V27, P710, DOI 10.1017/S0963180118000191; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Julich Supercomputing Centre, 2019, J LARGESCALE RES FAC, V5, pA135, DOI 10.17815/jlsrf-5-171; King NMP, 2013, AM J BIOETHICS, V13, P13, DOI 10.1080/15265161.2013.828126; Kriebel D, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454986; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Metzl JM, 2014, SOC SCI MED, V103, P126, DOI 10.1016/j.socscimed.2013.06.032; Proctor R.N., 2008, AGNOTOLOGY MAKING UN; Robeson R, 2014, J LAW MED ETHICS, V42, P334, DOI 10.1111/jlme.12150; Rycroft-Malone J, 2001, QUAL HEALTH CARE, V10, P238, DOI 10.1136/qhc.0100238..; Truog RD, 2012, NEW ENGL J MED, V366, P581, DOI 10.1056/NEJMp1110848; Weisz G, 2007, MILBANK Q, V85, P691, DOI 10.1111/j.1468-0009.2007.00505.x; WORTMAN PM, 1988, J HEALTH POLIT POLIC, V13, P469, DOI 10.1215/03616878-13-3-469	26	1	1	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics		2021	49	3			SI		372	377	PII S1073110521000565	10.1017/jme.2021.56			6	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	XB3YB	WOS:000721266600008	34665101	Bronze			2022-02-06	
J	Celorrio, M; Rhodes, J; Vadivelu, S; Davies, M; Friess, SH				Celorrio, Marta; Rhodes, James; Vadivelu, Sangeetha; Davies, McKenzie; Friess, Stuart H.			N-acetylcysteine reduces brain injury after delayed hypoxemia following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Hypoxemia; N-acetylcysteine; Neuroprotection; Secondary injury; Pre-clinical trial	CONTROLLED CORTICAL IMPACT; ANTIOXIDANT THERAPY; CLINICAL-TRIAL; MOUSE MODEL; HEAD-INJURY; HYPOXIA; NEUROPROTECTION; PROGESTERONE; MICE; RATS	Preclinical investigations into neuroprotective agents for traumatic brain injury (TBI) have shown promise when administered before or very early after experimental TBI. However clinical trials of therapeutics demonstrating preclinical efficacy for TBI have failed to replicate these results in humans, a lost in translation phenomenon. N-acetylcysteine (NAC) is a potent anti-oxidant with demonstrated efficacy in pre-clinical TBI when administered early after primary injury. Utilizing our clinically relevant mouse model, we hypothesized that NAC administration in a clinically relevant timeframe could improve the brain's resilience to the secondary insult of hypoxemia. NAC or vehicle administered daily starting 2 h prior to hypoxemia (24 h after controlled cortical impact) for 3 doses in male mice reduced short-term axonal injury and hippocampal neuronal loss. Six month behavioral assessments including novel object recognition, socialization, Barnes maze, and fear conditioning did not reveal performance differences between sham controls and injured mice receiving NAC or saline vehicle. At 7 months after injury, NAC administered mice had reduced hippocampal neuronal loss but no reduction in lesion volume. In summary, our preclinical trial to test the neuroprotective efficacy of NAC against a secondary hypoxic insult after TBI demonstrated short and long-term neuropathological evidence of neuroprotection but a lack of detectable differences in long-term behavioral assessments between sham controls and injured mice limits conclusions on its impact on long-term neurobehavioral outcomes.	[Celorrio, Marta; Rhodes, James; Vadivelu, Sangeetha; Davies, McKenzie; Friess, Stuart H.] Washington Univ, Div Crit Care Med, Dept Pediat, Sch Med, One Childrens Pl, St Louis, MO 63110 USA		Friess, SH (corresponding author), Washington Univ, Div Crit Care Med, Dept Pediat, Sch Med, One Childrens Pl, St Louis, MO 63110 USA.	friess@wustl.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097721]	This work was supported by the National Institutes of Health (R01NS097721).	Abdel Baki SG, 2010, PLOS ONE, V5; Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Balogh SA, 2002, BEHAV NEUROSCI, V116, P947, DOI 10.1037//0735-7044.116.6.947; Barsukova AG, 2012, J NEUROSCI, V32, P12028, DOI 10.1523/JNEUROSCI.0408-12.2012; Bhatti J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00744; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI [10.1517/14728220802517901, 10.1517/14728220802517901 ]; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Duhaime AC, 2007, PEDIATR CRIT CARE ME, V8, P71, DOI 10.1097/01.PCC.0000253552.60687.AC; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Fang Raymond, 2015, J Trauma Acute Care Surg, V79, pS181, DOI 10.1097/TA.0000000000000769; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hagos FT, 2017, XENOBIOTICA, V47, P346, DOI 10.1080/00498254.2016.1187777; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; Lazarus RC, 2015, FREE RADICAL BIO MED, V78, P89, DOI 10.1016/j.freeradbiomed.2014.10.507; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lowe DW, 2017, NEUROPHARMACOLOGY, V123, P186, DOI 10.1016/j.neuropharm.2017.06.004; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Nie XJ, 2016, NEUROSCI RES, V108, P24, DOI 10.1016/j.neures.2016.01.008; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Parikh U, 2016, J NEUROPATH EXP NEUR, V75, P731, DOI 10.1093/jnen/nlw045; Pompl PN, 1999, J NEUROSCI METH, V87, P87, DOI 10.1016/S0165-0270(98)00169-1; PRESCOTT LF, 1977, LANCET, V2, P432; Rockswold GL, 2006, J NEUROSURG, V104, P170, DOI 10.3171/jns.2006.104.1.170; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Thomale UW, 2005, ACT NEUR S, V95, P429; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Tucker LB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222153; Varma MR, 2002, BRAIN RES, V951, P191, DOI 10.1016/S0006-8993(02)03161-X; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zhou Y, 2018, DRUG DES DEV THER, V12, P4117, DOI 10.2147/DDDT.S179227	57	1	1	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2021	335								113507	10.1016/j.expneurol.2020.113507			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PH8XX	WOS:000600689300015	33065076	Green Accepted			2022-02-06	
J	Chandrasekaran, S; Tripathi, BB; Espindola, D; Pinton, GF				Chandrasekaran, Sandhya; Tripathi, Bharat B.; Espindola, David; Pinton, Gianmarco F.			Modeling Ultrasound Propagation in the Moving Brain: Applications to Shear Shock Waves and Traumatic Brain Injury	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article						Biomedical acoustics; biomedical imaging; finite difference simulations; numerical simulation; shear shock waves; traumatic brain injury (TBI)	PIECEWISE PARABOLIC METHOD; SPATIAL COHERENCE; TIME-REVERSAL; TISSUE; SIMULATIONS	Traumatic brain injury (TBI) studies on the living human brain are experimentally infeasible due to ethical reasons and the elastic properties of the brain degrade rapidly postmortem. We present a simulation approach thatmodels ultrasound propagation in the human brain, while it is moving due to the complex shear shock wave deformation froma traumatic impact. Finite difference simulations can model ultrasound propagation in complex media such as human tissue. Recently, we have shown that the fullwave finite difference approach can also be used to represent displacements that are much smaller than the grid size, such as the motion encountered in shear wave propagation from ultrasound elastography. However, this subresolution displacement model, called impedance flow, was only implemented and validated for acoustical media composed of randomly distributed scatterers. Herein, we propose a generalization of the impedance flow method that describes the continuous subresolution motion of structured acoustical maps, and in particular of acoustical maps of the human brain. It is shown that the average error in simulating subresolution displacements using impedance flow is small when compared to the acoustical wavelength (lambda/1702). The method is then applied to acoustical maps of the human brain with a motion that is imposed by the propagation of a shear shock wave. This motion is determined numerically with a custom piecewise parabolic method that is calibrated to ex vivo observations of shear shocks in the porcine brain. Then the fullwave simulation tool is used to model transmit-receive imaging sequences based on an L7-4 imaging transducer. The simulated radio frequency data are beamformed using a conventional delay-and-sum method and a normalized cross-correlationmethod designed for shockwave tracking is used to determine the tissue motion. This overall process is an in silico reproduction of the experiments that were previously performed to observe shear shock waves in fresh porcine brain. It is shown that the proposed generalized impedance flow method accurately captures the shear wave motion in terms of the wave profile, shock front characteristics, odd harmonic spectrum generation, and acceleration at the shear shock front. We expect that this approach will lead to improvements in image sequence design that takes into account the aberration and multiple reflections from the brain and in the design of tracking algorithms that can more accurately capture the complex brain motion that occurs during a traumatic impact. These methods of modeling ultrasound propagation in moving media can also be applied to other displacements, such as those generated by shear wave elastography or blood flow.	[Chandrasekaran, Sandhya] North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA; [Tripathi, Bharat B.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Tripathi, Bharat B.; Pinton, Gianmarco F.] North Carolina State Univ, Raleigh, NC 27695 USA; [Tripathi, Bharat B.] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway H91 TK33, Ireland; [Espindola, David] Univ OHiggins, Inst Ciencias Ingn, Rancagua 2820000, Chile; [Pinton, Gianmarco F.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA		Pinton, GF (corresponding author), North Carolina State Univ, Raleigh, NC 27695 USA.; Pinton, GF (corresponding author), Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.	gia@email.unc.edu		Tripathi, Bharat/0000-0001-6757-0735; Espindola, David/0000-0001-6675-9560	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS091195]	This work was supported by the National Institute of Health under Grant R01-NS091195.	Ackerman MJ, 1998, P IEEE, V86, P504, DOI 10.1109/5.662875; Anderson ME, 2000, J ACOUST SOC AM, V107, P3540, DOI 10.1121/1.429422; Catheline S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.164301; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; Crow F. C., 1981, IEEE Computer Graphics and Applications, V1, P40; Dahl JJ, 2012, IEEE T ULTRASON FERR, V59, P648, DOI 10.1109/TUFFC.2012.2243; Damera-Venkata N, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1477926.1477935; Espindola D., 2017, 2017 IEEE INT ULTR S, P537; Espindola D., 2018, P IEEE INT ULTR S IU; Espindola D, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.044024; FINK M, 1992, IEEE T ULTRASON FERR, V39, P555, DOI 10.1109/58.156174; Fuchs H., 1985, P SIGGRAPH COMP GRAP, V19, P111; Jakovljevic M, 2017, IEEE T ULTRASON FERR, V64, P910, DOI 10.1109/TUFFC.2017.2683559; Joshi A, 2017, PHYS MED BIOL, V62, DOI 10.1088/1361-6560/aa6523; Korein J., 1983, Computer Graphics, V17, P377; Landau L.D., 1986, THEORY ELASTICITY, V7; LeVeque RJ, 2002, FINITE VOLUME METHOD, V31; Mast T. D., 2002, Acoustics Research Letters Online, V3, P53, DOI 10.1121/1.1447722; Mast TD, 1998, J ACOUST SOC AM, V104, P3651, DOI 10.1121/1.423947; Mast TD, 1997, J ACOUST SOC AM, V102, P1177, DOI 10.1121/1.421015; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Pernot M, 2007, J NEUROSURG, V106, P1061, DOI 10.3171/jns.2007.106.6.1061; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Pinton G, 2011, MED PHYS, V38, P1207, DOI 10.1118/1.3531553; Pinton GF, 2017, IEEE T ULTRASON FERR, V64, P537, DOI 10.1109/TUFFC.2016.2638801; Pinton GF, 2014, IEEE T ULTRASON FERR, V61, P1976, DOI 10.1109/TUFFC.2014.006362; Pinton GF, 2012, IEEE T ULTRASON FERR, V59, P1149, DOI [10.1109/TUFFC.2012.2305, http://dx.doi.org/10.1109/TUFFC.2012.2305]; Pinton GF, 2011, IEEE T ULTRASON FERR, V58, P1272, DOI 10.1109/TUFFC.2011.1938; Pinton GF, 2009, IEEE T ULTRASON FERR, V56, P474, DOI 10.1109/TUFFC.2009.1066; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Smoller J., 2012, SHOCK WAVES REACTION, V258; Soulioti DE, 2020, IEEE T ULTRASON FERR, V67, P25, DOI 10.1109/TUFFC.2019.2937733; Tripathi BB, 2017, SHOCK WAVES, V27, P879, DOI 10.1007/s00193-017-0734-8; Tripathi BB, 2019, J COMPUT PHYS, V395, P205, DOI 10.1016/j.jcp.2019.06.014; Tripathi BB, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3187; Ye W, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2901; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	38	1	1	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-3010	1525-8955		IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	JAN	2021	68	1					201	212		10.1109/TUFFC.2020.3022567			12	Acoustics; Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Engineering	PK8SE	WOS:000602706700020	32894713	Green Submitted			2022-02-06	
J	Chang, T; Yan, XG; Zhao, C; Zhang, YF; Wang, B; Gao, L				Chang, Tao; Yan, Xigang; Zhao, Chao; Zhang, Yufu; Wang, Bao; Gao, Li			Risk Factors and Neurologic Outcomes in Patients with Traumatic Brain Injury and Coagulopathy Within 72 h After Surgery	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						traumatic brain injury; postoperative coagulopathy; surgery; risk factor; mortality	RESUSCITATION; MANAGEMENT; MORTALITY	Objective: The purpose of this study was to explore the effect of coagulopathy in patients with traumatic brain injury (TBI) during the early postoperative period. Methods: The baseline characteristics, intraoperative management, and follow-up data of 462 patients with TBI between January 2015 and June 2019 were collected and retrospec-tively analyzed by multivariate logistic regression. Coagulopathy was defined as activated partial thromboplastin time > 40 s, international normalized ratio > 1.4, or platelet counts < 100x10(9)/L. Results: Multivariate logistic regression analysis revealed that the Glasgow Coma Scale (GCS) on admission, Injury Severity Score (ISS) on admission, pupil mydriasis, duration of surgery, intraoperative blood loss, and intraoperative crystalloid resuscitation were indepen-dent risk factors for patients who developed coagulopathy after surgery. There were statis-tical differences in mortality (p = 0.049), the Glasgow Outcome Scale-Extended (GCS-E; p = 0.024), and the modified Rankin Scale (p = 0.043) between the patients with and without coagulopathy 1 week after surgery. Coagulopathy within 72 h after surgery revealed the higher mortality at 1 week (66.7%), 3 months (71.4%), and 6 months (76.2%). Coagulopathy within 72 h after surgery in patients with a TBI predicted worse disease progression and unfavorable neurologic outcomes. Conclusion: Taking practical and reasonable measures to manage these risk factors may protect patients with TBI from postoperative coagulopathy.	[Chang, Tao] Air Force Med Univ, Dept Emergency, Affiliated Hosp 2, Xian 710038, Shaanxi, Peoples R China; [Yan, Xigang] Air Force Med Univ, Dept Anesthesiol, Affiliated Hosp 2, Xian 710038, Shaanxi, Peoples R China; [Zhao, Chao] Air Force Med Univ, Dept Neurol, Affiliated Hosp 2, Xian 710038, Shaanxi, Peoples R China; [Zhang, Yufu; Wang, Bao; Gao, Li] Air Force Med Univ, Dept Neurosurg, Affiliated Hosp 2, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China		Gao, L (corresponding author), Air Force Med Univ, Dept Neurosurg, Affiliated Hosp 2, 1 Xinsi Rd, Xian 710038, Shaanxi, Peoples R China.	gaoli553@163.com			General Program of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971186]	This work was supported by the General Program of National Natural Science Foundation of China [Grant number: 81971186].	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Davenport RA, 2017, ANESTHESIOLOGY, V126, P115, DOI 10.1097/ALN.0000000000001428; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Folkerson LE, 2018, AM J EMERG MED, V36, P38, DOI 10.1016/j.ajem.2017.06.057; Solla DJF, 2021, NEUROCRIT CARE, V34, P130, DOI 10.1007/s12028-020-00991-7; Frith D, 2010, SURG-J R COLL SURG E, V8, P159, DOI 10.1016/j.surge.2009.10.022; Fullenbach C, 2017, CURR OPIN ANESTHESIO, V30, P243, DOI 10.1097/ACO.0000000000000427; Gando S, 2016, SEMIN THROMB HEMOST, V42, P155, DOI 10.1055/s-0035-1564831; Goobie SM, 2019, PEDIATR ANESTH, V29, P231, DOI 10.1111/pan.13574; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hahn RG, 2017, ANAESTH INTENSIVE TH, V49, P303, DOI 10.5603/AIT.a2017.0045; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; Ko A, 2017, AM SURGEON, V83, P1447; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Nasi D, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01186; Rizoli SB, 2011, J TRAUMA, V71, pS427, DOI 10.1097/TA.0b013e318232e5ab; Schmidt LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166223; Shin CH, 2018, ANN SURG, V267, P1084, DOI 10.1097/SLA.0000000000002220; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	27	1	1	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2021	17						2905	2913		10.2147/NDT.S323897			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	UR8MM	WOS:000696996300001	34531657	gold, Green Published			2022-02-06	
J	Chen, W; Barback, CV; Wang, SS; Hoh, CK; Chang, EY; Hall, DJ; Head, BP; Vera, DR				Chen, Wen; Barback, Christopher, V; Wang, Shanshan; Hoh, Carl K.; Chang, Eric Y.; Hall, David J.; Head, Brian P.; Vera, David R.			A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [Tc-99m]Tc-tilmanocept	NUCLEAR MEDICINE AND BIOLOGY			English	Article						Traumatic brain injury; Blood brain barrier; Tilmanocept; cd206; Microglial cells; Fluorescence imaging	MANNOSE RECEPTOR; BARRIER PERMEABILITY; ENDOTHELIAL-CELLS; BLOOD; DYSFUNCTION; TILMANOCEPT; DISRUPTION; ACTIVATION; CLEARANCE; BREAKDOWN	Introduction: Blood-brain barrier (BBB) disruption and subsequent neuro-inflammation occur following traumatic brain injury (TBI), resulting in a spectrum of human nervous system disorders. [Tc-99m]Tc-tilmanocept is a receptor-binding radiopharmaceutical FDA-approved for sentinel lymph node mapping. We hypothesize that after an intravenous (i.v.) injection, [Tc-99m]Tc-tilmanocept, will traverse a disrupted BBB and bind to CD206-bea ring microglial cells. Methods: Age-matched mice were divided into three groups: 5-days post TBI (n = 4), and 5-days post sham (n = 4), and naive controls (n = 4). IRDye800CW-labeled [Tc-99m]Tc-tilmanocept (0.15 nmol per gram body weight) and FITC-labeled bovine scrum albumin (FITC-B5A) were injected (i.v.) into each mouse. Mice were imaged with a high-resolution gamma camera for 45 min. Immediately after imaging, the brains were perfused with fixative, excised, imaged with a fluorescence scanner, assayed for radioactivity, and prepared for histology. Results: In vivo nuclear imaging, ex vivo fluorescence imaging, ex vivo gamma well counting, and histomicroscopy demonstrated enhanced tilmanocept uptake in the TBI region. The normalized [Tc-99m]Tc-tilmanocept uptake value from nuclear imaging and the maximum pixel intensity from fluorescence imaging of the TBI group ( 1.12 +/- 0.12 and 2288 +/- 278 a.u., respectively) were significantly (P < 0.04) higher than the sham group (0.64 0.28 and 1708 +/- 101 am., respectively) and the naive group (0.76 +/- 024 and 1643 +/- 391 a.u., respectively). The mean [Tc-99m]Tc-tilmanocept scaled uptake in the TBI brains (0.058 +/- 0.013%/g) was significantly (P < 0.010) higher than the scaled brain uptake of the sham group (0.031 +/- 0.011%/g) and higher (P 0.04) than the uptake of the naive group (0.020 +/- 0.002%/g). Fluorescence microscopy demonstrated increased uptake of the IRDye800CW-tilmanocept and ITTC-BSA in the TBI brain regions. Conclusion: [Tc-99m]Tc-tilmanocept traverses disrupted blood-brain barrier and localizes within the injured region. Advances in knowledge and implications for patient care: [Tc-99m]Tc-tilmanocept could serve as an imaging biomarker for TBI-associated neuroinflammation and any disease process that involves a disruption of the blood-brain barrier. (C) 2020 Elsevier Inc. All rights reserved.	[Chen, Wen; Barback, Christopher, V; Hoh, Carl K.; Chang, Eric Y.; Hall, David J.; Vera, David R.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Wang, Shanshan; Chang, Eric Y.; Head, Brian P.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA; [Wang, Shanshan; Head, Brian P.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA		Vera, DR (corresponding author), Univ Calif San Diego, Dept Radiol, Moores Canc Ctr, 3855 Hlth Sci Dr 0819, La Jolla, CA 92093 USA.	dvera@ucsd.edu			NCI In Vivo Cancer and Molecular Imaging Program [P50 CA128346]	This work was funded in part by the NCI In Vivo Cancer and Molecular Imaging Program (P50 CA128346).	Anderson KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197842; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; ECKELMAN WC, 1979, J NUCL MED, V20, P350; ECKELMAN WC, 1978, J NUCL MED, V19, P1179; Egawa J, 2017, FASEB J, V31, P3403, DOI 10.1096/fj.201601288RRR; Emerson DK, 2012, RADIOLOGY, V265, P186, DOI 10.1148/radiol.12120638; European Medicines Agency (EMA), 2014, EMACHMP5254452014; Faul M, 2010, TRAUMATIC BRAIN INJU; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Gammeltoft TM, 2013, CURR ANTHROPOL, V54, pS159, DOI 10.1086/670389; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Haley MJ, 2017, J CEREBR BLOOD F MET, V37, P456, DOI 10.1177/0271678X16629976; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hosseini A, 2014, J SURG RES, V190, P528, DOI 10.1016/j.jss.2014.05.012; Ingrisch M, 2013, J PHARMACOKINET PHAR, V40, P281, DOI 10.1007/s10928-013-9315-3; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kanda T, 2015, RADIOLOGY, V276, P228, DOI 10.1148/radiol.2015142690; Kassner A, 2015, STROKE, V46, P3310, DOI 10.1161/STROKEAHA.115.008861; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lee HJ, 2017, J NUCL MED, V58, P547, DOI 10.2967/jnumed.116.178582; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Liss MA, 2014, UROLOGY, V84, P982, DOI DOI 10.1016/J.UROLOGY.2014.06.021; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Mazzone P, 2010, INT J ENV RES PUB HE, V7, P4111, DOI 10.3390/ijerph7124111; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Merkel SF, 2016, BLOOD BRAIN BARRIER, P48; Miki K, 2001, J NUCL MED, V42, P733; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Ozkul-Wermester O, 2014, EUR NEUROL, V72, P45, DOI 10.1159/000358297; Pan YJ, 2018, ADV DRUG DELIVER REV, V135, P62, DOI 10.1016/j.addr.2018.04.009; Patel JP, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/708306; Qin ZT, 2015, NUCL MED BIOL, V42, P917, DOI 10.1016/j.nucmedbio.2015.07.011; Qin ZT, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101315; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SCHLESINGER PH, 1978, BIOCHEM J, V176, P103, DOI 10.1042/bj1760103; Schnabl B, 2016, NUCL MED BIOL, V43, P179, DOI 10.1016/j.nucmedbio.2015.11.009; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; STADALNIK RC, 1993, INVEST RADIOL, V28, P64, DOI 10.1097/00004424-199301000-00018; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Stroup SP, 2012, CLIN EXP METASTAS, V29, P673, DOI 10.1007/s10585-012-9498-9; Taheri S, 2011, MAGN RESON MED, V65, P1036, DOI 10.1002/mrm.22686; Takeda S, 2013, NEUROBIOL AGING, V34, P2064, DOI 10.1016/j.neurobiolaging.2013.02.010; Tanford C., 1961, PHYS CHEM MACROMOLEC; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; van de Haar HJ, 2015, NEUROSCI BIOBEHAV R, V49, P71, DOI 10.1016/j.neubiorev.2014.11.022; Veksler R, 2014, ARCH MED RES, V45, P646, DOI 10.1016/j.arcmed.2014.11.016; Vera DR, 1996, J NUCL MED, V37, P160; Vera DR, 2001, J NUCL MED, V42, P951; Wallace AM, 2003, ANN SURG ONCOL, V10, P531, DOI 10.1245/ASO.2003.07.012; Wilson CM, 2009, INT J RADIAT ONCOL, V74, P934, DOI 10.1016/j.ijrobp.2009.02.035; Yorulmaz H, 2011, BOSNIAN J BASIC MED, V11, P108; ZIYLAN YZ, 1993, MOL CHEM NEUROPATHOL, V20, P203	59	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0969-8051	1872-9614		NUCL MED BIOL	Nucl. Med. Biol.	JAN	2021	92				SI		107	114		10.1016/j.nucmedbio.2020.02.013			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	QF1IL	WOS:000616652500013	32169304				2022-02-06	
J	De Freitas, DJ; De Carvalho, D; Paglioni, VM; Brunoni, AR; Valiengo, L; Thome-Souza, MS; Guirado, VMP; Zaninotto, AL; Paiva, WS				De Freitas, Daglie Jorge; De Carvalho, Daniel; Paglioni, Vanessa Maria; Brunoni, Andre R.; Valiengo, Leandro; Thome-Souza, Maria Sigride; Guirado, Vinicius M. P.; Zaninotto, Ana Luiza; Paiva, Wellingson S.			Effects of transcranial direct current stimulation (tDCS) and concurrent cognitive training on episodic memory in patients with traumatic brain injury: a double-blind, randomised, placebo-controlled study	BMJ OPEN			English	Article						neurological injury; rehabilitation medicine; clinical trials	DORSOLATERAL PREFRONTAL CORTEX; POWER SPECTRUM; AXONAL INJURY; FOLLOW-UP; DEFICITS; EEG; REHABILITATION; SAFETY	Introduction Deficits in episodic memory following traumatic brain injury (TBI) are common and affect independence in activities of daily living. Transcranial direct current stimulation (tDCS) and concurrent cognitive training may contribute to improve episodic memory in patients with TBI. Although previous studies have shown the potential of tDCS to improve cognition, the benefits of the tDCS applied simultaneously to cognitive training in participants with neurological disorders are inconsistent. This study aims to (1) investigate whether active tDCS combined with computer-assisted cognitive training enhances episodic memory compared with sham tDCS; (2) compare the differences between active tDCS applied over the left dorsolateral prefrontal cortex (lDLPFC) and bilateral temporal cortex (BTC) on episodic memory and; (3) investigate inter and intragroup changes on cortical activity measured by quantitative electroencephalogram (qEEG). Methods and analysis A randomised, parallel-group, double-blind placebo-controlled study is conducted. Thirty-six participants with chronic, moderate and severe closed TBI are being recruited and randomised into three groups (1:1:1) based on the placement of tDCS sponges and electrode activation (active or sham). TDCS is applied for 10 consecutive days for 20 min, combined with a computer-based cognitive training. Cognitive scores and qEEG are collected at baseline, on the last day of the stimulation session, and 3 months after the last tDCS session. We hypothesise that (1) the active tDCS group will improve episodic memory scores compared with the sham group; (2) differences on episodic memory scores will be shown between active BTC and lDLPFC and; (3) there will be significant delta reduction and an increase in alpha waves close to the location of the active electrodes compared with the sham group. Ethics and dissemination This study was approved by Hospital das Clinicas, University of Sao Paulo Ethical Institutional Review Border (CAAE: 87954518.0.0000.0068).	[De Freitas, Daglie Jorge; De Carvalho, Daniel; Paglioni, Vanessa Maria; Guirado, Vinicius M. P.; Zaninotto, Ana Luiza; Paiva, Wellingson S.] Univ Sao Paulo, Hosp Clin, Div Neurol Neurosurg, HCFMUSP,Fac Med, Sao Paulo, Brazil; [Brunoni, Andre R.; Valiengo, Leandro; Thome-Souza, Maria Sigride] Univ Sao Paulo, Hosp Clin, Inst Psychiat, IPq HCFMUSP, Sao Paulo, Brazil; [Brunoni, Andre R.; Valiengo, Leandro] Univ Sao Paulo, Interdisciplinary Ctr Appl Neuromodulat, Sao Paulo, Brazil; [Brunoni, Andre R.; Valiengo, Leandro] Univ Sao Paulo, Serv Interdisciplinary Neuromodulat, Sao Paulo, Brazil; [Zaninotto, Ana Luiza] MGH Inst Hlth Profess, Speech & Feeding Disorders Lab, Boston, MA 02129 USA		Zaninotto, AL (corresponding author), Univ Sao Paulo, Hosp Clin, Div Neurol Neurosurg, HCFMUSP,Fac Med, Sao Paulo, Brazil.; Zaninotto, AL (corresponding author), MGH Inst Hlth Profess, Speech & Feeding Disorders Lab, Boston, MA 02129 USA.	acostazaninotto@mghihp.edu	da Costa Lane Valiengo, Leandro/E-5406-2016; Paiva, Wellingson S/G-5517-2013; de Carvalho, Daniel/ABD-4710-2021; Guirado, Vinicius Monteiro de Paula/AAG-7299-2019; Costa Zaninotto, Ana Luiza/I-4095-2016; Russowsky Brunoni, Andre/H-8394-2012	da Costa Lane Valiengo, Leandro/0000-0002-7628-9993; Paiva, Wellingson S/0000-0002-5165-7040; de Carvalho, Daniel/0000-0003-4960-0800; Guirado, Vinicius Monteiro de Paula/0000-0002-7782-3609; Costa Zaninotto, Ana Luiza/0000-0003-0639-0612; Russowsky Brunoni, Andre/0000-0002-6310-3571	coordination for the Improvement of Higher Education Personnel (CAPES)-BrazilCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Institute of Health NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [3R01DC017291-02]; NIHR Global Health Research Group on Neurotrauma [16/137/105]	VMP reports grant from coordination for the Improvement of Higher Education Personnel (CAPES)-Brazil. ALZ is supported by the National Institute of Health NIDCD 3R01DC017291-02. WSP is supported by the NIHR Global Health Research Group on Neurotrauma, which was commissioned by the National Institute for Health Research (NIHR) using UK aid from the UK Government (project 16/137/105).	Amatachaya A, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/173073; Antal A, 2017, CLIN NEUROPHYSIOL, V128, P1774, DOI 10.1016/j.clinph.2017.06.001; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Antonenko D, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00200; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Balconi M, 2012, NEUROSCI LETT, V517, P25, DOI 10.1016/j.neulet.2012.04.010; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Britton JW., 2016, ELECTROENCEPHALOGRAP, P1, DOI [10.5698/978-0-9979756-0-4, DOI 10.5698/978-0-9979756-0-4]; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Cunha JA., 2001, MANUAL VERSAO PORTUG, V1st, P171; De Paula J., 2018, TESTE APRENDIZAGEM A; Denney DA, 2015, ARCH CLIN NEUROPSYCH, V30, P404, DOI 10.1093/arclin/acv035; Dressler O, 2004, BRIT J ANAESTH, V93, P806, DOI 10.1093/bja/aeh270; Eichenbaum H, 2017, NAT REV NEUROSCI, V18, P547, DOI 10.1038/nrn.2017.74; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Fernandez E, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8010004; Fileccia E, 2019, NEUROL SCI, V40, P1865, DOI 10.1007/s10072-019-03903-6; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Galli G, 2019, BRAIN STIMUL, V12, P231, DOI 10.1016/j.brs.2018.11.008; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gorenstein C., 2011, MANUAL INVENTARIO DE, V1st, P172; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Hughes J., 1994, EEG CLIN PRACTICE, V2nd, P242; Jacobson L, 2012, CLIN NEUROPHYSIOL, V123, P979, DOI 10.1016/j.clinph.2011.09.016; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Leshikar ED, 2017, NEUROPSYCHOLOGIA, V106, P390, DOI 10.1016/j.neuropsychologia.2017.10.022; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Liu AL, 2016, EPILEPSY BEHAV, V55, P11, DOI 10.1016/j.yebeh.2015.10.032; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Marceglia S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00134; Medvedeva A, 2019, CEREB CORTEX, V29, P657, DOI 10.1093/cercor/bhx347; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller J, 2015, NEUROSCI LETT, V588, P114, DOI 10.1016/j.neulet.2015.01.014; Miniussi Carlo, 2013, Handb Clin Neurol, V116, P739, DOI 10.1016/B978-0-444-53497-2.00056-5; Miniussi C, 2013, NEUROSCI BIOBEHAV R, V37, P1702, DOI 10.1016/j.neubiorev.2013.06.014; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; de Amorim RLO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00164; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Park SH, 2013, J KOREAN NEUROSURG S, V54, P484, DOI 10.3340/jkns.2013.54.6.484; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Ross LA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00016; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Sandrini M, 2019, NEUROBIOL LEARN MEM, V163, DOI 10.1016/j.nlm.2019.107037; Sandrini M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00289; Sozda CN, 2014, NEUROPSYCHOLOGY, V28, P347, DOI 10.1037/neu0000043; Tadini L, 2011, J ECT, V27, P134, DOI 10.1097/YCT.0b013e3181e631a8; Timmer ML, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00246; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Veisi-Pirkoohi S, 2020, J CLIN NEUROSCI, V71, P101, DOI 10.1016/j.jocn.2019.08.114; Wechsler D., 2004, WAIS 3 ESCALA INTELI, V1st, P276; Wilke S., 2016, J NEUROTRAUM, V2, P1; Wright MJ, 2011, J HEAD TRAUMA REHAB, V26, P182, DOI 10.1097/HTR.0b013e318218dcf9; Yoo C, 2015, J PHYS THER SCI, V27, P2487, DOI 10.1589/jpts.27.2487; Yun GJ, 2015, J STROKE, V17, P354, DOI 10.5853/jos.2015.17.3.354; Zaehle T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-2; Zaninotto Ana Luiza, 2019, Dement. neuropsychol., V13, P172, DOI 10.1590/1980-57642018dn13-020005; Zaninotto AL, 2017, ACTA NEUROPSYCHIATR, V29, P35, DOI 10.1017/neu.2016.29; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	71	1	1	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	8							e045285	10.1136/bmjopen-2020-045285			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UX5YJ	WOS:000700920300027	34446480				2022-02-06	
J	de Munter, L; Polinder, S; Havermans, RJM; Steyerberg, EW; de Jongh, MAC				de Munter, Leonie; Polinder, Suzanne; Havermans, Roos J. M.; Steyerberg, Ewout W.; de Jongh, Mariska A. C.			Prognostic factors for recovery of health status after injury: a prospective multicentre cohort study	BMJ OPEN			English	Article						trauma management; epidemiology; accident; emergency medicine	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; FUNCTIONAL STATUS; MAJOR TRAUMA; OUTCOMES; PATIENT; SYSTEM; CARE	Objectives To determine prognostic factors for health status and recovery patterns during the first 2 years after injury in the clinical trauma population. Design A prospective longitudinal cohort study. Setting Ten participating hospitals in Brabant, the Netherlands. Participants Injured adult patients admitted to a hospital between August 2015 and November 2016 were followed: 4883 (50%) patients participated. Main outcome measures Primary outcome was health status, measured with the EuroQol-5-dimensions-3-levels (EQ-5D), including a cognition item and the EuroQol Visual Analogue Scale. Health status was collected at 1 week, 1, 3, 6, 12 and 24 months after injury. Potential prognostic factors were based on literature and clinical experience (eg, age, sex, pre-injury frailty (Groningen Frailty Index), pre-injury EQ-5D). Results Health status increased mainly during the first 6 months after injury with a mean EQ-5D utility score at 1 week of 0.49 and 0.79 at 24 months. The dimensions mobility, pain/discomfort and usual activities improved up to 2 years after injury. Lower pre-injury health status, frailty and longer length of stay at the hospital were important prognostic factors for poor recovery. Spine injury, lower and upper extremity injury showed to be prognostic factors for problems after injury. Traumatic brain injury was a prognostic factor for cognitive problems. Conclusion This study contributes to the increase in knowledge of health recovery after injury. It could be a starting point to develop prediction models for specific injury classifications and implementation of personalised medicine.	[de Munter, Leonie; de Jongh, Mariska A. C.] Elisabeth TweeSteden Hosp, Trauma TopCare, Tilburg, Netherlands; [Polinder, Suzanne; Steyerberg, Ewout W.] Erasmus MC, Publ Hlth, Rotterdam, Netherlands; [Havermans, Roos J. M.; de Jongh, Mariska A. C.] Network Emergency Care Brabant, Brabant Trauma Registry, Tilburg, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Biomed Data Sci, Med Ctr, Leiden, Netherlands		de Munter, L (corresponding author), Elisabeth TweeSteden Hosp, Trauma TopCare, Tilburg, Netherlands.	l.demunter@etz.nl			Dutch organisation for health research and care innovation (ZonMW) section TopCare projects [80-84200-98-14226]	This work was supported by a grant of the Dutch organisation for health research and care innovation (ZonMW) section TopCare projects (grant number: 80-84200-98-14226).	Aitken LM, 2007, INJURY, V38, P19, DOI 10.1016/j.injury.2006.05.020; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Christensen MC, 2011, J TRAUMA, V70, P1524, DOI 10.1097/TA.0b013e3181f053c2; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gabbe BJ, 2012, J TRAUMA ACUTE CARE, V72, P1102, DOI 10.1097/TA.0b013e3182464503; Gennarelli TA., 2008, ABBREVIATED INJURY S; Geraerds AJLM, 2019, QUAL LIFE RES, V28, P1931, DOI 10.1007/s11136-019-02144-6; Haider AH, 2020, ANN SURG, V271, P1165, DOI 10.1097/SLA.0000000000003101; Harris I, 2007, INJURY, V38, P1102, DOI 10.1016/j.injury.2007.05.004; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Kruithof N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231649; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Liberman M, 2004, J TRAUMA, V56, P1330, DOI 10.1097/01.TA.0000071297.76727.8B; Mancuso CA, 2003, J ARTHROPLASTY, V18, P872, DOI 10.1016/S0883-5403(03)00276-6; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Moore L, 2010, WORLD J SURG, V34, P2069, DOI 10.1007/s00268-010-0588-z; Ophuis RH, 2019, QUAL LIFE RES, V28, P1941, DOI 10.1007/s11136-019-02156-2; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Quale AJ, 2009, INJURY, V40, P498, DOI 10.1016/j.injury.2008.11.006; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Sampalis JS, 2006, J TRAUMA, V60, P806, DOI 10.1097/01.ta.0000215103.62783.4d; Scholten AC, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0127-3; Sleney J, 2014, INJURY, V45, P312, DOI 10.1016/j.injury.2012.12.025; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Steverink N, 2001, GERONTOLOGIST, V41, P236; Ulvik A, 2008, ACTA ANAESTH SCAND, V52, P195, DOI 10.1111/j.1399-6576.2007.01533.x; Van Buuren S, 1999, PGVGZ99054; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z	39	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	1							e038707	10.1136/bmjopen-2020-038707			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	PV8OX	WOS:000610241800012	33408198	gold, Green Published			2022-02-06	
J	de Souza, MR; Fagundes, CF; Solla, DJF; da Silva, GCL; Barreto, RB; Teixeira, MJ; de Amorim, RLO; Kolias, AG; Godoy, D; Paiva, WS				de Souza, Matheus Rodrigues; Fagundes, Caroline Ferreira; Solla, Davi Jorge Fontoura; da Silva, Gustavo Carlos Lucena; Barreto, Rafaela Borin; Teixeira, Manoel Jacobsen; Oliveira de Amorim, Robson Luis; Kolias, Angelos G.; Godoy, Daniel; Paiva, Wellingson Silva			Mismatch between midline shift and hematoma thickness as a prognostic factor of mortality in patients sustaining acute subdural hematoma	TRAUMA SURGERY & ACUTE CARE OPEN			English	Article						brain edema; brain injuries; brain injuries; traumatic; prognosis	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; SURGICAL-MANAGEMENT; CLASSIFICATION; PREDICTION; COUNTRIES; OUTCOMES; MODELS; ADULTS; AGE	Background Acute subdural hematoma (ASDH) is a traumatic lesion commonly found secondary to traumatic brain injury. Radiological findings on CT, such as hematoma thickness (HT) and structures midline shift (MLS), have an important prognostic role in this disease. The relationship between HT and MLS has been rarely studied in the literature. Thus, this study aimed to assess the prognostic accuracy of the difference between MLS and HT for acute outcomes in patients with ASDH in a low-income to middle-income country. Methods This was a post-hoc analysis of a prospective cohort study conducted in a university-associated tertiary-level hospital in Brazil. The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis) statement guidelines were followed. The difference values between MLS and HT (Zumkeller index, ZI) were divided into three categories (<0.00, 0.01-3, and >3). Logistic regression analyses were performed to reveal the OR of categorized ZI in predicting primary outcome measures. A Cox regression was also performed and the results were presented through HR. The discriminative ability of three multivariate models including clinical and radiological variables (ZI, Rotterdam score, and Helsinki score) was demonstrated. Results A total of 114 patients were included. Logistic regression demonstrated an OR value equal to 8.12 for the ZI >3 category (OR 8.12, 95% CI 1.16 to 40.01; p=0.01), which proved to be an independent predictor of mortality in the adjusted model for surgical intervention, age, and Glasgow Coma Scale (GCS) score. Cox regression analysis demonstrated that this category was associated with 14-day survival (HR 2.92, 95% CI 1.38 to 6.16; p=0.005). A multivariate analysis performed for three models including age and GCS with categorized ZI or Helsinki or Rotterdam score demonstrated area under the receiver operating characteristic curve values of 0.745, 0.767, and 0.808, respectively. Conclusions The present study highlights the potential usefulness of the difference between MLS and HT as a prognostic variable in patients with ASDH.	[de Souza, Matheus Rodrigues; Fagundes, Caroline Ferreira; da Silva, Gustavo Carlos Lucena; Barreto, Rafaela Borin] Mato Grosso State Univ, Dept Med, Caceres, MG, Brazil; [Solla, Davi Jorge Fontoura; Teixeira, Manoel Jacobsen; Oliveira de Amorim, Robson Luis; Paiva, Wellingson Silva] Univ Sao Paulo, Dept Neurol, Sao Paulo, Brazil; [Solla, Davi Jorge Fontoura; Paiva, Wellingson Silva] Univ Cambridge, Dept Neurol, Cambridge, England; [Kolias, Angelos G.] Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Godoy, Daniel] San Juan Bautista Hosp, Intens Care Unit, San Fernando Del Valle D, Argentina		Paiva, WS (corresponding author), Univ Sao Paulo, Div Neurosurg, Dept Neurol, Sao Paulo, SP, Brazil.	wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013	Paiva, Wellingson S/0000-0002-5165-7040	National Council for Scientific and Technological Development (CNPq), BrazilConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); NIHR Global Health Research Group on Neurotrauma; National Institute for Health Research (NIHR) from the UK Government [16/137/105]	This research was partially funded by the National Council for Scientific and Technological Development (CNPq), Brazil. DJFS, WSP and AGK are supported by the NIHR Global Health Research Group on Neurotrauma, which was commissioned by the National Institute for Health Research (NIHR) using UK aid from the UK Government (project 16/137/105). The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.	ABRASZKO R, 1995, J NEUROTRAUM, V9, P769, DOI DOI 10.1080/02688699550040747; Alagoz F, 2017, TURK NEUROSURG, V27, P187, DOI 10.5137/1019-5149.JTN.15177-15.2; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; ARMIN S, 2006, PLOS MED, V28, P445, DOI DOI 10.1179/016164106X115053; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Baucher G, 2019, WORLD NEUROSURG, V126, pE944, DOI 10.1016/j.wneu.2019.02.194; BULLOCK M, 2006, PLOS MED, V58, pS2, DOI DOI 10.1227/01.NEU.0000210364.29290.C9; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; CHANG E, 2007, NEUROSURGERY, V61, P647, DOI DOI 10.1227/01.NEU.0000279217.45881.69; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; de Amorim R., 2014, AUSTIN NEUROSURG OPE, V1, P1011; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; GREENE K, 1995, BRIT MED J, V83, P445, DOI DOI 10.3171/JNS.1995.83.3.0445; Hawryluk GWJ, 2020, NEUROSURGERY, V87, P427, DOI 10.1093/neuros/nyaa278; HELLEWELL S, 2016, NEUROL RES, V1640, P36, DOI DOI 10.1016/J.BRAINRES.2015.12.024; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kiboi JG, 2011, WORLD NEUROSURG, V75, P586, DOI 10.1016/j.wneu.2010.05.041; KIM KH, 2009, LANCET NEUROL, V45, P143, DOI DOI 10.3340/JKNS.2009.45.3.143; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; KOLIAS A, 2019, B WORLD HEALTH ORGAN, V18, P136, DOI DOI 10.1016/S1474-4422(18)30494-0; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kotwica Z, 1993, Acta Neurochir (Wien), V121, P95; LALEVA M, 2016, BRIT J NEUROSURG, V158, P1465, DOI DOI 10.1007/S00701-016-2854-9; Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Liao CC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77667-x; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MATAMBEMBA D, 2015, ACTA NEUROCHIR, V32, P359, DOI DOI 10.1089/NEU.2014.3453; MENDELOW A, 1983, J NEUROTRAUM, V287, P1173, DOI DOI 10.1136/BMJ.287.6400.1173; Moussa WMM, 2018, NEUROSURG REV, V41, P483, DOI 10.1007/s10143-017-0873-5; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PERKINS N, 2005, J NEUROTRAUM, V47, P428, DOI DOI 10.1002/BIMJ.200410133; PHUENPATHOM N, 1993, ACTA NEUROCHIR, V40, P22, DOI DOI 10.1016/0090-3019(93)90164-V; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; ROOZENBEEK B, 2013, J NEUROSURG, V9, P231, DOI DOI 10.1038/NRNEUROL.2013.22; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; STEYERBERG E, 2008, BMC MED, V5, P1251, DOI DOI 10.1371/JOURNAL.PMED.0050165; TANDON P, 2001, BIOMETRICS, V49, P3; Taussky P, 2012, WORLD NEUROSURG, V78, P306, DOI 10.1016/j.wneu.2011.10.030; TEASDALE G, 1998, NAT REV NEUROL, V15, P587, DOI DOI 10.1089/NEU.1998.15.587; THELIN E, 2017, J NEUROSURG, V14; Tsang KKT, 2012, BRIT J ORAL MAX SURG, V50, P298, DOI 10.1016/j.bjoms.2011.03.004; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; WISBORG T, 2011, J NEUROTRAUM, V19, P62, DOI DOI 10.1186/1757-7241-19-62; Won YD, 2018, WORLD NEUROSURG, V111, pE120, DOI 10.1016/j.wneu.2017.12.025; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	55	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2397-5776		TRAUMA SURG ACUTE CA	Trauma Surg. Acute Care Open		2021	6	1							e000707	10.1136/tsaco-2021-000707			7	Critical Care Medicine; Surgery	Emerging Sources Citation Index (ESCI)	General & Internal Medicine; Surgery	SK3TI	WOS:000656141200001	34104799	Green Published, gold			2022-02-06	
J	Deakin, ND; Suckling, J; Hutchinson, PJ				Deakin, Naomi D.; Suckling, John; Hutchinson, Peter J.			Research Evaluating Sports ConcUssion Events-Rapid Assessment of Concussion and Evidence for Return (RESCUE-RACER): a two-year longitudinal observational study of concussion in motorsport	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						concussion; motor sports; accident; MRI; brain	TRAUMATIC BRAIN-INJURY; CONTACT SPORTS; PERFORMANCE; RELIABILITY; FOOTBALL; AGE; EPIDEMIOLOGY; MANAGEMENT; STATEMENT; DIAGNOSIS	Introduction Concussion is a clinical diagnosis, based on self-reported patient symptoms supported by clinical assessments across many domains including postural control, ocular/vestibular dysfunction, and neurocognition. Concussion incidence may be rising in motorsport which, combined with unresolved challenges to accurate diagnosis and lack of guidance on the optimal return-to-race timeframe, creates a difficult environment for healthcare practitioners. Methods and analysis Research Evaluating Sports ConcUssion Events-Rapid Assessment of Concussion and Evidence for Return (RESCUE-RACER) evaluates motorsports competitors at baseline (Competitor Assessment at Baseline; Ocular, Neuroscientific (CArBON) study) and post-injury (Concussion Assessment and Return to motorSport (CARS) study), including longitudinal data. CArBON collects pre-injury neuroscientific data; CARS repeats the CArBON battery sequentially during recovery for competitors involved in a potentially concussive event. As its primary outcome, RESCUE-RACER will develop the evidence base for an accurate trackside diagnostic tool. Baseline objective clinical scoring (Sport Concussion Assessment Tool-5th edition (SCAT5)) and neurocognitive data (Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT)) will be assessed for specificity to motorsport and relationship to existing examinations. Changes to SCAT5 and ocular, vestibular, and reaction time function (Dx 100) will be estimated by the reliability change index as a practical tool for trackside diagnosis. Neuropsychological (Cambridge Neuropsychological Test Automated Battery (CANTAB)) assessments, brain MRI (7 Tesla) and salivary biomarkers will be compared with the new tool to establish utility in diagnosing and monitoring concussive injuries. Ethics and dissemination Ethical approval was received from East of England-Cambridge Central Research Ethics Committee (18/EE/0141). Participants will be notified of study outcomes via publications (to administrators) and summary reports (funder communications). Ideally, all publications will be open access. Trial registration number February 2019 nationally (Central Portfolio Management System 38259) and internationally (ClinicalTrials.gov NCT03844282).	[Deakin, Naomi D.; Hutchinson, Peter J.] Univ Cambridge, Clin Neurosci, Cambridge, England; [Suckling, John] Univ Cambridge, Dept Psychiat, Cambridge, England		Deakin, ND (corresponding author), Univ Cambridge, Clin Neurosci, Cambridge, England.	naomi.deakin@cantab.net	Suckling, John/ABD-7246-2021	Suckling, John/0000-0002-5098-1527; Hutchinson, Peter/0000-0002-2796-1835	FIA Foundation;  [RG95299/G105928]	This work was supported by the FIA Foundation, initially via the research group of the FIA (formerly known as the Global Institute for Motorsport Safety, GIMSS; year 1) and later by the FIA directly (years 2 and 3) grant number RG95299/G105928. The Funder will appraise written submissions of the study results prior to publication.	Agency D & VL, 2018, ASS FITN DRIV GUID M; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Asken BM, SCAT5 VS SCAT3 SYMPT; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; Deakin ND, 2017, J CONCUSSION, V1, DOI [10.1177/2059700217733916, DOI 10.1177/2059700217733916]; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Federation Internationale de Motocyclisme, 2016, FIM MED COD; Foley C, 2014, CURR SPORT MED REP, V13, P390, DOI 10.1249/JSR.0000000000000104; Garrick JG, 2005, CLIN J SPORT MED, V15, P385, DOI 10.1097/01.jsm.0000181438.48892.1b; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Giza CC, 2001, J ATHL TRAINING, V36, P228; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hart MG, 2016, BRIT J NEUROSURG, V30, P506, DOI 10.1080/02688697.2016.1208809; Helmy A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5748; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Hoffer ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146039; Hutchinson P, CONCUSSION MOTOR SPO; ImPACT, IMPACT APPL CONC MAN; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kilianski J, 2017, J CLIN NEUROSCI, V45, P100, DOI 10.1016/j.jocn.2017.07.021; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lunter CM, 2019, EMERG MED AUSTRALAS, V31, P355, DOI 10.1111/1742-6723.13163; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meehan WP, 2018, JAMA PEDIATR, V172, P14, DOI 10.1001/jamapediatrics.2017.3924; Michetti F, 2011, CLIN BIOCHEM, V44, P245, DOI 10.1016/j.clinbiochem.2010.10.007; Motorsport Association, 2016, MSA CONC GUID; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Neselius S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099870; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Norheim N, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000412; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Sandel NK, 2018, BRAIN INJURY, V32, P493, DOI 10.1080/02699052.2018.1429020; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Solomon GS, 2014, AM J SPORT MED, V42, P934, DOI 10.1177/0363546513518742; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; Trafford P, 2015, SURVEY CONCUSSION; TT R, 2018, OCULOMOTOR VESTIBULA; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zahra D, 2010, PSYPAG Q; Zuckerman SL, 2013, J NEUROSURG PEDIAT	63	1	1	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2021	7	1							e000879	10.1136/bmjsem-2020-000879			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PY8HR	WOS:000612282800002	33500784	Green Published, gold			2022-02-06	
J	Di Lu, L; Heinze, KL				Di Lu, Landy; Heinze, Kathryn L.			Examining Institutional Entrepreneurship in the Passage of Youth Sport Concussion Legislation	JOURNAL OF SPORT MANAGEMENT			English	Article						institutional theory; institutional change; sport policy; qualitative case study	QUALITATIVE RESEARCH; POLICY; STRATEGIES; WORK; ENVIRONMENTS; MAINTENANCE; LEGITIMACY; PRESSURES; FIELD; RESPONSIBILITY	New sport policies often prompt organizations in the field to alter their structures and processes. Little is known, however, about the tactics of those leading institutional change around sport policy. To address this gap, the authors draw on the concept of institutional entrepreneurship-the activities of actors who leverage resources to create institutional change. Using a qualitative case study approach, the authors examine how two coalitions that served as institutional entrepreneurs in Washington and Oregon created and passed the first youth sport concussion legislation in the United States. The analysis of this study reveals that these coalitions (including victims' families, sport organizations, advocacy groups, and concussion specialists) engaged in political, technical, and cultural activities through the use of specific tactics that allowed them to harness expertise and resources and generate support for the legislation. Furthermore, the findings of this study suggest a sequencing to these activities, captured in a model of institutional entrepreneurship around sport policy.	[Di Lu, Landy] Western Univ, Sport Management, Sch Kinesiol, London, ON, Canada; [Heinze, Kathryn L.] Univ Michigan, Sport Management, Sch Kinesiol, Ann Arbor, MI USA		Di Lu, L (corresponding author), Western Univ, Sport Management, Sch Kinesiol, London, ON, Canada.	dlu97@uwo.ca					Abdelnour S, 2017, ORGAN STUD, V38, P1775, DOI 10.1177/0170840617708007; Adams WM, 2016, J ATHL TRAINING, V51, P358, DOI 10.4085/1062-6050-51.4.14; Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Agyemang KJA, 2018, J SPORT MANAGE, V32, P567, DOI 10.1123/jsm.2017-0268; Anderson DJ, 2006, J HIGH EDUC, V77, P225, DOI 10.1353/jhe.2006.0010; Babiak K, 2011, CORP SOC RESP ENV MA, V18, P11, DOI 10.1002/csr.229; Battilana J, 2009, ACAD MANAG ANN, V3, P65, DOI 10.1080/19416520903053598; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beland D, 2016, J EUR PUBLIC POLICY, V23, P428, DOI 10.1080/13501763.2015.1115533; Carney M, 2002, ORGAN STUD, V23, P1, DOI 10.1177/0170840602231001; Charmaz K, 2004, QUAL HEALTH RES, V14, P976, DOI 10.1177/1049732304266795; Chesnutt J., 2014, EXAMINING LATEST SCI; Cousens L, 2005, J SPORT MANAGE, V19, P13, DOI 10.1123/jsm.19.1.13; Creed WED, 2010, ACAD MANAGE J, V53, P1336, DOI 10.5465/AMJ.2010.57318357; Cunningham G. B., 2001, Sport Management Review, V4, P47, DOI 10.1016/S1441-3523(01)70069-1; D'Aunno T, 2000, ADMIN SCI QUART, V45, P679, DOI 10.2307/2667016; Danisman A, 2006, CAN J ADM SCI, V23, P301; Dejean F, 2004, HUM RELAT, V57, P741, DOI 10.1177/0018726704044954; Di Lu L, 2019, J SPORT MANAGE, V33, P493, DOI 10.1123/jsm.2018-0330; Djelic Marie-Laure, 1998, EXPORTING AM MODEL P; Dorado S, 2013, ORGAN STUD, V34, P533, DOI 10.1177/0170840612470255; Dowling M, 2016, J SPORT MANAGE, V30, P396, DOI 10.1123/jsm.2014-0290; Edelman LB, 1997, ANNU REV SOCIOL, V23, P479, DOI 10.1146/annurev.soc.23.1.479; Edwards JR, 2015, J SPORT MANAGE, V29, P291, DOI 10.1123/jsm.2012-0122; Ellenbogen Richard G, 2014, Neurosurgery, V75 Suppl 4, pS122, DOI 10.1227/NEU.0000000000000495; Fahlen J, 2019, EUR SPORT MANAG Q, V19, P265, DOI 10.1080/16184742.2018.1516795; Fligstein N, 1997, AM BEHAV SCI, V40, P397, DOI 10.1177/0002764297040004003; G4 Athlete, 2013, WHAT EV SHOULD KNOW; Garud R, 2002, ACAD MANAGE J, V45, P196, DOI 10.2307/3069292; Gough C., 2018, SEATTLE SEAHAWKS FRA; Green M, 2004, SOCIOL SPORT J, V21, P376, DOI 10.1123/ssj.21.4.376; Greenwood R, 2006, ACAD MANAGE J, V49, P27; Gross K, 2008, POLIT PSYCHOL, V29, P169, DOI 10.1111/j.1467-9221.2008.00622.x; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haveman HA, 2001, ORGAN SCI, V12, P253, DOI 10.1287/orsc.12.3.253.10104; Heinze KL, 2017, J SPORT MANAGE, V31, P497, DOI 10.1123/jsm.2016-0309; Heinze KL, 2016, ORGAN SCI, V27, P157, DOI 10.1287/orsc.2015.1028; Hoffman A. J., 2002, ORG POLICY NATURAL E; Hoffman AJ, 1999, ACAD MANAGE J, V42, P351, DOI 10.2307/257008; Houlihan B, 2009, PUBLIC ADMIN, V87, P678, DOI 10.1111/j.1467-9299.2008.01733.x; Inoue Y, 2012, SPORT MANAG REV, V15, P330, DOI 10.1016/j.smr.2011.12.002; King BG, 2007, ADMIN SCI QUART, V52, P413, DOI 10.2189/asqu.52.3.413; Koo G. Y., 2008, Sport Marketing Quarterly, V17, P30; Kracke D., 2015, FLAWED FANTASTIC GUE; Kwak DH, 2011, EUR SPORT MANAG Q, V11, P225, DOI 10.1080/16184742.2011.577792; Langley A, 1999, ACAD MANAGE REV, V24, P691, DOI 10.2307/259349; Lawrence TB, 2004, ORGANIZATION, V11, P689, DOI 10.1177/1350508404046457; Lawrence TB., 2006, SAGE HDB ORG STUDIES, V2; Lindsey I, 2020, SPORT EDUC SOC, V25, P27, DOI 10.1080/13573322.2018.1547274; Lounsbury M, 2007, ORGAN STUD, V28, P993, DOI 10.1177/0170840607078111; Maguire S, 2004, ACAD MANAGE J, V47, P657, DOI 10.2307/20159610; Miller TL, 2012, ACAD MANAGE REV, V37, P616, DOI 10.5465/amr.2010.0456; NFL Concussion Summit, 2010, ZACK LYST YOUTH SPOR; Nite C, 2019, SPORT MANAG REV, V22, P379, DOI 10.1016/j.smr.2018.05.002; Nite C, 2017, J SPORT MANAGE, V31, P575, DOI 10.1123/jsm.2017-0159; Nite C, 2017, SPORT MANAG REV, V20, P338, DOI 10.1016/j.smr.2016.10.005; Pacheco DF, 2010, J MANAGE, V36, P974, DOI 10.1177/0149206309360280; Paramio-Salcines JL, 2013, SPORT MANAG REV, V16, P337, DOI 10.1016/j.smr.2012.11.002; Perkmann M, 2008, HUM RELAT, V61, P811, DOI 10.1177/0018726708092406; Perkmann M, 2007, ORGAN STUD, V28, P1101, DOI 10.1177/0170840607078116; Ping Wang, 2007, Information and Organization, V17, P59, DOI 10.1016/j.infoandorg.2007.02.001; Read DB, 2018, INT J SPORT PHYSIOL, V13, P1331, DOI [10.1123/ijspp.2017-0625, 10.1080/19406940.2018.1544580]; Riehl S, 2019, J SPORT MANAGE, V33, P93, DOI 10.1123/jsm.2018-0041; Sahlin-Andersson Kerstin., 2008, SAGE HDB ORG I, P198, DOI DOI 10.4135/9781849200387; Sam MP, 2006, J SPORT MANAGE, V20, P366, DOI 10.1123/jsm.20.3.366; Sam MP, 2018, INT REV SOCIOL SPORT, V53, P550, DOI 10.1177/1012690216671515; Sam MP, 2005, SOCIOL SPORT J, V22, P78, DOI 10.1123/ssj.22.1.78; Seyfang G, 2007, ENVIRON POLIT, V16, P584, DOI 10.1080/09644010701419121; Silk ML, 2000, J SPORT MANAGE, V14, P267, DOI 10.1123/jsm.14.4.267; SLACK T, 1994, ORGAN STUD, V15, P803, DOI 10.1177/017084069401500602; Slack T., 1992, Journal of Sport Management, V6, P114; Smith A.C.T., 2007, J CORPORATE CITIZENS, V25, P43, DOI 10.9774/gleaf.4700.2007.sp.00007; STASSER G, 1995, J EXP SOC PSYCHOL, V31, P244, DOI 10.1006/jesp.1995.1012; STEVENSON WB, 1985, ACAD MANAGE REV, V10, P256, DOI 10.2307/257967; SUCHMAN MC, 1995, ACAD MANAGE REV, V20, P571, DOI 10.2307/258788; Suddaby R, 2005, ADMIN SCI QUART, V50, P35, DOI 10.2189/asqu.2005.50.1.35; Timmermans S, 2012, SOCIOL THEOR, V30, P167, DOI 10.1177/0735275112457914; Tracey P, 2011, ORGAN SCI, V22, P60, DOI 10.1287/orsc.1090.0522; Trendafilova S, 2013, SPORT MANAG REV, V16, P298, DOI 10.1016/j.smr.2012.12.006; van Dijk S, 2011, ORGAN STUD, V32, P1485, DOI 10.1177/0170840611421253; Voronov M, 2012, ACAD MANAGE REV, V37, P58, DOI 10.5465/amr.2010.0247; Wagner U, 2011, EUR SPORT MANAG Q, V11, P445, DOI 10.1080/16184742.2011.624107; Washington M, 2011, SPORT MANAG REV, V14, P1, DOI 10.1016/j.smr.2010.06.003; Wijen F, 2007, ORGAN STUD, V28, P1079, DOI 10.1177/0170840607078115; Woolf J, 2016, J SPORT MANAGE, V30, P438, DOI 10.1123/jsm.2014-0301; Woolfolk J., 2018, MERCURY NEWS    0209; Yin RK., 2009, CASE STUDY RES DESIG, V4	87	1	1	2	12	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0888-4773	1543-270X		J SPORT MANAGE	J.Sport Manage.	JAN	2021	35	1					1	16		10.1123/jsm.2019-0327			16	Hospitality, Leisure, Sport & Tourism; Management; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Business & Economics; Sport Sciences	PG9QX	WOS:000600062000001					2022-02-06	
J	Dubas, RL; Teel, EF; Kay, MC; Ryan, ED; Petschauer, MA; Register-Mihalik, JK				Dubas, Rebecca L.; Teel, Elizabeth F.; Kay, Melissa C.; Ryan, Eric D.; Petschauer, Meredith A.; Register-Mihalik, Johna K.			Comparison of Concussion Sideline Screening Measures Across Varying Exertion Levels Within Simulated Games	JOURNAL OF SPORT REHABILITATION			English	Article						balance; cognition; symptoms; exercise; baseline; reliability	ASSOCIATION POSITION STATEMENT; SPORT-RELATED CONCUSSION; BASE-LINE; HIGH-SCHOOL; STANDARDIZED ASSESSMENT; AEROBIC EXERCISE; SEX-DIFFERENCES; SYMPTOMS; MANAGEMENT; VALIDITY	Context: Currently, there is no gold standard to evaluate the effect of varying game-like exertion states on Sport Concussion Assessment Tool 3rd Edition (SCAT-3) outcomes. Baseline assessments may occur before, during, or after physical activity, while postinjury evaluations predominantly occur following physical activity. Thus, clinicians may be comparing postinjury evaluations completed following exertion to baseline evaluations completed following varying levels of rest or exertion, which may not be a valid method for clinical decision making. Objective: To determine the effect of various physical exertion levels on sideline concussion assessment outcomes and reliability. Design: Within-subjects, repeated measures. Setting: Field. Participants: Physically active participants (N = 36) who regularly participate in basketball activity. Intervention: Subjects participated in 2 simulated basketball games, completing a symptom checklist, Standardized Assessment of Concussion, and Balance Error Scoring System before game play, during halftime, and at the completion of each simulated game. Pulse rate was assessed as a proxy of physical exertion. Main Outcome Measures: Total symptom, Standardized Assessment of Concussion, and Balance Error Scoring System scores. Results: Physical exertion did not significantly predict symptom, Standardized Assessment of Concussion, or Balance Error Scoring System scores, although a trend toward higher symptom scores was observed for females (beta= 0.03, P= .09). All assessments had poor to moderate reliability across sessions (.15 < interclass correlation coefficient [2,1] < .60). Conclusion: Low- to moderate-intensity physical activity did not have a significant effect on clinical concussion sideline assessments; however, the low test-retest reliability observed prevents strong conclusions on these relationships. The poor overall reliability does not allow for clear recommendations for what state of baseline physical exertion (ie, rested or exerted) provides optimal data to make postinjury clinical decisions, although baseline concussion assessments completed at rest have the most valid and conservative normative values for injury comparison.	[Dubas, Rebecca L.] Villanova Univ, Athlet Dept, Villanova, PA 19085 USA; [Teel, Elizabeth F.] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Kay, Melissa C.] Univ Southern Mississippi, Sch Hlth Profess, Hattiesburg, MS 39406 USA; [Ryan, Eric D.; Petschauer, Meredith A.; Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA		Register-Mihalik, JK (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.	johnakay@email.unc.edu		Teel, Elizabeth/0000-0002-2846-5884			Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Guskiewicz KM, 2011, PHYS MED REH CLIN N, V22, P603, DOI 10.1016/j.pmr.2011.08.003; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Knicker AJ, 2011, SPORTS MED, V41, P307, DOI 10.2165/11586070-000000000-00000; Koscs M, 2009, ATHL TRAIN SPORTS HL, V1, P24; Lee H, 2015, J SCI MED SPORT, V18, P245, DOI 10.1016/j.jsams.2014.04.003; Lee JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117727261; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Piland SG, 2003, J ATHL TRAINING, V38, P104; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Santo A, 2017, J ATHL TRAINING, V52, P1096, DOI 10.4085/1062-6050-52.11.26; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Yamaya Y, 2002, J APPL PHYSIOL, V92, P162, DOI 10.1152/japplphysiol.00409.2001	32	1	1	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2021	30	1					90	96		10.1123/jsr.2019-0307			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PL0EW	WOS:000602807400014	32234998				2022-02-06	
J	Dugan, EL; Shilt, JS; Masterson, CM; Ernest, KM				Dugan, Eric L.; Shilt, Jeffrey S.; Masterson, Cara M.; Ernest, Kristin M.			The use of inertial measurement units to assess gait and postural control following concussion	GAIT & POSTURE			English	Article						Dual-task; Balance; Entropy; Return to play; Jerk; Complexity	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; ERROR SCORING SYSTEM; DUAL-TASK; CONTROL DEFICITS; MULTISCALE ENTROPY; DETECTING GAIT; BALANCE; ADOLESCENTS; RELIABILITY	Background: Impairments in gait and balance function are typical after concussion. There is evidence that these neuromuscular deficits persist past the typical time of symptom resolution. The ability to quantify these changes in gait and balance may provide useful information when making return to play decisions in clinical settings. Research Question: Are changes in gait function and postural control evident across the course of a concussion management program? Methods: A retrospective analysis of a convenience sample of 38 patients who were seen for concussion between October 2017 and May 2019 was performed. Gait and balance measures were assessed at their initial clinic visit post-injury and at their clearance visit using inertial measurement units. During dual-task walking trials, the medial-lateral motion of the center of mass and gait velocity were measured. Postural sway complexity and jerk index were measured during both eyes-open and eyes-closed balance trials. Results: Paired samples t-tests and Wilcoxon signed rank tests were used to determine whether statistically significant changes occurred for the gait and balance variables, respectively. Medial-lateral sway decreased (4.4 +/- 1.3 cm to 4.0 +/- 1.2 cm, p = 0.018) and gait velocity increased (0.78 +/- 0.23 m/s to 0.91 +/- 0.18 m/s, p < 0.001) from initial to clearance testing. Jerk index decreased (6.41 +/- 11.06 m(2)/s(5) to 5.73 + 4.28 m(2)/s(5), p = 0.031) and (11.87 +/- 26.42 m(2)/s(5) to 7.87 +/- 8.38 m(2)/s(5), p = 0.003) from initial to clearance testing for the eyes-open and eyes-closed conditions, respectively. Complexity index increased (2.38 +/- 1.08-2.86 +/- 0.72, p = 0.010) from initial to clearance testing for the eyes-closed condition. There was no change in complexity index for the eyes-open condition. Significance: These preliminary results support the potential use of measures of gait and postural control to assess recovery following a concussion in a clinical setting.	[Dugan, Eric L.; Shilt, Jeffrey S.; Masterson, Cara M.; Ernest, Kristin M.] Texas Childrens Hosp, 17580 Interstate 45 South, The Woodlands, TX 77384 USA; [Dugan, Eric L.; Shilt, Jeffrey S.] Baylor Coll Med, Dept Orthoped Surg, Houston, TX 77030 USA; [Ernest, Kristin M.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA		Dugan, EL (corresponding author), Texas Childrens Hosp, 17580 Interstate 45 South, The Woodlands, TX 77384 USA.	eldugan@texaschildren.org					Ahmed MU, 2012, INT CONF ACOUST SPEE, P3901, DOI 10.1109/ICASSP.2012.6288770; Ahmed MU, 2012, IEEE SIGNAL PROC LET, V19, P91, DOI 10.1109/LSP.2011.2180713; [Anonymous], 2016, CONCUSSION, DOI DOI 10.2217/CNC.15.5; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bizovska L, 2017, MED ENG PHYS, V50, P29, DOI 10.1016/j.medengphy.2017.08.017; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Busa MA, 2016, J SPORT HEALTH SCI, V5, P44, DOI 10.1016/j.jshs.2016.01.018; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Carlson C.D., 2020, ATHL TRAIN SPORT HLT, V122, P67, DOI [10.3928/19425864-20190401-02, DOI 10.3928/19425864-20190401-02]; Chen TZ, 2018, NEUROL RES, V40, P491, DOI 10.1080/01616412.2018.1451017; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gera G, 2020, ARCH PHYS MED REHAB, V101, P258, DOI 10.1016/j.apmr.2019.07.011; Ghislieri M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19194075; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; HOLM S, 1979, SCAND J STAT, V6, P65; Howell DR, 2020, GAIT POSTURE, V79, P53, DOI 10.1016/j.gaitpost.2020.04.013; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, J APPL BIOMECH, V35, P290, DOI 10.1123/jab.2018-0454; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kara S, 2020, CLIN J SPORT MED, V30, P96, DOI 10.1097/JSM.0000000000000811; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Purkayastha S, 2019, PM&R, V11, P1184, DOI 10.1002/pmrj.12129; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Rao NSV, 2005, UND COM SYS, P69; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Schepers M., 2018, XSENS MVN CONSISTENT, DOI [10.13140/RG.2.2.22099.07205, DOI 10.13140/RG.2.2.22099.07205]; Winter D., 2005, BIOMECHANICS MOTOR C, V4th	59	1	1	1	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	JAN	2021	83						262	267		10.1016/j.gaitpost.2020.10.004			6	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	PN3SQ	WOS:000604402600039	33220659				2022-02-06	
J	Dusak, WS; Dharmayuda, CGO; Kawiyana, KS; Afandi, R; Nugraha, GKAS				Dusak, Wayan Suryanto; Dharmayuda, Cokorda Gde Oka; Kawiyana, Ketut Siki; Afandi, Richard; Nugraha, Gede Ketut Alit Satria			Central fracture dislocation of the hip associated with fracture of femoral neck treated by femoral head autograft and total hip arthroplasty: A rare case report	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Central fracture dislocation of hip; Femoral neck fracture; Femoral head autograft; Total hip arthroplasty	CENTRAL ACETABULAR FRACTURE	Central Fracture Dislocation of the Hip is a rare condition requiring more attention in its management, caused by high-energy trauma and is often associated with other injuries. This case report presents a 57-years old female who was injured in a traffic accident and diagnosed with polytrauma, abdominal blunt trauma with 7th zone liver laceration, central fracture dislocation of the left hip associated with closed fracture left acetabulum anterior column and closed fracture left neck femur. Until now, there is no mandatory management to treat this kind of injury. Several surgical techniques were explained in previous literatures to treat this condition such as Open Reduction and Internal Fixation (ORIF) procedure and Total Hip Arthroplasty (THA). Some studies chose THA as a treatment for similar condition in older population due to high risk of nonunion and avascular necrosis of the femoral head, especially in cases of significant displacement and devitalization of the femoral head. In this case, we performed femoral head autograft and total hip arthroplasty as a definitive treatment. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.	[Dusak, Wayan Suryanto; Dharmayuda, Cokorda Gde Oka; Kawiyana, Ketut Siki; Afandi, Richard; Nugraha, Gede Ketut Alit Satria] Udayana Univ, Sanglah Gen Hosp, Fac Med, Orthopaed & Traumatol Dept, Jl Diponegoro, Bali 80113, Indonesia		Afandi, R (corresponding author), Udayana Univ, Sanglah Gen Hosp, Fac Med, Orthopaed & Traumatol Dept, Jl Diponegoro, Bali 80113, Indonesia.	drrich.afandi@gmail.com					Green DP, 2010, ROCKWOOD GREENS FRAC, V1; HITAGARCIA F, 2019, AAOS COMPREHENSIVE O, V3; Jung W, 2013, CASE REP MED, V2013, DOI 10.1155/2013/524603; MEINHARD BP, 1987, J BONE JOINT SURG AM, V69A, P612, DOI 10.2106/00004623-198769040-00020; Mesa A. Ceballos, 1917, HIP INT, V7, P75; Prabhakar Gautham, 2018, CASE REP ORTHOP, V2018; Salter Robert Bruce, 1999, RHEUMATOLOGY METABOL; Sheth H, 2016, CHIN J TRAUMATOL, V19, P59, DOI 10.1016/j.cjtee.2016.01.006; Solomon LWD., 2010, APLEYS SYSTEM ORTHOP, V9th; Xiao XL, 2018, J INT MED RES, V46, P3388, DOI 10.1177/0300060518761786	10	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2021	78						90	95		10.1016/j.ijscr.2020.11.148			6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	PT1TW	WOS:000608403500093	33316611	gold, Green Published			2022-02-06	
J	EbrahimAmini, A; Bazzigaluppi, P; Aquilino, MS; Stefanovic, B; Carlen, PL				EbrahimAmini, Azin; Bazzigaluppi, Paolo; Aquilino, Mark S.; Stefanovic, Bojana; Carlen, Peter L.			Neocortical in vivo focal and spreading potassium responses and the influence of astrocytic gap junctional coupling	NEUROBIOLOGY OF DISEASE			English	Article						Extracellular potassium concentration; Gap junctional coupling; Local field potential; Potassium buffering	GENERAL-ANESTHETICS; EPILEPTIFORM ACTIVITY; MIMETIC PEPTIDES; K+ CLEARANCE; DEPRESSION; CONDUCTANCE; PH; DEPOLARIZATION; EXCITABILITY; MODULATION	Raised extracellular potassium ion (K+) concentration is associated with several disorders including migraine, stroke, neurotrauma and epilepsy. K+ spatial buffering is a well-known mechanism for extracellular K+ regulation/distribution. Astrocytic gap junction-mediated buffering is a controversial candidate for K+ spatial buffering. To further investigate the existence of a K+ spatial buffering and to assess the involvement of astrocytic gap junctional coupling in K+ redistribution, we hypothesized that neocortical K+ and concomitant spreading depolarization (SD)-like responses are controlled by powerful local K+ buffering mechanisms and that K+ buffering/redistribution occurs partially through gap junctional coupling. Herein, we show, in vivo, that a threshold amount of focally applied KCl is required to trigger local and/or distal K+ responses, accompanied by a SD-like response. This observation indicates the presence of powerful local K+ buffering which mediates a rapid return of extracellular K+ to the baseline. Application of gap junctional blockers, carbenoxolone and Gap27, partially modulated the amplitude and shape of the K+ response and noticeably decreased the velocity of the spreading K+ and SD-like responses. Opening of gap junctions by trimethylamine, slightly decreased the amplitude of the K+ response and markedly increased the velocity of redistribution of K+ and SD-like events. We conclude that spreading K+ responses reflect powerful local K+ buffering mechanisms which are partially modulated by gap junctional communication. Gap junctional coupling mainly affected the velocity of the K+ and SD-like responses.	[EbrahimAmini, Azin; Bazzigaluppi, Paolo; Aquilino, Mark S.; Carlen, Peter L.] Toronto Westren Hosp, Krembil Res Inst, Toronto, ON M5T 0S8, Canada; [EbrahimAmini, Azin; Aquilino, Mark S.; Carlen, Peter L.] Univ Toronto, Inst Biomed Engn IBME, Toronto, ON M5S 3G9, Canada; [Bazzigaluppi, Paolo; Stefanovic, Bojana] Sunnybrook Res Inst, Med Biophys, Toronto, ON M4N 3M5, Canada; [Carlen, Peter L.] Univ Toronto, Dept Med, Toronto, ON M5S 3G9, Canada; [Carlen, Peter L.] Univ Toronto, Dept Physiol, Toronto, ON M5S 3G9, Canada		EbrahimAmini, A (corresponding author), Toronto Westren Hosp, Krembil Res Inst, Toronto, ON M5T 0S8, Canada.	azin.amini@mail.utoronto.ca; paolo.bazzigaluppi@sri.utoronto.ca; mark.aquilino@mail.utoronto.ca; bojana@sri.utoronto.ca; carlen@uhnresearch.ca		Carlen, Peter/0000-0002-3339-8102	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	The present work has been supported by Canadian Institutes of Health Research (CIHR). The authors would like to thank Dr. Dene Ringuette, Dr. Shanthini Mylvaganam and Dr. Hossam El-Beheiry for their useful discussions.	Anders S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0600; Bailey JM, 1997, ANESTH ANALG, V85, P681, DOI 10.1097/00000539-199709000-00036; Bazzigaluppi P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112269; Bazzigaluppi P, 2017, NEUROBIOL DIS, V101, P1, DOI 10.1016/j.nbd.2016.12.017; Bellot-Saez A, 2017, NEUROSCI BIOBEHAV R, V77, P87, DOI 10.1016/j.neubiorev.2017.03.002; Breithausen B, 2020, GLIA, V68, P918, DOI 10.1002/glia.23751; Brown AM, 2017, NEUROCHEM RES, V42, P2456, DOI 10.1007/s11064-017-2319-4; CORDINGLEY GE, 1978, BRAIN RES, V151, P291, DOI 10.1016/0006-8993(78)90886-7; CSIBA L, 1985, BRAIN RES, V336, P167, DOI 10.1016/0006-8993(85)90430-5; DIETZEL I, 1989, GLIA, V2, P25, DOI 10.1002/glia.440020104; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Enger R, 2015, CEREB CORTEX, V25, P4469, DOI 10.1093/cercor/bhv054; Erdemli G, 1998, J NEUROPHYSIOL, V80, P2378, DOI 10.1152/jn.1998.80.5.2378; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; FISHER RS, 1976, BRAIN RES, V101, P223, DOI 10.1016/0006-8993(76)90265-1; GAULT LM, 1994, BRAIN RES, V641, P176, DOI 10.1016/0006-8993(94)91835-X; HABLITZ JJ, 1989, DEV BRAIN RES, V46, P243, DOI 10.1016/0165-3806(89)90288-5; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Henneberger C., 2014, SPATIAL PROPERTIES A; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; Larsen BR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00141; Larsen BR, 2014, CHANNELS, V8, P544, DOI 10.4161/19336950.2014.970448; Larsen BR, 2014, GLIA, V62, P608, DOI 10.1002/glia.22629; Liu XH, 2016, GLIA, V64, P524, DOI 10.1002/glia.22946; MacAulay N, 2012, NEUROCHEM RES, V37, P2299, DOI 10.1007/s11064-012-0731-3; Major S., 2019, GEROSCIENCE, P1; MANTZ J, 1993, ANESTHESIOLOGY, V78, P892, DOI 10.1097/00000542-199305000-00014; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Medina-Ceja L, 2008, BRAIN RES, V1187, P74, DOI 10.1016/j.brainres.2007.10.040; Medina-Ceja L, 2010, SEIZURE-EUR J EPILEP, V19, P507, DOI 10.1016/j.seizure.2010.07.009; Miller AJ, 1995, METHOD CELL BIOL, V49, P275, DOI 10.1016/S0091-679X(08)61460-0; MIU P, 1989, EXP BRAIN RES, V75, P354; Muller M, 2000, J NEUROPHYSIOL, V83, P735, DOI 10.1152/jn.2000.83.2.735; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; Nilsen KE, 2006, EPILEPSIA, V47, P1169, DOI 10.1111/j.1528-1167.2006.00540.x; Ohta O., 1983, VASCULAR NEUROEFFECT, P353; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; PERACCHIA C, 1991, J MEMBRANE BIOL, V121, P67, DOI 10.1007/BF01870652; Peters O, 2003, J NEUROSCI, V23, P9888; Ransom BR, 2000, PROG BRAIN RES, V125, P217; Revah O, 2016, NEUROBIOL DIS, V95, P158, DOI 10.1016/j.nbd.2016.07.019; Rorig B, 1996, J PHYSIOL-LONDON, V490, P31; Samoilova M, 2003, J NEUROCHEM, V86, P687, DOI 10.1046/j.1471-4159.2003.01893.x; Samoilova M, 2008, EXP NEUROL, V210, P762, DOI 10.1016/j.expneurol.2008.01.005; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; Theis M, 2003, J NEUROSCI, V23, P766; Vilagi I, 2001, BRAIN RES, V898, P288, DOI 10.1016/S0006-8993(01)02196-5; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; WALZ W, 1984, BRAIN RES, V292, P367, DOI 10.1016/0006-8993(84)90772-8; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Wentlandt K, 2005, J NEUROSCI RES, V81, P746, DOI 10.1002/jnr.20577; Wentlandt K, 2006, ANESTH ANALG, V102, P1692, DOI 10.1213/01.ane.0000202472.41103.78	56	1	1	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JAN	2021	147								105160	10.1016/j.nbd.2020.105160			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PG2WS	WOS:000599601900004	33152505	gold			2022-02-06	
J	Engelman, G; Carry, P; Sochanska, A; Daoud, AK; Wilson, J; Provance, A				Engelman, Glenn; Carry, Patrick; Sochanska, Ada; Daoud, Ariel Kiyomi; Wilson, Julie; Provance, Aaron			Isometric Cervical Muscular Strength in Pediatric Athletes With Multiple Concussions	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport-related concussion; cervical muscular strength; head injury		Objective: To compare maximal cervical muscle strength among athletes with a history of 2 or more concussions relative to athletes with no history of a previous concussion. Design: Athletes in the 2 groups were frequency-matched. Linear mixed models were used to test for differences in peak isometric flexion, extension, left lateral flexion, and right lateral flexion cervical muscle torque between groups. Setting: Pediatric sports medicine clinic. Participants: Athletes with a history of multiple concussions (n = 16) and athletes with no previous concussion history (n = 17). Interventions (or Assessment of Risk Factors or Independent Variables): Concussion history (group), age, sex, neck girth, and height. Main Outcome Measures: Peak isometric torque measured with a stationary isokinetic dynamometer during a 3-second isometric hold. Results: There was no significant difference in peak flexion [mean difference: 21.2%, 95% confidence interval (CI): -6.6% to 57.4%, P = 0.1413], extension (mean difference: 17%, 95% CI, -6.8% to 47.1%, P = 0.1667), left lateral (mean difference: 4.4%, 95% CI, -16.9% to 31.1%, P = 0.7011), or right lateral (mean difference: 9.3%, 95% CI, -14.5% to 39.8%, P = 0.4627) isometric torque in the concussion group relative to the control group. Across all muscle actions, neck torque was significantly (P < 0.05) higher in male compared with female athletes. Increasing neck girth was also associated with a significant (P < 0.05) increase in neck torque. Conclusions: There was no evidence of a consistent cervical muscle strength deficit among athletes with a history of 2 or more concussions relative to athletes with no previous history of a concussion. Age, neck girth, and sex were significantly associated with cervical muscle strength. Clinical Relevance: Isometric cervical muscle strength testing may not be a reliable test for differentiating athletes with a history of multiple concussions relative to athletes with no history of concussions in the pediatric and adolescent population. Our study presents a reliable methodology for testing cervical muscle strength among young athletes.	[Engelman, Glenn] Univ Colorado, Dept Anesthesiol, Sch Med, Aurora, CO USA; [Carry, Patrick] Childrens Hosp Colorado, Musculoskeletal Res Ctr, Dept Orthoped, Aurora, CO USA; [Sochanska, Ada; Daoud, Ariel Kiyomi; Wilson, Julie; Provance, Aaron] Childrens Hosp Colorado, Ctr Sports Med, Dept Orthoped, 13123 East 16th Ave,Box 060, Aurora, CO 80045 USA; [Sochanska, Ada; Daoud, Ariel Kiyomi; Wilson, Julie; Provance, Aaron] Univ Colorado, Sch Med, Aurora, CO USA		Provance, A (corresponding author), Childrens Hosp Colorado, Ctr Sports Med, Dept Orthoped, 13123 East 16th Ave,Box 060, Aurora, CO 80045 USA.	aaron.provance@childrenscolorado.org			AMSSM Young Investigators Grant	Supported by AMSSM Young Investigators Grant.	Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McGuine T, 2006, CLIN J SPORT MED, V16, P488, DOI 10.1097/01.jsm.0000248848.62368.43; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Olivier PE, 2008, J SCI MED SPORT, V11, P96, DOI 10.1016/j.jsams.2007.01.009; Provance AJ, 2016, ORTHOPEDICS, V39, P24, DOI 10.3928/01477447-20151218-13; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Toit DD., 2003, S AFR J SPORTS MED, V15, P3; Vasavada AN, 2008, J BIOMECH, V41, P114, DOI 10.1016/j.jbiomech.2007.07.007	18	1	1	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					36	41		10.1097/JSM.0000000000000681			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800011	30346312				2022-02-06	
J	Erdodi, LA				Erdodi, Laszlo A.			Five shades of gray: Conceptual and methodological issues around multivariate models of performance validity	NEUROREHABILITATION			English	Article						Performance validity; embedded validity indicators; multivariate models; Erdodi Index	ADULT INTELLIGENCE SCALE; TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; VERBAL-LEARNING TEST; COMPLEX FIGURE TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; FALSE-POSITIVE RATES; FINGER TAPPING TEST; CARD SORTING TEST; CONSENSUS CONFERENCE STATEMENT	OBJECTIVE: This study was designed to empirically investigate the signal detection profile of various multivariate models of performance validity tests (MV-PVTs) and explore several contested assumptions underlying validity assessment in general and MV-PVTs specifically. METHOD: Archival data were collected from 167 patients (52.4% male; M-Age = 39.7) clinicially evaluated subsequent to a TBI. Performance validity was psychometrically defined using two free-standing PVTs and five composite measures, each based on five embedded PVTs. RESULTS: MV-PVTs had superior classification accuracy compared to univariate cutoffs. The similarity between predictor and criterion PVTs influenced signal detection profiles. False positive rates (FPR) in MV-PVTs can be effectively controlled using more stringent multivariate cutoffs. In addition to Pass and Fail, Borderline is a legitimate third outcome of performance validity assessment. Failing memory-based PVTs was associated with elevated self-reported psychiatric symptoms. CONCLUSIONS: Concerns about elevated FPR in MV-PVTs are unsubstantiated. In fact, MV-PVTs are psychometrically superior to individual components. Instrumentation artifacts are endemic to PVTs, and represent both a threat and an opportunity during the interpretation of a given neurocognitive profile. There is no such thing as too much information in performance validity assessment. Psychometric issues should be evaluated based on empirical, not theoretical models. As the number/severity of embedded PVT failures accumulates, assessors must consider the possibility of non-credible presentation and its clinical implications to neurorehabilitation.	[Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	lerdodi@gmail.com					Abeare C, 2021, PSYCHOL ASSESSMENT, V33, P90, DOI 10.1037/pas0000958; Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2021, CLIN NEUROPSYCHOL, V35, P1442, DOI 10.1080/13854046.2020.1779348; Alluri PR, 2020, COGN BEHAV NEUROL, V33, P77, DOI 10.1097/WNN.0000000000000218; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Arentsen TJ, 2013, CLIN NEUROPSYCHOL, V27, P1060, DOI 10.1080/13854046.2013.803603; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Ashendorf L, 2019, CLIN NEUROPSYCHOL, V33, P1388, DOI 10.1080/13854046.2018.1543454; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Berger C, 2021, J ATTEN DISORD, V25, P1032, DOI 10.1177/1087054719864656; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K. B., 2021, ASSESSMENT FEIGNED C, P218; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P675, DOI 10.1016/j.acn.2007.07.005; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2013, APPL NEUROPSYCH-ADUL, V20, P233, DOI 10.1080/09084282.2012.695757; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Boskovic I, 2019, J BEHAV THER EXP PSY, V65, DOI 10.1016/j.jbtep.2019.101483; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Burton V, 2012, ARCH CLIN NEUROPSYCH, V27, P262, DOI 10.1093/arclin/acs026; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carone DA, 2014, CLIN NEUROPSYCHOL, V28, P146, DOI 10.1080/13854046.2013.861019; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Cook CM, 2016, ARCH CLIN NEUROPSYCH, V31, P358, DOI 10.1093/arclin/acw015; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Dandachi-FitzGerald B, 2020, PSYCHOL INJ LAW, V13, P225, DOI 10.1007/s12207-020-09387-6; Dandachi-FitzGerald B, 2020, J INT NEUROPSYCH SOC, V26, P314, DOI 10.1017/S1355617719001139; Dandachi-FitzGerald B, 2013, ARCH CLIN NEUROPSYCH, V28, P771, DOI 10.1093/arclin/act073; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Denning JH, 2021, APPL NEUROPSYCH-ADUL, V28, P35, DOI 10.1080/23279095.2019.1588122; Denning JH, 2014, ARCH CLIN NEUROPSYCH, V29, P729, DOI 10.1093/arclin/acu051; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Elbaum T, 2020, APPL NEUROPSYCH-ADUL, V27, P403, DOI 10.1080/23279095.2018.1555161; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2021, J HEAD TRAUMA REHAB, V36, P103, DOI 10.1097/HTR.0000000000000576; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Forrest TJ, 2004, CLIN NEUROPSYCHOL, V18, P334, DOI 10.1080/13854040490501673; Fuermaier ABM, 2017, PSYCHOL ASSESSMENT, V29, P1466, DOI 10.1037/pas0000534; Fuermaier ABM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164297; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2016, APPL NEUROPSYCH-CHIL, V5, P25, DOI 10.1080/21622965.2014.935378; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2007, CLIN NEUROPSYCHOL, V21, P318, DOI 10.1080/13854040500488552; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Guilmette TJ, 2020, CLIN NEUROPSYCHOL, V34, P437, DOI 10.1080/13854046.2020.1722244; Hall VL, 2014, J NEUROPSYCHOL, V8, P216, DOI 10.1111/jnp.12021; Harrison AG, 2010, ASSESSMENT, V17, P283, DOI 10.1177/1073191109348590; Heaton R., 2004, PSYCHOL ASSESS RESOU; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Jodzio K, 2010, APPL NEUROPSYCHOL, V17, P267, DOI 10.1080/09084282.2010.525104; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Jurick SM, 2020, J INT NEUROPSYCH SOC, V26, P108, DOI 10.1017/S1355617719000997; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lau L, 2017, CLIN NEUROPSYCHOL, V31, P1412, DOI 10.1080/13854046.2017.1318954; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; MacAllister WS, 2019, CHILD NEUROPSYCHOL, V25, P1035, DOI 10.1080/09297049.2019.1569606; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2020, ARCH CLIN NEUROPSYCH, V35, P717, DOI 10.1093/arclin/acaa017; Martin PK, 2018, ASSESSMENT, V25, P640, DOI 10.1177/1073191116656796; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McDaniel MA, 2006, INTELLIGENCE, V34, P607, DOI 10.1016/j.intell.2006.08.007; Medici R, 2013, J FORENSIC PSYCHOL P, V13, P68, DOI 10.1080/15228932.2013.746909; Menon V, 2018, PERSONAL MENT HEALTH, V12, P145, DOI 10.1002/pmh.1405; Merckelbach H, 2012, CLIN NEUROPSYCHOL, V26, P1217, DOI 10.1080/13854046.2012.710252; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; Messa I, 2021, AUST J FORENSIC SCI, DOI 10.1080/00450618.2020.1865457; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; Miskey HM, 2020, J NEUROPSYCH CLIN N, V32, P161, DOI 10.1176/appi.neuropsych.17110340; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Morse CL, 2013, CLIN NEUROPSYCHOL, V27, P1395, DOI 10.1080/13854046.2013.832385; Neale AC, 2020, CLIN NEUROPSYCHOL, DOI 10.1080/13854046.2020.1799076; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Olsen DH, 2019, CLIN NEUROPSYCHOL, V33, P732, DOI 10.1080/13854046.2018.1501096; Ord AS, 2021, CLIN NEUROPSYCHOL, V35, P1426, DOI 10.1080/13854046.2020.1751301; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Pearson, 2009, ADV CLIN SOL WAIS 4; Powell MR, 2011, CLIN NEUROPSYCHOL, V25, P108, DOI 10.1080/13854046.2010.532912; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; RAI J, 2019, APPL NEUROPSYCHOL, DOI DOI 10.1080/23279095.2019.161.1613994; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Resch ZJ, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1742718; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sharland MJ, 2018, CLIN NEUROPSYCHOL, V32, P98, DOI 10.1080/13854046.2017.1332240; Shelley-Tremblay JE, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050109; Sherer M, 2020, J INT NEUROPSYCH SOC, V26, P932, DOI 10.1017/S1355617720000351; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stevens A, 2018, J FORENSIC PSYCHI PS, V29, P794, DOI 10.1080/14789949.2018.1477974; Stevens A, 2016, PSYCHIAT RES, V245, P74, DOI 10.1016/j.psychres.2016.08.022; Sugarman MA, 2016, APPL NEUROPSYCH-ADUL, V23, P105, DOI 10.1080/23279095.2015.1014557; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Tarachow S, 1947, PSYCHIAT QUART, V21, P233, DOI 10.1007/BF01641756; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tranel, 2012, NEUROPSYCHOLOGICAL A, P830, DOI [10.1017/S1355617713000337, DOI 10.1017/S1355617713000337]; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Webber TA, 2018, PSYCHOL INJ LAW, V11, P325, DOI 10.1007/s12207-018-9335-9; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	204	1	1	2	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2021	49	2					179	213		10.3233/NRE-218020			35	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WB2OK	WOS:000703416700003	34420986				2022-02-06	
J	Fickling, SD; Smith, AM; Stuart, MJ; Dodick, DW; Farrell, K; Pender, SC; D'Arcy, RCN				Fickling, Shaun D.; Smith, Aynsley M.; Stuart, Michael J.; Dodick, David W.; Farrell, Kyle; Pender, Sara C.; D'Arcy, Ryan C. N.			Subconcussive brain vital signs changes predict head-impact exposure in ice hockey players	BRAIN COMMUNICATIONS			English	Article						concussion; subconcussion; EEG; ERP; brain vital signs	CONSCIOUSNESS; POTENTIALS; SPORT	The brain vital signs framework is a portable, objective, neurophysiological evaluation of brain function at point-of-care. We investigated brain vital signs at pre- and post-season for age 14 or under (Bantam) and age 16-20 (Junior-A) male ice hockey players to (i) further investigate previously published brain vital sign results showing subconcussive cognitive deficits and (ii) validate these findings through comparison with head-impact data obtained from instrumented accelerometers. With a longitudinal study design, 23 male ice hockey players in Bantam (n = 1 . 3; age 13.63 +/- 0.62) and Tier II Junior-A (n = 10; age 18.62 +/- 0.86) divisions were assessed at pre- and post-season. None were diagnosed with a concussion during the season. Cognitive evoked potential measures of Auditory sensation (N100), Basic attention (P300) and Cognitive processing (N400) were analysed as changes in peak amplitudes and latencies (six standard scores total). A regression analysis examined the relationship between brain vital signs and the number of head impacts received during the study season. Significant pre/post differences in brain vital signs were detected for both groups. Bantam and Junior-A players also differed in number of head impacts (Bantam: 32.92 +/- 17.68; Junior-A: 195.00 +/- 61.08; P < 0.001). lmportandy, the regression model demonstrated a significant linear relationship between changes in brain vital signs and total head impacts received (R = 0.799, P = 0.007), with clear differences between the Bantam and Junior-A groups. In the absence of a clinically diagnosed concussion, the brain vital sign changes appear to have demonstrated the compounding effects of repetitive subconcussive impacts. The findings underscored the importance of an objective physiological measure of brain function along the spectrum of concussive impacts.	[Fickling, Shaun D.; D'Arcy, Ryan C. N.] Simon Fraser Univ, Fac Sci & Appl Sci, Metro Vancouver, BC V5A 1S6, Canada; [Fickling, Shaun D.; D'Arcy, Ryan C. N.] HealthTech Connex, Ctr Neurol Studies, Metro Vancouver, BC V3V OC6, Canada; [Fickling, Shaun D.; D'Arcy, Ryan C. N.] Hlth & Technol Dist, BrainNET, Surrey, BC V3V OC6, Canada; [Smith, Aynsley M.] Mayo Clin, Dept Phys Med & Rehabil, Sports Med Ctr, Rochester, MN 55905 USA; [Smith, Aynsley M.; Stuart, Michael J.] Mayo Clin, Dept Orthoped Surg, Sports Med Ctr, Rochester, MN 55905 USA; [Dodick, David W.] Mayo Clin, Dept Neurol, Phoenix, AZ 85259 USA; [Farrell, Kyle] Creighton Univ, Sch Med, Omaha, NE 68178 USA; [Pender, Sara C.] Univ Coll Dublin, Sch Med, Dublin D04 V1W8, Ireland; [D'Arcy, Ryan C. N.] Univ British Columbia, DM Ctr Brain Hlth, Radiol, Metro Vancouver, BC V6T 1Z4, Canada		D'Arcy, RCN (corresponding author), Galleria 4,SUR 4148,13450 102 Ave 250, Surrey, BC V3T 0A3, Canada.	rdarcy@sfu.ca			Mathematics of Information Technology and Complex Systems (MITACS); Natural Sciences and Engineering Council Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); USA Hockey; Johannson-Gund Endowment	Financial support was provided by Mathematics of Information Technology and Complex Systems (MITACS), Natural Sciences and Engineering Council Canada (NSERC), and Canadian Institutes for Health Research (CIHR) for this study. The research study was designed and carried out by the Mayo Clinic Sports Medicine Ice Hockey Research team, partially funded by USA Hockey and the Johannson-Gund Endowment.	Boshra R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53751-9; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Covassin T, 2020, PHYSICIAN SPORTSMED, V48, P442, DOI 10.1080/00913847.2020.1745717; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; D'Arcy RCN, 2000, CLIN NEUROPHYSIOL, V111, P40, DOI 10.1016/S1388-2457(99)00210-2; D'Arcy RCN, 2004, HUM BRAIN MAPP, V22, P40, DOI 10.1002/hbm.20008; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Davis PA, 1939, J NEUROPHYSIOL, V2, P494, DOI 10.1152/jn.1939.2.6.494; Fickling SD, 2019, BRAIN, V142, P255, DOI 10.1093/brain/awy317; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Gawryluk JR, 2010, HDB PHYS MED BIOL; Hajra SG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00211; Hajra SG, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/aae91e; He P, 2004, MED BIOL ENG COMPUT, V42, P407, DOI 10.1007/BF02344717; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McIntosh AS, 2019, J SCI MED SPORT, V22, P784, DOI 10.1016/j.jsams.2019.02.004; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Nauman EA, 2018, HAND CLINIC, V158, P245, DOI 10.1016/B978-0-444-63954-7.00024-0; Nowak MK, 2020, JAMA OPHTHALMOL, V138, P350, DOI 10.1001/jamaophthalmol.2019.6128; Pawlowski GM, 2019, FRONT NEUROSCI-SWITZ, V12, P1; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Quiroga RQ, 2003, CLIN NEUROPHYSIOL, V114, P376, DOI 10.1016/S1388-2457(02)00365-6; Saghafi B, 2018, PROC SPIE, V10575, DOI 10.1117/12.2293023; Sculthorpe-Petley L, 2015, J NEUROSCI METH, V245, P64, DOI 10.1016/j.jneumeth.2015.02.008; Smith A M, 2019, CURR SPORT MED REP, P1835, DOI [10.1249/JSR.00000000000000556, DOI 10.1249/JSR.00000000000000556]; Smith AM, 2019, CURR SPORT MED REP, V18, P23, DOI 10.1249/JSR.0000000000000557; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Veksler R, 2020, BRAIN, V143, P1826, DOI 10.1093/brain/awaa140; Wilson MJ, 2015, SOUTH MED J, V108, P559, DOI 10.14423/SMJ.0000000000000342	35	1	1	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	2							fcab019	10.1093/braincomms/fcab019			10	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TA5UJ	WOS:000667313900087	33855296	Green Published, gold			2022-02-06	
J	Flemmer, S; Boltzmann, M; Schmidt, S; Rollnik, JD				Flemmer, Stella; Boltzmann, Melanie; Schmidt, Simone; Rollnik, Jens D.			Impact of occupational problems on employment status six months after inpatient neurological rehabilitation	FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE			German	Article						work-related occupational rehabilitation; occupational problems; Wurzburg Screening; occupational reintegration	TRAUMATIC BRAIN-INJURY; RETURN; WORK; STROKE	Background By identifying occupational problems, job-related therapies may be included in rehabilitation at an early stage, increasing the return-to-work rate. The aim of the present study was to examine whether occupational problems that were identified were associated with the employment status six months after inpatient rehabilitation. Methods A total of 122 neurological patients undergoing neurological inpatient rehabilitation at the BDH-Clinic Hessisch Oldendorf were retrospectively analysed using clinical routine data from the database of the clinic. Occupational problems were identified with the help of a self-assessment (Wuerzburg Screening [WS]) and an ICF-compliant medical assessment (d850) at the beginning of neurological rehabilitation. In addition, data about the employment status six months after rehabilitation were collected. Results While the BPL identified in the WS was associated with the employment status at the time of follow-up (r=-0.288; p=.007), there was no relationship between the medical assessment of occupational impairment and the employment status. In binary logistic regression models for predicting the employment status, the duration of the incapacity to work, age, gender and an interdisciplinary assessment at the end of rehabilitation proved to be predictors for the employment status. Conclusion Occupational problems are associated with occupational reintegration six months after discharge from neurological inpatient rehabilitation. Since occupational problems are taken into account in the treatment planning, the impact on the return to work rate may be underestimated in the current study.	[Flemmer, Stella] Krankenhaus Lindenbrunn, Coppenbrugge, Germany; [Boltzmann, Melanie; Schmidt, Simone; Rollnik, Jens D.] Inst Neurorehabil Forsch InFo, Tubingen, Germany; [Boltzmann, Melanie; Schmidt, Simone; Rollnik, Jens D.] Assoziiertes Inst Med Hsch Hannover MHH, BDH Klin Hessisch Oldendorf GmbH, Neurol Zentrum Intensivmed Stroke Unit & Phasenub, Hannover, Germany		Boltzmann, M (corresponding author), Greitstr 18-28, D-31840 Hessisch Oldendorf, Germany.	m.boltzman@bdh-klinik-hessisch-oldendorf.de					Andersen G, 2012, ACTA NEUROL SCAND, V125, P248, DOI 10.1111/j.1600-0404.2011.01557.x; Burger W, 2009, REHABILITATION, V48, P211, DOI 10.1055/s-0029-1231062; Claros-Salinas D, 2012, NEUROREHABILITATION, V18, P275; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Deutsche Rentenversicherung Bund, 2015, ANF DURCHF MED OR RE; Leniger T, 2018, NEUROL REHABIL, V24, P61; Leniger T, 2019, FORTSCHR NEUROL PSYC, V87, P92, DOI 10.1055/a-0695-9074; Loffler S, 2008, GESUNDHEITSWESEN, P70, DOI [10.1055/s-0028-1086302, DOI 10.1055/S-0028-1086302]; Loffler S, 2012, PRAXISHANDBUCH ARBEI, V43; Pimmer V, 2008, DTSCH K VERS DRESD 2, P615; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rollnik JD, 2016, FORTSCHR NEUROL PSYC, V84, P682, DOI 10.1055/s-0042-116228; Rollnik JD, 2013, AKTUEL NEUROL, V40, P274, DOI 10.1055/s-0033-1343428; Streibelt M, 2007, Rehabilitation (Stuttg), V46, P266; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Wang YC, 2014, WORK, V47, P553, DOI 10.3233/WOR-131627; Wozniak MA, 1999, STROKE, V30, P2568, DOI 10.1161/01.STR.30.12.2568	19	1	1	1	6	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0720-4299	1439-3522		FORTSCHR NEUROL PSYC	Forschritte Neurol. Psychiatr.	JAN	2021	89	01/02					29	36		10.1055/a-1149-9151			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	PT6NN	WOS:000608730300012	32542621				2022-02-06	
J	Forslund, MV; Perrin, PB; Sigurdardottir, S; Howe, EI; van Walsem, MR; Arango-Lasprilla, JC; Lu, J; Aza, A; Jerstad, T; Roe, C; Andelic, N				Forslund, Marit V.; Perrin, Paul B.; Sigurdardottir, Solrun; Howe, Emilie I.; van Walsem, Marleen R.; Arango-Lasprilla, Juan Carlos; Lu, Juan; Aza, Alba; Jerstad, Tone; Roe, Cecilie; Andelic, Nada			Health-Related Quality of Life Trajectories across 10 Years after Moderate to Severe Traumatic Brain Injury in Norway	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; outcome assessment; physical health; mental health; SF-36; longitudinal studies; rehabilitation	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; PHYSICAL HEALTH; 1ST YEAR; MILD; INDIVIDUALS; ADULTS; SF-36; DEPRESSION; IMPACT	Traumatic brain injury (TBI) has a long-lasting impact on participation and health-related quality of life (HRQL). We aimed to describe the physical and mental health trajectories and to identify their predictors across the first 10 years after TBI. A prospective longitudinal cohort of 97 individuals with moderate to severe TBI (age 16-55 years) in Norway were followed up at 1, 2, 5, and 10 years post-injury. Their socio-demographic and injury characteristics were recorded at baseline; their responses to the 36-Item Short Form Health Survey (SF-36) were collected at each follow-up. The Physical (PCS) and Mental Component Summary (MCS) scores were used as the outcome measures of physical and mental health. The predictors of the trajectories were described and examined using hierarchical linear modelling. The subscale scores showed a stable or increasing trend, but only the Role Physical and Role Emotional subscales showed clinically relevant positive changes from 1 to 10 years post-injury. Longer time, male gender, employment pre-injury, and shorter length of post-traumatic amnesia were significant predictors of better physical health trajectories; longer time, male gender, and employment pre-injury were significant predictors of better mental health trajectories. At-risk individuals may be targeted to receive rehabilitation interventions to improve their long-term quality of life outcomes.	[Forslund, Marit V.; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23233 USA; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23233 USA; [Sigurdardottir, Solrun] Oslo Univ Hosp, Ctr Rare Disorders, N-0424 Oslo, Norway; [Howe, Emilie I.; Roe, Cecilie] Univ Oslo, Inst Clin Med, Fac Med, N-0318 Oslo, Norway; [van Walsem, Marleen R.] Oslo Univ Hosp, Dept Neurohabil, N-0424 Oslo, Norway; [van Walsem, Marleen R.] Oslo Univ Hosp, Dept Neurol, N-0424 Oslo, Norway; [van Walsem, Marleen R.; Roe, Cecilie; Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, N-0318 Oslo, Norway; [Arango-Lasprilla, Juan Carlos] Biocruces Bizkaia Hlth Res Inst, Baracaldo 48903, Spain; [Arango-Lasprilla, Juan Carlos] Ikerbasque, Basque Fdn Sci, Bilbao 48013, Spain; [Arango-Lasprilla, Juan Carlos] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa 48940, Spain; [Lu, Juan] Virginia Commonwealth Univ, Div Epidemiol, Dept Family Med & Populat Hlth, Richmond, VA 23233 USA; [Aza, Alba] Univ Salamanca, Fac Psychol, Salamanca 37005, Spain; [Aza, Alba] Univ Salamanca, Inst Community Inclus INICO, Salamanca 37005, Spain; [Jerstad, Tone] Oslo Univ Hosp, Dept Neuroradiol, N-0424 Oslo, Norway		Forslund, MV (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway.	mavfor@ous-hf.no; pperrin@vcu.edu; sosigu@ous-hf.no; e.i.howe@medisin.uio.no; r.m.van.walsem@medisin.uio.no; jcalasprilla@gmail.com; juan.lu@vcuhealth.org; azhernandez@usal.es; uxtoad@ous-hf.no; cecilie.roe@medisin.uio.no; nandelic@online.no	Hernandez, Alba Aza/AAB-1909-2021; Perrin, Paul/L-5373-2015	Hernandez, Alba Aza/0000-0002-1460-1195; Perrin, Paul/0000-0003-2070-215X; Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Lu, Juan/0000-0002-5389-7603; Howe, Emilie Isager/0000-0003-1587-5873	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	This research was funded by the Department of Physical Medicine and Rehabilitation, Oslo University Hospital, and by The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Andelic N, 2015, J NEUROL, V262, P523, DOI 10.1007/s00415-014-7595-1; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; C, 2020, MANAGEMENT SEVERE TR, P547; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Garratt AM, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0625-9; Gorgoraptis N, 2019, NEUROREHABILITATION, V44, P321, DOI 10.3233/NRE-182618; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Harfmann EJ, 2020, J NEUROTRAUM, V37, P1408, DOI 10.1089/neu.2019.6746; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hopman WM, 2006, QUAL LIFE RES, V15, P527, DOI 10.1007/s11136-005-2096-4; Hu XB, 2012, BRAIN INJURY, V26, P183, DOI 10.3109/02699052.2011.648707; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Soberg HL, 2015, J TRAUMA ACUTE CARE, V78, P628, DOI 10.1097/TA.0000000000000541; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; TEASDALE G, 1974, LANCET, V2, P81; Tenovuo O., 2020, MANAGEMENT SEVERE TR, P557; Tsyben A, 2018, ACTA NEUROCHIR, V160, P107, DOI 10.1007/s00701-017-3334-6; Ulfarsson T, 2014, BRAIN INJURY, V28, P328, DOI 10.3109/02699052.2013.865274; von Steinbuchel N, 2020, J NEUROTRAUM, V37, P1242, DOI 10.1089/neu.2019.6627; Voormolen DC, 2019, INJURY, V50, P1068, DOI 10.1016/j.injury.2018.12.002; Wang HM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-246; Ware J.E., 1993, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	45	1	1	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JAN	2021	10	1							157	10.3390/jcm10010157			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	PP8NR	WOS:000606113200001	33466321	Green Published, gold			2022-02-06	
J	Fortier, CB; Whitworth, JW; Fonda, JR; Currao, A; Beck, BM; Levin, L; Esterman, M; Milberg, WP; McGlinchey, RE				Fortier, Catherine B.; Whitworth, James W.; Fonda, Jennifer R.; Currao, Alyssa; Beck, Brigitta M.; Levin, Laura; Esterman, Michael; Milberg, William P.; McGlinchey, Regina E.			Early Adolescent Binge Drinking Increases Risk of Psychopathology in Post-9/11 Veterans and Mild Traumatic Brain Injury Exacerbates Symptom Severity	ALCOHOL AND ALCOHOLISM			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE DISORDERS; ALCOHOL-USE; DRUG-USE; PROBLEM BEHAVIOR; US MILITARY; ASSOCIATION; AFGHANISTAN; OEF/OIF; MISUSE	Aims: To demonstrate that early adolescent binge drinking (BD) increases the risk for and/or severity of psychopathology in post-9/11 Veterans and determine if mild traumatic brain injury (mTBI) modifies risk. Methods: Post-9/11 Veterans (n = 375) were classified into two groups: 57 Veterans with a history of early adolescent BD (E-BD; age of onset <15) and 318 who did not BD until age 15 or older (late-BD or L-BD; age of onset >= 15). History of military mTBI and mental health disorders were also assessed following military service. Results: Logistic regression and analysis of variance (ANOVA) analyses revealed that the E-BD's had significantly higher prevalence of alcohol use disorders (AUDs) and more severe symptoms of AUD, substance use disorder (SUD), depression and stress. Two-way ANOVAs showed that history of military mTBI was differentially associated with posttraumatic stress disorder (PTSD) incidence and severity among Veterans who had engaged in early adolescent BD. Specifically, Veterans with a history of both early adolescent BD and military mTBI were at greater risk for a PTSD diagnosis and had more severe symptoms of PTSD than those with only a history of adolescent BD. The greater PTSD symptom severity in the comorbid group was driven by hyperarousal symptoms. Conclusions: A history of BD during early adolescence is prevalent among Veterans and is related to higher risk for AUD and more severe AUD, SUD, mood and stress symptoms later in life. Veterans with early BD and military mTBI showed greater incidence and severity of PTSD, indicating that mTBI, a common comorbidity among post-9/11 Veterans, exacerbates risk.	[Fortier, Catherine B.; Whitworth, James W.; Fonda, Jennifer R.; Currao, Alyssa; Beck, Brigitta M.; Levin, Laura; Esterman, Michael; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, 150 S Huntington Ave, Boston, MA 02130 USA; [Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GREGG, 150 S Huntington Ave, Boston, MA 02130 USA; [Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Whitworth, James W.; Esterman, Michael] VA Boston Healthcare Syst, Natl Ctr PTSD, 150 S Huntington Ave, Boston, MA 02130 USA; [Whitworth, James W.; Esterman, Michael] VA Boston Healthcare Syst, Neuroimaging Res Vet Ctr, 150 S Huntington Ave, Boston, MA 02130 USA; [Fonda, Jennifer R.; Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA		Fortier, CB (corresponding author), VA Boston Healthcare Syst, TRACTS 182 JP, 150 S Huntington Ave, Boston, MA 02130 USA.	Catherine.fortier@va.gov	Fortier, Catherine/AAS-2163-2021; Fonda, Jennifer R./ABG-2890-2021	Fortier, Catherine/0000-0002-8953-9904; Fonda, Jennifer R./0000-0001-9482-2918; Beck, Brigitta/0000-0002-7249-3137; Whitworth, James/0000-0001-7084-7774	VA CSRD Merit Review [CX001327]; Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B3001-C]	VA CSR&D Merit Review (CX001327) and the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (B3001-C). There were no conflicts of interest in conducting or reporting of these results.	Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Trujillo CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225384; [Anonymous], 2014, GLOB STAT REP ALC HL; Bachman JG, 1999, AM J PUBLIC HEALTH, V89, P672, DOI 10.2105/AJPH.89.5.672; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; CHEN K, 1995, AM J PUBLIC HEALTH, V85, P41, DOI 10.2105/AJPH.85.1.41; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Dworkin ER, 2018, ALCOHOL RES-CURR REV, V39, P161; Esterman M, 2019, NEUROPSYCHOLOGY, V33, P711, DOI 10.1037/neu0000525; First M.B., 1996, STRUCTURED CLIN INTE; Fortier CB, 2018, J HEAD TRAUMA REHAB, V33, pE17, DOI 10.1097/HTR.0000000000000362; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gilpin NW, 2017, GENES BRAIN BEHAV, V16, P15, DOI 10.1111/gbb.12349; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Haller M, 2014, PSYCHOL ADDICT BEHAV, V28, P841, DOI 10.1037/a0035878; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoggatt KJ, 2017, AM J ADDICTION, V26, P357, DOI 10.1111/ajad.12534; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; King KM, 2007, J STUD ALCOHOL DRUGS, V68, P256, DOI 10.15288/jsad.2007.68.256; King LA, 2004, DEV RES PRACTICE POL; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Kyzar EJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00222; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McGue M, 2005, AM J PSYCHIAT, V162, P1118, DOI 10.1176/appi.ajp.162.6.1118; McGue M, 2006, BEHAV GENET, V36, P591, DOI 10.1007/s10519-006-9061-z; McIntosh N., 2003, FORFAR ARNEILS TXB P; Norman SB, 2012, NEUROPHARMACOLOGY, V62, P542, DOI 10.1016/j.neuropharm.2011.04.032; Samokhvalov AV, 2010, ALCOHOL CLIN EXP RES, V34, P1871, DOI 10.1111/j.1530-0277.2010.01275.x; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Shorter D, 2015, AM J ADDICTION, V24, P705, DOI 10.1111/ajad.12306; Siqueira L, 2015, PEDIATRICS, V136, pE718, DOI 10.1542/peds.2015-2337; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Stappenbeck CA, 2014, PSYCHOL TRAUMA-US, V6, P65, DOI 10.1037/a0031468; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Viner RM, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2005.038117; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684	51	1	1	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0735-0414	1464-3502		ALCOHOL ALCOHOLISM	Alcohol Alcohol.	JAN	2021	56	1					116	124		10.1093/alcalc/agaa075			9	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	PT1SH	WOS:000608399300016	32776121	hybrid			2022-02-06	
S	Fournier, ML; Clement, T; Aussudre, J; Plesnila, N; Obenaus, A; Badaut, J		Das, H		Fournier, Marie-Line; Clement, Tifenn; Aussudre, Justine; Plesnila, Nikolaus; Obenaus, Andre; Badaut, Jerome			Contusion Rodent Model of Traumatic Brain Injury: Controlled Cortical Impact	WOUND REGENERATION: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury; Pediatric; Behavior; MRI; Immunohistochemistry	LONG-TERM DISABILITY; UNITED-STATES; EDEMA; RATS	Traumatic brain injury (TBI) is a heterogeneous brain injury which represents one of the leading causes of mortality and disability worldwide. Rodent TBI models are helpful to examine the cellular and molecular mechanisms after injury. Controlled cortical impact (CCI) is one of the most commonly used TBI models in rats and mice, based on its consistency of injury and ease of implementation. Here, we describe a CCI protocol to induce a moderate contusion to the somatosensory motor cortex. We provide additional protocols for monitoring animals after CCI induction.	[Fournier, Marie-Line; Clement, Tifenn; Aussudre, Justine; Badaut, Jerome] Univ Bordeaux, CNRS UMR5287, INCIA, Bordeaux, France; [Plesnila, Nikolaus] Univ Munich Med Ctr, Inst Stroke & Dementia Res ISD, Munich, Germany; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Obenaus, Andre] Loma Linda Univ Sch Med, Dept Basic Sci, Loma Linda, CA USA		Fournier, ML (corresponding author), Univ Bordeaux, CNRS UMR5287, INCIA, Bordeaux, France.			Clement, Tifenn/0000-0003-4634-5955; Fournier, Marie-Line/0000-0001-7183-8132; Reis, AlessanRSS/0000-0001-8486-7469	Direction Generale des Armees	The authors declare to have no conflict of interests. Fig. 1 and 6 have been partly made using www.biorender.com.This study was supported by grants eraNET neuron CNSAflame (JB), TRAINS (JB), and Direction Generale des Armees (TC, JB).	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Badaut J, 2020, J NEUROSCI RES, V98, P129, DOI 10.1002/jnr.24415; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Faul M, 2010, TRAUMATIC BRAIN INJU; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zweckberger K, 2009, NEUROSCI LETT, V454, P115, DOI 10.1016/j.neulet.2009.02.014	20	1	1	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-0716-0845-6; 978-1-0716-0844-9	METHODS MOL BIOL	Methods Mol. Biol.		2021	2193						49	65		10.1007/978-1-0716-0845-6_6	10.1007/978-1-0716-0845-6		17	Biochemical Research Methods; Cell & Tissue Engineering; Biotechnology & Applied Microbiology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Cell Biology; Biotechnology & Applied Microbiology	BS0MT	WOS:000683429300007	32808258				2022-02-06	
J	Gerhalter, T; Chen, AM; Dehkharghani, S; Peralta, R; Adlparvar, F; Babb, JS; Bushnik, T; Silver, JM; Im, BS; Wall, SP; Brown, R; Baete, SH; Kirov, II; Madelin, G				Gerhalter, Teresa; Chen, Anna M.; Dehkharghani, Seena; Peralta, Rosemary; Adlparvar, Fatemeh; Babb, James S.; Bushnik, Tamara; Silver, Jonathan M.; Im, Brian S.; Wall, Stephen P.; Brown, Ryan; Baete, Steven H.; Kirov, Ivan I.; Madelin, Guillaume			Global decrease in brain sodium concentration after mild traumatic brain injury	BRAIN COMMUNICATIONS			English	Article						mild traumatic brain injury; sodium MRI; total sodium concentration; clinical and cognitive assessment; diffusion tensor imaging	WHITE-MATTER; MULTIPLE-SCLEROSIS; DIFFUSION MRI; SYMPTOMS; NMR; RECOMMENDATIONS; SPECTROSCOPY; GUIDELINES; RECOVERY; GRAY	The pathological cascade of tissue damage in mild traumatic brain injury is set forth by a perturbation in ionic homeostasis. However, whether this class of injury can be detected in vivo and serve as a surrogate marker of clinical outcome is unknown. We employ sodium MRI to test the hypotheses that regional and global total sodium concentrations: (i) are higher in patients than in controls and (ii) correlate with clinical presentation and neuropsychological function. Given the novelty of sodium imaging in traumatic brain injury, effect sizes from (i), and correlation types and strength from (ii), were compared to those obtained using standard diffusion imaging metrics. Twenty-seven patients (20 female, age 35.9 +/- 12.2 years) within 2 months after injury and 19 controls were scanned with proton and sodium MRI at 3 Testa. Total sodium concentration, fractional anisotropy and apparent diffusion coefficient were obtained with voxel averaging across 12 grey and white matter regions. Linear regression was used to obtain global grey and white matter total sodium concentrations. Patient outcome was assessed with global functioning, symptom profiles and neuropsychological function assessments. In the regional analysis, there were no statistically significant differences between patients and controls in apparent diffusion coefficient, while differences in sodium concentration and fractional anisotropy were found only in single regions. However, for each of the 12 regions, sodium concentration effect sizes were uni-directional, due to lower mean sodium concentration in patients compared to controls. Consequently, linear regression analysis found statistically significant lower global grey and white matter sodium concentrations in patients compared to controls. The strongest correlation with outcome was between global grey matter sodium concentration and the composite x-score from the neuropsychological testing. In conclusion, both sodium concentration and diffusion showed poor utility in differentiating patients from controls, and weak correlations with clinical presentation, when using a region-based approach. In contrast, sodium linear regression, capitalizing on partial volume correction and high sensitivity to global changes, revealed high effect sizes and associations with patient outcome. This suggests that well-recognized sodium imbalances in traumatic brain injury are (i) detectable non-invasively; (ii) non-focal; (iii) occur even when the antecedent injury is clinically mild. Finally, in contrast to our principle hypothesis, patients' sodium concentrations were lower than controls, indicating that the biological effect of traumatic brain injury on the sodium homeostasis may differ from that in other neurological disorders.	[Gerhalter, Teresa; Chen, Anna M.; Dehkharghani, Seena; Peralta, Rosemary; Adlparvar, Fatemeh; Babb, James S.; Brown, Ryan; Baete, Steven H.; Kirov, Ivan I.; Madelin, Guillaume] NYU, Grossman Sch Med, Ctr Biomed Imaging, Dept Radiol, New York, NY 10016 USA; [Dehkharghani, Seena; Kirov, Ivan I.] NYU, Grossman Sch Med, Dept Neurol, New York, NY 10016 USA; [Bushnik, Tamara; Im, Brian S.] NYU, Grossman Sch Med, Dept Rehabil Med, New York, NY 10016 USA; [Silver, Jonathan M.] NYU, Grossman Sch Med, Dept Psychiat, New York, NY 10016 USA; [Wall, Stephen P.] NYU, Grossman Sch Med, Ronald O Perelman Dept Emergency Med, New York, NY 10016 USA; [Brown, Ryan; Baete, Steven H.; Kirov, Ivan I.] NYU, Grossman Sch Med, Ctr Adv Imaging Innovat & Res, Dept Radiol, New York, NY 10016 USA		Kirov, II (corresponding author), NYU, Grossman Sch Med, Ctr Biomed Imaging, Dept Radiol, New York, NY 10016 USA.; Kirov, II (corresponding author), NYU, Grossman Sch Med, Dept Neurol, New York, NY 10016 USA.; Kirov, II (corresponding author), NYU, Grossman Sch Med, Ctr Adv Imaging Innovat & Res, Dept Radiol, New York, NY 10016 USA.; Madelin, G (corresponding author), NYU, Grossman Sch Med, Dept Radiol, 660 First Ave, New York, NY 10016 USA.	Ivan.kirov@nyulangone.org; Guillaume.madelin@nyulangone.org		Baete, Steven/0000-0003-3361-3789; Wall, Stephen/0000-0003-3965-5074; Silver, Jonathan/0000-0002-1841-424X; Dehkharghani, Seena/0000-0002-3141-1094; Bushnik, Tamara/0000-0003-3328-257X; , Anna/0000-0002-8466-7536; Kirov, Ivan/0000-0001-5641-8578; Brown, Ryan/0000-0002-2683-712X; Madelin, Guillaume/0000-0002-5556-5792; Gerhalter, Teresa/0000-0001-9734-4632; Babb, James/0000-0003-1798-1186	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097494, R01EB026456]	This work was supported by grants R01NS097494 and R01EB026456 from the National Institutes of Health (NIH).	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Baete SH, 2018, NEUROIMAGE, V174, P138, DOI 10.1016/j.neuroimage.2018.03.014; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Boicelli CA, 1996, MAGN RESON MATER PHY, V4, P241, DOI 10.1007/BF01772012; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; Dams-O'Connor K, 2018, J NEUROTRAUM, V35, P1138, DOI 10.1089/neu.2017.5347; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Davitz MS, 2019, J MAGN RESON IMAGING, V50, P1424, DOI 10.1002/jmri.26718; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Douglas David B, 2018, Med Sci (Basel), V7, DOI 10.3390/medsci7010002; Douglas DB, 2018, CURR OPIN NEUROL, V31, P362, DOI 10.1097/WCO.0000000000000567; DOYLE TJ, 1995, MAGNET RESON MED, V33, P755, DOI 10.1002/mrm.1910330603; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fessler JA, 2007, J MAGN RESON, V188, P191, DOI 10.1016/j.jmr.2007.06.012; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; GARNER WH, 1986, P NATL ACAD SCI USA, V83, P1901, DOI 10.1073/pnas.83.6.1901; Gerhalter T, 2020, NMR BIOMED, V33, DOI 10.1002/nbm.4279; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Grapperon AM, 2019, RADIOLOGY, V292, P422, DOI 10.1148/radiol.2019182276; Grover H, 2018, AM J NEURORADIOL, V39, P2200, DOI 10.3174/ajnr.A5903; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hancu I, 1999, MAGNET RESON MED, V42, P1146, DOI 10.1002/(SICI)1522-2594(199912)42:6<1146::AID-MRM20>3.0.CO;2-S; Holshouser B, 2019, J NEUROTRAUM, V36, P1352, DOI 10.1089/neu.2018.5919; Huang XJ, 2013, J NEUROTRAUM, V30, P39, DOI 10.1089/neu.2012.2508; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kennis M, 2016, NEUROIMAGE-CLIN, V11, P539, DOI 10.1016/j.nicl.2016.03.022; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Madelin G, 2013, J MAGN RESON IMAGING, V38, P511, DOI 10.1002/jmri.24168; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mikheev, 2013, INT J CARS S1, V8, P289; NARITOMI H, 1987, BIOPHYS J, V52, P611, DOI 10.1016/S0006-3495(87)83251-4; Pan JW, 1998, MAGNET RESON MED, V40, P363, DOI 10.1002/mrm.1910400305; Petracca M, 2016, BRAIN, V139, P795, DOI 10.1093/brain/awv386; Pipe JG, 2011, MAGN RESON MED, V66, P1303, DOI 10.1002/mrm.22918; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Ridley B, 2017, NEUROIMAGE, V157, P173, DOI 10.1016/j.neuroimage.2017.06.011; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ryff C., 2019, DOI 10.3886/ICPSR36346.v7; Schepkin VD, 1998, MAGN RESON MED, V39, P557, DOI 10.1002/mrm.1910390408; Shah NJ, 2016, NMR BIOMED, V29, P162, DOI 10.1002/nbm.3389; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stobbe R, 2005, MAGN RESON MED, V54, P1305, DOI 10.1002/mrm.20696; Stobbe RW, 2016, NMR BIOMED, V29, P119, DOI 10.1002/nbm.3376; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Tal A, 2012, NMR BIOMED, V25, P1392, DOI 10.1002/nbm.2812; Tauskela JS, 1997, J MAGN RESON, V127, P115, DOI 10.1006/jmre.1997.1181; Thulborn KR, 2018, NEUROIMAGE, V168, P250, DOI 10.1016/j.neuroimage.2016.11.056; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	75	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	2							51	10.1093/braincomms/fcab051			14	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TA5UJ	WOS:000667313900043	33928248	Green Published, gold			2022-02-06	
J	Gracies, JM; Jech, R; Valkovic, P; Marque, P; Vecchio, M; Denes, Z; Vilain, C; Delafont, B; Picaut, P				Gracies, Jean-Michel; Jech, Robert; Valkovic, Peter; Marque, Philippe; Vecchio, Michele; Denes, Zoltan; Vilain, Claire; Delafont, Bruno; Picaut, Philippe			When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?	BRAIN COMMUNICATIONS			English	Article						abobotulinumtoxinA; repeat injection; maximal effect; non-linear random coefficient; upper limb spastic paresis		Repeated injection cycles with abobotulinumtoxinA, a botulinum toxin type A, are recommended in current clinical guidelines as a treatment option for adults with upper limb spastic paresis. However, the magnitude of the maximal therapeutic effect of repeated abobotulinumtoxinA treatment across different efficacy parameters and the number of injection cycles required to reach maximal effect remain to be elucidated. Here, we present a post hoc exploratory analysis of a randomized, double-blind, placebo-controlled trial (12-24 weeks; NCT01313299) and open-label extension study (up to 12 months; NCT0131331), in patients aged 18-80 years with hemiparesis for >= 6 months after stroke/traumatic brain injury. Two inferential methods were used to assess the changes in efficacy parameters after repeat abobotulinumtoxinA treatment cycles: Mixed Model Repeated Measures analysis and Non-Linear Random Coefficients analysis. Using the latter model, the expected maximal effect size (not placebo-controlled) and the number of treatment cycles to reach 90% of this maximal effect were estimated. Treatment responses in terms of passive and perceived parameters (i.e. modified Ashworth scale in primary target muscle group, disability assessment scale for principal target for treatment or limb position, and angle of catch at fast speed) were estimated to reach near-maximal effect in two to three cycles. Near-maximal treatment effect for active parameters (i.e. active range of motion against the resistance of extrinsic finger flexors and active function, assessed by the Modified Frenchay Scale) was estimated to be reached one to two cycles later. In contrast to most parameters, active function showed greater improvements at Week 12 (estimated maximal change from baseline-modified Frenchay Scale overall score: +0.8 (95% confidence interval, 0.6; 1.0) than at Week 4 (+0.6 [95% confidence interval, 0.4; 0.8]). Overall, the analyses suggest that repeated treatment cycles with abobotulinumtoxinA in patients chronically affected with upper limb spastic paresis allow them to relearn how to use the affected arm with now looser antagonists. Future studies should assess active parameters as primary outcome measures over repeated treatment cycles, and assess efficacy at the 12-week time-point of each cycle, as the benefits of abobotulinumtoxinA may be underestimated in the studies of insufficient duration.	[Gracies, Jean-Michel] Univ Paris Est Creteil, Hop Univ Henri Mondor, Serv Reeduc Neurolocomotrice, UR 7377 BIOTN, F-94000 Creteil, France; [Jech, Robert] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Jech, Robert] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Jech, Robert] Gen Univ Hosp, Prague, Czech Republic; [Valkovic, Peter] Comenius Univ, Dept Neurol 2, Fac Med, Bratislava, Slovakia; [Valkovic, Peter] Univ Hosp Bratislava, Bratislava, Slovakia; [Marque, Philippe] Hop Rangueil, Serv Med Phys & Readaptat, Toulouse, France; [Vecchio, Michele] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Vecchio, Michele] AOU Policlin Vittorio Emanuele, Phys Med & Rehabil Unit, Catania, Italy; [Denes, Zoltan] Natl Inst Med Rehabil, Brain Injury Rehabil Unit, Budapest, Hungary; [Vilain, Claire; Picaut, Philippe] Ipsen Pharma, Les Ulis, France; [Delafont, Bruno] Delafont Stat, Alencon, France		Gracies, JM (corresponding author), Univ Paris Est Creteil, Hop Univ Henri Mondor, Serv Reeduc Neurolocomotrice, UR 7377 BIOTN, F-94000 Creteil, France.	jean-michel.gracies@aphp.fr	Denes, Zoltan/ABD-3470-2021	Delafont, Bruno/0000-0002-6605-3995; Jech, Robert/0000-0002-9732-8947	IpsenIpsen	This study was sponsored by Ipsen.	Bayle N, 2016, ANN PHYS REHABIL MED, V59, pE59; Bayles N, 2020, CLIN REHABIL, V34, P803, DOI 10.1177/0269215520911970; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Dashtipour K, 2015, AM J PHYS MED REHAB, V94, P229, DOI 10.1097/PHM.0000000000000208; Delafont B, 2018, PHARM STAT, V17, P515, DOI 10.1002/pst.1868; Francis HP, 2004, J NEUROL NEUROSUR PS, V75, P1547, DOI 10.1136/jnnp.2003.025551; Gordon MF, 2004, NEUROLOGY, V63, P1971, DOI 10.1212/01.WNL.0000144349.95487.91; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2018, MUSCLE NERVE, V57, P245, DOI 10.1002/mus.25721; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2009, ARCH PHYS MED REHAB, V90, pE5; Pila O, 2018, INT J NEUROSCI, V128, P1030, DOI 10.1080/00207454.2018.1461626; Prakash A, 2008, INT J CLIN PRACT, V62, P1147, DOI 10.1111/j.1742-1241.2008.01808.x; Royal College of Physicians, 2018, SPAST AD MAN US BOT; Sheean GL, 2001, CURR OPIN NEUROL, V14, P771, DOI 10.1097/00019052-200112000-00015; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; World Health Organization, 2001, INT CLASS FUNCT DIS	17	1	1	3	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	1							fcaa201	10.1093/braincomms/fcaa201			11	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RV0UT	WOS:000645553500006	33543139	Green Published, gold			2022-02-06	
J	Greig, F; McManus, S; Fear, NT				Greig, F.; McManus, S.; Fear, N. T.			Dementia in veterans and non-veterans in England: a cross-sectional survey	OCCUPATIONAL MEDICINE-OXFORD			English	Article						Dementia; depression; military; occupational health; PTSD; survey; veterans	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; COGNITIVE FUNCTION; OLDER; ASSOCIATION	Background Concerns have been raised that military veterans are at greater risk of dementia due to increased rates of depression, post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) found in this population. The prevalence of dementia in English veterans and whether this is different to non-veterans, however, are currently unknown. Aims To study the risk of dementia in the English veteran population, we aimed to calculate the prevalence of dementia in a group of veterans and compare this with a similar group, with no history of military service. Methods Male veterans and non-veterans aged over 64 years old were identified from the 2007 Adult Psychiatric Morbidity Survey, a national survey of community-dwelling adults in England. This survey was conducted via face-to-face interviews and incorporated questions on previous military service. Dementia was screened by using the modified Telephone Interview of Cognitive Status (TICS-M). Results A total of 496 male veterans and 294 non-veterans were identified. TICS-M scores indicated possible dementia in 24% of veterans and 26% non-veterans; after adjusting for age, the odds of possible dementia was significantly lower in veterans than non-veterans (adjusted OR 0.56; 95% CI 0.38-0.84, P < 0.01). Conclusions English male veterans were less likely to have dementia than similar male non-veterans. This study did not find any evidence to support the view that dementia is more common in veterans than non-veterans.	[Greig, F.] South London & Maudsley NHS Fdn Trust, London, England; [Greig, F.] Croydon Univ Hosp, Older Adults Liaison Serv, 530 London Rd, Croydon CR7 7YE, England; [McManus, S.] Natl Ctr Social Res, London EC1V 0AX, England; [McManus, S.] City Univ London, Violence & Soc Ctr, Sch Hlth Sci, London, England; [Fear, N. T.] Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, Cutcombe Rd, London SE5 9RJ, England; [Fear, N. T.] Kings Coll London, Acad Dept Mil Mental Hlth, Weston Educ Ctr, Cutcombe Rd, London SE5 9RJ, England		Greig, F (corresponding author), Croydon Univ Hosp, Older Adults Liaison Serv, 530 London Rd, Croydon CR7 7YE, England.	Flora.greig2@nhs.net		Greig, Flora/0000-0001-5586-0540; Fear, Nicola/0000-0002-5792-2925	Brotherhood of Maintenance of Way Employes Division (BMWED), International Brotherhood of Teamsters, Washington, DC	This study was funded by a contract from the Brotherhood of Maintenance of Way Employes Division (BMWED), International Brotherhood of Teamsters, Washington, DC to the Association of Occupational and Environmental Clinics (AOEC). The content of this paper reflects the views of the authors, and not those of the funders.	[Anonymous], 2020, ALZHEIMERS DEMENT, V16, P391, DOI 10.1002/alz.12068; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bellou V, 2017, ALZHEIMERS DEMENT, V13, P406, DOI 10.1016/j.jalz.2016.07.152; BRANDT J, 1993, ARCH NEUROL-CHICAGO, V50, P599, DOI 10.1001/archneur.1993.00540060039014; Bray R, 2009, DEP DEFENSE SURVEY H; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Cooper C, 2011, AGE AGEING, V40, P711, DOI 10.1093/ageing/afr121; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goodwin L, 2015, PSYCHOL MED, V45, P1881, DOI 10.1017/S0033291714002980; Hersi M, 2017, NEUROTOXICOLOGY, V61, P143, DOI 10.1016/j.neuro.2017.03.006; Hunt EJF, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23617; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; McManus S., 2009, ADULT PSYCHIAT MORBI; McManus S, 2020, INT J EPIDEMIOL, V49, P361, DOI 10.1093/ije/dyz224; Padula CB, 2016, GERONTOLOGIST, V56, P115, DOI 10.1093/geront/gnv663; Prince M, 2014, DEMENTIA UK, V2nd; Public Health England, 2017, HLTH PROF ENGL; Rafferty LA, 2018, PSYCHOL MED, V48, P1400, DOI 10.1017/S0033291717001386; Smith TC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-69; Stevelink SAM, 2018, BRIT J PSYCHIAT, V213, P690, DOI 10.1192/bjp.2018.175; Tampubolon G, 2018, INT J GERIATR PSYCH, V33, P1127, DOI 10.1002/gps.4903; The Ministry of Agriculture of the People's Republic of China, 2016, ANN 2428 MIN AGR PEO, P1; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Williamson V, 2018, AM J GERIAT PSYCHIAT, V26, P534, DOI 10.1016/j.jagp.2017.11.001; Woodhead C, 2011, SOC PSYCH PSYCH EPID, V46, P559, DOI 10.1007/s00127-010-0232-0; World Health Organization, 1992, ICD10 WHO, V67, P227; Wray LO, 2014, AM J GERIAT PSYCHIAT, V22, P1282, DOI 10.1016/j.jagp.2013.04.018	30	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480	1471-8405		OCCUP MED-OXFORD	Occup. Med.-Oxf.	JAN	2021	71	1					34	+		10.1093/occmed/kqaa213			18	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	UU2UW	WOS:000698657300010	33410882	Green Accepted			2022-02-06	
J	Gul, HF; Dolanbay, T; Simsek, AT; Aras, M				Gul, Huseyin Fatih; Dolanbay, Turgut; Simsek, Abdullah Talha; Aras, Murat			Evaluation of Blood Urea, Creatinine, and Glucose Levels as Biochemical Indicators of the Type and Severity of Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Fatality; Urea; Creatinine; Glucose	EPIDEMIOLOGY; NORWAY	AIM: To investigate the effects of trauma type and survival on biochemical parameters including blood urea, creatinine, and glucose levels on patients with traumatic brain injury (TBI). MATERIAL and METHODS: The medical records of 102 patients with TBIs who were admitted to the emergency department and/ or hospitalized in the neurosurgery department between 2016 and 2019 were examined retrospectively. RESULTS: Types of trauma included: 19 cases of subarachnoid hemorrhage, 25 cases of subdural hemorrhage, 9 cases of epidural hemorrhage, 28 cases of intracerebral hemorrhage, 4 cases of multiple hemorrhage, and 12 cases with other hemorrhages. We examined the effects of trauma type and survival on a total of 17 blood test parameters, but only three (blood urea, creatinine, and glucose) showed significance for the overall model, meaning that either trauma type or survival or an interaction between the two had significant effects on these three blood parameters. CONCLUSION: Our findings imply that the risk of fatality due to TBI might be deduced from observation of the patient's blood urea and glucose levels as these two parameters differed significantly in fatal versus surviving cases. Blood urea and creatinine levels were different for different trauma types and may be useful in distinguishing the type of injury.	[Gul, Huseyin Fatih] Kafkas Univ, Dept Med Biochem, Sch Med, Kars, Turkey; [Dolanbay, Turgut; Aras, Murat] Kafkas Univ, Dept Med Emergency, Sch Med, Kars, Turkey; [Simsek, Abdullah Talha] Kars Harakani State Hosp, Dept Neurosurg, Kars, Turkey		Gul, HF (corresponding author), Kafkas Univ, Dept Med Biochem, Sch Med, Kars, Turkey.	fth_2323@hotmail.com					Abhilash Kundavaram Paul Prabhakar, 2016, J Family Med Prim Care, V5, P558, DOI 10.4103/2249-4863.197279; Acar E, 2016, EUR J TRAUMA EMERG S, V42, P611, DOI 10.1007/s00068-015-0579-8; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Annoni J M, 1992, Disabil Rehabil, V14, P23; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Castillo LR, 2007, CRIT CARE CLIN, V22, P713; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; FIFE D, 1984, J NEUROSURG, V60, P697, DOI 10.3171/jns.1984.60.4.0697; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Kelly DF, 2001, WORLD J SURG, V25, P1179; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Mayer AR, 2019, NEUROSCI BIOBEHAV R, V104, P160, DOI 10.1016/j.neubiorev.2019.06.024; Naidech AM, 2006, NEUROSURGERY, V59, P775, DOI 10.1227/01.NEU.0000232662.86771.A9; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	26	1	1	3	4	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2021	31	3					333	338		10.5137/1019-5149.JTN.29843-20.2			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	SB8CI	WOS:000650214600005	33372252	Bronze			2022-02-06	
J	Hendrikx, LJ; Murphy, D				Hendrikx, Laura Josephine; Murphy, Dominic			Understanding the Link Between Traumatic Brain Injury Accompanied by Loss of Consciousness and Well-Being: A Sample of UK Military Veterans	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head trauma; loss of consciousness; treatment-seeking veterans; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MENTAL-HEALTH; IRAQI FREEDOM; ARMED-FORCES; AFGHANISTAN; OUTCOMES; PREVALENCE; DEPLOYMENT; PERSONNEL	Objective: To investigate the association between reported traumatic brain injury plus loss of consciousness (TBI + LOC) and a range of demographic, military, and physical and mental health factors among a sample of UK veterans seeking support for mental health difficulties. Design: The present study was a cross-sectional study. Participants: Clinical records were used to identify a sample of treatment-seeking UK veterans (N = 3335), of which a total of 403 took part. Main Measures: Information on demographic characteristics, military experiences, and a range of physical and mental health difficulties was collected. Results: Almost half of the sample (48%) reported a TBI + LOC, which was most strongly associated with drug use and childhood adversity. More modest associations also emerged with earlier service termination, likelihood of unemployment, as well as chronic pain and poor mobility. Conclusion: The findings suggested that TBI + LOC may not specifically be associated with symptoms of posttraumatic stress in a sample of treatment-seeking veterans. The demonstrated links between TBI + LOC and adverse childhood, drug use, physical health, and employment may be useful in improving the assessment and rehabilitation of veterans with TBI + LOC.	[Hendrikx, Laura Josephine; Murphy, Dominic] Combat Stress, Res Dept, Tyrwhitt House,Oaklawn Rd, London KT22 0BX, England		Murphy, D (corresponding author), Combat Stress, Res Dept, Tyrwhitt House,Oaklawn Rd, London KT22 0BX, England.	l.hendrikx94@gmail.com; dominic.murphy@combatstress.org.uk		Hendrikx, Laura/0000-0001-6760-3373			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bergman B, 2016, OCCUP ENV MED S1, V73, pA99; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Buckman JEJ, 2013, EUR J PUBLIC HEALTH, V23, P410, DOI 10.1093/eurpub/cks042; Carlson K, 2009, ASSESSMENT TREATMENT; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Forbes D, 2014, DEPRESS ANXIETY, V31, P166, DOI 10.1002/da.22148; Friedland D, 2015, ACNR, V15, P24; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Goldberg D., 1998, USERS GUIDE GEN HLTH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iversen AC, 2007, BRIT J PSYCHIAT, V191, P506, DOI 10.1192/bjp.bp.107.039818; Jansen D.J., 2013, POSTTRAUMATIC STRESS; Jones N, 2014, BRAIN INJURY, V28, P896, DOI 10.3109/02699052.2014.888479; Kulas JF, 2018, MIL MED, V183, pE114, DOI 10.1093/milmed/usx050; Leland Azadeh, 2017, Mater Sociomed, V29, P251, DOI 10.5455/msm.2017.29.251-256; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Murphy D., 2015, INT J EMERG MENT HLT, V17, P652; Murphy D, 2015, PSYCHOL RES, V11, P613; Murphy D, 2016, HLTH COUNS PSYCHOTHE, V14, P24; Murphy D, 2022, BMJ MILITARY HEALTH, V168, P38, DOI 10.1136/jramc-2019-001268; Murphy D, 2018, J ROY ARMY MED CORPS, V164, P3, DOI 10.1136/jramc-2017-000844; Murphy D, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1398001; Murphy D, 2019, J MENT HEALTH, V28, P654, DOI 10.1080/09638237.2017.1385739; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stevelink SAM, 2018, BRIT J PSYCHIAT, V213, P690, DOI 10.1192/bjp.2018.175; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Turgoose D, 2018, OPEN ACCESS J NEUROL, V7, P555713, DOI DOI 10.19080/OAJNN.2018.07.555713; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Weathers FW., 2019, PTSD CHECKLIST DSM 5; Wilk JE, 2013, J NERV MENT DIS, V201, P259, DOI 10.1097/NMD.0b013e318288d302; Woodhead C, 2011, PSYCHOL MED, V41, P363, DOI 10.1017/S0033291710000759; World Health Organization, 2007, ICD 10 CLASS MENT BE; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	52	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		34	43		10.1097/HTR.0000000000000599			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300007	32769834				2022-02-06	
J	Holtzhausen, LJ; Souissi, S; Al Sayrafi, O; May, A; Farooq, A; Grant, CC; Korakakis, V; Rabia, S; Segers, S; Chamari, K				Holtzhausen, Louis J.; Souissi, Sofiane; Al Sayrafi, Omar; May, Awartani; Farooq, Abdulaziz; Grant, Catharina C.; Korakakis, Vasileios; Rabia, Safia; Segers, Souhaila; Chamari, Karim			Arabic translation and cross-cultural adaptation of the Sport Concussion Assessment Tool 5 (SCAT5)	BIOLOGY OF SPORT			English	Article						Brain injury; Sport injury; Injury risk; Cognitive assessment; Head trauma	ORTHOGRAPHY; SCALES; RATES	The aim was to create a Modern Standard Arabic SCAT5 version for different Arabic dialects. This translation and cross-cultural adaptation was performed in eight stages: initial translations, reconciliation of translations and cultural adaptation, back translation, appraisal of back translations, validation of the translation, review and adjustment by reconciliation committee, pretesting in 12 football players and document finalisation. As an alternative to the problematic Months In Reverse Order Test (MIROT) in Arabic, the Serial 3s test (32 Arabic and 30 English participants), the Days of the Week Backwards test (DWBT), and the 'Adding Serial 3s' test were tested (30 English and 30 Arabic participants) for accuracy, difficulty and time of completion. The Arabic SCAT5 was similar and comparable to the original English version (7-point Likert scales =< 2). Testing of the pre-final version of the Arabic SCAT5 took 20.4 (SD 3.4) and 17.7 (SD 3.0) minutes respectively to complete and was found acceptable in terms of clarity, understandability, grammatical correctness and coherence. The Arabic Serial 3s test (subtraction version) was unsuitable due to high completion time, low pass rate and high difficulty perception [time = 47.2 (SD 28.0) s; accuracy = 55.2%; difficulty = 3.2 (SD 1.1)]. The Arabic DWBT was too fast and undemanding for concentration testing [time = 4.6 (SD 1.5) s; accuracy = 90%; difficulty = 1.1 (SD 0.3)]. The Adding Serial 3s tests produced similar completion times [18.4 (SD 6.8) vs. 21.1 (SD 5.3), p = 0.088], accuracy (100%) and self-rated difficulty [English = 2.0 (SD 0.7) vs. Arabic-speaking participants = 2.1 (SD 0.8), p = 0.512] and was therefore adopted to replace the MIROT. This culturally adapted Arabic-SCAT5 questionnaire is the first concussion assessment tool available for Arabic-speaking healthcare providers and athletes.	[Holtzhausen, Louis J.; Souissi, Sofiane; Al Sayrafi, Omar; May, Awartani; Farooq, Abdulaziz; Korakakis, Vasileios; Rabia, Safia; Segers, Souhaila; Chamari, Karim] Aspetar Orthopaed & Sports Med Hosp, Doha, Qatar; [Holtzhausen, Louis J.; Rabia, Safia] Weil Cornell Med Coll Qatar, Doha, Qatar; [Holtzhausen, Louis J.; Grant, Catharina C.] Univ Pretoria, Div Sports Med, Pretoria, South Africa; [Holtzhausen, Louis J.] Univ Free State, Dept Exercise & Sports Sci, Bloemfontein, South Africa		Holtzhausen, LJ (corresponding author), Aspetar Orthopaed & Sports Med Hosp, Doha, Qatar.	louis.holtzhausen@aspetar.com	CHAMARI, Karim/AAJ-7938-2021	CHAMARI, Karim/0000-0001-9178-7678			Akan F, 2019, ADV LANGUAGE LIT STU, P58; Baddeley A.D., 1986, WORKING MEMORY; Baddeley AD, 1992, SCI NEW SER, V225; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eirale C, 2015, CLIN J SPORT MED, V25, P73, DOI 10.1097/JSM.0000000000000066; Eviatar Z, 2004, NEUROPSYCHOLOGY, V18, P174, DOI 10.1037/0894-4105.18.1.174; Fasfous AF, 2017, NEUROPSYCHOL REV, V27, P158, DOI 10.1007/s11065-017-9347-3; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Ibrahim R, 2002, NEUROPSYCHOLOGY, V16, P322, DOI 10.1037//0894-4105.16.3.322; Kent PL, 2017, APPL NEUROPSYCH-ADUL, V24, P232, DOI 10.1080/23279095.2015.1135798; Korakakis V, 2019, PLOS ONE, V14, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2017, BR J SPORTS MED; Putukian M, 2019, BR J SPORTS MED; Saady A, 2015, PSICOLOGICA, V36, P123; Saiegh-Haddad E, 2003, APPL PSYCHOLINGUIST, V24, P431, DOI 10.1017/S0142716403000225; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; Sperber AD, 2004, GASTROENTEROLOGY, V126, pS124, DOI 10.1053/j.gastro.2003.10.016; Wechsler D., 2009, WECHSLER MEMORY SCAL; Yeung EW, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000450; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	24	1	1	1	1	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	0860-021X	2083-1862		BIOL SPORT	Biol. Sport		2021	38	1					129	144		10.5114/biolsport.2020.97673			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PG9RA	WOS:000600062300012	33795922				2022-02-06	
J	Howell, DR; Southard, J				Howell, David R.; Southard, Julia			The Molecular Pathophysiology of Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Mild traumatic brain injury; Pathophysiology; Molecular mechanisms	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; MOBILITY GROUP BOX-1; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; SPORT CONCUSSION; TEMPORAL WINDOW; NEUROINFLAMMATION; FLUID		[Howell, David R.; Southard, Julia] Childrens Hosp Colorado, Ctr Sports Med, 13123 East 16th Ave,B060, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Southard, Julia] Regis Univ, Dept Psychol & Neurosci, 3333 Regis Blvd, Denver, CO 80221 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Ctr Sports Med, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@cuanschutz.edu		Howell, David/0000-0002-2955-0191	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R41NS103698, R43NS108823]; MINDSOURCE Colorado Brain Injury Network	Dr D.R. Howell receives research support not related to this study from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R03HD094560), the National Institute of Neurological Disorders and Stroke (R01NS100952, R41NS103698, R43NS108823), and MINDSOURCE Colorado Brain Injury Network. The remaining author has nothing to disclose.	Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Alosco ML, 2017, SEMIN NEUROL, V37, P503, DOI 10.1055/s-0037-1608764; Anderson MN, 2019, DEV NEUROPSYCHOL, V44, P443, DOI 10.1080/87565641.2019.1667995; Ashbaugh A, 2016, CURR SPORT MED REP, V15, P16, DOI 10.1249/JSR.0000000000000219; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Augustine G., 2001, NEUROSCIENCE; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Bramley H, 2015, PEDIATR NEUROL, V52, P493, DOI 10.1016/j.pediatrneurol.2015.01.008; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Cristofori L, 2005, CLIN BIOCHEM, V38, P97, DOI 10.1016/j.clinbiochem.2004.09.013; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Deng-Bryant Y, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00699; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fehily B, 2019, J NEUROCHEM, V149, P660, DOI 10.1111/jnc.14673; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Grover H, 2018, AM J NEURORADIOL, V39, P2200, DOI 10.3174/ajnr.A5903; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoogenboom WS, 2019, PHARMACOL THERAPEUT, V198, P109, DOI 10.1016/j.pharmthera.2019.02.016; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2019, J CHILD NEUROL, V34, P256, DOI 10.1177/0883073818824000; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Katz PS, 2018, METHODS MOL BIOL, V1717, P27, DOI 10.1007/978-1-4939-7526-6_3; Kerr ZY, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2180; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Koerte IK, 2016, TRANSLATIONAL RES TR; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Mayers LB, 2011, J CLIN EXP NEUROPSYC, V33, P532, DOI 10.1080/13803395.2010.535506; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Osier N, 2018, NEUROMETHODS, V139, P81, DOI 10.1007/978-1-4939-8564-7_5; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Panchal H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00616; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Robinson S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00451; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; van Beijnum JR, 2013, ONCOGENE, V32, P363, DOI 10.1038/onc.2012.49; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Vokaty S, 2013, BRIT J SPORT MED, V47, pe1, DOI [10.1136/bjsports-2012-092101.18, DOI 10.1136/BJSPORTS-2012-092101.18]; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Wicklund Alissa H, 2013, Surg Neurol Int, V4, P50, DOI 10.4103/2152-7806.110150; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Yang S, 2014, J LEUKOCYTE BIOL, V95, P563, DOI 10.1189/jlb.0713412; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zander NE, 2016, J NEUROSCI RES, V94, P827, DOI 10.1002/jnr.23786; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	109	1	1	3	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					39	51		10.1016/j.csm.2020.08.001			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400005	33187612				2022-02-06	
J	Iida, Y; Chiba, H; Ikeda, S; Tohyama, H; Ikoma, K				Iida, Yuki; Chiba, Haruko; Ikeda, Satoshi; Tohyama, Harukazu; Ikoma, Katsunori			Association between the Wechsler Adult Intelligence Scale III and early return to work after traumatic brain injury	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article						Vocational rehabilitation; supported reemployment; neurobehavioral disability	HEAD-INJURY; EMPLOYMENT; PREDICTORS; RECOVERY; PEOPLE	BACKGROUND: Residual capacity evaluation via neuropsychological testing can facilitate the development of a rehabilitation plan in patients following a traumatic brain injury (TBI). OBJECTIVE: This study aimed to confirm the tasks that patients must perform well for early return towork (RTW) following TBI using the Wechsler Adult Intelligence Scale III (WAIS-III). METHODS: In total, 40 male and 13 female patients who suffered from neurobehavioral disabilities following TBI were recruited and classified into two groups: the successfully returned to work group (SRTW-G; n = 22) and the unsuccessfully returned to work group (USRTW-G; n = 31). The outcomes assessed by WAIS-III and the time to RTW were compared between the SRTW-G and USRTW-G groups. Multiple logistic regression, multiple regression analysis, and Cox regression were employed to assess differences between the groups. RESULTS: The Comprehension and Letter-Number Sequencing subtests of theWAIS-III were significantly correlated with early RTW more than the other subtests. CONCLUSIONS: We found that, as reflected in the two subtests, patients with TBI must be able to perform well in the following tasks for early RTW: Retention of information for short time periods, information processing, and social judgment based on the knowledge of the patient's experience.	[Iida, Yuki; Ikoma, Katsunori] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido, Japan; [Chiba, Haruko; Ikeda, Satoshi; Tohyama, Harukazu; Ikoma, Katsunori] Hokkaido Univ Hosp, Dept Rehabil Med, Sapporo, Hokkaido, Japan; [Iida, Yuki] Hokuyukai Neurol Hosp, Dept Neurol, Sapporo, Hokkaido, Japan; [Tohyama, Harukazu] Hokkaido Univ, Fac Hlth Sci, Dept Rehabil Sci, Sapporo, Hokkaido, Japan		Ikoma, K (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido, Japan.	ikoma@med.hokudai.ac.jp					Abiko K, 2018, BRAIN INJURY, V32, P1367, DOI 10.1080/02699052.2018.1496478; Arai H, 2015, GERIATR GERONTOL INT, V15, P673, DOI 10.1111/ggi.12450; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Bell C, 2018, BRIT J NEUROSURG, V32, P495, DOI 10.1080/02688697.2018.1490945; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; de la Cour FLD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00103; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Golden C, 2000, NEUROPSYCHOLOGICAL I; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hirota S, 2017, NEUROL MED-CHIR, V57, P94, DOI 10.2176/nmc.oa.2016-0049; Horn JohnL., 1989, LEARN INDIVID DIFFER, P61; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; KAUFMAN AS, 1999, ESSENTIALS WAIS 3 AS; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kunishio Katsuzo, 1993, Neurologia Medico-Chirurgica, V33, P824, DOI 10.2176/nmc.33.824; Kyllonen PC, 1987, HUMAN PRODUCTIVITY E, P338; Leung K L, 2005, Work, V25, P333; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Morrison CA, 2016, J TRAUMA ACUTE CARE, V80, P755, DOI 10.1097/TA.0000000000000997; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHNIC; Radford K, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22330; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Spitz G, 2019, J NEUROTRAUM, V36, P2533, DOI 10.1089/neu.2018.5850; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wang V, 2019, ANN PHYS REHABIL MED, V62, P28, DOI 10.1016/j.rehab.2018.08.003; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2006, WAIS 3 ADM SCORING M; Wechsler D, 1981, WECHSLER ADULT INTEL; Wechsler D., 1999, WAIS 3 ADM SCORING M; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	46	1	1	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2021	68	4					1101	1111		10.3233/WOR-213440			11	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	RX5OE	WOS:000647272000015	33843716				2022-02-06	
J	Izzy, S; Brown-Whalen, A; Yahya, T; Sarro-Schwartz, A; Jin, GN; Chung, JY; Lule, S; Morsett, LM; Alquraini, A; Wu, LM; Hickman, SE; Whalen, MJ; El Khoury, J				Izzy, Saef; Brown-Whalen, Alexander; Yahya, Taha; Sarro-Schwartz, Aliyah; Jin, Gina; Chung, Joon Yong; Lule, Sevda; Morsett, Liza M.; Alquraini, Ali; Wu, Limin; Hickman, Suzanne E.; Whalen, Michael J.; El Khoury, Joseph			Repetitive Traumatic Brain Injury Causes Neuroinflammation before Tau Pathology in Adolescent P301S Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						concussion; tau; adolescents; traumatic brain injury; CTE; microglia		Repetitive closed head injury (rCHI) is commonly encountered in young athletes engaged in contact and collision sports. Traumatic brain injury (TBI) including rCHI has been reported to be an important risk factor for several tauopathies in studies of adult humans and animals. However, the link between rCHI and the progression of tau pathology in adolescents remains to be elucidated. We evaluated whether rCHI can trigger the initial acceleration of pathological tau in adolescent mice and impact the long-term outcomes post-injury. To this end, we subjected adolescent transgenic mice expressing the P301S tau mutation to mild rCHI and assessed tau hyperphosphorylation, tangle formation, markers of neuroinflammation, and behavioral deficits at 40 days post rCHI. We report that rCHI did not accelerate tau pathology and did not worsen behavioral outcomes compared to control mice. However, rCHI induced cortical and hippocampal microgliosis and corpus callosum astrocytosis in P301S mice by 40 days post-injury. In contrast, we did not find significant microgliosis or astrocytosis after rCHI in age-matched WT mice or sham-injured P301S mice. Our data suggest that neuroinflammation precedes the development of Tau pathology in this rCHI model of adolescent repetitive mild TBI.	[Izzy, Saef; Yahya, Taha; Sarro-Schwartz, Aliyah] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Izzy, Saef; Brown-Whalen, Alexander; Morsett, Liza M.; Alquraini, Ali; Hickman, Suzanne E.; El Khoury, Joseph] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, 149 13th St, Charlestown, MA 02119 USA; [Izzy, Saef; Whalen, Michael J.; El Khoury, Joseph] Harvard Med Sch, Boston, MA 02115 USA; [Jin, Gina; Chung, Joon Yong; Lule, Sevda; Wu, Limin; Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Alquraini, Ali] Al Baha Univ, Fac Clin Pharm, Al Baha 65779, Saudi Arabia		El Khoury, J (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, 149 13th St, Charlestown, MA 02119 USA.; El Khoury, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	sizzy@bwh.harvard.edu; ABROWN-WHALEN@PARTNERS.ORG; tyahya@bwh.harvard.edu; aliyahss@alumni.stanford.edu; gina.jin@med.uvm.edu; jchung8@student.nymc.edu; SLULE@mgh.harvard.edu; LMORSETT@mgh.harvard.edu; AALQURAINI@mgh.harvard.edu; LWU11@mgh.harvard.edu; SHICKMAN@mgh.harvard.edu; MWHALEN@mgh.harvard.edu; jelkhoury@mgh.harvard.edu		Chung, Joon Yong/0000-0002-3980-2065; El Khoury, Joseph/0000-0003-1498-1703; Wu, Limin/0000-0001-9633-7481	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1 AG051506] Funding Source: Medline		Alquraini A, 2020, CURR BIOL, V30, pR790, DOI 10.1016/j.cub.2020.05.051; Bachstetter AD, 2020, EXP NEUROL, V326, DOI 10.1016/j.expneurol.2020.113180; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Brown GC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1564-7; Castellani RJ, 2019, J ALZHEIMERS DIS, V67, P447, DOI 10.3233/JAD-180721; Cheng H, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104683; Clayton EL, 2017, HUM MOL GENET, V26, P873, DOI 10.1093/hmg/ddx003; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Dani M, 2018, BRAIN, V141, P2740, DOI 10.1093/brain/awy188; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Flurkey K, 2007, MOUSE BIOMEDICAL RES, V2, P637; Gangolli M, 2019, J NEUROTRAUM, V36, P735, DOI 10.1089/neu.2018.5700; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Hamelin L, 2016, BRAIN, V139, P1252, DOI 10.1093/brain/aww017; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Leung E, 2011, NEUROBIOL AGING, V32, P387, DOI 10.1016/j.neurobiolaging.2009.02.025; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P1775, DOI 10.1001/jama.2010.1487; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sardari M, 2021, BRAIN BEHAV IMMUN, V91, P627, DOI 10.1016/j.bbi.2020.10.015; Scattoni ML, 2010, BEHAV BRAIN RES, V208, P250, DOI 10.1016/j.bbr.2009.12.002; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wu LM, 2019, J CEREBR BLOOD F MET, V39, P2196, DOI 10.1177/0271678X18786633; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang ZL, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9605265	60	1	1	1	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN	2021	22	2							907	10.3390/ijms22020907			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	PX4NV	WOS:000611334200001	33477535	Green Published, gold			2022-02-06	
J	Jeon, S; Son, J; Park, M; Ko, BS; Son, SH				Jeon, Sanghoon; Son, Joonwoo; Park, Myoungouk; Ko, Byuk Sung; Son, Sang Hyuk			Driving-PASS: A Driving Performance Assessment System for Stroke Drivers Using Deep Features	IEEE ACCESS			English	Article						Vehicles; Stroke (medical condition); Reactive power; Licenses; Visualization; Roads; Tools; Driving assessment; driving performance; stroke drivers; deep features	CONVOLUTIONAL NEURAL-NETWORKS; TRAUMATIC BRAIN-INJURY; ON-ROAD ASSESSMENT; P-DRIVE; SIMULATOR; RELIABILITY; GUIDELINES; VALIDITY; PHYSICIANS; BATTERY	Despite any doubts about driving safety, many stroke drivers drive again due to the absence of valid screening tools. The on-road test is considered a formal assessment, but there are safety issues in testing directly on stroke patients who are not fully capable of driving. A driving simulator is a promising tool since it provides meaningful information for identifying hazards to driving safety across different driver populations and driving conditions. Using the advantages of a driving simulator, we propose a Driving Performance Assessment System for Stroke drivers (Driving-PASS). Driving-PASS is designed not only to pre-screen invalid stroke drivers before the on-road test but also to provide problematic driving items for the use in driving rehabilitation. To design assessment classifiers, i.e., the core engine of Driving-PASS, we collect driving data from a total of twenty-seven participants in thirteen driving scenarios. Thereafter, we get subjective assessment results from ten driving evaluators in eleven assessment items. By using driving data and subjective assessment results, we construct eleven assessment classifiers for ten driving ability items and one driving suitability item. We addressed the technical challenges such as handcrafted features and imbalanced dataset by a feature extraction method using pre-trained CNN models and a resampling method. Through comprehensive performance evaluation, we build eleven accurate assessment classifiers in Driving-PASS by carefully selecting deep features in each assessment item. We envision that Driving-PASS can be used as a pre-screening tool for evaluating stroke drivers and will ultimately improve road safety.	[Jeon, Sanghoon; Son, Sang Hyuk] DGIST, Dept Informat & Commun Engn, Daegu 42988, South Korea; [Son, Joonwoo; Park, Myoungouk] DGIST, HumanLab, Daegu 42988, South Korea; [Jeon, Sanghoon; Ko, Byuk Sung] Hanyang Univ, Seoul Hosp, Coll Med, Dept Emergency Med, Seoul 04763, South Korea		Son, SH (corresponding author), DGIST, Dept Informat & Commun Engn, Daegu 42988, South Korea.; Son, J (corresponding author), DGIST, HumanLab, Daegu 42988, South Korea.	json@dgist.ac.kr; son@dgist.ac.kr			Institute for Information and Communications Technology Promotion (IITP) - Korean Government (MSIP) (Resilient Cyber-Physical Systems Research) [B0101-15-0557]; DGIST Research Program of the Ministry of Science, ICT and Future Planning (MSIP) [21-BT-05]; Transportation and Logistics Research and Development Program - Ministry of Land, Infrastructure and Transport of Korean Government [20TLRP-B131486-04]; National Research Foundation of Korea - Government of Korea (Ministry of Science and ICT) [NRF-2018R1C1B5043803]; Institute of Information and Communications Technology Planning and Evaluation (IITP) - Korean Government (MSIT) (Artificial Intelligence Graduate School Program (Hanyang University)) [2020-0-01373]; Hanyang University [HY-202000000700016]	This work was supported in part by the Institute for Information and Communications Technology Promotion (IITP) Grant funded by the Korean Government (MSIP) (Resilient Cyber-Physical Systems Research) under Grant B0101-15-0557, in part by the DGIST Research Program of the Ministry of Science, ICT and Future Planning (MSIP) under Project 21-BT-05, in part by the Transportation and Logistics Research and Development Program funded by Ministry of Land, Infrastructure and Transport of Korean Government under Grant 20TLRP-B131486-04, in part by the National Research Foundation of Korea Grant funded by the Government of Korea (Ministry of Science and ICT) under Grant NRF-2018R1C1B5043803, in part by the Institute of Information and Communications Technology Planning and Evaluation (IITP) Grant funded by the Korean Government (MSIT) (Artificial Intelligence Graduate School Program (Hanyang University)) under Grant 2020-0-01373, and in part by the research fund of Hanyang University under Grant HY-202000000700016.	Akinwuntan AE, 2013, TOP STROKE REHABIL, V20, P87, DOI 10.1310/tsr2001-87; Akinwuntan AE, 2012, J STROKE CEREBROVASC, V21, P478, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.001; Akinwuntan AE, 2005, NEUROLOGY, V65, P843, DOI 10.1212/01.wnl.0000171749.71919.fa; [Anonymous], 2019, ASSESSING FITNESS DR; [Anonymous], 2017, DETERMINING MED FITN, V9th; [Anonymous], 2013, MED PRACTITIONERS GL; Bellagamba D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233125; Berger JT, 2000, J GEN INTERN MED, V15, P667, DOI 10.1046/j.1525-1497.2000.04309.x; Biederman Joseph, 2007, Ann Gen Psychiatry, V6, P4, DOI 10.1186/1744-859X-6-4; Bjorkdahl A., 2015, PHYS MED REHABIL INT, V2, P1054; Brown T, 2018, J OCC THER SCH EARLY, V11, P229, DOI 10.1080/19411243.2018.1432441; Bulmash EL, 2006, J AFFECT DISORDERS, V93, P213, DOI 10.1016/j.jad.2006.01.015; Campos JL, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01428; Carr D. B., 2010, PHYS GUIDE ASSESSING; Casutt G, 2014, TRANSPORT RES F-TRAF, V22, P232, DOI 10.1016/j.trf.2013.12.007; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chikhaoui B, 2017, INT CONF DAT MIN WOR, P693, DOI 10.1109/ICDMW.2017.97; Choi SY, 2016, J PHYS THER SCI, V28, P837, DOI [10.1589/jpts.28.837, 10.1589/jpts.28.2110]; Cox D J, 1998, J Am Board Fam Pract, V11, P264; Cox SM, 2016, J AUTISM DEV DISORD, V46, P1379, DOI 10.1007/s10803-015-2677-1; Crundall D, 2010, ACCIDENT ANAL PREV, V42, P2117, DOI 10.1016/j.aap.2010.07.001; D'apolito AC, 2017, ANN PHYS REHABIL MED, V60, P263, DOI 10.1016/j.rehab.2017.04.001; de Vet HCW, 2017, J CLIN EPIDEMIOL, V85, P45, DOI 10.1016/j.jclinepi.2017.01.013; de Winter JCF, 2009, ERGONOMICS, V52, P137, DOI 10.1080/00140130802277521; Duquette J, 2010, AM J OCCUP THER, V64, P279, DOI 10.5014/ajot.64.2.279; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith J, 2015, BRIT J OCCUP THER, V78, P349, DOI 10.1177/0308022614562795; Galski T, 1997, AM J OCCUP THER, V51, P352, DOI 10.5014/ajot.51.5.352; Georgescu MI, 2019, IEEE ACCESS, V7, P64827, DOI 10.1109/ACCESS.2019.2917266; Gitbook, 2019, DEEP LEARNING; Gurtman CG, 2008, HUM PSYCHOPHARM CLIN, V23, P681, DOI 10.1002/hup.983; Hebert D, 2016, INT J STROKE, V11, P459, DOI 10.1177/1747493016643553; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Hird MA, 2014, J STROKE CEREBROVASC, V23, P2654, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.010; Hitosugi M, 2011, INT J GEN MED, V4, P191, DOI 10.2147/IJGM.S17475; Hoggarth PA, 2013, J AM GERIATR SOC, V61, P2192, DOI 10.1111/jgs.12540; Holowaychuk A, 2020, AM J OCCUP THER, V74, DOI 10.5014/ajot.119.040626; Huchler S., 2001, EURA MEDICOPHYS, V37, P283; Imhoff S, 2016, NEUROREHABILITATION, V39, P239, DOI 10.3233/NRE-161354; Jee S, 2018, J REHABIL MED, V50, P800, DOI 10.2340/16501977-2373; Jeon S, 2018, I C CONT AUTOMAT ROB, P1367, DOI 10.1109/ICARCV.2018.8581177; Karthaus Melanie, 2016, Geriatrics (Basel), V1, DOI 10.3390/geriatrics1020012; Kotterba S, 2003, EUR NEUROL, V50, P160, DOI 10.1159/000073057; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Kunimatsu-Sanuki S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006379; Lee H. C., 2002, AUST, V49, P138, DOI DOI 10.1046/J.1440-1630.2002.00314.X; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Li DC, 2010, COMPUT BIOL MED, V40, P509, DOI 10.1016/j.compbiomed.2010.03.005; Longadge R., 2013, REV INT J COMPUTER S, V2, P83, DOI DOI 10.1109/SIU.2013.6531574; Lopes UK, 2017, COMPUT BIOL MED, V89, P135, DOI 10.1016/j.compbiomed.2017.08.001; Lundqvist A, 2008, BRAIN INJURY, V22, P295, DOI 10.1080/02699050801966133; Mardh S, 2017, TRAFFIC INJ PREV, V18, P477, DOI 10.1080/15389588.2016.1265954; McNamara A, 2019, AUST OCCUP THER J, V66, P5, DOI 10.1111/1440-1630.12456; Mourant R. R., 2007, P HUM FACT ERG SOC A, V51, P1232; N. T. Agency, 2014, MED ASPECTS FITNESS; Nannia L., 2020, APPL COMPUT INFORM, P1; Oh H., 2013, P 15 JAP KOR JOINT S, P1; Park MO, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016315; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; Patomella AH, 2010, SCAND J OCCUP THER, V17, P86, DOI [10.1080/11038120903071776, 10.3109/11038120903071776]; Paul R, 2016, TOMOGRAPHY, V2, P388, DOI 10.18383/j.tom.2016.00211; Pratap T, 2019, BIOMED SIGNAL PROCES, V53, DOI 10.1016/j.bspc.2019.04.010; Ranchet M, 2016, EUR J NEUROL, V23, P1408, DOI 10.1111/ene.13050; Sawada T, 2019, INT J REHABIL RES, V42, P289, DOI 10.1097/MRR.0000000000000374; Shechtman O, 2009, TRAFFIC INJ PREV, V10, P379, DOI 10.1080/15389580902894989; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; stlund J., 2005, D225 AIDE; Szegedy C, 2017, THIRTY-FIRST AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4278; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Szlyk JP, 2002, J REHABIL RES DEV, V39, P483; Tabar YR, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2560/14/1/016003; Takasaki H, 2013, ACCIDENT ANAL PREV, V60, P5, DOI 10.1016/j.aap.2013.07.033; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Torgo L., 2013, COMPREHENSIVE R ARCH, P1; Tuncer T, 2020, J SUPERCOMPUT, V76, P2119, DOI 10.1007/s11227-020-03205-1; Wang ZQ, 2019, IEEE ACCESS, V7, P105146, DOI 10.1109/ACCESS.2019.2892795; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wynne RA, 2019, SAFETY SCI, V117, P138, DOI 10.1016/j.ssci.2019.04.004; Xu GW, 2019, IEEE ACCESS, V7, P112767, DOI 10.1109/ACCESS.2019.2930958; Yang W, 2016, PROC CVPR IEEE, P3073, DOI 10.1109/CVPR.2016.335; Zhou Y, 2018, PROC CVPR IEEE, P4490, DOI 10.1109/CVPR.2018.00472	82	1	1	1	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2021	9						21627	21641		10.1109/ACCESS.2021.3055870			15	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Engineering; Telecommunications	QE6CJ	WOS:000616293200001		gold			2022-02-06	
J	Jiang, JP; Dai, C; Liu, XY; Dai, LJ; Li, RX; Ma, K; Xu, HY; Zhao, F; Zhang, ZW; He, T; Niu, XG; Chen, XY; Zhang, S				Jiang, Jipeng; Dai, Chen; Liu, Xiaoyin; Dai, Lujia; Li, Ruixin; Ma, Ke; Xu, Huiyou; Zhao, Fei; Zhang, Zhiwen; He, Tao; Niu, Xuegang; Chen, Xuyi; Zhang, Sai			Implantation of regenerative complexes in traumatic brain injury canine models enhances the reconstruction of neural networks and motor function recovery	THERANOSTICS			English	Article						Hemiplegic limb; Collagen; Silk fibroin; Mesenchymal stem cell; Traumatic brain injury	SPINAL-CORD; MECHANICAL-PROPERTIES; THERMAL-STABILITY; ANIMAL-MODELS; CROSS-LINKING; COLLAGEN; INFLAMMATION; BIOMATERIAL; STRATEGIES; SCAFFOLDS	Rationale: The combination of medical and tissue engineering in neural regeneration studies is a promising field. Collagen, silk fibroin and seed cells are suitable options and have been widely used in the repair of spinal cord injury. In this study, we aimed to determine whether the implantation of a complex fabricated with collagen/silk fibroin (SF) and the human umbilical cord mesenchymal stem cells (hUCMSCs) can promote cerebral cortex repair and motor functional recovery in a canine model of traumatic brain injury (TBI). Methods: A porous scaffold was fabricated with cross-linked collagen and SF. Its physical properties and degeneration rate were measured. The scaffolds were co-cultured with hUCMSCs after which an implantable complex was formed. After complex implantation to a canine model of TBI, the motor evoked potential (MEP) and magnetic resonance imaging (MRI) were used to evaluate the integrity of the cerebral cortex. The neurologic score, motion capture, surface electromyography (sEMG), and vertical ground reaction force (vGRF) were measured in the analysis of motor functions. In vitro analysis of inflammation levels was performed by Elisa while immunohistochemistry was used in track the fate of hUCMSCs. In situ hybridization, transmission electron microscope, and immunofluorescence were used to assess neural and vascular regeneration. Results: Favorable physical properties, suitable degradation rate, and biocompatibility were observed in the collagen/SF scaffolds. The group with complex implantation exhibited the best cerebral cortex integrity and motor functions. The implantation also led to the regeneration of more blood vessels and nerve fibers, less glial fibers, and inflammatory factors. Conclusion: Implantation of this complex enhanced therapy in traumatic brain injury (TBI) through structural repair and functional recovery. These effects exhibit the translational prospects for the clinical application of this complex.	[Jiang, Jipeng; Dai, Chen; Ma, Ke; Xu, Huiyou; Zhao, Fei; Chen, Xuyi; Zhang, Sai] Chinese Peoples Armed Police Force PAP, Characterist Med Ctr, Ctr Neurol & Neurosurg, Inst Traumat Brain Injury & Neurosci,Tianjin Key, Chenglin Rd 220, Tianjin 300162, Peoples R China; [Jiang, Jipeng] Gen Hosp PLA, Chinese Peoples Liberat Army PLA, Med Sch, Postgrad Sch, Fuxing Rd 28, Beijing 100853, Peoples R China; [Liu, Xiaoyin] Sichuan Univ, West China Hosp, West China Med Sch, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Dai, Lujia] Armed Police Corps Hosp Zhejiang Prov, Dept Neurol, Hangzhou 310000, Peoples R China; [Li, Ruixin] Tianjin Stomatol Hosp, Tianjin Key Lab Oral & Maxillofacial Funct Recons, Tianjin 300041, Peoples R China; [Zhang, Zhiwen] Univ Tokyo, Southern Univ Sci & Technol, SUSTech UTokyo Joint Res Ctr Super Smart City, Ctr Spatial Informat Sci, Tokyo 2778568, Japan; [He, Tao] Chinese Peoples Armed Police Force PAP, Characterist Med Ctr, Dept Pathol, Chenglin Rd 220, Tianjin 300162, Peoples R China; [Niu, Xuegang] Tianjin Fourth Cent Hosp, Dept Neurosurg, Zhongshan Rd 1, Tianjin 300143, Peoples R China		Chen, XY; Zhang, S (corresponding author), Chinese Peoples Armed Police Force PAP, Characterist Med Ctr, Ctr Neurol & Neurosurg, Inst Traumat Brain Injury & Neurosci,Tianjin Key, Chenglin Rd 220, Tianjin 300162, Peoples R China.; Niu, XG (corresponding author), Tianjin Fourth Cent Hosp, Dept Neurosurg, Zhongshan Rd 1, Tianjin 300143, Peoples R China.	niuxuegang1@126.com; Chenxuyi1979@126.com; zhangsai718@vip.126.com		Jiang, Jipeng/0000-0002-8954-7277	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11672332, 11932013]; Research project of Tianjin rescue medicine and clinical medicine research center, China [15ZXLCSY00040]; Major Project of Tianjin Science and Technology Military and Civilian Integration [18ZXJMTG00260]	This work was supported by The National Natural Science Foundation of China (11672332, 11932013). Research project of Tianjin rescue medicine and clinical medicine research center, China (15ZXLCSY00040). The Major Project of Tianjin Science and Technology Military and Civilian Integration (18ZXJMTG00260).	Abbasi-Kangevari M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00238; Adams C, 2018, THERANOSTICS, V8, P4824, DOI 10.7150/thno.24747; Ahuja CS, 2016, STEM CELL TRANSL MED, V5, P914, DOI 10.5966/sctm.2015-0381; An B, 2016, ADV DRUG DELIVER REV, V97, P69, DOI 10.1016/j.addr.2015.11.013; Asboth L, 2018, NAT NEUROSCI, V21, P576, DOI 10.1038/s41593-018-0093-5; Bhardwaj N, 2015, INT J BIOL MACROMOL, V81, P31, DOI 10.1016/j.ijbiomac.2015.07.049; Castella M, 2005, ANN THORAC SURG, V79, P646, DOI 10.1016/j.athoracsur.2004.07.007; Dueland R, 1977, Bull Hosp Joint Dis, V38, P35; Ganau Mario, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010019; Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Guan FX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1433-4; Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/nmat4407, 10.1038/NMAT4407]; HUTTON WC, 1969, J SMALL ANIM PRACT, V10, P71, DOI 10.1111/j.1748-5827.1969.tb04022.x; JACOBSON WC, 1995, J ELECTROMYOGR KINES, V5, P37, DOI 10.1016/S1050-6411(99)80004-2; JAYES AS, 1978, J ZOOL, V185, P289, DOI 10.1111/j.1469-7998.1978.tb03334.x; Jiang JP, 2020, NEURAL REGEN RES, V15, P959, DOI 10.4103/1673-5374.268974; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JP, 2018, J NEUROSCI METH, V307, P95, DOI 10.1016/j.jneumeth.2018.06.025; Koo J, 2018, NAT MED, V24, P1830, DOI 10.1038/s41591-018-0196-2; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lai BQ, 2018, ADV SCI, V5, DOI 10.1002/advs.201800261; Lee JY, 2019, THERANOSTICS, V9, P1029, DOI 10.7150/thno.29868; Lin XL, 2019, MAT SCI ENG C-MATER, V105, DOI 10.1016/j.msec.2019.110018; Liu ZM, 2018, ADV MATER, V30, DOI 10.1002/adma.201705388; Luo ZY, 2016, COLLOID SURFACE B, V143, P243, DOI 10.1016/j.colsurfb.2016.03.047; Ma YH, 2018, BIOMATERIALS, V160, P37, DOI 10.1016/j.biomaterials.2018.01.015; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malay AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27573; Meyer M, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0647-0; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]; Neckel ND, 2020, J NEUROTRAUM, V37, P517, DOI 10.1089/neu.2018.5959; Negah SS, 2019, ACTA BIOMATER, V92, P132, DOI 10.1016/j.actbio.2019.05.010; Negah SS, 2018, CELL TISSUE RES, V371, P223, DOI 10.1007/s00441-017-2717-6; Ogle BM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad2304; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; PURDY PD, 1989, STROKE, V20, P1361, DOI 10.1161/01.STR.20.10.1361; Rahman MA, 2019, MAR DRUGS, V17, DOI 10.3390/md17020118; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; SHIN DY, 1989, ARCH PHYS MED REHAB, V70, P189; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Sonesson S, 2017, KNEE SURG SPORT TR A, V25, P2337, DOI 10.1007/s00167-015-3714-5; Ucar B, 2018, NEURAL REGEN RES, V13, P595, DOI 10.4103/1673-5374.230273; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; von Zitzewitz J, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026007; Wang F, 2017, MAT SCI ENG C-MATER, V79, P728, DOI 10.1016/j.msec.2017.05.120; Willenberg BJ, 2011, J BIOMAT SCI-POLYM E, V22, P1621, DOI 10.1163/092050610X519453; Wu XM, 2018, INT J BIOL MACROMOL, V109, P1319, DOI 10.1016/j.ijbiomac.2017.11.144; Wu XM, 2017, INT J BIOL MACROMOL, V98, P292, DOI 10.1016/j.ijbiomac.2017.01.127; Xian PP, 2019, THERANOSTICS, V9, P5956, DOI 10.7150/thno.33872; Xu YQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147184; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Zagra L, 2013, CLIN ORTHOP RELAT R, V471, P3830, DOI 10.1007/s11999-013-2926-6; Zheng B, 2016, THERANOSTICS, V6, P291, DOI 10.7150/thno.13728	55	1	1	13	28	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2021	11	2					768	788		10.7150/thno.50540			21	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	OM4IG	WOS:000585989200018	33391504	Green Published, gold			2022-02-06	
J	Jones, NS; Sethi, N; Wieschhaus, K; Mak, R; Wesolowski, M; Schiff, A; Tonino, PM				Jones, Nathaniel S.; Sethi, Neal; Wieschhaus, Kyle; Mak, Ryan; Wesolowski, Michael; Schiff, Adam; Tonino, Pietro M.			Medical Supervision of Illinois Public and Private High School Athletics	PHYSICIAN AND SPORTSMEDICINE			English	Article; Early Access						Athletic training; injury prevention; medical supervision; high school athletics; head injuries(concussion); sideline coverage		Background: High-school sports participation in the United States has increased over the years with a corresponding increase in the number of injuries. Leading medical and sports organizations nationwide advocate for an increase in proper medical supervision of athletes. Objectives: To analyze athletic medical coverage in Illinois high schools and compare differences between public and private Illinois high school. Methods: A survey addressing various components of sports medical coverage was distributed in 2018 to all 810 Illinois High School Association (IHSA) high schools to be completed electronically. Results: The response rate was 50% (407/810 schools). Of the responding schools, 14% were private high schools and 86% public high schools. An orthopedic surgeon, family doctor, pediatrician, or another type of physician were present on sidelines in 9.2% of private high schools and 8.5% of public high schools. Athletic trainers (ATs) were present on sidelines in 91% of private high schools and in 79% of public high schools. There was 68% of private high schools reporting coaches trained in CPR versus 85% in public high schools. Both private and public high schools had high rates of having written emergency action plans (89% vs 91%), AED on site (100% vs 99%), written concussion management protocols (96% vs 97%). Conclusion: Our study found similar rates of high school medical coverage as compared to national studies, with some significant differences found between private and public high schools. Most Illinois high schools had high rates of having written EAPs, concussion management protocols and AEDs on site. Overall, an increase of medical supervision and emergency preparedness is needed, which should come in the form of increasing AT and physician presence alongside community and school engagement for improved implementation of coverage.	[Jones, Nathaniel S.; Sethi, Neal; Wieschhaus, Kyle; Mak, Ryan; Wesolowski, Michael; Schiff, Adam; Tonino, Pietro M.] Loyola Univ Med Ctr, Dept Orthopaed Surg & Anesthesiol, Maywood, IL 60153 USA		Sethi, N (corresponding author), Loyola Univ Med Ctr, Dept Orthopaed Surg & Anesthesiol, Maywood, IL 60153 USA.	nealsethi@gmail.com		Sethi, Neal/0000-0002-8010-7101; Mak, Ryan/0000-0001-6046-3937			Adams WM, 2014, J ATHL TRAINING, V49, P469, DOI 10.4085/1062-6050-49.3.01; Almquist J, 2008, J ATHL TRAINING, V43, P416, DOI 10.4085/1062-6050-43.4.416; Andersen JC, 2002, J ATHL TRAINING, V37, P99; Casa DJ., 2008, J ATHL TRAINING, V43, P416; Centers for Disease Control and Prevention, 2019, MMWR MORB MORTAL WKL, V68, P466; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; Drezner JA, 2007, J ATHL TRAINING, V42, P143; Heck JF, 2004, J ATHL TRAINING, V39, P101; Huggins RA, 2019, J ATHL TRAINING, V54, P1129, DOI 10.4085/1062-6050-12-19; Johnson ST, 2017, SPORTS HEALTH, V9, P181, DOI 10.1177/1941738116686782; Jones NS, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119862503; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Lear A, 2015, J ATHL TRAINING, V50, P1054, DOI 10.4085/1062-6050-50.8.01; Mazerolle SM, 2015, J ATHL TRAINING, V50, P1059, DOI 10.4085/1062-6050-50.10.01; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; National Federation of State High School Associations Advisory Committee, 2018 2019 HIGH SCH A; Pike A, 2016, J ATHL TRAINING, V51, P717, DOI 10.4085/1062-6050-51.11.04c; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Pike AM., 2015, THESIS; Porter Marianne, 1980, Phys Sportsmed, V8, P95, DOI 10.1080/00913847.1980.11948564; Post E, 2019, J ATHL TRAINING, V54, P177, DOI 10.4085/1062-6050-440-17; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Salzman GA, 2015, J PEDIATR SURG, V50, P1192, DOI 10.1016/j.jpedsurg.2014.10.058; Schneider K, 2017, RURAL REMOTE HEALTH, V17; Tonino PM, 2004, PHYSICIAN SPORTSMED, V32, P37, DOI 10.3810/psm.2004.02.123; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wham GS, 2010, J ATHL TRAINING, V45, P75, DOI 10.4085/1062-6050-45.1.75	29	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.												10.1080/00913847.2020.1868954		JAN 2021	7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	PM7WJ	WOS:000604004000001	33356778				2022-02-06	
J	Jorgensen-Wagers, K; Young, V; Collins, D; Chavez, B; Lenski, D; Khokhar, B				Jorgensen-Wagers, Kendra; Young, Vanessa; Collins, Dawn; Chavez, Bianca; Lenski, Dayna; Khokhar, Bilal			Brain Injury: What Influences the Beliefs US Service Members Have About Reporting and Seeking Care?	MILITARY MEDICINE			English	Article								Introduction: Despite the recent Department of Defense emphasis on traumatic brain injury (TBI) education and improvements in treatment, social, and attitudinal beliefs instilled in the military community hinder seeking medical assistance at the time of injury. This survey research presents injury reporting and care seeking behavioral patterns of service members (SMs) stationed in the Landstuhl catchment area in the context of TBI. This descriptive study investigated whether sociocultural factors influence health decision-making among SMs stationed abroad and how these compare to the SMs stationed in Fort Bliss and Fort Hood. Materials and Methods: A total of 969 of U.S. Army, Air Force, and Navy SMs completed a voluntary and anonymous 2- to 5-minute paper survey during the month of March 2019. As a result of illegibility and incompleteness, 15 survey responses were removed from the total sample. Results: Data analyses show three main findings about SMs in the Landstuhl catchment area: (a) older population (25-34, >= 48%; 18-24, 26.1%; +35, 25.4%) when compared to Fort Hood and Fort Bliss (>= 48%; 18-24); (b) more years in service (7-13 years; 30.2%) versus 6 years or less in both Fort Hood and Fort Bliss (>= 69%); (c) 54.8% of participants did not think TBI requires care versus 63.5% in both Fort Bliss and Fort Hood. Conclusion: Results suggest that TBI beliefs and influences are constant variables hindering health decision-making choices in the military population. Beliefs about thinking that the injury does not require care, fear to jeopardize the career, and knowledge about TBI and treatments vary among the respondents and all these components influence treatment-seeking behaviors. The findings provide a preliminary framework to further investigate the role of culture in reporting and seeking treatment behaviors among SMs.	[Jorgensen-Wagers, Kendra; Young, Vanessa; Collins, Dawn] US Mil Installat Germany APO, Dept Phys Med & Rehabil, Traumat Brain Injury Clin, Landstuhl Reg Med Ctr, APO, AE 09180 USA; [Jorgensen-Wagers, Kendra; Collins, Dawn; Khokhar, Bilal] Def & Vet Brain Injury Ctr, Traumat Brain Injury Ctr Excellence, Washington, DC 22041 USA; [Chavez, Bianca] US Army Garrison, Traumat Brain Injury Clin, Ft Bliss, TX 79916 USA; [Lenski, Dayna] Ft Hood US Army Garrison, Intrepid Spirit Ctr Excellence, Traumat Brain Injury Clin, Ft Hood, TX 76544 USA		Jorgensen-Wagers, K (corresponding author), US Mil Installat Germany APO, Dept Phys Med & Rehabil, Traumat Brain Injury Clin, Landstuhl Reg Med Ctr, APO, AE 09180 USA.; Jorgensen-Wagers, K (corresponding author), Def & Vet Brain Injury Ctr, Traumat Brain Injury Ctr Excellence, Washington, DC 22041 USA.	Kendra.l.jorgensen-wagers.ctr@mail.mil	Young, Vanessa/ABD-3632-2021		Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The research was funded by the Defense and Veterans Brain Injury Center.	[Anonymous], 2020, DOD NUMBERS TRAUMATI; Azari J, 2010, ARMED FORCES SOC, V36, P585, DOI 10.1177/0095327X09358648; Barlas FM, 2011, HLTH RELATED BEHAV S; Butler D, 2009, TRAUMATIC BRAIN INJU, P31; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Chuck Y, 2008, MILD TRAUMATIC BRAIN; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Defense Manpower Data Center: DoD Personnel, 2004, WORKF REP PUBL; Escolas SM, 2020, J MIL MED, V185, P4; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Nichols AL, 2008, J GEN PSYCHOL, V135, P151, DOI 10.3200/GENP.135.2.151-166; Phelan SM, 2018, ARCH PHYS MED REHAB, V99, P2222, DOI 10.1016/j.apmr.2018.04.007; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Sharp ML, 2015, EPIDEMIOL REV, V37, P144, DOI 10.1093/epirev/mxu012; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Tanielian T, 2009, ASSESSING COMBAT EXP; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Weinick RM, 2012, RAND HLTH Q, V1; Zollman FS., MANUAL TRAUMATIC BRA	23	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			546	551		10.1093/milmed/usaa410			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600078	33499505	Bronze			2022-02-06	
J	Karton, C; Hoshizaki, TB				Karton, Clara; Hoshizaki, Thomas Blaine			Biomechanics of Sport-Related Neurological Injury	CLINICS IN SPORTS MEDICINE			English	Article						Injury mechanism; Sport-related concussion; Repetitive head impact; Tissue response; Clinical outcome; Cumulative exposure; Measurement metrics; Brain trauma profiling; Risk mitigation	TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; WHITE-MATTER INTEGRITY; SOCCER PLAYERS; PROFESSIONAL FOOTBALL; BARRIER DYSFUNCTION; WORKING-MEMORY; ICE HOCKEY; CONCUSSION; MILD		[Karton, Clara; Hoshizaki, Thomas Blaine] Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada		Karton, C (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	ckarton@uottawa.ca					Abbott NJ, 2018, ACTA NEUROPATHOL, V135, P387, DOI 10.1007/s00401-018-1812-4; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Beusenberg MC., 2000, P INT RES C BIOM IMP; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; Blyth BJ, 2008, ANN EMERG MED, V51, P538, DOI 10.1016/j.annemergmed.2008.01.193; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Chen W., 2018, THESIS; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Clark JM, 2018, J MECH BEHAV BIOMED, V80, P20, DOI 10.1016/j.jmbbm.2018.01.020; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Cournoyer J, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1600004; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164912; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Effgen GB, 2017, J NEUROTRAUM, V34, P914, DOI 10.1089/neu.2016.4477; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Farell M, 2019, CLIN NEUROPATHOL, V38, P51, DOI 10.5414/NP301130; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Finkel AM, 2019, HUM ECOL RISK ASSESS, V25, P564, DOI 10.1080/10807039.2018.1456899; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gadd CW, 1996, P 10 STAPP CAR CRASH; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki, 2020, J CONCUSSION, DOI [10.1177/2059700220911285., DOI 10.1177/2059700220911285]; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Karton C., 2016, P TRAUM BRAIN INJ CL; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kendall M., 2016, THESIS; Khatib A., 2019, THESIS; King A. I., 2003, IRCOBI C LISB PORT; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Newman J., 1986, INT IRCOBI C BIOM IM, V14, P121; O'Keeffe E, 2019, J NEUROTRAUM, V36, P1; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Paiement B, 2020, THESIS; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Public Health Agency of Canada (PHAC), 2019, UND AW SPORTS REL CO; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rousseau P., 2014, THESIS; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Silva VD, 2006, MECH STRENGTH MAT; Simon E, 2019, NEUROSCIENCE, V405, P24, DOI 10.1016/j.neuroscience.2018.01.059; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Smith DH, 1999, J NEUROSCI, V19, P4263; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor K, 2019, COMPUT METHOD BIOMEC, V22, P1047, DOI 10.1080/10255842.2019.1626840; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Versace J., 1971, P 15 STAPP CAR CRASH, V15, P43; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zanetti K, 2013, P IRCOBI GOTH SWED S; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	127	1	1	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					19	38		10.1016/j.csm.2020.09.001			20	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400004	33187609				2022-02-06	
J	Kasuske, LM; Hoover, P; Wu, T; French, LM; Caban, JJ				Kasuske, Lalon M.; Hoover, Peter; Wu, Tim; French, Louis M.; Caban, Jesus J.			Burden of Behavioral Health Comorbidities on Outpatient Health Care Utilization by Active Duty Service Members With a First Documented mTBI	MILITARY MEDICINE			English	Article								Objective: More than 280,000 Active Duty Service Members (ADSMs) sustained a mild traumatic brain injury (mTBI) between 2000 and 2019 (Q3). Previous studies of veterans have shown higher utilization of outpatient health clinics by veterans diagnosed with mTBI. Additionally, veterans with mTBI and comorbid behavioral health (BH) conditions such as post-traumatic stress disorder, depression, and substance use disorders have significantly higher health care utilization than veterans diagnosed with mTBI alone. However, few studies of the relationship between mTBI, health care utilization, and BH conditions in the active duty military population currently exist. We examined the proportion of ADSMs with a BH diagnosis before and after a first documented mTBI and quantified outpatient utilization of the Military Health System in the year before and following injury. Materials and Methods: Retrospective analysis of 4,901,840 outpatient encounters for 39,559 ADSMs with a first documented diagnosis of mTBI recorded in the Department of Defense electronic health record, subsets of who had a BH diagnosis. We examined median outpatient utilization 1 year before and 1 year after mTBI using Wilcoxon signed rank test, and the results are reported with an effect size r. Outpatient utilization is compared by BH subgroups. Results: Approximately 60% of ADSMs experience a first mTBI with no associated BH condition, but 17% of men and women are newly diagnosed with a BH condition in the year following mTBI. ADSMs with a history of a BH condition before mTBI increased their median outpatient utilization from 23 to 35 visits for men and from 32 to 42 visits for women. In previously healthy ADSMs with a new BH condition following mTBI, men more than tripled median utilization from 7 to 24 outpatient visits, and women doubled utilization from 15 to 32 outpatient visits. Conclusions: Behavioral health comorbidities affect approximately one-third of ADSMs following a first mTBI, and approximately 17% of previously healthy active duty men and women will be diagnosed with a new BH condition in the year following a first mTBI. Post-mTBI outpatient health care utilization is highly dependent on the presence or absence of BH condition and is markedly higher is ADSMs with a BH diagnosis in the year after a first documented mTBI.	[Kasuske, Lalon M.] Uniformed Serv Univ Hlth Sci, Daniel K Inouye Grad Sch Nursing, Bethesda, MD 20814 USA; [Kasuske, Lalon M.; Hoover, Peter; Wu, Tim; French, Louis M.; Caban, Jesus J.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [French, Louis M.] Def & Vet Brain Injury Ctr, Silver Spring, MD 20910 USA		Kasuske, LM (corresponding author), Uniformed Serv Univ Hlth Sci, Daniel K Inouye Grad Sch Nursing, Bethesda, MD 20814 USA.; Kasuske, LM (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA.			french, louis/0000-0002-9451-0604			[Anonymous], 2019, MSMR, V26, P19; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense and Veterans Brain Injury Center, 2019, DOD WORLDWIDE TBI NU; Department of Veteran Affairs and Department of Defense, 2016, VADOD CLIN PRACTICE; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; Lange RT, 2020, NEUROPSYCHOL REHABIL, V30, P1762, DOI 10.1080/09602011.2019.1604385; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Maguen S, 2012, PSYCHIAT SERV, V63, P1206, DOI 10.1176/appi.ps.201200051; Maguen S, 2012, J WOMENS HEALTH, V21, P666, DOI 10.1089/jwh.2011.3113; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ramchand R, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0575-z; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023	35	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			567	571		10.1093/milmed/usaa320			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600081	33499506	Bronze			2022-02-06	
J	Kerr, H; Bakken, B; House, G				Kerr, Hamish; Bakken, Bjorn; House, Gregory			Future Directions in Sports-Related Concussion Management	CLINICS IN SPORTS MEDICINE			English	Article						Biomarkers; Imaging; Video review; Accelerometers; Rule changes; Injury epidemiology	TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; WHITE-MATTER; BODY CHECKING; HEAD IMPACTS; DIFFUSION; BIOMARKERS; NETWORK; ABNORMALITIES; PLAYERS		[Kerr, Hamish] Albany Med Coll, Sports Med, Dept Med, 1019 New Loudon Rd, Cohoes, NY 12047 USA; [Bakken, Bjorn] Albany Med Ctr, Dept Med, 1019 New Loudon Rd, Cohoes, NY 12047 USA; [House, Gregory] Albany Med Ctr, Dept Family & Community Med, 391 Myrtle Ave, Albany, NY 12208 USA		Kerr, H (corresponding author), Albany Med Coll, Sports Med, Dept Med, 1019 New Loudon Rd, Cohoes, NY 12047 USA.	kerrh@amc.edu					Anto-Ocrah M, 2017, NEUROL CLIN, V35, P473, DOI 10.1016/j.ncl.2017.03.008; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; CHENEVERT TL, 1990, RADIOLOGY, V177, P401, DOI 10.1148/radiology.177.2.2217776; Chiampas GT, 2018, SCI MED FOOTBALL, V2, P80, DOI 10.1080/24733938.2017.1421771; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Emery C, 2020, BRIT J SPORT MED, V54, P414, DOI 10.1136/bjsports-2019-101092; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0093-0; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kawata K, 2018, HAND CLINIC, V158, P217, DOI 10.1016/B978-0-444-63954-7.00022-7; Klassen Aline, 2017, Adv Exp Med Biol, V965, P3, DOI 10.1007/978-3-319-47656-8_1; Lange RT, 2019, J CLIN EXP NEUROPSYC, V41, P497, DOI 10.1080/13803395.2019.1585518; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2019, J NEUROTRAUM, V37, P152; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parker RS, 2002, NEUROREHABILITATION, V17, P131; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Puffenbarger MS, 2019, ACAD EMERG MED, V26, P784, DOI 10.1111/acem.13666; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Putukian M, 2014, CURR SPORT MED REP, V13, P334, DOI 10.1249/JSR.0000000000000092; Raftery M, 2016, BRIT J SPORT MED, V50, P642, DOI 10.1136/bjsports-2016-095959; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	71	1	1	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					199	211		10.1016/j.csm.2020.08.009			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400017	33187610				2022-02-06	
J	Kessler, RA; Bhammar, A; Lakomkin, N; Shrivastava, RK; Rasouli, JJ; Steinberger, J; Bederson, J; Hadjipanayis, CG; Benzil, DL				Kessler, Remi A.; Bhammar, Ansh; Lakomkin, Nikita; Shrivastava, Raj K.; Rasouli, Jonathan J.; Steinberger, Jeremy; Bederson, Joshua; Hadjipanayis, Constantinos G.; Benzil, Deborah L.			Spinal cord injury in the United States Army Special Forces	JOURNAL OF NEUROSURGERY-SPINE			English	Article						spinal cord injury; trauma; military; combat; airborne; spine	AIRBORNE OPERATIONS; COMBAT; WAR; EPIDEMIOLOGY; AFGHANISTAN; MANAGEMENT; RISK	OBJECTIVE Spinal cord injury (SCI) is an area of key interest in military medicine but has not been studied among the US Army Special Forces (SF), the most elite group of US soldiers. SF soldiers make up a disproportionate 60% of all Special Operations casualties. The objective of this study was to better understand SCI incidence in the SF, its mechanisms of acquisition, and potential areas for intervention by addressing key issues pertaining to protective equipment and body armor use. METHODS An electronic survey questionnaire was formulated with the close collaboration of US board-certified neurosurgeons from the Mount Sinai Hospital and Cleveland Clinic Departments of Neurosurgery, retired military personnel of the SF, and operational staff of the Green Beret Foundation. The survey was sent to approximately 6000 SF soldiers to understand SCI diagnosis and its associations with various health and military variables. RESULTS The response rate was 8.2%. Among the 492 respondents, 94 (19.1%) self-reported an SCI diagnosis. An airborne operation was the most commonly attributed cause (54.8%). Moreover, 87.1% of SF soldiers reported wearing headgear at the time of injury, but only 36.6% reported wearing body armor, even though body armor use has significantly increased in post-9/11 SF soldiers compared with that in their pre-9/11 counterparts. SCI was significantly associated with traumatic brain injury, arthritis, low sperm count, low testosterone, erectile dysfunction, tinnitus, hyperacusis, sleep apnea, posttraumatic stress disorder, major depressive disorder, and generalized anxiety disorder. Only 16.5% of SF soldiers diagnosed with SCI had been rescued via medical evacuation (medevac) for treatment. CONCLUSIONS A high number of SF soldiers self-reported an SCI diagnosis. Airborne operations landings were the leading cause of SCI, which coincided with warfare tactics employed during the Persian Gulf War, Operation Iraqi Freedom, and other conflicts. A majority of SCIs occurred while wearing headgear and no body armor, suggesting the need for improvements in protective equipment use and design. The low rate of medevac rescue for these injuries may suggest that medical rescue was not attainable at the time or that certain SCIs were deemed minor at the time of injury.	[Kessler, Remi A.; Lakomkin, Nikita; Shrivastava, Raj K.; Steinberger, Jeremy; Bederson, Joshua; Hadjipanayis, Constantinos G.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Bhammar, Ansh] Johns Hopkins Univ, Baltimore, MD USA; [Rasouli, Jonathan J.; Benzil, Deborah L.] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA		Kessler, RA (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	remi.kessler@icahn.mssm.edu					Abrams GM, 2019, CHRONIC COMPLICATION; [Anonymous], 1990, AIRBORNE OPERATIONS; [Anonymous], 2013, SPOTL IMPR CAR VET S; Atiyeh B S, 2007, Ann Burns Fire Disasters, V20, P203; Ball VL, 2014, WILD ENVIRON MED, V25, P89, DOI 10.1016/j.wem.2013.10.003; Bauman WA, 2014, J SPINAL CORD MED, V37, P32, DOI 10.1179/2045772313Y.0000000122; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Bernstock JD, 2015, MIL MED, V180, P503, DOI 10.7205/MILMED-D-14-00215; Berwick D, 2016, ANATIONAL TRAUMA CAR; Blair JA, 2012, SPINE J, V12, P824, DOI 10.1016/j.spinee.2011.09.012; Bricknell MCM, 1999, OCCUP MED-OXFORD, V49, P17, DOI 10.1093/occmed/49.1.17; CICCONE R, 1948, J BONE JOINT SURG AM, V30-A, P77, DOI 10.2106/00004623-194830010-00010; Clancy T, 2001, SPECIAL FORCES GUIDE; Farr WD, 2017, DEATH GOLDEN HOUR RE; Fitzgerald GJ, 2008, AM J PUBLIC HEALTH, V98, P611, DOI 10.2105/AJPH.2007.11930; Furlan JC, 2012, TRAUMATIC BRAIN SPIN, P216; Furlan JC, 2019, GLOB SPINE J, V9, P545, DOI 10.1177/2192568218776914; Furlan JC, 2020, BMJ MILITARY HEALTH, V166, pE57, DOI 10.1136/jramc-2019-001197; Furlan JC, 2017, J SPINAL CORD MED, V40, P649, DOI 10.1080/10790268.2017.1368267; Grimm PD, 2019, SPORTS MED ARTHROSC, V27, P84, DOI 10.1097/JSA.0000000000000246; Ivins BJ, 2008, MIL MED, V173, P1168, DOI 10.7205/MILMED.173.12.1168; Johnson ES, 2019, AEROSP MED HUM PERF, V90, P637, DOI 10.3357/AMHP.5329.2019; Kellerman A, 2018, HEALTH AFFAIR, DOI [10.1377/hblog20180628.431867/full/, DOI 10.1377/HBLOG20180628.431867/FULL/]; Knapik J, 2016, J ATHL TRAINING, V51, P962, DOI 10.4085/1062-6050-51.9.10; Kotwal RS, 2004, AVIAT SPACE ENVIR MD, V75, P833; Lehman RA, 2012, SPINE J, V12, P784, DOI 10.1016/j.spinee.2011.09.005; Lillywhite L P, 1991, J R Army Med Corps, V137, P115; McCafferty RR, 2018, MIL MED, V183, P67, DOI 10.1093/milmed/usy071; Patki P, 2008, J SPINAL CORD MED, V31, P27, DOI 10.1080/10790268.2008.11753977; PIRSON J, 1985, AVIAT SPACE ENVIR MD, V56, P564; Rivera Jessica C, 2014, J Surg Orthop Adv, V23, P136; Schoenfeld AJ, 2013, SPINE, V38, P1770, DOI 10.1097/BRS.0b013e31829ef226; Schoenfeld AJ, 2012, SPINE J, V12, P817, DOI 10.1016/j.spinee.2011.04.028; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Steele JR, 2016, MECHANOBIOLOGY MECHA, P50; Ursano RJ, 2017, MIL MED, V182, DOI 10.7205/MILMED-D-16-00270	36	1	1	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JAN	2021	34	1					110	116		10.3171/2020.7.SPINE20804			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PY9BY	WOS:000612336500004	32977307	hybrid			2022-02-06	
J	Koreerat, NR; Giese, R				Koreerat, Nicholas R.; Giese, Russell			An Observation of Application of Structural Brain Injury Devices for Traumatic Brain Injury Evaluation in Austere Military Prehospital Settings	MILITARY MEDICINE			English	Article								Introduction: Military units lack the ability to quickly, objectively, and accurately assess individuals that have suffered a closed head injury for structural brain injury and functional brain impairments in forward settings, where neurological assessment equipment and expertise may be lacking. With acute traumatic brain injury patients, detached medical providers are often faced with a decision to wait and observe or medically evacuate, both of which have cascading consequences. Structural brain injury assessment devices, when employed in forward environments, have the potential to reduce the risk of undiagnosed and/or mismanaged traumatic brain injuries given their high negative predictive value and suggested increased specificity compared to common subjective clinical decision rules. These handheld devices are portable and have an ease of use, from combat medic to physician, allowing for use in austere environments, safely keeping soldiers with their teams when able and suggesting further evaluation via computed tomography (CT) scan when warranted. Methods: Data collected on 13 encounters at 5 locations were retrospectively analyzed using descriptive statistics. Results: A total number of 13 examinations were performed using the BrainScope One device during the 9-month deployment. The Structural Injury Classification was negative for 11 of the patients. Two of the 11 patients underwent head CT scans, which confirmed the absence of intracranial hemorrhage. Of the two positive Structural Injury Classification exams, one was CT negative and no CT was performed for the other based on clinical judgment. Conclusion: The data from this study suggest that structural brain injury devices may provide value by ruling out serious brain injury pathology while limiting excessive medical evacuations from austere settings, where neurological assessment equipment and expertise may be lacking, reducing unnecessary head CT scans.	[Koreerat, Nicholas R.; Giese, Russell] 1st Secur Force Assistance Brigade, Med Support Sect, Ft Benning, GA 31905 USA		Koreerat, NR (corresponding author), 1st Secur Force Assistance Brigade, Med Support Sect, Ft Benning, GA 31905 USA.						Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Cooksley R, 2018, AUST OCCUP THER J, V65, P168, DOI 10.1111/1440-1630.12457; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Heit JJ, 2017, J STROKE, V19, P11, DOI 10.5853/jos.2016.00563; Huff JS, 2017, AM J EMERG MED, V35, P1777, DOI 10.1016/j.ajem.2017.05.027; Jackson George L, 2008, N C Med J, V69, P43; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Manolakaki D, 2009, J TRAUMA, V66, P1008, DOI 10.1097/TA.0b013e31819adba2; Naunheim R, 2019, AM J EMERG MED, V37, P1987, DOI 10.1016/j.ajem.2019.04.037; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wieland Diane, 2010, Pa Nurse, V65, P4	18	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			579	583		10.1093/milmed/usaa397			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600083	33499547	Bronze			2022-02-06	
S	Kwiecien, JM; Yaron, JR; Delaney, KH; Lucas, AR		Lucas, AR		Kwiecien, Jacek M.; Yaron, Jordan R.; Delaney, Kathleen H.; Lucas, Alexandra R.			Neurologic and Histologic Tests Used to Measure Neuroprotective Effectiveness of Virus-Derived Immune-Modulating Proteins	VIRUSES AS THERAPEUTICS: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Serp-1; M-T7; Spinal cord injury; Neuroinflammation; Cavity of injury; Subdural infusion; Spinal cord implantation; Anti-inflammatory treatment; Neuroprotection; Macrophage quantification	SPINAL-CORD-INJURY; SERP-1; M-T7	Severe inflammatory disease initiated by neurotrauma and stroke is of primary concern in these intractable pathologies as noted in recent studies and understanding of the pathogenesis of spinal cord injury (SCI) in the rat model. Successful anti-inflammatory treatments should result in neuroprotection and limit the loss of neurological function to injury caused by the initial damage. Continuous subdural infusion offers direct access to the cavity of injury (COI) that forms after balloon crush SCI deep in the spinal cord. Some anti-inflammatory compounds are not likely capable of crossing the blood-spinal cord barrier. Subdural infusion of myxoma virus-derived Serp-1, an anti-thrombotic/anti-thrombolytic, and also of M-T7, a chemokine inhibitor, improved the locomotor scores and pain sensation scores as well as reduced the numbers of macrophages in the COI by 50 and 80%, respectively, while intraperitoneal infusion of either protein had little effect. Injection of a chitosan hydrogel loaded with Serp-1 into the dorsal spinal column crush also resulted in improved neurological deficits and in reduction of the size of the crush lesion 4 weeks after injury. While neurological scores in a simplified hind-end (HE) locomotor test together with a toe-pinch withdrawal test demonstrated improvement in all balloon crush injury and dorsal spinal crush injury rats, a severe inflammation is induced by the injury indicating additional damage to the spinal cord. Thus neurological function testing can be contradictory, rather than corresponding, to the pathogenesis of SCI. The count of macrophages in the COI offers a precise, reliable method of measuring the effectiveness of a neuroprotective treatment of SCI in preclinical studies.	[Kwiecien, Jacek M.; Delaney, Kathleen H.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Yaron, Jordan R.; Lucas, Alexandra R.] Arizona State Univ, Biodesign Inst, Ctr Personalized Diagnost, Tempe, AZ USA; [Yaron, Jordan R.; Lucas, Alexandra R.] Arizona State Univ, Biodesign Inst, Ctr Immunotherapy Vaccines & Virotherapy, Tempe, AZ USA; [Lucas, Alexandra R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Lucas, Alexandra R.] Creighton Univ, Dign Hlth, St Joseph Hosp, Phoenix, AZ USA; [Lucas, Alexandra R.] St Josephs Hosp, Dign Hlth, Div Cardiol, Phoenix, AZ USA		Kwiecien, JM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.			Yaron, Jordan/0000-0002-4133-474X			Bartee MY, 2009, METHOD ENZYMOL, V460, P209, DOI 10.1016/S0076-6879(09)05210-0; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Kwiecien JM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041221; Kwiecien JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226584; Kwiecien JM, 2019, FOLIA NEUROPATHOL, V57, P41, DOI 10.5114/fn.2019.83830; Kwiecien JM, 2016, NEUROL NEUROCHIR POL, V50, P7, DOI 10.1016/j.pjnns.2015.10.006; Kwiecien JM, 2015, FOLIA NEUROPATHOL, V53, P41, DOI 10.5114/fn.2015.49973; Kwiecien JM, 2013, FOLIA NEUROPATHOL, V51, P189, DOI 10.5114/fn.2013.37703; Kwiecien JM, 2016, ADV MED BIOL; Kwiecien JM, BIOMEDICINES; Kwiecien JM, 2018, METHODS MOL BIOL METHODS MOL BIOL, V1826; Rahman MM, 2009, ADV EXP MED BIOL, V666, P64; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044694	15	1	1	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-0716-1012-1; 978-1-0716-1011-4	METHODS MOL BIOL	Methods Mol. Biol.		2021	2225						227	239		10.1007/978-1-0716-1012-1_13	10.1007/978-1-0716-1012-1		13	Biochemical Research Methods; Biotechnology & Applied Microbiology; Virology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Virology	BS0MS	WOS:000683424200014	33108666				2022-02-06	
J	De Araujo, AVL; Areza-Fegyveres, R; Guariglia, CC; Ianof, JN; Baratho, RM; Demario, JLC; Watanabe, RGS; Anghinah, R				Lacerda De Araujo, Amanda Vitoria; Areza-Fegyveres, Renata; Guariglia, Carla Cristina; Ianof, Jessica Natuline; Baratho, Regina Maria; Carlos Demario, Jose Luiz; Sato Watanabe, Rafael Gustavo; Anghinah, Renato			Level of knowledge and misconceptions about brain concussion in Brazilian adults	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						Brain Concussion; Cerebral Concussion; Health Care; Questionnaires	INJURY; SPORT; EPIDEMIOLOGY; SYMPTOMS; ATTITUDES; IMPACT	Background: Brain concussion (BC) is seen as a public health priority due to its high incidence and morbidity rate, among thousands of people around the world. There are needs for fast identification, accurate diagnosis and correct management in order to reduce the short and long-term problems relating to BC. Proper knowledge of BC in the population and among clinicians is a critical factor in achieving this. Objectives: To evaluate the level of self-reported BC knowledge and gaps/misconceptions, and to identify variables correlated with this level. Methods: A cross-sectional descriptive survey was performed. A Brain Concussion Knowledge Questionnaire (BCKQ) that had been created to capture data was widely distributed. Total scores, domain partial scores and percentages of correct and incorrect answers were calculated to ascertain the level of knowledge relating to BC. Results: The sample was formed by 1,247 Brazilian adults (age: 41.7 +/- 11.8 years). Partial scores of the BCKQ revealed the existence of poor knowledge and misconceptions in all domains of the questionnaire, especially regarding questions about recovery from and management of BC. Moderate correlations between BCKQ scores and professions (p=0.312; P=0.00) or previous brain concussion knowledge (p=0.489; P=0.00) were observed. In a multiple linear regression model, age, profession and sports practice were predictors of BC knowledge. Conclusion: This first study to analyze the level of BC knowledge in a sample of Brazilian adults suggests that poor knowledge and misconceptions are present. Thus, meaningful and useful information was provided by this study for developing health education programs about BC for the population in order to improve fast diagnosis and correct BC management.	[Lacerda De Araujo, Amanda Vitoria; Areza-Fegyveres, Renata; Guariglia, Carla Cristina; Ianof, Jessica Natuline; Sato Watanabe, Rafael Gustavo; Anghinah, Renato] Univ Sao Paulo, Ambulatorio Reabilitacao Cognit Postrauma Cranioe, Sao Paulo, SP, Brazil; [Baratho, Regina Maria; Carlos Demario, Jose Luiz] Univ Sao Paulo, Ctr Dr Jair Minoto Abe, Sao Paulo, SP, Brazil		De Araujo, AVL (corresponding author), Univ Sao Paulo, Ambulatorio Reabilitacao Cognit Postrauma Cranioe, Sao Paulo, SP, Brazil.	amandavla@usp.br		anghinah, Renato/0000-0001-8414-8536; Watanabe, Rafael/0000-0003-1684-573X			Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Buchanan EA, 2009, J EMPIR RES HUM RES, V4, P37, DOI 10.1525/jer.2009.4.2.37; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Chow Ronald, 2018, Int J Adolesc Med Health, V32, DOI 10.1515/ijamh-2018-0003; Concannon LG, 2014, CURR SPORT MED REP, V13, P365, DOI 10.1249/JSR.0000000000000098; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Eagles ME, 2016, CAN J NEUROL SCI, V43, P659, DOI 10.1017/cjn.2016.263; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Griffin AS, 2017, BMJ OPENSPORT EXERC, V3, DOI [10.1136/bmjsem-2016-000174, DOI 10.1136/BMJSEM-2016-000174]; Jackson WT, 2019, MED CLIN N AM, V103, P251, DOI 10.1016/j.mcna.2018.10.005; Junge A, 2004, AM J SPORT MED, V32, p23S, DOI 10.1177/0363546503261246; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Melo JRT, 2005, ARQ NEURO-PSIQUIAT, V63, P1054, DOI 10.1590/S0004-282X2005000600026; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Register-Mihalik JK, DEMOGRAPHIC PARENTAL, V53, P768, DOI [10.4085/1062-6050-223-17, DOI 10.4085/1062-6050-223-17]; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Schellinger SK, 2018, BRAIN INJURY, V32, P1377, DOI 10.1080/02699052.2018.1492737; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Sullivan L, 2018, HEALTH EDUC RES, V33, P492, DOI 10.1093/her/cyy034; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Waltzman Dana, 2018, J Concussion, V2, P1, DOI 10.1177/2059700218769218; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10	39	1	1	0	0	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.		2021	79	6					469	477		10.1590/0004-282X-ANP-2019-0436			9	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	TS5DF	WOS:000679668800002	34320052	gold			2022-02-06	
J	Liu, CL; Xie, J; Xiao, XS; Li, TY; Li, H; Bai, XJ; Li, ZF; Wang, W				Liu, Chengli; Xie, Jie; Xiao, Xinshuang; Li, Tianyu; Li, Hui; Bai, Xiangjun; Li, Zhanfei; Wang, Wei			Clinical predictors of prognosis in patients with traumatic brain injury combined with extracranial trauma	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES			English	Article						prognosis; traumatic brain injury; multiple trauma; prognostic factor		Objective: The purpose of this study was to investigate whether routine blood tests on admission and clinical characteristics can predict prognosis in patients with traumatic brain injury (TBI) combined with extracranial trauma. Methods: Clinical data of 182 patients with TBI combined with extracranial trauma from April 2018 to December 2019 were retrospectively collected and analyzed. Based on GOSE score one month after discharge, the patients were divided into a favorable group (GOSE 1-4) and unfavorable group (GOSE 5-8). Routine blood tests on admission and clinical characteristics were recorded. Results: Overall, there were 48 (26.4%) patients with unfavorable outcome and 134 (73.6%) patients with favorable outcome. Based on multivariate analysis, independent risk factors associated with unfavorable outcome were age (odds ratio [OR], 1.070; 95% confidence interval [CI], 1.018-1.124; p<0.01), admission Glasgow Coma Scale (GCS) score (OR, 0.807; 95% CI, 0.675-0.965; p<0.05), heart rate (OR, 1.035; 95% CI, 1.004-1.067; p<0.05), platelets count (OR, 0.982; 95% CI, 0.967-0.997; p<0.05), and tracheotomy (OR, 15.201; 95% CI, 4.121-56.078; p<0.001). Areas under the curve (AUC) of age, admission GCS, heart rate, tracheotomy, and platelets count were 0.678 (95% CI, 0.584-0.771), 0.799 (95% CI, 0.723-0.875), 0.652 (95% CI, 0.553-0.751), 0.776 (95% CI, 0.692-0.859), and 0.688 (95% CI, 0.606-0.770), respectively. Conclusions: Age, admission GCS score, heart rate, tracheotomy, and platelets count can be recognized as independent predictors of clinical prognosis in patients with severe TBI combined with extracranial trauma.	[Liu, Chengli; Xie, Jie; Xiao, Xinshuang; Li, Tianyu; Li, Hui; Bai, Xiangjun; Li, Zhanfei; Wang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Traumat Surg, Wuhan 430030, Peoples R China		Li, ZF; Wang, W (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Traumat Surg, Wuhan 430030, Peoples R China.	lezhfei@163.com; wangwei@tjh.tjmu.edu.cn		wei, wang/0000-0001-6971-3461	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801174, 81571891]	This work was supported by grants from the National Natural Science Foundation of China (No. 81801174 to W.W. and No. 81571891 to Z.F.L.).	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Banoei MM, 2018, J NEUROTRAUM, V35, P1831, DOI 10.1089/neu.2017.5326; Baron DM, 2016, WIEN KLIN WOCHENSCHR, V128, P397, DOI 10.1007/s00508-016-1004-y; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chelly H, 2019, EUR J TRAUMA EMERG S, V45, P245, DOI 10.1007/s00068-017-0885-4; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; de Oliveira DV, 2017, ONCOTARGET, V8, P18622, DOI 10.18632/oncotarget.15740; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Dolmans RGF, 2020, WORLD NEUROSURG, V136, pE60, DOI 10.1016/j.wneu.2019.10.086; Dong XQ, 2017, CLIN CHIM ACTA, V471, P298, DOI 10.1016/j.cca.2017.06.020; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; El-Menyar A, 2018, J NEUROSURG, V129, P1541, DOI 10.3171/2017.7.JNS17675; Erlebach R, 2017, MINERVA ANESTESIOL, V83, P1169, DOI 10.23736/S0375-9393.17.11837-7; Furay E, 2018, J TRAUMA ACUTE CARE, V85, P881, DOI 10.1097/TA.0000000000002047; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Gritti P, 2019, WORLD NEUROSURG, V128, pE531, DOI 10.1016/j.wneu.2019.04.190; Grzalja N, 2017, INJURY, V48, pS1, DOI 10.1016/S0020-1383(17)30730-1; Huang JF, 2019, INT J SURG, V61, P48, DOI 10.1016/j.ijsu.2018.11.030; Humble SS, 2016, BRAIN INJURY, V30, P1642, DOI 10.1080/02699052.2016.1199915; Jo YG, 2017, J KOREAN MED SCI, V32, P750, DOI 10.3346/jkms.2017.32.5.750; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Kelly ML, 2018, WORLD NEUROSURG, V118, pE974, DOI 10.1016/j.wneu.2018.07.124; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Lenell S, 2019, ACTA NEUROCHIR, V161, P1243, DOI 10.1007/s00701-019-03893-6; Li ZQ, 2018, BRAIN INJURY, V32, P515, DOI 10.1080/02699052.2018.1429023; Litofsky NS, 2016, WORLD NEUROSURG, V90, P82, DOI 10.1016/j.wneu.2016.02.076; Liu H, 2018, INT J MED SCI, V15, P1072, DOI 10.7150/ijms.25799; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Loftus TJ, 2018, AM J RESP CRIT CARE, V198, P629, DOI 10.1164/rccm.201712-2536OC; Lu Q, 2018, WORLD NEUROSURG, V112, pE324, DOI 10.1016/j.wneu.2018.01.043; Lubelski D, 2017, J NEUROSURG-SPINE, V27, P633, DOI 10.3171/2017.4.SPINE16933; Luo LF, 2019, CLIN CHIM ACTA, V488, P25, DOI 10.1016/j.cca.2018.10.035; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Montazer Seyed Hossein, 2019, Med Arch, V73, P11, DOI 10.5455/medarh.2019.73.11-14; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pillay J, 2007, INJURY, V38, P1365, DOI 10.1016/j.injury.2007.09.016; Pin-on P, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013081; Polat O, 2019, ULUS TRAVMA ACIL CER, V25, P193, DOI 10.14744/tjtes.2019.59845; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Rupprecht H, 2017, ULUS TRAVMA ACIL CER, V23, P156, DOI 10.5505/tjtes.2016.77177; Shibahashi K, 2017, BRIT J NEUROSURG, V31, P564, DOI 10.1080/02688697.2017.1302071; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Tan AL, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0217-y; Tang B, 2019, CLIN CHIM ACTA, V495, P227, DOI 10.1016/j.cca.2019.04.070; Tian RF, 2019, WORLD NEUROSURG, V126, pE101, DOI 10.1016/j.wneu.2019.01.246; Travers S, 2016, BRAIN INJURY, V30, P1525, DOI 10.1080/02699052.2016.1199907; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; von Leden RE, 2019, EXP NEUROL, V317, P144, DOI 10.1016/j.expneurol.2019.03.004; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116; Wettervik TS, 2019, NEUROCRIT CARE, V31, P526, DOI 10.1007/s12028-019-00743-2; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolahan SM, 2017, NEUROCRIT CARE, V26, P239, DOI 10.1007/s12028-016-0313-3; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zhang B, 2017, CLIN LAB, V63, P1711, DOI 10.7754/Clin.Lab.2017.170520; Zhang Z L, 2019, Zhonghua Yi Xue Za Zhi, V99, P3797, DOI 10.3760/cma.j.issn.0376-2491.2019.48.008; Zhang ZY, 2019, CLIN CHIM ACTA, V497, P6, DOI 10.1016/j.cca.2019.07.008; Zhu CR, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011671	70	1	1	1	1	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-1907			INT J MED SCI	Int. J. Med. Sci.		2021	18	7					1639	1647		10.7150/ijms.54913			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG2WW	WOS:000617451700012	33746580	Green Published, gold			2022-02-06	
J	Majdan, M; Toth, I; Barila, P; Peracek, P; Perackova, J; Parnican, S; Cente, M; Filipcik, P				Majdan, Marek; Toth, Igor; Barila, Patrik; Peracek, Pavol; Perackova, Janka; Parnican, Silvio; Cente, Martin; Filipcik, Peter			Head impacts in youth national hockey leagues in Slovakia: a retrospective analysis of four seasons	GENERAL PHYSIOLOGY AND BIOPHYSICS			English	Article						Traumatic brain injury; Head impact; Neuropathology; Epidemiology	TRAUMATIC BRAIN-INJURY; ICE HOCKEY; SPORTS; CONCUSSION; NEUROPATHOLOGY; EPIDEMIOLOGY; CARE	Traumatic brain injury in contact sports can lead to serious health consequences either immediately or later in the life of injured subjects. The objective of this study was to estimate the incidence of head impacts in the Under 18 (U18) and Under 20 (U20) junior ice-hockey leagues in Slovakia over the seasons 2013/2014-2016/2017 using data from official game statistics. Incidence risks (IR) per 1000 athlete exposures were calculated for the season and stratified by a period of the game, by month, round, and part of the season. IR of head impacts ranged from 2.09 (95%CI: 2.07-2.12) to 2.89 (95%CI: 2.87-2.92) in the U18 league and from 2.14 (95%CI: 2.12-2.17) to 4.06 (95%CI: 4.02-4.09) in the U20. Higher IR was observed in the latter periods of games. This study brings first data on the incidence of concussions in youth ice-hockey leagues in Slovakia and calls for immediate implementation of measures to prevent these injuries.	[Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Inst Global Hlth & Epidemiol, Dept Publ Hlth, Trnava 91843, Slovakia; [Toth, Igor; Barila, Patrik; Peracek, Pavol; Parnican, Silvio] Comenius Univ, Fac Phys Educ & Sport, Dept Sports Games, Bratislava, Slovakia; [Perackova, Janka] Comenius Univ, Fac Phys Educ & Sport, Dept Sport Sci Educol & Humanities, Bratislava, Slovakia; [Cente, Martin; Filipcik, Peter] Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Sci & Social Work, Inst Global Hlth & Epidemiol, Dept Publ Hlth, Trnava 91843, Slovakia.	mmajdan@truni.sk		Cente, Martin/0000-0003-1420-1017	Slovak Research and Development AgencySlovak Research and Development Agency [APVV-170668, APVV-19-0568, APVV-20-0615]; JPsustaiND [681043]; Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences [VEGA 2/0154/19]; CENTER-TBI project from the European Commission [602150]	The work was supported by grants from the Slovak Research and Development Agency "APVV-170668", APVV-19-0568 and "APVV-20-0615". Work was further supported by JPsustaiND, Grant agreement ID: 681043. Dr. Perackova and Dr. Filipcik were further supported by the grant "VEGA 2/0154/19" from the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences. Part of the work of Dr. Majdan was supported by the CENTER-TBI project, grant #602150 from the European Commission.	Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cummings J, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00424-9; Delic V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00924-7; Duraes F, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11020044; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Guedes VA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00663; International Ice Hockey Federation, 2018, IIHF OFF RUL BOOK 20; Iverson L.M., 2021, GLASGOW COMA SCALE; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mackay DF, 2019, NEW ENGL J MED, V381, P1801, DOI 10.1056/NEJMoa1908483; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Quinn, 2021, IN PRESS; R Core Team, 2019, R LANG ENV STAT COMP; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Sandmo SB, 2020, BRAIN INJURY, V34, P602, DOI 10.1080/02699052.2020.1725129; Slovakia Hockey, 2020, SLOV HOCK NUMB; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Theadom A, 2020, NEUROEPIDEMIOLOGY, V54, P192, DOI 10.1159/000505424; Walker Lary C, 2018, Handb Clin Neurol, V153, P303, DOI 10.1016/B978-0-444-63945-5.00016-7; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015	35	1	1	1	1	AEPRESS SRO	BRATISLAVA	BAJZOVA 7, BRATISLAVA, 821 08, SLOVAKIA	0231-5882	1338-4325		GEN PHYSIOL BIOPHYS	Gen. Physiol. Biophys.		2021	40	6					569	576		10.4149/gpb_2021041			8	Biochemistry & Molecular Biology; Biophysics; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Physiology	XO8LB	WOS:000730428900011	34897028	gold			2022-02-06	
J	Mallas, EJ; De Simoni, S; Scott, G; Jolly, AE; Hampshire, A; Li, LM; Bourke, NJ; Roberts, SAG; Gorgoraptis, N; Sharp, DJ				Mallas, Emma-Jane; De Simoni, Sara; Scott, Gregory; Jolly, Amy E.; Hampshire, Adam; Li, Lucia M.; Bourke, Niall J.; Roberts, Stuart A. G.; Gorgoraptis, Nikos; Sharp, David J.			Abnormal dorsal attention network activation in memory impairment after traumatic brain injury	BRAIN			English	Article						TBI; imaging; goal-directed behaviour; memory	DEFAULT MODE NETWORK; SALIENCE NETWORK; MR-IMAGES; CONNECTIVITY; RECOGNITION; SYSTEM; CORTEX; ROBUST; CLASSIFICATION; REGISTRATION	Memory impairment is a common, disabling effect of traumatic brain injury. In healthy individuals, successful memory encoding is associated with activation of the dorsal attention network as well as suppression of the default mode network. Here, in traumatic brain injury patients we examined whether: (i) impairments in memory encoding are associated with abnormal brain activation in these networks; (ii) whether changes in this brain activity predict subsequent memory retrieval; and (iii) whether abnormal white matter integrity underpinning functional networks is associated with impaired subsequent memory. Thirty-five patients with moderate-severe traumatic brain injury aged 23-65 years (74% males) in the post-acute/chronic phase after injury and 16 healthy control subjects underwent functional MRI during performance of an abstract image memory encoding task. Diffusion tensor imaging was used to assess structural abnormalities across patient groups compared to 28 age-matched healthy controls. Successful memory encoding across all participants was associated with activation of the dorsal attention network, the ventral visual stream and medial temporal lobes. Decreased activation was seen in the default mode network. Patients with preserved episodic memory demonstrated increased activation in areas of the dorsal attention network. Patients with impaired memory showed increased left anterior prefrontal activity. White matter microstructure underpinning connectivity between core nodes of the encoding networks was significantly reduced in patients with memory impairment. Our results show for the first time that patients with impaired episodic memory show abnormal activation of key nodes within the dorsal attention network and regions regulating default mode network activity during encoding. Successful encoding was associated with an opposite direction of signal change between patients with and without memory impairment, suggesting that memory encoding mechanisms could be fundamentally altered in this population. We demonstrate a clear relationship between functional networks activated during encoding and underlying abnormalities within the structural connectome in patients with memory impairment. We suggest that encoding failures in this group are likely due to failed control of goal-directed attentional resources.	[Mallas, Emma-Jane; De Simoni, Sara; Scott, Gregory; Jolly, Amy E.; Hampshire, Adam; Li, Lucia M.; Bourke, Niall J.; Roberts, Stuart A. G.; Gorgoraptis, Nikos; Sharp, David J.] Imperial Coll London, Dept Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Hampshire, Adam; Li, Lucia M.; Sharp, David J.] Imperial Coll London, Care Res & Technol Ctr, UK Dementia Res Inst, London, England; [Roberts, Stuart A. G.] Royal Ctr Def Med RCDM, Acad Dept Mil Surg & Trauma ADMST, Birmingham, W Midlands, England; [Sharp, David J.] Imperial Coll London, Royal British Leg Ctr Blast Injury Studies, Dept Bioengn, London, England		Sharp, DJ (corresponding author), Imperial Coll London, Computat Cognit & Clin Neuroimaging Lab C3NL, 3rd Floor Burlington Danes Bldg, London W12 0NN, England.	david.sharp@imperial.ac.uk	Mallas, Emma-Jane/ABE-3115-2020	Mallas, Emma-Jane/0000-0002-4050-0208; Roberts, Stuart/0000-0002-6636-6326; Jolly, Amy/0000-0002-7413-9772; Scott, Gregory/0000-0001-8063-5871	National Institute of Health Research (NIHR) Invention for Innovation (i4i) Research AwardNational Institute for Health Research (NIHR) [II-LB-0715-20006]; NIHRNational Institute for Health Research (NIHR) [NIHR-RP-011-048]; Wellcome Trust Clinical Research Training FellowshipWellcome Trust [103429/Z/13/Z]; Royal College of Surgeons (RCSEng) Military Surgical Research Fellowship; Ministry of Defence; UK Dementia Research Institute; NIHR Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare NHS Trust; Royal British Legion Centre for Blast Injury Studies; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/L022141/1, UKDRI-7006] Funding Source: UKRI	E.M. is supported by a National Institute of Health Research (NIHR) Invention for Innovation (i4i) Research Award (II-LB-0715-20006) awarded to D.J.S. and A.H. G.S. is supported by NIHR. L.M.L. is supported by a Wellcome Trust Clinical Research Training Fellowship (103429/Z/13/Z). S.A.G.R. is supported by a Royal College of Surgeons (RCSEng) Military Surgical Research Fellowship and the Ministry of Defence. A.H. is supported by the UK Dementia Research Institute and NIHR. D.J.S. is supported by an NIHR Professorship (NIHR-RP-011-048), the NIHR Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare NHS Trust & The Royal British Legion Centre for Blast Injury Studies.	Ainsworth M, 2018, NEUROPSYCHOLOGIA, V119, P382, DOI 10.1016/j.neuropsychologia.2018.08.024; Arenth PM, 2012, J CLIN EXP NEUROPSYC, V34, P333, DOI 10.1080/13803395.2011.633896; Baddeley AD, 1994, DOORS PEOPLE TEST VI; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chiou KS, 2016, BRAIN IMAGING BEHAV, V10, P1274, DOI 10.1007/s11682-015-9497-y; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Criminisi A, 2008, LECT NOTES COMPUT SC, V5302, P99, DOI 10.1007/978-3-540-88682-2_9; Daselaar SM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.013.2009; de Chastelaine M, 2015, BRAIN RES, V1612, P16, DOI 10.1016/j.brainres.2014.09.045; De Simoni S, 2018, BRAIN, V141, P148, DOI 10.1093/brain/awx309; De Simoni S, 2016, BRAIN, V139, P3137, DOI 10.1093/brain/aww241; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis NA, 2007, NEUROBIOL AGING, V28, P1749, DOI 10.1016/j.neurobiolaging.2006.07.006; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dove A, 2006, NEUROIMAGE, V31, P1790, DOI 10.1016/j.neuroimage.2006.02.035; Gillis MM, 2015, BRAIN IMAGING BEHAV, V9, P801, DOI 10.1007/s11682-014-9337-5; Griffanti L, 2017, NEUROIMAGE, V154, P188, DOI 10.1016/j.neuroimage.2016.12.036; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Huijbers W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017463; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kim H, 2015, HIPPOCAMPUS, V25, P500, DOI 10.1002/hipo.22387; Kim H, 2011, NEUROIMAGE, V54, P2446, DOI 10.1016/j.neuroimage.2010.09.045; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Li LM, 2019, BRAIN, V142, P3280, DOI 10.1093/brain/awz252; Li LM, 2019, NEUROIMAGE, V185, P425, DOI 10.1016/j.neuroimage.2018.10.069; Majerus S, 2018, J COGNITIVE NEUROSCI, V30, P144, DOI 10.1162/jocn_a_01195; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nyberg L, 2017, J INTERN MED, V281, P65, DOI 10.1111/joim.12533; Peng K, 2018, PROG NEUROBIOL, V161, P1, DOI 10.1016/j.pneurobio.2017.11.004; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Schrouff J, 2013, NEUROINFORMATICS, V11, P319, DOI 10.1007/s12021-013-9178-1; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Uncapher MR, 2009, NEUROBIOL LEARN MEM, V91, P139, DOI 10.1016/j.nlm.2008.10.011; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Warren JE, 2009, BRAIN, V132, P3428, DOI 10.1093/brain/awp270; Wechsler D., 1991, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; WechslerD, 2001, WECHSLER TEST ADULT; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang SW, 2018, NEUROIMAGE, V172, P40, DOI 10.1016/j.neuroimage.2018.01.046; Zhang WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33203; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	61	1	1	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2021	144		1				114	127		10.1093/brain/awaa380			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6XJ	WOS:000649444700026	33367761	Bronze			2022-02-06	
J	Manole, MD; Hook, MJA; Nicholas, MA; Nelson, BP; Liu, AC; Stezoski, QC; Rowley, AP; Cheng, JP; Alexander, H; Moschonas, EH; Bondi, CO; Kline, AE				Manole, Mioara D.; Hook, Marcus J. A.; Nicholas, Melissa A.; Nelson, Brittany P.; Liu, Adanna C.; Stezoski, Quinn C.; Rowley, Andrew P.; Cheng, Jeffrey P.; Alexander, Henry; Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.			Preclinical neurorehabilitation with environmental enrichment confers cognitive and histological benefits in a model of pediatric asphyxial cardiac arrest	EXPERIMENTAL NEUROLOGY			English	Article						Cardiac arrest; Pediatric; Environmental enrichment; Cognitive; Motor; Anxiety-like behavior; Recovery	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SUBVENTRICULAR ZONE; HIPPOCAMPAL NEUROGENESIS; RECOVERY; RATS; PROLIFERATION; ANGIOGENESIS; INHIBITION; ASTROCYTES	Pediatric asphyxial cardiac arrest (ACA) often leaves children with physical, cognitive, and emotional disabilities that affect overall quality of life, yet rehabilitation is neither routinely nor systematically provided. Environmental enrichment (EE) is considered a preclinical model of neurorehabilitation and thus we sought to investigate its efficacy in our established model of pediatric ACA. Male Sprague-Dawley rat pups (post-natal day 16-18) were randomly assigned to ACA (9.5 min) or Sham injury. After resuscitation, the rats were assigned to 21 days of EE or standard (STD) housing during which time motor, cognitive, and anxiety-like (i.e., affective) outcomes were assessed. Hippocampal CA(1) cells were quantified on post-operative day-22. Both ACA + STD and ACA + EE performed worse on beam-balance vs. Sham controls (p < 0.05) and did not differ from one another overall (p > 0.05); however, a single day analysis on the last day of testing revealed that the ACA + EE group performed better than the ACA + STD group (p < 0.05) and did not differ from the Sham controls (p > 0.05). Both Sham groups performed better than ACA + STD (p < 0.05) but did not differ from ACA + EE (p > 0.05) in the open field test. Spatial learning and declarative memory were improved and CA1 neuronal loss was attenuated in the ACA + EE vs. ACA + STD group (p < 0.05). Collectively, the data suggest that providing rehabilitation after pediatric ACA can reduce histopathology and improve motor and cognitive ability.	[Manole, Mioara D.; Hook, Marcus J. A.; Nicholas, Melissa A.; Nelson, Brittany P.; Liu, Adanna C.; Stezoski, Quinn C.; Rowley, Andrew P.; Cheng, Jeffrey P.; Alexander, Henry; Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Manole, Mioara D.; Nicholas, Melissa A.; Nelson, Brittany P.; Rowley, Andrew P.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Cheng, Jeffrey P.; Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15224 USA; [Moschonas, Eleni H.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15224 USA; [Bondi, Corina O.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15224 USA; [Alexander, Henry; Kline, Anthony E.] Med Univ Pittsburgh, Dept Crit Care, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15224 USA; [Hook, Marcus J. A.] Univ Bath, Bath BA2 7AY, Avon, England		Manole, MD (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pediat, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Phys Med & Rehabil, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	manomd@upmc.edu; klineae@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD075760, NS117000, NS107785, NS060005, HD069620, NS084967, NS094950, NS099683, NS110609]; Children's Neuroscience Institute Award; Children's Hospital of Pittsburgh; University of Pittsburgh Physicians/UPMC Academic Foundation; Children's Hospital of Pittsburgh Research Advisory Committee Award	This work was supported, in part, by the National Institutes of Health grants HD075760, NS117000, NS107785 (MDM), NS060005, HD069620, NS084967 (AEK), NS094950, NS099683, NS110609 (COB), Children's Neuroscience Institute Award, Children's Hospital of Pittsburgh and Children's Hospital of Pittsburgh Research Advisory Committee Award (MDM) and the University of Pittsburgh Physicians/UPMC Academic Foundation (COB).	Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bondi CO, 2018, RESTOR NEUROL NEUROS, V36, P45, DOI 10.3233/RNN-170781; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones T L, 2000, Biol Res Nurs, V1, P299, DOI 10.1177/109980040000100406; Chen XP, 2017, NEUROCHEM RES, V42, P1308, DOI 10.1007/s11064-016-2172-x; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; de la Tremblaye PB, 2019, NEUROPHARMACOLOGY, V145, P13, DOI 10.1016/j.neuropharm.2018.02.032; de la Tremblaye PB, 2017, NEUROREHAB NEURAL RE, V31, P977, DOI 10.1177/1545968317739999; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Goncalves LV, 2018, BEHAV BRAIN RES, V348, P171, DOI 10.1016/j.bbr.2018.04.023; Hutson TH, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2064; Ichord R, 2018, NEUROLOGY, V91, pE123, DOI 10.1212/WNL.0000000000005773; Inacio AR, 2011, NEUROBIOL DIS, V41, P270, DOI 10.1016/j.nbd.2010.09.015; Jeffers MS, 2018, STROKE, V49, P1496, DOI 10.1161/STROKEAHA.118.020814; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; Lajud N, 2019, J NEUROTRAUM, V36, P756, DOI 10.1089/neu.2018.5866; Manole MD, 2012, J CEREBR BLOOD F MET, V32, P560, DOI 10.1038/jcbfm.2011.165; Matsumori Y, 2006, NEUROBIOL DIS, V22, P187, DOI 10.1016/j.nbd.2005.10.015; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Meert KL, 2016, PEDIATR CRIT CARE ME, V17, P498, DOI 10.1097/PCC.0000000000000726; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Nygren J, 2006, STROKE, V37, P2824, DOI 10.1161/01.STR.0000244769.39952.90; Plane JM, 2008, EXP NEUROL, V214, P125, DOI 10.1016/j.expneurol.2008.08.006; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Ruscher K, 2013, J CEREBR BLOOD F MET, V33, P1225, DOI 10.1038/jcbfm.2013.71; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Shaik JSB, 2015, J CEREBR BLOOD F MET, V35, P1757, DOI 10.1038/jcbfm.2015.117; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Silverstein FS, 2016, CRIT CARE MED, V44, pE1165, DOI 10.1097/CCM.0000000000002003; Slomine BS, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3412; Topjian AA, 2019, CIRCULATION, V140, pE194, DOI 10.1161/CIR.0000000000000697; Tress Erika E, 2010, J Emerg Trauma Shock, V3, P267, DOI 10.4103/0974-2700.66528; Wurm F, 2007, STROKE, V38, P2833, DOI 10.1161/STROKEAHA.107.485524; Xu XH, 2009, EXP BIOL MED, V234, P296, DOI 10.3181/0804-RM-128; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; Yu KW, 2014, J NEUROL SCI, V347, P275, DOI 10.1016/j.jns.2014.10.022; Zhang SG, 2020, CEREB CORTEX, V30, P3717, DOI 10.1093/cercor/bhz337; Zhang X, 2017, BRAIN RES, V1655, P176, DOI 10.1016/j.brainres.2016.11.001; Zhang YJ, 2018, BRAIN RES, V1687, P20, DOI 10.1016/j.brainres.2018.02.030; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	51	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2021	335								113522	10.1016/j.expneurol.2020.113522			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PH8XX	WOS:000600689300027	33152354	Green Accepted			2022-02-06	
J	Mantey, DS; Omega-Njemnobi, O; Kelder, SH				Mantey, Dale S.; Omega-Njemnobi, Onyinye; Kelder, Steven H.			Self-reported history of concussions is associated with risk factors for suicide completion among middle school students: A cross-sectional study	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Concussions; Youth; Suicide; Traumatic brain injury; Suicidality		Purpose: This study aims to examine the relationship between self-reported history of concussion and risk factors for completed suicide among middle school students. Methods: We analyzed state-level data from the 2017 YRBS. The study sample was n = 19,254 middle school students in 7 States: Delaware, Florida, Hawaii, Kentucky, Nevada, Rhode Island, and Virginia. We conducted multi-level, multivariate logistic regression models to assess the relationship between self-reported concussions and suicidal ideations, planned suicide attempt, and past suicide attempt. Results: Approximately 17.8% of the sample self-reported a history of concussion. Self-reported history of concussion was significantly associated with greater odds for history of suicidal ideation (Adj OR: 1.31), planned suicide attempt (Adj OR: 1.36), and past suicide attempt (Adj OR: 1.67). Conclusions: This is the first study to examine the relationship between self-reported concussion and risk factor for completed suicide among middle school students. Research findings mirror similar study done among high school students and young adults. Findings suggest the need to expand prevention programs, intervention strategies and education campaigns to include middle school students.	[Mantey, Dale S.; Omega-Njemnobi, Onyinye; Kelder, Steven H.] Univ Texas Austin, Sch Publ Hlth, Dept Hlth Promot & Behav Sci, Austin, TX 78701 USA		Mantey, DS (corresponding author), Univ Texas Austin, Sch Publ Hlth, 1616 Guadalupe,Suite 6-300, Austin, TX 78701 USA.	dale.s.mantey@uth.tmc.edu			University of Texas Health Science Center at Houston School of Public Health Cancer Education and Career Development Program - National Cancer Institute/NIH Grant - National Cancer Institute/NIH [T32/CA057712]	Funding was provided by the University of Texas Health Science Center at Houston School of Public Health Cancer Education and Career Development Program - National Cancer Institute/NIH Grant - National Cancer Institute/NIH Grant T32/CA057712. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Aranmolate R., 2017, JSM SCHIZOPHRENIA, V2, P1011; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Cha CB, 2018, J CHILD PSYCHOL PSYC, V59, P460, DOI 10.1111/jcpp.12831; Curtin S. C., 2019, DEATH RATES DUE SUIC; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Fralick M, 2019, JAMA NEUROL, V76, P144, DOI 10.1001/jamaneurol.2018.3487; Hinduja S, 2010, ARCH SUICIDE RES, V14, P206, DOI 10.1080/13811118.2010.494133; Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kim S, 2018, J YOUTH ADOLESCENCE, V47, P661, DOI 10.1007/s10964-017-0678-4; Mantey DS, 2020, J AFFECT DISORDERS, V263, P684, DOI 10.1016/j.jad.2019.11.047; Marshall Alexandra, 2016, Yale Journal of Biology and Medicine, V89, P205; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Robinson J, 2018, ECLINICALMEDICINE, V4-5, P52, DOI 10.1016/j.eclinm.2018.10.004; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wangnoo T, 2020, J NEUROTRAUM, V37, P1401, DOI 10.1089/neu.2018.5721; Wicklund A., 2020, CLIN J SPORT MED OFF; Yang MN, 2019, AM J HEALTH BEHAV, V43, P258, DOI 10.5993/AJHB.43.2.3	19	1	1	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	JAN	2021	132						191	194		10.1016/j.jpsychires.2020.10.022			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	PD6PJ	WOS:000597804300002	33126012	Green Accepted			2022-02-06	
J	Matyasova, K; Csicsatkova, N; Filipcik, P; Jurisica, I; Cente, M				Matyasova, Katarina; Csicsatkova, Nikoleta; Filipcik, Peter; Jurisica, Igor; Cente, Martin			Peripheral microRNA alteration and pathway signaling after mild traumatic brain injury	GENERAL PHYSIOLOGY AND BIOPHYSICS			English	Article						Mild traumatic brain injury; TBI; miRNA; Signaling pathways; Meta-analysis	CYCLASE ACTIVATING POLYPEPTIDE; ENDOTHELIAL GROWTH-FACTOR; RAT CEREBRAL-CORTEX; SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; INDUCED NEUROPROTECTION; GENE-EXPRESSION; HEAD-INJURY; BIOMARKERS; HYPOPITUITARISM	Discovering novel diagnostic biomarkers and signatures for traumatic brain injury (TBI) represents a major challenge in the brain trauma research. Detailed analysis of post-concussive molecular pathways based on experimental data could provide a new insight into the pathophysiological sequelae and mapping of recovery mechanisms involved in TBI. MicroRNAs (miRNAs) detectable in peripheral body fluids after TBI are promising carriers of this missing knowledge. In order to define the signature of peripheral miRNAs signaling associated with mild TBI (mTBI), we performed a comprehensive meta-analysis of miRNA profiles in mTBI patients using multiple curated pathway databases. Using a bioinformatic pipeline with integrated data analysis we identified a set of genes that are connected to deregulated circulating miRNAs following the mTBI. Identified genes belong to specific pathways of MAPK, TGF-beta, WNT, TLR2/4, PI3K/AKT, insulin, and growth factor signaling. Since the enriched pathways markedly overlap among the various biological fluids, signaling associated with mTBI that is concomitantly reflected in serum, plasma and saliva is robust and unique. Furthermore, we identified a network of 33 validated interacting proteins and their regulatory miRNAs that link the post-mTBI signaling in peripheral fluids with neurodegenerationassociated interaction pathways. Presented data provide a comprehensive insight into molecular events following mTBI, and the top predicted genes represent a group of novel candidate targets to be validated in connection with mTBI.	[Matyasova, Katarina; Csicsatkova, Nikoleta; Filipcik, Peter; Jurisica, Igor; Cente, Martin] Slovak Acad Sci, Inst Neuroimmunol, Dubravska Cesta 9, Bratislava 84510, Slovakia; [Filipcik, Peter; Cente, Martin] Axon Neurosci R&D Serv SE, Bratislava, Slovakia; [Jurisica, Igor] Univ Hlth Network, Schroeder Arthrit Inst, Div Orthoped Surg, Osteoarthrit Res Program, Toronto, ON, Canada; [Jurisica, Igor] Univ Hlth Network, Krembil Res Inst, Data Sci Discovery Ctr Chron Dis, 60 Leonard Ave,5KD-407, Toronto, ON M5T 0S8, Canada; [Jurisica, Igor] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada		Jurisica, I; Cente, M (corresponding author), Slovak Acad Sci, Inst Neuroimmunol, Dubravska Cesta 9, Bratislava 84510, Slovakia.; Jurisica, I (corresponding author), Univ Hlth Network, Krembil Res Inst, Data Sci Discovery Ctr Chron Dis, 60 Leonard Ave,5KD-407, Toronto, ON M5T 0S8, Canada.	juris@ai.utoronto.ca; martin.cente@savba.sk		Cente, Martin/0000-0003-1420-1017	Ministry of Education of the Slovak Republic [VEGA 2/0118/19, VEGA 2/0154/19, APVV-17-0668, APVV-19-0568, APVV-20-0615]; Natural Sciences Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [203475]; Canada Foundation for Innovation (CFI)Canada Foundation for Innovation [225404, 30865]; Ontario Research Fund (RDI) [34876]; IBMInternational Business Machines (IBM); Ian Lawson van Toch Fund	Bioinformatic analyses were in part supported by the Ministry of Education of the Slovak Republic, awarded to BrainTest, s.r.o. within the research scheme "Stimuli for research and development" and research grants VEGA 2/0118/19, VEGA 2/0154/19 and APVV-17-0668, APVV-19-0568, APVV-20-0615. We are grateful to Zlatica Cerna for her help with graphical design and artistic illustration. Development and maintenance of used tools and databases were supported in part by funding from Natural Sciences Research Council (NSERC #203475), Canada Foundation for Innovation (CFI #225404, #30865), Ontario Research Fund (RDI #34876), IBM and Ian Lawson van Toch Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Casas C, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00177; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaban V, 2020, J NEUROTRAUM, V37, P2120, DOI 10.1089/neu.2019.6963; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Das Gupta S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041563; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Devoto C, 2020, J NEUROTRAUM, V37, P2482, DOI 10.1089/neu.2019.6933; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Pietro V, 2021, BRIT J SPORT MED, V55, P1395, DOI 10.1136/bjsports-2020-103274; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00348; Edwards KA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00091; FAN L, 1995, MOL BRAIN RES, V30, P125; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Forstner P, 2020, FASEB J, V34, P3855, DOI 10.1096/fj.201902257RR; Gallant C, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1038; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Herrold AA, 2021, J HEAD TRAUMA REHAB, V36, pE155, DOI 10.1097/HTR.0000000000000632; Hicks SD, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.197; Hicks SD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207758; Iankova Andriana, 2006, Emerg Nurse, V14, P30; Iverson GL, 2000, BRAIN INJURY, V14, P1057; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Karelina Kate, 2016, Concussion, V1, pCNC9, DOI 10.2217/cnc.15.9; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Keller A, 2017, RNA BIOL, V14, P1791, DOI 10.1080/15476286.2017.1367888; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kotlyar M, 2019, NUCLEIC ACIDS RES, V47, pD581, DOI 10.1093/nar/gky1037; Kowalski EA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1605-2; Krieg SM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00455; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lin HJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1726, DOI 10.1159/000485778; Liu DZ, 2014, J NEUROTRAUM, V31, P1268, DOI 10.1089/neu.2013.3250; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Liu W, 2013, J MOL HISTOL, V44, P147, DOI 10.1007/s10735-013-9481-z; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Long J, 2013, NEURAL REGEN RES, V8, P1491, DOI 10.3969/j.issn.1673-5374.2013.16.006; Lu JJ, 2019, REGEN BIOMATER, V6, P325, DOI 10.1093/rb/rbz027; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannix RC, 2011, J NEUROTRAUM, V28, P1855, DOI 10.1089/neu.2011.1759; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marchetti B, 2013, TRENDS MOL MED, V19, P144, DOI 10.1016/j.molmed.2012.12.001; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meabon JS, 2020, J NEUROL SCI, V417, DOI 10.1016/j.jns.2020.117049; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murayama M, 1998, FEBS LETT, V433, P73, DOI 10.1016/S0014-5793(98)00886-2; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Omalu B, 2021, NEUROSURGERY, V89, pE97, DOI 10.1093/neuros/nyab138; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ou S, 2014, EUR REV MED PHARMACO, V18, P101; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Pinchi E, 2020, CURR NEUROPHARMACOL, V18, P319, DOI 10.2174/1570159X17666191113100808; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Qin XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204051; Rahmati S, 2020, NUCLEIC ACIDS RES, V48, pD479, DOI 10.1093/nar/gkz989; Rahmati S, 2017, NUCLEIC ACIDS RES, V45, pD419, DOI 10.1093/nar/gkw1082; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rubovitch V, 2011, NEUROCHEM INT, V58, P443, DOI 10.1016/j.neuint.2011.01.009; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Salinas PC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008003; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Sarkar C, 2020, AUTOPHAGY, V16, P466, DOI 10.1080/15548627.2019.1628538; Scranton RA, 2015, J CLIN MED, V4, P1463, DOI 10.3390/jcm4071463; Sheinerman KS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0316-0; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Siedlecki-Wullich D, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0501-4; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun LQ, 2018, BEHAV BRAIN RES, V340, P126, DOI 10.1016/j.bbr.2016.09.020; Sun YX, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01120; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; Tang CH, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/2923182; Tas Demet, 1800, J Clin Med Res, V12, P579, DOI 10.14740/jocmr4265; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Terzioglu B, 2015, J RES MED SCI, V20, P1166, DOI 10.4103/1735-1995.172984; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Tylicka M, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10100665; Uwatoko H, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0471-2; Ved R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84932-0; Wang YP, 2014, NEUROREPORT, V25, P954, DOI 10.1097/WNR.0000000000000219; Weisz HA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60133-z; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Wu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23003-3; Yan J, 2019, J NEUROCHEM, V150, P202, DOI 10.1111/jnc.14717; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yang L, 2021, ANN PALLIAT MED, V10, P372, DOI 10.21037/apm-20-2346; Yang T, 2016, J NEUROCHEM, V137, P122, DOI 10.1111/jnc.13534; Yao XL, 2006, NEUROSCI LETT, V409, P65, DOI 10.1016/j.neulet.2006.09.015; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871; Zhao JW, 2019, PEERJ, V7, DOI 10.7717/peerj.8324; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310; Zimering Mark B, 1800, J Endocrinol Diabetes, V6, DOI 10.15226/2374-6890/6/3/001137	133	1	1	1	1	AEPRESS SRO	BRATISLAVA	BAJZOVA 7, BRATISLAVA, 821 08, SLOVAKIA	0231-5882	1338-4325		GEN PHYSIOL BIOPHYS	Gen. Physiol. Biophys.		2021	40	6					523	539		10.4149/gpb_2021038			17	Biochemistry & Molecular Biology; Biophysics; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Biophysics; Physiology	XO8LB	WOS:000730428900007	34897024	gold			2022-02-06	
J	Medda, A; Funk, R; Ahuja, K; Kamimori, G				Medda, Alessio; Funk, Rob; Ahuja, Krish; Kamimori, Gary			Measurements of Infrasound Signatures From Grenade Blast During Training	MILITARY MEDICINE			English	Article								Introduction: Military personnel during training and military operations are exposed to a large number of repeated exposures to low-level blast overpressure from a variety of sources. These exposures rarely produce a concussion, but anecdotal evidence from soldiers indicates that it can still cause transient neurological effects. Impulsive acoustic sources, such as the ones encountered during military training, are characterized by a broadband energy distribution with resulting pressure measurements that exhibit frequency components well within the infrasound range. This infrasound can couple directly with the human body and in this way alter or influence physiological processes up to inducing concussion-like symptoms. Materials and Methods: This study explores the presence of infrasound energy in measured acoustic signals collected during grenade training at Ft. Benning, GA. Acoustic data from traditional microphones and specialized infrasound microphones were collected during one training session and time and time-frequency analysis was performed to highlight the frequency content of the signals. Results: The analysis of the collected measurements indicates peak SPLs between 140 and 160 dB during explosions corresponding to the shockwave. Also, high-intensity infrasound was observed during grenade explosions with significant energy in the infrasound range and in particular below 3 Hz. This energy appears in the form of three distinct tones at frequencies of 1.987, 2.296, and 2.528 Hz that are present only for the duration of the blast wave. Conclusions: The results presented in this article suggest that reported symptoms from military personnel exposed to repeated low-level blast may also be because of acoustic loading. Therefore, to take into account these findings, future studies aimed at characterizing the effects of repeated low-level blast exposure should consider including acoustic measurements in their investigations.	[Medda, Alessio; Funk, Rob; Ahuja, Krish] Georgia Tech Res Inst, Aerosp Transportat & Adv Syst Lab, Atlanta, GA 30318 USA; [Kamimori, Gary] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA		Medda, A (corresponding author), Georgia Tech Res Inst, Aerosp Transportat & Adv Syst Lab, Atlanta, GA 30318 USA.						ADES HARLOW W., 1958, JOUR AVIATION MED, V29, P454; [Anonymous], 1995, 7196 ISO; Bolin K, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035103; Brown R, 1973, NEW SCIENTIST, V60, P414; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Daubechies I, 2011, APPL COMPUT HARMON A, V30, P243, DOI 10.1016/j.acha.2010.08.002; Dommes E, 2009, BRAIN RES, V1304, P129, DOI 10.1016/j.brainres.2009.09.089; Hamilton J., NPR; Jakobsen J, 2005, J LOW FREQ NOISE V A, V24, P145, DOI 10.1260/026309205775374451; Johnson D, 1980, A081792 WRIGHT PATT; Mallat S., 2008, WAVELET TOUR SIGNAL, V3; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Persinger MA, 2014, NAT HAZARDS, V70, P501, DOI 10.1007/s11069-013-0827-3; Sajja VSSS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00891; Salt A.N., 2011, B SCI TECHNOL SOC, V31, P296, DOI [10.1177/0270467611412555, DOI 10.1177/0270467611412555]; Stein E.M., 2003, FOURIER ANAL INTRO; van Kamp I, 2018, ACOUST AUST, V46, P31, DOI 10.1007/s40857-017-0115-6; Woodsworth RS, 1962, EXP PSYCHOL	18	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			523	528		10.1093/milmed/usaa423			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600075	33499530	Bronze			2022-02-06	
J	Muller, J; Middleton, D; Alizadeh, M; Zabrecky, G; Wintering, N; Bazzan, AJ; Lang, J; Wu, CY; Monti, DA; Wu, QH; Newberg, AB; Mohamed, FB				Muller, Jennifer; Middleton, Devon; Alizadeh, Mahdi; Zabrecky, George; Wintering, Nancy; Bazzan, Anthony J.; Lang, Ji; Wu, Chengyuan; Monti, Daniel A.; Wu, Qianhong; Newberg, Andrew B.; Mohamed, Feroze B.			Hybrid diffusion imaging reveals altered white matter tract integrity and associations with symptoms and cognitive dysfunction in chronic traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Hybrid diffusion imaging; Post-concussion syndrome; Diffusion tensor imaging; Neurite orientation dispersion and density; imaging; Multi-band imaging	NEURITE ORIENTATION DISPERSION	The detection and association of in vivo biomarkers in white matter (WM) pathology after acute and chronic mild traumatic brain injury (mTBI) are needed to improve care and develop therapies. In this study, we used the diffusion MRI method of hybrid diffusion imaging (HYDI) to detect white matter alterations in patients with chronic TBI (cTBI). 40 patients with cTBI presenting symptoms at least three months post injury, and 17 healthy controls underwent magnetic resonance HYDI. cTBI patients were assessed with a battery of neuropsychological tests. A voxel-wise statistical analysis within the white matter skeleton was performed to study between group differences in the diffusion models. In addition, a partial correlation analysis controlling for age, sex, and time after injury was performed within the cTBI cohort, to test for associations between diffusion metrics and clinical outcomes. The advanced diffusion modeling technique of neurite orientation dispersion and density imaging (NODDI) showed large clusters of between-group differences resulting in lower values in the cTBI across the brain, where the single compartment diffusion tensor model failed to show any significant results. However, the diffusion tensor model appeared to be just as sensitive in detecting self-reported symptoms in the cTBI population using a within-group correlation. To the best of our knowledge this study provides the first application of HYDI in evaluation of cTBI using combined DTI and NODDI, significantly enhancing our understanding of the effects of concussion on white matter microstructure and emphasizing the utility of full characterization of complex diffusion to diagnose, monitor, and treat brain injury.	[Muller, Jennifer; Middleton, Devon; Alizadeh, Mahdi; Bazzan, Anthony J.; Wu, Chengyuan; Newberg, Andrew B.; Mohamed, Feroze B.] Thomas Jefferson Univ, Dept Radiol, Jefferson Integrated Magnet Resonance Imaging Ctr, Philadelphia, PA 19107 USA; [Zabrecky, George; Wintering, Nancy; Monti, Daniel A.; Newberg, Andrew B.] Thomas Jefferson Univ, Marcus Inst Integrat Hlth, Dept Integrat Med & Nutr Sci, Philadelphia, PA 19107 USA; [Muller, Jennifer; Lang, Ji; Wu, Qianhong] Villanova Univ, Cellular Biomech & Sports Sci, Dept Mech Engn, Villanova, PA 19085 USA; [Muller, Jennifer; Alizadeh, Mahdi; Wu, Chengyuan] Thomas Jefferson Univ, Vickie & Jack Farber Inst Neurosci, Dept Neurol Surg, Philadelphia, PA 19107 USA		Wu, QH (corresponding author), Cellular Biomech & Sports Sci Lab, Tolentine Hall 113F, Villanova, PA 19085 USA.; Wu, QH (corresponding author), Dept Mech Engn, Tolentine Hall 113F, Villanova, PA 19085 USA.	qianhong.wu@villanova.edu	Wu, Chengyuan/AAE-2502-2020	Wu, Chengyuan/0000-0002-3954-2929	Marcus Foundation	Funding for this study is from a gift from the Marcus Foundation.	Alexander Andrew L, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2245; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bigler ED, 2015, BRAIN NEUROTRAUMA MO, P1; Cercignani M, 2018, NEUROIMAGE, V182, P117, DOI 10.1016/j.neuroimage.2017.10.052; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Gazdzinski LM, 2020, J NEUROTRAUM, V37, P1818, DOI 10.1089/neu.2020.6992; Hosseinbor AP, 2013, NEUROIMAGE, V64, P650, DOI 10.1016/j.neuroimage.2012.08.072; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jafari SS, 1997, J NEUROCYTOL, V26, P207, DOI 10.1023/A:1018588114648; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lerma-Usabiaga G, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116048; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li L, 2016, CHINESE MED J-PEKING, V129, P1091, DOI 10.4103/0366-6999.180518; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Palacios E., SCI ADV, DOI [10.1101/345629, DOI 10.1101/345629]; Palacios E., 2018, NODDI STUDY BIORXIV, DOI [10.1101/345629, DOI 10.1101/345629]; Palacios EM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6892; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Voets NL, 2006, BRAIN, V129, P754, DOI 10.1093/brain/awh679; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067; Xiao M, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00194; Yamagata B, 2020, J NEUROTRAUM, V37, P975, DOI 10.1089/neu.2019.6751; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634	44	1	1	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2021	30								102681	10.1016/j.nicl.2021.102681			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TE9IY	WOS:000670321100008	34215151	Green Published, gold			2022-02-06	
J	Nabhan, D; Taylor, D; Hedges, A; Bahr, R				Nabhan, Dustin; Taylor, David; Hedges, Andrew; Bahr, Roald			The Value of the Patient History in the Periodic Health Evaluation: Patient Interviews Capture 4 Times More Injuries Than Electronic Questionnaires	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						electronic medical records; epidemiology; informatics; injury prevention	OVERUSE INJURIES; RISK-FACTORS; SPORTS; SNOWBOARDERS; VALIDATION; FOOTBALL; ILLNESS; SYSTEM; MEMORY; SKIERS	OBJECTIVE: To assess the value of the patient interview and electronic questionnaire methods of health history data collection in elite athletes. DESIGN: Cohort study. METHODS: A retrospective chart review compared health history data collected by questionnaire and by interview in a cohort of 142 athletes who participated in a periodic health evaluation at the US Olympic & Paralympic Training Center sports medicine clinic. The main outcome measure was number of injuries reported by either interview or written questionnaire. RESULTS: Six hundred twenty-six injuries were reported by interview and 157 by questionnaire. The mean +/- SD number of injuries reported per participant was 4.4 +/- 4.2 by interview and 1.1 +/- 1.3 by questionnaire (difference, 3.3; P<.001). Capture rate by method was similar across sexes and for both Olympic and Paralympic athletes. More injuries were reported by interview than by questionnaire for all injury categories, except for concussions and surgeries. CONCLUSION: Patient interviews capture 4 times as many past or current injuries than electronic questionnaires in athletes training for the Olympic and Paralympic Games. Questionnaires provide incomplete health history information in this patient population.	[Nabhan, Dustin; Taylor, David] US Olymp & Paralymp Comm, Sports Med Div, Colorado Springs, CO USA; [Nabhan, Dustin; Taylor, David] US Coalit Prevent Illness & Injury Sport, Colorado Springs, CO USA; [Nabhan, Dustin; Bahr, Roald] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Oslo, Norway; [Hedges, Andrew] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA		Nabhan, D (corresponding author), 1 Olymp Plaza, Colorado Springs, CO 80909 USA.	Dustin.Nabhan@usoc.org			International Olympic Comittee Medical and Scientific Commission; US Coalition for the Prevention of Illness and Injury in Sport	The authors recognize the International Olympic Comittee Medical and Scientific Commission and the US Coalition for the Prevention of Illness and Injury in Sport for supporting this work.	American Academy of Family Physicians American Academy of Pediatrics American College of Sports Medicine American Medical Society for Sports Medicine American Orthopaedic Society for Sports Medicine, 2019, PPE PREP PHYS EV; Bahr R, 2003, BRIT J SPORT MED, V37, P384, DOI 10.1136/bjsm.37.5.384; Barboza Saulo Delfino, 2017, BMJ Open Sport Exerc Med, V3, pe000275, DOI 10.1136/bmjsem-2017-000275; Barsky AJ, 2002, ARCH INTERN MED, V162, P981, DOI 10.1001/archinte.162.9.981; Boissonnault WG, 2005, PHYS THER, V85, P531, DOI 10.1093/ptj/85.6.531; Clarsen B, 2020, BRIT J SPORT MED, V54, P390, DOI 10.1136/bjsports-2019-101337; Clarsen B, 2014, BRIT J SPORT MED, V48, P754, DOI 10.1136/bjsports-2012-092087; COHEN G, 1995, APPL COGNITIVE PSYCH, V9, P273, DOI 10.1002/acp.2350090402; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Florenes TW, 2011, SCAND J MED SCI SPOR, V21, P196, DOI 10.1111/j.1600-0838.2009.01048.x; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Gallagher J, 2017, SPORTS MED, V47, P1335, DOI 10.1007/s40279-016-0651-5; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hagglund M, 2005, BRIT J SPORT MED, V39, P340, DOI 10.1136/bjsm.2005.018267; Hammond LE, 2009, BRIT J SPORT MED, V43, P498, DOI 10.1136/bjsm.2008.051979; Hirschmuller A, 2017, BRIT J SPORT MED, V51, P260, DOI 10.1136/bjsports-2016-096669; Karlsson D, 2018, HEALTH INFORM J, V24, P136, DOI 10.1177/1460458216661861; Lipkin M, 1995, MED INTERVIEW, P65; Ljungqvist A, 2009, CLIN J SPORT MED, V19, P347, DOI 10.1097/JSM.0b013e3181b7332c; McGuire LC, 1996, EXP AGING RES, V22, P403, DOI 10.1080/03610739608254020; Menachemi N, 2011, RISK MANAG HEALTHC P, V4, P47, DOI 10.2147/RMHP.S12985; Miller RH, 2004, HEALTH AFFAIR, V23, P116, DOI 10.1377/hlthaff.23.2.116; Moller M, 2018, SCAND J MED SCI SPOR, V28, P252, DOI 10.1111/sms.12869; Nordstrom A, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120902407; Rosner BI, 2018, J MED INTERNET RES, V20, DOI 10.2196/10405; Steenstrup SE, 2014, BRIT J SPORT MED, V48, P41, DOI 10.1136/bjsports-2013-093145; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Taylor MJ, 2011, HEALTH INFORM J, V17, P5, DOI 10.1177/1460458210393914; van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291; Walther B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025348	30	1	1	2	4	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	JAN	2021	51	1					46	51		10.2519/jospt.2021.9821			6	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	PQ5JF	WOS:000606581100007	33306928				2022-02-06	
J	Nagy, EN; Ali, AY; Behiry, ME; Naguib, MM; Elsayed, MM				Nagy, Ebtesam N.; Ali, Ahmed Y.; Behiry, Mervat E.; Naguib, Mervat M.; Elsayed, Marwa M.			Impact of Combined Photo-Biomodulation and Aerobic Exercise on Cognitive Function and Quality-of-Life in Elderly Alzheimer Patients with Anemia: A Randomized Clinical Trial	INTERNATIONAL JOURNAL OF GENERAL MEDICINE			English	Article						Alzheimer's disease; cognition; laser; exercise; quality of life	LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; LIGHT; PERFORMANCE	Purpose: Few data are available on the positive impact of photo-biomodulation (PBM) using low-level laser therapy as a complementary treatment for improving the cognitive function and optimizing the hemoglobin (Hb) level and oxygen carrying capacity in anemic elderly patients and consequently improving the quality-of-life. The present study aimed to evaluate a new, safe, and easy therapeutic approach to improve Alzheimer's disease-related symptoms that interfere with the whole life activities and social interaction of elderly patients. Patients and Methods: In this placebo-controlled clinical trial, 60 elderly patients suffering from anemia and mild cognitive dysfunction were randomly assigned into two equal groups to receive active or placebo low-level laser in addition to a moderate-intensity aerobic exercise over a 12-week period. Hb level as well as cognitive and functional tests were reassessed for any change after 12 weeks of intervention. Results: By the end of this study, both groups showed significant improvements in Hb level, Montreal Cognitive Assessment Scale (MoCa - B basic), Quality-of-Life for Alzheimer's Disease scale, and Berg Balance scale scores along with significant reduction in body mass index (BMI) and waist-hip ratio (WHR) (P<0.0001). The experimental group which received active low-level laser in addition to moderate-intensity aerobic exercise showed more significant results compared to the control group which received placebo low-level laser in addition to moderate-intensity aerobic exercise in all the measured outcomes (P<0.001). Conclusion: Combined low-level laser therapy and moderate-intensity aerobic exercises are more effective in improving the cognitive function and quality-of-life of Alzheimer's disease patients.	[Nagy, Ebtesam N.; Elsayed, Marwa M.] Cairo Univ, Fac Phys Therapy, Phys Therapy Cardiovasc Resp Disorder & Geriatr D, Giza, Egypt; [Ali, Ahmed Y.; Behiry, Mervat E.; Naguib, Mervat M.] Cairo Univ, Fac Med, Internal Med Dept, Giza 12511, Egypt; [Ali, Ahmed Y.; Behiry, Mervat E.] Armed Forces Coll Med, Internal Med Dept, Cairo, Egypt		Ali, AY (corresponding author), Cairo Univ, Fac Med, Internal Med Dept, Giza 12511, Egypt.	themythaysa@kasralainy.edu.eg	Nagy, Ebtasm/AAG-7685-2021				Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; [Anonymous], 2011, VIT MIN NUTR INF SYS; Argyriadou S, 2001, BMC Fam Pract, V2, P5, DOI 10.1186/1471-2296-2-5; Atti AR, 2006, NEUROBIOL AGING, V27, P278, DOI 10.1016/j.neurobiolaging.2005.02.007; Avci P, 2013, LASER SURG MED, V45, P349, DOI 10.1002/lsm.22153; Azarbayjani MA, 2014, TURK FIZ TIP REHAB D, V60, P92, DOI 10.5152/tftrd.2014.24654; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beghe C, 2004, AM J MED, V116, P3, DOI 10.1016/j.amjmed.2003.12.009; Berman Marvin H, 2017, J Neurol Neurosci, V8, DOI 10.21767/2171-6625.1000176; BURNS A, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B1582; Chan AS, 2019, INT J GERIATR PSYCH, V34, P369, DOI 10.1002/gps.5039; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Croghan IT, 2020, LASER MED SCI, V35, P663, DOI 10.1007/s10103-019-02867-5; Croghan Ivana T, 2016, BMC Obes, V3, P42; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Farivar S, 2014, J LASERS MED SCI, V5, P58; Gonzalez-Lima F, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00036; Gupta A, 2013, BIOTECHNOL ADV, V31, P607, DOI 10.1016/j.biotechadv.2012.08.003; HAGBERG JM, 1994, BAILLIERE CLIN RHEUM, V8, P29, DOI 10.1016/S0950-3579(05)80223-7; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hermez J, 2017, E MEDITERR HEALTH J, V23, P647, DOI 10.26719/2017.23.10.647; Hipskind SG, 2019, PHOTOBIOMODULATION P, V37, P77, DOI 10.1089/photob.2018.4489; Ibrahim A., 2013, ENCY CROSS CULTURAL; Ihle-Hansen H, 2017, DEMENT GER COGN D EX, V7, P318, DOI 10.1159/000480496; Kampragkou C, 2017, INT J PHYSIOTHER, V4, P262, DOI 10.15621/ijphy/2017/v4i5/159420; Karger R, 2012, TRANSFUS MED HEMOTH, V39, P277, DOI 10.1159/000339809; Leung MCP, 2002, LASER SURG MED, V31, P283, DOI 10.1002/lsm.10096; Lista I, 2010, CELL MOL NEUROBIOL, V30, P493, DOI 10.1007/s10571-009-9488-x; Litscher G., 2016, INTEGR MED INT, V3, P75, DOI [10.1159/000448099, DOI 10.1159/000448099]; Ma WJ, 2012, LASER MED SCI, V27, P585, DOI 10.1007/s10103-011-0991-1; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Matsuzono K, 2016, GERIATR GERONTOL INT, V16, P200, DOI 10.1111/ggi.12455; McPherson Susan, 2012, Minn Med, V95, P36; Michie S, 2009, HEALTH PSYCHOL, V28, P690, DOI 10.1037/a0016136; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Otto JM, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-33; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Qiu X, 2017, SCANNING, P8; Requena C, 2004, DEMENT GERIATR COGN, V18, P50, DOI 10.1159/000077735; Rolland Y, 2000, J Nutr Health Aging, V4, P109; Sharma SK, 2011, LASER SURG MED, V43, P851, DOI 10.1002/lsm.21100; Stimpson NJ, 2018, NEUROSCI BIOBEHAV R, V88, P177, DOI 10.1016/j.neubiorev.2018.03.018; Thompson Carl A, 2007, BMC Geriatr, V7, P18, DOI 10.1186/1471-2318-7-18; Venturelli M, 2011, AM J ALZHEIMERS DIS, V26, P381, DOI 10.1177/1533317511418956; Vinay K, 2007, ROBBINS BASIC PATHOL, P16; Yang SY, 2015, CNS NEUROL DISORD-DR, V14, P1292, DOI 10.2174/1871527315666151111123319; Yu F, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-394; ZHANG Y, 2018, NEUROPSYCHIATRY, V6, P477, DOI DOI 10.1039/C7TB02864D	49	1	2	4	4	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-7074		INT J GEN MED	Int. J. Gen. Med.		2021	14						141	152		10.2147/IJGM.S280559			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QB3IU	WOS:000614036100001	33469351	gold, Green Published			2022-02-06	
J	Neumann, D; Sander, AM; Perkins, SM; Bhamidipalli, SS; Hammond, FM				Neumann, Dawn; Sander, Angelle M.; Perkins, Susan M.; Bhamidipalli, Surya Sruthi; Hammond, Flora M.			Negative Attribution Bias and Related Risk Factors After Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; anger; attributions; brain injury; cognition; social inference	TORONTO-ALEXITHYMIA-SCALE; AGGRESSIVE-BEHAVIOR; PARTICIPATION ASSESSMENT; AFFECT RECOGNITION; SOCIAL COGNITION; ANGER; DEPRESSION; EMPATHY; STYLE; ASSOCIATION	Objective: In participants with traumatic brain injury (TBI) and peer controls, examine (1) differences in negative attributions (interpret ambiguous behaviors negatively); (2) cognitive and emotional factors associated with negative attributions; and (3) negative attribution associations with anger responses, life satisfaction, and participation. Setting: Two TBI outpatient rehabilitation centers. Participants: Participants with complicated mild to severe TBI (n = 105) and peer controls (n = 105). Design: Cross-sectional survey study. Main Measures: Hypothetical scenarios describing ambiguous behaviors were used to assess situational anger and attributions of intent, hostility, and blame. Executive functioning, perspective taking, emotion perception and social inference, alexithymia, aggression, anxiety, depression, participation, and life satisfaction were also assessed. Results: Compared with peer controls, participants with TBI rated behaviors significantly more intentional, hostile, and blameworthy. Regression models explained a significant amount of attribution variance (25%-43%). Aggression was a significant predictor in all models; social inference was also a significant predictor of intent and hostility attributions. Negative attributions were associated with anger responses and lower life satisfaction. Conclusion: People with TBI who have higher trait aggression and poor social inferencing skills may be prone to negative interpretations of people's ambiguous actions. Negative attributions and social inferencing skills should be considered when treating anger problems after TBI.	[Neumann, Dawn; Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Perkins, Susan M.; Bhamidipalli, Surya Sruthi] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Neumann, Dawn; Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Div Clin Neuropsychol & Rehabil Psychol, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Neumann, D (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dneumann73@gmail.com; SanAngelle.Sander@memorialhermann.org; sperkin1@iu.edu; sbhamid@iu.edu; Flora.Hammond@rhin.com			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Field Initiated Program [90IF00-95-01-00]	This study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Field Initiated Program, award #90IF00-95-01-00.	An SK, 2010, SCHIZOPHR RES, V118, P54, DOI 10.1016/j.schres.2010.01.025; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brookshire R, 1993, DISCOURSE COMPREHENS, P105; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Combs Dennis R, 2009, Cogn Neuropsychiatry, V14, P30, DOI 10.1080/13546800902732970; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dodge KA, 2006, DEV PSYCHOPATHOL, V18, P791, DOI 10.1017/S0954579406060391; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; EPPS J, 1995, COGNITIVE THER RES, V19, P159, DOI 10.1007/BF02229692; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Greve KW, 2001, BRAIN INJURY, V15, P255; Harris JA, 1997, J BUS PSYCHOL, V12, P39, DOI 10.1023/A:1025058032195; Holtzworth-Munroe Amy, 2000, Behavior Therapy, V31, P603, DOI 10.1016/S0005-7894(00)80034-9; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Jeon IH, 2013, PSYCHIAT INVEST, V10, P34, DOI 10.4306/pi.2013.10.1.34; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P194, DOI 10.1076/jcen.20.2.194.1173; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McNiel DE, 2003, J CONSULT CLIN PSYCH, V71, P399, DOI 10.1037/0022-006X.71.2.399; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P205, DOI 10.1097/HTR.0000000000000261; Neumann D, 2017, J HEAD TRAUMA REHAB, V32, P197, DOI 10.1097/HTR.0000000000000259; Neumann D, 2015, REHABIL PSYCHOL, V60, P155, DOI 10.1037/rep0000036; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Palmer EJ, 2005, AGGRESSIVE BEHAV, V31, P56, DOI 10.1002/ab.20072; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Sansone RA, 2013, COMPR PSYCHIAT, V54, P70, DOI 10.1016/j.comppsych.2012.06.005; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spreen O, 1991, COMPENDIUM NEUROPSYC, P219; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vitale JE, 2005, AGGRESSIVE BEHAV, V31, P99, DOI 10.1002/ab.20050; Waldheter EJ, 2005, J NERV MENT DIS, V193, P609, DOI 10.1097/01.nmd.0000177788.25357.de; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Winegardner J, 2016, NEUROREHABILITATION, V39, P153, DOI 10.3233/NRE-161347; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	52	1	1	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		E61	E70		10.1097/HTR.0000000000000600			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300012	32769831	Green Accepted			2022-02-06	
J	Ohbe, H; Matsui, H; Fushimi, K; Yasunaga, H				Ohbe, Hiroyuki; Matsui, Hiroki; Fushimi, Kiyohide; Yasunaga, Hideo			Epidemiology of Chronic Critical Illness in Japan: A Nationwide Inpatient Database Study	CRITICAL CARE MEDICINE			English	Article						chronic critical illness; intensive care unit; Japan; long-term care; mechanical ventilation; sepsis		OBJECTIVES: The epidemiology of chronic critical illness is not well known. We aimed to estimate the prevalence, mortality, and costs associated with chronic critical illness in Japan. DESIGN: A nationwide inpatient administrative database study in Japan from April 2011 to March 2018. SETTING: Six hundred seventy-nine acute-care hospitals with ICU beds in Japan. PATIENTS: Adult patients who met our definition for chronic critical illness: one of six eligible clinical conditions (prolonged acute mechanical ventilation, tracheotomy, stroke, traumatic brain injury, sepsis, and severe wound) plus at least 8 consecutive days in an ICU. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among 2,395,016 ICU admissions during the study period, 216,434 (9.0%) met the definition for chronic critical illness. The most common eligible condition was prolonged acute mechanical ventilation (73.9%), followed by sepsis (50.6%), tracheostomy (23.8%), and stroke (22.8%). Overall inhospital mortality was 28.6%. The overall age-specific population prevalence was 42.0 per 100,000. The age-specific population prevalence steadily increased with age, reaching 109.6 per 100,000 in persons aged greater than 85 years. With extrapolation to national estimates in Japan, there were 47,729 chronic critical illness cases in 2011 and the number remained similar at 46,494 cases in 2017. Hospitalization costs increased gradually, rising from U.S.$2.3 billion in 2011 to U.S.$2.7 billion in 2017. Inhospital mortality decreased from 30.6% to 28.2%, whereas the proportion of patients with total/severe dependence increased from 29.6% to 33.2% and the proportion of patients with decreased consciousness at discharge increased from 18.7% to 19.6%. CONCLUSIONS: Using a nationwide inpatient database in Japan, we found substantial clinical and economic burdens of chronic critical illness in Japan. Chronic critical illness was particularly common in elderly people. Although inhospital mortality of chronic critical illness patients continues to decrease, costs and patients with dependence for activities of daily living or decreased consciousness at discharge are increasing.	[Ohbe, Hiroyuki; Matsui, Hiroki; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan		Ohbe, H (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan.	hohbey@gmail.com	Ohbe, Hiroyuki/ABB-6008-2021	Ohbe, Hiroyuki/0000-0001-8544-2569	Ministry of Health, Labour and Welfare of JapanMinistry of Health, Labour and Welfare, Japan [19AA2007, H30-Policy-Designated-004]; Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17H04141, 17H05077]; Ministry of Health, Labour, and Welfare, JapanMinistry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Japanese Government	Supported, in part, by grants from the Ministry of Health, Labour and Welfare of Japan (19AA2007 and H30-Policy-Designated-004) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (17H04141).; Dr. Matsui disclosed that this work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17H05077). Dr. Yasunaga's institution received funding from Ministry of Health, Labour, and Welfare, Japan, and the Ministry of Education, Culture, Sports, Science and Technology, Japan. Drs. Fushimi and Yasunaga received grant support from the Japanese Government. Dr. Ohbe has disclosed that he does not have any potential conflicts of interest.	[Anonymous], 2017, JAP MIN HLTH LAB WEL; [Anonymous], 2014, JAP MIN HLTH LAB WEL; Bagshaw SM, 2018, INTENS CARE MED, V44, P2134, DOI 10.1007/s00134-018-5440-1; Carson SS, 2012, RESP CARE, V57, P848, DOI 10.4187/respcare.01736; Chelluri L, 2004, CRIT CARE MED, V32, P61, DOI 10.1097/01.CCM.0000098029.65347.F9; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Imanaka Y., 2010, JPN SOC INTENSIVE CA, V17, P227; Iwashita Y, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2250-3; Iwashyna TJ, 2004, AM J RESP CRIT CARE, V170, P981, DOI 10.1164/rccm.200403-260oc; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kandilov A., 2014, CHRONICALLY CRITICAL; Lamas D, 2014, NEW ENGL J MED, V370, P175, DOI 10.1056/NEJMms1310675; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; MAHONEY F I, 1965, Md State Med J, V14, P61; Makino J, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-9; Ministry of Internal Affairs and Communications, 2020, POP AG 5 YEAR AG GRO; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Scheinhorn DJ, 2007, CHEST, V131, P85, DOI 10.1378/chest.06-1081; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Shigematsu K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002736; Swoboda SM, 2002, AM J CRIT CARE, V11, P459, DOI 10.4037/ajcc2002.11.5.459; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; White DB, 2007, ARCH INTERN MED, V167, P461, DOI 10.1001/archinte.167.5.461; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Yamana H, 2017, J EPIDEMIOL, V27, P476, DOI 10.1016/j.je.2016.09.009; Yasunaga H., 2019, ANN CLIN EPIDEMIOL, V1, P76	31	1	1	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2021	49	1					70	78		10.1097/CCM.0000000000004723			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PE8RB	WOS:000598627500015	33177360				2022-02-06	
J	Olczak, M; Poniatowski, LA; Siwinska, A; Kwiatkowska, M; Chutoranski, D; Wierzba-Bobrowicz, T				Olczak, Mieszko; Poniatowski, Lukasz A.; Siwinska, Agnieszka; Kwiatkowska, Magdalena; Chutoranski, Dominik; Wierzba-Bobrowicz, Teresa			Elevated serum and urine levels of progranulin (PGRN) as a predictor of microglia activation in the early phase of traumatic brain injury: a further link with the development of neurodegenerative diseases	FOLIA NEUROPATHOLOGICA			English	Article						progranulin; traumatic brain injury; microglia; serum; urine; neurodegenerative diseases	FRONTOTEMPORAL DEMENTIA; CELLULAR-LOCALIZATION; EPITHELIN PRECURSOR; GENE-EXPRESSION; SPINAL-CORD; BIOMARKERS; NEUROINFLAMMATION; EPIDEMIOLOGY; GRANULINS; RISK	Traumatic brain injury (TBI) is a frequent finding during forensic autopsies and neuropathological examinations in medico-legal practices. Despite the unprecedented attention currently focused on TBI pathogenesis, there is a need to improve its diagnostics through the use of novel biomarkers to facilitate detection, treatment, and prognosis. Recently, growth factor progranulin (PGRN) has attracted significant attention because of its neurotrophic and anti-inflammatory activities. The role of PGRN in TBI has not been widely discussed, although PGRN-related neuroinflammatory and neurodegenerative phenomena have been described. The aim of this study was to identify PGRN concentration levels in biofluids and examine PGRN and CD68 protein expression in brain tissue using immunohistochemical staining in individuals with fatal TBI in its early phase. The study was performed using cases (n = 30) of fatal head injury and control cases (n = 30) of sudden death. The serum and urine were collected within similar to 24 h after death and compared using the ELISA test, where brain specimens were stained with anti-PGRN and anti-CD68 antibodies. In our study, we observed elevated concentration levels of PGRN in the serum and urine of TBI individuals in the early phase of TBI. These changes were accompanied by increased expression of PGRN in the frontal cortex (1st-3rd layers), in which anti-CD68 immunostaining revealed disseminated cortical microglia activation. The possible implementation of performing such assays offers a novel and interesting tool for investigation and research regarding TBI diagnosis and pathogenesis. Furthermore, the above-mentioned surrogate biofluid assays may be useful in clinical prognosis and risk calculation of non-fatal cases of TBI, considering the development of neurodegenerative conditions of TBI individuals.	[Olczak, Mieszko; Siwinska, Agnieszka; Kwiatkowska, Magdalena] Med Univ Warsaw, Ctr Biostruct Res, Dept Forens Med, Warsaw, Poland; [Poniatowski, Lukasz A.] Med Univ Warsaw, Ctr Preclin Res & Technol CePT, Dept Expt & Clin Pharmacol, 1B Banacha St, PL-02097 Warsaw, Poland; [Poniatowski, Lukasz A.] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Neurosurg, Warsaw, Poland; [Chutoranski, Dominik; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, Warsaw, Poland		Poniatowski, LA (corresponding author), Med Univ Warsaw, Ctr Preclin Res & Technol CePT, Dept Expt & Clin Pharmacol, 1B Banacha St, PL-02097 Warsaw, Poland.	lukasz.poniatowski@gmail.com			Medical University of Warsaw [1MB/PM1/18]; European Union (EU) -The European Regional Development Fund (ERDF) within the "Infrastructure and Environment'' operational program	This study was supported by internal grant 1MB/PM1/18 conducted in the years 2018-2019 from the Medical University of Warsaw. The project was implemented with infrastructure financed by the European Union (EU) -The European Regional Development Fund (ERDF) within the "Infrastructure and Environment'' operational program for the years 2007-2013. No additional external funding or support was received for this study.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Almeida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026454; An MX, 2015, GENOM PROTEOM BIOINF, V13, P345, DOI 10.1016/j.gpb.2015.08.005; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; BHANDARI V, 1993, ENDOCRINOLOGY, V133, P2682, DOI 10.1210/en.133.6.2682; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Chen-Plotkin AS, 2011, ARCH NEUROL-CHICAGO, V68, P488, DOI 10.1001/archneurol.2011.53; Chitramuthu BP, 2017, BRAIN, V140, P3081, DOI 10.1093/brain/awx198; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Diaz-Arrastia R, 2020, CURR OPIN CRIT CARE, V26, P103, DOI 10.1097/MCC.0000000000000703; Eriksen JL, 2010, ACTA NEUROPATHOL, V119, P107, DOI 10.1007/s00401-009-0623-z; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Jeromin A, 2017, ADV NEUROBIOL, V15, P491, DOI 10.1007/978-3-319-57193-5_20; Karve Ila P, 2016, Br J Pharmacol, V173, P692, DOI 10.1111/bph.13125; Lasek-Bal A, 2019, J PHYSIOL PHARMACOL, V70, P209, DOI 10.26402/jpp.2019.2.04; Li KW, 2019, J NEUROCHEM, V151, P435, DOI 10.1111/jnc.14603; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Morenas-Rodriguez E, 2016, J ALZHEIMERS DIS, V50, P539, DOI 10.3233/JAD-150746; Naphade SB, 2010, ACTA NEUROPATHOL, V119, P123, DOI 10.1007/s00401-009-0616-y; Nicoletto BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165177; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Prout AJ, 2017, CURR OPIN PEDIATR, V29, P272, DOI 10.1097/MOP.0000000000000488; Raitano S, 2015, STEM CELL REP, V4, P16, DOI 10.1016/j.stemcr.2014.12.001; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Soukup V, 2015, UROL INT, V95, P56, DOI 10.1159/000368166; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wilke C, 2017, NEURODEGENER DIS, V17, P83, DOI 10.1159/000448896; Wilke C, 2016, CURR ALZHEIMER RES, V13, P654, DOI 10.2174/1567205013666160314151247; Wu JB, 2016, RHEUMATOL INT, V36, P759, DOI 10.1007/s00296-016-3458-7; Xie S, 2016, EUR J NEUROL, V23, P648, DOI 10.1111/ene.12920; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003; Zhang B, 2014, EXP NEUROL, V258, P112, DOI 10.1016/j.expneurol.2014.04.007; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	57	1	1	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2021	59	1					81	90		10.5114/fn.2021.105137			10	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	RN0BO	WOS:000640021200008	33969679	gold			2022-02-06	
J	Ostergaard, PJ; Tarabochia, MA; Hall, MJ; Dyer, G; Earp, BE; Blazar, P; Zhang, DF				Ostergaard, Peter J.; Tarabochia, Matthew A.; Hall, Matthew J.; Dyer, George; Earp, Brandon E.; Blazar, Philip; Zhang, Dafang			What Factors Are Associated with Reoperation After Operative Treatment of Terrible Triad Injuries?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							RADIAL HEAD; ELBOW; DISLOCATION; DEPRIVATION; FRACTURES; MORTALITY; RISK	Background Terrible triad injuries of the elbow, consisting of posterior ulnohumeral joint dislocation with associated fractures of the radial head and coronoid process, are challenging injuries due to the difficulty in restoring stability to the joint surgically while also attempting to allow early ROM to prevent stiffness. Furthermore, complications are both debilitating and relatively common, frequently requiring reoperation. Questions/purposes (1) What patient-, injury-, or surgery-related factors are associated with reoperation after surgical treatment of terrible triad injuries of the elbow? (2) What are the most common causes of reoperation after these injuries? Methods Between January 2000 and June 2017, we identified 114 patients who had surgery for terrible triad injuries at two tertiary-care referral centers. Of those, 40% (46 of 114) were lost to follow-up before 1 year, and an additional 5% (6 of 114) were excluded because they underwent the index surgery at an outside institution (n = 4) or underwent closed reduction with or without percutaneous pinning (n = 2). That left 62 patients for analysis in this retrospective study with a minimum of 1-year follow-up (median 22 months; range 12 to 65) or who met the endpoint of reoperation before 1 year. During the study period, indications for surgical treatment of terrible triad injuries of the elbow included joint incongruity or instability precluding early ROM. In our study cohort, 45% (28 of 62) underwent reoperation. Indications for reoperation after surgical treatment included stiffness that interfered with activities of daily life, symptomatic prominent hardware, ulnar neuropathy, instability of the elbow joint at rest or with range of motion, and infection. Patient-related (such as age, sex, race), injury-related (for example, ipsilateral extremity fracture, open fracture), and surgery-related factors (for instance, time to surgery, radial head treatment) as well as outcomes were collected by the treating surgeon at the time of follow-up and ascertained using chart review. The primary outcome measure was reoperation after surgical treatment of a terrible triad injury of the elbow. Bivariate analysis was used to assess whether explanatory variables were associated with reoperation after surgical treatment of terrible triad injuries of the elbow. Results Of the patient-, injury-, and surgery-related factors that were analyzed, only radial head treatment was associated with an increased reoperation risk (p = 0.03). No other variable met criteria for inclusion in our multivariable logistic regression model (p < 0.10), and therefore, a multivariable logistic regression model was not performed. The most common indication for reoperation was stiffness (21% [13 of 62 patients]), followed by symptomatic hardware (18% [11 of 62 patients]), nerve symptoms (ulnar neuropathy 16% [10 of 62 patients] and incisional neuroma 2% [1 of 62 patients]), instability (6% [4 of 62 patients]), and wound problems (infection 2% [1 of 62 patients]). Conclusion The reoperation risk after surgical treatment of terrible triad injuries of the elbow is high. No patient- or injury-related factors were associated with the reoperation risk. Based on our finding, we recommend fixation of radial head fractures in these injuries when feasible and compatible with early postoperative motion, and we suggest the use of radial head excision or arthroplasty as a secondary options.	Brigham & Womens Hosp, Boston, MA USA; Harvard Med Sch, Boston, MA 02115 USA; [Ostergaard, Peter J.; Tarabochia, Matthew A.; Hall, Matthew J.; Dyer, George; Earp, Brandon E.; Blazar, Philip; Zhang, Dafang] Harvard Med Sch, Brigham & Womens Hosp, Dept Orthoped, Div Hand & Upper Extrem Surg, Boston, MA 02115 USA; [Ostergaard, Peter J.; Tarabochia, Matthew A.; Hall, Matthew J.; Dyer, George] Harvard Med Sch, Massachusetts Gen Hosp, Div Orthoped Surg, Boston, MA 02115 USA		Ostergaard, PJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Div Orthoped Surg, 55 Fruit St,Off 53, Boston, MA 02115 USA.	postergaard@partners.org					Chen NC, 2015, J HAND SURG-AM, V40, P2297, DOI 10.1016/j.jhsa.2015.04.039; CHILDRESS HM, 1975, CLIN ORTHOP RELAT R, P168; Duckworth AD, 2012, INJURY, V43, P1102, DOI 10.1016/j.injury.2012.02.017; Faierman E, 2001, J HAND SURG-AM, V26A, P675, DOI 10.1053/jhsu.2001.26186; Fitzgibbons PG, 2014, ORTHOPEDICS, V37, pE373, DOI 10.3928/01477447-20140401-59; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Henry P, 2015, J ORTHOP TRAUMA, V29, P182, DOI 10.1097/BOT.0000000000000237; Hotchkiss RN., 1996, ROCKWOOD GREENS FRAC, V4th, P929; Jeong WK, 2010, J ORTHOP SCI, V15, P612, DOI 10.1007/s00776-010-1515-8; Kind AJH, 2014, ANN INTERN MED, V161, P765, DOI 10.7326/M13-2946; Lakomkin N, 2017, J ORTHOP TRAUMA, V31, P21, DOI 10.1097/BOT.0000000000000701; Leigh WB, 2012, J SHOULDER ELB SURG, V21, P1336, DOI 10.1016/j.jse.2012.03.005; Lindenhovius ALC, 2008, J HAND SURG-AM, V33A, P920, DOI 10.1016/j.jhsa.2008.02.007; O'Driscoll S W, 2001, Instr Course Lect, V50, P89; Ochenjele G, 2018, J ORTHOP TRAUMA, V32, pE245, DOI 10.1097/BOT.0000000000001170; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Seijas Roberto, 2009, J Orthop Surg (Hong Kong), V17, P335; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Sullivan MP, 2017, J ORTHOP TRAUMA, V31, P497, DOI 10.1097/BOT.0000000000000876; Watters TS, 2014, CLIN ORTHOP RELAT R, V472, P2128, DOI 10.1007/s11999-013-3331-x; Whiting PS, 2017, EUR J TRAUMA EMERG S, V43, P255, DOI 10.1007/s00068-016-0642-0; Zagorski J B, 1990, Instr Course Lect, V39, P265; Zhang DF, 2016, J ORTHOP TRAUMA, V30, P660, DOI 10.1097/BOT.0000000000000674	25	1	1	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JAN	2021	479	1					119	125		10.1097/CORR.0000000000001391			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	PR6TU	WOS:000607367200022	32667748	Bronze, Green Published			2022-02-06	
J	Oyesanya, TO; Moran, TP; Espinoza, TR; Wright, DW				Oyesanya, Tolu O.; Moran, Tim P.; Espinoza, Tamara R.; Wright, David W.			Regional Variations in Rehabilitation Outcomes of Adult Patients With Traumatic Brain Injury: A Uniform Data System for Medical Rehabilitation Investigation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Patients; Outcome assessment; health care; Rehabilitation	INPATIENT REHABILITATION; FUNCTIONAL OUTCOMES; MODEL SYSTEMS; RISK-FACTORS; INSTITUTIONALIZATION; SEVERITY; NEEDS	Objectives: To examine regional differences in rehabilitation outcomes among adult patients with moderate-to-severe traumatic brain injury (TBI) who received care at an inpatient rehabilitation facility (IRF). Design: We conducted a secondary analysis of a large, multi-center dataset from the Uniform Data System for Medical Rehabilitation. Setting: More than 70% of all IRFs in the United States. Participants: Adult TBI patients (N=175,358) aged 18 years or older who were admitted and discharged from an IRF in the United States between 2004 and 2014. Qualifying etiology included traumatic brain dysfunction Impairment Group codes 02.21 (traumatic, open injury) and 02.22 (traumatic, closed injury). Interventions: Not applicable. Main Outcome Measures: Discharge functional status (total, cognitive, motor), length of stay, and discharge to home. Results: Patient and clinical characteristics varied significantly by geographic location, as did median functional status, length of stay, and percentage of patients discharged home. The region where IRF care was received, race and ethnicity, age, occurrence of 1 or more falls during the IRF stay, case mix group, and insurance status were associated with discharge functional status, length of stay, and discharge to home. Conclusions: Our findings provide evidence of geographic differences in outcomes and potential disparities in care of TBI patients who received IRF care. More research is needed to identify TBI patients at risk for poor discharge outcomes to inform development and testing of interventions to reduce disparities in outcomes for these patients. Archives of Physical Medicine and Rehabilitation 2021;102:68-75 (c) 2020 by the American Congress of Rehabilitation Medicine	[Oyesanya, Tolu O.] Duke Univ, Sch Nursing, 307 Trent Dr,Room 2029, Durham, NC 27710 USA; [Moran, Tim P.; Espinoza, Tamara R.; Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA		Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, 307 Trent Dr,Room 2029, Durham, NC 27710 USA.	tolu.oyesanya@duke.edu			Emory University School of Medicine Department of Emergency Medicine	Supported by internal funds from the Emory University School of Medicine Department of Emergency Medicine.	Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Birkmeyer JD, 1998, SURGERY, V124, P917, DOI 10.1067/msy.1998.90268; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.2307/3868138; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Centers for Medicare & Medicaid Services, 2012, INP REH FAC PAT ASS; Centers for Medicare & Medicaid Services, IRF QUAL REP PROGR M; Centers for Medicare & Medicaid Services, MED SHAR SAV PROGR Q; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Chernick M. R., 2011, BOOTSTRAP METHODS GU, V619; Cohen J., 2003, APPL MULTIPLE REGRES, V3; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Eum RS, 2017, J HEAD TRAUMA REHAB, V32, P158, DOI 10.1097/HTR.0000000000000246; Eum RS, 2015, J NEUROTRAUM, V32, P280, DOI 10.1089/neu.2014.3351; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Gunn S, 2018, ARCH PHYS MED REHAB, V99, P1805, DOI 10.1016/j.apmr.2018.04.005; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Harrington, 1995, DRUGS SOC, V8, P7; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Kane RL, 2010, CONDUCTING HLTH OUTC; Kolakowsky-Hayner SA, 2016, NEUROREHABILITATION, V39, P363, DOI 10.3233/NRE-161368; Kraus L., 2015, DISABILITY STAT ANN; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Mendez CM, 2014, POPUL HEALTH MANAG, V17, P28, DOI 10.1089/pop.2013.0002; Nalder E, 2019, DISABIL REHABIL, V41, P2708, DOI 10.1080/09638288.2018.1474495; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Patel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161554; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Reistetter TA, 2014, ARCH PHYS MED REHAB, V95, P29, DOI 10.1016/j.apmr.2013.07.018; Rutkowski L, 2010, EDUC RESEARCHER, V39, P142, DOI 10.3102/0013189X10363170; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Seel RT, 2016, NEUROREHABILITATION, V39, P371, DOI 10.3233/NRE-161369; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Shepherd-Banigan ME, 2018, J GEN INTERN MED, V33, P1177, DOI 10.1007/s11606-018-4417-7; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Uniform Data System for Medical Rehabilitation, UDSPRO SYST; Uniform Data System for Medical Rehabilitation, FIM STRUM ITS BACKGR; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	45	1	1	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2021	102	1					68	75		10.1016/j.apmr.2020.07.011			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	QA5ST	WOS:000613505800009	32861669				2022-02-06	
J	Qaid, EYA; Zakaria, R; Yusof, NAM; Sulaiman, SF; Shafin, N; Ahmad, AH; Othman, Z; Al-Rahbi, B; Muthuraju, S				Qaid, Entesar Yaseen Abdo; Zakaria, Rahimah; Yusof, Nurul Aiman Mohd; Sulaiman, Shaida Fariza; Shafin, Nazlahshaniza; Ahmad, Asma Hayati; Othman, Zahiruddin; Al-Rahbi, Badryia; Muthuraju, Sangu			Tualang Honey prevents neuronal damage in medial prefrontal cortex (mPFC) through enhancement of cholinergic system in male rats following exposure to normobaric hypoxia	BANGLADESH JOURNAL OF MEDICAL SCIENCE			English	Article						medial prefrontal cortex; acetylcholine; acetyl cholinesterase; normobaric hypoxia; Tualang honey	PRELIMBIC CORTEX; EXTRACELLULAR ACETYLCHOLINE; INTERMITTENT HYPOXIA; IMPAIRED SYNTHESIS; MEMORY; HIPPOCAMPUS; RELEASE; STRESS; BRAIN; OSCILLATIONS	Background: Medial prefrontal cortex (mPFC) is considered to be involved in human cognition to mPFC in terms of learning and memory. Hypoxia is one of the crucial factors causing secondary damage in cerebral hemorrhage and traumatic brain injury. However, the underlying mechanisms and possible therapeutic approach to prevent neuronal damage has not been attempted yet. Therefore, the present study aimed to investigate the role of Tualang honey on medial prefrontal cortical neuronal morphology and cholinergic markers such as acetylcholine (ACh) and acetylcholinesterase (AChE) following exposure to normobaric hypoxia in rats. Material and methods: Adult male Sprague-Dawley rats were divided into four groups: (i) sucrose treated non-hypoxia, (ii) sucrose treated hypoxia, (iii) Tualang honey treated non-hypoxia and (iv)Tualang honey treated hypoxia. Rats received sucrose (1 mL of 7.9%) and Tualang honey (0.2 g/kg), respectively, for 2 weeks prior to hypoxia exposure. Morphological study was performed by using Nissl staining and cholinergic markers were estimated by ELISA technique. Results and discussion: Sucrose treated hypoxia group showed significantly lower mean ACh and higher mean AChE concentrations (P<0.05) compared to sucrose and honey treated non-hypoxia groups. Interestingly, mean ACh concentration was significantly increased and mean AChE concentration was significantly decreased in Tualang honey treated hypoxic rats compared to sucrose treated hypoxic rats. Morphological data showed that hypoxia caused neuronal damage in mPFC in sucrose treated hypoxia group whereas Tualang honey treated hypoxia group significantly prevent neuronal damage. Conclusion: Tualang honey protects hypoxia-induced mPFC neuronal damage through improvement of the brain cholinergic markers in male rats exposed to normobaric hypoxia.	[Qaid, Entesar Yaseen Abdo; Zakaria, Rahimah] Univ Sains Malaysia, Dept Physiol, George Town 11800, Malaysia; [Yusof, Nurul Aiman Mohd] Univ Sains Malaysia, Dept Anat, George Town 11800, Malaysia; [Sulaiman, Shaida Fariza] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia; [Shafin, Nazlahshaniza; Ahmad, Asma Hayati] Minist Hlth, Dept Physiol, Muscat, Oman; [Othman, Zahiruddin] Minist Hlth, Dept Psychiat, Muscat, Oman; [Al-Rahbi, Badryia] Minist Hlth, Inst Hlth Sci, Muscat, Oman; [Muthuraju, Sangu] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Malaysia		Zakaria, R (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Physiol, Kubang Kerian 16150, Kelantan, Malaysia.	rahimah@usm.my	Shafin, Nazlahshaniza/D-4606-2016; Othman, Zahiruddin/E-3914-2012	Shafin, Nazlahshaniza/0000-0002-8524-1852; QAID, ENTESAR YASEEN ABDO/0000-0002-0823-996X; Othman, Zahiruddin/0000-0002-9070-2078	USM Short-term Grant [304/PPSP/61313086]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research received funding from USM Short-term Grant (304/PPSP/61313086).	Al-Rahbi B., 2014, International Journal of Applied Research in Natural Products, V7, P28; Al-Rahbi Badriya, 2014, Int Sch Res Notices, V2014, P521065, DOI 10.1155/2014/521065; Al-Rahbi B, 2014, ACTA HISTOCHEM, V116, P79, DOI 10.1016/j.acthis.2013.05.004; Al-Rahbi B, 2014, SCI WORLD J, DOI 10.1155/2014/310821; Azman KF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1549158; Bashkaran K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-90; Brockmann MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083074; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Colgin LL, 2011, CURR OPIN NEUROBIOL, V21, P467, DOI 10.1016/j.conb.2011.04.006; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Farovik A, 2008, J NEUROSCI, V28, P13428, DOI 10.1523/JNEUROSCI.3662-08.2008; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; FREEMAN GB, 1986, J NEUROCHEM, V47, P1924, DOI 10.1111/j.1471-4159.1986.tb13109.x; FREEMAN GB, 1987, NEUROCHEM RES, V12, P1019, DOI 10.1007/BF00970931; GIBSON GE, 1988, NEUROCHEM RES, V13, P9, DOI 10.1007/BF00971849; GIBSON GE, 1981, J NEUROCHEM, V36, P28, DOI 10.1111/j.1471-4159.1981.tb02373.x; GIBSON GE, 1976, J NEUROCHEM, V27, P37, DOI 10.1111/j.1471-4159.1976.tb01540.x; GIBSON GE, 1988, NEUROCHEM RES, V13, P329, DOI 10.1007/BF00972482; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HEITKAMP K, 1986, Z LEBENSM UNTERS FOR, V182, P279, DOI 10.1007/BF01027625; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitsushima D, 2008, ENDOCRINOLOGY, V149, P802, DOI 10.1210/en.2007-0827; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; Muthuraju S, 2009, BEHAV BRAIN RES, V203, P1, DOI 10.1016/j.bbr.2009.03.026; NINOMIYA H, 1988, J NEUROCHEM, V51, P1111, DOI 10.1111/j.1471-4159.1988.tb03075.x; Othman Zahiruddin, 2015, Med Sci (Basel), V3, P3, DOI 10.3390/medsci3020003; Passetti F, 2002, CEREB CORTEX, V12, P1254, DOI 10.1093/cercor/12.12.1254; PASTUSZKO A, 1982, J NEUROCHEM, V38, P1657, DOI 10.1111/j.1471-4159.1982.tb06647.x; PETERSON C, 1982, J PHARMACOL EXP THER, V222, P576; Rahman MM, 2014, EVID-BASED COMPL ALT, V2014, DOI [10.1155/2014/958721, 10.1155/2014/190342]; Rossi MA, 2012, J NEUROPHYSIOL, V108, P1211, DOI 10.1152/jn.01060.2011; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; Row BW, 2007, BEHAV BRAIN RES, V177, P308, DOI 10.1016/j.bbr.2006.11.028; Row BW, 2003, AM J RESP CRIT CARE, V167, P1548, DOI 10.1164/rccm.200209-1050OC; Sairazi NSM, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1534-x; Schwindel CD, 2011, PROG BRAIN RES, V193, P163, DOI 10.1016/B978-0-444-53839-0.00011-9; Shafin N., 2014, J BIOCH PHARM RES, V2, P110; SHUKITTHALE B, 1993, BRAIN RES, V621, P291, DOI 10.1016/0006-8993(93)90118-7; SILVERSTEIN FS, 1986, J NEUROCHEM, V47, P1614, DOI 10.1111/j.1471-4159.1986.tb00803.x; Small DH, 1996, NEUROCHEM INT, V28, P453, DOI 10.1016/0197-0186(95)00099-2; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tan HT, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-34; Tang SP, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4605782; Totah NKB, 2009, J NEUROSCI, V29, P6418, DOI 10.1523/JNEUROSCI.1142-09.2009; Treadway MT, 2015, BIOL PSYCHIAT, V77, P285, DOI 10.1016/j.biopsych.2014.06.018; Tronel S, 2003, J NEUROSCI, V23, P5472; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wallace M, 2006, BRAIN RES, V1126, P176, DOI 10.1016/j.brainres.2006.07.064; ZAKUT H, 1992, MUTAT RES, V276, P275, DOI 10.1016/0165-1110(92)90013-Y; Zhang XJ, 2002, CELL DEATH DIFFER, V9, P790, DOI 10.1038/sj.cdd.4401034	55	1	1	0	0	IBN SINA TRUST	DHAKA	1-1B KALLYANPUR, MIRPUR RD, DHAKA, 1216, BANGLADESH	2223-4721	2076-0299		BANGLADESH J MED SCI	Bangladesh J. Med. Sci.	JAN	2021	20	1					122	129		10.3329/bjms.v20i1.50356			8	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	PO2OQ	WOS:000605009400019		gold			2022-02-06	
J	Rizzone, KH; Ackerman, KE				Rizzone, Katherine H.; Ackerman, Kathryn E.			Female Athlete and Sports-Related Concussions	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Female athlete; Injury epidemiology; Gender disparity	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SEX-DIFFERENCES; HIGH-SCHOOL; GENDER-DIFFERENCES; UNITED-STATES; HEAD-INJURY; BASE-LINE; EPIDEMIOLOGY; SYMPTOMS		[Rizzone, Katherine H.] Univ Rochester, Med Ctr, Orthopaed & Pediat, 601 Elmwood Ave Box 665, Rochester, NY 14642 USA; [Ackerman, Kathryn E.] Harvard Med Sch, Boston Childrens Hosp, Massachusetts Gen Hosp, Med,Sports Med, 319 Longwood Ave 6th Floor, Boston, MA 02115 USA		Rizzone, KH (corresponding author), Univ Rochester, Med Ctr, Orthopaed & Pediat, 601 Elmwood Ave Box 665, Rochester, NY 14642 USA.	katherine_rizzone@urmc.rochester.edu			American Medical Society of Sports Medicine	The author, K.H. Rizzone, do not have any commercial or financial conflicts of interest. I have a grant funded by the American Medical Society of Sports Medicine. The author, K.E. Ackerman, do not have any commercial or financial conflicts of interest. I have received grant funding from the National Institutes of Health, the Department of Defense, the American Medical Society of Sports Medicine, the American College of Sports Medicine, and the International Olympic Committee.	[Anonymous], 2019, FREE MOVEMENT RULE C; Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Associations N.F.o.S.H.S., 2018, HIGH SCH SPORTS PART; Balestrini CS, 2021, CLIN J SPORT MED, V31, P257, DOI 10.1097/JSM.0000000000000734; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bloom GA, 2008, EUR J SPORT SCI, V8, P295, DOI 10.1080/17461390802251836; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bull JR, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0152-7; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Cain KL, 2015, PEDIATRICS, V135, P1066, DOI 10.1542/peds.2014-2415; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Clair R, 2020, APPL NEUROPSYCH-CHIL, V9, P206, DOI 10.1080/21622965.2018.1556102; Clark JF, 2017, MED HYPOTHESES, V100, P10, DOI 10.1016/j.mehy.2016.12.016; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cooley CN, 2019, AM J EMERG MED, V37, P199, DOI 10.1016/j.ajem.2018.05.011; Covassin T, 2010, NEUROL NEUROSURG PSY, V81; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Currie DW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2447; Cusimano MD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00492; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Eme R, 2013, PRACTITIONER SCHOLAR, V2, P43; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Esposito G, 1996, J NUCL MED, V37, P559; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Gauvin-Lepage J, 2019, J HEAD TRAUMA REHAB, V34, P96, DOI 10.1097/HTR.0000000000000402; Green L., 2019, IMPACT COMPETITIVE C; Guo D, 2017, CLIN J SPORT MED, P1; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell DR, 2019, J NEUROSURG-PEDIATR, V24, P54, DOI 10.3171/2018.11.PEDS18626; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; La Fountaine MF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00691; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McGuine T, 2020, BRIT J SPORT MED, V54, P408, DOI 10.1136/bjsports-2018-100238; McIntyre Lauren, 2016, J Dance Med Sci, V20, P79, DOI 10.12678/1089-313X.20.2.79; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mormile MEE, 2018, J SPORT REHABIL, V27, P16, DOI 10.1123/jsr.2016-0140; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; O'Kane JW, 2011, CLIN J SPORT MED, V21, P486, DOI 10.1097/JSM.0b013e31822e89a8; Putukian M, 2014, CURR SPORT MED REP, V13, P334, DOI 10.1249/JSR.0000000000000092; Rhea C, 2019, ATHL TRAIN SPORTS HL, V11, P224; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rubin TG, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519844020; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Senne J., 2016, SPORT J, V21; Shields BJ, 2009, J ATHL TRAINING, V44, P586, DOI 10.4085/1062-6050-44.6.586; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; Statista, 2019, NUMB PART US HIGH SC; Stein Cynthia J, 2014, J Dance Med Sci, V18, P53, DOI 10.12678/1089-313X.18.2.53; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Sullivan Lindsay, 2018, Int J Adolesc Med Health, V33, DOI 10.1515/ijamh-2018-0031; Tamura K, 2020, J ATHL TRAINING, V55, P6, DOI 10.4085/1062-6050-452-18; Thibeault CM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00590; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Vassallo AJ, 2017, MED PROBL PERFORM AR, V32, P170, DOI 10.21091/mppa.2017.3028; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Willer BS, 2019, ARCH PHYS MED REHAB, V100, P2267, DOI 10.1016/j.apmr.2019.07.003; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	86	1	1	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					133	145		10.1016/j.csm.2020.08.006			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PE8NO	WOS:000598618400012	33187604				2022-02-06	
J	Rutter, B; Song, HL; DePalma, RG; Hubler, G; Cui, JK; Gu, ZZ; Johnson, CE				Rutter, Barbara; Song, Hailong; DePalma, Ralph G.; Hubler, Graham; Cui, Jiankun; Gu, Zezong; Johnson, Catherine E.			Shock Wave Physics as Related to Primary Non-Impact Blast-Induced Traumatic Brain Injury	MILITARY MEDICINE			English	Article								Introduction: Blast overpressure exposure, an important cause of traumatic brain injury (TBI), may occur during combat or military training. TBI, most commonly mild TBI, is considered a signature injury of recent combat in Iraq and Afghanistan. Low intensity primary blast-induced TBI (bTBI), caused by exposure to an explosive shock wave, commonly leaves no obvious physical external signs. Numerous studies have been conducted to understand its biological effects; however, the role of shock wave energy as related to bTBI remains poorly understood. This report combines shock wave analysis with established biological effects on the mouse brain to provide insights into the effects of shock wave physics as related to low intensity bTBI outcomes from both open-air and shock tube environments. Methods: Shock wave peak pressure, rise time, positive phase duration, impulse, shock velocity, and particle velocity were measured using the Missouri open-air blast model from 16 blast experiments totaling 122 mice to quantify physical shock wave properties. Open-air shock waves were generated by detonating 350-g 1-m suspended Composition C-4 charges with targets on 1-m elevated stands at 2.15, 3, 4, and 7 m from the source. Results: All mice sustained brain injury with no observable head movement, because of mice experiencing lower dynamic pressures than calculated in shock tubes. Impulse, pressure loading over time, was found to be directly related to bTBI severity and is a primary shock physics variable that relates to bTBI. Discussion: The physical blast properties including shock wave peak pressure, rise time, positive phase duration, impulse, shock velocity, and particle velocity were examined using the Missouri open-air blast model in mice with associated neurobehavioral deficits. The blast-exposed mice sustained ultrastructural abnormalities in mitochondria, myelinated axons, and synapses, implicating that primary low intensity blast leads to nanoscale brain damage by providing the link to its pathogenesis. The velocity of the shock wave reflected back from the target stand was calculated from high-speed video and compared with that of the incident shock wave velocity. Peak incident pressure measured from high sample rate sensors was found to be within 1% of the velocity recorded by the high-speed camera, concluding that using sensors in or close to an animal brain can provide useful information regarding shock velocity within the brain, leading to more advanced knowledge between shock wave physics and tissue damage that leads to bTBIs.	[Rutter, Barbara; Johnson, Catherine E.] Missouri Univ Sci & Technol, Dept Min & Nucl Engn, Rolla, MO 65401 USA; [Song, Hailong; Hubler, Graham; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [DePalma, Ralph G.] US Dept Vet Affairs, Off Res & Dev, Washington, DC 20420 USA; [DePalma, Ralph G.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Cui, Jiankun; Gu, Zezong] Truman VA Hosp Res Serv, Columbia, MO 65201 USA		Rutter, B (corresponding author), Missouri Univ Sci & Technol, Dept Min & Nucl Engn, Rolla, MO 65401 USA.		Song, Hailong/I-9418-2018	Song, Hailong/0000-0002-4204-6459	DoD Congressionally Directed Medical Research Programs (CDMRP) [AZ140109]; Department of Pathology and Anatomical Sciences from the University of Missouri School of Medicine; Veterans Affairs Office of Research and Development BLRD	This publication was made possible in part by funding from the DoD Congressionally Directed Medical Research Programs (CDMRP) for the Peer Reviewed Alzheimer's Research Program Convergence Science Research Award (PRARP-CSRA; AZ140109), the research funds from Department of Pathology and Anatomical Sciences from the University of Missouri School of Medicine (ZG) and Veterans Affairs Office of Research and Development BLR&D.	Arakeri JH, 2004, PHYS FLUIDS, V16, P1008, DOI 10.1063/1.1649339; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chen M, 2018, J ALZHEIMERS DIS, V66, P751, DOI 10.3233/JAD-180726; Cooper PW., 1996, EXPLOSIVES ENG; Defense and Veterans Brain Injury Center, DOD NUMBERS TRAUMATI; Dewey JM, 2016, SHOCK WAVE SCI TECHN, V9, P53, DOI 10.1007/978-3-319-23745-9_2; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Johnson C, 2018, AIP CONF PROC, V1979, DOI 10.1063/1.5044977; Kingery CN., UNSAFERGUARD KINGERY; Kleinschmit NN, 2011, THESIS U NEBRASK LIN; Konan LM, 2019, J NEUROTRAUM, V36, P2117, DOI 10.1089/neu.2018.6260; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Langenderfer M, 2019, 45 ANN C EXPL BLAST, P1; Mayo Clinic, 2018, TRAUMATIC BRAIN INJU; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; MTS Systems Corporation, 137B23B QUARTZ FREE; Needham CE., 2018, BLAST WAVES; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rutter B, 2017, 44 ANN C EXPL BLAST; Rutter B., 2019, THESIS MISSOURI U SC; Song HL, 2019, J NEUROTRAUM, V36, P1591, DOI 10.1089/neu.2018.6114; Song HL, 2018, NEURAL REGEN RES, V13, P1516, DOI 10.4103/1673-5374.237110; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Swisdak MM., 1975, NSWCWOLTR 75 116; Wang HX, 2016, J NEUROPATH EXP NEUR, V75, P183, DOI 10.1093/jnen/nlv019; Westrol MS, 2017, ANN EMERG MED, V69, pS4, DOI 10.1016/j.annemergmed.2016.09.005; Wortman JD, 1982, AD A123247; Zhu F, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500656	33	1	1	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			601	609		10.1093/milmed/usaa290			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600086	33499439	Bronze			2022-02-06	
J	Sackheim, AM; Villalba, N; Sancho, M; Harraz, OF; Bonev, AD; D'Alessandro, A; Nemkov, T; Nelson, MT; Freeman, K				Sackheim, Adrian M.; Villalba, Nuria; Sancho, Maria; Harraz, Osama F.; Bonev, Adrian D.; D'Alessandro, Angelo; Nemkov, Travis; Nelson, Mark T.; Freeman, Kalev			Traumatic Brain Injury Impairs Systemic Vascular Function through Disruption of Inward-Rectifier Potassium Channels	FUNCTION			English	Article						traumatic brain injury; vascular endothelium; ion channels; metabolopathy	SMOOTH-MUSCLE; LIPID-PEROXIDATION; PHOSPHOLIPASE A(2); ARACHIDONIC-ACID; CELL-DAMAGE; K+ CHANNELS; METABOLOMICS; DYSFUNCTION; ACTIVATION; HISTONES	Trauma can lead to widespread vascular dysfunction, but the underlying mechanisms remain largely unknown. Inward-rectifier potassium channels (Kir2.1) play a critical role in the dynamic regulation of regional perfusion and blood flow. Kir2.1 channel activity requires phosphatidylinositol 4,5-bisphosphate (PIP2), a membrane phospholipid that is degraded by phospholipase A(2) (PLA(2)) in conditions of oxidative stress or inflammation. We hypothesized that PLA(2)-induced depletion of PIP2 after trauma impairs Kir2.1 channel function. A fluid percussion injury model of traumatic brain injury (TBI) in rats was used to study mesenteric resistance arteries 24 h after injury. The functional responses of intact arteries were assessed using pressure myography. We analyzed circulating PLA(2), hydrogen peroxide (H2O2), and metabolites to identify alterations in signaling pathways associated with PIP2 in TBI. Electrophysiology analysis of freshly-isolated endothelial and smooth muscle cells revealed a significant reduction of Ba2+-sensitive Kir2.1 currents after TBI. Additionally, dilations to elevated extracellular potassium and BaCl2- or ML 133-induced constrictions in pressurized arteries were significantly decreased following TBI, consistent with an impairment of Kir2.1 channel function. The addition of a PIP2 analog to the patch pipette successfully rescued endothelial Kir2.1 currents after TBI. Both H2O2 and PLA(2) activity were increased after injury. Metabolomics analysis demonstrated altered lipid metabolismsignaling pathways, including increased arachidonic acid, and fatty acid mobilization after TBI. Our findings support a model in which increased H2O2-induced PLA(2) activity after trauma hydrolyzes endothelial PIP2, resulting in impaired Kir2.1 channel function.	[Sackheim, Adrian M.; Villalba, Nuria; Freeman, Kalev] Univ Vermont, Dept Surg, Larner Coll Med, Burlington, VT 05405 USA; [Sancho, Maria; Harraz, Osama F.; Bonev, Adrian D.; Nelson, Mark T.; Freeman, Kalev] Univ Vermont, Dept Pharmacol, Larner Coll Med, Burlington, VT 05405 USA; [D'Alessandro, Angelo] Univ Colorado, Dept Surg, Sch Med, Aurora, CO USA; [D'Alessandro, Angelo; Nemkov, Travis] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO USA; [Nelson, Mark T.] Univ Manchester, Div Cardiovasc Sci, Manchester, Lancs, England		Freeman, K (corresponding author), Univ Vermont, Dept Surg, Larner Coll Med, Burlington, VT 05405 USA.; Freeman, K (corresponding author), Univ Vermont, Dept Pharmacol, Larner Coll Med, Burlington, VT 05405 USA.	kalev.freeman@uvm.edu	D'Alessandro, Angelo/AAA-4695-2019; Harraz, Osama/C-8841-2011	D'Alessandro, Angelo/0000-0002-2258-6490; Harraz, Osama/0000-0003-2061-1100	American Heart AssociationAmerican Heart Association [17POST33650030, 20CDA35310097]; Department of Defense Henry M. Jackson Foundation for the Advancement of Military Medicine [HU001-18-2-0016]; EC Horizon 2020 Foundation Leducq; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM135007, R01GM123010, UM1 HL120877, R35HL140027, R01NS110656]; Totman Medical Research Trust	This work was supported by the American Heart Association (17POST33650030 and 20CDA35310097), the Department of Defense Henry M. Jackson Foundation for the Advancement of Military Medicine (HU001-18-2-0016), EC Horizon 2020 Foundation Leducq, and the National Institutes of Health (P20GM135007, R01GM123010, UM1 HL120877, R35HL140027, and R01NS110656), and the Totman Medical Research Trust.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Ahn SJ, 2017, J PHYSIOL-LONDON, V595, P2339, DOI 10.1113/JP273255; Alhamdi Y, 2016, CRIT CARE MED, V44, pE278, DOI 10.1097/CCM.0000000000001413; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; Armstead WM, 1998, AM J PHYSIOL-HEART C, V274, pH1674, DOI 10.1152/ajpheart.1998.274.5.H1674; Armstead WM, 1997, BRAIN RES, V768, P177, DOI 10.1016/S0006-8993(97)00641-0; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; BOYER CS, 1995, BIOCHEM PHARMACOL, V50, P753, DOI 10.1016/0006-2952(95)00195-6; Bradley KK, 1999, J PHYSIOL-LONDON, V515, P639, DOI 10.1111/j.1469-7793.1999.639ab.x; Chen H, 2018, AM J PHYSIOL-HEART C, V314, pH681, DOI 10.1152/ajpheart.00314.2017; Chrissobolis S, 2003, CURR DRUG TARGETS, V4, P281, DOI 10.2174/1389450033491046; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Climent B, 2011, BIOCHEM BIOPH RES CO, V410, P501, DOI 10.1016/j.bbrc.2011.06.011; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; Colston JT, 2005, FEBS LETT, V579, P2533, DOI 10.1016/j.febslet.2005.03.057; Crane GJ, 2003, J VASC RES, V40, P159, DOI 10.1159/000070713; Dan P, 1996, FEBS LETT, V383, P75, DOI 10.1016/0014-5793(96)00227-X; Ekaney ML, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0543-8; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Fattahi F, 2015, IMMUNOL RES, V61, P177, DOI 10.1007/s12026-015-8628-2; Filkin SY, 2020, BIOCHEMISTRY-MOSCOW+, V85, P177, DOI 10.1134/S0006297920140096; GINSBURG I, 1993, INFLAMMATION, V17, P295, DOI 10.1007/BF00918992; GOLDMAN R, 1992, FEBS LETT, V309, P190, DOI 10.1016/0014-5793(92)81092-Z; Haley MJ, 2020, TRANSL STROKE RES, V11, P837, DOI 10.1007/s12975-019-00763-2; Hansen SB, 2015, BBA-MOL CELL BIOL L, V1851, P620, DOI 10.1016/j.bbalip.2015.01.011; Harraz OF, 2020, P NATL ACAD SCI USA, V117, P20378, DOI 10.1073/pnas.2006737117; Harraz OF, 2018, P NATL ACAD SCI USA, V115, pE3569, DOI 10.1073/pnas.1800201115; Heron Melonie, 2019, Natl Vital Stat Rep, V68, P1; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; Homayoun P, 1997, J NEUROCHEM, V69, P199; Horton JW, 2003, TOXICOLOGY, V189, P75, DOI 10.1016/S0300-483X(03)00154-9; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Longden TA, 2015, MICROCIRCULATION, V22, P183, DOI 10.1111/micc.12190; Marrelli SP, 1998, STROKE, V29, P1469, DOI 10.1161/01.STR.29.7.1469; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mughal A, 2020, J CEREBR BLOOD F MET, DOI [10.1177/0271678X20962594, DOI 10.1177/0271678X20962594]; Nemkov T, 2019, METHODS MOL BIOL, V1978, P13, DOI 10.1007/978-1-4939-9236-2_2; Nemkov T, 2017, RAPID COMMUN MASS SP, V31, P663, DOI 10.1002/rcm.7834; Parihar A, 2008, BURNS, V34, P6, DOI 10.1016/j.burns.2007.04.009; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Polson D, 2018, REDOX REP, V23, P125, DOI 10.1080/13510002.2018.1456000; Povlsen GK, 2016, J CEREBR BLOOD F MET, V36, P1195, DOI 10.1177/0271678X16638350; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Rodriguez EG, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0565-3; Russell RT, 2018, SHOCK, V49, P44, DOI 10.1097/SHK.0000000000000902; Slaughter AL, 2018, SHOCK, V49, P580, DOI 10.1097/SHK.0000000000000948; Smith PD, 2008, J PHYSIOL-LONDON, V586, P1147, DOI 10.1113/jphysiol.2007.145474; Sonkusare SK, 2016, J PHYSIOL-LONDON, V594, P3271, DOI 10.1113/JP271652; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu F, 2020, SHOCK, V53, P575, DOI 10.1097/SHK.0000000000001378; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zeerleder S, 2012, CRIT CARE MED, V40, P3224, DOI 10.1097/CCM.0b013e318265695f	60	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2633-8823		FUNCTION	Function		2021	2	3							zqab018	10.1093/function/zqab018			11	Cell Biology; Physiology	Emerging Sources Citation Index (ESCI)	Cell Biology; Physiology	XV4DP	WOS:000734894700005	34568829	Green Accepted, gold			2022-02-06	
J	Safar, K; Zhang, J; Emami, Z; Gharehgazlou, A; Ibrahim, G; Dunkley, BT				Safar, Kristina; Zhang, Jing; Emami, Zahra; Gharehgazlou, Avideh; Ibrahim, George; Dunkley, Benjamin T.			Mild traumatic brain injury is associated with dysregulated neural network functioning in children and adolescents	BRAIN COMMUNICATIONS			English	Article						mild traumatic brain injury; functional connectivity; magnetoencephalography; machine learning classification; children	POST-CONCUSSIVE SYMPTOMS; RESTING-STATE; DELTA WAVES; CORTICAL EXCITABILITY; IMAGING APPROACH; UNITED-STATES; HEAD-INJURY; CONNECTIVITY; MEG; MAGNETOENCEPHALOGRAPHY	Mild traumatic brain injury is highly prevalent in paediatric populations, and can result in chronic physical, cognitive and emotional impairment, known as persistent post-concussive symptoms. Magnetoencephalography has been used to investigate neurophysiological dysregulation in mild traumatic brain injury in adults; however, whether neural dysrhythmia persists in chronic mild traumatic brain injury in children and adolescents is largely unknown. We predicted that children and adolescents would show similar dysfunction as adults, including pathological slow-wave oscillations and maladaptive, frequency-specific, alterations to neural connectivity. Using magnetoencephalography, we investigated regional oscillatory power and distributed brain-wide networks in a cross-sectional sample of children and adolescents in the chronic stages of mild traumatic brain injury. Additionally, we used a machine learning pipeline to identify the most relevant magnetoencephalography features for classifying mild traumatic brain injury and to test the relative classification performance of regional power versus functional coupling. Results revealed that the majority of participants with chronic mild traumatic brain injury reported persistent post-concussive symptoms. For neurophysiological imaging, we found increased regional power in the delta band in chronic mild traumatic brain injury, predominantly in bilateral occipital cortices and in the right inferior temporal gyms. Those with chronic mild traumatic brain injury also showed dysregulated neuronal coupling, including decreased connectivity in the delta range, as well as hyper-connectivity in the theta, low gamma and high gamma bands, primarily involving frontal, temporal and occipital brain areas. Furthermore, our multivariate classification approach combined with functional connectivity data outperformed regional power in terms of between-group classification accuracy. For the first time, we establish that local and large-scale neural activity are altered in youth in the chronic phase of mild traumatic brain injury, with the majority presenting persistent post-concussive symptoms, and that dysregulated interregional neural communication is a reliable marker of lingering paediatric 'mild' traumatic brain injury.	[Safar, Kristina; Zhang, Jing; Emami, Zahra; Gharehgazlou, Avideh; Ibrahim, George; Dunkley, Benjamin T.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 0A4, Canada; [Safar, Kristina; Zhang, Jing; Emami, Zahra; Gharehgazlou, Avideh; Ibrahim, George; Dunkley, Benjamin T.] SickKids Res Inst, Neurosci & Mental Hlth, Toronto, ON M5G 0A4, Canada; [Gharehgazlou, Avideh] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Ibrahim, George] Univ Toronto, Dept Surg, Toronto, ON M5T 1P5, Canada; [Ibrahim, George] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Dunkley, Benjamin T.] Univ Toronto, Dept Med Imaging, Toronto, ON M5T 1W7, Canada		Safar, K (corresponding author), Hosp Sick Children, Dept Diagnost Imaging, Peter Gilgan Ctr Res & Learning, 686 Bay St, Toronto, ON M5G 0A4, Canada.	kristina.safar@sickkids.ca			Hospital for Sick Children Foundation; Centre for Brain and Mental Health `Chase an Idea' Grant; Brain Canada; Restracomp funding award	This study was funded by the Hospital for Sick Children Foundation and Centre for Brain and Mental Health `Chase an Idea' Grant, Brain Canada and Restracomp funding award.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Antonakakis M, 2020, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00090; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cabral J, 2014, PROG NEUROBIOL, V114, P102, DOI 10.1016/j.pneurobio.2013.12.005; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Colclough GL, 2015, NEUROIMAGE, V117, P439, DOI 10.1016/j.neuroimage.2015.03.071; Comte M, 2018, SOC COGN AFFECT NEUR, V13, P381, DOI 10.1093/scan/nsx083; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Deco G, 2017, NEUROIMAGE, V152, P538, DOI 10.1016/j.neuroimage.2017.03.023; Dimitriadis SI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00506; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Douw L, 2018, HUM BRAIN MAPP, V39, P104, DOI 10.1002/hbm.23827; Dunkley BT, 2015, NEUROIMAGE-CLIN, V6, P140; Dunkley BT., 2015, FRONT PSYCHIATRY, V7, P611; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Ghandour H, 2018, EMERG MED INVESTIG, V2, P175; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Huang MX, 2020, J NEUROTRAUM, V37, P994, DOI 10.1089/neu.2019.6417; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hunt BAE, 2019, NETW NEUROSCI, V3, P497, DOI 10.1162/netn_a_00077; Ju YE, 2017, BRAIN, V140, P2104, DOI 10.1093/brain/awx148; Kaltiainen H, 2019, J NEUROTRAUM, V36, P2222, DOI 10.1089/neu.2018.6306; Kaltiainen H, 2018, BRAIN TOPOGR, V31, P1037, DOI 10.1007/s10548-018-0667-2; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; King R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00451; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Leung RC, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-51; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Liu ZM, 2012, NEUROIMAGE, V63, P1060, DOI 10.1016/j.neuroimage.2012.08.025; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Messaritaki E, 2017, NEUROIMAGE, V159, P302, DOI 10.1016/j.neuroimage.2017.07.038; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Morawska MM, 2016, J NEUROSCI, V36, P3422, DOI 10.1523/JNEUROSCI.3274-15.2016; O'Neill GC, 2015, PHYS MED BIOL, V60, pR271, DOI 10.1088/0031-9155/60/21/R271; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2018, NEUROIMAGE, V173, P632, DOI 10.1016/j.neuroimage.2018.02.032; Patle A, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCES IN TECHNOLOGY AND ENGINEERING (ICATE); Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Safar K, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00408; Schaul N, 1998, ELECTROEN CLIN NEURO, V106, P101, DOI 10.1016/S0013-4694(97)00111-9; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Smieja DA, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116455; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stevenson CM, 2011, HUM BRAIN MAPP, V32, P182, DOI 10.1002/hbm.21016; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Tokariev A, 2019, CEREB CORTEX, V29, P814, DOI 10.1093/cercor/bhy012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vakorin VA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004914; Valdes-Hernandez PA, 2010, NEUROIMAGE, V49, P2328, DOI 10.1016/j.neuroimage.2009.10.030; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zhang J, 2016, NEURAL PLAST, V2016, P1; Zhang J, 2020, SCI REP-UK, V10, P10; Zhang J, 2020, J NEUROPHYSIOL, V124, P1948, DOI 10.1152/jn.00333.2020; Zhang J, 2016, J INTEGR BIOINFORMAT, V13, DOI 10.2390/biecoll-jib-2016-306; Zhang WH, 2020, J RES ADOLESCENCE, V30, P334, DOI 10.1111/jora.12527	93	1	1	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2021	3	2							fcab044	10.1093/braincomms/fcab044			16	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	TA5UJ	WOS:000667313900003	34095832	gold, Green Published			2022-02-06	
J	Santiago-Castaneda, C; Segovia-Oropeza, M; Concha, L; Orozco-Suarez, SA; Rocha, L				Santiago-Castaneda, Cindy; Segovia-Oropeza, Marysol; Concha, Luis; Adela Orozco-Suarez, Sandra; Rocha, Luisa			Propylparaben Reduces the Long-Term Consequences in Hippocampus Induced by Traumatic Brain Injury in Rats: Its Implications as Therapeutic Strategy to Prevent Neurodegenerative Diseases	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; brain trauma; hippocampus; neuroprotection; propylparaben	DIFFUSE AXONAL INJURY; MOUSE MODEL; GLUTAMATE RELEASE; OXIDATIVE STRESS; PROPYL PARABEN; RECEPTOR; CELLS; BETA; METHYLPARABEN; ACTIVATION	Background: Severe traumatic brain injury (TBI), an important risk factor for Alzheimer's disease, induces long-term hippocampal damage and hyperexcitability. On the other hand, studies support that propylparaben (PPB) induces hippocampal neuroprotection in neurodegenerative diseases. Objective: Experiments were designed to evaluate the effects of subchronic treatment with PPB on TBI-induced changes in the hippocampus of rats. Methods: Severe TBI was induced using the lateral fluid percussion model. Subsequently, rats received subchronic administration with PPB (178 mg/kg, TBI+PPB) or vehicle (TBI+PEG) daily for 5 days. The following changes were examined during the experimental procedure: sensorimotor dysfunction, changes in hippocampal excitability, as well as neuronal damage and volume. Results: TBI+PEG group showed sensorimotor dysfunction (p <0.001), hyperexcitability (64.2%, p <0.001), and low neuronal preservation ipsi- and contralateral to the trauma. Magnetic resonance imaging (MRI) analysis revealed lower volume (17.2%; p <0.01) and great damage to the ipsilateral hippocampus. TBI+PPB group showed sensorimotor dysfunction that was partially reversed 30 days after trauma. This group showed hippocampal excitability and neuronal preservation similar to the control group. However, MRI analysis revealed lower hippocampal volume (p < 0.05) when compared with the control group. Conclusion: The present study confirms that post-TBI subchronic administration with PPB reduces the long-term consequences of trauma in the hippocampus. Implications of PPB as a neuroprotective strategy to prevent the development of Alzheimer's disease as consequence of TBI are discussed.	[Santiago-Castaneda, Cindy; Segovia-Oropeza, Marysol; Rocha, Luisa] Ctr Res & Adv Studies CINVESTAV, Dept Pharmacobiol, Mexico City, DF, Mexico; [Concha, Luis] Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico; [Adela Orozco-Suarez, Sandra] Natl Med Ctr SXXI CMN SXXI, Specialties Hosp, Unit Med Res Neurol Dis, Mexico City, DF, Mexico		Rocha, L (corresponding author), Ctr Res & Adv Studies, Pharmacobiol Dept, Calz Tenorios 235, Mexico City 14330, DF, Mexico.	lrocha@cinvestav.mx			National Council for Sciences and Technology of Mexico (CONACYT Scholarship) [615621 CSC]; Research Coordination of IMSS research coordination [99097560]	The authors acknowledge the technical assistance of Mrs. Carmen Baltazar Cortez during the histology procedures and Dr. Juan Ortiz during the MRI experiments. This study was supported by the National Council for Sciences and Technology of Mexico (CONACYT Scholarship number 615621 CSC) and the Research Coordination of IMSS research coordination (Scholarship number 99097560).	[Anonymous], 1999, ELECT MED COMPENDIUM; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Brito-Moreira J, 2011, CURR ALZHEIMER RES, V8, P552, DOI 10.2174/156720511796391917; Carron SF., 2019, J COMP NEUROL, V24, P746; Cassano T, 2016, CURR ALZHEIMER RES, V13, P185, DOI 10.2174/1567205013666151218132725; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Edwards G, 2019, J NEUROTRAUM, DOI 10.1089/neu.2018.6348; Ellegood J, 2010, NEUROIMAGE, V53, P1023, DOI 10.1016/j.neuroimage.2010.03.038; Santana-Gomez CE, 2018, NEUROCHEM INT, V120, P224, DOI 10.1016/j.neuint.2018.09.004; Santana-Gomez CE, 2017, NEUROTOXICOLOGY, V59, P110, DOI 10.1016/j.neuro.2017.01.009; Enrique A, 2020, BIOMED PHARMACOTHER, V128, DOI 10.1016/j.biopha.2020.110250; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geer LA, 2017, J HAZARD MATER, V323, P177, DOI 10.1016/j.jhazmat.2016.03.028; Gooijers J, 2016, BRAIN, V139, P2469, DOI 10.1093/brain/aww177; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Guo H, 2020, CURR NEUROPHARMACOL, V18, P485, DOI 10.2174/1570159X18666200123165652; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Haroon E, 2015, BRAIN BEHAV IMMUN, V46, P17, DOI 10.1016/j.bbi.2014.12.004; Irimia A, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S79174; Jain K., 2019, HDB NEUROPROTECTION, P281, DOI DOI 10.1007/978-1-4939-9465-6_4; Jellinger KA., 2001, BMC NEUROL, V1, P1; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Kopalli SR, 2013, NEUROTOXICOLOGY, V34, P25, DOI 10.1016/j.neuro.2012.10.003; Lara-Valderrabano L, 2017, EPILEPSY RES, V136, P126, DOI 10.1016/j.eplepsyres.2017.08.006; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moe HK, 2020, J NEUROSURG, V133, P1559, DOI 10.3171/2019.6.JNS191040; Mrdjen D, 2019, ACTA NEUROPATHOL, V138, P729, DOI 10.1007/s00401-019-02054-4; Myhrer T, 1998, NEUROSCI BIOBEHAV R, V23, P131, DOI 10.1016/S0149-7634(98)00039-6; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petric Z, 2021, ACTA PHARMACEUT, V71, P17, DOI 10.2478/acph-2021-0001; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pinheiro JL, 2018, J CLIN NUTR METABO, V2, P1; Pollock T, 2017, TOXICOL APPL PHARM, V325, P18, DOI 10.1016/j.taap.2017.04.001; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Routledge EJ, 1998, TOXICOL APPL PHARM, V153, P12, DOI 10.1006/taap.1998.8544; Schelman WR, 2004, MOL BRAIN RES, V128, P160, DOI 10.1016/j.molbrainres.2004.06.011; Segovia-Oropeza M, 2020, J NEUROTRAUM, V37, P2595, DOI 10.1089/neu.2019.6975; Shahrokhi N, 2012, PAK J PHARM SCI, V25, P219; Sharma B, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-1281-4; Shin MY, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.104917; Soni MG, 2001, FOOD CHEM TOXICOL, V39, P513, DOI 10.1016/S0278-6915(00)00162-9; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; SUN FY, 1995, BRAIN RES, V673, P133, DOI 10.1016/0006-8993(94)01413-C; Sun JF, 2020, CELL MOL NEUROBIOL, V40, P1405, DOI 10.1007/s10571-020-00826-1; Szelag S, 2016, TOXICOL IN VITRO, V31, P30, DOI 10.1016/j.tiv.2015.11.011; Talevi A, 2007, J COMPUT AID MOL DES, V21, P527, DOI 10.1007/s10822-007-9136-9; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wagstyl K, 2018, NEUROMETHODS, V136, P35, DOI 10.1007/978-1-4939-7647-8_3; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Wrobel AM, 2014, TOXICOL LETT, V230, P375, DOI 10.1016/j.toxlet.2014.08.012; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yushkevich PA, 2019, NEUROINFORMATICS, V17, P83, DOI 10.1007/s12021-018-9385-x; Zhao JW, 2019, PEERJ, V7, DOI 10.7717/peerj.8324; Zysk M, 2019, J ALZHEIMERS DIS, V72, P161, DOI 10.3233/JAD-190572	82	1	1	2	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2021	82			1	SI		S215	S226		10.3233/JAD-200914			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TA8FL	WOS:000667480300014	33185606				2022-02-06	
J	Sastry, RA; Pertsch, N; Tang, O; Shao, B; Toms, SA; Weil, RJ				Sastry, Rahul A.; Pertsch, Nathan; Tang, Oliver; Shao, Belinda; Toms, Steven A.; Weil, Robert J.			Frailty and Outcomes after Craniotomy or Craniectomy for Atraumatic Chronic Subdural Hematoma	WORLD NEUROSURGERY			English	Article						Complications; Geriatrics; Neurosurgery; Outcomes; Risk stratification; Traumatic brain injury	AMERICAN-COLLEGE; MANAGEMENT; NSQIP; RISK; ASSOCIATION; EVACUATION; SURGERY; TRAUMA; AGE	OBJECTIVE: Frailty is a measure of decreased physiologic reserve and has been associated with increased morbidity and mortality in a variety of surgical disciplines. No data exist regarding the relationship of frailty with adverse outcomes in craniotomy for chronic subdural evacuation. We assessed the relationship between frailty and the incidence of major postoperative complication, discharge destination other than home, 30-day readmission, and 30-day mortality after craniotomy for atraumatic subdural evacuation. METHODS: A retrospective cohort study was conducted on a population of 1647 adult patients undergoing craniotomy for evacuation of atraumatic subdural hematoma in the 2005-2018 American College of Surgeons National Surgical Quality Improvement Program database. Frailty was assessed using the modified frailty index (mFI-5). Multivariable logistic regression was performed using all covariates deemed eligible through clinical relevance and statistical significance. RESULTS: The overall rates of major complication (25.4%), discharge to destination other than home (49.8%), 30-day readmission (11.7%), and 30-day mortality (12.8%) in this analysis were high and rose with increasing frailty. In multivariable regression analyses, medium frailty (mFI5 = 2) was associated with increased odds of major complication (adjusted odds ratio [aOR] 1.64, 95% confidence interval [CI) 1.03-2.63), discharge to destination other than home (aOR 2.04, 95% CI 1.38-3.02), and 30-day mortality (aOR 2.27, 95% CI 1.08-4.78). High frailty (mFI-5 >2) was associated with increased odds of 30-day mortality (aOR 2.85, 95% Cl 1.13-7.14). CONCLUSIONS: Preoperative frailty, as determined by mFI-5, is associated with increased odds of major postoperative complication, discharge to destination other than home, and 30-day mortality after craniotomy for chronic subdural hematoma.	[Sastry, Rahul A.; Pertsch, Nathan; Tang, Oliver; Shao, Belinda; Toms, Steven A.] Brown Univ, Warren Alpert Sch Med, Dept Neurosurg, Providence, RI 02912 USA; [Weil, Robert J.] Lifespan Hlth Syst, Dept Neurosurg, Rhode Isl Hosp, Providence, RI USA		Sastry, RA (corresponding author), Brown Univ, Warren Alpert Sch Med, Dept Neurosurg, Providence, RI 02912 USA.	rsastry@lifespan.org		Pertsch, Nathan/0000-0001-9551-0123; Toms, Steven/0000-0001-8732-0522; Shao, Belinda/0000-0002-6392-0643			Adhiyaman V, 2017, QJM-INT J MED, V110, P375, DOI [10.1093/qjmed/hcw231, 10.1093/qjmed/hcx143]; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Baschera D, 2018, WORLD NEUROSURG, V116, pE983, DOI 10.1016/j.wneu.2018.05.145; Brennan Paul M, 1800, J Neurosurg, V127, P732, DOI 10.3171/2016.8.JNS16134; Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510; Chimukangara M, 2017, SURG ENDOSC, V31, P2509, DOI 10.1007/s00464-016-5253-7; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cuccolo NG, 2020, J PLAST SURG HAND SU, V54, P67, DOI 10.1080/2000656X.2019.1688166; Dohoo IR, 1997, PREV VET MED, V29, P221, DOI 10.1016/S0167-5877(96)01074-4; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dumont TM, 2013, WORLD NEUROSURG, V80, P889, DOI 10.1016/j.wneu.2012.06.026; Finnerty BM, 2020, WORLD J SURG, V44, P1876, DOI 10.1007/s00268-020-05422-4; Fiorella D, 2019, J NEUROINTERV SURG, V11, P912, DOI 10.1136/neurintsurg-2019-014730; Haron S, 2019, J CLIN NEUROSCI, V59, P47, DOI 10.1016/j.jocn.2018.11.009; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Harrell FE Jr, 2017, REGRESSION MODELING; Jones S, 1999, AGE AGEING, V28, P519, DOI 10.1093/ageing/28.6.519; Joseph B, 2017, J TRAUMA ACUTE CARE, V82, P575, DOI 10.1097/TA.0000000000001329; Joseph B, 2014, JAMA SURG, V149, P766, DOI 10.1001/jamasurg.2014.296; Khalafallah AM, 2020, J NEUROSURG, V135, P78, DOI 10.3171/2020.5.JNS20766; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Knopman J, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3737; Kwon CS, 2018, WORLD NEUROSURG, V109, pE707, DOI 10.1016/j.wneu.2017.10.058; Lakomkin N, 2020, J CLIN NEUROSCI, V75, P35, DOI 10.1016/j.jocn.2020.03.042; Link TW, 2019, NEUROSURGERY, V85, P801, DOI 10.1093/neuros/nyy521; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Morris NA, 2016, NEUROCRIT CARE, V24, P226, DOI 10.1007/s12028-015-0178-x; Motiei-Langroudi R, 2018, J NEUROSURG, V129, P1143, DOI 10.3171/2017.6.JNS17130; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Murthy SB, 2020, STROKE, V51, P1464, DOI 10.1161/STROKEAHA.119.028510; Pandit V, 2020, ANN VASC SURG, V62, P159, DOI 10.1016/j.avsg.2019.10.001; Rauhala M, 2020, J NEUROSURG, V132, P1147, DOI 10.3171/2018.12.JNS183035; Rothenberg KA, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4330; Rubinfeld Ilan, 2010, AMIA Annu Symp Proc, V2010, P777; Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Seib CD, 2018, JAMA SURG, V153, P160, DOI 10.1001/jamasurg.2017.4007; Shimizu K, 2018, GERIATR GERONTOL INT, V18, P1173, DOI 10.1111/ggi.13436; Soleman J, 2017, WORLD NEUROSURG, V107, P778, DOI 10.1016/j.wneu.2017.08.065; Subramaniam S, 2018, J AM COLL SURGEONS, V226, P173, DOI 10.1016/j.jamcollsurg.2017.11.005; Traven SA, 2019, J SHOULDER ELB SURG, V28, P1854, DOI 10.1016/j.jse.2019.03.009; Traven SA, 2019, J ARTHROPLASTY, V34, P1412, DOI 10.1016/j.arth.2019.02.060; Traven SA, 2019, J ORTHOP TRAUMA, V33, P319, DOI 10.1097/BOT.0000000000001455; Van der Veken J, 2014, ACTA NEUROCHIR, V156, P981, DOI 10.1007/s00701-014-2042-8; Velanovich V, 2018, J AM COLL SURGEONS, V226, P181, DOI 10.1016/j.jamcollsurg.2017.11.009; Yagi M, 2019, SPINE, V44, pE1083, DOI 10.1097/BRS.0000000000003063; Yang WY, 2017, NEUROSURG CLIN N AM, V28, P205, DOI 10.1016/j.nec.2016.11.002	48	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2021	145						E242	E251		10.1016/j.wneu.2020.10.022			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PH8NR	WOS:000600662600030	33065346				2022-02-06	
J	Shaheen, MJ; Bekdash, AM; Itani, HA; Borjac, JM				Shaheen, Mariam J.; Bekdash, Amira M.; Itani, Hana A.; Borjac, Jamilah M.			Saffron extract attenuates neuroinflammation in rmTBI mouse model by suppressing NLRP3 inflammasome activation via SIRT1	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; HUMAN SERUM-ALBUMIN; CROCUS-SATIVUS L.; CROCETIN; EXPRESSION; PATHWAY; SYSTEM; CAROTENOIDS; INVOLVEMENT	Traumatic brain injury (TBI) remains a major cause of morbidity and disability worldwide and a healthcare burden. TBI is an important risk factor for neurodegenerative diseases hallmarked by exacerbated neuroinflammation. Neuroinflammation in the cerebral cortex plays a critical role in secondary injury progression following TBI. The NOD-like receptors (NLR) family pyrin domain containing 3 (NLRP3) inflammasome is a key player in initiating the inflammatory response in various central nervous system disorders entailing TBI. This current study aims to investigate the role of NLRP3 in repetitive mild traumatic brain injury (rmTBI) and identify the potential neuroprotective effect of saffron extract in regulating the NLRP3 inflammasome. 24 hours following the final injury, rmTBI causes an upregulation in mRNA levels of NLRP3, caspase-1, the apoptosis-associated speck-like protein containing a CARD (ASC), nuclear factor kappa B (NF-kappa B), interleukin-1Beta (IL-1 beta), interleukin 18 (IL-18), nuclear factor erythroid 2-related factor 2 (NRF2) and heme oxygenase 1 (HMOX1). Protein levels of NLRP3, sirtuin 1 (SIRT1), glial fibrillary acidic protein (GFAP), ionized calcium-binding adaptor molecule 1 (Iba1), and neuronal nuclei (Neu N) also increased after rmTBI. Administration of saffron alleviated the degree of TBI, as evidenced by reducing the neuronal damage, astrocyte, and microglial activation. Pretreatment with saffron inhibited the activation of NLRP3, caspase-1, and ASC concurrent to reduced production of the inflammatory cytokines IL-1 beta and IL-18. Additionally, saffron extract enhanced SIRT1 expression, NRF2, and HMOX1 upregulation. These results suggest that NLRP3 inflammasome activation and the subsequent inflammatory response in the mice cortex are involved in the process of rmTBI. Saffron blocked the inflammatory response and relieved TBI by activating detoxifying genes and inhibiting NLRP3 activation. The effect of saffron on the NLRP3 inflammasome may be SIRT1 and NF-kappa B dependent in the rmTBI model. Thus, brain injury biomarkers will help in identifying a potential therapeutic target in treating TBI-induced neurodegenerative diseases.	[Shaheen, Mariam J.; Borjac, Jamilah M.] Beirut Arab Univ, Dept Biol Sci, Debbieh, Lebanon; [Bekdash, Amira M.; Itani, Hana A.] Amer Univ Beirut, Fac Med, Dept Pharmacol & Toxicol, Beirut, Lebanon; [Itani, Hana A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA		Borjac, JM (corresponding author), Beirut Arab Univ, Dept Biol Sci, Debbieh, Lebanon.; Itani, HA (corresponding author), Amer Univ Beirut, Fac Med, Dept Pharmacol & Toxicol, Beirut, Lebanon.; Itani, HA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA.	hi40@aub.edu.lb; j.borjac@bau.edu.lb		Bekdash, Amira/0000-0002-5065-5131	HAI through the AUB Medical Practice Plan fund; Carl W. Gottschalk Research Scholar Award [M0048845]; American University of Beirut Faculty of Medicine Medical Practice Plan [MPP 320174]	This study has been supported by MS, the first author of this paper, who purchased the kits needed to measure the cytokines levels, the primers, and the kits needed to measure the gene expression, and by HAI through the AUB Medical Practice Plan fund who covered for the reagents used in western blot experiment along with 3 antibodies (NLRP3, SIRT1, and Beta tubulin). The lab assistant AB received a salary from the American Society of Nephrology (ASN), Carl W. Gottschalk Research Scholar Award (M0048845), and the American University of Beirut Faculty of Medicine Medical Practice Plan (MPP 320174). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedimanesh N, 2020, PHYTOTHER RES, V34, P1114, DOI 10.1002/ptr.6580; Alavizadeh SH, 2014, FOOD CHEM TOXICOL, V64, P65, DOI 10.1016/j.fct.2013.11.016; Amin B, 2015, EXCLI J, V14, P411, DOI 10.17179/excli2014-510; Asai A, 2005, J AGR FOOD CHEM, V53, P7302, DOI 10.1021/jf0509355; Baldwin KT, 2017, CURR OPIN NEUROBIOL, V45, P113, DOI 10.1016/j.conb.2017.05.006; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bian YQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.579052; Bostan HB, 2017, IRAN J BASIC MED SCI, V20, P110, DOI 10.22038/ijbms.2017.8230; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Canadian Council on Animal Care (CCAC), 1993, GUIDE CARE USE EXPT; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chalatsa I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00249; Christodoulou E, 2015, J PHARM PHARMACOL, V67, P1634, DOI 10.1111/jphp.12456; Das N, 2016, CELL REP, V17, P1128, DOI 10.1016/j.celrep.2016.09.076; Dempsey C, 2017, BRAIN BEHAV IMMUN, V61, P306, DOI 10.1016/j.bbi.2016.12.014; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diao M, 2017, EXP THER MED, V13, P117, DOI 10.3892/etm.2016.3912; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Ettehadi H., 2013, J BEHAV BRAIN SCI, V3, P315, DOI [10.4236/jbbs.2013.33031, DOI 10.4236/JBBS.2013.33031]; Fan KH, 2017, CHEM-BIOL INTERACT, V271, P15, DOI 10.1016/j.cbi.2017.04.021; Farokhnia M, 2014, HUM PSYCHOPHARM CLIN, V29, P351, DOI 10.1002/hup.2412; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fernandez-Albarral JA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174110; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Gout B, 2010, NUTR RES, V30, P305, DOI 10.1016/j.nutres.2010.04.008; Gudarzi S, 2020, NUTR NEUROSCI, DOI 10.1080/1028415X.2020.1840118; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Hatziagapiou K, 2019, CURR NEUROPHARMACOL, V17, P377, DOI 10.2174/1570159X16666180321095705; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hosseinzadeh H, 2008, DNA CELL BIOL, V27, P657, DOI 10.1089/dna.2008.0767; Huang KP, 2015, MOL CELL ENDOCRINOL, V399, P178, DOI 10.1016/j.mce.2014.08.014; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Jafarisani M, 2018, J BIOMOL STRUCT DYN, V36, P1681, DOI 10.1080/07391102.2017.1331865; Jaliani HZ, 2013, IRAN J BASIC MED SCI, V16, P101; Jiao FZ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6782872; Bagur MJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23010030; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Kigerl KA, 2018, BRAIN BEHAV IMMUN, V72, P22, DOI 10.1016/j.bbi.2017.11.018; Kim JH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/728709; Kopitar-Jerata N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00073; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lautenschlager M, 2015, PHYTOMEDICINE, V22, P36, DOI 10.1016/j.phymed.2014.10.009; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2017, ASIAN PAC J TROP MED, V10, P1185, DOI 10.1016/j.apjtm.2017.10.027; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mashmoul M, 2014, J FUNCT FOODS, V8, P180, DOI 10.1016/j.jff.2014.03.017; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Miyamoto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00070; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Naghshineh A, 2015, CHEM-BIOL INTERACT, V238, P151, DOI 10.1016/j.cbi.2015.06.023; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Pathophysiology KwonB., 2004, SPINE J, V4, DOI [10.1016/j.spinee.2003.07.007, DOI 10.1016/J.SPINEE.2003.07.007]; Ramli FN, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1247946; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Salman M, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.045021; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Toy Dana, 2013, Exp Neurobiol, V22, P68, DOI 10.5607/en.2013.22.2.68; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Wang H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01863-9; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; World Health Organization Geneva, 2003, WHO GUID GOOD AGR CO; Xiong YY, 2015, IMMUNOPHARM IMMUNOT, V37, P236, DOI 10.3109/08923973.2015.1021356; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yoshino F, 2011, J CLIN BIOCHEM NUTR, V49, P182, DOI 10.3164/jcbn.11-01; Zhang XJ, 2018, CELL PHYSIOL BIOCHEM, V48, P1088, DOI 10.1159/000491975; Zhang YQ, 2020, EUR J PHARMACOL, V867, DOI 10.1016/j.ejphar.2019.172847; Ziaee T, 2014, JUNDISHAPUR J NAT PH, V9, P3; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	92	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257211	10.1371/journal.pone.0257211			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	WOS:000729120700107	34506597	gold, Green Published			2022-02-06	
J	Sheth, C; Rogowska, J; Legarreta, M; McGlade, E; Yurgelun-Todd, D				Sheth, Chandni; Rogowska, Jadwiga; Legarreta, Margaret; McGlade, Erin; Yurgelun-Todd, Deborah			Functional connectivity of the anterior cingulate cortex in Veterans with mild traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Resting state functional connectivity; Anterior cingulate cortex; Mild traumatic brain injury; Veterans	ORBITOFRONTAL CONNECTIVITY; NETWORK; MRI; CONCUSSION; SYMPTOMS; ANXIETY; TIME	Background: Traumatic brain injury (TBI) is one of the most prevalent injuries in the military with mild traumatic brain injury (mTBI) accounting for approximately 70-80 % of all TBI. TBI has been associated with diffuse and focal brain changes to structures and networks underlying cognitive-emotional processing. Although the anterior cingulate cortex (ACC) plays a critical role in emotion regulation and executive function and is susceptible to mTBI, studies focusing on ACC resting state functional connectivity (rs-fc) in Veterans are limited. Methods: Veterans with mTBI (n = 49) and with no history of TBI (n = 25), ages 20-54 completed clinical assessments and an 8-minute resting state functional magnetic resonance imaging (rs-fMRI) on a 3 T Siemens scanner. Imaging results were analyzed with left and right ACC as seed regions using SPM8. Regression analyses were performed with time since injury. Results: Seed-based analysis showed increased connectivity of the left and right ACC with brain regions including middle and posterior cingulate regions, preceneus, and occipital regions in the mTBI compared to the non-TBI group. Conclusions: The rs-fMRI results indicate hyperconnectivity in Veterans with mTBI. These results are consistent with previous studies of recently concussed athletes showing ACC hyperconnectivity. Enhanced top-down control of attention networks necessary to compensate for the microstructural damage following mTBI may explain ACC hyperconnectivity post-mTBI.	[Sheth, Chandni; Rogowska, Jadwiga; McGlade, Erin; Yurgelun-Todd, Deborah] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Sheth, Chandni; Legarreta, Margaret; McGlade, Erin; Yurgelun-Todd, Deborah] Univ Utah, Diagnost Neuroimaging, Salt Lake City, UT USA; [Legarreta, Margaret; McGlade, Erin; Yurgelun-Todd, Deborah] George E Wahlen Dept Vet Affairs Med Ctr, VA VISN Mental Illness Res Educ & Clin Ctr MIRECC, Salt Lake City, UT USA		Sheth, C (corresponding author), 383 Colorow Dr,Rm 325, Salt Lake City, UT 84108 USA.	Chandni.sheth@utah.edu; ika.rogowska@gmail.com; Margaret.Legarreta@va.gov; Erin.McGlade@hsc.utah.edu; Deborah.Yurgelun-Todd@hsc.utah.edu			Military Suicide Research Consortium (MSRC) [W81XWH-10-2-0178]; Veterans Health Administration Merit review grant [5I01CX000253-02]; Department of Veterans Affairs Rocky Mountain Network Mental Illness Research, Education, and Clinical Center (MIRECC)	This research is supported in part by Department of Veterans Affairs Rocky Mountain Network Mental Illness Research, Education, and Clinical Center (MIRECC); the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs (W81XWH-10-2-0178); and a Veterans Health Administration Merit review grant (5I01CX000253-02, PI: YurgelunTodd). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Veterans Affairs, MSRC, DoD, or the United States Government.	Abdallah CG, 2018, PHARMACOL THERAPEUT, V190, P148, DOI 10.1016/j.pharmthera.2018.05.010; Akiki TJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0840-4; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Defense and V.B.I. Center, 2012, DOD WORLDW NUMB TBI; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Filley CM, 2018, J ALZHEIMERS DIS, V65, P345, DOI 10.3233/JAD-180287; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Galatzer-Levy IR, 2013, PERSPECT PSYCHOL SCI, V8, P651, DOI 10.1177/1745691613504115; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hostetter T.A., 2019, J HEAD TRAUMA REHABI; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Komura A, 2019, J NEUROTRAUM, V36, P641, DOI 10.1089/neu.2018.5641; Kukolja J, 2016, NEUROBIOL AGING, V45, P197, DOI 10.1016/j.neurobiolaging.2016.06.004; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Palomero-Gallagher N, 2008, J COMP NEUROL, V508, P906, DOI 10.1002/cne.21684; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shin YW, 2013, J AFFECT DISORDERS, V150, P1091, DOI 10.1016/j.jad.2013.04.026; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121; Subramaniam P, 2018, J AFFECT DISORDERS, V239, P234, DOI 10.1016/j.jad.2018.07.002; Sullivan D.R., 2018, J INT NEUROPSYCH SOC, P1; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tang W, 2019, ELIFE, V8, DOI 10.7554/eLife.43761; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	60	1	1	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 1	2021	396								112882	10.1016/j.bbr.2020.112882			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	OD3SC	WOS:000579771900012	32853657	hybrid			2022-02-06	
J	Smith, BG; Whiffin, CJ; Esene, IN; Karekezi, C; Bashford, T; Khan, MM; Solla, DJF; Devi, BI; Hutchinson, PJ; Kolias, AG; Figaji, A; Rubiano, AM				Smith, Brandon George; Whiffin, Charlotte Jane; Esene, Ignatius N.; Karekezi, Claire; Bashford, Tom; Khan, Muhammad Mukhtar; Fontoura Solla, Davi Jorge; Devi, Bhagavatula Indira; Hutchinson, Peter John; Kolias, Angelos G.; Figaji, Anthony; Rubiano, Andres M.			Neurotrauma clinicians' perspectives on the contextual challenges associated with long-term follow-up following traumatic brain injury in low-income and middle-income countries: a qualitative study protocol	BMJ OPEN			English	Article						qualitative research; neurosurgery; neurological injury	HEALTH	Introduction Traumatic brain injury (TBI) is a global public health concern; however, low/middle-income countries (LMICs) face the greatest burden. The WHO recognises the significant differences between patient outcomes following injuries in high-income countries versus those in LMICs. Outcome data are not reliably recorded in LMICs and despite improved injury surveillance data, data on disability and long-term functional outcomes remain poorly recorded. Therefore, the full picture of outcome post-TBI in LMICs is largely unknown. Methods and analysis This is a cross-sectional pragmatic qualitative study using individual semistructured interviews with clinicians who have experience of neurotrauma in LMICs. The aim of this study is to understand the contextual challenges associated with long-term follow-up of patients following TBI in LMICs. For the purpose of the study, we define 'long-term' as any data collected following discharge from hospital. We aim to conduct individual semistructured interviews with 24-48 neurosurgeons, beginning February 2020. Interviews will be recorded and transcribed verbatim. A reflexive thematic analysis will be conducted supported by NVivo software. Ethics and dissemination The University of Cambridge Psychology Research Ethics Committee approved this study in February 2020. Ethical issues within this study include consent, confidentiality and anonymity, and data protection. Participants will provide informed consent and their contributions will be kept confidential. Participants will be free to withdraw at any time without penalty; however, their interview data can only be withdrawn up to 1 week after data collection. Findings generated from the study will be shared with relevant stakeholders such as the World Federation of Neurosurgical Societies and disseminated in conference presentations and journal publications.	[Smith, Brandon George; Hutchinson, Peter John; Kolias, Angelos G.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Smith, Brandon George; Whiffin, Charlotte Jane; Bashford, Tom; Khan, Muhammad Mukhtar; Fontoura Solla, Davi Jorge; Devi, Bhagavatula Indira; Hutchinson, Peter John; Kolias, Angelos G.; Figaji, Anthony; Rubiano, Andres M.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England; [Whiffin, Charlotte Jane] Univ Derby, Coll Hlth Social Care, Derby, England; [Esene, Ignatius N.] Univ Bamenda, Fac Hlth Sci, Neurosurg Div, Bambili, Northwest Regio, Cameroon; [Karekezi, Claire] Rwanda Mil Hosp, Dept Neurosurg, Kigali, Rwanda; [Khan, Muhammad Mukhtar] Northwest Gen Hosp & Res Ctr, Dept Neurosurg, Peshawar, Pakistan; [Fontoura Solla, Davi Jorge] Univ Sao Paulo, Dept Neurosci & Behav Sci, Ribeirao Preto, Brazil; [Devi, Bhagavatula Indira] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Figaji, Anthony] Univ Cape Town, Div Neurosurg, Rondebosch, South Africa; [Rubiano, Andres M.] El Bosque Univ, Neurosci Inst, Dept Neurosurg, Bogota, Colombia		Kolias, AG (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.; Kolias, AG (corresponding author), Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England.	ak721@cam.ac.uk	Karekezi, Claire/AAR-9283-2021; Bashford, Tom/H-9586-2019; ESENE, IGNATIUS/AAX-8716-2020	Karekezi, Claire/0000-0002-7183-899X; Bashford, Tom/0000-0003-0228-9779; ESENE, IGNATIUS/0000-0001-8785-8875; Smith, Brandon/0000-0001-8471-1368; Whiffin, Charlotte/0000-0002-9767-2123; Hutchinson, Peter/0000-0002-2796-1835	National Institute for Health Research (NIHR) Global Health Research Group on NeurotraumaNational Institute for Health Research (NIHR) [16/137/105]; UK government	This research was supported by the National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma (grant number 16/137/105) using UK aid from the UK government.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Braun V, 2021, QUAL RES SPORT EXERC, V13, P201, DOI 10.1080/2159676X.2019.1704846; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Butler-Kisber L., 2010, QUAL INQ, V1st; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Vo DH, 2019, J RISK FINANC MANAG, V12, DOI 10.3390/jrfm12010040; Haagsma JA, 2020, INJURY PREV, V26, P12, DOI 10.1136/injuryprev-2019-043296; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Korstjens I, 2017, EUR J GEN PRACT, V24, P120, DOI 10.1080/13814788.2017.1375092; LaGrone LN, 2017, INJURY, V48, P1985, DOI 10.1016/j.injury.2017.03.003; Laytin Adam D, 2018, Trauma Surg Acute Care Open, V3, pe000256, DOI 10.1136/tsaco-2018-000256; Levers MJD, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013517243; Lincoln Y.S., 1985, INT J INTERCULT REL, V9, P438, DOI [10.1016/0147-1767(85)90062-8, DOI 10.1016/0147-1767(85)90062-8]; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375092, 10.1080/13814788.2017.1375091]; Mowafi H, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001442; Nicholls D, 2017, INT J THER REHABIL, V24, P114, DOI 10.12968/ijtr.2017.24.3.114; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Peden, 2004, GUIDELINES ESSENTIAL; Polit D., 2011, RESOURCE MANUAL NURS, V9th; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Servadei F, 2019, WORLD NEUROSURG, V130, pE822, DOI 10.1016/j.wneu.2019.06.230; Smith Joanna, 2011, Nurse Res, V18, P39; Sullivan-Bolyai S, 2005, NURS OUTLOOK, V53, P127, DOI 10.1016/j.outlook.2005.03.005; Ulin PR., 2016, QUALITATIVE METHODS, V2nd; Vaca SD, 2019, J NEUROSURG-PEDIATR, V23, P125, DOI 10.3171/2018.7.PEDS17601; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; World Bank, 2019, WORLD BANK LIST EC 2	34	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2021	11	3							e041442	10.1136/bmjopen-2020-041442			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT4WB	WOS:000626588600005	33664068	Green Published, gold			2022-02-06	
J	Soleimani, T; Mosher, B; Ochoa-Frongia, L; Stevens, P; Kepros, JP				Soleimani, Tahereh; Mosher, Benjamin; Ochoa-Frongia, Laura; Stevens, Penny; Kepros, John P.			Delayed Intracranial Hemorrhage After Blunt Head Injury With Direct Oral Anticoagulants	JOURNAL OF SURGICAL RESEARCH			English	Article						Intracranial bleeding; Direct oral anticoagulant; DOAC; Delayed head bleed; Delayed intracranial bleeding	TRAUMATIC BRAIN-INJURY; ATRIAL-FIBRILLATION; MANAGEMENT; PREVALENCE; PATIENT	Introduction: Patients presenting to the Emergency Department (ED) following head injury are frequently evaluated with an initial computed tomography scan (CT) of the brain. Imaging is particularly important in patients who are receiving medications that alter normal blood hemostasis. As an imaging modality, CT has a high negative predictive value when used to rule out clinically significant acute intracranial hemorrhage. Patients receiving anticoagulant or antiplatelet therapy have both an increased risk of initial hemorrhage, as well as an increased risk of mortality above nonanticoagulated patients, should they suffer hemorrhage. Multiple studies of delayed intracranial hemorrhage have placed the risk among the patients taking warfarin at the time of head injury in the range of 0.6-6.0%. However, data regarding the risk of delayed intracranial hemorrhage in patients taking the class of agents referred to as Direct-Acting Oral Anticoagulants (DOACs) remains limited. This study aims to estimate this risk. Methods: A retrospective chart review was performed to identify patients on DOACs who presented to our Level I trauma center following blunt head injury between January 2017 and August 2018. Patients with a negative initial head CT were selected. From this subset, data regarding demographics, injury characteristics, anticoagulant use, and antiplatelet use were collected. Results: Overall, 314 patients were included; 129 patients taking rivaroxaban, 182 patients taking apixaban, and four patients taking dabigatran. In approximately 29% of the patients, the sole indication for admission was close monitoring following head injury while taking an anticoagulant agent. The mechanism of injury for the majority of the patients was fall. Of the 314 patients, three were found to have delayed intracranial hemorrhage on the repeated head CT (0.95%). Two of these three patients were on concomitant antiplatelet medication. None of the three individuals required neurosurgical intervention Conclusions: at the time of submission, this is the largest study estimating the risk of delayed intracranial hemorrhage among patients on DOACs. Based on the results of this study, patients who sustain a blunt head injury while taking only DOACs; that is, without concurrent antiplatelet medication, admission, and repeat head CT may not be necessary after confirming a negative initial CT scan. (C) 2020 Elsevier Inc. All rights reserved.	[Soleimani, Tahereh; Ochoa-Frongia, Laura] Michigan State Univ, Coll Human Med, Dept Surg, Lansing, MI USA; [Mosher, Benjamin; Stevens, Penny] Sparrow Hlth Syst, Trauma Dept, Lansing, MI USA; [Kepros, John P.] Honor Hlth Syst, Trauma Dept, Scottsdale, AZ USA		Soleimani, T (corresponding author), Michigan State Univ, Sparrow Hosp, Dept Surg, 1200 E Michigan Ave, Lansing, MI 48912 USA.	Soleima4@msu.edu					Ang D, 2017, AM SURGEON, V83, P527; Barmparas G, 2019, AM J SURG, V217, P1051, DOI 10.1016/j.amjsurg.2018.10.016; Bruce DA, 2000, CHILD NERV SYST, V16, P755, DOI 10.1007/PL00013720; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Cocca AT, 2019, J EMERG MED, V57, P812, DOI 10.1016/j.jemermed.2019.09.011; Cohan CM, 2020, J SURG RES, V249, P114, DOI 10.1016/j.jss.2019.11.009; Colilla S, 2013, AM J CARDIOL, V112, P1142, DOI 10.1016/j.amjcard.2013.05.063; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Hill JH, 2018, BRAIN INJURY, V32, P735, DOI 10.1080/02699052.2018.1441442; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688	15	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2021	257						394	398		10.1016/j.jss.2020.08.024			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PF5MA	WOS:000599097100043	32892136				2022-02-06	
J	Stika, MM; Riordan, P; Aaronson, A; Herrold, AA; Ellison, RL; Kletzel, S; Drzewiecki, M; Evans, CT; Mallinson, T; High, WM; Babcock-Parziale, J; Urban, A; Pape, TLB; Smith, B				Stika, Monica M.; Riordan, Patrick; Aaronson, Alexandra; Herrold, Amy A.; Ellison, Rachael L.; Kletzel, Sandra; Drzewiecki, Michelle; Evans, Charlesnika T.; Mallinson, Trudy; High, Walter M.; Babcock-Parziale, Judith; Urban, Amanda; Pape, Theresa Louise-Bender; Smith, Bridget			Cognition and Other Predictors of Functional Disability Among Veterans With Mild Traumatic Brain Injury and Posttraumatic Stress Disorder	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; mental health conditions; mild traumatic brain injury; mTBI; neuropsychological assessment; posttraumatic stress disorder; PTSD; veteran; WHODAS	SERVICE MEMBERS; NEUROPSYCHOLOGICAL PERFORMANCE; INSTRUMENTAL ACTIVITIES; OEF/OIF VETERANS; MENTAL-HEALTH; US VETERANS; SYMPTOMS; OUTCOMES; PERSPECTIVES; ASSOCIATION	Background: Limitations in everyday functioning are frequently reported by veterans with a history of mild traumatic brain injury (mTBI) and/or posttraumatic stress disorder (PTSD). Multiple factors are associated with functional disability among veterans, including depression, poor social support, cognition, and substance use. However, the degree to which these factors, particularly cognitive capacities, contribute to functional limitations remains unclear. Methods: We evaluated performance on tests of processing speed, executive functioning, attention, and memory as predictors of functioning on the World Health Organization Disability Assessment Scale (WHODAS) 2.0 in 288 veterans. Participants were placed in one of the following groups: PTSD-only, mTBI-only, mTBI + PTSD, and neither PTSD nor mTBI (deployed control group). Cognitive test performances were evaluated as predictors of WHODAS 2.0 functional ratings in regression models that included demographic variables and a range of mood, behavioral health, and postconcussive symptom ratings. Results: Multiple cognitive test performances predicted WHODAS 2.0 scores in the deployed control group, but they generally did not predict functioning in the clinical groups when accounting for demographics, mood, behavioral health, and postconcussive symptoms. Conclusions: In veterans with mTBI and/or PTSD, cognitive test performances are less associated with everyday functioning than mood and postconcussive symptoms.	[Stika, Monica M.] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, 5000 South 5th Ave,Bldg 1, Hines, IL 60141 USA; [Stika, Monica M.] Mental Hlth Serv Line, Spinal Cord Injury Disorder Serv, Hines, IL USA; [Riordan, Patrick; Drzewiecki, Michelle; Urban, Amanda] Neuropsychol Serv, Hines, IL USA; [Aaronson, Alexandra] Psychiat Serv, Hines, IL USA; [Herrold, Amy A.; Ellison, Rachael L.; Pape, Theresa Louise-Bender] Res Serv, Hines, IL USA; [Herrold, Amy A.; Kletzel, Sandra; Evans, Charlesnika T.; Pape, Theresa Louise-Bender; Smith, Bridget] Ctr Innovat Complex Chron Healthcare, Hines, IL USA; [Aaronson, Alexandra; Herrold, Amy A.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Smith, Bridget] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Evans, Charlesnika T.] Northwestern Univ, Feinberg Sch Med, Ctr Hlth Serv & Outcomes Res, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Mallinson, Trudy] George Washington Univ, Dept Clin Res & Leadership, Washington, DC 20052 USA; [High, Walter M.] New Mexico VA Hlth Care Syst, Dept Vet Affairs VA, Albuquerque, NM USA; [Ellison, Rachael L.] IIT, Chicago, IL 60616 USA; [Babcock-Parziale, Judith] Southern AZ VA Hlth Care Syst 3 124, Dept Vet Affairs VA, Tucson, AZ USA		Smith, B (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs VA, 5000 South 5th Ave,Bldg 1, Hines, IL 60141 USA.	monica.stika@gmail.com; patrick.riordan@va.gov; Alexandra.Aaronson@va.gov; Amy.Herrold@va.gov; rellison1@iit.edu; Sandra.Kletzel@va.gov; Michelle.Drzewiecki@va.gov; Charlesnika.Evans@va.gov; trudy@email.gwu.edu; Walter.High@va.gov; jbabparzi@gmail.com; Amanda.Urban@va.gov; Theresa.Pape@va.gov; Bridget.Smith@va.gov	Mallinson, Trudy/S-7381-2019	Mallinson, Trudy/0000-0002-4888-5579	US Department of Veterans Affairs, Office of Research& Development, HSRDUS Department of Veterans Affairs [SDR-08-377]; U.S. Department of Veterans Affairs Rehabilitation ResearchUS Department of Veterans Affairs [RX001850, RX002938, RX000949]	This study was funded by US Department of Veterans Affairs, Office of Research& Development, HSR&D SDR-08-377 and the Career Development Award (RX001850 and RX002938 to S.L.K. and RX000949 to A.A.H.) from the U.S. Department of Veterans Affairs Rehabilitation Research.	Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1988, MANUAL BECK ANXIETY; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Conners C. K., 2000, CONNERS CONTINUOUS P; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Heaton R., 2000, WISCONSIN CARD SORTI; Herrold AA, 2019, MIL MED, V184, P138, DOI 10.1093/milmed/usy306; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holdnack H.A., 2001, WECHSLER TEST ADULT; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Soble JR, 2013, J CLIN EXP NEUROPSYC, V35, P551, DOI 10.1080/13803395.2013.798398; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Toglia J, 2017, ARCH PHYS MED REHAB, V98, P2280, DOI 10.1016/j.apmr.2017.04.007; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 2008, WECHSLER ADULT INTEL; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zakzanis KK, 2016, BRAIN INJURY, V30, P986, DOI 10.3109/02699052.2016.1147077; Zlotnick C, 2004, J NERV MENT DIS, V192, P153, DOI 10.1097/01.nmd.0000110287.16635.8e	47	1	1	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2021	36	1			SI		44	55		10.1097/HTR.0000000000000611			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PM7ZE	WOS:000604011300009	32898030				2022-02-06	
J	Taghavi, S; Ramirez, S; Duchesne, J; Tatum, D				Taghavi, Sharven; Ramirez, Saul; Duchesne, Juan; Tatum, Danielle			Preinjury Use of Marijuana and Outcomes in Trauma Patients	JOURNAL OF SURGICAL RESEARCH			English	Article						Marijuana; Tetrahydrocannabinol; Trauma; Endocannabinoid; Outcomes	INFLAMMATORY RESPONSE SYNDROME; TUMOR-NECROSIS-FACTOR; LENGTH-OF-STAY; UNITED-STATES; CANNABINOID RECEPTORS; SYNDROME SCORE; TNF-ALPHA; DRUG-USE; ENDOCANNABINOIDS; ALCOHOL	Background: Recent studies have examined the effects of marijuana in various populations; however, there has been limited research on the effect of marijuana use in severely injured trauma patients. We hypothesized that preinjury use of marijuana would be associated with improved outcomes in severely injured trauma patients. Methods: All adult (18+ y) level I and level II trauma activations who presented to two large regional trauma centers between 2014 and 2018 were reviewed. Delta-9-tetrahydrocannabinol (THC)indicated absence of drugs confirmed by testing and as THC + confirmed THC without another drug present. Results: Of the 4849 patients included, 1373 (28.3%) were THC+. The THC + cohort was younger, had more males, and was more likely to be injured by penetrating mechanism (P < 0.001 for all) than THC-. THC + patients had shorter median length of stay (LOS) (P < 0.001) and intensive care unit LOS (P < 0.001). Mortality rate was lower in the THC + group (4.3% versus 7.6%, P 0.001), but not in multivariate analysis. THC + patients with traumatic brain injury had shorter hospital LOS (P = 0.025) and shorter ventilator days (P = 0.033) than THCpatients. In patients with Injury Severity Score 16, THC + patients had significantly lower intensive care unit LOS (P = 0.009) and mortality (19.3% versus 25.0% P = 0.038) than drug-negative patients. Conclusions: Although preinjury use of marijuana does not improve survival in trauma patients, it may provide some improvement in outcomes in patients with traumatic brain injury and those that are more severely injured (Injury Severity Score >16). The mechanism behind this finding needs further evaluation. (c) 2020 Elsevier Inc. All rights reserved.	[Taghavi, Sharven; Duchesne, Juan] Tulane Univ, Sch Med, Dept Surg, Div Trauma & Crit Care, New Orleans, LA 70112 USA; [Ramirez, Saul; Tatum, Danielle] Our Lady Lake Reg Med Ctr, Trauma Specialist Program, Baton Rouge, LA USA; [Ramirez, Saul] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA		Tatum, D (corresponding author), Our Lady Lake Reg Med Ctr, 5000 Hennessy Blvd, Baton Rouge, LA 70808 USA.	Danielle.Tatum@fmolhs.org					Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Berry EM, 2002, PHARMACOL THERAPEUT, V95, P185, DOI 10.1016/S0163-7258(02)00257-7; Chambers AP, 2004, PHYSIOL BEHAV, V82, P863, DOI [10.1016/j.physbeh.2004.07.004, 10.1016/S0031-9384(04)00302-6]; Chu YWL, 2014, J HEALTH ECON, V38, P43, DOI 10.1016/j.jhealeco.2014.07.003; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; DISA, MAP MAR LEG STAT; Dunham CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047999; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Glass M, 2001, PROG NEURO-PSYCHOPH, V25, P743, DOI 10.1016/S0278-5846(01)00162-2; Grundy RI, 2002, EXPERT OPIN INV DRUG, V11, P1365, DOI 10.1517/13543784.11.10.1365; Hall W, 2005, LANCET ONCOL, V6, P35, DOI 10.1016/S1470-2045(05)70024-3; Hasin DS, 2017, JAMA PSYCHIAT, V74, P579, DOI 10.1001/jamapsychiatry.2017.0724; Jacome T, 2018, NEUROCRIT CARE, V28, P110, DOI 10.1007/s12028-017-0410-y; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kozela E, 2013, J NEUROIMMUNE PHARM, V8, P1265, DOI 10.1007/s11481-013-9493-1; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Ligresti A, 2016, PHYSIOL REV, V96, P1593, DOI 10.1152/physrev.00002.2016; London JA, 2007, ARCH SURG-CHICAGO, V142, P633, DOI 10.1001/archsurg.142.7.633; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Martins SS, 2016, DRUG ALCOHOL DEPEN, V169, P26, DOI 10.1016/j.drugalcdep.2016.10.004; Mauro PM, 2018, J STUD ALCOHOL DRUGS, V79, P423, DOI 10.15288/jsad.2018.79.423; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Napolitano LM, 2000, J TRAUMA, V49, P647, DOI 10.1097/00005373-200010000-00011; National Institute onDrugAbuse, WHAT IS SCOP MAR US; NeSmith EG, 2009, AM J CRIT CARE, V18, P339, DOI 10.4037/ajcc2009267; Pacek LR, 2015, DRUG ALCOHOL DEPEN, V149, P232, DOI 10.1016/j.drugalcdep.2015.02.009; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Pellati F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1691428; Pope C, 2010, NEUROTOXICOLOGY, V31, P562, DOI 10.1016/j.neuro.2009.12.002; RIVARA FP, 1989, J TRAUMA, V29, P462, DOI 10.1097/00005373-198904000-00008; Sarris J, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-019-2409-8; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Stinson FS, 2005, DRUG ALCOHOL DEPEN, V80, P105, DOI 10.1016/j.drugalcdep.2005.03.009; Sun Dong, 1999, Keio Journal of Medicine, V48, P28; Vila N, 2003, STROKE, V34, P671, DOI 10.1161/01.STR.0000057976.53301.69; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646	41	1	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2021	257						42	49		10.1016/j.jss.2020.07.011			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PF5MA	WOS:000599097100005	32818783				2022-02-06	
J	Thau-Zuchman, O; Svendsen, L; Dyall, SC; Paredes-Esquivel, U; Rhodes, M; Priestley, JV; Feichtinger, RG; Kofler, B; Lotstra, S; Verkuyl, JM; Hageman, RJ; Broersen, LM; van Wijk, N; Silva, JP; Tremoleda, JL; Michael-Titus, AT				Thau-Zuchman, Orli; Svendsen, Linda; Dyall, Simon C.; Paredes-Esquivel, Ursula; Rhodes, Molly; Priestley, John, V; Feichtinger, Rene G.; Kofler, Barbara; Lotstra, Susanne; Verkuyl, J. Martin; Hageman, Robert J.; Broersen, Laus M.; van Wijk, Nick; Silva, Jose P.; Tremoleda, Jordi L.; Michael-Titus, Adina T.			A new ketogenic formulation improves functional outcome and reduces tissue loss following traumatic brain injury in adult mice	THERANOSTICS			English	Article						Adult traumatic brain injury; epigenetic modifications; ketogenic diet; neurological outcome; neuroprotection	CORTICAL IMPACT INJURY; MAMMALIAN TARGET; DIET; AGE; DAMAGE; ASTROCYTES; MODEL; TSPO; NEUROINFLAMMATION; PROLIFERATION	Rationale: Traumatic brain injury (TBI) leads to neurological impairment, with no satisfactory treatments available. Classical ketogenic diets (KD), which reduce reliance on carbohydrates and provide ketones as fuel, have neuroprotective potential, but their high fat content reduces compliance, and experimental evidence suggests they protect juvenile brain against TBI, but not adult brain, which would strongly limit their applicability in TBI. Methods: We designed a new-KD with a fat to carbohydrate plus protein ratio of 2:1, containing medium chain triglycerides (MCT), docosahexaenoic acid (DHA), low glycaemic index carbohydrates, fibres and the ketogenic amino acid leucine, and evaluated its neuroprotective potential in adult TBI. Adult male C57BL6 mice were injured by controlled cortical impact (CCI) and assessed for 70 days, during which they received a control diet or the new-KD. Results: The new-KD, that markedly increased plasma Beta-hydroxybutyrate (beta-HB), significantly attenuated sensorimotor deficits and corrected spatial memory deficit. The lesion size, perilesional inflammation and oxidation were markedly reduced. Oligodendrocyte loss appeared to be significantly reduced. TBI activated the mTOR pathway and the new-KD enhanced this increase and increased histone acetylation and methylation. Conclusion: The behavioural improvement and tissue protection provide proof of principle that this new formulation has therapeutic potential in adult TBI.	[Thau-Zuchman, Orli; Svendsen, Linda; Paredes-Esquivel, Ursula; Rhodes, Molly; Priestley, John, V; Tremoleda, Jordi L.; Michael-Titus, Adina T.] Queen Mary Univ London, Ctr Neurosci Surg & Trauma, Blizard Inst, Barts & London Sch Med & Dent, 4 Newark St, London E1 2AT, England; [Dyall, Simon C.; Silva, Jose P.] Univ Roehampton, Dept Life Sci, Grove House,Roehampton Lane, London SW15 5PJ, England; [Feichtinger, Rene G.; Kofler, Barbara] Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, Univ Hosp, Mullner Hauptstr 48, A-5020 Salzburg, Austria; [Lotstra, Susanne; Verkuyl, J. Martin; Hageman, Robert J.; Broersen, Laus M.; van Wijk, Nick] Danone Nutricia Res, Uppsalalaan 12, NL-3584 CT Utrecht, Netherlands		Thau-Zuchman, O (corresponding author), Queen Mary Univ London, Ctr Neurosci Surg & Trauma, Blizard Inst, 4 Newark St, London E1 2AT, England.	o.thau-zuchman@qmul.ac.uk		Thau-Zuchman, Orli/0000-0003-0403-7962; Dyall, Simon/0000-0001-7591-4219			Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Alam MM, 2017, NUCL MED MOLEC IMAG, V51, P283, DOI 10.1007/s13139-017-0475-8; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; APPLETON DB, 1974, EPILEPSIA, V15, P211, DOI 10.1111/j.1528-1157.1974.tb04943.x; Bae YH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1180-y; Bailes JE, 2014, MIL MED, V179, P112, DOI 10.7205/MILMED-D-14-00139; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Blanco MMB, 2016, NEUROSURG CLIN N AM, V27, P453, DOI 10.1016/j.nec.2016.05.003; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cai QY, 2017, WORLD J PEDIATR, V13, P528, DOI 10.1007/s12519-017-0053-2; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Cheng XY, 2019, J INTEGR NEUROSCI, V18, P203, DOI 10.31083/j.jin.2019.02.110; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Ding K., 2016, TRANSLATIONAL RES TR; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dyall SC, 2007, NEUROBIOL AGING, V28, P424, DOI 10.1016/j.neurobiolaging.2006.01.002; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gipson TT, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/486402; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Harun-Or-Rashid M, 2018, J NEUROSCI, V38, P5122, DOI 10.1523/JNEUROSCI.3652-17.2018; Hori A, 1997, EPILEPSIA, V38, P750, DOI 10.1111/j.1528-1157.1997.tb01461.x; Huang K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00516; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kim M, 2018, FREE RADICAL BIO MED, V124, P517, DOI 10.1016/j.freeradbiomed.2018.06.040; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; McDaniel SS, 2011, EPILEPSIA, V52, pe7, DOI 10.1111/j.1528-1167.2011.02981.x; McDonald TJW, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080148; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Murphy MP, 2016, BIOCHEM SOC T, V44, P1219, DOI 10.1042/BST20160108; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Pandya JD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00605; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Pu HJ, 2017, CELL TRANSPLANT, V26, P555, DOI [10.3727/096368916x693842, 10.3727/096368916X693842]; Rho JM, 1999, EPILEPSY RES, V37, P233, DOI 10.1016/S0920-1211(99)00068-6; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roebuck-Spencer T., 2014, HDB NEUROPSYCHOLOGY, P3; Ruan HB, 2018, CURR OPIN CLIN NUTR, V21, P260, DOI 10.1097/MCO.0000000000000475; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Terenzio M, 2018, SCIENCE, V359, P1416, DOI 10.1126/science.aan1053; Thau-Zuchman O, 2019, J NEUROTRAUM, V1, P66; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thiele EA, 2003, EPILEPSIA, V44, P26, DOI 10.1046/j.1528-1157.44.s7.4.x; Thiele EA, 2013, J CHILD NEUROL, V28, P1054, DOI 10.1177/0883073813488827; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; Wilder RM., 1921, MAYO CLIN B, V2, P307; Zhang HL, 2018, J MOL CELL CARDIOL, V123, P38, DOI 10.1016/j.yjmcc.2018.08.022	71	1	1	2	10	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2021	11	1					346	360		10.7150/thno.48995			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	OI0DJ	WOS:000582957500023	33391479	Green Submitted, Green Published, gold			2022-02-06	
J	Tramontana, MG; Prokop, JW; Williamson, E; Duffie, T; LaFever, H				Tramontana, Michael G.; Prokop, Jonathan W.; Williamson, Edwin; Duffie, Tara; LaFever, Hayden			Traumatic Brain Injury-Related Attention Deficits in Children: A Controlled Treatment Trial with Lisdexamfetamine Dimesylate (Vyvanse)	BRAIN SCIENCES			English	Article						traumatic brain injury; concussion; attention deficits; children; stimulant medication treatment		Attention deficits are among the most common and persistent impairments resulting from traumatic brain injury (TBI). This study was the first to examine the effects of lisdexamfetamine dimesylate (LDX, Vyvanse) in treating TBI-related attention deficits in children. It was an extension of a previous controlled trial with adults. This was a 12-week, randomized, double-blind, placebo-controlled, dose-titration, crossover trial. In addition to weekly safety monitoring, there were assessments on a broad range of neuropsychological and behavioral measures at baseline, 6-weeks, and 12-weeks. A total of 20 carefully selected children were enrolled, ranging from 10 to 16 years of age. The sample consisted of cases with mainly mild TBI (based on the known details regarding their injuries), but they had persisting attention deficits and other post-concussion symptoms lasting from 2 to 29 months by the time of enrollment. A total of 16 children completed the trial. One of the children withdrew due to a mild anxiety reaction while on LDX. There were no other adverse effects. Positive treatment results were found on both formal testing of sustained attention and in terms of parent ratings of attention, emotional status, behavioral controls, and various aspects of executive functioning. The findings also served to highlight broader insights into the nature of attention deficits and their treatment in children with TBI.	[Tramontana, Michael G.; Prokop, Jonathan W.; Williamson, Edwin; Duffie, Tara; LaFever, Hayden] Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, Suite 2200,1500 21st Ave South, Nashville, TN 37212 USA		Tramontana, MG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Psychiat & Behav Sci, Suite 2200,1500 21st Ave South, Nashville, TN 37212 USA.	michael.tramontana@vumc.org; jonathanwprokop@gmail.com; edwin.williamson@vumc.org; taraduffie@icloud.com; hayden.a.lafever@vumc.org		Williamson, Edwin/0000-0003-3764-8989	Shire International GmbH, a member of the Takeda group of companies [IIR-USA-000881]	This study was based on an investigator-initiated research trial (IIR-USA-000881; Michael G. Tramontana, PhD, Principal Investigator) funded by Shire International GmbH, a member of the Takeda group of companies.	Bales James W, 2010, Open Drug Discov J, V2, P119; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Faraone SV, 2010, J AM ACAD CHILD PSY, V49, P24, DOI 10.1016/j.jaac.2009.10.003; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; LeBlond E, 2019, J INT NEUROPSYCH SOC, V25, P740, DOI 10.1017/S1355617719000444; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Nikles CJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-54; Park BS, 2009, APPL NEUROPSYCHOL, V16, P1, DOI 10.1080/09084280802636371; Rieger B, 2019, J INT NEUROPSYCH SOC, V25, P777, DOI 10.1017/S1355617719000468; Samuels JA, 2006, PEDIATR NEPHROL, V21, P92, DOI 10.1007/s00467-005-2051-1; Sherman E., 2020, COMPENDIUM NEUROPSYC, V4th ed.; Thaler NS, 2010, J CLIN EXP NEUROPSYC, V32, P929, DOI 10.1080/13803391003596488; Tramontana MG, 2014, BRAIN INJURY, V28, P1461, DOI 10.3109/02699052.2014.930179; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	22	1	1	2	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JAN	2021	11	1							117	10.3390/brainsci11010117			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PV2MN	WOS:000609827000001	33467178	Green Published, gold			2022-02-06	
J	Truss, K; Hearps, SJC; Babl, FE; Takagi, M; Davis, GA; Clarke, C; Anderson, N; Rausa, VC; Bressan, S; Dunne, K; Anderson, V				Truss, Katie; Hearps, Stephen J. C.; Babl, Franz E.; Takagi, Michael; Davis, Gavin A.; Clarke, Cathriona; Anderson, Nicholas; Rausa, Vanessa C.; Bressan, Silvia; Dunne, Kevin; Anderson, Vicki			Trajectories and Risk Factors for Pediatric Postconcussive Symptom Recovery	NEUROSURGERY			English	Article						Concussion; Mild traumatic brain injury; Pediatrics; Trajectory	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; POST-CONCUSSIVE SYMPTOMS; HEAD-INJURY; MILD; CHILDREN; PREDICTORS; SPORT	BACKGROUND: Persistent postconcussive symptoms (PCS) are poorly understood in children. Research has been limited by an assumption that children with concussion are a homogenous group. OBJECTIVE: To identify (i) distinctive postconcussive recovery trajectories in children and (ii) injury-related and psychosocial factors associated with these trajectories. METHODS: This study is part of a larger prospective, longitudinal study. Parents of 169 children (5-18 yr) reported their child's PCS over 3 mo following concussion. PCS above baseline levels formed the primary outcome. Injury-related, demographic, and preinjury information, and child and parent mental health were assessed for association with trajectory groups. Data were analyzed using group-based trajectory modeling, multi-nomial logistic regression, and chi-squared tests. RESULTS: We identified 5 postconcussive recovery trajectories from acute to 3 mo postinjury. (1) Low Acute Recovered (26.6%): consistently low PCS; (2) Slow to Recover (13.6%): elevated symptoms gradually reducing; (3) High Acute Recovered (29.6%): initially elevated symptoms reducing quickly to baseline; (4) Moderate Persistent (18.3%): consistent, moderate levels of PCS; (5) Severe Persistent (11.8%): persisting high PCS. Higher levels of child internalizing behaviors and greater parental distress were associated with membership to the Severe Persistent group, relative to the Low Acute Recovered group. CONCLUSION: This study indicates variability in postconcussive recovery according to 5 differential trajectories, with groups distinguished by the number of reported symptoms, levels of child internalizing behavior problems, and parental psychological distress. Identification of differential recovery trajectories may allow for targeted early intervention for children at risk of poorer outcomes.	[Truss, Katie; Hearps, Stephen J. C.; Babl, Franz E.; Takagi, Michael; Davis, Gavin A.; Clarke, Cathriona; Anderson, Nicholas; Rausa, Vanessa C.; Bressan, Silvia; Dunne, Kevin; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Truss, Katie; Babl, Franz E.; Takagi, Michael; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.; Dunne, Kevin] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia		Babl, FE (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au		Takagi, Michael/0000-0003-2903-7598; Hearps, Stephen/0000-0003-2984-1172	Royal Children's Hospital Foundation; Victorian Government Operational Infrastructure Scheme; Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia; Royal Children's Hospital Foundation (Melbourne Campus Clinician Scientist Fellowship); NHMRCNational Health and Medical Research Council of Australia	This study was funded by The Royal Children's Hospital Foundation and the Victorian Government Operational Infrastructure Scheme. The authors have no personal, financial or institutional interest in any of the drugs, materials, or devices described in this article. Dr Hearps was funded by an Australian National Health and Medical Research Council (NHMRC) Development grant. Dr Babl was funded by The Royal Children's Hospital Foundation (Melbourne Campus Clinician Scientist Fellowship) and an NHMRC Practitioner Fellowship. Dr Anderson was funded by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jones BL, 2012, STATA PLUGIN ESTIMAT; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Nagin D.S., 2005, GROUP BASED MODELING; Peden M, 2008, WORLD REPORT CHILD I; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	36	1	1	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JAN	2021	88	1					36	45		10.1093/neuros/nyaa310			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	PR1EZ	WOS:000606986200027	32717073				2022-02-06	
J	VanRavenhorst-Bell, HA; Muzeau, MA; Luinstra, L; Goering, J; Amick, RZ				VanRavenhorst-Bell, Heidi A.; Muzeau, Melissa A.; Luinstra, Lindsay; Goering, Jared; Amick, Ryan Z.			Accuracy of the SWAY Mobile Cognitive Assessment Application	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						sway app; cognitive assessment; reaction time; mobile device; impact qt	REACTION-TIME; QUICK TEST; CONCUSSION; SCORES; PREVALENCE	Background Mobile electronic devices have become integral tools in addressing the need for portable assessment of cognitive function following neurocognitive/motor injury. SWAY Medical, Inc., has employed mobile device motion-based technology in the SWAY Cognitive Assessment (SWAY CA) application to assess cognitive function. Purpose The purpose of this study was to assess whether the SWAY CA application (reaction time, impulse control and inspective time) was able to reliably operate on different mobile devices and operating systems (iOS, Android). The study further sought to assess the validity of the SWAY CA application against the FDA approved ImPACT OT mobile device application. Study Design Original Research, observational study of validity. Methods 88 healthy, young adults, 18 to 48 years (mean= 22.09 +/- sd=4.47 years) completed four, randomized and counter-balanced, reaction time tests (2- SWAY RT, 2- ImPACT OT) using different operating systems (iOS, Android) of 4 randomly assigned mobile devices. Results ANOVAs reported the SWAY CA application (reaction time, impulse control, inspection time) operated reliably with iPhone 6S, Samsung Galaxy S9, and iPad Pro 5 mobile devices (p > 0.05), respectively. Google Pixel 3 reliability with SWAY CA application remains undetermined. SWAY CA simple reaction motion measures were in agreement (r = -0.46 to 0.22, p <= 0.05) with several ImPACT OT reaction time measures. SWAY CA impulse control and inspection time measures are weakly correlated (r = -0.25 to -0.46, p <= 0.05) with five ImPACT OT reaction time measures. Conclusion The motion-based SWAY CA mobile device application appears to reliably operate when being administered on different mobile devices and software operating systems. Furthermore, the SWAY CA application appears to be comparable to the ImPACT OT and serve as a valid tool for assessing reaction time measures.	[VanRavenhorst-Bell, Heidi A.; Luinstra, Lindsay] Wichita State Univ, Human Performance Studies, Wichita, KS 67260 USA; [Muzeau, Melissa A.] Univ Savoie Mt Blanc, Engn & Ergon Phys Act, Chambery, France; [Goering, Jared] Wichita State Univ, Coll Innovat & Design, Wichita, KS 67260 USA		VanRavenhorst-Bell, HA (corresponding author), Wichita State Univ, Dept Human Performance Studies, 1845 Fairmount St,Campus Box 016, Wichita, KS 67260 USA.	heidi.bell@wichita.edu		VanRavenhorst-Bell, Heidi/0000-0002-1491-1660			Amick R.Z., 2015, J MOB TECHNOL MED, V4, P40, DOI [10.7309/jmtm.4.2.6, DOI 10.7309/JMTM.4.2.6]; Android Developers, 2020, MOT SENS WEBS; Apple Inc, 2020, GETT RAW ACC EV WEBS; Apple Inc, 2017, IOS DEV COMP REF WEB; Badau D, 2018, SPORTS, V6, DOI 10.3390/sports6020045; Brett BL, 2020, CLIN J SPORT MED, V30, P458, DOI 10.1097/JSM.0000000000000632; Burghart M, 2016, AM J OCCUP THER, V70, DOI [10.5014/ajot.2016.70s1-po5064, DOI 10.5014/AJOT.2016.70S1-PO5064]; Burghart M, 2019, APPL NEUROPSYCH-ADUL, V26, P558, DOI 10.1080/23279095.2018.1469491; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Daponte P, 2013, MEASUREMENT, V46, P3291, DOI 10.1016/j.measurement.2013.05.006; Deber J, 2015, C P 33 ANN CHI HUM F, DOI [10.1145/2702123, DOI 10.1145/2702123]; del Rosario MB, 2015, SENSORS-BASEL, V15, P18901, DOI 10.3390/s150818901; Del Rossi G, 2017, J ATHL TRAINING, V52, P766, DOI 10.4085/1062-6050-52.6.02; Department of Health and Human Services-Food and Drug Administration, 2017, IMPACT QUICK TEST IM; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Elbin RJ, 2020, ARCH CLIN NEUROPSYCH, V35, P326, DOI 10.1093/arclin/acz072; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Horaczek S, 2019, POPULAR SCI; Gonzalez-Canete FJ, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20030622; mPACT Applications Inc, 2020, IMPACT APPL CONC MAN; Patterson J.A., 2014, INT J ATHL THER TRAI, V19, P4, DOI [10.1123/ijatt.2013-0094, DOI 10.1123/IJATT.2013-0094]; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Peart DJ, 2019, J STRENGTH COND RES, V33, P1167, DOI 10.1519/JSC.0000000000002344; Plant RR, 2013, COGN AFFECT BEHAV NE, V13, P598, DOI 10.3758/s13415-013-0166-6; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; SWAY Medical LLC, 2020, SWAY MOB REACT TIM O; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Ventola C Lee, 2014, P T, V39, P356; Wallace J, 2019, ARCH CLIN NEUROPSYCH, V34, P747, DOI 10.1093/arclin/acz026.17; Wallace J, 2020, ARCH CLIN NEUROPSYCH, V35, P1276, DOI 10.1093/arclin/acaa078; Warburton DE, 2019, PAR Q PHYS ACTIVITY; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131	34	1	1	0	0	NORTH AMER SPORTS MEDICINE INST-NASMI	NASHVILLE	6011 HILLSBORO PIKE, NASHVILLE, TN, UNITED STATES	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.		2021	16	4					991	1000		10.26603/001c.24924			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	UA9UO	WOS:000685499400005	34386278	gold, Green Published			2022-02-06	
J	Wang, HC; Chen, J; Gao, C; Chen, W; Chen, G; Zhang, MY; Luo, CL; Wang, T; Chen, XP; Tao, LY				Wang, Haochen; Chen, Jie; Gao, Cheng; Chen, Wei; Chen, Guang; Zhang, Mingyang; Luo, Chengliang; Wang, Tao; Chen, Xiping; Tao, Luyang			TMT-based proteomics analysis to screen potential biomarkers of acute-phase TBI in rats	LIFE SCIENCES			English	Article						Traumatic brain injury; Quantitative proteomics; TMT; Protein-protein interaction networks; Biomarkers	TRAUMATIC BRAIN-INJURY; CELL-DEATH; PROTEIN; MODEL; ITRAQ; IDENTIFICATION; EXPRESSION; BIOLOGY; S100B	Aims: Traumatic brain injury (TBI) is a common nervous system injury. However, the detailed mechanisms about functional dysregulation and dignostic biomarkers post-TBI are still unclear. So we aimed to identify potential differentially expressed proteins and genes in TBI for clinical diagnosis and therapeutic purposes. Main methods: Rat TBI model was established by the weight-drop method. First, through TMT-proteomics, we screened for the change in the proteins expression profile acute phase post-TBI. The DAVID and Reactome databases were used to analyze and visualize the dysregulation proteins. Then, using publicly available microarray datasets GSE45997, differentially expressed genes (DGEs) were identified for the 24 h post-TBI stage. Also, the proteomic data were compared with microarray data to analyze the similarity. Key findings: We found significant proteomics and transcriptomic changes in post-TBI samples. 989, 881, 832, 1057 proteins were quantitated at 1 h, 6 h, 24 h, and 3 d post-injury correspondingly. Concerning proteomics findings, oxygen transport, acute-phase response, and negative regulation of endopeptidase activity were influenced throughout the acute phrase of TBI. Also, pathways related to scavenging of heme from plasma, binding, and uptake of ligands by scavenger receptors were highly enriched in all time-points of TBI samples. Significance: We noticed that the interaction-networks trend to get complicated with more node connections following the progression of TBI. We inferred that Hk-1, PRKAR2A, and MBP could be novel candidate biomarkers related to time-injury in acute-phase TBI. Also, Ceruloplasmin and Complement C3 were found to be important proteins and genes are involved in the TBI.	[Wang, Haochen; Chen, Jie; Gao, Cheng; Chen, Wei; Chen, Guang; Zhang, Mingyang; Luo, Chengliang; Wang, Tao; Chen, Xiping; Tao, Luyang] Soochow Univ, Dept Forens Med, Med Sch, Suzhou 215123, Peoples R China		Chen, XP; Tao, LY (corresponding author), Soochow Univ, Dept Forens Med, Med Sch, Suzhou 215123, Peoples R China.	545898973@qq.com; xipingchen@suda.edu.cn; taoluyang@suda.edu.cn			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81971800, 81871536]; PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions)	This study was supported by the National Nature Science Foundation of China (No. 81530062, 81971800, 81871536) and PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions).	Abu Hamdeh S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25060-0; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Alluri H, 2018, METHODS MOL BIOL, V1717, P37, DOI 10.1007/978-1-4939-7526-6_4; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; BAKKER AV, 1990, BIOCHEM J, V271, P559, DOI 10.1042/bj2710559; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bowler EH, 2015, EXPERT REV PROTEOMIC, V12, P449, DOI 10.1586/14789450.2015.1084875; Cai SW, 2010, TOXICON, V55, P818, DOI 10.1016/j.toxicon.2009.11.017; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Casey TM, 2017, J PROTEOME RES, V16, P384, DOI 10.1021/acs.jproteome.5b01154; Cheng L., 2014, PLOS ONE, V9; Chmielewska N, 2018, NEUROL NEUROCHIR POL, V52, P318, DOI 10.1016/j.pjnns.2018.02.002; Dayon L, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0397-4; Ding J, 2015, ARQ NEURO-PSIQUIAT, V73, P342, DOI 10.1590/0004-282X20150006; Edlow BL, 2018, J NEUROTRAUM, V35, P1604, DOI 10.1089/neu.2017.5457; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Filley CM, 2018, J ALZHEIMERS DIS, V65, P345, DOI 10.3233/JAD-180287; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; GRIFFIN LD, 1992, BIOCHIM BIOPHYS ACTA, V1129, P309, DOI 10.1016/0167-4781(92)90508-W; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; HAW R, 2012, CURR PROTOC BIOINFOR, V38; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Huang SX, 2018, NEUROCHEM RES, V43, P1814, DOI 10.1007/s11064-018-2597-5; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Jaber Z, 2016, METHODS MOL BIOL, V1462, P139, DOI 10.1007/978-1-4939-3816-2_9; Johnson EA, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-40; KALWANT S, 1991, BIOCHEM J, V276, P237, DOI 10.1042/bj2760237; Kim J, 2020, GLIA, V68, P2070, DOI 10.1002/glia.23827; KNIGHT G, 1986, DIABETIC MED, V3, P82, DOI 10.1111/j.1464-5491.1986.tb00714.x; Kobori N, 2015, J NEUROTRAUM, V32, P139, DOI 10.1089/neu.2014.3487; Kois L.E., 2018, BRAIN INJURY, P1; Kong D., 2016, J EXP MED, V213; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Fernandez-Coto DL, 2018, J PROTEOMICS, V186, P15, DOI 10.1016/j.jprot.2018.07.013; Leithner C, 2014, J CEREBR BLOOD F MET, V34, P19, DOI 10.1038/jcbfm.2013.181; Li L, 2017, ONCOL REP, V38, P2607, DOI 10.3892/or.2017.5946; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Miani M, 2018, J MOL BIOL, V430, P3041, DOI 10.1016/j.jmb.2018.07.022; Mondello S, 2018, EXPERT REV PROTEOMIC, V15, P451, DOI 10.1080/14789450.2018.1464914; Pfeiffer S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.426; Pichler P, 2010, ANAL CHEM, V82, P6549, DOI 10.1021/ac100890k; Pierce JD, 2018, J NEUROSCI RES, V96, P1080, DOI 10.1002/jnr.24210; Pita-Juarez Y, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006042; Prabhakara KS, 2018, MOL THER, V26, P2152, DOI 10.1016/j.ymthe.2018.06.022; Rauniyar N, 2013, J PROTEOME RES, V12, P1031, DOI 10.1021/pr3008896; Regenold WT, 2012, J PSYCHIATR RES, V46, P95, DOI 10.1016/j.jpsychires.2011.09.018; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Safaeian N, 2013, J CEREBR BLOOD F MET, V33, P1633, DOI 10.1038/jcbfm.2013.119; Sarkis GA, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0736-z; Sivandzade F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01818-0; Sivandzade F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082721; Sivandzade F, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-019-0497-5; Su E, 2012, NEUROCRIT CARE, V17, P401, DOI 10.1007/s12028-012-9767-0; Sui L, 2012, NEUROBIOL LEARN MEM, V97, P425, DOI 10.1016/j.nlm.2012.03.007; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tramutola A, 2018, BBA-MOL BASIS DIS, V1864, P3309, DOI 10.1016/j.bbadis.2018.07.017; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xu BH, 2016, BRAIN RES, V1642, P344, DOI 10.1016/j.brainres.2016.04.008; Zatroch KK, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0982-y; Zhang P, 2016, J PROTEOMICS, V133, P93, DOI 10.1016/j.jprot.2015.12.014; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231; Zhou M, 2018, NEUROSCIENCE, V376, P24, DOI 10.1016/j.neuroscience.2018.02.010	69	1	1	2	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	JAN 1	2021	264								118631	10.1016/j.lfs.2020.118631			14	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	PH6UZ	WOS:000600546400030	33131748				2022-02-06	
S	Wang, ZH; Pu, QQ; Huang, CH; Wu, M		Wang, YX		Wang, Zhihan; Pu, Qinqin; Huang, Canhua; Wu, Min			Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation	LUNG INFLAMMATION IN HEALTH AND DISEASE, VOL I	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Pneumonia; Lung inflammation; Intercellular networks; Interorgan networks; Acute lung injury; Chronic lung disease	RESPIRATORY-DISTRESS-SYNDROME; TRAUMATIC BRAIN-INJURY; VENTILATOR-ASSOCIATED PNEUMONIA; STROKE-INDUCED IMMUNODEPRESSION; OBSTRUCTIVE PULMONARY-DISEASE; INFLUENZA-A VIRUS; INTESTINAL MICROBIOTA; MECHANICAL VENTILATION; NOSOCOMIAL INFECTIONS; BIOFILM FORMATION	Acute and chronic lung inflammation is a risk factor for various diseases involving lungs and extrapulmonary organs. Intercellular and interorgan networks, including crosstalk between lung and brain, intestine, heart, liver, and kidney, coordinate host immunity against infection, protect tissue, and maintain homeostasis. However, this interaction may be counterproductive and cause acute or chronic comorbidities due to dysregulated inflammation in the lung. In this chapter, we review the relationship of the lung with other key organs during normal cell processes and disease development. We focus on how pneumonia may lead to a systemic pathophysiological response to acute lung injury and chronic lung disease through organ interactions, which can facilitate the development of undesirable and even deleterious extrapulmonary sequelae.	[Wang, Zhihan; Huang, Canhua] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu, Sichuan, Peoples R China; [Wang, Zhihan; Pu, Qinqin; Wu, Min] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA		Huang, CH (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu, Sichuan, Peoples R China.; Wu, M (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.	min.wu@und.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AI138203, AI109317, P20 GM103442, GM113123]; Sevier Medical Art (SMART)	This work was supported by the National Institutes of Health (NIH) grants R01 AI138203, AI109317, P20 GM103442, and GM113123. Figures were created by modifying illustrations provided by Sevier Medical Art (SMART), licensed under a Creative Commons Attribution 3.0 Unported License.	Abdennour L, 2012, Ann Fr Anesth Reanim, V31, pe101, DOI 10.1016/j.annfar.2012.04.013; Afshar M, 2014, J TRAUMA ACUTE CARE, V76, P1447, DOI 10.1097/TA.0000000000000238; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Allais L, 2016, ENVIRON MICROBIOL, V18, P1352, DOI 10.1111/1462-2920.12934; Alves JC, 2010, SHOCK, V34, P15, DOI 10.1097/SHK.0b013e3181e7e61b; Anand N, 2009, SEMIN RESP CRIT CARE, V30, P3, DOI 10.1055/s-0028-1119803; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Benjamin JL, 2012, INFLAMM BOWEL DIS, V18, P1092, DOI 10.1002/ibd.21864; Bernard H, 2015, J INFECT DIS, V211, P156, DOI 10.1093/infdis/jiu391; Bickenbach J, 2009, ANESTH ANALG, V109, P847, DOI 10.1213/ane.0b013e3181ad5769; Biedermann L, 2014, INFLAMM BOWEL DIS, V20, P1496, DOI 10.1097/MIB.0000000000000129; Brack MC, 2019, CURR OPIN PULM MED, V25, P257, DOI 10.1097/MCP.0000000000000584; Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Brown AO, 2015, AM J RESP CRIT CARE, V191, P739, DOI 10.1164/rccm.201411-1951PP; Budden KF, 2017, NAT REV MICROBIOL, V15, P55, DOI 10.1038/nrmicro.2016.142; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chen C, 2020, Zhonghua Shao Shang Za Zhi, V36, P471, DOI 10.3760/cma.j.cn501120-20200224-00088; Chen R, BIORXIV2020202004070; Clarke TB, 2014, INFECT IMMUN, V82, P4596, DOI 10.1128/IAI.02212-14; Cookson WOCM, 2018, NAT REV MICROBIOL, V16, P111, DOI 10.1038/nrmicro.2017.122; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Cummings CJ, 1999, J IMMUNOL, V162, P2341; Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014; Dickson RP, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.113, 10.1038/nmicrobiol.2016.113]; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Doran SJ, 2020, CRIT CARE MED, V48, pE418, DOI 10.1097/CCM.0000000000004273; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Einarsson GG, 2016, THORAX, V71, P795, DOI 10.1136/thoraxjnl-2015-207235; Quilez ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10230; Elkind MSV, 2020, CIRCULATION, V141, pE743, DOI 10.1161/CIRCULATIONAHA.120.046749; Ellul M, 2018, CLIN MED, V18, P155, DOI 10.7861/clinmedicine.18-2-155; Fagundes CT, 2012, J IMMUNOL, V188, P1411, DOI 10.4049/jimmunol.1101682; Ferrante G, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00186; Gauguet S, 2015, INFECT IMMUN, V83, P4003, DOI 10.1128/IAI.00037-15; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; Hammadi M, 2009, WORLD J GASTROENTERO, V15, P4016, DOI 10.3748/wjg.15.4016; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; He S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005743; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Hevia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147809; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hu JQ, 2015, AN ACAD BRAS CIENC, V87, P997, DOI 10.1590/0001-3765201520140518; Hua X, 2016, EBIOMEDICINE, V3, P172, DOI 10.1016/j.ebiom.2015.11.038; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Hurley JC, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010002; Husain-Syed F, 2016, AM J RESP CRIT CARE, V194, P402, DOI 10.1164/rccm.201602-0420CP; Husain-Syed F, 2015, J AM COLL CARDIOL, V65, P2433, DOI 10.1016/j.jacc.2015.04.024; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI 10.1056/NEJMoa1500245; Kabeerdoss J, 2015, INDIAN J MED RES, V142, P23, DOI 10.4103/0971-5916.162091; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Khan HA, 2017, ASIAN PAC J TROP BIO, V7, P478, DOI 10.1016/j.apjtb.2017.01.019; Kim JE, 2017, J CLIN NEUROL, V13, P227, DOI 10.3988/jcn.2017.13.3.227; Kishino Eriko, 2015, Biosci Microbiota Food Health, V34, P67, DOI 10.12938/bmfh.2015-005; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kovach MA, 2012, CURR OPIN INFECT DIS, V25, P321, DOI 10.1097/QCO.0b013e3283528c9b; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Kulkarni R, 2012, INFECT IMMUN, V80, P3804, DOI 10.1128/IAI.00689-12; Lakshminarayan K, 2010, STROKE, V41, P2849, DOI 10.1161/STROKEAHA.110.597039; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Letko M, 2018, CELL REP, V24, P1730, DOI 10.1016/j.celrep.2018.07.045; Li Y, 2004, J VIROL, V78, P3398, DOI 10.1128/JVI.78.7.3398-3406.2004; Li YC, 2013, J COMP NEUROL, V521, P203, DOI 10.1002/cne.23171; Li YC, 2012, VIRUS RES, V163, P628, DOI 10.1016/j.virusres.2011.12.021; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Lim CC, 2019, AM J RESP CRIT CARE, V200, P1022, DOI 10.1164/rccm.201806-1161OC; Liu DD, 2018, NEUROCHEM INT, V114, P42, DOI 10.1016/j.neuint.2018.01.002; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Maramattom BV, 2006, NEUROCRIT CARE, V5, P115, DOI 10.1385/NCC:5:2:115; Matsuda K, 2004, VET PATHOL, V41, P101, DOI 10.1354/vp.41-2-101; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Michelena J, 2015, HEPATOLOGY, V62, P762, DOI 10.1002/hep.27779; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mizgerd JP, 2012, AM J RESP CRIT CARE, V186, P824, DOI 10.1164/rccm.201206-1063PP; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Nassenstein C, 2018, J ALLERGY CLIN IMMUN, V142, P1415, DOI 10.1016/j.jaci.2018.09.011; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Paradisi F, 2001, CLIN MICROBIOL INFEC, V7, P34, DOI 10.1046/j.1469-0691.2001.00056.x; Pell Jill P, 2008, N Engl J Med, V359, P482, DOI 10.1056/NEJMsa0706740; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Poole LG, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030062; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Pu QQ, 2019, PRECIS CLIN MED, V2, P166, DOI 10.1093/pcmedi/pbz019; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quilez ME, 2012, CURR OPIN CRIT CARE, V18, P23, DOI 10.1097/MCC.0b013e32834ef3ea; Quinton LJ, 2018, PHYSIOL REV, V98, P1417, DOI 10.1152/physrev.00032.2017; Quinton LJ, 2015, ANNU REV PHYSIOL, V77, P407, DOI 10.1146/annurev-physiol-021014-071937; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Rincon F, 2014, J INTENSIVE CARE MED, V29, P357, DOI 10.1177/0885066613491919; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Roussos A, 2003, RESP MED, V97, P75, DOI 10.1053/rmed.2001.1409; Rutten EPA, 2014, CHEST, V145, P245, DOI 10.1378/chest.13-0584; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z; Schwab C, 2014, ISME J, V8, P1101, DOI 10.1038/ismej.2013.223; Semlali A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-61; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shichino S, BIORXIV2020202005150; Siore AM, 2005, AM J PHYSIOL-LUNG C, V289, pL769, DOI 10.1152/ajplung.00137.2005; Stephan F, 2006, ANESTHESIOLOGY, V104, P235, DOI 10.1097/00000542-200602000-00006; Stephan F, 2002, CRIT CARE MED, V30, P315, DOI 10.1097/00003246-200202000-00009; Sullivan A, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0479-4; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tamayo E, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.09.001; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Veeravagu A, 2014, WORLD NEUROSURG, V82, pE235, DOI 10.1016/j.wneu.2014.02.030; Verschuere S, 2011, LAB INVEST, V91, P1056, DOI 10.1038/labinvest.2011.74; Vieira AT, 2016, MICROBES INFECT, V18, P180, DOI 10.1016/j.micinf.2015.10.008; Vieira WA, 2010, J ASTHMA ALLERGY, V3, P123, DOI 10.2147/JAA.S10592; Wang F, 2015, INFECT DIS-NOR, V47, P597, DOI 10.3109/00365548.2014.989539; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Wang ZH, 2019, JOVE-J VIS EXP, DOI 10.3791/59386; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Winklewski PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0213-4; Wu M, 2009, J NEUROCHEM, V111, P1011, DOI 10.1111/j.1471-4159.2009.06390.x; Wypych TP, 2019, NAT IMMUNOL, V20, P1279, DOI 10.1038/s41590-019-0451-9; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169267; Yazar A, 2001, AM J GASTROENTEROL, V96, P1511, DOI 10.1111/j.1572-0241.2001.03748.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369; Zhou XK, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0006-9; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065	147	1	1	2	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-63046-1; 978-3-030-63045-4	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2021	1303						333	350		10.1007/978-3-030-63046-1_18	10.1007/978-3-030-63046-1		18	Medicine, Research & Experimental; Respiratory System	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Respiratory System	BR3MA	WOS:000647696800019	33788201				2022-02-06	
J	Xiong, WC; Qian, KJ				Xiong, Weichuan; Qian, KeJian			Low-Protein, Hypocaloric Nutrition with Glutamine versus Full-Feeding in the Acute Phase in ICU Patients with Severe Traumatic Brain Injury	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						acute phase; severe traumatic brain injury; nutrition; low-protein; hypocaloric; glutamine	CRITICALLY-ILL PATIENTS; PARENTERAL-NUTRITION; SUPPLEMENTATION; STANDARD	Objective: To investigate the 28-day mortality, the length of ICU stay, days in the hospital, days of ventilator use, adverse events, and nosocomial infection events of low-protein, hypocaloric nutrition with glutamine in the first 7 days of the intensive care unit (ICU) patients with severe traumatic brain injury (STBI). Patients and Methods: A total of 53 patients diagnosed with STBI enrolled from the third affiliated hospital of Nanchang University (Nanchang, China), from January 2019 to July 2020, were divided into two groups. We performed a randomized prospective controlled trial. The intervention group (n=27) was nutritional supported (intestinal or parenteral) with a caloric capacity of 20-40% of European Conference on Clinical Nutrition and Metabolism (ESPEN) recommendations; specifically, low-protein intake was 0.5-0.7g/kg per day (containing the amount of alanyl-glutamine), glutamine was 0.3 g/kg per day, and the intervention treatment lasted for 7 days. The control group (n=26) was nutritionally supported with a caloric capacity of 70-100% of ESPEN recommendations, and the protein intake was 1.2-1.7 g/kg per day. The primary endpoint was 28-day mortality. Secondary endpoints were the length of ICU stay, days in the hospital, days of ventilator use, adverse events and nosocomial infection events. Results: There were no differences in baseline characteristics between groups. Survival curve analysis using the Kaplan-Meier method revealed no significant difference in 28-day mortality between the two groups (P=0.31) while adverse events (chi(2)= 5.853, P=0.016), nosocomial infection rate (chi(2) = 4.316, P=0.038), the length of ICU stay (t=-2.617, P=0.012), hospitalization time (t=-2.169, P=0.036), and days of ventilator use (t=-2.144, P=0.037) of patients in the intervention group were significantly lower than those in the control group. Conclusion: Low-protein, hypocaloric nutrition with glutamine did not show different outcomes in 28-day mortality compared to full-feeding nutritional support in the ICU patients with STBI. However, low-protein, hypocaloric nutrition with glutamine could provide a lower need for ICU time, hospitalization time, and ventilator time in the ICU patients with STBI.	[Xiong, Weichuan] Nanchang Univ, Affiliated Hosp 3, Dept Crit Care Med, Nanchang 330006, Jiangxi, Peoples R China; [Xiong, Weichuan; Qian, KeJian] Nanchang Univ, Affiliated Hosp 1, Dept Crit Care Med, Nanchang 330006, Jiangxi, Peoples R China		Qian, KJ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Crit Care Med, Nanchang 330006, Jiangxi, Peoples R China.	kejianqian@sina.com		xiong, weichuan/0000-0003-4815-575X			Abdullah MI, 2020, CHIN J TRAUMATOL, V23, P290, DOI 10.1016/j.cjtee.2020.04.004; Abe T, 2019, ESOPHAGUS-TOKYO, V16, P63, DOI 10.1007/s10388-018-0630-z; Allingstrup MJ, 2017, INTENS CARE MED, V43, P1637, DOI 10.1007/s00134-017-4880-3; Apostolopoulou A, 2020, NUTRITION, V78, DOI 10.1016/j.nut.2020.110960; Arabi YM, 2015, NEW ENGL J MED, V373, P1175, DOI 10.1056/NEJMc1509259; Arabi YM, 2010, JPEN-PARENTER ENTER, V34, P280, DOI 10.1177/0148607109353439; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Casaer MP, 2013, AM J RESP CRIT CARE, V187, P247, DOI 10.1164/rccm.201206-0999OC; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Frankenfield DC, 2012, NUTRITION, V28, P906, DOI 10.1016/j.nut.2011.12.008; Juang P, 2007, PHARMACOTHERAPY, V27, P11, DOI 10.1592/phco.27.1.11; Marik PE, 2016, CURR OPIN CLIN NUTR, V19, P155, DOI 10.1097/MCO.0000000000000256; McClave SA, 2009, NUTR CLIN PRACT, V24, P305, DOI 10.1177/0884533609335176; Moe-Byrne T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001457.pub6; Leite JSM, 2016, APPL PHYSIOL NUTR ME, V41, P842, DOI 10.1139/apnm-2016-0049; Nageli M, 2014, CRIT CARE, V18, DOI 10.1186/cc13962; Quintard H, 2019, CURR OPIN CRIT CARE, V25, P126, DOI 10.1097/MCC.0000000000000588; Reignier J, 2018, LANCET, V391, P133, DOI [10.1016/S0140-6736(17)32146-3, 10.1016/s0140-6736(17)32146-3]; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Sandoval CP, 2015, CRIT CARE NURSE, V35, P71, DOI 10.4037/ccn2015220; Shariatpanahi ZV, 2019, INDIAN J CRIT CARE M, V23, P356, DOI 10.5005/jp-journals-10071-23218; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Stehle P, 2017, CLIN NUTR ESPEN, V17, P75, DOI 10.1016/j.clnesp.2016.09.007; Stroud M, 2007, P NUTR SOC, V66, P378, DOI 10.1017/S0029665107005642; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Van Dyck L, 2018, NUTR CLIN PRACT, V33, P339, DOI 10.1002/ncp.10084; Vanhorebeek I, 2017, LANCET RESP MED, V5, P475, DOI 10.1016/S2213-2600(17)30186-8; Wernerman J, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2597-0; Zeng Jing, 2009, Zhonghua Shao Shang Za Zhi, V25, P335	29	1	1	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2021	17						703	710		10.2147/NDT.S296296			8	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	QQ5ML	WOS:000624567700001	33688193	gold, Green Published			2022-02-06	
J	Xu, WD				Xu, Wen-Dong			Surgical Technique of Xu's CC7 Procedure "Contralateral C7 to C7 Cross Nerve Transfer Through a Trans Longus Colli, Prespinal Route for Treating Spastic Arm"	OPERATIVE NEUROSURGERY			English	Article						Nerve transfer; Prespinal route; Seventh cervical nerve; Spastic arm	BRACHIAL-PLEXUS INJURIES; ROOT TRANSFER; MEDIAN NERVE; AVULSION; REPAIR; NEUROTIZATION; TRUNK; PALSY	BACKGROUND: The contralateral C7 transfer has been used for the treatment of brachial plexus root avulsion since 1986, and several modifications of this surgery have been described. Previous trial has verified the safety and effectiveness of the contralateral C7 to C7 cross nerve transfer for patients with longstanding spastic paralysis due to cerebral injuries, including stroke, traumatic brain injury, or cerebral palsy. However, the procedures for the surgery were not introduced in detail, with only rough descriptions. OBJECTIVE: To introduce and promote the Xu's CC7 procedure (contralateral C7 to C7 cross nerve transfer through a trans longus colli, prespinal route). METHODS: The renewed procedures were elaborated step by step, and the tips and tricks were clarified by case illustration in detail. Briefly, a modified trans longus colli, prespinal route was created, allowing the displaced C7 nerve to pass through the channel safely at the shortest distance. RESULTS: Tension-free anastomosis of the bilateral C7 nerves was achieved via the Xu's CC7 procedure with less surgical trauma while reducing the surgery time, postoperative recovery time, and nerve regeneration time. CONCLUSION: The Xu's CC7 procedure is a safer and more efficient technique for contralateral C7 to C7 cross nerve transfer. The detailed description in this article provides meaningful information for surgeons interested in the procedure.	[Xu, Wen-Dong] Fudan Univ, Huashan Hosp, Dept Hand Surg, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China; [Xu, Wen-Dong] Jing Dist Cent Hosp, Dept Hand & Upper Extrem Surg, Shanghai, Peoples R China; [Xu, Wen-Dong] Shanghai Clin Med Ctr Limb Funct Reconstruct, Shanghai, Peoples R China; [Xu, Wen-Dong] Fudan Univ, MOE Frontier Ctr Brain Sci, Shanghai, Peoples R China; [Xu, Wen-Dong] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Xu, Wen-Dong] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Xu, Wen-Dong] Chinese Acad Med Sci, Res Unit Synergist Reconstruct Upper & Lower Limb, Shanghai, Peoples R China		Xu, WD (corresponding author), Fudan Univ, Huashan Hosp, Dept Hand Surg, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	wendongxu@fudan.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972157, 81525009]; Shanghai Top Priority Clinical Medicine Center Construction Project [2017ZZ01006]; Chinese Academy of Medical Sciences Research Fund [2018RU007]	This work is supported by grants from National Natural Science Foundation of China [grant numbers 81972157, 81525009], Shanghai Top Priority Clinical Medicine Center Construction Project [grant number 2017ZZ01006], and Chinese Academy of Medical Sciences Research Fund [grant number 2018RU007].	Bhatia A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.4.FOCUS1794; Chen L, 2007, J HAND SURG-AM, V32A, P96, DOI 10.1016/j.jhsa.2006.05.013; Chim H, 2019, J HAND SURG-AM, V44, P1027, DOI 10.1016/j.jhsa.2019.06.014; CHUANG DCC, 1993, PLAST RECONSTR SURG, V92, P717, DOI 10.1097/00006534-199309001-00023; Gu YD, 1998, J RECONSTR MICROSURG, V14, P57, DOI 10.1055/s-2007-1006902; GU YD, 1992, J HAND SURG-BRIT EUR, V17B, P518, DOI 10.1016/S0266-7681(05)80235-9; Hua XY, 2015, NEUROSURGERY, V76, P187, DOI 10.1227/NEU.0000000000000590; Li PY, 2020, ACTA NEUROCHIR, V162, P141, DOI 10.1007/s00701-019-04069-y; Li WJ, 2015, J NEUROSURG, V122, P1421, DOI 10.3171/2014.10.JNS131574; Liu J, 1997, J RECONSTR MICROSURG, V13, P237, DOI 10.1055/s-2007-1000230; McGuiness CN, 2002, J HAND SURG-BRIT EUR, V27B, P159, DOI 10.1054/jhsb.2001.0665; Songcharoen P, 2001, J HAND SURG-AM, V26A, P1058, DOI 10.1053/jhsu.2001.27764; Standing S, 2008, GRAYS ANATOMY ANATOM; Terzis JK, 2009, PLAST RECONSTR SURG, V123, P927, DOI 10.1097/PRS.0b013e31819ba48a; Waikakul S, 1999, J HAND SURG-BRIT EUR, V24B, P556, DOI 10.1054/jhsb.1999.0264; Wang SF, 2013, J BONE JOINT SURG AM, V95A, P821, DOI 10.2106/JBJS.L.00039; Wang SF, 2012, MICROSURG, V32, P183, DOI 10.1002/micr.20963; Xu L, 2008, NEUROSURGERY, V63, P553, DOI 10.1227/01.NEU.0000324729.03588.BA; Xu WD, 2011, MICROSURG, V31, P404, DOI 10.1002/micr.20877; Yu Ai-Ping, 2019, Br J Neurosurg, P1, DOI 10.1080/02688697.2019.1584661; Zhang L, 2017, NEUROSURGERY, V80, P627, DOI 10.1093/neuros/nyw160; Zheng MX, 2018, NEUROSURGERY, V83, P819, DOI 10.1093/neuros/nyx474; Zheng MX, 2018, NEW ENGL J MED, V378, P22, DOI 10.1056/NEJMoa1615208	23	1	2	3	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	JAN	2021	20	1					61	68		10.1093/ons/opaa325			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PR1IR	WOS:000606996600053	33047132				2022-02-06	
J	Yang, L; Wu, HY; Yang, FL; Li, P; Huang, YJ; Zhang, XY; Qian, CY				Yang, Li; Wu, Haiying; Yang, Fanglin; Li, Ping; Huang, Yongjie; Zhang, Xinyue; Qian, Chuanyun			Identification of candidate genes and pathways in dexmedetomidine-induced neuroprotection in rats using RNA sequencing and bioinformatics analysis	ANNALS OF PALLIATIVE MEDICINE			English	Article						Traumatic brain injury (TBI); dexmedetomidine (DEX); RNA sequencing; bioinformatics analysis	TRAUMATIC BRAIN-INJURY; DOWN-REGULATION; CELL-CYCLE; NEUROAPOPTOSIS; ACTIVATION; IMPACT; EXPRESSION; NETWORKS; CARE	Background: Traumatic brain injury (TBI) is a major cause of disability worldwide, without definitive and effective intervention. Dexmedetomidine (DEX) has a neuroprotective effect against TBI; however, the detailed mechanism underlying this effect remains unclear. Methods: Ten male Sprague Dawley rats were used to establish a TBI model. The rats were randomly divided into two groups: the TBI group (TBI, control group) and the DEX treatment group (DEX). The next day, the neurological function of the rats were evaluated by the modified neurological severity score (mNSS). Then, the rats were sacrificed, and RNA sequencing was performed to identify differentially expressed messenger RNAs (mRNAs) and microRNAs (miRNAs) in brain tissue samples. Additionally, we performed a bioinformatics analysis to explore the candidate genes and pathways that might play important roles in DEX-induced neuroprotection. The most significantly differentially expressed miRNAs and possible hub genes were validated by quantitate reverse transcription-polymerase chain reaction (qRT-PCR) using more samples. Results: In the DEX group, 517 mRNAs (352 up-regulated and 165 down-regulated) and 35 miRNAs (18 up-regulated and 17 down-regulated) were differentially expressed compared to the TBI group. Gene Ontology analysis revealed the up-regulated mRNAs to be significantly enriched in microtubule-based movement or processes, microtubule and tubulin binding. Kyoto Encyclopedia of Genes and Genomes analysis showed that these up-regulated mRNAs were significantly enriched in the B-cell receptor signaling pathway as well as the cell cycle pathway. Also, Lyn and Cdk1 were found to be associated with the B-cell receptor signaling and cell cycle pathways, respectively. Furthermore, the down-regulated miRNAs were significantly enriched in cellular components, although no significant Gene Ontology terms or KEGG pathways were found for the down-regulated mRNAs or up-regulated miRNAs. Conclusions: Differentially expressed mRNAs and miRNAs were identified after the administration of DEX in a TBI rat model. The B-cell receptor signaling pathway and the cell cycle pathway might be involved in the neuroprotective effect of DEX against TBI, Lyn and Cdk1 might be hub genes.	[Yang, Li; Yang, Fanglin; Zhang, Xinyue] Kunming Med Univ, Kunming, Yunnan, Peoples R China; [Yang, Li; Wu, Haiying; Yang, Fanglin; Huang, Yongjie; Qian, Chuanyun] Kunming Med Univ, Affiliated Hosp 1, Emergency Dept, 295 Xichang Rd, Kunming, Yunnan, Peoples R China; [Li, Ping] Kunming Med Univ, Fac Basic Med Sci, Dept Anat & Histol Embryol, Kunming, Yunnan, Peoples R China; [Zhang, Xinyue] Kunming Med Univ, Affiliated Hosp 1, Dept Geriatr Neurol, Kunming, Yunnan, Peoples R China		Qian, CY (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Emergency Dept, 295 Xichang Rd, Kunming, Yunnan, Peoples R China.	qianchuanyun@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81960817, 82060241]; Association Foundation Program of Yunnan Science and Technology Department and Kunming Medical University [2018FE001[-004]]; Innovation Team of Yunnan Province [2019HC014]; Doctoral Innovation Fund of Kunming Medical University [2020D012]	This study was supported by the National Natural Science Foundation of China (No. 81960817; 82060241), the Association Foundation Program of Yunnan Science and Technology Department and Kunming Medical University (2018FE001[-004]), the Innovation Team of Yunnan Province (2019HC014), and the Doctoral Innovation Fund of Kunming Medical University (2020D012).	Afshordel S, 2015, PHARMACOL RES, V91, P69, DOI 10.1016/j.phrs.2014.11.006; Alam A, 2017, NEUROTOXICOL TERATOL, V60, P102, DOI 10.1016/j.ntt.2017.01.001; [Anonymous], 2017, BIOMED RES INT, DOI DOI 10.1155/2017/6352159; Bao NR, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/6136105; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Brodie EJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00401; Chu CY, 2018, NEUROCHEM RES, V43, P1714, DOI 10.1007/s11064-018-2594-8; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cortes N, 2019, J ALZHEIMERS DIS, V68, P843, DOI 10.3233/JAD-180792; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Duan X, 2014, ACTA ANAESTH SCAND, V58, P1121, DOI 10.1111/aas.12356; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Endesfelder S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171498; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Frade JM, 2015, CELL CYCLE, V14, P712, DOI 10.1080/15384101.2015.1004937; Guedes VA, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00663; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jiang LX, 2017, J CLIN ANESTH, V40, P25, DOI 10.1016/j.jclinane.2017.04.003; Jones MC, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0227; Li FY, 2018, NEUROPEPTIDES, V72, P58, DOI 10.1016/j.npep.2018.10.004; Li SZ, 2010, INT J MOL SCI, V11, P2291, DOI 10.3390/ijms11062291; Lin N, 2019, J NEUROSURG ANESTH, V31, P366, DOI 10.1097/ANA.0000000000000554; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu ZG, 2016, INT IMMUNOPHARMACOL, V35, P210, DOI 10.1016/j.intimp.2016.04.003; Lv J, 2017, ENVIRON TOXICOL PHAR, V52, P121, DOI 10.1016/j.etap.2017.03.017; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Marlier Q, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0044-7; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Myserlis P, 2020, NEUROTHERAPEUTICS, V17, P563, DOI 10.1007/s13311-020-00838-1; Ning QQ, 2017, NEUROL RES, V39, P357, DOI 10.1080/01616412.2017.1281197; Qian XL, 2015, EUR J PHARMACOL, V746, P206, DOI 10.1016/j.ejphar.2014.11.017; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Sifringer M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/530371; Sun YB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1416-5; Sun ZX, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1583-7; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tan YH, 2019, DRUG DES DEV THER, V13, P2067, DOI 10.2147/DDDT.S199572; Tang BH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00214; Wang P, 2020, ANN PALLIAT MED, V9, P2381, DOI 10.21037/apm-20-1264; Xiaoxiu Z, 2018, CHINESE ELECT J CRIT, V4, P176; Zhang QG, 2010, HIPPOCAMPUS, V20, P65, DOI 10.1002/hipo.20593; Zhu YJ, 2016, BRAIN RES, V1644, P1, DOI 10.1016/j.brainres.2016.04.074	51	1	1	0	0	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2224-5820	2224-5839		ANN PALLIAT MED	Ann. Pallliat. Med.	JAN	2021	10	1					372	+		10.21037/apm-20-2346			20	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	QC0UM	WOS:000614549600040	33545770	gold			2022-02-06	
J	Yee, J; Marchany, K; Greenan, MA; Walker, WC; Pogoda, TK				Yee, Jonathan; Marchany, Katelyn; Greenan, Mary Alexis; Walker, William C.; Pogoda, Terri K.			Potential Concussive Event Narratives of Post-9/11 Combat Veterans: Chronic Effects of Neurotrauma Consortium Study	MILITARY MEDICINE			English	Article								Introduction: Deployment-related mild traumatic brain injury (mTBI) affects a significant proportion of those who served in Post-9/11 combat operations. The prevalence of head injuries, including those that lead to mTBI, is often reported quantitatively. However, service member (SM) and Veteran firsthand accounts of their potential concussive events (PCEs) and mTBIs can serve as a rich resource for better understanding the nuances and context of these exposures. Materials and Methods: Post-9/11 SMs and Veterans with a history of combat deployment were recruited through the Chronic Effects of Neuro-trauma Consortium's observational study of deployment-related mTBI. During a comprehensive assessment, participants completed the Virginia Commonwealth University retrospective Concussion Diagnostic Interview, a specialized validated interview measure which obtains detailed narratives of deployment-incurred blast and non-blast-related PCEs. Qualitative thematic analysis was used to identify and code recurring themes within the narratives. Results: Among the sample of 106 SMs and Veterans, deployment-related mTBI was highly prevalent (67.0%). Over half (50.9%) of the participants identified a blast as the cause of their worst PCE, frequently with accompanying themes of self-reported acute neurological symptoms, intense physical blast forces, and tertiary head impact. Exposure to blast at close range, such as driving directly over an improvised explosive device, occurred in 24.7% of all blast-related narratives and in 59.3% of narratives where blast was identified as causing the worst PCE. Themes of potentially preventable head impacts experienced during noncombat circumstances were also frequent, accounting for 35% of all non-blast-related head injuries in the sample. Conclusions: Prevalence of deployment-related close-range blast exposure, non-blast impact PCEs, and mTBIs among this Post-9/11 combatant sample was substantial, and in many cases potentially preventable. The use of detailed semi-structured interviews may help health care providers and policymakers to better understand the context and circumstances of deployment-related PCEs and mTBIs.	[Yee, Jonathan; Marchany, Katelyn; Greenan, Mary Alexis; Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA 02130 USA; [Walker, William C.] Hunter Holmes McGuire VA Med Ctr, Dept Hlth Law Policy & Management, Richmond, VA 23249 USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Dept Phys Med & Rehabil, Boston, MA 02118 USA		Yee, J (corresponding author), VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA 02130 USA.				Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) [W81XWH-132-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from Department of Defense Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-132-0095 and Department of Veterans Affairs CENC Award I01 CX001135. The CENC also provided material support for the study in the form of equipment and supplies.	Attride-Stirling J., 2001, QUALITATIVE RES, V1, P385, DOI [10.1177/146879410100100307, DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Boyatzis R. E., 1998, TRANSFORMING QUALITA; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Butler FK, 2015, J TRAUMA ACUTE CARE, V79, P321, DOI 10.1097/TA.0000000000000745; Chase RP, 2015, SOC SCI MED, V147, P309, DOI 10.1016/j.socscimed.2015.11.015; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Eggleston B, 2019, BRAIN INJURY, V33, P1602, DOI 10.1080/02699052.2019.1655793; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fish L., 2018, PROTECTING WARFIGHTE; Force-7 CJT, 2004, OIF SMART CARD 4; Hatzfeld JJ, 2014, ANNU REV NURS RES-SE, V32, P41, DOI 10.1891/0739-6686.32.41; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Mendez MF, 2013, BRAIN INJURY, V27, P10, DOI 10.3109/02699052.2012.722252; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Mowatt RA, 2011, THER RECREAT J, V45, P286; O'Hanlon C, 2017, J GEN INTERN MED, V32, P105, DOI 10.1007/s11606-016-3775-2; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Palombo DJ, 2015, NEUROPSYCHOLOGY, V29, P543, DOI 10.1037/neu0000198; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575; U.S. Department of Defense and Department of Veterans Affairs, 2016, CLIN PRACTICE GUIDEL; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Watkins KE, 2016, PSYCHIAT SERV, V67, P391, DOI 10.1176/appi.ps.201400537	34	1	1	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186			1			559	566		10.1093/milmed/usaa308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ0XS	WOS:000637327600080	33499440	hybrid			2022-02-06	
J	Yurgil, KA; Barkauskas, DA; Baker, DG				Yurgil, Kate A.; Barkauskas, Donald A.; Baker, Dewleen G.			Deployment and Psychological Correlates of Suicide Ideation: A Prospective, Longitudinal Study of Risk and Resilience Among Combat Veterans	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; OPERATION ENDURING FREEDOM; ADMINISTERED PTSD SCALE; MENTAL-HEALTH PROBLEMS; MILITARY PERSONNEL; AFGHANISTAN VETERANS; FOLLOW-UP; IRAQ; ASSOCIATION	Introduction: Suicide rates among military personnel have risen in part due to war zone deployments. Yet, the degree to which deployment-related stressors, in combination with preexisting and co-occurring psychiatric symptoms and individual resilience factors, contribute to suicide ideation (SI) remains unclear. The current study leverages prospective, longitudinal data to examine both risk and protective factors associated with SI in deployed service members. Materials and Methods: Participants were 1,805 active duty enlisted Marines and Navy service members assessed before and after a 7-month deployment for SI, preexisting and concurrent symptoms of depression, post-traumatic stress disorder (PTSD), alcohol consumption, as well as prior and deployment-related traumatic brain injury (TBI). Current self-reported psychological resilience and social support were analyzed as potential protective factors. Results: Rates of SI were 7.3% and 3.9% before and after deployment, respectively. Of those with post-deployment SI, 68.6% were new-onset cases. Multivariate regression revealed that concurrent mild depression was the strongest risk factor (odds ratio [OR]= 10.03, 95% CI 5.28-19.07). Other significant risk factors included prior SI (OR= 3.36, 95% CI 1.60-7.05), prior subthreshold PTSD (OR= 2.10, 95% CI 1.10-3.99), and deployment TBI (OR= 1.84, 95% CI 1.03-3.28). Controlling for clinical symptoms and TBI, the risk of SI was reduced for those with moderate (OR= 0.50, 95% CI 0.27-0.93) and high psychological resilience scores (OR= 0.25, 95% CI 0.08-0.79) after deployment. Conclusions: Results indicate that even mild symptoms of depression and PTSD may increase the risk of SI. Screening for subthreshold clinical symptoms and TBI while incorporating psychological resilience training would allow for a more multidimensional approach to suicide risk assessment.	[Yurgil, Kate A.] Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA; [Yurgil, Kate A.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Dept Psychiat, San Diego, CA 92161 USA; [Yurgil, Kate A.; Baker, Dewleen G.] Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA; [Barkauskas, Donald A.] Univ Southern Calif, Dept Preventat Med, Keck Sch Med, Los Angeles, CA 90032 USA; [Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, Sch Med, La Jolla, CA 92093 USA		Yurgil, KA (corresponding author), Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA.; Yurgil, KA (corresponding author), VA San Diego Healthcare Syst, Dept Psychiat, San Diego, CA 92161 USA.; Yurgil, KA (corresponding author), Ctr Excellence Stress & Mental Hlth, San Diego, CA 92161 USA.				VA Health Service Research and Development [SDR 09-0128]; Navy Bureau of Medicine and Surgery; VA Center of Excellence For Stress and Mental Health; Marine Corps	Support for data collection and manuscript preparation was provided by VA Health Service Research and Development project no. SDR 09-0128, the Marine Corps and the Navy Bureau of Medicine and Surgery, and VA Center of Excellence For Stress and Mental Health.	American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Baker DG, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110134; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bethune A, 2017, ARCH SUICIDE RES, V21, P392, DOI 10.1080/13811118.2016.1199990; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, BEHAV RES THER, V33, P369, DOI 10.1016/0005-7967(94)00067-T; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Clifford RE, 2019, MIL MED, V184, P839, DOI 10.1093/milmed/usz016; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Corson K, 2013, J AFFECT DISORDERS, V149, P291, DOI 10.1016/j.jad.2013.01.043; DeBruyne NF., 2019, RL3249 CRS; Defense and Veterans Brain Injury Center Working Group, 2006, CLIN PRACTICE GUIDEL; Department of the Army, 2012, ARM 2020 GEN HLTH DI; Desseilles M, 2013, J HEAD TRAUMA REHAB, V28, P149, DOI 10.1097/HTR.0b013e3182527138; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fischer, 2019, RECENT TRENDS ACTIVE; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Green KT, 2010, J CLIN PSYCHIAT, V71, P823, DOI 10.4088/JCP.09m05780blu; Guerra VS, 2011, J ANXIETY DISORD, V25, P12, DOI 10.1016/j.janxdis.2010.06.025; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Homaifar BY, 2012, REHABIL PSYCHOL, V57, P337, DOI 10.1037/a0030480; Hosmer DW, 1999, APPL SURVIVAL ANAL R; Hostetter TA, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000489; Institute of Medicine, 2008, GULF WAR HLTH VOLUME; Jakupcak M, 2011, J NERV MENT DIS, V199, P272, DOI 10.1097/NMD.0b013e3182124604; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kalivas PW, 2003, AM J PSYCHIAT, V160, P1, DOI 10.1176/appi.ajp.160.1.1; Kimbrel NA, 2016, PSYCHIAT RES, V243, P232, DOI 10.1016/j.psychres.2016.06.039; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Lee DJ, 2018, DEPRESS ANXIETY, V35, P609, DOI 10.1002/da.22736; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Maguen S, 2011, J ANXIETY DISORD, V25, P563, DOI 10.1016/j.janxdis.2011.01.003; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mancini AD, 2009, J PERS, V77, P1805, DOI 10.1111/j.1467-6494.2009.00601.x; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Pernin C.G., 2011, WAR PREVENTING SUICI; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P720, DOI 10.1016/j.jpsychires.2010.11.015; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Roy A, 2007, DEPRESS ANXIETY, V24, P273, DOI 10.1002/da.20265; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shura RD, 2019, PSYCHOL SERV, V16, P312, DOI 10.1037/ser0000208; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Skopp Nancy A, 2012, MSMR, V19, P7; SPSS IBM, STAT WIND VERS 26 0; Stein MB, 2016, JAMA PSYCHIAT, V172, P1101; Tanielian T, 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/MG720CCF, DOI 10.7249/MG720CCF, 10.7249/mg720ccf]; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilks CR, 2019, J PSYCHIATR RES, V109, P139, DOI 10.1016/j.jpsychires.2018.11.026; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Youssef NA, 2013, ARCH SUICIDE RES, V17, P106, DOI 10.1080/13811118.2013.776445; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Yurgil KA, 2016, J HEAD TRAUMA REHAB, V31, P30, DOI 10.1097/HTR.0000000000000117; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zielinski MJ, 2017, COMPR PSYCHIAT, V73, P187, DOI 10.1016/j.comppsych.2016.11.013; Zimmerman L, 2016, MIL BEHAV HLTH, V3, P296	81	1	1	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2021	186	1-2					E58	E66		10.1093/milmed/usaa450			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SE1HS	WOS:000651826400006	33201239	Bronze			2022-02-06	
J	Zhou, JY; Zhang, X; Gao, HB; Cao, Z; Sun, W				Zhou, Jian-Yun; Zhang, Xin; Gao, Hai-Bin; Cao, Ze; Sun, Wei			Endoscopic-assisted surgery for skull defects with subdural effusion	VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES			English	Article						skull defect; subdural effusion; endoscopic	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; VENTRICULOPERITONEAL SHUNT; INTERHEMISPHERIC HYGROMA; HYDROCEPHALUS; COMPLICATIONS; CRANIOPLASTY	Introduction: Subdural effusion is a common complication that occurs after decompressive craniectomy. According to the endoscopy results, the formation mechanism of subdural effusion after decompressive craniectomy was discussed. Aim: The morphological structure of subdural effusion in skull defects was observed with endoscopy, and endoscopic-assisted surgery was performed for subdural effusion. Material and methods: From January 2018 to March 2020, 19 cases of skull repair and treatment of subdural effusion were performed. The external wall of the capsule was kept intact during the operation, subdural effusion and surgical procedure of the subdural effusion under an endoscope could be observed, and the results of endoscopic observation were described and recorded. A hemostasis gauze was placed between the two layers of the subdural effusion cavity. Another 13 cases of skull defects with subdural effusion treated without endoscopy during the same time period were enrolled in the study as the control group. The postoperative disappearance of effusion and the incidence of postoperative complications were compared between the two groups. Results: Analysis with an endoscope revealed that all cases of subdural effusion in skull defects presented capsules. The main structures included the outer wall, boundary, inner wall, and fistula. The outer wall was made up of new tissue that had formed after removing the bone flap under the skin flap by artificial peeling under the condition of keeping the whole cavity. The inner wall consisted of thickened arachnoid, dura, and artificial dura. It presented with neovascularization networks, which showed a tendency to form new membrane structures through mutual adhesion and fusion. The inner and outer wall of the skull had fused to form the boundary of the cavity. Cerebrospinal fluid fistulas were detected in 31.6% of the internal walls. Subdural effusion was effectively treated in both the experimental group and the control group. Compared with the control group, complications in the experimental group were significantly reduced. Conclusions: The effusion cavity can be divided into three types based on its structural characteristics: fistula type, membrane type, and closed type. In this study, the formation mechanism of skull defects combined with subdural effusion was explored. This represents a new method for treating subdural effusion in which hemostasis gauze is placed between the two layers of the effusion cavity and cerebrospinal fluid fistula under an endoscope, which can effectively reduce the incidence of postoperative complications.	[Zhou, Jian-Yun; Zhang, Xin; Gao, Hai-Bin; Cao, Ze; Sun, Wei] Beijing Boai Hosp, Dept Neurosurg, China Rehabil Res Ctr, 10 Jiaomen North Rd, Beijing 100068, Peoples R China; [Zhou, Jian-Yun; Zhang, Xin; Gao, Hai-Bin; Cao, Ze; Sun, Wei] Capital Med Univ, Coll Rehabil, Beijing, Peoples R China; [Sun, Wei] Beijing Inst Brain Disorders, Inst Nerve Injury & Repair, Beijing, Peoples R China		Sun, W (corresponding author), Beijing Boai Hosp, Dept Neurosurg, China Rehabil Res Ctr, 10 Jiaomen North Rd, Beijing 100068, Peoples R China.	weisun123456@yeah.net					Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Akins PT, 2019, WORLD NEUROSURG, V130, pE941, DOI 10.1016/j.wneu.2019.07.041; Avecillas-Chasin JM, 2015, ACTA NEUROCHIR, V157, P2121, DOI 10.1007/s00701-015-2537-y; Avecillas-Chasin JM, 2014, ACTA NEUROCHIR, V156, P1375, DOI 10.1007/s00701-014-2077-x; Cho Jun Beom, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P273; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kiviniemi V, 2016, J CEREBR BLOOD F MET, V36, P1033, DOI 10.1177/0271678X15622047; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Kutty RK, 2018, J NEUROSCI RURAL PRA, V9, P232, DOI 10.4103/jnrp.jnrp_395_17; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Nakada T, 2019, NEUROSCIENTIST, V25, P155, DOI 10.1177/1073858418775027; Nasi D, 2018, ACTA NEUROCHIR, V160, P1691, DOI 10.1007/s00701-018-3639-0; Park SH, 2008, J CLIN NEUROSCI, V15, P868, DOI 10.1016/j.jocn.2007.08.003; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wang YD, 2015, BRAIN INJURY, V29, P462, DOI 10.3109/02699052.2014.990513; Yoshimoto Y, 1998, J NEUROSURG, V88, P485, DOI 10.3171/jns.1998.88.3.0485	25	1	1	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1895-4588	2299-0054		VIDEOSURGERY MINIINV	Videosurgery Miniinvasive Tec.		2021	16	1					219	226		10.5114/wiitm.2020.99350			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	QP9EV	WOS:000624132700028	33786137	gold, Green Published			2022-02-06	
J	Zimmerman, SD; Vernau, BT; Meehan, WP; Master, CL				Zimmerman, Stessie Dort; Vernau, Brian T.; Meehan, William P., III; Master, Christina L.			Sports-Related Concussions and the Pediatric Patient	CLINICS IN SPORTS MEDICINE			English	Article						Pediatric concussions; Adolescent concussions; Head injury; Return to learn; Return to sport	TRAUMATIC BRAIN-INJURY; RECOVERY; CHILDREN; ADOLESCENTS; SYMPTOMS; PERFORMANCE; PREVALENCE; EXERCISE; SCHOOL; RETURN		[Zimmerman, Stessie Dort] Seattle Childrens Hosp, Urgent Care, 4800 Sand Point Way Northeast,M-S MB 7-520, Seattle, WA 98105 USA; [Vernau, Brian T.] Childrens Hosp Philadelphia, Pediat & Adolescent Sports Med, Div Pediat Orthoped, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Meehan, William P., III] Harvard Med Sch, Div Sports Med, Micheli Ctr Sports Injury Prevent, Boston Childrens Hosp, 9 Hope Ave Suite 100, Waltham, MA 02453 USA; [Master, Christina L.] Univ Penn, Childrens Hosp Philadelphia, Minds Matter Concuss Program,Perelman Sch Med, Pediat & Adolescent Sports Med,Div Pediat Orthope, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA		Master, CL (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Minds Matter Concuss Program,Perelman Sch Med, Pediat & Adolescent Sports Med,Div Pediat Orthope, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	masterc@email.chop.edu			National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; National Football League; National Institutes of Health-National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health-National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI); National Institutes of Health-National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Collegiate Athletic Association; Pennsylvania Department of Health; Children's Hospital of Philadelphia Frontier Program; Department of DefenseUnited States Department of Defense	S.D. Zimmerman: The author has nothing to disclose. B.T. Vernau: The author has nothing to disclose. W.P. Meehan III: Dr W.P. Meehan receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athletes; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and a grant from the National Football League. C. L. Master: Dr C.L. Master does not have any conflicts of interest directly related to this article, but her research is funded by the National Institutes of Health-National Institute of Neurological Disorders and Stroke, National Eye Institute, and National Institute of Nursing Research, as well as the National Collegiate Athletic Association and Department of Defense, Pennsylvania Department of Health, and the Children's Hospital of Philadelphia Frontier Program.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; Cook NE, 2019, J PEDIATR-US, V214, P168, DOI 10.1016/j.jpeds.2019.07.048; Copenhaver EA, 2017, PEDIATR ANN, V46, pE106, DOI 10.3928/19382359-20170221-01; Coxe KA, 2019, J ADOLESCENT HEALTH, DOI [10.1016/j.jadohealth.2019.08.01., DOI 10.1016/J.JADOHEALTH.2019.08.01.]; Danielson ML, 2018, J CLIN CHILD ADOLESC, V47, P199, DOI 10.1080/15374416.2017.1417860; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; DeMatteo C, 2020, CLIN PEDIATR, V59, P5, DOI 10.1177/0009922819879457; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grady MF, 2017, PEDIATR ANN, V46, pE93, DOI 10.3928/19382359-20170220-04; Haider MN, 2019, SPORTS HEALTH, V11, P492, DOI 10.1177/1941738119870189; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson W, 2015, AM MED SOC SPORTS ME; Karic S, 2019, CHILD CARE HLTH DEV, V45, P688, DOI 10.1111/cch.12684; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Sarmiento K, 2020, CLIN J SPORT MED, V30, P612, DOI 10.1097/JSM.0000000000000704; Scharf RJ, 2016, PEDIATR REV, V37, P25, DOI 10.1542/pir.2014-0103; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tomfohr-Madsen L, 2019, J HEAD TRAUMA REHAB, DOI [10.1097/HTR.0000000000000504., DOI 10.1097/HTR.0000000000000504.]	45	1	1	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2021	40	1					147	158		10.1016/j.csm.2020.08.010			12	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PE8NO	WOS:000598618400013	33187605				2022-02-06	
J	Harrison, AT; McAllister, T; McCrea, M; Broglio, SP; Moore, RD				Harrison, Adam T.; McAllister, Thomas; McCrea, Michael; Broglio, Steven P.; Moore, Robert D.		CARE Consortium Investigators	Recovery Profiles after Concussion among Male Student-Athletes and Service Cadets with a Family History of Neurodegenerative Disease: Data from the NCAA-DoD CARE Consortium	JOURNAL OF NEUROTRAUMA			English	Article						cognitive control; neurodegenerative diseases; recovery; sports-related concussion	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; PARKINSONS-DISEASE; APOLIPOPROTEIN-E; POST-CONCUSSION; NEUROCOGNITIVE PERFORMANCE; POSTCONCUSSION SYNDROME; GENETIC POLYMORPHISMS; COGNITIVE IMPAIRMENT	Preliminary evidence indicates that genetic factors associated with having a family history of neurodegenerative disease (fhNDD) may predispose an individual to persistent symptoms and poorer cognitive performance after concussion. No previous study, however, longitudinally examined athletes with (+) and without (-) a fhNDD. Therefore, we aimed to compare clinical symptoms and cognitive performance of fhNDD+ and fhNDD- athletes at baseline and at multiple time points after concussion. Questionnaire data from the Concussion Assessment, Research and Education (CARE) Consortium were used to identify male athletes and cadets with (n = 51) and without (n = 102) a fhNDD (Alzheimer disease, Parkinson disease, mild cognitive impairment, and non-Alzheimer dementia). All athletes completed the SCAT3 symptom checklist and ImPACT test before their sport season and again within 24-48 h of injury, at the unrestricted return-to-play, and at six months post-concussion. Compared with fhNDD-, fhNDD+ individuals demonstrated greater decrements in visual memory (relative to baseline) 24-48 h post-injury (p < 0.05, d = 0.18). In addition, a main effect of group was observed for impulse control. Compared with fhNDD- athletes, fhNDD+ individuals demonstrated greater decrements in impulse control, 24-48 h post-injury, at the return to play, and at six-month assessments (p < 0.01, d = 0.23). These findings suggest that male athletes with a fhNDD may exhibit greater decrements in cognitive performance after concussion. Small, subtle deficits in cognitive performance may still significantly hinder day-to-day function in student-athletes.	[Harrison, Adam T.; Moore, Robert D.] Univ South Carolina, Dept Exercise Sci, 921 Assembly St,Suite 302, Columbia, SC 29208 USA; [McAllister, Thomas] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA		Harrison, AT (corresponding author), Univ South Carolina, Dept Exercise Sci, 921 Assembly St,Suite 302, Columbia, SC 29208 USA.	harri735@email.sc.edu			Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; U.S. Army Medical Research Acquisition Activity; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brian Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity (820 Chandler Street, Fort Detrick, MD 217025014) is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brian Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, and conclusions are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Carney N, 2014, NEUROSURGERY, V75, pS1, DOI 10.1227/NEU.0000000000000434; Ciccarelli N, 2018, AGING CLIN EXP RES, V30, P877, DOI 10.1007/s40520-017-0838-0; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Evans S, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.612; Evans SL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59272-0; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hoenig MC, 2017, NEUROBIOL AGING, V57, P1, DOI 10.1016/j.neurobiolaging.2017.05.004; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kercood S, 2017, J POSTSECOND EDUC DI, V30, P329; Klebe S, 2013, J NEUROL NEUROSUR PS, V84, P666, DOI 10.1136/jnnp-2012-304475; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin YT, 2018, NEURON, V98, P1294, DOI 10.1016/j.neuron.2018.06.011; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Liu YW, 2002, J CEREBR BLOOD F MET, V22, P1336, DOI 10.1097/01.WCB.0000033200.58646.B3; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Mitchell AJ, 2010, ACTA NEUROPSYCHIATR, V22, P2, DOI 10.1111/j.1601-5215.2009.00439.x; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Soloveva MV, 2018, NEUROSCI BIOBEHAV R, V88, P155, DOI 10.1016/j.neubiorev.2018.03.003; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Welsh JA, 2010, J EDUC PSYCHOL, V102, P43, DOI 10.1037/a0016738; Yue JK, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.791; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	59	1	1	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					485	492		10.1089/neu.2020.7386		DEC 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000605064400001	33280495				2022-02-06	
J	Fisher, AP; Gies, LM; Chapman, L; Aguilar, JM; Yeates, KO; Taylor, HG; Wade, SL				Fisher, Allison P.; Gies, Lisa M.; Chapman, Leah; Aguilar, Jessica M.; Yeates, Keith Owen; Taylor, H. Gerry; Wade, Shari L.			The clinical utility of the Children's Communication Checklist-2 in children with early childhood traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Early Access						Traumatic brain injury; social communication; communication deficits; Children&#8217; s Communication Checklist; parent-report measures; neuropsychological measures; pediatric		Objective Pediatric traumatic brain injury (TBI) is associated with long-term cognitive and behavioral deficits. Social communication impairments are common and impact functional outcomes, such as social engagement and academic performance. There are many barriers to identifying social communication deficits following TBI, including the absence of a standardized parent-reported communication measure for use in this population. The Children's Communication Checklist-Second Edition (CCC-2) has demonstrated utility in identifying communication deficits in diagnoses other than TBI. This study investigated the clinical utility of the CCC-2's social communication scales in children with TBI. Method: 203 children who sustained TBI or orthopedic injuries between the ages of 36 and 83 months were recruited as part of a larger, longitudinal study. We analyzed social communication subscale scores from the CCC-2 an average of 3.5 years postinjury. We used binary logistic regression analyses to examine the measure's accuracy in classifying children with and without social communication deficits on other measures of pragmatic language and social competence. Correlation analyses and linear mixed models were used to examine the construct validity of the CCC-2. Results: The CCC-2 was able to accurately classify those with and without pragmatic language impairments on the Comprehensive Assessment of Spoken Language 92% of the time (sensitivity = 55%) and 96% of the time on the Home and Community Social Behavior scale (sensitivity = 72%). The CCC-2 demonstrated strong correlations with and predictive validity for measures of social communication and competence. Conclusions: The findings offer support for the clinical utility of the CCC-2 in the pediatric TBI population.	[Fisher, Allison P.; Gies, Lisa M.; Aguilar, Jessica M.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Fisher, Allison P.; Gies, Lisa M.; Wade, Shari L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Chapman, Leah] Wake Forest Baptist Hlth, Dept Neurol, Winston Salem, NC USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA		Fisher, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Fisher, AP (corresponding author), Univ Cincinnati, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	allison.fisher@cchmc.org	Yeates, Keith/AAJ-4223-2020	Gies, Lisa/0000-0002-8996-4281	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; State of Ohio Emergency Medical Services; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077]	This publication was supported by Grant R01 HD42729 from the National Institute of Child Health and Human Development and by Trauma Research grants from the State of Ohio Emergency Medical Services. Additional support was provided through Grant 8 UL1 TR000077 from the National Center for Advancing Translational Sciences of the National Institutes of Health.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Annett RD, 2015, PEDIATR BLOOD CANCER, V62, pS460, DOI 10.1002/pbc.25749; Atay C, 2016, J HEAD TRAUMA REHAB, V31, pE30, DOI 10.1097/HTR.0000000000000182; Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; Berenguer C, 2018, J AUTISM DEV DISORD, V48, P430, DOI 10.1007/s10803-017-3349-0; Bishop D.V.M., 2003, CHILDRENS COMMUNICAT; Bishop DVM, 2006, AM J MED GENET B, V141B, P117, DOI 10.1002/ajmg.b.30267; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chow JC, 2018, ASSES EFF INTERV, V43, P90, DOI 10.1177/1534508417702063; Ciccia AH, 2018, NEUROREHABILITATION, V42, P331, DOI 10.3233/NRE-172384; Coffey B.J., 2020, LANGUAGE NETWORK REE, DOI [https://doi.org/10.1101/2020.01.10.20017004, DOI 10.1101/2020.01.10.20017004]; Coret MC, 2015, J PSYCHOEDUC ASSESS, V33, P495, DOI 10.1177/0734282914557616; Deighton S, 2020, J HEAD TRAUMA REHAB, V35, pE113, DOI 10.1097/HTR.0000000000000515; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Elliott C. D., 1990, DIFFERENTIAL ABILITY; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Federal Financial Institutions Examination Council, GEOC SYST; Finch E, 2016, ARCH PHYS MED REHAB, V97, P1352, DOI [10.1016/j.apmr.2015.11.005, 10.1016/j.apmr.20.15.11.005]; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Franzen M.D., 2013, RELIABILITY VALIDITY; Genova HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00850; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Haarbauer-Krupa J, 2019, J HEAD TRAUMA REHAB, V34, P111, DOI 10.1097/HTR.0000000000000414; Hardy KK, 2015, NEURO-ONCOL PRACT, V2, P32, DOI 10.1093/nop/npu026; Howieson D, 2019, CLIN NEUROPSYCHOL, V33, P200, DOI 10.1080/13854046.2018.1552762; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kemp, 1998, NEPSY DEV NEUROPSYCH; Kemp S.L., 2001, ESSENTIALS NEPSY ASS; Kim SH, 2020, AM J MED GENET B, V183, P380, DOI 10.1002/ajmg.b.32809; Lloyd O, 2015, J HEAD TRAUMA REHAB, V30, P311, DOI 10.1097/HTR.0000000000000113; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Mather N., 2001, WOODCOCK JOHNSON 3 T; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Merrell K. W., 2002, PRESCHOOL KINDERGART; Merrell KM., 2002, HOME COMMUNITY SOCIA; MERRELL KW, 1993, SCHOOL PSYCHOL REV, V22, P115; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Norbury CF, 2004, INT J LANG COMM DIS, V39, P345, DOI 10.1080/13682820410001654883; Olson K, 2013, APPL NEUROPSYCH-CHIL, V2, P17, DOI 10.1080/21622965.2012.686330; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Roth R.M., 2014, HDB EXECUTIVE FUNCTI, P301, DOI DOI 10.1007/978-1-4614-8106-5_18; Russell RL, 2008, CLIN CHILD FAM PSYCH, V11, P59, DOI 10.1007/s10567-008-0032-1; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Sacco K, 2008, J COGN SCI, V9, P111; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Staikova E, 2013, J CHILD PSYCHOL PSYC, V54, P1275, DOI 10.1111/jcpp.12082; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Vogel Sally J, 2015, Alzheimers Dement (Amst), V1, P289, DOI 10.1016/j.dadm.2015.05.002; Volden J, 2010, AM J SPEECH-LANG PAT, V19, P204, DOI 10.1044/1058-0360(2010/09-0011); Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	68	1	1	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.												10.1080/13854046.2020.1866675		DEC 2020	18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	PM5TA	WOS:000603860000001	33375912				2022-02-06	
J	Schmitt, AJ; Beidler, E; O'Connor, S; Eagle, S; Wallace, J; Anderson, M; Kontos, A				Schmitt, Ara J.; Beidler, Erica; O'Connor, Siobhan; Eagle, Shawn; Wallace, Jessica; Anderson, Morgan; Kontos, Anthony			Development and factor structure of the perceptions of concussion inventory for athletes (PCI-A)	BRAIN INJURY			English	Article						Sport-related concussion; college athletes; concussion perception; factor analysis		Purpose: This study evaluated the factor structure of the Perceptions of Concussion Inventory for Athletes (PCI-A) using exploratory factor analytic (EFA) techniques in a sample of collegiate student-athletes. Perception differences by sex and sport-related concussion (SRC) risk level were explored. Methods: This cross-sectional-design study included 298 male and 183 female collegiate student-athletes from 18 sports at six institutions. Participants completed a demographic and concussion history survey, and the PCI-A. Results: The EFA revealed a 6-factor solution (Anxiety, Effects, Clarity, Treatment, Control, and Symptom Variability) that accounted for 56.1% of the variance in responses. Female collegiate student-athletes displayed statistically higher levels of Anxiety, Clarity, Symptom Variability, and Control than males. Lower concussion risk sport athletes reported statistically higher levels of anxiety surrounding SRC and concerns relating to the long-term and major effects of an SRC. Conclusions: This study provides evidence that the PCI-A is an acceptable measure to examine the perceptions of collegiate student-athletes regarding SRC. The findings supported a six-factor structure of the PCI-A in the current study for collegiate student-athletes compared to the seven-factor structure indicated in previous research. The findings reveal sex and concussion risk sport differences in PCI-A responses.	[Schmitt, Ara J.] Duquesne Univ, Dept Counseling Psychol & Special Educ, Pittsburgh, PA 15219 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [O'Connor, Siobhan] Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland; [Eagle, Shawn; Kontos, Anthony] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Wallace, Jessica] Univ Alabama, Dept Hlth Sci, Tuscaloosa, AL USA; [Anderson, Morgan] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		Schmitt, AJ (corresponding author), Duquesne Univ, Pittsburgh, PA 15219 USA.	schmitta2106@duq.edu	; O Connor, Siobhan/Q-8568-2018	Anderson, Morgan/0000-0001-9170-6663; O Connor, Siobhan/0000-0002-2001-0746; Beidler, Erica/0000-0002-0179-5074			Adame BJ, 2020, COMMUN SPORT, V8, P852, DOI 10.1177/2167479519845372; Aujla N, 2020, J HEALTH PSYCHOL, V25, P1989, DOI 10.1177/1359105318781942; Barr WB, 2013, NEUROPSYCHOL REV, V23, P271, DOI 10.1007/s11065-013-9244-3; Birchard J., 2011, SPORT EXERC PERFORM, V1, P38, DOI [DOI 10.1037/2157-3905.1.S.38, 10.1037/2157-3905.1.S.38]; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Chojnacka-Szawlowska G, 2019, PAIN MANAG NURS, V20, P599, DOI 10.1016/j.pmn.2019.02.009; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Golics CJ, 2013, INT J GEN MED, V6, P787, DOI 10.2147/IJGM.S45156; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hsu CJ, 2017, SPORTS HEALTH, V9, P162, DOI 10.1177/1941738116666813; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kontos, 2004, RELATIONSHIPS 3 COMP; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Lee Y, 2019, PATIENT PREFER ADHER, V13, P1557, DOI 10.2147/PPA.S225561; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; LEVENTHAL H, 1997, PERCEPTIONS HLTH ILL, P00001; LEVENTHAL H, 1980, MED PSYCHOL, P00517; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; Malfliet A, 2018, PHYS THER, V98, P357, DOI 10.1093/ptj/pzx092; McAllister-Deitrick J, 2022, CLIN J SPORT MED, V32, P56, DOI 10.1097/JSM.0000000000000833; McChesney K., 2014, J EXERC MED SPORTS, V46, P189; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morgan K., 2014, BMC PSYCHOL, V2, DOI 10.1186/s40359-014-0050-3; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Schmidt, 2020, ATHL TRAIN SPORTS HL, V12, P210, DOI [10.3928/19425864-20190618-01, DOI 10.3928/19425864-20190618-01]; Schmidt JD, 2020, J NEUROTRAUM, V37, P593, DOI 10.1089/neu.2019.6637; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	38	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2021	35	3					292	298		10.1080/02699052.2020.1861655		DEC 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RO9AV	WOS:000603922700001	33370168				2022-02-06	
J	Arora, R; White, EN; Niedbala, D; Ravichandran, Y; Sethuraman, U; Radovic, N; Watson, K; Nypaver, M				Arora, Rajan; White, Emily N.; Niedbala, Deborah; Ravichandran, Yagnaram; Sethuraman, Usha; Radovic, Nancy; Watson, Kristin; Nypaver, Michele			Reducing Computed Tomography Scan Utilization for Pediatric Minor Head Injury in the Emergency Department: A Quality Improvement Initiative	ACADEMIC EMERGENCY MEDICINE			English	Article							CLINICAL DECISION-SUPPORT; UNITED-STATES; CHILDREN; TRAUMA; TRENDS	Background The validated Pediatric Emergency Care Applied Research Network (PECARN) prediction rules are meant to aid clinicians in safely reducing unwarranted imaging in children with minor head injuries (MHI). Even so, computed tomography (CT) scan utilization remains high, especially in intermediate-risk (per PECARN) MHI patients. The primary objective of this quality improvement initiative was to reduce CT utilization rates in the intermediate-risk MHI patients. Methods This project was conducted in a Level I trauma pediatric emergency department (ED). Children < 18 years evaluated for intermediate-risk MHI from June 2016 through July 2019 were included. Our key drivers were provider education, decision support, and performance feedback. Our primary outcome was change in head CT utilization rate (%). Balancing measures included return visit within 72 hours of the index visit, ED length of stay (LOS), and clinically important traumatic brain injury (ciTBI) on the revisit. We used statistical process control methodology to assess head CT rates over time. Results A total of 1,535 eligible intermediate-risk MHI patients were analyzed. Our intervention bundle was associated with a decrease in CT use from 18.5% (95% confidence interval [CI] = 14.5% to 22.5%) in the preintervention period to 13.9% (95% CI = 13.8% to 14.1%) in the postintervention period, an absolute reduction of 4.6% (p = 0.015). Over time, no difference was noted in either ED LOS or return visit rate. There was only one revisit with a ciTBI to our institution during the study period. Conclusions Our multifaceted quality improvement initiative was both safe and effective in reducing our CT utilization rates in children with intermediate-risk MHI.	[Arora, Rajan; Ravichandran, Yagnaram; Sethuraman, Usha] Cent Michigan Univ, Dept Pediat, Div Pediat Emergency Med, Childrens Hosp Michigan, Detroit, MI 48226 USA; [White, Emily N.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Niedbala, Deborah; Radovic, Nancy; Watson, Kristin] Childrens Hosp Michigan, Dept Qual, Detroit, MI 48201 USA; [Ravichandran, Yagnaram] Wright State Univ, Dayton Childrens Hosp, Dept Pediat, Dayton, OH 45435 USA; [Nypaver, Michele] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Nypaver, Michele] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA		Arora, R (corresponding author), Cent Michigan Univ, Dept Pediat, Div Pediat Emergency Med, Childrens Hosp Michigan, Detroit, MI 48226 USA.	rarora@dmc.org			Blue Cross Blue Shield of Michigan; Blue Care Network	The Michigan Emergency Department Improvement Collaborative (MEDIC) is supported by Blue Cross Blue Shield of Michigan and Blue Care Network.	Atabaki Shireen M, 2017, Pediatr Qual Saf, V2, pe019, DOI 10.1097/pq9.0000000000000019; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Ballard DW, 2019, ANN EMERG MED, V73, P440, DOI 10.1016/j.annemergmed.2018.11.011; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Forrest CB, 2013, PEDIATRICS, V131, pE1071, DOI 10.1542/peds.2012-1988; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Jamtvedt G, 2006, QUAL SAF HEALTH CARE, V15, P433, DOI 10.1136/qshc.2006.018549; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Navathe AS, 2016, JAMA-J AM MED ASSOC, V316, P1759, DOI 10.1001/jama.2016.13739; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Puffenbarger MS, 2019, ACAD EMERG MED, V26, P784, DOI 10.1111/acem.13666; Sencer A, 2012, J NEUROSURG-PEDIATR, V9, P139, DOI 10.3171/2011.11.PEDS11177; Tham E, 2016, APPL CLIN INFORM, V7, P534, DOI 10.4338/ACI-2015-10-CR-0144	25	1	1	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUN	2021	28	6					655	665		10.1111/acem.14177		DEC 2020	11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	TD1IX	WOS:000602137800001	33368815				2022-02-06	
J	Bakhtiarydavijani, A; Khalid, G; Murphy, MA; Johnson, KL; Peterson, LE; Jones, M; Horstemeyer, MF; Dobbins, AC; Prabhu, RK				Bakhtiarydavijani, A.; Khalid, G.; Murphy, M. A.; Johnson, K. L.; Peterson, L. E.; Jones, M.; Horstemeyer, M. F.; Dobbins, A. C.; Prabhu, R. K.			A mesoscale finite element modeling approach for understanding brain morphology and material heterogeneity effects in chronic traumatic encephalopathy	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Mesoscale modeling; multiscale modeling; chronic traumatic encephalopathy; sulci; traumatic brain injury; American football		Chronic Traumatic Encephalopathy (CTE) affects a significant portion of athletes in contact sports but is difficult to quantify using clinical examinations and modeling approaches. We use an in silico approach to quantify CTE biomechanics using mesoscale Finite Element (FE) analysis that bridges with macroscale whole head FE analysis. The sulci geometry produces complex stress waves that interact with one another to create increased shear stresses at the sulci depth that are significantly larger than in analyses without sulci (from 0.5 to 18.0 kPa). Sulci peak stress concentration regions coincide with experimentally observed CTE sites documented in the literature.	[Bakhtiarydavijani, A.; Murphy, M. A.; Peterson, L. E.; Prabhu, R. K.] Mississippi State Univ, Ctr Adv Vehicular Syst, Starkville, MS 39759 USA; [Khalid, G.] Middle Tech Univ, Baghdad, Iraq; [Johnson, K. L.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA; [Jones, M.] Cardiff Univ, Inst Med Engn & Med Phys, Cardiff, Wales; [Horstemeyer, M. F.] Liberty Univ, Lynchburg, VA USA; [Dobbins, A. C.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Prabhu, R. K.] Mississippi State Univ, Dept Agr & Biol Engn, Starkville, MS 39759 USA		Prabhu, RK (corresponding author), Mississippi State Univ, Ctr Adv Vehicular Syst, Starkville, MS 39759 USA.; Prabhu, RK (corresponding author), Mississippi State Univ, Dept Agr & Biol Engn, Starkville, MS 39759 USA.	rprabhu@abe.msstate.edu	khalid, ghaidaa/D-2694-2019; Prabhu, Raj/M-7188-2017	khalid, ghaidaa/0000-0001-6270-6445; Bakhtiarydavijani, Amirhamed/0000-0002-1483-5346; Murphy, Michael/0000-0001-9158-1709; Prabhu, Raj/0000-0002-6073-4802	Center for Advanced Vehicular Systems (CAVS) at Mississippi State University	The authors would like to acknowledge the Center for Advanced Vehicular Systems (CAVS) at Mississippi State University for supporting this work.	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Allman John, 2000, EVOLVING BRAINS; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bakhtiarydavijani A, 2019, MODEL SIMUL MATER SC, V27, DOI 10.1088/1361-651X/ab1efe; Bakhtiarydavijani AH, 2019, BIOPHYS J, V116, p322A, DOI 10.1016/j.bpj.2018.11.1748; Bayly PV, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/016005; Beusenberg, 2001, P INT RES COUNC BIOK, P353; Beusenberg MC., 2000, P INT RES C BIOM IMP; Budday S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05644; Cajigal S., 2007, NEUROLOGY TODAY, V7, P1; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; El Sayed T, 2008, J BIOMECH, V41, P1458, DOI 10.1016/j.jbiomech.2008.02.023; Farid MH, 2018, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2017, VOL 3, DOI 10.1115/IMECE2017-70356; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Francis DK, 2014, INT J SOLIDS STRUCT, V51, P2765, DOI 10.1016/j.ijsolstr.2014.03.025; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Ho J, 2009, INT J CRASHWORTHINES, V14, P555, DOI 10.1080/13588260902895708; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Horstemeyer MF, 2019, ANN BIOMED ENG, V47, P1873, DOI 10.1007/s10439-019-02294-1; Hosseini-Farid M, 2019, INT J NONLIN MECH, V116, P147, DOI 10.1016/j.ijnonlinmec.2019.06.008; Johnson KL, 2016, MATER DESIGN, V111, P108, DOI 10.1016/j.matdes.2016.08.064; Katsumoto A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00980; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Lamy Michael, 2011, Ann Adv Automot Med, V55, P125; Lauret C, 2009, MED ENG PHYS, V31, P392, DOI 10.1016/j.medengphy.2008.05.004; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Murphy MA, 2019, J BIOMOL STRUCT DYN, V37, P1346, DOI 10.1080/07391102.2018.1453376; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Newman, 1986, GEN ACCELERATION MOD; Newman J.A., 2000, STAPP CAR CRASH J; Noel L, 2019, COMPUT MECH, V64, P1375, DOI 10.1007/s00466-019-01717-z; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Raghavan R, 1997, J THEOR BIOL, V187, P285, DOI 10.1006/jtbi.1997.0450; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Song XW, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/816405; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Takhounts EG, 2008, STAPP CAR C, V52, P1; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Yang B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/408278; Yao JF, 2008, SAFETY SCI, V46, P1103, DOI 10.1016/j.ssci.2007.06.021	62	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	SEP 8	2021	24	11					1169	1183		10.1080/10255842.2020.1867851		DEC 2020	15	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	UM6UE	WOS:000622247300001	33635182	Green Submitted			2022-02-06	
J	Yeshokumar, AK; Blum, RA; Randell, T; Jette, N; Easton, A				Yeshokumar, Anusha K.; Blum, Raia A.; Randell, Taylor; Jette, Nathalie; Easton, Ava			Exploration of patient- and relative-reported outcomes of cognitive, emotional, and social function after encephalitis	BRAIN INJURY			English	Article						Encephalitis; outcomes; relatives; EBIQ		Objective: We evaluated cognitive, emotional, and social function after encephalitis, as perceived and reported by individuals post-encephalitis and their relatives. Hypothesis: There will be differential effects on various domains as self-reported by individuals post-encephalitis. Outcomes will be worse than in prior studies of other forms of acute brain injury. Post-encephalitis relative-report will demonstrate worse outcomes than self-report. Methods and Procedures: Members of The Encephalitis Society residing in the United Kingdom and Ireland were recruited to complete a demographic questionnaire and the European Brain Injury Questionnaire (EBIQ). Results: 266 individuals affected by encephalitis and 140 relatives participated in this study. The three domains with the highest (worst) mean scores were somatic, cognitive, and communication (p < .001). Individuals post-encephalitis self-reported worse outcomes than individuals post-stroke in seven of nine domains (p < .005), but there were no differences compared to individuals post-traumatic brain injury (TBI). Relatives reported worse encephalitis outcomes in seven of nine domains than did individuals directly affected by encephalitis (p < .005). Conclusions: Individuals affected by encephalitis experience the most significant symptoms in the somatic, cognitive, and communication domains. Outcomes as assessed by relatives were notably worse than those assessed by individuals themselves in nearly all domains.	[Yeshokumar, Anusha K.; Blum, Raia A.; Randell, Taylor; Jette, Nathalie] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Easton, Ava] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Easton, Ava] Encephalitis Soc, Malton YO17 7JQ, N Yorkshire, England		Easton, A (corresponding author), Encephalitis Soc, Malton YO17 7JQ, N Yorkshire, England.	Ava@encephalitis.info					Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Blum RA, 2020, EPILEPSY BEHAV, V108, DOI 10.1016/j.yebeh.2020.107088; Chaudhuri A, 2002, POSTGRAD MED J, V78, P575, DOI 10.1136/pmj.78.924.575; Chen W, 2018, EUR J NEUROL, V25, P1228, DOI 10.1111/ene.13678; Dowell, 2006, J NEUROSCI NURS, V2, P488, DOI [10.12968/bjnn.2006.2.10.22531, DOI 10.12968/BJNN.2006.2.10.22531]; Easton A., 2016, LIFE ENCEPHALITIS NA; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Finke C, 2012, J NEUROL NEUROSUR PS, V83, P195, DOI 10.1136/jnnp-2011-300411; Granerod J, 2017, J NEUROL, V264, P407, DOI 10.1007/s00415-016-8316-8; Harris L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230436; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Jmor F, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-134; Kang J, 2021, AUST CRIT CARE, V34, P246, DOI 10.1016/j.aucc.2020.08.006; Khandaker G, 2016, DEV MED CHILD NEUROL, V58, P1108, DOI 10.1111/dmcn.13197; LaBuzetta JN, 2019, NEUROCRIT CARE, V31, P534, DOI 10.1007/s12028-019-00826-0; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; McKeon GL, 2018, J CLIN EXP NEUROPSYC, V40, P234, DOI 10.1080/13803395.2017.1329408; Michaeli O, 2014, PEDIATRICS, V133, pE546, DOI 10.1542/peds.2013-3010; Moorthi S, 1999, BRAIN INJURY, V13, P139, DOI 10.1080/026990599121809; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Pewter SM, 2007, NEUROPSYCHOL REHABIL, V17, P478, DOI 10.1080/09602010701202238; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Ramanuj PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103496; Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; Su H, 2021, J ADV NURS, V77, P653, DOI 10.1111/jan.14631; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; TEASDALE T, 1997, BRAIN INJURY, V11; Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1; Tomlinson AR, 2020, EPILEPSY BEHAV, V108, DOI 10.1016/j.yebeh.2020.107066; van den Born-van Zanten SA, 2016, REHABIL PSYCHOL, V61, P173, DOI 10.1037/rep0000081; Yeshokumar AK, 2017, J NEUROIMMUNOL, V312, P8, DOI 10.1016/j.jneuroim.2017.08.010	33	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 18	2021	35	2					255	263		10.1080/02699052.2020.1865567		DEC 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QW7IZ	WOS:000603770600001	33356613				2022-02-06	
J	Beuriat, PA; Cohen-Zimerman, S; Smith, GNL; Krueger, F; Gordon, B; Grafman, J				Beuriat, Pierre-Aurelien; Cohen-Zimerman, Shira; Smith, Gretchen N. L.; Krueger, Frank; Gordon, Barry; Grafman, Jordan			A New Insight on the Role of the Cerebellum for Executive Functions and Emotion Processing in Adults	FRONTIERS IN NEUROLOGY			English	Article						cerebellum; executive functions; emotion; brain network; traumatic brain injury	COGNITIVE DEFICITS; BRAIN-DAMAGE; LESIONS	Objective: We investigated whether the cerebellum plays a critical or supportive role in in executive and emotion processes in adults. Many investigators now espouse the hypothesis that participants with cerebellar lesions experience executive functions and emotions (EE) disorders. But we hypothesized that these disorders would be milder if the damage is relatively limited to the cerebellum compared to damage involving the cerebellum plus additional cortical areas. Methods: We studied veterans with penetrating Traumatic Brain Injury (pTBI) participating in the Vietnam Head Injury Study (VHIS). We selected veterans with a cerebellar lesion (n = 24), a prefrontal cortex lesion (n = 20), along with healthy controls (HC) (n = 55). Tests of executive functions and emotions were analyzed as well as caregiver burden. We performed between-group null hypothesis significance testing, Bayesian hypothesis tests and correlational analyses. Results: Performance of participants with cerebellar lesions which extended to the cerebral cortex was similar to the HC on the Executive Function tests but they were significantly impaired on the Working Memory Index. No differences were found on the emotional processing tasks with one exception-the Facial Expression of Emotion-Test (FEEST). We then examined a sub-group of participants with large cerebellar lesions (>15%) but minimal lesions in the cerebral cortex (<15%). This sub-group of participants performed similarly to the HC on the Working Memory Index and on the FEEST. Conclusions: We suggest that the cerebellar cortex may not be critical for executive functions or processing emotional stimuli in adults as suggested. Instead, we find that the cerebellum has a supportive role characterized by its computing of the motor requirements when EE processing is required.	[Beuriat, Pierre-Aurelien; Cohen-Zimerman, Shira; Smith, Gretchen N. L.; Grafman, Jordan] Shirley Ryan Abil Lab, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL 60611 USA; [Beuriat, Pierre-Aurelien] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Beuriat, Pierre-Aurelien] Hosp Civils Lyon, Hop Femme Mere Enfant, Dept Pediat Neurosurg, Lyon, France; [Beuriat, Pierre-Aurelien] Claude Bernard Univ, Rockfeller Sch Med, Lyon, France; [Krueger, Frank] George Mason Univ, Sch Syst Biol, Fairfax, VA USA; [Krueger, Frank] Univ Mannheim, Dept Psychol, Mannheim, Germany; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Cognit Neurol & Alzheimers Dis, Chicago, IL 60611 USA		Beuriat, PA (corresponding author), Shirley Ryan Abil Lab, Brain Injury Res, Cognit Neurosci Lab, Chicago, IL 60611 USA.; Beuriat, PA (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.; Beuriat, PA (corresponding author), Hosp Civils Lyon, Hop Femme Mere Enfant, Dept Pediat Neurosurg, Lyon, France.; Beuriat, PA (corresponding author), Claude Bernard Univ, Rockfeller Sch Med, Lyon, France.	pierre-aurelien.beuriat@chu-lyon.fr	Cohen-Zimerman, Shira/X-8330-2019	Cohen-Zimerman, Shira/0000-0001-6098-2550	Therapeutic Cognitive Neuroscience Fund	This research was supported by the Therapeutic Cognitive Neuroscience Fund (BG).	Adamaszek M, 2017, CEREBELLUM, V16, P552, DOI 10.1007/s12311-016-0815-8; Alexander MP, 2012, CORTEX, V48, P980, DOI 10.1016/j.cortex.2011.03.012; [Anonymous], HOM MRICROGL; Beldarrain MG, 1997, EUR NEUROL, V37, P82; Beuriat PA, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa027; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Cohen-Zimerman S, 2018, TRENDS NEUROSCI EDUC, V13, P1, DOI 10.1016/j.tine.2018.08.001; Cohen-Zimerman S, 2017, NEUROPSYCHOLOGIA, V107, P68, DOI 10.1016/j.neuropsychologia.2017.11.007; Courchesne E, 1997, LEARN MEMORY, V4, P1, DOI 10.1101/lm.4.1.1; Cristofori I, 2019, HAND CLINIC, V163, P197, DOI 10.1016/B978-0-12-804281-6.00011-2; Cristofori I, 2018, COGN AFFECT BEHAV NE, V18, P925, DOI 10.3758/s13415-018-0613-5; Dennis M, 1996, J NEURO-ONCOL, V29, P91, DOI 10.1007/BF00165522; Desmurget M, 2007, BRAIN, V130, P898, DOI 10.1093/brain/awl300; Desmurget M, 2018, CURR BIOL, V28, P3303, DOI 10.1016/j.cub.2018.08.027; Dimitrov M, 1996, BEHAV BRAIN RES, V79, P131, DOI 10.1016/0166-4328(96)00007-1; Gottwald B, 2004, J NEUROL NEUROSUR PS, V75, P1524, DOI 10.1136/jnnp.2003.018093; GRAFMAN J, 1992, NEUROLOGY, V42, P1493, DOI 10.1212/WNL.42.8.1493; Hogeveen J, 2016, NEUROPSYCHOLOGIA, V82, P142, DOI 10.1016/j.neuropsychologia.2016.01.021; Hokkanen LSK, 2006, EUR J NEUROL, V13, P161, DOI 10.1111/j.1468-1331.2006.01157.x; IRLE E, 1987, BRAIN RES REV, V12, P307, DOI 10.1016/0165-0173(87)90003-8; JASP Team, 2019, JASP VERS 0 11 1; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; King M, 2019, NAT NEUROSCI, V22, P1371, DOI 10.1038/s41593-019-0436-x; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Kruschke J.K, 2014, DOING BAYESIAN DATA, DOI [10.1016/B978-0-12-405888-0.00008-8, DOI 10.1016/B978-0-12-405888-0.00008-8]; Leggio MG, 2000, J NEUROL NEUROSUR PS, V69, P102, DOI 10.1136/jnnp.69.1.102; Lettieri G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13599-z; Manto M, 2002, CEREBELLUM ITS DISOR, DOI [10.1017/CBO9780511666469, DOI 10.1017/CBO9780511666469]; Mottolese C, 2015, NEUROCHIRURGIE, V61, P101, DOI 10.1016/j.neuchi.2013.05.004; Mottolese C, 2013, BRAIN, V136, P330, DOI 10.1093/brain/aws186; Nummenmaa L, 2012, P NATL ACAD SCI USA, V109, P9599, DOI 10.1073/pnas.1206095109; Ravizza SM, 2001, BRAIN LANG, V77, P95, DOI 10.1006/brln.2000.2435; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Richter S, 2007, NEUROCASE, V13, P25, DOI 10.1080/13554790601186942; Robinson KE, 2013, J INT NEUROPSYCH SOC, V19, P44, DOI 10.1017/S1355617712000987; Sarikaya Hakan, 2018, Handb Clin Neurol, V155, P301, DOI 10.1016/B978-0-444-64189-2.00020-2; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 2019, NEUROSCI LETT, V688, P62, DOI 10.1016/j.neulet.2018.07.005; Spunt RP, 2019, NEUROSCI LETT, V693, P44, DOI 10.1016/j.neulet.2017.06.018; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105	43	1	1	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 23	2020	11								593490	10.3389/fneur.2020.593490			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PP6GT	WOS:000605959600001	33424746	Green Published, gold			2022-02-06	
J	DeMartini, AL; Kim, S; Connaughton, DP; McArdle, D				DeMartini, Anne L.; Kim, Sungwon; Connaughton, Daniel P.; McArdle, David			A comparison of US and Scotland youth soccer coaches' legal consciousness regarding concussion safety regulations	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Association football; coach education; sports law; traumatic brain injury		Due to the severe health consequences of sport related concussion (SRC), governments and sport governing bodies around the world have enacted numerous measures including changes to legislation and rules of the game, and increased emphasis on coach education. This study compared the legal consciousness of girls' youth soccer coaches regarding concussion management under a statutory legal regime in the U.S. and a voluntary regime in Scotland by analyzing qualitative data through ten interviews of girls' youth soccer coaches in Scotland and another ten interviews of girls' high school soccer coaches in the U.S. Utilizing the socio-legal theory of legal consciousness, the findings support the idea that people make connections from their past experiences to shape their understanding of the law, broadly defined. We observed variance between U.S. and Scottish coaches' legal consciousness. Overall, all coaches exhibited a version of conformity to and engagement with SRC management guidance and little resistance. Florida coaches displayed more conformity, likely due to the SRC education mandated by law. Scottish coaches who had coached in the U.S. previously demonstrated the strongest resistance. The findings suggest a need for continued improvement in the implementation of SRC laws and guidelines including updated training and better dissemination of educational materials.	[DeMartini, Anne L.] Flagler Coll, Sport Management Program, 74 King St, St Augustine, FL 32080 USA; [Kim, Sungwon] St Johns Univ, Div Sport Management, Collins Coll Profess Studies, Jamaica, NY 11439 USA; [Connaughton, Daniel P.] Univ Florida, Coll Hlth & Human Performance, Dept Sport Management, Gainesville, FL USA; [McArdle, David] Stirling Univ, Law & Philosophy Div, Stirling, Scotland		DeMartini, AL (corresponding author), Flagler Coll, Sport Management Program, 74 King St, St Augustine, FL 32080 USA.	ademartini@flagler.edu		DeMartini, Anne/0000-0001-5921-0641; Connaughton, Daniel/0000-0001-7421-3138	Royal Society of Edinburgh Arts and Humanities Small Research Grant	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: McArdle received a Royal Society of Edinburgh Arts and Humanities Small Research Grant.	Abbott KW, 2000, INT ORGAN, V54, P421, DOI 10.1162/002081800551280; Abrego LJ, 2019, LAW SOC REV, V53, P641, DOI 10.1111/lasr.12414; Anderson M., 2019, KINESIOL REV, V8, P220; [Anonymous], 2019, SCOTTISH SPORTS CONC; [Anonymous], 2020, STAFF; [Anonymous], 2019, STAFF; Augustine D, 2019, LAW SOCIAL INQUIRY, V44, P726, DOI 10.1017/lsi.2018.23; Baugh CM., 2017, J HLTH CARE LAW POLI, V19, P99; Baye MR, 2005, ECON J, V115, P583, DOI 10.1111/j.1468-0297.2005.01010.x; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bowen v., 2019, TELFAIR COUNTY SCH D, P1265; Cane J., 2008, NEW OXFORD COMPANION, P1200; Cole SA, 2009, STANFORD LAW REV, V61, P1335; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Cornut St-Pierre P, 2019, LAW SOC REV, V53, P323, DOI 10.1111/lasr.12397; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davies S, 2018, J ATHL TRAINING, V53, P873, DOI 10.4085/1062-6050-529-17; Ewick P, 2003, AM J SOCIOL, V108, P1328, DOI 10.1086/378035; Finch CF, 2013, BRIT J SPORT MED, V47, P12, DOI 10.1136/bjsports-2012-091796; Haltom William, 2004, DISTORTING LAW POLIT; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey Hosea H, 2014, Yale J Health Policy Law Ethics, V14, P66; Hauser W, 2018, AM J CRIM JUSTICE, V43, P247, DOI 10.1007/s12103-017-9398-2; Ketcham, 2017, NEUROSCIENCE RES PRO; Kim S, 2017, J LEG ASP SPORT, V27, P162, DOI [10.1123/jlas. 2016-0007, DOI 10.1123/JLAS.2016-0007]; Klambauer E, 2019, INT J LAW CONTEXT, V15, P327, DOI 10.1017/S1744552319000041; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kurkchiyan, 2011, WIS INT LAW J, V29, P366; Levine K, 2001, LAW SOCIAL INQUIRY, V26, P169, DOI 10.1111/j.1747-4469.2001.tb00175.x; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; McArdle D, 2021, SCOTT AFF, V30, P53, DOI 10.3366/scot.2021.0352; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nguyen DHK., 2018, J COLL U STUDENT HOU, V44, P126; Nielsen LB, 2000, LAW SOC REV, V34, P1055, DOI 10.2307/3115131; Podlas K., 2004, GOLDEN GATE U L REV, V34, P239; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Roberts CNJ., 2008, ANN REV LAW SOC, V4, P40; Saldaa J., 2015, CODING MANUAL QUALIT; Sarat A., 1990, YALE JL HUMANS, V2, P343; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Scottish Football Association, 2018, CONC MAN GUID UPD; @ ScottishFA, 2018, NEW IF DOUBT SIT THE; Shen FX., 2018, DUQ L REV, V56, P7; Silbey, 2005, ANN REV LAW SOC, V1, P45; Silbey, 1998, COMMON PLACE LAW, P28; Silbey SusanS., 2018, DROIT SOC, V3, P685; Sunshine J, 2003, LAW SOC REV, V37, P513, DOI 10.1111/1540-5893.3703002; Swank, 2017, VALLEY CHRISTIAN SCH, P663; Trebilcock, 2016, GLOBAL ENV GOVERNANC; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Watson A, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2759; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yeo PC, 2020, J SPORT SCI MED, V19, P65; Young KM, 2020, LAW SOC REV, V54, P33, DOI 10.1111/lasr.12455; Young KM, 2014, LAW SOC REV, V48, P499, DOI 10.1111/lasr.12094; Zielezienski SJ., 2001, FLORIDA STATE L REV, V28, P855; Zynda Aaron J, 2020, Int J Exerc Sci, V13, P87	62	1	1	2	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	JUN	2021	16	3					554	567	1747954120981197	10.1177/1747954120981197		DEC 2020	14	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	SQ0KV	WOS:000608781300001		Green Accepted			2022-02-06	
J	Allen, N; Hevey, D; Carton, S; O'Keeffe, F				Allen, Niamh; Hevey, David; Carton, Simone; O'Keeffe, Fiadhnait			Life is about "constant evolution": the experience of living with an acquired brain injury in individuals who report higher or lower posttraumatic growth	DISABILITY AND REHABILITATION			English	Article; Early Access						post-traumatic growth; acquired brain injury; traumatic brain injury; rehabilitation; qualitative; comparison groups		Objective To explore the experience of living with an Acquired Brain Injury (ABI) in individuals who report higher or lower posttraumatic growth (PTG). Method A multi-method design was employed. Participant scores on the Posttraumatic Growth Inventory (PTGI) were used to identify groups for qualitative comparative analysis. Individual semi-structured interviews were conducted with fourteen individuals with ABI. Data were analysed thematically. Results Four themes emerged. The first two themes: "In my mind I was fine" surviving in aftermath of acquiring a brain injury and The everyday as "derailing" capture the transition process from an initial rehabilitation state characterised by neuropsychological and avoidance coping, towards active rebuilding for PTG. Internal building blocks for PTG and Growing in the social world: "you need to have that social connection" elaborate on the internal (e.g., acceptance, integration of the pre and post-injury self) and external (e.g., social relationships) factors seen to facilitate or obstruct PTG. Conclusions Under certain conditions, individuals living with ABI may construe positive growth from their experiences. Practitioners can support PTG development by providing individual and family-based supports aimed at increasing acceptance, the integration of self, and social connection throughout all stages of ABI rehabilitation.	[Allen, Niamh; Hevey, David] Trinity Coll Dublin, Sch Psychol, Dublin, Ireland; [O'Keeffe, Fiadhnait] St Vincents Univ Hosp, Elmpk, Dublin, Ireland; [Carton, Simone] Natl Rehabil Hosp, Dublin, Ireland		Allen, N (corresponding author), Trinity Coll Dublin, Sch Psychol, Dublin, Ireland.	allenni@tcd.ie		Hevey, David/0000-0003-2844-0449; Allen, Niamh/0000-0003-1902-3141			Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Ackroyd K, 2011, J CLIN PSYCHOL MED S, V18, P372, DOI 10.1007/s10880-011-9265-0; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Ashworth F, 2015, PSYCHOL PSYCHOTHER-T, V88, P143, DOI 10.1111/papt.12037; Askew J, 2009, HEALTH CARE WOMEN IN, V30, P728, DOI 10.1080/07399330903018427; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Beadle EJ, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000158; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Boals A, 2020, J LOSS TRAUMA, V25, P74, DOI 10.1080/15325024.2019.1655988; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Braun V., 2012, APA HANDBOOK OF RESE, V2, P57, DOI DOI 10.1037/13620-004; Braun V, 2021, QUAL RES SPORT EXERC, V13, P201, DOI 10.1080/2159676X.2019.1704846; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Burke S, 2020, HEALTH POLICY, V124, P225, DOI 10.1016/j.healthpol.2019.12.018; Calhoun, 1995, TRAUMA TRANSFORMATIO; Calhoun LG, 1998, J SOC ISSUES, V54, P357, DOI 10.1111/0022-4537.701998070; Cann A, 2011, ANXIETY STRESS COPIN, V24, P137, DOI 10.1080/10615806.2010.529901; Cappa KA, 2011, HEALTH PSYCHOL, V30, P542, DOI 10.1037/a0025220; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Couchman G, 2014, NEUROPSYCHOL REHABIL, V24, P809, DOI 10.1080/09602011.2014.912957; D'Cruz K, 2019, NEUROPSYCHOL REHABIL, V29, P985, DOI 10.1080/09602011.2017.1361844; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Evans S., 2017, NEUROPSYCHOLOGIST, V3, P58; Fletcher AJ, 2017, INT J SOC RES METHOD, V20, P181, DOI 10.1080/13645579.2016.1144401; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Fraas MR, 2009, AM J SPEECH-LANG PAT, V18, P315, DOI 10.1044/1058-0360(2009/08-0008); Frazier P, 2009, PSYCHOL SCI, V20, P912, DOI 10.1111/j.1467-9280.2009.02381.x; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Gilbert, 2009, ADV PSYCHIAT TREATME, V15, P199, DOI [10.1192/apt.bp.107.005264, https://doi.org/10.1192/apt.bp.107.005264, DOI 10.1192/APT.BP.107.005264, 10.1192/apt.bp.107.005264.]; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gleibs IH, 2011, PSYCHOL HEALTH, V26, P1361, DOI 10.1080/08870446.2010.529140; Gosling J, 1999, BRAIN INJURY, V13, P785; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Gratz K. L., 2010, ASSESSING MINDFULNES, P107, DOI DOI 10.1037/A0022144; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Haslam S.A., 2009, PSYCHOL PROSOCIAL BE, DOI DOI 10.1002/9781444307948.CH7; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Health Service Executive (HSE) , 2019, NATL STRATEGY POLICY; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Holloway M., 2014, SOCIAL CARE NEURODIS, V5, P201, DOI [10.1108/SCN-12-2013-0043, DOI 10.1108/SCN-12-2013-0043]; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Joseph S, 2012, CLIN PSYCHOL PSYCHOT, V19, P316, DOI 10.1002/cpp.1798; Karagiorgou O, 2018, DISABIL REHABIL, V40, P655, DOI 10.1080/09638288.2016.1274337; Karagiorgou O, 2016, J LOSS TRAUMA, V21, P589, DOI 10.1080/15325024.2016.1161427; Kashdan TB, 2011, PERS INDIV DIFFER, V50, P84, DOI 10.1016/j.paid.2010.08.028; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Kuenemund A, 2016, J HEALTH PSYCHOL, V21, P679, DOI 10.1177/1359105314535457; Laroi F, 2003, BRAIN INJURY, V17, P175, DOI 10.1080/0269905021000010140; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Lindsay S, 2019, QUAL HEALTH RES, V29, P455, DOI 10.1177/1049732318807208; Lyon I, 2021, DISABIL REHABIL, V43, P3225, DOI 10.1080/09638288.2020.1741699; Maercker A, 2004, PSYCHOL INQ, V15, P41; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Moola FJ, 2012, QUAL HEALTH RES, V22, P212, DOI 10.1177/1049732311421486; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Muldoon OT, 2019, EUR REV SOC PSYCHOL, V30, P311, DOI 10.1080/10463283.2020.1711628; Muldoon OT, 2019, EUR J SOC PSYCHOL, V49, P1272, DOI 10.1002/ejsp.2564; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; O'Keeffe F, 2020, BRAIN INJURY, V34, P496, DOI 10.1080/02699052.2020.1725641; Odumuyiwa M, 2019, J LONG TERM CARE, P164, DOI DOI 10.31389/JLTC.6; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Pais-Hrit C., 2019, NEUROPSYCHOL REHABIL, V30, P1; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2, DOI 10.1037/1089-2680.1.2.115, 10.1037/1089-2680.1.2.115]; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Rigon J, 2017, RESTOR NEUROL NEUROS, V35, P115, DOI 10.3233/RNN-150538; Ritchie J., 2014, QUALITATIVE RES PRAC, V2nd; Rogan C, 2013, NEUROPSYCHOL REHABIL, V23, P639, DOI 10.1080/09602011.2013.799076; Roundhill SJ., 2007, QUAL RES PSYCHOL, V4, P1294; Schaefer J., 1992, PERSONAL COPING THEO, P149; Sekely A, 2019, DISABIL REHABIL, V41, P2669, DOI 10.1080/09638288.2018.1476598; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Tajfel H., 1978, DIFFERENTIATION SOCI; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33; Tedeschi R.G., 2015, POSITIVE PSYCHOL PRA, P503, DOI DOI 10.1002/9781118996874.CH30; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Villalobos D, 2019, BRAIN IMPAIR, V20, P268, DOI 10.1017/BrImp.2019.10; Vishnevsky T, 2010, PSYCHOL WOMEN QUART, V34, P110, DOI 10.1111/j.1471-6402.2009.01546.x; Walsh RS, 2015, NEUROPSYCHOL REHABIL, V25, P555, DOI 10.1080/09602011.2014.993658; Walsh RS, 2014, HEALTH PSYCHOL REV, V8, P458, DOI 10.1080/17437199.2012.733914; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Whitley R, 2016, CAN J PSYCHIAT, V61, P340, DOI 10.1177/0706743716643740; Xu JP, 2011, J AFFECT DISORDERS, V133, P274, DOI 10.1016/j.jad.2011.03.034; Yeates GN, 2008, NEUROPSYCHOL REHABIL, V18, P566, DOI 10.1080/09602010802151532; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	114	1	1	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.												10.1080/09638288.2020.1867654		DEC 2020	14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	PT0TC	WOS:000608332900001	33459069				2022-02-06	
J	Velle, F; Lewen, A; Howells, T; Nilsson, P; Enblad, P				Velle, Fartein; Lewen, Anders; Howells, Timothy; Nilsson, Pelle; Enblad, Per			Temporal effects of barbiturate coma on intracranial pressure and compensatory reserve in children with traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Children; Barbiturate coma; Refractory intracranial hypertension; Intracranial compensatory reserve	CEREBRAL PERFUSION-PRESSURE; DECOMPRESSIVE CRANIECTOMY; PENTOBARBITAL COMA; TISSUE OXYGENATION; WAVE-FORM; THERAPY; HYPERTENSION; MANAGEMENT; REACTIVITY; ICP	Background The aim was to study the effects of barbiturate coma treatment (BCT) on intracranial pressure (ICP) and intracranial compensatory reserve (RAP index) in children (< 17 years of age) with traumatic brain injury (TBI) and refractory intracranial hypertension (RICH). Methods High-resolution monitoring data were used to study the effects of BCT on ICP, mean arterial pressure (MAP), cerebral perfusion pressure (CPP), and RAP index. Four half hour long periods were studied: before bolus injection and at 5, 10, and 24 hours thereafter, respectively, and a fifth tapering period with S-thiopental between < 100 and < 30 mu mol/L. S-thiopental concentrations and administered doses were registered. Results Seventeen children treated with BCT 2007-2017 with high-resolution data were included; median age 15 (range 6-17) and median Glasgow coma score 7 (range 3-8). Median time from trauma to start of BCT was 44.5 h (range 2.5-197.5) and from start to stop 99.0 h (range 21.0-329.0). Median ICP was 22 (IQR 20-25) in the half hour period before onset of BCT and 16 (IQR 11-20) in the half hour period 5 h later (p = 0.011). The corresponding figures for CPP were 65 (IQR 62-71) and 63 (57-71) (p > 0.05). The RAP index was in the half hour period before onset of BCT 0.6 (IQR 0.1-0.7), in the half hour period 5 h later 0.3 (IQR 0.1-0.7) (p = 0.331), and in the whole BCT period 0.3 (IQR 0.2-0.4) (p = 0.004). Eighty-two percent (14/17) had favorable outcome (good recovery = 8 patients and moderate disability = 6 patients). Conclusion BCT significantly reduced ICP and RAP index with preserved CPP. BCT should be considered in case of RICH.	[Velle, Fartein; Lewen, Anders; Howells, Timothy; Nilsson, Pelle; Enblad, Per] Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden		Velle, F (corresponding author), Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden.	fartein.velle@neuro.uu.se		Velle, Fartein/0000-0003-2928-7132	Uppsala University	Open access funding provided by Uppsala University.	Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Burman R, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0115-4; Cordato DJ, 2003, J CLIN NEUROSCI, V10, P283, DOI 10.1016/S0967-5868(03)00034-1; Czosnyka M, 2005, ACT NEUR S, V95, P341; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Figaji AA, 2017, CHILD NERV SYST, V33, P1651, DOI 10.1007/s00381-017-3562-3; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2012, INTENS CARE MED, V38, P1061, DOI 10.1007/s00134-012-2571-7; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Kiening KL, 2005, ACT NEUR S, V95, P293; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Nyholm Lena, 2012, ISRN Neurol, V2012, P903954, DOI 10.5402/2012/903954; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Signorini DF, 1997, CRIT CARE MED, V25, P2048, DOI 10.1097/00003246-199712000-00024; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Thorat JD, 2008, J CLIN NEUROSCI, V15, P143, DOI 10.1016/j.jocn.2006.08.014; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Velle F, 2020, J NEUROSURG-PEDIATR, V25, P375, DOI 10.3171/2019.10.PEDS19268; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y	39	1	1	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2021	163	2					489	498		10.1007/s00701-020-04677-z		DEC 2020	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PU1PR	WOS:000600268500001	33341913	hybrid, Green Published			2022-02-06	
J	Mader, MMD; Rotermund, R; Lefering, R; Westphal, M; Maegele, M; Czorlich, P				Mader, Marius Marc-Daniel; Rotermund, Roman; Lefering, Rolf; Westphal, Manfred; Maegele, Marc; Czorlich, Patrick		TraumaRegister DGU	The faster the better? Time to first CT scan after admission in moderate-to-severe traumatic brain injury and its association with mortality	NEUROSURGICAL REVIEW			English	Article						Traumatic brain injury; Trauma; Register; Computed tomography; Mortality; Admission	OUTCOMES; TRIAL; ROOM	Fast acquisition of a first computed tomography (CT) scan after traumatic brain injury (TBI) is recommended. This study is aimed at investigating whether the length of the period preceding initial CT scan influences mortality in patients with leading TBI. A retrospective cohort analysis of patients registered in the TraumaRegister DGU (R) was conducted including adult patients with TBI, defined as Abbreviated Injury Scale(Head) >= 3 and GCS <= 13 who had been treated in level 1 or 2 trauma centers from 2007-2016. Patients were grouped according to time intervals either from trauma or from admission to CT. A total of 6904 patients met the inclusion criteria. Mean time period from trauma to hospital admission was 68.8 min. From admission to first CT, a mean of 19.0 min elapsed. Trauma severity was higher in groups with a longer duration from trauma to CT as represented by a mean (+/- standard deviation) Injury Severity Score (ISS) of 19.8 +/- 9.0, 20.7 +/- 9.3, and 21.4 +/- 7.5 and similar distribution of mortality of 24.9%, 29.9%, and 36.3% in the <= 60-min, 61-120-min, and >= 121-min groups, respectively. An adjusted multivariable logistic regression model showed a significant influence of the level of the trauma center (p = 0.037) but not for interval from admission to CT (p = 0.528). TBI patients with a longer time span from trauma to first CT were more severely injured and demonstrated a worse prognosis, but received a CT scan faster when duration from admission is observed. The duration until the CT scan was obtained showed no significant impact on the mortality.	[Mader, Marius Marc-Daniel; Rotermund, Roman; Westphal, Manfred; Czorlich, Patrick] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany; [Lefering, Rolf; Maegele, Marc] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Maegele, Marc] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Trauma & Orthoped Surg, Cologne, Germany; [TraumaRegister DGU] German Trauma Soc DGU, Comm Emergency Med Intens Care & Trauma Managemen, Sekt NIS, Berlin, Germany		Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany.	p.czorlich@uke.de		Czorlich, Patrick/0000-0003-0865-241X; Mader, Marius/0000-0002-7467-9672	Projekt DEAL	Open Access funding enabled and organized by Projekt DEAL.	[Anonymous], 2020, DGU WEI BUCH SCHWERV; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Gross T, 2010, BRIT J SURG, V97, P118, DOI 10.1002/bjs.6842; Huber-Wagner S, 2014, INJURY, V45, pS76, DOI 10.1016/j.injury.2014.08.022; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Huijben JA, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2791-0; Jin PHPFK, 2008, J NEUROTRAUM, V25, P1003, DOI 10.1089/neu.2007.0463; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Kompanje EJ, 2007, PROG BRAIN RES, V161, P243, DOI 10.1016/S0079-6123(06)61017-0; Lee KL, 2009, INJURY, V40, P873, DOI 10.1016/j.injury.2008.12.001; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Nagesh M, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19527; Picetti E, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0270-1; Saltzherr TP, 2012, BRIT J SURG, V99, P105, DOI 10.1002/bjs.7705; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Wulffeld S, 2017, ACTA ANAESTH SCAND, V61, P832, DOI 10.1111/aas.12927	20	1	1	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	OCT	2021	44	5					2697	2706		10.1007/s10143-020-01456-3		DEC 2020	10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WB5EZ	WOS:000600081100001	33340052	Green Published, hybrid			2022-02-06	
J	Lempke, LB; Lynall, RC; Le, RK; McCrea, M; McAllister, T; Schmidt, JD				Lempke, Landon B.; Lynall, Robert C.; Le, Rachel K.; McCrea, Michael; McAllister, Thomas; Schmidt, Julianne D.		CARE Consortium Investigators	The Effects of On-Field Heat Index and Altitude on Concussion Assessments and Recovery Among NCAA Athletes	SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; ENVIRONMENTAL-CONDITIONS; MILD HYPOTHERMIA; FOOTBALL; HYPERTHERMIA; STATEMENT; RATES; RISK; EPIDEMIOLOGY; CONSENSUS	Background Recent literature has indicated altitude may be a protective factor for concussion but it is unknown whether altitude or heat index affects recovery. Objective To examine whether on-field heat index and altitude at the time of injury alter acute (< 48 h) concussion assessments, days-to-asymptomatic, and days-to-return-to-play in collegiate athletes following concussion. Methods Collegiate athletes (n = 187; age = 19.7 +/- 1.4 years; male = 70.6%) underwent baseline assessments across 30 universities and experienced a concussion in this retrospective cohort study. Altitude (m) and heat index (degrees C) at the time and location of injury were determined using valid online database tools. Acute concussion assessments included the Sport Concussion Assessment Tool (SCAT) symptom inventory, Balance Error Scoring System (BESS), and the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT). We used multiple linear regression models to determine whether heat index and altitude predicted each acute assessment outcome, days-to-asymptomatic, and days-to-return-to-play. Results Collegiate athletes were concussed at a 181.1 m (range - 0.6 to 2201.9 m) median altitude and 17.8 degrees C (range - 6.1 to 35.6 degrees C) median heat index. Altitude did not predict (p >= 0.265) any outcomes. Every one-degree increase in heat index reduced days-to-asymptomatic (p = 0.047; R-2 = 0.06) and days-to-return-to-play (p = 0.006; R-2 = 0.09) by 0.05 and 0.14 days, respectively. Heat index and altitude did not explain significant variance in SCAT, BESS, and ImPACT composite scores (p's = 0.20-0.922). Conclusion Our findings suggest that on-field altitude and heat index at the time of injury do not contribute to clinically meaningful changes on acute assessments or concussion recovery. On-field altitude and heat index do not appear to significantly alter assessment outcomes or clinical recovery, suggesting that environmental factors at altitudes below < 2500 m are negligible outcomes for researchers and clinicians to consider post-concussion.	[Lempke, Landon B.; Lynall, Robert C.; Le, Rachel K.; Schmidt, Julianne D.] Univ Georgia, Ramsey Student Ctr, Dept Kinesiol, UGA Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA; [McCrea, Michael] Dept Neurosurg, Milwaukee, WI USA; [McCrea, Michael] Dept Neurol, Milwaukee, WI USA; [McAllister, Thomas] Sch Med, Dept Psychiat, Indianapolis, IN USA		Lempke, LB (corresponding author), Univ Georgia, Ramsey Student Ctr, Dept Kinesiol, UGA Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA.	lblempke@uga.edu	Lempke, Landon/C-4800-2018; Lynall, Robert/M-2888-2014	Lempke, Landon/0000-0003-0007-1362; Lynall, Robert/0000-0002-0785-6640	National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Grand Alliance Concussion Assessment, Research, and Education Consortium	This study was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education Consortium, funded by the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, USA is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award no. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Beaudouin F, 2017, BR J SPORTS MED; Breedlove KM, 2017, J ATHL TRAINING, V52, P802, DOI 10.4085/1062-6050-52.6.01; Broglio SP, 2017, SPORTS MED, DOI 10.1007/s40279-017-0707-1; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Chandra N, 2016, ATMOS CHEM PHYS, V16, P6153, DOI 10.5194/acp-16-6153-2016; Cooper ER, 2016, J ATHL TRAINING, V51, P593, DOI 10.4085/1062-6050-51.8.08; Cooper ER, 2006, J ATHL TRAINING, V41, P332; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Godek SF, 2004, J ATHL TRAINING, V39, P235; Haider S, 2018, CUREUS; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Laurent JGC, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002605; Lempke L, 2019, J SPORT REHABIL, V28, P99, DOI 10.1123/jsr.2017-0217; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; Lewis MD, 2011, MIL MED, V176, P1120, DOI 10.7205/MILMED-D-10-00466; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Lynall RC, 2016, J ORTHOP SPORT PHYS, V46, P96, DOI 10.2519/jospt.2016.6315; McCrory P, 2017, BR J SPORTS MED; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P2093, DOI 10.1249/MSS.0000000000001325; Myer GD, 2016, BR J SPORTS MED; Myer GD, 2018, BR J SPORTS MED; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; Nielsen B, 2003, SPORTS MED, V33, P1, DOI 10.2165/00007256-200333010-00001; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ozgunen KT, 2010, SCAND J MED SCI SPOR, V20, P140, DOI 10.1111/j.1600-0838.2010.01219.x; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Rothfusz LP, 1990, HEAT INDEX EQUATION, P9023; RStudio Team, 2016, RSTUDIO INT DEV ENV; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smoliga JM, 2017, EPIDEMIOLOGY, V28, P753, DOI 10.1097/EDE.0000000000000694; Smoliga JM, 2017, J APPL PHYSIOL, V122, P221, DOI 10.1152/japplphysiol.01020.2016; Stone JG, 1997, NEUROSURGERY, V41, P20, DOI 10.1097/00006123-199707000-00007; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Truettner JS, 2018, J NEUROTRAUM, V35, P940, DOI 10.1089/neu.2017.5303; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; TWC Product and Technology LLC, WEATH FOR REP LONG R; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Verges S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00393; Wang H, 2015, TRANSL NEUROSCI, V6, P20, DOI 10.1515/tnsci-2015-0004; Wasserman E, 2018, J SPORT MED; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Zavorsky GS, 2017, JAMA NEUROL, V74, P485, DOI 10.1001/jamaneurol.2016.6068; Zavorsky GS, 2016, JAMA NEUROL, V73, P1368, DOI 10.1001/jamaneurol.2016.0795; Zavorsky GS, 2016, J ORTHOP SPORT PHYS, V46, P226, DOI 10.2519/jospt.2016.0201; Zavorsky GS, 2014, J ORTHOP SPORT PHYS, V44, P458, DOI 10.2519/jospt.2014.0201; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	59	1	1	1	2	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	APR	2021	51	4					825	835		10.1007/s40279-020-01395-5		DEC 2020	11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	QZ6YP	WOS:000599794900005	33332015				2022-02-06	
J	Popovitz, J; Mysore, SP; Adwanikar, H				Popovitz, Juliana; Mysore, Shreesh P.; Adwanikar, Hita			Neural Markers of Vulnerability to Anxiety Outcomes after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						anxiety; controlled cortical impact; mice; resilience; traumatic brain injury; vulnerability	CONTROLLED CORTICAL IMPACT; ELEVATED PLUS-MAZE; MEDIAL PREFRONTAL CORTEX; NEUROPEPTIDE-Y; MOUSE MODEL; VENTRAL HIPPOCAMPUS; OVERPRESSURE BLAST; EMOTIONAL DEFICITS; CONDITIONED FEAR; STRESS-RESPONSE	Anxiety outcomes after traumatic brain injury (TBI) are complex, and the underlying neural mechanisms are poorly understood. Here, we developed a multi-dimensional behavioral profiling approach to investigate anxiety-like outcomes in mice that takes into account individual variability. Departing from the tradition of comparing outcomes in TBI versus sham groups, we identified a subgroup within the TBI group that is vulnerable to anxiety dysfunction, and present increased exploration of the anxiogenic zone compared to sham controls or resilient injured animals, by applying dimensionality reduction, clustering, and post hoc validation to behavioral data obtained from multiple assays for anxiety at several post-injury time points. These vulnerable animals expressed distinct molecular profiles in the corticolimbic network, with downregulation in gamma-aminobutyric acid and glutamate and upregulation in neuropeptide Y markers. Indeed, among vulnerable animals, not resilient or sham controls, severity of anxiety-related outcomes correlated strongly with expression of molecular markers. Our results establish a foundational approach, with predictive power, for reliably identifying maladaptive anxiety outcomes after TBI and uncovering neural signatures of vulnerability to anxiety.	[Popovitz, Juliana; Mysore, Shreesh P.; Adwanikar, Hita] Johns Hopkins Univ, Dept Psychol & Brain Sci, 3400 North Charles St,Dunning Hall 418, Baltimore, MD 21218 USA; [Mysore, Shreesh P.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA		Adwanikar, H (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, 3400 North Charles St,Dunning Hall 418, Baltimore, MD 21218 USA.	hita@jhu.edu			Johns Hopkins UniversityJohns Hopkins University	This work was supported by start-up funding from the Johns Hopkins University (H.A. and S.P.M.).	Abramson LY, 2002, HANDBOOK OF DEPRESSION, P268; Adhikari A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00112; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Adwanikar H, 2011, NEUROMETHODS, V50, P237, DOI 10.1007/978-1-60761-883-6_10; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Alves JL, 2020, EUR J TRAUMA EMERG S, DOI 10.1007/s00068-020-01431-z; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Beitchman JA, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01434; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Berg L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210949; Bertoglio LJ, 2000, BEHAV BRAIN RES, V108, P197, DOI 10.1016/S0166-4328(99)00148-5; Borkovec TD, 2004, GENERALIZED ANXIETY DISORDER: ADVANCES IN RESEARCH AND PRACTICE, P77; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Caspi Y, 2005, J LOSS TRAUMA, V10, P319, DOI 10.1080/15325020590956756; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cicchetti D, 2010, WORLD PSYCHIATRY, V9, P145, DOI 10.1002/j.2051-5545.2010.tb00297.x; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2008, INT J NEUROPSYCHOPH, V11, P331, DOI 10.1017/S1461145707007912; Cohen H, 2007, EUR NEUROPSYCHOPHARM, V17, P464, DOI 10.1016/j.euroneuro.2006.11.003; Cohen H, 2006, BIOL PSYCHIAT, V59, P1208, DOI 10.1016/j.biopsych.2005.12.003; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Cohen J, 1998, STAT POWER ANAL BEHA; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Cutler SM, 2006, PHARMACOL BIOCHEM BE, V84, P420, DOI 10.1016/j.pbb.2006.05.029; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Fecteau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083598; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Figueiredo T, 2020, MOL NEUROBIOL, V57, P23, DOI 10.1007/s12035-019-01753-z; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Greve KW, 2001, BRAIN INJURY, V15, P255; GRIEBEL G, 1993, BEHAV PROCESS, V29, P37, DOI 10.1016/0376-6357(93)90026-N; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Ha HTT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00405; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; HEILIG M, 1989, ACTA PHYSIOL SCAND, V137, P243, DOI 10.1111/j.1748-1716.1989.tb08745.x; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Horsell A, 1999, NEUROREPORT, V10, P3003, DOI 10.1097/00001756-199909290-00024; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Klein RC, 2016, J NEUROSCI RES, V94, P579, DOI 10.1002/jnr.23702; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lee SC, 2017, NEURON, V96, P81, DOI 10.1016/j.neuron.2017.09.002; Lindell SG, 2010, ARCH GEN PSYCHIAT, V67, P423, DOI 10.1001/archgenpsychiatry.2010.23; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Luthar S.S., 2014, HDB DEV PSYCHOPATHOL, P125, DOI [10.1007/978-1-4614-9608-3_7, DOI 10.1007/978-1-4614-9608-3_7]; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; Machado CJ, 2009, EMOTION, V9, P147, DOI 10.1037/a0014539; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moscarello JM, 2018, CURR OPIN BEHAV SCI, V19, P44, DOI 10.1016/j.cobeha.2017.09.010; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Noggle CA, 2010, APPL NEUROPSYCHOL, V17, P110, DOI 10.1080/09084281003708977; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P300, DOI 10.1093/schbul/10.2.300; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Parfitt GM, 2017, NEUROPSYCHOPHARMACOL, V42, P1715, DOI 10.1038/npp.2017.56; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Popovitz J, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00006; Prager EM, 2016, J NEUROSCI RES, V94, P548, DOI 10.1002/jnr.23690; Primeaux SD, 2005, NEUROPSYCHOPHARMACOL, V30, P1589, DOI 10.1038/sj.npp.1300705; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; RESNICK HS, 1992, J NERV MENT DIS, V180, P424, DOI 10.1097/00005053-199207000-00004; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rutter M., 1993, J ADOLESCENT HEALTH, V14, P690, DOI [DOI 10.1016/1054-139X(93)90196-V, 10.1016/1054-139X(93)90196-V]; Sajdyk TJ, 2008, J NEUROSCI, V28, P893, DOI 10.1523/JNEUROSCI.0659-07.2008; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shah AA, 2004, BRAIN RES, V1028, P112, DOI 10.1016/j.brainres.2004.08.061; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Smith BW, 2010, J POSIT PSYCHOL, V5, P166, DOI 10.1080/17439760.2010.482186; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Statz JK, 2019, BEHAV BRAIN RES, V368, P101, DOI 10.1016/j.bbr.2019.04.009; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; White B, 2010, REHABIL PSYCHOL, V55, P23, DOI 10.1037/a0018451; Williams N.L., 2005, DEV PSYCHOPATHOL, P289; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	123	1	1	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1006	1022		10.1089/neu.2020.7320		DEC 2020	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000600123800001	33050836	Green Submitted			2022-02-06	
J	Gunasekaran, P; Fraser, CL; Hodge, C				Gunasekaran, Premkumar; Fraser, Clare L.; Hodge, Christopher			The learning effect of the King-Devick test in semi-professional rugby union athletes	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Sports-related concussion; Oculomotor function; Saccadic rhythm; King-Devick test; Vision	VISUAL SCREENING TOOL; SPORTS-RELATED CONCUSSION; BRAIN-FUNCTION; EYE-MOVEMENTS; LEAGUE	Objective: Abnormalities of eye movement and visual processing are common in traumatic brain injury. The King-Devick test (KDT) has been widely used in the detection and recovery of concussion. Current recommendations propose performing the initial test at baseline and then repeating annually to account for potential learning effects. In practice, this may still account for large deviations. The aim of this study was to determine the number of trials needed for a player to achieve a ceiling effect and to determine the validity of the existing protocol requiring two tests at baseline. Methods: One hundred and eighty-three semi-professional male rugby union players (median age = 22.5 (21.0-25.3) years) were recruited. Over the duration, all athletes performed the KDT on an iPad, under standardised baseline procedures and then repeated the test based on availability during weekly in-season training. Results: The improvement through each repeated trial was 0.60 +/- 0.1 s (P < 0.001). The ceiling effect was determined at 30 trials. A median difference of 4.2 s (range 0-14.9) was calculated between the initial and best trial overall, although the greatest difference occurred within the first eight attempts. There was a significant positive correlation between the initial test value and the difference between first and fastest time (P < 0.001, r = 0.455). Conclusion: We have shown continuous improvement with repeated attempts which suggests that administrators ideally should continue to perform the KDT over the duration of the season to optimise the value of the test.	[Gunasekaran, Premkumar; Hodge, Christopher] Univ Technol Sydney, Grad Sch Hlth, Discipline Orthopt, Sydney, NSW, Australia; [Fraser, Clare L.; Hodge, Christopher] Univ Sydney, Fac Hlth & Med, Discipline Ophthalmol, Save Sight Inst, Sydney, NSW, Australia		Gunasekaran, P (corresponding author), Univ Technol Sydney, Grad Sch Hlth, Discipline Orthopt, Sydney, NSW, Australia.	Premkumar.Gunasekaran@student.uts.edu.au; clare.fraser@sydney.edu.au; christopher.hodge@vei.com.au		Fraser, Clare/0000-0002-0379-7743; Gunasekaran, Premkumar/0000-0002-8872-2600			Balcer LJ, 2013, J NEUROL SCI, V327, P81, DOI 10.1016/j.jns.2013.01.026; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Clugston JR, 2019, J ATHL TRAINING, V54, P1247, DOI 10.4085/1062-6050-455-18; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dhawan P., 2014, KINGDEVICK TEST IDEN; Dhawan PS, 2017, NEUROL-CLIN PRACT, V7, P464, DOI 10.1212/CPJ.0000000000000381; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Faul M., 2015, HDB CLIN NEUROL, V127, P3, DOI 10.1016.B978-0-444-52892-6.00001-5; Finch C.F., 2013, MED J AUST, V198; Fuller GW, 2019, BRIT J SPORT MED, V53, P1526, DOI 10.1136/bjsports-2017-098560; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2016, CONCUSSION, V1, pCNC8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Kaliappan SB, 2019, SUSTAINABLE MANAGEMENT OF SOIL AND ENVIRONMENT, P1, DOI 10.1007/978-981-13-8832-3_1; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; PANG Y, 2015, INVEST OPHTHALMOL VI, V56; Silver D, 2018, J NEUROL SCI, V388, P40, DOI 10.1016/j.jns.2018.02.046; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938	36	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	DEC 15	2020	419								117168	10.1016/j.jns.2020.117168			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PB7CV	WOS:000596475700007	33038568				2022-02-06	
J	Naess-Schmidt, ET; Blicher, JU; Thastum, MM; Rask, CU; Svendsen, SW; Schroder, A; Tuborgh, AH; Ostergaard, L; Sangill, R; Lund, T; Jespersen, SN; Pedersen, AR; Hansen, B; Eskildsen, SF; Nielsen, JF				Naess-Schmidt, Erhard Trillingsgaard; Udby Blicher, Jakob; Moller Thastum, Mille; Ulrikka Rask, Charlotte; Wulff Svendsen, Susanne; Schroder, Andreas; Hogh Tuborgh, Astrid; ostergaard, Leif; Sangill, Ryan; Lund, Torben; Norhoj Jespersen, Sune; Roer Pedersen, Asger; Hansen, Brian; Fristed Eskildsen, Simon; Nielsen, Jorgen Feldbaek			Microstructural changes in the brain after long-term post-concussion symptoms: A randomized trial	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						brain plasticity; concussion; diffusion kurtosis imaging; diffusion tensor imaging; mean kurtosis tensor; mild traumatic brain injury	DIFFUSION TENSOR; SEX-DIFFERENCES; HEAD-INJURY; LONGITUDINAL DIFFUSION; COGNITIVE IMPAIRMENT; WORKING-MEMORY; MILD; KURTOSIS; SEGMENTATION; THALAMUS	A recent randomized controlled trial in young patients with long-term post-concussion symptoms showed that a novel behavioral intervention "Get going After concussIoN" is superior to enhanced usual care in terms of symptom reduction. It is unknown whether these interventional effects are associated with microstructural brain changes. The aim of this study was to examine whether diffusion-weighted MRI indices, which are sensitive to the interactions between cellular structures and water molecules' Brownian motion, respond differently to the interventions of the above-mentioned trial and whether such differences correlate with the improvement of post-concussion symptoms. Twenty-three patients from the intervention group (mean age 22.8, 18 females) and 19 patients from the control group (enhanced usual care) (mean age 23.9, 14 females) were enrolled. The primary outcome measure was the mean kurtosis tensor, which is sensitive to the microscopic complexity of brain tissue. The mean kurtosis tensor was significantly increased in the intervention group (p = 0.003) in the corpus callosum but not in the thalamus (p = 0.78) and the hippocampus (p = 0.34). An increase in mean kurtosis tensor in the corpus callosum tended to be associated with a reduction in symptoms, but this association did not reach significance (p = 0.059). Changes in diffusion tensor imaging metrics did not differ between intervention groups and were not associated with symptoms. The current study found different diffusion-weighted MRI responses from the microscopic cellular structures of the corpus callosum between patients receiving a novel behavioral intervention and patients receiving enhanced usual care. Correlations with improvement of post-concussion symptoms were not evident.	[Naess-Schmidt, Erhard Trillingsgaard; Moller Thastum, Mille; Roer Pedersen, Asger; Nielsen, Jorgen Feldbaek] Hammel Neurorehabil Ctr, Voldbyvej 15, DK-8450 Hammel, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Moller Thastum, Mille; Roer Pedersen, Asger; Nielsen, Jorgen Feldbaek] Univ Res Clin, Voldbyvej 15, DK-8450 Hammel, Denmark; [Naess-Schmidt, Erhard Trillingsgaard; Moller Thastum, Mille; Roer Pedersen, Asger; Nielsen, Jorgen Feldbaek] Aarhus Univ, Dept Clin Hlth, Aarhus, Denmark; [Udby Blicher, Jakob; ostergaard, Leif; Sangill, Ryan; Lund, Torben; Norhoj Jespersen, Sune; Hansen, Brian; Fristed Eskildsen, Simon] Aarhus Univ, Ctr Funct Integrat Neurosci, Dept Clin Med, Aarhus, Denmark; [Ulrikka Rask, Charlotte; Hogh Tuborgh, Astrid] Aarhus Univ Hosp, Dept Child & Adolescent Psychiat, Aarhus, Denmark; [Wulff Svendsen, Susanne] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Schroder, Andreas] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, Aarhus, Denmark; [ostergaard, Leif] Aarhus Univ Hosp, Dept Neuroradiol, Aarhus, Denmark; [Norhoj Jespersen, Sune] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark		Naess-Schmidt, ET (corresponding author), Hammel Neurorehabil Ctr, Voldbyvej 15, DK-8450 Hammel, Denmark.; Naess-Schmidt, ET (corresponding author), Univ Res Clin, Voldbyvej 15, DK-8450 Hammel, Denmark.	erhnae@rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021; Nass-Schmidt, Erhard/AAP-8212-2021; Lund, Torben E/B-1919-2008	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Nass-Schmidt, Erhard/0000-0002-2539-0362; Lund, Torben E/0000-0002-9002-4676; Eskildsen, Simon/0000-0003-4242-9158; Norhoj Jespersen, Sune/0000-0003-3146-4329	Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab); Public Health in Central Denmark Region	This project was supported by the Danish Ministry of Science, Technology and Innovation's University Investment Grant (MINDLab). It was also supported by government funds earmarked to improve the treatment options for 15-30-year-old patients with concussion or acquired brain injury and by Public Health in Central Denmark Region. The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report.	Ab Aziz CB, 2006, MALAYS J MED SCI, V13, P11; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chuhutin A, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3777; Churchill NW, 2020, HUM BRAIN MAPP, V41, P2567, DOI 10.1002/hbm.24962; Coupe P, 2011, NEUROIMAGE, V54, P940, DOI 10.1016/j.neuroimage.2010.09.018; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Garza-Villarreal EA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.92; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gujral S, 2017, GEN HOSP PSYCHIAT, V49, P2, DOI 10.1016/j.genhosppsych.2017.04.012; Hansen B, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00040; Hansen B, 2016, MAGN RESON MED, V76, P1455, DOI 10.1002/mrm.26055; Hansen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23999; Hansen B, 2014, MAGN RESON MED, V71, P2250, DOI 10.1002/mrm.25090; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Irie R, 2018, MAGN RESON MED SCI, V17, P138, DOI 10.2463/mrms.mp.2017-0031; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Karlsen RH, 2019, J NEUROSCI RES, V97, P568, DOI 10.1002/jnr.24383; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kelma ND, 2016, NEUROIMAGE, V124, P612, DOI 10.1016/j.neuroimage.2015.09.028; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Leow AD, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1 AND 2, P622, DOI 10.1109/ISBI.2009.5193124; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Mitchell AS, 2014, J NEUROSCI, V34, P15340, DOI 10.1523/JNEUROSCI.3289-14.2014; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Naess-Schmidt E, 2016, INT J COMPUT ASS RAD, V11, P1979, DOI 10.1007/s11548-016-1433-0; Naess-Schmidt ET, 2018, BRAIN INJURY, V32, P91, DOI 10.1080/02699052.2017.1377352; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Novikov DS, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3998; Novikov DS, 2018, MAGN RESON MED, V79, P3172, DOI 10.1002/mrm.27101; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Rytter HM, 2019, BRAIN INJURY, V33, P266, DOI 10.1080/02699052.2018.1552022; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Singaravelu K. J., 2020, ECLINICALMEDICINE, V18, DOI [10.1016/j.eclinm.2019.11.007, DOI 10.1016/J.ECLINM.2019.11.007]; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Thastum MM, 2019, ECLINICALMEDICINE, V17, DOI 10.1016/j.eclinm.2019.11.007; Thastum MM, 2018, NEUROREHABILITATION, V43, P155, DOI 10.3233/NRE-172391; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	70	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAR	2021	99	3					872	886		10.1002/jnr.24773		DEC 2020	15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PZ1QJ	WOS:000598582300001	33319932				2022-02-06	
J	Grayson, L; Brady, MC; Togher, L; Ali, M				Grayson, Lynn; Brady, Marian C.; Togher, Leanne; Ali, Myzoon			The impact of cognitive-communication difficulties following traumatic brain injury on the family; a qualitative, focus group study	BRAIN INJURY			English	Article						Traumatic brain injury; cognitive-communication difficulties; family experience; focus groups; service provision	PSYCHOLOGICAL DISTRESS; HEAD-INJURY; NEEDS; INDIVIDUALS; REHABILITATION; EXPERIENCES; CAREGIVERS; MANAGEMENT; RELATIVES; OUTCOMES	Primary Objective: To identify how families experience cognitive-communication difficulties following Traumatic Brain Injury (TBI). Experiences of information, training and support for managing communication changes were also explored. Research Design: Qualitative focus group methodology using thematic analysis. Method: 15 family members of individuals with cognitive-communication difficulties following severe TBI participated in the study; four parents, six spouses, three siblings and two offspring. The majority of participants were female (80%, n = 12), with a mean age of 51 (range 19-71). Four focus groups were held with family members at 0-12 months, 12-36 months and 36+ months post-injury. The data were transcribed verbatim and analyzed using NVIVO 12. Results: Cognitive-communication difficulties were found to impact upon family functioning and psychological wellbeing for several years post-injury. Changes to social cognition, insight and the "filter switch" of the person following TBI were key areas of distress. Participants highlighted the need for information about communication changes to be provided at several time points post-injury. The need for peer support from other families with experience of cognitive-communication difficulties was also identified. Conclusion: Cognitive-communication difficulties impact upon family functioning for many years following injury with families continuing to have support needs for communication well beyond the acute rehabilitation stage.	[Grayson, Lynn; Brady, Marian C.; Ali, Myzoon] Glasgow Caledonian Univ, NMAHP Res Unit, Glasgow, Lanark, Scotland; [Grayson, Lynn] NHS Lanarkshire, Carluke, Scotland; [Togher, Leanne] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia		Grayson, L (corresponding author), NHS Lanarkshire, Community Brain Injury Team, Carluke ML8 5EP, Scotland.; Grayson, L (corresponding author), Glasgow Caledonian Univ, Sch Hlth & Life Sci, NMAHP RU, Govan Mbeki Bldg,Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland.	lynn.grayson@gcu.ac.uk	Brady, Marian C/ABA-4241-2021	Brady, Marian C/0000-0002-4589-7021; Ali, Myzoon/0000-0001-5899-2485; Grayson, Lynn/0000-0002-5677-5732	NHS Lanarkshire	This work is part of an MPhil qualification, undertaken by the first author, which was funded by NHS Lanarkshire.	Allain P, 2019, BRAIN INJURY, V33, P1, DOI 10.1080/02699052.2018.1533143; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Behn N, 2021, J HEAD TRAUMA REHAB, V36, P56, DOI 10.1097/HTR.0000000000000580; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bellon M, 2017, HEALTH SOC CARE COMM, V25, P204, DOI 10.1111/hsc.12294; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Eliacin J, 2018, BRAIN INJURY, V32, P1510, DOI 10.1080/02699052.2018.1499964; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Grayson L, 2020, INT J LANG COMM DIS, V55, P712, DOI 10.1111/1460-6984.12555; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Holloway M, 2019, BRAIN INJURY, V33, P401, DOI 10.1080/02699052.2019.1566967; King NS, 2003, HDB CLIN NEUROPSYCHO, P487; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kolakowsky-Hayner SA, 1999, NEUROREHABILITATION, V13, P27; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Lefebvre H, 2012, BRAIN INJURY, V26, P1084, DOI 10.3109/02699052.2012.666364; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mbakile-Mahlanza L, 2017, DISABIL REHABIL, V39, P559, DOI 10.3109/09638288.2016.1152605; McDonald S, 2014, SOCIAL COMMUNICATION, DOI [10.4324/9780203557198, DOI 10.4324/9780203557198]; Minnes P, 2000, BRAIN INJURY, V14, P737; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Moules S, 1999, BRAIN INJURY, V13, P983; Niemeier JP, 2019, ARCH PHYS MED REHAB, V100, pS65, DOI 10.1016/j.apmr.2018.07.422; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Plosker R, 2014, J SYSTEMIC THER, V33, P35, DOI [DOI 10.1521/JSYT.2014.33.2.35, 10.1521/jsyt.2014.33.2.35]; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Rispoli MJ, 2010, DEV NEUROREHABIL, V13, P141, DOI 10.3109/17518420903468464; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Saint-Jean M, 2019, BRAIN INJURY, V33, P40, DOI 10.1080/02699052.2018.1531306; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Snow P, 1997, BRAIN INJURY, V11, P409; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; Stebbins P, 1998, J REHABIL, V64, P15; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Townshend J, 2018, FAM J, V26, P77, DOI 10.1177/1066480717752905; Tran S, 2018, BRAIN INJURY, V32, P1700, DOI 10.1080/02699052.2018.1537006; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wearne T, 2019, BRAIN INJURY, V33, P12, DOI 10.1080/02699052.2018.1531300; Whiffin CJ, 2019, NEUROPSYCHOL REHABIL, V29, P1256, DOI 10.1080/09602011.2017.1387577; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wiseman-Hakes Catherine, 2020, Arch Rehabil Res Clin Transl, V2, P100036, DOI 10.1016/j.arrct.2019.100036; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	69	1	1	2	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 5	2021	35	1					15	25		10.1080/02699052.2020.1849800		DEC 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QU1AU	WOS:000599397200001	33327774	Green Accepted			2022-02-06	
J	Nelson, LD; Barber, JK; Temkin, NR; Dams-O'Connor, K; Dikmen, S; Giacino, JT; Kramer, MD; Levin, HS; McCrea, MA; Whyte, J; Bodien, YG; Yue, JK; Manley, GT				Nelson, Lindsay D.; Barber, Jason K.; Temkin, Nancy R.; Dams-O'Connor, Kristen; Dikmen, Sureyya; Giacino, Joseph T.; Kramer, Mark D.; Levin, Harvey S.; McCrea, Michael A.; Whyte, John; Bodien, Yelena G.; Yue, John K.; Manley, Geoffrey T.		TRACK-TBI Investigators	Validity of the Brief Test of Adult Cognition by Telephone in Level 1 Trauma Center Patients Six Months Post-Traumatic Brain Injury: A TRACK-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						Brief Test of Adult Cognition by Telephone; BTACT; phone-based cognitive assessment; telemedicine; traumatic brain injury	OF-FIT INDEXES; EXECUTIVE FUNCTIONS; HEAD-INJURY; FRONTAL-LOBE; RELIABILITY; PERFORMANCE; DISABILITY; DIVERSITY; OUTCOMES; UNITY	Our objective was to examine the construct validity of the Brief Test of Adult Cognition by Telephone (BTACT) and its relationship to traumatic brain injury (TBI) of differing severities. Data were analyzed on 1422 patients with TBI and 170 orthopedic trauma controls (OTC) from the multi-center Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study. Participants were assessed at 6 months post-injury with the BTACT and an in-person neuropsychological battery. We examined the BTACT's factor structure, factorial group invariance, convergent and discriminant validity, and relationship to TBI and TBI severity. Confirmatory factor analysis supported both a 1-factor model and a 2-factor model comprising correlated Episodic Memory and Executive Function (EF) factors. Both models demonstrated strict invariance across TBI severity and OTC groups. Correlations between BTACT and criterion measures suggested that the BTACT memory indices predominantly reflect verbal episodic memory, whereas the BTACT EF factor correlated with a diverse range of cognitive tests. Although the EF factor and other BTACT indices showed significant relationships with TBI and TBI severity, some group effect sizes were larger for more comprehensive in-person cognitive tests than the BTACT. The BTACT is a promising, brief, phone-based cognitive screening tool for patients with TBI. Although the BTACT's memory items appear to index verbal Episodic Memory, items that purport to assess EFs may reflect a broader array of cognitive domains. The sensitivity of the BTACT to TBI severity is lower than domain-specific neuropsychological measures, suggesting it should not be used as a substitute for comprehensive, in-person cognitive testing at 6 months post-TBI.	[Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Barber, Jason K.; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil, Neurol, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Human Performance, Neurol, New York, NY 10029 USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Bodien, Yelena G.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Bodien, Yelena G.] Harvard Med Sch, Boston, MA 02115 USA; [Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Yue, John K.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA		Nelson, LD (corresponding author), Med Coll Wisconsin, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Bulters, Diederik/0000-0001-9884-9050; Hemphill, Claude/0000-0003-4019-7525	U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS1365885, R01 NS110856]; NeuroTrauma Sciences LLC; U.S. Department of Defense TED InitiativeUnited States Department of Defense [W81XWH-14-2-0176]; OneMind	The study was funded by the U.S. National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS; Grants #U01 NS1365885 and #R01 NS110856), OneMind, and NeuroTrauma Sciences LLC. This work was also supported by the U.S. Department of Defense TED Initiative (Grant #W81XWH-14-2-0176). The article's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH and are not necessarily endorsed by the Department of Defense.	[Anonymous], 2016, PIL CLIN OUTC ASS CO; Bashshur RL, 2009, TELEMED J E-HEALTH, V15, P600, DOI 10.1089/tmj.2009.9960; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dams-O'Connor K, 2018, J NEUROTRAUM, V35, P1138, DOI 10.1089/neu.2017.5347; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Gavett BE, 2013, NEUROREHABILITATION, V32, P253, DOI 10.3233/NRE-130842; GEFFEN GM, 1994, ARCH CLIN NEUROPSYCH, V9, P303, DOI 10.1016/0887-6177(94)90018-3; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hughes ML, 2018, J INT NEUROPSYCH SOC, V24, P805, DOI 10.1017/S1355617718000425; Ivnik R.J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnston B, 2000, ARCH FAM MED, V9, P40, DOI 10.1001/archfami.9.1.40; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Latzman RD, 2010, ASSESSMENT, V17, P172, DOI 10.1177/1073191109356254; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; Marra DE, 2020, CLIN NEUROPSYCHOL, V34, P1411, DOI 10.1080/13854046.2020.1769192; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tangalos, 1992, CLIN NEUROPSYCHOL, V6, P83, DOI [10.1080/13854049208401880, DOI 10.1080/13854049208401880]; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Walton MK, 2015, VALUE HEALTH, V18, P741, DOI 10.1016/j.jval.2015.08.006; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wechsler, 1997, WECHSLER ADULT INTEL; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	44	1	1	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1048	1059		10.1089/neu.2020.7295		DEC 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000599863000001	33107388				2022-02-06	
J	Robinson, D; Pyle, L; Foreman, B; Ngwenya, LB; Adeoye, O; Woo, D; Kreitzer, N				Robinson, David; Pyle, Logan; Foreman, Brandon; Ngwenya, Laura B.; Adeoye, Opeolu; Woo, Daniel; Kreitzer, Natalie			Factors Associated with Early versus Delayed Expansion of Acute Subdural Hematomas Initially Managed Conservatively	JOURNAL OF NEUROTRAUMA			English	Article						intracranial hemorrhage; subdural hematoma; traumatic brain injury	RISK-FACTORS; NEUROLOGICAL DETERIORATION; SURGICAL INTERVENTION; NATURAL-HISTORY; HEMORRHAGE; PROGRESSION; PREDICTORS; TRAUMA	Acute subdural hematomas (ASDHs) are highly morbid and increasingly common. Hematoma expansion is a potentially fatal complication, and few studies have examined whether factors associated with hematoma expansion vary over time. To answer this, we performed a case-control study in a cohort of initially conservatively managed patients with ASDH. Two time periods were considered, early (<72 h from injury) and delayed (>72 h from injury). Cases were defined as patients who developed ASDH expansion in the appropriate period; controls were patients who had stable imaging. Associated factors were determined with logistic regression. We identified 68 cases and 237 controls in the early follow-up cohort. Early ASDH expansion was associated with coagulopathy (adjusted odds ratio [aOR] 2.3, 95 % CI: 1.2-4.5; p = 0.02), thicker ASDHs (aOR 1.1, 95% CI: 1.03-1.2; p = 0.006), additional intracranial lesions (aOR 3, 95% CI: 1.6-6.2; p = 0.002), no/minimal trauma history (aOR 0.4, 95% CI: 0.2-0.9; p = 0.03), and duration between injury and initial scan (aOR 0.9, 95% CI: 0.8-0.97; p = 0.04). In the delayed follow-up cohort, there were 41 cases and 126 controls. Delayed ASDH expansion was associated with older age (aOR 1.3 per 10 years, 95% CI: 1.1-1.6; p = 0.01), systolic blood pressure (SBP) >160 on hospital presentation (aOR 4.5, 95% CI: 1.8-11.3; p = 0.001), midline shift (aOR 1.5 per 1 mm, 95% CI: 1.3-1.9; p < 0.001), and convexity location (aOR 14.1, 95% CI: 2.6-265; p = 0.013). We conclude that early and delayed ASDH expansion are different processes with different associated factors, and that elevated SBP may be a modifiable risk factor of delayed expansion.	[Robinson, David; Pyle, Logan; Foreman, Brandon; Woo, Daniel] Univ Cincinnati, Dept Neurol & Rehabil Med, 231 Albert Sabin Way,Room 7101, Cincinnati, OH 45267 USA; [Foreman, Brandon; Ngwenya, Laura B.] Univ Cincinnati, Collaborat Res Acute Neurol Injuries, Cincinnati, OH USA; [Ngwenya, Laura B.; Adeoye, Opeolu] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Adeoye, Opeolu; Kreitzer, Natalie] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA		Robinson, D (corresponding author), Univ Cincinnati, Dept Neurol & Rehabil Med, 231 Albert Sabin Way,Room 7101, Cincinnati, OH 45267 USA.	robin2dv@ucmail.uc.edu		Robinson, David/0000-0003-3221-3599	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5T32NS047996-14]	David Robinson reports relevant funding from the National Institute of Neurological Disorders and Stroke (5T32NS047996-14).	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Alves JL, 2016, AM J FOREN MED PATH, V37, P174, DOI 10.1097/PAF.0000000000000255; Andersen-Ranberg NC, 2019, ACTA NEUROCHIR, V161, P885, DOI 10.1007/s00701-019-03858-9; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Bajsarowicz P, 2015, J NEUROSURG, V123, P1176, DOI 10.3171/2014.10.JNS141728; Bin Zahid A, 2018, J NEUROSURG, V129, P1579, DOI 10.3171/2017.8.JNS17477; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Connolly SJ, 2019, NEW ENGL J MED, V380, P1326, DOI 10.1056/NEJMoa1814051; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; Edlmann E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0881-y; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Gernsback JE, 2018, WORLD NEUROSURG, V120, pE414, DOI 10.1016/j.wneu.2018.08.095; Hamahata NT, 2020, NEUROCRIT CARE, V32, P633, DOI 10.1007/s12028-019-00873-7; HARPER G, 1994, STROKE, V25, P1726, DOI 10.1161/01.STR.25.9.1726; Howard BM, 2017, J NEUROTRAUM, V34, P128, DOI 10.1089/neu.2015.4270; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Huang KT, 2016, NEUROCRIT CARE, V24, P294, DOI 10.1007/s12028-015-0194-x; Kaestner S, 2019, J NEUROL SURG PART A, V80, P359, DOI 10.1055/s-0039-1685188; Karri J, 2017, SHOCK, V48, P644, DOI 10.1097/SHK.0000000000000912; Kayahara T, 2020, ACTA NEUROCHIR, V162, P357, DOI 10.1007/s00701-019-04187-7; Kim BJ, 2014, ACTA NEUROCHIR, V156, P1605, DOI 10.1007/s00701-014-2151-4; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Kuhn EN, 2018, WORLD NEUROSURG, V119, pE374, DOI 10.1016/j.wneu.2018.07.168; Kwon H, 2017, J KOREAN NEUROSURG S, V60, P723, DOI 10.3340/jkns.2017.0506.011; Laviv Y, 2014, BRIT J NEUROSURG, V28, P733, DOI 10.3109/02688697.2014.918578; Lee Jong Joo, 2015, Korean J Neurotrauma, V11, P52, DOI 10.13004/kjnt.2015.11.2.52; Marion DW, 2006, NEUROSURGERY, V58, P655; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Munro D, 1936, ARCH NEURO PSYCHIATR, V35, P64, DOI 10.1001/archneurpsyc.1936.02260010074005; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Poulsen FR, 2016, PHARMACOEPIDEM DR S, V25, P1253, DOI 10.1002/pds.4058; Pruitt P, 2017, ACAD EMERG MED, V24, P1377, DOI 10.1111/acem.13306; Puffer RC, 2019, J NEUROSURG, V131, P596, DOI 10.3171/2018.2.JNS173138; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shibahashi K, 2017, WORLD NEUROSURG, V107, P82, DOI [10.1016/J.WNEU.2017.07.117, 10.1016/j.wneu.2017.07.117]; Vega RA, 2017, NEUROSURG CLIN N AM, V28, P247, DOI 10.1016/j.nec.2016.11.007; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang D, 2016, J NEUROL SCI, V362, P91, DOI 10.1016/j.jns.2016.01.017; Wang D, 2010, J NEUROTRAUM, V27, P1489, DOI 10.1089/neu.2009.1057; Weimer JM, 2017, NEUROCRIT CARE, V26, P70, DOI 10.1007/s12028-016-0279-1; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; You SJ, 2019, STROKE, V50, P1409, DOI 10.1161/STROKEAHA.118.024403; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233	45	1	1	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					903	910		10.1089/neu.2020.7192		DEC 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000599322200001	33107370				2022-02-06	
J	Saber, M; Murphy, SM; Cho, Y; Lifshitz, J; Rowe, RK				Saber, Maha; Murphy, Sean M.; Cho, Yerin; Lifshitz, Jonathan; Rowe, Rachel K.			Experimental diffuse brain injury and a model of Alzheimer's disease exhibit disease-specific changes in sleep and incongruous peripheral inflammation	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						aging; Alzheimer's disease; blood cytokines; monocytes; RRID:AB_839504; RRID:AB_312791; RRID:AB_312977; RRID:AB_2340846; RRID:AB_2340855; RRID:AB_2562218; RRID:AB_2562351; RRID:AB_2722581; RRID:AB_2732058; RRID:AB_2734548; RRID:AB_10640819; RRID:AB_11203896; RRID:SCR_00044; RRID:SCR_001905; RRID:SCR_004633; sleep; traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; 3XTG-AD MOUSE MODEL; POSTTRAUMATIC SLEEP; MULTILEVEL ANALYSIS; BAYESIAN-ESTIMATION; AMYLOID DEPOSITION; CIRCADIAN-RHYTHMS; R PACKAGE; CYTOKINES; WAKE	Elderly populations (>= 65 years old) have the highest risk of developing Alzheimer's disease (AD) and/or obtaining a traumatic brain injury (TBI). Using translational mouse models, we investigated sleep disturbances and inflammation associated with normal aging, TBI and aging, and AD. We hypothesized that aging results in marked changes in sleep compared with adult mice, and that TBI and aging would result in sleep and inflammation levels similar to AD mice. We used female 16-month-old wild-type (WT Aged) and 3xTg-AD mice, as well as a 2-month-old reference group (WT Adult), to evaluate sleep changes. WT Aged mice received diffuse TBI by midline fluid percussion, and blood was collected from both WT Aged (pre- and post-TBI) and 3xTg-AD mice to evaluate inflammation. Cognitive behavior was tested, and tissue was collected for histology. Bayesian generalized additive and mixed-effects models were used for analyses. Both normal aging and AD led to increases in sleep compared with adult mice. WT Aged mice with TBI slept substantially more, with fragmented shorter bouts, than they did pre TBI and compared with AD mice. However, differences between WT Aged and 3xTg-AD mice in immune cell populations and plasma cytokine levels were incongruous, cognitive deficits were similar, and cumulative sleep was not predictive of inflammation or behavior for either group. Our results suggest that in similarly aged individuals, TBI immediately induces more profound sleep alterations than in AD, although both diseases likely include cognitive impairments. Unique pathological sleep pathways may exist in elderly individuals who incur TBI compared with similarly aged individuals who have AD, which may warrant disease-specific treatments in clinical settings.	[Saber, Maha; Cho, Yerin; Lifshitz, Jonathan; Rowe, Rachel K.] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Saber, Maha; Murphy, Sean M.; Cho, Yerin; Lifshitz, Jonathan; Rowe, Rachel K.] Univ Arizona, Dept Child Hlth, Coll Med, Phoenix, AZ USA; [Lifshitz, Jonathan; Rowe, Rachel K.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ USA		Rowe, RK (corresponding author), Univ Arizona, Coll Med, Translat Neurotrauma Res Program, Dept Child Hlth, ABC 1 Bldg,425 N,5th St, Phoenix, AZ 85004 USA.		Murphy, Sean/AAM-4692-2021; Lang, Steven/AAE-8102-2021	Murphy, Sean/0000-0002-9404-8878; Lang, Steven/0000-0003-1669-9146; Rowe, Rachel/0000-0002-9034-3159	Arizona Alzheimer's Consortium [NIH-R21-NS096515]; Phoenix Children's Hospital Mission Support funds [T32-AG044402]	This research was funded by NIH-R21-NS096515, Arizona Alzheimer's Consortium, T32-AG044402, and Phoenix Children's Hospital Mission Support funds	Aarts E, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0228-5; Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; ANCOLIISRAEL S, 1991, J AM GERIATR SOC, V39, P258, DOI 10.1111/j.1532-5415.1991.tb01647.x; Bamberger ME, 2002, NEUROSCIENTIST, V8, P276, DOI 10.1177/1073858402008003013; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Belfiore R, 2019, AGING CELL, V18, DOI 10.1111/acel.12873; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Breitve MH, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0171-4; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Ciaburro G, 2018, REGRESSION ANAL R DE; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cordone S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00695; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; dos Santos AB, 2015, NEUROCHEM RES, V40, P421, DOI 10.1007/s11064-014-1488-7; dos Santos AB, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00273; Duncan MJ, 2019, ALZH DEMENT-TRCI, V5, P70, DOI 10.1016/j.trci.2019.01.003; Duncan MJ, 2012, EXP NEUROL, V236, P249, DOI 10.1016/j.expneurol.2012.05.011; Espiritu JRD, 2008, CLIN GERIATR MED, V24, P1, DOI 10.1016/j.cger.2007.08.007; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Farace E, 2000, Neurosurg Focus, V8, pe6; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Figueroa-Zuniga JI, 2013, COMPUT STAT DATA AN, V61, P137, DOI 10.1016/j.csda.2012.12.002; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Gabry J., 2019, BAYESPLOT PLOTTING B; Gabry J, 2019, J R STAT SOC A STAT, V182, P389, DOI 10.1111/rssa.12378; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gelman A., 2013, BAYESIAN DATA ANAL M, V3rd; Gelman A., 2011, INFERENCE SIMULATION; Gelman A., 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Giordano KR, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113242; Green TRF, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00894; Guarnieri B, 2012, DEMENT GERIATR COGN, V33, P50, DOI 10.1159/000335363; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hilbe JM, 2014, MODELING COUNT DATA, P126; Iboaya A, 2019, NEUROREHAB NEURAL RE, V33, P975, DOI 10.1177/1545968319883879; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; KRUEGER JM, 1995, ADV NEUROIMMUNOL, V5, P171, DOI 10.1016/0960-5428(95)00007-O; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liguori C, 2020, J ALZHEIMERS DIS, V74, P501, DOI 10.3233/JAD-191124; Lueptow LM, 2017, JOVE-J VIS EXP, DOI 10.3791/55718; Mander BA, 2016, TRENDS NEUROSCI, V39, P552, DOI 10.1016/j.tins.2016.05.002; Mang GM, 2014, SLEEP, V37, P1383, DOI 10.5665/sleep.3936; Mattis J, 2016, TRENDS ENDOCRIN MET, V27, P192, DOI 10.1016/j.tem.2016.02.003; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McNeish D, 2016, STRUCT EQU MODELING, V23, P750, DOI 10.1080/10705511.2016.1186549; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Miyata S, 2013, J SLEEP RES, V22, P535, DOI 10.1111/jsr.12054; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Musiek ES, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00029; MYERS BL, 1995, NEUROSCI BIOBEHAV R, V19, P553, DOI 10.1016/0149-7634(95)00018-6; Newcombe EA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1313-3; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; Perperoglou A, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0666-3; PRINZ PN, 1982, NEUROBIOL AGING, V3, P361, DOI 10.1016/0197-4580(82)90024-0; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; R Core Team, 2019, R LANG ENV STAT COMP; Rietz S, 1999, Rehabilitation (Stuttg), V38, P16; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Rosenberg RN, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0441-4; Rowe RK, 2019, J NEUROTRAUM, V36, P1318, DOI 10.1089/neu.2018.5980; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Saber M, 2021, SHOCK, V55, P256, DOI 10.1097/SHK.0000000000001618; Saber M, 2020, EUR J NEUROSCI, V52, P2791, DOI 10.1111/ejn.14611; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Sethi M, 2015, NEUROSCIENCE, V290, P80, DOI 10.1016/j.neuroscience.2015.01.035; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Simpson N, 2007, NUTR REV, V65, pS244, DOI 10.1301/nr.2007.dec.S244-S252; Soltani S, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00051; Sterniczuk R, 2010, BRAIN RES, V1348, P139, DOI 10.1016/j.brainres.2010.05.013; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Stevens JA, 2001, JAMA-J AM MED ASSOC, V286, P2665, DOI 10.1001/jama.286.21.2665; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Torres-Lista V, 2017, J ALZHEIMERS DIS REP, V1, P47, DOI 10.3233/ADR-170011; van de Schoot R, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.25216; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wei L, 2020, J HEAD TRAUMA REHAB, V35, P288, DOI 10.1097/HTR.0000000000000563; West B., 2015, LINEAR MIXED MODELS; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wimmer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081880; WITTING W, 1990, BIOL PSYCHIAT, V27, P563, DOI 10.1016/0006-3223(90)90523-5; Wu L., 2010, MIXED EFFECTS MODELS; Yang JT, 2018, NEUROSCI BULL, V34, P736, DOI 10.1007/s12264-018-0268-9; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zondervan-Zwijnenburg M, 2017, RES HUM DEV, V14, P305, DOI 10.1080/15427609.2017.1370966	107	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2021	99	4					1136	1160		10.1002/jnr.24771		DEC 2020	25	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QT7LP	WOS:000598390300001	33319441				2022-02-06	
J	Zeiler, FA; Mathieu, F; Monteiro, M; Glocker, B; Ercole, A; Cabeleira, M; Stocchetti, N; Smielewski, P; Czosnyka, M; Newcombe, V; Menon, DK				Zeiler, Frederick A.; Mathieu, Francois; Monteiro, Miguel; Glocker, Ben; Ercole, Ari; Cabeleira, Manuel; Stocchetti, Nino; Smielewski, Peter; Czosnyka, Marek; Newcombe, Virginia; Menon, David K.		Collaborative European Neurotrauma	Systemic Markers of Injury and Injury Response Are Not Associated with Impaired Cerebrovascular Reactivity in Adult Traumatic Brain Injury: A Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebrovascular reactivity; extra-cranial injury; injury burden; TBI	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; AUTOREGULATION; MANAGEMENT; MODERATE; INDEX	The role of extra-cranial injury burden and systemic injury response on cerebrovascular response in traumatic brain injury (TBI) is poorly documented. This study preliminarily assesses the association between admission features of extra-cranial injury burden on cerebrovascular reactivity. Using the Collaborative European Neurotrauma Effectiveness Research in TBI High-Resolution ICU (HR ICU) sub-study cohort, we evaluated those patients with both archived high-frequency digital intra-parenchymal intra-cranial pressure monitoring data of a minimum of 6 h in duration, and the presence of a digital copy of their admission computed tomography (CT) scan. Digital physiologic signals were processed for pressure reactivity index (PRx) and both the percent time above defined PRx thresholds and mean hourly dose above threshold. This was conducted for both the first 72 h and entire duration of recording. Admission extra-cranial injury characteristics and CT injury scores were obtained from the database, with quantitative contusion, edema, intraventricular hemorrhage, and extra-axial lesion volumes were obtained via semi-automated segmentation. Comparison between admission extra-cranial markers of injury and PRx metrics was conducted using Mann-Whitney U testing, and logistic regression techniques, adjusting for known CT injury metrics associated with impaired PRx. A total of 165 patients were included. Evaluating the entire ICU recording period, there was limited association between metrics of extra-cranial injury burden and impaired cerebrovascular reactivity. Using the first 72 h of recording, admission temperature (p = 0.042) and white blood cell % (WBC %; p = 0.013) were statistically associated with impaired cerebrovascular reactivity on Mann-Whitney U and univariate logistic regression. After adjustment for admission age, pupillary status, GCS motor score, pre-hospital hypoxia/hypotension, and intra-cranial CT characteristics associated with impaired reactivity, temperature (p = 0.021) and WBC % (p = 0.013) remained significantly associated with mean PRx values above +0.25 and +0.35, respectively. Markers of extra-cranial injury burden and systemic injury response do not appear to be strongly associated with impaired cerebrovascular reactivity in TBI during both the initial and entire ICU stay.	[Zeiler, Frederick A.; Mathieu, Francois; Ercole, Ari; Newcombe, Virginia; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Mathieu, Francois] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Monteiro, Miguel; Glocker, Ben] Imperial Coll London, Biomed Image Anal Grp, London, England; [Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Cambridge, England; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.	Frederick.zeiler@umanitoba.ca	Monteiro, Miguel/AAE-6334-2021; Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Moller, Kirsten/A-4751-2009	Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Zeiler, Frederick/0000-0003-1737-0510; Moller, Kirsten/0000-0003-3058-1072; Sakowitz, Oliver/0000-0003-3248-6335	European Union 7th Framework program (EC grant) [602150]; Integra LifeSciences Corporation (USA); Hannelore Kohl Stiftung (Germany); OneMind (USA)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).	Aries MJH, 2016, CRIT CARE MED, V44, pE996, DOI 10.1097/CCM.0000000000001816; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Lavinio A, 2009, INTENS CARE MED, V35, P546, DOI 10.1007/s00134-008-1311-5; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Mathieu F, 2020, J NEUROTRAUM, V37, P1556, DOI 10.1089/neu.2019.6814; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Zeiler FA, 2020, J NEUROTRAUM, V37, P1597, DOI 10.1089/neu.2019.6959; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2019, NAT REV NEUROL, V15, P25, DOI 10.1038/s41582-018-0105-9; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2018, J NEUROTRAUM, V35, P1569, DOI 10.1089/neu.2017.5595; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00379	30	1	1	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					870	878		10.1089/neu.2020.7304		DEC 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000599863400001	33096953	Green Submitted			2022-02-06	
J	Zhang, P; Roberts, T; Richards, B; Haseler, LJ				Zhang, Ping; Roberts, Tegan; Richards, Brent; Haseler, Luke J.			Utilizing heart rate variability to predict ICU patient outcome in traumatic brain injury	BMC BIOINFORMATICS			English	Article; Proceedings Paper	3rd International Workshop on Computational Methods for the Immune System Function (CMISF) in conjunction with IEEE International Conference on Bioinformatics and Biomedicine (BIBM)	NOV 18-21, 2019	San Diego, CA			ECG; Time series; HRV; Feature extraction; Euclidean distance; Patient outcome; ICU	INTENSIVE-CARE-UNIT; CHRONIC HEALTH EVALUATION; III PROGNOSTIC SYSTEM; 1ST 24 H; SPECTRAL-ANALYSIS; ACUTE PHYSIOLOGY; HOSPITAL MORTALITY; SCORING SYSTEMS; SEVERITY SCORE; APACHE-II	BackgroundPrediction of patient outcome in medical intensive care units (ICU) may help for development and investigation of early interventional strategies. Several ICU scoring systems have been developed and are used to predict clinical outcome of ICU patients. These scores are calculated from clinical physiological and biochemical characteristics of patients. Heart rate variability (HRV) is a correlate of cardiac autonomic regulation and has been evident as a marker of poor clinical prognosis. HRV can be measured from the electrocardiogram non-invasively and monitored in real time. HRV has been identified as a promising 'electronic biomarker' of disease severity. Traumatic brain injury (TBI) is a subset of critically ill patients admitted to ICU, with significant morbidity and mortality, and often difficult to predict outcomes. Changes of HRV for brain injured patients have been reported in several studies. This study aimed to utilize the continuous HRV collection from admission across the first 24 h in the ICU in severe TBI patients to develop a patient outcome prediction system.ResultsA feature extraction strategy was applied to measure the HRV fluctuation during time. A prediction model was developed based on HRV measures with a genetic algorithm for feature selection. The result (AUC: 0.77) was compared with earlier reported scoring systems (highest AUC: 0.76), encouraging further development and practical application.ConclusionsThe prediction models built with different feature sets indicated that HRV based parameters may help predict brain injury patient outcome better than the previously adopted illness severity scores.	[Zhang, Ping] Griffith Univ, Menzies Hlth Inst QLD, Gold Coast, Australia; [Roberts, Tegan] Griffith Univ, Sch Med Sci, Gold Coast, Australia; [Richards, Brent] Griffith Univ, Sch Med, Gold Coast, Australia; [Richards, Brent] Gold Coast Univ Hosp, Gold Coast, Australia; [Haseler, Luke J.] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia		Zhang, P (corresponding author), Griffith Univ, Menzies Hlth Inst QLD, Gold Coast, Australia.	pzhang@griffith.edu.au	zhang, ping/L-3901-2017	zhang, ping/0000-0002-3907-1127	Menzies Health Institute QLD, Griffith University, Australia	Publication costs are funded by Menzies Health Institute QLD, Griffith University, Australia.	Baillard C, 2002, CRIT CARE MED, V30, P306, DOI 10.1097/00003246-200202000-00007; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; Camm AJ, 1996, EUR HEART J, V17, P354; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Haji-Michael PG, 2000, CRIT CARE MED, V28, P2578, DOI 10.1097/00003246-200007000-00066; Hildebrandt H, 1998, EUR ARCH PSY CLIN N, V248, P46, DOI 10.1007/s004060050016; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jeong S, 2018, ACUTE CRIT CARE, V33, P102, DOI 10.4266/acc.2018.00185; Johnson P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S11; Kao R, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0143-6; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kox M, 2012, J NEUROTRAUM, V29, P747, DOI 10.1089/neu.2011.2035; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liu Yangchi, 1988, ESSENTIAL BOOK TRADI; LOWENSOHN RI, 1977, LANCET, V1, P626; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Piantino JA, 2019, PEDIATR CRIT CARE ME, V20, P38, DOI 10.1097/PCC.0000000000001759; Rapsang AG, 2014, INDIAN J CRIT CARE M, V18, P220, DOI 10.4103/0972-5229.130573; Rivera-Fernandez R, 1998, INTENS CARE MED, V24, P574, DOI 10.1007/s001340050618; Roberts T, 2018, AUST CRIT CARE, V31, P115, DOI 10.1016/j.aucc.2017.12.011; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Todd J, 2019, INT J MED INFORM, V129, P318, DOI 10.1016/j.ijmedinf.2019.07.002; Vandewater L, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WHO, 2014, INJ VIOL FACTS; Winchell RJ, 1997, J TRAUMA, V43, P927, DOI 10.1097/00005373-199712000-00010; Winchell RJ, 1996, J SURG RES, V63, P11, DOI 10.1006/jsre.1996.0214; WONG DT, 1995, CRIT CARE MED, V23, P1177, DOI 10.1097/00003246-199507000-00005; World Health Organization, VIOL INJ PREV DIS; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang P, 2005, PATTERN RECOGN LETT, V26, P909, DOI 10.1016/j.patrec.2004.09.053; Zhang P, 2019, IEEE INT C BIOINFORM, P2222, DOI 10.1109/BIBM47256.2019.8983177; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	43	1	1	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2105			BMC BIOINFORMATICS	BMC Bioinformatics	DEC 14	2020	21			17	SI				481	10.1186/s12859-020-03814-w			11	Biochemical Research Methods; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Mathematical & Computational Biology	PG6UD	WOS:000599867600003	33308142	Green Published, gold			2022-02-06	
J	D'Silva, L; Devos, H; Hunt, SL; Chen, J; Smith, D; Rippee, MA				D'Silva, L.; Devos, H.; Hunt, S. L.; Chen, J.; Smith, D.; Rippee, M. A.			Concussion symptoms experienced during driving may influence driving habits	BRAIN INJURY			English	Article						Concussion; driving habits; symptoms; driving restrictions		Objective: To examine the symptoms experienced and the change in driving habits in individuals with concussion. Materials and methods: A survey was created by a team of rehabilitation professionals who see persons with concussion in their clinics. The survey captured demographics, mechanism of injury, date of injury, symptoms experienced during driving, if drivers felt safe when driving, and changes in driving habits since the concussion. Non-parametric tests were used to compare symptoms experienced and driving habits across three groups which were created based on time since injury. Results: Of the 140 participants, 74% (104/140) had resumed driving after concussion; of these 27% (28/104) reported that they felt unsafe while driving. Forty-four per cent (46/104) experienced symptoms while driving, of which headache, and difficulty concentrating were the most common symptoms experienced throughout the concussion spectrum (acute to chronic phase). Most drivers (78/104, 75%) with concussion had changed their driving habits by driving less often and shorter distances, and by avoiding nighttime driving and heavy traffic areas. Conclusions: Headache and concentration problems were experienced by drivers regardless of the time since injury. Most drivers had made changes to their driving habits. Clinicians should consider the symptom burden patients experience and discuss driving restrictions to ensure driving safety.	[D'Silva, L.; Devos, H.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Lawrence, KS 66045 USA; [Hunt, S. L.] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Lawrence, KS 66045 USA; [Chen, J.; Smith, D.; Rippee, M. A.] Univ Kansas Hlth Syst, Ctr Concuss Management, Kansas City, KS USA		D'Silva, L (corresponding author), 3901 Rainbow Blvd,Mail Stop 2002, Kansas City, KS 66160 USA.	ldsilva@kumc.edu					Akinwuntan AE, 2012, J STROKE CEREBROVASC, V21, P478, DOI 10.1016/j.jstrokecerebrovasdis.2010.12.001; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Blake AL, 2019, SLEEP HEALTH, V5, P72, DOI 10.1016/j.sleh.2018.10.011; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Chen J, 2020, HEALTH SERV INSIGHTS, V13, DOI 10.1177/1178632920938674; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Gardner, 2018, CONCUSSION LONDON EN, V3; Guskiewicz, 2011, J SPEC OPER MED, V11; Howell DR, 2019, CLIN PEDIATR, V58, P42, DOI 10.1177/0009922818806308; Klein TA, 2017, J PEDIATR HEALTH CAR, V31, P441, DOI 10.1016/j.pedhc.2016.11.004; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lucas S, 2016, HEADACHE, V56, P323, DOI 10.1111/head.12762; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Neyens DM, 2012, ACCIDENT ANAL PREV, V49, P266, DOI 10.1016/j.aap.2012.01.008; Preece MHW, 2016, BRAIN INJURY, V30, P1096, DOI 10.3109/02699052.2016.1165868; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Schmidt JD, 2018, J NEUROTRAUM, V35, P2418, DOI 10.1089/neu.2018.5707; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Traumatic Brain Injury in the United States, 2010, EMERGENCY DEP VISITS; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z	25	1	1	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 5	2021	35	1					59	64		10.1080/02699052.2020.1857839		DEC 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QU1AU	WOS:000597862500001	33297775				2022-02-06	
J	de Guise, E; Degre, C; Beaujean, O; Julien, J; Lague-Beauvais, M; Dagher, J; Marcoux, J				de Guise, Elaine; Degre, Catherine; Beaujean, Oceane; Julien, Jessica; Lague-Beauvais, Maude; Dagher, Jehane; Marcoux, Judith			Comparison of executive functions and functional outcome between older patients with traumatic brain injury and normal older controls	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Aging; cognitive reserve; executive functioning; outcome; traumatic brain injury		Context The aim of this preliminary study was to assess the impact of traumatic brain injury (TBI) in older age on executive functioning and on their functional outcome. We also aimed to explore the influence of cognitive reserve (CR) and estimated premorbid cognitive functioning (EPCF) on these components. Methods A neuropsychological and functional assessment that included tests measuring Inhibition, Updating and Shifting, and functional outcome was administered to 29 patients who sustained a mild or moderate TBI in older age and a group of 24 healthy older participants. CR (level of education) and EPCF variables collected in the TBI group were associated with executive function performance and functional outcome. Results Patients with TBI obtained significantly worse performances on the spatial working memory (WM) task-reverse condition, and on the completion time of the Trails A and B than the control group. The TBI group also obtained worse functional outcome scores. A higher level of education was associated with better WM performance, and higher estimated premorbid cognitive functioning was associated with better functional outcome post TBI. Conclusions Further studies with a larger sample should be conducted to better understand the profile and determinants of recovery from TBI in the elderly.	[de Guise, Elaine; Degre, Catherine; Beaujean, Oceane; Julien, Jessica] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [de Guise, Elaine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [de Guise, Elaine] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Lague-Beauvais, Maude] McGill Univ, Hlth Ctr, Traumat Brain Injury Program, Montreal, PQ, Canada; [Dagher, Jehane] McGill Univ, Hlth Ctr, Montreal, PQ, Canada; [Marcoux, Judith] MUHC MGH, Montreal, PQ, Canada		de Guise, E (corresponding author), Univ Montreal, Montreal, PQ, Canada.	elaine.de.guise@umontreal.ca					AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Anderson LB, 2017, J CLIN EXP NEUROPSYC, V39, P890, DOI 10.1080/13803395.2016.1277513; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Brockmole JR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00012; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Donders J, 2019, ARCH CLIN NEUROPSYCH, V34, P206, DOI 10.1093/arclin/acy035; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Goleburn G, 2001, J CLIN GEROPSYCHOL, V7, P161, DOI DOI 10.1023/A:1011335027445; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Head D, 2002, PSYCHOL AGING, V17, P72, DOI 10.1037//0882-7974.17.1.72; Jorm AF, 1996, CLIN PSYCHOL REV, V16, P51, DOI 10.1016/0272-7358(95)00056-9; JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie-Dugre S., 2015, THESIS U LAVAL QUEBE; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lewis Frank D, 2013, J Spec Oper Med, V13, P56; Lezak, 2008, MANUAL MAYO PORTLAND; Liu-Ambrose T, 2008, ARCH PHYS MED REHAB, V89, P1335, DOI 10.1016/j.apmr.2007.11.052; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mathias JL, 2015, NEUROSCI BIOBEHAV R, V55, P573, DOI 10.1016/j.neubiorev.2015.06.001; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morrison S., 2017, ENCY GEROPSYCHOLOGY, DOI [10.1007/978-981-287-082-7_230, DOI 10.1007/978-981-287-082-7_230]; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Nucci Massimo, 2012, Aging Clin Exp Res, V24, P218, DOI 10.3275/7800; Opdebeeck C, 2016, AGING NEUROPSYCHOL C, V23, P40, DOI 10.1080/13825585.2015.1041450; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Plenger P, 2016, BRAIN IMAGING BEHAV, V10, P357, DOI 10.1007/s11682-015-9401-9; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Richards B., 2001, THESIS YORK U TORONT; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rojas N, 2019, APPL NEUROPSYCH-ADUL, V26, P319, DOI 10.1080/23279095.2017.1422506; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tardif PA, 2017, INJURY, V48, P94, DOI 10.1016/j.injury.2016.10.042; TEASDALE G, 1974, LANCET, V2, P81; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Toglia J., 2017, CHANGES BRAIN IMPACT, P117, DOI [10.1007/978-0-387-98188-8_6, DOI 10.1007/978-0-387-98188-8_6]; Van der Linden M., 2014, TRAIT NEUROPSYCHOLOG, V1, P461; Van derLinden., 1994, VIEILLISSEMENT COGNI, V1ere, P37; Weschler D., 2001, ECHELLE CLIN MEMOIRE; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Xu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14867-y; Zimmerman ME, 2006, AM J GERIAT PSYCHIAT, V14, P823, DOI 10.1097/01.JGP.0000238502.40963.ac; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	89	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1862118		DEC 2020	14	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	PM6ZU	WOS:000603945300001	33372562				2022-02-06	
J	McKenna, F; Miles, L; Donaldson, J; Castellanos, FX; Lazar, M				McKenna, Faye; Miles, Laura; Donaldson, Jeffrey; Castellanos, F. Xavier; Lazar, Mariana			Diffusion kurtosis imaging of gray matter in young adults with autism spectrum disorder	SCIENTIFIC REPORTS			English	Article							HIGH-FUNCTIONING AUTISM; TRAUMATIC BRAIN-INJURY; HUMAN CEREBRAL-CORTEX; COGNITIVE IMPAIRMENT; FRONTAL-CORTEX; MICROSTRUCTURAL ABNORMALITIES; MRI; QUANTIFICATION; CONNECTIVITY; INDIVIDUALS	Prior ex vivo histological postmortem studies of autism spectrum disorder (ASD) have shown gray matter microstructural abnormalities, however, in vivo examination of gray matter microstructure in ASD has remained scarce due to the relative lack of non-invasive methods to assess it. The aim of this work was to evaluate the feasibility of employing diffusional kurtosis imaging (DKI) to describe gray matter abnormalities in ASD in vivo. DKI data were examined for 16 male participants with a diagnosis of ASD and IQ>80 and 17 age- and IQ-matched male typically developing (TD) young adults 18-25 years old. Mean (MK), axial (AK), radial (RK) kurtosis and mean diffusivity (MD) metrics were calculated for lobar and sub-lobar regions of interest. Significantly decreased MK, RK, and MD were found in ASD compared to TD participants in the frontal and temporal lobes and several sub-lobar regions previously associated with ASD pathology. In ASD participants, decreased kurtosis in gray matter ROIs correlated with increased repetitive and restricted behaviors and poor social interaction symptoms. Decreased kurtosis in ASD may reflect a pathology associated with a less restrictive microstructural environment such as decreased neuronal density and size, atypically sized cortical columns, or limited dendritic arborizations.	[McKenna, Faye; Miles, Laura; Donaldson, Jeffrey; Lazar, Mariana] NYU, Dept Radiol, Sch Med, Ctr Biomed Imaging, 660 First Ave, New York, NY 10016 USA; [Castellanos, F. Xavier] NYU, Dept Child & Adolescent Psychiat, Sch Med, New York, NY USA; [McKenna, Faye; Lazar, Mariana] NYU, Sch Med, Vilcek Inst Grad Biomed Sci, New York, NY 10016 USA; [Castellanos, F. Xavier] Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA		McKenna, F (corresponding author), NYU, Dept Radiol, Sch Med, Ctr Biomed Imaging, 660 First Ave, New York, NY 10016 USA.; McKenna, F (corresponding author), NYU, Sch Med, Vilcek Inst Grad Biomed Sci, New York, NY 10016 USA.	faye.mckenna@nyulangone.org		Castellanos, Francisco/0000-0001-9192-9437	Global and Regional Asperger Syndrome Partnership (GRASP); Interactive Autism Network (IAN); Asperger Syndrome and High Functioning Autism Association (AHANY); National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [NIMH R03-MH076180]; ResearchMatch	We greatly thank all our participants for their help with this study and the Global and Regional Asperger Syndrome Partnership (GRASP), Interactive Autism Network (IAN), Asperger Syndrome and High Functioning Autism Association (AHANY), and ResearchMatch for their support in advertising the study and recruiting participants. We also thank Kelly Anne McGorty, William Fazio, David Mossa and Kamil Banibaker for their assistance with acquiring the MR data. This study was funded in part by the National Institutes of Mental Health through NIMH R03-MH076180 award.	Adisetiyo V, 2014, HUM BRAIN MAPP, V35, P2148, DOI 10.1002/hbm.22317; Aggarwal M, 2015, NEUROIMAGE, V105, P198, DOI 10.1016/j.neuroimage.2014.10.053; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ameis SH, 2015, CORTEX, V62, P158, DOI 10.1016/j.cortex.2014.10.014; American Psychiatric Association, 2013, DSM 5 DIAGN CLASS DI, V5th; Aung Wint Yan, 2013, Imaging Med, V5, P427; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bester M, 2015, MULT SCLER J, V21, P935, DOI 10.1177/1352458514556295; Blakemore SJ, 2008, NAT REV NEUROSCI, V105, P111; Blockx I, 2012, NEUROIMAGE, V63, P653, DOI 10.1016/j.neuroimage.2012.06.032; Blumberg SJ, 2013, NATL HLTH STAT REPOR, V1-11; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buxhoeveden DP, 2006, NEUROPATH APPL NEURO, V32, P483, DOI 10.1111/j.1365-2990.2006.00745.x; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Carper RA, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00610; Casanova MF, 2007, AUTISM, V11, P557, DOI 10.1177/1362361307083261; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Casanova MF, 2002, J CHILD NEUROL, V17, P692, DOI 10.1177/088307380201700908; Casanova MF, 2015, MOL BASIS AUTISM, V17, P422; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Chen X, 2017, SHOCK VIB, V2017, P1, DOI DOI 10.1016/J.T0X.2017.01; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Cottaar M, 2018, NEUROIMAGE, V176, P417, DOI 10.1016/j.neuroimage.2018.04.040; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2005, INT J DEV NEUROSCI, V23, P153, DOI 10.1016/j.ijdevneu.2005.01.003; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Das SK, 2017, CLIN NEURORADIOL, V27, P283, DOI 10.1007/s00062-015-0490-z; Palacios RDY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095077; Dementieva YA, 2005, PEDIATR NEUROL, V32, P102, DOI 10.1016/j.pediatrneurol.2004.08.005; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Edwards LJ, 2018, NEUROIMAGE, V182, P184, DOI 10.1016/j.neuroimage.2018.02.055; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Golarai G, 2006, CLIN NEUROSCI RES, V6, P145, DOI 10.1016/j.cnr.2006.08.001; Groen WB, 2011, J PSYCHIATR NEUROSCI, V36, P32, DOI 10.1503/jpn.090100; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Gulban OF, 2018, NEUROIMAGE, V178, P104, DOI 10.1016/j.neuroimage.2018.05.010; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; Irie R, 2018, MAGN RESON MED SCI, V17, P138, DOI 10.2463/mrms.mp.2017-0031; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2012, IEEE T MED IMAGING, V31, P16, DOI 10.1109/TMI.2011.2162099; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; KEMPER TL, 1993, NEUROL CLIN, V11, P175, DOI 10.1016/S0733-8619(18)30176-2; Khairnar A, 2017, BRAIN BEHAV IMMUN, V61, P197, DOI 10.1016/j.bbi.2016.11.027; Kleinnijenhuis M, 2013, ORG HUMAN BRAIN MAPP; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; McKenna FF, 2019, CORTEX, V121, P201, DOI 10.1016/j.cortex.2019.08.013; McNab JA, 2013, NEUROIMAGE, V69, P87, DOI 10.1016/j.neuroimage.2012.11.065; Nazeri A, 2020, BIOL PSYCHIAT-COGN N, V5, P855, DOI 10.1016/j.bpsc.2020.03.003; Nie XJ, 2015, MAGN RESON IMAGING, V33, P437, DOI 10.1016/j.mri.2014.12.008; Ota M, 2017, JPN J RADIOL, V35, P584, DOI 10.1007/s11604-017-0670-7; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Vanhoutte G, 2013, MAGN RESON MED, V69, P1115, DOI 10.1002/mrm.24680; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Velikonja T, 2019, JAMA PSYCHIAT, V76, P135, DOI 10.1001/jamapsychiatry.2018.3645; Wang, 2015, PARK DIS, V2015, P1, DOI DOI 10.3969/j.issn.1006-4427.2015.01.009; Wang ML, 2018, NEUROSCIENCE, V392, P180, DOI 10.1016/j.neuroscience.2018.09.030; Wang Y, 2015, BRAIN, V138, P1223, DOI 10.1093/brain/awv046; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th, DOI [10.1037/t15169-000, DOI 10.1037/T15169-000]; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Yang AW, 2013, J MAGN RESON IMAGING, V37, P365, DOI 10.1002/jmri.23840; Yang D, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.213; Yasuno F, 2020, AUTISM RES, V13, P729, DOI 10.1002/aur.2280; Zhang Y, 2016, PAIN PHYSICIAN, V19, pE601; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	82	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 8	2020	10	1							21465	10.1038/s41598-020-78486-w			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PH0RY	WOS:000600132400069	33293640	gold, Green Published			2022-02-06	
J	Shi, YB; Tu, T; Jiang, J; Zhang, QL; Ai, JQ; Pan, AH; Manavis, J; Tu, E; Yan, XX				Shi, Yan-Bin; Tu, Tian; Jiang, Juan; Zhang, Qi-Lei; Ai, Jia-Qi; Pan, Aihua; Manavis, Jim; Tu, Ewen; Yan, Xiao-Xin			Early Dendritic Dystrophy in Human Brains With Primary Age-Related Tauopathy	FRONTIERS IN AGING NEUROSCIENCE			English	Article						Alzheimer&#8217; s disease; brain aging; neurodegeneration; neuritic dystrophy; synaptic pathology	MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SENILE PLAQUE; AMYLOID DEPOSITS; BETA-SECRETASE-1 ELEVATION; IMMUNOREACTIVE NEURITES; NEUROFIBRILLARY CHANGES; QUANTITATIVE ASSESSMENT; SYNAPTIC PATHOLOGY; AXONAL PATHOLOGY	Dystrophic neurites (DNs) are found in many neurological conditions such as traumatic brain injury and age-related neurodegenerative diseases. In Alzheimer's disease (AD) specifically, senile plaques containing silver-stained DNs were already described in the original literature defining this disease. These DNs could be both axonal and dendritic in origin, while axonal dystrophy relative to plaque formation has been more extensively studied. Here, we demonstrate an early occurrence of dendritic dystrophy in the hippocampal CA1 and subicular regions in human brains (n = 23) with primary age-related tauopathy (PART), with neurofibrillary tangle (NFT) burden ranging from Braak stages I to III in the absence of cerebral beta-amyloid (A beta) deposition. In Bielschowsky's silver stain, segmented fusiform swellings on the apical dendrites of hippocampal and subicular pyramidal neurons were observed in all the cases, primarily over the stratum radiatum (s.r.). The numbers of silver-stained neuronal somata and dendritic swellings counted over CA1 to subiculum were positively correlated among the cases. Swollen dendritic processes were also detected in sections immunolabeled for phosphorylated tau (pTau) and sortilin. In aged and AD brains with both A beta and pTau pathologies, silver- and immunolabeled dystrophic-like dendritic profiles occurred around and within individual neuritic plaques. These findings implicate that dendritic dystrophy can occur among hippocampal pyramidal neurons in human brains with PART. Therefore, as with the case of axonal dystrophy reported in literature, dendritic dystrophy can develop prior to Alzheimer-type plaque and tangle formation in the human brain.	[Shi, Yan-Bin] Cent South Univ, Xiangya Sch Med, Med Doctor Program, Changsha, Peoples R China; [Tu, Tian; Jiang, Juan; Zhang, Qi-Lei; Ai, Jia-Qi; Pan, Aihua; Yan, Xiao-Xin] Cent South Univ, Dept Anat & Neurobiol, Xiangya Sch Med, Changsha, Peoples R China; [Manavis, Jim] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Tu, Ewen] Brain Hosp Hunan Prov, Dept Neurol, Changsha, Peoples R China		Yan, XX (corresponding author), Cent South Univ, Dept Anat & Neurobiol, Xiangya Sch Med, Changsha, Peoples R China.; Tu, E (corresponding author), Brain Hosp Hunan Prov, Dept Neurol, Changsha, Peoples R China.	tuewen612@163.com; xiaoxinyan@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371095, 91632116, 82071223]; Natural Science Foundation of Hunan ProvinceNatural Science Foundation of Hunan Province [2018JJ6014, 2018SK1030]	This study was supported by the National Natural Science Foundation of China (grants #31371095, #91632116 and #82071223) and the Natural Science Foundation of Hunan Province (#2018JJ6014 and #2018SK1030).	Adalbert R, 2013, NEUROPATH APPL NEURO, V39, P90, DOI 10.1111/j.1365-2990.2012.01308.x; ALLSOP D, 1986, NEUROSCI LETT, V68, P252, DOI 10.1016/0304-3940(86)90152-7; Bell WR, 2019, ALZHEIMERS DEMENT, V15, P8, DOI 10.1016/j.jalz.2018.07.215; Berron D, 2020, BRAIN, V143, P1233, DOI 10.1093/brain/awaa068; Besser LM, 2017, NEUROLOGY, V89, P1707, DOI 10.1212/WNL.0000000000004521; Blazquez-Llorca L, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0415-y; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2020, J NEUROPATH EXP NEUR, V79, P163, DOI 10.1093/jnen/nlz123; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; BRION JP, 1991, BRAIN RES, V539, P143, DOI 10.1016/0006-8993(91)90697-T; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Cai Y, 2010, EUR J NEUROSCI, V32, P1223, DOI 10.1111/j.1460-9568.2010.07376.x; Cardozo PL, 2019, CURR NEUROPHARMACOL, V17, P1071, DOI 10.2174/1570159X17666190603170511; Carmichael ST, 2017, EXP NEUROL, V287, P384, DOI 10.1016/j.expneurol.2016.02.007; Chen MK, 2018, JAMA NEUROL, V75, P1215, DOI 10.1001/jamaneurol.2018.1836; Colom-Cadena M, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00588-4; CORIA F, 1988, LAB INVEST, V58, P454; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Critchley M, 1929, J NEUROL PSYCHOPATHO, V10, P124; Das SR, 2019, ALZHEIMERS DEMENT, V15, P1286, DOI 10.1016/j.jalz.2019.05.009; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Deng Xiaohua, 2014, Adv Alzheimer Dis, V3, P78; DICKSON DW, 1994, ACTA NEUROPATHOL, V87, P269; Duyckaerts C, 2015, ACTA NEUROPATHOL, V129, P749, DOI 10.1007/s00401-015-1390-7; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; Gai WP, 1995, BRAIN, V118, P1447, DOI 10.1093/brain/118.6.1447; Galasko D, 2019, ALZH DEMENT-TRCI, V5, P871, DOI 10.1016/j.trci.2019.11.002; Garcia-Marina V, 2007, J ALZHEIMERS DIS, V12, P161; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GONATAS NK, 1967, J NEUROPATH EXP NEUR, V26, P25, DOI 10.1097/00005072-196701000-00003; Grace EA, 2002, NEUROSCIENCE, V114, P265, DOI 10.1016/S0306-4522(02)00241-5; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Hall GF, 2000, MICROSC RES TECHNIQ, V48, P32, DOI 10.1002/(SICI)1097-0029(20000101)48:1<32::AID-JEMT5>3.3.CO;2-3; Herms J, 2016, ANNU REV PATHOL-MECH, V11, P221, DOI 10.1146/annurev-pathol-012615-044216; Hu X, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00045; Jefferson-George KS, 2017, ALZHEIMERS DEMENT, V13, P1048, DOI 10.1016/j.jalz.2017.01.028; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Jellinger KA, 2019, ALZHEIMERS DEMENT, V15, P720, DOI 10.1016/j.jalz.2019.01.005; Judkins AR, 2006, EPILEPSY RES, V70, P49, DOI 10.1016/j.eplepsyres.2006.03.006; Kaufman SK, 2018, ACTA NEUROPATHOL, V136, P57, DOI 10.1007/s00401-018-1855-6; Kay KR, 2013, NAT PROTOC, V8, P1366, DOI 10.1038/nprot.2013.078; Kelley CM, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0861-9; Kim D, 2019, J PATHOL TRANSL MED, V53, P159, DOI 10.4132/jptm.2019.03.14; Kimura N, 2018, NEUROCHEM INT, V119, P35, DOI 10.1016/j.neuint.2017.07.002; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Lleo A, 2019, MOL CELL PROTEOMICS, V18, P546, DOI 10.1074/mcp.RA118.001290; LUSE SA, 1964, AM J PATHOL, V44, P553; Maat-Schieman MLC, 1999, J NEUROPATH EXP NEUR, V58, P129, DOI 10.1097/00005072-199902000-00003; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; Mecca AP, 2020, ALZHEIMERS DEMENT, V16, P974, DOI 10.1002/alz.12097; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MUNOZ DG, 1991, LAB INVEST, V64, P826; MUNOZ DG, 1992, AM J PATHOL, V140, P1167; Ohry A, 2015, ROM J MORPHOL EMBRYO, V56, P1545; Oifa A I, 1973, Zh Nevropatol Psikhiatr Im S S Korsakova, V73, P1078; Perdigao C, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00072; Qiu WY, 2019, NEUROSCI BULL, V35, P270, DOI 10.1007/s12264-018-0306-7; Quintas-Neves M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0842-z; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Scheff SW, 2001, NEUROBIOL AGING, V22, P355, DOI 10.1016/S0197-4580(01)00222-6; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shishido H, 2016, NEUROSCI LETT, V629, P62, DOI 10.1016/j.neulet.2016.06.066; SHOJI M, 1990, BRAIN RES, V512, P164, DOI 10.1016/0006-8993(90)91187-L; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; STRUBLE RG, 1982, SCIENCE, V216, P413, DOI 10.1126/science.6803359; STRUBLE RG, 1987, J NEUROPATH EXP NEUR, V46, P567, DOI 10.1097/00005072-198709000-00006; SU JH, 1993, BRAIN RES, V625, P228, DOI 10.1016/0006-8993(93)91063-X; Su JH, 1996, BRAIN RES, V739, P79, DOI 10.1016/S0006-8993(96)00811-6; Su JH, 1998, ACTA NEUROPATHOL, V96, P463, DOI 10.1007/s004010050920; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Takahashi RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051965; Teylan M, 2020, BRAIN, V143, P611, DOI 10.1093/brain/awz403; Thal DR, 1998, J BRAIN RES, V39, P175; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Toth Z, 1998, J NEUROSCI, V18, P4285; TOURTELLOTTE WG, 1991, NEUROSCI LETT, V129, P11, DOI 10.1016/0304-3940(91)90709-3; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tsartsalis S, 2018, NEUROBIOL AGING, V62, P34, DOI 10.1016/j.neurobiolaging.2017.10.002; Tu T, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00093; WALKER LC, 1985, NEUROSCI LETT, V59, P165, DOI 10.1016/0304-3940(85)90194-6; WANG D, 1995, J NEUROPATH EXP NEUR, V54, P548, DOI 10.1097/00005072-199507000-00009; Wang X, 2020, J ZHEJIANG UNIV-SC B, V21, P256, DOI 10.1631/jzus.B1900262; Weigand AJ, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcz046; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Xu SY, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00031; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V76, P541, DOI 10.1007/BF00689591; Yan XX, 2015, LANCET NEUROL, V14, P136, DOI 10.1016/S1474-4422(14)70259-5; Yan XX, 2014, J ALZHEIMERS DIS, V38, P705, DOI 10.3233/JAD-131400; Yan XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048782; Yan XX, 2012, EXP NEUROL, V235, P228, DOI 10.1016/j.expneurol.2012.01.003; Zhang H, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0407-6; Zhang XM, 2010, EUR J NEUROSCI, V31, P710, DOI 10.1111/j.1460-9568.2010.07103.x; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhou FQ, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0370-2; Zhu KQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00529	102	1	1	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	DEC 7	2020	12								596894	10.3389/fnagi.2020.596894			16	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	PH4PK	WOS:000600396500001	33364934	Green Published, gold			2022-02-06	
J	Yamane, DP; Maghami, S; Graham, A; Vaziri, K; Davison, D				Yamane, David P.; Maghami, Sam; Graham, Ada; Vaziri, Khashayar; Davison, Danielle			Association of Hyperchloremia and Acute Kidney Injury in Patients With Traumatic Brain Injury	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						critical care; hyperchloremia; hypertonic saline; acute kidney injury; traumatic brain injury		Introduction: Hypertonic saline is often used to treat patients with traumatic brain injury. It carries the undesired side effect of hyperchloremia, which has been linked to acute kidney injury (AKI). We sought to evaluate the relationship of hyperchloremia and AKI in this population and whether the absolute exposure to hyperchloremia, including maximal hyperchloremia and duration of hyperchloremia were associated with AKI. Methods: A retrospective study of severe traumatic brain injury patients who received hypertonic saline at a single academic institution. Demographics, head abbreviated injury scale, development of hyperchloremia (Cl >= 115), duration of hyperchloremia, highest chloride level, duration of hypertonic saline use, admission GFR, and administration of nephrotoxic medications were abstracted. The outcome of interest was the association between renal function and hyperchloremia. Results: A total of 123 patients were included in the study. Multivariable logistic regression analysis demonstrated that only duration of hyperchloremia (p = 0.014) and GFR on admission (p = 0.004) were independently associated with development of AKI. The number of days of hypertonic saline infusion (p = 0.79) without the persistence of hyperchloremia and highest serum chloride levels (p = 0.23) were not predictive of AKI development. Discussion: In patients with traumatic brain injury, admission GFR and prolonged hyperchloremia rather than the highest chloride level or the duration of hypertonic saline infusion were associated with the development of AKI.	[Yamane, David P.; Davison, Danielle] George Washington Univ, Sch Med & Hlth Sci, Dept Anesthesiol & Crit Care Med, Washington, DC 20052 USA; [Yamane, David P.] George Washington Univ, Sch Med & Hlth Sci, Dept Emergency Med, Washington, DC 20052 USA; [Maghami, Sam; Graham, Ada; Vaziri, Khashayar] George Washington Univ, Sch Med & Hlth Sci, Dept Surg, Washington, DC 20052 USA		Maghami, S (corresponding author), George Washington Univ, Sch Med & Hlth Sci, 900 23rd St NW, Washington, DC 20037 USA.	smaghami@email.gwu.edu		Vaziri, Khashayar/0000-0003-3977-8891			Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; Burgess LG, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008439; Chen H, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010904.pub3; Commereuc M, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0570-3; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; de Vasconcellos K, 2018, J CRIT CARE, V45, P45, DOI 10.1016/j.jcrc.2018.01.019; Goad NT, 2020, J INTENSIVE CARE MED, V35, P1307, DOI 10.1177/0885066619865469; Jiang F, 2019, BLOOD PURIFICAT, V47, P317, DOI 10.1159/000499029; Kurita A, 2018, CRIT CARE MED, V46, P787, DOI 10.1097/01.ccm.0000529606.54981.3e; Lee JY, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0311-7; Levey AS, 2020, KIDNEY INT, V97, P1117, DOI 10.1016/j.kint.2020.02.010; Maguigan KL, 2017, J CLIN NEUROSCI, V39, P147, DOI 10.1016/j.jocn.2017.01.025; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Mao WJ, 2019, PANCREATOLOGY, V19, P136, DOI 10.1016/j.pan.2018.11.006; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Oh TK, 2019, WORLD NEUROSURG, V125, pE1226, DOI 10.1016/j.wneu.2019.02.015; Oh TK, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2216-5; Oh TK, 2019, J NEUROSURG ANESTH, V31, P311, DOI 10.1097/ANA.0000000000000512; Patel Nachiket, 2016, Proc (Bayl Univ Med Cent), V29, P7; Rein JL, 2019, AM J PHYSIOL-RENAL, V316, pF587, DOI 10.1152/ajprenal.00130.2018; Riha HM, 2017, CRIT CARE MED, V45, pE947, DOI 10.1097/CCM.0000000000002522; Sadan O, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3007-7; Sadan O, 2017, CRIT CARE MED, V45, P1382, DOI 10.1097/CCM.0000000000002497; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Sigmon J, 2020, ANN PHARMACOTHER, V54, P541, DOI 10.1177/1060028019891986; Suetrong B, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1499-7; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Yessayan L, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0750-z; Zacharia BE, 2009, STROKE, V40, P2375, DOI 10.1161/STROKEAHA.108.545210; Zorrilla-Vaca A, 2018, CEREBROVASC DIS, V45, P1, DOI 10.1159/000479338	33	1	1	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	JAN	2022	37	1					128	133	0885066620978735	10.1177/0885066620978735		DEC 2020	6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XB5LH	WOS:000625264300001	33283597				2022-02-06	
J	Doving, M; Galteland, P; Eken, T; Sehic, A; Utheim, TP; Skaga, NO; Helseth, E; Ramm-Pettersen, J				Doving, Mats; Galteland, Pal; Eken, Torsten; Sehic, Amer; Utheim, Tor Paaske; Skaga, Nils Oddvar; Helseth, Eirik; Ramm-Pettersen, Jon			Dentoalveolar injuries, bicycling accidents and helmet use in patients referred to a Norwegian Trauma Centre: A 12-year prospective study	DENTAL TRAUMATOLOGY			English	Article						epidemiology; head protective devices; maxillofacial injuries; tooth injuries; wounds and injuries	DENTAL TRAUMA; SAFETY HELMETS; RISK; BENEFITS; CRASHES; HEAD	Background/Aim Despite its many benefits, bicycling carries the risk of accidents. Although numerous studies have reported the effect of helmet use on traumatic brain injury, it remains unclear if, and to what extent, helmet use reduces the risk of facial injuries. This is particularly true in regard to injuries of the lower face. In addition, there is limited evidence of the effect of helmet use on dentoalveolar injuries. Thus, the aim of this study was to determine the frequency and distribution of dentoalveolar injuries in bicycling accidents and to explore the influence of helmet use. Material and Methods A total of 1543 bicyclists were included from the trauma registry of a Norwegian tertiary trauma center over a 12-year period. Data were collected prospectively, including patient characteristics, type of injury, and helmet use. The prevalence of dentoalveolar injuries was assessed in conjunction with helmet use and facial fractures. Results Twenty-five percent of the patients had maxillofacial injuries, and 18% of those with facial fractures exhibited concomitant dentoalveolar injuries. The most common type of dentoalveolar injury was tooth fracture (39%). The most frequent location of facial fractures with combined dentoalveolar injuries was the maxilla, which had fractured in 32 patients. Women had a higher risk of sustaining dentoalveolar injuries compared to men (odds ratio 1.50, 95% confidence interval 1.02-2.22). There were 1257 patients (81%) who had reliable registration of helmet use; 54% of these wore a helmet, while 46% did not. Helmet users had an increased risk of dentoalveolar injuries compared to non-helmeted bicyclists (adjusted odds ratio 1.54, 95% confidence interval 1.02-2.31). Conclusions Dentoalveolar injuries are fairly common in trauma patients admitted to a trauma center following bicycling accidents. Bicycling helmets are associated with an increased risk of dentoalveolar injuries.	[Doving, Mats; Galteland, Pal; Sehic, Amer; Utheim, Tor Paaske] Oslo Univ Hosp Ulleval, Dept Maxillofacial Surg, POB 4956 Nydalen, N-0424 Oslo, Norway; [Eken, Torsten; Skaga, Nils Oddvar] Oslo Univ Hosp Ulleval, Dept Anaesthesiol, Div Emergencies & Crit Care, Oslo, Norway; [Eken, Torsten; Helseth, Eirik] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Sehic, Amer; Utheim, Tor Paaske] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Helseth, Eirik; Ramm-Pettersen, Jon] Oslo Univ Hosp Ulleval, Dept Neurosurg, Oslo, Norway		Doving, M (corresponding author), Oslo Univ Hosp Ulleval, Dept Maxillofacial Surg, POB 4956 Nydalen, N-0424 Oslo, Norway.	matdov@ous-hf.no		Doving, Mats/0000-0002-2626-4982			Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; Association for the Advancement of Automotive Medicine, ABBREVIATED INJURY S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benjamin T, 2019, JAMA OTOLARYNGOL, V145, P140, DOI 10.1001/jamaoto.2018.3351; Bergenstal John, 2012, W V Med J, V108, P78; Boffano P, 2013, OR SURG OR MED OR PA, V116, P275, DOI 10.1016/j.oooo.2013.03.004; BRINGHURST C, 1993, AM J EMERG MED, V11, P486, DOI 10.1016/0735-6757(93)90091-O; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Dinh MM, 2015, EMERG MED AUSTRALAS, V27, P323, DOI 10.1111/1742-6723.12407; European Cyclists' Federation (ECF) asbl, 2017, EU CYCL STRAT REC DE; Farris C, 1997, ANN EMERG MED, V29, P625, DOI 10.1016/S0196-0644(97)70251-8; Fyhri A, 2013, ACCIDENT ANAL PREV, V50, P59, DOI 10.1016/j.aap.2012.03.027; Fyhri A, 2012, TRANSPORT RES F-TRAF, V15, P612, DOI 10.1016/j.trf.2012.06.003; Gassner R, 1999, ORAL SURG ORAL MED O, V87, P27, DOI 10.1016/S1079-2104(99)70290-8; Hansen Kari Schroder, 2003, Traffic Inj Prev, V4, P285, DOI 10.1080/714040486; Heng K. W. J., 2006, SMJ Singapore Medical Journal, V47, P367; Holst D, 2010, TANNLEGEFOREN, V120, P164; Hoye A, 2018, ACCIDENT ANAL PREV, V117, P85, DOI 10.1016/j.aap.2018.03.026; Hwang K, 2015, ARCH PLAST SURG-APS, V42, P407, DOI 10.5999/aps.2015.42.4.407; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; Kaushik Ruchi, 2015, Inj Epidemiol, V2, P16; Krafft, 2013, CYCLIST INJURIES LEA; Lee JY, 2009, PEDIATR DENT, V31, P96; Lieger O, 2009, J ORAL MAXIL SURG, V67, P1680, DOI 10.1016/j.joms.2009.03.052; LINDQVIST C, 1986, INT J ORAL MAX SURG, V15, P12, DOI 10.1016/S0300-9785(86)80005-9; Linn S, 1998, Inj Prev, V4, P122; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; McGuire L, 2000, Inj Prev, V6, P285, DOI 10.1136/ip.6.4.285; Oikarinen K S, 1995, Dent Clin North Am, V39, P113; Oja P, 2011, SCAND J MED SCI SPOR, V21, P496, DOI 10.1111/j.1600-0838.2011.01299.x; Olofsson E, 2017, SAFETY SCI, V92, P311, DOI 10.1016/j.ssci.2015.11.024; Otte D, 2014, SAE INT J TRANSP SAF, V2, P257, DOI 10.4271/2014-01-0517; Phillips RO, 2011, RISK ANAL, V31, P1187, DOI 10.1111/j.1539-6924.2011.01589.x; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Robinson DL, 2007, ACCIDENT ANAL PREV, V39, P86, DOI 10.1016/j.aap.2006.06.007; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Sovik S, 2014, INJURY, V45, P1722, DOI 10.1016/j.injury.2014.05.038; Stier R, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.30011; Sze NN, 2011, HONG KONG J EMERG ME, V18, P136, DOI 10.1177/102490791101800302; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Wagner J, 2012, AM SURGEON, V78, P1066; Webman R, 2013, J TRAUMA ACUTE CARE, V75, P877, DOI 10.1097/TA.0b013e3182a85f97; Zibung E, 2015, EUR J TRAUMA EMERG S, V41, P517, DOI 10.1007/s00068-014-0471-y	46	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2021	37	2					240	246		10.1111/edt.12627		DEC 2020	7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Dentistry, Oral Surgery & Medicine	QT5TK	WOS:000596086700001	33220164	Green Accepted			2022-02-06	
J	Harve-Rytsala, H; Angerman, S; Kirves, H; Nurmi, J				Harve-Rytsala, Heini; Angerman, Susanne; Kirves, Hetti; Nurmi, Jouni			Arterial and end-tidal carbon dioxide partial pressure difference during prehospital anaesthesia in critically ill patients	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						Air Ambulances; Anaesthesia; Capnography; Carbon Dioxide	TRAUMATIC BRAIN-INJURY; MANAGEMENT; CAPNOGRAPHY; VENTILATION; GUIDELINES; ACCURACY; PETCO2; PCO2	Background Normoventilation is crucial for many critically ill patients. Ventilation is routinely guided by end-tidal capnography during prehospital anaesthesia, based on the assumption of the gap between arterial partial pressure of carbon dioxide (PaCO2) and end-tidal carbon dioxide partial pressure (PetCO(2)) of approximately 0.5 kPa (3.8 mmHg). Methods We retrospectively analysed the airway registry and patient chart data of patients who had been anaesthetised and intubated endotracheally by the prehospital critical care team and had their prehospital arterial blood gases analysed. Bland-Altman analysis was used to estimate the bias and limits of agreement. Results Altogether 502 patients were included in the study, with a median age of 58 years. The most common patient groups were post-resuscitation (155, 31%), neurological emergencies (96, 19%), intoxication (75, 15%) and trauma (68, 14%). The median of the gap between PaCO2 and PetCO(2) was 1.3 kPa (interquartile range 0.7 to 2.2) (9.8 (5.3-16.5) mmHg). Mean bias of PetCO(2) was -1.6 kPa/12.0 mmHg (standard deviation 1.7 kPa/12.8 mmHg) with 95% confidence limits of agreement -4.9 to 1.9 kPa (-36.8 to 14.3 mmHg). The gap was >= 1.0 kPa (>7.5 mmHg) in 297 (66%, 95% confidence interval 55 to 63) patients. Conclusion Our results suggest that end-tidal capnography alone might not be an adequate method to achieve normoventilation for critically ill patients intubated and mechanically ventilated in prehospital setting. Thus, an arterial blood gas analysis might be useful to recognize patients with an increased gap between PaCO2 and PetCO(2).	[Harve-Rytsala, Heini; Angerman, Susanne; Nurmi, Jouni] Helsinki Univ Hosp, Emergency Med & Serv, Helsinki, Finland; [Harve-Rytsala, Heini; Angerman, Susanne; Nurmi, Jouni] Univ Helsinki, Dept Emergency Med, Helsinki, Finland; [Kirves, Hetti] Hosp Dist Helsinki, Hyvinkaa Hosp Area, Prehosp Emergency Care, Uusimaa, Finland		Nurmi, J (corresponding author), Helsinki Univ Hosp, Emergency Med & Serv, FinnHEMS 10,Vesikuja 9, FI-01530 Vantaa, Finland.; Nurmi, J (corresponding author), Univ Helsinki, Dept Emergency Med, FinnHEMS 10,Vesikuja 9, FI-01530 Vantaa, Finland.	jouni.nurmi@hus.fi			Helsinki University Hospital [VTR TYH2017220]	Helsinki University Hospital, Grant/Award Number: VTR TYH2017220	Angerman S, 2018, ANAESTHESIA, V73, P348, DOI 10.1111/anae.14182; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper CJ, 2013, PREHOSP DISASTER MED, V28, P87, DOI 10.1017/S1049023X12001768; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; FLETCHER R, 1984, BRIT J ANAESTH, V56, P109, DOI 10.1093/bja/56.2.109; Gellerfors M, 2018, BRIT J ANAESTH, V120, P1103, DOI 10.1016/j.bja.2017.12.036; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Hinkelbein J, 2008, J TRAUMA, V65, P10, DOI 10.1097/TA.0b013e31815eba83; Nassar BS, 2017, ANN AM THORAC SOC, V14, P1005, DOI 10.1513/AnnalsATS.201701-034FR; Nassar BS, 2016, CHEST, V149, P576, DOI 10.1378/chest.15-1369; NUNN JF, 1960, J APPL PHYSIOL, V15, P383, DOI 10.1152/jappl.1960.15.3.383; Sunde GA, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0509-y; Suominen PK, 2007, ASAIO J, V53, P670, DOI 10.1097/MAT.0b013e3181569bf3	17	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	APR	2021	65	4					534	539		10.1111/aas.13751		DEC 2020	6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	QS4RT	WOS:000595664100001	33210725	Green Accepted			2022-02-06	
J	Warwick, J; Slavova, S; Bush, J; Costich, J				Warwick, James; Slavova, Svetla; Bush, Joshua; Costich, Julia			Validation of ICD-10-CM surveillance codes for traumatic brain injury inpatient hospitalizations	BRAIN INJURY			English	Article						Surveillance definition; traumatic brain injury; positive predictive value; ICD-10-CM; medical record review	UNITED-STATES; ADMINISTRATIVE DATA	Objective: Using inpatient data from a 1,160-bed health system, we assessed the positive predictive value (PPV) of ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical Modification) codes included in a traumatic brain injury (TBI) surveillance definition proposed by the Centers for Disease Control and Prevention (CDC) in 2016. Methods: A random sample of 196 records with ICD-10-CM TBI codes was reviewed. The PPVs for the ICD-10-CM codes' ability to capture true TBI cases were calculated as the percentage of records with confirmed clinical provider-documented TBI and reported with 95% confidence intervals [95%CIs]. Results: The estimated overall PPV was 74% [67.9%, 80.1%] when the codes were listed in any diagnostic field, but 91.5% [86.2%, 96.8%] when listed as the principal diagnosis. S06 codes (intracranial injury) had an overall PPV of 80.2% [74.3%, 86.1%] and 96.9% [93.3%, 100%] when listed as the principal diagnosis. S02.0-.1 codes (vault/base skull fractures) in any position without co-existing S06 codes had a PPV of 15.8% [0%, 33.2%]. Conclusions: Intracranial injury codes (S06) in any diagnostic position had a very high estimated PPV. Further research is needed to determine the utility of other codes included in the CDC proposed definition for TBI surveillance.	[Warwick, James] Univ Kentucky, Coll Med, Lexington, KY USA; [Slavova, Svetla; Bush, Joshua; Costich, Julia] Univ Kentucky, Kentucky Injury Prevent & Res Ctr, Lexington, KY 40506 USA; [Slavova, Svetla] Univ Kentucky, Dept Biostat, Lexington, KY USA; [Costich, Julia] Univ Kentucky, Dept Hlth Management & Policy, Coll Publ Hlth, Lexington, KY 40506 USA		Slavova, S (corresponding author), Univ Kentucky, Hlth Kentucky Res Bldg RB2,Off 261, Lexington, KY 40536 USA.	ssslav2@email.uky.edu		Warwick, James/0000-0002-9178-4239; Bush, Joshua/0000-0001-6879-7990	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U17 CE924846]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001997]	This work was supported by the Centers for Disease Control and Prevention [U17 CE924846]; National Center for Advancing Translational Sciences [TL1TR001997].	Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Buduhan G, 2000, J TRAUMA, V49, P600, DOI 10.1097/00005373-200010000-00005; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; CDC, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention (CDC), 2019, SURV REP TRAUM BRAIN; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Control CfD. Prevention, 1999, CONTROL CFD PREVENTI; Faul M, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gabella B, 2019, CSTE ANN C 2019; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hedegaard Holly, 2016, Natl Health Stat Report, P1; McChesney-Corbeil J, 2017, CAN J NEUROL SCI, V44, P161, DOI 10.1017/cjn.2016.419; Misch MR, 2020, EMERG MED CLIN N AM, V38, P207, DOI 10.1016/j.emc.2019.09.010; NASEM, 2019, EV DIS DET PROC TRAU; Peterson AB, 2020, INJ PREV; PMIC, 2016, INT CLASS DIS 10 REV; Pozzato I, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034494; Pozzato I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016222; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; SAS, 2012, SAS VERS 9 4; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1	24	1	1	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 5	2020	34	13-14					1763	1770		10.1080/02699052.2020.1849801		DEC 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PH5MZ	WOS:000596196200001	33280404	Green Accepted			2022-02-06	
J	Fares, MY; Salhab, HA; Fares, J; Khachfe, HH; Fares, Y; Baydoun, H; Abboud, JA; Alaaeddine, N				Fares, Mohamad Y.; Salhab, Hamza A.; Fares, Jawad; Khachfe, Hussein H.; Fares, Youssef; Baydoun, Hasan; Abboud, Joseph A.; Alaaeddine, Nada			Craniofacial and traumatic brain injuries in mixed martial arts	PHYSICIAN AND SPORTSMEDICINE			English	Article						Mixed martial arts; traumatic brain injury; injury epidemiology; Ultimate Fighting Championship; head injury; combat sport	PROFESSIONAL FOOTBALL; CONCUSSION	Objective: Mixed-Martial-Arts (MMA) has witnessed a rapid growth over the recent years. This study aims to explore the patterns and trends of head injuries in MMA. Design: Descriptive epidemiological study. Setting: Ringside physician reports of the Ultimate Fighting Championship (UFC) fights between 2016 and 2019 (inclusive) were screened. Data were extracted from the Nevada State Athletic Commission (NSAC) database. Play-by-play video analysis was also conducted. Participants: UFC fighters involved in fights sanctioned by the NSAC, between 2016 and the end of 2019 (N = 816). Independent variables: Sex, location of head injury, type of head injury, injury mechanism, number of significant head strikes, type of finish, and weight division. Main outcome measures: Head injury rates were calculated. A one-way analysis of variance (ANOVA) was used to explore any statistically significant differences between injury rates of different locations, types, and types of finishes. An independent t-test was used to determine whether any significant differences existed between the two sexes, and a Joinpoint regression analysis was used to determine the statistical significance of the trends of head injury rates across different weight divisions. P-values <0.05 were considered significant (95% CI). Results: A total of 288 head injuries in 408 fights were recorded during our study period. Head injury rate constituted 35 injuries per 100 athletic-exposures (AE) in sanctioned fights. Traumatic brain injuries (TBI) were the most common type of injury, with a rate of 16 per 100AE, significantly greater than that of fractures (p = 0.003). Males had a head injury rate of 37 per 100AE, higher than that of females which was 23 per 100AE. Technical Knockout (TKO)/ Knockout(KO) was the type of finish with the highest rate of head injuries, significantly greater than that of decision or submission (p < 0.001). In general, head injury rates were higher as weight divisions increased. Conclusion: Head injuries are prevalent in MMA. Preventive measures need to be implemented to ensure fighter safety and limit injury risk.	[Fares, Mohamad Y.; Salhab, Hamza A.; Fares, Youssef; Alaaeddine, Nada] Lebanese Univ, Fac Med, Neurosci Res Ctr, Beirut, Lebanon; [Fares, Mohamad Y.; Salhab, Hamza A.; Khachfe, Hussein H.] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Fares, Mohamad Y.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Fares, Jawad] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Baydoun, Hasan] Amer Univ Beirut, Med Ctr, Dept Orthoped, Beirut, Lebanon; [Abboud, Joseph A.] Thomas Jefferson Univ Hosp, Dept Orthopaed Surg, Rothman Inst, Philadelphia, PA 19107 USA		Fares, MY (corresponding author), Lebanese Univ, Fac Med, Neurosci Res Ctr, Beirut, Lebanon.	myf04@mail.aub.edu	Fares, Mohamad Y./AAC-6328-2020; Fares, Jawad/X-4341-2018; Fares, Mohamad Y/AAJ-5149-2021; Khachfe, Hussein H./AAC-3520-2020; Baydoun, Hasan/AAL-9760-2020	Fares, Mohamad Y./0000-0001-8228-3953; Fares, Jawad/0000-0002-5368-8764; Khachfe, Hussein H./0000-0001-7537-9033; Baydoun, Hasan/0000-0002-0889-637X			Bastidas N, 2012, ANN PLAS SURG, V68, P43, DOI 10.1097/SAP.0b013e31820eb325; Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Bolelli D., 2016, JOMEC J; Brechney Grant C, 2019, J Strength Cond Res, DOI 10.1519/JSC.0000000000003368; Channon A, 2013, SOCIOL SPORT J, V30, P487, DOI 10.1123/ssj.30.4.487; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Fares MY, 2019, PHYSICIAN SPORTSMED, V47, P205, DOI 10.1080/00913847.2018.1546108; Follmer B, 2019, SPORTS HEALTH, V11, P280, DOI 10.1177/1941738119827966; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Kreiswirth EM, 2011, J STRENGTH COND RES, V25, pS11; Lim LJH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020254; Lockwood J, 2018, TRAUMA, V20, P245, DOI 10.1177/1460408617740902; Lundberg GD, 1996, JAMA-J AM MED ASSOC, V275, P1684, DOI 10.1001/jama.275.21.1684; Miarka B, 2018, INT J PERF ANAL SPOR, V18, P78, DOI 10.1080/24748668.2018.1447210; Miarka B, 2018, J STRENGTH COND RES, V32, P534, DOI 10.1519/JSC.0000000000001804; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Rainey Charles E, 2009, N Am J Sports Phys Ther, V4, P190; Roberts SP, 2017, AM J SPORT MED, V45, P480, DOI 10.1177/0363546516668296; Sharkey EJ, 2012, INT J LEGAL MED, V126, P835, DOI 10.1007/s00414-011-0608-z; Statistical Research, 2018, STAT RES; Stellpflug SJ, 2019, BRAIN INJURY, V33, P959, DOI 10.1080/02699052.2019.1629023; Stellpflug SJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061059; Stellpflug SJ, 2019, INT J ENV RES PUB HE, V16, P254; Thomas RE, 2018, PHYSICIAN SPORTSMED, V46, P155, DOI 10.1080/00913847.2018.1430451; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walrod B, 2011, CURR SPORT MED REP, V10, P288, DOI 10.1249/JSR.0b013e31822dc2c2; Weaving C, 2014, J PHILOS SPORT, V41, P129, DOI 10.1080/00948705.2013.858393; Yiemsiri Pichet, 2014, Journal of the Medical Association of Thailand, V97, pS9; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321	29	1	1	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT 2	2021	49	4					420	428		10.1080/00913847.2020.1847623		DEC 2020	9	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	WN3QO	WOS:000596635100001	33151104				2022-02-06	
J	Ondek, K; Pevzner, A; Tercovich, K; Schedlbauer, AM; Izadi, A; Ekstrom, AD; Cowen, SL; Shahlaie, K; Gurkoff, GG				Ondek, Katelynn; Pevzner, Aleksandr; Tercovich, Kayleen; Schedlbauer, Amber M.; Izadi, Ali; Ekstrom, Arne D.; Cowen, Stephen L.; Shahlaie, Kiarash; Gurkoff, Gene G.			Recovery of Theta Frequency Oscillations in Rats Following Lateral Fluid Percussion Corresponds With a Mild Cognitive Phenotype	FRONTIERS IN NEUROLOGY			English	Article						spatial learning; traumatic brain injury; theta oscillations; biomarker; in vivo electrophysiology; phase coherence	TRAUMATIC BRAIN-INJURY; SPATIAL WORKING-MEMORY; HEAD-INJURY; EXTRACELLULAR POTASSIUM; GAMMA OSCILLATIONS; HUMAN HIPPOCAMPAL; UNITED-STATES; IMPACT MODEL; CONCUSSION; RHYTHM	Whether from a fall, sports concussion, or even combat injury, there is a critical need to identify when an individual is able to return to play or work following traumatic brain injury (TBI). Electroencephalogram (EEG) and local field potentials (LFP) represent potential tools to monitor circuit-level abnormalities related to learning and memory: specifically, theta oscillations can be readily observed and play a critical role in cognition. Following moderate traumatic brain injury in the rat, lasting changes in theta oscillations coincide with deficits in spatial learning. We hypothesized, therefore, that theta oscillations can be used as an objective biomarker of recovery, with a return of oscillatory activity corresponding with improved spatial learning. In the current study, LFP were recorded from dorsal hippocampus and anterior cingulate in awake, behaving adult Sprague Dawley rats in both a novel environment on post-injury days 3 and 7, and Barnes maze spatial navigation on post-injury days 8-11. Theta oscillations, as measured by power, theta-delta ratio, peak theta frequency, and phase coherence, were significantly altered on day 3, but had largely recovered by day 7 post-injury. Injured rats had a mild behavioral phenotype and were not different from shams on the Barnes maze, as measured by escape latency. Injured rats did use suboptimal search strategies. Combined with our previous findings that demonstrated a correlation between persistent alterations in theta oscillations and spatial learning deficits, these new data suggest that neural oscillations, and particularly theta oscillations, have potential as a biomarker to monitor recovery of brain function following TBI. Specifically, we now demonstrate that oscillations are depressed following injury, but as oscillations recover, so does behavior.	[Ondek, Katelynn; Pevzner, Aleksandr; Tercovich, Kayleen; Schedlbauer, Amber M.; Izadi, Ali; Shahlaie, Kiarash; Gurkoff, Gene G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Ondek, Katelynn; Tercovich, Kayleen; Schedlbauer, Amber M.; Izadi, Ali; Gurkoff, Gene G.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Ekstrom, Arne D.; Cowen, Stephen L.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Ekstrom, Arne D.; Cowen, Stephen L.] Univ Arizona, McKnight Brain Inst, Tucson, AZ USA		Gurkoff, GG (corresponding author), Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA.; Gurkoff, GG (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	gggurkoff@ucdavis.edu		Ondek, Katelynn/0000-0002-9116-0805	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS084026-05]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32MH112507-02]	Funding was provided from NINDS 5R01NS084026-05 and NIH 5T32MH112507-02.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Agoston DV, 2019, J NEUROTRAUM, V36, P1724, DOI 10.1089/neu.2018.6261; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Apartis E, 1998, J NEUROPHYSIOL, V79, P1633, DOI 10.1152/jn.1998.79.4.1633; Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Atlan LS, 2019, J NEUROTRAUM, V36, P2558, DOI 10.1089/neu.2017.5574; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Cashdollar N, 2009, P NATL ACAD SCI USA, V106, P20493, DOI 10.1073/pnas.0904823106; Cohen M. X., 2014, ANAL NEURAL TIME SER, DOI [10.7551/mitpress/9609.001.0001, DOI 10.7551/MITPRESS/9609.001.0001]; Cornwell BR, 2008, J NEUROSCI, V28, P5983, DOI 10.1523/JNEUROSCI.5001-07.2008; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Ekstrom AD, 2014, NEUROIMAGE, V85, P667, DOI 10.1016/j.neuroimage.2013.06.049; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Foster DJ, 2007, HIPPOCAMPUS, V17, P1093, DOI 10.1002/hipo.20345; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; GRAY JA, 1970, SCIENCE, V168, P1246, DOI 10.1126/science.168.3936.1246; GREENSTEIN YJ, 1988, BRAIN RES, V438, P331, DOI 10.1016/0006-8993(88)91358-3; GRONWALL D, 1975, LANCET, V2, P995; Gurkoff GG, 2013, BRAIN RES, V1515, P98, DOI 10.1016/j.brainres.2013.03.043; Gurkoff GG, 2013, J NEUROTRAUM, V30, P292, DOI 10.1089/neu.2012.2463; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Hajiaghamemar M, 2019, EXP NEUROL, V318, P101, DOI 10.1016/j.expneurol.2019.04.019; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hattori N, 2003, J NUCL MED, V44, P1709; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; Izadi A, 2019, BRAIN STIMUL, V12, P735, DOI 10.1016/j.brs.2019.01.005; Jackson PA, 2015, NEUROBIOLOGICAL BASI; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kavi T, 2019, CUREUS, V11, DOI 10.7759/cureus.5677; Kawata K, 2018, HAND CLINIC, V158, P217, DOI 10.1016/B978-0-444-63954-7.00022-7; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson J, 2015, BRAIN RES, V1621, P38, DOI 10.1016/j.brainres.2014.10.034; Lee DJ, 2017, EPILEPSY RES, V130, P53, DOI 10.1016/j.eplepsyres.2017.01.005; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lee JB, 2018, DEV NEUROSCI-BASEL, V40, P358, DOI 10.1159/000494134; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; MIZUMORI SJY, 1990, EXP BRAIN RES, V80, P365; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; O'Neill PK, 2013, J NEUROSCI, V33, P14211, DOI 10.1523/JNEUROSCI.2378-13.2013; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Ondek K, 2020, EXP NEUROL, V331, DOI 10.1016/j.expneurol.2020.113360; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shirvalkar PR, 2010, P NATL ACAD SCI USA, V107, P7054, DOI 10.1073/pnas.0911184107; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Trimper JB, 2014, HIPPOCAMPUS, V24, P341, DOI 10.1002/hipo.22228; Van KC, 2016, METHODS MOL BIOL, V1462, P231, DOI 10.1007/978-1-4939-3816-2_14; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Watrous AJ, 2013, HIPPOCAMPUS, V23, P656, DOI 10.1002/hipo.22124; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	124	1	1	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 4	2020	11								600171	10.3389/fneur.2020.600171			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PG2SZ	WOS:000599592100001	33343499	gold, Green Published			2022-02-06	
J	Wright, DK; Mayo, JN; Sun, MJ; O'Brien, TJ; Shultz, SR				Wright, David K.; Mayo, Jamie N.; Sun, Mujun; O'Brien, Terence J.; Shultz, Sandy R.			Contrast enhanced magnetic resonance imaging highlights neurovasculature changes following experimental traumatic brain injury in the rat	SCIENTIFIC REPORTS			English	Article							CEREBRAL BLOOD-VOLUME; SEX-DIFFERENCES; UP-REGULATION; VASCULATURE; RECOVERY; GENDER; MICROVASCULATURE; ANGIOGENESIS; EXPRESSION; DENSITY	Neurovascular injury has been proposed as a universal pathological hallmark of traumatic brain injury (TBI) with molecular markers of angiogenesis and endothelial function associated with injury severity and morbidity. Sex differences in the neurovasculature response post-TBI may contribute to the differences seen in how males and females respond to injury. Steady-state contrast enhanced magnetic resonance imaging (SSCE-MRI) can be used to non-invasively assess the neurovasculature and may be a useful tool in understanding and predicting outcomes post-TBI. Here we used SSCE-MRI to investigate the neurovasculature of male and female rats at 48 h after an experimental TBI, and how these changes related to neuromotor function at 1-week post-TBI. In addition to TBI induced changes, we found that female rats had greater vessel density, greater cerebral blood volumes and performed better on a neuromotor task than their male counterparts. These results suggest that acute post-TBI cerebrovascular function is worse in males, and that this may contribute to the greater functional deficits observed post-injury. Furthermore, these results highlight the potential of SSCE-MRI to provide insights into the cerebral microvasculature post-TBI. Future studies, incorporating both males and females, are warranted to investigate the evolution of these changes and the underlying mechanisms.	[Wright, David K.; Sun, Mujun; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Alfred Ctr, Cent Clin Sch, Dept Neurosci, 99 Commercial Rd, Melbourne, Vic 3004, Australia; [Mayo, Jamie N.; Sun, Mujun; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia; [Mayo, Jamie N.] VA Salt Lake City Hlth Care Syst, IDEAS Ctr Innovat 2 0, Salt Lake City, UT USA; [Mayo, Jamie N.] Univ Utah, Sch Med, Dept Med, Div Epidemiol, Salt Lake City, UT USA		Shultz, SR (corresponding author), Monash Univ, Alfred Ctr, Cent Clin Sch, Dept Neurosci, 99 Commercial Rd, Melbourne, Vic 3004, Australia.; Shultz, SR (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; Sun, Mujun/0000-0002-9923-9913	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1141643, 1159645, 1174040]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Health and Medical Research Council to SRS [Grant number: 1141643; fellowship: 1159645] and to DKW [Grant number: 1174040].	Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim E, 2015, ANGIOGENESIS, V18, P125, DOI 10.1007/s10456-014-9450-5; Kim E, 2013, MAGN RESON MED, V70, P1106, DOI 10.1002/mrm.24530; Kim J, 2018, J MAGN RESON IMAGING, V47, P1589, DOI 10.1002/jmri.25898; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Obenaus A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00161-4; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Vagnerova K, 2008, ANESTH ANALG, V107, P201, DOI 10.1213/ane.0b013e31817326a5; Varallyay CG, 2017, AM J NEURORADIOL, V38, P1297, DOI 10.3174/ajnr.A5188; Varallyay CG, 2013, J CEREBR BLOOD F MET, V33, P780, DOI 10.1038/jcbfm.2013.36; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu EX, 2004, NMR BIOMED, V17, P507, DOI 10.1002/nbm.921; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yeh HJ, 1998, J NEUROSCI, V18, P3699; Zhang Y., 2013, SPRINGER SERIES TRAN, V5, P141	35	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 4	2020	10	1							21252	10.1038/s41598-020-77975-2			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PT8JE	WOS:000608856300016	33277513	Green Published, gold			2022-02-06	
J	Heled, E; Tal, K; Zeilig, G				Heled, Eyal; Tal, Keren; Zeilig, Gabi			Does lack of brain injury mean lack of cognitive impairment in traumatic spinal cord injury?	JOURNAL OF SPINAL CORD MEDICINE			English	Article; Early Access						Spinal cord injury; Cognitive functions; Traumatic brain injury; Depression	CLOSED HEAD-INJURY; VERBAL-LEARNING TEST; QUALITY-OF-LIFE; WORD RETRIEVAL; DECISION-MAKING; INDIVIDUALS; PERFORMANCE; PEOPLE; DAMAGE; REHABILITATION	Objective Traumatic spinal cord injury (tSCI) has implications in many areas, including cognitive functioning. Findings regarding cognitive problems in people with SCI are inconsistent, presumably due to multiple variables than can affect performance, among them emotional variables. The purpose of the current study was to elucidate cognitive sequalae in some individuals with tSCI with no medical record of brain injury, while taking emotional variables into consideration. Design Cross-sectional, with two groups. Setting A public rehabilitation center. Participants Twenty participants with tSCI at least ten months post injury and twenty non-SCI controls, matched for sex, age, and education. Intervention None. Outcome Measures A battery of neuropsychological tests tapping executive functions, memory, attention, and naming abilities, in addition to questionnaires assessing depression and distress. Results When emotional variables were statistically controlled, participants with tSCI showed higher levels of depression and distress and scored lower than non-SCI control participants on all cognitive tests except naming. Executive functions were found to have the highest effect size, though no specific ability was sensitive enough to differentiate between the groups in a binary logistic regression analysis. Conclusion In some individuals with chronic tSCI, lower cognitive ability that is unrelated to emotional distress might result from spinal cord damage and its implications in a population who's medical records show no indication of brain injury. This highlights the importance of conducting cognitive evaluation following SCI, so that deficits can be effectively addressed during rehabilitation.	[Heled, Eyal; Tal, Keren] Ariel Univ, Dept Psychol, Ariel, Israel; [Heled, Eyal; Zeilig, Gabi] Sheba Med Ctr, Dept Neurol Rehabil, Ramat Gan, Israel; [Zeilig, Gabi] Tel Aviv Univ, Sackler Sch Med, Dept Phys Med & Rehabil, Tel Aviv, Israel		Heled, E (corresponding author), Ariel Univ, Dept Psychol, Ariel, Israel.	eyalheled@gmail.com					Barrow IM, 2006, BRAIN INJURY, V20, P845, DOI 10.1080/02699050600832445; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Bloch A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158396; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chiaravalloti ND, 2020, J SPINAL CORD MED, V43, P88, DOI 10.1080/10790268.2018.1543103; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; Cook KF, 2017, QUAL LIFE RES, V26, P139, DOI 10.1007/s11136-016-1363-x; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1986, PARAPLEGIA, V24, P97, DOI 10.1038/sc.1986.13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P334, DOI 10.1016/0003-9993(92)90006-I; Deady DK, 2010, PSYCHOL HEALTH MED, V15, P406, DOI 10.1080/13548506.2010.482138; Derogatis L R., 1992, BSI BRIEF SYMPTOM IN; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Fehlings MG, 2017, J NEUROTRAUM, V34, P2841, DOI 10.1089/neu.2016.4926; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gilbar O, 2002, INT J STRESS MANAGE, V9, P1, DOI 10.1023/A:1013097816238; Golden CJ., 2002, STROOP COLOR WORD TE; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Hough MS, 2008, APHASIOLOGY, V22, P644, DOI 10.1080/02687030701541024; Karunakaran KD, 2019, J NEUROTRAUM, V36, P2045, DOI 10.1089/neu.2018.6040; Kave G, 2005, BRAIN LANG, V92, P204, DOI 10.1016/j.bandl.2004.06.004; Kave G, 2010, PSYCHOL AGING, V25, P719, DOI 10.1037/a0018927; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kurylo M, 2001, REHABIL PSYCHOL, V46, P247, DOI 10.1037/0090-5550.46.3.247; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Lim SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169623; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Mikulis DJ, 2008, ARCH PHYS MED REHA S, V89, pS77; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P62, DOI 10.1590/S0004-282X2010000100014; Molina B, 2018, SPINAL CORD, V56, P796, DOI 10.1038/s41393-018-0076-0; Mollayeva T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017165; Muller R, 2017, J REHABIL MED, V49, P489, DOI 10.2340/16501977-2241; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newcombe F., 1969, MISSILE WOUNDS BRAIN; North NT, 2001, NEUROPSYCHOLOGIA, V39, P521, DOI 10.1016/S0028-3932(00)00107-X; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Strubreither W, 1997, SPINAL CORD, V35, P487, DOI 10.1038/sj.sc.3100495; Stutts M, 1991, NEUROREHABILITATION, V1; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; Wingfield A, 2003, AM J PHYS MED REHAB, V82, P547, DOI 10.1097/00002060-200307000-00009	61	1	1	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.												10.1080/10790268.2020.1847564		DEC 2020	8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PG6OO	WOS:000599853100001	33320804				2022-02-06	
J	Qian, QY; Ling, YT; Zhong, H; Zheng, YP; Alam, M				Qian, Qiuyang; Ling, Yan To; Zhong, Hui; Zheng, Yong-Ping; Alam, Monzurul			Restoration of arm and hand functions via noninvasive cervical cord neuromodulation after traumatic brain injury: a case study	BRAIN INJURY			English	Article						Traumatic brain injury; bilateral upper extremity motor deficits; transcutaneous electrical stimulation; neuromodulation; functional rehabilitation		Objectives: To investigate the effects of transcutaneous electrical stimulation (tES) on upper limb functional rehabilitation in a patient with traumatic brain injury (TBI), and to identify the optimum stimulation parameters of tES. Design: A preliminary case study. Methods: Two successive interventions: Phase I-voluntary physical training (vPT) and Phase II - tES along with vPT (tES+vPT). tES was delivered at C3 and C6 cervical regions. Clinical assessments presented the variation of muscle tone and motor functions, before and after each training phase, and evaluated at 1-month follow up after the last intervention. Results: Our results indicate that vPT alone contributed to a release of muscle spasticity of both arms of the patient with no significant improvement of hand function, while tES+vPT further reduced the spasticity of the left arm, and improved the voluntary motor function of both arms. The grip forces were also increased after the tES+vPT treatment. We found that 1 ms biphasic tES at 30 Hz produced optimum motor outputs. Conclusion: The study demonstrates, for the first time, the potential benefits of cervical tES in regard to improving upper limb motor functions in a patient with chronic TBI.	[Qian, Qiuyang; Ling, Yan To; Zheng, Yong-Ping; Alam, Monzurul] Hong Kong Polytech Univ, Dept Biomed Engn, Hong Kong, Peoples R China; [Zhong, Hui] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA		Alam, M (corresponding author), Hong Kong Polytech Univ, Dept Biomed Engn, Hong Kong, Peoples R China.	md.malam@connect.polyu.hk	Qian, Qiuyang/AAH-3695-2021; Zheng, Yong-Ping/M-1197-2015	Zheng, Yong-Ping/0000-0002-3407-9226; Alam, Monzurul/0000-0003-0987-1999	Hong Kong Polytechnic UniversityHong Kong Polytechnic University [H-ZG4W]; Guangdong Provincial Work Injury Rehabilitation Center [H-ZG4W]; Hong Kong Innovation and Technology Fund [ITS/276/17]; Tai Hung Fai Charitable Foundation [847L]; Telefield Charitable Fund [83D1]	This research study was partially supported by the Hong Kong Polytechnic University (H-ZG4W), Guangdong Provincial Work Injury Rehabilitation Center (H-ZG4W), Hong Kong Innovation and Technology Fund (ITS/276/17), Tai Hung Fai Charitable Foundation (847L), and Telefield Charitable Fund (83D1).	Bao SC, 2020, J STROKE, V22, P47, DOI 10.5853/jos.2019.03027; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; BOHANNON R, 1987, PHYS THER, V67; Carmel JB, 2013, EUR J NEUROSCI, V37, P1090, DOI 10.1111/ejn.12119; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ferreira IS, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0561-5; Freyvert Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33123-5; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gad P, 2020, J NEUROPHYSIOL, V124, P774, DOI 10.1152/jn.00320.2020; Gad P, 2018, J NEUROTRAUM, V35, P2145, DOI 10.1089/neu.2017.5461; Gad P, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00333; Gad PN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00432; Gerasimenko Y, 2015, J NEUROPHYSIOL, V113, P834, DOI 10.1152/jn.00609.2014; Gomes-Osman J, 2015, CLIN REHABIL, V29, P771, DOI 10.1177/0269215514556087; HAGBARTH KE, 1950, ACTA PHYSIOL, V21; Hofstoetter US, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192013; Inanici F, 2018, IEEE T NEUR SYS REH, V26, P1272, DOI 10.1109/TNSRE.2018.2834339; Kahn MB, 2016, BRAIN INJURY, V30, P252, DOI 10.3109/02699052.2015.1117657; Kanno T, 2009, NEUROMODULATION, V12, P33, DOI 10.1111/j.1525-1403.2009.00185.x; KLEIM J, 2003, NEUROL RES, V25; LANGLEY GB, 1985, RHEUMATOL INT, V5, P145, DOI 10.1007/BF00541514; Lombardi F, 2002, CLIN REHABIL, V16, P464, DOI 10.1191/0269215502cr519oa; McDonnell M, 2008, AUST J PHYSIOTHER, V54, P220, DOI 10.1016/S0004-9514(08)70034-5; MENDELL JR, 1990, MUSCLE NERVE, V13, pS16, DOI 10.1002/mus.880131307; Milosevic M, 2019, J NEUROPHYSIOL, V121, P1672, DOI 10.1152/jn.00802.2018; Nardone R, 2014, J SPINAL CORD MED, V37, P19, DOI 10.1179/2045772313Y.0000000140; Nguyen Ha Son, 2016, Surg Neurol Int, V7, pS121, DOI 10.4103/2152-7806.176133; PLAUTZ E, 2003, NEUROL RES, V25; Polinder S, 2013, LANCET, V381, P116; Qian QY, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0537-5; Reddy CG, 2018, J PAIN RES, V11, P1147, DOI 10.2147/JPR.S139843; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Silva S, 2008, CLIN NEUROPHYSIOL, V119, P2405, DOI 10.1016/j.clinph.2008.07.248; SUTHANA N, 2012, NEW ENGL J MED, V366; SWAINE BR, 1996, BRAIN INJURY, V10; TOFTS P, 1990, PHYS MED BIOL, V35; Tolleson C, 2014, STEREOT FUNCT NEUROS, V92, P227, DOI 10.1159/000362934; Verheyden G, 2004, CLIN REHABIL, V18, P326, DOI 10.1191/0269215504cr733oa; Visocchi M, 2001, STEREOT FUNCT NEUROS, V76, P276, DOI 10.1159/000066731; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wassermann EM, 2012, PHARMACOL THERAPEUT, V133, P98, DOI 10.1016/j.pharmthera.2011.09.003; Yamamoto T, 2005, ACTA NEUROCHIR SUPPL, V93, P101; YAMAMOTO T, 2012, NEUROLOGIA MEDICO CH, V52; Yamamoto T, 2017, ACTA NEUROCHIR SUPPL, V124, P37, DOI 10.1007/978-3-319-39546-3_6; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yoon YS, 2012, ANN REHABIL MED-ARM, V36, P596, DOI 10.5535/arm.2012.36.5.596	50	1	1	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 5	2020	34	13-14					1771	1780		10.1080/02699052.2020.1850864		DEC 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PH5MZ	WOS:000596632800001	33264033				2022-02-06	
J	Gaitanidis, A; Breen, KA; Maurer, LR; Saillant, NN; Kaafarani, HMA; Velmahos, GC; Mendoza, AE				Gaitanidis, Apostolos; Breen, Kerry A.; Maurer, Lydia R.; Saillant, Noelle N.; Kaafarani, Haytham M. A.; Velmahos, George C.; Mendoza, April E.			Systolic Blood Pressure < 110 mm Hg as a Threshold of Hypotension in Patients with Isolated Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						mortality; systolic blood pressure; traumatic brain injury	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PROGNOSTIC VALUE; UNITED-STATES; MORTALITY; GUIDELINES; MANAGEMENT; INSULTS; IMPACT	Hypotension is a known risk factor for poor neurologic outcomes after traumatic brain injury (TBI). Current guidelines suggest that higher systolic blood pressure (SBP) thresholds likely confer a mortality benefit. However, there is no consensus on the ideal perfusion pressure among different age groups (i.e., recommended SBP >= 100 mm Hg for patients age 50-69 years; >= 110 mm Hg for all other adults). We hypothesize that admission SBP >= 110 mm Hg will be associated with improved outcomes regardless of age group. A retrospective database review of the 2010-2016 Trauma Quality Improvement Program database was performed for adults (>= 18 years) with isolated moderate-to-severe TBIs (head Abbreviated Injury Scale [AIS] >= 3; all other AIS <3). Sub-analyses were performed after dividing patients by SBP and age; comparison groups were matched with propensity score matching. Primary outcomes were early (6 h, 12 h, and 1 day) and overall in-hospital mortality. Overall, 154,725 patients met the inclusion criteria (mean age 62.8 +/- 19.8 years, 89,431 [57.8%] males, Injury Severity Score13.9 +/- 6.8). Multi-variate logistic regression showed that the risk of in-hospital mortality decreased with increasing SBP, plateauing at 110 mm Hg. Among patients of all ages, SBP >= 110 mm Hg was associated with improved mortality (SBP 110-129 vs. 90-109 mm Hg: 12 h 0.4% vs. 0.8%, p = 0.001; 1 day 0.8% vs. 1.4%, p = 0.004; overall 3.2% vs. 4.9%, p < 0.001). Among patients age 50-69 years, SBP >= 110 mm Hg was associated with improved mortality (SBP 110-119 vs. 100-109 mm Hg: 12 h 0.3% vs. 0.9%, p = 0.018; 1 day 0.5% vs. 1.5%, p = 0.007; overall 2.7% vs. 4.3%, p = 0.015). In conclusion, SBP >= 110 mm Hg is associated with lower in-hospital mortality in adult patients with isolated TBIs, including patients age 50-69 years. SBP <110 mm Hg should be used to define hypotension in adult patients of all ages.	[Gaitanidis, Apostolos; Breen, Kerry A.; Maurer, Lydia R.; Saillant, Noelle N.; Kaafarani, Haytham M. A.; Velmahos, George C.; Mendoza, April E.] Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA		Mendoza, AE (corresponding author), Massachusetts Gen Hosp, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	aemendoza@mgh.harvard.edu					Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; GENTLEMAN D, 1992, INT SURG, V77, P297; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; JEFFREYS RV, 1981, LANCET, V2, P459; Khalil M, 2014, J AM COLL SURGEONS, V219, pS67, DOI 10.1016/j.jamcollsurg.2014.07.156; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; Launey Y, 2020, JAMA NEUROL, V77, P339, DOI 10.1001/jamaneurol.2019.3854; Ley EJ, 2011, J TRAUMA, V71, P1689, DOI 10.1097/TA.0b013e31823cc5df; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McCredie VA, 2018, CRIT CARE MED, V46, P1139, DOI 10.1097/CCM.0000000000003149; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	32	1	1	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					879	885		10.1089/neu.2020.7358		DEC 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000596399500001	33107386				2022-02-06	
J	Nieves, MD; Furmanski, O; Doughty, ML				Nieves, Michael D.; Furmanski, Orion; Doughty, Martin L.			Sensorimotor dysfunction in a mild mouse model of cortical contusion injury without significant neuronal loss is associated with increases in inflammatory proteins with innate but not adaptive immune functions	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						chemokine; controlled cortical impact; cytokine; innate immune response; RRID; AB_10711153; RRID; AB_2811722; RRID; AB_839506; sensorimotor; traumatic brain injury	TRAUMATIC BRAIN-INJURY; T-CELLS; MOTOR CORTEX; INTERLEUKIN-1-BETA; NEUROPROTECTION; ACTIVATION; MICROGLIA; MEDIATORS; APOPTOSIS; SEVERITY	Traumatic brain injury is a leading cause of mortality and morbidity in the United States. Acute trauma to the brain triggers chronic secondary injury mechanisms that contribute to long-term neurological impairment. We have developed a single, unilateral contusion injury model of sensorimotor dysfunction in adult mice. By targeting a topographically defined neurological circuit with a mild impact, we are able to track sustained behavioral deficits in sensorimotor function in the absence of tissue cavitation or neuronal loss in the contused cortex of these mice. Stereological histopathology and multiplex enzyme-linked immunosorbent assay proteomic screening confirm contusion resulted in chronic gliosis and the robust expression of innate immune cytokines and monocyte attractant chemokines IL-1 beta, IL-5, IL-6, TNF alpha, CXCL1, CXCL2, CXCL10, CCL2, and CCL3 in the contused cortex. In contrast, the expression of neuroinflammatory proteins with adaptive immune functions was not significantly modulated by injury. Our data support widespread activation of innate but not adaptive immune responses, confirming an association between sensorimotor dysfunction with innate immune activation in the absence of tissue or neuronal loss in our mice.	[Nieves, Michael D.; Furmanski, Orion; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Nieves, Michael D.; Furmanski, Orion; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Nieves, Michael D.; Doughty, Martin L.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Grad Program Neurosci, Bethesda, MD 20814 USA		Doughty, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.	martin.doughty@usuhs.edu		Nieves, Michael/0000-0001-7958-814X	Center for Neuroscience and Regenerative Medicine (CNRM)United States Department of Defense [G170244014]	Center for Neuroscience and Regenerative Medicine (CNRM), Grant/Award Number: G170244014	Batsaikhan B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030502; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Furmanski O, 2019, JOVE-J VIS EXP, DOI 10.3791/59561; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Haarmann A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030602; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Iljazi A, 2020, NEUROL SCI, V41, P2737, DOI 10.1007/s10072-020-04458-7; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jung YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00313; Katz PS, 2018, METHODS MOL BIOL, V1717, P27, DOI 10.1007/978-1-4939-7526-6_3; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lewis CT, 2019, J CLIN NEUROSCI, V70, P37, DOI 10.1016/j.jocn.2019.09.004; Liu KKY, 2012, INT J MOL SCI, V13, P16119, DOI 10.3390/ijms131216119; Liva SM, 2001, NEUROCHEM RES, V26, P629, DOI 10.1023/A:1010983119125; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Morandell K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15835-2; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Mukherjee S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01854-w; MYCHASIUK R, 2014, JOVE-J VIS EXP, V94, DOI [10.3791/51820, DOI 10.3791/51820]; Nieves MD, 2020, BRAIN RES, V1748, DOI 10.1016/j.brainres.2020.147120; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Petrisko TJ, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00220; Putatunda R, 2018, CHIN J TRAUMATOL, V21, P125, DOI 10.1016/j.cjtee.2018.02.002; Radomski KL, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-142; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; SAWADA M, 1993, NEUROSCI LETT, V155, P175, DOI 10.1016/0304-3940(93)90701-L; Schwartz M, 2000, ANN NY ACAD SCI, V917, P341; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Siva Sai Sujith Sajja Benkata, 2014, Biomed Sci Instrum, V50, P375; Sorensen TL, 2002, J NEUROIMMUNOL, V127, P59, DOI 10.1016/S0165-5728(02)00097-8; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Tweedie D, 2020, ELIFE, V9, DOI 10.7554/eLife.55827; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; von Leden RE, 2019, EXP NEUROL, V317, P144, DOI 10.1016/j.expneurol.2019.03.004; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Wang C, 2019, NEUROSCI LETT, V699, P199, DOI 10.1016/j.neulet.2019.02.012; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wofford KL, 2019, NEURAL REGEN RES, V14, P1481, DOI 10.4103/1673-5374.255958; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	67	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2021	99	6					1533	1549		10.1002/jnr.24766		DEC 2020	17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RU2RS	WOS:000595067000001	33269491				2022-02-06	
J	Srisaikaew, P; Wongpakaran, N; Anderson, ND; Chen, JJ; Kothan, S; Varnado, P; Unsrisong, K; Mahakkanukrauh, P				Srisaikaew, Patcharaporn; Wongpakaran, Nahathai; Anderson, Nicole D.; Chen, J. Jean; Kothan, Suchart; Varnado, Pairada; Unsrisong, Kittisak; Mahakkanukrauh, Pasuk			Fornix Integrity Is Differently Associated With Cognition in Healthy Aging and Non-amnestic Mild Cognitive Impairment: A Pilot Diffusion Tensor Imaging Study in Thai Older Adults	FRONTIERS IN AGING NEUROSCIENCE			English	Article						non-amnestic mild cognitive impairment (n-aMCI); fornix; diffusion tensor imaging (DTI); fractional anisotropy (FA); fiber tract length (FTL); cognitive performance; executive function; vascular dementia (VaD)	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; WALLERIAN DEGENERATION; EPISODIC MEMORY; FIBER TRACKING; EXECUTIVE FUNCTIONS; HIPPOCAMPAL VOLUME; WATER DIFFUSION; SOFTWARE TOOLS; AXONAL DAMAGE	Damage to the fornix leads to significant memory impairment and executive dysfunction and is associated with dementia risk. We sought to identify if fornix integrity and fiber length are disrupted in mild cognitive impairment (MCI) and how they associate with cognition. Data from 14 healthy older adult controls (HCs) and 17 subjects with non-amnestic MCI (n-aMCI) were analyzed. Diffusion tensor imaging (DTI) at 1.5 Tesla MRI was performed to enable manual tracing of the fornix and calculation of DTI parameters. Higher fractional anisotropy of body and column of the fornix was associated with better executive functioning and memory, more strongly in the HC than in the n-aMCI group. Fornix fiber tract length (FTL) was associated with better executive function, more strongly in the n-aMCI than in the HC group, and with better memory, more strongly in the HC than in the n-aMCI group. These results highlight a decline in the contributions of the fornix to cognition in n-aMCI and suggest that maintenance of fornix FTL is essential for sustaining executive functioning in people with n-aMCI.	[Srisaikaew, Patcharaporn] Chiang Mai Univ, Fac Med, PhD Program Anat, Chiang Mai, Thailand; [Srisaikaew, Patcharaporn; Mahakkanukrauh, Pasuk] Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai, Thailand; [Wongpakaran, Nahathai; Varnado, Pairada] Chiang Mai Univ, Fac Med, Dept Psychiat, Geriatr Psychiat Unit, Chiang Mai, Thailand; [Anderson, Nicole D.; Chen, J. Jean] Baycrest Hlth Sci, Rotman Res Inst, Toronto, ON, Canada; [Anderson, Nicole D.] Univ Toronto, Dept Psychol & Psychiat, Toronto, ON, Canada; [Chen, J. Jean] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Kothan, Suchart] Chiang Mai Univ, Fac Associated Med Sci, Dept Radiol Technol, Chiang Mai, Thailand; [Unsrisong, Kittisak] Chiang Mai Univ, Fac Med, Dept Radiol, Chiang Mai, Thailand; [Mahakkanukrauh, Pasuk] Chiang Mai Univ, Excellence Osteol Res & Training Ctr ORTC, Chiang Mai, Thailand		Mahakkanukrauh, P (corresponding author), Chiang Mai Univ, Fac Med, Dept Anat, Chiang Mai, Thailand.; Mahakkanukrauh, P (corresponding author), Chiang Mai Univ, Excellence Osteol Res & Training Ctr ORTC, Chiang Mai, Thailand.	pasuk034@gmail.com	Chen, Jean/A-2846-2013	Chen, Jean/0000-0001-5469-7542; kothan, suchart/0000-0001-7390-8878	Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. ProgrammeThailand Research Fund (TRF) [PHD/0069/2559]; Faculty of Medicine Research Fund [087/2562]; Excellence in Osteology Research and Training Center (ORTC); Chiang Mai University	This research was funded by the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Programme (Grant No. PHD/0069/2559) to PS and PM, Faculty of Medicine Research Fund (Grant No. 087/2562), and the Excellence in Osteology Research and Training Center (ORTC) with partially support by Chiang Mai University is acknowledged.	Alber J, 2019, ALZH DEMENT-TRCI, V5, P107, DOI 10.1016/j.trci.2019.02.001; ALMKVIST O, 1993, CORTEX, V29, P661, DOI 10.1016/S0010-9452(13)80289-4; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Alzheimer's Disease International, 2019, WORLD ALZH REP ATT D; Alzheimer's Disease International, 2018, WORLD ALZH REP STAT; Alzheimer's Disease International, 2014, DEM AS PAC REG; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anderson ND, 2019, CNS SPECTRUMS, V24, P78, DOI 10.1017/S1092852918001347; Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P495, DOI 10.1016/S0887-6177(99)00040-2; Aung Wint Yan, 2013, Imaging Med, V5, P427; BARR A, 1992, INT J GERIATR PSYCH, V7, P621, DOI 10.1002/gps.930070903; Baweja R, 2015, CAN J NEUROL SCI, V42, P205, DOI 10.1017/cjn.2015.27; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Burgel U, 2009, CENT EUR NEUROSURG, V70, P27, DOI 10.1055/s-0028-1087212; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chao LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065175; Chao LL, 2009, ALZ DIS ASSOC DIS, V23, P245, DOI 10.1097/WAD.0b013e318199ff46; Chen YJ, 2017, J NEUROIMAGING, V27, P272, DOI 10.1111/jon.12404; Cho ZH, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00151; Christiansen K, 2016, NEUROIMAGE, V130, P35, DOI 10.1016/j.neuroimage.2015.12.055; Christidi F, 2016, EUR J RADIOL OPEN, V3, P153, DOI 10.1016/j.ejro.2016.06.002; Coad Bethany M, 2020, Brain Neurosci Adv, V4, p2398212819899316, DOI 10.1177/2398212819899316; CUMMINGS JL, 1994, DEMENTIA, V5, P177, DOI 10.1159/000106718; da Rocha JLD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59327-2; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Denckla M B, 1994, FRAMES REFERENCE ASS, P117; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Dimitra S, 2013, ACTA NEUROL BELG, V113, P441, DOI 10.1007/s13760-013-0197-3; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Douet V, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00343; Falch T, 2011, ECON INQ, V49, P838, DOI 10.1111/j.1465-7295.2010.00312.x; Farlow MR, 2004, NEUROLOGY, V63, P1898, DOI 10.1212/01.WNL.0000144279.21502.B7; Fletcher E, 2013, JAMA NEUROL, V70, P1389, DOI 10.1001/jamaneurol.2013.3263; Gaffan D., 1992, NEUROPSYCHOLOGY MEMO, P336; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Guerra-Carrillo B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182276; Gupta M, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00291; Hagler DJ, 2009, HUM BRAIN MAPP, V30, P1535, DOI 10.1002/hbm.20619; He J, 2009, ARCH NEUROL-CHICAGO, V66, P1393, DOI 10.1001/archneurol.2009.252; Hemrungrojn S., 2011, THAI VERSION MONTREA; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jak AJ, 2009, INT REV NEUROBIOL, V84, P81, DOI 10.1016/S0074-7742(09)00405-X; Jhoo JH, 2008, DEMENT GERIATR COGN, V26, P270, DOI 10.1159/000160960; Kalaria Raj N, 2006, J Clin Neurol, V2, P1, DOI 10.3988/jcn.2006.2.1.1; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kauppila LA, 2018, J NEUROL SCI, V390, P10, DOI 10.1016/j.jns.2018.03.034; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kiuchi K, 2009, BRAIN RES, V1287, P184, DOI 10.1016/j.brainres.2009.06.052; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Le Carret N, 2003, DEV NEUROPSYCHOL, V23, P317, DOI 10.1207/S15326942DN2303_1; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Liu M, 2013, NEUROIMAGE, V74, P128, DOI 10.1016/j.neuroimage.2013.01.069; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Liu ZX, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: FROM NANO TO MACRO, VOLS 1 AND 2, P807, DOI 10.1109/ISBI.2009.5193172; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; Mariani E, 2007, DEMENT GERIATR COGN, V24, P448, DOI 10.1159/000110653; Marner L, 2003, J COMP NEUROL, V462, P144, DOI 10.1002/cne.10714; Mayo CD, 2017, NEUROIMAGE-CLIN, V13, P330, DOI 10.1016/j.nicl.2016.12.012; McGuinness B, 2010, J NEUROL NEUROSUR PS, V81, P157, DOI 10.1136/jnnp.2008.164483; MENDEZ MF, 1991, J CLIN EXP NEUROPSYC, V13, P923, DOI 10.1080/01688639108405108; Metzler-Baddeley C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51737-1; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moriguchi Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00867; Mugikura S, 2015, NEURORADIOLOGY, V57, P757, DOI 10.1007/s00234-015-1504-x; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Muller H-P, 2007, SYNTH LECT BIOMED EN, V2, P1, DOI [10.2200/S00099ED1V01Y200710BME016, DOI 10.2200/S00099ED1V01Y200710BME016]; Narasimhalu K, 2008, DEMENT GERIATR COGN, V25, P17, DOI 10.1159/000111128; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nestor PG, 2007, PSYCHIAT RES-NEUROIM, V155, P21, DOI 10.1016/j.pscychresns.2006.12.020; Nowrangi MA, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00001; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; Pelletier A, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00084; Pendlebury ST, 2019, LANCET NEUROL, V18, P248, DOI 10.1016/S1474-4422(18)30442-3; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Peters A, 2002, J NEUROCYTOL, V31, P581, DOI 10.1023/A:1025731309829; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rabin JS, 2019, NEUROBIOL AGING, V81, P38, DOI 10.1016/j.neurobiolaging.2019.05.005; Rizek P, 2013, CAN J NEUROL SCI, V40, P738, DOI 10.1017/S0317167100015031; Rizzi L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/908915; Rudebeck SR, 2009, J NEUROSCI, V29, P14987, DOI 10.1523/JNEUROSCI.4707-09.2009; Salvadores N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00451; Salvalaggio A, 2018, EUR J NEUROL, V25, P787, DOI 10.1111/ene.13592; Sasson E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00032; Sengupta P, 2019, INDIAN J MED RES, V149, P503, DOI 10.4103/ijmr.IJMR_1336_17; Sexton CE, 2010, PSYCHIAT RES-NEUROIM, V184, P57, DOI 10.1016/j.pscychresns.2010.07.005; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Takano Y, 2018, AM J CASE REP, V19, P1382, DOI 10.12659/AJCR.912508; Tang Y, 1997, NEUROBIOL AGING, V18, P609, DOI 10.1016/S0197-4580(97)00155-3; Teipel SJ, 2008, EUR J NUCL MED MOL I, V35, pS58, DOI 10.1007/s00259-007-0703-z; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomas AG, 2011, RADIOGRAPHICS, V31, P1107, DOI 10.1148/rg.314105729; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Trongsakul S, 2015, GERIATR GERONTOL INT, V15, P594, DOI 10.1111/ggi.12318; Turine G, 2016, ACTA NEUROL BELG, V116, P371, DOI 10.1007/s13760-015-0553-6; Uchino A, 2004, NEURORADIOLOGY, V46, P183, DOI 10.1007/s00234-003-1159-x; Vann SD, 2009, P NATL ACAD SCI USA, V106, P5442, DOI 10.1073/pnas.0812097106; Venkat P, 2015, EXP NEUROL, V272, P97, DOI 10.1016/j.expneurol.2015.05.006; Venketasubramanian N, 2010, DEMENT GERIATR COGN, V30, P492, DOI 10.1159/000321675; Wang JP, 2018, J STROKE CEREBROVASC, V27, P1431, DOI 10.1016/j.jstrokecerebrovasdis.2017.12.040; Wang P, 2020, J ALZHEIMERS DIS, V75, P1153, DOI 10.3233/JAD-200066; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Wongpakaran N, 2012, PSYCHOGERIATRICS, V12, P11, DOI 10.1111/j.1479-8301.2011.00383.x; Xie RM, 2012, NEURAL REGEN RES, V7, P900, DOI 10.3969/j.issn.1673-5374.2012.12.004; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeo SS, 2013, YONSEI MED J, V54, P315, DOI 10.3349/ymj.2013.54.2.315; Yu QW, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00228; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zhang ZY, 2018, CHINESE MED J-PEKING, V131, P665, DOI 10.4103/0366-6999.226890; Zhu QY, 2018, NEUROLOGY, V90, P706, DOI 10.1212/WNL.0000000000005306; Zhuang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058887; Zhuang L, 2012, J ALZHEIMERS DIS, V29, P629, DOI 10.3233/JAD-2012-111766	127	1	1	5	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	DEC 2	2020	12								594002	10.3389/fnagi.2020.594002			13	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	PG2NN	WOS:000599577500001	33343334	gold, Green Published			2022-02-06	
J	Adame, BJ; Adame, EA; Liu, YQ; Posteher, KA; Tsai, JY; Corman, SR				Adame, Bradley J.; Adame, Elissa A.; Liu, Yanqin; Posteher, Karlee A.; Tsai, Jiun-Yi; Corman, Steven R.			Promoting the Development of Evidence-Based Concussion Education for Power-5 Collegiate Athletes: The Influences of Organizational Elements on Perceived Vestedness	COMMUNICATION & SPORT			English	Article						collegiate sports; concussion reporting; risk perception; communication; organizational influence	IDENTIFICATION; SPORT; RISK; IDENTITY; IMPACT; COMMUNICATION; EPIDEMIOLOGY; COMPETITION; COMMITMENT; ATTITUDES	Concussions present a significant health concern for collegiate athletes, team leaders, and university administrators. The consequences of these injuries can affect athletes' scholastic and athletic performance in the short term, and manifest later in life, long after their athletic career ends. Present educational efforts are ineffective because they neglect important influences on athletes' decisions to report potential concussion injuries. Here, we present research that examines organization-based influences on vestedness in attitudes related to athletes' perceived risk of concussion consequences and team commitment. Examining a sample of 435 collegiate athletes from 11 universities, participating in six Division I/Power-5 conference high-concussion-risk sports, our findings support that organizational-based perceptions exert influence on these key concussion-related variables. In synthesizing the results, we offer evidence-based recommendations that organizational members can use to create environments that promote concussion injury reporting and adherence to recovery protocols. This research contributes to the growing body of literature calling for the development of educational concussion injury education modules that recognize contextual influences grounded in communication theory and provide a persuasive impetus.	[Adame, Bradley J.; Adame, Elissa A.; Liu, Yanqin; Posteher, Karlee A.; Corman, Steven R.] Arizona State Univ, Hugh Downs Sch Human Commun, Ctr Strateg Commun, Tempe, AZ 85287 USA; [Tsai, Jiun-Yi] No Arizona Univ, Sch Commun, Flagstaff, AZ 86011 USA		Adame, BJ (corresponding author), Arizona State Univ, Hugh Downs Sch Human Commun, Ctr Strateg Commun, Tempe, AZ 85287 USA.; Adame, BJ (corresponding author), Arizona State Univ, Hugh Downs Sch Human Commun, POB 871205, Tempe, AZ 85287 USA.	badame@asu.edu		Tsai, Jiun-Yi/0000-0001-7333-2821; Adame, Bradley/0000-0002-9825-7300	National Collegiate Athletic Association; U.S. Department of Defense under the Mind Matters Challenge grant program	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Collegiate Athletic Association and the U.S. Department of Defense under the Mind Matters Challenge grant program.	Adame B. J., 2018, NATURAL DISASTERS RI, P49; Adame B, 2016, DISASTER PREV MANAG, V25, P282, DOI 10.1108/DPM-08-2015-0196; Adame BJ, 2019, HEALTH COMMUN, V34, P1673, DOI 10.1080/10410236.2018.1517707; Adame BJ, 2015, HEALTH COMMUN, V30, P271, DOI 10.1080/10410236.2013.842527; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Bisel RS, 2010, MANAGE COMMUN Q, V24, P124, DOI 10.1177/0893318909351582; Bisel RS, 2007, WESTERN J COMM, V71, P136, DOI 10.1080/10570310701368039; Blau PM, 1954, AM J SOCIOL, V59, P530, DOI 10.1086/221438; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown SP, 1998, J MARKETING, V62, P88, DOI 10.2307/1252289; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cole MS, 2006, J ORGAN BEHAV, V27, P585, DOI 10.1002/job.378; Corman S.R., 2019, CHANGING CULTURE CON, DOI [10.3886/E109184V1, DOI 10.3886/E109184V1]; Crano WD, 2006, ANNU REV PSYCHOL, V57, P345, DOI 10.1146/annurev.psych.57.102904.190034; Cusimano MD, 2017, SAGE OPEN MED, V5, DOI [10.1177/2050312117694794, 10.1177/2050312117699799]; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Dominicis S, 2014, J APPL SOC PSYCHOL, V44, P364, DOI 10.1111/jasp.12229; DILLARD JP, 1993, COMMUN MONOGR, V60, P90, DOI 10.1080/03637759309376299; DION KL, 1973, J PERS SOC PSYCHOL, V28, P163, DOI 10.1037/h0035725; Dukerich JM, 2002, ADMIN SCI QUART, V47, P507, DOI 10.2307/3094849; Fisher RJ, 1998, PSYCHOL MARKET, V15, P23, DOI 10.1002/(SICI)1520-6793(199801)15:1<23::AID-MAR3>3.3.CO;2-W; Harris GE, 2005, CAN J BEHAV SCI, V37, P159, DOI 10.1037/h0087253; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lehman BJ, 2002, J EXP SOC PSYCHOL, V38, P101, DOI 10.1006/jesp.2001.1489; Luft J, 2016, MANAGE ACCOUNT RES, V31, P75, DOI 10.1016/j.mar.2016.02.006; MAEL F, 1992, J ORGAN BEHAV, V13, P103, DOI 10.1002/job.4030130202; MAEL F, 1988, THESIS; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Miller CH, 2013, DISASTERS, V37, P1, DOI 10.1111/j.1467-7717.2012.01290.x; National Collegiate Athletic Association, 2017, DIV 1 MAN; Olkkonen ME, 2006, ORGAN BEHAV HUM DEC, V100, P202, DOI 10.1016/j.obhdp.2005.08.007; Ploeger NA, 2013, MANAGE COMMUN Q, V27, P155, DOI 10.1177/0893318912469770; Riketta M, 2005, J VOCAT BEHAV, V66, P358, DOI 10.1016/j.jvb.2004.05.005; Sallis J.F., 2002, HLTH BEHAV HLTH ED T; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Sitkin SB, 1995, ACAD MANAGE J, V38, P1573, DOI 10.2307/256844; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; Smidts A, 2001, ACAD MANAGE J, V44, P1051, DOI 10.2307/3069448; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; TOMPKINS PK, 1985, ORG COMMUNICATION TR, V13, P179; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Weiner Y., 1982, ACAD MANAGE REV, V7, P418, DOI [10.5465/amr.1982.4285349, DOI 10.2307/257334]; Witte K, 2001, EFFECTIVE HLTH RISK; Zoller HM, 2003, J APPL COMMUN RES, V31, P118, DOI 10.1080/0090988032000064588; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	52	1	1	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	DEC	2020	8	6					852	869		10.1177/2167479519845372			18	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	NV8LU	WOS:000574566600007					2022-02-06	
J	Asmar, G; Chassat, R; Falcone, MO				Asmar, G.; Chassat, R.; Falcone, M-O			Altered hand proprioception following regional anesthesia as a cause of traumatic jersey finger: Report of two cases	HAND SURGERY & REHABILITATION			English	Article						Regional anesthesia; Proprioception; Jersey finger; Body ownership		The sense of body ownership is being increasingly studied by manipulating incoming signals from the periphery with local anesthetics. We sought to understand how altered proprioception induced by anesthesia triggered a traumatic jersey finger, immediately postoperatively, in two patients who underwent surgical carpal tunnel release. Multiple mechanisms contributed to these postoperative injuries associated with a fall. Hand anesthesia deprives the brain of important afferent sensory information and modifies hand size perception in the brain. Moreover, it blocks efferent motor signals that contribute to the perception of hand position with sensory afferent signals. When the patients fell, their movement control was inadequate, generating a strong contraction of the hand extrinsic flexor muscles, against forceful distal phalanx extension. Lastly, both patients had removed their numb operated hand from their arm sling. Disrupted sensory and motor paths modify self-attribution of the hand, and thus halt adequate efferent commands. Protecting the operated hand until full sensory and motor control is regained could have prevented such rare accidents from happening. (C) 2020 SFCM. Published by Elsevier Masson SAS. All rights reserved.	[Asmar, G.; Falcone, M-O] Ramsay Gen Sante Capio Hop Prive Paul Egine, 4 Ave Marx Dormoy, F-94500 Champigny Sur Marne, France; [Chassat, R.] Ramsay Gen Sante Capio Hop Prive Ouest Parisien, 14 Rue Castiglione Lago, F-78190 Trappes, France; [Chassat, R.; Falcone, M-O] Clin Int Parc Monceau, 21 Rue Chazelles, F-75017 Paris, France		Falcone, MO (corresponding author), Ramsay Gen Sante Capio Hop Prive Paul Egine, 4 Ave Marx Dormoy, F-94500 Champigny Sur Marne, France.; Falcone, MO (corresponding author), Clin Int Parc Monceau, 21 Rue Chazelles, F-75017 Paris, France.	falcone.research@gmail.com		Falcone, Marc-Olivier/0000-0003-0609-9550; ASMAR, Ghada/0000-0002-1238-3833			Al-Qattan MM, 2001, J HAND SURG-BRIT EUR, V26, P427, DOI 10.1054/jhsb.2001.0619; CHOW J C Y, 1989, Arthroscopy, V5, P19, DOI 10.1016/0749-8063(89)90085-6; Heroux ME, 2013, J PHYSIOL-LONDON, V591, P5661, DOI 10.1113/jphysiol.2013.261461; Inui N, 2012, EXP BRAIN RES, V218, P487, DOI 10.1007/s00221-012-3040-9; Palmer AK, 1999, J HAND SURG-AM, V24A, P561; Paqueron X, 2004, ANESTHESIOLOGY, V100, P979, DOI 10.1097/00000542-200404000-00032; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; Walsh LD, 2015, EXP BRAIN RES, V233, P1761, DOI 10.1007/s00221-015-4249-1	8	1	1	0	0	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	2468-1229	2468-1210		HAND SURG REHABIL	Hand Surg. Rehabil.	DEC	2020	39	6					582	584		10.1016/j.hansur.2020.08.007			3	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	OP0JP	WOS:000587762200019	32961288				2022-02-06	
J	Baron, SL; Veasley, SJ; Kingery, MT; Nguyen, MV; Alaia, MJ; Cardone, DA				Baron, Samuel L.; Veasley, Shayla J.; Kingery, Matthew T.; Nguyen, Michael, V; Alaia, Michael J.; Cardone, Dennis A.			Decreased Injury Rate Following Mandated Headgear Use in Women's Lacrosse	BULLETIN OF THE HOSPITAL FOR JOINT DISEASES			English	Article							STATES HIGH-SCHOOL; UNITED-STATES; EPIDEMIOLOGY; FACE; CONCUSSIONS; HELMET; GIRLS	Introduction: There has been controversy regarding whether headgear use in womens lacrosse will affect the rate of head and musculoskeletal injuries. The purpose of this study was to investigate the effect of mandated headgear use on the rate of head and musculoskeletal injuries in high school women's lacrosse. Methods: This was a prospective cohort study of eight high school women's lacrosse teams and their game opponents who were mandated to wear F3137 headgear for the 2017 and 2018 seasons. Athletic trainers documented all injuries that occurred as a result of participation on the lacrosse teams. Injury rates in the headgear cohort were compared to a retrospective (control) cohort from the High School Reporting Information Online injury data reports. Results: Over the study period, 17 total injuries were reported in the headgear cohort during 22397 exposures for an injury rate of 0.76 injuries per 1,000 athlete-exposures. The headgear cohort demonstrated significant decreases in rates of in-game head and face injury (RR 0.141, 95% CI [0.004, 0.798]), in-game concussion (RR 0.152, 95% CI [0.004, 0.860]), and practice trunk and extremity injury (RR 0.239, 95% CI [0.049, 0.703]) when compared to the control cohort. Conclusion: Mandated use of headgear was shown to be effective at lowering the rate of head or face injury and concussions in women's lacrosse. Additionally, mandated headgear use was also shown to lower the rate of injury to body locations other than the head or face during practice. To our knowledge, this is the first study to demonstrate a decrease in injury rates associated with ASTM approved headgear in women's lacrosse.	[Baron, Samuel L.; Kingery, Matthew T.; Alaia, Michael J.; Cardone, Dennis A.] NYU Langone Hlth, NYU Langone Orthoped Hosp, Dept Orthoped Surg, New York, NY USA; [Veasley, Shayla J.] New York Dept Educ, New York, NY USA; [Kingery, Matthew T.; Nguyen, Michael, V] NYU Sch Med, New York, NY USA		Kingery, MT (corresponding author), 333 E 38th St,4th Floor, New York, NY 10016 USA.	matthew.kingery@nyumc.org		Kingery, Matthew/0000-0001-7627-775X			Barth JT, 2001, J ATHL TRAINING, V36, P253; Brandenburg MA, 2002, CLIN J SPORT MED, V12, P360, DOI 10.1097/00042752-200211000-00007; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Comstock RD, PROGRAM INJURY PREVE; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goldenberg Michael S., 1995, Journal of Athletic Training, V30, P37; Herman DC, 2018, AMSSM 2018 ANN M LAK; Kahanov Leamor, 2005, Res Sports Med, V13, P77, DOI 10.1080/15438620590956025; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Webster DA, 1999, MED SCI SPORT EXER, V31, P938, DOI 10.1097/00005768-199907000-00004; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	23	1	1	0	1	J MICHAEL RYAN PUBLISHING INC	BYRAM TOWNSHIP	24 CRESCENT DR N, BYRAM TOWNSHIP, NJ 07821 USA	2328-4633	2328-5273		BULL HOSP JT DIS	Bull. Hosp. Jt. Dis.	DEC	2020	78	4					260	265					6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	OV7CI	WOS:000592362700007	33207148				2022-02-06	
J	Caswell, SV; Kelshaw, PM; Lincoln, AE; Herman, DC; Hepburn, LH; Vincent, HK; Dunn, RE; Cortes, N				Caswell, Shane, V; Kelshaw, Patricia M.; Lincoln, Andrew E.; Herman, Daniel C.; Hepburn, Lisa H.; Vincent, Heather K.; Dunn, Reginald E.; Cortes, Nelson			The Effects of Headgear in High School Girls' Lacrosse	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						helmets; women&#8217; s lacrosse; effectiveness		Background: Girls' lacrosse headgear that met the ASTM International performance standard (ASTM F3137) became available in 2017. However, the effects of headgear use on impact forces during game play are unknown. Purpose: To evaluate potential differences in rates, magnitudes, and game-play characteristics associated with verified impacts among players with and without headgear during competition. Study Design: Cohort study; Level of evidence, 3. Methods: A total of 49 female high school participants (mean age, 16.2 +/- 1.2 years; mean height, 1.66 +/- 0.05 m; mean weight, 61.2 +/- 6.4 kg) volunteered for this study, which took place during the 2016 (no headgear; 18 games) and 2017 (headgear; 15 games) seasons. Wearable sensors synchronized with video verification were used. Descriptive statistics, impact rates, and chi-square analyses described impacts and game-play characteristics among players with and without headgear. Differences in mean peak linear acceleration (PLA) and peak rotational velocity (PRV) between the no headgear and headgear conditions were evaluated using a linear generalized estimating equation regression model to control for repeated within-player measurements. Results: Overall, 649 sensor-instrumented player-games were recorded. A total of 204 impacts >= 20g recorded by the wearable sensors were verified with video analysis (102 no headgear; 102 headgear). Most impacts were imparted to the player's body (n = 152; 74.5%) rather than to the player's head (n = 52; 25.5%). Impact rates per player-game did not vary between the no headgear and headgear conditions (0.30 vs 0.34, respectively; impact rate ratio, 0.88 [95% CI, 0.37-2.08]). There was no association between impact frequency by mechanism or penalties administered between the no headgear and headgear conditions for overall or direct head impacts. The generalized estimating equation model estimated a significant reduction in mean impact magnitudes overall (PLA: -7.9g [95% CI, -13.3 to -2.5]; PRV: -212 deg/s [95% CI, -359 to -64]) with headgear relative to no headgear. No game-related concussions were reported during this study. Conclusion: Lacrosse headgear use was associated with a reduction in the magnitude of overall impacts but not a significant change in the rate of impacts, how they occur, or how penalties were administered for impacts sustained during competition. Further research is needed with a larger sample and different levels of play to evaluate the consequences of headgear use in girls' lacrosse.	[Caswell, Shane, V; Kelshaw, Patricia M.; Lincoln, Andrew E.; Herman, Daniel C.; Hepburn, Lisa H.; Vincent, Heather K.; Dunn, Reginald E.; Cortes, Nelson] George Mason Univ, Sch Kinesiol, Sports Med Assessment Res & Testing SMART Lab, Fairfax, VA 22030 USA; [Kelshaw, Patricia M.] Univ New Hampshire, Coll Hlth & Human Serv, Dept Kinesiol, Durham, NH 03824 USA; [Lincoln, Andrew E.; Hepburn, Lisa H.; Dunn, Reginald E.] MedStar Hlth, MedStar Sports Med Res Ctr, Baltimore, MD USA; [Lincoln, Andrew E.] George Washington Univ, Med Ctr, Dept Rehabil Med, Washington, DC 20037 USA; [Herman, Daniel C.] Univ Florida, Coll Med, Dept Orthopaed & Rehabil, Div Phys Med & Rehabil, Gainesville, FL USA; [Herman, Daniel C.] Univ Florida, Coll Med, Dept Orthopaed & Rehabil, Div Sports Med, Gainesville, FL USA; [Herman, Daniel C.] Univ Florida, Coll Med, Dept Orthopaed & Rehabil, Div Res, Gainesville, FL USA; [Vincent, Heather K.] Univ Florida, Human Performance Lab, Gainesville, FL USA; [Vincent, Heather K.] Univ Florida, Sports Performance Ctr, Gainesville, FL USA		Caswell, SV (corresponding author), George Mason Univ, Sch Kinesiol, SMART Lab, 10890 George Mason Circle, Manassas, VA 20110 USA.	scaswell@gmu.edu	Kelshaw, Patricia/AAC-7220-2021	Cortes, Nelson/0000-0001-8762-3144	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Virginia Department of Health; Prince William County Public Schools; US Lacrosse; National Operating Committee on Standards for Athletic Equipment	S.V.C. acknowledges research grant funding from the Centers for Disease Control and Prevention and the Virginia Department of Health as well as the Prince William County Public Schools. S.V.C., P.M.K., A.E.L., D.C.H., L.H.H., H.K.V., and N.C. acknowledge unrestricted grant funding from US Lacrosse. S.V.C., P.M.K., A.E.L., D.C.H., and H.K.V. acknowledge unrestricted grant funding from the National Operating Committee on Standards for Athletic Equipment. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. All authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. S.V.C. and A.E.L. are members of the US Lacrosse Sports Science and Safety Committee. D.C.H. has received hospitality payments from DJO and consulting fees from Pacira Pharmaceuticals. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	ASTM International, F313715 ASTM INT, DOI [10.1520/F3137-15, DOI 10.1520/F3137-15]; Atkinson L., 2018, 2019 NFHS GIRLS LACR; Caswell SV, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119835587; Caswell SV, 2017, AM J SPORT MED, V45, P3374, DOI 10.1177/0363546517724754; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Chancellor SE, 2019, SEMIN PEDIATR NEUROL, V30, P14, DOI 10.1016/j.spen.2019.03.004; Chandran A, 2019, J ATHL TRAINING, V54, P1192, DOI 10.4085/1062-6050-438-18; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; De Lench B., ASTM STANDARD WOMEN; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Foss KDB, 2017, PHYSICIAN SPORTSMED, V45, P224, DOI 10.1080/00913847.2017.1355209; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Kelshaw P, 2018, INT J ATHL THER TRAI, V23, P234, DOI 10.1123/ijatt.2017-0102; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Pan W, 2002, STAT MED, V21, P1429, DOI 10.1002/sim.1142; PELTZMAN S, 1975, J POLIT ECON, V83, P677, DOI 10.1086/260352; Pennington B., HEADGEAR HERE GIRLS; Pennington B., CONCUSSION WORRIES R; R C. T, 2019, R LANGUAGE ENV STAT; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Schwarz A., WOMENS LACROSSE HEAD; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; The National Federation of State High School Associations, 2014 15 HIGH SCH ATH; US Lacrosse, STAT FLOR GIRLS HEAD; US Lacrosse, US LACR PART SURV; Veasley S., 2019, ORTHOP J SPORTS MED, V7; Weaver J., 2017, 2018 NFHS GIRLS LACR; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	34	1	1	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC	2020	8	12							2325967120969685	10.1177/2325967120969685			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	PO6OS	WOS:000605290200001	33447621	Green Published, gold			2022-02-06	
J	Chia, MYC				Chia, Michael Yih Chong			Development of a delayed chronic subdural hematoma 2 months after mild traumatic brain injury with a normal initial brain computed tomography: A case report	JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN			English	Article						burr hole; chronic subdural hematoma; surgical decompression; traumatic brain injury	RISK-FACTORS; HEMORRHAGE	This is a case involving the development of a delayed chronic subdural hematoma 2 months after a minor head injury with normal clinical neurological findings and brain computed tomography at initial presentation. An 84-year-old man visited the emergency department (ED) after a minor head trauma. The patient complained of dizziness and vomiting 8 hours after an injury. He was not on an antiplatelet or anticoagulant. He did not have any abnormal findings during neurological examination, and brain computed tomography did not show any intracranial pathology or skull fractures. He was admitted to the ED short-stay ward for observation and was discharged asymptomatic and stable 12 hours later. However, he presented 2 months later with dizziness and unsteady gait. He was asymptomatic within those 2 months. At the ED, his brain computed tomography showed a large right chronic subdural hematoma, compressing the right lateral and third ventricles, with a 1.2 cm midline shift, subfalcine and uncal herniations, and early hydrocephalus. An emergency burr-hole evacuation was performed. He was discharged without neurological deficit 3 days later. Emergency physicians attending to patients with normal neurologic examination and initial brain computed tomography after suffering a mild traumatic brain injury should be vigilant for a chronic subdural hematoma should the patient re-present for evaluation subsequently. The attending physician may be biased as patients could have symptoms attributed to postconcussion syndrome that may overlap with symptoms of chronic subdural hematoma. Unsteady gait and ataxia are uncommon clinical signs of postconcussion syndrome and should prompt the physician to consider a repeat brain computed tomography.	[Chia, Michael Yih Chong] Tan Tock Seng Hosp, Emergency Dept, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore		Chia, MYC (corresponding author), Tan Tock Seng Hosp, Emergency Dept, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	michael_yc_chia@ttsh.com.sg			JACEP Open policy	By JACEP Open policy, all authors are required to disclose any and all commercial, financial, and other relationships in anyway related to the subject of this article as per ICMJEconflict of interest guidelines (see www.icmje.org).The authors have stated that no such relationships exist.	BARATHAM G, 1972, J NEUROL NEUROSUR PS, V35, P698, DOI 10.1136/jnnp.35.5.698; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; DEITCH D, 1989, NEUROLOGY, V39, P985, DOI 10.1212/WNL.39.7.985; DOHERTY DL, 1988, ARCH PHYS MED REHAB, V69, P542; Edlmann E, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0881-y; Feng JF, 2008, MED HYPOTHESES, V70, P1147, DOI 10.1016/j.mehy.2007.11.014; FUKAMACHI A, 1985, ACTA NEUROCHIR, V74, P35, DOI 10.1007/BF01413274; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Komiyama K, 2019, NEUROSURG FOCUS, V47, DOI 10.3171/2019.8.FOCUS19535; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lee KS, 1998, BRAIN INJURY, V12, P901; Marion DW, 2006, NEUROSURGERY, V58, P655; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a; MATSUMURA A, 1985, SURG NEUROL, V24, P503, DOI 10.1016/0090-3019(85)90264-2; Mayer S, 2000, MERRITTS NEUROLOGY, P401; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; Olivero WC, 2017, J CLIN NEUROSCI, V42, P129, DOI 10.1016/j.jocn.2017.03.005; OMMAYA AK, 1969, LANCET, V2, P237; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	22	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2688-1152		JACEP OPEN	J. Am. Coll. Emerg. Phys. Open	DEC	2020	1	6					1723	1728		10.1002/emp2.12198			6	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	RZ6GR	WOS:000648695500078	33392581	Green Published, gold			2022-02-06	
J	Degeneffe, CE; Tucker, M; Ahonle, ZJ				Degeneffe, Charles Edmund; Tucker, Mark; Ahonle, Zaccheus James			State-level differences in public vocational rehabilitation closures among transition-aged youth with traumatic brain injury	AUSTRALIAN JOURNAL OF REHABILITATION COUNSELLING			English	Article						Vocational rehabilitation; traumatic brain injury; school to work transition; service disparities; adolescence		This study aimed to understand state-level variation in participation in the State/Federal Vocational Rehabilitation (State VR) System in the United States among transition-aged youth (persons under the age of 22 years at application for State VR services) with traumatic brain injury (TBI) in Federal Fiscal Year 2016. A weighted least squares regression analysis was conducted to determine the relationship of state-level population size, unemployment rate, and per-capita income to the number of State VR closures in each state for transition-aged youth with TBI. Population size and per-capita income significantly predicted closures, while there was no relationship between closures and unemployment rate. Research is needed that further explores and explains state-level disparities in participation among transition-aged youth with TBI.	[Degeneffe, Charles Edmund; Tucker, Mark] San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, Rehabil Counseling Program, San Diego, CA 92182 USA; [Ahonle, Zaccheus James] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA; [Ahonle, Zaccheus James] Mississippi State Univ, Dept Counseling Educ Psychol & Fdn, Mississippi State, MS 39762 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, Rehabil Counseling Program, San Diego, CA 92182 USA.	cdegenef@sdsu.edu					Ahonle ZJ, 2020, REHABIL COUNS BULL, V63, P143, DOI 10.1177/0034355219864684; Buys N, 2011, DISABIL REHABIL, V33, P1125, DOI 10.3109/09638288.2010.521614; Degeneffe C.E., 2019, J APPL REHABIL COUS, V50, P252; Degeneffe CE, 2020, REHABIL COUNS BULL, DOI 10.1177/0034355220967109; Degeneffe CE, 2015, REHABIL RES POL EDUC, V29, P208, DOI 10.1891/2168-6653.29.3.208; Friedman C, 2018, REHABIL RES POL EDUC, V32, P123, DOI 10.1891/2168-6653.32.2.123; IBM Corporation, 2019, IBM SPSS STAT MAC VE; Strnadova I, 2014, AUST J EDUC, V58, P318, DOI 10.1177/0004944114543603; Trach J. S., 2014, CAREER DEV EMPLOYMEN, P389; Tucker MS, 2017, REHABIL COUNS BULL, V60, P215, DOI 10.1177/0034355216660279; United States Bureau of Labor Statistics, 2020, LOC AR UN STAT UN RA; United States Census Bureau, MED HOUS INC 2018 DO; United States Census Bureau, 2019, NSTEST201901 US CENS; United States Centers for Disease Control and Prevention, 2019, TBI GET THE FACTS; United States Department of Education, IDEA; United States Department of Education, 2016, FED REG; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029	17	1	1	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1323-8922	1838-6059		AUST J REHABIL COUNS	Aust. J. Rehabil. Couns.	DEC	2020	26	2					136	142	PII S1323892220000186	10.1017/jrc.2020.18			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	PI2BY	WOS:000600903300006					2022-02-06	
J	Duda, T; Sharma, A; Ellenbogen, Y; Martyniuk, A; Kasper, E; Engels, PT; Sharma, S				Duda, Taylor; Sharma, Arjun; Ellenbogen, Yosef; Martyniuk, Amanda; Kasper, Ekkehard; Engels, Paul T.; Sharma, Sunjay			Outcomes of civilian pediatric craniocerebral gunshot wounds: A systematic review	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	54th Annual Congress of the Canadian-Neurological-Sciences-Federation	JUN 15-19, 2019	Montreal, CANADA	Canadian Neurol Sci Federat		Pediatric; neurotrauma; intracranial; gunshot wound; craniocerebral gunshot injury	TRAUMATIC BRAIN-INJURY; MANAGEMENT; CHILDREN; ADOLESCENTS; GUIDELINES; PREDICTORS; MORTALITY; SURVIVAL; UPDATE; HEAD	BACKGROUND Pediatric craniocerebral gunshot injuries (CGIs) occur both in the context of accidental and intentional trauma. The incidence and physiology of pediatric CGIs merit reexamination of prognostic factors and treatment priorities. This study characterizes the current understanding of mortality and prognostic factors in this patient population. METHODS A systematic search was conducted. Selection criteria included all studies published since 2000, which described civilian isolated CGIs in pediatric patients. Data were analyzed qualitatively and quantitatively to identify factors prognostic for the primary outcome of mortality. Secondary outcomes included functional outcome status, requirement for surgery, and injury complications. Study quality was assessed with the Newcastle-Ottawa Scale. This study was registered with PROSPERO (CRD42019134231). RESULTS Initial search revealed 349 unique studies. Forty underwent full text screening, and eight studies were included in the final synthesis. The overall mortality rate was 44.8%. Most CGIs occurred in older teenagers. Aggressive surgical treatment was recommended by one author, while remaining studies emphasized clinical judgment. Reported prognostic factors include initial Glasgow Coma Scale, pupil reactivity, involvement of multiple lobes or deep nuclei, and bihemispheric injuries. Reported complications from CGIs included seizure, meningitis, abscess, cerebrospinal fluid leak, bullet migration, focal neurological deficits, endocrine abnormalities, cognitive deficits, and neuropsychological deficits. The Glasgow Outcome Scale was the predominant measure of function and demonstrated a moderate recovery in 17.4% and a good recovery in 27.3% of patients. CONCLUSION This systematic review analyzed the existing evidence for prognostic factors in the context of pediatric CGIs. Significant long-term clinical improvement is possible with interventions including urgent surgical therapy. Fixed bilateral pupils and low initial Glasgow Coma Scale correlate with mortality but do not predict all patient outcomes. Patients younger than 15 years are underreported and may have differences in outcome. The literature on pediatric CGIs is limited and requires further characterization.	[Duda, Taylor; Sharma, Arjun; Ellenbogen, Yosef; Martyniuk, Amanda; Kasper, Ekkehard; Engels, Paul T.; Sharma, Sunjay] McMaster Univ, Div Neurosurg, HSC 2P7D,1200 Main St W, Hamilton, ON L8N 3Z5, Canada		Duda, T (corresponding author), McMaster Univ, Div Neurosurg, HSC 2P7D,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	taylor.duda@medportal.ca	Duda, Taylor/ABA-4882-2021; Sharma, Sunjay/AAR-7129-2021; Engels, Paul/AAU-3049-2021	Duda, Taylor/0000-0002-4092-4721; Sharma, Sunjay/0000-0001-7826-9075; 			Allen CJ, 2016, PEDIATR SURG INT, V32, P657, DOI 10.1007/s00383-016-3900-7; Alvis-Miranda Hernando Raphael, 2016, Bull Emerg Trauma, V4, P65; Avarello JT, 2007, EMERG MED CLIN N AM, V25, P803, DOI 10.1016/j.emc.2007.06.013; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; Cunningham RM, 2018, NEW ENGL J MED, V379, P2468, DOI 10.1056/NEJMsr1804754; Davis JS, 2013, J SURG RES, V184, P556, DOI 10.1016/j.jss.2012.12.047; DeCuypere M, 2016, J NEUROSURG-PEDIATR, V17, P595, DOI 10.3171/2015.7.PEDS15285; Demirbilek H, 2013, J CLIN RES PEDIATR E, V5, P209, DOI 10.4274/Jcrpe.1027; Frosen J, 2019, ACTA NEUROCHIR, V161, P1285, DOI 10.1007/s00701-019-03952-y; Gavaghan DJ, 2000, PAIN, V85, P415, DOI 10.1016/S0304-3959(99)00302-4; Glapa M, 2007, WORLD J SURG, V31, P2104, DOI 10.1007/s00268-007-9220-2; Gordon AS, 2014, CHILD NERV SYST, V30, P1589, DOI 10.1007/s00381-014-2429-0; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Hussain M, 2011, JCPSP-J COLL PHYSICI, V21, P182, DOI 03.2011/JCPSP.182183; Institute of Medicine, 1993, EMERGENCY MED SERVIC; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; Kerwin AJ, 2018, ANN SURG, V267, pe11; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kountakis SE, 1996, OTOLARYNG HEAD NECK, V114, P756, DOI 10.1016/S0194-5998(96)70098-0; Lichte P, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0159-8; Lin DJ., 2012, SURG NEUROL INT, V3, P98, DOI [DOI 10.4103/2152-7806, 10.4103/2152-7806.100187, DOI 10.4103/2152-7806.100187]; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; McFadyen J Grant, 2012, Int J Crit Illn Inj Sci, V2, P121, DOI 10.4103/2229-5151.100888; McLaughlin C, 2018, J PEDIATR SURG, V53, P344, DOI 10.1016/j.jpedsurg.2017.10.006; Mikhael M, 2018, J NEUROSURG ANESTH, V30, P290, DOI 10.1097/ANA.0000000000000441; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Murad MH, 2018, BMJ EVID-BASED MED, V23, P60, DOI 10.1136/bmjebm-2017-110853; Murphy S, 2016, CURR TRAUMA REP, V2, P222, DOI 10.1007/s40719-016-0065-8; Newgard CD, 2013, PEDIATRICS, V132, P862, DOI 10.1542/peds.2013-1350; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Parikh Kavita, 2017, Hosp Pediatr, V7, P303, DOI 10.1542/hpeds.2016-0146; Schafer I, 2006, PSYCHOPATHOLOGY, V39, P159, DOI 10.1159/000092676; Seid Terrence, 2012, Int J Crit Illn Inj Sci, V2, P114, DOI 10.4103/2229-5151.100887; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Wells GA, 2021, NEWCASTLE OTTAWA SCA	38	1	1	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2020	89	6					1239	1247		10.1097/TA.0000000000002900			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	OZ3WN	WOS:000594860700045	32756261				2022-02-06	
J	Fesharaki-Zadeh, A; Miyauchi, JT; St Laurent-Arriot, K; Tsirka, SE; Bergold, PJ				Fesharaki-Zadeh, Arman; Miyauchi, Jeremy T.; St Laurent-Arriot, Karrah; Tsirka, Stella E.; Bergold, Peter J.			Increased Behavioral Deficits and Inflammation in a Mouse Model of Co-Morbid Traumatic Brain Injury and Post-Traumatic Stress Disorder	ASN NEURO			English	Article						behavior; cognition; memory; astrocytes; macrophage; microglia		Comorbid post-traumatic stress disorder with traumatic brain injury (TBI) produce more severe affective and cognitive deficits than PTSD or TBI alone. Both PTSD and TBI produce long-lasting neuroinflammation, which may be a key underlying mechanism of the deficits observed in co-morbid TBI/PTSD. We developed a model of co-morbid TBI/PTSD by combining the closed head (CHI) model of TBI with the chronic variable stress (CVS) model of PTSD and examined multiple behavioral and neuroinflammatory outcomes. Male C57/Bl6 mice received sham treatment, CHI, CVS, CHI then CVS (CHI -> CVS) or CVS then CHI (CVS -> CHI). The CVS -> CHI group had deficits in Barnes maze or active place avoidance not seen in the other groups. The CVS -> CHI, CVS and CHI -> CVS groups displayed increased basal anxiety level, based on performance on elevated plus maze. The CVS -> CHI had impaired performance on Barnes Maze, and Active Place Avoidance. These performance deficits were strongly correlated with increased hippocampal Iba-1 level an indication of activated MP/MG. These data suggest that greater cognitive deficits in the CVS -> CHI group were due to increased inflammation. The increased deficits and neuroinflammation in the CVS -> CHI group suggest that the order by which a subject experiences TBI and PTSD is a major determinant of the outcome of brain injury in co-morbid TBI/PTSD.	[Fesharaki-Zadeh, Arman] SUNY Downstate Med Ctr, Dept Psychiat, Brooklyn, NY 11215 USA; [Miyauchi, Jeremy T.; Tsirka, Stella E.] SUNY Downstate Med Ctr, Dept Physiol, Brooklyn, NY 11215 USA; [St Laurent-Arriot, Karrah; Bergold, Peter J.] SUNY Downstate Med Ctr, Dept Pharmacol, Brooklyn, NY 11215 USA; [Bergold, Peter J.] SUNY Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11215 USA; [Bergold, Peter J.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook Med, Stony Brook, NY 11794 USA; [Fesharaki-Zadeh, Arman] Yale Univ, Dept Psychiat & Neurol, Sch Med, New Haven, CT 06536 USA		Bergold, PJ (corresponding author), SUNY Downstate Med Ctr, Box 29,450 Clarkson Ave, Brooklyn, NY 11215 USA.; Fesharaki-Zadeh, A (corresponding author), SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	arman.fesharaki@yale.edu; peter.bergold@downstate.edu		Tsirka, Stella/0000-0003-0022-1770	State University of New York Brain Network of Excellence; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F30CA196110]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a grant to P. J. B. and S. E. T. from the State University of New York Brain Network of Excellence and National Institutes of Health F30CA196110 to J. T. M.	Amos T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006239.pub2; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Bodnar CN, 2019, J NEUROTRAUM, V36, P1683, DOI 10.1089/neu.2018.6127; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Daskalakis NP, 2016, EXP NEUROL, V284, P133, DOI 10.1016/j.expneurol.2016.07.024; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Goodwill HL, 2019, NEUROPSYCHOPHARMACOL, V44, P711, DOI 10.1038/s41386-018-0195-5; Goswami S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00089; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Grillon C, 2017, PSYCHOL MED, V47, P484, DOI 10.1017/S0033291716002555; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hendrickson RC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0908-5; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jones KA, 2013, MOL CELL NEUROSCI, V53, P52, DOI 10.1016/j.mcn.2012.10.002; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238; Khoury NM, 2012, J CLIN PSYCHIAT, V73, P849, DOI 10.4088/JCP.11m07316; Kim DJ, 2017, NEUROBIOL LEARN MEM, V137, P92, DOI 10.1016/j.nlm.2016.11.014; Lam D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0941-3; Lamers F, 2013, MOL PSYCHIATR, V18, P692, DOI 10.1038/mp.2012.144; Lesburgueres E, 2016, HIPPOCAMPUS, V26, P1481, DOI 10.1002/hipo.22666; Lezak KR, 2017, DIALOGUES CLIN NEURO, V19, P181; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McKim DB, 2016, J NEUROSCI, V36, P2590, DOI 10.1523/JNEUROSCI.2394-15.2016; Mellon SH, 2018, BIOL PSYCHIAT, V83, P866, DOI 10.1016/j.biopsych.2018.02.007; Mendoza C, 2016, MOL CELL ENDOCRINOL, V434, P266, DOI 10.1016/j.mce.2016.05.016; Mikolic A, 2019, CLIN PSYCHOL REV, V73, DOI 10.1016/j.cpr.2019.101776; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Motzkin Julian C, 2015, Handb Clin Neurol, V128, P633, DOI 10.1016/B978-0-444-63521-1.00039-X; Ostrander MM, 2006, ENDOCRINOLOGY, V147, P2008, DOI 10.1210/en.2005-1041; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rodriguez PC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00093; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Sangobowale M.A., 2018, J NEUROTRAUM, V35, P1; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Silver J.M., 2018, TXB TRAUMATIC BRAIN; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Spadoni AD, 2018, CURR TOP BEHAV NEURO, V38, P163, DOI 10.1007/7854_2017_35; Sunyer B.P.S., 2007, NAT PROTOC, V198, P58; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Teutsch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6037015; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Watkins LE, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00258; Whitaker AM, 2014, BEHAV PHARMACOL, V25, P398, DOI 10.1097/FBP.0000000000000069; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zhao J, 2018, J NEUROTRAUM, V35, P149, DOI 10.1089/neu.2016.4898	76	1	1	2	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	DEC	2020	12								1759091420979567	10.1177/1759091420979567			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PK7WL	WOS:000602650000001	33342261	Green Published, gold			2022-02-06	
J	Gamble, M; Luggya, TS; Mabweijano, J; Nabulime, J; Mowafi, H				Gamble, Miriam; Luggya, Tonny Stone; Mabweijano, Jacqueline; Nabulime, Josephine; Mowafi, Hani			Impact of nursing education and a monitoring tool on outcomes in traumatic brain injury	AFRICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Uganda; Secondary brain injury; Emergency care; Traumatic brain injury; Low resource settings; Nursing chart	ACUTE SUBDURAL-HEMATOMA; HEAD-INJURY; LOW-INCOME; MORTALITY; HYPOTENSION; KAMPALA; MANAGEMENT; HYPOXIA; BURDEN; UGANDA	Introduction: Throughout the world, traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Low-and middle-income countries experience an especially high burden of TBI. While guidelines for TBI management exist in high income countries, little is known about the optimal management of TBI in low resource settings. Prevention of secondary injuries is feasible in these settings and has potential to improve mortality. Methods: A pragmatic quasi-experimental study was conducted in the emergency centre (EC) of Mulago National Referral Hospital to evaluate the impact of TBI nursing education and use of a monitoring tool on mortality. Over 24 months, data was collected on 541 patients with moderate (GCS9-13) to severe (GCS <= 8) TBI. The primary outcome was in-hospital mortality and secondary outcomes included time to imaging, time to surgical intervention, time to advanced airway, length of stay and number of vital signs recorded. Results: Data were collected on 286 patients before the intervention and 255 after. Unadjusted mortality was higher in the post-intervention group but appeared to be related to severity of TBI, not the intervention itself. Apart from number of vital signs, secondary outcomes did not differ significantly between groups. In the post-intervention group, vital signs were recorded an average of 2.85 times compared to 0.49 in the pre-intervention group (95% CI 2.08-2.62, p <= 0.001). The median time interval between vital signs in the post-intervention group was 4.5 h (IQR 2.1-10.6). Conclusion: Monitoring of vital signs in the EC improved with nursing education and use of a monitoring tool, however, there was no detectable impact on mortality. The high mortality among patients with TBI underscores the need for treatment strategies that can be implemented in low resource settings. Promising approaches include improved monitoring, organized trauma systems and protocols with an emphasis on early aggressive care and primary prevention.	[Gamble, Miriam; Mowafi, Hani] Yale Univ, Dept Emergency Med, New Haven, CT 06520 USA; [Luggya, Tonny Stone] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Anesthesia, Kampala, Uganda; [Mabweijano, Jacqueline] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Surg, Kampala, Uganda; [Nabulime, Josephine] Mulago Natl Referral Hosp, Kampala, Uganda		Gamble, M (corresponding author), Yale Univ, Dept Emergency Med, New Haven, CT 06520 USA.	Miriam.gamble@epcfonline.com			Yale University Department of Emergency Medicine, Global Health Division	Funding was provided by Yale University Department of Emergency Medicine, Global Health Division. The authors declare no further conflict of interest.	Alexander T, 2009, S AFR J SURG, V47, P120; [Anonymous], 2012, INJURY PREVENTION S1, V24, pA194, DOI DOI 10.1136/INJURYPREV-2012-040590S.17; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Duric Amira, 2006, Med Arh, V60, P120; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Institute for Health Metrics and Evaluation, 2010, GBD PROF UG GLOB BUR; Jeremitsky E, 2003, J TRAUMA, V54, P8; Kamulegeya LH, 2015, AFR HEALTH SCI, V15, P1016, DOI 10.4314/ahs.v15i3.41; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Krebs E, 2017, WORLD NEUROSURG, V102, P571, DOI 10.1016/j.wneu.2017.03.001; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Lu J, 2005, ACT NEUR S, V95, P281; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Opondo E, 2007, ANN AFR SURG, V1, P6; Reed AR, 2002, SAMJ S AFR MED J, V92, P221; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shima Katsuji, 2010, Asian J Neurosurg, V5, P15; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Tobi K, 2016, AFR J ANAESTH ANAL, V22, P5; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Uganda Bureau of Statistics. Statistics UBo, 2010, UG NAT HOUS SURV REP; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y; World Health Organization, 2014, NONC DIS COUNTR PROF, P1; World Health Organization, 2004, GUIDELINES ESSENTIAL; World Health Organization, 2006, NEUR DIS PUBL HLTH A; World Health Organization Department of Injuries and Violence Prevention Noncommunicable Diseases and Mental Health Cluster, 2002, INJURY CHART BOOK GR; Wynveen L, 2018, AFR J EMERG MED, V8, P64, DOI 10.1016/j.afjem.2018.01.002	39	1	1	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2211-419X	2211-4203		AFR J EMERG MED	Afr. J. Emerg. Med.	DEC	2020	10	4					181	187		10.1016/j.afjem.2020.05.013			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	OY6FH	WOS:000594340000003	33299746	gold, Green Published			2022-02-06	
J	Garbe, A; Graef, F; Appelt, J; Schmidt-Bleek, K; Jahn, D; Lunnemann, T; Tsitsilonis, S; Seemann, R				Garbe, Anja; Graef, Frank; Appelt, Jessika; Schmidt-Bleek, Katharina; Jahn, Denise; Luennemann, Tim; Tsitsilonis, Serafeim; Seemann, Ricarda			Leptin Mediated Pathways Stabilize Posttraumatic Insulin and Osteocalcin Patterns after Long Bone Fracture and Concomitant Traumatic Brain Injury and Thus Influence Fracture Healing in a Combined Murine Trauma Model	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						fracture healing; TBI; Insulin; osteocalcin; leptin; posttraumatic hormone household; bone hormone interaction		Recent studies on insulin, leptin, osteocalcin (OCN), and bone remodeling have evoked interest in the interdependence of bone formation and energy household. Accordingly, this study attempts to investigate trauma specific hormone changes in a murine trauma model and its influence on fracture healing. Thereunto 120 female wild type (WT) and leptin-deficient mice underwent either long bone fracture (Fx), traumatic brain injury (TBI), combined trauma (Combined), or neither of it and therefore served as controls (C). Blood samples were taken weekly after trauma and analyzed for insulin and OCN concentrations. Here, WT-mice with Fx and, moreover, with combined trauma showed a greater change in posttraumatic insulin and OCN levels than mice with TBI alone. In the case of leptin-deficiency, insulin changes were still increased after bony lesion, but the posttraumatic OCN was no longer trauma specific. Four weeks after trauma, hormone levels recovered to normal/basal line level in both mouse strains. Thus, WT- and leptin-deficient mice show a trauma specific hyperinsulinaemic stress reaction leading to a reduction in OCN synthesis and release. In WT-mice, this causes a disinhibition and acceleration of fracture healing after combined trauma. In leptin-deficiency, posttraumatic OCN changes are no longer specific and fracture healing is impaired regardless of the preceding trauma.	[Garbe, Anja; Graef, Frank; Appelt, Jessika; Jahn, Denise; Luennemann, Tim; Tsitsilonis, Serafeim; Seemann, Ricarda] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Garbe, Anja; Graef, Frank; Appelt, Jessika; Jahn, Denise; Luennemann, Tim; Tsitsilonis, Serafeim; Seemann, Ricarda] Humboldt Univ, Freie Univ Berlin, D-13353 Berlin, Germany; [Garbe, Anja; Graef, Frank; Appelt, Jessika; Jahn, Denise; Luennemann, Tim; Tsitsilonis, Serafeim; Seemann, Ricarda] Berlin Inst Hlth, D-13353 Berlin, Germany; [Appelt, Jessika; Schmidt-Bleek, Katharina; Jahn, Denise] Charite Univ Med Berlin, Julius Wolff Inst Biomech & Musculoskeletal Regen, D-13353 Berlin, Germany		Garbe, A (corresponding author), Charite Univ Med Berlin, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.; Garbe, A (corresponding author), Humboldt Univ, Freie Univ Berlin, D-13353 Berlin, Germany.; Garbe, A (corresponding author), Berlin Inst Hlth, D-13353 Berlin, Germany.	anja.garbe@charite.de; frank.graef@charite.de; jessika.appelt@charite.de; katharina.schmidt-bleek@charite.de; denise.jahn@charite.de; tim.luennemann@gmail.com; serafeim.tsitsilonis@charite.de; ricarda.seemann@charite.de		Graef, Frank/0000-0002-0435-9059; Jahn, Denise/0000-0001-8912-5851; Seemann, Ricarda/0000-0001-5752-070X	German Research Society (DFG)German Research Foundation (DFG) [TS 303/1-1]	This study was funded by the German Research Society (DFG, project TS 303/1-1).	Amling M, 2000, BIOESSAYS, V22, P970; CALANDRIELLO B, 1964, Bull Hosp Joint Dis, V25, P170; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Cheung KMC, 2003, J ORTHOP RES, V21, P685, DOI 10.1016/S0736-0266(03)00026-3; Confavreux CB, 2011, KIDNEY INT, V79, pS14, DOI 10.1038/ki.2011.25; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2014, ARCH BIOCHEM BIOPHYS, V561, P137, DOI 10.1016/j.abb.2014.05.022; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Ghazali A, 2003, NEPHROL DIAL TRANSPL, V18, P1882, DOI 10.1093/ndt/gfg268; Graef F, 2017, J MUSCULOSKEL NEURON, V17, P78; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; HAUSCHKA PV, 1975, P NATL ACAD SCI USA, V72, P3925, DOI 10.1073/pnas.72.10.3925; Hinoi E, 2009, ANN NY ACAD SCI, V1173, pE20, DOI 10.1111/j.1749-6632.2009.05061.x; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Karsenty G, 2001, Adv Nephrol Necker Hosp, V31, P119; Karsenty G, 2012, ANNU REV PHYSIOL, V74, P87, DOI 10.1146/annurev-physiol-020911-153233; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kerimoglu G, 2013, EKLEM HAST CERRAHISI, V24, P102, DOI 10.5606/ehc.2013.23; Khan SN, 2013, J ORTHOP TRAUMA, V27, P656, DOI 10.1097/BOT.0b013e3182847968; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lombardi G, 2015, ENDOCRINE, V48, P394, DOI 10.1007/s12020-014-0401-0; Peters A, 2004, NEUROSCI BIOBEHAV R, V28, P143, DOI 10.1016/j.neubiorev.2004.03.002; Peters A, 2011, AM J HUM BIOL, V23, P29, DOI 10.1002/ajhb.21106; Seemann R, 2018, J MUSCULOSKEL NEURON, V18, P32; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Takeda S, 2001, J BONE MINER METAB, V19, P195, DOI 10.1007/s007740170042; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Turner RT, 2013, J BONE MINER RES, V28, P22, DOI 10.1002/jbmr.1734; Wang L, 2011, J SPINAL CORD MED, V34, P501, DOI 10.1179/2045772311Y.0000000034; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Yadav VK, 2009, AGING-US, V1, P954, DOI 10.18632/aging.100100	43	1	1	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2020	21	23							9144	10.3390/ijms21239144			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	PD9QL	WOS:000598010100001	33266324	Green Published, gold			2022-02-06	
J	Ge, JB; Chen, DD; Ben, JJ; Song, XJ; Zou, LQ; Yi, X				Ge, Jianbin; Chen, Dandan; Ben, Jingjing; Song, Xinjian; Zou, Linqing; Yi, Xin			EFFECT OF MELATONIN ON REGENERATION OF CORTICAL NEURONS IN RATS WITH TRAUMATIC BRAIN INJURY	CLINICAL AND INVESTIGATIVE MEDICINE			English	Article							OXIDATIVE STRESS; NEONATAL-RAT; BLOOD-FLOW; NEUROPROTECTION; ISCHEMIA; CORTEX; DAMAGE; CELLS; ACTIVATION; APOPTOSIS	Purpose: To investigate the effect of melatonin on regeneration of cortical neurons in rats with traumatic brain injury (TBI). Methods: Sprague-Dawley rats (n=36) were randomly divided into sham, TBI+vehicle and TBI+melatonin groups. Cerebral blood flow and cognitive function were observed via laser Doppler flowmetry and by Morris water maze testing, respectively. The serum matondiatdehyde (MDA) and superoxide dismutase (SOD) levels were used to assess oxidative stress. Immunofluorescence and terminal deoxynucteotidyt transferase dUTP nick end labelling assay was used to observe the newborn neurons and apoptotic cells. Results: Cerebral blood flow in the TBI+melatonin group was higher than that of the TBI+vehicle group at one, 12, 24 and 48 h post-injury, but the difference was not statistically significant (P>0.05). The cognitive function of the rats was better in the TBI+metatonin group than the TBI+vehicle group (P<0.05). The MDA and SOD Levels were better in the TBI+melatonin group than the TBI+vehicle group (P<0.05) and it was similar to the sham group at 14 d (P>0.05). The number of apoptotic cells was lower in the TBI+melatonin group than the TBI+vehicle group (P<0.05). The number of DCX+/BrdU+ immature newborn neurons and NeuN+/BrdU+ mature newborn neurons was higher in the TBI+melatonin group than the TBI+vehicle group (P<0.05). Conclusion: These results indicated that melatonin reduced oxidative stress level and cells apoptosis of brain and promoted the regeneration of neurons in the cortex of rats with TBI, leading to improve cognitive functional recovery.	[Ge, Jianbin; Chen, Dandan; Ben, Jingjing] Second Peoples Hosp Nantong, Dept Pharm, Nantong, Peoples R China; [Song, Xinjian] Second Peoples Hosp Nantong, Dept Rehabil Med, Nantong, Peoples R China; [Zou, Linqing; Yi, Xin] Nantong Univ, Med Coll, Dept Human Anat, Nantong, Peoples R China		Yi, X (corresponding author), Nantong Univ, Med Coll, Dept Human Anat, Nantong, Peoples R China.	ntuyixin@foxmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801301]; Key Talents Project for Youth Medicine in Jiangsu Province [QNRC2016397]; Jiangsu Pharmaceutical Association-Aosaikang Clinical Pharmacy Fund [A201819]	This work was supported by National Natural Science Foundation of China (No. 81801301), the Key Talents Project for Youth Medicine in Jiangsu Province (QNRC2016397), and the Jiangsu Pharmaceutical Association-Aosaikang Clinical Pharmacy Fund (A201819).	Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Balduini W, 2012, J MATERN-FETAL NEO M, V25, P119, DOI 10.3109/14767058.2012.663232; Barlow KM, 2019, J NEUROTRAUM, V36, P523, DOI 10.1089/neu.2018.5752; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bellon A, 2007, J PINEAL RES, V42, P214, DOI 10.1111/j.1600-079X.2006.00408.x; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Benitez-King G, 2006, J PINEAL RES, V40, P1, DOI 10.1111/j.1600-079X.2005.00282.x; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Cardinali DP, 2012, J PINEAL RES, V52, P365, DOI 10.1111/j.1600-079X.2011.00962.x; Carloni S, 2008, J PINEAL RES, V44, P157, DOI 10.1111/j.1600-079X.2007.00503.x; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Doolen S, 1998, EUR J PHARMACOL, V345, P67, DOI 10.1016/S0014-2999(98)00064-8; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; GATOO MA, 2014, THESCIENTIFICWORLDJO, V2014, DOI DOI 10.1155/2014/586270; Gitto E, 2009, J PINEAL RES, V46, P128, DOI 10.1111/j.1600-079X.2008.00649.x; Gressens P, 2008, EUR J PHARMACOL, V588, P58, DOI 10.1016/j.ejphar.2008.04.016; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hilario E, 2005, ACTA PAEDIATR, V94, P903, DOI 10.1080/08035250510031151; Ikeda T, 2005, AM J OBSTET GYNECOL, V193, P849, DOI 10.1016/j.ajog.2005.01.029; Khalatbary AR, 2010, BRAIN RES, V1306, P168, DOI 10.1016/j.brainres.2009.09.109; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; McCarty MF, 2012, MED HYPOTHESES, V78, P45, DOI 10.1016/j.mehy.2011.09.039; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Osier N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051539; Otero L, 2012, HISTOL HISTOPATHOL, V27, P303, DOI 10.14670/HH-27.303; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rosen J, 2006, J PINEAL RES, V41, P374, DOI 10.1111/j.1600-079X.2006.00379.x; Salman M, 2021, CELL MOL NEUROBIOL, V41, P765, DOI 10.1007/s10571-020-00884-5; Santoro R, 2012, ONCOGENE, V31, P2931, DOI 10.1038/onc.2011.469; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tarocco A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1556-7; Tian HL, 2019, JOVE-J VIS EXP, DOI 10.3791/60055; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Ugoya SO, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/141624; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306	45	1	1	3	7	CANADIAN SOC CLINICAL INVESTIGATION	OTTAWA	114 CHEYENNE WAY, OTTAWA, ON K2J 0E9, CANADA	0147-958X	1488-2353		CLIN INVEST MED	Clin. Invest. Med.	DEC	2020	43	4					E8	E16		10.25011/cim.v43i4.34829			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	PN3PJ	WOS:000604394100002	33370520	Bronze			2022-02-06	
J	Ghawami, H; Jazayeri, SB; Nowsud, AS; Sharif-Alhoseini, M; Shirvani, A; Kheyri, M; Zadegan, SA; Noorian, N; Mohammadian, F; Yarandi, KK; Azad, A; Rezaeitalab, F; Barekatain, M; Bakhtiyari, J; Moradi, A; Khatoonabadi, AR; Haghgoo, HA; Gheini, MR; Khadivi, M; Jouibari, MF; Kashani, HRK; Mirzaasgari, Z; Meshkini, A; Haghshenas, H; Samini, F; Mohit, P; Akbarfahimi, M; Alimohammadi, Y; Payandemehr, P; Ahranjani, JA; Arabkheradmand, J; Vahabi, Z; Arbabi, M; Kermanpour, H; Ghandehari, K; Bakhshani, NM; Pirooz, FM; Ghaedi, G; Dolatshahi, B; Tavakoli, SF; Vosough, I; Amirjamshidi, A; Hatami, J; Rahimi-Movaghar, V				Ghawami, Heshmatollah; Jazayeri, Seyed Behnam; Nowsud, Azad Sabeti; Sharif-Alhoseini, Mahdi; Shirvani, Armin; Kheyri, Maryam; Zadegan, Shayan Abdollah; Noorian, Nahid; Mohammadian, Fatemeh; Yarandi, Kourosh Karimi; Azad, Akram; Rezaeitalab, Fariborz; Barekatain, Majid; Bakhtiyari, Jalal; Moradi, Alireza; Khatoonabadi, Ahmad Reza; Haghgoo, Hojjat Allah; Gheini, Mohammad Reza; Khadivi, Masoud; Jouibari, Morteza Faghih; Kashani, Hamid Reza Khayat; Mirzaasgari, Zahra; Meshkini, Ali; Haghshenas, Hassan; Samini, Fariborz; Mohit, Parviz; Akbarfahimi, Malahat; Alimohammadi, Yadollah; Payandemehr, Pooya; Ahranjani, Jalal Abbaszadeh; Arabkheradmand, Jalil; Vahabi, Zahra; Arbabi, Mohammad; Kermanpour, Hossein; Ghandehari, Kavian; Bakhshani, Nour-Mohammad; Pirooz, Farhad Motlagh; Ghaedi, Gholamhossein; Dolatshahi, Behrooz; Tavakoli, Seyed Fakhredin; Vosough, Iraj; Amirjamshidi, Abbas; Hatami, Javad; Rahimi-Movaghar, Vafa			National Guidelines for Cognitive Assessment and Rehabilitation of Iranian Traumatic Brain Injury Patients	ARCHIVES OF IRANIAN MEDICINE			English	Article						Cognitive rehabilitation; Guideline; Neuropsychology; Practice guideline; traumatic brain injury	OF-THE-LITERATURE; INCOG RECOMMENDATIONS; MANAGEMENT	Background: Individuals with moderate to severe traumatic brain injury (TBI) often have prolonged cognitive impairments, resulting in long-term problems with their real-life activities. Given the urgent need for evidence-based recommendations (or neuropsychological management of Iranian TB1 patients, the current work aimed to adapt eligible international guidelines for cognitive assessment and rehabilitation of the TBI patients in Iran. Methods: The project was led by an executive committee, under the supervision of the Iranian Ministry of Health and Medical Education (MOHME). Following a systematic literature search and selection process, four guidelines were included for adaptation. Clinical recommendations of the source guidelines were tabulated as possible clinical scenarios for 90 PICO clinical questions covering all relevant phases of care. After summing up the scenarios, our initial list of recommendations was drafted according to the Iranian patients' conditions. The final decision-making, with the contribution of a national interdisciplinary panel of 37 experts from across the country, was conducted in two rounds using online and offline survey forms (Round 1), and face-to-face and telephone meetings (Round 2). Results: A total of 63 recommendations in six sections were included in the final list of recommendations, among which 21 were considered as key recommendations. In addition, some of the recommendations were identified as fundamental, meaning that proper implementation of the other recommendations is largely dependent on their implementation. Conclusion: Iranian health policy makers and rehabilitation program managers are recommended to address some fundamental issues to provide the necessary infrastructure to set up an efficient cognitive rehabilitation service system.	[Ghawami, Heshmatollah; Nowsud, Azad Sabeti] Univ Tehran Med Sci, Neuropsychol Div, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Jazayeri, Seyed Behnam] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Jazayeri, Seyed Behnam; Sharif-Alhoseini, Mahdi; Zadegan, Shayan Abdollah; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Dept Neurotrauma, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Shirvani, Armin] Natl Agcy Strateg Res Med Educ NASR, Tehran, Iran; [Kheyri, Maryam] Iranian Minist Hlth & Med Educ MOHME, Clin Guideline Dev & Standardizat Grp, Off Hlth Technol Assessment Standardizat & Tariff, Deputy Curat Affairs, Tehran, Iran; [Noorian, Nahid] Shahid Rajaee Univ SRTTU, Dept Psychol, Tehran, Iran; [Mohammadian, Fatemeh] Univ Tehran Med Sci, Roozbeh Hosp, Dept Neurol, Tehran, Iran; [Yarandi, Kourosh Karimi; Amirjamshidi, Abbas] Univ Tehran Med Sci, Sina Hosp, Dept Neurosurg, Tehran, Iran; [Azad, Akram; Akbarfahimi, Malahat] Iran Univ Med Sci, Sch Rehabil Sci, Dept Occupat Therapy, Rehabil Res Ctr, Tehran, Iran; [Rezaeitalab, Fariborz; Ghandehari, Kavian] Mashhad Univ Med Sci, Sch Med, Dept Neurol, Mashhad, Razavi Khorasan, Iran; [Barekatain, Majid] Isfahan Univ Med Sci, Sch Med, Dept Psychiat, Esfahan, Iran; [Bakhtiyari, Jalal] Semnan Univ Med Sci, Sch Rehabil Sci, Neuromuscular Rehabil Res Ctr, Dept Speech Therapy, Semnan, Iran; [Moradi, Alireza] Kharazmi Univ, Dept Clin Psychol, Tehran, Iran; [Moradi, Alireza] Inst Cognit Sci Studies, Dept Cognit Psychol, Tehran, Iran; [Khatoonabadi, Ahmad Reza] Univ Tehran Med Sci, Sch Rehabil, Dept Speech Therapy, Tehran, Iran; [Haghgoo, Hojjat Allah] Univ Social Welf & Rehabil Sci, Sch Rehabil Sci, Dept Occupat Therapy, Tehran, Iran; [Gheini, Mohammad Reza] Univ Tehran Med Sci, Sina Hosp, Dept Neurol, Tehran, Iran; [Khadivi, Masoud; Jouibari, Morteza Faghih; Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Shariati Hosp, Dept Neurosurg, Tehran, Iran; [Kashani, Hamid Reza Khayat] Shahid Beheshti Univ Med Sci, Dept Neurosurg, Tehran, Iran; [Mirzaasgari, Zahra] Iran Univ Med Sci, Firoozgar Hosp, Neurol Dept, Tehran, Iran; [Meshkini, Ali] Tabriz Univ Med Sci, Dept Neurosurg, Rd Traff Injury Res Ctr, Tabriz, Iran; [Haghshenas, Hassan] Shiraz Univ Med Sci, Dept Psychiat, Shiraz, Iran; [Samini, Fariborz] Mashhad Univ Med Sci, Dept Neurosurg, Fac Med, Mashhad, Razavi Khorasan, Iran; [Mohit, Parviz] Mazandaran Univ Med Sci, Dept Neurosurg, Sari, Iran; [Alimohammadi, Yadollah] Bahman Hosp, Neurosurg Unit, Tehran, Iran; [Payandemehr, Pooya] Univ Tehran Med Sci, Sina Hosp, Dept Emergency Med, Tehran, Iran; [Ahranjani, Jalal Abbaszadeh] Urmia Univ Med Sci, Dept Neurosurg, Orumiyeh, Iran; [Arabkheradmand, Jalil] Ahya Neurosci Res Ctr, Tehran, Iran; [Vahabi, Zahra] Univ Tehran Med Sci, Roozbeh Hosp, Memory & Behav Neurol Div, Tehran, Iran; [Arbabi, Mohammad] Univ Tehran Med Sci, Psychosomat Med Res Ctr, Dept Psychiat, Tehran, Iran; [Kermanpour, Hossein] Univ Tehran Med Sci, Sina Hosp, Emergency Dept, Tehran, Iran; [Bakhshani, Nour-Mohammad] Zahedan Univ Med Sci, Dept Psychol, Zahedan, Iran; [Pirooz, Farhad Motlagh; Tavakoli, Seyed Fakhredin] Islamic Azad Univ, Med Branch, Dept Neurosurg, Mashhad, Razavi Khorasan, Iran; [Ghaedi, Gholamhossein] Shahed Univ, Neurophysiol Res Ctr, Dept Psychiat, Tehran, Iran; [Dolatshahi, Behrooz] Univ Social Welf & Rehabil Sci, Sch Behav Sci, Dept Psychol, Tehran, Iran; [Tavakoli, Seyed Fakhredin] Farabi Hosp, Social Secur Org, Mashhad, Razavi Khorasan, Iran; [Vosough, Iraj] Razavi Hosp, Res & Educ Dept, Mashhad, Razavi Khorasan, Iran; [Hatami, Javad] Univ Tehran, Dept Psychol, Tehran, Iran; [Rahimi-Movaghar, Vafa] Univ Tehran, Res Ctr Neural Repair, Tehran, Iran		Hatami, J (corresponding author), Univ Tehran, Dept Psychol, Tehran, Iran.; Rahimi-Movaghar, V (corresponding author), Univ Tehran Med Sci, Sina Gen Hosp, Sina Trauma & Surg Res Ctr, Hassan Abad Sq,Imam Khomeini St, Tehran 113653876, Iran.	hatamijm@ut.ac.ir; v_rahimi@sina.tums.ac.ir	Mohammadian, Fatemeh/AAZ-9490-2021; Bakhtiyari, Jalal/ABB-1076-2021; Arbabi, Mohammad/AAT-7558-2021; Payandemehr, Pooya/J-9588-2017; Akbarfahimi, Malahat/M-2355-2018; Mirzaasgari, Zahra/ABD-1347-2021; Mirzaasgari, Zahra/ABC-5413-2021; Hatami, Javad/L-4750-2019; Haghgoo, Hojjat/AAD-7124-2021; Bakhshani, Nour Mohammad/L-5109-2017; bakhtiyari, Jalal/L-5537-2017; Moradi, Alireza/K-8652-2017; Zadegan, Shayan/AAU-9866-2020; Rahimi-Movaghar, Vafa/T-7816-2017	Payandemehr, Pooya/0000-0003-3556-4052; Mirzaasgari, Zahra/0000-0002-4046-8471; bakhtiyari, Jalal/0000-0002-8789-5737; Moradi, Alireza/0000-0001-5351-6017; Zadegan, Shayan/0000-0002-6517-0567; Rahimi-Movaghar, Vafa/0000-0001-7347-8767; shirvani, armin/0000-0001-9048-8289; Ghawami, Heshmatollah/0000-0002-9801-881X	Cognitive Science and Technologies Council (CSTC), Iran's Vice-Presidency for Science and Technology	This research was supported by Cognitive Science and Technologies Council (CSTC), Iran's Vice-Presidency for Science and Technology. The project was conducted in the Neuropsychology Division, Sina Trauma and Surgery Research Center (STSRC), Tehran University of Medical Sciences (TUMS). The methodology was designed and supervised by Clinical Guideline Development and Standardization Group; Office of Health Technology Assessment, Standardization and Tariffs; Deputy for Curative Affairs; Iranian Ministry of Health and Medical Education (MOHME). The final report of the project has been approved by the council. We would like to thank Dr. Keith Cicerone and Dr. Mark Bayley for their helpful information.	Alshafai N, 2019, OXFORD TXB NEUROLOGI, P475; Baruch Y, 2008, HUM RELAT, V61, P1139, DOI 10.1177/0018726708094863; Bayley MT, 2018, J HEAD TRAUMA REHAB, V33, P296, DOI 10.1097/HTR.0000000000000428; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P268, DOI 10.1097/HTR.0000000000000053; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bhalla K, 2011, ROAD INJURIES 18 COU; Bragge P, 2010, INJURY, V41, P3, DOI 10.1016/j.injury.2010.04.016; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Field MJ, 1990, CLIN PRACTICE GUIDEL; Ghawami H, 2015, CLIN NEUROPSYCHOLOGY; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Guidelines International Network, 2009, ADAPTE RES TOOLK GUI; INESSS & ONF, 2016, CLIN PRACT GUID REH; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; KATZ DI, 2006, COGNITIVE REHABILITA; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Scottish Intercollegiate Guidelines Network (SIGN), 2013, SIGN PUBL, V130; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; World Health Organization, 2009, GLOB STAT REP ROAD S; Yazdani S, 2015, CLIN PRACTICE GUIDEL; Zadegan SA, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.28012	32	1	1	0	2	ACAD MEDICAL SCIENCES I R IRAN	TEHRAN	PO BOX 19395-5655, TEHRAN, 00000, IRAN	1029-2977	1735-3947		ARCH IRAN MED	Arch. Iran. Med.	DEC	2020	23	12					813	820		10.34172/aim.2020.108			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PI5YI	WOS:000601165700001	33356338	hybrid			2022-02-06	
J	Ghods, M; Faiz, J				Ghods, Mehrage; Faiz, Jawad			Permanent magnet vernier generator under dynamic eccentricity fault: diagnosis and detection	IET ELECTRIC POWER APPLICATIONS			English	Article						machine windings; finite element analysis; rotors; air gaps; stators; fault diagnosis; permanent magnet generators; healthy machines; mechanical faults; static eccentricity; healthy generator; dynamic eccentricity fault diagnosis; PMVG; power concussion requirements; traffic enforcement cameras; traffic-driven applications; permanent magnet Vernier generator; dynamic eccentricity fault detection; inclined rotor; run-out faults; analytical model; air-gap permeance estimation; induced voltages; two-dimensional time stepping finite-element method; three-dimensional time stepping finite-element method; stator current spectrum; side-band components; specific frequency pattern	MOTORS; ROTOR	Permanent magnet vernier generators (PMVGs) are suitable for meeting power concussion requirements of traffic enforcement cameras and traffic-driven applications. In this study, the performance of PMVGs at no-load and full-load are analysed in healthy machines and machines under different types of mechanical faults including static eccentricity, dynamic eccentricity, inclined rotor, and run-out faults. Furthermore, an analytical model is developed to estimate the air-gap permeance and the induced voltages in the healthy generator and generator under the above-mentioned mechanical faults. Then, the performance of the generator is predicted using a two-dimensional and three-dimensional time stepping finite-element method. Finally, from the stator current spectrum of the PMVG under dynamic eccentricity fault, the amplitude of the side-band components with a specific frequency pattern is extracted and compared with experimental results.	[Ghods, Mehrage; Faiz, Jawad] Univ Tehran, Coll Engn, Ctr Excellence Appl Electromagnet Syst, Sch Elect & Comp Engn, Tehran 1439957131, Iran		Faiz, J (corresponding author), Univ Tehran, Coll Engn, Ctr Excellence Appl Electromagnet Syst, Sch Elect & Comp Engn, Tehran 1439957131, Iran.	jfaiz@ut.ac.ir					Ebrahimi BM, 2010, IET ELECTR POWER APP, V4, P53, DOI 10.1049/iet-epa.2008.0308; Ebrahimi BM, 2009, IEEE T IND ELECTRON, V56, P4727, DOI 10.1109/TIE.2009.2029577; Faiz J., 2019, IET ELECTR POWER APP, V40, P1235; Georgoulas G, 2017, IEEE T IND INFORM, V13, P625, DOI 10.1109/TII.2016.2637169; Ghods M, 2018, IEEE T ENERGY CONVER, V33, P1213, DOI 10.1109/TEC.2018.2803058; Ghods M., 2018, 26 IR C EL ENG ICEE; Goktas T, 2016, IEEE T ENERGY CONVER, V31, P585, DOI 10.1109/TEC.2015.2512602; Haddad RZ, 2016, IEEE T ENERGY CONVER, V31, P924, DOI 10.1109/TEC.2016.2558183; Li DW, 2016, IEEE T IND APPL, V52, P125, DOI 10.1109/TIA.2015.2464173; Lv G, 2016, IET ELECTR POWER APP, V10, P1, DOI 10.1049/iet-epa.2014.0441; Mirimani SM, 2012, IEEE T MAGN, V48, P143, DOI 10.1109/TMAG.2011.2161876; Mirzaeva G, 2018, IEEE T IND APPL, V54, P2981, DOI 10.1109/TIA.2018.2805730; Nasiri-Gheidari Z, 2017, IEEE T ENERGY CONVER, V32, P1376, DOI 10.1109/TEC.2017.2718555; Nasiri-Gheidari Z, 2015, IEEE SENS J, V15, P4027, DOI 10.1109/JSEN.2015.2409199; Nasiri-Gheidari Z, 2013, IET ELECTR POWER APP, V7, P47, DOI 10.1049/iet-epa.2012.0131; Oraee, 2018, INT J IND ELECT CONT, V1, P121, DOI DOI 10.22111/IECO.2018.25203.1041; Rajagopalan S., 2004, P 2 INT C POW EL MAC; Xu L, 2015, IEEE T ENERGY CONVER, V30, P1483, DOI 10.1109/TEC.2015.2434931	18	1	1	2	8	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-8660	1751-8679		IET ELECTR POWER APP	IET Electr. Power Appl.	DEC	2020	14	12					2490	2498		10.1049/iet-epa.2020.0435			9	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PA7HE	WOS:000595801000025		Bronze			2022-02-06	
J	Islam, S; Shah, V; Gidde, STR; Hutapea, P; Song, SH; Picone, J; Kim, A				Islam, S.; Shah, V.; Gidde, S. T. R.; Hutapea, P.; Song, S. H.; Picone, J.; Kim, A.			A Machine Learning Enabled Wireless Intracranial Brain Deformation Sensing System	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Magnetic tunneling; Soft magnetic materials; Strain; Sensors; Brain modeling; Magnetic field measurement; Calibration; Traumatic brain injury; brain deformation measurement; magnetic field measurement; magnetic sensors; machine learning	MODELS; INJURY; TISSUE	A leading cause of traumatic brain injury (TBI) is intracranial brain deformation due to mechanical impact. This deformation is viscoelastic and differs from a traditional rigid transformation. In this paper, we describe a machine learning enabled wireless sensing system that predicts the trajectory of intracranial brain deformation. The sensing system consists of an implantable soft magnet and an external magnetic sensor array with a sensing volume of 12 x 12 x 4 mm(3). Machine learning algorithm predicts the brain deformation by interpreting the magnetic sensor outputs created by the change in position of the implanted soft magnet. Three different machine learning models were trained on calibration data: (1) random forests, (2) k-nearest neighbors, and (3) a multi-layer perceptron-based neural network. These models were validated using both in vitro (a needle inserted into PVC gel) and in vivo (blast exposure to live and dead rat brains) experiments. The in vitro gel deformation predicted by these machine learning models showed excellent agreement with the camera measurements and had absolute error = 138 mu m, Frechet distance = 372 mu m with normalized Procrustes disparity = 0.034. The in vivo brain deformation predicted by these models had absolute error = 50 mu m, Frechet distance = 95 mu m with normalized Procrustes disparity = 0.055 for dead animal and absolute error = 125 mu m, Frechet distance = 289 mu m with normalized Procrustes disparity = 0.2 for live animal respectively. These results suggest that the proposed machine learning enabled sensor system can be an effective tool for measuring in situ brain deformation.	[Islam, S.; Shah, V.; Picone, J.; Kim, A.] Temple Univ, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA; [Gidde, S. T. R.; Hutapea, P.] Temple Univ, Dept Mech Engn, Philadelphia, PA 19122 USA; [Song, S. H.] Sookmyung Womens Univ, Dept Elect Engn, Seoul, South Korea		Kim, A (corresponding author), Temple Univ, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA.	sayemul@temple.edu; vinitshah@temple.edu; tuh27079@temple.edu; hutapea@temple.edu; shsong.ee@sookmyung.ac.kr; picone@temple.edu; albertkim@temple.edu	Hutapea, Parsaoran/AAA-5196-2022; Islam, Sayemul/AAM-9958-2020; Kim, Albert/Q-9686-2017	Hutapea, Parsaoran/0000-0001-6917-1252; Islam, Sayemul/0000-0001-6062-1974; Shah, Vinit/0000-0001-5193-0206; Gidde, Sai Teja Reddy/0000-0003-3153-3902; Kim, Albert/0000-0003-1539-1246	Temple University	This work is supported by A. Kim's start-up fund provided by Temple University	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Alshareef A, 2020, BIOMED SIGNAL PROCES, V56, DOI 10.1016/j.bspc.2019.101691; [Anonymous], 2008, INVISIBLE WOUNDS WAR; Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Bear M. F., 2007, NEUROSCIENCE EXPLORI, P168; Belogay E, 1997, INFORM PROCESS LETT, V64, P17, DOI 10.1016/S0020-0190(97)00140-3; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Budday S., 2015, J MECH BEHAV BIOMED, V176, P139; Cardoso S, 2014, MICROSYST TECHNOL, V20, P793, DOI 10.1007/s00542-013-2035-1; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chamanzar A, 2019, I IEEE EMBS C NEUR E, P1155, DOI 10.1109/NER.2019.8717188; Chamanzar A, 2019, IEEE T BIO-MED ENG, V66, P1115, DOI 10.1109/TBME.2018.2867112; Chandrasekhar A., 2018, SCI REP, V8, P18; Chandrasekhar A., 2019, FRONT PHYSIOL, V10, P1; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chomboon K., 2015, P 3 INT C IND APPL E, P280, DOI [10.12792/iciae2015.051, DOI 10.12792/ICIAE2015.051]; Dvir H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar6277; Eiter T., 1994, CD TR, P64; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Galarneau M. R., 2008, J NEUROSURG; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Hajizadegan M, 2019, IEEE T ANTENN PROPAG, V67, P3445, DOI 10.1109/TAP.2019.2905892; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; HILL T, 1994, INT J FORECASTING, V10, P5, DOI 10.1016/0169-2070(94)90045-0; Hofmeijer J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00017; Jiang HJ, 2018, IEEE T BIOMED CIRC S, V12, P1076, DOI 10.1109/TBCAS.2018.2845462; Khomutov SY, 2017, GEOSCI INSTRUM METH, V6, P329, DOI 10.5194/gi-6-329-2017; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Lek S., 2013, ARTIFICIAL NEURAL NE, P139; Li CZ, 2018, IEEE J EM SEL TOP C, V8, P165, DOI 10.1109/JETCAS.2018.2822684; Li WS, 2015, PROCEDIA MANUF, V1, P866, DOI 10.1016/j.promfg.2015.09.078; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mahalanobis PC., 1936, P NATL I SCI INDIA, V2, P49; Micro Magnetics, 2006, MICR MAGN TUNN JUNCT; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Mukkamala R, 2015, IEEE T BIO-MED ENG, V62, P1879, DOI 10.1109/TBME.2015.2441951; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Roy MH, 2012, J NONPARAMETR STAT, V24, P993, DOI 10.1080/10485252.2012.715161; Rueckert D, 2003, IEEE T MED IMAGING, V22, P1014, DOI 10.1109/TMI.2003.815865; Schiavone P, 2009, MED IMAGE ANAL, V13, P673, DOI 10.1016/j.media.2009.04.001; Shiliang Sun, 2010, Proceedings of the 2010 Seventh International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2010), P91, DOI 10.1109/FSKD.2010.5569740; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Song S., 2015, SCI REP, V18, P141; Stutzke NA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1861375; Tallinen T, 2014, P NATL ACAD SCI USA, V111, P12667, DOI 10.1073/pnas.1406015111; Tanielian T. L., 2008, INVISIBLEWOUNDS OFWA; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tonutti M, 2017, ARTIF INTELL MED, V80, P39, DOI 10.1016/j.artmed.2017.07.004; Tseng JG, 2016, BIOENGINEERED, V7, P219, DOI 10.1080/21655979.2016.1197591; Van Rossum G., 1995, CSR9524 CWI; Vigneron LM, 2010, J COMPUT APPL MATH, V234, P2046, DOI 10.1016/j.cam.2009.08.062; Voo L, 1996, MED BIOL ENG COMPUT, V34, P375, DOI 10.1007/BF02520009; Yang X, 2019, IEEE T IND INFORM, V15, P3040, DOI 10.1109/TII.2019.2891738; Yang XD, 2018, IEEE J BIOMED HEALTH, V22, P1863, DOI 10.1109/JBHI.2017.2787595; Zhang L., 2018, SAE TECHNICAL PAPER	60	1	1	3	11	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	DEC	2020	67	12					3521	3530		10.1109/TBME.2020.2990071			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	OU9BZ	WOS:000591819700024	32340930				2022-02-06	
J	Kang, DH; Kim, GW				Kang, Dong-Ha; Kim, Gi-Wook			Changes in Diffuse Tensor Imaging and Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation in Traumatic Brain Injury with Central Pain	BRAIN SCIENCES			English	Article						traumatic brain injury; neuropathic pain; therapeutics; diagnosis	CENTRAL POSTSTROKE PAIN; MOTOR CORTEX RTMS; NEUROPATHIC PAIN; SPINOTHALAMIC TRACT; GRADING SYSTEM; PATHWAY	Post-trauma chronic pain characterized by central pain is a symptom following traumatic brain injury (TBI). Studies on the effect of repetitive transcranial magnetic stimulation (rTMS) on central pain and the association between central pain and spinothalamic tract (STT) have been reported, but few studies have examined the effect of rTMS in patients with mild TBI with central pain through changes in diffusion tensor imaging (DTI)-based metrics of STT before and after rTMS. This case series aimed to investigate the therapeutic effect of rTMS in TBI with central pain and the changes in diffusion tensor imaging (DTI)-based metrics of the spinothalamic tract (STT) before and after rTMS. This study included four patients who complained of severe pain in the left or right side of the body below the neck area after a car accident. We performed numeric rating scale (NRS), bedside sensory examination, electrodiagnostic study, and DTI-based metrics of the STT before and after rTMS. According to the guidelines of the diagnosis and grading for neuropathic pain, all patients had neuropathic pain corresponding to "probable grade." In all patients, rTMS was applied to the contralateral M1 cortex on the more painful side. There were no medication changes and other interventions during the rTMS. After rTMS, NRS decreased, bed sensory testing improved, and DTI-based STT metrics increased in all patients compared to before rTMS.	[Kang, Dong-Ha; Kim, Gi-Wook] Jeonbuk Natl Univ, Med Sch, Dept Phys Med & Rehabil, Jeonju 54907, South Korea; [Kang, Dong-Ha; Kim, Gi-Wook] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Biomed Res Inst, Res Inst Clin Med, Jeonju 54907, South Korea		Kim, GW (corresponding author), Jeonbuk Natl Univ, Med Sch, Dept Phys Med & Rehabil, Jeonju 54907, South Korea.; Kim, GW (corresponding author), Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Biomed Res Inst, Res Inst Clin Med, Jeonju 54907, South Korea.	fanta0915@gmail.com; k26@jbnu.ac.kr		Kim, Gi-Wook/0000-0002-1628-8382	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2019R1I1A3A01061885]	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1I1A3A01061885).	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Attal N, 2006, EUR J NEUROL, V13, P1153, DOI 10.1111/j.1468-1331.2006.01511.x; Bowsher D, 1996, J NEUROL NEUROSUR PS, V61, P62, DOI 10.1136/jnnp.61.1.62; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HOLMGREN H, 1990, PAIN, V40, P43, DOI 10.1016/0304-3959(90)91049-O; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Jang SH, 2017, NEURAL REGEN RES, V12, P2021, DOI 10.4103/1673-5374.221159; Jang SH, 2016, BRAIN INJURY, V30, P933, DOI 10.3109/02699052.2016.1146966; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Johnson S, 2006, PAIN, V123, P187, DOI 10.1016/j.pain.2006.02.030; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Kim JS, 2014, CNS DRUGS, V28, P787, DOI 10.1007/s40263-014-0194-y; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Lefaucheur JP, 2008, J NEUROL NEUROSUR PS, V79, P1044, DOI 10.1136/jnnp.2007.135327; Lefaucheur JP, 2020, CLIN NEUROPHYSIOL, V131, P474, DOI 10.1016/j.clinph.2019.11.002; Lefaucheur JP, 2010, CLIN NEUROPHYSIOL, V121, P895, DOI 10.1016/j.clinph.2009.12.028; Leung A, 2009, J PAIN, V10, P1205, DOI 10.1016/j.jpain.2009.03.010; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Pagani E, 2008, NEUROIMAGE, V41, P657, DOI 10.1016/j.neuroimage.2008.03.021; Platz T., 2015, THERAPEUTIC RTMS NEU; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Son BC, 2006, PAIN, V123, P210, DOI 10.1016/j.pain.2006.02.028; Suzuki R, 2005, NEUROSIGNALS, V14, P175, DOI 10.1159/000087656; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59	32	1	1	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2020	10	12							929	10.3390/brainsci10120929			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PJ6WF	WOS:000601904500001	33276440	Green Published, gold			2022-02-06	
J	Kim, HK; Lee, DW; Kim, E; Jeong, I; Kim, S; Kim, BJ; Park, HC				Kim, Hwan-Ki; Lee, Dong-Won; Kim, Eunmi; Jeong, Inyoung; Kim, Suhyun; Kim, Bum-Joon; Park, Hae-Chul			Notch Signaling Controls Oligodendrocyte Regeneration in the Injured Telencephalon of Adult Zebrafish	EXPERIMENTAL NEUROBIOLOGY			English	Article						Neural stem cells; Oligodendroglia; Regeneration; Telencephalon; Wounds and injuries; Zebrafish	NEURAL STEM-CELLS; SPINAL-CORD; PROGENITOR CELLS; RADIAL GLIA; BRAIN; NEUROGENESIS; MODEL; SPECIFICATION; HETEROGENEITY; RECRUITMENT	The myelination of axons in the vertebrate nervous system through oligodendrocytes promotes efficient axonal conduction, which is required for the normal function of neurons. The central nervous system (CNS) can regenerate damaged myelin sheaths through the process of remyelination, but the failure of remyelination causes neurological disorders such as multiple sclerosis. In mammals, parenchymal oligodendrocyte progenitor cells (OPCs) are known to be the principal cell type responsible for remyelination in demyelinating diseases and traumatic injuries to the adult CNS. However, growing evidence suggests that neural stem cells (NSCs) are implicated in remyelination in animal models of demyelination. We have previously shown that olig2(+) radial glia (RG) have the potential to function as NSCs to produce oligodendrocytes in adult zebrafish. In this study, we developed a zebrafish model of adult telencephalic injury to investigate cellular and molecular mechanisms underlying the regeneration of oligodendrocytes. Using this model, we showed that telencephalic injury induced the proliferation of olig2(+) RG and parenchymal OPCs shortly after injury, which was followed by the regeneration of new oligodendrocytes in the adult zebrafish. We also showed that blocking Notch signaling promoted the proliferation of olig2(+) RG and OPCs in the normal and injured telencephalon of adult zebrafish. Taken together, our data suggest that Notch-regulated proliferation of olig2(+) RG and parenchymal OPCs is responsible for the regeneration of oligodendrocytes in the injured telencephalon of adult zebrafish.	[Kim, Hwan-Ki; Lee, Dong-Won; Kim, Eunmi; Jeong, Inyoung; Kim, Suhyun; Park, Hae-Chul] Korea Univ, Coll Med, Dept Biomed Sci, Ansan 15355, South Korea; [Kim, Bum-Joon] Korea Univ, Ansan Hosp, Dept Neurosurg, Ansan 15355, South Korea		Kim, S; Park, HC (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Ansan 15355, South Korea.; Kim, BJ (corresponding author), Korea Univ, Ansan Hosp, Dept Neurosurg, Ansan 15355, South Korea.	dieslunae@naver.com; nsbjkim@korea.ac.kr; hcpark67@korea.ac.kr	Kim, Bum-Joon/AAU-1680-2021	Kim, Bum-Joon/0000-0002-3701-4030; Lee, Dong-Won/0000-0003-0989-0807; Kim, Suhyun/0000-0001-7425-1310	National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2018R1C1B5086223, NRF-2019R1I1A1A01043985]	This research was supported by the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT (NRF-2018R1C1B5086223, NRF-2019R1I1A1A01043985).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Alizadeh A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00035; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Chapouton P, 2006, DEVELOPMENT, V133, P4293, DOI 10.1242/dev.02573; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Jung SH, 2010, DEV DYNAM, V239, P592, DOI 10.1002/dvdy.22166; Kim H, 2008, DEV DYNAM, V237, P2081, DOI 10.1002/dvdy.21620; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Klingener M, 2014, J NEUROSCI, V34, P9590, DOI 10.1523/JNEUROSCI.3699-13.2014; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marz M, 2010, DEV DYNAM, V239, P3336, DOI 10.1002/dvdy.22455; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Park HC, 2007, DEV DYNAM, V236, P3402, DOI 10.1002/dvdy.21365; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Samanta J, 2015, NATURE, V526, P448, DOI 10.1038/nature14957; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800	29	1	1	1	2	KOREAN SOC BRAIN & NEURAL SCIENCE, KOREAN SOC NEURODEGENERATIVE DISEASE	SEOUL	EXPERIMENTAL NEUROBIOLOGY,  SEOUL NATL UNIV, RM 410, BLDG 152-1, SEOUL, 151-742, SOUTH KOREA	1226-2560	2093-8144		EXP NEUROBIOL	Exp. Neurobiol.	DEC	2020	29	6					417	424		10.5607/en20050			8	Medicine, Research & Experimental; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	PN5UD	WOS:000604542900002	33281119	gold, Green Published			2022-02-06	
J	Lee, MS; Kim, BS; Lim, JS				Lee, Mi Sook; Kim, Bo Seon; Lim, Jae Sung			Reliability and Validity of the Brief test of Cognitive-Communication Disorders	COMMUNICATION SCIENCES AND DISORDERS-CSD			Korean	Article						Acquired-cognitive communication disorders; Cognitive-communication test; Reliability; Validity	ALZHEIMERS-DISEASE; WORKING-MEMORY; OLDER-ADULTS; TEST BATTERY; DEMENTIA; IMPAIRMENT; EDUCATION; AGE; REHABILITATION; VERBOSITY	Objectives: Acquired cognitive-communication disorders (ACCD) will increase rapidly in aged populations. Accordingly, a standardized cognitive-communication test is essential for speech-language pathology. The purpose of this study was to develop the Brief test of Cognitive-Communication Disorders (BCCD) and test its reliability and validity. Methods: A total of 609 normal participants over the age of 55 were divided into groups by age and education. The patients with dementia (n= 116), mild cognitive impairment (n= 92), traumatic brain injury/right hemisphere damage (n= 51), and aphasia (n= 87) also performed the BCCD. This measure was completed through several stages that included a pilot study, expert review, and test of face validity, and the final version consisted of 27 items of cognitive-communication domains. Results: There were three main findings. Firstly, the BCCD had high levels of internal consistency, and inter-rater and intra-rater reliabilities. Secondly, verification of the construct validity resulted in a strong correlation between the total mean score of the BCCD and the individual scores of subtests. The concurrent validity also revealed high correspondences. Lastly, the BCCD had an accuracy rate of discriminant function with a high extent of sensitivity and specificity. Conclusion: We showed evidence that the BCCD has diagnostic accuracy as an assessment protocol for a cognitive-communication decline. The findings also have implications for the use of BCCD in planning intervention and improving its effectiveness.	[Lee, Mi Sook] Hallym Univ Grad Studies, Dept Audiol & Speech Language Pathol, HUGS Ctr Hearing & Speeds Res, Seoul, South Korea; [Kim, Bo Seon] Yonsei Speech Language Clin, 221 Gilju Ro, Bucheon 14547, South Korea; [Lim, Jae Sung] Hallym Univ, Dept Neurol, Med Ctr, Anyang, South Korea		Kim, BS (corresponding author), Yonsei Speech Language Clin, 221 Gilju Ro, Bucheon 14547, South Korea.	bskimslp@gmail.com	Kim, Bo Seon/ABB-9877-2021; Lim, Jae-Sung/D-5555-2012	Lim, Jae-Sung/0000-0001-6157-2908; Kim, Bo Seon/0000-0002-8351-1417			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Aguerrevere L., 2007, THESIS; American Speech-Language-Hearing Association (ASHA), 2005, ROL SPEECH LANG PATH; Anderson ND, 2017, J GERONTOL B-PSYCHOL, V72, P1, DOI 10.1093/geronb/gbw108; [Anonymous], 2009, VIS CHANG UND BIOL E; Anstey Kaarin J, 2004, Aust Fam Physician, V33, P783; Auriacombe S, 2006, DEMENT GERIATR COGN, V21, P260, DOI 10.1159/000091407; Bayles KA., 1994, FUNCTIONAL LINGUISTI; Bier N, 2008, NEUROPSYCHOL REHABIL, V18, P343, DOI 10.1080/09602010701694723; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Bo-Seon Kim，, 2019, Audiology and Speech Research, V15, P63; Borella E, 2008, ACTA PSYCHOL, V128, P33, DOI 10.1016/j.actpsy.2007.09.008; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Braver TS, 2005, PSYCHOL AGING, V20, P33, DOI 10.1037/0882-7974.20.1.33; Bryan K., 1995, RIGHT HEMISPHERE LAN, V2nd ed.; Chow TW, 2008, ALZ DIS ASSOC DIS, V22, P327, DOI 10.1097/WAD.0b013e31818026c4; Christina P, 2018, WORLD ALZHEIMERS REP, VVolume 2018, P1, DOI DOI 10.1111/J.0033-0124.1950.24_14.X; College of Audiologists and Speech Language Pathologists of Ontario (CASL- PO), 2015, PRACT STAND GUID ACQ; Connor LT, 2004, J GERONTOL B-PSYCHOL, V59, pP203, DOI 10.1093/geronb/59.5.P203; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Diehl M., 1999, GERONTOLOGY INTERDIS, P238; Edwards JD, 2015, J GERONTOL B-PSYCHOL, V70, P417, DOI 10.1093/geronb/gbt113; Ferreira D, 2015, PSICOTHEMA, V27, P216, DOI 10.7334/psicothema2014.192; Balthazar ML, 2008, NEUROPSYCHOLOGY, V22, P703, DOI 10.1037/a0012919; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes-McKay K, 2014, ACTA NEUROPSYCHIATR, V26, P246, DOI 10.1017/neu.2014.2; Forlenza OV, 2009, INT PSYCHOGERIATR, V21, P1088, DOI 10.1017/S1041610209990792; Frattali C. M., 2017, ASHA FUNCTIONAL ASSE; Gainotti G, 2014, CORTEX, V53, P78, DOI 10.1016/j.cortex.2014.01.009; Ganguli M, 2010, AGING MENT HEALTH, V14, P100, DOI 10.1080/13607860903071014; Goral M, 2011, EXP AGING RES, V37, P516, DOI 10.1080/0361073X.2011.619858; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Helm-Estabrooks N., 1990, BRIEF TEST HEAD INJU; Helm-Estabrooks N, 2017, COGNITIVE LINGUISTIC; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Hodges JR, 2006, DEMENT GERIATR COGN, V21, P380, DOI 10.1159/000092534; Holland A., 2018, COMMUNICATION ACTIVI; Holland Audrey L., 2010, Seminars in Speech and Language, V31, P137, DOI 10.1055/s-0030-1257529; Hoogendam YY, 2014, EUR J EPIDEMIOL, V29, P133, DOI 10.1007/s10654-014-9885-4; Jeong PY, 2014, COMMUN SCI DISORD-CS, V19, P199, DOI 10.12963/csd.14122; Jung Jae-Yeob, 2020, Audiology and Speech Research, V16, P236; Jung Jae-Yeob, 2018, 특수교육재활과학연구, V57, P115, DOI 10.23944/Jsers.2018.12.57.4.6; Jung Jae-Yeob, 2019, 특수교육재활과학연구, V58, P321, DOI 10.23944/Jsers.2019.12.58.4.14; Jung Jae-Yeob, 2019, Audiology and Speech Research, V15, P135; Jung Jae-Yeob, 2017, 특수교육재활과학연구, V56, P237, DOI 10.23944/Jsers.2017.06.56.2.11; Kang Yeonwook, 2006, [Korean Journal of Psychology: General, 한국심리학회지:일반], V25, P1; Kemper S, 2006, PSYCHOL AGING, V21, P32, DOI 10.1037/0882-7974.21.1.32; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; Kemper S, 2010, PSYCHOL AGING, V25, P949, DOI 10.1037/a0020000; Kim Bo-Seon, 2019, 특수교육재활과학연구, V58, P217, DOI 10.23944/Jsers.2019.06.58.2.10; Kim H., 2012, PARADISE KOREA W APH; Kim H., 2008, SCREENING TEST APHA; Kim H., 2001, PARADISE KOREAN VERS; Kim YS, 2016, COMMUN SCI DISORD-CS, V21, P271, DOI 10.12963/csd.16292; Kumar R., 2015, J GERIATRIC MENTAL H, V2; Lee A. Y., 2008, KOREAN J REHABIL NUR, V11, P90; Lee M. S., 2020, GLOSSARY NEUROGENIC; Lee M. S., 2013, THESIS; Lee MS, 2021, NEUROPSYCHOL REHABIL, V31, P1557, DOI 10.1080/09602011.2020.1789479; Lee Mi Sook, 2020, Audiology and Speech Research, V16, P167; Lee S, 2003, AM J EPIDEMIOL, V157, P712, DOI 10.1093/aje/kwg042; Lee SY, 2017, ANN GERIATR MED RES, V21, P188, DOI 10.4235/agmr.2017.21.4.188; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lin JS, 2013, ANN INTERN MED, V159, P601, DOI 10.7326/0003-4819-159-9-201311050-00730; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Martin N, 2018, J NEUROLINGUIST, V48, P199, DOI 10.1016/j.jneuroling.2018.02.006; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mitchell AJ, 2010, AM J GERIAT PSYCHIAT, V18, P759, DOI 10.1097/JGP.0b013e3181cdecb8; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Paula Jonas Jardim de, 2013, Estud. psicol. (Natal), V18, P117, DOI 10.1590/S1413-294X2013000100019; Peach R. K., 2020, COGNITION ACQUIRED L; Pushkar D, 2000, PSYCHOL AGING, V15, P361, DOI 10.1037//0882-7974.15.2.361; Reilly J, 2011, NEUROPSYCHOLOGY, V25, P413, DOI 10.1037/a0022738; Ruffman T, 2010, PSYCHOL AGING, V25, P492, DOI 10.1037/a0018247; Shin J, 2008, COMMUN SCI DISORD-CS, V13, P193; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Soares FC, 2014, CLIN INTERV AGING, V10, P37; Sook Lee， Mi, 2015, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V15, P359, DOI 10.5392/JKCA.2015.15.11.359; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109; Tomoeda C., 1993, ARIZONA BATTERY COMM; Treitz FH, 2007, AGING NEUROPSYCHOL C, V14, P370, DOI 10.1080/13825580600678442; Trunk DL, 2009, PSYCHOL AGING, V24, P324, DOI 10.1037/a0015259; Tsoi KKF, 2015, JAMA INTERN MED, V175, P1450, DOI 10.1001/jamainternmed.2015.2152; Uekermann J, 2008, BRAIN COGNITION, V67, P51, DOI 10.1016/j.bandc.2007.11.003; Unsworth N, 2012, MEMORY, V20, P167, DOI 10.1080/09658211.2011.651087; Vohn R., 2008, THESIS; Wang J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027313; World Health Organization, 2007, INT CLASS FUNCT DIS; 최현주, 2012, [Journal of speech-language & hearing disorders, 언어치료연구], V21, P37	92	1	1	0	1	KOREAN ACAD SPEECH-LANGUAGE PATHOLOGY & AUDIOLOGY	CHUONGNAM	KOREA NAZARENE UNIV, DEPT COMMUNICATION DISORDERS, CHUONGNAM, 331-718, SOUTH KOREA	2288-1328	2288-0917		COMMUN SCI DISORD-CS	Commun. Sci. Disord.-CSD	DEC	2020	25	4					872	889		10.12963/csd.20757			18	Audiology & Speech-Language Pathology	Emerging Sources Citation Index (ESCI)	Audiology & Speech-Language Pathology	PS4YA	WOS:000607927400006		gold			2022-02-06	
J	Lesniak, E; Ramsey, KG; Brady, C; Beydoun, HA; Johnstone, B				Lesniak, Elizabeth; Ramsey, Kathryn G.; Brady, Christine; Beydoun, Hind A.; Johnstone, Brick			Predicting military readiness using objective and subjective indices of neuropsychological impairment in service members with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Absolute value; mild TBI; military; readiness; relative decline		The military is interested in identifying factors to improve the readiness of service members with traumatic brain injury (TBI). TBI outcome studies have primarily used objective neuropsychological data interpreted using the absolute level of functioning (i.e., high average, average, low average), though research suggests it is also important to consider other objective indices of the relative degree of decline (e.g., mild, moderate, severe) and subjective complaints. The current study determined the predictive ability of objective indices of neuropsychological functioning (i.e., absolute level and the relative degree of decline) and subjective complaints (i.e., Neurobehavioral Symptom Inventory) in terms of military work status (i.e., return to duty, medically disabled, retired) for 113 service members with mild TBI. ANOVAs and post-hoc tests indicated individuals who were able to return to duty had higher absolute indices and lower relative decline scores in working memory and overall intelligence, as well as lower subjective neuropsychological complaints when compared to those who were disabled or retired. Multinomial logistic regression models generally supported these findings, except relative decline scores were not predictive of military work status likely due to issues of collinearity (i.e., relative decline scores are calculated using absolute scores). In conclusion, indices of absolute functioning and subjective neuropsychological impairments appear to be predictors of the ability to return to duty post-TBI in military populations, emphasizing the need to focus on cognitive reserve and emotional resilience as potential interventions.	[Lesniak, Elizabeth] Ft Belvoir Community Hosp, Adult Behav Hlth Dept, Ft Belvoir, VA USA; [Ramsey, Kathryn G.; Brady, Christine; Johnstone, Brick] Ft Belvoir Intrepid Spirit Ctr, Ft Belvoir, VA USA; [Ramsey, Kathryn G.; Johnstone, Brick] Ft Belvoir Intrepid Spirit Ctr, Def & Vet Brain Injury Ctr, Ft Belvoir, VA USA; [Beydoun, Hind A.] Ft Belvoir Community Hosp, Dept Res Programs, Ft Belvoir, VA USA; [Johnstone, Brick] Shepherd Ctr, Atlanta, GA USA		Lesniak, E (corresponding author), Ft Belvoir Community Hosp, 5980,9th St, Ft Belvoir, VA 22060 USA.	Lesniak.elizabeth@gmail.com					CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cook PA, 2018, J NEUROTRAUM, V35, P991, DOI 10.1089/neu.2017.5141; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Defense and Veteran's Brain Injury Center, 2014, TRAUMATIC BRAIN INJU; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Elliott TR, 2019, REHABIL PSYCHOL, V64, P383, DOI 10.1037/rep0000282; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Harvey SB, 2011, ANN EPIDEMIOL, V21, P666, DOI 10.1016/j.annepidem.2011.05.004; Hayes D.K., 2015, OTOLARYNGOLOGY HEAD; Hinkebein JH, 2003, BRAIN INJURY, V17, P1035, DOI 10.1080/0269905031000110490; Holdnack JA, 2017, REHABIL PSYCHOL, V62, P496, DOI 10.1037/rep0000198; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Johnstone B, 2002, ARCH CLIN NEUROPSYCH, V17, P273, DOI 10.1016/S0887-6177(01)00112-3; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; Johnstone B, 1997, ARCH CLIN NEUROPSYCH, V12, P591, DOI 10.1016/S0887-6177(97)00002-4; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; Skeel R L, 2000, Appl Neuropsychol, V7, P96, DOI 10.1207/S15324826AN0702_5; Skell RL, 2000, BRAIN INJURY, V14, P705; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sternberg RJ, 2001, MERRILL PALMER QUART, V47, P1, DOI 10.1353/mpq.2001.0005; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Stewart-Willis JJ, 2018, ARCH CLIN NEUROPSYCH, V33, P206, DOI 10.1093/arclin/acx053; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT	35	1	1	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1855588		DEC 2020	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	PM4YY	WOS:000603807800001	33356571				2022-02-06	
J	Logan, JE; Ertl, AM; Rostad, WL; Herbst, JH; Plant, EA				Logan, Joseph E.; Ertl, Allison M.; Rostad, Whitney L.; Herbst, Jeffrey H.; Ashby Plant, E.			Shared correlates of prescription drug misuse and severe suicide ideation among clinical patients at risk for suicide	SUICIDE AND LIFE-THREATENING BEHAVIOR			English	Article							TRAUMATIC BRAIN-INJURY; COMBAT EXPOSURE; OVERDOSE DEATHS; OPIOID MISUSE; USE DISORDERS; DEPRESSION; SYMPTOMS; INSOMNIA; SAMPLE; STATES	Objective Unintentional drug overdose and suicide have emerged as public health problems. Prescription drug misuse can elevate risk of overdose. Severe suicidal ideation increases risk of suicide. We identified shared correlates of both risk factors to inform cross-cutting prevention efforts. Methods We conducted a cross-sectional study using the Military Suicide Research Consortium's Common Data Elements survey; 2012-2017 baseline data collected from 10 research sites were analyzed. The sample included 3962 clinical patients at risk of suicide. Factors examined in relation to the outcomes, prescription drug misuse and severe suicidal ideation, included demographic characteristics and symptoms of: hopelessness; anxiety; post-traumatic stress disorder; alcohol use; other substance use; prior head/neck injury; insomnia; and belongingness. Poisson regression models with robust estimates provided adjusted prevalence ratios (aPRs) and 97.5% confidence intervals (CIs). Results Medium and high (vs. low) levels of insomnia were positively associated with prescription drug misuse (aPRs p < 0.025). Medium (vs. low) level of insomnia was positively associated with severe suicidal ideation (aPR: 1.09; CI: 1.01-1.18). Medium and high (vs. low) levels of perceived belongingness were inversely associated with both outcomes (aPRs p < 0.025). Conclusions Research should evaluate whether addressing sleep problems and improving belongingness can reduce prescription drug misuse and suicidal ideation simultaneously.	[Logan, Joseph E.; Ertl, Allison M.; Rostad, Whitney L.; Herbst, Jeffrey H.] Ctr Dis Control & Prevent CDC, Natl Ctr Injury Prevent & Control, Div Violence Prevent, 4770 Buford Hwy NE, Atlanta, GA 30341 USA; [Ashby Plant, E.] Florida State Univ, Dept Psychol, 1107 W Call St, Tallahassee, FL 32306 USA		Logan, JE (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Div HIV AIDS Prevent, 1600 Clifton Rd NE,MS US8-2, Atlanta, GA 30333 USA.	ffa3@cdc.gov					AKERLIND I, 1992, SOC SCI MED, V34, P405, DOI 10.1016/0277-9536(92)90300-F; Al-Ameri LT, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9010010; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Argyropoulos SV, 2005, INT REV PSYCHIATR, V17, P237, DOI 10.1080/09540260500104458; Ashrafioun L, 2020, PSYCHOL MED, V50, P2107, DOI 10.1017/S0033291719002307; Ashrafioun L, 2017, J PSYCHIATR RES, V92, P1, DOI 10.1016/j.jpsychires.2017.03.011; Ballantyne JC, 2012, J MED TOXICOL, V8, P417, DOI 10.1007/s13181-012-0257-8; Blanco C, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.18m12174; Blumenthal H, 2019, BEHAV THER, V50, P50, DOI 10.1016/j.beth.2018.03.010; Bohnert ASB, 2019, NEW ENGL J MED, V380, P71, DOI 10.1056/NEJMra1802148; Bohnert ASB, 2013, INJURY PREV, V19, P326, DOI 10.1136/injuryprev-2012-040631; Bohnert KM, 2017, ADDICTION, V112, P1193, DOI 10.1111/add.13774; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Bryan CJ, 2015, DEPRESS ANXIETY, V32, P349, DOI 10.1002/da.22372; Bryan CJ, 2013, J AFFECT DISORDERS, V150, P1226, DOI 10.1016/j.jad.2013.05.087; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Calabrese JR, 2011, J CLIN PSYCHIAT, V72, P1072, DOI 10.4088/JCP.11m06956; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Center for Substance Abuse Treatment, 1999, TREATMENT IMPROVEMEN, V35; Center for Substance Abuse Treatment, 1999, HHS PUBL, V(SMA) 13- 4212; Centers for Disease Control and Prevention (CDC), 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention [CDC], 2020, WISQARS WEB BAS INJ; Chakravorty S, 2013, AM J ADDICTION, V22, P266, DOI 10.1111/j.1521-0391.2012.12009.x; Coppens E, 2014, J AFFECT DISORDERS, V165, P142, DOI 10.1016/j.jad.2014.04.052; Dasgupta N, 2018, AM J PUBLIC HEALTH, V108, P182, DOI 10.2105/AJPH.2017.304187; Dobscha SK, 2014, J GEN INTERN MED, V29, pS853, DOI 10.1007/s11606-014-3028-1; Edinger JD, 2005, CLIN PSYCHOL REV, V25, P539, DOI 10.1016/J.CPR.2005.04.003; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Garland EL, 2017, J ADDICT DIS, V36, P23, DOI 10.1080/10550887.2016.1220800; Golub A, 2013, SUBST USE MISUSE, V48, P811, DOI 10.3109/10826084.2013.796988; Grattan A, 2012, ANN FAM MED, V10, P304, DOI 10.1370/afm.1371; Guo L, 2016, JAMA PEDIATR, V170, P971, DOI 10.1001/jamapediatrics.2016.1802; Han B, 2018, J CLIN PSYCHIAT, V79, P4, DOI 10.4088/JCP.17m11973; Hansen LP, 2018, MIL MED, V183, pE396, DOI 10.1093/milmed/usy107; Harnod D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193524; Hedegaard H, 1999, NCHS DATA BRIEF, V2017, P1; Hedegaard H., 2020, INCREASE SUICIDE MOR; Ilgen MA, 2016, PAIN, V157, P1079, DOI 10.1097/j.pain.0000000000000484; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Jack SPD, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6711a1; Joiner T., 2007, WHY PEOPLE DIE SUICI, DOI 10.2307/j.ctvjghv2f; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Jones CM, 2015, MMWR-MORBID MORTAL W, V64, P719; Kaminski JW, 2010, J YOUTH ADOLESCENCE, V39, P460, DOI 10.1007/s10964-009-9472-2; Kelley ML, 2019, PSYCHOL TRAUMA-US, V11, P621, DOI 10.1037/tra0000447; Kral MJ, 2009, INT J CIRCUMPOL HEAL, V68, P292, DOI 10.3402/ijch.v68i3.18330; Logan JE, 2011, CRISIS, V32, P299, DOI 10.1027/0227-5910/a000091; Logan J, 2012, AM J PUBLIC HEALTH, V102, pS40, DOI 10.2105/AJPH.2011.300481; Logan J, 2011, ARCH GEN PSYCHIAT, V68, P935, DOI 10.1001/archgenpsychiatry.2011.85; Logan JE, 2019, SUICIDE LIFE-THREAT, V49, P1693, DOI 10.1111/sltb.12567; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Manber R, 2011, J CLIN SLEEP MED, V7, P645, DOI 10.5664/jcsm.1472; Metalsky GI, 1997, COGNITIVE THER RES, V21, P359, DOI 10.1023/A:1021882717784; Minkel J, 2013, SLEEP MED CLIN, V8, P333, DOI 10.1016/j.jsmc.2013.06.002; Mitchell MM, 2012, SUICIDE LIFE-THREAT, V42, P486, DOI 10.1111/j.1943-278X.2012.00106.x; National Institute of Drug Abuse, 2018, BENZ OP; Nock MK, 2017, PSYCHOL MED, V47, P2663, DOI 10.1017/S0033291717001179; O'Neill S, 2019, J AFFECT DISORDERS, V246, P195, DOI 10.1016/j.jad.2018.12.018; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Petrosky E, 2018, ANN INTERN MED, V169, P448, DOI 10.7326/M18-0830; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Ringer FB, 2018, PSYCHOL ASSESSMENT, V30, P767, DOI 10.1037/pas0000519; Rockett IRH, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2014.302244; Rogers ML, 2018, J PSYCHIATR RES, V98, P78, DOI 10.1016/j.jpsychires.2017.12.017; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; SAMHSA, 2019, HHS PUBL, VPEP19- 5068, P51; Schepis TS, 2019, INT J GERIATR PSYCH, V34, P122, DOI 10.1002/gps.4999; Scholl L, 2019, MMWR-MORBID MORTAL W, V67, P1419; SCHONFELD L, 1989, COMMUNITY MENT HLT J, V25, P245, DOI 10.1007/BF00754441; Seo DC, 2012, J SCHOOL HEALTH, V82, P21, DOI 10.1111/j.1746-1561.2011.00663.x; Sheu Y, 2015, MMWR-MORBID MORTAL W, V64, P76; Shura RD, 2019, PSYCHOL SERV, V16, P312, DOI 10.1037/ser0000208; Soberay KA, 2019, ARCH SUICIDE RES, V23, P391, DOI 10.1080/13811118.2018.1479322; Substance Abuse and Mental Health Services Administration, 2019, KEY SUBSTANCE USE ME, VH-54; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; Vanderploeg RD, 2015, ARCH SUICIDE RES, V19, P453, DOI 10.1080/13811118.2014.957454; Wichniak A, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0816-4; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; World Health Organization, 2018, PREV SUIC COMM ENG T	80	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-0234	1943-278X		SUICIDE LIFE-THREAT	Suicide Life-Threat. Behav.	DEC	2020	50	6					1276	1287		10.1111/sltb.12685			12	Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	PF7OZ	WOS:000599240400022	32860264	hybrid, Green Published			2022-02-06	
J	Lu, N; Butler, CC; Gogineni, A; Sarmiento, JM; Lineen, EB; Yeh, DD; Babu, M; Byers, PM				Lu, Ning; Butler, Caroline Choi; Gogineni, Avinash; Sarmiento, Julissa Marie; Lineen, Edward B.; Yeh, Daniel Dante; Babu, Maya; Byers, Patricia Marie			Redefining Preventable Death-Potentially Survivable Motorcycle Scene Fatalities as a New Frontier	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Blunt trauma; Motorcycle; Preventable deaths; Airway	HEAD-INJURY; MORTALITY; SEVERITY; PATTERNS; LEVEL; TIME	Background: The National Academies of Science, Engineering, and Medicine defined a roadmap to achieve zero preventable trauma deaths. In the United States, there are over 5000 motorcycle fatalities annually. Florida leads the nation in annual motorcycle crash (MCC) deaths and injuries. It is unknown how many are potentially preventable. We hypothesize that certain patterns of injuries in on-scene fatalities that are potentially survivable and aim to make recommendations to achieve the National Academies of Science, Engineering, and Medicine objective. Materials and methods: Miami-Dade County medical examiner reports of MCC deaths pronounced on scene, and emergency medical service or law enforcement reports from 2010 to 2012 were reviewed by board-certified trauma surgeons. Causes of death were categorized into exsanguination, traumatic brain injury or decapitation, crushed chest, or airway complications. Determination of potentially survivable versus nonsurvivable injuries was based upon whether the riders had potentially survivable injuries and had they been transported immediately to a trauma center. Traumatic brain injury cases were reviewed by a board-certified neurosurgeon. Results: Sixty MCC scene deaths were analyzed. Ninety-five percent were men, 55% were helmeted, and 42% had positive toxicology. The median Injury Severity Score was 41 (Range 14-75, IQR 31-75). Nineteen (32%) deaths were potentially survivable, with death due to airway in 14 (23%) and exsanguination in 4 (7%) patients. Conclusions: One-third of on-scene urban motorcycle deaths are potentially survivable in a young patient population. ISS score comparison demonstrates the lower injury burden in those deemed potentially survivable. Automatic alert systems in motorcycles and first responder training to police are recommended to improve trauma system efficacy in reducing preventable deaths from MCCs. (C) 2020 Elsevier Inc. All rights reserved.	[Lu, Ning; Butler, Caroline Choi; Lineen, Edward B.; Yeh, Daniel Dante; Byers, Patricia Marie] Jackson Mem Hosp, Ryder Trauma Ctr, Miami, FL USA; [Lu, Ning; Butler, Caroline Choi; Gogineni, Avinash; Sarmiento, Julissa Marie; Lineen, Edward B.; Yeh, Daniel Dante; Babu, Maya; Byers, Patricia Marie] Univ Miami, Dewitt Daughtry Dept Surg, Miller Sch Med, Miami, FL USA; [Lu, Ning] Scripps Mem Hosp La Jolla, 9888 Genesee Ave, La Jolla, CA 92037 USA; [Butler, Caroline Choi] Grady Mem Hosp, 80 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA; [Babu, Maya] Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA		Lu, N (corresponding author), 9888 Genesee Ave, La Jolla, CA 92037 USA.; Lu, N (corresponding author), Scripps Mem Hosp La Jolla, 9888 Genesee Ave, La Jolla, CA 92037 USA.	Lu.Ning@scrippshealth.org		Lu, Ning/0000-0001-8272-3883	Florida Department of Transportation, United States [MC-1910-03]	This work was supported by the Florida Department of Transportation, United States [Grant number MC-1910-03].	Ankarath S, 2002, INJURY, V33, P473, DOI 10.1016/S0020-1383(02)00048-7; Centers for Disease Control and Prevention National Center for Health Statistics, 2010, NAT HOSP DISCH SURV; CLEVENGER FW, 1988, J TRAUMA, V28, P441, DOI 10.1097/00005373-198804000-00004; Cowley R A, 1975, Md State Med J, V24, P37; Davis JS, 2014, J TRAUMA ACUTE CARE, V77, P213, DOI 10.1097/TA.0000000000000292; Deasy C, 2012, RESUSCITATION, V83, P465, DOI 10.1016/j.resuscitation.2011.09.025; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; DUFFIN J, 1978, CAN ANAESTH SOC J, V25, P181, DOI 10.1007/BF03004877; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; GERVIN AS, 1982, J TRAUMA, V22, P443, DOI 10.1097/00005373-198206000-00001; Granieri SS, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00297-1; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Houston Jr DJ, 2007, AM J PUBLIC HEALTH, V97, P7; JOHNSTONE RE, 1972, J AMER MED ASSOC, V222, P486; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kraus JF, 2002, J TRAUMA, V52, P548, DOI 10.1097/00005373-200203000-00022; Lu CH, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0679-2; MacLeod JBA, 2010, J TRAUMA, V69, P1101, DOI 10.1097/TA.0b013e3181f8a9cc; Matsumoto H, 2016, J EMERG MED, V50, P437, DOI 10.1016/j.jemermed.2015.11.001; Mercier E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022070; National Academies of Sciences Engineering and Medicine 2016, 2016, NAT TRAUM CAR SYST I, DOI [10.17226/23511, DOI 10.17226/23511]; National Highway Traffic Safety Administration, FAT AN REP SYST FARS; National Highway Traffic Safety Administration, 2018, TRAFF SAF FACTS 2016; Powell TC, 2018, MOTORCYCLIST TRAFFIC; Ross EM, 2018, PREHOSP DISASTER MED, V33, P127, DOI 10.1017/S1049023X18000055; SAMPALIS JS, 1993, J TRAUMA, V34, P252, DOI 10.1097/00005373-199302000-00014; Saunders RN, 2019, AM J SURG, V217, P552, DOI 10.1016/j.amjsurg.2018.10.007; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Wilson Kevin C, 2004, J Intensive Care Med, V19, P183, DOI 10.1177/0885066604263918	31	1	1	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2020	256						70	75		10.1016/j.jss.2020.06.014			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	OH5EJ	WOS:000582602700010	32683059				2022-02-06	
J	Martin-Rojas, T; Sastre-Oliva, T; Esclarin-Ruz, A; Gil-Dones, F; Mourino-Alvarez, L; Corbacho-Alonso, N; Moreno-Luna, R; Hernandez-Fernandez, G; Lopez, JA; Oliviero, A; Barderas, MG				Martin-Rojas, Tatiana; Sastre-Oliva, Tamara; Esclarin-Ruz, Ana; Gil-Dones, Felix; Mourino-Alvarez, Laura; Corbacho-Alonso, Nerea; Moreno-Luna, Rafael; Hernandez-Fernandez, German; Antonio Lopez, Juan; Oliviero, Antonio; Barderas, Maria G.			Effects of Growth Hormone Treatment and Rehabilitation in Incomplete Chronic Traumatic Spinal Cord Injury: Insight from Proteome Analysis	JOURNAL OF PERSONALIZED MEDICINE			English	Article						spinal cord injury; somatropin; therapy; proteomic	THYROID-HORMONES; IDENTIFICATION; REGENERATION; COMPLEMENT; DEFICIENCY; GUIDELINES; PROTEINS; RECOVERY; IMPACT; BRAIN	Despite promising advances in the medical management of spinal cord injury (SCI), there is still no available e ffective therapy to repair the neurological damage in patients who experience this life-transforming condition. Recently, we performed a phase II/III placebo-controlled randomized trial of safety and e fficacy of growth hormone (GH) treatment in incomplete chronic traumatic spinal cord injury. The main findings were that the combined treatment of GH plus rehabilitation treatment is feasible and safe, and that GH but not placebo slightly improves the SCI individual motor score. Moreover, we found that an intensive and long-lasting rehabilitation program per se increases the functional outcome of SCI individuals. To understand the possible mechanisms of the improvement due to GH treatment (motor score) and due to rehabilitation (functional outcome), we used a proteomic approach. Here, we used a multiple proteomic strategy to search for recovery biomarkers in blood plasma with the potential to predict response to somatropin treatment and to delayed intensive rehabilitation. Forty-six patients were recruited and followed for a minimum period of 1 year. Patients were classified into two groups based on their treatment: recombinant somatropin (0.4 mg) or placebo. Both groups received rehabilitation treatment. Our strategy allowed us to perform one of the deepest plasma proteomic analyses thus far, which revealed two proteomic signatures with predictive value: (i) response to recombinant somatropin treatment and (ii) response to rehabilitation. The proteins implicated in these signatures are related to homeostasis, inflammation, and coagulation functions. These findings open novel possibilities to assess and therapeutically manage patients with SCI, which could have a positive impact on their clinical response.	[Martin-Rojas, Tatiana; Sastre-Oliva, Tamara; Gil-Dones, Felix; Mourino-Alvarez, Laura; Corbacho-Alonso, Nerea; Moreno-Luna, Rafael; Hernandez-Fernandez, German; Barderas, Maria G.] Hosp Nacl Paraplejicos HNP, SESCAM, Dept Vasc Physiopathol, Toledo 45071, Spain; [Esclarin-Ruz, Ana] Hosp Nacl Paraplejicos, SESCAM, Dept Phys Med & Rehabil, Toledo 45071, Spain; [Gil-Dones, Felix] UCM, Fac Ciencias Biol, Dept Genet, Madrid 28040, Spain; [Moreno-Luna, Rafael] Hosp Nacl Paraplejicos HNP, SESCAM, Dept Neuroinflammat, Toledo 45004, Spain; [Antonio Lopez, Juan] Unidad Prote CNIC, Madrid 28029, Spain; [Oliviero, Antonio] Hosp Nacl Paraplejicos, SESCAM, FENNSI Grp, Toledo 45071, Spain		Barderas, MG (corresponding author), Hosp Nacl Paraplejicos HNP, SESCAM, Dept Vasc Physiopathol, Toledo 45071, Spain.; Oliviero, A (corresponding author), Hosp Nacl Paraplejicos, SESCAM, FENNSI Grp, Toledo 45071, Spain.	rojas@hotmail.com; tsastre@sescam.jccm.es; anae@sescam.jccm.es; gildones@yahoo.es; lmourino@sescam.jccm.es; ncorbacho@sescam.jccm.es; rmluna@sescam.jccm.es; ghernandezf@externas.sescam.jccm.es; jalopez@cnic.es; antonio.oliviero@hotmail.com; megonzalezb@sescam.jccm.es	Mourino-Alvarez, Laura/AAS-8231-2021; Dones, Felix Gil/ABG-3859-2020; Lopez, Juan Antonio/G-7750-2015	Mourino-Alvarez, Laura/0000-0002-3928-1554; Dones, Felix Gil/0000-0003-4255-9198; Lopez, Juan Antonio/0000-0002-9097-6060; Barderas, Maria G./0000-0003-4290-4721; Esclarin-Ruz, Ana/0000-0002-1397-9364; Sastre Oliva, Tamara/0000-0002-2399-2773; Corbacho Alonso, Nerea/0000-0002-5911-9589	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI14/01917, PI18/00995, PT13/0001/0013]; European Regional Development Fund/European Social Fund; Redes Tematicas de Investigacion Cooperativa (FONDOS FEDER) [RD12/0042/0071]; Grant PRB3 [IPT17/0019-ISCIII-SGEFI/ERDF]; Fondo Europeo de Desarrollo Regional-FEDEREuropean Commission [TRA-173]; Sociedad Espanola de Cardiologia para la Investigacion Basica 2017; Proyecto Fundacion-Mapfre 2013; "Ministerio de Sanidad y Politicas Sociales" of Spain	This study has been funded by Instituto de Salud Carlos III through the projects PI14/01917, PI18/00995, PT13/0001/0013 (Co-funded by European Regional Development Fund/European Social Fund) "Investing in your future". Redes Tematicas de Investigacion Cooperativa (FONDOS FEDER, RD12/0042/0071). Sociedad Espanola de Cardiologia para la Investigacion Basica 2017. Proyecto Fundacion-Mapfre 2013. Grant PRB3 (IPT17/0019-ISCIII-SGEFI/ERDF). "Ministerio de Sanidad y Politicas Sociales" of Spain and the "Fondo Europeo de Desarrollo Regional-FEDER" (project: TRA-173). These results are aligned with the Spanish initiative on the Human Proteome Project (SpHPP).	Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Alonso-Orgaz Sergio, 2013, Methods Mol Biol, V1005, P109, DOI 10.1007/978-1-62703-386-2_9; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Andreassen TT, 2003, CALCIFIED TISSUE INT, V73, P258, DOI 10.1007/S00223-002-2074-6; Bajwa NM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00115; Baldan-Martin M, 2016, HYPERTENSION, V68, P157, DOI 10.1161/HYPERTENSIONAHA.116.07412; Barakat-Walter I, 2018, NEURAL REGEN RES, V13, P599, DOI 10.4103/1673-5374.230274; Barbara-Bataller E, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0491-4; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; BENVENGA S, 1993, TRENDS ENDOCRIN MET, V4, P194, DOI 10.1016/1043-2760(93)90116-V; Bonzon-Kulichenko E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003335; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpanini SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00362; Cuatrecasas G, 2018, ENDOCR CONNECT, V7, P1031, DOI 10.1530/EC-18-0296; Darde Veronica M, 2007, Methods Mol Biol, V357, P351; Darde Veronica M, 2013, Methods Mol Biol, V1000, P191, DOI 10.1007/978-1-62703-405-0_14; Doucette AA, 2020, J MASS SPECTROM, V55, DOI 10.1002/jms.4494; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Gibney J, 2007, ENDOCR REV, V28, P603, DOI 10.1210/er.2006-0052; Hua K, 2009, GLIA, V57, P1062, DOI 10.1002/glia.20829; Huang HY, 2020, J ORTHOP TRANSL, V20, P14, DOI 10.1016/j.jot.2019.10.006; Hwang DH, 2018, EXP NEUROBIOL, V27, P489, DOI 10.5607/en.2018.27.6.489; Iwamoto N, 2018, PHARMACOL THERAPEUT, V185, P147, DOI 10.1016/j.pharmthera.2017.12.007; Jiang SD, 2006, CLIN ENDOCRINOL, V65, P555, DOI 10.1111/j.1365-2265.2006.02683.x; Jutzeler CR, 2019, ANN CLIN TRANSL NEUR, V6, P68, DOI 10.1002/acn3.679; Kasperska-Zajac A, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-22; KIERNAN JA, 1979, BIOL REV, V54, P155, DOI 10.1111/j.1469-185X.1979.tb00871.x; Li SY, 2019, INT J MOL MED, V44, P1877, DOI 10.3892/ijmm.2019.4341; Liang GY, 2007, GLIA, V55, P632, DOI 10.1002/glia.20496; Lindsey ML, 2015, CIRCULATION, V132, P852, DOI 10.1161/CIR.0000000000000226; Lopez J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39738-6; Lovejoy JC, 1999, AM J PHYSIOL-ENDOC M, V277, pE370, DOI 10.1152/ajpendo.1999.277.2.E370; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Martin-Rojas T, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9147-z; Martin-Rojas T, 2012, J PROTEOME RES, V11, P1537, DOI 10.1021/pr2005692; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Martinez-Moreno CG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020375; Mourino-Alvarez L, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033423; Navarro P, 2014, J PROTEOME RES, V13, P1234, DOI 10.1021/pr4006958; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rezaei M, 2012, J RES MED SCI, V17, P681; Rubin MR, 2010, ARQ BRAS ENDOCRINOL, V54, P220, DOI 10.1590/S0004-27302010000200019; Sarkis GA, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0736-z; Schuld C, 2016, J SPINAL CORD MED, V39, P504, DOI 10.1080/10790268.2016.1180831; Seeds NW, 2009, RESP PHYSIOL NEUROBI, V169, P141, DOI 10.1016/j.resp.2009.07.021; Sengupta Mohor B, 2016, Front Biosci (Elite Ed), V8, P460; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sun YT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S2; TATOR CH, 1980, J NEUROSURG, V53, P381, DOI 10.3171/jns.1980.53.3.0381; Toby TK, 2019, NAT PROTOC, V14, P119, DOI 10.1038/s41596-018-0085-7; Walser M, 2012, J ENDOCRINOL, V215, P257, DOI 10.1530/JOE-12-0077; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690	55	1	1	1	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4426		J PERS MED	J. Pers. Med.	DEC	2020	10	4							183	10.3390/jpm10040183			19	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	PK8HO	WOS:000602679000001	33096745	gold, Green Published			2022-02-06	
J	Modrak, CG; Giesler, LP; Vonder Haar, C				Modrak, Cassandra G.; Giesler, Lauren P.; Vonder Haar, Cole			Traumatic brain injury substantially reduces the conditioned reinforcing effects of environmental cues in rats	BRAIN RESEARCH			English	Article						Addiction; Brain injury; Cue; Pavlovian	ALCOHOL-CONSUMPTION; DOPAMINE; COCAINE; REWARD; DISORDERS; IMPACT; RISK; IMPAIRMENTS; SALIENCE; STIMULUS	Traumatic brain injury affects millions of people each year and is an established risk factor for addiction. Recent animal studies have causally demonstrated that injuries can increase drug self-administration across a variety of substances. One potential behavioral mediator for this finding is an increased responsivity to drug-associated cues. This endophenotype can be identified by profiling non-drug-related behaviors. The current study evaluated several paradigms (conditioned approach, conditioned reinforcement, extinction from variable interval responding, conditioned facilitation) to determine how rats with a frontal TBI differed in their response to Pavlovian conditioning in response to food-paired cues. Surprisingly, rats with a TBI demonstrated increased goal-tracking in a conditioned approach paradigm and exerted less effort for a conditioned reinforcer. Moreover, they had slightly facilitated extinction (as demonstrated by significantly larger interresponse times) in the face of reinforcer-associated cues. Despite these effects, TBI rats still demonstrated conditioned facilitation to an auditory stimulus. Together, these effects suggest a phenotype in the opposite direction of what might be anticipated. Cues still served a strong discriminative function and altered behavior; however, they did not function as strong conditioned reinforcers for TBI animals. One potential reason for this is that substantial changes to the dopamine system after TBI may reduce the conditioned reinforcing effects of cues, but sensitize the brain to potent drugs of abuse. More research will be needed to determine whether this is the case.	[Modrak, Cassandra G.; Giesler, Lauren P.; Vonder Haar, Cole] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26505 USA; [Vonder Haar, Cole] West Virginia Univ, Dept Neurosci, Morgantown, WV 26505 USA		Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.	cole.vonderhaar@mail.wvu.edu		Vonder Haar, Cole/0000-0001-7949-2068	National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS11090501]	We would like to thank Kristen Pecachek, Michelle Frankot, Alix Gondringer, Anastasios Lake, and Virginia Milleson for their assistance with behavioral testing and other assistance during this project. We would like to thank Dr. Kate Wassum for providing a protocol that was adapted for experiment 4. This work was funded by a grant from the National Institutes of Neurological Disorders and Stroke (NS11090501).	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2016, AM PSYCHOL, V71, P670, DOI 10.1037/amp0000059; Bhatti JA, 2019, SOC PSYCH PSYCH EPID, V54, P517, DOI 10.1007/s00127-018-1583-1; Bogner J, 2020, J HEAD TRAUMA REHAB, V35, pE43, DOI 10.1097/HTR.0000000000000488; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Cannella LA, 2020, J NEUROTRAUM, V37, P27, DOI 10.1089/neu.2019.6472; Cannella LA, 2019, EXP NEUROL, V317, P191, DOI 10.1016/j.expneurol.2019.03.003; Center for Disease Control, 2014, INJ PREV CONTR TRAUM, V2020; Chow JJ, 2016, NEUROPHARMACOLOGY, V109, P320, DOI 10.1016/j.neuropharm.2016.06.028; Cocker PJ, 2016, BEHAV BRAIN RES, V312, P55, DOI 10.1016/j.bbr.2016.06.007; Corrigan JD, 2020, J NEUROTRAUM, V37, P1637, DOI 10.1089/neu.2019.6897; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Drummond DC, 2000, ADDICTION, V95, pS129, DOI 10.1046/j.1360-0443.95.8s2.2.x; Dulaney AE, 2008, BEHAV PROCESS, V78, P253, DOI 10.1016/j.beproc.2007.12.006; ESTES WK, 1948, J EXP PSYCHOL, V38, P173, DOI 10.1037/h0057525; Ferland JMN, 2017, ADDICT BIOL, V22, P991, DOI 10.1111/adb.12388; Flagel SB, 2007, PSYCHOPHARMACOLOGY, V191, P599, DOI 10.1007/s00213-006-0535-8; Flagel SB, 2017, CURR OPIN BEHAV SCI, V13, P178, DOI 10.1016/j.cobeha.2016.12.004; Fucich EA, 2019, J NEUROTRAUM, V36, P1847, DOI 10.1089/neu.2018.5854; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Istin M, 2017, ADDICT BIOL, V22, P958, DOI 10.1111/adb.12384; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Karelina K, 2018, BRAIN BEHAV IMMUN, V69, P532, DOI 10.1016/j.bbi.2018.01.012; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Kuhn BN, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00262; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McHugh RK, 2016, AM J ADDICTION, V25, P105, DOI 10.1111/ajad.12344; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nawarawong NN, 2019, EUR J NEUROSCI, V50, P2101, DOI 10.1111/ejn.14281; Ostlund SB, 2014, NEUROPSYCHOPHARMACOL, V39, P2441, DOI 10.1038/npp.2014.96; Otis JM, 2017, NATURE, V543, P103, DOI 10.1038/nature21376; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Panlilio LV, 1996, PSYCHOPHARMACOLOGY, V125, P202, DOI 10.1007/BF02247329; Serrano-Barroso A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223109; Shaver TK, 2019, BRAIN RES, V1704, P103, DOI 10.1016/j.brainres.2018.10.004; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Swendsen J, 2010, ADDICTION, V105, P1117, DOI 10.1111/j.1360-0443.2010.02902.x; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; Tomie A, 2008, BRAIN RES REV, V58, P121, DOI 10.1016/j.brainresrev.2007.12.003; Turner NE, 2019, PSYCHIAT RES, V272, P692, DOI 10.1016/j.psychres.2018.12.170; Vonder Haar C, 2019, EUR J NEUROSCI, V50, P2134, DOI 10.1111/ejn.14123; Vonder Haar C, 2016, J NEUROTRAUM, V33, P1892, DOI 10.1089/neu.2015.4276; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	54	1	1	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 1	2020	1748								147084	10.1016/j.brainres.2020.147084			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OC8TB	WOS:000579428000024	32871136	Green Accepted			2022-02-06	
J	Moure-Guardiola, C; Rubio, I; Antona-Makoshi, J; Olmedo, A; Loya, JA; Rodriguez-Millan, M				Moure-Guardiola, Carlos; Rubio, Ignacio; Antona-Makoshi, Jacobo; Olmedo, Alvaro; Antonio Loya, Jose; Rodriguez-Millan, Marcos			Evaluation of Combat Helmet Behavior under Blunt Impact	APPLIED SCIENCES-BASEL			English	Article						combat helmet; TBI; HIC; peak linear acceleration; blunt impact; human head; LS-Dyna		New threats are a challenge for the design and manufacture of modern combat helmets. These helmets must satisfy a wide range of impact velocities from ballistic impacts to blunt impacts. In this paper, we analyze European Regulation ECE R22.05 using a standard surrogate head and a human head model to evaluate combat helmet performance. Two critical parameters on traumatic brain analysis are studied for different impact locations, i.e., peak linear acceleration value and head injury criterion (HIC). The results obtained are compared with different injury criteria to determine the severity level of damage induced. Furthermore, based on different impact scenarios, analyses of the influence of impact velocity and the geometry impact surface are performed. The results show that the risks associated with a blunt impact can lead to a mild traumatic brain injury at high impact velocities and some impact locations, despite satisfying the different criteria established by the ECE R22.05 standard. The results reveal that the use of a human head for the estimation of brain injuries differs slightly from the results obtained using a surrogate head. Therefore, the current combat helmet configuration must be improved for blunt impacts. Further standards should take this into account and, consequently, combat helmet manufacturers on their design process.	[Moure-Guardiola, Carlos; Rubio, Ignacio; Rodriguez-Millan, Marcos] Univ Carlos III Madrid, Dept Mech Engn, Avda Univ 30, Madrid 28911, Spain; [Antona-Makoshi, Jacobo] Japan Automobile Res Inst, 2530 Karima, Tsukuba, Ibaraki 3050822, Japan; [Olmedo, Alvaro] FECSA Co, Calle Acacias 3, Madrid 28703, Spain; [Antonio Loya, Jose] Univ Carlos III Madrid, Dept Continuum Mech & Struct Anal, Avda Univ 30, Madrid 28911, Spain		Rodriguez-Millan, M (corresponding author), Univ Carlos III Madrid, Dept Mech Engn, Avda Univ 30, Madrid 28911, Spain.	100346468@alumnos.uc3m.es; igrubiod@pa.uc3m.es; ajacobo@jari.or.jp; aolmedo@fecsa.net; jloya@ing.uc3m.es; mrmillan@ing.uc3m.es	Millan, Marcos Rodriguez/A-3945-2012	Millan, Marcos Rodriguez/0000-0002-9081-8425; LOYA, JOSE ANTONIO/0000-0002-9797-2126	FEDER program by the Ministerio de Economia, Industria y Competitividad [DPI2017-88166-R]; Spanish Ministry of Education, Culture and Sports [CAS18/00292]	This work has been carried out within the framework of the research project DPI2017-88166-R of the FEDER program financed by the Ministerio de Economia, Industria y Competitividad and the Spanish Ministry of Education, Culture and Sports for the professor's mobility program Jose Castillejo's 2018 grant (CAS18/00292).	ANTONA-MAKOSHI J., 2016, TRAUMATIC BRAIN INJU; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bandak, 1999, DEV IMPROVED INJURY; Barlow GJ, 2021, P I MECH ENG C-J MEC, V235, P2934, DOI 10.1177/0954406220960764; Bass Cameron R Dale, 2005, Int J Occup Saf Ergon, V11, P347; Begonia M, 2019, MIL MED, V184, P237, DOI 10.1093/milmed/usy282; Bin Tan L, 2012, INT J IMPACT ENG, V50, P99, DOI 10.1016/j.ijimpeng.2012.06.003; Brolin K, 2004, SPINE, V29, P376, DOI 10.1097/01.BRS.0000090820.99182.2D; BSI Standards Publication, 1997, HELM PED CYCL US SKA; Cai ZH, 2020, APPL BIONICS BIOMECH, V2020, DOI 10.1155/2020/2348064; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CHANG FK, 1987, J COMPOS MATER, V21, P834, DOI 10.1177/002199838702100904; CHANG FK, 1987, J COMPOS MATER, V21, P809, DOI 10.1177/002199838702100903; Chinn B., 2001, COST 327 MOTORCYCLE; Dionne JP, 2018, SHOCK WAVES, V28, P5, DOI 10.1007/s00193-017-0737-5; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fitek John., 2013, DESIGN HELMET LINER, DOI [10.21236/ADA578032, DOI 10.21236/ADA578032]; Hayes WC, 2007, ANNU REV BIOMED ENG, V9, P55, DOI 10.1146/annurev.bioeng.9.060906.151946; Hopping J., 2010, P PERS ARM SYST S QU, P1; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Knapik JJ, 2011, AVIAT SPACE ENVIR MD, V82, P797, DOI 10.3357/ASEM.3061.2011; Li XG, 2016, INT J IMPACT ENG, V91, P56, DOI 10.1016/j.ijimpeng.2015.12.010; Li YQ, 2015, J APPL MECH-T ASME, V82, DOI 10.1115/1.4031095; Maach S., 2017, P IRCOBI C P ANTW BE; McElhaney JH, 1976, HDB HUMAN TOLERANCE; McEntire B.J., 2005, SEMANT SCH, DOI [10.21236/ada437530, DOI 10.21236/ADA437530]; Melvin J.W., 2015, BIOMECHANICS BRAIN I; Miranda-Vicario A, 2018, COMPOS STRUCT, V203, P233, DOI 10.1016/j.compstruct.2018.07.012; NATO Standarization Agency, 2003, STAND 2920 PPS ED 2; Palomar M, 2018, COMPOS STRUCT, V201, P49, DOI 10.1016/j.compstruct.2018.05.076; Palta E, 2018, INT J IMPACT ENG, V112, P125, DOI 10.1016/j.ijimpeng.2017.10.010; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Rodriguez-Millan M, 2016, MATER DESIGN, V110, P391, DOI 10.1016/j.matdes.2016.08.015; Rubio I, 2019, COMPOS STRUCT, V226, DOI 10.1016/j.compstruct.2019.111153; Rubio I, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20102853; Sepulveda-Lopez D, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10113692; Staniszewski J., 2019, IMPROVE LOW VELOCITY; Tham CY, 2008, INT J IMPACT ENG, V35, P304, DOI 10.1016/j.ijimpeng.2007.03.008; Tse KM, 2015, ACCIDENT ANAL PREV, V79, P13, DOI 10.1016/j.aap.2015.03.012; U.S. Department of Justice, 1981, 010601 US DEP JUST N; (UNECE) U.N.E.C. for E, 2002, 2205 UNEC ECE, P1; Van Hoof J., 2001, P 19 INT S BALL INT, P7; Yoganandan N, 2000, J BIOMECH ENG-T ASME, V122, P623, DOI 10.1115/1.1322034; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088	44	1	1	2	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	DEC	2020	10	23							8470	10.3390/app10238470			20	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering; Materials Science; Physics	PD5QF	WOS:000597738100001		Green Published, gold			2022-02-06	
J	Padmanabhan, P; Cheema, AS; Todd, JF; Lim, LT; Paliyath, G				Padmanabhan, Priya; Cheema, Amer S.; Todd, James F.; Lim, Loong-Tak; Paliyath, Gopinadhan			Ripening responses, fruit quality and phospholipase D gene expression in bell peppers exposed to hexanal vapor	POSTHARVEST BIOLOGY AND TECHNOLOGY			English	Article						Capsicum annuum; Bell Pepper; Hexanal; Postharvest; Phospholipase D; Volatiles	CAPSICUM-ANNUUM; SHELF-LIFE; CHILLING INJURY; SWEET-PEPPER; VOLATILE; TOMATO; LIPOXYGENASE; L.; GENERATION; RESISTANCE	Phospholipase D (PLD) is a key enzyme involved in membrane lipid catabolism. Hexanal, a C6 volatile aldehyde is a strong PLD -inhibitor, and has been observed to enhance the shelf life and quality of horticultural produce. In the present study, the effect of hexanal vapor exposure on the postharvest quality and ripening response of bell pepper fruit was evaluated. Hexanal exposure for a minimum of 6 h was found to be essential to delay ripening in bell pepper fruit. Quantification of head space hexanal levels in the presence of pepper fruit revealed a gradual decrease in concentration, while it remained relatively steady close to the peak value in the absence of pepper fruit. Hexanal treated bell peppers subjected to 21 d of postharvest storage evolved higher levels of aroma volatiles than untreated peppers. Hexanal vapor treatment induced significant alterations in the transcript accumulation and expression of genes involved in the carotenoid biosynthetic pathway, antioxidant enzyme systems, and the LOX pathway in stored pepper fruit. Real time PCR analysis also confirmed the near-complete downregulation of expression of genes encoding PLD alpha, beta, delta and zeta isoforms in hexanal vapor treated peppers. The results suggest that hexanal vapor treatment can beneficially influence the expression of genes in multiple biochemical pathways, which could ultimately result in enhancing the shelf life and quality of horticultural produce.	[Padmanabhan, Priya; Cheema, Amer S.; Paliyath, Gopinadhan] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Todd, James F.] Ontario Minist Agr Food & Rural Affairs, Simcoe Res Stn, 4690 Blueline Rd, Simcoe, ON, Canada; [Lim, Loong-Tak] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada		Paliyath, G (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	gpaliyat@uoguelph.ca					Ahn T, 2007, FOOD RES INT, V40, P1012, DOI 10.1016/j.foodres.2007.05.007; Bai JH, 2011, POSTHARVEST BIOL TEC, V60, P111, DOI 10.1016/j.postharvbio.2010.12.002; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Buttery R.G., 1993, VOLATILE COMPOUNDS P, P23, DOI 10.1021/bk-1993-0525.ch003; CEPONIS MJ, 1987, PLANT DIS, V71, P380; Cheema A, 2018, POSTHARVEST BIOL TEC, V136, P80, DOI 10.1016/j.postharvbio.2017.10.006; Cheema A, 2014, POSTHARVEST BIOL TEC, V95, P13, DOI 10.1016/j.postharvbio.2014.03.012; Chen GP, 2004, PLANT PHYSIOL, V136, P2641, DOI 10.1104/pp.104.041608; Dek MSP, 2018, POSTHARVEST BIOL TEC, V140, P50, DOI 10.1016/j.postharvbio.2018.02.009; Eggink PM, 2012, FOOD CHEM, V132, P301, DOI 10.1016/j.foodchem.2011.10.081; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gill KS, 2016, POSTHARVEST BIOL TEC, V112, P224, DOI 10.1016/j.postharvbio.2015.09.010; Han Y., 2016, J EXP FOOD CHEM, V1, P1, DOI [10.4172/24720542.1000102., DOI 10.4172/24720542.1000102]; Hethelyi E., 1986, Flavour and Fragrance Journal, V1, P169, DOI 10.1002/ffj.2730010408; Howard LR, 2000, J AGR FOOD CHEM, V48, P1713, DOI 10.1021/jf990916t; Kim DS, 2014, J EXP BOT, V65, P2295, DOI 10.1093/jxb/eru109; Koonin EV, 1996, TRENDS BIOCHEM SCI, V21, P242, DOI 10.1016/S0968-0004(96)30024-8; Lama K, 2016, SCI HORTIC-AMSTERDAM, V213, P42, DOI 10.1016/j.scienta.2016.10.015; Lamikanra O, 2004, J SCI FOOD AGR, V84, P1812, DOI 10.1002/jsfa.1891; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Loreto F, 1998, PLANT CELL ENVIRON, V21, P101, DOI 10.1046/j.1365-3040.1998.00268.x; LUNING PA, 1995, J AGR FOOD CHEM, V43, P1493, DOI 10.1021/jf00054a015; Matsui K, 1997, BIOSCI BIOTECH BIOCH, V61, P199, DOI 10.1271/bbb.61.1814; Mazida MM, 2005, J FOOD COMPOS ANAL, V18, P427, DOI 10.1016/j.jfca.2004.02.001; Misran A, 2015, CAN J PLANT SCI, V95, P115, DOI 10.4141/CJPS-2014-245; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Oke M, 2003, FOOD BIOTECHNOL, V17, P163, DOI 10.1081/FBT-120026338; Padmanabhan P., 2019, POSTHARVEST BIOL NAN, P243, DOI [10.1002/9781119289470.ch14, DOI 10.1002/9781119289470.CH14]; PALIYATH G, 1987, PHYSIOL PLANTARUM, V71, P503, DOI 10.1111/j.1399-3054.1987.tb02891.x; Paliyath G, 1999, J AGR FOOD CHEM, V47, P2579, DOI 10.1021/jf981048n; PALIYATH G, 1992, PLANT PHYSIOL BIOCH, V30, P789; Paliyath G., 2003, Patent No. [US6514914B1, 6514914]; Paliyath G., 2019, POSTHARVEST BIOL NAN, P89, DOI [10.1002/9781119289470.ch4, DOI 10.1002/9781119289470.CH4]; Paliyath G., 2007, US patent, Patent No. [7,198-811, 7198811]; Pinhero RG, 2003, PLANT PHYSIOL BIOCH, V41, P223, DOI 10.1016/S0981-9428(03)00014-7; PRETEL MT, 1995, POSTHARVEST BIOL TEC, V5, P295, DOI 10.1016/0925-5214(94)00025-N; SELABUURLAGE MB, 1993, PLANT PHYSIOL, V101, P857, DOI 10.1104/pp.101.3.857; Sharma M, 2010, SCI HORTIC-AMSTERDAM, V125, P239, DOI 10.1016/j.scienta.2010.03.020; Tiwari K, 2011, PLANT PHYSIOL BIOCH, V49, P329, DOI 10.1016/j.plaphy.2011.01.007; Wampler B, 2012, J FOOD SCI, V77, pC677, DOI 10.1111/j.1750-3841.2012.02727.x; Wang JE, 2013, EUR J PLANT PATHOL, V136, P625, DOI 10.1007/s10658-013-0193-8; Wang LB, 2015, LWT-FOOD SCI TECHNOL, V62, P115, DOI 10.1016/j.lwt.2014.12.062; Wang Q, 2016, POSTHARVEST BIOL TEC, V112, P114, DOI 10.1016/j.postharvbio.2015.07.008	43	1	1	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0925-5214	1873-2356		POSTHARVEST BIOL TEC	Postharvest Biol. Technol.	DEC	2020	170								111317	10.1016/j.postharvbio.2020.111317			11	Agronomy; Food Science & Technology; Horticulture	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Food Science & Technology	OG0EQ	WOS:000581569200006					2022-02-06	
J	Pitt, W; Chen, SH; Chou, LS				Pitt, Will; Chen, Szu-Hua; Chou, Li-Shan			Using IMU-based kinematic markers to monitor dual-task gait balance control recovery in acutely concussed individuals	CLINICAL BIOMECHANICS			English	Article						mTBI; Accelerometry; Dual-task; Dynamic balance control	INTER-JOINT COORDINATION; DIVIDED-ATTENTION; STABILITY; ADOLESCENTS; MOBILITY; SINGLE	Background: Concussion may result in acutely impaired dynamic balance control that can persist up to two months post injury. Such impairment has been detected using sophisticated whole body center of mass kinematic metrics derived from camera-based motion analysis under a dual-task paradigm. However, wearable sensor kinematics for describing gait imbalance is lacking. Methods: This study employed a longitudinal design. Gait balance control of acutely concussed and healthy matched control participants was assessed at five post-injury time points (within 72 h of injury, at one week, two weeks, one month, and two months). Tri-axial accelerations and angular velocities were collected with a dual-task gait protocol using an inertial measurement unit placed over the fifth lumbar vertebra. Findings: Eight consistent gait event specific peak accelerations and six peak angular velocities measured by the inertial measurement unit were examined. Peak yaw and roll angular velocities at heel strike and peak roll angular velocities during early single-support, distinguished healthy from concussed participants across the two month post-injury period, while peak vertical acceleration at the end of terminal stance peak medial-lateral acceleration to the right during loading response showed promise. Interpretation: Utilization of peak accelerations and angular velocities collected from a single inertial measurement unit placed over the fifth lumbar vertebra in a divided attention paradigm may offer a clinically feasible method for detecting subtle changes in gait balance control in concussed individuals.	[Pitt, Will; Chen, Szu-Hua; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; [Chou, Li-Shan] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Pitt, Will] Baylor Univ, Keller Army Community Hosp, Div Sports Phys Therapy Fellowship 1, West Point, NY 10963 USA		Chou, LS (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.	chou@iastate.edu			American College of Sports Medicine (ACSM Foundation Doctoral Research Fellowship); Eugene and Clarissa Evonuk Memorial Graduate Fellowship; Shapiro Family Scholarship; Jan Broekhoff Graduate Scholarship	We would like to thank Dr. Craig Davidson and Dr. Christian Stowell for their assistance with participant recruitment. This work was funded in part by the American College of Sports Medicine (ACSM Foundation Doctoral Research Fellowship), the Eugene and Clarissa Evonuk Memorial Graduate Fellowship, the Shapiro Family Scholarship, and the Jan Broekhoff Graduate Scholarship.	Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Chen HL, 2015, J MED BIOL ENG, V35, P28, DOI 10.1007/s40846-015-0002-2; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Esser P, 2009, J BIOMECH, V42, P1578, DOI 10.1016/j.jbiomech.2009.03.049; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Floor-Westerdijk MJ, 2012, IEEE T BIO-MED ENG, V59, P2080, DOI 10.1109/TBME.2012.2197211; Fujimoto M, 2012, J BIOMECH, V45, P543, DOI 10.1016/j.jbiomech.2011.11.037; Gouwanda D, 2015, MED ENG PHYS, V37, P219, DOI 10.1016/j.medengphy.2014.12.004; Hahn ME, 2003, CLIN BIOMECH, V18, P737, DOI 10.1016/S0268-0033(03)00139-6; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2016, J HEAD TRAUMA REHAB, V31, P262, DOI 10.1097/HTR.0000000000000176; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Kavanagh J, 2006, EXP BRAIN RES, V172, P454, DOI 10.1007/s00221-006-0353-6; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pitt W, 2019, GAIT POSTURE, V71, P279, DOI 10.1016/j.gaitpost.2019.05.014; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Weiss A, 2013, NEUROREHAB NEURAL RE, V27, P742, DOI 10.1177/1545968313491004; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869	30	1	1	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	DEC	2020	80								105145	10.1016/j.clinbiomech.2020.105145			7	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	PK3FJ	WOS:000602335100007	32836079				2022-02-06	
J	Purcell, LN; Prin, M; Sincavage, J; Kadyaudzu, C; Phillips, MR; Charles, A				Purcell, Laura N.; Prin, Meghan; Sincavage, John; Kadyaudzu, Clement; Phillips, Michael R.; Charles, Anthony			Outcomes Following Intensive Care Unit Admission in a Pediatric Cohort in Malawi	JOURNAL OF TROPICAL PEDIATRICS			English	Article						pediatric critical care; critical care in LMIC; critical care in resource poorsettings; pediatric critical care in Malawi	GOAL-DIRECTED RESUSCITATION; SEVERE ANEMIA; SEVERE SEPSIS; BLOOD-TRANSFUSION; INCOME COUNTRIES; SEPTIC SHOCK; CHILDREN; MORTALITY; EPIDEMIOLOGY; TRENDS	Introduction: The burden of critical illness in low- and middle-income countries (LMICs) is high; however, there is a paucity of data describing pediatric critical care outcomes in this setting. Methods: We performed a prospective observational study of the pediatric (<= 18 years) intensive care population in Malawi, from August 2016 to May 2018. Data collected include patient demographics and clinical data, admission criteria and outcome. A multivariate Poisson regression was performed to determine risk factors for mortality. Results: Over the study period, 499 patients were admitted to the intensive care unit (ICU) and 105 (21.0%) were children. The average age was 10.6 +/- 6 5.4 years. Primary indications for ICU admission were sepsis (n = 30, 30.3%) and traumatic brain injury (TBI, n = 23, 23.2%). Of those who died, sepsis (n = 18, 32.7%), acute respiratory failure (n = 11, 20.0%) and TBI (n = 11, 20.0%) were the primary admission diagnoses. Overall, ICU mortality was 54.3% (n = 57). Multivariate regression for increased ICU mortality revealed: age <= 5 years [risk ratio (RR) 1.96, 95% CI 1.10-2.26, p < 0.001], hemoglobin < 10 g/dl (RR 1.58, 95% CI 1.08-2.01, p = 0.01) and shock requiring epinephrine support (RR 2.76, 95% CI 1.80-4.23, p < 0.001). Conclusions: Pediatric ICU mortality is high. Predictors of mortality were age <= 5 years, anemia at ICU admission and the need for epinephrine support. Training of pediatric intensive care specialists and increased blood product availability may attenuate the high mortality for critically ill children in Malawi.	[Purcell, Laura N.; Phillips, Michael R.; Charles, Anthony] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA; [Prin, Meghan] Univ Colorado, Dept Anesthesiol, Denver, CO 80045 USA; [Sincavage, John] UNC Project Malawi, Dept Surg, Lilongwe, Malawi; [Kadyaudzu, Clement; Charles, Anthony] Kamuzu Cent Hosp, Dept Anesthesia, Lilongwe, Malawi		Charles, A (corresponding author), Univ North Carolina Chapel Hill, Dept Surg, UNC Sch Med, 4008 Burnett Womack Bldg,CB 7228, Chapel Hill, NC 27599 USA.	anthchar@med.unc.edu					Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Annez PC, 2010, AGENDA RES URBANIZAT, DOI [10.1596/1813-9450-5476, DOI 10.1596/1813-9450-5476]; Austin S, 2014, INTENS CARE MED, V40, P342, DOI 10.1007/s00134-013-3174-7; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baker T, 2009, TROP MED INT HEALTH, V14, P143, DOI 10.1111/j.1365-3156.2008.02202.x; Burns JP, 2014, CRIT CARE MED, V42, P2101, DOI 10.1097/CCM.0000000000000498; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Chihana ML, 2015, JAIDS-J ACQ IMM DEF, V68, P81, DOI 10.1097/QAI.0000000000000405; Dondorp AM, 2016, JAMA-J AM MED ASSOC, V315, P753, DOI 10.1001/jama.2016.0976; Egbohou P, 2019, ANESTHESIOL RES PRAC, V2019, DOI 10.1155/2019/4038319; English M, 2002, LANCET, V359, P494, DOI 10.1016/S0140-6736(02)07666-3; Firth P, 2012, NEW ENGL J MED, V367, P1974, DOI 10.1056/NEJMp1204957; Gallaher JR, 2017, LANCET GLOB HEALTH, V5, pE131, DOI 10.1016/S2214-109X(16)30364-3; Gathara D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-307; Gregson J., 2018, RICHEST COUNTRIES WO; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kanter RK, 1997, PEDIATRICS, V99, P59, DOI 10.1542/peds.99.1.59; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; Kredo T, 2014, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD007331.PUB3; Kumar R, 2019, PEDIATR CRIT CARE ME, V20, pE538, DOI 10.1097/PCC.0000000000002130; Kutko Martha C, 2003, Pediatr Crit Care Med, V4, P333, DOI 10.1097/01.PCC.0000074266.10576.9B; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Murthy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116949; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Okechukwu A A, 2011, Niger J Med, V20, P109; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Polus S, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0002-2; Prin M, 2018, INT J SURG, V60, P60, DOI 10.1016/j.ijsu.2018.10.043; Rosenberg DI, 2004, CRIT CARE MED, V32, P2117, DOI 10.1097/01.CCM.0000142704.36378.E9; Ruth A, 2014, PEDIATR CRIT CARE ME, V15, P828, DOI 10.1097/PCC.0000000000000254; Sands R, 2009, NURS CRIT CARE, V14, P235, DOI 10.1111/j.1478-5153.2009.00348.x; Schlapbach LJ, 2015, LANCET INFECT DIS, V15, P46, DOI 10.1016/S1473-3099(14)71003-5; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Slusher T, 2017, J PEDIATR INTENSIVE, V6, P66, DOI 10.1055/s-0036-1584677; Slusher TM, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00049; The United Nations, 2019, HUMAN DEV REPORTS; UNICEF WHO, COUNTD 2015 DEC REP; US Department of Health and Human Services. National Cancer Institute, COMMON TERMINOLOGY C; van Nassau SC, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00266; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wani AA, 2017, J PEDIATR NEUROSCI, V12, P332, DOI 10.4103/jpn.JPN_80_17; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; World Health Organization,, 2013, POCK HOSP CAR CHILDR, Vsecond 2nd; World Health Organization, 2010, LEV TRENDS CHILD MOR; World Health Organization, 2008, 1 GLOB C TASK SHIFT; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	50	1	1	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	DEC	2020	66	6					621	629		10.1093/tropej/fmaa025			9	Pediatrics; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Tropical Medicine	PQ9EF	WOS:000606844000007	32417909				2022-02-06	
J	Rapoport, K; Mateo, I; Peery, D; Mazaki-Tovi, M; Klainbart, S; Kelmer, E; Ruggeri, M; Shamir, MH; Chai, O				Rapoport, K.; Mateo, I.; Peery, D.; Mazaki-Tovi, M.; Klainbart, S.; Kelmer, E.; Ruggeri, M.; Shamir, M. H.; Chai, O.			The prognostic value of the Koret CT score in dogs following traumatic brain injury	VETERINARY JOURNAL			English	Article						Computed tomography; Dog; Koret CT score; Prognosis; Traumatic brain injury	HEAD TRAUMA; SYSTEM; CLASSIFICATION; PATIENT; SCALE	Traumatic brain injury (TBI) is a common condition in veterinary medicine with relatively high mortality rate. Recently, a study that correlated abnormal computed tomography (CT) findings with outcome in dogs with head trauma established a prognostic scoring system termed Koret CT score (KCTS). The purpose of this study was to evaluate the accuracy of the KCTS in making shortand long-term prognosis in dogs presented within 72 h of TBI. Thirty-five dogs that were admitted to a hospital during 2010-2019 with TBI and were CT-scanned within 72 h of injury were included in the study. Retrospectively collected data included signalment, modified Glasgow Coma Scale score (MGCS), CT findings, and outcome, i.e. short-term (defined as 10 days) and long-term (6 months) survival. CT images were reviewed and the KCTS was calculated for all dogs. Association between KCTS and outcome was examined. A significant negative association was found between KCTS and both shortand long-term survival. The area under receiver operating characteristic curve for KCTS for short- and long-term survival was 0.9 and 0.87, respectively. Furthermore, the probability of survival in the short term was predicated by the KCTS in an almost linear fashion and a score of 3 points or less on the KCTS was associated with survival with 85% sensitivity and 100% specificity. These results validate the prognostic value of the KCTS in dogs with TBI and provide a complementary tool for serial clinical and neurological evaluation. (C) 2020 Elsevier Ltd. All rights reserved.	[Rapoport, K.; Ruggeri, M.; Shamir, M. H.; Chai, O.] Hebrew Univ Jerusalem, Koret Sch Vet Med, Teaching Hosp, Dept Neurol & Neurosug, IL-76100 Rehovot, Israel; [Mateo, I.] Univ Alfonso X El Sabio, Hosp Clin Vet, Dept Neurol, Madrid 28691, Spain; [Peery, D.] Hebrew Univ Jerusalem, Med Teaching Hosp, Koret Sch Vet, Dept Radiol, IL-76100 Rehovot, Israel; [Mazaki-Tovi, M.] Hebrew Univ Jerusalem, Koret Sch Vet Med, Teaching Hosp, Dept Internal Med, IL-76100 Rehovot, Israel; [Klainbart, S.; Kelmer, E.] Hebrew Univ Jerusalem, Teaching Hosp, Koret Sch Vet Med, Dept Emergency & Crit Care, IL-76100 Rehovot, Israel		Rapoport, K (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Teaching Hosp, Dept Neurol & Neurosug, IL-76100 Rehovot, Israel.	kira.rapoport@mail.huji.ac.il			Hebrew University Veterinary Teaching Hospital Clinical Study Fund	This study was supported by a grant from the Hebrew University Veterinary Teaching Hospital Clinical Study Fund.	Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Chai O, 2017, AM J VET RES, V78, P1085, DOI 10.2460/ajvr.78.9.1085; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; Dewey C.W., 2015, PRACTICAL GUIDE CANI, P244; Dewey CW, 2000, VET CLIN N AM-SMALL, V30, P207, DOI 10.1016/S0195-5616(00)50010-2; Dos Santos LO, 2018, VET MED-CZECH, V63, P345, DOI 10.17221/20/2017-VETMED; Giannuzzi AP, 2017, OPEN VET J, V7, P306, DOI 10.4314/ovj.v7i4.3; Hall KE, 2014, JAVMA-J AM VET MED A, V244, P300, DOI 10.2460/javma.244.3.300; Hayes G, 2010, J VET INTERN MED, V24, P1034, DOI 10.1111/j.1939-1676.2010.0552.x; Kolias AG, 2018, CURR TRAUMA REP, V4, P326, DOI 10.1007/s40719-018-0147-x; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; Noh D, 2019, J VET SCI, V20, DOI 10.4142/jvs.2019.20.e10; Pargaonkar R, 2019, J CLIN NEUROSCI, V66, P100, DOI 10.1016/j.jocn.2019.05.011; Platt S., 2008, 33rd World Small Animal Veterinary Association Congress, Dublin, Ireland, 20-24 August 2008, P498; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Simpson SA, 2009, J VET EMERG CRIT CAR, V19, P588, DOI 10.1111/j.1476-4431.2009.00468.x; Sribnick EA, 2019, WEST J EMERG MED, V20, P578, DOI 10.5811/westjem.2019.4.41802; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311; Yanai H, 2015, JAVMA-J AM VET MED A, V246, P1222, DOI 10.2460/javma.246.11.1222	25	1	1	1	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-0233	1532-2971		VET J	Vet. J.	DEC	2020	266								105563	10.1016/j.tvjl.2020.105563			5	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	PK4JQ	WOS:000602413800003	33323172				2022-02-06	
J	Ross, M; Pang, PS; Raslan, AM; Selden, NR; Cetas, JS				Ross, Miner; Pang, Priscilla S.; Raslan, Ahmed M.; Selden, Nathan R.; Cetas, Justin S.			External retrospective validation of Brain Injury Guidelines criteria and modified guidelines for improved care value in the management of patients with low-risk neurotrauma	JOURNAL OF NEUROSURGERY			English	Article						closed head injury; traumatic brain injury; Brain Injury Guidelines; trauma	COMPUTED-TOMOGRAPHY	OBJECTIVE Conventional management of patients with neurotrauma frequently consists of routine, repeat head CT at preordained intervals with ICU-level monitoring, regardless of injury severity. The Brain Injury Guidelines (BIG) are a classification tool for stratifying patients into injury severity and risk-of-progression categories based on presenting clinical and radiographic findings. In the present study, the authors aimed to validate BIG criteria at a single level 1 trauma center. METHODS Patients were classified according to BIG criteria and evaluated for subsequent radiographic progression or development of neurological decline. A 2-year retrospective cohort review of consecutive patients with neurotrauma (n = 590) was undertaken. The authors then developed a modified BIG algorithm for use at their institution and followed its implementation prospectively over 555 consecutive patients. RESULTS In the retrospective analysis, no patient in the BIG 1 category (n = 88, 14.9%) demonstrated progression or neurological decline, and 7.5% of BIG 2 patients (n = 107, 18.1%) demonstrated mild radiographic progression without any decline or need for additional neurosurgical or medical intervention, whereas 15.4% of BIG 3 patients (n = 395, 66.9%) underwent additional neurosurgical procedures. In the prospective analysis, no BIG 1 (n = 105, 18.9%) or BIG 2 (n = 48, 8.6%) patients demonstrated a clinical decline or required any further neurosurgical intervention. By contrast, 12.9% of BIG 3 patients (n = 402, 72%) required immediate neurosurgical intervention, and a further 2.0% required delayed intervention based on clinical and/or radiographic evidence of injury progression. CONCLUSIONS Application of the BIG criteria in a single large level 1 trauma center reliably sorted patients into appropriate risk categories that accurately guided ongoing management.	[Ross, Miner; Pang, Priscilla S.; Raslan, Ahmed M.; Selden, Nathan R.; Cetas, Justin S.] Oregon Hlth & Sci Univ, Neurol Surg, Portland, OR 97201 USA		Cetas, JS (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.	cetasj@ohsu.edu					Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427	6	1	1	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2020	133	6					1880	1885		10.3171/2019.6.JNS19584			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QE5RY	WOS:000616265500002	31703198				2022-02-06	
J	Rosyidi, RM; Priyanto, B; Islam, AA; Hatta, M; Bukhari, A; Prihastomo, KT; Nasution, RA; Rozikin; Prihatina, LM				Rosyidi, Rohadi Muhammad; Priyanto, Bambang; Islam, Andi Asadul; Hatta, Mochammad; Bukhari, Agussalim; Prihastomo, Krisna Tsaniadi; Nasution, Rizha Anshori; Rozikin; Prihatina, Lale Maulin			Role of MLC901 in increasing neurogenesis in rats with traumatic brain injury	ANNALS OF MEDICINE AND SURGERY			English	Article						MLC 901; Neurogenesis; IHC Markers; Synaptophysin; Traumatic brain injury	TRADITIONAL CHINESE MEDICINE; SYNAPTOPHYSIN; EDEMA; CAPE	Background: Traumatic brain injury is a dangerous life threatening condition. This study examines the role of MLC901 in increasing neurogenesis. The aim of this study was to demonstrate the role of MLC901 in increasing neuron cell (neurogenesis) in rat with traumatic brain injury using the synaptophysin marker. Methods: The synaptophysin levels were measured as a marker for neuron cell (neurogenesis) of brain nerve cells in Sprague-Dawley rats aged 10-12 weeks, weighing 200-300 g. All rats (n = 10) were performed as traumatic brain injury using The Modified Marmourou Model, then they were divided into 2 group, one group was given MLC901 (n = 5) and the other group was not given MLC901 (n = 5). The synaptophysin levels in both groups were assessed after 6 weeks and also carried out an examination of immnuhistochemical from the brain tissue of both groups. Results: There was an increase in the number of neuron cells as evidenced by synaptophysin ihc staining in the rats given MLC 901 (Neuroaid II) compared to those without MLC 901. Synaptophysin levels were lower in the control group than in the MLC 901 group (81.6, SD: 13.52 vs 118.4, SD: 12.198, p = 0.062). Conclusion: These research suggest that MLC901 can increase neurogenesis in traumatic brain injury and also appeared as synaptophysin antibody that binding to cytoplasm of neuronal cells in the rat brain.	[Rosyidi, Rohadi Muhammad; Priyanto, Bambang; Islam, Andi Asadul; Hatta, Mochammad; Bukhari, Agussalim] Hasanuddin Univ, Med Fac, Makassar, Indonesia; [Rosyidi, Rohadi Muhammad] Mataram Univ, Med Fac, Dept Neurosurg, West Nusa Tenggara Providence Gen Hosp, Mataram, Indonesia; [Prihastomo, Krisna Tsaniadi] Dr Kariadi Gen Hosp, Med Ctr, Dept Neurosurg, Semarang, Center Java, Indonesia; [Nasution, Rizha Anshori] Pelamonia Hosp, Dept Neurosurg, Makassar, Indonesia; [Rozikin] Al Azhar Islamic Univ, Res Unit, Fac Med, Mataram, Indonesia; [Prihatina, Lale Maulin] Mataram Univ, Med Fac, Mataram, Indonesia		Rosyidi, RM (corresponding author), Mataram Univ, Med Fac, Dept Neurosurg, West Nusa Tenggara Providence Gen Hosp, Mataram, Indonesia.	rha.ns2010@gmail.com	Rosyidi, Rohadi Muhammad/AAC-9249-2021; Hatta, Mochammad/D-3742-2019	Hatta, Mochammad/0000-0002-8456-4203			Al Fauzi A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10020060; Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Branton, 2017, INT J CLIN DEV ANAT, V3, P9, DOI [10.11648/j.ijcda.20170303.11, DOI 10.11648/J.IJCDA.20170303.11]; Cameron HA, 1998, NEUROSCIENCE, V82, P349; Critchley G, 2009, HEAD INJURY: A MULTIDISCIPLINARY APPROACH, P1; Dabbs, 2011, IMMUNOHISTOLOGY META; Dodd, 2009, EXCITOTOXICITY NEURO; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Gordon SL, 2011, J NEUROSCI, V31, P14032, DOI 10.1523/JNEUROSCI.3162-11.2011; Heurteaux C, 2013, CEREBROVASC DIS, V35, P1, DOI 10.1159/000346228; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Kokotos AC, 2019, J NEUROCHEM, V151, P28, DOI 10.1111/jnc.14797; Leary S., 2020, AVMA GUIDELINES EUTH; Lotfus, 2009, NEUROTRAUMA CRITICAL, P3; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Nasution RA, 2020, ANN MED SURG, V57, P328, DOI 10.1016/j.amsu.2020.08.016; Nasution RA, 2020, ANN MED SURG, V57, P118, DOI 10.1016/j.amsu.2020.07.036; Nasution RA, 2020, ANN MED SURG, V57, P109, DOI 10.1016/j.amsu.2020.07.029; Nasution RA, 2020, ANN MED SURG, V54, P89, DOI 10.1016/j.amsu.2020.04.015; Nourian, 2011, STROKE RES TREAT, P1; Perriot A, 2011, PHILOS MAG, V91, P1245, DOI 10.1080/14786435.2010.491808; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Theadom A, 2018, EUR J NEUROL, V25, P1055, DOI 10.1111/ene.13653; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9	27	1	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	DEC	2020	60						36	40		10.1016/j.amsu.2020.10.013			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	PN9DF	WOS:000604772400009	33101671	gold, Green Published			2022-02-06	
J	Seroto, P; Kelly, A; Lekgwara, P				Seroto, Paseka; Kelly, Adrian; Lekgwara, Patrick			Mild traumatic brain injury at a single neurosurgical center in South africa	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Mild traumatic brain injury; South African experience	EPIDEMIOLOGY; CONCUSSION; PROGNOSIS; MORTALITY; OUTCOMES	Background: For several decades mild traumatic brain injury (mTBI) has been increasingly recognized as a distinct clinical entity with its own specific diagnostic criteria and risk of persistent sequelae. Methods: We conducted a retrospective chart review of 228 patients referred to the neurosurgical department at our institution, over a 3-year period, with mTBI. Data collected and analyzed in this study included subject age, gender, mechanism of injury, presenting symptoms, presenting Glasgow Coma Score, presenting CT brain findings, symptoms in subjects who followed-up 1-month post discharge, and symptoms in subjects who followed-up between 1 and 3 months post discharge. Results: Regarding age 108/228 (47%) subjects were 19 to 35-years old, 61/228 (27%) subjects were above 35 years, 46/228 (20%) subjects were 1 to 12-years old, and 13/228 (6%) subjects were 12 to 18-years old. In terms of gender 186/228 (82%) subjects were male and 42/228 (18%) subjects were female. Considering the most common mechanisms of injury 141/228 (62%) subjects reported having been assaulted, 66/228 (29%) subjects reported a fall, and 18/228 (8%) subjects had been involved in a motor vehicle accident. In terms of presentation, 67/228 (29%) subjects reported a history of loss of consciousness, and 62/228 (27%) subjects reported a headache, which were the most common presentations. Considering outcome, at the 1-month post injury out-patient neurosurgical appointment only 100/228 (44%) subjects attended and 128/228 (56%) absconded. Conclusion: Our study supports a loss of consciousness and headache as the most common presentations in mTBI. Our further study finding was that in our environment the majority of patients do not attend their scheduled 1 month out-patient follow-up appointment.	[Seroto, Paseka; Kelly, Adrian; Lekgwara, Patrick] Sefako Makgatho Hlth Sci Univ, Dr George Mukhari Acad Hosp, Dept Neurosurg, POB Medunsa, Pretoria, South Africa		Kelly, A (corresponding author), Sefako Makgatho Hlth Sci Univ, Dr George Mukhari Acad Hosp, Dept Neurosurg, POB Medunsa, Pretoria, South Africa.	adriankelly1000@yahoo.co.uk		Lekgwara, Patrick/0000-0002-2238-8443			Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bradshaw D, 2005, SAMJ S AFR MED J, V95, P496; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; HaarbauerKrupa J, 2016, J NEUROTRAUM, V2-016, P1; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Levin K, 2004, DISABIL REHABIL, V26, P306, DOI 10.1080/0963828032000174089; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McRea M., MILD TRAUMATIC BRAIN; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Ruff RL, 2011, NEUROLOGY, V76, pA161; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Zimmermann LL, 2016, NEUROSURG CLIN N AM, V27, P499, DOI 10.1016/j.nec.2016.06.001	25	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2214-7519		INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2020	22								100869	10.1016/j.inat.2020.100869			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NT4OZ	WOS:000572923500020		gold			2022-02-06	
J	Simpson, AM; Donato, DP; Veith, J; Magno-Padron, D; Agarwal, JP				Simpson, Andrew M.; Donato, Daniel P.; Veith, Jacob; Magno-Padron, David; Agarwal, Jayant P.			Hand and Wrist Injuries Among Collegiate Athletes: The Role of Sex and Competition on Injury Rates and Severity	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						hand injuries; wrist injuries; NCAA; collegiate sport injuries	SURVEILLANCE SYSTEM; DESCRIPTIVE EPIDEMIOLOGY; ASSOCIATION SPORTS; CONTACT INJURIES; SOCCER; CONCUSSION; TIME	Background: There is a high incidence of hand and wrist injuries in athletes participating in collegiate sports, but there is little information published characterizing them. Purpose: To characterize hand and wrist injuries in collegiate athletes using a large national database. Study Design: Descriptive epidemiology study. Methods: This retrospective cross-sectional analysis was designed using data from the National Collegiate Athletic Association (NCAA) Injury Surveillance Program database to identify hand and wrist injuries (exclusive of any radial or ulnar fractures) in male and female collegiate athletes participating in NCAA Division I, II, and III sports from 2004 to 2015. Descriptive analyses were performed on stratified data to examine the associations between these injuries and sport, event type, and sex. Results: Men's ice hockey (8.25 per 10,000 athlete-exposures [AEs]) and women's ice hockey (8.21 per 10,000 AEs) had the highest rate of hand and wrist injuries in all exposures. In every sport except women's gymnastics (P = .107), injuries were more commonly sustained during competition rather than during practice. Ligamentous injury to the phalynx was the most commonly sustained injury overall (1.416 per 10,000 AEs), and a metacarpal fracture was the most commonly sustained hand or wrist fracture (0.507 per 10,000 AEs). Injuries sustained during men's wrestling (14.08 days) and women's gymnastics (10.39 days) incurred the most time lost from sport. Surgery for hand and wrist injuries was most commonly required for men's football (0.413 per 10,000 AEs) and women's field hockey (0.404 per 10,000 AEs). Conclusion: Hand and wrist injuries were common among collegiate athletes. Male athletes experienced injuries with more frequency and severity. Injuries occurred more commonly during competition. While the majority of injuries were minor and did not require surgery, certain sports conferred a much higher risk of significant injuries requiring a surgical intervention.	[Simpson, Andrew M.; Donato, Daniel P.; Veith, Jacob; Magno-Padron, David; Agarwal, Jayant P.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Veith, Jacob; Magno-Padron, David; Agarwal, Jayant P.] Univ Utah, Div Plast & Reconstruct Surg, Dept Surg, 30 North 1900 East,3B400, Salt Lake City, UT 84132 USA; [Simpson, Andrew M.] Western Univ, Div Plast & Reconstruct Surg, Dept Surg, London, ON, Canada; [Donato, Daniel P.] Univ Texas Med Branch, Dept Surg, Div Plast & Reconstruct Surg, Galveston, TX 77555 USA		Veith, J (corresponding author), Univ Utah, Div Plast & Reconstruct Surg, Dept Surg, 30 North 1900 East,3B400, Salt Lake City, UT 84132 USA.	jacob.veith@utah.edu			NCAA	This publication contains materials created, compiled or produced by the Datalys Center for Sports Injury Research and Prevention, Inc. on behalf of the National Collegiate Athletic Association (NCAA). (c) 2020. National Collegiate Athletic Association. All rights reserved. The NCAA Injury Surveillance Program data were provided by the Datalys Centerfor Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Datalys Center or the NCAA. We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA Injury Surveillance Program. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes.	Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2016, CLIN J SPORT MED, V26, P518, DOI 10.1097/JSM.0000000000000290; AMADIO PC, 1990, HAND CLIN, V6, P379; Avery DM, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0432-8; Bowers AL, 2010, AM J SPORT MED, V38, P527, DOI 10.1177/0363546509348754; Bowers AL, 2008, MED SCI SPORT EXER, V40, P2022, DOI 10.1249/MSS.0b013e318182afe3; Cross KM, 2013, AM J SPORT MED, V41, P742, DOI 10.1177/0363546513475342; Dalton SL, 2015, AM J SPORT MED, V43, P2671, DOI 10.1177/0363546515599631; Dick R, 2007, J ATHL TRAINING, V42, P211; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P173; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Fraser MA, 2017, J ATHL TRAINING, V52, P698, DOI 10.4085/1062-6050-52.3.10; Goodman AD, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967117750105; Hibberd EE, 2016, AM J SPORT MED, V44, P2667, DOI 10.1177/0363546516643721; Irick E., NTR; Kay MC, 2017, J ATHL TRAINING, V52, P117, DOI 10.4085/1062-6050-52.1.01; Kerr ZY, 2017, J ATHL TRAINING, V52, P446, DOI 10.4085/1062-6050-52.2.15; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Lievers WB, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115581593; Lynall RC, 2018, J ATHL TRAINING, V53, P938, DOI 10.4085/1062-6050-173-17; NCAA, NTR; Sands WA, 2000, SPORTS MED, V30, P359, DOI 10.2165/00007256-200030050-00004; Tummala SV, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118805400; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	28	1	1	3	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	DEC	2020	8	12							2325967120964622	10.1177/2325967120964622			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	PG6AH	WOS:000599815600001	33403205	Green Published, gold			2022-02-06	
J	Singh, G; Singhal, S; Sharma, S; Paul, BS; Bansal, N; Chaudhary, A; Sharma, S; Bansal, RK; Goraya, JS; Setia, RK; Sander, JW				Singh, Gagandeep; Singhal, Sachi; Sharma, Suman; Paul, Birinder S.; Bansal, Namita; Chaudhary, Anurag; Sharma, Sarit; Bansal, Rajnder K.; Goraya, Jatinder S.; Setia, Raj K.; Sander, Josemir W.			Clinical characteristics of epilepsy in resource-limited communities in Punjab, Northwest India	EPILEPSIA OPEN			English	Article						classification; epileptic syndromes; etiology; perinatal accidents; prevention	ACTIVE CONVULSIVE EPILEPSY; NATIONAL GENERAL-PRACTICE; TANZANIAN CHILDREN; ILAE COMMISSION; RISK-FACTORS; PREVALENCE; CLASSIFICATION; EPIDEMIOLOGY; COMORBIDITY; DEFINITION	ObjectivesTo describe clinical characteristics of a community-based epilepsy cohort from resource-limited communities in Punjab, Northwest India. MethodsThe cohort was gathered following a two-stage screening survey. We cross-sectionally examined and followed up the cohort for one year. A panel of neurologists assigned seizure types, syndromes, and putative etiologies and categorized drug responsiveness. ResultsThe cohort of 240 included 161 (67.1%) men, 109 (45.4%) illiterates and 149 (62.1%) unemployed. Current age was >18 years in 155 (64.6%) but age at epilepsy onset was <18 years in 173 (72.1%). Epilepsies due to structural and metabolic causes were diagnosed in 99 (41.3%), but syndromic assignments were not possible in 97 (40.4%). After one year, drug-resistant epilepsy was established in 74 (30.8%). Perinatal events (n = 35; 14.6%) followed by CNS infections (n = 32; 13.3%) and traumatic brain injury (n = 12; 5.0%) were common risk factors. Most of those with CNS infections (n = 19; 63.3%), perinatal antecedents (n = 23; 76.7%), and other acquired risk factors (n = 27; 90.0%) presented with epilepsy due to structural and metabolic causes. Perinatal events were the putative etiology for nearly 40.7% of generalized epilepsies due to structural and metabolic causes and 28.2% of all epilepsies with onset <10 years. SignificanceExisting classifications schemes should be better suited to field conditions in resource-limited communities in low- and middle-income countries. The finding of drug-resistant epilepsy in nearly at least a third in a community-based sample underscores an unmet need for enhancing services for this segment within healthcare systems. Perinatal events, CNS infections, and head injury account for a third of all epilepsies and hence preventative interventions focusing on these epilepsy risk factors should be stepped up.	[Singh, Gagandeep; Singhal, Sachi; Sharma, Suman; Bansal, Namita] Dayanand Med Coll, Res & Dev Unit, Ludhiana, Punjab, India; [Singh, Gagandeep; Paul, Birinder S.; Bansal, Rajnder K.] Dayanand Med Coll, Dept Neurol, Ludhiana, Punjab, India; [Singh, Gagandeep; Sander, Josemir W.] NIHR Univ Coll London Hosp Biomed Res Ctr, UCL Queen Sq Inst Neurol, London, England; [Chaudhary, Anurag; Sharma, Sarit] Dayanand Med Coll, Dept Social & Prevent Med, Ludhiana, Punjab, India; [Goraya, Jatinder S.] Dayanand Med Coll, Dept Paediat, Ludhiana, Punjab, India; [Setia, Raj K.] Punjab Remote Sensing Ctr, Ludhiana, Punjab, India; [Sander, Josemir W.] Chalfont Ctr Epilepsy, Gerrards Cross, England; [Sander, Josemir W.] Stichting Epilepsie Instellingen Nederland SEIN, Heemstede, Netherlands		Sander, JW (corresponding author), UCL Queen Sq Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England.	l.sander@ucl.ac.uk	Sander, Ley/C-1576-2008	Sander, Ley/0000-0001-6041-9661; Singh, Gagandeep/0000-0001-6661-3553	Ad hoc grant of the Indian Council of Medical Research [5/4-5/127/Neuro/2013-NCD-I]	The study was funded by an Ad hoc grant (no:5/4-5/127/Neuro/2013-NCD-I) of the Indian Council of Medical Research.	[Anonymous], BETTERBIRTH TRIAL WH; [Anonymous], PREVENTION EPILEPSY; Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Bruno E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139108; Burton K, 2012, SEIZURE-EUR J EPILEP, V21, P169, DOI 10.1016/j.seizure.2011.10.011; Burton K, 2011, DEV MED CHILD NEUROL, V53, P1135, DOI 10.1111/j.1469-8749.2011.04109.x; Burton KJ, 2012, EPILEPSIA, V53, P752, DOI 10.1111/j.1528-1167.2011.03395.x; Chawla A, 2020, EPILEPSY BEHAV, V112, DOI 10.1016/j.yebeh.2020.107438; Das M, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0738-8; Del Brutto OH, 2017, J NEUROL SCI, V372, P202, DOI 10.1016/j.jns.2016.11.045; Ding D, 2013, EPILEPSIA, V54, P512, DOI 10.1111/epi.12048; Ding Ding, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P1000; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; Farghaly WMA, 2013, SEIZURE-EUR J EPILEP, V22, P611, DOI 10.1016/j.seizure.2013.04.010; Fisher RS, 2017, EPILEPSIA, V58, P531, DOI 10.1111/epi.13671; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gadhave S, 2015, INDIAN J PEDIATR, V82, P1175, DOI 10.1007/s12098-015-1753-z; Garcia HH, 2016, NEW ENGL J MED, V374, P2335, DOI [10.1056/NEJMoa1515520, 10.1056/NEJMc1609161]; Giussani G, 2016, EPILEPSY BEHAV, V55, P30, DOI 10.1016/j.yebeh.2015.11.021; Hara HS, 2015, NEUROEPIDEMIOLOGY, V45, P273, DOI 10.1159/000438509; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; Kwan P, 2015, EPILEPSIA, V56, P667, DOI 10.1111/epi.12957; Kwan P, 2013, EPILEPSIA, V54, P537, DOI 10.1111/epi.12022; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Mac TL, 2007, LANCET NEUROL, V6, P533, DOI 10.1016/S1474-4422(07)70127-8; MANFORD M, 1992, ARCH NEUROL-CHICAGO, V49, P801, DOI 10.1001/archneur.1992.00530320025008; MANFORD M, 1992, NEUROLOGY, V42, P1911; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Medina MT, 2011, EPILEPSIA, V52, P1177, DOI 10.1111/j.1528-1167.2010.02945.x; Medina MT, 2005, EPILEPSIA, V46, P124, DOI 10.1111/j.0013-9580.2005.11704.x; Munyoki G, 2010, EPILEPSIA, V51, P2370, DOI 10.1111/j.1528-1167.2010.02653.x; Murthy JMK, 2019, EPILEPSY BEHAV, V98, P168, DOI 10.1016/j.yebeh.2019.07.024; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Panagariya A, 2011, J Indian Med Assoc, V109, P14; Panagariya A, 2018, ANN NEUROSCI, V25, P177, DOI 10.1159/000487072; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Semrau KEA, 2017, NEW ENGL J MED, V377, P2313, DOI 10.1056/NEJMoa1701075; Shorvon SD, 2011, EPILEPSIA, V52, P1052, DOI 10.1111/j.1528-1167.2011.03041.x; Singh G, 2020, NAT REV NEUROL, V16, P333, DOI 10.1038/s41582-020-0361-3; Singh G, 2020, EPILEPSY BEHAV, V105, DOI 10.1016/j.yebeh.2020.106949; Singh G, 2020, NEUROLOGY, V94, P165, DOI 10.1212/WNL.0000000000008839; Singh G, 2019, EPILEPSIA OPEN, V4, P264, DOI 10.1002/epi4.12311; Singh G, 2016, EPILEPSY BEHAV, V61, P242, DOI 10.1016/j.yebeh.2016.05.034; Sridharan R, 1999, EPILEPSIA, V40, P631, DOI 10.1111/j.1528-1157.1999.tb05566.x; St Germaine-Smith C, 2011, EPILEPSIA, V52, P2161, DOI 10.1111/j.1528-1167.2011.03292.x; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; Thurman DJ, 2018, EPILEPSIA, V59, P905, DOI 10.1111/epi.14068; Wagner RG, 2014, EPILEPSY RES, V108, P782, DOI 10.1016/j.eplepsyres.2014.01.004; WHO, EP PUBL HLTH IMP	50	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2470-9239		EPILEPSIA OPEN	Epilepsia Open	DEC	2020	5	4					582	595		10.1002/epi4.12439			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ4FP	WOS:000648552900006	33336129	Green Published, gold			2022-02-06	
